PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sharma, V; Nayak, J; DeRossi, C; Charbono, A; Ichikawa, M; Ng, BG; Grajales-Esquivel, E; Srivastava, A; Wang, L; He, P; Scott, DA; Russell, J; Contreras, E; Guess, CM; Krajewski, S; Del Rio-Tsonis, K; Freeze, HH				Sharma, Vandana; Nayak, Jonamani; DeRossi, Charles; Charbono, Adriana; Ichikawa, Mie; Ng, Bobby G.; Grajales-Esquivel, Erika; Srivastava, Anand; Wang, Ling; He, Ping; Scott, David A.; Russell, Joseph; Contreras, Emily; Guess, Cherise M.; Krajewski, Stan; Del Rio-Tsonis, Katia; Freeze, Hudson H.			Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice	FASEB JOURNAL			English	Article						eye defects; congenital disorder of glycosylation; lens; MPI-CDG	6-PHOSPHATE RECEPTORS; CONGENITAL DISORDERS; LENS DEVELOPMENT; TRANSGENIC MICE; GLYCOSYLATION; MOUSE; EYE; DEFICIENCY; GROWTH; METABOLISM	Patients with congenital disorder of glycosylation (CDG), type Ib (MPI-CDG or CDG-Ib) have mutations in phosphomannose isomerase (MPI) that impair glycosylation and lead to stunted growth, liver dysfunction, coagulopathy, hypoglycemia, and intestinal abnormalities. Mannose supplements correct hypoglycosylation and most symptoms by providing mannose-6-P (Man-6-P) via hexokinase. We generated viable Mpi hypomorphic mice with residual enzymatic activity comparable to that of patients, but surprisingly, these mice appeared completely normal except for modest (similar to 15%) embryonic lethality. To overcome this lethality, pregnant dams were provided 1-2% mannose in their drinking water. However, mannose further reduced litter size and survival to weaning by 40 and 66%, respectively. Moreover, similar to 50% of survivors developed eye defects beginning around midgestation. Mannose started at birth also led to eye defects but had no effect when started after eye development was complete. Man-6-P and related metabolites accumulated in the affected adult eye and in developing embryos and placentas. Our results demonstrate that disturbing mannose metabolic flux in mice, especially during embryonic development, induces a highly specific, unanticipated pathological state. It is unknown whether mannose is harmful to human fetuses during gestation; however, mothers who are at risk for having MPI-CDG children and who consume mannose during pregnancy hoping to benefit an affected fetus in utero should be cautious.-Sharma, V., Nayak, J., DeRossi, C., Charbono, A., Ichikawa, M., Ng, B. G., Grajales-Esquivel, E., Srivastava, A., Wang, L., He, P., Scott, D. A., Russell, J., Contreras, E., Guess, C. M., Krajewski, S., Del Rio-Tsonis, K., Freeze, H. H. Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.	[Sharma, Vandana; Nayak, Jonamani; DeRossi, Charles; Charbono, Adriana; Ichikawa, Mie; Ng, Bobby G.; Srivastava, Anand; Wang, Ling; He, Ping; Scott, David A.; Russell, Joseph; Contreras, Emily; Guess, Cherise M.; Krajewski, Stan; Freeze, Hudson H.] SBMRI, La Jolla, CA 92037 USA; [Grajales-Esquivel, Erika; Del Rio-Tsonis, Katia] Miami Univ, Dept Biol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Freeze, HH (corresponding author), SBMRI, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org		Scott, David/0000-0002-8668-2449; Grajales-Esquivel, Erika/0000-0001-8423-416X; Freeze, Hudson/0000-0001-6316-0501	U.S. National Institutes of Health [R01-DK55615]; Children's Heart Fund; Rocket Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615, T32DK007202] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Heart Fund; Rocket Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the U.S. National Institutes of Health (R01-DK55615), the Children's Heart Fund, and the Rocket Fund (to H. H. F.). The authors thank Dr. Peter Westenskow [The Scripps Research Institute (TSRI), La Jolla, CA, USA] for sharing some of the antibodies. The authors also thank Dr. Amanda Roberts (TSRI mouse behavioral assessment core) for providing access to the optic drum. The authors greatly appreciate Guillermina Garcia and Robbin Newlin [Sanford-Burnham Medical Research Institute (SBMRI) histology core facility] for exceptional technical support with histology. The authors thank the SBMRI animal facility staff for setting up the mouse breeding and taking care of the animals and Buddy Charbono for technical support. The authors also acknowledge technical support provided by Jamie Smolin in their laboratory.	ARONSON M, 1979, J INFECT DIS, V139, P329, DOI 10.1093/infdis/139.3.329; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; BOYLE D, 1991, INVEST OPHTH VIS SCI, V32, P1464; BREITMAN ML, 1989, DEVELOPMENT, V106, P457; BUCHANAN T, 1985, J CLIN INVEST, V75, P1927, DOI 10.1172/JCI111908; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Chu J, 2013, DIS MODEL MECH, V6, P95, DOI 10.1242/dmm.010116; Cline A, 2012, MOL BIOL CELL, V23, P4175, DOI 10.1091/mbc.E12-05-0411; COULOMBRE AJ, 1964, J EXP ZOOL, V156, P39, DOI 10.1002/jez.1401560104; COULOMBRE AJ, 1965, EXP EYE RES, V4, P302, DOI 10.1016/S0014-4835(65)80045-8; CROSSLEY JR, 1977, BRIT MED J, V1, P428, DOI 10.1136/bmj.1.6058.428-a; Davis JA, 2002, GLYCOBIOLOGY, V12, P435, DOI 10.1093/glycob/cwf060; Davis JA, 2001, BBA-GEN SUBJECTS, V1528, P116, DOI 10.1016/S0304-4165(01)00183-0; de Lonlay P, 2009, BBA-MOL BASIS DIS, V1792, P841, DOI 10.1016/j.bbadis.2008.11.012; de Lonlay P, 1999, J PEDIATR-US, V135, P379, DOI 10.1016/S0022-3476(99)70139-3; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; DeRossi C, 2006, J BIOL CHEM, V281, P5916, DOI 10.1074/jbc.M511982200; Donthi Rajakumar V., 2007, V139, P151; DVORNIK D, 1973, SCIENCE, V182, P1146, DOI 10.1126/science.182.4117.1146; GENISGAL.JM, 1966, NATURE, V210, P209, DOI 10.1038/210209a0; GITZELMANN R, 1967, EXP EYE RES, V6, P1, DOI 10.1016/S0014-4835(67)80047-2; GRACY RW, 1968, J BIOL CHEM, V243, P3161; Halket JM, 2003, EUR J MASS SPECTROM, V9, P1, DOI 10.1255/ejms.527; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; JACKSON D, 1994, SCIENCE, V266, P1581, DOI 10.1126/science.7527157; KINOSHITA JIN H., 1965, INVEST OPHTHALMOL, V4, P786; Kranjcec B, 2014, WORLD J UROL, V32, P79, DOI 10.1007/s00345-013-1091-6; LEE SJ, 1988, J BIOL CHEM, V263, P3521; Li QX, 1997, DEV BIOL, V181, P257, DOI 10.1006/dbio.1996.8444; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Marklova E, 2007, CLIN CHIM ACTA, V385, P6, DOI 10.1016/j.cca.2007.07.002; MATZNER U, 1992, DEVELOPMENT, V114, P965; Michelakakis H, 2009, CLIN CHIM ACTA, V401, P81, DOI 10.1016/j.cca.2008.11.024; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Price NPJ, 2004, ANAL CHEM, V76, P6566, DOI 10.1021/ac049198m; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Schneider A, 2012, NAT MED, V18, P71, DOI 10.1038/nm.2548; Sharma V, 2011, J BIOL CHEM, V286, P39431, DOI 10.1074/jbc.M111.285502; Sharma V, 2011, J BIOL CHEM, V286, P10193, DOI 10.1074/jbc.M110.194241; SOLS A, 1960, SCIENCE, V131, P297, DOI 10.1126/science.131.3396.297; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; VARMA SD, 1979, INVEST OPHTH VIS SCI, V18, P236; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Wilt SD, 1999, EXP EYE RES, V69, P405, DOI 10.1006/exer.1999.0714; Yamamoto Y, 2000, SCIENCE, V289, P631, DOI 10.1126/science.289.5479.631; Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009	49	16	16	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1854	1869		10.1096/fj.13-245514	http://dx.doi.org/10.1096/fj.13-245514			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24421398	Green Published			2022-12-25	WOS:000335344300030
J	Mantilidewi, KI; Murata, Y; Mori, M; Otsubo, C; Kotani, T; Kusakari, S; Ohnishi, H; Matozaki, T				Mantilidewi, Kemala Isnainiasih; Murata, Yoji; Mori, Munemasa; Otsubo, Chihiro; Kotani, Takenori; Kusakari, Shinya; Ohnishi, Hiroshi; Matozaki, Takashi			Shear Stress-induced Redistribution of Vascular Endothelial-Protein-tyrosine Phosphatase (VE-PTP) in Endothelial Cells and Its Role in Cell Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Membrane Proteins; Shear Stress; Small GTPases; Protein-tyrosine Phosphatase (Tyrosine Phosphatase)	VEGFR2 ACTIVITY; CDC42; INTEGRINS; ACTIVATION; MIGRATION; RESPONSES; GTPASES; RHO; PHOSPHORYLATION; REORGANIZATION	Background: Mechanical stimuli such as shear stress regulate endothelial cell (EC) function. Results: Shear stress induced a rapid redistribution of the protein-tyrosine phosphatase VE-PTP in ECs, and knockdown of VE-PTP prevented shear stress-induced EC elongation. Conclusion: VE-PTP is important for shear stress-induced changes in EC morphology. Significance: VE-PTP is implicated in regulation of EC function by shear stress. Vascular endothelial cells (ECs) are continuously exposed to shear stress (SS) generated by blood flow. Such stress plays a key role in regulation of various aspects of EC function including cell proliferation and motility as well as changes in cell morphology. Vascular endothelial-protein-tyrosine phosphatase (VE-PTP) is an R3-subtype PTP that possesses multiple fibronectin type III-like domains in its extracellular region and is expressed specifically in ECs. The role of VE-PTP in EC responses to SS has remained unknown, however. Here we show that VE-PTP is diffusely localized in ECs maintained under static culture conditions, whereas it undergoes rapid accumulation at the downstream edge of the cells relative to the direction of flow in response to SS. This redistribution of VE-PTP triggered by SS was found to require its extracellular and transmembrane regions and was promoted by integrin engagement of extracellular matrix ligands. Inhibition of actin polymerization or of Cdc42, Rab5, or Arf6 activities attenuated the SS-induced redistribution of VE-PTP. VE-PTP also underwent endocytosis in the static and SS conditions. SS induced the polarized distribution of internalized VE-PTP. Such an effect was promoted by integrin engagement of fibronectin but prevented by inhibition of Cdc42 activity or of actin polymerization. In addition, depletion of VE-PTP by RNA interference in human umbilical vein ECs blocked cell elongation in the direction of flow induced by SS. Our results suggest that the polarized redistribution of VE-PTP in response to SS plays an important role in the regulation of EC function by blood flow.	[Mantilidewi, Kemala Isnainiasih; Murata, Yoji; Otsubo, Chihiro; Kotani, Takenori; Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Mori, Munemasa; Kusakari, Shinya; Matozaki, Takashi] Gunma Univ, Inst Mol & Cellular Regulat, Lab Biosignal Sci, Maebashi, Gunma 3718512, Japan; [Ohnishi, Hiroshi] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gunma 3718514, Japan	Kobe University; Gunma University; Gunma University	Murata, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ymurata@med.kobe-u.ac.jp; matozaki@med.kobe-u.ac.jp		Murata, Yoji/0000-0002-9576-7030; Mori, Munemasa/0000-0002-7283-7198; Kotani, Takenori/0000-0001-8571-4210; Mantilidewi, Kemala/0000-0003-4588-8018	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Scientific Research (B) and (C), a grant-in-aid for Scientific Research on Innovative Areas, and a grant to the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; ANDO J, 1993, BIOCHEM BIOPH RES CO, V190, P716, DOI 10.1006/bbrc.1993.1108; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; BARBEE KA, 1994, CIRC RES, V74, P163, DOI 10.1161/01.RES.74.1.163; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davies PF, 1995, J BIOMECH, V28, P1553, DOI 10.1016/0021-9290(95)00102-6; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Fisslthaler B, 2008, CIRC RES, V102, P1520, DOI 10.1161/CIRCRESAHA.108.172072; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; KAMIYA A, 1984, B MATH BIOL, V46, P127, DOI 10.1016/S0092-8240(84)80038-5; Kotani T, 2010, J COMP NEUROL, V518, P119, DOI 10.1002/cne.22239; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Kusakari S, 2008, J CELL SCI, V121, P1213, DOI 10.1242/jcs.025015; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Miyake A, 2008, GENES CELLS, V13, P209, DOI 10.1111/j.1365-2443.2007.01161.x; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Mori M, 2010, J CELL PHYSIOL, V224, P195, DOI 10.1002/jcp.22122; Murata Y, 2010, GENES CELLS, V15, P513, DOI 10.1111/j.1365-2443.2010.01398.x; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Orlando K., 2009, COLD SPRING HARB PER, V1; Potter BA, 2006, TRAFFIC, V7, P146, DOI 10.1111/j.1600-0854.2005.00371.x; Sadakata H, 2009, GENES CELLS, V14, P295, DOI 10.1111/j.1365-2443.2008.01270.x; Stamatas GN, 1997, TISSUE ENG, V3, P391, DOI 10.1089/ten.1997.3.391; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tai LK, 2002, ARTERIOSCL THROM VAS, V22, P1790, DOI 10.1161/01.ATV.0000034475.40227.40; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135	46	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6451	6461		10.1074/jbc.M113.529503	http://dx.doi.org/10.1074/jbc.M113.529503			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451369	Green Published, hybrid			2022-12-25	WOS:000332389400013
J	Nasirikenari, M; Veillon, L; Collins, CC; Azadi, P; Lau, JTY				Nasirikenari, Mehrab; Veillon, Lucas; Collins, Christine C.; Azadi, Parastoo; Lau, Joseph T. Y.			Remodeling of Marrow Hematopoietic Stem and Progenitor Cells by Non-self ST6Gal-1 Sialyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosylation; Hematopoiesis; Plasma; Serum; Sialic Acid; Sialyltransferase; Hematopoietic Stem and Progenitor Cells; st6gal1	DROSOPHILA-MELANOGASTER EMBRYO; E-SELECTIN LIGAND; DEATH RECEPTOR; BREAST-CANCER; P1 PROMOTER; INFLAMMATION; SIALYLATION; EXPRESSION; MICE; GLYCOPROTEINS	Background: The circulatory ST6Gal-1 level is inversely related to hematopoietic activity, but the biochemical function of systemic ST6Gal-1 is unknown. Results: Hematopoietic progenitors do not express self-ST6Gal-1 but are acted upon by remotely produced enzyme. Conclusion: Distally produced rather than endogenous ST6Gal-1 is the principal modifier of the early hematopoietic progenitor cell surface. Significance: Extrinsic ST6Gal-1 may be a potent systemic regulator of hematopoiesis. Glycans occupy the critical cell surface interface between hematopoietic cells and their marrow niches. Typically, glycosyltransferases reside within the intracellular secretory apparatus, and each cell autonomously generates its own cell surface glycans. In this study, we report an alternate pathway to generate cell surface glycans where remotely produced glycosyltransferases remodel surfaces of target cells and for which endogenous expression of the cognate enzymes is not required. Our data show that extracellular ST6Gal-1 sialyltransferase, originating mostly from the liver and released into circulation, targets marrow hematopoietic stem and progenitor cells (HSPCs) and mediates the formation of cell surface 2,6-linked sialic acids on HSPCs as assessed by binding to the specific lectins Sambucus nigra agglutinin and Polysporus squamosus lectin and confirmed by mass spectrometry. Marrow HSPCs, operationally defined as the Lin-c-Kit+ and Lin-Sca-1+c-Kit+ populations, express negligible endogenous ST6Gal-1. Animals with reduced circulatory ST6Gal-1 have marrow Lin-Sca-1+c-Kit+ cells with reduced S. nigra agglutinin reactivity. Bone marrow chimeras demonstrated that 2,6-sialylation of HSPCs is profoundly dependent on circulatory ST6Gal-1 status of the recipients and independent of the ability of HSPCs to express endogenous ST6Gal-1. Biologically, HSPC abundance in the marrow is inversely related to circulatory ST6Gal-1 status, and this relationship is recapitulated in the bone marrow chimeras. We propose that remotely produced, rather than the endogenously expressed, ST6Gal-1 is the principal modifier of HSPC glycans for 2,6-sialic acids. In so doing, liver-produced ST6Gal-1 may be a potent systemic regulator of hematopoiesis.	[Nasirikenari, Mehrab; Lau, Joseph T. Y.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Veillon, Lucas; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Veillon, Lucas; Azadi, Parastoo] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Roswell Park Cancer Institute; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lau, JTY (corresponding author), Roswell Pk Canc Inst, MRC 330,Elm & Carlton Sts, Buffalo, NY 14263 USA.	joseph.lau@roswellpark.org			National Cancer Institute Cancer Center Support Grant [CA15056]; National Institutes of Health/National Center for Research Resources [8P41GM103490]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The core facilities of Roswell Park Cancer Institute used in this work were supported in part by National Cancer Institute Cancer Center Support Grant CA15056. Glycomics analysis was supported by National Institutes of Health/National Center for Research Resources Grant 8P41GM103490 to the Complex Carbohydrate Research Center, University of Georgia.	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Appenheimer MM, 2003, GLYCOBIOLOGY, V13, P591, DOI 10.1093/glycob/cwg066; Arata-Kawai H, 2011, AM J PATHOL, V178, P423, DOI 10.1016/j.ajpath.2010.11.009; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; BERGE PG, 1982, KLIN WOCHENSCHR, V60, P445, DOI 10.1007/BF01720358; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hu YP, 1997, GLYCOCONJUGATE J, V14, P407, DOI 10.1023/A:1018535014976; Hui N, 2001, J HEMATOTH STEM CELL, V10, P661, DOI 10.1089/152581601753193878; Ilarregui JM, 2005, ANN RHEUM DIS, V64, P96, DOI 10.1136/ard.2005.044347; JAMIESON JC, 1987, COMP BIOCHEM PHYS B, V87, P11, DOI 10.1016/0305-0491(87)90463-9; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kobayashi M, 2012, SEMIN IMMUNOPATHOL, V34, P401, DOI 10.1007/s00281-012-0302-3; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2010, J LEUKOCYTE BIOL, V87, P457, DOI 10.1189/jlb.1108704; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seppo A, 2000, EUR J BIOCHEM, V267, P3549, DOI 10.1046/j.1432-1327.2000.01383.x; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Stubke K, 2012, CANCER LETT, V321, P89, DOI 10.1016/j.canlet.2012.02.019; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Toma V, 2001, HISTOCHEM CELL BIOL, V116, P183; Wandall HH, 2012, BLOOD, V120, P626, DOI 10.1182/blood-2012-02-409235; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; WANG XC, 1990, J BIOL CHEM, V265, P17849; WEISER MM, 1981, CRC CR REV CL LAB SC, V14, P189, DOI 10.3109/10408368109105864; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826	41	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7178	7189		10.1074/jbc.M113.508457	http://dx.doi.org/10.1074/jbc.M113.508457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425878	hybrid, Green Published			2022-12-25	WOS:000332389400076
J	Xu, JX; Si, M; Zhang, HR; Chen, XJ; Zhang, XD; Wang, C; Du, XN; Zhang, HL				Xu, Jia-Xi; Si, Man; Zhang, Hui-Ran; Chen, Xing-Juan; Zhang, Xi-Dong; Wang, Chuan; Du, Xiao-Na; Zhang, Hai-Lin			Phosphoinositide Kinases Play Key Roles in Norepinephrine- and Angiotensin II-induced Increase in Phosphatidylinositol 4,5-Bisphosphate and Modulation of Cardiac Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Hypertrophy; G Protein-coupled Receptors (GPCR); Phosphatidylinositol Kinase; Phospholipid Metabolism; Signal Transduction	HEART-FAILURE; PHOSPHOLIPASE-C; SIGNAL-TRANSDUCTION; PANCREAS SLICES; GENE-EXPRESSION; PIP2; HYPERTROPHY; CARDIOMYOCYTES; MECHANISMS; INHIBITION	Background: The mechanism and significance of phosphoinositide metabolism during heart stress stimulations are not clear. Results: Norepinephrine and angiotensin II increase cardiac phosphatidylinositol 4,5-bisphosphate levels via an enhanced interaction between phosphatidylinositol 4-kinase III and PKC, which correlate with a maintained systolic function. Conclusion: Cardiac phosphoinositide turnover is enhanced. Significance: A novel mechanism of phosphoinositide metabolism is described for modulation of cardiac function. The seemly paradoxical G(q) agonist-stimulated phosphoinositide production has long been known, but the underlying mechanism and its physiological significance are not known. In this study, we studied cardiac phosphoinositide levels in both cells and whole animals under the stimulation of norepinephrine (NE), angiotensin II (Ang II), and other physiologically relevant interventions. The results demonstrated that activation of membrane receptors related to NE or Ang II caused an initial increase and a later fall in phosphatidylinositol 4,5-bisphosphate (PIP2) levels in the primary cultured cardiomyocytes from adult rats. The possible mechanism underlying this increase in PIP2 was found to be through an enhanced activity of phosphatidylinositol 4-kinase III, which was mediated by an up-regulated interaction between phosphatidylinositol 4-kinase III and PKC; the increased activity of phosphatidylinositol 4-phosphate 5-kinase was also involved for NE-induced increase of PIP2. When the systolic functions of the NE/Ang II-treated cells were measured, a maintained or failed contractility was found to be correlated with a rise or fall in corresponding PIP2 levels. In two animal models of cardiac hypertrophy, PIP2 levels were significantly reduced in hypertrophic hearts induced by isoprenaline but not in those induced by swimming exercise. This study describes a novel mechanism for phosphoinositide metabolism and modulation of cardiac function.	Hebei Med Univ, Key Lab Neural & Vasc Biol, Minist Educ, Shijiazhuang 050017, Hebei, Peoples R China; Hebei Med Univ, Key Lab New Drug Pharmacol & Toxicol, Shijiazhuang 050017, Hebei, Peoples R China; [Zhang, Hai-Lin] Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Zhang, HL (corresponding author), Hebei Med Univ, Dept Pharmacol, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China.	zhanghl@hebmu.edu.cn	Xu, Jiaxi/N-3532-2018; xu, jia/GSD-6347-2022	Xu, Jiaxi/0000-0002-0694-813X	National Natural Science Foundation of China [31270882]; National Basic Research Program of China [2013CB531302]; NATIONAL EYE INSTITUTE [R01EY013147, R01EY018417] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work supported by National Natural Science Foundation of China Grant 31270882 (to H.Z.) and National Basic Research Program of China Grant 2013CB531302 (to H.Z.).	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659; Chen XJ, 2011, J BIOL CHEM, V286, P39760, DOI 10.1074/jbc.M111.289090; Cho H, 2005, P NATL ACAD SCI USA, V102, P4643, DOI 10.1073/pnas.0408844102; Cho H, 2006, MOL CELLS, V22, P97; Clayton EL, 2013, MOL NEUROBIOL, V47, P361, DOI 10.1007/s12035-012-8358-6; Clerk A, 1999, AM J CARDIOL, V83, p64H; Colucci WS, 1998, CLIN CARDIOL, V21, P20, DOI 10.1002/clc.4960211305; Dent MR, 2006, J CELL MOL MED, V10, P470, DOI 10.1111/j.1582-4934.2006.tb00412.x; Ding WG, 2004, J BIOL CHEM, V279, P50726, DOI 10.1074/jbc.M409374200; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann DW, 2007, PFLUG ARCH EUR J PHY, V455, P55, DOI 10.1007/s00424-007-0280-9; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; HOKIN LE, 1967, J CELL BIOL, V33, P521, DOI 10.1083/jcb.33.3.521; HOKIN LE, 1956, CAN J BIOCHEM PHYS, V34, P349; HOKIN LE, 1955, BIOCHIM BIOPHYS ACTA, V18, P102, DOI 10.1016/0006-3002(55)90013-5; Howes AL, 2003, J BIOL CHEM, V278, P40343, DOI 10.1074/jbc.M305964200; Jalili T, 1999, CARDIOVASC RES, V44, P5, DOI 10.1016/S0008-6363(99)00211-4; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mellman DL, 2009, ADV ENZYME REGUL, V49, P11, DOI 10.1016/j.advenzreg.2009.01.007; Min L, 2000, REGUL PEPTIDES, V95, P93, DOI 10.1016/S0167-0115(00)00162-2; Minogue Shane, 2012, Subcell Biochem, V58, P1, DOI 10.1007/978-94-007-3012-0_1; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Nicolas CS, 2008, CARDIOVASC RES, V79, P427, DOI 10.1093/cvr/cvn085; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Prasad SVN, 2003, TRENDS CARDIOVAS MED, V13, P206, DOI 10.1016/S1050-1738(03)00080-X; Rajala RVS, 2010, EXP EYE RES, V91, P324, DOI 10.1016/j.exer.2010.05.001; Singal T, 2006, J MOL CELL CARDIOL, V41, P126, DOI 10.1016/j.yjmcc.2006.03.004; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; SINGHAL RL, 1994, CANCER RES, V54, P5574; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vanamala SK, 2009, BIOCHEM BIOPH RES CO, V386, P386, DOI 10.1016/j.bbrc.2009.05.151; Wang Yibin, 2001, Current Opinion in Pharmacology, V1, P134, DOI 10.1016/S1471-4892(01)00029-7; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Yaradanakul A, 2007, J PHYSIOL-LONDON, V582, P991, DOI 10.1113/jphysiol.2007.132712; Yue JC, 2001, J BIOL CHEM, V276, P49093, DOI 10.1074/jbc.M101328200; Zhang X, 2010, J BIOL CHEM, V285, P9402, DOI 10.1074/jbc.M109.068205	50	10	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6941	6948		10.1074/jbc.M113.527952	http://dx.doi.org/10.1074/jbc.M113.527952			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24448808	hybrid, Green Published			2022-12-25	WOS:000332389400054
J	Ascioglu, S; Chan, KA				Ascioglu, Sibel; Chan, K. Arnold			Utilization and Comparative Effectiveness of Caspofungin and Voriconazole Early after Market Approval in the US	PLOS ONE			English	Article							EMPIRICAL ANTIFUNGAL THERAPY; LIPOSOMAL AMPHOTERICIN-B; OFF-LABEL; FUNGAL-INFECTIONS; PROPENSITY SCORE; ASPERGILLOSIS	Objectives: Both caspofungin and voriconazole were initially approved by the FDA with very narrow indications. Our aim was to evaluate the utilization patterns and comparative effectiveness of these agents early after marketing before any labeling change occurred. Methods: This was a retrospective cohort study utilizing a large healthcare database in the United States. Patients who received at least one dose of systemic antifungal agent between the years 2001 and 2003 were included. Information was available for each hospital-day including underlying conditions, medications, procedures and disease severity scores. Tests for proportions, trend tests and logistic regression were used for evaluation of utilization. Propensity score analysis was used in comparison of mortality. Results: The study cohort included 381,245 patients with serious underlying conditions. In just two years after marketing, caspofungin and voriconazole use increased to 40% of the total systemic antifungal consumption. However, only 3.4% of caspofungin and 12.5% of voriconazole were used as indicated in labeling. In the propensity score analyses, caspofungin was associated with 7% decrease in mortality (OR: 0.93 95% CI: 0.85-0.98). Voriconazole use was not found to be associated with mortality (OR: 1.95% CI: 0.89-1.12) Conclusions: Caspofungin and voriconazole were mostly used of unapproved indications immediately after their marketing. Although unapproved drug use might be due to a crucial need by clinicians, this may create problems in further antifungal drug development. Our results suggest a survival benefit with caspofungin; however, similar comparative effectiveness studies must be repeated using more recent data.	[Ascioglu, Sibel; Chan, K. Arnold] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Ascioglu, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	ascioglu@hacettepe.edu.tr		Chan, Kinwei/0000-0001-8161-1986	Pharmacoepidemiology Program at Harvard School of Public Health; Pfizer; Novartis; Aventis; Weyth	Pharmacoepidemiology Program at Harvard School of Public Health; Pfizer(Pfizer); Novartis(Novartis); Aventis(Sanofi-Aventis); Weyth	The study was supported by the Pharmacoepidemiology Program at Harvard School of Public Health, which received unrestricted donations from the following pharmaceutical companies for education and training purpose (Pfizer, Novartis, Aventis and Weyth). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averill R, 2003, WHAT ARE APR DRGS IN; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; BINDSCHADLER DD, 1969, J INFECT DIS, V120, P427, DOI 10.1093/infdis/120.4.427; Dai CL, 2005, ARCH INTERN MED, V165, P171, DOI 10.1001/archinte.165.2.171; Dasbach EJ, 2000, CLIN INFECT DIS, V31, P1524, DOI 10.1086/317487; de With Katja, 2005, BMC Clin Pharmacol, V5, P1; Fanaroff AA, 2006, PEDIATRICS, V117, P214, DOI 10.1542/peds.2005-2183; GRASELA TH, 1994, ANN PHARMACOTHER, V28, P252, DOI 10.1177/106002809402800219; Gutierrez F, 1996, J ANTIMICROB CHEMOTH, V37, P175, DOI 10.1093/jac/37.1.175; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Largent EA, 2009, ARCH INTERN MED, V169, P1745, DOI 10.1001/archinternmed.2009.314; Lortholary O, 2004, J ANTIMICROB CHEMOTH, V54, P456, DOI 10.1093/jac/dkh348; Maertens J, 2006, INT J ANTIMICROB AG, V27, P457, DOI 10.1016/j.ijantimicag.2006.03.019; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; Prasad PA, 2008, PEDIATR INFECT DIS J, V27, P1083, DOI 10.1097/INF.0b013e31817eeee5; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Rex JH, 2001, CLIN INFECT DIS, V33, P95, DOI 10.1086/320876; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Sipsas NV, 2009, CANCER-AM CANCER SOC, V115, P4745, DOI 10.1002/cncr.24507; Sobel JD, 2007, NEW ENGL J MED, V356, P2525, DOI 10.1056/NEJMe078078; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Walsh TJ, 2002, NEW ENGL J MED, V346, P1499; Walsh TJ, 2004, NEW ENGL J MED, V351, P1391, DOI 10.1056/NEJMoa040446; Walsh TJ, 2002, NEW ENGL J MED, V346, P225, DOI 10.1056/NEJM200201243460403; Westreich D, 2010, PHARMACOEPIDEM DR S; Wynn BO, 2007, RAND HLTH WORKING PA	32	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83658	10.1371/journal.pone.0083658	http://dx.doi.org/10.1371/journal.pone.0083658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427277	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200017
J	Minami, A; Otsubo, T; Ieno, D; Ikeda, K; Kanazawa, H; Shimizu, K; Ohata, K; Yokochi, T; Horii, Y; Fukumoto, H; Taguchi, R; Takahashi, T; Oku, N; Suzuki, T				Minami, Akira; Otsubo, Tadamune; Ieno, Daisuke; Ikeda, Kiyoshi; Kanazawa, Hiroaki; Shimizu, Kosuke; Ohata, Ko; Yokochi, Tsunehiro; Horii, Yuuki; Fukumoto, Hokuto; Taguchi, Risa; Takahashi, Tadanobu; Oku, Naoto; Suzuki, Takashi			Visualization of Sialidase Activity in Mammalian Tissues and Cancer Detection with a Novel Fluorescent Sialidase Substrate	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; PLASMA-MEMBRANE; LYSOSOMAL SIALIDASE; COLON-CANCER; EXPRESSION; CELLS; BRAIN; ACID; NEU3; 2-ARYLBENZOTHIAZOLES	Sialidase removes sialic acid from sialoglycoconjugates and plays crucial roles in many physiological and pathological processes. Various human cancers express an abnormally high level of the plasma membrane-associated sialidase isoform. Visualization of sialidase activity in living mammalian tissues would be useful not only for understanding sialidase functions but also for cancer diagnosis. However, since enzyme activity of mammalian sialidase is remarkably weak compared with that of bacterial and viral sialidases, it has been difficult to detect sialidase activity in mammalian tissues. We synthesized a novel benzothiazolylphenol-based sialic acid derivative (BTP-Neu5Ac) as a fluorescent sialidase substrate. BTP-Neu5Ac can visualize sialidase activities sensitively and selectively in acute rat brain slices. Cancer cells implanted orthotopically in mouse colons and human colon cancers (stages T3-T4) were also clearly detected with BTP-Neu5Ac. The results suggest that BTP-Neu5Ac is useful for histochemical imaging of sialidase activities.	[Minami, Akira; Ieno, Daisuke; Horii, Yuuki; Fukumoto, Hokuto; Taguchi, Risa; Takahashi, Tadanobu; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, Hiroshima, Japan; [Kanazawa, Hiroaki] Univ Shizuoka, Sch Nursing, Dept Funct Anat, Shizuoka 4228526, Japan; [Shimizu, Kosuke; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka 4228526, Japan; [Ohata, Ko] Shizuoka Prefectural Gen Hosp, Dept Gastroenterol Surg, Shizuoka, Japan; [Yokochi, Tsunehiro] Shizuoka Prefectural Gen Hosp, Dept Med Technol, Shizuoka, Japan	University of Shizuoka; University of Shizuoka; University of Shizuoka; Shizuoka General Hospital; Shizuoka General Hospital	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp		Otsubo, Tadamune/0000-0003-1949-9780; Shimizu, Kosuke/0000-0003-3789-2447	KAKENHI [24790080]; Sasakawa Scientific Research Grant from the Japan Science Society; Naito Foundation; Grants-in-Aid for Scientific Research [23590549, 24790080] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sasakawa Scientific Research Grant from the Japan Science Society; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Young Scientists (B) (KAKENHI; no. 24790080), The Sasakawa Scientific Research Grant from the Japan Science Society and The Naito Foundation Subsidy for Promotion of Specific Research Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY K, 1984, J CHEM SOC PERK T 2, P2111, DOI 10.1039/p29840002111; Azarifar D, 2009, PHOSPHORUS SULFUR, V184, P2097, DOI 10.1080/10426500802423933; Deligeorgiev TG, 2010, PHOSPHORUS SULFUR, V185, P2292, DOI 10.1080/10426501003598648; Du ZY, 2010, BBA-MOL CELL BIOL L, V1801, P526, DOI 10.1016/j.bbalip.2010.01.002; Friedland S, 2005, GASTROINTEST ENDOSC, V61, P395, DOI 10.1016/S0016-5107(04)02775-0; Fujii I, 1993, Bioorg Med Chem, V1, P147, DOI 10.1016/S0968-0896(00)82112-4; Ha KT, 2004, MOL CELLS, V17, P267; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kiernan JA, 2007, BIOTECH HISTOCHEM, V82, P73, DOI 10.1080/10520290701375278; Koda T, 2009, BIOCHEM BIOPH RES CO, V387, P729, DOI 10.1016/j.bbrc.2009.07.100; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Marmillot P, 1999, ALCOHOL CLIN EXP RES, V23, P376, DOI 10.1097/00000374-199902000-00027; Minami A, 2012, TRENDS GLYCOSCI GLYC, V24, P112, DOI 10.4052/tigg.24.112; Minami A, 2011, NEUROIMAGE, V58, P34, DOI 10.1016/j.neuroimage.2011.06.017; MIYAGI T, 1984, EUR J BIOCHEM, V141, P75, DOI 10.1111/j.1432-1033.1984.tb08159.x; Miyagi T, 2012, ADV EXP MED BIOL, V749, P257, DOI 10.1007/978-1-4614-3381-1_17; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Nomura H, 2006, ONCOL RES, V16, P289, DOI 10.3727/000000006783981035; Oku N, 2011, INT J PHARMACEUT, V403, P170, DOI 10.1016/j.ijpharm.2010.10.001; Otsubo T, 2013, BIOORG MED CHEM LETT, V23, P2245, DOI 10.1016/j.bmcl.2013.01.043; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Saito M, 2002, HISTOCHEM CELL BIOL, V117, P453, DOI 10.1007/s00418-002-0399-x; SAITO M, 1993, J NEUROSCI RES, V36, P127, DOI 10.1002/jnr.490360203; Santra M, 2011, ORG LETT, V13, P3422, DOI 10.1021/ol2011693; Sawada M, 2002, INT J CANCER, V97, P180, DOI 10.1002/ijc.1598; Sun W, 2012, TETRAHEDRON LETT, V53, P2332, DOI 10.1016/j.tetlet.2012.02.098; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Takahashi T, 2004, CANCER SCI, V95, P514, DOI 10.1111/j.1349-7006.2004.tb03242.x; Urano Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002823; Urano Y, 2009, NAT MED, V15, P104, DOI 10.1038/nm.1854	31	42	42	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e81941	10.1371/journal.pone.0081941	http://dx.doi.org/10.1371/journal.pone.0081941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427265	Green Submitted, Green Published, gold			2022-12-25	WOS:000329868200005
J	Molnar, PK; Lewis, MA; Derocher, AE				Molnar, Peter K.; Lewis, Mark A.; Derocher, Andrew E.			Estimating Allee Dynamics before They Can Be Observed: Polar Bears as a Case Study	PLOS ONE			English	Article							URSUS-MARITIMUS; POPULATION-DYNAMICS; EXTINCTION RISK; MATING SYSTEM; BODY-SIZE; VIABILITY; ECOLOGY; CONSEQUENCES; CONSERVATION; ERADICATION	Allee effects are an important component in the population dynamics of numerous species. Accounting for these Allee effects in population viability analyses generally requires estimates of low-density population growth rates, but such data are unavailable for most species and particularly difficult to obtain for large mammals. Here, we present a mechanistic modeling framework that allows estimating the expected low-density growth rates under a mate-finding Allee effect before the Allee effect occurs or can be observed. The approach relies on representing the mechanisms causing the Allee effect in a process-based model, which can be parameterized and validated from data on the mechanisms rather than data on population growth. We illustrate the approach using polar bears (Ursus maritimus), and estimate their expected low-density growth by linking a mating dynamics model to a matrix projection model. The Allee threshold, defined as the population density below which growth becomes negative, is shown to depend on age-structure, sex ratio, and the life history parameters determining reproduction and survival. The Allee threshold is thus both density-and frequency-dependent. Sensitivity analyses of the Allee threshold show that different combinations of the parameters determining reproduction and survival can lead to differing Allee thresholds, even if these differing combinations imply the same stable-stage population growth rate. The approach further shows how mate-limitation can induce long transient dynamics, even in populations that eventually grow to carrying capacity. Applying the models to the overharvested low-density polar bear population of Viscount Melville Sound, Canada, shows that a mate-finding Allee effect is a plausible mechanism for slow recovery of this population. Our approach is generalizable to any mating system and life cycle, and could aid proactive management and conservation strategies, for example, by providing a priori estimates of minimum conservation targets for rare species or minimum eradication targets for pests and invasive species.	[Molnar, Peter K.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Lewis, Mark A.] Univ Alberta, Dept Math & Stat Sci, Ctr Math Biol, Edmonton, AB, Canada; [Lewis, Mark A.; Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Princeton University; University of Alberta; University of Alberta	Molnar, PK (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	pmolnar@princeton.edu	Lewis, Mark/A-2659-2014; Lewis, Mark A/C-5015-2008; Derocher, Andrew/J-4469-2012	Lewis, Mark A/0000-0002-7155-7426; Derocher, Andrew/0000-0002-1104-7774	Aquarium du Quebec; ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Canadian Circumpolar Institute's Boreal Alberta Research; Environment Canada; Hauser Bears; Natural Sciences and Engineering Research Council of Canada; Scientific Training Program of Aboriginal Affairs and Northern Development Canada; Polar Continental Shelf Project; Polar Bears International; Quark Expeditions; World Wildlife Fund (Canada International); NSERC; Killam Foundation	Aquarium du Quebec; ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Canadian Circumpolar Institute's Boreal Alberta Research; Environment Canada(CGIAR); Hauser Bears; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Scientific Training Program of Aboriginal Affairs and Northern Development Canada; Polar Continental Shelf Project(Natural Resources Canada); Polar Bears International; Quark Expeditions; World Wildlife Fund (Canada International); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Foundation	The authors gratefully acknowledge the financial and logistic support from the Aquarium du Quebec, ArcticNet, Canadian Association of Zoos and Aquariums, Canadian Wildlife Federation, Canadian Circumpolar Institute's Boreal Alberta Research, Environment Canada, Hauser Bears, Natural Sciences and Engineering Research Council of Canada, Northern Scientific Training Program of Aboriginal Affairs and Northern Development Canada, Polar Continental Shelf Project, Polar Bears International, Quark Expeditions, and World Wildlife Fund (Canada & International). MAL gratefully acknowledges a Canada Research Chair, NSERC Discovery and Accelerator Grants, and a Research Fellowship from the Killam Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P23; Allee W.C, 1931, ANIMAL AGGREGATION S; Angulo E, 2007, CONSERV BIOL, V21, P1082, DOI 10.1111/j.1523-1739.2007.00721.x; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Bethke R, 1996, ECOL APPL, V6, P311, DOI 10.2307/2269574; Blackwood JC, 2012, P ROY SOC B-BIOL SCI, V279, P2807, DOI 10.1098/rspb.2012.0255; Boukal DS, 2009, POPUL ECOL, V51, P445, DOI 10.1007/s10144-009-0154-4; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; Buhnerkempe MG, 2011, BIOL CONSERV, V144, P1808, DOI 10.1016/j.biocon.2011.03.012; Calabrese JM, 2008, J ANIM ECOL, V77, P746, DOI 10.1111/j.1365-2656.2008.01385.x; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Courchamp F, 2002, BEHAV ECOL, V13, P20, DOI 10.1093/beheco/13.1.20; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; DEMASTER D P, 1981, Mammalian Species, P1, DOI 10.2307/3503828; Dennis B, 2002, OIKOS, V96, P389, DOI 10.1034/j.1600-0706.2002.960301.x; Deredec A, 2007, ECOSCIENCE, V14, P440, DOI 10.2980/1195-6860(2007)14[440:IOTAEF]2.0.CO;2; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Derocher AE, 1997, J WILDLIFE MANAGE, V61, P1075, DOI 10.2307/3802104; DEROCHER AE, 1992, CAN J ZOOL, V70, P561, DOI 10.1139/z92-084; Derocher AE, 2010, BEHAV ECOL SOCIOBIOL, V64, P939, DOI 10.1007/s00265-010-0909-0; Ferguson SH, 1998, J BIOGEOGR, V25, P1081; Gilroy JJ, 2012, CONSERV LETT, V5, P313, DOI 10.1111/j.1755-263X.2012.00245.x; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Gregory SD, 2010, ECOLOGY, V91, P2151, DOI 10.1890/09-1128.1; Gusset Markus, 2012, BMC Research Notes, V5, P313, DOI 10.1186/1756-0500-5-313; Gusset M, 2009, BIOL CONSERV, V142, P2774, DOI 10.1016/j.biocon.2009.07.007; Hackney EE, 2001, CONSERV BIOL, V15, P129, DOI 10.1046/j.1523-1739.2001.98546.x; Henle K, 2004, BIODIVERS CONSERV, V13, P9, DOI 10.1023/B:BIOC.0000004312.41575.83; Hunter C. M., 2007, POLAR BEARS SO BEAUF; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Kokko H, 2005, EVOLUTION, V59, P1876; Koons DN, 2005, ECOL MODEL, V185, P283, DOI 10.1016/j.ecolmodel.2004.12.011; Kovach AI, 2003, CAN J ZOOL, V81, P1257, DOI 10.1139/Z03-111; Lacy Robert C., 2000, Ecological Bulletins, V48, P39; Laidre KL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2371; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Molnar PK, 2008, P R SOC B, V275, P217, DOI 10.1098/rspb.2007.1307; Molnar PK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1183; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Molnar PK, 2009, J EXP BIOL, V212, P2313, DOI 10.1242/jeb.026146; Morris DW, 2002, ECOLOGY, V83, P14; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; Obbard M.E., 2010, P 15 WORK M IUCN SSC; Ovaskainen O, 2010, TRENDS ECOL EVOL, V25, P643, DOI 10.1016/j.tree.2010.07.009; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; RAMSAY MA, 1986, CAN J ZOOL, V64, P2142, DOI 10.1139/z86-329; RAMSAY MA, 1988, J ZOOL, V214, P601, DOI 10.1111/j.1469-7998.1988.tb03762.x; Rasmussen GSA, 2008, AM NAT, V172, P508, DOI 10.1086/590965; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Rosing-Asvid A, 2002, POLAR BIOL, V25, P878, DOI 10.1007/s00300-002-0430-7; Schreiber SJ, 2004, P AM MATH SOC, V132, P3047, DOI 10.1090/S0002-9939-04-07406-4; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Stephens PA, 2002, J ANIM ECOL, V71, P343, DOI 10.1046/j.1365-2656.2002.00605.x; Stephens PA, 2002, J APPL ECOL, V39, P629, DOI 10.1046/j.1365-2664.2002.00740.x; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; STIRLING I, 1978, CAN J ZOOL, V56, P1768, DOI 10.1139/z78-242; TAYLOR M, 1995, ARCTIC, V48, P147; Taylor MK, 2008, WILDLIFE BIOL, V14, P52, DOI 10.2981/0909-6396(2008)14[52:SHOPBU]2.0.CO;2; Taylor MK, 2002, URSUS, V13, P185; Taylor MK, 2005, ARCTIC, V58, P203; Taylor MK, 2001, CAN J ZOOL, V79, P690, DOI 10.1139/cjz-79-4-690; TAYLOR MK, 1987, J WILDLIFE MANAGE, V51, P811, DOI 10.2307/3801746; TAYLOR MK, 2001, RISKMAN STOCHASTIC D; Tobin PC, 2011, ECOL LETT, V14, P615, DOI 10.1111/j.1461-0248.2011.01614.x; Veit RR, 1996, AM NAT, V148, P255, DOI 10.1086/285924; WIIG O, 1992, Polar Record, V28, P157	73	14	14	0	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85410	10.1371/journal.pone.0085410	http://dx.doi.org/10.1371/journal.pone.0085410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427306	gold, Green Published, Green Submitted			2022-12-25	WOS:000329868200047
J	Gorman, JL; Liu, STK; Slopack, D; Shariati, K; Hasanee, A; Olenich, S; Olfert, IM; Haas, TL				Gorman, Jennifer L.; Liu, Sammy T. K.; Slopack, Dara; Shariati, Khashayar; Hasanee, Adam; Olenich, Sara; Olfert, I. Mark; Haas, Tara L.			Angiotensin II Evokes Angiogenic Signals within Skeletal Muscle through Co-ordinated Effects on Skeletal Myocytes and Endothelial Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; STRESS-INDUCED ANGIOGENESIS; GROWTH-FACTOR EXPRESSION; MATRIX METALLOPROTEINASES; IN-VITRO; EXTRACELLULAR-MATRIX; CAPILLARY GROWTH; TYPE-1 RECEPTOR; GENE-EXPRESSION; PROTEIN-KINASE	Skeletal muscle overload induces the expression of angiogenic factors such as vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-2, leading to new capillary growth. We found that the overload-induced increase in angiogenesis, as well as increases in VEGF, MMP-2 and MT1-MMP transcripts were abrogated in muscle VEGF KO mice, highlighting the critical role of myocyte-derived VEGF in controlling this process. The upstream mediators that contribute to overload-induced expression of VEGF have yet to be ascertained. We found that muscle overload increased angiotensinogen expression, a precursor of angiotensin (Ang) II, and that Ang II signaling played an important role in basal VEGF production in C2C12 cells. Furthermore, matrix-bound VEGF released from myoblasts induced the activation of endothelial cells, as evidenced by elevated endothelial cell phospho-p38 levels. We also found that exogenous Ang II elevates VEGF expression, as well as MMP-2 transcript levels in C2C12 myotubes. Interestingly, these responses also were observed in skeletal muscle endothelial cells in response to Ang II treatment, indicating that these cells also can respond directly to the stimulus. The involvement of Ang II in muscle overload-induced angiogenesis was assessed. We found that blockade of AT1R-dependent Ang II signaling using losartan did not attenuate capillary growth. Surprisingly, increased levels of VEGF protein were detected in overloaded muscle from losartan-treated rats. Similarly, we observed elevated VEGF production in cultured endothelial cells treated with losartan alone or in combination with Ang II. These studies conclusively establish the requirement for muscle derived VEGF in overload-induced angiogenesis and highlight a role for Ang II in basal VEGF production in skeletal muscle. However, while Ang II signaling is activated following overload and plays a role in muscle VEGF production, inhibition of this pathway is not sufficient to halt overload-induced angiogenesis, indicating that AT1-independent signals maintain VEGF production in losartan-treated muscle.	[Gorman, Jennifer L.; Liu, Sammy T. K.; Slopack, Dara; Shariati, Khashayar; Hasanee, Adam; Haas, Tara L.] York Univ, Angiogenesis Res Grp, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Gorman, Jennifer L.; Liu, Sammy T. K.; Slopack, Dara; Shariati, Khashayar; Hasanee, Adam; Haas, Tara L.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Olenich, Sara; Olfert, I. Mark] W Virginia Univ, Sch Med, Ctr Cardiovasc & Resp Sci, Div Exercise Physiol, Morgantown, WV 26506 USA	York University - Canada; York University - Canada; West Virginia University	Haas, TL (corresponding author), York Univ, Angiogenesis Res Grp, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	thaas@yorku.ca	Haas, Tara/F-6788-2013	Haas, Tara/0000-0001-8559-9574	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this project to TLH from Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoudemos MM, 2005, MICROCIRCULATION, V12, P627, DOI 10.1080/10739680500301664; Amaral SL, 2001, MICROCIRCULATION, V8, P57, DOI 10.1038/sj.mn.7300142; Amaral SL, 2001, AM J PHYSIOL-HEART C, V281, pH1163, DOI 10.1152/ajpheart.2001.281.3.H1163; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; BAKER KM, 1990, AM J PHYSIOL, V259, pH324, DOI 10.1152/ajpheart.1990.259.2.H324; Baumann M, 2007, HYPERTENS RES, V30, P853, DOI 10.1291/hypres.30.853; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Bellamy LM, 2010, AM J PHYSIOL-CELL PH, V299, pC1402, DOI 10.1152/ajpcell.00306.2010; Benndorf R, 2003, CIRC RES, V93, P438, DOI 10.1161/01.RES.0000088358.99466.04; Brassard P, 2005, HYPERTENSION, V46, P598, DOI 10.1161/01.HYP.0000176744.15592.7d; BROWN LF, 1997, EXS, V79, P233; Bryan BA, 2008, MOL BIOL CELL, V19, P994, DOI 10.1091/mbc.E07-09-0856; Carbajo-Lozoya J, 2012, CELL SIGNAL; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Chua CC, 1998, BBA-MOL CELL RES, V1401, P187, DOI 10.1016/S0167-4889(97)00129-8; Clapp C, 2009, PHYSIOL REV, V89, P1177, DOI 10.1152/physrev.00024.2009; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Day RT, 2010, CELL SIGNAL, V22, P1849, DOI 10.1016/j.cellsig.2010.07.012; Doyle JL, 2009, J CELL BIOCHEM, V107, P272, DOI 10.1002/jcb.22123; Egginton S, 1998, J APPL PHYSIOL, V85, P2025, DOI 10.1152/jappl.1998.85.6.2025; Failli P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-32; FERRARA N, 1995, ANN NY ACAD SCI, V752, P246, DOI 10.1111/j.1749-6632.1995.tb17435.x; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; Fujiyama S, 2001, CIRC RES, V88, P22, DOI 10.1161/01.RES.88.1.22; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Gordon SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE150, DOI 10.1152/ajpendo.2001.280.1.E150; Haas TL, 2000, AM J PHYSIOL-HEART C, V279, pH1540, DOI 10.1152/ajpheart.2000.279.4.H1540; Han XY, 2003, J BIOL CHEM, V278, P47785, DOI 10.1074/jbc.M309482200; Hoier B, 2010, AM J PHYSIOL-HEART C, V299, pH857, DOI 10.1152/ajpheart.00082.2010; Ispanovic E, 2008, AM J PHYSIOL-CELL PH, V295, pC600, DOI 10.1152/ajpcell.00460.2007; Johnston APW, 2011, J RENIN-ANGIO-ALDO S, V12, P75, DOI 10.1177/1470320310381795; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Linderman JR, 2001, MICROCIRCULATION, V8, P275, DOI 10.1038/sj.mn.7800097; Mac Gabhann F, 2007, J APPL PHYSIOL, V102, P722, DOI 10.1152/japplphysiol.00800.2006; Madsen K, 2010, J AM SOC NEPHROL, V21, P448, DOI 10.1681/ASN.2009010045; Masuda T, 2012, AM J PHYSIOL-HEART C, V302, pH1871, DOI 10.1152/ajpheart.00663.2011; Milkiewicz M, 2005, AM J PHYSIOL-HEART C, V289, pH1315, DOI 10.1152/ajpheart.00284.2005; Milkiewicz M, 2007, J PHYSIOL-LONDON, V583, P753, DOI 10.1113/jphysiol.2007.136325; Munk VC, 2007, HYPERTENSION, V49, P1178, DOI 10.1161/HYPERTENSIONAHA.106.080242; Olfert IM, 2010, AM J PHYSIOL-REG I, V299, pR1059, DOI 10.1152/ajpregu.00347.2010; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384; Otani A, 1998, CIRC RES, V82, P619, DOI 10.1161/01.RES.82.5.619; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Rhoads RP, 2009, AM J PHYSIOL-CELL PH, V296, pC1321, DOI 10.1152/ajpcell.00391.2008; Rivilis I, 2002, AM J PHYSIOL-HEART C, V283, pH1430, DOI 10.1152/ajpheart.00082.2002; Rocha FL, 2007, AM J PHYSIOL-HEART C, V293, pH3575, DOI 10.1152/ajpheart.01251.2006; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Rullman E, 2007, J APPL PHYSIOL, V102, P2346, DOI 10.1152/japplphysiol.00822.2006; Rullman E, 2009, J APPL PHYSIOL, V106, P804, DOI 10.1152/japplphysiol.90872.2008; Sasaki K, 2002, J CLIN INVEST, V109, P603, DOI 10.1172/JCI200213055; SCHUNKERT H, 1990, J CLIN INVEST, V86, P1913, DOI 10.1172/JCI114924; SUZUKI J, 1993, CIRC RES, V73, P439, DOI 10.1161/01.RES.73.3.439; Wang JW, 2004, BBA-MOL BASIS DIS, V1690, P177, DOI 10.1016/j.bbadis.2004.06.004; Westerkamp CM, 2005, AM J PHYSIOL-REG I, V289, pR1223, DOI 10.1152/ajpregu.00730.2004; WILLIAMS B, 1995, HYPERTENSION, V25, P913, DOI 10.1161/01.HYP.25.5.913; Williams JL, 2006, MICROCIRCULATION, V13, P499, DOI 10.1080/10739680600785717; Williams JL, 2006, CLIN SCI, V110, P587, DOI 10.1042/CS20050185; Yamagishi S, 2003, DRUG EXP CLIN RES, V29, P75; Zhou AL, 1998, ANAT REC, V252, P49, DOI 10.1002/(SICI)1097-0185(199809)252:1<49::AID-AR6>3.0.CO;2-9	66	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85537	10.1371/journal.pone.0085537	http://dx.doi.org/10.1371/journal.pone.0085537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416421	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300085
J	Liu, P; Liu, Y; Wang, JN; Guo, Y; Zhang, YJ; Xiao, SQ				Liu, Ping; Liu, Yi; Wang, Jianning; Guo, Yang; Zhang, Yujie; Xiao, Shuiqing			Detection of Fusobacterium Nucleatum and fadA Adhesin Gene in Patients with Orthodontic Gingivitis and Non-Orthodontic Periodontal Inflammation	PLOS ONE			English	Article							MICROBIOLOGIC CHANGES; HEALTH	Fusobacterium nucleatum is one of the most abundant gram-negative bacilli colonizing the subgingival plaque and closely associated with periodontal disease. However it is unclear whether F. nucleatum is involved in gingival inflammation under orthodontic appliance. A novel adhesin, FadA, which is unique to oral Fusobacteria, is required for F. nucleatum binding and invasion to epithelial cells and thus may play an important role in colonization of Fusobacterium in the host. In this study, we evaluated the prevalence of F. nucleatum and its virulence factor FadA adhesion gene (fadA) in 169 subgingival biofilm samples from 55 cases of gingivitis patients with orthodontic appliances, 49 cases of gingivitis patients without orthodontic treatment, 35 cases of periodontitis patients and 30 cases of periodontally healthy people via PCR. The correlations between the F. nucleatum/fadA and gingivitis index(GI) was also analyzed. The detection rate of F. nucleatum/fadA in periodontitis group and non-orthodontic gingivitis group was higher than the other two groups (p<0.01) while it was higher in orthodontic gingivitis group than in health people (p<0.05). An obviously positive correlation was observed between the prevalence of F. nucleatum/fadA and GI. F. nucleatum carrying fadA may be more closely related to the development of gingivitis and periodontal disease compared with orthodontic gingivitis.	[Liu, Ping; Guo, Yang; Zhang, Yujie; Xiao, Shuiqing] Jinan Stomatol Hosp, Dept Orthodont, Jinan, Peoples R China; [Liu, Yi] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250100, Peoples R China; [Wang, Jianning] Jinan Stomatol Hosp, Dept Periodont, Jinan, Peoples R China	Shandong University	Xiao, SQ (corresponding author), Jinan Stomatol Hosp, Dept Orthodont, Jinan, Peoples R China.	shqxiao@126.com			Jinan Science and Technology Committee [JK200905034]	Jinan Science and Technology Committee	This work was funded by Jinan science and technology research project (JK200905034) from Jinan Science and Technology Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER SA, 1991, AM J ORTHOD DENTOFAC, V100, P337, DOI 10.1016/0889-5406(91)70071-4; Belibasakis GN, 2013, APMIS, DOI [10.1111/apm.12151, DOI 10.1111/APM.12151.[]; Bollen AM, 2008, J AM DENT ASSOC, V139, P413, DOI 10.14219/jada.archive.2008.0184; Conrads G, 1997, J ENDODONT, V23, P433, DOI 10.1016/S0099-2399(97)80297-X; Edwards AM, 2006, INFECT IMMUN, V74, P654, DOI 10.1128/IAI.74.1.654-662.2006; Feng X, 2013, J PERIODONTOL; Gursoy UK, 2008, ORAL MICROBIOL IMMUN, V23, P432, DOI 10.1111/j.1399-302X.2008.00453.x; Gursoy UK, 2012, J PERIODONTOL, V83, P242, DOI 10.1902/jop.2011.110177; HALL ER, 1994, ORAL MICROBIOL IMMUN, V9, P327, DOI 10.1111/j.1399-302X.1994.tb00282.x; Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005; Jewett A, 2000, INFECT IMMUN, V68, P1893, DOI 10.1128/IAI.68.4.1893-1898.2000; Joshi Vinayak M, 2007, Indian J Dent Res, V18, P6; Kim SH, 2012, ANGLE ORTHOD, V82, P254, DOI 10.2319/030311-156.1; Lee SM, 2005, J MICROBIOL, V43, P260; Liu HY, 2011, ANGLE ORTHOD, V81, P609, DOI 10.2319/082310-352.1; Liu X, 2009, CHIN J LAB DIAGN, V13, P1579; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061028; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; MOMBELLI A, 1989, J CLIN PERIODONTOL, V16, P451, DOI 10.1111/j.1600-051X.1989.tb01674.x; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; POLSON AM, 1988, AM J ORTHOD DENTOFAC, V93, P51, DOI 10.1016/0889-5406(88)90193-X; Sallum EJ, 2004, AM J ORTHOD DENTOFAC, V126, P363, DOI 10.1016/j.ajodo.2004.04.017; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Stingu CS, 2012, QUINTESSENCE INT, V43, pE23	24	35	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85280	10.1371/journal.pone.0085280	http://dx.doi.org/10.1371/journal.pone.0085280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416378	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300064
J	Pyatnitskiy, M; Mazo, I; Shkrob, M; Schwartz, E; Kotelnikova, E				Pyatnitskiy, Mikhail; Mazo, Ilya; Shkrob, Maria; Schwartz, Elena; Kotelnikova, Ekaterina			Clustering Gene Expression Regulators: New Approach to Disease Subtyping	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; BREAST-CANCER; PATHWAY; MICROARRAY; CLASSIFICATION; SIGNATURE; ADENOMA; PROTEIN; TOOL; IDENTIFICATION	One of the main challenges in modern medicine is to stratify different patient groups in terms of underlying disease molecular mechanisms as to develop more personalized approach to therapy. Here we propose novel method for disease subtyping based on analysis of activated expression regulators on a sample-by-sample basis. Our approach relies on SubNetwork Enrichment Analysis algorithm (SNEA) which identifies gene subnetworks with significant concordant changes in expression between two conditions. Subnetwork consists of central regulator and downstream genes connected by relations extracted from global literature-extracted regulation database. Regulators found in each patient separately are clustered together and assigned activity scores which are used for final patients grouping. We show that our approach performs well compared to other related methods and at the same time provides researchers with complementary level of understanding of pathway-level biology behind a disease by identification of significant expression regulators. We have observed the reasonable grouping of neuromuscular disorders (triggered by structural damage vs triggered by unknown mechanisms), that was not revealed using standard expression profile clustering. For another experiment we were able to suggest the clusters of regulators, responsible for colorectal carcinoma vs adenoma discrimination and identify frequently genetically changed regulators that could be of specific importance for the individual characteristics of cancer development. Proposed approach can be regarded as biologically meaningful feature selection, reducing tens of thousands of genes down to dozens of clusters of regulators. Obtained clusters of regulators make possible to generate valuable biological hypotheses about molecular mechanisms related to a clinical outcome for individual patient.	[Pyatnitskiy, Mikhail] RAMS, Inst Biomed Chem, Moscow, Russia; [Pyatnitskiy, Mikhail; Mazo, Ilya; Schwartz, Elena; Kotelnikova, Ekaterina] Ariadne Diagnost LLC, Rockville, MD USA; [Shkrob, Maria] Elsevier Inc, Rockville, MD USA; [Kotelnikova, Ekaterina] RAMS, Inst Informat Transmiss Problems, Moscow, Russia	Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Reed Elsevier; Elsevier; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Medical Sciences	Pyatnitskiy, M (corresponding author), RAMS, Inst Biomed Chem, Moscow, Russia.	mpyat@bioinformatics.ru	Pyatnitskiy, Mikhail/F-1588-2017; Mazo, Ilya A/G-6549-2014; Kotelnikova, Elena/N-8496-2013	Pyatnitskiy, Mikhail/0000-0002-4803-8150; Mazo, Ilya A/0000-0002-8587-4895; Kotelnikova, Ekaterina/0000-0002-8026-078X	Russian Ministry of Education and Science [14.512.11.0042]	Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work was partly supported by the Russian Ministry of Education and Science, contract #14.512.11.0042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abraham G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-277; Alexeyenko A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Breslin T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-163; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038650; Cleven AHG, 2008, BRIT J CANCER, V99, P727, DOI 10.1038/sj.bjc.6604547; Cui GL, 2012, SCAND J GASTROENTERO, V47, P1304, DOI 10.3109/00365521.2012.725089; Daraselia N, 2004, BIOINFORMATICS, V20, P604, DOI 10.1093/bioinformatics/btg452; Daraselia N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-243; Efroni S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002901; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Gerlach K, 2012, CANCER RES, V72, P4340, DOI 10.1158/0008-5472.CAN-11-4155; Greenblum SI, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-133; Guo Z, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-58; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; He ZY, 2010, COMPUT BIOL CHEM, V34, P215, DOI 10.1016/j.compbiolchem.2010.07.002; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Hummel M, 2008, BIOINFORM BIOL INSIG, V2, P329; Hung JH, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r23; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kappeler A, 2000, HISTOL HISTOPATHOL, V15, P167, DOI 10.14670/HH-15.167; Kaufman L., 2005, FINDING GROUPS DATA; Kel A, 2008, SAR QSAR ENVIRON RES, V19, P481, DOI 10.1080/10629360802083806; Ko Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-54; Koch M, 2006, ANN SURG, V244, P986, DOI 10.1097/01.sla.0000247058.43243.7b; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Kotelnikova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002365; Kressner U, 1997, BRIT J CANCER, V76, P526, DOI 10.1038/bjc.1997.419; Larsson L, 2008, ADV EXP MED BIOL, V642, P92; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nistala K, 2013, CURR OPIN RHEUMATOL, V25, P742, DOI 10.1097/01.bor.0000434674.62644.02; Novichkova S, 2003, BIOINFORMATICS, V19, P1699, DOI 10.1093/bioinformatics/btg207; Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394; Pollard KS, 2005, STAT BIOL HEALTH, P209; Pusztai L, 2006, CLIN CANCER RES, V12, P7209, DOI 10.1158/1078-0432.CCR-06-2649; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Sis B, 2004, PATHOL RES PRACT, V200, P379, DOI 10.1016/j.prp.2004.02.012; Sivachenko AY, 2007, J BIOINF COMPUT BIOL, V5, P429, DOI 10.1142/S0219720007002795; Sivachenko AY, 2007, EXPERT OPIN THER TAR, V11, P411, DOI 10.1517/14728222.11.3.411; Su JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008161; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiyama D, 2013, P NATL ACAD SCI US; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Walhout AJM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-109; Yuryev A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-171; Yuryev A, 2009, EXPERT OPIN DRUG DIS, V4, P1307, DOI 10.1517/17460440903413488	61	24	25	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84955	10.1371/journal.pone.0084955	http://dx.doi.org/10.1371/journal.pone.0084955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416320	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300043
J	Quintanilla, RH; Asprer, JST; Vaz, C; Tanavde, V; Lakshmipathy, U				Quintanilla, Rene H., Jr.; Asprer, Joanna S. T.; Vaz, Candida; Tanavde, Vivek; Lakshmipathy, Uma			CD44 Is a Negative Cell Surface Marker for Pluripotent Stem Cell Identification during Human Fibroblast Reprogramming	PLOS ONE			English	Article							GENE-EXPRESSION; INDUCTION; TRANSCRIPTOME; RECEPTOR; VECTOR; NANOG	Induced pluripotent stem cells (iPSCs) are promising tools for disease research and cell therapy. One of the critical steps in establishing iPSC lines is the early identification of fully reprogrammed colonies among unreprogrammed fibroblasts and partially reprogrammed intermediates. Currently, colony morphology and pluripotent stem cell surface markers are used to identify iPSC colonies. Through additional clonal characterization, we show that these tools fail to distinguish partially reprogrammed intermediates from fully reprogrammed iPSCs. Thus, they can lead to the selection of suboptimal clones for expansion. A subsequent global transcriptome analysis revealed that the cell adhesion protein CD44 is a marker that differentiates between partially and fully reprogrammed cells. Immunohistochemistry and flow cytometry confirmed that CD44 is highly expressed in the human parental fibroblasts used for the reprogramming experiments. It is gradually lost throughout the reprogramming process and is absent in fully established iPSCs. When used in conjunction with pluripotent cell markers, CD44 staining results in the clear identification of fully reprogrammed cells. This combination of positive and negative surface markers allows for easier and more accurate iPSC detection and selection, thus reducing the effort spent on suboptimal iPSC clones.	[Quintanilla, Rene H., Jr.; Asprer, Joanna S. T.; Lakshmipathy, Uma] Life Technol, Cell Biol & Stem Cell Sci, Carlsbad, CA USA; [Vaz, Candida; Tanavde, Vivek] ASTAR, Bioinformat Inst, Singapore, Singapore; [Tanavde, Vivek] ASTAR, Inst Med Biol, Singapore, Singapore	Thermo Fisher Scientific; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Lakshmipathy, U (corresponding author), Life Technol, Cell Biol & Stem Cell Sci, Carlsbad, CA USA.	uma.lakshmipathy@lifetech.com	Tanavde, Vivek/B-4758-2011; Lakshmipathy, Uma/L-4706-2013; Vaz, Candida/HHZ-7196-2022	Tanavde, Vivek/0000-0001-7404-5568; Lakshmipathy, Uma/0000-0003-4004-8212; Vaz, Candida/0000-0002-6650-7889	Life Technologies	Life Technologies	Please note that authors RHQ, JSTA and UL are employed by Life Technologies and receive financial compensation. This does not alter the authors' adherence to all the PLOS One policies on sharing data and materials.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Kahler DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059867; KENNEL SJ, 1993, J CELL SCI, V104, P373; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schwartz DR, 2003, CANCER RES, V63, P2913; Singh U, 2012, STEM CELL REV REP, V8, P1021, DOI 10.1007/s12015-012-9359-6; Sorrell JM, 2003, EXP DERMATOL, V12, P315, DOI 10.1034/j.1600-0625.2003.120312.x; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	38	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85419	10.1371/journal.pone.0085419	http://dx.doi.org/10.1371/journal.pone.0085419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416407	gold, Green Submitted, Green Published			2022-12-25	WOS:000329866300078
J	Winberg, J; Gustavsson, P; Papadogiannakis, N; Sahlin, E; Bradley, F; Nordenskjold, E; Svensson, PJ; Anneren, G; Iwarsson, E; Nordgren, A; Nordenskjold, A				Winberg, Johanna; Gustavsson, Peter; Papadogiannakis, Nikos; Sahlin, Ellika; Bradley, Frideborg; Nordenskjold, Edvard; Svensson, Par-Johan; Anneren, Goran; Iwarsson, Erik; Nordgren, Ann; Nordenskjold, Agneta			Mutation Screening and Array Comparative Genomic Hybridization Using a 180K Oligonucleotide Array in VACTERL Association	PLOS ONE			English	Article							ESOPHAGEAL ATRESIA; FANCONI-ANEMIA; CHD7 GENE; IDENTIFICATION; HETEROTAXY; DISORDERS; PATIENT	In order to identify genetic causes of VACTERL association (V vertebral defects, A anorectal malformations, C cardiac defects, T tracheoesofageal fistula, E esophageal atresia, R renal anomalies, L limb deformities), we have collected DNA samples from 20 patients diagnosed with VACTERL or with a VACTERL-like phenotype as well as samples from 19 aborted fetal cases with VACTERL. To investigate the importance of gene dose alterations in the genetic etiology of VACTERL association we have performed a systematic analysis of this cohort using a 180K array comparative genomic hybridization (array-CGH) platform. In addition, to further clarify the significance of PCSK5, HOXD13 and CHD7 genes in the VACTERL phenotype, mutation screening has been performed. We identified pathogenic gene dose imbalances in two fetal cases; a hemizygous deletion of the FANCB gene and a (9;18)(p24;q12) unbalanced translocation. In addition, one pathogenic mutation in CHD7 was detected, while no apparent disease-causing mutations were found in HOXD13 or PCSK5. Our study shows that although large gene dose alterations do not seem to be a common cause in VACTERL association, array-CGH is still important in clinical diagnostics to identify disease cause in individual cases.	[Winberg, Johanna; Gustavsson, Peter; Sahlin, Ellika; Bradley, Frideborg; Nordenskjold, Edvard; Iwarsson, Erik; Nordgren, Ann] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Winberg, Johanna; Gustavsson, Peter; Sahlin, Ellika; Bradley, Frideborg; Nordenskjold, Edvard; Svensson, Par-Johan; Iwarsson, Erik; Nordgren, Ann; Nordenskjold, Agneta] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Gustavsson, Peter; Sahlin, Ellika; Iwarsson, Erik; Nordgren, Ann] Karolinska Univ Hosp, Clin Genet Unit, Stockholm, Sweden; [Papadogiannakis, Nikos] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Svensson, Par-Johan; Nordenskjold, Agneta] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Svensson, Par-Johan; Nordenskjold, Agneta] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Anneren, Goran] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Winberg, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	johanna.winberg@ki.se	Iwarsson, Erik/J-4677-2019; Nordgren, Ann/AAQ-9142-2021; Nordgren, Ann C/N-4057-2013	Iwarsson, Erik/0000-0002-3827-0263; Nordgren, Ann/0000-0003-3285-4281; Nordgren, Ann C/0000-0003-3285-4281; Sahlin, Ellika/0000-0002-2564-4406; Nordenskjold, Agneta/0000-0001-6638-4631	Swedish Research Council [K2012-64X-14506-10-5]; Stockholm City Council; H R H Crown Princess Lovisa's Association for Child Medical Care; Torsten and Ragnar Soderbergs Foundation at Center for Molecular Medicine, Karolinska Institutet; KID-scholarship; Board of Doctoral Education at Karolinska Institutet; A research internship at Karolinska Institutet/Karolinska University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm City Council; H R H Crown Princess Lovisa's Association for Child Medical Care; Torsten and Ragnar Soderbergs Foundation at Center for Molecular Medicine, Karolinska Institutet; KID-scholarship; Board of Doctoral Education at Karolinska Institutet; A research internship at Karolinska Institutet/Karolinska University Hospital	The work was supported by: 1. The Swedish Research Council (grant number K2012-64X-14506-10-5) http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html. 2. The Stockholm City Council, http://www.forskningsstod.sll.se/Ansokan/start.asp. 3. H R H Crown Princess Lovisa's Association for Child Medical Care, http://www.kronprinsessanlovisa.se/pages/ansoekan/om-ansoekan.php. 4. Torsten and Ragnar Soderbergs Foundation at Center for Molecular Medicine, Karolinska Institutet. http://ragnarsoderbergsstiftelse.se/. 5. KID-scholarship granted by the Board of Doctoral Education at Karolinska Institutet (J.W.), http://ki.se/ki/jsp/polopoly.jsp;jsessionid = aXF-gX4gZdQgYzl7Nd? l = en&d = 13467. 6. A research internship at Karolinska Institutet/Karolinska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BP, 2013, MOL SYNDROMOL, V4, P87, DOI 10.1159/000346035; Arrington CB, 2010, AM J MED GENET A; Bartels CF, 2010, GENET TEST MOL BIOMA, V14, P881, DOI 10.1089/gtmb.2010.0101; Bartels E, 2012, CLIN DYSMORPHOL, V21, P191, DOI 10.1097/MCD.0b013e328358243c; Bartels E, 2012, PEDIATR SURG INT, V28, P681, DOI 10.1007/s00383-012-3100-z; Brosens E, 2013, MOL SYNDROMOL, V4, P20, DOI 10.1159/000345577; Chung B, 2011, AM J MED GENET A, V155A, P1123, DOI 10.1002/ajmg.a.33859; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garcia-Barcelo MM, 2008, AM J MED GENET A, V146A, P3181, DOI 10.1002/ajmg.a.32426; Gordon CT, 2012, J MED GENET, V49, P737, DOI 10.1136/jmedgenet-2012-101173; Hernandez-Garcia A, 2012, AM J MED GENET A, V158A, P1785, DOI 10.1002/ajmg.a.35391; Hilger A, 2013, EUR J HUM GENET; Hilger A, 2012, PEDIATR SURG INT, V28, P725, DOI 10.1007/s00383-012-3073-y; Holden ST, 2006, J MED GENET, V43, P750, DOI 10.1136/jmg.2006.041673; Nagamani SCS, 2011, EUR J HUM GENET, V19, P280, DOI 10.1038/ejhg.2010.184; Qi Qiu-feng, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P637; Ramalingam A, 2011, J HUM GENET, V56, P541, DOI 10.1038/jhg.2011.42; Reutter H, 2013, MOL SYNDROMOL, V4, P16, DOI 10.1159/000345300; Rittler M, 1996, AM J MED GENET, V63, P529, DOI 10.1002/(SICI)1096-8628(19960628)63:4<529::AID-AJMG4>3.0.CO;2-J; Sanlaville D, 2002, CLIN GENET, V61, P135, DOI 10.1034/j.1399-0004.2002.610208.x; Schramm C, 2010, EUR J MED GENET; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Solomon BD, 2013, MOL SYNDROMOL, V4, P27, DOI 10.1159/000345406; Solomon BD, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-56; Solomon BD, 2010, AM J MED GENET A, V152A, P2236, DOI 10.1002/ajmg.a.33572; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Stevenson RE, 2013, MOL SYNDROMOL, V4, P7, DOI 10.1159/000346192; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Tyreman M, 2009, J MED GENET, V46, P531, DOI 10.1136/jmg.2008.065482; Umana LA, 2011, AM J MED GENET A, V155A, P3071, DOI 10.1002/ajmg.a.34296; van der Veken LT, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-13; Walsh LE, 2001, AM J MED GENET, V98, P137, DOI 10.1002/1096-8628(20010115)98:2<137::AID-AJMG1022>3.0.CO;2-5; Wessels MW, 2010, J MED GENET, V47, P351, DOI 10.1136/jmg.2008.060913; Zu SL, 2011, J PEDIATR SURG, V46, P1390, DOI 10.1016/j.jpedsurg.2011.02.039	35	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85313	10.1371/journal.pone.0085313	http://dx.doi.org/10.1371/journal.pone.0085313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416387	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300069
J	Beck, C; Kardatzki, B; Ethofer, T				Beck, Claudia; Kardatzki, Bernd; Ethofer, Thomas			Mondegreens and Soramimi as a Method to Induce Misperceptions of Speech Content - Influence of Familiarity, Wittiness, and Language Competence	PLOS ONE			English	Article							MEMORY; MUSIC; VASE; FACE	Expectations and prior knowledge can strongly influence our perception. In vision research, such top-down modulation of perceptual processing has been extensively studied using ambiguous stimuli, such as reversible figures. Here, we propose a novel method to address this issue in the auditory modality during speech perception by means of Mondgreens and Soramimi which represent song lyrics with the potential for misperception within one or across two languages, respectively. We demonstrate that such phenomena can be induced by visual presentation of the alternative percept and occur with a sufficient probability to exploit them in neuroscientific experiments. Song familiarity did not influence the occurrence of such altered perception indicating that this tool can be employed irrespective of the participants' knowledge of music. On the other hand, previous knowledge of the alternative percept had a strong impact on the strength of altered perception which is in line with frequent reports that these phenomena can have long-lasting effects. Finally, we demonstrate that the strength of changes in perception correlated with the extent to which they were experienced as amusing as well as the vocabulary of the participants as source of potential interpretations. These findings suggest that such perceptional phenomena might be linked to the pleasant experience of resolving ambiguity which is in line with the long-existing theory of Hermann von Helmholtz that perception and problem-solving recruit similar processes.	[Beck, Claudia; Kardatzki, Bernd; Ethofer, Thomas] Univ Tubingen, Dept Biomed Magnet Resonance, Tubingen, Germany; [Ethofer, Thomas] Univ Tubingen, Univ Clin Psychiat & Psychotherapy, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Ethofer, T (corresponding author), Univ Tubingen, Dept Biomed Magnet Resonance, Tubingen, Germany.	thomas.ethofer@med.uni-tuebingen.de			University of Tubingen	University of Tubingen	The study was supported by the Open Access Publishing Fund of the University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Andrews TJ, 2002, NEUROIMAGE, V17, P890, DOI 10.1006/nimg.2002.1243; [Anonymous], SCI AM MIND; Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Bond Z. S, 1999, SLIPS EAR ERRORS PER; Bond ZS, 1999, BRAIN LANG, V68, P144, DOI 10.1006/brln.1999.2071; Cahill L, 1995, CONSCIOUS COGN, V4, P410, DOI 10.1006/ccog.1995.1048; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 2009, EMOTIONAL LEARNING H; Dean ME, 2006, J ROY SOC MED, V99, P375, DOI 10.1258/jrsm.99.7.375; Eschrich S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-48; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Hasson U, 2001, J COGNITIVE NEUROSCI, V13, P744, DOI 10.1162/08989290152541412; Helmholtz v, 1866, PERCEPTIONS GEN; Kensinger EA, 2004, REV NEUROSCIENCE, V15, P241, DOI 10.1515/REVNEURO.2004.15.4.241; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Melloni L, 2011, J NEUROSCI, V31, P1386, DOI 10.1523/JNEUROSCI.4570-10.2011; Meyer S, 2011, HNO, V59, P926, DOI 10.1007/s00106-011-2335-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pereira CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027241; Platel H, 2003, NEUROIMAGE, V20, P244, DOI 10.1016/S1053-8119(03)00287-8; Plato, CHARMIDES, p155C; Rubin E, 1915, VISUELL WASHRGENOMME; Stalinski SM, 2013, J EXP PSYCHOL LEARN, V39, P700, DOI 10.1037/a0029671; Woods AT, 2011, NEUROREPORT, V22, P365, DOI 10.1097/WNR.0b013e3283469581; Wright S., 1954, HARPERS MAGAZINE, V209, P48	26	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84667	10.1371/journal.pone.0084667	http://dx.doi.org/10.1371/journal.pone.0084667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416261	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500147
J	Hoffmann, CJ; Chaisson, RE; Martinson, NA				Hoffmann, Christopher J.; Chaisson, Richard E.; Martinson, Neil A.			Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV	PLOS ONE			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE; MYCOBACTERIUM-TUBERCULOSIS; INFECTED ADULTS; COTE-DIVOIRE; MORTALITY; TRIAL; SUSCEPTIBILITY; COMBINATION; MORBIDITY; ABIDJAN	Objectives: Many randomized and cohort studies have reported a survival benefit with cotrimoxazole prophylaxis without detecting a difference in tuberculosis (TB) incidence by cotrimoxazole status. However, several in vitro studies have reported that cotrimoxazole possesses anti-TB activity. We sought to compare TB incidence and TB diagnostic yield by cotrimoxazole use among participants in a well characterized cohort of HIV-infected adults living in a high TB prevalence region. Methods: We analyzed prospective data from a long-term longitudinal cohort of adults receiving HIV care and TB investigations in Soweto, South Africa. Using longitudinal analysis, we compared total and laboratory confirmed TB incidence by cotrimoxazole status as well as all-cause mortality. In addition, we compared TB culture results by cotrimoxazole status. Results: In a multivariable analysis, adjusted for sex, body mass index, WHO clinical stage, time-updated CD4 count, and antiretroviral therapy status, we observed an association between cotrimoxazole and an increase in TB incidence (hazard ratio 1.7, 95% CI: 1.2, 2.2). However, when restricted to laboratory-confirmed TB, there was no association between cotrimoxazole and TB incidence (hazard ratio: 0.97, 95% CI: 0.39, 2.4). In TB cases, we found no difference in the proportion of positive sputum cultures or days to culture positivity by cotrimoxazole status. Cotrimoxazole was associated with a reduction in mortality. Conclusions: In this cohort with a mortality benefit from cotrimoxazole, we found an increased risk of all TB among individuals using cotrimoxazole, likely a result of residual confounding, but no association between use of cotrimoxazole and laboratory-confirmed TB. Cotrimoxazole did not compromise TB diagnosis.	[Hoffmann, Christopher J.; Chaisson, Richard E.; Martinson, Neil A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Hoffmann, Christopher J.; Chaisson, Richard E.; Martinson, Neil A.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Martinson, Neil A.] Perinatal HIV Res Unit, Johannesburg, South Africa	Johns Hopkins University; Johns Hopkins University	Hoffmann, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	choffmann@jhmi.edu		Hoffmann, Christopher/0000-0002-9422-0519	National Heart, Lung, and Blood Institute Lung Health [R01 HL90312]; Johns Hopkins University Center for AIDS Research [P30-AI094189-01A1]; National Institutes of Health [AI083099]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, K23AI083099] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute Lung Health; Johns Hopkins University Center for AIDS Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a National Heart, Lung, and Blood Institute Lung Health research grant [R01 HL90312]. REC is partly supported by the Johns Hopkins University Center for AIDS Research [P30-AI094189-01A1]. CJH is supported by a National Institutes of Health K23 research grant [AI083099]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Badri M, 2001, AIDS, V15, P1143, DOI 10.1097/00002030-200106150-00009; DUBAR V, 1990, J ANTIMICROB CHEMOTH, V26, P791, DOI 10.1093/jac/26.6.791; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Huang TS, 2012, J ANTIMICROB CHEMOTH, V67, P633, DOI 10.1093/jac/dkr501; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; Omar T, 2011, AIDS, V25, P87, DOI 10.1097/QAD.0b013e328340fd99; Ong W, 2010, ANTIMICROB AGENTS CH, V54, P2748, DOI 10.1128/AAC.00029-10; Rubin DB, 2004, MULTIPLE IMPUTATION; Sesay M, 2006, GUIDELINES COTRIMOXA; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015	19	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83750	10.1371/journal.pone.0083750	http://dx.doi.org/10.1371/journal.pone.0083750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421903	Green Published, gold			2022-12-25	WOS:000329862500070
J	Liao, K; Xiao, R; Gonzalez, J; Ding, L				Liao, Ke; Xiao, Ran; Gonzalez, Jania; Ding, Lei			Decoding Individual Finger Movements from One Hand Using Human EEG Signals	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; ONLINE CLASSIFICATION; MOTOR IMAGERY; MEG; COMMUNICATION; DESYNCHRONIZATION; DISCRIMINATION; EXECUTION; FEATURES; TRIALS	Brain computer interface (BCI) is an assistive technology, which decodes neurophysiological signals generated by the human brain and translates them into control signals to control external devices, e. g., wheelchairs. One problem challenging noninvasive BCI technologies is the limited control dimensions from decoding movements of, mainly, large body parts, e. g., upper and lower limbs. It has been reported that complicated dexterous functions, i.e., finger movements, can be decoded in electrocorticography (ECoG) signals, while it remains unclear whether noninvasive electroencephalography (EEG) signals also have sufficient information to decode the same type of movements. Phenomena of broadband power increase and low-frequency-band power decrease were observed in EEG in the present study, when EEG power spectra were decomposed by a principal component analysis (PCA). These movement-related spectral structures and their changes caused by finger movements in EEG are consistent with observations in previous ECoG study, as well as the results from ECoG data in the present study. The average decoding accuracy of 77.11% over all subjects was obtained in classifying each pair of fingers from one hand using movement-related spectral changes as features to be decoded using a support vector machine (SVM) classifier. The average decoding accuracy in three epilepsy patients using ECoG data was 91.28% with the similarly obtained features and same classifier. Both decoding accuracies of EEG and ECoG are significantly higher than the empirical guessing level (51.26%) in all subjects (p<0.05). The present study suggests the similar movement-related spectral changes in EEG as in ECoG, and demonstrates the feasibility of discriminating finger movements from one hand using EEG. These findings are promising to facilitate the development of BCIs with rich control signals using noninvasive technologies.	[Liao, Ke; Xiao, Ran; Ding, Lei] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA; [Gonzalez, Jania; Ding, Lei] Univ Oklahoma, Ctr Biomed Engn, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Ding, L (corresponding author), Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA.	leiding@ou.edu	Xiao, Ran/AAN-5293-2020	Xiao, Ran/0000-0002-3689-1680	NSF CAREER [ECCS-0955260]; DOT-FAA [10-G-008]; OCAST [HR09-125S]; Directorate For Engineering [0955260] Funding Source: National Science Foundation	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); DOT-FAA; OCAST; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by NSF CAREER ECCS-0955260, DOT-FAA 10-G-008, and OCAST HR09-125S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2010, J NEURAL ENG, V7, DOI [10.1088/1741-2560/7/4/046002, 10.2202/1553-3840.1324]; Bai O, 2007, CLIN NEUROPHYSIOL, V118, P2637, DOI 10.1016/j.clinph.2007.08.025; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Boostani R, 2003, PHYSIOL MEAS, V24, P309, DOI 10.1088/0967-3334/24/2/307; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Bradberry TJ, 2009, NEUROIMAGE, V47, P1691, DOI 10.1016/j.neuroimage.2009.06.023; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; Bundhoo V, 2005, 2005 12TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS, P368; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang GC, 1996, MED ENG PHYS, V18, P529, DOI 10.1016/1350-4533(96)00006-9; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; Darvas F, 2010, NEUROIMAGE, V49, P930, DOI 10.1016/j.neuroimage.2009.08.041; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ding L, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036008; Doud AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026322; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Flamary R, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00029; Glaser E., 1976, PRINCIPLES NEUROBIOL; Gonzalez SL, 2006, NEUROIMAGE, V32, P170, DOI 10.1016/j.neuroimage.2006.02.041; Gu Y, 2009, CLIN NEUROPHYSIOL, V120, P1596, DOI 10.1016/j.clinph.2009.05.006; Han J, 2012, MOR KAUF D, P1; Hinterberger T., 2005, ADV NEURAL INFORM PR, V17, P737; Hochberg LR, 2006, IEEE ENG MED BIOL, V25, P32, DOI 10.1109/MEMB.2006.1705745; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Huang DD, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046005; Huggins JE, 2011, AMYOTROPH LATERAL SC, V12, P318, DOI 10.3109/17482968.2011.572978; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; Jain RK, 2012, COMPUTATIONAL INTELL; Kauhanen L, 2006, CLIN NEUROPHYSIOL, V117, P430, DOI 10.1016/j.clinph.2005.10.024; Khan YU, 2010, IET SIGNAL PROCESS, V4, P510, DOI 10.1049/iet-spr.2008.0235; Kohlmorgen J., 2007, BRAIN COMPUTER INTER, P409; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lehtonen J, 2008, IEEE T BIO-MED ENG, V55, P713, DOI 10.1109/TBME.2007.912653; Li Y, 2004, IEEE T BIO-MED ENG, V51, P1019, DOI 10.1109/TBME.2004.826688; Liang NY, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00091; Liao X, 2007, IEEE T BIO-MED ENG, V54, P821, DOI 10.1109/TBME.2006.889206; Liyanage SR, 2009, CLASSIFICATION SELF; M³ller K-R., 2004, BIOMED TECH, V49, P11, DOI [DOI 10.13109/9783666351419.11, 10.13109/9783666351419.11]; Makeig S, 2012, P IEEE, V100, P1567, DOI 10.1109/JPROC.2012.2185009; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Miller KJ, 2008, BCI COMPETITION; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Mohamed AK, 2011, IEEE ENG MED BIO, P6289, DOI 10.1109/IEMBS.2011.6091552; Morash V, 2008, CLIN NEUROPHYSIOL, V119, P2570, DOI 10.1016/j.clinph.2008.08.013; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Obermaier B, 2001, PATTERN RECOGN LETT, V22, P1299, DOI 10.1016/S0167-8655(01)00075-7; Onaran I, 2011, IEEE ENG MED BIO, P5424, DOI 10.1109/IEMBS.2011.6091341; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Quandt F, 2012, NEUROIMAGE, V59, P3316, DOI 10.1016/j.neuroimage.2011.11.053; Samiee S, 2010, 2010 INT C INT ADV S, P1; Santello M, 1997, SOMATOSENS MOT RES, V14, P203; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Scherer R, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0981; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Shenoy P, 2008, IEEE T BIO-MED ENG, V55, P273, DOI 10.1109/TBME.2007.903528; Shenoy P, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P192, DOI 10.1109/CNE.2007.369644; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Soechting JF, 1997, J COMPUT NEUROSCI, V4, P29, DOI 10.1023/A:1008812426305; van den Broek SP, 1998, ELECTROEN CLIN NEURO, V106, P522, DOI 10.1016/S0013-4694(97)00147-8; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; Vuckovic A, 2009, CLIN NEUROPHYSIOL, V120, P1422, DOI 10.1016/j.clinph.2009.06.007; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Wang W, 2009, IEEE ENG MED BIO, P586, DOI 10.1109/IEMBS.2009.5333704; Welford A.T., 1980, REACTION TIMES; Wilson JA, 2006, IEEE T NEUR SYS REH, V14, P246, DOI 10.1109/TNSRE.2006.875570; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe; Zanos S, 2008, IEEE ENG MED BIO, P5939, DOI 10.1109/IEMBS.2008.4650569; Zhou J, 2009, COMPUT BIOL MED, V39, P443, DOI 10.1016/j.compbiomed.2009.02.004	86	85	88	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85192	10.1371/journal.pone.0085192	http://dx.doi.org/10.1371/journal.pone.0085192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416360	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500225
J	Morita, S; Horii, T; Kimura, M; Arai, Y; Kamei, Y; Ogawa, Y; Hatada, I				Morita, Sumiyo; Horii, Takuro; Kimura, Mika; Arai, Yuji; Kamei, Yasutomi; Ogawa, Yoshihiro; Hatada, Izuho			Paternal Allele Influences High Fat Diet-Induced Obesity	PLOS ONE			English	Article							GROWTH-FACTOR-II; INSULIN SECRETORY FUNCTION; ALTERED BODY-COMPOSITION; GLUCOSE-HOMEOSTASIS; HORMONE ADIPONECTIN; MICE; RESISTANCE; IGF2; METHYLATION; REGION	C57BL/6J (B6) mice are susceptible to high-fat diet (HFD)-induced obesity and have been used in metabolism research for many decades. However, the genetic component of HFD-induced obesity has not yet been elucidated. This study reports evidence for a paternal transmission of HFD-induced obesity and a correlated expression of Igf2 and Peg3 (paternal expressed gene 3) imprinted genes. We found that PWK mice are resistant to HFD-induced obesity compared to C57BL/6J mice. Therefore, we generated and analyzed reciprocal crosses between these mice, namely; (PWK6B6) F1 progeny with B6 father and (B66PWK) F1 progeny with PWK father. The (PWK6B6) F1 mice were more sensitive to diet-induced obesity compared to (B66PWK) F1 mice, suggesting a paternal transmission of diet-induced obesity. Expression analysis of imprinted genes in adipocytes revealed that HFD influences the expression of some of the imprinted genes in adipose tissue in B6 and PWK mice. Interestingly, Igf2 and Peg3, which are paternally expressed imprinted genes involved in the regulation of body fat accumulation, were down-regulated in B6 and (PWK6B6) F1 mice, which are susceptible to HFD-induced obesity, but not in PWK and (B66PWK) F1 mice, which are resistant. Furthermore, in vitro analysis showed that Igf2, but not Peg3, had an anti-inflammatory effect on TNF-alpha induced MCP-1 expression in adipocytes. Taken together, our findings suggest that the down-regulation of Igf2 and Peg3 imprinted genes in adipocytes may be involved in the paternal transmission of HFD-induced obesity.	[Morita, Sumiyo; Horii, Takuro; Kimura, Mika; Hatada, Izuho] Gunma Univ, Lab Genome Sci, Biosignal Genome Resource Ctr, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan; [Arai, Yuji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biosci & Genet, Div Dev Biotechnol, Suita, Osaka, Japan; [Kamei, Yasutomi] Kyoto Prefectural Univ, Lab Mol Nutr, Grad Sch Environm & Life Sci, Sakyo Ku, Kyoto 606, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan	Gunma University; National Cerebral & Cardiovascular Center - Japan; Kyoto Prefectural University; Tokyo Medical & Dental University (TMDU)	Hatada, I (corresponding author), Gunma Univ, Lab Genome Sci, Biosignal Genome Resource Ctr, Inst Mol & Cellular Regulat, Showa Machi, Maebashi, Gunma 371, Japan.	hatada@gunma-u.ac.jp		Ogawa, Yoshihiro/0000-0002-0834-2836	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; National Institute of Biomedical Innovation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare of Japan; the National Institute of Biomedical Innovation; and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2002, AM J PHYSIOL-ENDOC M, V283, pE738, DOI 10.1152/ajpendo.00199.2002; Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; FEIL R, 1994, DEVELOPMENT, V120, P2933; Gaunt TR, 2001, HUM MOL GENET, V10, P1491, DOI 10.1093/hmg/10.14.1491; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Jones BK, 2001, HUM MOL GENET, V10, P807, DOI 10.1093/hmg/10.8.807; Kooptiwut S, 2002, ENDOCRINOLOGY, V143, P2085, DOI 10.1210/en.143.6.2085; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Matsuzawa Y, 2010, CURR PHARM DESIGN, V16, P1896, DOI 10.2174/138161210791208893; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; O'Dell SD, 1999, EUR J HUM GENET, V7, P821, DOI 10.1038/sj.ejhg.5200381; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Ravussin E., 2002, Pharmacogenomics Journal, V2, P4, DOI 10.1038/sj.tpj.6500068; ROGLER CE, 1994, J BIOL CHEM, V269, P13779; Rossetti L, 1996, J BIOL CHEM, V271, P203, DOI 10.1074/jbc.271.1.203; Sandhu MJS, 2003, DIABETES, V52, P1403, DOI 10.2337/diabetes.52.6.1403; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Smas CM, 1996, INT J OBESITY, V20, pS65; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	38	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85477	10.1371/journal.pone.0085477	http://dx.doi.org/10.1371/journal.pone.0085477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416415	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500252
J	Pang, LY; Gatenby, EL; Kamida, A; Whitelaw, BA; Hupp, TR; Argyle, DJ				Pang, Lisa Y.; Gatenby, Emma L.; Kamida, Ayako; Whitelaw, Bruce A.; Hupp, Ted R.; Argyle, David J.			Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; BREAST-CANCER CELLS; PROSPECTIVE IDENTIFICATION; MALIGNANT-TUMORS; BONE-MARROW; CYCLOOXYGENASE-2; SUBPOPULATION; MELOXICAM; PATHWAY; GROWTH	Osteosarcoma is the most common primary bone tumour of both children and dogs. It is an aggressive tumour in both species with a rapid clinical course leading ultimately to metastasis. In dogs and children distant metastasis occurs in.80% of individuals treated by surgery alone. Both canine and human osteosarcoma has been shown to contain a sub-population of cancer stem cells (CSCs), which may drive tumour growth, recurrence and metastasis, suggesting that naturally occurring canine osteosarcoma could act as a preclinical model for the human disease. Here we report the successful isolation of CSCs from primary canine osteosarcoma, as well as established cell lines. We show that these cells can form tumourspheres, and demonstrate relative resistance to chemotherapy. We demonstrate similar results for the human osteosarcma cell lines, U2OS and SAOS2. Utilizing the Affymetrix canine microarray, we are able to definitively show that there are significant differences in global gene expression profiles of isolated osteosarcoma stem cells and the daughter adherent cells. We identified 13,221 significant differences (p = 0.05), and significantly, COX-2 was expressed 141-fold more in CSC spheres than daughter adherent cells. To study the role of COX-2 expression in CSCs we utilized the COX-2 inhibitors meloxicam and mavacoxib. We found that COX-2 inhibition had no effect on CSC growth, or resistance to chemotherapy. However inhibition of COX-2 in daughter cells prevented sphere formation, indicating a potential significant role for COX-2 in tumour initiation.	[Pang, Lisa Y.; Gatenby, Emma L.; Kamida, Ayako; Whitelaw, Bruce A.; Argyle, David J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Pang, Lisa Y.; Gatenby, Emma L.; Kamida, Ayako; Whitelaw, Bruce A.; Argyle, David J.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Hupp, Ted R.] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Pang, LY (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland.	lisa.pang@ed.ac.uk		Hupp, Ted/0000-0003-0391-0352; Whitelaw, Bruce/0000-0002-2918-1605	Biotechnology and Biological Sciences Research Council (BBSRC) [BBSRC - BB/F008848/1]; Biotechnology and Biological Sciences Research Council [BB/F008848/1, BBS/E/D/20310000, BBS/E/D/20221658, BBS/E/D/05251444, BBS/E/D/05251443, BBS/E/D/05251445, BBS/E/D/05251442] Funding Source: researchfish; BBSRC [BBS/E/D/20221658, BBS/E/D/05251444, BBS/E/D/20310000, BBS/E/D/05251445, BB/F008848/1, BBS/E/D/05251443, BBS/E/D/05251442] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant: BBSRC - BB/F008848/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Argyle DJ, 2008, DECISION MAKING SMAL, Vxi; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Basu-Roy U, 2012, CANC LETT; Bj P, 2013, PLAST RECONSTR SURG; Blacking TM, 2007, VET COMP ONCOL, V5, P76, DOI 10.1111/j.1476-5829.2007.00127.x; Bozzi F, 2011, CYTOM PART B-CLIN CY, V80B, P238, DOI 10.1002/cyto.b.20589; Busch U, 1998, DRUG METAB DISPOS, V26, P576; Chen YT, 2012, KAOHSIUNG J MED SCI, V28, P545, DOI 10.1016/j.kjms.2012.04.017; Chiou YS, 2013, CARCINOGENESIS, V34, P1315, DOI 10.1093/carcin/bgt042; Christ O, 2007, HAEMATOLOGICA, V92, P1165, DOI 10.3324/haematol.11366; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cotterill SJ, 2004, PEDIATR BLOOD CANCER, V42, P59, DOI 10.1002/pbc.10437; Cox SR, 2011, J VET PHARMACOL THER, V34, P1, DOI 10.1111/j.1365-2885.2010.01183.x; Dannhardt G, 2001, INFLAMM RES, V50, P262, DOI 10.1007/s000110050752; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duan DP, 2012, ONCOL REP, V28, P1693, DOI 10.3892/or.2012.1992; Ek ETH, 2006, CRIT REV ONCOL HEMAT, V60, P1, DOI 10.1016/j.critrevonc.2006.03.006; El-Badawi Zeinab H, 2012, Malays J Pathol, V34, P15; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fan TM, 2010, EXPERT REV ANTICANC, V10, P1327, DOI 10.1586/ERA.10.107; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Federman N, 2009, CURR TREAT OPTION ON, V10, P82, DOI 10.1007/s11864-009-0087-3; FRAUMENI JF, 1967, CANCER, V20, P967, DOI 10.1002/1097-0142(196706)20:6<967::AID-CNCR2820200606>3.0.CO;2-P; Gatta G, 2005, J CLIN ONCOL, V23, P3742, DOI 10.1200/JCO.2005.00.554; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Gisina AM, 2012, B EXP BIOL MED+, V152, P739, DOI 10.1007/s10517-012-1620-0; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hodgkiss-Geere HM, 2012, VET J, V194, P361, DOI 10.1016/j.tvjl.2012.05.011; Hong SH, 2011, VET COMP ONCOL, V9, P207, DOI 10.1111/j.1476-5829.2010.00249.x; Kanojia D, 2012, PROTEOMICS, V12, P3407, DOI 10.1002/pmic.201200103; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Lewis IJ, 2007, JNCI-J NATL CANCER I, V99, P112, DOI 10.1093/jnci/djk015; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Millanta F, 2012, J COMP PATHOL, V147, P153, DOI 10.1016/j.jcpa.2012.02.003; Mohammed SI, 2004, PROSTAG LEUKOTR ESS, V70, P479, DOI 10.1016/j.plefa.2003.10.002; Mueller F, 2007, ANTICANCER RES, V27, P155; Mullins MN, 2004, J VET INTERN MED, V18, P859, DOI 10.1892/0891-6640(2004)18&lt;859:CEICAO&gt;2.0.CO;2; MURRAY L, 1995, BLOOD, V85, P368; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; Naruse T, 2006, CARCINOGENESIS, V27, P584, DOI 10.1093/carcin/bgi240; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pang Lisa Y, 2011, Cancers (Basel), V3, P1744, DOI 10.3390/cancers3021744; Pang LY, 2010, VET J, V185, P15, DOI 10.1016/j.tvjl.2010.04.008; Pang LY, 2009, BBA-MOL BASIS DIS, V1792, P380, DOI 10.1016/j.bbadis.2009.02.010; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Saini V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041401; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Singh B, 2008, J SURG RES, V147, P240, DOI 10.1016/j.jss.2008.02.026; Singh SK, 2003, CANCER RES, V63, P5821; Takahashi RH, 2012, PATHOL RES PRACT, V208, P736, DOI 10.1016/j.prp.2012.09.003; Takemitsu H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-150; Urakawa H, 2009, CLIN ORTHOP RELAT R, V467, P2932, DOI 10.1007/s11999-009-0814-x; Wagemakers M, 2009, TRANSL ONCOL, V2, P1, DOI 10.1593/tlo.08160; Wang L, 2009, CANCER BIOL THER, V8, P543, DOI 10.4161/cbt.8.6.7695; Wilson H, 2008, VET J, V175, P69, DOI 10.1016/j.tvjl.2007.07.025; Wolfesberger B, 2006, RES VET SCI, V80, P308, DOI 10.1016/j.rvsc.2005.07.013; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7; Zhang XP, 2000, EXP CELL RES, V254, P232, DOI 10.1006/excr.1999.4758	63	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83144	10.1371/journal.pone.0083144	http://dx.doi.org/10.1371/journal.pone.0083144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416158	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500031
J	Prins, SA; Przybycien-Szymanska, MM; Rao, YS; Pak, TR				Prins, Sarah A.; Przybycien-Szymanska, Magdalena M.; Rao, Yathindar S.; Pak, Toni R.			Long-Term Effects of Peripubertal Binge EtOH Exposure on Hippocampal microRNA Expression in the Rat	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; ETHANOL EXPOSURE; RNA-INTERFERENCE; ALCOHOL EXPOSURE; GENE-EXPRESSION; ADULT RATS; BRAIN; ADOLESCENCE; DRINKING; NEUROGENESIS	Adolescent binge alcohol abuse induces long-term changes in gene expression, which impacts the physiological stress response and memory formation, two functions mediated in part by the ventral (VH) and dorsal (DH) hippocampus. microRNAs (miRs) are small RNAs that play an important role in gene regulation and are potential mediators of long-term changes in gene expression. Two genes important for regulating hippocampal functions include brain-derived neurotrophic factor (BDNF) and sirtuin-1 (SIRT1), which we identified as putative gene targets of miR-10a-5p, miR-26a, miR-103, miR-495. The purpose of this study was to quantify miR-10a-5p, miR-26a, miR-103, miR-495 expression levels in the dorsal and ventral hippocampus of male Wistar rats during normal pubertal development and then assess the effects of repeated binge-EtOH exposure. In addition, we measured the effects of binge EtOH-exposure on hippocampal Drosha and Dicer mRNA levels, as well as the putative miR target genes, BDNF and SIRT1. Overall, mid/peri-pubertal binge EtOH exposure altered the normal expression patterns of all miRs tested in an age-and brain region-dependent manner and this effect persisted for up to 30 days post-EtOH exposure. Moreover, our data revealed that mid/peri-pubertal binge EtOH exposure significantly affected miR biosynthetic processing enzymes, Drosha and Dicer. Finally, EtOH-induced significant changes in the expression of a subset of miRs, which correlated with changes in the expression of their predicted target genes. Taken together, these data demonstrate that EtOH exposure during pubertal development has long-term effects on miRNA expression in the rat hippocampus.	[Prins, Sarah A.; Przybycien-Szymanska, Magdalena M.; Rao, Yathindar S.; Pak, Toni R.] Loyola Univ, Chicago Hlth Sci Div, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Pak, TR (corresponding author), Loyola Univ, Chicago Hlth Sci Div, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.	tpak@lumc.edu			NIH [R01AA021517, R21AA018398, T32 AA013527]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527, R21AA018398, R01AA021517] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH R01AA021517, NIH R21AA018398 and NIH T32 AA013527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2011, NEUROSCIENCE, V182, P162, DOI 10.1016/j.neuroscience.2011.03.003; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Caputo V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028656; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Criado JR, 2008, ALCOHOL CLIN EXP RES, V32, P1752, DOI 10.1111/j.1530-0277.2008.00760.x; Ehlers CL, 2011, NEUROSCIENCE, V199, P333, DOI 10.1016/j.neuroscience.2011.10.011; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2006, HIPPOCAMPUS, V16, P664, DOI 10.1002/hipo.20193; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028; Juhila J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021495; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; KETELSLEGERS JM, 1978, ENDOCRINOLOGY, V103, P212, DOI 10.1210/endo-103-1-212; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Krebs MO, 2000, MOL PSYCHIATR, V5, P558, DOI 10.1038/sj.mp.4000749; Lauing K, 2008, ALCOHOL, V42, P649, DOI 10.1016/j.alcohol.2008.08.005; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Matthews DB, 2000, HIPPOCAMPUS, V10, P122, DOI 10.1002/(SICI)1098-1063(2000)10:1<122::AID-HIPO13>3.3.CO;2-M; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Miranda RC, 2010, ALCOHOL CLIN EXP RES, V34, P575, DOI 10.1111/j.1530-0277.2009.01126.x; Montag C, 2010, PSYCHIAT RES, V179, P86, DOI 10.1016/j.psychres.2008.08.005; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Morris SA, 2010, HIPPOCAMPUS, V20, P596, DOI 10.1002/hipo.20665; Mulligan Megan K., 2013, Frontiers in Genetics, V4, P126, DOI 10.3389/fgene.2013.00126; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Oscar-Berman Marlene, 2005, Neuropsychiatr Dis Treat, V1, P211; Pak TR, 2013, PFLUG ARCH EUR J PHY, V465, P655, DOI 10.1007/s00424-013-1227-y; Pappalardo-Carter DL, 2013, ALCOHOL CLIN EXP RES; Parada M, 2011, ALCOHOL CLIN EXP RES, V35, P1475, DOI 10.1111/j.1530-0277.2011.01484.x; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026647; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018350; Przybycien-Szymanska MM, 2010, AM J PHYSIOL-ENDOC M, V298, pE320, DOI 10.1152/ajpendo.00615.2009; Read JP, 2008, ADDICT BEHAV, V33, P225, DOI 10.1016/j.addbeh.2007.09.001; Richardson HN, 2009, NEUROBIOL DIS, V36, P1, DOI 10.1016/j.nbd.2009.05.021; Ros-Simo C, 2013, J NEUROCHEMISTRY; Rosellini AJ, 2013, J PSYCHOPATHOL BEHAV, V35, P356, DOI 10.1007/s10862-013-9338-5; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schulteis G, 2008, ALCOHOL, V42, P459, DOI 10.1016/j.alcohol.2008.05.002; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Silvers JM, 2003, ALCOHOL CLIN EXP RES, V27, P1606, DOI 10.1097/01.ALC.0000090141.66526.22; SODERSTEN P, 1975, HORM BEHAV, V6, P307, DOI 10.1016/0018-506X(75)90001-X; SODERSTEN P, 1977, HORM BEHAV, V8, P320, DOI 10.1016/0018-506X(77)90006-X; Strickland ER, 2011, NEUROSCIENCE, V186, P146, DOI 10.1016/j.neuroscience.2011.03.063; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Uchida N, 2010, CELL STEM CELL, V6, P294, DOI 10.1016/j.stem.2010.03.010; Walker BM, 2009, PHARMACOL BIOCHEM BE, V91, P560, DOI 10.1016/j.pbb.2008.09.017; Wang GH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S19; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; White AM, 2006, ALCOHOL CLIN EXP RES, V30, P1006, DOI 10.1111/j.1530-0277.2006.00122.x	71	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83166	10.1371/journal.pone.0083166	http://dx.doi.org/10.1371/journal.pone.0083166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416161	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500034
J	Victoni, T; Gleonnec, F; Lanzetti, M; Tenor, H; Valenca, S; Porto, LC; Lagente, V; Boichot, E				Victoni, Tatiana; Gleonnec, Florence; Lanzetti, Manuella; Tenor, Hermann; Valenca, Samuel; Porto, Luis Cristovao; Lagente, Vincent; Boichot, Elisabeth			Roflumilast N-Oxide Prevents Cytokine Secretion Induced by Cigarette Smoke Combined with LPS through JAK/STAT and ERK1/2 Inhibition in Airway Epithelial Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; OBSTRUCTIVE PULMONARY-DISEASE; SIGNAL-REGULATED KINASE; PHOSPHODIESTERASE-4 INHIBITOR; KAPPA-B; INFLAMMATORY CYTOKINES; BACTERIAL-COLONIZATION; CHEMOKINE RELEASE; IL-8 EXPRESSION; SMOOTH-MUSCLE	Cigarette smoke is a major cause of chronic obstructive pulmonary disease (COPD). Airway epithelial cells and macrophages are the first defense cells against cigarette smoke and these cells are an important source of pro-inflammatory cytokines. These cytokines play a role in progressive airflow limitation and chronic airways inflammation. Furthermore, the chronic colonization of airways by Gram-negative bacteria, contributes to the persistent airways inflammation and progression of COPD. The current study addressed the effects of cigarette smoke along with lipolysaccharide (LPS) in airway epithelial cells as a representative in vitro model of COPD exacerbations. Furthermore, we evaluated the effects of PDE4 inhibitor, the roflumilast N-oxide (RNO), in this experimental model. A549 cells were stimulated with cigarette smoke extract (CSE) alone (0.4% to 10%) or in combination with a low concentration of LPS (0.1 mu g/ml) for 2 h or 24 h for measurement of chemokine protein and mRNAs and 5-120 min for protein phosphorylation. Cells were also pre-incubated with MAP kinases inhibitors and Prostaglandin E-2 alone or combined with RNO, before the addition of CSE+LPS. Production of cytokines was determined by ELISA and protein phosphorylation by western blotting and phospho-kinase array. CSE did not induce production of IL-8/CXCL8 and Gro-alpha/CXCL1 from A549 cells, but increase production of CCL2/MCP-1. However the combination of LPS 0.1 mu g/ml with CSE 2% or 4% induced an important production of these chemokines, that appears to be dependent of ERK1/2 and JAK/STAT pathways but did not require JNK and p38 pathways. Moreover, RNO associated with PGE(2) reduced CSE+LPS-induced cytokine release, which can happen by occur through of ERK1/2 and JAK/STAT pathways. We report here an in vitro model that can reflect what happen in airway epithelial cells in COPD exacerbation. We also showed a new pathway where CSE+LPS can induce cytokine release from A549 cells, which is reduced by RNO.	[Victoni, Tatiana; Gleonnec, Florence; Lagente, Vincent; Boichot, Elisabeth] Univ Rennes 1, INSERM, UMR991, Rennes, France; [Lanzetti, Manuella; Valenca, Samuel; Porto, Luis Cristovao] Univ Estado Rio De Janeiro, IBRAG, DHE, Lab Reparo Tecidual, Rio De Janeiro, Brazil; [Tenor, Hermann] Nycomed GmbH, Constance, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universidade do Estado do Rio de Janeiro; Nycomed GmbH	Victoni, T (corresponding author), Univ Rennes 1, INSERM, UMR991, Rennes, France.	tatiana.victoni@univ-rennes1.fr	Lanzetti, Manuella/D-5915-2016; Porto, Luis Cristovao M S/I-2984-2013; Valenca, Samuel S/J-7986-2013; Porto, Luis Cristovao/U-6499-2019; dos Santos Valença, Samuel/C-7772-2009; Victoni, Tatiana/AAX-2629-2020	Lanzetti, Manuella/0000-0003-3913-608X; Porto, Luis Cristovao M S/0000-0003-1499-1821; Valenca, Samuel S/0000-0002-1868-9905; Porto, Luis Cristovao/0000-0003-1499-1821; dos Santos Valença, Samuel/0000-0002-1868-9905; Victoni, Tatiana/0000-0001-7263-8300; Lagente, Vincent/0000-0003-4920-009X; LORANT, Elisabeth/0000-0002-4914-0122	INSERM; Falcute de Pharmacie de Rennes 1; CAPES-COFECUB	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Falcute de Pharmacie de Rennes 1; CAPES-COFECUB(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by INSERM and Falcute de Pharmacie de Rennes 1. The authors M. L., T. V., V. L., L. C. P., and S. S. V. are grateful to the CAPES-COFECUB for funding and bilateral agreement (Brazil-France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2006, EUR J PHARMACOL, V533, P118, DOI 10.1016/j.ejphar.2005.12.054; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Biswas SK, 2002, INT IMMUNOPHARMACOL, V2, P1095, DOI 10.1016/S1567-5769(02)00055-3; Buenestado A, 2011, BRIT J PHARMACOL, V165, P1877; Choi SY, 2012, INFLAMM RES, V61, P493, DOI 10.1007/s00011-012-0437-7; Diamant Z, 2011, PULM PHARMACOL THER, V24, P353, DOI 10.1016/j.pupt.2010.12.011; Field SK, 2011, CLIN MED INSIGHTS-CI, V5, P57, DOI 10.4137/CCRPM.S7049; Fuke S, 2004, AM J RESP CELL MOL, V31, P405, DOI 10.1165/rcmb.2004-0131OC; Goyal A, 2010, BBA-GEN SUBJECTS, V1800, P574, DOI 10.1016/j.bbagen.2010.03.009; Gross NJ, 2010, COPD, V7, P141, DOI 10.3109/15412551003758304; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Hellermann GR, 2002, RESP RES, V3, DOI 10.1186/rr172; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ip WK, 2006, CLIN EXP IMMUNOL, V145, P162, DOI 10.1111/j.1365-2249.2006.03085.x; Issa R, 2006, AM J PHYSIOL-LUNG C, V291, pL66, DOI 10.1152/ajplung.00384.2005; Kitagawa D, 2002, J BIOL CHEM, V277, P366, DOI 10.1074/jbc.M107110200; Korsgren M, 2012, CLIN PHYSIOL FUNCT I, V32, P71, DOI 10.1111/j.1475-097X.2011.01058.x; Laan M, 2004, J IMMUNOL, V173, P4164, DOI 10.4049/jimmunol.173.6.4164; Liu R, 2001, J LEUKOCYTE BIOL, V70, P961; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Ortiz JL, 2010, PULM PHARMACOL THER, V23, P222, DOI 10.1016/j.pupt.2009.11.001; Martorana PA, 2005, AM J RESP CRIT CARE, V172, P848, DOI 10.1164/rccm.200411-1549OC; Mata M, 2005, THORAX, V60, P144, DOI 10.1136/thx.2004.025692; Mercer Becky A, 2006, Int J Chron Obstruct Pulmon Dis, V1, P137, DOI 10.2147/copd.2006.1.2.137; Milara J, 2012, BRIT J PHARMACOL, V166, P2243, DOI 10.1111/j.1476-5381.2012.01929.x; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Oyaizu T, 2012, INTENS CARE MED, V38, P894, DOI 10.1007/s00134-012-2498-z; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Reynolds PR, 2006, AM J RESP CELL MOL, V35, P314, DOI 10.1165/rcmb.2005-0428OC; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Sabatini F, 2010, PULM PHARMACOL THER, V23, P283, DOI 10.1016/j.pupt.2010.02.004; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Tsuji T, 2010, RESPIRATION, V80, P59, DOI 10.1159/000268287; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Wuyts WA, 2003, RESP MED, V97, P811, DOI 10.1016/S0954-6111(03)00036-2; Zalacain R, 1999, EUR RESPIR J, V13, P343, DOI 10.1034/j.1399-3003.1999.13b21.x	45	29	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85243	10.1371/journal.pone.0085243	http://dx.doi.org/10.1371/journal.pone.0085243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416369	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500229
J	Zhou, B; Zhao, B				Zhou, Bin; Zhao, Bin			Analysis of Intervention Strategies for Inhalation Exposure to Polycyclic Aromatic Hydrocarbons and Associated Lung Cancer Risk Based on a Monte Carlo Population Exposure Assessment Model	PLOS ONE			English	Article							PARTICULATE MATTER; INDOOR; POLLUTANTS; IMPACT; STOVE	It is difficult to evaluate and compare interventions for reducing exposure to air pollutants, including polycyclic aromatic hydrocarbons (PAHs), a widely found air pollutant in both indoor and outdoor air. This study presents the first application of the Monte Carlo population exposure assessment model to quantify the effects of different intervention strategies on inhalation exposure to PAHs and the associated lung cancer risk. The method was applied to the population in Beijing, China, in the year 2006. Several intervention strategies were designed and studied, including atmospheric cleaning, smoking prohibition indoors, use of clean fuel for cooking, enhancing ventilation while cooking and use of indoor cleaners. Their performances were quantified by population attributable fraction (PAF) and potential impact fraction (PIF) of lung cancer risk, and the changes in indoor PAH concentrations and annual inhalation doses were also calculated and compared. The results showed that atmospheric cleaning and use of indoor cleaners were the two most effective interventions. The sensitivity analysis showed that several input parameters had major influence on the modeled PAH inhalation exposure and the rankings of different interventions. The ranking was reasonably robust for the remaining majority of parameters. The method itself can be extended to other pollutants and in different places. It enables the quantitative comparison of different intervention strategies and would benefit intervention design and relevant policy making.	[Zhou, Bin; Zhao, Bin] Tsinghua Univ, Dept Bldg Sci, Sch Architecture, Beijing 100084, Peoples R China	Tsinghua University	Zhao, B (corresponding author), Tsinghua Univ, Dept Bldg Sci, Sch Architecture, Beijing 100084, Peoples R China.	binzhao@tsinghua.edu.cn	Zhao, Bin/B-5158-2012; Zhou, Bin/E-4102-2017	Zhao, Bin/0000-0003-1325-6091; Zhou, Bin/0000-0002-1741-8628	National Natural Science Foundation of China [51136002]; 12th Five-year National Key Technology RD Program [2012BAJ02B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-year National Key Technology RD Program(Chinese Academy of Sciences)	Financial support was provided by the National Natural Science Foundation of China (Grant No. 51136002) and the 12th Five-year National Key Technology R&D Program (Grant No. 2012BAJ02B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RW, 2011, AM J RESP CRIT CARE, V183, P1222, DOI 10.1164/rccm.201010-1572OC; Armstrong B, 2004, ENVIRON HEALTH PERSP, V112, P970, DOI 10.1289/ehp.6895; Batterman S, 2012, INDOOR AIR, V22, P235, DOI 10.1111/j.1600-0668.2011.00761.x; Beijing Municipal Bureau of Statistics, 2007, BEIJ STAT YB; Burke JM, 2001, J EXPO ANAL ENV EPID, V11, P470, DOI 10.1038/sj.jea.7500188; Cho SH, 2000, J OCCUP HEALTH, V42, P138, DOI 10.1539/joh.42.138; Ezzati M, 2004, COMP QUANTIFICATION; HE XZ, 1989, INT CONGR SER, V860, P227; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Kruize H, 2003, J EXPO ANAL ENV EPID, V13, P87, DOI 10.1038/sj.jea.7500258; Lan Q, 1999, CHINESE J PUBLIC HLT, V15; Li Q, 2011, CHARACTERIZING COMMU; Li Z, 2011, ENVIRON INT, V37, P1157, DOI 10.1016/j.envint.2011.03.024; Liu L, 2007, J SAFETY ENV, P35; Liu Y, 2011, J ENV HLTH, P240; Loh MM, 2007, ENVIRON HEALTH PERSP, V115, P1160, DOI 10.1289/ehp.9884; Mastrangelo G, 1996, ENVIRON HEALTH PERSP, V104, P1166, DOI 10.2307/3432909; NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X; Riojas-Rodriguez H, 2011, ENVIRON HEALTH PERSP, V119, P1301, DOI 10.1289/ehp.1002927; Shi SS, 2012, ATMOS ENVIRON, V59, P93, DOI 10.1016/j.atmosenv.2012.05.007; Vardoulakis S, 2008, SCI TOTAL ENVIRON, V394, P244, DOI 10.1016/j.scitotenv.2008.01.037; World Health Organization, 2000, AIR QUALITY GUIDELIN, V2nd; Zartarian V, 2008, 600R08118 EPA OFF RE; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P21063, DOI 10.1073/pnas.0905756106; Zhou B, 2012, ATMOS ENVIRON, V62, P472, DOI 10.1016/j.atmosenv.2012.08.059; Zidek JV, 2005, ENVIRONMETRICS, V16, P481, DOI 10.1002/env.716	27	16	16	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85676	10.1371/journal.pone.0085676	http://dx.doi.org/10.1371/journal.pone.0085676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416436	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500260
J	Zuo, XY; Pan, W; Feng, TT; Shi, XH; Dai, JF				Zuo, Xiangyang; Pan, Wen; Feng, Tingting; Shi, Xiaohong; Dai, Jianfeng			Matrix Metalloproteinase 3 Promotes Cellular Anti-Dengue Virus Response via Interaction with Transcription Factor NF kappa B in Cell Nucleus	PLOS ONE			English	Article							SIGNALING PATHWAY; GENE-EXPRESSION; INFLAMMATION; LOCALIZATION; INFECTION; MECHANISMS; MODULATORS; MICROGLIA; APOPTOSIS; ISCHEMIA	Dengue virus (DENV), the causative agent of human Dengue hemorrhagic fever, is a mosquito-borne virus of immense global health importance. Characterization of cellular factors promoting or inhibiting DENV infection is important for understanding the mechanism of DENV infection. In this report, MMP3 (stromelysin-1), a secretory endopeptidase that degrades extracellular matrices, has been shown promoting cellular antiviral response against DENV infection. Quantitative RT-PCR and Western Blot showed that the expression of MMP3 was upregulated in DENV-infected RAW264.7 cells. The intracellular viral loads were significantly higher in MMP3 silenced cells compared with controls. The expression level of selective anti-viral cytokines were decreased in MMP3 siRNA treated cells, and the transcription factor activity of NFkB was significantly impaired upon MMP3 silencing during DENV infection. Further, we found that MMP3 moved to cell nucleus upon DENV infection and colocalized with NF kappa B P65 in nucleus. Co-immunoprecipitation analysis suggested that MMP3 directly interacted with NF kappa B in nucleus during DENV infection and the C-terminal hemopexin-like domain of MMP3 was required for the interaction. This study suggested a novel role of MMP3 in nucleus during viral infection and provided new evidence for MMPs in immunomodulation.	[Zuo, Xiangyang; Pan, Wen; Feng, Tingting; Shi, Xiaohong; Dai, Jianfeng] Soochow Univ, Inst Biol & Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Dai, JF (corresponding author), Soochow Univ, Inst Biol & Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou, Jiangsu, Peoples R China.	daijianfeng@suda.edu.cn	Dai, Jianfeng/ACP-1114-2022		Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1075]; National Natural Science Foundation of China (NSFC) [81172812, 81271792, 31200648]; Jiangsu Natural Science Foundation [BK2012180]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (IRT1075), National Natural Science Foundation of China (NSFC) (81172812, 81271792, 31200648) and Jiangsu Natural Science Foundation (BK2012180), J.D. is a member of Jiangsu Provincial Innovative Research Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Cousin H, 2011, DEV CELL, V20, P256, DOI 10.1016/j.devcel.2010.12.009; Cuadrado E, 2009, J CEREBR BLOOD F MET, V29, P398, DOI 10.1038/jcbfm.2008.130; Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Ip YC, 2007, MOL CARCINOGEN, V46, P225, DOI 10.1002/mc.20270; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Kim EM, 2011, J NEUROCHEM, V116, P22, DOI 10.1111/j.1471-4159.2010.07082.x; Kim EM, 2010, J BIOL CHEM, V285, P16444, DOI 10.1074/jbc.M109.093799; Kim YS, 2005, J NEUROSCI, V25, P3701, DOI 10.1523/JNEUROSCI.4346-04.2005; Li CKF, 2004, J IMMUNOL, V173, P5171, DOI 10.4049/jimmunol.173.8.5171; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Mannello F, 2012, PROG HISTOCHEM CYTO, V47, P27, DOI 10.1016/j.proghi.2011.12.002; McMillan SJ, 2004, J IMMUNOL, V172, P2586, DOI 10.4049/jimmunol.172.4.2586; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Ruta A, 2009, EXP LUNG RES, V35, P59, DOI 10.1080/01902140802406059; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Si-Tayeb K, 2006, AM J PATHOL, V169, P1390, DOI 10.2353/ajpath.2006.060005; Souslova V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009902; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Walker EJ, 2009, EXP NEUROL, V216, P122, DOI 10.1016/j.expneurol.2008.11.022; Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08; Wetzel M, 2003, EUR J NEUROSCI, V18, P1050, DOI 10.1046/j.1460-9568.2003.02838.x; WHITE LA, 1987, J CLIN MICROBIOL, V25, P1221, DOI 10.1128/JCM.25.7.1221-1224.1987; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; Woo MS, 2008, J NEUROCHEM, V106, P770, DOI 10.1111/j.1471-4159.2008.05430.x	35	23	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84748	10.1371/journal.pone.0084748	http://dx.doi.org/10.1371/journal.pone.0084748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416274	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500157
J	Grunberg, JR; Hammarstedt, A; Hedjazifar, S; Smith, U				Grunberg, John R.; Hammarstedt, Ann; Hedjazifar, Shahram; Smith, Ulf			The Novel Secreted Adipokine WNT1-inducible Signaling Pathway Protein 2 (WISP2) Is a Mesenchymal Cell Activator of Canonical WNT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; Beta-catenin; Bone Morphogenetic Protein (BMP); Cell Biology; Obesity; Peroxisome Proliferator-activated receptor (PPAR); Wnt Pathway	PLURIPOTENT STEM-CELLS; HYPERTROPHIC OBESITY; METABOLIC SYNDROME; ABDOMINAL OBESITY; DIFFERENTIATION; ADIPOGENESIS; COMMITMENT; DEDIFFERENTIATION; ACCUMULATION; INFLAMMATION	Background: WISP2 is a cytosolic and secreted protein produced by precursor cells. Results: Secreted, but not cytosolic, WISP2 activates canonical WNT and prevents adipogenic differentiation. Conclusion: WISP2 is an important regulator of both adipogenic commitment and differentiation. Significance: Secreted WISP2 is a novel regulator of canonical WNT and PPAR activation. WNT1-inducible-signaling pathway protein 2 (WISP2) is primarily expressed in mesenchymal stem cells, fibroblasts, and adipogenic precursor cells. It is both a secreted and cytosolic protein, the latter regulating precursor cell adipogenic commitment and PPAR induction by BMP4. To examine the effect of the secreted protein, we expressed a full-length and a truncated, non-secreted WISP2 in NIH3T3 fibroblasts. Secreted, but not truncated WISP2 activated the canonical WNT pathway with increased -catenin levels, its nuclear targeting phosphorylation, and LRP5/6 phosphorylation. It also inhibited Pparg activation and the effect of secreted WISP2 was reversed by the WNT antagonist DICKKOPF-1. Differentiated 3T3-L1 adipose cells were also target cells where extracellular WISP2 activated the canonical WNT pathway, inhibited Pparg and associated adipose genes and, similar to WNT3a, promoted partial dedifferentiation of the cells and the induction of a myofibroblast phenotype with activation of markers of fibrosis. Thus, WISP2 exerts dual actions in mesenchymal precursor cells; secreted WISP2 activates canonical WNT and maintains the cells in an undifferentiated state, whereas cytosolic WISP2 regulates adipogenic commitment.	[Grunberg, John R.; Hammarstedt, Ann; Hedjazifar, Shahram; Smith, Ulf] Univ Gothenburg, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Ctr Excellence Cardiovasc & Metab Res,Sahlgrenska, SE-41345 Gothenburg, Sweden	University of Gothenburg	Smith, U (corresponding author), Sahlgrens Univ Hosp, Dept Mol & Clin Med, Vita Straket 12 L, SE-41345 Gothenburg, Sweden.	ulf.smith@medic.gu.se		Grunberg, John/0000-0002-7839-2302	Swedish Medical Research Council [K2013-54X-03506-42-5]; Swedish ALF funds; Torsten Soderbergs Foundation; O.E and Edla Johansson Foundation; Fredrik and Ingrid Thuring Foundation; Wilhelm and Martina Lundgren Foundation; Edgar Sjolund Foundation; Novo Nordisk Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish ALF funds; Torsten Soderbergs Foundation; O.E and Edla Johansson Foundation; Fredrik and Ingrid Thuring Foundation; Wilhelm and Martina Lundgren Foundation; Edgar Sjolund Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by grants from the Swedish Medical Research Council (K2013-54X-03506-42-5), the Swedish ALF funds, the Torsten Soderbergs Foundation, the O.E and Edla Johansson Foundation, the Fredrik and Ingrid Thuring Foundation, the Wilhelm and Martina Lundgren Foundation, the Edgar Sjolund Foundation, and the Novo Nordisk Foundation.	Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Cruciat C. M., 2013, COLD SPRING HARB PER, V5; Dahlman I, 2012, ARCH PHYSIOL BIOCHEM, V118, P84, DOI 10.3109/13813455.2012.685745; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Gustafson B, 2013, DIABETES, V62, P2997, DOI 10.2337/db13-0473; Gustafson B, 2012, DIABETES, V61, P1217, DOI 10.2337/db11-1419; Gustafson B, 2010, J BIOL CHEM, V285, P14031, DOI 10.1074/jbc.M110.102855; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; He X, 2006, CELL, V127, P40, DOI 10.1016/j.cell.2006.09.016; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Perbal B, 2013, J CELL COMMUN SIGNAL, V7, P169, DOI 10.1007/s12079-013-0193-7; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Willert K., 2012, COLD SPRING HARB PER, V4	34	51	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6899	6907		10.1074/jbc.M113.511964	http://dx.doi.org/10.1074/jbc.M113.511964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451367	hybrid, Green Published			2022-12-25	WOS:000332389400050
J	Li, JH; Zhuo, M; Pei, L; Rajagopal, M; Yu, ASL				Li, Jiahua; Zhuo, Min; Pei, Lei; Rajagopal, Madhumitha; Yu, Alan S. L.			Comprehensive Cysteine-scanning Mutagenesis Reveals Claudin-2 Pore-lining Residues with Different Intrapore Locations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epithelial Cell; Ion Channels; Membrane Transport; Sodium Transport; Tight Junctions	TIGHT JUNCTION; CATION SELECTIVITY; EPITHELIAL-CELLS; EXPRESSION; MEMBRANE; CHANNELS	Background: The composition of the claudin paracellular pore region is incompletely known. Results: Cysteine-scanning mutagenesis of the first extracellular domain of claudin-2 was used to identify all pore-lining residues and their intrapore locations. Conclusion: This study maps out the claudin-2 pore region. Significance: This advances understanding of the structure-function relationship of claudin pores. The first extracellular loop (ECL1) of claudins forms paracellular pores in the tight junction that determine ion permselectivity. We aimed to map the pore-lining residues of claudin-2 by comprehensive cysteine-scanning mutagenesis of ECL1. We screened 45 cysteine mutations within the ECL1 by expression in polyclonal Madin-Darby canine kidney II Tet-Off cells and found nine mutants that displayed a significant decrease of conductance after treatment with the thiol-reactive reagent 2-(trimethylammonium)ethyl methanethiosulfonate, indicating the location of candidate pore-lining residues. Next, we stably expressed these candidates in monoclonal Madin-Darby canine kidney I Tet-Off cells and exposed them to thiol-reactive reagents. The maximum degree of inhibition of conductance, size selectivity of degree of inhibition, and size dependence of the kinetics of reaction were used to deduce the location of residues within the pore. Our data support the following sequence of pore-lining residues located from the narrowest to the widest part of the pore: Ser(68), Ser(47), Thr(62)/Ile(66), Thr(56), Thr(32)/Gly(45), and Met(52). The paracellular pore appears to primarily be lined by polar side chains, as expected for a predominantly aqueous environment. Furthermore, our results strongly suggest the existence of a continuous sequence of residues in the ECL1 centered around Asp(65)-Ser(68) that form a major part of the lining of the pore.	[Li, Jiahua; Zhuo, Min; Pei, Lei; Rajagopal, Madhumitha; Yu, Alan S. L.] Univ Kansas, Med Ctr, Div Nephrol & Hypertens, Kansas City, KS 66160 USA; [Li, Jiahua; Zhuo, Min; Pei, Lei; Rajagopal, Madhumitha; Yu, Alan S. L.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA; [Pei, Lei; Yu, Alan S. L.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Li, Jiahua] John H Stroger Jr Hosp Cook Cty, Dept Med, Chicago, IL 60612 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yu, ASL (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, 3901 Rainbow Blvd,Mail Stop 3018, Kansas City, KS 66160 USA.	ayu@kumc.edu	Yu, Alan/AID-7467-2022	Yu, Alan/0000-0002-1776-2533	National Institutes of Health [R01DK062283, U01GM094627]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK062283 and U01GM094627 (to A. Y.).	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Cukierman L, 2009, J VIROL, V83, P5477, DOI 10.1128/JVI.02262-08; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li JH, 2013, J BIOL CHEM, V288, P22790, DOI 10.1074/jbc.M113.484238; Li JH, 2013, AM J PHYSIOL-CELL PH, V305, pC190, DOI 10.1152/ajpcell.00074.2013; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Yu ASL, 2011, METHODS MOL BIOL, V762, P27, DOI 10.1007/978-1-61779-185-7_3; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	19	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6475	6484		10.1074/jbc.M113.536888	http://dx.doi.org/10.1074/jbc.M113.536888			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24436330	Green Published, hybrid			2022-12-25	WOS:000332389400015
J	Liu, C; Chen, XR; Yang, L; Kisseleva, T; Brenner, DA; Seki, E				Liu, Cheng; Chen, Xiaorong; Yang, Ling; Kisseleva, Tatiana; Brenner, David A.; Seki, Ekihiro			Transcriptional Repression of the Transforming Growth Factor beta (TGF-beta) Pseudoreceptor BMP and Activin Membrane-bound Inhibitor (BAMBI) by Nuclear Factor kappa B (NF-kappa B) p50 Enhances TGF-beta Signaling in Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatic Stellate Cells; Lipopolysaccharide (LPS); NF-B; Toll-like Receptors (TLR); Transcription Promoter; Transforming Growth Factor (TGF-)	LIVER; FIBROSIS; IDENTIFICATION; INFLAMMATION; MECHANISMS; CYTOKINES; SUBUNIT; TARGET; GENE	Background: Toll-like receptor 4 (TLR4) mediates BAMBI down-regulation, which activates hepatic stellate cells (HSCs). Results: LPS and TNF- induced binding of NF-Bp50 to HDAC1, which suppressed BAMBI promoter activity and mRNA expression in HSCs. Conclusion: TLR4-mediated HSC activation is regulated by promoter regulation of BAMBI. Significance: Studying the regulation of BAMBI expression by TLR4 is important for understanding liver fibrosis. TLR4 signaling induces down-regulation of the bone morphogenic protein (BMP) and activin membrane-bound inhibitor (BAMBI), which enhances TGF- signaling during hepatic stellate cell (HSC) activation. We investigated the mechanism by which TLR4 signaling down-regulates BAMBI expression in HSCs and found that TLR4- and TNF--mediated BAMBI down-regulation is dependent on regulation of BAMBI promoter activity through the interaction with NF-Bp50 and HDAC1 in HSCs. Bambi was predominantly expressed in HSCs, at high levels in quiescent HSCs but at low levels in in vivo-activated and LPS-stimulated HSCs. In human HSCs, BAMBI expression was down-regulated in response to LPS and TNF-. A BAMBI reporter assay demonstrated that the regulatory element to repress BAMBI transcription is located between 3384 and 1560 bp upstream from the transcription start site. LPS stimulation down-regulated BAMBI expression in cells with NF-Bp65 knockdown. However, it failed to down-regulate BAMBI in cells with inactivation of NF-B or NF-Bp50 silencing, indicating that NF-Bp50 is a factor for BAMBI down-regulation. ChIP analysis revealed that LPS and TNF- induced binding of the NF-Bp50/p50 homodimer to the BAMBI promoter region. We also found that HDAC1 is bound to this region as part of the NF-Bp50-HDAC1 complex, repressing transcriptional activity of the BAMBI promoter. Finally, we confirmed that LPS does not repress BAMBI reporter activity using a BAMBI reporter construct with a mutation at 3166 bp upstream of the coding region. In summary, our study demonstrates that LPS- and TNF--induced NF-Bp50-HDAC1 interaction represses BAMBI transcriptional activity, which contributes to TLR4-mediated enhancement of TGF- signaling in HSCs during liver fibrosis.	[Liu, Cheng; Yang, Ling; Kisseleva, Tatiana; Brenner, David A.; Seki, Ekihiro] Univ Calif San Diego, Sch Med, Div Gastroenterol, Dept Med, La Jolla, CA 92093 USA; [Liu, Cheng] Shanghai Publ Clin Hlth Ctr, Ctr Sci Res, Shanghai 201508, Peoples R China; [Liu, Cheng; Chen, Xiaorong] Shanghai Publ Clin Hlth Ctr, Dept Tradit Chinese Med, Shanghai 201508, Peoples R China	University of California System; University of California San Diego	Seki, E (corresponding author), Univ Calif San Diego, Sch Med, Div Gastroenterol, Dept Med, 9500 Gilman Dr,MC 0063,LBR 118B, La Jolla, CA 92093 USA.	ekseki@ucsd.edu	Seki, Ekihiro/K-2481-2016; Liu, Cheng/I-3979-2015	Seki, Ekihiro/0000-0002-9472-6085; Brenner, David/0000-0003-2573-525X	National Institutes of Health [R01DK085252, R01AA020172, R01 GM041804]; NIEHS, National Institutes of Health [P42ES010337, 5]; National Institutes of Health/National Center for Advancing Translational Sciences/Clinical and Translational Research Institute [KL2TR000099]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099205, R01DK085252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA021856, R01AA020172, P50AA011999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health/National Center for Advancing Translational Sciences/Clinical and Translational Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK085252 and R01AA020172 and NIEHS, National Institutes of Health Grant P42ES010337 (Project 5) (to E. S.); National Institutes of Health/National Center for Advancing Translational Sciences/Clinical and Translational Research Institute Grant KL2TR000099 (to T. K.); and National Institutes of Health Grant R01 GM041804 (to D. A. B.).	Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; De Minicis S, 2013, AM J PATHOL, V183, P820, DOI 10.1016/j.ajpath.2013.05.030; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Friedman SL, 2007, NAT MED, V13, P1281, DOI 10.1038/nm1107-1281; Friedman SL, 2004, HEPATOLOGY, V40, P1041, DOI 10.1002/hep.20476; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Gao ZG, 2009, J BIOL CHEM, V284, P18368, DOI 10.1074/jbc.M109.007260; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Grundstrom S, 2004, J BIOL CHEM, V279, P8460, DOI 10.1074/jbc.M312398200; Hatano E, 2001, GASTROENTEROLOGY, V120, P1251, DOI 10.1053/gast.2001.23239; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lei SG, 2012, STEM CELLS, V30, P2810, DOI 10.1002/stem.1251; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Luedde Tom, 2008, Hepatology, V47, P1089, DOI 10.1002/hep.22232; Luo X, 2012, DIABETES, V61, P124, DOI 10.2337/db11-0998; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Villar AV, 2013, BBA-MOL BASIS DIS, V1832, P323, DOI 10.1016/j.bbadis.2012.11.007; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xavier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012995; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	33	68	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7082	7091		10.1074/jbc.M113.543769	http://dx.doi.org/10.1074/jbc.M113.543769			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24448807	Green Published, hybrid			2022-12-25	WOS:000332389400067
J	Wan, L; Huang, J				Wan, Li; Huang, Jun			The PSO4 Protein Complex Associates with Replication Protein A (RPA) and Modulates the Activation of Ataxia Telangiectasia-mutated and Rad3-related (ATR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Checkpoint Control; DNA Damage Response; DNA Repair; Signal Transduction	PRE-MESSENGER-RNA; DNA-DAMAGE; U-BOX; PRP19-ASSOCIATED COMPLEX; SPLICEOSOME; REPAIR; CDC5L; PRIMPOL; BINDING; PRP19	Background: The function of the PSO4 complex in response to DNA damage remains unclear. Results: The PSO4 complex is required for efficient accumulation of ATRIP at DNA damage sites and the subsequent CHK1 activation and RPA2 phosphorylation. Conclusion: The PSO4 complex modulates ATR activation through interaction with RPA. Significance: We reveal a role for RNA processing factor PSO4 in ATR activation. The PSO4 core complex is composed of PSO4/PRP19/SNEV, CDC5L, PLRG1, and BCAS2/SPF27. Besides its well defined functions in pre-mRNA splicing, the PSO4 complex has been shown recently to participate in the DNA damage response. However, the specific role for the PSO4 complex in the DNA damage response pathways is still not clear. Here we show that both the BCAS2 and PSO4 subunits of the PSO4 complex directly interact and colocalize with replication protein A (RPA). Depletion of BCAS2 or PSO4 impairs the recruitment of ATR-interacting protein (ATRIP) to DNA damage sites and compromises CHK1 activation and RPA2 phosphorylation. Moreover, we demonstrate that both the RPA1-binding ability of BCAS2 and the E3 ligase activity of PSO4 are required for efficient accumulation of ATRIP at DNA damage sites and the subsequent CHK1 activation and RPA2 phosphorylation. Our results suggest that the PSO4 complex functionally interacts with RPA and plays an important role in the DNA damage response.	[Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Huang, J (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	jhuang@zju.edu.cn	Wan, Li/AFR-0017-2022		National Program for Special Support of Eminent Professionals; National Basic Research Program of China [2012CB944402, 2013CB911003]; National Natural Science Funds for Distinguished Young Scholars; Zhejiang University K.P. Chao's High Technology Development Foundation; China Fundamental Research Funds for the Central Universities	National Program for Special Support of Eminent Professionals; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Funds for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Zhejiang University K.P. Chao's High Technology Development Foundation; China Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Program for Special Support of Eminent Professionals, National Basic Research Program of China Grants 2012CB944402 and 2013CB911003, by National Natural Science Funds for Distinguished Young Scholars, by Zhejiang University K.P. Chao's High Technology Development Foundation, and by China Fundamental Research Funds for the Central Universities.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Ajuh P, 2001, J BIOL CHEM, V276, P42370, DOI 10.1074/jbc.M105453200; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2006, RNA, V12, P765, DOI 10.1261/rna.2292106; Chen PH, 2013, RNA, V19, P208, DOI 10.1261/rna.034835.112; CHENG SC, 1993, MOL CELL BIOL, V13, P1876, DOI 10.1128/MCB.13.3.1876; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Grey M, 1996, NUCLEIC ACIDS RES, V24, P4009, DOI 10.1093/nar/24.20.4009; Groenen PMA, 1998, GENOMICS, V49, P218, DOI 10.1006/geno.1998.5254; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Helleday T, 2013, NAT STRUCT MOL BIOL, V20, P1348, DOI 10.1038/nsmb.2727; HENRIQUES JAP, 1989, MUTAT RES, V218, P111, DOI 10.1016/0921-8777(89)90017-7; Im JS, 2013, EMBO REP, V14, P1032, DOI 10.1038/embor.2013.171; Kleinridders A, 2009, MOL CELL BIOL, V29, P3173, DOI 10.1128/MCB.01807-08; Legerski RJ, 2009, CELL CYCLE, V8, P3448, DOI 10.4161/cc.8.21.9760; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Loscher M, 2005, BIOCHEM J, V388, P593, DOI 10.1042/BJ20041517; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Maass N, 2002, CANCER LETT, V185, P219, DOI 10.1016/S0304-3835(02)00286-0; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Marechal A., 2014, MOL CELL, V10; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; TARN WY, 1993, MOL CELL BIOL, V13, P1883, DOI 10.1128/MCB.13.3.1883; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159; Wan L, 2013, P NATL ACAD SCI USA, V110, P10646, DOI 10.1073/pnas.1220921110; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	36	43	43	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6619	6626		10.1074/jbc.M113.543439	http://dx.doi.org/10.1074/jbc.M113.543439			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443570	hybrid, Green Published			2022-12-25	WOS:000332389400026
J	Jemth, P; Mu, X; Engstrom, A; Dogan, J				Jemth, Per; Mu, Xin; Engstrom, Ake; Dogan, Jakob			A Frustrated Binding Interface for Intrinsically Disordered Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Intrinsically Disordered Proteins; Kinetics; Protein Domains; Protein Engineering; Protein-Protein Interactions	TRANSACTIVATION DOMAIN; ACTIVATION DOMAIN; TRANSITION-STATE; COACTIVATOR; COMPLEX; MECHANISM; RECOGNITION; MODULATION; CBP/P300; SLOW	Background: Protein-protein interactions often involve intrinsically disordered protein domains. Results: The binding interface between two disordered protein domains is suboptimal, or frustrated, with regard to the energetics. Conclusion: The frustration likely results from the promiscuous binding behavior of these disordered domains. Significance: Suboptimal binding interfaces may be common among intrinsically disordered proteins with multiple binding partners. Intrinsically disordered proteins are very common in the eukaryotic proteome, and many of them are associated with diseases. Disordered proteins usually undergo a coupled binding and folding reaction and often interact with many different binding partners. Using double mutant cycles, we mapped the energy landscape of the binding interface for two interacting disordered domains and found it to be largely suboptimal in terms of interaction free energies, despite relatively high affinity. These data depict a frustrated energy landscape for interactions involving intrinsically disordered proteins, which is likely a result of their functional promiscuity.	[Jemth, Per; Mu, Xin; Engstrom, Ake; Dogan, Jakob] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University	Jemth, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden.	per.jemth@imbim.uu.se; jakob.dogan@imbim.uu.se			Swedish Research Council (Natural and Engineering Sciences); Human Frontiers Young Investigator Science Program; Magnus Bergvall Foundation	Swedish Research Council (Natural and Engineering Sciences)(Swedish Research Council); Human Frontiers Young Investigator Science Program; Magnus Bergvall Foundation	This work was supported by the Swedish Research Council (Natural and Engineering Sciences) and the Human Frontiers Young Investigator Science Program (to P. J.) and by the Magnus Bergvall Foundation (to J. D.).	BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; Drobnak I, 2013, J AM CHEM SOC, V135, P1288, DOI 10.1021/ja305081b; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebert MO, 2008, BIOCHEMISTRY-US, V47, P1299, DOI 10.1021/bi701767j; Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Goldman ER, 1997, BIOCHEMISTRY-US, V36, P49, DOI 10.1021/bi961769k; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Hultqvist G, 2013, STRUCTURE, V21, P1193, DOI 10.1016/j.str.2013.05.010; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Kiel C, 2004, J MOL BIOL, V340, P1039, DOI 10.1016/j.jmb.2004.05.050; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Mas C, 2011, P NATL ACAD SCI USA, V108, P10484, DOI 10.1073/pnas.1017029108; Matsuda S, 2004, J BIOL CHEM, V279, P14055, DOI 10.1074/jbc.M310188200; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Rogers JM, 2013, J AM CHEM SOC, V135, P1415, DOI 10.1021/ja309527h; Ryan CM, 2006, CELL CYCLE, V5, P2146, DOI 10.4161/cc.5.18.3207; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Shammas SL, 2012, BIOPHYS J, V103, P2203, DOI 10.1016/j.bpj.2012.10.012; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Zhou HX, 2012, TRENDS BIOCHEM SCI, V37, P43, DOI 10.1016/j.tibs.2011.11.002	39	28	28	6	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5528	5533		10.1074/jbc.M113.537068	http://dx.doi.org/10.1074/jbc.M113.537068			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24421312	Green Published, hybrid			2022-12-25	WOS:000332015500017
J	Legrain, Y; Touat-Hamici, Z; Chavatte, L				Legrain, Yona; Touat-Hamici, Zahia; Chavatte, Laurent			Interplay between Selenium Levels, Selenoprotein Expression, and Replicative Senescence in WI-38 Human Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Senescence; Glutathione Peroxidase; Selenium; Thioredoxin Reductase; Translation Control; SECIS; UGA Recoding; Selenoproteome	NONSENSE-MEDIATED DECAY; RNA-BINDING PROTEIN; SELENOCYSTEINE INCORPORATION; MESSENGER-RNAS; CELLULAR SENESCENCE; UGA; TRANSLATION; DEFICIENCY; MACHINERY; COMPLEXES	Background: Selenoproteins are important enzymes for antioxidant defense, redox homeostasis, and redox signaling. Results: We report that, in WI-38 human fibroblasts, replicative senescence is controlled by selenium levels and selectively modulates selenoprotein expression. Conclusion: Our data indicate that the selenoproteome is regulated at the translational and mRNA levels in WI-38 cells. Significance: We have characterized a strong interplay between selenium levels, selenoprotein expression, and replicative senescence. Selenium is an essential trace element, which is incorporated as selenocysteine into at least 25 selenoproteins using a unique translational UGA-recoding mechanism. Selenoproteins are important enzymes involved in antioxidant defense, redox homeostasis, and redox signaling pathways. Selenium levels decline during aging, and its deficiency is associated with a marked increase in mortality for people over 60 years of age. Here, we investigate the relationship between selenium levels in the culture medium, selenoprotein expression, and replicative life span of human embryonic lung fibroblast WI-38 cells. Selenium levels regulate the entry into replicative senescence and modify the cellular markers characteristic for senescent cells. Whereas selenium supplementation extends the number of population doublings, its deficiency impairs the proliferative capacity of WI-38 cells. We observe that the expression of several selenoproteins involved in antioxidant defense is specifically affected in response to cellular senescence. Their expression is selectively controlled by the modulation of mRNA levels and translational recoding efficiencies. Our data provide novel mechanistic insights into how selenium impacts the replicative life span of mammalian cells by identifying several selenoproteins as new targets of senescence.	[Legrain, Yona; Touat-Hamici, Zahia; Chavatte, Laurent] CNRS, Ctr Genet Mol, UPR3404, F-91198 Gif Sur Yvette, France; [Chavatte, Laurent] CNRS UPPA, Lab Chim Analyt Bioinorgan & Environm, UMR5254, F-64000 Pau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour	Chavatte, L (corresponding author), CNRS UPPA, Lab Chim Analyt Bioinorgan & Environm, UMR5254, F-64000 Pau, France.	laurent.chavatte@univ-pau.fr		Chavatte, Laurent/0000-0001-7696-2431	CNRS (ATIP program); Fondation pour la Recherche Medicale; Ligue Contre le Cancer (Comite de l'Essonne); Association pour la Recherche sur le Cancer Grant [4849]; Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement; Agence Nationale de la Recherche [ANR-09-BLAN-0048]	CNRS (ATIP program); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Contre le Cancer (Comite de l'Essonne); Association pour la Recherche sur le Cancer Grant; Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the CNRS (ATIP program) (to L. C.), the Fondation pour la Recherche Medicale (to L. C.), the Ligue Contre le Cancer (Comite de l'Essonne) (to L. C.), Association pour la Recherche sur le Cancer Grant 4849 (to L. C.), the Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement (to L. C.), and Agence Nationale de la Recherche Grant ANR-09-BLAN-0048 (to L.C.).	Ahmed EK, 2007, ANN NY ACAD SCI, V1119, P88, DOI 10.1196/annals.1404.020; Akbaraly NT, 2005, CLIN CHEM, V51, P2117, DOI 10.1373/clinchem.2005.055301; Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 2002, METHOD ENZYMOL, V347, P226; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; BERMANO G, 1995, BIOCHEM J, V311, P425, DOI 10.1042/bj3110425; BERRY MJ, 1994, NUCLEIC ACIDS RES, V22, P3753, DOI 10.1093/nar/22.18.3753; Berry MJ, 2001, BIOFACTORS, V14, P17, DOI 10.1002/biof.5520140104; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; de Jesus LA, 2006, MOL CELL BIOL, V26, P1795, DOI 10.1128/MCB.26.5.1795-1805.2006; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Grune T, 2005, FREE RADICAL BIO MED, V39, P1208, DOI 10.1016/j.freeradbiomed.2005.06.009; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; HORNSBY PJ, 1987, EXP CELL RES, V168, P203, DOI 10.1016/0014-4827(87)90429-0; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Latreche L, 2012, RNA BIOL, V9, P681, DOI 10.4161/rna.20147; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Low SC, 2000, EMBO J, V19, P6882, DOI 10.1093/emboj/19.24.6882; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; OLIVIERI O, 1994, AM J CLIN NUTR, V60, P510, DOI 10.1093/ajcn/60.4.510; Papp LV, 2006, MOL CELL BIOL, V26, P4895, DOI 10.1128/MCB.02284-05; Ray AL, 2006, J NUTR, V136, P172, DOI 10.1093/jn/136.1.172; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Squires JE, 2007, MOL CELL BIOL, V27, P7848, DOI 10.1128/MCB.00793-07; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Yoo MH, 2010, ANTIOXID REDOX SIGN, V12, P819, DOI 10.1089/ars.2009.2891	37	45	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6299	6310		10.1074/jbc.M113.526863	http://dx.doi.org/10.1074/jbc.M113.526863			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425862	Green Published, hybrid			2022-12-25	WOS:000332015500081
J	Ding, H; Zhao, CJ; Cui, X; Gu, YF; Jia, WT; Rahaman, MN; Wang, Y; Huang, WH; Zhang, CQ				Ding, Hao; Zhao, Cun-Ju; Cui, Xu; Gu, Yi-Fei; Jia, Wei-Tao; Rahaman, Mohamed N.; Wang, Yang; Huang, Wen-Hai; Zhang, Chang-Qing			A Novel Injectable Borate Bioactive Glass Cement as an Antibiotic Delivery Vehicle for Treating Osteomyelitis	PLOS ONE			English	Article							CONTROLLABLE DEGRADATION BEHAVIOR; RESISTANT STAPHYLOCOCCUS-AUREUS; BONE SUBSTITUTE MATERIALS; CALCIUM-PHOSPHATE CEMENT; IN-VITRO; GLASS/CHITOSAN COMPOSITE; ADULT OSTEOMYELITIS; CARRIER MATERIAL; LOCAL-DELIVERY; DRUG-RELEASE	Background: A novel injectable cement composed of chitosan-bonded borate bioactive glass (BG) particles was evaluated as a carrier for local delivery of vancomycin in the treatment of osteomyelitis in a rabbit tibial model. Materials and Methods: The setting time, injectability, and compressive strength of the borate BG cement, and the release profile of vancomycin from the cement were measured in vitro. The capacity of the vancomycin-loaded BG cement to eradicate methicillin-resistant Staphylococcus aureus (MRSA)-induced osteomyelitis in rabbit tibiae in vivo was evaluated and compared with that for a vancomycin-loaded calcium sulfate (CS) cement and for intravenous injection of vancomycin. Results: The BG cement had an injectability of >90% during the first 3 minutes after mixing, hardened within 30 minutes and, after hardening, had a compressive strength of 18+/-2 MPa. Vancomycin was released from the BG cement into phosphate-buffered saline for up to 36 days, and the cumulative amount of vancomycin released was 86% of the amount initially loaded into the cement. In comparison, vancomycin was released from the CS cement for up 28 days and the cumulative amount released was 89%. Two months post-surgery, radiography and microbiological tests showed that the BG and CS cements had a better ability to eradicate osteomyelitis when compared to intravenous injection of vancomycin, but there was no significant difference between the BG and CS cements in eradicating the infection. Histological examination showed that the BG cement was biocompatible and had a good capacity for regenerating bone in the tibial defects. Conclusions: These results indicate that borate BG cement is a promising material both as an injectable carrier for vancomycin in the eradication of osteomyelitis and as an osteoconductive matrix to regenerate bone after the infection is cured.	[Jia, Wei-Tao; Wang, Yang; Zhang, Chang-Qing] Shanghai Jiao Tong Univ, Dept Orthoped Surg, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Zhao, Cun-Ju] Liaocheng Peoples Hosp, Dept Orthoped Surg, Liaocheng, Shandong, Peoples R China; [Cui, Xu; Gu, Yi-Fei; Huang, Wen-Hai] Tongji Univ, Inst Bioengn & Informat Technol Mat, Shanghai 200092, Peoples R China; [Rahaman, Mohamed N.] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO USA	Shanghai Jiao Tong University; Tongji University; University of Missouri System; Missouri University of Science & Technology	Huang, WH (corresponding author), Tongji Univ, Inst Bioengn & Informat Technol Mat, Shanghai 200092, Peoples R China.	whhuang@tongji.edu.cn; zcqgk@hotmail.com	Cui, Xu/P-1610-2015	zhang, changqing/0000-0002-7408-4126	National Natural Science Foundation of China [51072133, 81000788, 81201377]; Shanghai Science Committee [12JC1408500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science Committee	This work was supported by the National Natural Science Foundation of China through the project 51072133, 81000788 and 81201377, and by the Shanghai Science Committee through the project 12JC1408500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoci V, 2007, CLIN ORTHOP RELAT R, P200, DOI 10.1097/BLO.0b013e31811ff866; Arcos D, 2001, BIOMATERIALS, V22, P701, DOI 10.1016/S0142-9612(00)00233-7; ASTM International C26699, 2007, C26699 ASTM INT; Brown RF, 2009, J BIOMED MATER RES A, V88A, P392, DOI 10.1002/jbm.a.31679; Buranapanitkit B, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000130268.27024.c1; Cevher E, 2006, INT J PHARMACEUT, V317, P127, DOI 10.1016/j.ijpharm.2006.03.014; Chang W, 2007, ACTA ORTHOP BELG, V73, P238; Cierny G, 2003, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000088564.81746.62; Englert C, 2007, UNFALLCHIRURG, V110, P408, DOI 10.1007/s00113-007-1229-3; Ginebra MP, 2001, J BIOMED MATER RES, V57, P113, DOI 10.1002/1097-4636(200110)57:1<113::AID-JBM1149>3.0.CO;2-5; GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6; Haleem AA, 2004, CLIN ORTHOP RELAT R, P22, DOI 10.1097/01.blo.0000144477.43661.59; Hanssen AD, 2005, CLIN ORTHOP RELAT R, P91, DOI 10.1097/01.blo.0000175713.30506.77; Jia WT, 2010, INT J PHARMACEUT, V387, P184, DOI 10.1016/j.ijpharm.2009.12.002; Jia WT, 2010, ACTA BIOMATER, V6, P812, DOI 10.1016/j.actbio.2009.09.011; Jia WT, 2010, ANTIMICROB AGENTS CH, V54, P170, DOI 10.1128/AAC.01122-09; Jiang JL, 2012, INFLAMM RES, V61, P207, DOI 10.1007/s00011-011-0402-x; Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083; Kanellakopoulou K, 2009, INT J ANTIMICROB AG, V33, P354, DOI 10.1016/j.ijantimicag.2008.09.008; Kluin OS, 2013, EXPERT OPIN DRUG DEL, V10, P341, DOI 10.1517/17425247.2013.751371; Liu H, 2006, ACTA BIOMATER, V2, P557, DOI 10.1016/j.actbio.2006.03.007; Marion NW, 2005, MECH ADV MATER STRUC, V12, P239, DOI 10.1080/15376490590928615; McCann SJ, 2002, J ANTIMICROB CHEMOTH, V50, P107, DOI 10.1093/jac/dkf067; McLaren AC, 2004, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000143554.56897.26; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; National Committee for Clinical Laboratory Standards NCCLS, 2000, M7A5 NCCLS; NORDEN CW, 1980, BRIT J EXP PATHOL, V61, P451; Patwardhan S, 2013, J BONE JOINT SURG AM, V95A, DOI 10.2106/JBJS.K.01338; Phaechamud T, 2008, AAPS PHARMSCITECH, V9, P829, DOI 10.1208/s12249-008-9117-x; Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045; Sanicola Shawn M, 2005, J Foot Ankle Surg, V44, P121, DOI 10.1053/j.jfas.2005.01.006; Simpson AHRW, 2001, J BONE JOINT SURG BR, V83B, P403, DOI 10.1302/0301-620X.83B3.10727; Smeltzer MS, 1997, J ORTHOPAED RES, V15, P414, DOI 10.1002/jor.1100150314; Tang H, 2009, ARCH ORTHOP TRAUM SU, V129, P1301, DOI 10.1007/s00402-008-0782-8; Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012; Yao AH, 2007, CHINESE SCI BULL, V52, P272, DOI 10.1007/s11434-007-0023-5; Yao AH, 2007, J AM CERAM SOC, V90, P303, DOI 10.1111/j.1551-2916.2006.01358.x; Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6; Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312	39	35	40	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85472	10.1371/journal.pone.0085472	http://dx.doi.org/10.1371/journal.pone.0085472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427311	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200052
J	Mullerova, H; Lu, C; Li, H; Tabberer, M				Muellerova, Hana; Lu, Chao; Li, Hao; Tabberer, Maggie			Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care	PLOS ONE			English	Article							REPORTED OUTCOMES; DYSPNEA; COPD; SEVERITY; MECHANISMS; SYMPTOMS; HYPERINFLATION; EXACERBATION; POPULATION; SPIROMETRY	Background & Aims: Breathlessness is a primary clinical feature of chronic obstructive pulmonary disease (COPD). We aimed to describe the frequency of and factors associated with breathlessness in a cohort of COPD patients identified from the Clinical Practice Research Datalink (CPRD), a general practice electronic medical records database. Methods: Patients with a record of COPD diagnosis after January 1 2008 were identified in the CPRD. Breathlessness was assessed using the Medical Research Council (MRC) dyspnoea scale, with scoring ranging from 1-5, which has been routinely administered as a part of the regular assessment of patients with COPD in the general practice since April 2009. Stepwise multivariate logistic regression estimated independent associations with dyspnoea. Negative binomial regression evaluated a relationship between breathlessness and exacerbation rate during follow-up. Results: The total cohort comprised 49,438 patients diagnosed with COPD; 40,425 (82%) had any MRC dyspnoea grade recorded. Of those, 22,770 (46%) had moderate-to-severe dyspnoea (MRC >= 3). Breathlessness increased with increasing airflow limitation; however, moderate-to-severe dyspnoea was also observed in 32% of patients with mild airflow obstruction. Other factors associated with increased dyspnoea grade included female gender, older age (>= 70 years), obesity (BMI >= 30), history of moderate-to-severe COPD exacerbations, and frequent visits to the general practitioner. Patients with worse breathlessness were at higher risk of COPD exacerbations during follow-up. Conclusions: Moderate-to-severe dyspnoea was reported by >40% of patients diagnosed with COPD in primary care. Presence of dyspnoea, including even a perception of mild dyspnoea (MRC = 2), was associated with increased disease severity and a higher risk of COPD exacerbations during follow-up.	[Muellerova, Hana] GlaxoSmithKline R&D, Resp Epidemiol, Uxbridge, Middx, England; [Lu, Chao; Li, Hao] GlaxoSmithKline R&D, Observat Data Analyt, Res Triangle Pk, NC USA; [Tabberer, Maggie] GlaxoSmithKline R&D, Global Hlth Outcomes, Uxbridge, Middx, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Mullerova, H (corresponding author), GlaxoSmithKline R&D, Resp Epidemiol, Uxbridge, Middx, England.	hana.x.muellerova@gsk.com		Mullerova, Hana/0000-0002-0949-0101	GlaxoSmithKline Plc.	GlaxoSmithKline Plc.(GlaxoSmithKline)	Editorial support (in the form of development of a draft outline in consultation with the authors, development of a manuscript first draft in consultation with the authors, editorial suggestions to draft versions of this paper, analyses of key data to provide test statistics, assembling tables and figures, collating author comments, copyediting, fact checking, referencing and graphic services) was provided by Jane Davies and Carol Cooper of Caudex Medical and was funded by GlaxoSmithKline Plc. The open-access charge was paid for by GlaxoSmithKline Plc.	Bausewein C, 2007, RESP MED, V101, P399, DOI 10.1016/j.rmed.2006.07.003; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; BMA & NHS Employers, 2009, QUALITY OUTCOMES FRA; Booth Sara, 2009, Expert Rev Respir Med, V3, P21, DOI 10.1586/17476348.3.1.21; Burgel PR, 2012, RESP MED; Chronic Obstructive Pulmonary Disease, 2004, THORAX S1, V59; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dransfield MT, 2011, PRIM CARE RESP J, V20, P46, DOI 10.4104/pcrj.2010.00059; Figarska SM, 2012, EUR J EPIDEMIOL, V27, P867, DOI 10.1007/s10654-012-9736-0; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; Gold Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Howard K, 2012, VALUE HEALTH, V15, P1042, DOI 10.1016/j.jval.2012.06.018; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jolley CJ, 2009, EUR RESPIR REV, V18, P66, DOI 10.1183/09059180.00000809; Jones PW, 2011, EUR RESPIR J, V38, P29, DOI 10.1183/09031936.00177210; Jones PW, 2011, RESP MED, V105, P57, DOI 10.1016/j.rmed.2010.09.004; Jones P, 2012, INT J CHRONIC OBSTR, V7, P697, DOI 10.2147/COPD.S32675; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; Laveneziana P, 2009, EUR J APPL PHYSIOL, V107, P633, DOI 10.1007/s00421-009-1169-4; Mahler DA, 2012, COPD, V9, P522, DOI 10.3109/15412555.2012.701678; NICE, 2007, MRC DYSPN SCAL; NICE, 2011, MAN CHRON OBSTR PULM; O'Donnell DE, 2006, EUR RESPIR REV, V15, P61, DOI 10.1183/09059180.00010002; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; O'Donnell Denis E, 2007, COPD, V4, P225, DOI 10.1080/15412550701480455; O'Donnell Denis E, 2007, Proc Am Thorac Soc, V4, P145, DOI 10.1513/pats.200611-159CC; O'Donnell DE, 2009, RESP PHYSIOL NEUROBI, V167, P116, DOI 10.1016/j.resp.2009.01.010; Oga T, 2007, RESP MED, V101, P146, DOI 10.1016/j.rmed.2006.04.001; Ora J, 2010, CURR OPIN PULM MED, V16, P144, DOI 10.1097/MCP.0b013e328334a728; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Redelmeier DA, 1996, CHEST, V109, P1163, DOI 10.1378/chest.109.5.1163; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Sahebjami H, 2000, AM J RESP CRIT CARE, V161, P886, DOI 10.1164/ajrccm.161.3.9905023; Sarkar S, 2006, PRIMARY CARE, V33, P643, DOI 10.1016/j.pop.2006.06.007; Sheel AW, 2011, CURR OPIN PHARMACOL, V11, P195, DOI 10.1016/j.coph.2011.04.004; Soriano JB, 2001, EUR J EPIDEMIOL, V17, P1075, DOI 10.1023/A:1021235123382; Strong M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-108; Uzaslan E, 2012, RESP MED, V106, pS45, DOI 10.1016/S0954-6111(12)70014-8; Walke LM, 2007, ARCH INTERN MED, V167, P2503, DOI 10.1001/archinte.167.22.2503; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC	42	74	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85540	10.1371/journal.pone.0085540	http://dx.doi.org/10.1371/journal.pone.0085540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427316	Green Submitted, gold, Green Published			2022-12-25	WOS:000329868200057
J	Nunes, T; Etchevers, MJ; Sandi, MJ; Donnay, SP; Grandjean, T; Pellise, M; Panes, J; Ricart, E; Iovanna, JL; Dagorn, JC; Chamaillard, M; Sans, M				Nunes, Tiago; Josefina Etchevers, Maria; Sandi, Maria Jose; Pino Donnay, Susana; Grandjean, Teddy; Pellise, Maria; Panes, Julian; Ricart, Elena; Iovanna, Juan Lucio; Dagorn, Jean-Charles; Chamaillard, Mathias; Sans, Miquel			Pancreatitis-Associated Protein Does Not Predict Disease Relapse in Inflammatory Bowel Disease Patients	PLOS ONE			English	Article							FECAL CALPROTECTIN; GENE-EXPRESSION; CROHNS-DISEASE; BACTERIAL; LECTIN; MICE; PATHOGENS; CHILDREN; DIARRHEA; COLITIS	Background: The pancreatitis-associated protein (PAP) is increased in the serum of active inflammatory bowel disease (IBD) patients and its levels seem to be correlated with disease activity. Our aim was to evaluate the usefulness of serum and fecal PAP measurements to predict relapse in patients with inactive IBD. Materials and Methods: We undertook a 12-month prospective study that included 66 Crohn's disease (CD) and 74 ulcerative colitis (UC) patients. At inclusion, patients were in clinical remission, defined by a Harvey-Bradshaw (HB) Index <= 4 (CD) or a partial Mayo Score (MS)<3 (UC), along with a normal serum C reactive protein (CRP) and fecal calprotectin. Patients were followed every 3 months. Blood and stool samples were collected and a clinical evaluation was performed at each visit. Serum PAP and CRP levels as well as fecal concentrations of PAP and calprotectin were assessed. Results: Active CD patients had an increased mean serum PAP at the diagnosis of the flare (104.1 ng/ml) and 3 months prior to activity (22.68 ng/ml) compared with patients in remission (13.26 ng/ml), p<0.05. No significant change in serum PAP levels in UC and fecal PAP levels in CD and UC were detected during disease activity. In CD, serum PAP was a poor diagnostic predictor of disease activity, with an AUC of 0.69. In patients in remission, fecal PAP was barely detectable in UC compared with CD patients. Conclusion: Serum PAP is increased only in active CD patients, but this marker does not predict disease activity. Inactive UC patients have marked low levels of PAP in fecal samples compared with CD patients.	[Nunes, Tiago; Josefina Etchevers, Maria; Pino Donnay, Susana; Pellise, Maria; Panes, Julian; Ricart, Elena] Hosp Clin Barcelona, Dept Gastroenterol, IDIBAPS, Ctr Invest Biome Red Enfermedades Hepa & Digest C, Barcelona, Catalonia, Spain; [Sandi, Maria Jose; Iovanna, Juan Lucio; Dagorn, Jean-Charles] Aix Marseille Univ, CNRS, INSERM, U1068,UMR 7258,CRCM, Marseille, France; [Sandi, Maria Jose; Iovanna, Juan Lucio; Dagorn, Jean-Charles] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Grandjean, Teddy; Chamaillard, Mathias] Univ Lille Nord France, F-59000 Lille, France; [Grandjean, Teddy; Chamaillard, Mathias] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Grandjean, Teddy; Chamaillard, Mathias] CNRS, UMR8204, F-59021 Lille, France; [Grandjean, Teddy; Chamaillard, Mathias] INSERM, U1019, Team 7, Equipe FRM, F-59019 Lille, France; [Sans, Miquel] Ctr Med Teknon, Dept Digest Dis, Barcelona, Catalonia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Sans, M (corresponding author), Ctr Med Teknon, Dept Digest Dis, Barcelona, Catalonia, Spain.	sans@dr.teknon.es	Grandjean, Teddy/AAV-8005-2020; Iovanna, Juan/M-9805-2017; Pellise, Maria/ABC-3246-2021; Grandjean, Teddy/V-1309-2017; Chamaillard, Mathias/L-6542-2013; Panes, Julian/H-5991-2015	Grandjean, Teddy/0000-0002-6244-0154; Iovanna, Juan/0000-0003-1822-2237; Grandjean, Teddy/0000-0002-6244-0154; Chamaillard, Mathias/0000-0002-0243-9717; Panes, Julian/0000-0002-4971-6902; Pellise, Maria/0000-0001-9739-4998	Fondation pour la Recherche Medicale; Broad Medical Research Program on Inflammatory Bowel Disease, The Eli and Edythe Broad Foundation [IBD-0222R]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Broad Medical Research Program on Inflammatory Bowel Disease, The Eli and Edythe Broad Foundation	This work was supported by the Fondation pour la Recherche Medicale and by the Broad Medical Research Program on Inflammatory Bowel Disease, The Eli and Edythe Broad Foundation grant number IBD-0222R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeza N, 2001, DIGESTION, V64, P233, DOI 10.1159/000048867; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chen CC, 2012, J PEDIATR GASTR NUTR, V55, P541, DOI 10.1097/MPG.0b013e318262a718; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Desjeux A, 2002, GASTROEN CLIN BIOL, V26, P23; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Folch-Puy E, 2006, J IMMUNOL, V176, P3774, DOI 10.4049/jimmunol.176.6.3774; Gironella M, 2005, GUT, V54, P1244, DOI 10.1136/gut.2004.056309; Gironella M, 2007, GUT, V56, P1091, DOI 10.1136/gut.2006.116087; IOVANNA J, 1991, J BIOL CHEM, V266, P24664; IOVANNA JL, 1993, AM J PHYSIOL, V265, pG611, DOI 10.1152/ajpgi.1993.265.4.G611; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Mizoguchi E, 2003, GASTROENTEROLOGY, V125, P148, DOI 10.1016/S0016-5085(03)00665-6; Moniaux N, 2011, HEPATOLOGY, V53, P618, DOI 10.1002/hep.24087; MUNKHOLM P, 1995, SCAND J GASTROENTERO, V30, P699, DOI 10.3109/00365529509096316; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Papi C, 2013, DIGEST LIVER DIS, V45, P978, DOI 10.1016/j.dld.2013.07.006; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Shastri YM, 2008, AM J MED, V121, P1099, DOI 10.1016/j.amjmed.2008.06.034; Sykora J, 2010, ACTA PAEDIATR, V99, P1389, DOI 10.1111/j.1651-2227.2010.01843.x; van Ampting MTJ, 2012, INFECT IMMUN, V80, P1115, DOI 10.1128/IAI.06165-11; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003	23	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84957	10.1371/journal.pone.0084957	http://dx.doi.org/10.1371/journal.pone.0084957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416322	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300044
J	Somvanshi, RK; Kumar, U				Somvanshi, Rishi K.; Kumar, Ujendra			delta-Opioid Receptor and Somatostatin Receptor-4 Heterodimerization: Possible Implications in Modulation of Pain Associated Signaling	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DORSAL-ROOT GANGLIA; RAT SPINAL-CORD; NEUROPATHIC PAIN; OCTAPEPTIDE ANALOGS; OPIATE RECEPTORS; KNOCKOUT MICE; H-3 CTOP; MU; MORPHINE	Pain relief is the principal action of opioids. Somatostatin (SST), a growth hormone inhibitory peptide is also known to alleviate pain even in cases when opioids fail. Recent studies have shown that mice are prone to sustained pain and devoid of analgesic effect in the absence of somatostatin receptor 4 (SSTR4). In the present study, using brain slices, cultured neurons and HEK-293 cells, we showed that SSTR4 and delta-Opioid receptor (delta OR) exist in a heteromeric complex and function in synergistic manner. SSTR4 and delta OR co-expressed in cortical/striatal brain regions and spinal cord. Using cultured neuronal cells, we describe the heterogeneous complex formation of SSTR4 and delta OR at neuronal cell body and processes. Cotransfected cells display inhibition of cAMP/PKA and co-activation of SSTR4 and delta OR oppose receptor trafficking induced by individual receptor activation. Furthermore, downstream signaling pathways either associated with withdrawal or pain relief are modulated synergistically with a predominant role of SSTR4. Inhibition of cAMP/PKA and activation of ERK1/2 are the possible cellular adaptations to prevent withdrawal induced by chronic morphine use. Our results reveal direct intra-membrane interaction between SSTR4 and delta OR and provide insights for the molecular mechanism for the anti-nociceptive property of SST in combination with opioids as a potential therapeutic approach to avoid undesirable withdrawal symptoms.	[Somvanshi, Rishi K.; Kumar, Ujendra] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	University of British Columbia	Kumar, U (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.	ujkumar@mail.ubc.ca		Somvanshi, Rishi/0000-0002-7965-3068	Canadian Institute of Health Research [CIHR MOP 74465]; Canadian Breast Cancer Foundation BC/Yukon; NSERC	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation BC/Yukon; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from Canadian Institute of Health Research (CIHR MOP 74465), Canadian Breast Cancer Foundation BC/Yukon and NSERC to UK. UK is a Senior Scholar of Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BJ, 2010, J NEUROSCI, V30, P11537, DOI 10.1523/JNEUROSCI.6103-09.2010; Bagley EE, 2005, NEURON, V45, P433, DOI 10.1016/j.neuron.2004.12.049; Buzas B, 1997, NEUROSCIENCE, V76, P479, DOI 10.1016/S0306-4522(96)00242-4; Chrubasik J., 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P289; CHRUBASIK J, 1984, LANCET, V1, P738; Ciruela A, 2003, BRIT J PHARMACOL, V138, P751, DOI 10.1038/sj.bjp.0705103; Coop A, 2000, DRUG NEWS PERSPECT, V13, P481; Cruz CD, 2007, CURR NEUROPHARMACOL, V5, P244, DOI 10.2174/157015907782793630; Csaba Z, 2001, NEUROPEPTIDES, V35, P1, DOI 10.1054/npep.2001.0848; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; Dai Min, 2002, J Anesth, V16, P211, DOI 10.1007/s005400200027; Dolan S, 2001, NEUROSCI LETT, V309, P157, DOI 10.1016/S0304-3940(01)02063-8; Foldes F F, 1991, Anaesthesiol Reanim, V16, P287; FOLDES FF, 1991, ANESTHESIOLOGY, V75, P191, DOI 10.1097/00000542-199108000-00004; Fraser GL, 2000, BRIT J PHARMACOL, V129, P1668, DOI 10.1038/sj.bjp.0703248; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gaveriaux-Ruff C, 2002, NEUROPEPTIDES, V36, P62, DOI 10.1054/npep.2002.0900; Gaveriaux-Ruff C, 2011, PAIN, V152, P1238, DOI 10.1016/j.pain.2010.12.031; Grant M, 2004, J BIOL CHEM, V279, P38636, DOI 10.1074/jbc.M406276200; Grant M, 2008, MOL ENDOCRINOL, V22, P2278, DOI 10.1210/me.2007-0334; GULYA K, 1986, LIFE SCI, V38, P2221, DOI 10.1016/0024-3205(86)90574-6; Hammond DL, 1998, J PHARMACOL EXP THER, V284, P378; HAWKINS KN, 1989, J PHARMACOL EXP THER, V248, P73; HAWKINS KN, 1988, LIFE SCI, V42, P2541, DOI 10.1016/0024-3205(88)90322-0; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Helyes Z, 2009, P NATL ACAD SCI USA, V106, P13088, DOI 10.1073/pnas.0900681106; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2000, NEUROPSYCHOPHARMACOL, V23, pS5, DOI 10.1016/S0893-133X(00)00143-3; Kieffer BL, 1995, CELL MOL NEUROBIOL, V15, P615, DOI 10.1007/BF02071128; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; KNAPP RJ, 1995, FASEB J, V9, P516, DOI 10.1096/fasebj.9.7.7737460; Kovelowski CJ, 1999, BRAIN RES, V843, P12, DOI 10.1016/S0006-8993(99)01803-X; Kumar U, 2004, NEUROSCI RES, V49, P29, DOI 10.1016/j.neures.2004.01.011; Kumar U, 2007, J COMP NEUROL, V504, P185, DOI 10.1002/cne.21444; Lancranjan I, 1999, Pituitary, V1, P105; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Macey TA, 2009, J PHARMACOL EXP THER, V331, P412, DOI 10.1124/jpet.109.152157; Mika J, 2001, EUR J PHARMACOL, V415, P31, DOI 10.1016/S0014-2999(01)00814-7; MOLLENHOLT P, 1994, ANESTHESIOLOGY, V81, P534, DOI 10.1097/00000542-199409000-00004; Nadal X, 2006, EUR J NEUROSCI, V23, P830, DOI 10.1111/j.1460-9568.2006.04569.x; Narita M, 2004, NEUROSCIENCE, V124, P515, DOI 10.1016/j.neuroscience.2003.11.023; Narita M, 2002, NEUROSCIENCE, V113, P647, DOI 10.1016/S0306-4522(02)00197-5; Notas G, 2004, J HEPATOL, V40, P792, DOI 10.1016/j.jhep.2004.01.016; Notas G, 2007, EUR J PHARMACOL, V555, P1, DOI 10.1016/j.ejphar.2006.10.018; Obata K, 2007, J NEUROCHEM, V102, P1569, DOI 10.1111/j.1471-4159.2007.04656.x; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; PELTON JT, 1986, J MED CHEM, V29, P2370, DOI 10.1021/jm00161a037; PELTON JT, 1985, P NATL ACAD SCI USA, V82, P236, DOI 10.1073/pnas.82.1.236; PENN RD, 1992, PAIN, V49, P13, DOI 10.1016/0304-3959(92)90182-B; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Pollandt S, 2006, EUR J NEUROSCI, V24, P1733, DOI 10.1111/j.1460-9568.2006.05049.x; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; PUGSLEY TA, 1978, RES COMMUN CHEM PATH, V21, P153; Quock RM, 1999, PHARMACOL REV, V51, P503; Rajput PS, 2009, J CHEM NEUROANAT, V38, P20, DOI 10.1016/j.jchemneu.2009.05.004; Schulz R, 2002, J PHARMACOL EXP THER, V300, P376, DOI 10.1124/jpet.300.2.376; Schulz S, 1998, EUR J NEUROSCI, V10, P3700, DOI 10.1046/j.1460-9568.1998.00386.x; SICUTERI F, 1984, PAIN, V18, P359, DOI 10.1016/0304-3959(84)90048-4; Skyba D. A., 2004, DRUG DISCOV TODAY, V1, P115, DOI [10.1016/j.ddmod.2004.07.003, DOI 10.1016/J.DDMOD.2004.07.003]; Somvanshi RK, 2011, CELL SIGNAL, V23, P794, DOI 10.1016/j.cellsig.2011.01.002; Somvanshi RK, 2009, CELL SIGNAL, V21, P1396, DOI 10.1016/j.cellsig.2009.04.007; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; STEWART PE, 1993, J PHARMACOL EXP THER, V266, P820; TERENIUS L, 1976, EUR J PHARMACOL, V38, P211, DOI 10.1016/0014-2999(76)90221-1; Van Op den Bosch J, 2009, J CELL MOL MED, V13, P3283, DOI 10.1111/j.1582-4934.2009.00760.x; VINCENT SR, 1982, NATURE, V298, P65, DOI 10.1038/298065a0; WALKER JM, 1987, PEPTIDES, V8, P869; WILLIAMS G, 1986, NEW ENGL J MED, V315, P1166; Xu JT, 2007, EXP NEUROL, V206, P269, DOI 10.1016/j.expneurol.2007.05.029	71	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85193	10.1371/journal.pone.0085193	http://dx.doi.org/10.1371/journal.pone.0085193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416361	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500226
J	Thomas, RC; Willette, DA; Carpenter, KE; Santos, MD				Thomas, Rey C., Jr.; Willette, Demian A.; Carpenter, Kent E.; Santos, Mudjekeewis D.			Hidden Diversity in Sardines: Genetic and Morphological Evidence for Cryptic Species in the Goldstripe Sardinella, Sardinella gibbosa (Bleeker, 1849)	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; MORPHOMETRIC VARIATION; POPULATION; MITOCHONDRIAL; DNA; DELIMITATION; TELEOSTEI; FISHES; LEVEL	Cryptic species continue to be uncovered in many fish taxa, posing challenges for fisheries conservation and management. In Sardinella gibbosa, previous investigations revealed subtle intra-species variations, resulting in numerous synonyms and a controversial taxonomy for this sardine. Here, we tested for cryptic diversity within S. gibbosa using genetic data from two mitochondrial and one nuclear gene regions of 248 individuals of S. gibbosa, collected from eight locations across the Philippine archipelago. Deep genetic divergence and subsequent clustering was consistent across both mitochondrial and nuclear markers. Clade distribution is geographically limited: Clade 1 is widely distributed in the central Philippines, while Clade 2 is limited to the northernmost sampling site. In addition, morphometric analyses revealed a unique head shape that characterized each genetic clade. Hence, both genetic and morphological evidence strongly suggests a hidden diversity within this common and commercially-important sardine.	[Thomas, Rey C., Jr.; Santos, Mudjekeewis D.] Natl Fisheries Res & Dev Inst, Genet Fingerprinting Lab, Quezon City, Metro Manila, Philippines; [Willette, Demian A.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Carpenter, Kent E.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA	University of California System; University of California Los Angeles; Old Dominion University	Thomas, RC (corresponding author), Natl Fisheries Res & Dev Inst, Genet Fingerprinting Lab, Quezon City, Metro Manila, Philippines.	reycthomas@gmail.com		Willette, Demian/0000-0002-2843-9715; Santos, Mudjekeewis/0000-0002-4770-1221	National Fisheries Research and Development Institute grant; National Science Foundation [NSF OISE-0730256]	National Fisheries Research and Development Institute grant; National Science Foundation(National Science Foundation (NSF))	This project was funded mainly through a National Fisheries Research and Development Institute grant to Mudjekeewis Santos, Demian Willette and Eunice Bognot. This research was partly supported by a grant from the National Science Foundation (NSF OISE-0730256) to Kent Carpenter and Paul Barber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarhouch T, 2006, MOL PHYLOGENET EVOL, V39, P373, DOI 10.1016/j.ympev.2005.08.003; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boissin E, 2008, MOL ECOL, V17, P1732, DOI 10.1111/j.1365-294X.2007.03652.x; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Bruford Michael W., 1998, P287; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Chow S, 1998, MOL ECOL, V7, P1255; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colborn J, 2001, EVOLUTION, V55, P807, DOI 10.1554/0014-3820(2001)055[0807:TEEOBA]2.0.CO;2; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; DUTT S., 1961, JOUR ZOOL SOC INDIA, V13, P78; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAO, 2006, NATL AQUACULTURE SEC; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gill A, 1995, P BIOL SOC WASH, V117, P17; Gill Anthony C., 2011, Zootaxa, V3140, P49; Goodman SM, 2009, ZOOL SCR, V38, P339, DOI 10.1111/j.1463-6409.2008.00377.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haudorf B, 2011, EVOLUTION, V65, P923; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HEDGECOCK D, 1989, FISH B-NOAA, V87, P653; Hey J, 2003, TRENDS ECOL EVOL, V18, P597, DOI 10.1016/j.tree.2003.08.014; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; KINSEY ST, 1994, MAR BIOL, V118, P309, DOI 10.1007/BF00349798; Kishinouye K., 1908, J FISH BUR, V14, P71; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Ladner JT, 2012, MOL ECOL, V21, P2224, DOI 10.1111/j.1365-294X.2012.05528.x; Lavoue S, 2003, BIOL J LINN SOC, V78, P273, DOI 10.1046/j.1095-8312.2003.00170.x; Lavoue S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036287; Lazarus S, 1975, INDIAN J FISH, V24, P107; LEE WJ, 1995, J MOL EVOL, V41, P54; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mathews LM, 2009, MOL PHYLOGENET EVOL, V50, P268, DOI 10.1016/j.ympev.2008.10.026; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McCune B, 1999, MULTIVARIATE ANAL EC; Nair R, 1973, CSIR ZOOLOGICAL MONO; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Nyunja Judith A., 2002, Western Indian Ocean Journal of Marine Science, V1, P181; OKERA W, 1974, J FISH BIOL, V6, P801, DOI 10.1111/j.1095-8649.1974.tb05123.x; Okera W, 1970, J E AFRICA NATURAL H, V28, P1; Palumbi S, 1996, MOL SYSTEMATICS; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Piggott MP, 2011, BIOL J LINN SOC, V102, P391, DOI 10.1111/j.1095-8312.2010.01571.x; RAJA B T A, 1969, Records of Oceanographic Works in Japan, V10, P75; Rao, 1969, INDIAN J FISH, V16, P156; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Silva A, 2003, ICES J MAR SCI, V60, P1352, DOI 10.1016/S1054-3139(03)00141-3; SOKAL RR, 1970, AM NAT, V104, P127, DOI 10.1086/282646; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WHITEHEAD PJP, 1985, FAO FISHERIES SYNOPS, V7, P1; WHITLEY G. P., 1940, AUSTRALIAN ZOOL, V9, P397; Willette D, 2014, B MARINE SC IN PRESS, V90; Willette D, 2011, BFAR TECHNICAL PAPER, V13, P1; Willette DA, 2011, J FISH BIOL, V79, P2087, DOI 10.1111/j.1095-8649.2011.03133.x	66	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84719	10.1371/journal.pone.0084719	http://dx.doi.org/10.1371/journal.pone.0084719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416271	Green Published, gold			2022-12-25	WOS:000329862500154
J	Ye, TH; Xiong, Y; Yan, YP; Xia, Y; Song, XJ; Liu, L; Li, DL; Wang, NY; Zhang, LD; Zhu, YX; Zeng, J; Wei, YQ; Yu, LT				Ye, Tinghong; Xiong, Ying; Yan, Yupeng; Xia, Yong; Song, Xuejiao; Liu, Li; Li, Deliang; Wang, Ningyu; Zhang, Lidan; Zhu, Yongxia; Zeng, Jun; Wei, Yuquan; Yu, Luoting			The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; SUPPRESSOR-CELLS; STEM-CELLS; STAT3; EXPRESSION; CARCINOMA; SURVIVAL; GROWTH; PHOSPHORYLATION; DIFFERENTIATION	Breast carcinoma is the most common female cancer with considerable metastatic potential. Discovery of new therapeutic approaches for treatment of metastatic breast cancer is still needed. Here, we reported our finding with niclosamide, an FDA approved anthelmintic drug. The potency of niclosamide on breast cancer was assessed in vitro and in vivo. In this investigation, we found that niclosamide showed a dramatic growth inhibition against breast cancer cell lines and induced apoptosis of 4T1 cells in a dose-dependent manner. Further, Western blot analysis demonstrated the occurrence of its apoptosis was associated with activation of Cleaved caspases-3, down-regulation of Bcl-2, Mcl-1 and Survivin. Moreover, niclosamide blocked breast cancer cells migration and invasion, and the reduction of phosphorylated STAT3(Tyr705), phosphorylated FAK(Tyr925) and phosphorylated Src(Tyr416) were also observed. Furthermore, in our animal experiments, intraperitoneal administration of 20 mg/kg/d niclosamide suppressed 4T1 tumor growth without detectable toxicity. Histological and immunohistochemical analyses revealed a decrease in Ki67-positive cells, VEGF-positive cells and microvessel density (MVD) and an increase in Cleaved caspase-3-positive cells upon niclosamide. Notably, niclosamide reduced the number of myeloid-derived suppressor cells (MDSCs) in tumor tissues and blocked formation of pulmonary metastases. Taken together, these results demonstrated that niclosamide may be a promising candidate for breast cancer.	[Ye, Tinghong; Xiong, Ying; Yan, Yupeng; Xia, Yong; Song, Xuejiao; Liu, Li; Li, Deliang; Wang, Ningyu; Zhang, Lidan; Zhu, Yongxia; Zeng, Jun; Wei, Yuquan; Yu, Luoting] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Ye, Tinghong; Xiong, Ying; Yan, Yupeng; Xia, Yong; Song, Xuejiao; Liu, Li; Li, Deliang; Wang, Ningyu; Zhang, Lidan; Zhu, Yongxia; Zeng, Jun; Wei, Yuquan; Yu, Luoting] Sichuan Univ, West China Med Sch, West China Hosp, Ctr Canc, Chengdu 610064, Peoples R China; [Yan, Yupeng] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China; [Liu, Li; Zhang, Lidan] Sichuan Univ, Coll Chem Engn, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Wei, YQ (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	yuquawei@vip.sina.com; yuluot@scu.edu.cn		Wang, Ning-Yu/0000-0003-3571-4903	National Key Basic Research Program of China [2010 CB 529900]; National Natural Science Foundation of China [81123003]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Key Basic Research Program of China (2010 CB 529900) and the National Natural Science Foundation of China (81123003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BO, 2006, BREAST J, V12, pS54, DOI 10.1111/j.1075-122X.2006.00203.x; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Brennan K, 2003, BREAST CANCER RES, V5, P69, DOI 10.1186/bcr559; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Cataldo L, 2000, INT J ONCOL, V17, P1179; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; GARIN J P, 1964, Lyon Med, V212, P1581; Hao H, 2011, CANCER LETT, V309, P85, DOI 10.1016/j.canlet.2011.05.020; Harrison H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3396; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Khan S, 2013, CANCER LETT, V337, P90, DOI 10.1016/j.canlet.2013.05.020; Kodumudi KN, 2010, CLIN CANCER RES, V16, P4583, DOI 10.1158/1078-0432.CCR-10-0733; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Li R, 2013, MOL CANCER THER, V12, P2200, DOI 10.1158/1535-7163.MCT-13-0095; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074670; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Page C, 2000, INT J ONCOL, V17, P23; Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pulaski BA, 1998, CANCER RES, V58, P1486; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Sack U, 2011, JNCI-J NATL CANCER I, V103, P1018, DOI 10.1093/jnci/djr190; Saunders MM, 2001, CANCER RES, V61, P1765; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063900; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Wang AM, 2009, J CELL BIOCHEM, V106, P682, DOI 10.1002/jcb.22065; Wang YS, 2009, CLIN CANCER RES, V15, P6901, DOI 10.1158/1078-0432.CCR-09-0484; Wang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074538; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wiebe JP, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3422; Xin H, 2011, CANCER RES, V71, P6601, DOI 10.1158/0008-5472.CAN-11-1217; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yo YT, 2012, MOL CANCER THER, V11, P1703, DOI 10.1158/1535-7163.MCT-12-0002; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang T, 2012, BREAST CANCER RES TR, V135, P445, DOI 10.1007/s10549-012-2175-5; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109	46	86	90	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85887	10.1371/journal.pone.0085887	http://dx.doi.org/10.1371/journal.pone.0085887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416452	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500267
J	Koeberl, DD; Austin, S; Case, LE; Smith, EC; Buckley, AF; Young, SP; Bali, D; Kishnani, PS				Koeberl, Dwight D.; Austin, Stephanie; Case, Laura E.; Smith, Edward C.; Buckley, Anne F.; Young, Sarah P.; Bali, Deeksha; Kishnani, Priya S.			Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease	FASEB JOURNAL			English	Article						mannose-6-phosphate receptor; acid -glucosidase; acid maltase; glycogen storage disease type II	ACID-ALPHA-GLUCOSIDASE; BECKER MUSCULAR-DYSTROPHY; MOUSE MODEL; EFFICACY; GLYCOGEN; MASS; RECOMBINANT; DUCHENNE; VECTOR; TRIAL	Effective dosages for enzyme replacement therapy (ERT) in Pompe disease are much higher than for other lysosomal storage disorders, which has been attributed to low cation-independent mannose-6-phosphate receptor (CI-MPR) in skeletal muscle. We have previously demonstrated the benefit of increased CI-MPR-mediated uptake of recombinant human acid--glucosidase during ERT in mice with Pompe disease following addition of albuterol therapy. Currently we have completed a pilot study of albuterol in patients with late-onset Pompe disease already on ERT for >2 yr, who were not improving further. The 6-min walk test (6MWT) distance increased in all 7 subjects at wk 6 (30 +/- 13 m; P=0.002), wk 12 (34 +/- 14 m; P=0.004), and wk 24 (42 +/- 37 m; P=0.02), in comparison with baseline. Grip strength was improved significantly for both hands at wk 12. Furthermore, individual subjects reported benefits; e.g., a female patient could stand up from sitting on the floor much more easily (time for supine to standing position decreased from 30 to 11 s), and a male patient could readily swing his legs out of his van seat (hip abduction increased from 1 to 2+ on manual muscle testing). Finally, analysis of the quadriceps biopsies suggested increased CI-MPR at wk 12 (P=0.08), compared with baseline. With the exception of 1 patient who succumbed to respiratory complications of Pompe disease in the first week, only mild adverse events have been reported, including tremor, transient difficulty falling asleep, and mild urinary retention (requiring early morning voiding). Therefore, this pilot study revealed initial safety and efficacy in an open label study of adjunctive albuterol therapy in patients with late-onset Pompe disease who had been stable on ERT with no improvements noted over the previous several years.Koeberl, D. D., Austin, S., Case, L. E., Smith, E. C., Buckley, A. F., Young, S. P., Bali, D., Kishnani, P. S. Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease.	[Koeberl, Dwight D.; Austin, Stephanie; Young, Sarah P.; Bali, Deeksha; Kishnani, Priya S.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Case, Laura E.] Duke Univ, Med Ctr, Dept Community & Family Med, Div Phys Therapy, Durham, NC 27710 USA; [Smith, Edward C.] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Genet, Durham, NC 27710 USA; [Buckley, Anne F.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Koeberl, DD (corresponding author), Duke Univ, Med Ctr, Box 103856, Durham, NC 27710 USA.	koebe001@mc.duke.edu		Case, Laura/0000-0002-2941-2186; Buckley, Anne/0000-0003-1209-5791	Duke University Medical Center	Duke University Medical Center	This study was funded by a Bridge Funding grant from the Duke University Medical Center. The authors express appreciation to Dr. Y.-T. Chen for discussions regarding study design and therapy in Pompe disease. In addition, the authors deeply appreciate Ms. Songtao Li and Ms. Jian Dai for their outstanding technical support of this project, and Ms. Carla Johnson for logistical support.	Amalfitano A, 1999, P NATL ACAD SCI USA, V96, P8861, DOI 10.1073/pnas.96.16.8861; Angelini EPC, 2004, BASIC APPL MYOL, V14, P71; Cardone Monica, 2008, Pathogenetics, V1, P6, DOI 10.1186/1755-8417-1-6; CARUSO JF, 1995, MED SCI SPORT EXER, V27, P1471; Fowler EG, 2004, NEUROLOGY, V62, P1006, DOI 10.1212/01.WNL.0000118530.71646.0F; Kissel JT, 2001, NEUROLOGY, V57, P1434, DOI 10.1212/WNL.57.8.1434; Koeberl DD, 2012, MOL GENET METAB, V105, P221, DOI 10.1016/j.ymgme.2011.11.005; Koeberl DD, 2011, MOL GENET METAB, V103, P107, DOI 10.1016/j.ymgme.2011.02.006; Li ST, 2013, FASEB J, V27, P34, DOI 10.1096/fj.12-207472; Matsumoto T, 2006, ARCH ORAL BIOL, V51, P603, DOI 10.1016/j.archoralbio.2006.01.003; McVie-Wylie AJ, 2008, MOL GENET METAB, V94, P448, DOI 10.1016/j.ymgme.2008.04.009; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Skura CL, 2008, NEUROLOGY, V70, P137, DOI 10.1212/01.WNL.0000287070.00149.a9; Sun BD, 2005, MOL THER, V11, P57, DOI 10.1016/j.ymthe.2004.10.004; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; Young SP, 2009, GENET MED, V11, P536, DOI 10.1097/GIM.0b013e3181a87867; Young SP, 2003, ANAL BIOCHEM, V316, P175, DOI 10.1016/S0003-2697(03)00056-3; Zhu YX, 2009, MOL THER, V17, P954, DOI 10.1038/mt.2009.37	20	26	26	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2171	2176		10.1096/fj.13-241893	http://dx.doi.org/10.1096/fj.13-241893			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24443373	Green Submitted			2022-12-25	WOS:000335336000020
J	Sato, K; Iemitsu, M; Matsutani, K; Kurihara, T; Hamaoka, T; Fujita, S				Sato, Koji; Iemitsu, Motoyuki; Matsutani, Kenji; Kurihara, Toshiyuki; Hamaoka, Takafumi; Fujita, Satoshi			Resistance training restores muscle sex steroid hormone steroidogenesis in older men	FASEB JOURNAL			English	Article						aging; muscle strength; skeletal muscle; exercise	METABOLIC SYNDROME; TESTOSTERONE; EXERCISE; DHEA; DEHYDROEPIANDROSTERONE; STRENGTH; PATHWAY	Skeletal muscle can synthesize testosterone and 5 alpha-dihydrotestosterone (DHT) from dehydroepiandrosterone (DHEA) via steroidogenic enzymes in vitro, but hormone levels and steroidogenic enzyme expression decline with aging. Resistance exercise has been shown to increase in plasma sex steroid hormone levels. However, it remains unclear whether resistance training can restore impaired steroidogenic enzyme expressions in older individuals. Six young and 13 older men were recruited, and muscle biopsies were taken from the vastus lateralis at basal state. The same group of older subjects underwent resistance training involving knee extension and flexion exercises for 12 wk, and post-training biopsies were performed 4-5 d after the last exercise session. Muscular sex steroid hormone levels and sex steroidgenesis-related enzyme expressions were significantly lower in older subjects than younger ones at baseline, but 12 wk of resistance training significantly restored hormone levels (DHEA: 432 +/- 26 at baseline, 682 +/- 31 pg/mu g protein, DHT: 6.2 +/- 0.9 at baseline, 9.8 +/- 1.4 pg/mu g protein). Furthermore, the steroidogenesis-related enzymes such as 3 beta-hydroxysteroid dehydrogenase (HSD), 17 beta-HSD, and 5 alpha-reductase expressions were significantly restored by resistance training. We conclude progressive resistance training restores age-related declines in sex steroidogenic enzyme and muscle sex steroid hormone levels in older men.-Sato, K., Iemitsu, M., Matsutani, K., Kurihara, T., Hamaoka, T., Fujita, S. Resistance training restores muscle sex steroid hormone steroidogenesis in older men.	[Sato, Koji; Iemitsu, Motoyuki; Matsutani, Kenji; Kurihara, Toshiyuki; Hamaoka, Takafumi; Fujita, Satoshi] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan	Ritsumeikan University	Fujita, S (corresponding author), Ritsumeikan Univ, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	safujita@fc.ritsumei.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23700849, 24300235, 22680050]; Yamaha Motor Foundation for Sports; Grants-in-Aid for Scientific Research [25560378, 23300217] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamaha Motor Foundation for Sports; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors specially thank Dr. Noboru Mesaki for supporting this study. This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23700849, 24300235, and 22680050). This work was also funded by the Yamaha Motor Foundation for Sports (to K. S., S. F., and M. I.). The authors declare no conflicts of interest.	Aizawa K, 2007, AM J PHYSIOL-ENDOC M, V292, pE577, DOI 10.1152/ajpendo.00367.2006; Aizawa K, 2010, STEROIDS, V75, P219, DOI 10.1016/j.steroids.2009.12.002; Akishita M, 2010, ATHEROSCLEROSIS, V210, P232, DOI 10.1016/j.atherosclerosis.2009.10.037; Belanger A., 2005, J CLIN ENDOCR METAB, V79, P1086; Caron Marc-Andre, 2011, BMC Res Notes, V4, P488, DOI 10.1186/1756-0500-4-488; Copeland JL, 2002, J GERONTOL A-BIOL, V57, pB158, DOI 10.1093/gerona/57.4.B158; Ferrando AA, 2002, AM J PHYSIOL-ENDOC M, V282, pE601, DOI 10.1152/ajpendo.00362.2001; Fujita S, 2009, DIABETOLOGIA, V52, P1889, DOI 10.1007/s00125-009-1430-8; Hawkins VN, 2008, MED SCI SPORT EXER, V40, P223, DOI 10.1249/mss.0b013e31815bbba9; Jubrias SA, 2001, J APPL PHYSIOL, V90, P1663, DOI 10.1152/jappl.2001.90.5.1663; Labrie F, 2005, J ENDOCRINOL, V187, P169, DOI 10.1677/joe.1.06264; Li CY, 2010, DIABETES CARE, V33, P1618, DOI 10.2337/dc09-1788; Lo JC, 2006, AM J MED, V119, P69, DOI 10.1016/j.amjmed.2006.07.009; Muller M, 2005, J CLIN ENDOCR METAB, V90, P2618, DOI 10.1210/jc.2004-1158; Pollanen E, 2011, AGING CELL, V10, P650, DOI 10.1111/j.1474-9726.2011.00701.x; Pollanen E, 2010, GROWTH HORM IGF RES, V20, P372, DOI 10.1016/j.ghir.2010.07.003; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Sato K, 2011, AM J PHYSIOL-ENDOC M, V301, pE274, DOI 10.1152/ajpendo.00564.2010; Sattler FR, 2009, J CLIN ENDOCR METAB, V94, P1991, DOI 10.1210/jc.2008-2338; Sheffield-Moore M, 2011, J CLIN ENDOCR METAB, V96, pE1831, DOI 10.1210/jc.2011-1262; Sinha-Hikim I., 2001, AM J PHYSIOL-ENDOC M, V283, pE154; Taekema DG, 2011, EUR J ENDOCRINOL, V164, P189, DOI 10.1530/EJE-10-0703; Villareal DT, 2006, AM J PHYSIOL-ENDOC M, V291, pE1003, DOI 10.1152/ajpendo.00100.2006; Vingren JL, 2010, SPORTS MED, V40, P1037, DOI 10.2165/11536910-000000000-00000; Vingren JL, 2008, J APPL PHYSIOL, V105, P1754, DOI 10.1152/japplphysiol.91235.2008; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019	26	47	49	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1891	1897		10.1096/fj.13-245480	http://dx.doi.org/10.1096/fj.13-245480			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24443372				2022-12-25	WOS:000335344300033
J	Xie, Y; An, J; Yang, GY; Wu, G; Zhang, Y; Cui, L; Feng, Y				Xie, Yuan; An, Jiao; Yang, Guangyu; Wu, Geng; Zhang, Yong; Cui, Li; Feng, Yan			Enhanced Enzyme Kinetic Stability by Increasing Rigidity within the Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Lipase; Mutagenesis; Protein Design; Protein Stability; Active Site; Local Rigidity	ANTARCTICA LIPASE-B; ITERATIVE SATURATION MUTAGENESIS; ACYLPEPTIDE HYDROLASE; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; THERMOSTABILITY; STABILIZATION; INACTIVATION; EXPRESSION; RESIDUES	Background: Improving the kinetic stability of enzymes is a key issue for protein engineers. Results: Mutagenesis of residues with a high B factor located within 10 of the catalytic Ser(105) residue enhances kinetic stability dramatically. Conclusion: Increasing the rigidity of the flexible segment within the active site improves enzymatic kinetic stability. Significance: Optimization of the active site may an alternative, efficient approach for enhancing protein stabilization. Enzyme stability is an important issue for protein engineers. Understanding how rigidity in the active site affects protein kinetic stability will provide new insight into enzyme stabilization. In this study, we demonstrated enhanced kinetic stability of Candida antarctica lipase B (CalB) by mutating the structurally flexible residues within the active site. Six residues within 10 of the catalytic Ser(105) residue with a high B factor were selected for iterative saturation mutagenesis. After screening 2200 colonies, we obtained the D223G/L278M mutant, which exhibited a 13-fold increase in half-life at 48 degrees C and a 12 degrees C higher T-50(15), the temperature at which enzyme activity is reduced to 50% after a 15-min heat treatment. Further characterization showed that global unfolding resistance against both thermal and chemical denaturation also improved. Analysis of the crystal structures of wild-type CalB and the D223G/L278M mutant revealed that the latter formed an extra main chain hydrogen bond network with seven structurally coupled residues within the flexible 10 helix that are primarily involved in forming the active site. Further investigation of the relative B factor profile and molecular dynamics simulation confirmed that the enhanced rigidity decreased fluctuation of the active site residues at high temperature. These results indicate that enhancing the rigidity of the flexible segment within the active site may provide an efficient method for improving enzyme kinetic stability.	[Xie, Yuan; An, Jiao; Yang, Guangyu; Wu, Geng; Zhang, Yong; Cui, Li; Feng, Yan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Xie, Yuan; An, Jiao] Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130023, Peoples R China	Shanghai Jiao Tong University; Jilin University	Feng, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	yfeng2009@sjtu.edu.cn			National Basic Research Program of China (973 Program) [2012CB721003, 2011CBA00800]; Natural Science Foundation of China [31370106]; National High Technology Research and Development Program of China [2013AA102801]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (973 Program Grants 2012CB721003 and 2011CBA00800), the Natural Science Foundation of China (Grant 31370106), and the National High Technology Research and Development Program of China (Grant 2013AA102801).	Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Ahmad S, 2008, J MOL BIOL, V381, P324, DOI 10.1016/j.jmb.2008.05.063; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Gallardo O, 2010, J BIOL CHEM, V285, P2721, DOI 10.1074/jbc.M109.064394; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Imani M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1167, DOI 10.1039/c0pp00105h; Iyer PV, 2008, PROCESS BIOCHEM, V43, P1019, DOI 10.1016/j.procbio.2008.06.004; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Joo JC, 2010, J BIOTECHNOL, V146, P31, DOI 10.1016/j.jbiotec.2009.12.021; Kamal MZ, 2011, J MOL BIOL, V413, P726, DOI 10.1016/j.jmb.2011.09.002; Kamondi S, 2008, BIOCHEM BIOPH RES CO, V374, P725, DOI 10.1016/j.bbrc.2008.07.095; Kim HS, 2010, ENZYME MICROB TECH, V47, P1, DOI 10.1016/j.enzmictec.2010.04.003; Kim SJ, 2010, BIOTECHNOL PROGR, V26, P1038, DOI 10.1002/btpr.408; Koudelakova T, 2013, ANGEW CHEM INT EDIT, V52, P1959, DOI 10.1002/anie.201206708; Larsen MW, 2008, PROTEIN EXPRES PURIF, V62, P90, DOI 10.1016/j.pep.2008.07.012; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Liang XL, 2010, APPL MICROBIOL BIOT, V87, P999, DOI 10.1007/s00253-010-2534-2; MASUI A, 1994, APPL ENVIRON MICROB, V60, P3579, DOI 10.1128/AEM.60.10.3579-3584.1994; Perl D, 2002, CHEMBIOCHEM, V3, P39, DOI 10.1002/1439-7633(20020104)3:1<39::AID-CBIC39>3.0.CO;2-D; Quang ATL, 2012, BIOTECHNOL BIOENG, V109, P867, DOI 10.1002/bit.24371; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Reetz MT, 2009, ANGEW CHEM INT EDIT, V48, P8268, DOI 10.1002/anie.200904209; Singh AK, 2012, APPL BIOCHEM BIOTECH, V166, P486, DOI 10.1007/s12010-011-9444-3; Skjot M, 2009, CHEMBIOCHEM, V10, P520, DOI 10.1002/cbic.200800668; Tian JA, 2010, FEBS J, V277, P4901, DOI 10.1111/j.1742-4658.2010.07895.x; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Treichel H, 2010, FOOD BIOPROCESS TECH, V3, P182, DOI 10.1007/s11947-009-0202-2; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158; TSOU CL, 1995, BBA-PROTEIN STRUCT M, V1253, P151, DOI 10.1016/0167-4838(95)00172-5; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Voutilainen SP, 2009, APPL MICROBIOL BIOT, V83, P261, DOI 10.1007/s00253-008-1848-9; Wulf H, 2012, ENZYME MICROB TECH, V51, P217, DOI 10.1016/j.enzmictec.2012.06.006; Yang GY, 2009, BBA-PROTEINS PROTEOM, V1794, P94, DOI 10.1016/j.bbapap.2008.09.007; Yi ZL, 2011, BIORESOURCE TECHNOL, V102, P3636, DOI 10.1016/j.biortech.2010.11.043; Yu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046388; Yun BY, 2011, BIOCHEM BIOPH RES CO, V416, P92, DOI 10.1016/j.bbrc.2011.11.002; Zhang JH, 2012, ENZYME MICROB TECH, V50, P325, DOI 10.1016/j.enzmictec.2012.03.002; Zhang NY, 2003, PROTEIN ENG, V16, P599, DOI 10.1093/protein/gzg074; Zhang ZM, 2008, BBA-PROTEINS PROTEOM, V1784, P1176, DOI 10.1016/j.bbapap.2008.05.011	44	169	188	8	157	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7994	8006		10.1074/jbc.M113.536045	http://dx.doi.org/10.1074/jbc.M113.536045			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24448805	hybrid, Green Published			2022-12-25	WOS:000332761500063
J	Glauben, R; Sonnenberg, E; Wetzel, M; Mascagni, P; Siegmund, B				Glauben, Rainer; Sonnenberg, Elena; Wetzel, Martin; Mascagni, Paolo; Siegmund, Britta			Histone Deacetylase Inhibitors Modulate Interleukin 6-dependent CD4(+) T Cell Polarization in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Colitis; Histone Deacetylase Inhibitors; Inflammatory Bowel Disease; Macrophages; STAT3; IL-6R; Il-17; T Helper Cells; Promoter Acetylation	INFLAMMATORY-BOWEL-DISEASE; SUBEROYLANILIDE HYDROXAMIC ACID; ACTIVE CROHNS-DISEASE; GROWTH-FACTOR-BETA; TH17 CELLS; MULTIPLE-MYELOMA; INTESTINAL INFLAMMATION; EXPERIMENTAL COLITIS; SIGNAL TRANSDUCER; DOUBLE-BLIND	Background: HDAC inhibitors exert anti-inflammatory properties. Results: ITF2357 shifts the balance from Th17 cells toward regulatory T cells via suppression of the IL-6R expression on naive T cells. Conclusion: The HDAC inhibitor ITF2357 modulates T cell polarization in experimental colitis. Significance: Learning the mode of action of this compound class will serve to optimize future therapeutic strategies. Histone deacetylase (HDAC) inhibitors have been associated primarily with an anti-proliferative effect in vitro and in vivo. Recent data provide evidence for an anti-inflammatory potency of HDAC inhibitors in models of experimental colitis. Because the balance of T cell subpopulations is critical for the balance of the mucosal immune system, this study explores the regulatory potency of HDAC inhibitors on T cell polarization as a mechanistic explanation for the observed anti-inflammatory effects. Although HDAC inhibition suppressed the polarization toward the pro-inflammatory T helper 17 (Th17) cells, it enhanced forkhead box P3 (FoxP3)(+) regulatory T cell polarization in vitro and in vivo at the site of inflammation in the lamina propria. This was paralleled by a down-regulation of the interleukin 6 receptor (IL-6R) on naive CD4(+) T cells on the mRNA as well as on the protein level and changes in the chromatin acetylation at the IL6R gene and its promoter. Downstream of the IL-6R, HDAC inhibition was followed by a decrease in STAT3 phosphorylation as well as retinoic acid receptor-related orphan receptor T (RORT) expression, thus identifying the IL-6/STAT3/IL-17 pathway as an important target of HDAC inhibitors. These results directly translated to experimental colitis, where IL-6R expression was suppressed in naive T cells, paralleled by a significant reduction of Th17 cells in the lamina propria of ITF2357-treated animals, resulting in the amelioration of disease. This study indicates that, in experimental colitis, inhibition of HDAC exerts an anti-inflammatory potency by directing T helper cell polarization via targeting the IL-6 pathway.	[Glauben, Rainer; Sonnenberg, Elena; Wetzel, Martin; Siegmund, Britta] Charite, Campus Benjamin Franklin, Dept Med 1, D-12200 Berlin, Germany; [Mascagni, Paolo] Italfarmaco SpA, Res Ctr, I-20092 Cinisello Balsamo, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Italfarmaco	Siegmund, B (corresponding author), Charite, Campus Benjamin Franklin, Dept Med 1, Hindenburgdamm 30, D-12200 Berlin, Germany.	britta.siegmund@charite.de	Siegmund, Britta/E-6929-2018	Siegmund, Britta/0000-0002-0055-958X; Sonnenberg, Elena/0000-0002-9513-8816	Deutsche Forschungsgemeinschaft [SI 749/5-3]; Helmholtz Alliance Preclinical Cancer Comprehensive Center	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Alliance Preclinical Cancer Comprehensive Center	This work was supported by the Deutsche Forschungsgemeinschaft Grant SI 749/5-3 and by the Helmholtz Alliance Preclinical Cancer Comprehensive Center.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bosisio D, 2008, J LEUKOCYTE BIOL, V84, P1540, DOI 10.1189/jlb.0708401; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dohi T, 2006, CURR OPIN GASTROEN, V22, P651, DOI 10.1097/01.mog.0000245545.80160.0f; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fantini MC, 2007, EUR J IMMUNOL, V37, P3155, DOI 10.1002/eji.200737766; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Glauben R, 2008, GUT, V57, P613, DOI 10.1136/gut.2007.134650; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hosokawa T, 1999, J GASTROEN HEPATOL, V14, P987, DOI 10.1046/j.1440-1746.1999.01989.x; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Kjellev S, 2006, INT IMMUNOPHARMACOL, V6, P1341, DOI 10.1016/j.intimp.2006.04.017; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; Noguchi D, 2011, IMMUNOL LETT, V136, P146, DOI 10.1016/j.imlet.2011.01.004; Powrie F, 2004, ANN NY ACAD SCI, V1029, P132, DOI 10.1196/annals.1309.030; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sands BE, 2010, INFLAMM BOWEL DIS, V16, P1209, DOI 10.1002/ibd.21159; Siegmund B, 2009, EUR J IMMUNOL, V39, P2026, DOI 10.1002/eji.200939601; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Todoerti K, 2010, HAEMATOL-HEMATOL J, V95, P260, DOI 10.3324/haematol.2009.012088; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vojinovic J, 2011, ARTHRITIS RHEUM-US, V63, P1452, DOI 10.1002/art.30238; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Weber DM, 2012, CL LYMPH MYELOM LEUK, V12, P319, DOI 10.1016/j.clml.2012.07.007; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200	53	51	54	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6142	6151		10.1074/jbc.M113.517599	http://dx.doi.org/10.1074/jbc.M113.517599			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24421314	hybrid, Green Published			2022-12-25	WOS:000332015500068
J	Zouine, M; Fu, YY; Chateigner-Boutin, AL; Mila, I; Frasse, P; Wang, H; Audran, C; Roustan, JP; Bouzayen, M				Zouine, Mohamed; Fu, Yongyao; Chateigner-Boutin, Anne-Laure; Mila, Isabelle; Frasse, Pierre; Wang, Hua; Audran, Corinne; Roustan, Jean-Paul; Bouzayen, Mondher			Characterization of the Tomato ARF Gene Family Uncovers a Multi-Levels Post-Transcriptional Regulation Including Alternative Splicing	PLOS ONE			English	Article							AUXIN-RESPONSE-FACTOR; GENOME-WIDE IDENTIFICATION; FRUIT-SET; DOWN-REGULATION; ARABIDOPSIS; EXPRESSION; AUX/IAA; TRANSCRIPTION; INTEGRATION; PROTEINS	Background: The phytohormone auxin is involved in a wide range of developmental processes and auxin signaling is known to modulate the expression of target genes via two types of transcriptional regulators, namely, Aux/IAA and Auxin Response Factors (ARF). ARFs play a major role in transcriptional activation or repression through direct binding to the promoter of auxin-responsive genes. The present study aims at gaining better insight on distinctive structural and functional features among ARF proteins. Results: Building on the most updated tomato (Solanum lycopersicon) reference genome sequence, a comprehensive set of ARF genes was identified, extending the total number of family members to 22. Upon correction of structural annotation inconsistencies, renaming the tomato ARF family members provided a consensus nomenclature for all ARF genes across plant species. In silico search predicted the presence of putative target site for small interfering RNAs within twelve Sl-ARFs while sequence analysis of the 5'-leader sequences revealed the presence of potential small uORF regulatory elements. Functional characterization carried out by transactivation assay partitioned tomato ARFs into repressors and activators of auxin-dependent gene transcription. Expression studies identified tomato ARFs potentially involved in the fruit set process. Genome-wide expression profiling using RNA-seq revealed that at least one third of the gene family members display alternative splicing mode of regulation during the flower to fruit transition. Moreover, the regulation of several tomato ARF genes by both ethylene and auxin, suggests their potential contribution to the convergence mechanism between the signaling pathways of these two hormones. Conclusion: All together, the data bring new insight on the complexity of the expression control of Sl-ARF genes at the transcriptional and post-transcriptional levels supporting the hypothesis that these transcriptional mediators might represent one of the main components that enable auxin to regulate a wide range of physiological processes in a highly specific and coordinated manner.	[Zouine, Mohamed; Fu, Yongyao; Chateigner-Boutin, Anne-Laure; Mila, Isabelle; Frasse, Pierre; Wang, Hua; Audran, Corinne; Roustan, Jean-Paul; Bouzayen, Mondher] Univ Toulouse, INP ENSA Toulouse, Castanet Tolosan, France; [Zouine, Mohamed; Fu, Yongyao; Chateigner-Boutin, Anne-Laure; Mila, Isabelle; Frasse, Pierre; Wang, Hua; Audran, Corinne; Roustan, Jean-Paul; Bouzayen, Mondher] INRA, Genom & Biotechnol Fruits, Auzeville, France	Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; INRAE	Zouine, M (corresponding author), Univ Toulouse, INP ENSA Toulouse, Castanet Tolosan, France.	mohamed.zouine@ensat.fr; bouzayen@ensat.fr	Wang, Hua Cassan/AAF-5966-2021; Bouzayen, Mondher/AFQ-0802-2022	Wang, Hua Cassan/0000-0002-7395-9285; Audran, Corinne/0000-0002-3083-8088; FU, YONGYAO/0000-0001-9524-1234; Isabelle, Mila/0000-0002-8878-0018	Laboratoire d'Excellence (LABEX) [TULIP ANR-10-LABX-41]	Laboratoire d'Excellence (LABEX)	This work was supported by the Laboratoire d'Excellence (LABEX, TULIP ANR-10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Causier B, 2012, PLANT SIGNAL BEHAV, V7, P325, DOI 10.4161/psb.19283; Cole M, 2009, DEVELOPMENT, V136, P1643, DOI 10.1242/dev.032177; de Jong M, 2009, PLANT J, V57, P160, DOI 10.1111/j.1365-313X.2008.03671.x; de Jong M, 2011, J EXP BOT, V62, P617, DOI 10.1093/jxb/erq293; de Jong M, 2009, J EXP BOT, V60, P1523, DOI 10.1093/jxb/erp094; Devoghalaere F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-7; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; Guilfoyle T, 1998, PLANT PHYSIOL, V118, P341, DOI 10.1104/pp.118.2.341; Guilfoyle TJ, 2001, J PLANT GROWTH REGUL, V20, P281, DOI 10.1007/s003440010026; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guillon F, 2008, J EXP BOT, V59, P273, DOI 10.1093/jxb/erm323; HAMILTON AJ, 1990, NATURE, V346, P284, DOI 10.1038/346284a0; Hayashi K, 2012, PLANT CELL PHYSIOL, V53, P965, DOI 10.1093/pcp/pcs035; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jones B, 2002, PLANT J, V32, P603, DOI 10.1046/j.1365-313X.2002.01450.x; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Liu Zhen-Hua, 2011, Yichuan, V33, P1335, DOI 10.3724/SP.J.1005.2011.01335; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Maza Elie, 2013, Commun Integr Biol, V6, pe25849, DOI 10.4161/cib.25849; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Rademacher EH, 2012, DEV CELL, V22, P211, DOI 10.1016/j.devcel.2011.10.026; Rosado A, 2012, P NATL ACAD SCI USA, V109, P19537, DOI 10.1073/pnas.1214774109; Sagar M, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25647; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Serrani JC, 2008, PLANT J, V56, P922, DOI 10.1111/j.1365-313X.2008.03654.x; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Teale WD, 2008, MOL PLANT, V1, P229, DOI 10.1093/mp/ssn006; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Varaud E, 2011, PLANT CELL, V23, P973, DOI 10.1105/tpc.110.081653; Vert G, 2008, P NATL ACAD SCI USA, V105, P9829, DOI 10.1073/pnas.0803996105; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang L, 2013, P NATL ACAD SCI USA, V110, P761, DOI 10.1073/pnas.1215010110; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Wu J, 2011, PLANT CELL REP, V30, P2059, DOI 10.1007/s00299-011-1113-z; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; Yoon EK, 2010, J PLANT BIOL, V53, P150, DOI 10.1007/s12374-010-9100-4; Zhou F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-193	57	115	121	5	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84203	10.1371/journal.pone.0084203	http://dx.doi.org/10.1371/journal.pone.0084203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427281	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200021
J	Darvekar, SR; Elvenes, J; Brenne, HB; Johansen, T; Sjottem, E				Darvekar, Sagar Ramesh; Elvenes, Julianne; Brenne, Hanne Britt; Johansen, Terje; Sjottem, Eva			SPBP Is a Sulforaphane Induced Transcriptional Coactivator of NRF2 Regulating Expression of the Autophagy Receptor p62/SQSTM1	PLOS ONE			English	Article							RNA-POLYMERASE-II; ANTIOXIDANT RESPONSE; IN-VIVO; P62; BINDING; DISEASE; DEGRADATION; NUCLEOSOME; INDUCTION; CHROMATIN	Organisms exposed to oxidative stress respond by orchestrating a stress response to prevent further damage. Intracellular levels of antioxidant agents increase, and damaged components are removed by autophagy induction. The KEAP1-NRF2 signaling pathway is the main pathway responsible for cell defense against oxidative stress and for maintaining the cellular redox balance at physiological levels. Sulforaphane, an isothiocyanate derived from cruciferous vegetables, is a potent inducer of KEAP1-NRF2 signaling and antioxidant response element driven gene expression. In this study, we show that sulforaphane enhances the expression of the transcriptional coregulator SPBP. The expression curve peaks 6-8 hours post stimulation, and parallels the sulforaphane-induced expression of NRF2 and the autophagy receptor protein p62/SQSTM1. Reporter gene assays show that SPBP stimulates the expression of p62/SQSTM1 via ARE elements in the promoter region, and siRNA mediated knock down of SPBP significantly decreases the expression of p62/SQSTM1 and the formation of p62/SQSTM1 bodies in HeLa cells. Furthermore, SPBP siRNA reduces the sulforaphane induced expression of NRF2, and the expression of the autophagy marker protein LC3B. Both these proteins contain ARE-like elements in their promoter regions. Over-expressed SPBP and NRF2 acts synergistically on the p62/SQSTM1 promoter and colocalize in nuclear speckles in HeLa cells. Collectively, these results suggest that SPBP is a coactivator of NRF2, and hence may be important for securing enhanced and sustained expression of NRF2 induced genes such as proteins involved in selective autophagy.	[Darvekar, Sagar Ramesh; Elvenes, Julianne; Brenne, Hanne Britt; Johansen, Terje; Sjottem, Eva] Univ Tromso, Dept Med Biol, Mol Canc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso	Sjottem, E (corresponding author), Univ Tromso, Dept Med Biol, Mol Canc Res Grp, Tromso, Norway.	eva.sjottem@uit.no	Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Sjottem, Eva/0000-0003-2668-1708	Norwegian Research Council; Familien Blix Fond; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Familien Blix Fond; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the Norwegian Research Council, Familien Blix Fond and the Norwegian Cancer Society to Prof. Terje Johansen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boddupalli Sekhar, 2012, Frontiers in Genetics, V3, P7, DOI 10.3389/fgene.2012.00007; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Darvekar S, 2012, BIOCHEM J, V442, P65, DOI 10.1042/BJ20111230; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Elvenes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024659; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Gburcik V, 2005, MOL CELL BIOL, V25, P3421, DOI 10.1128/MCB.25.9.3421-3430.2005; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2011, AUTOPHAGY, V7, P1088, DOI 10.4161/auto.7.9.16474; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lee JS, 2011, P NATL ACAD SCI USA, V108, P13510, DOI 10.1073/pnas.1106106108; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Lee SH, 2012, J MOL CELL CARDIOL, V52, P718, DOI 10.1016/j.yjmcc.2011.12.002; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lyngso C, 2000, J BIOL CHEM, V275, P26144, DOI 10.1074/jbc.M003405200; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mauvezin C, 2010, EMBO REP, V11, P37, DOI 10.1038/embor.2009.242; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nowak J, 2009, MOL BIOL CELL, V20, P870, DOI 10.1091/mbc.E08-07-0671; Ohta K, 2007, BIOCHEM J, V402, P559, DOI 10.1042/BJ20061194; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Partensky PD, 2009, J MOL BIOL, V391, P12, DOI 10.1016/j.jmb.2009.04.085; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Rekdal C, 2000, J BIOL CHEM, V275, P40288, DOI 10.1074/jbc.M006978200; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; SANZ L, 1995, MOL CELL BIOL, V15, P3164; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Seillier M, 2012, CELL DEATH DIFFER; Sjottem E, 2007, NUCLEIC ACIDS RES, V35, P6648, DOI 10.1093/nar/gkm739; Solaimani P, 2013, TOXICOL SCI; Subtil-Rodriguez A, 2010, EMBO REP, V11, P751, DOI 10.1038/embor.2010.131; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Uruno A, 2011, NITRIC OXIDE-BIOL CH, V25, P153, DOI 10.1016/j.niox.2011.02.007; Yun JH, 2010, BIOL PHARM BULL, V33, P1650, DOI 10.1248/bpb.33.1650; Zhu LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055695	63	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85262	10.1371/journal.pone.0085262	http://dx.doi.org/10.1371/journal.pone.0085262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416372	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300060
J	Filardy, AA; Costa-da-Silva, AC; Koeller, CM; Guimaraes-Pinto, K; Ribeiro-Gomes, FL; Lopes, MF; Heise, N; Freire-de-Lima, CG; Nunes, MP; DosReis, GA				Filardy, Alessandra A.; Costa-da-Silva, Ana Caroline; Koeller, Carolina M.; Guimaraes-Pinto, Kamila; Ribeiro-Gomes, Flavia L.; Lopes, Marcela F.; Heise, Norton; Freire-de-Lima, Celio G.; Nunes, Marise P.; DosReis, George A.			Infection with Leishmania major Induces a Cellular Stress Response in Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; FAS LIGAND; TNF-ALPHA; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; T-LYMPHOCYTES; MAP KINASES; EXPRESSION; MICE	We investigated early cellular responses induced by infection with Leishmania major in macrophages from resistant C57/BL6 mice. Infection increased production of reactive oxygen species by resident, but not inflammatory peritoneal macrophages. In addition, infection increased activation of stress-activated protein kinases/c-Jun N-terminal kinases (SAPK/JNK) in resident, but not in inflammatory peritoneal macrophages. Infection also increased expression of membrane and soluble FasL, but infected macrophages remained viable after 48 h. Infection increased secretion of cytokines/chemokines TNF-alpha, IL-6, TIMP-1, IL-1RA, G-CSF, TREM, KC, MIP-1 alpha, MIP-1 beta, MCP-1, and MIP-2 in resident macrophages. Addition of antioxidants deferoxamine and N-acetylcysteine reduced ROS generation and JNK activation. Addition of antioxidants or JNK inhibitor SP600125 reduced secretion of KC. Furthermore, treatment with antioxidants or JNK inhibitor also reduced intracellular parasite replication. These results indicated that infection triggers a rapid cellular stress response in resident macrophages which induces proinflammatory signals, but is also involved in parasite survival and replication in host macrophages.	[Filardy, Alessandra A.; Costa-da-Silva, Ana Caroline; Koeller, Carolina M.; Guimaraes-Pinto, Kamila; Lopes, Marcela F.; Heise, Norton; Freire-de-Lima, Celio G.; DosReis, George A.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil; [Ribeiro-Gomes, Flavia L.] NIH, Parasit Dis Lab, Bethesda, MD 20892 USA; [Nunes, Marise P.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; National Institutes of Health (NIH) - USA; Fundacao Oswaldo Cruz	DosReis, GA (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil.	gdosreis@biof.ufrj.br	Filardy, Alessandra/AAH-6034-2020; Ribeiro-Gomes, Flávia L/F-7609-2015; de Lima, Celio Geraldo Freire/A-9057-2012; Lopes, Marcela Freitas/E-2201-2012; Koeller, Carolina/ABB-1968-2021; Heise, Norton/I-4098-2013	Filardy, Alessandra/0000-0003-4098-3235; Ribeiro-Gomes, Flávia L/0000-0003-0297-6341; Lopes, Marcela Freitas/0000-0002-4508-0505; Koeller, Carolina/0000-0002-1919-7582; Heise, Norton/0000-0003-0154-7406; Guimaraes Pinto, Kamila/0000-0003-2642-5229; Costa da silva, Ana Caroline/0000-0002-2729-5836; DosReis, George/0000-0002-8924-4727	Brazilian National Research Council (CNPq); Rio de Janeiro State Science Foundation (FAPERJ); Programa Institutos Nacionais de Ciencia e Tecnologia (INCT), CNPq, Brazil	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa Institutos Nacionais de Ciencia e Tecnologia (INCT), CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian National Research Council (CNPq), Rio de Janeiro State Science Foundation (FAPERJ), and Programa Institutos Nacionais de Ciencia e Tecnologia (INCT), CNPq, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 1998, EUR J IMMUNOL, V28, P1389, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt;1389::AID-IMMU1389&gt;3.0.CO;2-1; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; Chakour R, 2003, INFECT IMMUN, V71, P5287, DOI 10.1128/IAI.71.9.5287-5295.2003; Choudhury R, 2013, IMMUNOBIOLOGY, V218, P114, DOI 10.1016/j.imbio.2012.02.008; Conceicao-Silva F, 1998, EUR J IMMUNOL, V28, P237, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;237::AID-IMMU237&gt;3.0.CO;2-O; Das M, 2009, CELL, V136, P249, DOI 10.1016/j.cell.2008.11.017; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Faris M, 1998, J IMMUNOL, V160, P134; Feng GJ, 1999, J IMMUNOL, V163, P6403; Filardy AA, 2010, J IMMUNOL, V185, P2044, DOI 10.4049/jimmunol.1000017; Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011; FORTIER AH, 1982, INFECT IMMUN, V38, P1304, DOI 10.1128/IAI.38.3.1304-1308.1982; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; GORDON S, 1974, J EXP MED, V139, P1228, DOI 10.1084/jem.139.5.1228; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; Hojo Y, 2002, CIRC RES, V91, P712, DOI 10.1161/01.RES.0000037981.97541.25; Huang FP, 1998, J IMMUNOL, V160, P4143; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kautz-Neu K, 2011, EXP DERMATOL, V20, P77, DOI 10.1111/j.1600-0625.2010.01172.x; Kavurma MM, 2003, CELL DEATH DIFFER, V10, P36, DOI 10.1038/sj.cdd.4401179; Kayagaki N, 1997, P NATL ACAD SCI USA, V94, P3914, DOI 10.1073/pnas.94.8.3914; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; LOUIS J, 1979, EUR J IMMUNOL, V9, P841, DOI 10.1002/eji.1830091103; Majumder S, 2012, J INFECT DIS, V205, P1607, DOI 10.1093/infdis/jis229; MALLINSON DJ, 1989, INT J PARASITOL, V19, P647, DOI 10.1016/0020-7519(89)90043-X; Maretti-Mira AC, 2011, CLIN EXP IMMUNOL, V163, P207, DOI 10.1111/j.1365-2249.2010.04285.x; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525; Pfeiffer ZA, 2007, FREE RADICAL BIO MED, V42, P1506, DOI 10.1016/j.freeradbiomed.2007.02.010; Rabhi I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001763; Ribeiro-Gomes FL, 2005, J INFECT DIS, V192, P1127, DOI 10.1086/432764; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Sardar AH, 2013, J PROTEOMICS, V81, P185, DOI 10.1016/j.jprot.2013.01.011; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wiese M, 2003, INT J PARASITOL, V33, P1577, DOI 10.1016/S0020-7519(03)00252-2; Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75	47	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85715	10.1371/journal.pone.0085715	http://dx.doi.org/10.1371/journal.pone.0085715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416445	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300100
J	Campbell, C; Grapov, D; Fiehn, O; Chandler, CJ; Burnett, DJ; Souza, EC; Casazza, GA; Gustafson, MB; Keim, NL; Newman, JW; Hunter, GR; Fernandez, JR; Garvey, WT; Harper, ME; Hoppel, CL; Meissen, JK; Take, K; Adams, SH				Campbell, Caitlin; Grapov, Dmitry; Fiehn, Oliver; Chandler, Carol J.; Burnett, Dustin J.; Souza, Elaine C.; Casazza, Gretchen A.; Gustafson, Mary B.; Keim, Nancy L.; Newman, John W.; Hunter, Gary R.; Fernandez, Jose R.; Garvey, W. Timothy; Harper, Mary-Ellen; Hoppel, Charles L.; Meissen, John K.; Take, Kohei; Adams, Sean H.			Improved Metabolic Health Alters Host Metabolism in Parallel with Changes in Systemic Xeno-Metabolites of Gut Origin	PLOS ONE			English	Article							GLUCOSE-TOLERANCE TEST; INSULIN-RESISTANCE; MENSTRUAL-CYCLE; ACID CYCLE; PLASMA; PROFILES; MOUSE; SENSITIVITY; MICROBIOME; OBESITY	Novel plasma metabolite patterns reflective of improved metabolic health (insulin sensitivity, fitness, reduced body weight) were identified before and after a 14-17 wk weight loss and exercise intervention in sedentary, obese insulin-resistant women. To control for potential confounding effects of diet- or microbiome-derived molecules on the systemic metabolome, sampling was during a tightly-controlled feeding test week paradigm. Pairwise and multivariate analysis revealed intervention-and insulin-sensitivity associated: (1) Changes in plasma xeno-metabolites ("non-self'' metabolites of dietary or gut microbial origin) following an oral glucose tolerance test (e.g. higher post-OGTT propane-1,2,3-tricarboxylate [tricarballylic acid]) or in the overnight-fasted state (e.g., lower gamma-tocopherol); (2) Increased indices of saturated very long chain fatty acid elongation capacity; (3) Increased post-OGTT alpha-ketoglutaric acid (alpha-KG), fasting alpha-KG inversely correlated with Matsuda index, and altered patterns of malate, pyruvate and glutamine hypothesized to stem from improved mitochondrial efficiency and more robust oxidation of glucose. The results support a working model in which improved metabolic health modifies host metabolism in parallel with altering systemic exposure to xeno-metabolites. This highlights that interpretations regarding the origins of peripheral blood or urinary "signatures'' of insulin resistance and metabolic health must consider the potentially important contribution of gut-derived metabolites toward the host's metabolome.	[Campbell, Caitlin; Chandler, Carol J.; Burnett, Dustin J.; Souza, Elaine C.; Gustafson, Mary B.; Keim, Nancy L.; Newman, John W.; Adams, Sean H.] ARS, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Grapov, Dmitry; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA USA; [Fiehn, Oliver; Meissen, John K.; Take, Kohei] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Casazza, Gretchen A.] Univ Calif Davis, Sch Med, Sports Med Program, Sacramento, CA 95817 USA; [Keim, Nancy L.; Newman, John W.; Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Hunter, Gary R.; Fernandez, Jose R.; Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Hunter, Gary R.] Univ Alabama Birmingham, Human Studies Dept, Birmingham, AL USA; [Harper, Mary-Ellen] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Hoppel, Charles L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Ottawa; Case Western Reserve University	Fiehn, O (corresponding author), Univ Calif Davis, West Coast Metabol Ctr, Davis, CA USA.	ofiehn@ucdavis.edu; sean.h.adams@ars.usda.gov	Casazza, Gretchen Ann/GPC-8610-2022; ADAMS, SEAN/N-9262-2018	ADAMS, SEAN/0000-0002-9515-2319; Newman, John/0000-0001-9632-6571; Harper, Mary-Ellen/0000-0003-3864-5886; Grapov, Dmitry/0000-0002-7204-3128	USDA-ARS intramural [5306-51530-016-00D, 5306-51530-019-00]; NIH-NIDDK [R01DK078328]; NIH [1 U24 DK097154, P20 HL113452]; West Coast Metabolomics Center; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626, R01DK078328, U24DK097154] Funding Source: NIH RePORTER	USDA-ARS intramural; NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Coast Metabolomics Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by USDA-ARS intramural Projects 5306-51530-016-00D and 5306-51530-019-00 (JWN, NLK, SHA), NIH-NIDDK R01DK078328 (OF, NLK, JWN, GH, JF, WTG, CLH, MEH, SHA), NIH 1 U24 DK097154 for the West Coast Metabolomics Center (OF, JWN), and NIH P20 HL113452 (OF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, FASEB J IN PRESS; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bingley CA, 2008, HORM METAB RES, V40, P901, DOI 10.1055/s-0028-1082081; Bjom-Helge Mevik R.W., 2011, PLS PARTIAL LEAST SQ; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bowtell JL, 2002, NUTRITION, V18, P222, DOI 10.1016/S0899-9007(01)00795-X; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; Deo RC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000692; Devaraj S, 2013, CLIN CHEM, V59, P617, DOI 10.1373/clinchem.2012.187617; Fiehn Oliver, 2007, V358, P3, DOI 10.1007/978-1-59745-244-1_1; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; GOODWIN BL, 1994, BIOCHEM PHARMACOL, V47, P2294, DOI 10.1016/0006-2952(94)90268-2; Grapov D, 2012, BIOINFORMATICS; Grapov D, 2012, APPL TARGETED METABO, P236; Hardt-Stremayr M, 2013, J SEP SCI, V36, P670, DOI 10.1002/jssc.201200768; Hardt-Stremayr M, 2012, J SEP SCI, V35, P2567, DOI 10.1002/jssc.201200251; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Hyotylainen T, 2012, MOL BIOSYST, V8, P2559, DOI 10.1039/c2mb25115a; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Kernan WN, 2003, STROKE, V34, P1431, DOI 10.1161/01.STR.0000071108.00234.0E; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; LANOUE KF, 1971, METABOLISM, V20, P119, DOI 10.1016/0026-0495(71)90087-4; Marcobal A, 2013, ISME J; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MCDEVITT J, 1991, FOOD CHEM TOXICOL, V29, P107, DOI 10.1016/0278-6915(91)90164-3; Messier V, 2010, OBESITY, V18, P911, DOI 10.1038/oby.2009.364; Messier V, 2010, METABOLISM, V59, P20, DOI 10.1016/j.metabol.2009.06.020; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Palermo Giuseppe, 2009, Adv Appl Bioinform Chem, V2, P57; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; PETTERSEN JE, 1972, CLIN CHIM ACTA, V41, P199, DOI 10.1016/0009-8981(72)90512-8; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramos-Roman MA, 2012, METABOLISM, V61, P202, DOI 10.1016/j.metabol.2011.06.008; Romick-Rosendale LE, 2009, MAGN RESON CHEM, V47, pS36, DOI 10.1002/mrc.2511; RUSSELL JB, 1985, APPL ENVIRON MICROB, V49, P120, DOI 10.1128/AEM.49.1.120-126.1985; RUSSELL JB, 1986, BRIT J NUTR, V56, P153, DOI 10.1079/BJN19860095; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Seifert EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009834; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Swann JR, 2011, J PROTEOME RES, V10, P3590, DOI 10.1021/pr200243t; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; Toledo FG, 2013, MOL CELL ENDOCRINOL; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wierckx N, 2011, APPL MICROBIOL BIOT, V92, P1095, DOI 10.1007/s00253-011-3632-5; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; WOLFFRAM S, 1993, EXP PHYSIOL, V78, P473, DOI 10.1113/expphysiol.1993.sp003699; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Wurtz P, 2012, DIABETES CARE, V35, P1749, DOI 10.2337/dc11-1838; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Yeung EH, 2010, J CLIN ENDOCR METAB, V95, P5435, DOI 10.1210/jc.2010-0702; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	71	36	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84260	10.1371/journal.pone.0084260	http://dx.doi.org/10.1371/journal.pone.0084260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416208	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500106
J	Geenes, V; Lovgren-Sandblom, A; Benthin, L; Lawrance, D; Chambers, J; Gurung, V; Thornton, J; Chappell, L; Khan, E; Dixon, P; Marschall, HU; Williamson, C				Geenes, Victoria; Lovgren-Sandblom, Anita; Benthin, Lisbet; Lawrance, Dominic; Chambers, Jenny; Gurung, Vinita; Thornton, Jim; Chappell, Lucy; Khan, Erum; Dixon, Peter; Marschall, Hanns-Ulrich; Williamson, Catherine			The Reversed Feto-Maternal Bile Acid Gradient in Intrahepatic Cholestasis of Pregnancy Is Corrected by Ursodeoxycholic Acid	PLOS ONE			English	Article							MATERNAL LIVER TANDEM; HUMAN PLACENTA; OBSTETRIC CHOLESTASIS; SALT METABOLISM; OATP-C; FETAL; EXPRESSION; DIAGNOSIS; TRANSPORT; PROFILES	Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific liver disorder associated with an increased risk of adverse fetal outcomes. It is characterised by raised maternal serum bile acids, which are believed to cause the adverse outcomes. ICP is commonly treated with ursodeoxycholic acid (UDCA). This study aimed to determine the fetal and maternal bile acid profiles in normal and ICP pregnancies, and to examine the effect of UDCA treatment. Matched maternal and umbilical cord serum samples were collected from untreated ICP (n = 18), UDCA-treated ICP (n = 46) and uncomplicated pregnancy (n = 15) cases at the time of delivery. Nineteen individual bile acids were measured using HPLC-MS/MS. Maternal and fetal serum bile acids are significantly raised in ICP compared with normal pregnancy (p = <0.0001 and <0.05, respectively), predominantly due to increased levels of conjugated cholic and chenodeoxycholic acid. There are no differences between the umbilical cord artery and cord vein levels of the major bile acid species. The feto-maternal gradient of bile acids is reversed in ICP. Treatment with UDCA significantly reduces serum bile acids in the maternal compartment (p = <0.0001), thereby reducing the feto-maternal transplacental gradient. UDCA-treatment does not cause a clinically important increase in lithocholic acid (LCA) concentrations. ICP is associated with significant quantitative and qualitative changes in the maternal and fetal bile acid pools. Treatment with UDCA reduces the level of bile acids in both compartments and reverses the qualitative changes. We have not found evidence to support the suggestion that UDCA treatment increases fetal LCA concentrations to deleterious levels.	[Geenes, Victoria; Lawrance, Dominic; Chambers, Jenny; Khan, Erum; Dixon, Peter; Williamson, Catherine] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Lovgren-Sandblom, Anita; Benthin, Lisbet] Karolinska Inst, Dept Clin Chem, Stockholm, Sweden; [Lovgren-Sandblom, Anita; Benthin, Lisbet] Karolinska Inst, Dept Med, Stockholm, Sweden; [Gurung, Vinita; Thornton, Jim] Univ Nottingham, Sch Human Dev, Nottingham NG7 2RD, England; [Chappell, Lucy; Dixon, Peter; Williamson, Catherine] Kings Coll London, Womens Hlth Acad Ctr, London WC2R 2LS, England; [Chappell, Lucy; Dixon, Peter; Williamson, Catherine] Kings Hlth Partners, London, England; [Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	Imperial College London; Karolinska Institutet; Karolinska Institutet; University of Nottingham; University of London; King's College London; University of London; King's College London; University of Gothenburg	Williamson, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England.	catherine.williamson@kcl.ac.uk	Marschall, Hanns-Ulrich/K-8842-2017; Thornton, Jim/B-8336-2008	Marschall, Hanns-Ulrich/0000-0001-7347-3085; Thornton, Jim/0000-0001-9764-6876; Dixon, Peter/0000-0002-0197-2632; Williamson, Catherine/0000-0002-6226-7611	MRC; National Institute for Health Research (NIHR) Biomedical Research Centres bile acidsed at Imperial College Healthcare NHS Trust, Imperial College London; NIHR [PB-PG-0107-12037]; National Institute for Health Research [PB-PG-0107-12037] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centres bile acidsed at Imperial College Healthcare NHS Trust, Imperial College London; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by an MRC PhD Studentship (VG). The research was also supported by the National Institute for Health Research (NIHR) Biomedical Research Centres bile acidsed at Imperial College Healthcare NHS Trust, Imperial College London and the NIHR Research for Patient Benefit programme (grant number PB-PG-0107-12037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Bacq Y, 2012, GASTROENTEROLOGY, V143, P1492, DOI 10.1053/j.gastro.2012.08.004; Brites D, 1998, EUR J OBSTET GYN R B, V80, P31, DOI 10.1016/S0301-2115(98)00086-4; Briz O, 2003, BIOCHEM J, V371, P897, DOI 10.1042/BJ20030034; Chappell LC, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3799; COLOMBO C, 1985, PEDIATR RES, V19, P227, DOI 10.1203/00006450-198502000-00018; Cui T, 2009, SAUDI MED J, V30, P1406; Geenes VL, 2011, PLACENTA, V32, P1026, DOI 10.1016/j.placenta.2011.09.006; Geenes VL, 2011, PLACENTA, V32, P535, DOI 10.1016/j.placenta.2011.04.014; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; HEIKKINEN J, 1981, BRIT J OBSTET GYNAEC, V88, P240, DOI 10.1111/j.1471-0528.1981.tb00975.x; HEIKKINEN J, 1983, OBSTET GYNECOL, V61, P581; ITOH S, 1982, BIOCHEM J, V204, P141, DOI 10.1042/bj2040141; LAATIKAINEN T, 1977, OBSTET GYNECOL, V50, P313; LAATIKAINEN TJ, 1975, AM J OBSTET GYNECOL, V122, P852, DOI 10.1016/0002-9378(75)90727-9; Lucangioli SE, 2009, ANN CLIN BIOCHEM, V46, P44, DOI 10.1258/acb.2008.008130; LUNZER M, 1986, GASTROENTEROLOGY, V91, P825, DOI 10.1016/0016-5085(86)90682-7; Macias RIR, 2000, HEPATOLOGY, V31, P975, DOI 10.1053/he.2000.5921; Miragoli M, 2011, HEPATOLOGY, V54, P1282, DOI 10.1002/hep.24492; Patel P, 2003, PLACENTA, V24, P39, DOI 10.1053/plac.2002.0879; Reyes H, 2000, ANN MED, V32, P94, DOI 10.3109/07853890009011758; Serrano MA, 2007, PLACENTA, V28, P107, DOI 10.1016/j.placenta.2006.03.009; Serrano MA, 1998, J HEPATOL, V28, P829, DOI 10.1016/S0168-8278(98)80234-1; SEWELL RB, 1980, AM J PHYSIOL, V239, pG354, DOI 10.1152/ajpgi.1980.239.5.G354; SEWELL RB, 1982, AM J PHYSIOL, V243, pG172, DOI 10.1152/ajpgi.1982.243.2.G172; SHAW D, 1982, AM J OBSTET GYNECOL, V142, P621, DOI 10.1016/S0002-9378(16)32430-9; Sinakos E, 2010, HEPATOLOGY, V52, P197, DOI 10.1002/hep.23631; Sinakos E, 2010, AM J GASTROENTEROL, V105, P596, DOI 10.1038/ajg.2009.639; SJOVALL K, 1966, CLIN CHIM ACTA, V13, P207, DOI 10.1016/0009-8981(66)90294-4; St-Pierre MV, 2000, AM J PHYSIOL-REG I, V279, pR1495, DOI 10.1152/ajpregu.2000.279.4.R1495; Tribe RM, 2010, AM J GASTROENTEROL, V105, P585, DOI 10.1038/ajg.2009.633; Williamson C, 2004, BJOG-INT J OBSTET GY, V111, P676, DOI 10.1111/j.1471-0528.2004.00167.x; Xu Zhou, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P430	32	61	66	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83828	10.1371/journal.pone.0083828	http://dx.doi.org/10.1371/journal.pone.0083828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421907	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500076
J	Kowalewski, M; Domenech, R; Martinell, J				Kowalewski, Michal; Domenech, Rosa; Martinell, Jordi			Vanishing Clams on an Iberian Beach: Local Consequences and Global Implications of Accelerating Loss of Shells to Tourism	PLOS ONE			English	Article							MOLLUSCAN DEATH ASSEMBLAGES; HERMIT-CRABS; SANDY BEACH; SEA; REPRODUCTION; NOURISHMENT; TRANSPORT; OYSTERS; IMPACT; FISH	Multi-decadal increase in shell removal by tourists, a process that may accelerate degradation of natural habitats, was quantified via two series of monthly surveys, conducted thirty years apart (1978-1981 and 2008-2010) in one small embayment on the Mediterranean coast of the Iberian Peninsula. Over the last three decades, the local tourist arrivals have increased almost three-fold (2.74), while the area has remained unaffected by urban encroachment and commercial fisheries. During the same time interval the abundance of mollusk shells along the shoreline decreased by a comparable factor (2.62) and was significantly and negatively correlated with tourist arrivals (r = -0.52). The strength of the correlation increased when data were restricted to months with high tourist arrivals (r = -0.72). In contrast, the maximum monthly wave energy (an indirect proxy for changes in rate of onshore shell transport) was not significantly correlated with shell abundance (r = 0.10). Similarly, rank dominance of common species, drilling predation intensity, and body size-frequency distribution patterns have all remained stable over recent decades. A four-fold increase in global tourist arrivals over the last 30 years may have induced a comparable worldwide acceleration in shell removal from marine shorelines, resulting in multiple, currently unquantifiable, habitat changes such as increased beach erosion, changes in calcium carbonate recycling, and declines in diversity and abundance of organisms, which are dependent on shell availability.	[Kowalewski, Michal] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Domenech, Rosa; Martinell, Jordi] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; [Domenech, Rosa; Martinell, Jordi] Univ Barcelona, Dept Estratig Paleontol & Geociencies Marines, Fac Geol, Barcelona, Spain	State University System of Florida; University of Florida; University of Barcelona; University of Barcelona	Kowalewski, M (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	kowalewski@ufl.edu	Domènech, Rosa/X-5080-2019; Kowalewski, Michal/B-4263-2008; Domènech, Rosa/M-6195-2013; Martinell, Jordi/K-2981-2014; Martinell, Jordi/X-4501-2019	Domènech, Rosa/0000-0002-4174-8942; Kowalewski, Michal/0000-0002-8575-4711; Domènech, Rosa/0000-0002-4174-8942; Martinell, Jordi/0000-0003-2638-8106; Martinell, Jordi/0000-0003-2638-8106	Spanish Science and Innovation Ministry [CGL2010-15047]; Jon A. and Beverly L. Thompson Foundation (University of Florida)	Spanish Science and Innovation Ministry(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Jon A. and Beverly L. Thompson Foundation (University of Florida)	The study was supported by the research project CGL2010-15047 (Spanish Science and Innovation Ministry) and by the Jon A. and Beverly L. Thompson Foundation (University of Florida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 1983, SENCKENBERG MARIT, V15, P87; CARTER RWG, 1976, J SEDIMENT PETROL, V46, P418, DOI 10.1306/212F6F8C-2B24-11D7-8648000102C1865D; Carver CE, 2010, J SHELLFISH RES, V29, P905, DOI 10.2983/035.029.0423; Chauvaud L, 2003, LIMNOL OCEANOGR, V48, P2086, DOI 10.4319/lo.2003.48.6.2086; Dalgic G, 2009, J ANIM VET ADV, V8, P2009; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; DAVIES DJ, 1989, PALAEOGEOGR PALAEOCL, V72, P317, DOI 10.1016/0031-0182(89)90150-8; de la Rua A. Rodriguez, 2003, Boletin Instituto Espanol de Oceanografia, V19, P57; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; den Hollander J., 1974, Entomologische Berichten, V34, P155; Dias TLP, 2011, BIODIVERS CONSERV, V20, P2393, DOI 10.1007/s10531-011-9991-5; Dietl GP, 2011, TRENDS ECOL EVOL, V26, P30, DOI 10.1016/j.tree.2010.09.010; EVANS JW, 1969, AM ZOOL, V9, P775; Fanini L, 2005, OCEANOLOGIA, V47, P93; Flessa KW, 1998, GEOLOGY, V26, P187, DOI 10.1130/0091-7613(1998)026<0187:WTCSTD>2.3.CO;2; Gossling S, 2004, BIODIVERS CONSERV, V13, P2623, DOI 10.1007/s10531-004-2139-0; Gossling S, 2002, GLOBAL ENVIRON CHANG, V12, P283, DOI 10.1016/S0959-3780(02)00044-4; Grey M, 2005, ORYX, V39, P413, DOI 10.1017/S0030605305000967; Griffiths J, 2006, MAR BIOL, V149, P1489, DOI 10.1007/s00227-006-0289-1; Guo HY, 2012, OECOLOGIA, V170, P789, DOI 10.1007/s00442-012-2356-2; Hofrichter R., 2004, MAR MEDITERRANEO FAU; Hunter C., 1995, TOURISM ENV SUSTAINA; Jimenez H, 2011, FISH RES, V108, P195, DOI 10.1016/j.fishres.2010.12.021; KELLOGG CW, 1976, J EXP MAR BIOL ECOL, V22, P101, DOI 10.1016/0022-0981(76)90112-X; Kidwell SM, 2008, LETHAIA, V41, P199, DOI 10.1111/j.1502-3931.2007.00050.x; Kidwell SM, 2007, P NATL ACAD SCI USA, V104, P17701, DOI 10.1073/pnas.0707194104; Kinzelman JL, 2003, LAKE RESERV MANAGE, V19, P349, DOI 10.1080/07438140309353944; Kowalewski M, 2000, GEOLOGY, V28, P1059, DOI 10.1130/0091-7613(2000)28<1059:DDFPTT>2.0.CO;2; Kowalewski Michal, 2009, Paleontological Society Papers, V15, P1; Kyle R, 1997, BIOL CONSERV, V82, P183, DOI 10.1016/S0006-3207(97)00022-0; Laidre ME, 2011, J EXP MAR BIOL ECOL, V397, P65, DOI 10.1016/j.jembe.2010.10.024; Lebrato M, 2010, ECOL MONOGR, V80, P441, DOI 10.1890/09-0553.1; Lenu║ek Lena., 1999, BEACH HIST PARADISE; Lescinsky HL, 2002, PALAIOS, V17, P171, DOI 10.1669/0883-1351(2002)017<0171:MSEABR>2.0.CO;2; MARTINELL J, 1982, MALACOLOGIA, V22, P587; Masio B, 2011, RESTOR ECOL, V19, P194; Mathieson A, 1982, TOURISM EC SOCIAL PH; McLachlan A, 1996, OCEANOGR MAR BIOL, V34, P163; Murray SN, 1999, CAL COOP OCEAN FISH, V40, P100; Olszewski TD, 2012, BIOL LETTERS, V8, P131, DOI 10.1098/rsbl.2011.0337; Pawlowska AM, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P109, DOI 10.1007/978-3-540-77598-0_6; Peres J. M., 1964, RECUEIL TRAVAUX STAT, V47, P5; Peter Dance S., 1986, HIST SHELL COLLECTIN, P99; Peterson CH, 2000, J COASTAL RES, V16, P368; Poppe G. T., 1991, EUROPEAN SEASHELLS, V1; POWELL EN, 1992, J MAR RES, V50, P229, DOI 10.1357/002224092784797665; Preston-Whyte R., 2004, COMPANION TOURISM, P349, DOI DOI 10.1002/9780470752272; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Roberts L, 2011, SCIENCE, V333, P540, DOI 10.1126/science.333.6042.540; Rodland DL, 2004, PALAIOS, V19, P381, DOI 10.1669/0883-1351(2004)019<0381:COALWE>2.0.CO;2; Schlacher TA, 2007, DIVERS DISTRIB, V13, P556, DOI 10.1111/j.1472-4642.2007.00363.x; Scyphers SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022396; Seung-Woo L, 2010, MICRON, V41, P273; Smith Stephen A., 2004, COMPANION TOURISM, P25; Spanish Government, 2007, B OFIC ESTADO, V299, P51275; Speybroeck J, 2006, AQUAT CONSERV, V16, P419, DOI 10.1002/aqc.733; Terry RC, 2010, P ROY SOC B-BIOL SCI, V277, P1193, DOI 10.1098/rspb.2009.1984; Tirado C, 1999, MAR ECOL-P S Z N I, V20, P111, DOI 10.1046/j.1439-0485.1999.00068.x; Tlili S, 2011, CHEMOSPHERE, V84, P1362, DOI 10.1016/j.chemosphere.2011.05.009; Tomasovych A, 2006, PALEOBIOLOGY, V32, P278, DOI 10.1666/0094-8373(2006)32[278:MSAAIS]2.0.CO;2; van der Meij SET, 2009, MAR POLLUT BULL, V59, P101, DOI 10.1016/j.marpolbul.2009.02.021; van der Wal D, 1998, J COASTAL RES, V14, P620; Warwick RM, 2002, J MAR BIOL ASSOC UK, V82, P847, DOI 10.1017/S0025315402006227; Warwick RM, 2002, BIODIVERS CONSERV, V11, P99, DOI 10.1023/A:1014094829984; Wells SM, 1989, MARINE INVERTEBRATE; Wilson SK, 2005, MAR BIOL, V147, P179, DOI 10.1007/s00227-005-1556-2; Wong P.P., 2004, COMPANION TOURISM, P450, DOI [10.1002/9780470752272, DOI 10.1002/9780470752272]; Yanes Y, 2012, PALAIOS, V27, P373, DOI 10.2110/palo.2011.p11-089r; Zuschin M, 2007, FACIES, V53, P319, DOI 10.1007/s10347-007-0110-8	69	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83615	10.1371/journal.pone.0083615	http://dx.doi.org/10.1371/journal.pone.0083615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421895	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500059
J	Liu, YH; Lv, XY; Tan, RZ; Liu, TM; Chen, TL; Li, M; Liu, YH; Nie, F; Wang, XY; Zhou, PH; Chen, MZ; Zhou, Q				Liu, Yunhong; Lv, Xiaoyan; Tan, Ruizhi; Liu, Tianming; Chen, Tielin; Li, Mi; Liu, Yuhang; Nie, Fang; Wang, Xiaoyan; Zhou, Puhui; Chen, Mianzhi; Zhou, Qin			A Modified TALEN-Based Strategy for Rapidly and Efficiently Generating Knockout Mice for Kidney Development Studies	PLOS ONE			English	Article							EMBRYO MICROINJECTION; III EFFECTORS; GENE	The transcription activator-like effector nucleases (TALENs) strategy has been widely used to delete and mutate genes in vitro. This strategy has begun to be used for in vivo systemic gene manipulation, but not in an organ-specific manner. In this study, we developed a modified, highly efficient TALEN strategy using a dual-fluorescence reporter. We used this modified strategy and, within 5 weeks, we successfully generated kidney proximal tubule-specific gene Ttc36 homozygous knockout mice. Unilateral nephrectomy was performed on the 6-week-old founders (F0) to identify the knockout genotype prior to the birth of the offspring. This strategy was found to have little effect on reproduction in the knockout mice and inheritability of the knockout genotypes. The modified TALEN knockout strategy in combination with unilateral nephrectomy can be readily used for studies of gene function in kidney development and diseases.	[Liu, Yunhong; Tan, Ruizhi; Li, Mi; Liu, Yuhang; Chen, Mianzhi; Zhou, Qin] Sichuan Univ, Core Facil Genetically Engn Mice, Regenerat Med Res Ctr, West China Hosp,West China Med Sch, Chengdu 610064, Sichuan, Peoples R China; [Lv, Xiaoyan] Sichuan Univ, Dept Dermatol, West China Hosp, West China Med Sch, Chengdu 610064, Sichuan, Peoples R China; [Liu, Tianming; Nie, Fang; Wang, Xiaoyan; Zhou, Puhui] Chongqing Med Univ, Lab Mol Nephrol, Chongqing, Peoples R China; [Chen, Tielin] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Chen, Tielin] Sichuan Univ, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Chongqing Medical University; Sichuan University; Sichuan University	Zhou, PH (corresponding author), Chongqing Med Univ, Lab Mol Nephrol, Chongqing, Peoples R China.	pkdzhou@126.com; zhouqin@scu.edu.cn	Liu, Tianming/AAA-4602-2022	, Mianzhi/0000-0002-9960-0588; Li, Mi/0000-0002-6038-4144	National Basic Research Program of China [2011CB944002]; National Natural Science Foundation of China [31271563]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB944002) to Prof. Qin Zhou M. D. & Ph.D. and the Grant from National Natural Science Foundation of China (No. 31271563) to Prof. Qin Zhou M. D. & Ph.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Davies B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060216; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Hermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041796; Hou Z, 2013, P NATL ACAD SCI US; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Snouber LC, 2012, BIOTECHNOL PROGR, V28, P474, DOI 10.1002/btpr.743; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang Z, 2013, BBA-MOL BASIS DIS, V1832, P805, DOI 10.1016/j.bbadis.2013.02.022	19	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84893	10.1371/journal.pone.0084893	http://dx.doi.org/10.1371/journal.pone.0084893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416307	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500186
J	Rodriguez-Ramirez, A; Grove, CA; Zinke, J; Pandolfi, JM; Zhao, JX				Rodriguez-Ramirez, Alberto; Grove, Craig A.; Zinke, Jens; Pandolfi, John M.; Zhao, Jian-xin			Coral Luminescence Identifies the Pacific Decadal Oscillation as a Primary Driver of River Runoff Variability Impacting the Southern Great Barrier Reef	PLOS ONE			English	Article							INTERDECADAL CLIMATE VARIABILITY; FITZROY RIVER; MULTIDECADAL VARIABILITY; FLUORESCENT BANDS; EL-NINO; SPECTRAL LUMINESCENCE; RAINFALL VARIABILITY; EASTERN AUSTRALIA; SEDIMENT SOURCES; ENSO	The Pacific Decadal Oscillation (PDO) is a large-scale climatic phenomenon modulating ocean-atmosphere variability on decadal time scales. While precipitation and river flow variability in the Great Barrier Reef (GBR) catchments are sensitive to PDO phases, the extent to which the PDO influences coral reefs is poorly understood. Here, six Porites coral cores were used to produce a composite record of coral luminescence variability (runoff proxy) and identify drivers of terrestrial influence on the Keppel reefs, southern GBR. We found that coral skeletal luminescence effectively captured seasonal, inter-annual and decadal variability of river discharge and rainfall from the Fitzroy River catchment. Most importantly, although the influence of El Nino-Southern Oscillation (ENSO) events was evident in the luminescence records, the variability in the coral luminescence composite record was significantly explained by the PDO. Negative luminescence anomalies (reduced runoff) were associated with El Nino years during positive PDO phases while positive luminescence anomalies (increased runoff) coincided with strong/moderate La Nino years during negative PDO phases. This study provides clear evidence that not only ENSO but also the PDO have significantly affected runoff regimes at the Keppel reefs for at least a century, and suggests that upcoming hydrological disturbances and ecological responses in the southern GBR region will be mediated by the future evolution of these sources of climate variability.	[Rodriguez-Ramirez, Alberto; Zhao, Jian-xin] Univ Queensland, Sch Earth Sci, Radiogen Isotope Facil, Brisbane, Qld, Australia; [Grove, Craig A.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Geol, Den Burg, Texel, Netherlands; [Zinke, Jens] Univ Western Australia, Sch Earth & Environm, Nedlands, WA 6009, Australia; [Zinke, Jens] Australian Inst Marine Sci, Perth, WA, Australia; [Pandolfi, John M.] Univ Queensland, Sch Biol Sci, Ctr Marine Sci, Australian Res Council Ctr Excellence Coral Reef, Brisbane, Qld, Australia	University of Queensland; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Western Australia; Australian Institute of Marine Science; University of Queensland	Rodriguez-Ramirez, A (corresponding author), Univ Queensland, Sch Earth Sci, Radiogen Isotope Facil, Brisbane, Qld, Australia.	alberto.rodriguez@uq.edu.au	Pandolfi, John M/A-3121-2009; Zhao, Jian-xin/A-5938-2008; Zinke, Jens/G-5026-2011	Pandolfi, John M/0000-0003-3047-6694; Zhao, Jian-xin/0000-0002-2413-6178; Zinke, Jens/0000-0002-0634-8281; Rodriguez-Ramirez, Alberto/0000-0003-4855-7345	University of Queensland and the PADI foundation; Royal Netherlands Institute for Sea Research (NIOZ); Marine and Tropical Science Research Facility (MTSRF) [1.1.4]; ARC [DP0773081]; NERP Tropical Ecosystems [1.3]; GBRMPA [G10/33402.1]; IOMRC UWA/AIMS/CSIRO	University of Queensland and the PADI foundation; Royal Netherlands Institute for Sea Research (NIOZ); Marine and Tropical Science Research Facility (MTSRF); ARC(Australian Research Council); NERP Tropical Ecosystems; GBRMPA; IOMRC UWA/AIMS/CSIRO	A Graduate School International Travel Award (GSITA) from The University of Queensland and the PADI foundation to ARR supported the luminescence analysis of the cores at the Royal Netherlands Institute for Sea Research (NIOZ). This work was partially funded by the Marine and Tropical Science Research Facility (MTSRF) Project 1.1.4 granted to JXZ, JMP and others; the ARC discovery project DP0773081 granted to JXZ, and others; the NERP Tropical Ecosystems Hub Project 1.3 to JXZ, JMP., and others. Sample collection was conducted under the GBRMPA permit number G10/33402.1. JZ was supported by an IOMRC UWA/AIMS/CSIRO postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arblaster JM, 2002, CLIM DYNAM, V18, P519, DOI 10.1007/s00382-001-0191-y; Ayliffe LK, 2004, CONT SHELF RES, V24, P2343, DOI 10.1016/j.csr.2004.07.013; Berkelmans R, 2012, CORAL REEFS, V31, P1103, DOI 10.1007/s00338-012-0930-z; BOM, 2012, ANN CLIM SUMM 2011; BOM, 2013, QUEENSL JAN 2013 EXT; Bostock HC, 2007, SEDIMENT GEOL, V201, P321, DOI 10.1016/j.sedgeo.2007.07.001; Cai WJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050820; Cai WJ, 2010, J CLIMATE, V23, P4944, DOI 10.1175/2010JCLI3501.1; Calvo E, 2007, PALAEOGEOGR PALAEOCL, V248, P190, DOI 10.1016/j.palaeo.2006.12.003; Chiba S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052912; Chiew FHS, 1998, J HYDROL, V204, P138, DOI 10.1016/S0022-1694(97)00121-2; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Douglas GB, 2008, ENVIRON CHEM, V5, P243, DOI 10.1071/EN07091; Douglas GB, 2006, ENVIRON CHEM, V3, P377, DOI 10.1071/EN06010; Evans MN, 2001, GEOPHYS RES LETT, V28, P3689, DOI 10.1029/2001GL013223; Felis T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043572; Fensham RJ, 2003, J ENVIRON MANAGE, V68, P409, DOI 10.1016/S0301-4797(03)00110-5; Folland CK, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014201; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; Franks SW, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000232; Furnas M, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P37; Furnas M., 2003, CATCHMENTS CORALS TE; Gedalof Z, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015824; Gilbert M., 2001, POPULATION MAJOR LAN; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Grottoli AG, 2007, EARTH-SCI REV, V81, P67, DOI 10.1016/j.earscirev.2006.10.001; Grove CA, 2013, CLIM PAST, V9, P641, DOI 10.5194/cp-9-641-2013; Grove CA, 2012, BIOGEOSCIENCES, V9, P3063, DOI 10.5194/bg-9-3063-2012; Grove CA, 2010, CORAL REEFS, V29, P579, DOI 10.1007/s00338-010-0629-y; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Heinrich I, 2009, CLIM DYNAM, V33, P63, DOI 10.1007/s00382-009-0544-5; Hendy EJ, 2003, HOLOCENE, V13, P187, DOI 10.1191/0959683603hl606rp; Henley BJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010034; Holbrook NJ, 2009, MARINE CLIMATE CHANG, P1; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; ISDALE P, 1984, NATURE, V310, P578, DOI 10.1038/310578a0; Isdale PJ, 1998, HOLOCENE, V8, P1, DOI 10.1191/095968398670905088; Johnston N, 2008, FITZROY BASIN WATER; Jones Alison M., 2011, Diversity, V3, P329, DOI 10.3390/d3030329; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Jupiter S, 2008, CORAL REEFS, V27, P887, DOI 10.1007/s00338-008-0422-3; Kiem AS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015992; Kiem AS, 2004, HYDROL PROCESS, V18, P2039, DOI 10.1002/hyp.1460; King AD, 2013, GEOPHYS RES LETT, V40, P2271, DOI 10.1002/grl.50427; King B, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P145; KLEIN R, 1990, NATURE, V345, P145, DOI 10.1038/345145a0; Klingaman NP, 2013, INT J CLIMATOL, V33, P2413, DOI 10.1002/joc.3593; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Lee HS, 2012, PROG OCEANOGR, V105, P67, DOI 10.1016/j.pocean.2012.04.009; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lewis SE, 2012, MAR POLLUT BULL, V65, P306, DOI 10.1016/j.marpolbul.2011.09.030; Lewis SE, 2007, PALAEOGEOGR PALAEOCL, V246, P471, DOI 10.1016/j.palaeo.2006.10.021; Linsley BK, 2000, SCIENCE, V290, P1145, DOI 10.1126/science.290.5494.1145; Linsley BK, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001539; LLOYD PL, 1984, BRIGALOW BELT AUSTR, P81, DOI DOI 10.1071/RJ06027; Lough JM, 2011, CORAL REEFS, V30, P169, DOI 10.1007/s00338-010-0688-0; Lough JM, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002050; Lough JM, 2010, WIRES CLIM CHANGE, V1, P318, DOI 10.1002/wcc.39; LOUGH JM, 1991, INT J CLIMATOL, V11, P745, DOI 10.1002/joc.3370110704; Lough JM, 2007, PALEOCEANOGRAPHY, V22, P1; Maina J, 2012, MAR POLLUT BULL, V64, P2047, DOI 10.1016/j.marpolbul.2012.06.027; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martinez E, 2009, SCIENCE, V326, P1253, DOI 10.1126/science.1177012; Maue RN, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047711; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; McGowan HA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037049; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; McGregor S, 2010, CLIM PAST, V6, P1, DOI 10.5194/cp-6-1-2010; Meehl GA, 2001, CLIM DYNAM, V17, P515, DOI 10.1007/PL00007929; Meehl GA, 2010, J CLIMATE, V23, P2959, DOI 10.1175/2010JCLI3296.1; Menge BA, 2011, J EXP MAR BIOL ECOL, V400, P236, DOI 10.1016/j.jembe.2011.02.003; Micevski T, 2006, J HYDROL, V327, P219, DOI 10.1016/j.jhydrol.2005.11.017; Minobe S, 1999, GEOPHYS RES LETT, V26, P855, DOI 10.1029/1999GL900119; Nagtegaal R, 2012, CHEM GEOL, V318, P6, DOI 10.1016/j.chemgeo.2012.05.006; Neil DT, 2002, MAR FRESHWATER RES, V53, P733, DOI 10.1071/MF00151; Nott J, 2001, NATURE, V413, P508, DOI 10.1038/35097055; Nyberg J, 2002, PHILOS T ROY SOC A, V360, P749, DOI 10.1098/rsta.2001.0963; Nyberg J, 2007, NATURE, V447, P698, DOI 10.1038/nature05895; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Pfeiffer M, 2009, INT J EARTH SCI, V98, P53, DOI 10.1007/s00531-008-0326-z; Power S, 1999, CLIM DYNAM, V15, P319, DOI 10.1007/s003820050284; Power S, 2006, J CLIMATE, V19, P4755, DOI 10.1175/JCLI3868.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Redondo-Rodriguez A, 2012, MAR FRESHWATER RES, V63, P34, DOI 10.1071/MF11151; Risbey JS, 2009, MON WEATHER REV, V137, P3233, DOI 10.1175/2009MWR2861.1; Schulz M, 2002, COMPUT GEOSCI-UK, V28, P421, DOI 10.1016/S0098-3004(01)00044-9; Shen CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024804; Smith J, 2008, ENVIRON CHEM, V5, P231, DOI 10.1071/EN07094; Tan JCH, 2012, P 112 INT COR REEF S, p11E; Thompson A, 2011, REEF RESCUE MARINE M, DOI 10.13140/rg.2.1.1287.1206; van Woesik R, 1991, IMMEDIATE IMPACT JAN; VanWoesik R, 1995, MAR ECOL PROG SER, V128, P261, DOI 10.3354/meps128261; Verdon DC, 2004, WATER RESOUR RES, V40, DOI 10.1029/2004WR003234	97	33	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84305	10.1371/journal.pone.0084305	http://dx.doi.org/10.1371/journal.pone.0084305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416214	gold, Green Published			2022-12-25	WOS:000329862500112
J	Sato, S; Kawauchi, S; Okuda, W; Nishidate, I; Nawashiro, H; Tsumatori, G				Sato, Shunichi; Kawauchi, Satoko; Okuda, Wataru; Nishidate, Izumi; Nawashiro, Hiroshi; Tsumatori, Gentaro			Real-Time Optical Diagnosis of the Rat Brain Exposed to a Laser-Induced Shock Wave: Observation of Spreading Depolarization, Vasoconstriction and Hypoxemia-Oligemia	PLOS ONE			English	Article							CLOSED-HEAD-INJURY; CONTROLLED CORTICAL IMPACT; INDUCED STRESS WAVES; FLUID-PERCUSSION MODEL; BLAST OVERPRESSURE; EXPLOSIVE BLAST; INDUCED NEUROTRAUMA; HIPPOCAMPAL SLICE; CEREBRAL-CORTEX; VISUAL-CORTEX	Despite many efforts, the pathophysiology and mechanism of blast-induced traumatic brain injury (bTBI) have not yet been elucidated, partially due to the difficulty of real-time diagnosis and extremely complex factors determining the outcome. In this study, we topically applied a laser-induced shock wave (LISW) to the rat brain through the skull, for which real-time measurements of optical diffuse reflectance and electroencephalogram (EEG) were performed. Even under conditions showing no clear changes in systemic physiological parameters, the brain showed a drastic light scattering change accompanied by EEG suppression, which indicated the occurrence of spreading depression, long-lasting hypoxemia and signal change indicating mitochondrial energy impairment. Under the standard LISW conditions examined, hemorrhage and contusion were not apparent in the cortex. To investigate events associated with spreading depression, measurement of direct current (DC) potential, light scattering imaging and stereomicroscopic observation of blood vessels were also conducted for the brain. After LISW application, we observed a distinct negative shift in the DC potential, which temporally coincided with the transit of a light scattering wave, showing the occurrence of spreading depolarization and concomitant change in light scattering. Blood vessels in the brain surface initially showed vasodilatation for 3-4 min, which was followed by long-lasting vasoconstriction, corresponding to hypoxemia. Computer simulation based on the inverse Monte Carlo method showed that hemoglobin oxygen saturation declined to as low as similar to 35% in the long-term hypoxemic phase. Overall, we found that topical application of a shock wave to the brain caused spreading depolarization/depression and prolonged severe hypoxemia-oligemia, which might lead to pathological conditions in the brain. Although further study is needed, our findings suggest that spreading depolarization/depression is one of the key events determining the outcome in bTBI. Furthermore, a rat exposed to an LISW(s) can be a reliable laboratory animal model for blast injury research.	[Sato, Shunichi; Kawauchi, Satoko] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan; [Okuda, Wataru; Nishidate, Izumi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo, Japan; [Nawashiro, Hiroshi] Tokorozawa Cent Hosp, Div Neurosurg, Tokorozawa, Saitama, Japan; [Tsumatori, Gentaro] Natl Def Med Coll, Dept Def Med, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; Tokyo University of Agriculture & Technology; National Defense Medical College - Japan	Sato, S (corresponding author), Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan.	shunsato@ndmc.ac.jp	NISHIDATE, IZUMI/C-8826-2013		Ministry of Defense; General Insurance Association of Japan	Ministry of Defense; General Insurance Association of Japan	This study was supported by the Research Promotion Program for Defense Medicine under the Ministry of Defense and a research grant from The General Insurance Association of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Aizawa K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253325; Ando T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051744; ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Bahar S, 2000, J NEUROPHYSIOL, V84, P311; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Center for Chemical Process Safety, 1994, GUID EV CHAR VAP CLO, P351; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I., 1996, CHIN J TRAUMATOL, V12, P28; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039353; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dreckhahn C, 2012, BRAIN, V135, P853; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Ebersberger A, 2001, ANN NEUROL, V49, P7, DOI 10.1002/1531-8249(200101)49:1<7::AID-ANA4>3.3.CO;2-B; Elsayed NM, 1997, TOXICOLOGY, V121, P81, DOI 10.1016/S0300-483X(97)03657-3; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fischer H, 2013, CRS REP C; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Guy RJ, 1998, J TRAUMA, V45, P983, DOI 10.1097/00005373-199812000-00001; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hartings JA, 2008, NEUROL RES, V30, P876, DOI 10.1179/174313208X309739; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hatano B, 2011, P SPIE, V7897; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; JAFFIN JH, 1987, J TRAUMA, V27, P349, DOI 10.1097/00005373-198704000-00002; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kawauchi S, 2008, APPL OPTICS, V47, P4164, DOI 10.1364/AO.47.004164; Kawauchi S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.015003; Kawauchi S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3542046; Kurita A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3628313; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Manor T, 2008, NEUROL RES, V30, P1075, DOI 10.1179/174313208X346107; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mourant J., 2003, ELASTIC SCATTERING S; NARAYAN SM, 1995, J CEREBR BLOOD F MET, V15, P754, DOI 10.1038/jcbfm.1995.95; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; Ogura M, 2004, LASER SURG MED, V34, P242, DOI 10.1002/lsm.20024; OKUSKY J, 1982, J COMP NEUROL, V210, P307, DOI 10.1002/cne.902100309; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; PAINTAL AS, 1969, J PHYSIOL-LONDON, V203, P511, DOI 10.1113/jphysiol.1969.sp008877; PIPER RD, 1991, AM J PHYSIOL, V261, pH96, DOI 10.1152/ajpheart.1991.261.1.H96; Polischuk TM, 1998, NEUROBIOL DIS, V4, P423, DOI 10.1006/nbdi.1998.0172; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Sato S, 2011, OPT LETT, V36, P4545, DOI 10.1364/OL.36.004545; Satoh Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2128432; Satoh Y, 2010, LASER SURG MED, V42, P313, DOI 10.1002/lsm.20899; Schumacher RN, 1977, 2724 US BALL RES LAB; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; Showstack R., 2013, EOS T AGU, V94, P87; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Somjen GG, 2008, J COMPUT NEUROSCI, V25, P349, DOI 10.1007/s10827-008-0083-9; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sunami K, 1989, Neurol Med Chir (Tokyo), V29, P975, DOI 10.2176/nmc.29.975; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; VANDERZEE P, 1993, P SOC PHOTO-OPT INS, V1888, P454, DOI 10.1117/12.154665; VANHARREVELD A, 1956, AM J PHYSIOL, V184, P312; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wharton D.C., 1966, BIOCH COPPER, P235; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zhang FY, 2002, J NEUROSURG, V97, P963, DOI 10.3171/jns.2002.97.4.0963; Zuckerman S, 1940, LANCET, V2, P219	96	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82891	10.1371/journal.pone.0082891	http://dx.doi.org/10.1371/journal.pone.0082891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416150	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500022
J	Stein, ML; van Steenbergen, JE; Chanyasanha, C; Tipayamongkholgul, M; Buskens, V; van der Heijden, PGM; Sabaiwan, W; Bengtsson, L; Lu, X; Thorson, AE; Kretzschmar, MEE				Stein, Mart L.; van Steenbergen, Jim E.; Chanyasanha, Charnchudhi; Tipayamongkholgul, Mathuros; Buskens, Vincent; van der Heijden, Peter G. M.; Sabaiwan, Wasamon; Bengtsson, Linus; Lu, Xin; Thorson, Anna E.; Kretzschmar, Mirjam E. E.			Online Respondent-Driven Sampling for Studying Contact Patterns Relevant for the Spread of Close-Contact Pathogens: A Pilot Study in Thailand	PLOS ONE			English	Article							INFECTIOUS-DISEASE; SOCIAL CONTACTS; MIXING PATTERNS; NETWORK; TRANSMISSION; RECRUITMENT; POPULATIONS; PARAMETERS; BEHAVIOR; MODELS	Background: Information on social interactions is needed to understand the spread of airborne infections through a population. Previous studies mostly collected egocentric information of independent respondents with self-reported information about contacts. Respondent-driven sampling (RDS) is a sampling technique allowing respondents to recruit contacts from their social network. We explored the feasibility of webRDS for studying contact patterns relevant for the spread of respiratory pathogens. Materials and Methods: We developed a webRDS system for facilitating and tracking recruitment by Facebook and email. One-day diary surveys were conducted by applying webRDS among a convenience sample of Thai students. Students were asked to record numbers of contacts at different settings and self-reported influenza-like-illness symptoms, and to recruit four contacts whom they had met in the previous week. Contacts were asked to do the same to create a network tree of socially connected individuals. Correlations between linked individuals were analysed to investigate assortativity within networks. Results: We reached up to 6 waves of contacts of initial respondents, using only non-material incentives. Forty-four (23.0%) of the initially approached students recruited one or more contacts. In total 257 persons participated, of which 168 (65.4%) were recruited by others. Facebook was the most popular recruitment option (45.1%). Strong assortative mixing was seen by age, gender and education, indicating a tendency of respondents to connect to contacts with similar characteristics. Random mixing was seen by reported number of daily contacts. Conclusions: Despite methodological challenges (e. g. clustering among respondents and their contacts), applying RDS provides new insights in mixing patterns relevant for close-contact infections in real-world networks. Such information increases our knowledge of the transmission of respiratory infections within populations and can be used to improve existing modelling approaches. It is worthwhile to further develop and explore webRDS for the detection of clusters of respiratory symptoms in social networks.	[Stein, Mart L.; Kretzschmar, Mirjam E. E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Stein, Mart L.; van Steenbergen, Jim E.; Kretzschmar, Mirjam E. E.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Steenbergen, Jim E.] Leiden Univ, Med Ctr, Ctr Infect Dis, Leiden, Netherlands; [Chanyasanha, Charnchudhi] Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok 10700, Thailand; [Tipayamongkholgul, Mathuros] Mahidol Univ, Fac Publ Hlth, Dept Epidemiol, Bangkok 10700, Thailand; [Buskens, Vincent; van der Heijden, Peter G. M.] Univ Utrecht, Fac Social & Behav Sci, Utrecht, Netherlands; [van der Heijden, Peter G. M.] Univ Southampton, Southampton Stat Sci Res Inst, Southampton, Hants, England; [Sabaiwan, Wasamon] Chulalongkorn Univ, Fac Commun Arts, Bangkok, Thailand; [Bengtsson, Linus; Lu, Xin; Thorson, Anna E.] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Lu, Xin] Natl Univ Def Technol, Coll Informat Syst & Management, Changsha, Hunan, Peoples R China	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Mahidol University; Mahidol University; Utrecht University; University of Southampton; Chulalongkorn University; Karolinska Institutet; National University of Defense Technology - China	Stein, ML (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	m.l.stein-2@umcutrecht.nl	Buskens, Vincent/B-3134-2012; lu, xin/C-1940-2009; Stein, Mart/U-8914-2019; Buskens, Vincent/N-8762-2019	Buskens, Vincent/0000-0002-4483-7238; lu, xin/0000-0002-3547-6493; Buskens, Vincent/0000-0002-4483-7238; Kretzschmar, Mirjam/0000-0002-4394-7697; Tipayamongkholgul, Mathuros/0000-0002-2585-1659; Stein, Mart L./0000-0003-0502-7993; van der Heijden, Peter/0000-0002-3345-096X; Thorson, Anna/0000-0002-8703-6561	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Swedish Research Council (vr.se) has financed the programming of the RDS web-survey system and the technical implementation of the surveys in Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; [Anonymous], 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Ball F, 2013, J MATH BIOL, V66, P979, DOI 10.1007/s00285-012-0609-7; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bauermeister JA, 2012, J STUD ALCOHOL DRUGS, V73, P834, DOI 10.15288/jsad.2012.73.834; Bengtsson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049417; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Bolton KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030893; Brooks-Pollock E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-68; Chen CY, 2002, SAGE U PAPER SERIES; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Eames KTD, 2008, THEOR POPUL BIOL, V73, P104, DOI 10.1016/j.tpb.2007.09.007; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Johnston LG, 2010, AIDS CARE, V22, P784, DOI 10.1080/09540120903373557; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kretzschmar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005931; Marquet RL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-242; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; Mccaw JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-166; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; McCreesh N, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-56; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; National Statistical Office Ministry of Information and Communication Technology Thailand, 2012, INF COMM TECHN SURV; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Socialbakers, 2013, CHECKF FAC STAT THAI; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Szendroi B, 2004, P ROY SOC B-BIOL SCI, V271, pS364, DOI 10.1098/rsbl.2004.0188; van der Weijden CP, 2013, HEALTH POLICY, V109, P52, DOI 10.1016/j.healthpol.2012.05.007; Volz E, 2008, J OFF STAT, V24, P79; Volz EM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002042; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wejnert C, 2008, SOCIOL METHOD RES, V37, P105, DOI 10.1177/0049124108318333; Wejnert C, 2009, SOCIOL METHODOL, V39, P73, DOI 10.1111/j.1467-9531.2009.01216.x	46	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85256	10.1371/journal.pone.0085256	http://dx.doi.org/10.1371/journal.pone.0085256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416371	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000329862500230
J	Sun, YB; Jiang, CQ; Cheng, KK; Zhang, WS; Leung, GM; Lam, TH; Schooling, CM				Sun, Yangbo; Jiang, Chaoqiang; Cheng, Kar Keung; Zhang, Weisen; Leung, Gabriel M.; Lam, Tai Hing; Schooling, C. Mary			Milk Consumption and Cardiovascular Risk Factors in Older Chinese: The Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CORONARY-HEART-DISEASE; VITAMIN-D; DAIRY CONSUMPTION; BLOOD-PRESSURE; CALCIUM; HEALTH; HYPERTENSION; METAANALYSIS; CHOLESTEROL	Background: Dairy products consumption is increasingly common globally. Most of the evidence concerning dairy products comes from observational studies in western populations which are inevitably open to confounding. To triangulate the evidence concerning dairy products, we examined the associations of whole cow's milk consumption with cardiovascular risk factors in a non-Western setting with a different pattern of milk consumption and cardiovascular diseases from Western populations. Methods: We used multivariable censored linear or logistic regression to examine cross-sectionally the adjusted associations of whole cow's milk consumption (none (n = 14892), 1-3/week (n = 2689) and 3+/week (n = 2754)) with cardiovascular risk factors in Chinese (>= 50 years) in the Guangzhou Biobank Cohort Study. Results: Whole cow's milk consumption was negatively associated with systolic blood pressure (3+/week compared to none -2.56 mmHg, 95% confidence interval (CI) -3.63 to -1.49), diastolic blood pressure (-1.32 mmHg, 95% CI -1.87 to -0.77) and triglycerides (-0.06 mmol/L, 95% CI -0.11 to -0.002), but was positively associated with HDL-cholesterol (0.02 mmol/L, 95% CI 0.01 to 0.04) and fasting glucose (0.08 mmol/L, 95% CI 0.01 to 0.16) adjusted for age, sex, phase of study, socio-economic position, lifestyle (smoking, alcohol use and physical activity) and adiposity, but had no obvious association with LDL-cholesterol or the presence of diabetes. Conclusions: Whole cow's milk consumption had heterogeneous associations with cardiovascular risk factors. Higher whole cow's milk consumption was associated with lower levels of specific cardiovascular risk factors which might suggest risk factor specific biological pathways with different relations to blood pressure and lipids than glucose.	[Sun, Yangbo; Leung, Gabriel M.; Lam, Tai Hing; Schooling, C. Mary] Univ Hong Kong, Lifestyle & Lifecourse Epidemiol Grp, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Jiang, Chaoqiang; Zhang, Weisen] Guangzhou 12 Hosp, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System	Lam, TH (corresponding author), Univ Hong Kong, Lifestyle & Lifecourse Epidemiol Grp, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; Schooling, Mary/0000-0001-9933-5887; Lam, Tai Hing/0000-0002-2033-9971; Leung, Gabriel/0000-0002-2503-6283	University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau, Guangzhou, China; University of Birmingham, UK	University of Hong Kong Foundation for Development and Research; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau, Guangzhou, China; University of Birmingham, UK	This work was supported by The University of Hong Kong Foundation for Development and Research, and the University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Bureau, Guangzhou, China; and The University of Birmingham, UK. The funding sources had no role in any of the following: study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the paper for publication.	Akinsete JA, 2012, CARCINOGENESIS, V33, P140, DOI 10.1093/carcin/bgr238; Almon R, 2010, EUR J NUTR, V49, P141, DOI 10.1007/s00394-009-0058-2; Alonso A, 2009, J HUM NUTR DIET, V22, P336, DOI 10.1111/j.1365-277X.2009.00967.x; AVALOS EE, 2012, PUBLIC HEALTH NUTR, P1; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Bolland MJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2040; Delgado CL, 2003, J NUTR, V133, p3907S, DOI 10.1093/jn/133.11.3907S; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Huth PJ, 2012, ADV NUTR, V3, P266, DOI 10.3945/an.112.002030; Itan Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-36; Jakala P, 2010, PHARMACEUTICALS-BASE, V3, P251, DOI 10.3390/ph3010251; James WPT, 1997, BMJ-BRIT MED J, V314, P1545, DOI 10.1136/bmj.314.7093.1545; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Kinjo Y, 1999, J Epidemiol, V9, P268; Kipnis V, 2002, PUBLIC HEALTH NUTR, V5, P915, DOI 10.1079/PHN2002383; Kirii K, 2009, DIABETOLOGIA, V52, P2542, DOI 10.1007/s00125-009-1554-x; Larsson SC, 2009, EPIDEMIOLOGY, V20, P355, DOI 10.1097/EDE.0b013e3181935dd5; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Margolis KL, 2008, HYPERTENSION, V52, P847, DOI 10.1161/HYPERTENSIONAHA.108.114991; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; NAITO C, 1990, ANN NY ACAD SCI, V598, P482, DOI 10.1111/j.1749-6632.1990.tb42318.x; Ponda MP, 2012, ARTERIOSCL THROM VAS, V32, P2510, DOI 10.1161/ATVBAHA.112.254110; Qiao R, 2011, BIOMED ENVIRON SCI, V24, P512, DOI 10.3967/0895-3988.2011.05.009; Ralston RA, 2012, J HUM HYPERTENS, V26, P3, DOI 10.1038/jhh.2011.3; ROSSOUW JE, 1981, AM J CLIN NUTR, V34, P351, DOI 10.1093/ajcn/34.3.351; Sanchez-Villegas A, 2003, EUR J CLIN NUTR, V57, P917, DOI 10.1038/sj.ejcn.1601626; Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.086553; SMITH AM, 1992, J EPIDEMIOL COMMUN H, V46, P409, DOI 10.1136/jech.46.4.409; Soedamah-Muthu SS, 2012, HYPERTENSION, V60, P1131, DOI 10.1161/HYPERTENSIONAHA.112.195206; Soedamah-Muthu SS, 2011, AM J CLIN NUTR, V93, P158, DOI 10.3945/ajcn.2010.29866; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tong X, 2011, EUR J CLIN NUTR, V65, P1027, DOI 10.1038/ejcn.2011.62; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Villegas R, 2009, AM J CLIN NUTR, V89, P1059, DOI 10.3945/ajcn.2008.27182; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zemel MB, 2001, J AM COLL NUTR, V20, p428S, DOI 10.1080/07315724.2001.10719180	40	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84813	10.1371/journal.pone.0084813	http://dx.doi.org/10.1371/journal.pone.0084813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416290	Green Published, gold			2022-12-25	WOS:000329862500172
J	Wilson, CL; Mann, J; Walsh, M; Perrugoria, MJ; Oakley, F; Wright, MC; Brignole, C; Di Paolo, D; Perri, P; Ponzoni, M; Karin, M; Mann, DA				Wilson, Caroline L.; Mann, Jelena; Walsh, Meagan; Perrugoria, Maria J.; Oakley, Fiona; Wright, Matthew C.; Brignole, Chiara; Di Paolo, Daniela; Perri, Patrizia; Ponzoni, Mirco; Karin, Michael; Mann, Derek A.			Quiescent Hepatic Stellate Cells Functionally Contribute to the Hepatic Innate Immune Response via TLR3	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; PATTERN-RECOGNITION RECEPTORS; NONPARENCHYMAL LIVER-CELLS; LARGE GRANULAR LYMPHOCYTES; NATURAL-KILLER ACTIVITY; DOUBLE-STRANDED-RNA; C VIRUS; FIBROSIS; AUGMENTATION; INFLAMMATION	Toll-like Receptor 3 (TLR3) is a pathogen pattern recognition receptor that plays a key role in innate immunity. TLR3 signalling has numerous functions in liver, both in health and disease. Here we report that TLR3 is expressed by quiescent hepatic stellate cells (HSC) where it functions to induce transcription and secretion of functional interferons as well as a number of other cytokines and chemokines. Upon transdifferentiation into myofibroblasts, HSCs rapidly loose the ability to produce interferon gamma (IFN gamma). Mechanistically, this gene silencing may be due to Polycomb complex mediated repression via methylation of histone H3 lysine 27. In contrast to wild type, quiescent HSC isolated from tlr3 knockout mice do not produce IFN gamma in response to Poly(I:C) treatment. Therefore, quiescent HSC may contribute to induction of the hepatic innate immune system in response to injury or infection.	[Wilson, Caroline L.; Mann, Jelena; Walsh, Meagan; Perrugoria, Maria J.; Oakley, Fiona; Wright, Matthew C.; Mann, Derek A.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Brignole, Chiara; Di Paolo, Daniela; Perri, Patrizia; Ponzoni, Mirco] Ist Giannina Gaslini, Lab Oncol, Expt Therapy Unit, I-16148 Genoa, Italy; [Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol & Pathol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	Newcastle University - UK; University of Genoa; IRCCS Istituto Giannina Gaslini; University of California System; University of California San Diego	Mann, DA (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Derek.Mann@ncl.ac.uk	Di Paolo, Daniela/J-7681-2016; Perri, Patrizia/AFV-5794-2022; Brignole, Chiara/H-9986-2018; Ponzoni, Mirco/J-7713-2016; Perri, Patrizia/I-8124-2018	Di Paolo, Daniela/0000-0001-7264-6888; Perri, Patrizia/0000-0003-2538-8278; Brignole, Chiara/0000-0002-2563-6991; Ponzoni, Mirco/0000-0002-6164-4286; Perri, Patrizia/0000-0003-2538-8278; Wright, Matthew/0000-0003-3167-6743; Mann, Derek/0000-0003-0950-243X; , Caroline/0000-0002-9016-6025	National Institutes of Health (NIH) [U01AA018663, P50AA11199, R24AA12885]; Newcastle Biomedical Research Centre; Wellcome Trust [WT086755MA]; Medical Research Council [MK/K001949/1, G0700890]; European Commission FP7 program grant 'INFLA-CARE' (EC) [223151]; Medical Research Council [MR/K001949/1] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA018663, R24AA012885, P50AA011999] Funding Source: NIH RePORTER; MRC [MR/K001949/1, G0700890] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Newcastle Biomedical Research Centre; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission FP7 program grant 'INFLA-CARE' (EC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The present study was supported by the National Institutes of Health (NIH) grants (U01AA018663, P50AA11199, R24AA12885), Newcastle Biomedical Research Centre, the Wellcome Trust (WT086755MA to D. A. M. and M. K.), Medical Research Council grants (MK/K001949/1 to D. A. M., J.M., F.O. and G0700890 to D. A. M., M. C. W. and F.O.) and the European Commission FP7 program grant 'INFLA-CARE' (EC Contract No. 223151; http://inflacare.imbb.forth.gr/ to D. A. M., M. P., C. B., D. D. P. and P. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; BLOMHOFF R, 1991, FASEB J, V5, P271, DOI 10.1096/fasebj.5.3.2001786; Broering R, 2008, J HEPATOL, V48, P914, DOI 10.1016/j.jhep.2008.01.028; Byun JS, 2013, J HEPATOL, V58, P342, DOI 10.1016/j.jhep.2012.09.016; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Paik YH, 2006, LAB INVEST, V86, P676, DOI 10.1038/labinvest.3700422; Perugorria MJ, 2012, HEPATOLOGY, V56, P1129, DOI 10.1002/hep.25754; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Saile B, 2004, EUR J CELL BIOL, V83, P469, DOI 10.1078/0171-9335-00409; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Watanabe A, 2007, HEPATOLOGY, V46, P1509, DOI 10.1002/hep.21867; Wilson CL, 2012, IMMUNOLOGY, V135, P344, DOI 10.1111/j.1365-2567.2011.03548.x; WILTROUT RH, 1989, J IMMUNOL, V143, P372; WILTROUT RH, 1984, J EXP MED, V160, P1431, DOI 10.1084/jem.160.5.1431; Wu J, 2010, IMMUNOLOGY, V129, P363, DOI 10.1111/j.1365-2567.2009.03179.x; Yin S, 2010, GASTROENT RES PRACT, P2010	35	30	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83391	10.1371/journal.pone.0083391	http://dx.doi.org/10.1371/journal.pone.0083391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416163	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500045
J	Xie, L; Zhou, QM; Liu, SG; Wu, QY; Ji, YJ; Zhang, LJ; Xu, F; Gong, W; Melgiri, ND; Xie, P				Xie, Liang; Zhou, Qinming; Liu, Shigang; Wu, Qingyuan; Ji, Yongjia; Zhang, Lujun; Xu, Fan; Gong, Wei; Melgiri, Narayan D.; Xie, Peng			Normal Thoracic Radiographic Appearance of the Cynomolgus Monkey (Macaca fascicularis)	PLOS ONE			English	Article							MACAQUES; MODEL; SIZE	Background: The cynomolgus monkey (Macaca fascicularis) has been increasingly used as a non-human primate model in biomedical research. As establishing baseline thoracic radiography for the cynomolgus monkey is essential, we tested the hypothesis that age and sex may affect the thoracic radiography parameters of this species. Methods: Here, 697 healthy cynomolgus monkeys were segregated by sex and age (three age groups: 25-36 months, 37-48 months, 49-60 months). The lung length (LL), maximal interior thoracic depth (TD), maximal interior thoracic breadth (TBr), cardiac silhouette breadth (CBr), cardiothoracic ratio (CR), right and left costophrenic angles (RCA and LCA), and right hilar height ratio (R-HHR) were assessed by chest film. Statistical analysis was applied to examine the effect of age, sex, and age x sex interactions. Results: Significant effects by age were shown for LL, TD, TBr, CBr, and CR. Significant effects by sex were found for TD, TBr, CBr, CR, and R-HHR. Significant effects by age x sex were observed for TD, TBr, CBr, and CR. Both TD and TBr increased with age in both sexes, and both were significantly higher in males than in females in the group aged 49-60 months. CBr increased with age and was significantly higher in males than in females across all age groups. CR declined with age and was significantly higher in males than females across all age groups, and CR was similar or slightly higher relative to those previously found in other non-human primate species. As to the other parameters with no significant sex nor age-related differences, the R-HHR was greater than 1.00, and the angulation of bilateral costophrenic angles were sharp. Conclusions: The thoracic radiographic parameters for the healthy cynomolgus monkey presented here should prove useful in veterinary practice, research involving non-human primate models of respiratory or cardiovascular disorders, and morphological studies on cynomolgus monkeys.	[Xie, Liang; Zhou, Qinming; Wu, Qingyuan; Ji, Yongjia; Zhang, Lujun; Xu, Fan; Gong, Wei; Melgiri, Narayan D.; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Xie, Liang; Zhou, Qinming; Wu, Qingyuan; Ji, Yongjia; Zhang, Lujun; Xu, Fan; Gong, Wei; Melgiri, Narayan D.; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Xie, Liang; Zhou, Qinming; Wu, Qingyuan; Ji, Yongjia; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Liu, Shigang] Suzhou Xishan Zhongke Lab Anim Co Ltd, Suzhou, Peoples R China	Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Zhou, Qinming/GWZ-7229-2022	Zhou, Qinming/0000-0001-6211-0588	National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program; Grant No. 2009CB918300) and the National Natural Science Foundation of China (Grant No. 31271189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FR, 2012, PESQUISA VET BRASIL, V32, P1345, DOI 10.1590/S0100-736X2012001200021; Andrade MCR, 2004, MEM I OSWALDO CRUZ, V99, P581, DOI 10.1590/S0074-02762004000600009; Brining DL, 2010, COMPARATIVE MED, V60, P389; Campbell RM, 2003, J BONE JOINT SURG AM, V85A, P399, DOI 10.2106/00004623-200303000-00001; HAMMERMEISTER KE, 1979, CIRCULATION, V59, P89, DOI 10.1161/01.CIR.59.1.89; HOMER MJ, 1978, RADIOLOGY, V129, P11, DOI 10.1148/129.1.11; HUBBELL FA, 1985, NEW ENGL J MED, V312, P209, DOI 10.1056/NEJM198501243120404; Ji Y, 2013, J AM ASS LAB ANIM, V52, P1; Lawler JV, 2006, PLOS MED, V3, P677, DOI 10.1371/journal.pmed.0030149; LEIGH SR, 1992, J HUM EVOL, V23, P27, DOI 10.1016/0047-2484(92)90042-8; Liang Sao-Ling, 2005, Taiwan Veterinary Journal, V31, P85; Mattison LE, 1997, CHEST, V111, P1018, DOI 10.1378/chest.111.4.1018; REICH SB, 1985, AM J ROENTGENOL, V144, P695, DOI 10.2214/ajr.144.4.695; Schillaci MA, 2008, J MED PRIMATOL, V37, P141, DOI 10.1111/j.1600-0684.2007.00250.x; Schillaci MA, 2010, RADIOGRAPHY, V16, P163, DOI 10.1016/j.radi.2010.01.003; Schillaci MA, 2009, RADIOGRAPHY, V15, pE29, DOI 10.1016/j.radi.2009.05.005; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; SILVERMAN S, 1980, AM J VET RES, V41, P1704; Wagner WM, 2005, VET RADIOL ULTRASOUN, V46, P217, DOI 10.1111/j.1740-8261.2005.00044.x; Wolfe-Coote S, 2005, LAB PRIMATE, P371; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064892	21	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84599	10.1371/journal.pone.0084599	http://dx.doi.org/10.1371/journal.pone.0084599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416248	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500139
J	Lagrange, J; Li, ZL; Fassot, C; Bourhim, M; Louis, H; Cat, AND; Parlakian, A; Wahl, D; Lacolley, P; Jaisser, F; Regnault, V				Lagrange, Jeremy; Li, Zhenlin; Fassot, Celine; Bourhim, Mustapha; Louis, Huguette; Cat, Aurelie Nguyen Dinh; Parlakian, Ara; Wahl, Denis; Lacolley, Patrick; Jaisser, Frederic; Regnault, Veronique			Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice	FASEB JOURNAL			English	Article						aldosterone; thrombin; SP1; smooth muscle cell; transcriptional regulation	MYOCARDIAL-INFARCTION; PLATELET ACTIVATION; HEART-FAILURE; ALDOSTERONE; CELLS; GENERATION; PLASMA; GENE; RATS; DYSFUNCTION	Previous studies have shown that aldosterone, which activates the mineralocorticoid receptor (MR), promotes thrombosis in animal models. Our objective was to determine whether MR activation/expression in the vascular endothelium could modify thrombotic risk in vivo and to examine thrombin generation at the surface of aortic endothelial cells (HAECs). MR was conditionally overexpressed in vivo in vascular endothelial cells in mice (MR-EC mice) or stimulated with aldosterone in HAECs. Thrombosis after ferric chloride injury was delayed in MR-EC mice compared with controls as well as in wild-type FVB/NRj mice treated with aldosterone (60 g/kg/d for 21 d). Thrombin generation in platelet-poor plasma did not differ between MR-EC mice and controls. In MR-EC mice, aortic endothelial cell protein C receptor (EPCR) expression was increased. Aldosterone (10(-8) M) attenuated thrombin generation at the surface of cultured HAECs, and this effect was associated with up-regulation of expression of EPCR, which promotes formation of activated protein C. Aldosterone increases EPCR expression via a transcriptional mechanism involving interaction of MR with the specificity protein 1 site. These findings demonstrate that MR activation acts on endothelial cells to protect against thrombosis in physiological conditions and that MR-mediated EPCR overexpression drives this antithrombotic property through enhancing protein C activation.Lagrange, J., Li, Z., Fassot, C., Bourhim, M., Louis, H., Nguyen Dinh Cat, A., Parlakian, A., Wahl, D., Lacolley, P., Jaisser, F., Regnault, V. Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice.	[Lagrange, Jeremy; Bourhim, Mustapha; Louis, Huguette; Wahl, Denis; Lacolley, Patrick; Regnault, Veronique] Fac Med, INSERM, U1116, F-54500 Vandoeuvre Les Nancy, France; [Lagrange, Jeremy; Bourhim, Mustapha; Louis, Huguette; Wahl, Denis; Lacolley, Patrick; Regnault, Veronique] Univ Lorraine, Nancy, France; [Li, Zhenlin; Fassot, Celine; Cat, Aurelie Nguyen Dinh; Parlakian, Ara; Jaisser, Frederic] Univ Paris 06, Paris, France; [Fassot, Celine; Cat, Aurelie Nguyen Dinh; Jaisser, Frederic] INSERM, U872, Ctr Rech Cordeliers, Paris, France; [Wahl, Denis; Lacolley, Patrick; Jaisser, Frederic; Regnault, Veronique] Ctr Hosp Univ CHU Nancy, Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; CHU de Nancy	Regnault, V (corresponding author), Fac Med, INSERM, U1116, 9 Ave Foret Haye, F-54500 Vandoeuvre Les Nancy, France.	veronique.regnault@inserm.fr	Lacolley, Patrick/G-3118-2013; lagrange, jeremy/AAQ-2538-2021; Lagrange, Jeremy/AAB-4505-2020; Fassot, Celine/K-1494-2015; CAT, Aurelie NGUYEN DINH/H-8182-2013; Regnault, Veronique/H-9138-2016; Li, Zhenlin/E-3937-2016; REGNAULT, Veronique/AAY-1711-2020; Jaisser, Frederic/P-4287-2017	Lagrange, Jeremy/0000-0002-0811-565X; REGNAULT, Veronique/0000-0001-6418-5022; Jaisser, Frederic/0000-0001-9051-1901; LI, Zhenlin/0000-0002-3706-4505; ARA, PARLAKIAN/0000-0002-0928-2185	Agence Nationale de la Recherche (ANR) Blanc program [NT09_450866]; Region Lorraine; Communaute Urbaine du Grand Nancy (Nancy, France)	Agence Nationale de la Recherche (ANR) Blanc program(French National Research Agency (ANR)); Region Lorraine(Region Grand-Est); Communaute Urbaine du Grand Nancy (Nancy, France)	The authors thank Christos Chatzantoniou and Sandrine Placier for assistance in setting up the arterial thrombosis model. The authors are grateful to Sebastien Hupont (FR 3209) for his participation. The authors thank Mary Osborne-Pellegrin and Peter Lenting for helpful discussion and comments on the manuscript, and Simon N. Thornton for manuscript editing. This study was supported by the Agence Nationale de la Recherche (ANR) Blanc program NT09_450866. J.L. is supported by the Region Lorraine and the Communaute Urbaine du Grand Nancy (Nancy, France).	Barr JD, 2013, BLOOD, V121, P3733, DOI 10.1182/blood-2012-11-468983; Bodary PF, 2006, ARTERIOSCL THROM VAS, V26, P233, DOI 10.1161/01.ATV.0000195782.07637.44; BRILLA CG, 1990, CIRC RES, V67, P1355, DOI 10.1161/01.RES.67.6.1355; Burger D, 2012, J AM SOC HYPERTENS, V6, P85, DOI 10.1016/j.jash.2011.11.003; Cat AND, 2010, FASEB J, V24, P2454, DOI 10.1096/fj.09-147926; Centelles MN, 2010, THROMB HAEMOSTASIS, V103, P1239, DOI 10.1160/TH09-11-0750; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Ducros E, 2008, BIOCHEM BIOPH RES CO, V373, P192, DOI 10.1016/j.bbrc.2008.05.185; Esmon CT, 2004, CRIT CARE MED, V32, pS298, DOI 10.1097/01.CCM.0000126128.64614.81; Funder JW, 2004, TRENDS ENDOCRIN MET, V15, P139, DOI 10.1016/j.tem.2004.03.006; Gromotowicz A, 2011, J RENIN-ANGIO-ALDO S, V12, P430, DOI 10.1177/1470320310397405; Hackeng TM, 1996, BIOCHEM J, V319, P399, DOI 10.1042/bj3190399; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Itoh Y, 2010, ARTERIOSCL THROM VAS, V30, P1725, DOI 10.1161/ATVBAHA.110.207365; Jeong Y, 2009, P NATL ACAD SCI USA, V106, P3782, DOI 10.1073/pnas.0804037106; Kolkhof P, 2012, MOL CELL ENDOCRINOL, V350, P310, DOI 10.1016/j.mce.2011.06.025; Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Mao XQ, 2012, CARDIOVASC RES, V96, P513, DOI 10.1093/cvr/cvs274; McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014; Meinel S, 2013, NUCLEIC ACIDS RES, V41, P8045, DOI 10.1093/nar/gkt581; Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038; Messaoudi S, 2009, FASEB J, V23, P2176, DOI 10.1096/fj.08-125302; Mollica LR, 2006, BLOOD, V108, P1251, DOI 10.1182/blood-2006-02-001461; Newfell BG, 2011, ARTERIOSCL THROM VAS, V31, P1871, DOI 10.1161/ATVBAHA.111.229070; Parlakian A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009299; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Qu D, 2007, J THROMB HAEMOST, V5, P395, DOI 10.1111/j.1538-7836.2007.02347.x; REGNAULT V, 1991, THROMB RES, V63, P629, DOI 10.1016/0049-3848(91)90089-F; REGNAULT V, 1995, THROMB HAEMOSTASIS, V73, P1365; Regnault W, 2004, THROMB RES, V114, P539, DOI 10.1016/j.thromres.2004.06.017; Schafer A, 2003, THROMB HAEMOSTASIS, V89, P1024, DOI 10.1055/s-0037-1613404; Schafer A, 2010, J PHYSIOL PHARMACOL, V61, P45; SIMPSON SA, 1953, EXPERIENTIA, V9, P333, DOI 10.1007/BF02155834; Skott O, 2006, PHARMACOL THERAPEUT, V111, P495, DOI 10.1016/j.pharmthera.2005.10.010; Stankiewicz A, 2007, THROMB HAEMOSTASIS, V98, P697, DOI 10.1160/TH07-03-0237; Tchaikovski SN, 2007, J THROMB HAEMOST, V5, P2079, DOI 10.1111/j.1538-7836.2007.02719.x; vantVeer C, 1997, J BIOL CHEM, V272, P7983, DOI 10.1074/jbc.272.12.7983; Weiler H, 2011, HAMOSTASEOLOGIE, V31, P185, DOI 10.5482/ha-1166; Wu CQ, 2013, BJOG-INT J OBSTET GY, V120, P801, DOI 10.1111/1471-0528.12210; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhao M, 2012, J CLIN INVEST, V122, P2672, DOI 10.1172/JCI61427	43	19	19	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2062	2072		10.1096/fj.13-238188	http://dx.doi.org/10.1096/fj.13-238188			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24451386				2022-12-25	WOS:000335336000011
J	Wolff, NA; Ghio, AJ; Garrick, LM; Garrick, MD; Zhao, L; Fenton, RA; Thevenod, F				Wolff, Natascha A.; Ghio, Andrew J.; Garrick, Laura M.; Garrick, Michael D.; Zhao, Lin; Fenton, Robert A.; Thevenod, Frank			Evidence for mitochondrial localization of divalent metal transporter 1 (DMT1)	FASEB JOURNAL			English	Article						adenine nucleotide translocator; early endosomal antigen 1; kiss-and-run; lysosome-associated membrane protein; transferrin	KIDNEY PROXIMAL TUBULE; CYTOCHROME-C-OXIDASE; IRON-METABOLISM; SUPEROXIDE-DISMUTASE; MEMBRANE-PROTEINS; EPITHELIAL-CELLS; ION TRANSPORTER; OUTER-MEMBRANE; RAT-KIDNEY; TRAFFICKING	In mammalian cells, mitochondria receive most incoming iron, yet no entry pathway for iron at the outer mitochondrial membrane (OMM) has been characterized. Our results show that the divalent metal transporter 1 (DMT1) occurs in the OMM. Immunoblots detected DMT1 in mitochondria from a pneumocyte cell model in their OMM. Using the split-ubiquitin yeast 2-hybrid system, we found that cytochrome c oxidase subunit II (COXII) and the translocase of OMM 6-kDa subunit (Tom6) homologue interact with DMT1. COXII coimmunoprecipitates with DMT1. There are 4 DMT1 isoforms that differ at the N and C termini. Using HEK293 cells that inducibly express all of the 4 ends of DMT1, we found all of them in the OMM, as detected by immunoblots after cell fractionation, and in isolated mitochondria, as detected by immunofluorescence. Immunoblot analysis of purified cell fractions from rat renal cortex confirmed and extended these results to the kidney, which expressed high levels of DMT1. Immunogold labeling detected DMT1 colocalization in mitochondria with the voltage-dependent anion-selective channel protein-1, which is expressed in the OMM. We suggest that DMT1 not only exports iron from endosomes, but also serves to import the metal into the mitochondria.Wolff, N. A., Ghio, A. J., Garrick, L. M., Garrick, M. D., Zhao, L., Fenton, R. A., Thevenod, F. Evidence for mitochondrial localization of divalent metal transporter 1 (DMT1).	[Wolff, Natascha A.; Thevenod, Frank] Univ Witten Herdecke, Dept Physiol & Pathophysiol, D-58453 Witten, Germany; [Wolff, Natascha A.; Thevenod, Frank] Univ Witten Herdecke, Ctr Biomed Educ & Res ZBAF, D-58453 Witten, Germany; [Ghio, Andrew J.] US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Chapel Hill, NC USA; [Garrick, Laura M.; Garrick, Michael D.; Zhao, Lin] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Fenton, Robert A.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Fenton, Robert A.] Aarhus Univ, Interact Prot Epithelial Transport InterPrET Ctr, Aarhus, Denmark	Witten Herdecke University; Witten Herdecke University; United States Environmental Protection Agency; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Aarhus University; Aarhus University	Thevenod, F (corresponding author), Univ Witten Herdecke, Dept Physiol & Pathophysiol, Stockumer Str 12, D-58453 Witten, Germany.	natascha.wolff@uni-wh.de; frank.thevenod@uni-wh.de	Fenton, Robert/AFR-6983-2022; Fenton, Robert A/ABD-9824-2021	Fenton, Robert/0000-0003-1623-199X; Garrick, Michael/0000-0001-7342-6983	Deutsche Forschungsgemeinschaft (DFG) [TH345/11-1]; Center for Biomedical Education and Research (ZBAF; University of Witten/Herdecke, Witten, Germany); Laura and Michael Garrick Fund; Danish Medical Research Council; Lundbeck Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Center for Biomedical Education and Research (ZBAF; University of Witten/Herdecke, Witten, Germany); Laura and Michael Garrick Fund; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	The authors thank Dr. Sabine Brast and Dr. Giuliano Ciarimboli for advice regarding the split-ubiquitin yeast 2-hybrid system, Tobias Dreser and Else-Merete Locke for technical assistance, and Dr. Funmei Yang (University of Texas at San Antonio, San Antonio, TX, USA) for assistance in performing the immunoblot in Fig. 1. Access to the Zeiss AxioImager fluorescence microscope was provided by the State University of New York (SUNY) Buffalo Confocal Microscopy Facility (Buffalo, NY, USA). Financial support was obtained from Deutsche Forschungsgemeinschaft (DFG) grant TH345/11-1, The Center for Biomedical Education and Research (ZBAF; University of Witten/Herdecke, Witten, Germany), the Laura and Michael Garrick Fund, the Danish Medical Research Council, and the Lundbeck Foundation. The hDMT1-1A/+IRE plasmids were provided by Dr. Matthias Hentze [European Molecular Biology Laboratory (EMBL), Heidelberg, Germany].	Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; Abouhamed M, 2007, AM J PHYSIOL-RENAL, V293, pF705, DOI 10.1152/ajprenal.00198.2007; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breuer W, 2008, INT J BIOCHEM CELL B, V40, P350, DOI 10.1016/j.biocel.2007.03.010; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Chen XZ, 1999, J BIOL CHEM, V274, P35089, DOI 10.1074/jbc.274.49.35089; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Ferguson CJ, 2001, AM J PHYSIOL-RENAL, V280, pF803, DOI 10.1152/ajprenal.2001.280.5.F803; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Garrick MD, 2006, BIOCHEM J, V398, P539, DOI 10.1042/BJ20051987; Garrick MD, 2009, BBA-GEN SUBJECTS, V1790, P309, DOI 10.1016/j.bbagen.2009.03.018; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; Greenawalt J W, 1974, Methods Enzymol, V31, P310; Grefen C., 2007, CURR PROTOC NEUROSCI, V41; Griparic L, 2005, METHOD ENZYMOL, V404, P620, DOI 10.1016/S0076-6879(05)04054-1; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Kato H, 2008, BIOCHEM BIOPH RES CO, V369, P958, DOI 10.1016/j.bbrc.2008.02.150; Kuo HC, 2004, J NEUROSCI RES, V76, P497, DOI 10.1002/jnr.20112; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Martines AMF, 2013, NAT REV NEPHROL, V9, P385, DOI 10.1038/nrneph.2013.98; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Norden AGW, 2001, KIDNEY INT, V60, P1885, DOI 10.1046/j.1523-1755.2001.00016.x; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; RICHMOND VS, 1972, BRIT J HAEMATOL, V23, P605, DOI 10.1111/j.1365-2141.1972.tb07095.x; Roth JA, 2000, J NEUROSCI, V20, P7595; Roth JA, 2010, J NEUROCHEM, V113, P454, DOI 10.1111/j.1471-4159.2010.06607.x; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shvartsman M, 2012, BIOMETALS, V25, P711, DOI 10.1007/s10534-012-9529-7; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Tchernitchko D, 2002, BIOCHEM J, V363, P449, DOI 10.1042/0264-6021:3630449; Thevenod F, 2003, BIOCHEM BIOPH RES CO, V300, P546, DOI 10.1016/S0006-291X(02)02871-1; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Veuthey T, 2008, AM J PHYSIOL-RENAL, V295, pF1213, DOI 10.1152/ajprenal.90216.2008; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Wang XC, 2002, AM J PHYSIOL-LUNG C, V282, pL987, DOI 10.1152/ajplung.00253.2001; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wolff NA, 2011, TOXICOL LETT, V203, P210, DOI 10.1016/j.toxlet.2011.03.014; Wolff NA, 2011, J CELL MOL MED, V15, P209, DOI 10.1111/j.1582-4934.2009.00985.x; Xu WJ, 2013, CELL METAB, V17, P319, DOI 10.1016/j.cmet.2013.02.004; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200	57	40	41	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2134	2145		10.1096/fj.13-240564	http://dx.doi.org/10.1096/fj.13-240564			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24448823				2022-12-25	WOS:000335336000017
J	Polito, D; Cukras, S; Wang, XZ; Spence, P; Moreau, L; D'Andrea, AD; Kee, Y				Polito, David; Cukras, Scott; Wang, Xiaozhe; Spence, Paige; Moreau, Lisa; D'Andrea, Alan D.; Kee, Younghoon			The Carboxyl Terminus of FANCE Recruits FANCD2 to the Fanconi Anemia (FA) E3 Ligase Complex to Promote the FA DNA Repair Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Repair; E3 Ubiquitin Ligase; Protein Degradation; Protein Dynamics; Protein Folding; Protein Targeting; Protein-protein Interactions; Ubiquitin	CROSS-LINK REPAIR; MONOUBIQUITINATED FANCD2; NUCLEAR ACCUMULATION; SENSITIZES CELLS; DAMAGE RESPONSE; CORE COMPLEX; S-PHASE; PROTEIN; INHIBITION; IDENTIFICATION	Background: Monoubiquitination of FANCD2 and FANCI is critical in the FA pathway. Results: Specific mutations in FANCE that disrupt FANCD2 binding impair the FA pathway. Conclusion: Inhibition of the FANCE-FANCD2 interaction via FANCE point mutations in the C terminus disrupts the FA pathway. Significance: Recruitment of FANCD2 and FANCI to the FA E3 ligase is a critical step in the FA pathway. Fanconi anemia (FA) is a genome instability syndrome characterized by bone marrow failure and cellular hypersensitivity to DNA cross-linking agents. In response to DNA damage, the FA pathway is activated through the cooperation of 16 FA proteins. A central player in the pathway is a multisubunit E3 ubiquitin ligase complex or the FA core complex, which monoubiquitinates its substrates FANCD2 and FANCI. FANCE, a subunit of the FA core complex, plays an essential role by promoting the integrity of the complex and by directly recognizing FANCD2. To delineate its role in substrate ubiquitination from the core complex assembly, we analyzed a series of mutations within FANCE. We report that a phenylalanine located at the highly conserved extreme C terminus, referred to as Phe-522, is a critical residue for mediating the monoubiquitination of the FANCD2-FANCI complex. Using the FANCE mutant that specifically disrupts the FANCE-FANCD2 interaction as a tool, we found that the interaction-deficient mutant conferred cellular sensitivity in reconstituted FANCE-deficient cells to a similar degree as FANCE null cells, suggesting the significance of the FANCE-FANCD2 interaction in promoting cisplatin resistance. Intriguingly, ectopic expression of the FANCE C terminus fragment alone in FA normal cells disrupts DNA repair, consolidating the importance of the FANCE-FANCD2 interaction in the DNA cross-link repair.	[Polito, David; Cukras, Scott; Spence, Paige; Kee, Younghoon] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Wang, Xiaozhe; D'Andrea, Alan D.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Moreau, Lisa] Dana Farber Canc Inst, Cytogenet Core Lab, Boston, MA 02115 USA	State University System of Florida; University of South Florida; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Kee, Y (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	Ykee@usf.edu	Kee, Younghoon/J-4107-2019		National Institutes of Health [RO1HL52725]; University of South Florida departmental startup funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Florida departmental startup funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HL52725 (to A.D.D.) and University of South Florida departmental startup funds (to Y.K.).	Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Chen CC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-24; Dorsman JC, 2007, CELL ONCOL, V29, P211; Fu DC, 2013, CELL CYCLE, V12, P803, DOI 10.4161/cc.23755; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Gordon SM, 2005, J BIOL CHEM, V280, P36118, DOI 10.1074/jbc.M507758200; Gordon SM, 2003, BLOOD, V102, P136, DOI 10.1182/blood-2002-11-3517; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jacquemont C, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-26; Joo W, 2011, SCIENCE, V333, P312, DOI 10.1126/science.1205805; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kee Y, 2012, MOL CANCER RES, V10, P369, DOI 10.1158/1541-7786.MCR-11-0497; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Leveille F, 2006, DNA REPAIR, V5, P556, DOI 10.1016/j.dnarep.2006.01.005; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Nookala RK, 2007, NUCLEIC ACIDS RES, V35, P1638, DOI 10.1093/nar/gkm033; Osorio A, 2013, HUM MUTAT, V34, P1615, DOI 10.1002/humu.22438; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Sareen A, 2012, NUCLEIC ACIDS RES, V40, P8425, DOI 10.1093/nar/gks638; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108	31	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7003	7010		10.1074/jbc.M113.533976	http://dx.doi.org/10.1074/jbc.M113.533976			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451376	hybrid, Green Published			2022-12-25	WOS:000332389400060
J	Ranjha, L; Anand, R; Cejka, P				Ranjha, Lepakshi; Anand, Roopesh; Cejka, Petr			The Saccharomyces cerevisiae Mlh1-Mlh3 Heterodimer Is an Endonuclease That Preferentially Binds to Holliday Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Mismatch Repair; DNA Repair; Homologous Recombination; Meiosis; DNA Endonuclease; Holliday Junction; Mlh1; Mlh3; MutL	DNA MISMATCH-REPAIR; DOUBLE-STRAND BREAK; MUTL-ALPHA; MEIOTIC CHROMOSOMES; DISTINCT FUNCTIONS; YEAST MLH1; MEIOSIS; COMPLEX; RECOMBINATION; RECOGNITION	Background: Mlh1-Mlh3 is required for meiotic interference-dependent crossovers. Results: We produced recombinant Mlh1-Mlh3 and show that it is an endonuclease that binds specifically Holliday junctions. Conclusion: Mlh1-Mlh3 prefers to bind the open conformation of Holliday junctions, which infers that it acts as part of a larger complex to process Holliday junctions in meiosis. Significance: Recombinant Mlh1-Mlh3 complexes will be invaluable for further studies. MutL, a heterodimer of the MutL homologues Mlh1 and Mlh3, plays a critical role during meiotic homologous recombination. The meiotic function of Mlh3 is fully dependent on the integrity of a putative nuclease motif DQHAX(2)EX(4)E, inferring that the anticipated nuclease activity of Mlh1-Mlh3 is involved in the processing of joint molecules to generate crossover recombination products. Although a vast body of genetic and cell biological data regarding Mlh1-Mlh3 is available, mechanistic insights into its function have been lacking due to the unavailability of the recombinant protein complex. Here we expressed the yeast Mlh1-Mlh3 heterodimer and purified it into near homogeneity. We show that recombinant MutL is a nuclease that nicks double-stranded DNA. We demonstrate that MutL binds DNA with a high affinity and shows a marked preference for Holliday junctions. We also expressed the human MLH1-MLH3 complex and show that preferential binding to Holliday junctions is a conserved capacity of eukaryotic MutL complexes. Specific DNA recognition has never been observed with any other eukaryotic MutL homologue. MutL thus represents a new paradigm for the function of the eukaryotic MutL protein family. We provide insights into the mode of Holliday junction recognition and show that Mlh1-Mlh3 prefers to bind the open unstacked Holliday junction form. This further supports the model where MutL is part of a complex acting on joint molecules to generate crossovers in meiosis.	[Ranjha, Lepakshi; Anand, Roopesh; Cejka, Petr] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland	University of Zurich	Cejka, P (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	cejka@imcr.uzh.ch		Cejka, Petr/0000-0002-9087-032X	Swiss National Science Foundation [PP00P3 133636, PDFMP3 141759]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants discontinuous strand and generates new entry points for the PP00P3 133636 (to P. C.) and PDFMP3 141759 (to J. Jiricny (University of Zurich) and P. C.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; BENNETT RJ, 1995, J MOL BIOL, V252, P213, DOI 10.1006/jmbi.1995.0489; Biswas EE, 1995, PROTEIN EXPRES PURIF, V6, P763, DOI 10.1006/prep.1995.0007; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Brown MS, 2013, G3-GENES GENOM GENET, V3, P9, DOI 10.1534/g3.112.004622; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; de los Santos T, 2003, GENETICS, V164, P81; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Guarne A, 2012, PROG MOL BIOL TRANSL, V110, P41, DOI 10.1016/B978-0-12-387665-2.00003-1; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Hall MC, 2003, NUCLEIC ACIDS RES, V31, P2025, DOI 10.1093/nar/gkg324; Hall MC, 2002, J BIOL CHEM, V277, P3673, DOI 10.1074/jbc.M106120200; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Harfe BD, 2000, CURR BIOL, V10, P145, DOI 10.1016/S0960-9822(00)00314-6; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiricny J., 2013, COLD SPRING HARB PER, V5; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; LILLEY DMJ, 1993, ANNU REV BIOPH BIOM, V22, P299, DOI 10.1146/annurev.bb.22.060193.001503; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Marcon E, 2003, GENETICS, V165, P2283; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Phadnis N, 2011, TRENDS GENET, V27, P411, DOI 10.1016/j.tig.2011.06.007; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Plys AJ, 2012, J MOL BIOL, V422, P192, DOI 10.1016/j.jmb.2012.05.030; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Santucci-Darmanin S, 2002, HUM MOL GENET, V11, P1697, DOI 10.1093/hmg/11.15.1697; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Snowden T, 2008, J BIOL CHEM, V283, P145, DOI 10.1074/jbc.M704060200; Svetlanov A, 2008, GENETICS, V178, P1937, DOI 10.1534/genetics.107.084798; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; Wang TF, 2002, BIOCHEM BIOPH RES CO, V296, P949, DOI 10.1016/S0006-291X(02)02034-X; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; White MF, 1997, J MOL BIOL, V266, P122, DOI 10.1006/jmbi.1996.0795; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6	62	78	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5674	5686		10.1074/jbc.M113.533810	http://dx.doi.org/10.1074/jbc.M113.533810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24443562	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000332015500030
J	Banerjee, A; Supakar, S; Banerjee, R				Banerjee, Aulie; Supakar, Subhrangshu; Banerjee, Raja			Melanin from the Nitrogen-Fixing Bacterium Azotobacter chroococcum: A Spectroscopic Characterization	PLOS ONE			English	Article							HUMAN HAIR MELANIN; 5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACID; MAGNETIC-RESONANCE; SUBSTANTIA-NIGRA; SEPIA MELANIN; H-1-NMR; C-13	Melanins, the ubiquitous hetero-polymer pigments found widely dispersed among various life forms, are usually dark brown/black in colour. Although melanins have variety of biological functions, including protection against ultraviolet radiation of sunlight and are used in medicine, cosmetics, extraction of melanin from the animal and plant kingdoms is not an easy task. Using complementary physicochemical techniques (i.e. MALDI-TOF, FTIR absorption and cross-polarization magic angle spinning solid-state C-13 NMR), we report here the characterization of melanins extracted from the nitrogen-fixing non-virulent bacterium Azotobacter chroococcum, a safe viable source. Moreover, considering dihydroxyindole moiety as the main constituent, an effort is made to propose the putative molecular structure of the melanin hetero-polymer extracted from the bacterium. Characterization of the melanin obtained from Azotobacter chroococcum would provide an inspiration in extending research activities on these hetero-polymers and their use as protective agent against UV radiation.	[Banerjee, Aulie; Supakar, Subhrangshu; Banerjee, Raja] West Bengal Univ Technol, Dept Bioinformat, Kolkata, W Bengal, India	Maulana Abul Kalam Azad University of Technology	Banerjee, R (corresponding author), West Bengal Univ Technol, Dept Bioinformat, Kolkata, W Bengal, India.	ban_raja@yahoo.com			Department of Biotechnology, Govt. of India [BT/BI/25/001/2006-Vol. II]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This study was supported by the Department of Biotechnology, Govt. of India, sanction number BT/BI/25/001/2006-Vol. II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhyaru BB, 2003, MAGN RESON CHEM, V41, P466, DOI 10.1002/mrc.1193; Baraboy V. A., 1999, Ukrainskii Biokhimicheskii Zhurnal, V71, P5; Becking JH, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P759, DOI 10.1007/0-387-30746-x_26; Becking JH, 1981, PROKARYOTES HDB HABI, V1, P795; Burk D, 1930, J BACTERIOL, V19, P389, DOI 10.1128/JB.19.6.389-414.1930; Burk D, 1930, J PHYS CHEM-US, V34, P1195, DOI 10.1021/j150312a006; Castelvecchi D., 2009, SCI NEWS, V171, P325, DOI [10.1002/scin.2007.5591712106, DOI 10.1002/SCIN.2007.5591712106]; CHEDEKEL MR, 1982, PHOTOCHEM PHOTOBIOL, V35, P881, DOI 10.1111/j.1751-1097.1982.tb02663.x; CHEDEKEL MR, 1992, PIGM CELL RES, V5, P240, DOI 10.1111/j.1600-0749.1992.tb00543.x; Clarke HT, 1975, HDB ORGANIC ANAL; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; DALTON H, 1968, J GEN MICROBIOL, V54, P463, DOI 10.1099/00221287-54-3-463; Dobrzynska D, 1997, ACTA CRYSTALLOGR C, V53, P238, DOI 10.1107/S0108270196012802; Double KL, 2000, J NEUROCHEM, V75, P2583, DOI 10.1046/j.1471-4159.2000.0752583.x; DUFF GA, 1988, BIOCHEMISTRY-US, V27, P7112, DOI 10.1021/bi00418a067; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Finar IL, 1986, ORGANIC CHEM, V1; Geng J, 2010, ARCH MICROBIOL, V192, P321, DOI 10.1007/s00203-010-0560-1; Ghiani S, 2008, MAGN RESON CHEM, V46, P471, DOI 10.1002/mrc.2202; GOWER RP, 1969, J CHEM EDUC, V46, P606, DOI 10.1021/ed046p606; Hamilton AJ, 2002, J MED MICROBIOL, V51, P189, DOI 10.1099/0022-1317-51-3-189; HERVE M, 1994, BBA-PROTEIN STRUCT M, V1204, P19, DOI 10.1016/0167-4838(94)90027-2; Hewedy M, 2009, AUST J BASIC APPL SC, V3; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; JENSEN HL, 1954, BACTERIOL REV, V18, P195, DOI 10.1128/MMBR.18.4.195-214.1954; Katritzky AR, 2002, PIGM CELL RES, V15, P93, DOI 10.1034/j.1600-0749.2002.1o062.x; Kemp W., 1987, ORGANIC SPECTROSCOPY; Lindgren J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1819; Magarelli M., 2010, Revista CES Medicina Veterinaria y Zootecnia, V5, P18; Moores OT, 1995, SCI MELANIN; Morzyk-Ociepa B, 2004, J MOL STRUCT, V688, P79, DOI 10.1016/j.molstruc.2003.09.027; Napolitano A, 1996, RAPID COMMUN MASS SP, V10, P204, DOI 10.1002/(SICI)1097-0231(19960131)10:2<204::AID-RCM460>3.0.CO;2-E; NICOLAUS RA, 1964, TETRAHEDRON, V20, P1163, DOI 10.1016/S0040-4020(01)98983-5; Peter MG, 1989, ANGEW CHEM INT EDIT, P28741; Pezzella A, 1996, TETRAHEDRON, V52, P7913, DOI 10.1016/0040-4020(96)00362-6; Pezzella A, 1997, TETRAHEDRON, V53, P8281, DOI 10.1016/S0040-4020(97)00494-8; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429, DOI 10.18388/abp.2006_3314; PYSH ES, 1977, J AM CHEM SOC, V99, P6211, DOI 10.1021/ja00461a007; Reinheimer P, 1999, BBA-GEN SUBJECTS, V1472, P240, DOI 10.1016/S0304-4165(99)00127-0; Schaefer J., 1979, TOP CARBON 13 NMR SP, P283, DOI [10.1021/acs.jafc.5b03206, DOI 10.1021/ACS.JAFC.5B03206]; Schneider HJ, 1989, THEIS I ANGEW CHEM, V101, P757; SCHNITZER M, 1986, SOIL SCI SOC AM J, V50, P67, DOI 10.2136/sssaj1986.03615995005000010013x; SHIVPRASAD S, 1989, APPL ENVIRON MICROB, V55, P1811, DOI 10.1128/AEM.55.7.1811-1817.1989; Solano F, 1997, APPL ENVIRON MICROB, V63, P3499, DOI 10.1128/AEM.63.9.3499-3506.1997; Swan G A, 1974, Fortschr Chem Org Naturst, V31, P521; Thompson JP, 1979, AZOTOBACTERACEAE TAX; Tine A, 1998, SPECTROCHIM ACTA A, V54, P1451, DOI 10.1016/S1386-1425(98)00046-8; TONIOLO C, 1988, BIOPOLYMERS, V27, P373, DOI 10.1002/bip.360270303; Wilson P.W., 1952, EXPT BACTERIAL PHYSL; ZECCA L, 1992, BIOCHIM BIOPHYS ACTA, V1138, P6, DOI 10.1016/0925-4439(92)90144-C	50	38	39	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84574	10.1371/journal.pone.0084574	http://dx.doi.org/10.1371/journal.pone.0084574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416247	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300028
J	Belkaya, S; van Oers, NSC				Belkaya, Serkan; van Oers, Nicolai S. C.			Transgenic Expression of MicroRNA-181d Augments the Stress-Sensitivity of CD4(+)CD8(+) Thymocytes	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED APOPTOSIS; BONE-MARROW-TRANSPLANTATION; LEUKEMIA INHIBITORY FACTOR; THYMIC EPITHELIAL-CELLS; ROLES; MIRNA; RNA; MECHANISMS; WEBGESTALT; INVOLUTION	Physiological stress resulting from infections, trauma, surgery, alcoholism, malnutrition, and/or pregnancy results in a substantial depletion of immature CD4(+)CD8(+) thymocytes. We previously identified 18 distinct stress-responsive microRNAs (miRs) in the thymus upon systemic stress induced by lipopolysaccharide (LPS) or the synthetic glucocorticoid, dexamethasone (Dex). MiRs are short, non-coding RNAs that play critical roles in the immune system by targeting diverse mRNAs, suggesting that their modulation in the thymus in response to stress could impact thymopoiesis. MiR-181d is one such stress-responsive miR, exhibiting a 15-fold down-regulation in expression. We utilized both transgenic and gene-targeting approaches to study the impact of miR-181d on thymopoiesis under normal and stress conditions. The overexpression of miR-181d in developing thymocytes reduced the total number of immature CD4(+)CD8(+) thymocytes. LPS or Dex injections caused a 4-fold greater loss of these cells when compared with the wild type controls. A knockout mouse was developed to selectively eliminate miR-181d, leaving the closely spaced and contiguous family member miR-181c intact. The targeted elimination of just miR-181d resulted in a thymus stress-responsiveness similar to wild-type mice. These experiments suggest that one or more of three other miR-181 family members have overlapping or compensatory functions. Gene expression comparisons of thymocytes from the wild type versus transgenic mice indicated that miR-181d targets a number of stress, metabolic, and signaling pathways. These findings demonstrate that selected miRs enhance stress-mediated thymic involution in vivo.	[Belkaya, Serkan; van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	van Oers, NSC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	nicolai.vanoers@utsouthwestern.edu	Van+Oers, Nicolai/ABA-2437-2021; Belkaya, Serkan/ABD-4504-2020	Belkaya, Serkan/0000-0003-4214-382X; van Oers, Nicolai/0000-0002-6545-8405	National Institutes of Health (NIH) [R21 AI083827-01]; University of Texas Southwestern Medical Center (Beecher Foundation); Childrens' Medical Center Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083827] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern Medical Center (Beecher Foundation); Childrens' Medical Center Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from the National Institutes of Health (NIH) R21 AI083827-01 and internal grants from the University of Texas Southwestern Medical Center (Beecher Foundation) and Childrens' Medical Center Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGEEV AK, 1986, ARK PATOL, V48, P33; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker AM, 2010, J IMMUNOL, V184, P6822, DOI 10.4049/jimmunol.0902058; Belkaya S, 2013, J BIOL CHEM, V288, P30752, DOI 10.1074/jbc.M113.503532; Belkaya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027580; Billard MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017940; Chatham WW, 2001, LUPUS, V10, P140, DOI 10.1191/096120301675075008; Choi YI, 2001, P NATL ACAD SCI USA, V98, P10267, DOI 10.1073/pnas.181076198; Cichocki F, 2011, J IMMUNOL, V187, P6171, DOI 10.4049/jimmunol.1100835; de la Morena MT, 2013, CLIN IMMUNOL, V147, P11, DOI 10.1016/j.clim.2013.01.011; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Dooley J, 2012, EUR J IMMUNOL, V42, P1073, DOI 10.1002/eji.201142305; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dozmorov MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012657; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Frankfurt O, 2004, CURR OPIN ONCOL, V16, P553, DOI 10.1097/01.cco.0000142072.22226.09; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Hauri-Hohl MM, 2008, BLOOD, V112, P626, DOI 10.1182/blood-2007-10-115618; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; Heinonen KM, 2011, BLOOD, V118, P5163, DOI 10.1182/blood-2011-04-350553; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003592; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Luz C, 2003, MECH AGEING DEV, V124, P887, DOI 10.1016/S0047-6374(03)00148-9; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; MULLERHERMELINK HK, 1987, AM J PATHOL, V129, P242; Murgita R A, 1981, Prog Allergy, V29, P54; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; ROCKLIN RE, 1979, ANNU REV MED, V30, P375, DOI 10.1146/annurev.me.30.020179.002111; Sempowski GD, 2000, J IMMUNOL, V164, P2180, DOI 10.4049/jimmunol.164.4.2180; Sempowski GD, 2002, EUR J IMMUNOL, V32, P3066, DOI 10.1002/1521-4141(200211)32:11<3066::AID-IMMU3066>3.0.CO;2-J; Sionov Ronit Vogt, 2013, ISRN Hematol, V2013, P348212, DOI 10.1155/2013/348212; Smith LK, 2010, J BIOL CHEM, V285, P36698, DOI 10.1074/jbc.M110.162123; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; Zietara N, 2013, P NATL ACAD SCI USA, V110, P7407, DOI 10.1073/pnas.1221984110	62	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85274	10.1371/journal.pone.0085274	http://dx.doi.org/10.1371/journal.pone.0085274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416377	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300063
J	Dhiman, P; Kai, J; Horsfall, L; Walters, K; Qureshi, N				Dhiman, Paula; Kai, Joe; Horsfall, Laura; Walters, Kate; Qureshi, Nadeem			Availability and Quality of Coronary Heart Disease Family History in Primary Care Medical Records: Implications for Cardiovascular Risk Assessment	PLOS ONE			English	Article							GENERAL-PRACTICE; VALIDATION	Background: The potential to use data on family history of premature disease to assess disease risk is increasingly recognised, particularly in scoring risk for coronary heart disease (CHD). However the quality of family health information in primary care records is unclear. Aim: To assess the availability and quality of family history of CHD documented in electronic primary care records Design: Cross-sectional study Setting: 537 UK family practices contributing to The Health Improvement Network database. Method: Data were obtained from patients aged 20 years or more, registered with their current practice between 1st January 1998 and 31st December 2008, for at least one year. The availability and quality of recorded CHD family history was assessed using multilevel logistic and ordinal logistic regression respectively. Results: In a cross-section of 1,504,535 patients, 19% had a positive or negative family history of CHD recorded. Multilevel logistic regression showed patients aged 50-59 had higher odds of having their family history recorded compared to those aged 20-29 (OR: 1.23 (1.21 to 1.25)), however most deprived patients had lower odds compared to those least deprived (OR: 0.86 (0.85 to 0.88)). Of the 140,058 patients with a positive family history recorded (9% of total cohort), age of onset was available in 45%; with data specifying both age of onset and relative affected available in only 11% of records. Multilevel ordinal logistic regression confirmed no statistical association between the quality of family history recording and age, gender, deprivation and year of registration. Conclusion: Family history of CHD is documented in a small proportion of primary care records; and where positive family history is documented the details are insufficient to assess familial risk or populate cardiovascular risk assessment tools. Data capture needs to be improved particularly for more disadvantaged patients who may be most likely to benefit from CHD risk assessment.	[Dhiman, Paula; Kai, Joe; Qureshi, Nadeem] Univ Nottingham, Sch Med, Div Primary Care, Nottingham, England; [Horsfall, Laura; Walters, Kate] UCL, Res Dept Primary Care & Populat Hlth, London, England	University of Nottingham; University of London; University College London	Qureshi, N (corresponding author), Univ Nottingham, Sch Med, Div Primary Care, Univ Pk, Nottingham, England.	nadeem.qureshi@nottingham.ac.uk		Kai, Joe/0000-0001-9040-9384; Walters, Kate/0000-0003-2173-2430; Qureshi, Nadeem/0000-0003-4909-0644	Faculty of Medicine, University of Nottingham	Faculty of Medicine, University of Nottingham	The study was supported by pump-primed funding from the Faculty of Medicine, University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson LS, 2000, GENET MED, V2, P180, DOI 10.1097/00125817-200005000-00004; [Anonymous], 1997, Eur Heart J, V18, P1569; Bankhead C, 2001, FAM PRACT, V18, P475, DOI 10.1093/fampra/18.5.475; Bennett RL, 2004, PRIMARY CARE, V31, P479, DOI 10.1016/j.pop.2004.05.004; Berg AO, 2009, ANN INTERN MED, V151, P872, DOI [10.7326/0000605-200912150-00165, 10.7326/0003-4819-151-12-200912150-00165]; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bourke Alison, 2004, Inform Prim Care, V12, P171; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Cooper A, 2008, CLIN GUIDELINES EVID; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; de la Iglesia B, 2011, HEART, V97, P491, DOI 10.1136/hrt.2010.203364; de Lusignan S, 2006, FAM PRACT, V23, P253, DOI 10.1093/fampra/cmi106; *DEP HLTH, 1989, TERMS SERV DOCT GEN; Department of Health, 2009, PUTT PREV 1 VASC CHE; Frezzo TM, 2003, GENET MED, V5, P84, DOI 10.1097/01.GIM.0000055197.23822.5E; Hall R, 2007, FAM PRACT, V24, P435, DOI 10.1093/fampra/cmm037; Hawe E, 2003, ANN HUM GENET, V67, P97, DOI 10.1046/j.1469-1809.2003.00017.x; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Kardia SLR, 2003, AM J PREV MED, V24, P143, DOI 10.1016/S0749-3797(02)00587-1; KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; MANT D, 1991, BRIT MED J, V302, P1057, DOI 10.1136/bmj.302.6784.1057; Marston L, 2010, PHARMACOEPIDEM DR S, V19, P618, DOI 10.1002/pds.1934; Nieburg I, 2010, BLOOD PRESSURE, V19, P176, DOI 10.3109/08037051.2010.483053; O'Neill SM, 2009, AM J PREV MED, V36, P506, DOI 10.1016/j.amepre.2009.03.002; Pous Maria Font, 2010, Inform Prim Care, V18, P109; Qureshi N, 2012, ANN INTERN MED, V156, P253, DOI 10.7326/0003-4819-156-4-201202210-00002; Rabash J, 2011, MLWIN 2 23; Rafter N, 2008, NEW ZEAL MED J, V121, P24; Rich EC, 2004, J GEN INTERN MED, V19, P273, DOI 10.1111/j.1525-1497.2004.30401.x; Scheuner MT, 2009, GENET MED, V11, P510, DOI 10.1097/GIM.0b013e3181a53331; Sheerin Ian, 2007, N Z Med J, V120, pU2714; StataCorp, 2019, STATA STAT SOFTWARE; Summerton N, 1997, FAM PRACT, V14, P285, DOI 10.1093/fampra/14.4.285; Townsend PP., 1988, HLTH DEPRIVATION INE; Weiner Mark G, 2007, Inform Prim Care, V15, P121; Wilson BJ, 2009, ANN INTERN MED, V151, P878, DOI [10.7326/0000605-200912150-00177, 10.7326/0003-4819-151-12-200912150-00177]; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	41	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e81998	10.1371/journal.pone.0081998	http://dx.doi.org/10.1371/journal.pone.0081998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416135	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300007
J	Harari, D; Abramovich, R; Zozulya, A; Smith, P; Pouly, S; Koster, M; Hauser, H; Schreiber, G				Harari, Daniel; Abramovich, Renne; Zozulya, Alla; Smith, Paul; Pouly, Sandrine; Koester, Mario; Hauser, Hansjoerg; Schreiber, Gideon			Bridging the Species Divide: Transgenic Mice Humanized for Type-I Interferon Response	PLOS ONE			English	Article							RECEPTOR; PHARMACOKINETICS; PHARMACODYNAMICS; INVOLVEMENT; ALPHA/BETA; ACTIVATION; EXPRESSION; BINDING; PROTEIN; IMPACT	We have generated transgenic mice that harbor humanized type I interferon receptors (IFNARs) enabling the study of type I human interferons (Hu-IFN-Is) in mice. These "HyBNAR" (Hybrid IFNAR) mice encode transgenic variants of IFNAR1 and IFNAR2 with the human extracellular domains being fused to transmembrane and cytoplasmic segments of mouse sequence. B16F1 mouse melanoma cells harboring the HyBNAR construct specifically bound Hu-IFN-Is and were rendered sensitive to Hu-IFN-I stimulated anti-proliferation, STAT1 activation and activation of a prototypical IFN-I response gene (MX2). HyBNAR mice were crossed with a transgenic strain expressing the luciferase reporter gene under the control of the IFN-responsive MX2 promoter (MX2-Luciferase). Both the HyBNAR and HyBNAR/MX2-Luciferase mice were responsive to all Hu-IFN-Is tested, inclusive of IFN alpha 2A, IFN beta, and a human superagonist termed YNS alpha 8. The mice displayed dose-dependent pharmacodynamic responses to Hu-IFN-I injection, as assessed by measuring the expression of IFN-responsive genes. Our studies also demonstrated a weak activation of endogenous mouse interferon response, especially after high dose administration of Hu-IFNs. In sharp contrast to data published for humans, our pharmacodynamic readouts demonstrate a very short-lived IFN-I response in mice, which is not enhanced by sub-cutaneous (SC) injections in comparison to other administration routes. With algometric differences between humans and mice taken into account, the HyBNAR mice provides a convenient non-primate pre-clinical model to advance the study of human IFN-Is.	[Harari, Daniel; Abramovich, Renne; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Zozulya, Alla; Smith, Paul; Pouly, Sandrine] Merck Serono, MS Platform, Geneva, Switzerland; [Koester, Mario; Hauser, Hansjoerg] Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, Braunschweig, Germany	Weizmann Institute of Science; Merck KGaA; EMD Serono Inc.; Helmholtz Association; Helmholtz-Center for Infection Research	Harari, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	daniel.harari@weizmann.ac.il; gideon.schreiber@weizmann.ac.il			Merck-KGaA	Merck-KGaA(Merck & Company)	This study was funded by a research grant awarded to GS from Merck-KGaA. Authors AZ, PS and SP are/were members of Merck-Serono, a division of Merck KGaA. The Weizmann Institute of Science holds patent rights to the interferon superagonists described in this paper. Scientists from the funding agency (AZ,PS,SP) have contributed to this paper with advice of how to enhance pharmacodynamic studies, and thus are listed as co-authors and have additionally contributed to proof-reading this manuscript. Members of the funding agency however have had no role in data collection and analysis, decision to publish, nor have constrained in any way conclusions reached by the senior authors of this study.	Apelbaum A, 2013, MOL CELL BIOL, V33, P800, DOI 10.1128/MCB.01430-12; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Carbone CJ, 2012, P NATL ACAD SCI USA, V109, P19226, DOI 10.1073/pnas.1211491109; Chen JB, 2004, J INTERF CYTOK RES, V24, P687, DOI 10.1089/jir.2004.24.687; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Fuchs SY, 2012, GROWTH FACTORS, V30, P141, DOI 10.3109/08977194.2012.669382; Kagan L, 2010, PHARM RES-DORDR, V27, P920, DOI 10.1007/s11095-010-0098-6; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Kalincik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050101; Kraus J, 2006, DRUG DISCOV TODAY, V11, P755, DOI 10.1016/j.drudis.2006.06.008; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Neuhaus O, 2007, J NEUROL SCI, V259, P27, DOI 10.1016/j.jns.2006.05.071; Peleg-Shulman T, 2004, J MED CHEM, V47, P4897, DOI 10.1021/jm0497693; Pepinsky RB, 2001, J PHARMACOL EXP THER, V297, P1059; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Radaeva S, 2004, BIOCHEM J, V379, P199, DOI 10.1042/BJ20031495; Roberts RM, 1998, J INTERF CYTOK RES, V18, P805, DOI 10.1089/jir.1998.18.805; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Schlapschy M, 2013, PROTEIN ENG DES SEL, V26, P489, DOI 10.1093/protein/gzt023; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shen XN, 2000, FEBS LETT, V480, P132, DOI 10.1016/S0014-5793(00)01905-0; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; STAEHELI P, 1988, MOL CELL BIOL, V8, P4524, DOI 10.1128/MCB.8.10.4524; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Williams GJ, 1998, J INTERF CYTOK RES, V18, P967, DOI 10.1089/jir.1998.18.967; Yong VW, 1998, NEUROLOGY, V51, P682; Zheng H, 2011, BLOOD, V118, P4003, DOI 10.1182/blood-2011-06-359745	36	20	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84259	10.1371/journal.pone.0084259	http://dx.doi.org/10.1371/journal.pone.0084259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416207	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300021
J	Hoopes, LA; Rea, LD; Christ, A; Worthy, GAJ				Hoopes, Lisa A.; Rea, Lorrie D.; Christ, Aaron; Worthy, Graham A. J.			No Evidence of Metabolic Depression in Western Alaskan Juvenile Steller Sea Lions (Eumetopias jubatus)	PLOS ONE			English	Article							NORTHERN ELEPHANT SEAL; FUR-SEAL; BODY-COMPOSITION; CALLORHINUS-URSINUS; PHOCA-VITULINA; MATERNAL INVESTMENT; NUTRITIONAL STRESS; THYROID-HORMONES; MASS-LOSS; PUPS	Steller sea lion (Eumetopias jubatus) populations have undergone precipitous declines through their western Alaskan range over the last four decades with the leading hypothesis to explain this decline centering around changing prey quality, quantity, or availability for this species (i.e., nutritional stress hypothesis). Under chronic conditions of reduced food intake sea lions would conserve energy by limiting energy expenditures through lowering of metabolic rate known as metabolic depression. To examine the potential for nutritional stress, resting metabolic rate (RMR) and body composition were measured in free-ranging juvenile Steller sea lions (N = 91) at three distinct geographical locations (Southeast Alaska, Prince William Sound, Central Aleutian Islands) using open-flow respirometry and deuterium isotope dilution, respectively. Average sea lion RMR ranged from 6.7 to 36.2 MJ d(-1) and was influenced by body mass, total body lipid, and to a lesser extent, ambient air temperature and age. Sea lion pups captured in the Aleutian Islands (region of decline) had significantly greater body mass and total body lipid stores when compared to pups from Prince William Sound (region of decline) and Southeast Alaska (stable region). Along with evidence of robust body condition in Aleutian Island pups, no definitive differences were detected in RMR between sea lions sampled between eastern and western populations that could not be accounted for by higher percent total body lipid content, suggesting that that at the time of this study, Steller sea lions were not experiencing metabolic depression in the locations studied.	[Hoopes, Lisa A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Rea, Lorrie D.; Christ, Aaron] Alaska Dept Fish & Game, Div Wildlife Conservat, Anchorage, AK 99518 USA; [Worthy, Graham A. J.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	Texas A&M University System; Texas A&M University College Station; Alaska Department of Fish & Game; State University System of Florida; University of Central Florida	Hoopes, LA (corresponding author), Georgia Aquarium, Atlanta, GA 30313 USA.	lhoopes@georgiaaquarium.org			National Oceanic and Atmospheric Administration (NOAA) [NA17FX1079, NA04NMF4390170]; University of Central Florida; Texas A&M University at Galveston; Hubbs-SeaWorld Research Institute	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); University of Central Florida; Texas A&M University at Galveston; Hubbs-SeaWorld Research Institute	Financial support for this project was provided to Alaska Department of Fish and Game under National Oceanic and Atmospheric Administration (NOAA) cooperative agreements NA17FX1079 and NA04NMF4390170 and through a Research Enhancement Award from University of Central Florida to GAJW. Graduate support to LAH was provided by Texas A&M University at Galveston, University of Central Florida, and Hubbs-SeaWorld Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B. M., 2013, NMFSAFSC245 NOAA US; [Anonymous], 2000, MAR FISH REV; Arnould JPY, 2002, J ZOOL, V256, P351, DOI 10.1017/S0952836902000389; Arnould JPY, 1996, PHYSIOL ZOOL, V69, P93, DOI 10.1086/physzool.69.1.30164202; Ashwell-Erickson S., 1981, E BERING SEA SHELF O, P869; ASHWELLERICKSON S, 1986, CAN J ZOOL, V64, P1086, DOI 10.1139/z86-163; Atkinson S, 2008, MAMMAL REV, V38, P1, DOI 10.1111/j.1365-2907.2008.00128.x; Baker JD, 2000, CAN J ZOOL, V78, P100, DOI 10.1139/cjz-78-1-100; Beauplet G, 2003, PHYSIOL BIOCHEM ZOOL, V76, P262, DOI 10.1086/367951; Boily P, 1996, AM J PHYSIOL-REG I, V270, pR1051, DOI 10.1152/ajpregu.1996.270.5.R1051; BOILY P, 1995, PHYSIOL ZOOL, V68, P1181, DOI 10.1086/physzool.68.6.30163799; Boltnev AI, 2001, J ZOOL, V254, P219, DOI 10.1017/S0952836901000735; Bowen WD, 1998, PHYSIOL ZOOL, V71, P329, DOI 10.1086/515921; Brandon EAA, 2005, FISH B-NOAA, V103, P246; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; CORNISH ER, 1965, ANIM BEHAV, V13, P242, DOI 10.1016/0003-3472(65)90042-4; Craig MP, 1999, MAR MAMMAL SCI, V15, P786, DOI 10.1111/j.1748-7692.1999.tb00843.x; Donohue MJ, 2000, J EXP BIOL, V203, P1003; du Dot TJ, 2009, PHYSIOL BIOCHEM ZOOL, V82, P516, DOI 10.1086/603637; du Dot TJ, 2009, COMP BIOCHEM PHYS A, V152, P524, DOI 10.1016/j.cbpa.2008.12.010; Fadely BS, 2004, SEA LIONS WORLD CONS, P21; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; Fritz L, 2005, NMFSAFSC183 NOAA US; Fritz LW, 2003, NMFSAFSC153 NOAA US; Fuglei E, 1999, J COMP PHYSIOL B, V169, P361, DOI 10.1007/s003600050232; GALLIVAN GJ, 1986, PHYSIOL ZOOL, V59, P552, DOI 10.1086/physzool.59.5.30156119; Guinet C, 1999, BEHAV ECOL SOCIOBIOL, V46, P157, DOI 10.1007/s002650050605; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Harrell FE, 2001, REGRESSION MODELING; HEATH ME, 1977, COMP BIOCHEM PHYS A, V57, P203, DOI 10.1016/0300-9629(77)90456-X; Heath RB, 1997, J WILDLIFE DIS, V33, P206, DOI 10.7589/0090-3558-33.2.206; Hoopes LA, 2007, METABOLIC THERMOREGU; IRVING LAURENCE, 1957, CANADIAN JOUR ZOOL, V35, P497, DOI 10.1139/z57-041; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; King JC, 2007, MAR MAMMAL SCI, V23, P262, DOI 10.1111/j.1748-7692.2007.00108.x; Kleiber M., 1975, FIRE LIFE INTRO ANIM; KOVACS KM, 1992, CAN J ZOOL, V70, P1953, DOI 10.1139/z92-265; Kumagai S, 2006, J COMP PHYSIOL B, V176, P589, DOI 10.1007/s00360-006-0082-y; Markussen NH, 1995, DEV MAR BIO, V4, P383; Mellish JAE, 2007, J MAMMAL, V88, P408, DOI 10.1644/06-MAMM-A-157R2.1; MERRICK RL, 1995, FISH B-NOAA, V93, P753; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Myers MJ, 2006, COMP BIOCHEM PHYS A, V145, P90, DOI 10.1016/j.cbpa.2006.05.004; NORDOY ES, 1990, ACTA PHYSIOL SCAND, V139, P361, DOI 10.1111/j.1748-1716.1990.tb08935.x; OFTEDAL OT, 1987, PHYSIOL ZOOL, V60, P560, DOI 10.1086/physzool.60.5.30156130; Pitcher KW, 2007, FISH B-NOAA, V105, P102; Pitcher KW, 2000, MAR MAMMAL SCI, V16, P427, DOI 10.1111/j.1748-7692.2000.tb00934.x; Pitcher KW, 2001, J MAMMAL, V82, P1047, DOI 10.1644/1545-1542(2001)082<1047:SATVIT>2.0.CO;2; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; Rea LD, 2007, CAN J ZOOL, V85, P190, DOI 10.1139/Z06-204; REA LD, 1992, PHYSIOL ZOOL, V65, P97, DOI 10.1086/physzool.65.1.30158241; Rea LD, 2013, SCI TOTAL ENVIRON, V454, P277, DOI 10.1016/j.scitotenv.2013.02.095; ROBIN JP, 1988, AM J PHYSIOL, V254, pR61, DOI 10.1152/ajpregu.1988.254.1.R61; Rosen DAS, 2002, COMP BIOCHEM PHYS B, V132, P389, DOI 10.1016/S1096-4959(02)00048-9; Rosen DAS, 1998, CAN J ZOOL, V76, P1520, DOI 10.1139/cjz-76-8-1520; Rosen DAS, 1999, PHYSIOL BIOCHEM ZOOL, V72, P723, DOI 10.1086/316705; Rutishauser MR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P669, DOI 10.1086/421749; Soto KH, 2004, J ZOOL, V264, P419, DOI 10.1017/s0952836904005965; THOMPSON SD, 1987, PHYSIOL ZOOL, V60, P730, DOI 10.1086/physzool.60.6.30159989; TRITES AW, 1992, CAN J ZOOL, V70, P2125, DOI 10.1139/z92-286; WESTERTERP K, 1977, PHYSIOL ZOOL, V50, P331, DOI 10.1086/physzool.50.4.30155736; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; WORTHY GAJ, 1987, PHYSIOL ZOOL, V60, P352, DOI 10.1086/physzool.60.3.30162289; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x; York AE, 1991, PINNIPEDS EL NINO RE, P94	66	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85339	10.1371/journal.pone.0085339	http://dx.doi.org/10.1371/journal.pone.0085339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416394	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300072
J	Ji, DM; Zhang, Z; Cheng, L; Chang, JJ; Wang, SS; Zheng, BQ; Zheng, RL; Sun, ZJ; Wang, CC; Zhang, ZQ; Liu, RJ; Zhang, XW; Liu, X; Wang, XF; Li, J				Ji, Dongmei; Zhang, Zhe; Cheng, Lei; Chang, Jinjia; Wang, Shanshan; Zheng, Biqiang; Zheng, Rongliang; Sun, Zuojun; Wang, Chenchen; Zhang, Zhiqing; Liu, Rujiao; Zhang, Xiaowei; Liu, Xin; Wang, Xiaofeng; Li, Jin			The Combination of RAD001 and MK-2206 Exerts Synergistic Cytotoxic Effects against PTEN Mutant Gastric Cancer Cells: Involvement of MAPK-Dependent Autophagic, but Not Apoptotic Cell Death Pathway	PLOS ONE			English	Article							SIGNALING PATHWAY; PI3K/AKT/MTOR PATHWAY; MAMMALIAN TARGET; PROTEIN-KINASE; BREAST-CANCER; IN-VIVO; INHIBITION; MTOR; AKT; THERAPY	In the current study, we showed that the combination of mammalian target of rapamycin (mTOR) inhibitor RAD001 (everolimus) and Akt inhibitor MK-2206 exerted synergistic cytotoxic effects against low-phosphatase and tensin homolog (PTEN) gastric cancer cells (HGC-27 and SNU-601 lines). In HGC-27 cells, RAD001 and MK-2206 synergistically induced G1/S cell cycle arrest, growth inhibition, cell death but not apoptosis. RAD001 and MK-2206 synergistically induced light chain 3B (LC3B) and beclin-1 expression, two important autophagy indicators. Meanwhile, the autophagy inhibitor 3-methyladenine (3-MA) and chloroquine inhibited the cytotoxic effects by RAD001 and MK-2206, suggesting that autophagic, but not apoptotic cell death was important for the cytotoxic effects by the co-administration. We observed that the combination of RAD001 and MK-2206 exerted enhanced effects on Akt/mTOR inhibition, cyclin D1 down-regulation and ERK/MAPK(extracellular signal-regulated kinase/mitogen-activated protein kinases) activation. Intriguingly, MEK/ERK inhibitors PD98059 and U0126 suppressed RAD001 plus MK-2206-induced beclin-1 expression, autophagy induction and cytotoxicity in HGC-27 cells. In conclusion, these results suggested that the synergistic anti-gastric cancer cells ability by RAD001 and MK-2206 involves ERK-dependent autophagic cell death pathway.	[Ji, Dongmei; Zhang, Zhe; Chang, Jinjia; Wang, Shanshan; Zheng, Rongliang; Sun, Zuojun; Wang, Chenchen; Liu, Rujiao; Zhang, Xiaowei; Liu, Xin; Wang, Xiaofeng; Li, Jin] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Cheng, Lei] Nanjing Med Univ, Suzhou Hosp, Dept Intervent Radiol, Suzhou, Jiangsu, Peoples R China; [Zheng, Biqiang] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcomas, Shanghai 200433, Peoples R China; [Zhang, Zhiqing] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China	Fudan University; Nanjing Medical University; Fudan University; Soochow University - China	Li, J (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China.	fudanlijin@163.com			Construction of new drug clinical research technology platform [JKB1101-1]	Construction of new drug clinical research technology platform	The source of funding for this study was the Construction of new drug clinical research technology platform, grant number JKB1101-1 (http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798; Almhanna K, 2011, ANTICANCER RES, V31, P4387; Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Byun DS, 2003, INT J CANCER, V104, P318, DOI 10.1002/ijc.10962; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cervantes A, 2013, CANCER TREAT REV, V39, P60, DOI 10.1016/j.ctrv.2012.09.007; Cheng Y, 2012, MOL CANCER THER, V11, P154, DOI 10.1158/1535-7163.MCT-11-0606; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Crazzolara R, 2009, AUTOPHAGY, V5, P727, DOI 10.4161/auto.5.5.8507; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lin CI, 2010, MOL CANCER RES, V8, P1217, DOI 10.1158/1541-7786.MCR-10-0162; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047049; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Marinov M, 2009, CLIN CANCER RES, V15, P1277, DOI 10.1158/1078-0432.CCR-08-2166; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P2423, DOI 10.4161/cc.9.12.12048; Mezhir JJ, 2010, J SURG ONCOL, V101, P305, DOI 10.1002/jso.21483; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Ramirez-Fort MK, 2012, AM J CLIN ONCOL; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Smyth EC, 2012, CURR TREAT OPTION ON, V13, P377, DOI 10.1007/s11864-012-0192-6; Sukawa Y, 2012, WORLD J GASTROENTERO, V18, P6577, DOI 10.3748/wjg.v18.i45.6577; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Wu CH, 2012, NANO LETT, V12, P5475, DOI 10.1021/nl301865c; Wu P, 2010, CURR MED CHEM, V17, P4326, DOI 10.2174/092986710793361234; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yang Z, 2012, CLIN RES HEPATOL GAS; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-114; Zhang XW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-40; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	45	37	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85116	10.1371/journal.pone.0085116	http://dx.doi.org/10.1371/journal.pone.0085116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416349	gold, Green Submitted, Green Published			2022-12-25	WOS:000329866300050
J	Anfossi, S; Giordano, A; Gao, H; Cohen, EN; Tin, S; Wu, Q; Garza, RJ; Debeb, BG; Alvarez, RH; Valero, V; Hortobagyi, GN; Calin, GA; Ueno, NT; Woodward, WA; Reuben, JM				Anfossi, Simone; Giordano, Antonio; Gao, Hui; Cohen, Evan N.; Tin, Sanda; Wu, Qiong; Garza, Raul J.; Debeb, Bisrat G.; Alvarez, Ricardo H.; Valero, Vicente; Hortobagyi, Gabriel N.; Calin, George A.; Ueno, Naoto T.; Woodward, Wendy A.; Reuben, James M.			High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2(+) Inflammatory Breast Cancer	PLOS ONE			English	Article							BLOOD-BASED MARKERS; CIRCULATING MICRORNAS; UP-REGULATION; EXPRESSION; BIOMARKERS; MIR-21; THERAPY; TRASTUZUMAB; MECHANISMS; RESISTANCE	Introduction: Altered serum microRNA (miRNA) levels may be correlated with a dysregulated expression pattern in parental tumor tissue and reflect the clinical evolution of disease. The overexpression of miR-21, miR-10b, and miR-19a is associated with the acquisition of malignant characteristics (increased tumor cell proliferation, migration, invasion, dissemination, and metastasis); thus, we determined their utility as serum biomarkers for aggressive breast cancer (HER2-overexpressed or -amplified [HER2(+)] and inflammatory breast cancer [IBC]). Experimental Design: In this prospective study, we measured miR-21, miR-10b, and miR-19a levels using quantitative reverse transcriptase-polymerase chain reaction in the serum of 113 breast cancer patients and determined their association with clinicopathologic factors and clinical outcome. Thirty healthy donors with no history of cancer were enrolled as controls. Results: Patients with non-metastatic HER2(+) breast cancer had higher serum miR-21 median levels than patients with non-metastatic HER2(-) disease (p = 0.044); whereas patients with metastatic HER2(+) breast cancer had higher serum miR-10b median levels than patients with metastatic HER2(-) disease (p = 0.0004). There were no significant differences in serum miR-19a median levels between HER2(+) and HER2(-) groups, regardless of the presence of metastases. High serum miR-19a levels were associated with IBC (p = 0.039). Patients with metastatic IBC had significantly higher serum miR-19a median levels than patients with metastatic non-IBC (p = 0.019). Finally, high serum miR-19a levels were associated with longer progression-free survival time (10.3 vs. 3.2 months; p = 0.022) and longer overall survival time (median not reached vs. 11.2 months; p = 0.003) in patients with metastatic HER2(+) IBC. Conclusion: High levels of miR-21 and miR-10b were present in the serum of patients with non-metastatic and metastatic HER2(+) breast cancer, respectively. High levels of serum miR-19a may represent a biomarker for IBC that is predictive for favorable clinical outcome in patients with metastatic HER2(+) IBC.	[Anfossi, Simone; Giordano, Antonio; Gao, Hui; Cohen, Evan N.; Tin, Sanda; Wu, Qiong; Garza, Raul J.; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Anfossi, Simone; Giordano, Antonio; Gao, Hui; Cohen, Evan N.; Debeb, Bisrat G.; Alvarez, Ricardo H.; Valero, Vicente; Ueno, Naoto T.; Woodward, Wendy A.; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Debeb, Bisrat G.; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Alvarez, Ricardo H.; Valero, Vicente; Hortobagyi, Gabriel N.; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Anfossi, Simone; Cohen, Evan N.] Univ Texas MD Anderson Canc Ctr, Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Reuben, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.	jreuben@mdanderson.org	Giordano, Antonio/AAU-1201-2020; Woodward, Wendy/AAX-6593-2020; Calin, George/E-9390-2011; Cohen, Evan N/AFP-3323-2022	Giordano, Antonio/0000-0002-5959-016X; Cohen, Evan N/0000-0003-4192-9644; Calin, George/0000-0001-6704-5615; Anfossi, Simone/0000-0001-5745-7587; Woodward, Wendy/0000-0002-7935-739X; Calin, George/0000-0002-7427-0578	Human Breast Cancer Stem Cell Surrogates, NIH/NCI [CA138239-02]; State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, DOD [W81XWH-09-1-0031 01]; NATIONAL CANCER INSTITUTE [R01CA138239, P30CA016672] Funding Source: NIH RePORTER	Human Breast Cancer Stem Cell Surrogates, NIH/NCI; State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, DOD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by: Human Breast Cancer Stem Cell Surrogates, CA138239-02, NIH/NCI; State of Texas Rare and Aggressive Breast Cancer Research Program, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Assessment of Circulating Breast Cancer Stem Cells To Predict Recurrent Disease, W81XWH-09-1-0031 01, DOD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson William F, 2005, Breast Dis, V22, P9; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Cristofanilli M, 2007, CANCER-AM CANCER SOC, V110, P1436, DOI 10.1002/cncr.22927; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang TH, 2009, J BIOL CHEM, V284, P18515, DOI 10.1074/jbc.M109.006676; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Lin QY, 2013, J SURG ONCOL, V107, P767, DOI 10.1002/jso.23312; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mariani G, 2009, NAT CLIN PRACT ONCOL, V6, P93, DOI 10.1038/ncponc1298; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Rechavi O, 2009, GENE DEV, V23, P1971, DOI 10.1101/gad.1789609; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Sasaki K, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-17; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wu TQ, 2012, P NATL ACAD SCI USA, V109, P9965, DOI 10.1073/pnas.1207327109; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	44	65	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83113	10.1371/journal.pone.0083113	http://dx.doi.org/10.1371/journal.pone.0083113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416156	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500029
J	Bengtsson, F; Jorntell, H				Bengtsson, Fredrik; Jorntell, Henrik			Specific Relationship between Excitatory Inputs and Climbing Fiber Receptive Fields in Deep Cerebellar Nuclear Neurons	PLOS ONE			English	Article							LATERAL RETICULAR NUCLEUS; NOCICEPTIVE WITHDRAWAL REFLEXES; PRE-CEREBULLAR AFFERENTS; INTERPOSITUS ANTERIOR; HORSERADISH-PEROXIDASE; IN-VIVO; TOPOGRAPHICAL ORGANIZATION; INHIBITORY PROJECTION; PURKINJE-CELLS; PRECISION GRIP	Many mossy fiber pathways to the neurons of the deep cerebellar nucleus (DCN) originate from the spinal motor circuitry. For cutaneously activated spinal neurons, the receptive field is a tag indicating the specific motor function the spinal neuron has. Similarly, the climbing fiber receptive field of the DCN neuron reflects the specific motor output function of the DCN neuron. To explore the relationship between the motor information the DCN neuron receives and the output it issues, we made patch clamp recordings of DCN cell responses to tactile skin stimulation in the forelimb region of the anterior interposed nucleus in vivo. The excitatory responses were organized according to a general principle, in which the DCN cell responses became stronger the closer the skin site was located to its climbing fiber receptive field. The findings represent a novel functional principle of cerebellar connectivity, with crucial importance for our understanding of the function of the cerebellum in movement coordination.	[Bengtsson, Fredrik; Jorntell, Henrik] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Jorntell, H (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	henrik.jorntell@med.lu.se			NINDS/NIH [R01 NS040863]; Hand Embodied (THE) (Integrated Project, EU FP7) [248587]; Swedish Research Council (VR Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040863] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hand Embodied (THE) (Integrated Project, EU FP7); Swedish Research Council (VR Medicine)(Swedish Research Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from NINDS/NIH (R01 NS040863), The Hand Embodied (THE) (Integrated Project, EU FP7, project no. 248587), and the Swedish Research Council (VR Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstermark B, 2007, ACTA PHYSIOL, V189, P123, DOI 10.1111/j.1748-1716.2006.01655.x; ALSTERMARK B, 1984, EXP BRAIN RES, V56, P293, DOI 10.1007/BF00236285; Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; Alvina K, 2008, NAT NEUROSCI, V11, P1256, DOI 10.1038/nn.2195; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Bengtsson F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018822; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; Dum RP, 2013, CURR OPIN NEUROBIOL, V23, P245, DOI 10.1016/j.conb.2012.12.002; EKEROT CF, 1991, J PHYSIOL-LONDON, V441, P275, DOI 10.1113/jphysiol.1991.sp018751; EKEROT CF, 1990, EXP BRAIN RES, V79, P109, DOI 10.1007/BF00228879; Ekerot CF, 2003, CEREBELLUM, V2, P101, DOI 10.1080/14734220309411; EKEROT CF, 1991, J PHYSIOL-LONDON, V441, P257, DOI 10.1113/jphysiol.1991.sp018750; EKEROT CF, 1990, EXP BRAIN RES, V79, P129, DOI 10.1007/BF00228881; EKEROT CF, 1990, EXP BRAIN RES, V79, P120, DOI 10.1007/BF00228880; EKEROT CF, 1995, EXP BRAIN RES, V106, P365; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; GARWICZ M, 1994, J PHYSIOL-LONDON, V474, P245, DOI 10.1113/jphysiol.1994.sp020017; Garwicz M, 1996, EUR J NEUROSCI, V8, P2726, DOI 10.1111/j.1460-9568.1996.tb01567.x; Gauck V, 2003, J NEUROSCI, V23, P8109; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Holdefer RN, 2005, J NEUROPHYSIOL, V93, P35, DOI 10.1152/jn.00603.2004; Holmberg H, 1996, J PHYSIOL-LONDON, V493, P239, DOI 10.1113/jphysiol.1996.sp021379; Holmberg H, 1997, J NEUROSCI, V17, P2071; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jorntell H, 1999, J PHYSIOL-LONDON, V514, P551, DOI 10.1111/j.1469-7793.1999.551ae.x; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Jorntell H, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00003; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; KITAI ST, 1977, BRAIN RES, V122, P197, DOI 10.1016/0006-8993(77)90289-X; KITAI ST, 1974, EXP BRAIN RES, V21, P419; Levinsson A, 2002, J NEUROSCI, V22, P8170; MACKAY WA, 1988, BRAIN RES, V442, P240, DOI 10.1016/0006-8993(88)91509-0; MACKAY WA, 1988, EXP BRAIN RES, V71, P47; Mason CR, 1998, J NEUROPHYSIOL, V79, P537, DOI 10.1152/jn.1998.79.2.537; Matsushita M, 1999, J COMP NEUROL, V412, P633, DOI 10.1002/(SICI)1096-9861(19991004)412:4<633::AID-CNE5>3.0.CO;2-Q; MATSUSHITA M, 1982, J COMP NEUROL, V208, P127, DOI 10.1002/cne.902080203; MCCREA RA, 1977, BRAIN RES, V122, P215, DOI 10.1016/0006-8993(77)90290-6; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Niedermayer E, 1993, ELECTROENCEPHALOGRAP; NOBLE R, 1988, J PHYSIOL-LONDON, V396, P497, DOI 10.1113/jphysiol.1988.sp016974; Oscarsson O., 1973, HDB SENSORY PHYSL VO, P339; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; ROSEN I, 1972, BRAIN RES, V45, P580, DOI 10.1016/0006-8993(72)90486-6; Rowland NC, 2008, J NEUROPHYSIOL, V99, P704, DOI 10.1152/jn.01100.2007; Santello M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00023; SCHOUENBORG J, 1995, EXP BRAIN RES, V106, P19; Spanne A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002979; Takei T, 2013, J NEUROSCI, V33, P8850, DOI 10.1523/JNEUROSCI.4032-12.2013; Takei T, 2010, J NEUROSCI, V30, P17041, DOI 10.1523/JNEUROSCI.4297-10.2010; TROTT JR, 1987, EXP BRAIN RES, V66, P318; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P57, DOI 10.1152/jn.1993.69.1.57; VANKAN PLE, 1994, J PHYSIOL-LONDON, V480, P171, DOI 10.1113/jphysiol.1994.sp020351; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O	59	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84616	10.1371/journal.pone.0084616	http://dx.doi.org/10.1371/journal.pone.0084616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416251	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500140
J	Kendall, CJ; Virani, MZ; Hopcraft, JGC; Bildstein, KL; Rubenstein, DI				Kendall, Corinne J.; Virani, Munir Z.; Hopcraft, J. Grant C.; Bildstein, Keith L.; Rubenstein, Daniel I.			African Vultures Don't Follow Migratory Herds: Scavenger Habitat Use Is Not Mediated by Prey Abundance	PLOS ONE			English	Article							MARA NATIONAL RESERVE; GYPS-AFRICANUS; SERENGETI WILDEBEEST; GRIFFON VULTURES; POPULATION; FACILITATION; COEXISTENCE; YELLOWSTONE; COMPETITION; CARCASSES	The ongoing global decline in vulture populations raises major conservation concerns, but little is known about the factors that mediate scavenger habitat use, in particular the importance of abundance of live prey versus prey mortality. We test this using data from the Serengeti-Mara ecosystem in East Africa. The two hypotheses that prey abundance or prey mortality are the main drivers of vulture habitat use provide alternative predictions. If vultures select areas based only on prey abundance, we expect tracked vultures to remain close to herds of migratory wildebeest regardless of season. However, if vultures select areas where mortality rates are greatest then we expect vultures to select the driest regions, where animals are more likely to die of starvation, and to be attracted to migratory wildebeest only during the dry season when wildebeest mortality is greatest. We used data from GSM-GPS transmitters to assess the relationship between three vulture species and migratory wildebeest in the Mara-Serengeti ecosystem. Results indicate that vultures preferentially cluster around migratory herds only during the dry season, when herds experience their highest mortality. Additionally during the wet season, Ruppell's and Lappet-faced vultures select relatively dry areas, based on Normalized Difference Vegetation Index, whereas White-backed vultures preferred wetter areas during the wet season. Differences in habitat use among species may mediate coexistence in this scavenger guild. In general, our results suggest that prey abundance is not the primary driver of avian scavenger habitat use. The apparent reliance of vultures on non-migratory ungulates during the wet season has important conservation implications for vultures in light of on-going declines in non-migratory ungulate species and use of poisons in unprotected areas.	[Kendall, Corinne J.; Rubenstein, Daniel I.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Kendall, Corinne J.; Virani, Munir Z.] Natl Museums Kenya, Dept Zool, Ornithol Sect, Nairobi, Kenya; [Virani, Munir Z.] Peregrine Fund, Boise, ID USA; [Hopcraft, J. Grant C.] Frankfurt Zool Soc, Arusha, Tanzania; [Bildstein, Keith L.] Hawk Mt Sanctuary, Acopian Ctr Conservat Learning, Orwigsburg, PA USA	Princeton University	Kendall, CJ (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	cjk2113@columbia.edu			Hawk Mountain Sanctuary; Peregrine Fund; Explorer's Club; SeaWorld and Busch Gardens Conservation Fund; Pompeo M. Maresi Memorial Fund from Princeton University's Department of Ecology and Evolutionary Biology; PEI's Development Grand Challenge; National Science Foundation [IBN-9874523, CNS-025214, IOB-9874523]	Hawk Mountain Sanctuary; Peregrine Fund; Explorer's Club; SeaWorld and Busch Gardens Conservation Fund; Pompeo M. Maresi Memorial Fund from Princeton University's Department of Ecology and Evolutionary Biology; PEI's Development Grand Challenge; National Science Foundation(National Science Foundation (NSF))	Funds were provided by Hawk Mountain Sanctuary, The Peregrine Fund, The Explorer's Club, and SeaWorld and Busch Gardens Conservation Fund. Funds were also provided by Pompeo M. Maresi Memorial Fund from Princeton University's Department of Ecology and Evolutionary Biology. DIR was funded by PEI's Development Grand Challenge and National Science Foundation (IBN-9874523, CNS-025214, and IOB-9874523). While individuals from funding institutions were involved in this study, the funding institutions themselves had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford AJ, 2007, BIRD CONSERV INT, V17, P331, DOI 10.1017/S0959270907000846; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Blazquez M, 2009, ACTA OECOL, V35, P645, DOI 10.1016/j.actao.2009.06.002; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dobson A, 2010, NATURE, V467, P272, DOI 10.1038/467272a; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Fryxell J.M., 1997, INDIVIDUAL BEHAV COM; FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; FRYXELL JM, 1988, AFR J ECOL, V26, P17, DOI 10.1111/j.1365-2028.1988.tb01125.x; Guan K, REMOTE SENS IN PRESS; HILLS RC, 1979, T I BRIT GEOGR, V4, P329, DOI 10.2307/622055; Hopcraft G, 2011, J ANIM ECOL; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Hopcraft JGC, SERENGETI IN PRESS; Houston D.C., 1979, SERENGETI DYNAMICS E, P263; HOUSTON DC, 1974, J ZOOL, V172, P35; HOUSTON DC, 1976, IBIS, V118, P14, DOI 10.1111/j.1474-919X.1976.tb02008.x; Houston DC, 2001, VULTURES CONDORS; Jackson AL, 2008, BIOL LETTERS, V4, P311, DOI 10.1098/rsbl.2008.0038; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kendall C, 2012, CONDOR, V114, P523, DOI 10.1525/cond.2012.100196; Kendall CJ, 2013, BEHAV ECOL SOCIOBIOL, V67, P383, DOI 10.1007/s00265-012-1458-5; Kendall CJ, 2012, J RAPTOR RES, V46, P135, DOI 10.3356/JRR-10-87.1; KRUUK H, 1967, ARDEA, V55, P171; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; MAYHEW P, 1989, IBIS, V131, P1, DOI 10.1111/j.1474-919X.1989.tb02736.x; Mduma SAR, 1999, J ANIM ECOL, V68, P1101, DOI 10.1046/j.1365-2656.1999.00352.x; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Mundy P., 1992, VULTURES AFRICA; NORTON-GRIFFITHS M, 1975, East African Wildlife Journal, V13, P347, DOI 10.1111/j.1365-2028.1975.tb00144.x; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ogutu JO, 2009, J ZOOL, V278, P1, DOI 10.1111/j.1469-7998.2008.00536.x; Pennycuick C.J., 1983, P172; Pennycuick C.J., 1979, SERENGETI; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Phipps WL, 2013, PLOSONE, V8; Pinheiro J, 2001, MIXED EFFECTS MODELS; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Shivik JA, 2006, BIOSCIENCE, V56, P819, DOI 10.1641/0006-3568(2006)56[819:AVBADS]2.0.CO;2; SINCLAIR ARE, 1995, ECOLOGY, V76, P882, DOI 10.2307/1939353; Spiegel O, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-5; Thiollay JM, 2007, OSTRICH, V78, P405, DOI 10.2989/OSTRICH.2007.78.2.46.126; Virani M, 2010, OSTRICH, V81, P205, DOI 10.2989/00306525.2010.519894; Virani MZ, 2012, BIRD CONSERV INT, V22, P260, DOI 10.1017/S0959270911000505; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; WALLACE MP, 1980, J FIELD ORNITHOL, V51, P309; WATSON RT, 1985, S AFR J WILDL RES, V15, P63; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x	57	31	33	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83470	10.1371/journal.pone.0083470	http://dx.doi.org/10.1371/journal.pone.0083470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421887	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000329862500049
J	Neumann, S; Vladimirov, N; Krembel, AK; Wingreen, NS; Sourjik, V				Neumann, Silke; Vladimirov, Nikita; Krembel, Anna K.; Wingreen, Ned S.; Sourjik, Victor			Imprecision of Adaptation in Escherichia coli Chemotaxis	PLOS ONE			English	Article							BACTERIAL CHEMOTAXIS; INHIBITION; ROBUSTNESS; PROTEINS; KINETICS; SERINE; TARGET; CELLS	Adaptability is an essential property of many sensory systems, enabling maintenance of a sensitive response over a range of background stimulus levels. In bacterial chemotaxis, adaptation to the preset level of pathway activity is achieved through an integral feedback mechanism based on activity-dependent methylation of chemoreceptors. It has been argued that this architecture ensures precise and robust adaptation regardless of the ambient ligand concentration, making perfect adaptation a celebrated property of the chemotaxis system. However, possible deviations from such ideal adaptive behavior and its consequences for chemotaxis have not been explored in detail. Here we show that the chemotaxis pathway in Escherichia coli shows increasingly imprecise adaptation to higher concentrations of attractants, with a clear correlation between the time of adaptation to a step-like stimulus and the extent of imprecision. Our analysis suggests that this imprecision results from a gradual saturation of receptor methylation sites at high levels of stimulation, which prevents full recovery of the pathway activity by violating the conditions required for precise adaptation. We further use computer simulations to show that limited imprecision of adaptation has little effect on the rate of chemotactic drift of a bacterial population in gradients, but hinders precise accumulation at the peak of the gradient. Finally, we show that for two major chemoeffectors, serine and cysteine, failure of adaptation at concentrations above 1 mM might prevent bacteria from accumulating at toxic concentrations of these amino acids.	[Neumann, Silke; Vladimirov, Nikita; Krembel, Anna K.; Sourjik, Victor] Heidelberg Univ, Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Heidelberg, Baden Wurttembe, Germany; [Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Princeton University	Sourjik, V (corresponding author), Heidelberg Univ, Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Heidelberg, Baden Wurttembe, Germany.	v.sourjik@zmbh.uni-heidelberg.de			European Research Council (ERC) [294761-MicRobE]; National Institutes of Health (NIH) [R01 GM082938]; Deutsche Forschungsgemeinschaft (DFG) [SO 421/11-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by European Research Council (ERC, http://erc.europa.eu) advanced grant 294761-MicRobE, grant R01 GM082938 from the National Institutes of Health (NIH, www.nih.gov) and by grant SO 421/11-1 from the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; AMOS H, 1954, BIOCHEM J, V57, P338, DOI 10.1042/bj0570338; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; HAMA H, 1990, BIOCHEM BIOPH RES CO, V168, P1211, DOI 10.1016/0006-291X(90)91157-N; HAMA H, 1991, J BIOCHEM-TOKYO, V109, P604, DOI 10.1093/oxfordjournals.jbchem.a123427; Hansen CH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040001; HARRIS CL, 1981, J BACTERIOL, V145, P1031, DOI 10.1128/JB.145.2.1031-1035.1981; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 2010, CURR OPIN MICROBIOL, V13, P124, DOI 10.1016/j.mib.2009.12.014; KEHRY MR, 1983, P NATL ACAD SCI-BIOL, V80, P3599, DOI 10.1073/pnas.80.12.3599; Lan G, 2012, NAT PHYS, V8, P422, DOI 10.1038/NPHYS2276; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Meir Y, 2010, BIOPHYS J, V99, P2766, DOI 10.1016/j.bpj.2010.08.051; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; Min TJL, 2012, P NATL ACAD SCI USA, V109, P9869, DOI 10.1073/pnas.1120218109; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; Sambrock J, 2001, MOL CLONING LAB MANU, V3rd; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2011, CURR OPIN CELL BIOL, V24, P1; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; Stocker R, 2012, MICROBIOL MOL BIOL R, V76, P792, DOI 10.1128/MMBR.00029-12; Vladimirov N, 2009, BIOL CHEM, V390, P1097, DOI 10.1515/BC.2009.130; Vladimirov N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000242; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	30	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84904	10.1371/journal.pone.0084904	http://dx.doi.org/10.1371/journal.pone.0084904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416308	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500187
J	Rose, S; Frye, RE; Slattery, J; Wynne, R; Tippett, M; Pavliv, O; Melnyk, S; James, SJ				Rose, Shannon; Frye, Richard E.; Slattery, John; Wynne, Rebecca; Tippett, Marie; Pavliv, Oleksandra; Melnyk, Stepan; James, S. Jill			Oxidative Stress Induces Mitochondrial Dysfunction in a Subset of Autism Lymphoblastoid Cell Lines in a Well-Matched Case Control Cohort	PLOS ONE			English	Article							SPARE RESPIRATORY CAPACITY; NECROSIS-FACTOR-ALPHA; COMPLEX-I; SPECTRUM DISORDERS; METHYL MERCURY; CYTOCHROME-C; CHILDREN; GLUTATHIONE; DNA; TRANSPORT	There is increasing recognition that mitochondrial dysfunction is associated with the autism spectrum disorders. However, little attention has been given to the etiology of mitochondrial dysfunction or how mitochondrial abnormalities might interact with other physiological disturbances associated with autism, such as oxidative stress. In the current study we used respirometry to examine reserve capacity, a measure of the mitochondrial ability to respond to physiological stress, in lymphoblastoid cell lines (LCLs) derived from children with autistic disorder (AD) as well as age and gender-matched control LCLs. We demonstrate, for the first time, that LCLs derived from children with AD have an abnormal mitochondrial reserve capacity before and after exposure to increasingly higher concentrations of 2,3-dimethoxy-1,4-napthoquinone (DMNQ), an agent that increases intracellular reactive oxygen species (ROS). Specifically, the AD LCLs exhibit a higher reserve capacity at baseline and a sharper depletion of reserve capacity when ROS exposure is increased, as compared to control LCLs. Detailed investigation indicated that reserve capacity abnormalities seen in AD LCLs were the result of higher ATP-linked respiration and maximal respiratory capacity at baseline combined with a marked increase in proton leak respiration as ROS was increased. We further demonstrate that these reserve capacity abnormalities are driven by a subgroup of eight (32%) of 25 AD LCLs. Additional investigation of this subgroup of AD LCLs with reserve capacity abnormalities revealed that it demonstrated a greater reliance on glycolysis and on uncoupling protein 2 to regulate oxidative stress at the inner mitochondria membrane. This study suggests that a significant subgroup of AD children may have alterations in mitochondrial function which could render them more vulnerable to a pro-oxidant microenvironment derived from intrinsic and extrinsic sources of ROS such as immune activation and pro-oxidant environmental toxicants. These findings are consistent with the notion that AD is caused by a combination of genetic and environmental factors.	[Rose, Shannon; Frye, Richard E.; Slattery, John; Wynne, Rebecca; Tippett, Marie; Pavliv, Oleksandra; Melnyk, Stepan; James, S. Jill] Arkansas Childrens Hosp, Res Inst, Dept Pediat, Little Rock, AR 72202 USA	Arkansas Children's Hospital	Frye, RE (corresponding author), Arkansas Childrens Hosp, Res Inst, Dept Pediat, 800 Marshall St, Little Rock, AR 72202 USA.	REFrye@uams.edu	Frye, Richard/AAB-5543-2020	Rose, Shannon/0000-0003-0595-4367	National Institute for Child Health and Development; Arkansas Biosciences Institute; Jane Botsford Johnson Foundation	National Institute for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Arkansas Biosciences Institute; Jane Botsford Johnson Foundation	This research was funded by the National Institute for Child Health and Development (SJJ), the Arkansas Biosciences Institute (REF, SJJ), and the Jane Botsford Johnson Foundation (REF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg M. R., 1973, CLUSTER ANAL APPL; Anitha A, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-12; APA, 1994, DIAGN STAT MAN MENT; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P840, DOI 10.1016/j.bbi.2010.09.002; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; BANNAI S, 1986, J MEMBRANE BIOL, V89, P1, DOI 10.1007/BF01870891; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001; Evangeliou A, 2003, J CHILD NEUROL, V18, P113, DOI 10.1177/08830738030180020501; FernandezCheca JC, 1997, AM J PHYSIOL-GASTR L, V273, pG7, DOI 10.1152/ajpgi.1997.273.1.G7; FOWLER BA, 1977, EXP MOL PATHOL, V27, P403, DOI 10.1016/0014-4800(77)90010-7; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Frye RE, 2012, N AM J MED SCI, V5, P141; Frye RE, 2012, J PEDIATR NEUROL, V10, P35, DOI 10.3233/JPN-2012-0530; Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Goyer RA, 1997, ANNU REV NUTR, V17, P37, DOI 10.1146/annurev.nutr.17.1.37; Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601; Gu F, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.68; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hiura TS, 2000, J IMMUNOL, V165, P2703, DOI 10.4049/jimmunol.165.5.2703; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Melnyk S, 2000, CLIN CHEM, V46, P265; Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Nickles D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-477; Oh JH, 2013, J HUM GENET, V58, P16, DOI 10.1038/jhg.2012.123; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Pourahmad J, 2001, ADV EXP MED BIOL, V500, P249; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Rose Shannon, 2012, Autism Res Treat, V2012, P986519, DOI 10.1155/2012/986519; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; Shenker BJ, 1999, TOXICOL APPL PHARM, V157, P23, DOI 10.1006/taap.1999.8652; Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x; STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1; STUBBS EG, 1977, J AUTISM CHILD SCHIZ, V7, P49, DOI 10.1007/BF01531114; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Vali S, 2007, NEUROSCIENCE, V149, P917, DOI 10.1016/j.neuroscience.2007.08.028; Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06; Ward J. H., 1963, J AM STAT SOC, V77, P841; Wong PW, 2001, J NEUROCHEM, V76, P450, DOI 10.1046/j.1471-4159.2001.00022.x; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; YAMANO T, 1995, ARCH ENVIRON CON TOX, V28, P1, DOI 10.1007/BF00213961	59	102	103	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85436	10.1371/journal.pone.0085436	http://dx.doi.org/10.1371/journal.pone.0085436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416410	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500249
J	Siciliano, P; Scolari, F; Gomulski, LM; Falchetto, M; Manni, M; Gabrieli, P; Field, LM; Zhou, JJ; Gasperi, G; Malacrida, AR				Siciliano, Paolo; Scolari, Francesca; Gomulski, Ludvik M.; Falchetto, Marco; Manni, Mose; Gabrieli, Paolo; Field, Linda M.; Zhou, Jing-Jiang; Gasperi, Giuliano; Malacrida, Anna R.			Sniffing Out Chemosensory Genes from the Mediterranean Fruit Fly, Ceratitis capitata	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; SEMINAL FLUID PROTEINS; PHEROMONE-BINDING; MATING-BEHAVIOR; FLIES DIPTERA; CIRCADIAN-RHYTHMS; AEDES-AEGYPTI; DROSOPHILA; TEPHRITIDAE; IDENTIFICATION	The Mediterranean fruit fly, Ceratitis capitata (medfly), is an extremely invasive agricultural pest due to its extremely wide host range and its ability to adapt to a broad range of climatic conditions and habitats. Chemosensory behaviour plays an important role in many crucial stages in the life of this insect, such as the detection of pheromone cues during mate pursuit and odorants during host plant localisation. Thus, the analysis of the chemosensory gene repertoire is an important step for the interpretation of the biology of this species and consequently its invasive potential. Moreover, these genes may represent ideal targets for the development of novel, effective control methods and pest population monitoring systems. Expressed sequence tag libraries from C. capitata adult heads, embryos, male accessory glands and testes were screened for sequences encoding putative odorant binding proteins (OBPs). A total of seventeen putative OBP transcripts were identified, corresponding to 13 Classic, three Minus-C and one Plus-C subfamily OBPs. The tissue distributions of the OBP transcripts were assessed by RT-PCR and a subset of five genes with predicted proteins sharing high sequence similarities and close phylogenetic affinities to Drosophila melanogaster pheromone binding protein related proteins (PBPRPs) were characterised in greater detail. Real Time quantitative PCR was used to assess the effects of maturation, mating and time of day on the transcript abundances of the putative PBPRP genes in the principal olfactory organs, the antennae, in males and females. The results of the present study have facilitated the annotation of OBP genes in the recently released medfly genome sequence and represent a significant contribution to the characterisation of the medfly chemosensory repertoire. The identification of these medfly OBPs/PBPRPs permitted evolutionary and functional comparisons with homologous sequences from other tephritids of the genera Bactrocera and Rhagoletis.	[Siciliano, Paolo; Scolari, Francesca; Gomulski, Ludvik M.; Falchetto, Marco; Manni, Mose; Gabrieli, Paolo; Gasperi, Giuliano; Malacrida, Anna R.] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Field, Linda M.; Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	University of Pavia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Malacrida, AR (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Via Palestro 3, I-27100 Pavia, Italy.	malacrid@unipv.it	Gabrieli, Paolo/A-3206-2016; Scolari, Francesca/ABC-2285-2020; Gomulski, Ludvik/AAG-2709-2022; Gasperi, Giuliano/Y-1894-2019; Gomulski, Ludvik/AFK-3930-2022	Gabrieli, Paolo/0000-0002-4996-2468; Scolari, Francesca/0000-0003-3085-9038; Gasperi, Giuliano/0000-0001-6972-8591; Field, Linda/0000-0002-3328-2513; GOMULSKI, LUDVIK/0000-0002-1506-7051; malacrida, anna/0000-0003-4566-8795	Italian Ministry of education, University and Research PRIN [20077RCHRW]; FAO/IAEA(Food and Agriculture Organization of the United Nations (FAO)/International Atomic Energy Agency (IAEA)) [16966]; UK Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BBS/E/C/00005194, BBS/E/C/00004947] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004947, BBS/E/C/00005194] Funding Source: researchfish	Italian Ministry of education, University and Research PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FAO/IAEA(Food and Agriculture Organization of the United Nations (FAO)/International Atomic Energy Agency (IAEA)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partially funded by Italian Ministry of education, University and Research PRIN grant 20077RCHRW (LMG, ARM, GG), and a FAO/IAEA(Food and Agriculture Organization of the United Nations (FAO)/International Atomic Energy Agency (IAEA)) Technical Contract No. 16966 (GG). The work was also carried out within the FAO/IAEA research CRP programme "Identification of molecular and transgenic tools for sexing strategies and development of strain and sperm marking systems for fruitfly pests" - "Development and evaluation of improved strains of insect pests for SIT" (GG). Rothamsted Research receives grant-aided support from the UK Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro C, 2011, J AGR FOOD CHEM, V59, P298, DOI 10.1021/jf104183c; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anholt RRH, 2010, CHEM SENSES, V35, P21, DOI 10.1093/chemse/bjp073; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Ashburner M, 1998, BIOESSAYS, V20, P949, DOI 10.1002/(SICI)1521-1878(199811)20:11&lt;949::AID-BIES10&gt;3.0.CO;2-0; Ayala FJ, 1996, P NATL ACAD SCI USA, V93, P11729, DOI 10.1073/pnas.93.21.11729; BAKER R, 1985, J CHEM SOC CHEM COMM, P824, DOI 10.1039/c39850000824; BARUFFI L, 1995, HEREDITY, V74, P425, DOI 10.1038/hdy.1995.60; Briceno RD, 2002, FLA ENTOMOL, V85, P32, DOI 10.1653/0015-4040(2002)085[0032:VITIBS]2.0.CO;2; Diaz-Fleischer F, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P811; Drew RAI, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P731; Dyck V.A., 2006, STERILE INSECT TECHN; Emery P, 2008, CURR BIOL, V18, pR569, DOI 10.1016/j.cub.2008.05.011; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; FLATH RA, 1993, J AGR FOOD CHEM, V41, P830, DOI 10.1021/jf00029a029; FLETCHER BS, 1989, FRUIT FLIES THEIR B, V3, P209; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gomulski LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030857; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JANG EB, 1995, J INSECT PHYSIOL, V41, P705, DOI 10.1016/0022-1910(95)00015-M; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; LANDOLT PJ, 1992, ENTOMOL EXP APPL, V65, P259, DOI 10.1007/BF02343859; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Levinson H, 2003, J APPL ENTOMOL, V127, P269, DOI 10.1046/j.1439-0418.2003.00750.x; Light DM, 1999, J CHEM ECOL, V25, P2757, DOI 10.1023/A:1020855625244; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; MCDONALD PT, 1987, ANN ENTOMOL SOC AM, V80, P17, DOI 10.1093/aesa/80.1.17; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; NAKAGAWA S, 1973, J ECON ENTOMOL, V66, P583, DOI 10.1093/jee/66.2.583; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Papadopoulos NT, 2006, J INSECT BEHAV, V19, P403, DOI 10.1007/s10905-006-9031-6; Papadopoulos NT, 2010, J INSECT PHYSIOL, V56, P283, DOI 10.1016/j.jinsphys.2009.10.014; Papadopoulos NT, 1998, ENTOMOL EXP APPL, V89, P175, DOI 10.1023/A:1003580814122; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; PROKOPY RJ, 1979, ANN ENTOMOL SOC AM, V72, P642, DOI 10.1093/aesa/72.5.642; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; SAUL SH, 1982, ANN ENTOMOL SOC AM, V75, P480, DOI 10.1093/aesa/75.4.480; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; Scolari F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046812; Shelly TE, 2002, FLA ENTOMOL, V85, P150, DOI 10.1653/0015-4040(2002)085[0150:EOADOS]2.0.CO;2; Shelly T, 2012, ANN ENTOMOL SOC AM, V105, P368, DOI 10.1603/AN11125; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Sivinski J, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P751; South A, 2011, INSECT MOL BIOL, V20, P447, DOI 10.1111/j.1365-2583.2011.01083.x; Takemori N, 2009, PROTEOMICS, V9, P2484, DOI 10.1002/pmic.200800795; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor PW, 1999, ANIM BEHAV, V58, P247, DOI 10.1006/anbe.1999.1137; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Valenzuela JG, 2002, INSECT MOL BIOL, V11, P149, DOI 10.1046/j.1365-2583.2002.00319.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanickova L, 2012, J AGR FOOD CHEM, V60, P7168, DOI 10.1021/jf301474d; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WHITTIER TS, 1992, ANN ENTOMOL SOC AM, V85, P214, DOI 10.1093/aesa/85.2.214; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yuval B, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P429; Zheng WW, 2013, INT J MOL SCI, V14, P14936, DOI 10.3390/ijms140714936; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zhou SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000681; Zucoloto FS, 1990, J PHYSL ENTOMOL, V37, P21	85	33	34	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85523	10.1371/journal.pone.0085523	http://dx.doi.org/10.1371/journal.pone.0085523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416419	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500254
J	Xu, HJ; Qin, W; Chen, H; Jiang, L; Li, KC; Yu, CS				Xu, Huijuan; Qin, Wen; Chen, Hai; Jiang, Lin; Li, Kuncheng; Yu, Chunshui			Contribution of the Resting-State Functional Connectivity of the Contralesional Primary Sensorimotor Cortex to Motor Recovery after Subcortical Stroke	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LONGITUDINAL FMRI; BRAIN ACTIVATION; INTERHEMISPHERIC INTERACTIONS; CONTROLLED TRIAL; NEURAL ACTIVITY; HAND MOVEMENTS; REORGANIZATION; NETWORK; MECHANISMS	It remains uncertain if the contralesional primary sensorimotor cortex (CL_PSMC) contributes to motor recovery after stroke. Here we investigated longitudinal changes in the resting-state functional connectivity (rsFC) of the CL_PSMC and their association with motor recovery. Thirteen patients who had experienced subcortical stroke underwent a series of resting-state fMRI and clinical assessments over a period of 1 year at 5 time points, i.e., within the first week, at 2 weeks, 1 month, 3 months, and 1 year after stroke onset. Thirteen age-and gender-matched healthy subjects were recruited as controls. The CL_PSMC was defined as a region centered at the voxel that had greatest activation during hand motion task. The dynamic changes in the rsFCs of the CL_PSMC within the whole brain were evaluated and correlated with the Motricity Index (MI) scores. Compared with healthy controls, the rsFCs of the CL_PSMC with the bilateral PSMC were initially decreased, then gradually increased, and finally restored to the normal level 1 year later. Moreover, the dynamic change in the interhemispheric rsFC between the bilateral PSMC in these patients was positively correlated with the MI scores. However, the intra-hemispheric rsFC of the CL_PSMC was not correlated with the MI scores. This study shows dynamic changes in the rsFCs of the CL_PSMC after stroke and suggests that the increased inter-hemispheric rsFC between the bilateral PSMC may facilitate motor recovery in stroke patients. However, generalization of our findings is limited by the small sample size of our study and needs to be confirmed.	[Xu, Huijuan; Qin, Wen; Jiang, Lin; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Xu, Huijuan; Qin, Wen; Jiang, Lin; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Tianjin Key Lab Funct Imaging, Tianjin, Peoples R China; [Chen, Hai] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing, Peoples R China; [Li, Kuncheng] Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China	Tianjin Medical University; Tianjin Medical University; Capital Medical University; Capital Medical University	Yu, CS (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	chunshuiyu@tijmu.edu.cn	QIN, WEN/F-3783-2015	QIN, WEN/0000-0002-9121-8296; Yu, Chunshui/0000-0001-5648-5199	National Basic Research Program of China (973 program) [2011CB707804]; Natural Science Foundation of China [81271564]; Natural Science Foundation of Tianjin [12JCZDJC23800]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This study was supported by the National Basic Research Program of China (973 program, 2011CB707804), the Natural Science Foundation of China (81271564), and the Natural Science Foundation of Tianjin (12JCZDJC23800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Bohannon R., 1999, J PHYS THER SCI, V11, P59, DOI [10.1589/jpts.11.59, DOI 10.1589/JPTS.11.59]; Calautti C, 2001, STROKE, V32, P2534, DOI 10.1161/hs1101.097401; Cameron D, 2000, CLIN REHABIL, V14, P208, DOI 10.1191/026921500675786655; Carmichael ST, 2008, STROKE, V39, P1380, DOI 10.1161/STROKEAHA.107.499962; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carter AR, 2012, NEUROREHAB NEURAL RE, V26, P7, DOI 10.1177/1545968311411054; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Cowey A, 2011, BRAIN, V134, P2149, DOI 10.1093/brain/awr125; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Dancause N, 2006, REV NEUROSCIENCE, V17, P561; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; GIBBONS RD, 1988, PSYCHOPHARMACOL BULL, V24, P438; Golestani AM, 2013, NEUROREHAB NEURAL RE, V27, P153, DOI 10.1177/1545968312457827; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Grefkes C, 2010, NEUROIMAGE, V50, P233, DOI 10.1016/j.neuroimage.2009.12.029; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Jaillard A, 2005, BRAIN, V128, P1122, DOI 10.1093/brain/awh456; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Lewis GN, 2004, J MOTOR BEHAV, V36, P174, DOI 10.3200/JMBR.36.2.174-188; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Luft AR, 2005, NEUROIMAGE, V26, P184, DOI 10.1016/j.neuroimage.2005.01.027; Luft AR, 2004, NEUROIMAGE, V21, P924, DOI 10.1016/j.neuroimage.2003.10.026; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nowak DA, 2008, ARCH NEUROL-CHICAGO, V65, P741, DOI 10.1001/archneur.65.6.741; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rehme AK, 2012, NEUROIMAGE, V59, P2771, DOI 10.1016/j.neuroimage.2011.10.023; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; Rose DK, 2005, CLIN REHABIL, V19, P452, DOI 10.1191/0269215505cr806oa; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Schaechter JD, 2008, NEUROIMAGE, V39, P1370, DOI 10.1016/j.neuroimage.2007.09.071; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; Talelli P, 2012, NEUROREHAB NEURAL RE, V26, P976, DOI 10.1177/1545968312437940; Tombari D, 2004, NEUROIMAGE, V23, P827, DOI 10.1016/j.neuroimage.2004.07.058; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Varkuti B, 2013, NEUROREHAB NEURAL RE, V27, P53, DOI 10.1177/1545968312445910; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2007, EUR J NEUROSCI, V25, P1865, DOI 10.1111/j.1460-9568.2007.05434.x; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Warren JE, 2009, BRAIN, V132, P3428, DOI 10.1093/brain/awp270; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; Werhahn KJ, 2003, ANN NEUROL, V54, P464, DOI 10.1002/ana.10686	60	45	46	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84729	10.1371/journal.pone.0084729	http://dx.doi.org/10.1371/journal.pone.0084729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416273	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500156
J	Ming, M; Soltani, K; Shea, CR; Li, X; He, YY				Ming, M.; Soltani, K.; Shea, C. R.; Li, X.; He, Y. Y.			Dual role of SIRT1 in UVB-induced skin tumorigenesis	ONCOGENE			English	Article						SIRT1; UVB; skin tumorigenesis; DNA repair; apoptosis	DNA-DAMAGE RESPONSE; CELL-SURVIVAL; CALORIE RESTRICTION; MAMMALIAN SIRTUINS; CANCER; MICE; P53; DEACETYLASE; PROTEIN; REPAIR	The protein deacetylase SIRT1 regulates various pathways in metabolism, aging and cancer. However, the role of SIRT1 in skin cancer remains unclear. Here, using mice with targeted deletions of SIRT1 in their epidermis in both resistant B6 and sensitive SKH1 hairless backgrounds, we show that the role of SIRT1 in skin cancer development induced by ultraviolet B (UVB) radiation is dependent on its gene dose. Keratinocyte-specific heterozygous deletion of SIRT1 promotes UVB-induced skin tumorigenesis, whereas homozygous deletion of SIRT1 suppresses skin tumor development but sensitizes the B6 mice to chronic solar injury. In mouse skin, SIRT1 is haploinsufficient for UVB-induced DNA damage repair and expression of xeroderma pigmentosum C (XPC), a protein critical for repairing UVB-induced DNA damage. As compared with normal human skin, downregulation of SIRT1 is in parallel with downregulation of XPC in human cutaneous squamous cell carcinoma at both the protein and mRNA levels. In contrast, homozygous SIRT1 deletion in mouse skin augments p53 acetylation and expression of its transcriptional target Noxa, and sensitizes the epidermis to UVB-induced apoptosis in vivo, while heterozygous SIRT1 deletion has no such effect. The gene dosage-dependent function of SIRT1 in DNA repair and cell survival is consistent with the dual roles of SIRT1 in UVB-induced skin tumorigenesis. Our results reveal the gene dosage-dependent in vivo functions of SIRT1 in skin tumorigenesis and may shed light on the role of SIRT1 in epithelial cancer induced by DNA damage.	[Ming, M.; Soltani, K.; Shea, C. R.; He, Y. Y.] Univ Chicago, Dermatol Sect, Dept Med, Chicago, IL 60637 USA; [Li, X.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC USA	University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	He, YY (corresponding author), Univ Chicago, Dermatol Sect, Dept Med, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	Shea, Christopher R./AAJ-7143-2021; Li, Xiaoling/A-2994-2015	Li, Xiaoling/0000-0001-5920-7784	NIH/NIEHS [ES016936]; American Cancer Society (ACS) [RSG-13-078-01]; University of Chicago Cancer Research Center [P30 CA014599]; CTSA [NIH UL1RR024999]; University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936] Funding Source: NIH RePORTER	NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Cancer Society (ACS)(American Cancer Society); University of Chicago Cancer Research Center; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NIH/NIEHS Grant ES016936 (to YYH), the American Cancer Society (ACS) Grant RSG-13-078-01 (to YYH), the University of Chicago Cancer Research Center (P30 CA014599), the CTSA (NIH UL1RR024999) and the University of Chicago Friends of Dermatology Endowment Fund. We thank Terri Li for Ki67 and TUNEL and XPC immunohistochemical analysis, and Dr Xiaobing Shi for kindly providing the WT and K382R mutant p53 plasmids.	Berg RJW, 1998, J INVEST DERMATOL, V110, P405, DOI 10.1111/j.1523-1747.1998.00173.x; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheo DL, 2000, CANCER RES, V60, P1580; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Fan W, MOL CELL, V39, P247; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Herranz D, 2013, ONCOGENE, V32, P4052, DOI 10.1038/onc.2012.407; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Itoh T, 2004, P NATL ACAD SCI USA, V101, P2052, DOI 10.1073/pnas.0306551101; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Kamel C, 2006, AGING CELL, V5, P81, DOI 10.1111/j.1474-9726.2006.00191.x; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Ming M, P NATL ACAD SCI US, V107, P22623; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Oka M, 2010, CARCINOGENESIS, V31, P1897, DOI 10.1093/carcin/bgq164; Powell MJ, 2011, CANCER RES, V71, P964, DOI 10.1158/0008-5472.CAN-10-3172; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; Smith JS, 2002, TRENDS CELL BIOL, V12, P404, DOI 10.1016/S0962-8924(02)02342-5; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Sugasawa K, 2008, CARCINOGENESIS, V29, P455, DOI 10.1093/carcin/bgm282; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu CL, 2013, ONCOGENE, V32, P2682, DOI 10.1038/onc.2012.279; Yuan Z, 2007, CELL CYCLE, V6, P2869, DOI 10.4161/cc.6.23.5026; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	45	36	36	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 15	2015	34	3					281	287		10.1038/onc.2013.583	http://dx.doi.org/10.1038/onc.2013.583			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ3RY	24441046	Green Accepted			2022-12-25	WOS:000348145500002
J	Sundriyal, A; Massa, C; Samoray, D; Zehender, F; Sharpe, T; Jenal, U; Schirmer, T				Sundriyal, Amit; Massa, Claudia; Samoray, Dietrich; Zehender, Fabian; Sharpe, Timothy; Jenal, Urs; Schirmer, Tilman			Inherent Regulation of EAL Domain-catalyzed Hydrolysis of Second Messenger Cyclic di-GMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Bacterial Signal Transduction; Chromatography; Crystal Structure; Phosphodiesterases; c-di-GMP Signaling; Second Messenger	ESCHERICHIA-COLI; MECHANISM; PROTEIN; PHOSPHODIESTERASE; ACTIVATION; ROCR	Background: The bacterial second messenger cyclic di-GMP (c-di-GMP) is degraded by EAL phosphodiesterases. Results: The isolated EAL domain is active only as a homodimer. Substrate binding is coupled with EAL dimerization. Conclusion: Activity of many full-length EAL phosphodiesterases may be regulated by catalytic domain dimerization. Significance: A generic mechanism for the regulation of a central node of c-di-GMP signaling is provided. The universal second messenger cyclic di-GMP (cdG) is involved in the regulation of a diverse range of cellular processes in bacteria. The intracellular concentration of the dinucleotide is determined by the opposing actions of diguanylate cyclases and cdG-specific phosphodiesterases (PDEs). Whereas most PDEs have accessory domains that are involved in the regulation of their activity, the regulatory mechanism of this class of enzymes has remained unclear. Here, we use biophysical and functional analyses to show that the isolated EAL domain of a PDE from Escherichia coli (YahA) is in a fast thermodynamic monomer-dimer equilibrium, and that the domain is active only in its dimeric state. Furthermore, our data indicate thermodynamic coupling between substrate binding and EAL dimerization with the dimerization affinity being increased about 100-fold upon substrate binding. Crystal structures of the YahA-EAL domain determined under various conditions (apo, Mg2+, cdGCa(2+) complex) confirm structural coupling between the dimer interface and the catalytic center. The built-in regulatory properties of the EAL domain probably facilitate its modular, functional combination with the diverse repertoire of accessory domains.	[Sundriyal, Amit; Massa, Claudia; Samoray, Dietrich; Zehender, Fabian; Schirmer, Tilman] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland; [Sharpe, Timothy] Univ Basel, Biozentrum, Biophys Facil, CH-4056 Basel, Switzerland; [Jenal, Urs] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Schirmer, T (corresponding author), Klingelbergstr 70, CH-4056 Basel, Switzerland.	tilman.schirmer@unibas.ch		Sharpe, Timothy/0000-0002-4980-1330	Swiss National Science Foundation [31003A_138414, 31003A_130469]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31003A_138414 (to T. Sch.) and 31003A_130469 (to U. J.).	Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Claret L, 2007, J BIOL CHEM, V282, P33275, DOI 10.1074/jbc.M702800200; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Robert-Paganin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052424; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Tarnawski M, 2013, ACTA CRYSTALLOGR D, V69, P1045, DOI 10.1107/S0907444913004423; Tchigvintsev A, 2010, J MOL BIOL, V402, P524, DOI 10.1016/j.jmb.2010.07.050; WALKER GM, 1994, CRIT REV BIOTECHNOL, V14, P311, DOI 10.3109/07388559409063643; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Zahringer F, 2013, STRUCTURE, V21, P1149, DOI 10.1016/j.str.2013.04.026; Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x	37	51	54	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6978	6990		10.1074/jbc.M113.516195	http://dx.doi.org/10.1074/jbc.M113.516195			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451384	Green Published, hybrid			2022-12-25	WOS:000332389400058
J	Patzina, C; Haller, O; Kochs, G				Patzina, Corinna; Haller, Otto; Kochs, Georg			Structural Requirements for the Antiviral Activity of the Human MxA Protein against Thogoto and Influenza A Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agents; GTPase; Influenza Virus; Innate Immunity; Interferon; MxA; Dynamin; Myxovirus Resistance	RESISTANCE GENE; GTPASE; SPECIFICITY; SENSITIVITY; LOCALIZES; INHIBITOR; INFECTION; DOMAIN	Background: Interferon-induced human MxA GTPase is an innate immunity factor with broad antiviral activity. Results: Antiviral specificity against orthomyxoviruses (influenza A and Thogoto viruses) is determined by a bipartite element in disordered loop L4. Conclusion: A few critical amino acids allow multiple antiviral conformations of L4. Significance: The MxA antiviral interface may provide clues for the design of novel antivirals. The interferon-induced dynamin-like MxA protein has broad antiviral activity against many viruses, including orthomyxoviruses such as influenza A and Thogoto virus and bunyaviruses such as La Crosse virus. MxA consists of an N-terminal globular GTPase domain, a connecting bundle signaling element, and the C-terminal stalk that mediates oligomerization and antiviral specificity. We previously reported that the disordered loop L4 that protrudes from the compact stalk is a key determinant of antiviral specificity against influenza A and Thogoto virus. However, the role of individual amino acids for viral target recognition remained largely undefined. By mutational analyses, we identified two regions in the C-terminal part of L4 that contribute to an antiviral interface. Mutations in the proximal motif, at positions 561 and 562, abolished antiviral activity against orthomyxoviruses but not bunyaviruses. In contrast, mutations in the distal motif, around position 577, abolished antiviral activity against both viruses. These results indicate that at least two structural elements in L4 are responsible for antiviral activity and that the proximal motif determines specificity for orthomyxoviruses, whereas the distal sequence serves a conserved structural function.	[Patzina, Corinna; Haller, Otto; Kochs, Georg] Univ Freiburg, Inst Virol, D-79008 Freiburg, Germany	University of Freiburg	Kochs, G (corresponding author), Univ Med Ctr, Inst Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany.	georg.kochs@uniklinik-freiburg.de			Deutsche Forschungsgemeinschaft [Ko 1579/8-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant Ko 1579/8-2 (to G. K.).	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; HALLER O, 1995, J VIROL, V69, P2596, DOI 10.1128/JVI.69.4.2596-2601.1995; Haller O, 2013, CELL HOST MICROBE, V14, P371, DOI 10.1016/j.chom.2013.10.002; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kochs G, 2000, J VIROL, V74, P10785, DOI 10.1128/JVI.74.22.10785-10789.2000; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Manz B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003279; Matzinger SR, 2013, J VIROL, V87, P1150, DOI 10.1128/JVI.02271-12; Mitchell PS, 2013, CURR OPIN MICROBIOL, V16, P493, DOI 10.1016/j.mib.2013.04.005; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Xiao H, 2013, J VIROL, V87, P13053, DOI 10.1128/JVI.02220-13; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	30	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6020	6027		10.1074/jbc.M113.543892	http://dx.doi.org/10.1074/jbc.M113.543892			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24448803	hybrid, Green Published			2022-12-25	WOS:000332015500057
J	Chang, HC; Lee, HJ; Tzeng, OJL; Kuo, WJ				Chang, Hui-Chuan; Lee, Hsin-Ju; Tzeng, Ovid J. L.; Kuo, Wen-Jui			Implicit Target Substitution and Sequencing for Lexical Tone Production in Chinese: An fMRI Study	PLOS ONE			English	Article							HEMISPHERIC-SPECIALIZATION; LANGUAGE LATERALITY; MANDARIN CHINESE; WORD PRODUCTION; FUNCTIONAL MRI; SPEECH; PERCEPTION; DOMINANCE; BRAIN; AREAS	In this study, we examine the neural substrates underlying Tone 3 sandhi and tone sequencing in Mandarin Chinese using fMRI. Tone 3 sandhi is traditionally described as the substitution of Tone 3 with Tone 2 when followed by another Tone 3 (i.e., 33 -> 23). According to current speech production models, target substitution is expected to engage the posterior inferior frontal gyrus. Since Tone 3 sandhi is, to some extent, independent of segments, which makes it more similar to singing, right-lateralized activation in this region was predicted. As for tone sequencing, based on studies in sequencing, we expected the involvement of the supplementary motor area. In the experiments, participants were asked to produce twelve four-syllable sequences with the same tone assignment (the repeated sequences) or a different tone assignment (the mixed sequences). We found right-lateralized posterior inferior frontal gyrus activation for the sequence 3333 (Tone 3 sandhi) and left-lateralized activation in the supplementary motor area for the mixed sequences (tone sequencing). We proposed that tones and segments could be processed in parallel in the left and right hemispheres, but their integration, or the product of their integration, is hosted in the left hemisphere.	[Chang, Hui-Chuan; Lee, Hsin-Ju; Tzeng, Ovid J. L.; Kuo, Wen-Jui] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Tzeng, Ovid J. L.] Acad Sinica, Inst Linguist, Taipei 115, Taiwan; [Kuo, Wen-Jui] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Kuo, WJ (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	wjkuo@ym.edu.tw		Tzeng, Ovid J. L./0000-0002-0844-7865; Lee, Hsin-Ju/0000-0003-3358-8720; CHANG, CLAIRE H. C./0000-0002-3773-1777	National Science Council of Taiwan [97-2752-H-010-002-PAE, 96-2752-H-010-002-PAE, 95-2752-H-010-002-PAE, 94-2752-H-010-002-PAE]; thematic research program of Academia Sinica, Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); thematic research program of Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This study was supported by the grants from the National Science Council of Taiwan (97-2752-H-010-002-PAE, 96-2752-H-010-002-PAE, 95-2752-H-010-002-PAE, 94-2752-H-010-002-PAE) and the thematic research program of Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 2004, BRAIN LANG, V89, P320, DOI 10.1016/S0093-934X(03)00347-X; Binder JR, 1996, NEUROLOGY, V46, P978, DOI 10.1212/WNL.46.4.978; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Boersma P, 2001, GLOT INT, V5, P341; Boersma P., 2013, PRAAT DOING PHONETIC; Bohland JW, 2006, NEUROIMAGE, V32, P821, DOI 10.1016/j.neuroimage.2006.04.173; Bortoletto M, 2010, NEUROIMAGE, V49, P3338, DOI 10.1016/j.neuroimage.2009.11.048; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Chao Y. R., 1948, MANDARIN PRIMER; Chen JY, 1999, APPL PSYCHOLINGUIST, V20, P289, DOI 10.1017/S0142716499002064; Chen M.Y., 2000, TONE SANDHI PATTERNS; Fon J, 1997, WHAT ARE TONES REALL; FOWLER CA, 1993, LANG SPEECH, V36, P171, DOI 10.1177/002383099303600304; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gandour J, 2003, HUM BRAIN MAPP, V20, P185, DOI 10.1002/hbm.10137; Garraux G, 2005, J NEUROSCI, V25, P5290, DOI 10.1523/JNEUROSCI.0340-05.2005; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Huang T, 2010, PHONETICA, V67, P243, DOI 10.1159/000327392; Hyde KL, 2011, CEREB CORTEX, V21, P292, DOI 10.1093/cercor/bhq094; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Keating P. A., 1990, PAPERS LAB PHONOLOGY, VI, P451, DOI [DOI 10.1017/CBO9780511627736, 10.1017/CBO9780511627736.026, DOI 10.1017/CBO9780511627736.026]; Kell CA, 2011, CEREB CORTEX, V21, P932, DOI 10.1093/cercor/bhq167; Klein D, 2001, NEUROIMAGE, V13, P646, DOI 10.1006/nimg.2000.0738; Kochanski G, 2003, SPEECH COMMUN, V41, P625, DOI 10.1016/S0167-6393(03)00100-6; Kochanski G, 2006, P SPEECH PROSODY, P5; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; LI CN, 1977, J CHILD LANG, V4, P185, DOI 10.1017/S0305000900001598; Li XJ, 2010, NEUROREPORT, V21, P690, DOI 10.1097/WNR.0b013e32833b0a10; Liu L, 2006, NEUROIMAGE, V29, P515, DOI 10.1016/j.neuroimage.2005.07.046; Loui P, 2011, NEUROIMAGE, V55, P500, DOI 10.1016/j.neuroimage.2010.12.022; Loui P, 2009, J NEUROSCI, V29, P10215, DOI 10.1523/JNEUROSCI.1701-09.2009; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; Munhall KK, 2000, LAB PHONOLOGY, P9; Myers J., 2003, TAIWAN J LINGUISTICS, V1, P29; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; OHALA JJ, 1993, LANG SPEECH, V36, P155, DOI 10.1177/002383099303600303; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozdemir E, 2006, NEUROIMAGE, V33, P628, DOI 10.1016/j.neuroimage.2006.07.013; Peng S.-H., 2000, PAPERS LAB PHONOLOGY, P152; Peretz I, 2011, 13 BIOL FDN MUS INS, DOI DOI 10.1016/B978-0-12-381460-9.00013-4; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Prom-on S, 2009, J ACOUST SOC AM, V125, P405, DOI 10.1121/1.3037222; Pulvermuller F, 2012, CORTEX, V48, P871, DOI 10.1016/j.cortex.2011.02.006; Reimold M, 2006, J CEREBR BLOOD F MET, V26, P751, DOI 10.1038/sj.jcbfm.9600231; Riecker A, 2000, NEUROREPORT, V11, P1997, DOI 10.1097/00001756-200006260-00038; Riecker A, 2000, NEUROIMAGE, V11, pS315; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Shih C.-l., 1986, PROSODIC DOMAIN TONE; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Shtyrov Y, 2000, NEUROIMAGE, V12, P657, DOI 10.1006/nimg.2000.0646; Shtyrov Y, 2005, NEUROIMAGE, V27, P37, DOI 10.1016/j.neuroimage.2005.02.003; Speer S, 1989, LANGUAGE SPEECH; Talairach I., 1988, COPLANAR STEREOTACTI; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van der Merwe A, 1997, THEORETICAL FRAMEWOR, P1; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Wan I -ping, 1998, PHONOLOGY, V15, P417, DOI [10.1017/S0952675799003668, DOI 10.1017/S0952675799003668]; WANG WSY, 1967, J SPEECH HEAR RES, V10, P629, DOI 10.1044/jshr.1003.629; Wang Y, 2003, J ACOUSTICAL SOC; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010; Wong PCM, 2002, BRAIN RES BULL, V59, P83, DOI 10.1016/S0361-9230(02)00860-2; Wong PS, 2005, J SPEECH LANG HEAR R, V48, P1065, DOI 10.1044/1092-4388(2005/074); Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; Xu Y, 1999, J PHONETICS, V27, P55, DOI 10.1006/jpho.1999.0086; Xu Y, 2005, J PHONETICS, V33, P159, DOI 10.1016/j.wocn.2004.11.001; Xu Y, 1997, J PHONETICS, V25, P61, DOI 10.1006/jpho.1996.0034; Zatorre R, 1994, J NEUROSCIENCE; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161; Zhang J, 2006, TESTING ROLE PHONETI, V28, P65; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953, 10.1371/journal.pone.0028432]	80	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83126	10.1371/journal.pone.0083126	http://dx.doi.org/10.1371/journal.pone.0083126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427269	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200009
J	Mao, XG; Chen, SS; Li, A; Zhai, CC; Jing, RL				Mao, Xinguo; Chen, Shuangshuang; Li, Ang; Zhai, Chaochao; Jing, Ruilian			Novel NAC Transcription Factor TaNAC67 Confers Enhanced Multi-Abiotic Stress Tolerances in Arabidopsis	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; SECONDARY WALL SYNTHESIS; ABSCISIC-ACID; SALT TOLERANCE; DROUGHT TOLERANCE; COMPREHENSIVE ANALYSIS; SIGNAL-TRANSDUCTION; FUNCTIONAL-ANALYSIS; LOW-TEMPERATURE; PROTEIN-KINASE	Abiotic stresses are major environmental factors that affect agricultural productivity worldwide. NAC transcription factors play pivotal roles in abiotic stress signaling in plants. As a staple crop, wheat production is severely constrained by abiotic stresses whereas only a few NAC transcription factors have been characterized functionally. To promote the application of NAC genes in wheat improvement by biotechnology, a novel NAC gene designated TaNAC67 was characterized in common wheat. To determine its role, transgenic Arabidopsis overexpressing TaNAC67-GFP controlled by the CaMV-35S promoter was generated and subjected to various abiotic stresses for morphological and physiological assays. Gene expression showed that TaNAC67 was involved in response to drought, salt, cold and ABA treatments. Localization assays revealed that TaNAC67 localized in the nucleus. Morphological analysis indicated the transgenics had enhanced tolerances to drought, salt and freezing stresses, simultaneously supported by enhanced expression of multiple abiotic stress responsive genes and improved physiological traits, including strengthened cell membrane stability, retention of higher chlorophyll contents and Na+ efflux rates, improved photosynthetic potential, and enhanced water retention capability. Overexpression of TaNAC67 resulted in pronounced enhanced tolerances to drought, salt and freezing stresses, therefore it has potential for utilization in transgenic breeding to improve abiotic stress tolerance in crops.	[Mao, Xinguo; Chen, Shuangshuang; Li, Ang; Zhai, Chaochao; Jing, Ruilian] Chinese Acad Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Jing, RL (corresponding author), Chinese Acad Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China.	jingrl@caas.net.cn	Xinguo, Mao/AAF-3195-2020	Xinguo, Mao/0000-0003-4712-437X	National High-tech R&D Project (863 Project) [2012AA10A308]; National Basic Research Program of China (973 Program) [2010CB951501]; Beijing Natural Science Foundation [6132030]	National High-tech R&D Project (863 Project); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National High-tech R&D Project (863 Project, 2012AA10A308), National Basic Research Program of China (973 Program, 2010CB951501) and Beijing Natural Science Foundation (6132030). The funders had no role in study design, data collection and analysis, desision to publish, or prepare of the manuscript.	Baloglu MC, 2012, PLANT MOL BIOL REP, V30, P1246, DOI 10.1007/s11105-012-0445-3; Bent A, 2006, METH MOL B, V343, P87; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Chen ZH, 2007, FUNCT PLANT BIOL, V34, P150, DOI 10.1071/FP06237; Christianson JA, 2009, PLANT PHYSIOL, V149, P1724, DOI 10.1104/pp.108.131912; Cuin TA, 2012, PLANT BIOLOGY, V14, P438, DOI 10.1111/j.1438-8677.2011.00526.x; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Farooq S, 2006, J PLANT PHYSIOL, V163, P629, DOI 10.1016/j.jplph.2005.06.006; FINKELSTEIN RR, 1990, PLANT PHYSIOL, V94, P1172, DOI 10.1104/pp.94.3.1172; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gao F, 2010, PLANT CELL TISS ORG, V100, P255, DOI 10.1007/s11240-009-9640-9; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Hao YJ, 2010, PLANTA, V232, P1033, DOI 10.1007/s00425-010-1238-2; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; LANG V, 1992, PLANT MOL BIOL, V20, P951, DOI 10.1007/BF00027165; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Levitt J., 1980, WATER RAD SALT OTHER, V1; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Mao Xin-Guo, 2005, Acta Genetica Sinica, V32, P811; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Mao XG, 2011, FUNCT INTEGR GENOMIC, V11, P445, DOI 10.1007/s10142-011-0218-3; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Meng CM, 2009, PLANT SCI, V176, P352, DOI 10.1016/j.plantsci.2008.12.003; Mitsuda N, 2008, PLANT J, V56, P768, DOI 10.1111/j.1365-313X.2008.03633.x; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Ozhuner E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059543; Pang XiaoBin, 2007, Acta Agronomica Sinica, V33, P333; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shabala S., 2006, PLANT ELECTROPHYSIOL, P35; Shen HS, 2012, PLANT MOL BIOL, V80, P241, DOI 10.1007/s11103-012-9941-y; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Strasser A, 2002, PROBING PHOTOSYNTHES, P443; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Tang YM, 2012, PHYSIOL PLANTARUM, V144, P210, DOI 10.1111/j.1399-3054.2011.01539.x; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Wakeel A, 2011, PLANT PHYSIOL BIOCH, V49, P341, DOI 10.1016/j.plaphy.2011.01.006; Wang CX, 2011, J EXP BOT, V62, P1299, DOI 10.1093/jxb/erq377; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Xia N, 2010, MOL BIOL REP, V37, P3703, DOI 10.1007/s11033-010-0023-4; Xia N, 2010, PHYSIOL MOL PLANT P, V74, P394, DOI 10.1016/j.pmpp.2010.06.005; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Xiong LM, 1999, PLANT PHYSIOL, V119, P205, DOI 10.1104/pp.119.1.205; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Xue GP, 2006, FUNCT PLANT BIOL, V33, P43, DOI 10.1071/FP05161; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V236, P331, DOI 10.1007/BF00277130; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yokotani N, 2009, PLANTA, V229, P1065, DOI 10.1007/s00425-009-0895-5; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	77	92	114	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84359	10.1371/journal.pone.0084359	http://dx.doi.org/10.1371/journal.pone.0084359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427285	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200025
J	Takaya, J; Yamanouchi, S; Kaneko, K				Takaya, Junji; Yamanouchi, Sohsaku; Kaneko, Kazunari			A Calcium-Deficient Diet in Rat Dams during Gestation and Nursing Affects Hepatic 11 beta-hydroxysteroid dehydrogenase-1 Expression in the Offspring	PLOS ONE			English	Article							DEHYDROGENASE TYPE-1 ACTIVITY; INSULIN-RESISTANCE SYNDROME; METABOLIC SYNDROME; GLUCOCORTICOID METABOLISM; PROTEIN RESTRICTION; GENE-EXPRESSION; ADIPOSE-TISSUE; BLOOD-PRESSURE; OBESE-PATIENTS; CELL FUNCTION	Background: Prenatal malnutrition can affect the phenotype of offspring by changing epigenetic regulation of specific genes. Several lines of evidence demonstrate that calcium (Ca) plays an important role in the pathogenesis of insulin resistance syndrome. We hypothesized that pregnant female rats fed a Ca-deficient diet would have offspring with altered hepatic glucocorticoid-related gene expression and that lactation would modify these alterations. Methodology: We determined the effects of Ca deficiency during pregnancy and/or lactation on hepatic 11 beta-hydroxysteroid dehydrogenase-1 (Hsd11b1) expression in offspring. Female Wistar rats consumed either a Ca-deficient (D: 0.008% Ca) or control (C: 0.90% Ca) diet ad libitum from 3 weeks preconception to 21 days postparturition. On postnatal day 1, pups were cross-fostered to the same or opposite dams and divided into the following four groups: CC, DD, CD, and DC (first letter: original mother's diet; second letter: nursing mother's diet). All offspring were fed a control diet beginning at weaning (day 21) and were killed on day 200 +/- 7. Serum insulin and adipokines in offspring were measured using ELISA kits. Principal Findings: In males, mean levels of insulin, glucose, and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) were higher in the DD and DC groups than in the CC group. We found no difference in HOMA-IR between the CC and CD groups in either males or females. Expression of Hsd11b1 was lower in male DD rats than in CC rats. Hsd11b1 expression in male offspring nursed by cross-fostered dams was higher than that in those nursed by dams fed the same diet; CC vs. CD and DD vs. DC. In females, Hsd11b1 expression in DC rats was higher than that in CC rats. Conclusions: These findings indicated that maternal Ca restriction during pregnancy and/or lactation alters postnatal growth, Hsd11b1 expression, and insulin resistance in a sex-specific manner.	[Takaya, Junji; Yamanouchi, Sohsaku; Kaneko, Kazunari] Kansai Med Univ, Dept Pediat, Moriguchi, Osaka 570, Japan	Kansai Medical University	Takaya, J (corresponding author), Kansai Med Univ, Dept Pediat, Moriguchi, Osaka 570, Japan.	takaya@takii.kmu.ac.jp			Mami Mizutani Foundation; Japanese Society for the Promotion of Science [24591614]	Mami Mizutani Foundation; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the Mami Mizutani Foundation and by a Grant-in-Aid for Scientific research (C) from the Japanese Society for the Promotion of Science (No. 24591614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker R, 2008, AM J EPIDEMIOL, V168, P1374, DOI 10.1093/aje/kwn258; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Belizan JM, 2004, CIRCULATION, V110, P1990; Bergel E, 2002, BJOG-INT J OBSTET GY, V109, P540; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Drouillet P, 2007, NUTR METAB CARDIOVAS, V17, P486, DOI 10.1016/j.numecd.2007.01.006; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gong L, 2010, EPIGENETICS-US, V5, P619, DOI 10.4161/epi.5.7.12882; Goodwin JE, 2012, PEDIATR NEPHROL, V27, P1059, DOI 10.1007/s00467-011-1928-4; Heaney RP, 2002, J AM COLL NUTR, V21, p152S, DOI 10.1080/07315724.2002.10719213; Hemanowski-Vosatka A, 2005, J EXP MED, V202, P517; Hermans MP, 1999, DIABETES, V48, P1779, DOI 10.2337/diabetes.48.9.1779; LAX ER, 1978, ACTA ENDOCRINOL-COP, V89, P352, DOI 10.1530/acta.0.0890352; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lin YC, 2000, J AM COLL NUTR, V19, P754, DOI 10.1080/07315724.2000.10718075; Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P2738, DOI 10.1210/jc.2002-030017; Liu YJ, 2003, DIABETES, V52, P1409, DOI 10.2337/diabetes.52.6.1409; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; LOW SC, 1994, J MOL ENDOCRINOL, V13, P167, DOI 10.1677/jme.0.0130167; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matthews PA, 2011, J PHYSIOL-LONDON, V589, P3969, DOI 10.1113/jphysiol.2011.212324; Morley R, 2004, INT J EPIDEMIOL, V33, P1304, DOI 10.1093/ije/dyh284; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Patel MS, 2011, ANN NUTR METAB, V58, P18, DOI 10.1159/000328040; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; Peixoto-Silva N, 2011, BRIT J NUTR, V106, P1364, DOI 10.1017/S0007114511001735; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Srinivasan M, 2013, AM J PHYSIOL-ENDOC M, V304, pE486, DOI 10.1152/ajpendo.00519.2012; Stimson RH, 2011, DIABETES, V60, P720, DOI 10.2337/db10-0726; Takaya J, 2013, NUTR RES, V33, P961, DOI 10.1016/j.nutres.2013.07.015; Takaya J, 2011, ANN NUTR METAB, V59, P73, DOI 10.1159/000332915; Torrecilla E, 2012, OBES SURG, V22, P478, DOI 10.1007/s11695-011-0524-9; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/s001250050157; Valsamakis G, 2004, J CLIN ENDOCR METAB, V89, P4755, DOI 10.1210/jc.2003-032240; Voice MW, 1996, BIOCHEM J, V317, P621, DOI 10.1042/bj3170621; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Weaver ICG, 2009, SEMIN FETAL NEONAT M, V14, P143, DOI 10.1016/j.siny.2008.12.002; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-7; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84125	10.1371/journal.pone.0084125	http://dx.doi.org/10.1371/journal.pone.0084125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427280	gold, Green Submitted, Green Published			2022-12-25	WOS:000329868200020
J	Wang, M; Chen, D; Cheng, H; Li, B; Yan, FG; Su, JJ; Peng, C; Sun, ML; Hu, YW; Wang, XS; Wang, GH; Chen, ZW; Li, QL				Wang Mei; Chen Dong; Cheng Hui; Li Bin; Yan Fenggen; Su Jingjing; Peng Cheng; Sun Meiling; Hu Yawen; Wang Xiaoshan; Wang Guanghui; Chen Zhiwu; Li Qinglin			Gambogenic Acid Kills Lung Cancer Cells through Aberrant Autophagy	PLOS ONE			English	Article							ENHANCES PEMETREXED CYTOTOXICITY; MALIGNANT GLIOMA-CELLS; DEPENDENT MECHANISM; TARGETING AUTOPHAGY; APOPTOSIS; INHIBITION; DEATH; DIFFERENTIATION; DEGRADATION; MDA-7/IL-24	Lung cancer is one of the most common types of cancer and causes 1.38 million deaths annually, as of 2008 worldwide. Identifying natural anti-lung cancer agents has become very important. Gambogenic acid (GNA) is one of the active compounds of Gamboge, a traditional medicine that was used as a drastic purgative, emetic, or vermifuge for treating tapeworm. Recently, increasing evidence has indicated that GNA exerts promising anti-tumor effects; however, the underlying mechanism remains unclear. In the present paper, we found that GNA could induce the formation of vacuoles, which was linked with autophagy in A549 and HeLa cells. Further studies revealed that GNA triggers the initiation of autophagy based on the results of MDC staining, AO staining, accumulation of LC3 II, activation of Beclin 1 and phosphorylation of P70S6K. However, degradation of p62 was disrupted and free GFP could not be released in GNA treated cells, which indicated a block in the autophagy flux. Further studies demonstrated that GNA blocks the fusion between autophagosomes and lysosomes by inhibiting acidification in lysosomes. This dysfunctional autophagy plays a pro-death role in GNA-treated cells by activating p53, Bax and cleaved caspase-3 while decreasing Bcl-2. Beclin 1 knockdown greatly decreased GNA-induced cell death and the effects on p53, Bax, cleaved caspase-3 and Bcl-2. Similar results were obtained using a xenograft model. Our findings show, for the first time, that GNA can cause aberrant autophagy to induce cell death and may suggest the potential application of GNA as a tool or viable drug in anticancer therapies.	[Wang Mei; Chen Zhiwu] Anhui Med Univ, Dept Pharmacol, Hefei, Anhui, Peoples R China; [Wang Mei; Cheng Hui; Yan Fenggen; Su Jingjing; Peng Cheng; Sun Meiling; Hu Yawen; Wang Xiaoshan; Li Qinglin] Anhui Univ Tradit Chinese Med, Minist Educ, Key Lab Xinan Med, Hefei, Anhui, Peoples R China; [Chen Dong; Li Bin; Wang Guanghui] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Lab Mol Neuropathol, Suzhou, Jiangsu, Peoples R China	Anhui Medical University; Anhui University of Chinese Medicine; Soochow University - China	Chen, ZW (corresponding author), Anhui Med Univ, Dept Pharmacol, Hefei, Anhui, Peoples R China.	kuller_chen@163.com; qinglin_lee@hotmail.com		Li, Bin/0000-0001-9341-4672; Yan, Fenggen/0000-0001-5832-6597	National Natural Science Foundation of China [81173600]; National Natural Science Foundation of Anhui Province, China [11040606M190]; Key Project in the National Science&Technology Pillar Program [2009ZX09103-399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Anhui Province, China; Key Project in the National Science&Technology Pillar Program	This work was supported by the National Natural Science Foundation of China, No. 81173600 (Q.-L. Li); the National Natural Science Foundation of Anhui Province, China, No. 11040606M190 (Q.-L. Li) and Key Project in the National Science&Technology Pillar Program 2009ZX09103-399 (Q.-L. Li, Co-PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Asano J, 1996, PHYTOCHEMISTRY, V41, P815, DOI 10.1016/0031-9422(95)00682-6; Bareford MD, 2011, AUTOPHAGY, V7, P1261, DOI 10.4161/auto.7.10.17029; Bareford MD, 2011, CANCER RES, V71, P4955, DOI 10.1158/0008-5472.CAN-11-0898; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bhutia SK, 2011, AUTOPHAGY, V7, P1076, DOI 10.4161/auto.7.9.16163; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Cheng H, 2011, J ASIAN NAT PROD RES, V13, P993, DOI 10.1080/10286020.2011.605062; Cooper S, 2006, RESPIROLOGY, V11, P241, DOI 10.1111/j.1440-1843.2006.00850.x; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Dent P, 2010, PHARMACOL THERAPEUT, V128, P375, DOI 10.1016/j.pharmthera.2010.08.001; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guo QL, 2004, ACTA PHARMACOL SIN, V25, P769; Hwang SH, 2013, EUROPEAN RADIOLOGY; Kanematsu S, 2010, ANTICANCER RES, V30, P3381; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kawaguchi T, 2011, INT J ONCOL, V38, P643, DOI 10.3892/ijo.2010.882; LEI QM, 1985, CHIN J TUMOR, V7, P282; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li B, 2010, CELL DEATH DIFFER, V17, P1773, DOI 10.1038/cdd.2010.55; Li QL, 2010, BIOL PHARM BULL, V33, P415, DOI 10.1248/bpb.33.415; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LIU Jing-bing QS-k, 2005, CHINESE CLIN ONCOLOG, V10; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Martin AP, 2009, CANCER BIOL THER, V8, P2084; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Munafo DB, 2001, J CELL SCI, V114, P3619; QU BX, 1991, CHIN J CLIN ONCOL, V18, P53; QU BX, 1991, CHIN J CLIN ONCOL, V18, P50; Sesen M Berkan, 2012, AMIA Annu Symp Proc, V2012, P838; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Yan F, EUR J PHARM, V652, P23; Yan F, ENV TOXICOL PHARM, V33, P181; Yang Li, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1217; Yu XJ, 2012, CANCER LETT, V322, P185, DOI 10.1016/j.canlet.2012.03.004; Zhuang WZ, 2009, ACTA BIOCH BIOPH SIN, V41, P341, DOI 10.1093/abbs/gmp028	41	19	20	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83604	10.1371/journal.pone.0083604	http://dx.doi.org/10.1371/journal.pone.0083604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427275	Green Submitted, Green Published, gold			2022-12-25	WOS:000329868200015
J	Gardiner, DM; Upadhyaya, NM; Stiller, J; Ellis, JG; Dodds, PN; Kazan, K; Manners, JM				Gardiner, Donald M.; Upadhyaya, Narayana M.; Stiller, Jiri; Ellis, Jeff G.; Dodds, Peter N.; Kazan, Kemal; Manners, John M.			Genomic Analysis of Xanthomonas translucens Pathogenic on Wheat and Barley Reveals Cross-Kingdom Gene Transfer Events and Diverse Protein Delivery Systems	PLOS ONE			English	Article							III SECRETION SYSTEM; EFFECTORS; IDENTIFICATION; TRANSLOCATION; VIRULENCE; SEQUENCE; ALBILINEANS; EVOLUTION; ACCURATE; INSIGHTS	In comparison to dicot-infecting bacteria, only limited numbers of genome sequences are available for monocot-infecting and in particular cereal-infecting bacteria. Herein we report the characterisation and genome sequence of Xanthomonas translucens isolate DAR61454 pathogenic on wheat and barley. Based on phylogenetic analysis of the ATP synthase beta subunit (atpD) gene, DAR61454 is most closely related to other X. translucens strains and the sugarcane- and banana-infecting Xanthomonas strains, but shares a type III secretion system (T3SS) with X. translucens pv. graminis and more distantly related xanthomonads. Assays with an adenylate cyclase reporter protein demonstrate that DAR61454's T3SS is functional in delivering proteins to wheat cells. X. translucens DAR61454 also encodes two type VI secretion systems with one most closely related to those found in some strains of the rice infecting strain X. oryzae pv. oryzae but not other xanthomonads. Comparative analysis of 18 different Xanthomonas isolates revealed 84 proteins unique to cereal (i.e. rice) infecting isolates and the wheat/barley infecting DAR61454. Genes encoding 60 of these proteins are found in gene clusters in the X. translucens DAR61454 genome, suggesting cereal-specific pathogenicity islands. However, none of the cereal pathogen specific proteins were homologous to known Xanthomonas spp. effectors. Comparative analysis outside of the bacterial kingdom revealed a nucleoside triphosphate pyrophosphohydrolase encoding gene in DAR61454 also present in other bacteria as well as a number of pathogenic Fusarium species, suggesting that this gene may have been transmitted horizontally from bacteria to the Fusarium lineage of pathogenic fungi. This example further highlights the importance of horizontal gene acquisition from bacteria in the evolution of fungi.	[Gardiner, Donald M.; Stiller, Jiri; Kazan, Kemal; Manners, John M.] CSIRO, Brisbane, Qld, Australia; [Upadhyaya, Narayana M.; Ellis, Jeff G.; Dodds, Peter N.] CSIRO, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Gardiner, DM (corresponding author), CSIRO, Brisbane, Qld, Australia.	Donald.Gardiner@csiro.au	Kazan, Kemal/B-8032-2008; Stiller, Jiri/E-1564-2012; Upadhyaya, Narayana M/A-1480-2008; Gardiner, Donald/A-1297-2010; Ellis, Jeffrey G/A-1999-2010; Manners, John M/A-4922-2008; Dodds, Peter/D-1181-2009	Kazan, Kemal/0000-0002-5169-8934; Upadhyaya, Narayana M/0000-0002-3052-0416; Gardiner, Donald/0000-0002-2162-8716; Dodds, Peter/0000-0003-0620-5923	Australian Government National Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative; Two Blades Foundation; Grains Research and Development Corporation (GRDC), an Australian Commonwealth Government Authority	Australian Government National Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative(Australian GovernmentDepartment of Industry, Innovation and Science); Two Blades Foundation; Grains Research and Development Corporation (GRDC), an Australian Commonwealth Government Authority	This work was supported through access to facilities managed by Bioplatforms Australia and funded by the Australian Government National Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative (www.bioplatforms.com.au/special-initiatives/agriculture/wheat-datasets) and through funding from the Two Blades Foundation. DMG was partially supported by the Grains Research and Development Corporation (GRDC), an Australian Commonwealth Government Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria MC, 2005, J BACTERIOL, V187, P2315, DOI 10.1128/JB.187.7.2315-2325.2005; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Birch RG, 2001, MOL PLANT PATHOL, V2, P1, DOI 10.1046/j.1364-3703.2001.00046.x; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Casper-Lindley C, 2002, P NATL ACAD SCI USA, V99, P8336, DOI 10.1073/pnas.122220299; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; da Silva FG, 2004, MOL PLANT MICROBE IN, V17, P593, DOI 10.1094/MPMI.2004.17.6.593; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duveiller E., 1997, BACTERIAL DIS WHEAT, P25; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gardiner DM, 2013, GENOME A, V1; Gardiner DM, 2013, PLANT SCI, V210, P151, DOI 10.1016/j.plantsci.2013.06.002; Gardiner DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002952; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajri A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006632; Hayward AC, 2010, J APPL MICROBIOL, V108, P756, DOI 10.1111/j.1365-2672.2009.04471.x; Kleemann J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002643; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; MINSAVAGE GV, 1990, MOL PLANT MICROBE IN, V3, P41, DOI 10.1094/MPMI-3-041; Moolhuljzen PM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00670-13; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P264, DOI 10.1099/ijs.0.65825-0; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schechter LM, 2010, APPL ENVIRON MICROB, V76, P3758, DOI 10.1128/AEM.03122-09; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Studholme DJ, 2011, GENES-BASEL, V2, P1050, DOI 10.3390/genes2041050; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Upadhyaya NM, 2013, MOL PLANT M IN PRESS; Wichmann F, 2013, MOL PLANT PATHOL, V14, P576, DOI 10.1111/mpp.12030; Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121; Yin CT, 2011, EUPHYTICA, V179, P57, DOI 10.1007/s10681-010-0285-x	49	20	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84995	10.1371/journal.pone.0084995	http://dx.doi.org/10.1371/journal.pone.0084995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416331	gold, Green Submitted, Green Published			2022-12-25	WOS:000329866300047
J	Rajashekhar, G; Ramadan, A; Abburi, C; Callaghan, B; Traktuev, DO; Evans-Molina, C; Maturi, R; Harris, A; Kern, TS; March, KL				Rajashekhar, Gangaraju; Ramadan, Ahmed; Abburi, Chandrika; Callaghan, Breedge; Traktuev, Dmitry O.; Evans-Molina, Carmella; Maturi, Raj; Harris, Alon; Kern, Timothy S.; March, Keith L.			Regenerative Therapeutic Potential of Adipose Stromal Cells in Early Stage Diabetic Retinopathy	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; VASCULAR NETWORK FORMATION; IFATS COLLECTION; PROGENITOR CELLS; IN-VIVO; ENDOTHELIAL-CELLS; MOUSE MODEL; RETINAL ANGIOGENESIS; INTENSIVE TREATMENT; TACTILE ALLODYNIA	Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults. Early stage DR involves inflammation, vascular leakage, apoptosis of vascular cells and neurodegeneration. In this study, we hypothesized that cells derived from the stromal fraction of adipose tissue (ASC) could therapeutically rescue early stage DR features. Streptozotocin (STZ) induced diabetic athymic nude rats received single intravitreal injection of human ASC into one eye and saline into the other eye. Two months post onset of diabetes, administration of ASC significantly improved "b" wave amplitude (as measured by electroretinogram) within 1-3 weeks of injection compared to saline treated diabetic eyes. Subsequently, retinal histopathological evaluation revealed a significant decrease in vascular leakage and apoptotic cells around the retinal vessels in the diabetic eyes that received ASC compared to the eyes that received saline injection. In addition, molecular analyses have shown down-regulation in inflammatory gene expression in diabetic retina that received ASC compared to eyes that received saline. Interestingly, ASC were found to be localized near retinal vessels at higher densities than seen in age matched non-diabetic retina that received ASC. In vitro, ASC displayed sustained proliferation and decreased apoptosis under hyperglycemic stress. In addition, ASC in co-culture with retinal endothelial cells enhance endothelial survival and collaborate to form vascular networks. Taken together, our findings suggest that ASC are able to rescue the neural retina from hyperglycemia-induced degeneration, resulting in importantly improved visual function. Our pre-clinical studies support the translational development of adipose stem cell-based therapy for DR to address both retinal capillary and neurodegeneration.	[Rajashekhar, Gangaraju; Traktuev, Dmitry O.; March, Keith L.] Indiana Univ Sch Med, Indiana Ctr Vasc Biol & Med, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Ramadan, Ahmed; Abburi, Chandrika; Callaghan, Breedge; Maturi, Raj; Harris, Alon] Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Traktuev, Dmitry O.; Evans-Molina, Carmella; March, Keith L.] Indiana Univ Sch Med, Vasc & Cardiac Ctr Adult Stem Cell Therapy, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Traktuev, Dmitry O.; March, Keith L.] Indiana Univ Sch Med, VA Ctr Regenerat Med, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Ramadan, Ahmed; Abburi, Chandrika; Callaghan, Breedge; Maturi, Raj; Harris, Alon] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Rajashekhar, Gangaraju; Evans-Molina, Carmella; Harris, Alon; March, Keith L.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Traktuev, Dmitry O.; Evans-Molina, Carmella; March, Keith L.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Evans-Molina, Carmella] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Maturi, Raj] Midwest Eye Inst, Indianapolis, IN USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Case Western Reserve University; Case Western Reserve University	Rajashekhar, G (corresponding author), Indiana Univ Sch Med, Indiana Ctr Vasc Biol & Med, Indianapolis, IN 46202 USA.	rgangara@iupui.edu	Traktuev, Dmitry/AAP-1160-2020; Gangaraju, Rajashekhar/I-7852-2019	Traktuev, Dmitry/0000-0002-6757-512X; Gangaraju, Rajashekhar/0000-0002-6664-8286; March, Keith/0000-0001-5677-0379	National Eye Institute [EY023427]; Ralph W. and Grace M. Showalter Research Trust; ICVBM/Signature Vascular and Cardiac Center for Adult Stem Cell Therapy; Indiana Center for Vascular Biology and Medicine; NIH [K08 DK080225, R03 DK 089147, R01 DK093954]; NIH/NCATS-Indiana Clinical and Translational Sciences Institute - K12 Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089147, R01DK093954, K08DK080225] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001733] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ralph W. and Grace M. Showalter Research Trust; ICVBM/Signature Vascular and Cardiac Center for Adult Stem Cell Therapy; Indiana Center for Vascular Biology and Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS-Indiana Clinical and Translational Sciences Institute - K12 Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grants from the National Eye Institute (EY023427), Ralph W. and Grace M. Showalter Research Trust grant, an ICVBM/Signature Vascular and Cardiac Center for Adult Stem Cell Therapy grant, gifts from the Cryptic Masons Medical Research Foundation, support from the Indiana Center for Vascular Biology and Medicine to G.R and NIH, and grants K08 DK080225, R03 DK 089147, and R01 DK093954 to C.E.M. G.R is a recipient of NIH/NCATS-Indiana Clinical and Translational Sciences Institute - K12 Program (A. Shekhar, PI), 5/01/08-04/30/13. The funders played no role in the conduct of the study, collection of data, management of the study, analysis of data, interpretation of data, or preparation of the manuscript.	Al-Shabrawey M, 2012, MOL VIS, V18, P1895; Amos PJ, 2008, STEM CELLS, V26, P2682, DOI 10.1634/stemcells.2008-0030; Amos PJ, 2011, AM J PHYSIOL-CELL PH, V301, pC1378, DOI 10.1152/ajpcell.00460.2010; Antonetti D, 2009, NAT MED, V15, P1248, DOI 10.1038/nm1109-1248; Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Bassi EJ, 2012, DIABETES, V61, P2534, DOI 10.2337/db11-0844; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Burch S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1921887; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen YJ, 2002, BLOOD, V100, P1373, DOI 10.1182/blood-2002-01-0174; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dauchy RT, 2004, CANCER LETT, V209, P7, DOI 10.1016/j.canlet.2003.12.012; Dhong ES, 2012, J CRANIOFAC SURG, V23, P805, DOI 10.1097/SCS.0b013e31824e6c87; Dong N, 2012, INVEST OPHTH VIS SCI, V53, P7567, DOI 10.1167/iovs.12-9446; Du YP, 2010, INVEST OPHTH VIS SCI, V51, P2158, DOI 10.1167/iovs.09-3674; ESSER P, 1993, BRIT J OPHTHALMOL, V77, P731, DOI 10.1136/bjo.77.11.731; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; FESTING MFW, 1978, NATURE, V274, P365, DOI 10.1038/274365a0; Freeman WM, 2010, PHARMACOGENOMICS J, V10, P385, DOI 10.1038/tpj.2009.60; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Grimshaw MJ, 2002, EUR J IMMUNOL, V32, P2393, DOI 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4; Hong SJ, 2010, CURR OPIN ORGAN TRAN, V15, P86, DOI 10.1097/MOT.0b013e328334f074; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jarajapu YPR, 2010, CIRC RES, V106, P854, DOI 10.1161/CIRCRESAHA.109.213140; Joussen AM, 2002, FASEB J, V16, P76, DOI 10.1096/fj.02-0157fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Kern TS, 2010, MOL VIS, V16, P2121; Kern TS, 2010, MOL VIS, V16, P1629; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Krohne TU, 2012, STEM CELL TRANSL MED, V1, P96, DOI 10.5966/sctm.2011-0057; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Li QH, 2010, INVEST OPHTH VIS SCI, V51, P5240, DOI 10.1167/iovs.09-5147; LUNDQUIST O, 1994, GRAEF ARCH CLIN EXP, V232, P71, DOI 10.1007/BF00171666; MacIsaac ZM, 2012, EXP CELL RES, V318, P416, DOI 10.1016/j.yexcr.2011.12.002; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Maumus M, 2011, INT J OBESITY, V35, P1141, DOI 10.1038/ijo.2010.269; Mendel TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065691; Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Park SS, 2012, INVEST OPHTH VIS SCI, V53, P986, DOI 10.1167/iovs.11-8833; Rajashekhar G, 2005, J CELL BIOCHEM, V96, P36, DOI 10.1002/jcb.20507; Rajashekhar G, 2008, STEM CELLS, V26, P2674, DOI 10.1634/stemcells.2008-0277; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rehman J, 2011, J MOL MED, V89, P943, DOI 10.1007/s00109-011-0799-2; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Rose WC, 2001, CLIN CANCER RES, V7, P2016; Rubenstein JL, 2000, NEOPLASIA, V2, P306, DOI 10.1038/sj.neo.7900102; SARAWAR SR, 1991, IMMUNOLOGY, V73, P334; Shah K, 2012, ADV DRUG DELIVER REV, V64, P739, DOI 10.1016/j.addr.2011.06.010; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sorrell JM, 2011, BIOMATERIALS, V32, P9667, DOI 10.1016/j.biomaterials.2011.08.090; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Tremolada G, 2012, EXP DIABETES RES, DOI 10.1155/2012/728325; Trudeau K, 2010, AM J PATHOL, V177, P447, DOI 10.2353/ajpath.2010.091029; von Tell D, 2006, EXP CELL RES, V312, P623, DOI 10.1016/j.yexcr.2005.10.019; Wei X, 2009, NEUROSCI LETT, V462, P76, DOI 10.1016/j.neulet.2009.06.054; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Wong Vickie H Y, 2011, J Ocul Biol Dis Infor, V4, P42, DOI 10.1007/s12177-011-9069-3; Yang YI, 2010, J CELL PHYSIOL, V224, P807, DOI 10.1002/jcp.22188; Yang ZK, 2010, GRAEF ARCH CLIN EXP, V248, P1415, DOI 10.1007/s00417-010-1384-z; Yuen TJ, 2013, BRAIN, V136, P1035, DOI 10.1093/brain/awt024; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294; Zografou A, 2013, ANN PLAS SURG, V71, P225, DOI 10.1097/SAP.0b013e31826af01a; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	80	69	70	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84671	10.1371/journal.pone.0084671	http://dx.doi.org/10.1371/journal.pone.0084671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416262	Green Submitted, gold, Green Published			2022-12-25	WOS:000329866300034
J	Amaral, AR; Lovewell, G; Coelho, MM; Amato, G; Rosenbaum, HC				Amaral, Ana R.; Lovewell, Gretchen; Coelho, Maria M.; Amato, George; Rosenbaum, Howard C.			Hybrid Speciation in a Marine Mammal: The Clymene Dolphin (Stenella clymene)	PLOS ONE			English	Article							NATURAL HYBRIDIZATION; PHYLOGENETIC-RELATIONSHIPS; HAPLOTYPE RECONSTRUCTION; POPULATION-STRUCTURE; DELPHININAE CETACEA; ORIGIN; MODEL; SEQUENCES; INFERENCE; GENETICS	Natural hybridization may result in the exchange of genetic material between divergent lineages and even the formation of new taxa. Many of the Neo-Darwinian architects argued that, particularly for animal clades, natural hybridization was maladaptive. Recent evidence, however, has falsified this hypothesis, instead indicating that this process may lead to increased biodiversity through the formation of new species. Although such cases of hybrid speciation have been described in plants, fish and insects, they are considered exceptionally rare in mammals. Here we present evidence for a marine mammal, Stenella clymene, arising through natural hybridization. We found phylogenetic discordance between mitochondrial and nuclear markers, which, coupled with a pattern of transgressive segregation seen in the morphometric variation of some characters, support a case of hybrid speciation. S. clymene is currently genetically differentiated from its putative parental species, Stenella coerueloalba and Stenella longisrostris, although low levels of introgressive hybridization may be occurring. Although non-reticulate forms of evolution, such as incomplete lineage sorting, could explain our genetic results, we consider that the genetic and morphological evidence taken together argue more convincingly towards a case of hybrid speciation. We anticipate that our study will bring attention to this important aspect of reticulate evolution in non-model mammal species. The study of speciation through hybridization is an excellent opportunity to understand the mechanisms leading to speciation in the context of gene flow.	[Amaral, Ana R.; Coelho, Maria M.] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Amaral, Ana R.; Amato, George; Rosenbaum, Howard C.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Lovewell, Gretchen] Mote Marine Lab, Sarasota, FL 34236 USA; [Rosenbaum, Howard C.] Wildlife Conservat Soc, Ocean Giants Program, New York, NY USA	Universidade de Lisboa; American Museum of Natural History (AMNH); Mote Marine Laboratory & Aquarium; Wildlife Conservation Society	Amaral, AR (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	aramaral@fc.ul.pt	Amaral, Ana Rita/ABG-4271-2021; Coelho, Maria M/B-8672-2009; Amaral, Ana/D-1060-2010	Amaral, Ana Rita/0000-0002-0595-0086; Coelho, Maria M/0000-0003-3288-1693; Amaral, Ana/0000-0002-0595-0086	Portuguese Foundation for Science and Technology [SFRH/BPD/79002/2011]; NOAA Fisheries	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA)	AR Amaral was funded by a grant from the Portuguese Foundation for Science and Technology (SFRH/BPD/79002/2011). The authors thank NOAA Fisheries for funding to initiate this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Amaral AR, 2007, MAR BIOL, V151, P1967, DOI 10.1007/s00227-007-0635-y; Amaral AR, 2010, CONSERV GENET, V11, P1143, DOI 10.1007/s10592-009-9903-3; Amaral AR, 2012, MOL ECOL, V21, P4854, DOI 10.1111/j.1365-294X.2012.05728.x; Amaral AR, 2012, MOL PHYLOGENET EVOL, V64, P243, DOI 10.1016/j.ympev.2012.04.004; Arnason U, 2004, GENE, V333, P27, DOI 10.1016/j.gene.2004.02.010; ARNASON U, 1980, HEREDITAS, V92, P179, DOI 10.1111/j.1601-5223.1980.tb01693.x; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Baskett ML, 2011, THEOR ECOL-NETH, V4, P223, DOI 10.1007/s12080-011-0118-0; Bergman TJ, 2003, SEXUAL SELECTION PRI, P500; Berube M, 1998, MAR MAMMAL SCI, V14, P82, DOI 10.1111/j.1748-7692.1998.tb00692.x; Berube M., 2002, ENCY MARINE MAMMALS, P596; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Dittrich-Reed DR, 2013, EVOL BIOL, V40, P310, DOI 10.1007/s11692-012-9209-0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Jackson JA, 2009, MOL BIOL EVOL, V26, P2427, DOI 10.1093/molbev/msp169; Jefferson Thomas A., 2003, Mammalian Species, V726, P1, DOI 10.1644/726; Kingston SE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-245; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lyons LA, 1999, J HERED, V90, P15, DOI 10.1093/jhered/90.1.15; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mavarez J, 2008, MOL ECOL, V17, P4181, DOI 10.1111/j.1365-294X.2008.03898.x; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; PERRIN WF, 1981, J MAMMAL, V62, P583, DOI 10.2307/1380405; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosel PE, 1996, MAR BIOL, V125, P11, DOI 10.1007/BF00350756; Shurtliff QR, 2013, MAMMAL REV, V43, P1, DOI 10.1111/j.1365-2907.2011.00205.x; Silva-Jr JM, 2005, AQUATIC MAMMALS, V31; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tobler M, 2010, J EVOLUTION BIOL, V23, P1475, DOI 10.1111/j.1420-9101.2010.02014.x; Tosi AJ, 2003, EVOLUTION, V57, P1419; Willis PM, 2004, CAN J ZOOL, V82, P828, DOI 10.1139/Z04-059; YONEKAWA H, 1988, MOL BIOL EVOL, V5, P63; Zornetzer HR, 2003, CAN J ZOOL, V81, P1755, DOI 10.1139/Z03-150	52	64	66	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83645	10.1371/journal.pone.0083645	http://dx.doi.org/10.1371/journal.pone.0083645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421898	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500062
J	Baruch-Mordo, S; Wilson, KR; Lewis, DL; Broderick, J; Mao, JS; Breck, SW				Baruch-Mordo, Sharon; Wilson, Kenneth R.; Lewis, David L.; Broderick, John; Mao, Julie S.; Breck, Stewart W.			Stochasticity in Natural Forage Production Affects Use of Urban Areas by Black Bears: Implications to Management of Human-Bear Conflicts	PLOS ONE			English	Article							URSUS-AMERICANUS; COLLAR PERFORMANCE; ACTIVITY PATTERNS; NATIONAL-PARK; POPULATION; SURVIVAL; ECOLOGY; URBANIZATION; SELECTION; HABITUATION	The rapid expansion of global urban development is increasing opportunities for wildlife to forage and become dependent on anthropogenic resources. Wildlife using urban areas are often perceived dichotomously as urban or not, with some individuals removed in the belief that dependency on anthropogenic resources is irreversible and can lead to increased human-wildlife conflict. For American black bears (Ursus americanus), little is known about the degree of bear urbanization and its ecological mechanisms to guide the management of human-bear conflicts. Using 6 years of GPS location and activity data from bears in Aspen, Colorado, USA, we evaluated the degree of bear urbanization and the factors that best explained its variations. We estimated space use, activity patterns, survival, and reproduction and modeled their relationship with ecological covariates related to bear characteristics and natural food availability. Space use and activity patterns were dependent on natural food availability (good or poor food years), where bears used higher human density areas and became more nocturnal in poor food years. Patterns were reversible, i.e., individuals using urban areas in poor food years used wildland areas in subsequent good food years. While reproductive output was similar across years, survival was lower in poor food years when bears used urban areas to a greater extent. Our findings suggest that bear use of urban areas is reversible and fluctuates with the availability of natural food resources, and that removal of urban individuals in times of food failures has the potential to negatively affect bear populations. Given that under current predictions urbanization is expected to increase by 11% across American black bear range, and that natural food failure years are expected to increase in frequency with global climate change, alternative methods of reducing urban human-bear conflict are required if the goal is to prevent urban areas from becoming population sinks.	[Baruch-Mordo, Sharon; Wilson, Kenneth R.; Lewis, David L.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Baruch-Mordo, Sharon; Wilson, Kenneth R.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Broderick, John] Colorado Pk & Wildlife, Terr Programs, Ft Collins, CO USA; [Mao, Julie S.] Colorado Pk & Wildlife, Terr Programs, Glenwood Springs, CO USA; [Breck, Stewart W.] Wildlife Serv, USDA, Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	Colorado State University; Colorado State University; United States Department of Agriculture (USDA)	Baruch-Mordo, S (corresponding author), Nature Conservancy, Dev Design, Ft Collins, CO USA.	sbaruch-mordo@tnc.org	Wilson, Kenneth R./P-8692-2019; Breck, Stewart/GWC-5825-2022		United States Department of Agriculture - National Wildlife Research Center; city of Aspen [5353530]; Aspen Field Biology Lab; Jack H. Berryman Institute; Rocky Mountain Goats Foundation; Colorado Chapter of The Wildlife Society	United States Department of Agriculture - National Wildlife Research Center; city of Aspen; Aspen Field Biology Lab; Jack H. Berryman Institute; Rocky Mountain Goats Foundation; Colorado Chapter of The Wildlife Society	This study was funded by the United States Department of Agriculture - National Wildlife Research Center (SWB) (http://www.aphis.usda.gov/wildlife_damage/nwrc/). Additional funds awarded by the city of Aspen to KRW (CSU account no. 5353530). Fellowship and scholarship support given to SBM by Aspen Field Biology Lab, Jack H. Berryman Institute, Rocky Mountain Goats Foundation, and the Colorado Chapter of The Wildlife Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 2003, ECOLOGY, V84, P2476, DOI 10.1890/01-0707; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; [Anonymous], 2001, RESOLVING HUMAN WILD; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Baldwin Roger A., 2009, Human-Wildlife Conflicts, V3, P271; Baruch-Mordo S, 2013, BIOL CONSERV, V160, P263, DOI 10.1016/j.biocon.2013.02.002; Baruch-Mordo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015681; Beck T.D.I., 1991, TECHNICAL PUBLICATIO, V39; Beckmann JP, 2004, WEST N AM NATURALIST, V64, P269; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Beckmann JP, 2003, J MAMMAL, V84, P594, DOI 10.1644/1545-1542(2003)084<0594:UBBTTI>2.0.CO;2; Beckmann JP, 2008, HUMAN WILDLIFE CONFL, V2, P1698; Bierwagen BG, 2010, P NATL ACAD SCI USA, V107, P20887, DOI 10.1073/pnas.1002096107; Carter J, 2001, HORTSCIENCE, V36, P1027, DOI 10.21273/HORTSCI.36.6.1027; Colorado State Demography Office, 2011, POP TOT COL MUN; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; Davis H, 2006, URSUS, V17, P41, DOI 10.2192/1537-6176(2006)17[41:IOPOSS]2.0.CO;2; DeStefano S, 2003, FRONT ECOL ENVIRON, V1, P95, DOI 10.1890/1540-9295(2003)001[0095:ETEOSW]2.0.CO;2; Duong T, 2003, J NONPARAMETR STAT, V15, P17, DOI 10.1080/10485250306039; Duong T, 2010, KS KERNEL SMOOTHING; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Fall MW, 2002, INT BIODETER BIODEGR, V49, P87, DOI 10.1016/S0964-8305(01)00107-X; Freedman AH, 2003, ECOL MODEL, V167, P47, DOI 10.1016/S0304-3800(03)00171-6; Gehrt SD., 2010, URBAN CARNIVORES ECO; Gilbert B.K., 1989, BEAR PEOPLE CONFLICT, P1; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grinder MI, 2001, J WILDLIFE MANAGE, V65, P887, DOI 10.2307/3803038; Harveson PM, 2007, BIOL CONSERV, V134, P321, DOI 10.1016/j.biocon.2006.07.022; Hebblewhite M, 2003, BIOL CONSERV, V112, P415, DOI 10.1016/S0006-3207(02)00341-5; Hellgren EC, 2005, BIOL CONSERV, V122, P131, DOI 10.1016/j.biocon.2004.07.007; Herrero S, 2005, WILDLIFE SOC B, V33, P362, DOI 10.2193/0091-7648(2005)33[362:FTFBBH]2.0.CO;2; Hostetler JA, 2009, BIOL CONSERV, V142, P2456, DOI 10.1016/j.biocon.2009.05.029; Hristienko H, 2007, URSUS, V18, P72, DOI 10.2192/1537-6176(2007)18[72:GITSCA]2.0.CO;2; Jerzak Leszek, 2001, P403; JOHNSON PS, 2002, ECOLOGY SILVICULTURE; Kasbohm JW, 1996, J WILDLIFE MANAGE, V60, P408, DOI 10.2307/3802243; Kilpatrick HJ, 2000, WILDLIFE SOC B, V28, P1023; Kozakai C, 2011, J WILDLIFE MANAGE, V75, P867, DOI 10.1002/jwmg.122; Lee DJ, 2005, J WILDLIFE MANAGE, V69, P1641, DOI 10.2193/0022-541X(2005)69[1641:YASBBS]2.0.CO;2; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Lyons AJ, 2005, URSUS, V16, P255, DOI 10.2192/1537-6176(2005)016[0255:APOUAB]2.0.CO;2; Manfredo M., 2008, WHO CARES WILDLIFE S, Vfirst, DOI [10.1007/978-0-387-77040-6, DOI 10.1007/978-0-387-77040-6]; Marzluff J. M., 2008, URBAN ECOLOGY INT PE; Marzluff John M., 2001, P19; MATTSON DJ, 1992, J WILDLIFE MANAGE, V56, P432, DOI 10.2307/3808855; MCCULLOUGH D R, 1982, Wildlife Society Bulletin, V10, P27; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Messmer Terry A., 2009, Human-Wildlife Conflicts, V3, P10; Mitchell MS, 2009, URSUS, V20, P77, DOI 10.2192/1537-6176-20.2.77; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; NEILSON RP, 1980, AM J BOT, V67, P426, DOI 10.2307/2442353; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; Oka T, 2004, J WILDLIFE MANAGE, V68, P979, DOI 10.2193/0022-541X(2004)068[0979:RBCIBP]2.0.CO;2; OLSON AR, 1983, CAN J PLANT SCI, V63, P461, DOI 10.4141/cjps83-053; Pinheiro J, 2010, NLME LINEAR NONLINEA; R Development Core Team R, 2009, R LANG ENV STAT COMP; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Rodewald AD, 2008, ECOLOGY, V89, P515, DOI 10.1890/07-0358.1; Rolando A, 2003, REV ECOL-TERRE VIE, V58, P337; Rutz C, 2006, ARDEA, V94, P185; Ryan CW, 2007, URSUS, V18, P46, DOI 10.2192/1537-6176(2007)18[46:IOMPOB]2.0.CO;2; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schrage MW, 1998, URSUS-SERIES, V10, P49; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2004, OIKOS, V106, P622, DOI 10.1111/j.0030-1299.2004.13159.x; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Spencer RD, 2007, URSUS, V18, P217, DOI 10.2192/1537-6176(2007)18[217:HARTHB]2.0.CO;2; STPIERRE RG, 1989, CAN J BOT, V67, P726, DOI 10.1139/b89-097; STPIERRE RG, 1990, CAN FIELD NAT, V104, P379; United Nat ions Populat ion Division, 2008, WORLD URB PROSP 2007; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Waite TA, 2007, ECOHEALTH, V4, P278, DOI 10.1007/s10393-007-0112-6; Walter J, 2013, ENVIRON EXP BOT, V94, P3, DOI 10.1016/j.envexpbot.2012.02.009; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLEY CH, 1974, J WILDLIFE MANAGE, V38, P97, DOI 10.2307/3800203; Woodroffe R., 2005, PEOPLE WILDLIFE CONF	79	91	94	3	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85122	10.1371/journal.pone.0085122	http://dx.doi.org/10.1371/journal.pone.0085122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416350	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500218
J	Blanco, F; Barberia, I; Matute, H				Blanco, Fernando; Barberia, Itxaso; Matute, Helena			The Lack of Side Effects of an Ineffective Treatment Facilitates the Development of a Belief in Its Effectiveness	PLOS ONE			English	Article							CAUSAL JUDGMENT; CONTINGENCY; SUPERSTITION; COVARIATION; INFORMATION; ILLUSION; CUE	Some alternative medicines enjoy widespread use, and in certain situations are preferred over conventional, validated treatments in spite of the fact that they fail to prove effective when tested scientifically. We propose that the causal illusion, a basic cognitive bias, underlies the belief in the effectiveness of bogus treatments. Therefore, the variables that modulate the former might affect the latter. For example, it is well known that the illusion is boosted when a potential cause occurs with high probability. In this study, we examined the effect of this variable in a fictitious medical scenario. First, we showed that people used a fictitious medicine (i.e., a potential cause of remission) more often when they thought it caused no side effects. Second, the more often they used the medicine, the more likely they were to develop an illusory belief in its effectiveness, despite the fact that it was actually useless. This behavior may be parallel to actual pseudomedicine usage; that because a treatment is thought to be harmless, it is used with high frequency, hence the overestimation of its effectiveness in treating diseases with a high rate of spontaneous relief. This study helps shed light on the motivations spurring the widespread preference of pseudomedicines over scientific medicines. This is a valuable first step toward the development of scientifically validated strategies to counteract the impact of pseudomedicine on society.	[Blanco, Fernando; Barberia, Itxaso; Matute, Helena] Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain	University of Deusto	Blanco, F (corresponding author), Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain.	fernandoblanco@deusto.es	Blanco, Fernando/E-8941-2010; BARBERIA, ITXASO/L-8477-2014; Matute, Helena/A-8256-2011	Blanco, Fernando/0000-0003-1283-8313; BARBERIA, ITXASO/0000-0003-3045-2289; Matute, Helena/0000-0001-7221-1366	Direccion General de Investigacion of the Spanish Government [PSI2011-26965]; Departamento de Educacion, Universidades e Investigacion of the Basque Government [IT363-10]	Direccion General de Investigacion of the Spanish Government; Departamento de Educacion, Universidades e Investigacion of the Basque Government	Support for this research was provided by Direccion General de Investigacion of the Spanish Government (Grant PSI2011-26965) and Departamento de Educacion, Universidades e Investigacion of the Basque Government (Grant IT363-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN LG, 1983, LEARN MOTIV, V14, P381, DOI 10.1016/0023-9690(83)90024-3; Barberia I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071303; Blanco F, 2013, LEARN BEHAV, V41, P333, DOI 10.3758/s13420-013-0108-8; Blanco F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046203; Blanco F, 2011, Q J EXP PSYCHOL, V64, P1290, DOI 10.1080/17470218.2011.552727; Buehner MJ, 2003, J EXP PSYCHOL LEARN, V29, P1119, DOI 10.1037/0278-7393.29.6.1119; Frankel MS, 1999, WORKSH CONV AM ASS A; Freckelton I, 2012, J LAW MED, V19, P454; Hannah SD, 2009, CAN J EXP PSYCHOL, V63, P59, DOI 10.1037/a0013403; Hayes A.F., 2012, PROCESS VERSATILE CO; KAO SF, 1993, J EXP PSYCHOL LEARN, V19, P1363, DOI 10.1037/0278-7393.19.6.1363; Killeen PR, 2013, LEARN BEHAV, V41, P1, DOI 10.3758/s13420-012-0095-1; Matute H, 1996, PSYCHOL SCI, V7, P289, DOI 10.1111/j.1467-9280.1996.tb00376.x; Matute H, 2011, BRIT J PSYCHOL, V102, P392, DOI 10.1348/000712610X532210; Perales JC, 2007, PSYCHON B REV, V14, P577, DOI 10.3758/BF03196807; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; STADDON JER, 1971, PSYCHOL REV, V78, P3, DOI 10.1037/h0030305; WASSERMAN EA, 1990, PSYCHOL LEARN MOTIV, V26, P27, DOI DOI 10.1016/S0079-7421(08)60051-1; White PA, 2004, MEM COGNITION, V32, P353, DOI 10.3758/BF03195830; Yarritu I, 2014, EXP PSYCHOL, V61, P38, DOI 10.1027/1618-3169/a000225	22	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84084	10.1371/journal.pone.0084084	http://dx.doi.org/10.1371/journal.pone.0084084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416194	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500095
J	Gobler, CJ; DePasquale, EL; Griffith, AW; Baumann, H				Gobler, Christopher J.; DePasquale, Elizabeth L.; Griffith, Andrew W.; Baumann, Hannes			Hypoxia and Acidification Have Additive and Synergistic Negative Effects on the Growth, Survival, and Metamorphosis of Early Life Stage Bivalves	PLOS ONE			English	Article							ELEVATED CARBON-DIOXIDE; OCEAN ACIDIFICATION; COASTAL WATERS; MERCENARIA-MERCENARIA; CLIMATE-CHANGE; OXYGEN; IMPACTS; FISH; CONSEQUENCES; ECOSYSTEM	Low oxygen zones in coastal and open ocean ecosystems have expanded in recent decades, a trend that will accelerate with climatic warming. There is growing recognition that low oxygen regions of the ocean are also acidified, a condition that will intensify with rising levels of atmospheric CO2. Presently, however, the concurrent effects of low oxygen and acidification on marine organisms are largely unknown, as most prior studies of marine hypoxia have not considered pH levels. We experimentally assessed the consequences of hypoxic and acidified water for early life stage bivalves (bay scallops, Argopecten irradians, and hard clams, Mercenaria mercenaria), marine organisms of significant economic and ecological value and sensitive to climate change. In larval scallops, experimental and naturally-occurring acidification (pH, total scale = 7.4-7.6) reduced survivorship (by >50%), low oxygen (30-50 mM) inhibited growth and metamorphosis (by >50%), and the two stressors combined produced additively negative outcomes. In early life stage clams, however, hypoxic waters led to 30% higher mortality, while acidified waters significantly reduced growth (by 60%). Later stage clams were resistant to hypoxia or acidification separately but experienced significantly (40%) reduced growth rates when exposed to both conditions simultaneously. Collectively, these findings demonstrate that the consequences of low oxygen and acidification for early life stage bivalves, and likely other marine organisms, are more severe than would be predicted by either individual stressor and thus must be considered together when assessing how ocean animals respond to these conditions both today and under future climate change scenarios.	[Gobler, Christopher J.; DePasquale, Elizabeth L.; Griffith, Andrew W.; Baumann, Hannes] SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gobler, CJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY USA.	christopher.gobler@stonybrook.edu	Baumann, Hannes/D-1435-2010	Baumann, Hannes/0000-0002-4039-4230	NOAA's Ocean Acidification Program through National Centers for Coastal Ocean Science [NA12NOS4780148]; New Tamarind Foundation; NSF's Biological Oceanography Program [1129622]; Division Of Ocean Sciences [1129622] Funding Source: National Science Foundation	NOAA's Ocean Acidification Program through National Centers for Coastal Ocean Science; New Tamarind Foundation; NSF's Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the NOAA's Ocean Acidification Program through award #NA12NOS4780148 from the National Centers for Coastal Ocean Science, the New Tamarind Foundation, and NSF's Biological Oceanography Program (Award #1129622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, SUMMARY POLICYMAKERS; Arnold WS, 2008, REV FISH SCI, V16, P65, DOI 10.1080/10641260701678140; BAKER SM, 1994, MAR ECOL PROG SER, V104, P91, DOI 10.3354/meps104091; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bignami S, 2013, P NATL ACAD SCI USA, V110, P7366, DOI 10.1073/pnas.1301365110; Breitburg DL, 1997, ECOL MONOGR, V67, P489, DOI 10.1890/0012-9615(1997)067[0489:VEOLDO]2.0.CO;2; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Carriker MR, 2001, DEV AQUAC FISH SCI, V31, P77; Clark MS, 2013, GLOBAL CHANGE BIOL, V19, P2251, DOI 10.1111/gcb.12197; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cragg S.M., 2006, SCALLOPS BIOL ECOLOG, P45, DOI DOI 10.1016/S0167-9309(06)80029-3; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DICKSON AG, 1993, DEEP-SEA RES PT I, V40, P107, DOI 10.1016/0967-0637(93)90055-8; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Dupont S, 2010, ESTUAR COAST SHELF S, V89, P182, DOI 10.1016/j.ecss.2010.06.013; Eerkes-Medrano D, 2013, MAR ECOL PROG SER, V478, P139, DOI 10.3354/meps10130; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Gobler CJ, 2013, BIOGEOSCIENCES, V10, P2241, DOI 10.5194/bg-10-2241-2013; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Grasshoff K., 1983, VERLAG CHEMIE FRG, P419, DOI DOI 10.1002/IROH.19850700232; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; GROSBERG RK, 1992, TRENDS ECOL EVOL, V7, P130, DOI 10.1016/0169-5347(92)90148-5; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Justic D, 1996, LIMNOL OCEANOGR, V41, P992, DOI 10.4319/lo.1996.41.5.0992; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kelly MW, 2013, GLOBAL CHANGE BIOL, V19, P2536, DOI 10.1111/gcb.12251; Kraeuter J.N., 2001, BIOL HARD CLAM; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Llanso RJ, 2002, ESTUARIES, V25, P1231, DOI 10.1007/BF02692220; Maas AE, 2012, BIOGEOSCIENCES, V9, P747, DOI 10.5194/bg-9-747-2012; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Norkko J, 2005, MAR ECOL PROG SER, V298, P205, DOI 10.3354/meps298205; Padilla DK, 2006, HARMFUL ALGAE, V5, P736, DOI 10.1016/j.hal.2006.03.004; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Paulmier A, 2011, BIOGEOSCIENCES, V8, P239, DOI 10.5194/bg-8-239-2011; PIHL L, 1991, MAR BIOL, V108, P349, DOI 10.1007/BF01313644; Portner H.O., 2005, J GEOPHYS RES OCEANS, V110; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; RENAUD ML, 1986, FISH B-NOAA, V84, P19; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; S.C.D.H.S, 2010, ANN REP SURF WAT QUA; Shaffer G, 2009, NAT GEOSCI, V2, P105, DOI 10.1038/NGEO420; Sokolova IM, 2013, INTEGR COMP BIOL, V53, P597, DOI 10.1093/icb/ict028; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Swanson RL, 2010, MAR POLLUT BULL, V60, P804, DOI 10.1016/j.marpolbul.2010.03.007; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tamburri MN, 1996, LIMNOL OCEANOGR, V41, P1188, DOI 10.4319/lo.1996.41.6.1188; United States Environmental Protection Agency, 2000, AMB AQ LIF WAT QUAL; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Waldbusser GG, 2010, MAR ECOL PROG SER, V417, P171, DOI 10.3354/meps08809; Waldbusser GG, 2013, J GEOPHYS R IN PRESS; WANG WX, 1991, MAR ECOL PROG SER, V70, P223, DOI 10.3354/meps070223; Wang YJ, 2013, J MOLLUS STUD, V79, P42, DOI 10.1093/mollus/eys035; Wannamaker CM, 2000, J EXP MAR BIOL ECOL, V249, P145, DOI 10.1016/S0022-0981(00)00160-X	72	163	168	2	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83648	10.1371/journal.pone.0083648	http://dx.doi.org/10.1371/journal.pone.0083648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416169	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500063
J	Guadayol, O; Silbiger, NJ; Donahue, MJ; Thomas, FIM				Guadayol, Oscar; Silbiger, Nyssa J.; Donahue, Megan J.; Thomas, Florence I. M.			Patterns in Temporal Variability of Temperature, Oxygen and pH along an Environmental Gradient in a Coral Reef	PLOS ONE			English	Article							OCEAN ACIDIFICATION; STORM RUNOFF; KANEOHE BAY; PHYTOPLANKTON; TURBULENCE; PATCHINESS; DYNAMICS; PLANKTON; IMPACTS; SCALE	Spatial and temporal environmental variability are important drivers of ecological processes at all scales. As new tools allow the in situ exploration of individual responses to fluctuations, ecologically meaningful ways of characterizing environmental variability at organism scales are needed. We investigated the fine-scale spatial heterogeneity of high-frequency temporal variability in temperature, dissolved oxygen concentration, and pH experienced by benthic organisms in a shallow coastal coral reef. We used a spatio-temporal sampling design, consisting of 21 short-term time-series located along a reef flat-to-reef slope transect, coupled to a long-term station monitoring water column changes. Spectral analyses revealed sharp gradients in variance decomposed by frequency, as well as differences between physically-driven and biologically-reactive parameters. These results highlight the importance of environmental variance at organismal scales and present a new sampling scheme for exploring this variability in situ.	[Guadayol, Oscar; Silbiger, Nyssa J.; Donahue, Megan J.; Thomas, Florence I. M.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Silbiger, Nyssa J.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Guadayol, O (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, Yorks, England.	oscar@guadayol.cat	Guadayol, Òscar/N-2940-2013; Donahue, Megan/Q-3528-2017	Guadayol, Òscar/0000-0001-9552-1041; Silbiger, Nyssa/0000-0003-4916-3217; Thomas, Florence/0000-0003-4347-6474; Donahue, Megan/0000-0002-7529-001X	National Oceanic and Atmospheric Administration (NOAA) Office of National Marine Sanctuaries-HIMB partnership (MOA) [2009-039/7932]; National Oceanic and Atmospheric Administration [R/EL-33]; University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce [NA09OAR4170060]; NOAA [NA12NOS4290140]	National Oceanic and Atmospheric Administration (NOAA) Office of National Marine Sanctuaries-HIMB partnership (MOA); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding for this project came from National Oceanic and Atmospheric Administration (NOAA) Office of National Marine Sanctuaries-HIMB partnership (MOA #2009-039/7932). This paper is also funded in part by a grant/cooperative agreement from the National Oceanic and Atmospheric Administration, Project R/EL-33, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant No. NA09OAR4170060 from NOAA Office of Sea Grant, Department of Commerce. The views expressed herein are those of the author(s) and do not necessarily reflect the views of NOAA or any of its subagencies. UNIHI-SEAGRANT-JC-12-24. NJS was supported by NOAA Dr. Nancy Foster Scholarship Award No. NA12NOS4290140. This is HIMB contribution #1574 and SOEST contribution #9042. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; Bathen KH, 1968, 14 HAW I MAR BIOL; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; Bindoff NL, 2007, CLIMATE CHANGE 2007, P235; Boudreau B.P., 2001, BENTHIC BOUNDARY LAY; Chatfield C., 2003, ANAL TIME SERIES INT, V6, DOI 10.4324/9780203491683; De Carlo EH, 2007, APPL GEOCHEM, V22, P1777, DOI 10.1016/j.apgeochem.2007.03.034; Denny MW, 2004, ECOL MONOGR, V74, P513, DOI 10.1890/03-4043; Dickey TD, 2003, J MARINE SYST, V40, P5, DOI 10.1016/S0924-7963(03)00011-3; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; Dove S, 2006, LIMNOL OCEANOGR, V51, P1149, DOI 10.4319/lo.2006.51.2.1149; Drupp P, 2011, AQUAT GEOCHEM, V17, P473, DOI 10.1007/s10498-010-9115-y; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Edmunds PJ, 2008, MAR ECOL PROG SER, V361, P307, DOI 10.3354/meps07556; Falciatore A, 2000, SCIENCE, V288, P2363, DOI 10.1126/science.288.5475.2363; Franks PJS, 2005, MAR ECOL PROG SER, V294, P295, DOI 10.3354/meps294295; Gagliano M, 2010, MAR BIOL, V157, P1849, DOI 10.1007/s00227-010-1456-y; Gorospe Kelvin D., 2011, Journal of Marine Biology, V2011, P1; Helmuth B, 2010, J EXP BIOL, V213, P995, DOI 10.1242/jeb.038463; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Jimenez IM, 2012, MAR BIOL, V159, P1773, DOI 10.1007/s00227-012-1968-8; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Kelly MW, 2013, FUNCT ECOL, V27, P980, DOI 10.1111/j.1365-2435.2012.02061.x; Koehl MAR, 2010, INTEGR COMP BIOL, V50, P539, DOI 10.1093/icb/icq101; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Litchman E, 2000, FRESHWATER BIOL, V44, P223, DOI 10.1046/j.1365-2427.2000.00559.x; Lowe RJ, 2009, J PHYS OCEANOGR, V39, P873, DOI 10.1175/2008JPO3958.1; Lowe RJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005081; LUMLEY JL, 1983, J PHYS OCEANOGR, V13, P2000, DOI 10.1175/1520-0485(1983)013<2000:KOTCBA>2.0.CO;2; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; McCabe RM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006023; Middelboe AL, 2007, MAR ECOL PROG SER, V338, P107, DOI 10.3354/meps338107; Miner BG, 2004, ECOL LETT, V7, P794, DOI 10.1111/j.1461-0248.2004.00637.x; Niehaus AC, 2012, J EXP BIOL, V215, P694, DOI 10.1242/jeb.058032; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Ostrander CE, 2008, ESTUAR COAST, V31, P192, DOI 10.1007/s12237-007-9001-z; Peters F, 2000, MAR ECOL PROG SER, V205, P291, DOI 10.3354/meps205291; Pincebourde S, 2012, ECOL LETT, V15, P680, DOI 10.1111/j.1461-0248.2012.01785.x; Pinheiro J, 2016, NLME LINEAR NONLINEA, DOI DOI 10.1016/S0006-3207(01)00201-4; PLATT T, 1972, DEEP-SEA RES, V19, P183, DOI 10.1016/0011-7471(72)90029-0; POWELL TM, 1994, PHILOS T R SOC B, V343, P11, DOI 10.1098/rstb.1994.0002; Prairie J.C., 2012, LIMNOL OCEANOGR FLUI, V2, P121, DOI DOI 10.1215/21573689-1964713; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; Ringuet S, 2005, ESTUARIES, V28, P327, DOI 10.1007/BF02693916; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Searle S., 1992, VARIANCE COMPONENTS; Shaw EC, 2013, GEOPHYS RES LETT, V40, P4685, DOI 10.1002/grl.50883; Shaw EC, 2013, GLOBAL CHANGE BIOL, V19, P1632, DOI 10.1111/gcb.12154; SMITH SV, 1981, PAC SCI, V35, P279; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song B, 2007, J PHYCOL, V43, P542, DOI 10.1111/j.1529-8817.2007.00352.x; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; Team RDC, 2005, R LANG ENV STAT COMP; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; WING SR, 1993, MAR BIOL, V116, P519, DOI 10.1007/BF00350069; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yamazaki H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024103; YSI Incorporated, 2011, 6 SER MULT WAT QUAL	63	66	66	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85213	10.1371/journal.pone.0085213	http://dx.doi.org/10.1371/journal.pone.0085213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416364	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500227
J	Hernandez, I; Preston, JL; Hepler, J				Hernandez, Ivan; Preston, Jesse Lee; Hepler, Justin			Timescale Halo: Average-Speed Targets Elicit More Positive and Less Negative Attributions than Slow or Fast Targets	PLOS ONE			English	Article							POINT-LIGHT DISPLAYS; INTERPERSONAL-ATTRACTION; PERCEPTION; JUDGMENT; EMOTION; MOTION; MODELS; BEAUTY; CUES; MIND	Research on the timescale bias has found that observers perceive more capacity for mind in targets moving at an average speed, relative to slow or fast moving targets. The present research revisited the timescale bias as a type of halo effect, where normal-speed people elicit positive evaluations and abnormal-speed (slow and fast) people elicit negative evaluations. In two studies, participants viewed videos of people walking at a slow, average, or fast speed. We find evidence for a timescale halo effect: people walking at an average-speed were attributed more positive mental traits, but fewer negative mental traits, relative to slow or fast moving people. These effects held across both cognitive and emotional dimensions of mind and were mediated by overall positive/negative ratings of the person. These results suggest that, rather than eliciting greater perceptions of general mind, the timescale bias may reflect a generalized positivity toward average speed people relative to slow or fast moving people.	[Hernandez, Ivan; Preston, Jesse Lee; Hepler, Justin] Univ Illinois, Dept Psychol, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Hernandez, I (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL USA.	hernan27@illinois.edu		Preston, Jesse/0000-0003-1708-221X				ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Barrett HC, 2005, EVOL HUM BEHAV, V26, P313, DOI 10.1016/j.evolhumbehav.2004.08.015; Bauer DJ, 2006, PSYCHOL METHODS, V11, P142, DOI 10.1037/1082-989X.11.2.142; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323, 10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323]; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Bobko P, 2007, ORGAN RES METHODS, V10, P689, DOI 10.1177/1094428106294734; BYRNE D, 1961, J ABNORM SOC PSYCH, V62, P713, DOI 10.1037/h0044721; BYRNE D, 1967, J PERS SOC PSYCHOL, V5, P82, DOI 10.1037/h0021198; Cikara M, 2011, CURR DIR PSYCHOL SCI, V20, P149, DOI 10.1177/0963721411408713; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; DAWES RM, 1979, AM PSYCHOL, V34, P571, DOI 10.1037/0003-066X.34.7.571; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; EFRAN MG, 1974, J RES PERS, V8, P45, DOI 10.1016/0092-6566(74)90044-0; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; FISKE ST, 1980, J PERS SOC PSYCHOL, V38, P889, DOI 10.1037/0022-3514.38.6.889; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Koenig MA, 2011, CHILD DEV, V82, P1634, DOI 10.1111/j.1467-8624.2011.01618.x; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; LANDY D, 1974, J PERS SOC PSYCHOL, V29, P299, DOI 10.1037/h0036018; Loughnan S, 2010, EUR J SOC PSYCHOL, V40, P709, DOI 10.1002/ejsp.755; Morewedge CK, 2007, J PERS SOC PSYCHOL, V93, P1, DOI 10.1037/0022-3514.93.1.1; NISBETT RE, 1977, J PERS SOC PSYCHOL, V35, P250, DOI 10.1037//0022-3514.35.4.250; Prentice DA, 2010, MIND CONTEXT, P259; Roese NJ, 2007, PERSPECT PSYCHOL SCI, V2, P124, DOI 10.1111/j.1745-6916.2007.00033.x; ROSENBER.S, 1968, J PERS SOC PSYCHOL, V9, P283, DOI 10.1037/h0026086; SCHACHTER S, 1951, J ABNORM SOC PSYCH, V46, P190, DOI 10.1037/h0062326; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Tremoulet PD, 2000, PERCEPTION, V29, P943, DOI 10.1068/p3101; Waytz A, 2010, J PERS SOC PSYCHOL, V99, P410, DOI 10.1037/a0020240	31	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83320	10.1371/journal.pone.0083320	http://dx.doi.org/10.1371/journal.pone.0083320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421882	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500042
J	Jang, JY; Choi, YW; Kim, HN; Kim, YR; Hong, JW; Bae, DW; Park, SJ; Shin, HK; Choi, BT				Jang, Ji Yeon; Choi, Young Whan; Kim, Ha Neui; Kim, Yu Ri; Hong, Jin Woo; Bae, Dong Won; Park, Se Jin; Shin, Hwa Kyoung; Choi, Byung Tae			Neuroprotective Effects of a Novel Single Compound 1-Methoxyoctadecan-1-ol Isolated from Uncaria sinensis in Primary Cortical Neurons and a Photothrombotic Ischemia Model	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE STEP; EXTRASYNAPTIC NMDA RECEPTORS; CEREBRAL-ISCHEMIA; NITRIC-OXIDE; MOUSE MODEL; CELL-DEATH; P38 MAPK; ACTIVATION; EXCITOTOXICITY; DISORDERS	We identified a novel neuroprotective compound, 1-methoxyoctadecan-1-ol, from Uncaria sinensis (Oliv.) Havil and investigated its effects and mechanisms in primary cortical neurons and in a photothrombotic ischemic model. In primary rat cortical neurons against glutamate-induced neurotoxicity, pretreatment with 1-methoxyoctadecan-1-ol resulted in significantly reduced neuronal death in a dose-dependent manner. In addition, treatment with 1-methoxyoctadecan-1-ol resulted in decreased neuronal apoptotic death, as assessed by nuclear morphological approaches. To clarify the neuroprotective mechanism of 1-methoxyoctadecan-1-ol, we explored the downstream signaling pathways of N-methyl-D-aspartate receptor (NMDAR) with calpain activation. Treatment with glutamate leads to early activation of NMDAR, which in turn leads to calpain-mediated cleavage of striatal-enriched protein tyrosine phosphatase (STEP) and subsequent activation of p38 mitogen activated protein kinase (MAPK). However, pretreatment with 1-methoxyoctadecan-1-ol resulted in significantly attenuated activation of GluN2B-NMDAR and a decrease in calpain-mediated STEP cleavage, leading to subsequent attenuation of p38 MAPK activation. We confirmed the critical role of p38 MAPK in neuroprotective effects of 1-methoxyoctadecan-1-ol using specific inhibitor SB203580. In the photothrombotic ischemic injury in mice, treatment with 1-methoxyoctadecan-1-ol resulted in significantly reduced infarct volume, edema size, and improved neurological function. 1-methoxyoctadecan-1-ol effectively prevents cerebral ischemic damage through down-regulation of calpain-mediated STEP cleavage and activation of p38 MAPK. These results suggest that 1-methoxyoctadecan-1-ol showed neuroprotective effects through down-regulation of calpain-mediated STEP cleavage with activation of GluN2B-NMDAR, and subsequent alleviation of p38 MAPK activation. In addition, 1-methoxyoctadecan-1-ol might be a useful therapeutic agent for brain disorder such as ischemic stroke.	[Jang, Ji Yeon; Shin, Hwa Kyoung; Choi, Byung Tae] Pusan Natl Univ, Sch Korean Med, Div Meridian & Struct Med, Yangsan, Gyeongnam, South Korea; [Choi, Young Whan; Park, Se Jin] Pusan Natl Univ, Coll Nat Resource & Life Sci, Dept Hort Biosci, Miryang, Gyeongnam, South Korea; [Kim, Ha Neui; Kim, Yu Ri; Choi, Byung Tae] Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan, Gyeongnam, South Korea; [Hong, Jin Woo] Pusan Natl Univ, Sch Korean Med, Div Clin Med 1, Yangsan, Gyeongnam, South Korea; [Bae, Dong Won] Gyeongsang Natl Univ, Biomat Analyt Lab, Cent Instrument Facil, Jinju, Gyeongnam, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University; Gyeongsang National University	Shin, HK (corresponding author), Pusan Natl Univ, Sch Korean Med, Div Meridian & Struct Med, Yangsan, Gyeongnam, South Korea.	julie@pusan.ac.kr; choibt@pusan.ac.kr	Choi, Young-Whan/AAO-4826-2021	Kim, Haneui/0000-0002-5651-4727	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0022151]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0022151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asomugha CO, 2010, J NEUROCHEM, V112, P214, DOI 10.1111/j.1471-4159.2009.06447.x; Braithwaite SP, 2008, EUR J NEUROSCI, V27, P2444, DOI 10.1111/j.1460-9568.2008.06209.x; Bult A, 1997, EUR J CELL BIOL, V72, P337; CHOI DW, 1987, J NEUROSCI, V7, P369; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Fan J, 2012, NEUROBIOL DIS, V45, P999, DOI 10.1016/j.nbd.2011.12.019; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Gladding CM, 2012, HUM MOL GENET, V21, P3739, DOI 10.1093/hmg/dds154; Goebel-Goody SM, 2012, PHARMACOL REV, V64, P65, DOI 10.1124/pr.110.003053; Gurd JW, 1999, J NEUROCHEM, V73, P1990; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Jang JY, 2012, INT J MOL MED, V30, P1465, DOI 10.3892/ijmm.2012.1134; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Lin YW, 2011, J ETHNOPHARMACOL, V135, P313, DOI 10.1016/j.jep.2011.03.018; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 1999, METH MOL B, V128, P121; Mai HQ, 2003, J BIOL CHEM, V278, P1886, DOI 10.1074/jbc.M209044200; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Mulholland PJ, 2008, NEUROSCIENCE, V151, P419, DOI 10.1016/j.neuroscience.2007.11.001; Nguyen TH, 1999, J NEUROCHEM, V73, P1995; Nicotera P, 1997, Adv Neurol, V72, P95; Park SH, 2011, J ETHNOPHARMACOL, V138, P774, DOI 10.1016/j.jep.2011.10.026; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2010, J NEUROCHEM, V114, P1107, DOI 10.1111/j.1471-4159.2010.06835.x; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; Poddar R, 2010, J NEUROCHEM, V115, P1350, DOI 10.1111/j.1471-4159.2010.07035.x; Qiu S, 2011, SEMIN CELL DEV BIOL, V22, P521, DOI 10.1016/j.semcdb.2011.06.003; Shimada Y, 1999, J PHARM PHARMACOL, V51, P715, DOI 10.1211/0022357991772853; Shimada Y, 2001, AM J CHINESE MED, V29, P173, DOI 10.1142/S0192415X01000198; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soriano FX, 2007, J PHYSIOL-LONDON, V584, P381, DOI 10.1113/jphysiol.2007.138875; Suk K, 2002, LIFE SCI, V70, P2467, DOI 10.1016/S0024-3205(02)01534-5; Tan SN, 2011, TALANTA, V83, P891, DOI 10.1016/j.talanta.2010.10.048; Tu HJ, 2010, J NEUROSCI, V30, P749, DOI 10.1523/JNEUROSCI.2343-09.2010; Volbracht C, 2005, J NEUROCHEM, V93, P1280, DOI 10.1111/j.1471-4159.2005.03122.x; Watanabe H, 2003, PHARMACOL BIOCHEM BE, V75, P635, DOI 10.1016/S0091-3057(03)00109-6; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Yang JL, 2011, MECH AGEING DEV, V132, P405, DOI 10.1016/j.mad.2011.06.005; Zhou JY, 2010, J ETHNOPHARMACOL, V132, P15, DOI 10.1016/j.jep.2010.08.041	41	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85322	10.1371/journal.pone.0085322	http://dx.doi.org/10.1371/journal.pone.0085322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416390	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500239
J	Kirchner, EA; Tabie, M; Seeland, A				Kirchner, Elsa Andrea; Tabie, Marc; Seeland, Anett			Multimodal Movement Prediction - Towards an Individual Assistance of Patients	PLOS ONE			English	Article							REHABILITATION ROBOT; ARMIN II; EXOSKELETON; THERAPY; STROKE	Assistive devices, like exoskeletons or orthoses, often make use of physiological data that allow the detection or prediction of movement onset. Movement onset can be detected at the executing site, the skeletal muscles, as by means of electromyography. Movement intention can be detected by the analysis of brain activity, recorded by, e. g., electroencephalography, or in the behavior of the subject by, e. g., eye movement analysis. These different approaches can be used depending on the kind of neuromuscular disorder, state of therapy or assistive device. In this work we conducted experiments with healthy subjects while performing self-initiated and self-paced arm movements. While other studies showed that multimodal signal analysis can improve the performance of predictions, we show that a sensible combination of electroencephalographic and electromyographic data can potentially improve the adaptability of assistive technical devices with respect to the individual demands of, e. g., early and late stages in rehabilitation therapy. In earlier stages for patients with weak muscle or motor related brain activity it is important to achieve high positive detection rates to support self-initiated movements. To detect most movement intentions from electroencephalographic or electromyographic data motivates a patient and can enhance her/his progress in rehabilitation. In a later stage for patients with stronger muscle or brain activity, reliable movement prediction is more important to encourage patients to behave more accurately and to invest more effort in the task. Further, the false detection rate needs to be reduced. We propose that both types of physiological data can be used in an and combination, where both signals must be detected to drive a movement. By this approach the behavior of the patient during later therapy can be controlled better and false positive detections, which can be very annoying for patients who are further advanced in rehabilitation, can be avoided.	[Kirchner, Elsa Andrea; Tabie, Marc] Univ Bremen, Robot Lab, D-28359 Bremen, Germany; [Kirchner, Elsa Andrea; Seeland, Anett] German Res Ctr Artificial Intelligence DFKI, RIC, Bremen, Germany	University of Bremen; German Research Center for Artificial Intelligence (DFKI)	Kirchner, EA (corresponding author), Univ Bremen, Robot Lab, D-28359 Bremen, Germany.	elsa.kirchner@dfki.de			German Ministry of Economics and Technology [50 RA 1011, 50 RA 1012]	German Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi))	The work was funded by the German Ministry of Economics and Technology (grant no. 50 RA 1011 and grant no. 50 RA 1012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai O, 2011, CLIN NEUROPHYSIOL, V122, P364, DOI 10.1016/j.clinph.2010.07.010; Benitez LMV, 2013, INT C BIOM EL DEV OA; Benitez LMV, 2013, J ROBOT, V2013, DOI 10.1155/2013/610589; Cavallaro EE, 2006, IEEE T BIO-MED ENG, V53, P2387, DOI 10.1109/TBME.2006.880883; Chan A. D. C., 2010, 2010 IEEE International Instrumentation & Measurement Technology Conference - I2MTC 2010, P1234, DOI 10.1109/IMTC.2010.5488293; Corbett EA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036002; Cui RQ, 1999, BRAIN TOPOGR, V11, P233; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Feess D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067543; Folgheraiter M, 2012, INT J SOC ROBOT, V4, P285, DOI 10.1007/s12369-012-0147-x; Folgheraiter M, 2011, BIODEVICES 2011, P150; Hogan N, 2011, PROG BRAIN RES, V192, P59, DOI 10.1016/B978-0-444-53355-5.00004-X; Huang H, 2011, IEEE T BIO-MED ENG, V58, P2867, DOI 10.1109/TBME.2011.2161671; Ibanez J, 2011, LECT NOTES COMPUT SC, V6691, P370, DOI 10.1007/978-3-642-21501-8_46; Kirchner Elsa Andrea, 2013, Proceedings of the 6th International Conference on Biomedical Electronics and Devices. BIODEVICES 2013, P168; Kirchner E. A., 2010, P 10 INT S ART INT R, P448; Kirchner EA, 2013, IND ROBOT, V40, P530, DOI 10.1108/IR-01-2013-318; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Lew E., 2012, FRONT NEUROENG, V5, P13, DOI [10.3389/fneng.2012.00013, DOI 10.3389/FNENG.2012.00013]; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Mehrholz J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub3; Mihelj M, 2007, IEEE INT CONF ROBOT, P4120, DOI 10.1109/ROBOT.2007.364112; Muralidharan A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00039; Novak D, 2013, IEEE T BIO-MED ENG, V60, P2645, DOI 10.1109/TBME.2013.2262455; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Platt JC, 2000, ADV NEUR IN, P61; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Rivet B, 2009, IEEE T BIO-MED ENG, V56, P2035, DOI 10.1109/TBME.2009.2012869; Santucci E, 2009, NEUROPSYCHOL TRENDS, P59, DOI 10.7358/neur-2009-005-sant; Seeland A, 2013, I IEEE EMBS C NEUR E, P41, DOI 10.1109/NER.2013.6695866; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Staubli P, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-46; Tabie Marc, 2013, Proceedings of the 6th International Conference on Bio-inspired Systems and Signal Processing. BIOSIGNALS 2013, P242; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409	36	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85060	10.1371/journal.pone.0085060	http://dx.doi.org/10.1371/journal.pone.0085060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416341	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500211
J	Pages, N; Breard, E; Urien, C; Talavera, S; Viarouge, C; Lorca-Oro, C; Jouneau, L; Charley, B; Zientara, S; Bensaid, A; Solanes, D; Pujols, J; Schwartz-Cornil, I				Pages, Nonito; Breard, Emmanuel; Urien, Celine; Talavera, Sandra; Viarouge, Cyril; Lorca-Oro, Cristina; Jouneau, Luc; Charley, Bernard; Zientara, Stephan; Bensaid, Albert; Solanes, David; Pujols, Joan; Schwartz-Cornil, Isabelle			Culicoides Midge Bites Modulate the Host Response and Impact on Bluetongue Virus Infection in Sheep	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; SALIVARY-GLANDS; SEROTYPE 8; TRANSMISSION; VECTOR; SONORENSIS; ENCEPHALITIS; ENHANCEMENT; PARTICLES; DYNAMICS	Many haematophagous insects produce factors that help their blood meal and coincidently favor pathogen transmission. However nothing is known about the ability of Culicoides midges to interfere with the infectivity of the viruses they transmit. Among these, Bluetongue Virus (BTV) induces a hemorrhagic fever-type disease and its recent emergence in Europe had a major economical impact. We observed that needle inoculation of BTV8 in the site of uninfected C. nubeculosus feeding reduced viraemia and clinical disease intensity compared to plain needle inoculation. The sheep that developed the highest local inflammatory reaction had the lowest viral load, suggesting that the inflammatory response to midge bites may participate in the individual sensitivity to BTV viraemia development. Conversely compared to needle inoculation, inoculation of BTV8 by infected C. nubeculosus bites promoted viraemia and clinical symptom expression, in association with delayed IFN-induced gene expression and retarded neutralizing antibody responses. The effects of uninfected and infected midge bites on BTV viraemia and on the host response indicate that BTV transmission by infected midges is the most reliable experimental method to study the physio-pathological events relevant to a natural infection and to pertinent vaccine evaluation in the target species. It also leads the way to identify the promoting viral infectivity factors of infected Culicoides in order to possibly develop new control strategies against BTV and other Culicoides transmitted viruses.	[Pages, Nonito; Talavera, Sandra; Lorca-Oro, Cristina; Bensaid, Albert; Solanes, David; Pujols, Joan] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA, Inst Recerca & Tecnol Agroalimentaries, Bellaterra, Spain; [Breard, Emmanuel; Viarouge, Cyril; Zientara, Stephan] Ecole Natl Vet Alfort, Agence Natl Securite Sanitaire Alimentat Environm, Inst Natl Rech Agron, Unite Mixte Rech UMR1161, Maisons Alfort, France; [Urien, Celine; Jouneau, Luc; Charley, Bernard; Schwartz-Cornil, Isabelle] INRA, Unite Rech UR892, Jouy En Josas, France	Autonomous University of Barcelona; IRTA; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Schwartz-Cornil, I (corresponding author), INRA, Unite Rech UR892, Jouy En Josas, France.	isabelle.schwartz@jouy.inra.fr	Pujols, Joan/K-9693-2015; Bensaid, Albert/K-1960-2017; Zientara, Stephan/A-5336-2016; Pages, Nonito/Q-1274-2016; breard, emmanuel/E-2123-2011; Zientara, Stephan/AAA-7661-2021; schwartz-cornil, isabelle/D-8547-2011; Pujols, Joan/S-1141-2018; Pujols, Joan/AAV-6427-2020; Talavera, Sandra/ABG-8759-2020; Lorca-Oró, Cristina/ABE-7268-2021; Jouneau, Luc/AAC-4711-2020	Pujols, Joan/0000-0002-6940-1529; Bensaid, Albert/0000-0001-6493-3756; Zientara, Stephan/0000-0003-0089-8175; Pages, Nonito/0000-0001-6020-7175; Zientara, Stephan/0000-0002-6733-8503; Pujols, Joan/0000-0002-6940-1529; Lorca-Oró, Cristina/0000-0001-5351-4169; 	European Community [FP7-228394]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001701] Funding Source: researchfish; BBSRC [BBS/E/I/00001701] Funding Source: UKRI	European Community(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7, 2007-2013), Research Infrastructures action, under the grant agreement No. FP7-228394 (NADIR project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Andrade BB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00121; Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507; Baylis M, 2008, MED VET ENTOMOL, V22, P228, DOI 10.1111/j.1365-2915.2008.00732.x; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; Bishop JV, 2006, AM J TROP MED HYG, V75, P532, DOI 10.4269/ajtmh.2006.75.532; BOORMAN J, 1974, B ENTOMOL RES, V64, P371, DOI 10.1017/S0007485300031254; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Darpel KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017545; de Leon AAP, 1998, EXP PARASITOL, V88, P121, DOI 10.1006/expr.1998.4210; deLeon AAP, 1997, AM J TROP MED HYG, V57, P375, DOI 10.4269/ajtmh.1997.57.375; Di Gialleonardo L, 2011, RES VET SCI, V91, P316, DOI 10.1016/j.rvsc.2010.12.017; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Eschbaumer M, 2010, VET MICROBIOL, V146, P150, DOI 10.1016/j.vetmic.2010.05.004; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118; Girard YA, 2010, J MED ENTOMOL, V47, P421, DOI 10.1603/ME09249; Hemati B, 2009, J VIROL, V83, P8789, DOI 10.1128/JVI.00626-09; Howey R, 2009, J R SOC INTERFACE, V6, P835, DOI 10.1098/rsif.2008.0434; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; JENNINGS DM, 1988, VET MICROBIOL, V17, P1, DOI 10.1016/0378-1135(88)90074-0; Langner KFA, 2008, VET IMMUNOL IMMUNOP, V122, P126, DOI 10.1016/j.vetimm.2007.11.001; Limesand KH, 2003, J MED ENTOMOL, V40, P199, DOI 10.1603/0022-2585-40.2.199; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Martinelle L, 2011, VACCINE, V29, P3600, DOI 10.1016/j.vaccine.2011.02.055; Mercer DR, 2005, J MED ENTOMOL, V42, P554, DOI 10.1603/0022-2585(2005)042[0554:CIRSCO]2.0.CO;2; Moulin V, 2012, VACCINE, V30, P2228, DOI 10.1016/j.vaccine.2011.11.100; Quan M, 2004, J COMP PATHOL, V131, P294, DOI 10.1016/j.jcpa.2004.05.002; Reisen WK, 2000, J MED ENTOMOL, V37, P250, DOI 10.1603/0022-2585-37.2.250; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Stewart M, 2010, VACCINE, V28, P3047, DOI 10.1016/j.vaccine.2009.10.072; Stewart M, 2013, VACCINE, V31, P553, DOI 10.1016/j.vaccine.2012.11.016; Takamatsu H, 2003, J GEN VIROL, V84, P227, DOI 10.1099/vir.0.18705-0; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091	37	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83683	10.1371/journal.pone.0083683	http://dx.doi.org/10.1371/journal.pone.0083683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421899	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500065
J	Parra, EL; Ramos, V; Sanabria, O; Moreno, J				Parra, Eliana L.; Ramos, Viviana; Sanabria, Olga; Moreno, Jaime			Serotype and Genotype Distribution among Invasive Streptococcus pneumoniae Isolates in Colombia, 2005-2010	PLOS ONE			English	Article							PNEUMOCOCCAL DISEASE; UNITED-STATES; 19A; CLONES; EPIDEMIOLOGY; VACCINATION; DISCOVERY; CARRIAGE; PORTUGAL; SEPSIS	In Colombia, a laboratory-based surveillance of invasive Streptococcus pneumoniae isolates as part of SIREVA II PAHO has been conducted since 1994. This study describes the serotype distribution, antimicrobial resistance, and genetic relationships of pneumococcal isolates recovered in Colombia from 2005 to 2010. In this study, demographic data of invasive S. pneumoniae isolates were analyzed, and antimicrobial susceptibility patterns were determined. Pulse field gel electrophoresis (n = 629) and multilocus sequence typing (n = 10) were used to determine genetic relationship of isolates with minimal inhibitory concentration to penicillin >= 0.125 mg/mL. A total of 1775 isolates of S. pneumoniae were obtained. Fifteen serotypes accounted for 80.7% of isolates. Serotype 14 (23.1%) was the most frequent in the general population. Penicillin resistance was 30.7% in meningitis and 9.0% in non-meningitis. Clones Spain(6B)ST90, Spain(9V)ST156, Spain(23F)ST81, and Colombia(23F)ST338 were associated to isolates. Additionally, serotype 6A isolates were associated with ST460 and ST473, and 19A isolates with ST276, ST320, and ST1118. In conclusion, the surveillance program provided updated information of trends in serotype distribution, antimicrobial resistance and the circulation of clones in invasive pneumococcal diseases. These results could be helpful to understand the epidemiology of S. pneumoniae in Colombia, and provide a baseline to measure the impact of vaccine introduction.	[Parra, Eliana L.; Ramos, Viviana; Sanabria, Olga; Moreno, Jaime] Inst Nacl Salud, Microbiol Grp, Bogota, Colombia	Instituto Nacional de Salud (Colombia)	Moreno, J (corresponding author), Inst Nacl Salud, Microbiol Grp, Bogota, Colombia.	jmoreno@ins.gov.co		Parra Barrera, Eliana L./0000-0002-2745-7997				Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Agudelo Clara Inés, 2006, Biomédica, V26, P234; Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; [Anonymous], 2012, INF REG SIREVA 2; Baek JY, 2011, DIAGN MICR INFEC DIS, V69, P370, DOI 10.1016/j.diagmicrobio.2010.10.019; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; Castaneda E, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-124; Clinical and Laboratory Standards Institute, 2010, M100S21 CLSI; Constenla D, 2007, BURDEN PNEUMOCOCAL D; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Gherardi G, 2012, ANTIMICROB AGENTS CH, V56, P4965, DOI 10.1128/AAC.00830-12; Grall N, 2011, EUR J CLIN MICROBIOL, V30, P1511, DOI 10.1007/s10096-011-1251-9; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Henriques-Normark B, 2008, NAT REV MICROBIOL, V6, P827, DOI 10.1038/nrmicro2011; Hiller NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028850; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; Hsieh YC, 2009, CLIN MICROBIOL INFEC, V15, P991, DOI 10.1111/j.1469-0691.2009.02743.x; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Ko KS, 2013, J CLIN MICROBIOL, V51, P3395, DOI 10.1128/JCM.01645-13; Leal J, 2012, PEDIATR INFECT DIS J, V31, pE169, DOI 10.1097/INF.0b013e3182624a40; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Mahjoub-Messai F, 2009, J CLIN MICROBIOL, V47, P837, DOI 10.1128/JCM.01547-08; Ministerio de Salud y Proteccion Social, JORN VAC LAS AM 2012; Munoz-Almagro C, 2011, J INFECTION, V63, P151, DOI 10.1016/j.jinf.2011.06.002; Oliver MB, 2013, J BIOL CHEM, V288, P25976, DOI 10.1074/jbc.M113.480152; Parra EL, 2013, VACCINE, V31, P4033, DOI 10.1016/j.vaccine.2013.04.074; Pillai DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-642; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P3491, DOI 10.1128/AAC.48.9.3491-3497.2004; Reinert RR, 2009, CLIN MICROBIOL INFEC, V15, P7, DOI 10.1111/j.1469-0691.2009.02724.x; Reinert RR, 2010, VACCINE, V28, P4249, DOI 10.1016/j.vaccine.2010.04.020; Reinert RR, 2005, J CLIN MICROBIOL, V43, P1294, DOI 10.1128/JCM.43.3.1294-1300.2005; Rolo D, 2011, J ANTIMICROB CHEMOTH, V66, P1712, DOI 10.1093/jac/dkr193; Sa-Leao R, 2000, J INFECT DIS, V182, P1153, DOI 10.1086/315813; Schaaf B, 2007, EUR RESPIR J, V30, P517, DOI 10.1183/09031936.00021007; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; Serrano I, 2005, J CLIN MICROBIOL, V43, P1706, DOI 10.1128/JCM.43.4.1706-1715.2005; Shin J, 2011, J ANTIMICROB CHEMOTH, V66, P1001, DOI 10.1093/jac/dkr048; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Tan TQ, 2012, CLIN MICROBIOL REV, V25, P409, DOI 10.1128/CMR.00018-12; Vela MC, 2001, MICROB DRUG RESIST, V7, P153, DOI 10.1089/10766290152045020; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weisfelt M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-149	46	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84993	10.1371/journal.pone.0084993	http://dx.doi.org/10.1371/journal.pone.0084993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416330	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500203
J	Roth, T; Plattner, M; Amrhein, V				Roth, Tobias; Plattner, Matthias; Amrhein, Valentin			Plants, Birds and Butterflies: Short-Term Responses of Species Communities to Climate Warming Vary by Taxon and with Altitude	PLOS ONE			English	Article							RANGE SHIFTS; PINUS-CEMBRA; DIVERSITY; BIODIVERSITY; HOMOGENIZATION; TEMPERATURES; INDICATORS; MOUNTAINS; ELEVATION; RICHNESS	As a consequence of climate warming, species usually shift their distribution towards higher latitudes or altitudes. Yet, it is unclear how different taxonomic groups may respond to climate warming over larger altitudinal ranges. Here, we used data from the national biodiversity monitoring program of Switzerland, collected over an altitudinal range of 2500 m. Within the short period of eight years (2003-2010), we found significant shifts in communities of vascular plants, butterflies and birds. At low altitudes, communities of all species groups changed towards warm-dwelling species, corresponding to an average uphill shift of 8 m, 38 m and 42 m in plant, butterfly and bird communities, respectively. However, rates of community changes decreased with altitude in plants and butterflies, while bird communities changed towards warm-dwelling species at all altitudes. We found no decrease in community variation with respect to temperature niches of species, suggesting that climate warming has not led to more homogenous communities. The different community changes depending on altitude could not be explained by different changes of air temperatures, since during the 16 years between 1995 and 2010, summer temperatures in Switzerland rose by about 0.07 degrees C per year at all altitudes. We discuss that land-use changes or increased disturbances may have prevented alpine plant and butterfly communities from changing towards warm-dwelling species. However, the findings are also consistent with the hypothesis that unlike birds, many alpine plant species in a warming climate could find suitable habitats within just a few metres, due to the highly varied surface of alpine landscapes. Our results may thus support the idea that for plants and butterflies and on a short temporal scale, alpine landscapes are safer places than lowlands in a warming world.	[Roth, Tobias; Plattner, Matthias] Hintermann & Weber AG, Reinach, Switzerland; [Roth, Tobias; Amrhein, Valentin] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Roth, Tobias; Amrhein, Valentin] Res Stn Petite Camargue Alsacienne, St Louis, France	University of Basel	Roth, T (corresponding author), Hintermann & Weber AG, Reinach, Switzerland.	roth@hintermannweber.ch	Amrhein, Valentin/ABD-6432-2021; Roth, Tobias/H-7927-2019	Roth, Tobias/0000-0001-9742-8297	Swiss Federal Office for the Environment; Swiss Association Pro Petite Camargue Alsacienne	Swiss Federal Office for the Environment; Swiss Association Pro Petite Camargue Alsacienne	Financial support was provided by the Swiss Federal Office for the Environment and the Swiss Association Pro Petite Camargue Alsacienne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archaux F, 2004, IBIS, V146, P138, DOI 10.1111/j.1474-919X.2004.00246.x; Begert M, 2005, INT J CLIMATOL, V25, P65, DOI 10.1002/joc.1118; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cannone N, 2007, FRONT ECOL ENVIRON, V5, P360, DOI 10.1890/1540-9295(2007)5[360:UIOCCO]2.0.CO;2; Cantarel AAM, 2013, J VEG SCI, V24, P113, DOI 10.1111/j.1654-1103.2012.01452.x; Ceppi P, 2012, INT J CLIMATOL, V32, P203, DOI 10.1002/joc.2260; Chamberlain D, 2012, IBIS, V154, P205, DOI 10.1111/j.1474-919X.2011.01196.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Couvet D, 2011, CR BIOL, V334, P370, DOI 10.1016/j.crvi.2011.02.007; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Franzen M, 2012, BIODIVERS CONSERV, V21, P517, DOI 10.1007/s10531-011-0197-7; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/NCLIMATE1329, 10.1038/nclimate1329]; Graham EA, 2012, ARCT ANTARCT ALP RES, V44, P288, DOI 10.1657/1938-4246-44.3.288; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; Gusewell S, 2012, ECOL INDIC, V20, P134, DOI 10.1016/j.ecolind.2012.02.011; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/NCLIMATE1687, 10.1038/nclimate1687]; Hanspach J, ECOGRAPHY; HATTENSCHWILER S, 1995, J VEG SCI, V6, P357, DOI 10.2307/3236235; Hintermann U., 2000, SCHRIFTENREIHE LANDS, V62, P47; Ibanez I, 2013, ECOL EVOL, V3, P170, DOI 10.1002/ece3.433; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Korner C., 2005, ADV GLOB CHANGE RES, P367; Landolt E., 2010, FLORA INDICATIVA; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2013, GLOBAL CHANGE BIOL, V19, P1470, DOI 10.1111/gcb.12129; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Maggini R, 2011, ECOL MODEL, V222, P21, DOI 10.1016/j.ecolmodel.2010.09.010; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; Paulsen J, 2001, J VEG SCI, V12, P817, DOI 10.2307/3236869; Pellissier L, 2013, ECOGRAPHY, V36, P541, DOI 10.1111/j.1600-0587.2012.07716.x; Pinheiro J., 2011, NLME LINEAR NONLINEA; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; Quintero I, 2013, GLOBAL ECOL BIOGEOGR, V22, P422, DOI 10.1111/geb.12001; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Roth T, 2008, J APPL ECOL, V45, P987, DOI 10.1111/j.1365-2664.2007.01435.x; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Scherrer D, 2010, GLOBAL CHANGE BIOL, V16, P2602, DOI 10.1111/j.1365-2486.2009.02122.x; Schuepp M, 1980, BEOBACHTUNGSNETZE SC; Schweiger O, ZOOKEYS IN PRESS; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Settele J, 2008, CLIMATIC RISK ATLAS; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; van Strien AJ, 2012, ECOL INDIC, V14, P202, DOI 10.1016/j.ecolind.2011.07.007; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x; Vittoz P, 2008, ARCT ANTARCT ALP RES, V40, P225, DOI 10.1657/1523-0430(06-010)[VITTOZ]2.0.CO;2; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zuur Alain F., 2009, P1	64	64	67	5	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82490	10.1371/journal.pone.0082490	http://dx.doi.org/10.1371/journal.pone.0082490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416144	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500017
J	Sahebjada, S; Schache, M; Richardson, AJ; Snibson, G; Daniell, M; Baird, PN				Sahebjada, Srujana; Schache, Maria; Richardson, Andrea J.; Snibson, Grant; Daniell, Mark; Baird, Paul N.			Association of the Hepatocyte Growth Factor Gene with Keratoconus in an Australian Population	PLOS ONE			English	Article							VSX1 GENE; INFLAMMATORY MOLECULES; POLYMORPHISMS; MUTATIONS; TEARS; PROMOTER; ETIOLOGY; BROWSER; DISEASE; SOD1	Purpose: A previous study has indicated suggestive association of the hepatocyte growth factor (HGF) gene with Keratoconus. We wished to assess this association in an independent Caucasian cohort as well as assess its association with corneal curvature. Participants: Keratoconus patients were recruited from private and public clinics in Melbourne, Australia. Non-keratoconic individuals were identified from the Genes in Myopia (GEM) study from Australia. A total of 830 individuals were used for the analysis including 157 keratoconic and 673 non keratoconic subjects. Methods: Tag single nucleotide polymorphisms (tSNPs) were chosen to encompass the hepatocyte growth factor gene as well as 2 kb upstream of the start codon through to 2 kb downstream of the stop codon. Logistic and linear regression including age and gender as covariates were applied in statistical analysis with subsequent Bonferroni correction. Results: Ten tSNPs were genotyped. Following statistical analysis and multiple testing correction, a statistically significant association was found for the tSNP rs2286194 {p = 1.1x10-(3) Odds Ratio 0.52, 95% CI - 0.35, 0.77} for keratoconus. No association was found between the 10 tSNPs and corneal curvature. Conclusions: These findings provide additional evidence of significant association of the HGF gene with Keratoconus. This association does not appear to act through the corneal curvature route.	[Sahebjada, Srujana; Schache, Maria; Richardson, Andrea J.; Snibson, Grant; Daniell, Mark; Baird, Paul N.] Ctr Eye Res Australia, Melbourne, Vic, Australia; [Sahebjada, Srujana] Univ Melbourne, Melbourne, Vic, Australia; [Snibson, Grant] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia	Centre for Eye Research Australia; University of Melbourne; Royal Victorian Eye & Ear Hospital	Sahebjada, S (corresponding author), Ctr Eye Res Australia, Melbourne, Vic, Australia.	s.sahebjada@pgrad.unimelb.edu.au	Daniell, Mark/AAS-1363-2020	Daniell, Mark/0000-0001-9528-7005; Sahebjada, Srujana/0000-0002-1945-7209; Baird, Paul/0000-0002-1305-3502	National Health and Medical Research Council (NHMRC) [529923, 1028444]; Angior Family Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Angior Family Foundation	This project was funded by the National Health and Medical Research Council (NHMRC) Clinical Research Excellence grant 529923 - Translational Clinical Research in Major Eye Diseases, NHMRC Senior Research Fellowship 1028444 (PNB) and the Angior Family Foundation. The Centre for Eye Research Australia (CERA) receives Operational Infrastructure Support from the Victorian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2006, INVEST OPHTH VIS SCI, V47, P2820, DOI 10.1167/iovs.05-1530; Baird PN, 2010, PROG RETIN EYE RES, V29, P520, DOI 10.1016/j.preteyeres.2010.05.004; Balasubramanian SA, 2012, ACTA OPHTHALMOL, V90, pE303, DOI 10.1111/j.1755-3768.2011.02369.x; Bawazeer AM, 2000, BRIT J OPHTHALMOL, V84, P834, DOI 10.1136/bjo.84.8.834; Bisceglia L, 2005, INVEST OPHTH VIS SCI, V46, P39, DOI 10.1167/iovs.04-0533; Burdon KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/iovs.11-8261; Bykhovskaya Y, 2012, INVEST OPHTH VIS SCI, V53, P4152, DOI 10.1167/iovs.11-9268; Colin J, 2000, J CATARACT REFR SURG, V26, P1117, DOI 10.1016/S0886-3350(00)00451-X; Coster D., 2012, AUSTR CORNEAL GRAFT; Dash DP, 2010, EYE, V24, P1085, DOI 10.1038/eye.2009.217; Eran P, 2008, OPHTHALMIC GENET, V29, P53, DOI 10.1080/13816810802008242; FALLS HF, 1969, J GENET HUM, V17, P317; HARTSTEIN J, 1968, ARCH OPHTHALMOL-CHIC, V80, P345, DOI 10.1001/archopht.1968.00980050347009; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; JAEGER MJ, 1987, CORNEA, V6, P131; KARSERAS AG, 1976, BRIT J OPHTHALMOL, V60, P522, DOI 10.1136/bjo.60.7.522; Kim SH, 2008, MOL VIS, V14, P2109; Lema I, 2005, OPHTHALMOLOGY, V112, P654, DOI 10.1016/j.ophtha.2004.11.050; Lema I, 2009, BRIT J OPHTHALMOL, V93, P820, DOI 10.1136/bjo.2008.144253; Li Q, 1996, INVEST OPHTH VIS SCI, V37, P727; Li W, 2001, HEPATOLOGY, V33, P1377, DOI 10.1053/jhep.2001.24431; Li XH, 2007, EXP EYE RES, V85, P502, DOI 10.1016/j.exer.2007.06.016; Liskova P, 2007, MOL VIS, V13, P1887; LIU YH, 1994, J BIOL CHEM, V269, P4152; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; McMahon TT, 1999, CORNEA, V18, P444, DOI 10.1097/00003226-199907000-00010; Mok JW, 2008, J HUM GENET, V53, P842, DOI 10.1007/s10038-008-0319-6; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Owens H, 2003, CORNEA, V22, P122, DOI 10.1097/00003226-200303000-00008; Paliwal P, 2009, MOL VIS, V15, P2475; Rabinowitz Yaron S, 2003, Ophthalmol Clin North Am, V16, P607, DOI 10.1016/S0896-1549(03)00099-3; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Sekundo W, 2001, J REFRACT SURG, V17, P69; Snibson GR, 2010, CLIN EXP OPHTHALMOL, V38, P141, DOI 10.1111/j.1442-9071.2010.02228.x; Stabuc-Silih M, 2009, MOL VIS, V15, P2848; Stabuc-Silih M, 2010, CORNEA, V29, P172, DOI 10.1097/ICO.0b013e3181aebf7a; Tang YMG, 2008, CORNEA, V27, P189, DOI 10.1097/ICO.0b013e31815a50e7; Udar N, 2006, INVEST OPHTH VIS SCI, V47, P3345, DOI 10.1167/iovs.05-1500; Veerappan S, 2010, OPHTHALMOLOGY, V117, P239, DOI 10.1016/j.ophtha.2009.07.002; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang Y, 2000, AM J MED GENET, V93, P403, DOI 10.1002/1096-8628(20000828)93:5<403::AID-AJMG11>3.0.CO;2-A; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2544; Yanovitch T, 2009, MOL VIS, V15, P1028	43	38	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84067	10.1371/journal.pone.0084067	http://dx.doi.org/10.1371/journal.pone.0084067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416191	Green Published, gold			2022-12-25	WOS:000329862500091
J	Samartzis, EP; Noske, A; Meisel, A; Varga, Z; Fink, D; Imesch, P				Samartzis, Eleftherios P.; Noske, Aurelia; Meisel, Alexander; Varga, Zsuzsanna; Fink, Daniel; Imesch, Patrick			The G Protein-Coupled Estrogen Receptor (GPER) Is Expressed in Two Different Subcellular Localizations Reflecting Distinct Tumor Properties in Breast Cancer	PLOS ONE			English	Article							GPR30; 17-BETA-ESTRADIOL; MEMBRANE; CELLS; PROLIFERATION; ASSOCIATION; MIGRATION	Introduction: The G protein-coupled estrogen receptor (GPER) is a novel estrogen receptor that mediates proliferative effects induced by estrogen but also by tamoxifen. The aim of our study was to analyze the frequency of GPER in a large collective of primary invasive breast carcinomas, with special emphasis on the subcellular expression and to evaluate the association with clinicopathological parameters and patient overall survival. Methods: The tissue microarrays from formalin-fixed, paraffin embedded samples of primary invasive breast carcinomas (n = 981) were analyzed for GPER expression using immunohistochemistry. Expression data were compared to the clinicopathological parameters and overall survival. GPER localization was also analyzed in two immortalized breast cancer cell lines T47D and MCF7 by confocal immunofluorescence microscopy. Results: A predominantly cytoplasmic GPER expression was found in 189 carcinomas (19.3%), whereas a predominantly nuclear expression was observed in 529 cases (53.9%). A simultaneous comparable positive expression of both patterns was found in 32 of 981 cases (3.2%), and negative staining was detected in 295 cases (30%). Confocal microscopy confirmed the occurrence of cytoplasmic and nuclear GPER expression in T47D and MCF7. Cytoplasmic GPER expression was significantly associated with non-ductal histologic subtypes, low tumor stage, better histologic differentiation, as well as Luminal A and B subtypes. In contrast, nuclear GPER expression was significantly associated with poorly differentiated carcinomas and the triple-negative subtype. In univariate analysis, cytoplasmic GPER expression was associated with better overall survival (p = 0.012). Conclusion: Our data suggest that predominantly cytoplasmic and/or nuclear GPER expression are two distinct immunohistochemical patterns in breast carcinomas and may reflect different biological features, reason why these patterns should be clearly distinguished in histological evaluations. Prospective studies will be needed to assess whether the expression status of GPER in breast carcinomas should be routinely observed by clinicians, for instance, before implementing endocrine breast cancer treatment.	[Samartzis, Eleftherios P.; Fink, Daniel; Imesch, Patrick] Univ Zurich Hosp, Dept Gynecol, CH-8091 Zurich, Switzerland; [Noske, Aurelia; Varga, Zsuzsanna] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Meisel, Alexander] Univ Zurich Hosp, Dept Med Oncol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Imesch, P (corresponding author), Univ Zurich Hosp, Dept Gynecol, CH-8091 Zurich, Switzerland.	patrick.imesch@usz.ch	Samartzis, Eleftherios P./AAJ-5650-2020	Samartzis, Eleftherios P./0000-0002-8246-5842	Center for Clinical Research, University and University Hospital of Zurich; EMDO foundation; Hartmann-Mueller foundation	Center for Clinical Research, University and University Hospital of Zurich; EMDO foundation; Hartmann-Mueller foundation	This project was supported by grants from the Center for Clinical Research, University and University Hospital of Zurich, and by grants from the EMDO and the Hartmann-Mueller foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Bondar G, 2009, J NEUROSCI, V29, P15323, DOI 10.1523/JNEUROSCI.2107-09.2009; Cheng SB, 2011, STEROIDS, V76, P892, DOI 10.1016/j.steroids.2011.02.018; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Du GQ, 2012, BIOCHEM BIOPH RES CO, V420, P343, DOI 10.1016/j.bbrc.2012.02.161; ELSTON CW, 1993, J CLIN PATHOL, V46, P189; Filardo EJ, 2008, STEROIDS, V73, P870, DOI 10.1016/j.steroids.2007.12.025; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Han GC, 2013, PHARMACOL RES, V71, P53, DOI 10.1016/j.phrs.2013.02.008; Ignatov A, 2011, BREAST CANCER RES TR, V128, P457, DOI 10.1007/s10549-011-1584-1; Ignatov A, 2010, BREAST CANCER RES TR, V123, P87, DOI 10.1007/s10549-009-0624-6; Ignatov T, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.034; Kleuser B, 2008, MOL PHARMACOL, V74, P1533, DOI 10.1124/mol.108.046854; Kristiansen G, 2010, BRIT J CANCER, V102, P1736, DOI 10.1038/sj.bjc.6605702; Luo HJ, 2011, J BREAST CANCER, V14, P185, DOI 10.4048/jbc.2011.14.3.185; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Samartzis N, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-30; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344	23	35	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83296	10.1371/journal.pone.0083296	http://dx.doi.org/10.1371/journal.pone.0083296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421881	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500041
J	Sarker, S; Patterson, EI; Peters, A; Baker, GB; Forwood, JK; Ghorashi, SA; Holdsworth, M; Baker, R; Murray, N; Raidal, SR				Sarker, Subir; Patterson, Edward I.; Peters, Andrew; Baker, G. Barry; Forwood, Jade K.; Ghorashi, Seyed A.; Holdsworth, Mark; Baker, Rupert; Murray, Neil; Raidal, Shane R.			Mutability Dynamics of an Emergent Single Stranded DNA Virus in a Naive Host	PLOS ONE			English	Article							FEATHER-DISEASE-VIRUS; POLYMERASE-CHAIN-REACTION; PSITTACINE BEAK; PHYLOGENETIC EVIDENCE; MOLECULAR EVOLUTION; POSITIVE SELECTION; GENETIC DIVERSITY; VIRAL EVOLUTION; HIGH-RATES; RECOMBINATION	Quasispecies variants and recombination were studied longitudinally in an emergent outbreak of beak and feather disease virus (BFDV) infection in the orange-bellied parrot (Neophema chrysogaster). Detailed health monitoring and the small population size (<300 individuals) of this critically endangered bird provided an opportunity to longitudinally track viral replication and mutation events occurring in a circular, single-stranded DNA virus over a period of four years within a novel bottleneck population. Optimized PCR was used with different combinations of primers, primer walking, direct amplicon sequencing and sequencing of cloned amplicons to analyze BFDV genome variants. Analysis of complete viral genomes (n = 16) and Rep gene sequences (n = 35) revealed that the outbreak was associated with mutations in functionally important regions of the normally conserved Rep gene and immunogenic capsid (Cap) gene with a high evolutionary rate (3.41610 23 subs/site/year) approaching that for RNA viruses; simultaneously we observed significant evidence of recombination hotspots between two distinct progenitor genotypes within orange-bellied parrots indicating early cross-transmission of BFDV in the population. Multiple quasispecies variants were also demonstrated with at least 13 genotypic variants identified in four different individual birds, with one containing up to seven genetic variants. Preferential PCR amplification of variants was also detected. Our findings suggest that the high degree of genetic variation within the BFDV species as a whole is reflected in evolutionary dynamics within individually infected birds as quasispecies variation, particularly when BFDV jumps from one host species to another.	[Sarker, Subir; Patterson, Edward I.; Peters, Andrew; Ghorashi, Seyed A.; Raidal, Shane R.] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia; [Sarker, Subir; Patterson, Edward I.; Peters, Andrew; Forwood, Jade K.; Ghorashi, Seyed A.; Raidal, Shane R.] NSW Dept Primary Ind, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Sarker, Subir; Patterson, Edward I.; Peters, Andrew; Forwood, Jade K.; Ghorashi, Seyed A.; Raidal, Shane R.] Charles Sturt Univ, Wagga Wagga, NSW, Australia; [Baker, G. Barry] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Holdsworth, Mark] Dept Primary Ind Pk Water & Environm, Biodivers Conservat Branch, Hobart, Tas, Australia; [Murray, Neil] La Trobe Univ, Dept Genet, Bundoora, Vic, Australia	Charles Sturt University; Charles Sturt University; NSW Department of Primary Industries; Charles Sturt University; University of Tasmania; La Trobe University	Raidal, SR (corresponding author), Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia.	shraidal@csu.edu.au	Forwood, Jade K/K-4123-2014; Sarker, Subir/U-8444-2019; Raidal, Shane/C-4632-2008; Ghorashi, Seyed/C-1529-2016	Forwood, Jade K/0000-0003-3267-9997; Sarker, Subir/0000-0002-2685-8377; Baker, G. Barry/0000-0003-4766-8182; Patterson, Edward/0000-0003-3465-0848; Raidal, Shane/0000-0001-7917-8976; Ghorashi, Seyed/0000-0002-9820-5308; Peters, Andrew/0000-0003-4938-2823	Australian Research Council [DP1095408]	Australian Research Council(Australian Research Council)	This research was supported by Australian Research Council's Discovery Projects funding scheme (grant number DP1095408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; Andersson M, 2013, AM NAT, V181, P545, DOI 10.1086/669905; Andrew R, 2009, FIGTREE V1 4 COMPUTE; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Awadalla P, 2003, NAT REV GENET, V4, P50, DOI 10.1038/nrg964; Bassami MR, 2001, VIROLOGY, V279, P392, DOI 10.1006/viro.2000.0847; Belyi VA, 2010, J VIROL, V84, P12458, DOI 10.1128/JVI.01789-10; Bonne N, 2008, J VET DIAGN INVEST, V20, P60, DOI 10.1177/104063870802000111; Brown P., 1988, Australian Aviculture, V42, P165; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; Ge LM, 2007, J VIROL, V81, P5902, DOI 10.1128/JVI.02431-06; Gerlach H., 1994, AVIAN MED PRINCIPLES, P894; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Grasland B, 2005, VET RES, V36, P685, DOI 10.1051/vetres:2005024; Harris J, 2006, P AUSTR COMM ASS AV, P143; Hatwell JN, 2000, J GEN VIROL, V81, P1191, DOI 10.1099/0022-1317-81-5-1191; Heath L, 2004, J VIROL, V78, P9277, DOI 10.1128/JVI.78.17.9277-9284.2004; Higgins P.J., 1999, HDB AUSTR NZ ANTARCT, V4; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; IUCN, 2013, IUCN RED LIST THREAT; Julian L, 2013, J GEN VIROL, V94, P1086, DOI 10.1099/vir.0.050179-0; Khalesi B, 2005, J GEN VIROL, V86, P3039, DOI 10.1099/vir.0.81275-0; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Kondiah K, 2006, ARCH VIROL, V151, P2539, DOI 10.1007/s00705-006-0800-5; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kundu S, 2012, J VIROL, V86, P5221, DOI 10.1128/JVI.06504-11; Latimer K S, 1990, J Vet Diagn Invest, V2, P204; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; Lord CC, 1999, PHILOS T R SOC B, V354, P799, DOI 10.1098/rstb.1999.0432; Mankertz A, 1998, J GEN VIROL, V79, P381, DOI 10.1099/0022-1317-79-2-381; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2011, VIRUSES-BASEL, V3, P1699, DOI 10.3390/v3091699; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Massaro M, 2012, ARCH VIROL, V157, P1651, DOI 10.1007/s00705-012-1336-5; Minin VN, 2005, BIOINFORMATICS, V21, P3034, DOI 10.1093/bioinformatics/bti459; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; Niagro FD, 1998, ARCH VIROL, V143, P1723, DOI 10.1007/s007050050412; Nozawa M, 2009, P NATL ACAD SCI USA, V106, P6700, DOI 10.1073/pnas.0901855106; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PASS DA, 1984, AUST VET J, V61, P69, DOI 10.1111/j.1751-0813.1984.tb15520.x; Perales C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005554; Perry RA, 1981, P REFR COURS AV CAG, P81; Peters A, 2013, J WILDL DIS IN PRESS; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Pritchard R, 2012, UPDATE ORGANCE BELLI; Rahaus M, 2008, VET MED-CZECH, V53, P53, DOI 10.17221/1932-VETMED; RAIDAL SR, 1993, AUST VET J, V70, P137, DOI 10.1111/j.1751-0813.1993.tb06105.x; Ramsden C, 2008, MOL BIOL EVOL, V25, P1488, DOI 10.1093/molbev/msn093; Ritchie B.W, 1995, CIRCOVIRIDAE AVIAN V, P223; RITCHIE BW, 1989, VIROLOGY, V171, P83, DOI 10.1016/0042-6822(89)90513-8; RITCHIE BW, 1990, J WILDLIFE DIS, V26, P196, DOI 10.7589/0090-3558-26.2.196; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Shackelton LA, 2006, J VIROL, V80, P3666, DOI 10.1128/JVI.80.7.3666-3669.2006; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2006, J VIROL, V80, P9928, DOI 10.1128/JVI.00441-06; Shearer PL, 2008, AVIAN PATHOL, V37, P75, DOI 10.1080/03079450701802206; Suchard MA, 2003, J AM STAT ASSOC, V98, P427, DOI 10.1198/016214503000215; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd D, 2004, VET MICROBIOL, V98, P169, DOI 10.1016/j.vetmic.2003.10.010; Todd D, 2000, AVIAN PATHOL, V29, P373, DOI 10.1080/030794500750047126; Umemura T, 2002, FEBS LETT, V510, P171, DOI 10.1016/S0014-5793(01)03258-6; van der Walt E, 2009, J GEN VIROL, V90, P734, DOI 10.1099/vir.0.007724-0; Varsani A, 2011, J GEN VIROL, V92, P752, DOI 10.1099/vir.0.028126-0; Walsh P S, 1992, PCR Methods Appl, V1, P241, DOI 10.1101/gr.1.4.241; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Ypelaar I, 1999, VET MICROBIOL, V68, P141, DOI 10.1016/S0378-1135(99)00070-X	78	48	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85370	10.1371/journal.pone.0085370	http://dx.doi.org/10.1371/journal.pone.0085370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416396	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500242
J	Vall, O; Gomez-Culebras, M; Puig, C; Rodriguez-Carrasco, E; Baltazar, AG; Canchucaja, L; Joya, X; Garcia-Algar, O				Vall, Oriol; Gomez-Culebras, Mario; Puig, Carme; Rodriguez-Carrasco, Ernesto; Gomez Baltazar, Arelis; Canchucaja, Lizzeth; Joya, Xavier; Garcia-Algar, Oscar			Prenatal and Postnatal Exposure to DDT by Breast Milk Analysis in Canary Islands	PLOS ONE			English	Article							PERSISTENT ORGANOCHLORINE COMPOUNDS; ADIPOSE-TISSUE; PESTICIDE-RESIDUES; BIRTH-WEIGHT; INADVERTENT EXPOSURE; RISK-ASSESSMENT; SPAIN; WOMEN; SERUM; FOOD	Introduction: The use of p,p'-dichlorodiphenyltrichloroethane (DDT) has been banned since the late 1970s due to its toxicity. However, its long half-life makes it persistent in the environment and, consequently, almost everyone has DDT residues in the body. Human milk constitutes an ideal non-conventional matrix to investigate environmental chronic exposure to organochlorine compounds (OCs) residues. The study aimed to identify potential population risk factors of exposure to DDT due to the proximity to countries where it is still used. Methods: Seventy-two consecutive lactating women were prospectively included in Tenerife, Canary Islands (Spain). A validated questionnaire was used to obtain socioeconomic, demographics data, and daily habits during pregnancy. DDT levels in breast milk were measured by gas chromatography with-electron capture detector (GC-ECD). Anthropometrics measurements in newborns were obtained. Results: Thirty-four out of 72 (47.2%) of the analysed milk samples presented detectable levels of DDT (mean: 0.92 ng/g), ranging between 0.08 to 16.96 ng/g. The socio-demographic variables did not significantly differ between detectable DDT and non-detectable DDT groups. We found positive association between DDT levels and vegetables (OR (95% CI): 1.23 (1.01-1.50)) and poultry meat (OR (95% CI): 2.05 (1.16-3.60)) consumption, and also between the presence of DDT in breast milk and gestational age (OR (95% CI): 0.59 (0.40-0.90)). Conclusions: DDT is present in breast milk of women at the time of delivery. Residual levels and the spread from countries still using DDT explain DDT detection from vegetables and from animal origin food. The presence of this compound in breast milk represents a pre- and postnatal exposure hazard for foetuses and infants due to chronic bioaccumulation and poor elimination, with possible deleterious effects on health. This data should be used to raise awareness of the risks of OCs exposure and to help establish health policies in order to avoid its use worldwide and thus, to prevent its propagation.	[Vall, Oriol; Puig, Carme; Gomez Baltazar, Arelis; Canchucaja, Lizzeth; Joya, Xavier; Garcia-Algar, Oscar] Inst Hosp Mar Invest Mediques IMIM, URIE, Barcelona, Spain; [Vall, Oriol; Puig, Carme; Joya, Xavier; Garcia-Algar, Oscar] Inst Salud Carlos III, Red Salud Maternoinfantil & Desarrollo SAMID, Madrid, Spain; [Vall, Oriol; Gomez Baltazar, Arelis; Canchucaja, Lizzeth; Garcia-Algar, Oscar] Univ Autonoma Barcelona, Dept Pediat Obstet Ginecol & Med Prevent, E-08193 Barcelona, Spain; [Gomez-Culebras, Mario; Rodriguez-Carrasco, Ernesto] Univ Tenerife, Hosp Candelaria, Dept Cirugia Pediat, Santa Cruz De Tenerife, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Instituto de Salud Carlos III; Autonomous University of Barcelona	Garcia-Algar, O (corresponding author), Inst Hosp Mar Invest Mediques IMIM, URIE, Barcelona, Spain.	90458@parcdesalutmar.cat		GARCIA-ALGAR, OSCAR/0000-0001-5708-4362				AHLBORG UG, 1992, EUR J PHARM-ENVIRON, V228, P179, DOI 10.1016/0926-6917(92)90029-C; AHLBORG UG, 1995, CRIT REV TOXICOL, V25, P463, DOI 10.3109/10408449509017924; Akkina JE, 2004, J TOXICOL ENV HEAL A, V67, P1407, DOI 10.1080/15287390490483845; ALAWI MA, 1992, ARCH ENVIRON CON TOX, V23, P235, DOI 10.1007/BF00212281; Algar OG, 2004, INDOOR AIR, V14, P298, DOI 10.1111/j.1600-0668.2004.00256.x; Allen RH, 1997, ENVIRON HEALTH PERSP, V105, P679, DOI 10.2307/3433389; Arrebola JP, 2012, ENVIRON INT, V38, P54, DOI 10.1016/j.envint.2011.08.006; Botella B, 2004, ENVIRON RES, V96, P34, DOI 10.1016/j.envres.2003.10.001; Bouwman H, 2012, ENVIRON POLLUT, V170, P63, DOI 10.1016/j.envpol.2012.06.009; Burke ER, 2003, B ENVIRON CONTAM TOX, V71, P148, DOI 10.1007/s00128-003-0142-x; Cok I, 2012, ENVIRON INT, V40, P63, DOI 10.1016/j.envint.2011.11.012; CORRIGAN PJ, 1990, AUST VET J, V67, P56, DOI 10.1111/j.1751-0813.1990.tb07695.x; Covaci A, 2002, ENVIRON RES, V88, P210, DOI 10.1006/enrs.2002.4334; Cruz S, 2003, SCI TOTAL ENVIRON, V317, P23, DOI 10.1016/S0048-9697(03)00334-6; Diaz-Diaz R, 2001, ENVIRON TOXICOL CHEM, V20, P1958, DOI [10.1002/etc.5620200914, 10.1897/1551-5028(2001)020&lt;1958:ATPFPL&gt;2.0.CO;2]; Ennaceur S, 2008, ENVIRON RES, V108, P86, DOI 10.1016/j.envres.2008.05.005; Farhang L, 2005, AM J EPIDEMIOL, V162, P717, DOI 10.1093/aje/kwi276; Ferrer A., 2003, Anales Sis San Navarra, V26, P155, DOI 10.4321/s1137-66272003000200009; Fontcuberta M, 2008, SCI TOTAL ENVIRON, V389, P52, DOI 10.1016/j.scitotenv.2007.08.043; Gladen BC, 2003, ANN EPIDEMIOL, V13, P151, DOI 10.1016/S1047-2797(02)00268-5; Glynn AW, 2003, ENVIRON HEALTH PERSP, V111, P349, DOI 10.1289/ehp.5456; GOMEZCATALAN J, 1995, B ENVIRON CONTAM TOX, V54, P534, DOI 10.1007/BF00192596; GUITART R, 1990, B ENVIRON CONTAM TOX, V44, P555, DOI 10.1007/BF01700875; Harcz P, 2007, FOOD ADDIT CONTAM A, V24, P713, DOI 10.1080/02652030601185071; Jakszyn P, 2009, CHEMOSPHERE, V76, P1518, DOI 10.1016/j.chemosphere.2009.05.048; Jusko TA, 2006, EPIDEMIOLOGY, V17, P692, DOI 10.1097/01.ede.0000232226.06807.90; Kezios KL, 2013, REPROD TOXICOL, V35, P156, DOI 10.1016/j.reprotox.2012.10.013; Khanjani N, 2006, ENVIRON RES, V101, P373, DOI 10.1016/j.envres.2005.10.003; LaKind JS, 2004, TOXICOL APPL PHARM, V198, P184, DOI 10.1016/j.taap.2003.08.021; Majem LS, 2000, ARCH LATINOAM NUTR, V50, P7; Manosa S, 2003, ENVIRON POLLUT, V122, P351, DOI 10.1016/S0269-7491(02)00334-2; Minh NH, 2004, ENVIRON POLLUT, V129, P431, DOI 10.1016/j.envpol.2003.11.012; Olea N, 1999, TOXICOL IND HEALTH, V15, P151, DOI 10.1191/074823399678846682; Porta M, 2008, GAC SANIT, V22, P248, DOI 10.1157/13123971; Porta M, 2012, SCI TOTAL ENVIRON, V423, P151, DOI 10.1016/j.scitotenv.2012.02.001; Qu WY, 2010, SCI TOTAL ENVIRON, V408, P3133, DOI 10.1016/j.scitotenv.2010.04.023; Ribas-Fito N, 2006, AM J EPIDEMIOL, V164, P955, DOI 10.1093/aje/kwj299; Ridal JJ, 2001, ENVIRON TOXICOL CHEM, V20, P1312, DOI [10.1002/etc.5620200620, 10.1897/1551-5028(2001)020&lt;1312:EONLAP&gt;2.0.CO;2]; Rylander L, 1995, SCAND J WORK ENV HEA, V21, P419, DOI 10.5271/sjweh.57; RYLANDER L, 1995, SCAND J WORK ENV HEA, V21, P368, DOI 10.5271/sjweh.51; Saleh M, 1996, J ENVIRON SCI HEAL B, V31, P241, DOI 10.1080/03601239609372985; Schafer KS, 2002, J EPIDEMIOL COMMUN H, V56, P813, DOI 10.1136/jech.56.11.813; Schinas V, 2000, ARCH ENVIRON HEALTH, V55, P411, DOI 10.1080/00039890009604039; Smith D, 1999, INT J EPIDEMIOL, V28, P179, DOI 10.1093/ije/28.2.179; Tao S, 2009, ENVIRON POLLUT, V157, P497, DOI 10.1016/j.envpol.2008.09.005; UNEP, 2006, C PART STOCKH CONV I; WHO, 2003, HLTH RISKS PERS ORG; Windal I, 2009, SCI TOTAL ENVIRON, V407, P4430, DOI 10.1016/j.scitotenv.2008.11.063; Zumbado M, 2005, SCI TOTAL ENVIRON, V339, P49, DOI 10.1016/j.scitotenv.2004.07.022	49	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83831	10.1371/journal.pone.0083831	http://dx.doi.org/10.1371/journal.pone.0083831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416174	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500077
J	Vashum, KP; McEvoy, M; Milton, AH; Islam, MR; Hancock, S; Attia, J				Vashum, Khanrin P.; McEvoy, Mark; Milton, Abul Hasnat; Islam, Md Rafiqul; Hancock, Stephen; Attia, John			Is Serum Zinc Associated with Pancreatic Beta Cell Function and Insulin Sensitivity in Pre-Diabetic and Normal Individuals? Findings from the Hunter Community Study	PLOS ONE			English	Article							DIABETES-MELLITUS; TRACE-ELEMENTS; RESISTANCE; COPPER; SUPPLEMENTATION; IRON; PATHOGENESIS; DISEASE; OBESITY; RISK	Aim: To determine if there is a difference in serum zinc concentration between normoglycaemic, pre-diabetic and type-2 diabetic groups and if this is associated with pancreatic beta cell function and insulin sensitivity in the former 2 groups. Method: Cross sectional study of a random sample of older community-dwelling men and women in Newcastle, New South Wales, Australia. Beta cell function, insulin sensitivity and insulin resistance were calculated for normoglycaemic and prediabetes participants using the Homeostasis Model Assessment (HOMA-2) calculator. Result: A total of 452 participants were recruited for this study. Approximately 33% (N = 149) had diabetes, 33% (N = 151) had prediabetes and 34% (N = 152) were normoglycaemic. Homeostasis Model Assessment (HOMA) parameters were found to be significantly different between normoglycaemic and prediabetes groups (p<0.001). In adjusted linear regression, higher serum zinc concentration was associated with increased insulin sensitivity (p = 0.01) in the prediabetic group. There was also a significant association between smoking and worse insulin sensitivity. Conclusion: Higher serum zinc concentration is associated with increased insulin sensitivity. Longitudinal studies are required to determine if low serum zinc concentration plays a role in progression from pre-diabetes to diabetes.	[Vashum, Khanrin P.; McEvoy, Mark; Milton, Abul Hasnat; Islam, Md Rafiqul; Hancock, Stephen; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, CCEB, Newcastle, NSW 2300, Australia; [Vashum, Khanrin P.; McEvoy, Mark; Milton, Abul Hasnat; Islam, Md Rafiqul; Hancock, Stephen; Attia, John] Hunter Med Res Inst, Newcastle, NSW, Australia; [Islam, Md Rafiqul] Govt Bangladesh, Minist Hlth & Family Welf, Dhaka, Bangladesh	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Vashum, KP (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, CCEB, Newcastle, NSW 2300, Australia.	Khanrin.vashum@newcastle.edu.au	Attia, John R/F-5376-2013	Attia, John R/0000-0001-9800-1308; Vashum-Johnston, Khanrin/0000-0003-0433-4000; McEvoy, Mark/0000-0002-5505-5557	University of Newcastle; Vincent Fairfax Family Foundation; Lions District Diabetes foundation, Australia	University of Newcastle; Vincent Fairfax Family Foundation; Lions District Diabetes foundation, Australia	The University of Newcastle and Vincent Fairfax Family Foundation funded the Hunter Community study and this study was funded by Lions District Diabetes foundation, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2006, BIOCHEM BIOPH RES CO, V351, P165, DOI 10.1016/j.bbrc.2006.10.014; [Anonymous], 1978, MAIL TELEPHONE SURVE; Beletate V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005525.pub2; Bergman BC, 2012, DIABETES, V61, P3156, DOI 10.2337/db12-0418; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Chen H, 2012, BIOL TRACE ELEM RES, V147, P67, DOI 10.1007/s12011-011-9306-4; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dhingra U, 2009, J HEALTH POPUL NUTR, V27, P632; Ekmekcioglu C, 2001, BIOL TRACE ELEM RES, V79, P205, DOI 10.1385/BTER:79:3:205; Engelgau MM, 2000, DIABETES CARE, V23, P1563, DOI 10.2337/diacare.23.10.1563; Ferrannini E, 2004, DIABETES, V53, pS26, DOI 10.2337/diabetes.53.suppl_3.S26; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Forrer R, 2001, BIOL TRACE ELEM RES, V80, P77, DOI 10.1385/BTER:80:1:77; Hashemipour M, 2009, HORM-INT J ENDOCRINO, V8, P279, DOI 10.14310/horm.2002.1244; Health N, 2009, AUSTR GUIDELINES RED; Islam MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061776; Jayawardena R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-13; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y; Lee JH, 2012, ANN LAB MED, V32, P190, DOI 10.3343/alm.2012.32.3.190; Marreiro Dilina N., 2004, Arq Bras Endocrinol Metab, V48, P234, DOI 10.1590/S0004-27302004000200005; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; Meyer JA, 2009, METALLOMICS, V1, P32, DOI 10.1039/b817203j; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Noormagi A, 2010, BIOCHEM J, V430, P511, DOI 10.1042/BJ20100627; Nriagu J, 2010, ENCY ENV HLTH, P789; Ognjanovic S, 2012, INT J OBES LOND; Olivares M, 2007, NUTRITION, V23, P292, DOI 10.1016/j.nut.2007.01.006; Rahim A, 2011, J PAK MED ASSOC, V61, P853; SCHUHMACHER M, 1994, SCI TOTAL ENVIRON, V148, P67, DOI 10.1016/0048-9697(94)90376-X; Simon SF, 2001, EXP BIOL MED, V226, P43, DOI 10.1177/153537020122600107; Singh RB, 1998, J AM COLL NUTR, V17, P564, DOI 10.1080/07315724.1998.10718804; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Sun Q, 2009, DIABETES CARE, V32, P629, DOI 10.2337/dc08-1913; Tallman DL, 1999, CAN J PHYSIOL PHARM, V77, P919, DOI 10.1139/cjpp-77-12-919; Trirogoff ML, 2007, AM J CLIN NUTR, V86, P1642, DOI 10.1093/ajcn/86.5.1642; Twigg SM, 2007, MED J AUSTRALIA, V186, P461, DOI 10.5694/j.1326-5377.2007.tb00998.x; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; WHO, 2012, DIAB FACT SHEET 312; Wiernsperger N, 2010, WIERNSPERGER RAPIN D, V2; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zargar AH, 1998, POSTGRAD MED J, V74, P665, DOI 10.1136/pgmj.74.877.665; Zheng Y, 2008, HEMOGLOBIN, V32, P135, DOI 10.1080/03630260701727077	43	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83944	10.1371/journal.pone.0083944	http://dx.doi.org/10.1371/journal.pone.0083944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416185	gold, Green Published			2022-12-25	WOS:000329862500087
J	Zhao, DY; Han, LS; He, ZJ; Zhang, J; Zhang, YJ				Zhao, Dongying; Han, Lianshu; He, Zhengjuan; Zhang, Jun; Zhang, Yongjun			Identification of the Plasma Metabolomics as Early Diagnostic Markers between Biliary Atresia and Neonatal Hepatitis Syndrome	PLOS ONE			English	Article							CHOLESTATIC JAUNDICE; INFANTS; BIOMARKERS; ACCURACY; CHILDREN; DISEASE; AMINO	Early detection is the most effective way to improve the clinical outcome of biliary atresia (BA). Emerging metabolomics provides a powerful platform for discovering novel biomarkers and biochemical pathways to improve early diagnosis. The aim of this study is to find the potential biomarkers to distinguish BA from neonatal hepatitis syndrome (NHS) by using a metabolomics method. We comprehensively analyzed the serum metabolites in a total of 124 blood samples from patients with BA or neonatal hepatitis syndrome (NHS) and from normal individuals using advanced metabolomic approaches, and found that the levels of glutarylcarnitine (C5DC) significantly increased in the BA group while the levels of threonine (Thr) significantly rose in the NHS group comparing with the other groups. The levels of glutamic acid (Glu) in the BA group were significantly elevated compared to those in the NHS group, but still lower than the hyperbilirubinemia and normal controls. The levels of propionyl carnitine (C3), isovaleryl carnitine (C5) and glutamine (Gln) were reduced in the BA group compared to those in the NHS group, but still higher than the hyperbilirubinemia and normal controls. This study demonstrates the possibility of metabolomics as non-invasive biomarkers for the early detection of BA and also provides new insight into pathophysiologic mechanisms for BA.	[Zhao, Dongying; Han, Lianshu; He, Zhengjuan; Zhang, Jun; Zhang, Yongjun] Shanghai Jiao Tong Univ, XinHua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Jun; Zhang, Yongjun] MOE, Shanghai, Peoples R China; [Zhang, Jun; Zhang, Yongjun] Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zhang, YJ (corresponding author), Shanghai Jiao Tong Univ, XinHua Hosp, Sch Med, Shanghai 200030, Peoples R China.	zhangyongjun@sjtu.edu.cn	Zhao, Doreen/HHN-5678-2022		Shanghai Natural Science Foundation [11ZR1423800]; Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine; Science Foundation for The Excellent Youth Scholars of Xinhua Hospital	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine; Science Foundation for The Excellent Youth Scholars of Xinhua Hospital	This work was supported by the Shanghai Natural Science Foundation (No. 11ZR1423800), the Program of "New One Hundred Talented People" of the Shanghai Jiaotong University School of Medicine, Science Foundation for The Excellent Youth Scholars of Xinhua Hospital (to Y. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Baumann U, 2012, CLIN RES HEPATOL GAS, V36, P257, DOI 10.1016/j.clinre.2012.03.017; BYRD DJ, 1993, EUR J CLIN CHEM CLIN, V31, P197; Chardot C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-28; Dutta M, 2012, MOL BIOSYST, V8, P3281, DOI 10.1039/c2mb25353d; Esmaili J, 2007, ABDOM IMAGING, V32, P243, DOI 10.1007/s00261-006-9049-4; Feldman AG, 2012, SEMIN PEDIATR SURG, V21, P192, DOI 10.1053/j.sempedsurg.2012.05.003; Fleming KE, 2013, LIVER INT, V33, P525, DOI 10.1111/liv.12099; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021643; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Jimenez-Rivera C, 2013, J PEDIATR GASTR NUTR, V56, P344, DOI 10.1097/MPG.0b013e318282a913; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Kianifar HR, 2013, PEDIATR RADIOL, V43, P905, DOI 10.1007/s00247-013-2623-3; Krahenbuhl S, 2000, HEPATOLOGY, V31, P1217, DOI 10.1053/jhep.2000.8105; Couce ML, 2013, EUR J PAEDIATR NEURO, V17, P383, DOI 10.1016/j.ejpn.2013.01.003; Mack CL, 2012, SEMIN LIVER DIS, V32, P307, DOI 10.1055/s-0032-1329899; Moyer V, 2004, J PEDIATR GASTR NUTR, V39, P115, DOI 10.1097/00005176-200408000-00001; Mushtaq I, 1999, BRIT MED J, V319, P471, DOI 10.1136/bmj.319.7208.471; Noto A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/612032; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Ressom HW, 2012, ANAL CHIM ACTA, V743, P90, DOI 10.1016/j.aca.2012.07.013; Selimoglu MA, 2001, PEDIATR INT, V43, P391, DOI 10.1046/j.1442-200X.2001.01423.x; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005.12.054; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Szavay PO, 2002, EUR J PEDIATR SURG, V12, P248, DOI 10.1055/s-2002-34477; Wang XJ, 2013, HEPATOLOGY, V57, P2072, DOI 10.1002/hep.26130; Xu FG, 2011, MASS SPECTROM REV, V30, P1143, DOI 10.1002/mas.20316; Yang JG, 2009, CLIN IMAG, V33, P439, DOI 10.1016/j.clinimag.2009.01.003; Zabiegaj-Zwick C, 2012, SAMJ S AFR MED J, V102, P890, DOI 10.7196/SAMJ.6163; Zhang AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064381; Zhang AH, 2012, ANAL BIOANAL CHEM, V404, P1239, DOI 10.1007/s00216-012-6117-1; Zhou KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049270; Zytkovicz TH, 2001, CLIN CHEM, V47, P1945	33	15	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85694	10.1371/journal.pone.0085694	http://dx.doi.org/10.1371/journal.pone.0085694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416443	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500263
J	Zwiener, I; Frisch, B; Binder, H				Zwiener, Isabella; Frisch, Barbara; Binder, Harald			Transforming RNA-Seq Data to Improve the Performance of Prognostic Gene Signatures	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; VARIABLE SELECTION; SURVIVAL; REGRESSION; SHRINKAGE; NORMALIZATION	Gene expression measurements have successfully been used for building prognostic signatures, i.e for identifying a short list of important genes that can predict patient outcome. Mostly microarray measurements have been considered, and there is little advice available for building multivariable risk prediction models from RNA-Seq data. We specifically consider penalized regression techniques, such as the lasso and componentwise boosting, which can simultaneously consider all measurements and provide both, multivariable regression models for prediction and automated variable selection. However, they might be affected by the typical skewness, mean-variance-dependency or extreme values of RNA-Seq covariates and therefore could benefit from transformations of the latter. In an analytical part, we highlight preferential selection of covariates with large variances, which is problematic due to the mean-variance dependency of RNA-Seq data. In a simulation study, we compare different transformations of RNA-Seq data for potentially improving detection of important genes. Specifically, we consider standardization, the log transformation, a variance-stabilizing transformation, the Box-Cox transformation, and rank-based transformations. In addition, the prediction performance for real data from patients with kidney cancer and acute myeloid leukemia is considered. We show that signature size, identification performance, and prediction performance critically depend on the choice of a suitable transformation. Rank-based transformations perform well in all scenarios and can even outperform complex variance-stabilizing approaches. Generally, the results illustrate that the distribution and potential transformations of RNA-Seq data need to be considered as a critical step when building risk prediction models by penalized regression techniques.	[Zwiener, Isabella] Univ Med Ctr Mainz, CTH, Mainz, Germany; [Zwiener, Isabella; Frisch, Barbara; Binder, Harald] Univ Med Ctr Mainz, IMBEI, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Zwiener, I (corresponding author), Univ Med Ctr Mainz, CTH, Mainz, Germany.	zwieneri@uni-mainz.de	Binder, Harald/C-7413-2009	Binder, Harald/0000-0002-5666-8662	Federal Ministry of Education and Research [BMBF 01EO1003]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The project was supported by the Federal Ministry of Education and Research (BMBF 01EO1003). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Binder H, 2013, STAT MED, V32, P1778, DOI 10.1002/sim.5490; Binder H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-14; Binder H, 2011, BIOMETRICAL J, V53, P170, DOI 10.1002/bimj.201000152; Boulesteix AL, 2011, BIOMETRICAL J, V53, P673, DOI 10.1002/bimj.201000189; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bullinger L, 2008, BLOOD, V111, P4490, DOI 10.1182/blood-2007-09-115055; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gerds TA, 2007, BIOMETRICS, V63, P1283, DOI 10.1111/j.1541-0420.2007.00832.x; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Li J, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/527610; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tutz G, 2007, COMPUT STAT DATA AN, V51, P6044, DOI 10.1016/j.csda.2006.11.041; Tutz G, 2006, BIOMETRICS, V62, P961, DOI 10.1111/j.1541-0420.2006.00578.x; Van De Wiel MA, 2013, BIOSTATISTICS, V14, P113, DOI 10.1093/biostatistics/kxs031; van Houwelingen HC, 2006, STAT MED, V25, P3201, DOI 10.1002/sim.2353; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; VERWEIJ PJM, 1993, STAT MED, V12, P2305, DOI 10.1002/sim.4780122407; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu H, 2013, BIOSTATISTICS, V14, P232, DOI 10.1093/biostatistics/kxs033; Zytnicki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025988	38	87	87	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85150	10.1371/journal.pone.0085150	http://dx.doi.org/10.1371/journal.pone.0085150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416353	Green Published, gold			2022-12-25	WOS:000329862500221
J	Shin, HJ; Joo, J; Yoon, JH; Yoo, CW; Kim, JY				Shin, Hye-Jin; Joo, Jungnam; Yoon, Ji Hyun; Yoo, Chong Woo; Kim, Joo-Young			Physical Status of Human Papillomavirus Integration in Cervical Cancer Is Associated with Treatment Outcome of the Patients Treated with Radiotherapy	PLOS ONE			English	Article							DISEASE-FREE SURVIVAL; TYPE-16 DNA; INFECTION	Integration of human papillomavirus (HPV) DNA into the host genome is a critical aetiological event in the progression from normal cervix to intraepithelial neoplasm, and finally to invasive cervical cancer. However, there has been little work on how HPV integration status relates to treatment outcome for cervical carcinomas. In the current study, HPV E2 and E6 gene copy numbers were measured in 111 cervical cancer tissues using real-time QPCR. Integration patterns were divided into four groups: single copy-integrated with episomal components (group 1), single copy-integrated without episomal components (group 2), multicopy tandem repetition-integrated (group 3), and low HPV (group 4) groups. A relapse-predicting model was constructed using multivariable Cox proportional hazards model to classify patients into different risk groups for disease-free survival (DFS). The model was internally validated using bootstrap resampling. Oligonucleotide microarray analysis was performed to evaluate gene expression patterns in relation to the different integration groups. DFS rate was inferior in the order of the patients in group 4, group 2/3, and group 1. Multivariate analysis showed that histologic grade, clinical stage group, and integration pattern were significant prognostic factors for poor DFS. The current prognostic model accurately predicted the risk of relapse, with an area under the receiver operating characteristic curve (AUC) of 0.74 (bootstrap corrected, 0.71). In conclusion, these data suggest that HPV integration pattern is a potent prognostic factor for tailored treatment of cervical cancer.	[Shin, Hye-Jin; Kim, Joo-Young] Natl Canc Ctr, Radiat Med Branch, Res Inst & Hosp, Goyang, South Korea; [Joo, Jungnam] Natl Canc Ctr, Biometr Res Branch, Res Inst & Hosp, Goyang, South Korea; [Yoo, Chong Woo] Natl Canc Ctr, Ctr Uterine Canc, Res Inst & Hosp, Goyang, South Korea; [Yoon, Ji Hyun] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); McGill University	Kim, JY (corresponding author), Natl Canc Ctr, Radiat Med Branch, Res Inst & Hosp, Goyang, South Korea.	jooyoungcasa@ncc.re.kr			National Cancer Center, Goyang, Korea [1310300, 1110033]	National Cancer Center, Goyang, Korea	This work was supported by the National Cancer Center, Goyang, Korea (Grant 1310300 and 1110033). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Kim JY, 2009, J CLIN ONCOL, V27, P5088, DOI 10.1200/JCO.2009.22.4659; Kusumoto-Matsuo R, 2011, GENES CELLS, V16, P23, DOI 10.1111/j.1365-2443.2010.01458.x; Li W, 2008, J CANCER RES CLIN, V134, P1355, DOI 10.1007/s00432-008-0413-3; Lindel K, 2006, INT J RADIAT ONCOL, V65, P760, DOI 10.1016/j.ijrobp.2006.01.023; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Pett MR, 2006, P NATL ACAD SCI USA, V103, P3822, DOI 10.1073/pnas.0600078103; Sell S, 2011, CURR PHARM BIOTECHNO, V12, P182, DOI 10.2174/138920111794295675; Shin HJ, 2011, J CELL SCI, V124, P1077, DOI 10.1242/jcs.072207; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; UNGER ER, 1995, J INFECT DIS, V172, P1184, DOI 10.1093/infdis/172.5.1184; Vernon SD, 1997, INT J CANCER, V74, P50, DOI 10.1002/(SICI)1097-0215(19970220)74:1<50::AID-IJC9>3.3.CO;2-P; WAGATSUMA M, 1990, J VIROL, V64, P813, DOI 10.1128/JVI.64.2.813-821.1990	14	27	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e78995	10.1371/journal.pone.0078995	http://dx.doi.org/10.1371/journal.pone.0078995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427262	gold, Green Published, Green Submitted			2022-12-25	WOS:000329868200002
J	Zhao, J; Wan, SZ; Zhang, CL; Liu, ZF; Zhou, LX; Fu, SL				Zhao, Jie; Wan, Songze; Zhang, Chenlu; Liu, Zhanfeng; Zhou, Lixia; Fu, Shenglei			Contributions of Understory and/or Overstory Vegetations to Soil Microbial PLFA and Nematode Diversities in Eucalyptus Monocultures	PLOS ONE			English	Article							PLANT DIVERSITY; ECOSYSTEM; BIODIVERSITY; FOREST; COMMUNITIES; PRODUCTIVITY; GRASSLAND; IDENTITY; PLANTATIONS; DYNAMICS	Ecological interactions between aboveground and belowground biodiversity have received many attentions in the recent decades. Although soil biodiversity declined with the decrease of plant diversity, many previous studies found plant species identities were more important than plant diversity in controlling soil biodiversity. This study focused on the responses of soil biodiversity to the altering of plant functional groups, namely overstory and understory vegetations, rather than plant diversity gradient. We conducted an experiment by removing overstory and/or understory vegetation to compare their effects on soil microbial phospholipid fatty acid (PLFA) and nematode diversities in eucalyptus monocultures. Our results indicated that both overstory and understory vegetations could affect soil microbial PLFA and nematode diversities, which manifested as the decrease in Shannon-Wiener diversity index (H') and Pielou evenness index (J) and the increase in Simpson dominance index (lambda) after vegetation removal. Soil microclimate change explained part of variance of soil biodiversity indices. Both overstory and understory vegetations positively correlated with soil microbial PLFA and nematode diversities. In addition, the alteration of soil biodiversity might be due to a mixing effect of bottom-up control and soil microclimate change after vegetation removal in the studied plantations. Given the studied ecosystem is common in humid subtropical and tropical region of the world, our findings might have great potential to extrapolate to large scales and could be conducive to ecosystem management and service.	[Zhao, Jie; Wan, Songze; Liu, Zhanfeng; Zhou, Lixia; Fu, Shenglei] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Zhang, Chenlu] Henan Univ, Coll Life Sci, State Key Lab Cotton Biol, Key Lab Plant Stress Biol, Kaifeng, Peoples R China; [Zhao, Jie] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Henan University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Fu, SL (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	sfu@scbg.ac.cn	Liu, Zhanfeng/ABD-3933-2021; Zhou, Li/GSE-4531-2022; Fu, Shenglei/B-2729-2012	Liu, Zhanfeng/0000-0002-6602-6196; 	Chinese Academy of Sciences [KSCZ2-EW-Z-6]; Natural Science Fund of China [31210103920]	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCZ2-EW-Z-6) and Natural Science Fund of China (31210103920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell RC, 2008, FOREST ECOL MANAG, V255, P3621, DOI 10.1016/j.foreco.2008.02.049; Bardgett R.D., 2005, Biological Diversity and Function in Soil; Battigelli JP, 2004, CAN J FOREST RES, V34, P1136, DOI [10.1139/x03-267, 10.1139/X03-267]; BIRD GA, 1988, CAN J SOIL SCI, V68, P29, DOI 10.4141/cjss88-003; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Brussaard L, 1997, AMBIO, V26, P563; Busse MD, 1996, SOIL SCI SOC AM J, V60, P1614, DOI 10.2136/sssaj1996.03615995006000060004x; Chen DM, 2011, AGR FOREST METEOROL, V151, P1214, DOI 10.1016/j.agrformet.2011.04.011; De Deyn GB, 2004, OIKOS, V106, P576, DOI 10.1111/j.0030-1299.2004.13265.x; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; FAO, 2006, 103 FAO WORLD SOIL R; Forge TA, 2001, BIOL FERT SOILS, V34, P170, DOI 10.1007/s003740100390; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Hartmann M, 2012, ISME J; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Humphrey JW, 1999, FOREST ECOL MANAG, V113, P11, DOI 10.1016/S0378-1127(98)00413-7; Huston M A, 2000, Science, V289, P1255; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Konneke M, 2003, ENVIRON MICROBIOL, V5, P1064, DOI 10.1046/j.1462-2920.2003.00499.x; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lopez G, 1997, J APPL ECOL, V34, P1257, DOI 10.2307/2405236; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Neher DA, 1994, APPL SOIL ECOL, V1, P17, DOI 10.1016/0929-1393(94)90020-5; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Panesar TS, 2000, PEDOBIOLOGIA, V44, P641, DOI 10.1078/S0031-4056(04)70079-7; SEASTEDT TR, 1981, ECOLOGY, V62, P126, DOI 10.2307/1936676; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Viketoft M, 2005, APPL SOIL ECOL, V30, P90, DOI 10.1016/j.apsoil.2005.02.007; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Wardle DA, 2003, OIKOS, V102, P45, DOI 10.1034/j.1600-0706.2003.12481.x; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Wardle DA, 2006, SOIL BIOL BIOCHEM, V38, P1052, DOI 10.1016/j.soilbio.2005.09.003; Woodward FI, 1996, J VEG SCI, V7, P306, DOI 10.1111/j.1654-1103.1996.tb00489.x; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; Zhao J, 2014, APPL SOIL ECOL, V75, P134, DOI 10.1016/j.apsoil.2013.10.011; Zhao J, 2013, FOREST ECOL MANAG, V310, P80, DOI 10.1016/j.foreco.2013.08.013; Zhao J, 2013, ECOL INDIC, V24, P236, DOI 10.1016/j.ecolind.2012.06.012; Zhao J, 2012, SOIL BIOL BIOCHEM, V49, P78, DOI 10.1016/j.soilbio.2012.02.020; Zhao J, 2011, SOIL BIOL BIOCHEM, V43, P954, DOI 10.1016/j.soilbio.2011.01.010	46	16	21	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85513	10.1371/journal.pone.0085513	http://dx.doi.org/10.1371/journal.pone.0085513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427315	Green Published, gold			2022-12-25	WOS:000329868200056
J	Killer, SC; Blannin, AK; Jeukendrup, AE				Killer, Sophie C.; Blannin, Andrew K.; Jeukendrup, Asker E.			No Evidence of Dehydration with Moderate Daily Coffee Intake: A Counterbalanced Cross-Over Study in a Free-Living Population	PLOS ONE			English	Article							EXERCISE PERFORMANCE; CAFFEINE; HYDRATION; FLUID; WATER; BEVERAGES; INGESTION	It is often suggested that coffee causes dehydration and its consumption should be avoided or significantly reduced to maintain fluid balance. The aim of this study was to directly compare the effects of coffee consumption against water ingestion across a range of validated hydration assessment techniques. In a counterbalanced cross-over design, 50 male coffee drinkers (habitually consuming 3-6 cups per day) participated in two trials, each lasting three consecutive days. In addition to controlled physical activity, food and fluid intake, participants consumed either 4x200 mL of coffee containing 4 mg/kg caffeine (C) or water (W). Total body water (TBW) was calculated pre- and post-trial via ingestion of Deuterium Oxide. Urinary and haematological hydration markers were recorded daily in addition to nude body mass measurement (BM). Plasma was analysed for caffeine to confirm compliance. There were no significant changes in TBW from beginning to end of either trial and no differences between trials (51.5+/-1.4 vs. 51.4+/-1.3 kg, for C and W, respectively). No differences were observed between trials across any haematological markers or in 24 h urine volume (2409+/-660 vs. 2428+/-669 mL, for C and W, respectively), USG, osmolality or creatinine. Mean urinary Na+ excretion was higher in C than W (p = 0.02). No significant differences in BM were found between conditions, although a small progressive daily fall was observed within both trials (0.4+/-0.5 kg; p<0.05). Our data show that there were no significant differences across a wide range of haematological and urinary markers of hydration status between trials. These data suggest that coffee, when consumed in moderation by caffeine habituated males provides similar hydrating qualities to water.	[Killer, Sophie C.; Blannin, Andrew K.; Jeukendrup, Asker E.] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham, W Midlands, England	University of Birmingham	Blannin, AK (corresponding author), Univ Birmingham, Sch Sport & Exercise Sci, Birmingham, W Midlands, England.	A.K.Blannin@bham.ac.uk			Institute for Scientific Information on Coffee (ISIC)	Institute for Scientific Information on Coffee (ISIC)	Funding for this study was provided by the Institute for Scientific Information on Coffee (ISIC). ISIC is a non-profit organisation, devoted to the study and disclosure of science related to coffee and health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1459; Armstrong LE, 2005, INT J SPORT NUTR EXE, V15, P252, DOI 10.1123/ijsnem.15.3.252; Bellisle F, 2010, EUR J CLIN NUTR, V64, P350, DOI 10.1038/ejcn.2010.4; Bird ET, 2005, NEUROUROL URODYNAM, V24, P611, DOI 10.1002/nau.20179; Currell K, 2008, APPL PHYSIOL NUTR ME, V33, P1067, DOI 10.1139/H08-084; Debry G, 1994, COFFEE HLTH; DODD SL, 1993, SPORTS MED, V15, P14, DOI 10.2165/00007256-199315010-00003; DORFMAN LJ, 1970, CLIN PHARMACOL THER, V11, P869; EDDY NATHAN B., 1928, JOUR PHARMACOL & EXP THERAPEUT, V33, P167; FISHER SM, 1986, INT J SPORTS MED, V7, P276, DOI 10.1055/s-2008-1025774; Fredholm B B, 1984, Prog Clin Biol Res, V158, P303; Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883; Grandjean AC, 2000, J AM COLL NUTR, V19, P591, DOI 10.1080/07315724.2000.10718956; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; IOM (Institute of medicine), 2004, DIET REF INT WAT POT; Jequier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111; Kleiner SM, 1999, J AM DIET ASSOC, V99, P200, DOI 10.1016/S0002-8223(99)00048-6; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Lote CJ., 2012, PRINCIPLES RENAL PHY, DOI [10.1007/978-1-4614-3785-7, DOI 10.1007/978-1-4614-3785-7]; Metabolic Solutions Inc, 2009, MEAS TOT BOD WAT EXT; NeuhauserBerthold M, 1997, ANN NUTR METAB, V41, P29, DOI 10.1159/000177975; NUSSBERGER J, 1990, J CARDIOVASC PHARM, V15, P685, DOI 10.1097/00005344-199005000-00001; Osswald Hartmut, 2011, Handb Exp Pharmacol, P391, DOI 10.1007/978-3-642-13443-2_15; PASSMORE AP, 1987, CLIN SCI, V72, P749, DOI 10.1042/cs0720749; Perrier Erica, 2013, Br J Nutr, V109, P1678, DOI 10.1017/S0007114512003601; Riesenhuber A, 2006, AMINO ACIDS, V31, P81, DOI 10.1007/s00726-006-0363-5; ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124; Ruxton CH, 2011, BRIT J NUTR, V106, P588, DOI 10.1017/S0007114511000456; Silva A, 2013, APPL PHYSL NUTR META; The Fairtrade Foundation, 2012, FAIRTR COFF REP; WaterAid, 2012, HYDR TIPS WATERAID 2; Wemple RD, 1997, INT J SPORTS MED, V18, P40, DOI 10.1055/s-2007-972593	32	34	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84154	10.1371/journal.pone.0084154	http://dx.doi.org/10.1371/journal.pone.0084154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416202	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300019
J	Wang, SY; Teng, QY; Jia, L; Sun, XY; Wu, YP; Zhou, JY				Wang, Sanying; Teng, Qiaoyang; Jia, Lu; Sun, Xiaoyuan; Wu, Yongping; Zhou, Jiyong			Infectious Bursal Disease Virus Influences the Transcription of Chicken gamma(c) and gamma(c) Family Cytokines during Infection	PLOS ONE			English	Article							IN-VITRO EXPRESSION; T-CELLS; CHAIN; INTERLEUKIN-2; PROLIFERATION; ANTIBODY	Infectious bursal disease virus (IBDV) infection causes immunodeficiency in chickens. To understand cell-mediated immunity during IBDV infection, this study perform a detailed analysis of chicken gamma(c) chain (chCD132) and gamma(c) family cytokines, including interleukins 2, 4, 7, 9, and 15. The mouse anti-chCD132 monoclonal antibody (mAb) was first generated by the E.coli-expressed gamma(c) protein. Immunofluorescence assay further showed that gamma(c) was a protein located with the anti-chCD132 mAb on the surface of chicken's splenic mononuclear cells. Real-time quantitative RT-PCR revealed that the chCD132 mRNA transcript was persistently downregulated in embryo fibroblasts, spleen and thymus of chickens infected with IBDV. Correspondingly during IBDV infection, the transcription of five gamma(c) family cytokines was downregulated in the thymus and presented an imbalance in the spleen. Fluorescence-activated cell sorting analyses also indicated that the percentage of CD132(+)CD8(+) T cells linearly decreased in the bursa of IBDV-infected chickens. These results confirmed that IBDV infection disturbed the in vivo balance of CD132 and gamma(c) family cytokine expression and that IBDV-induced immunodeficiency involved cellular networks related to the gamma(c) family.	[Wang, Sanying; Teng, Qiaoyang; Jia, Lu; Sun, Xiaoyuan; Zhou, Jiyong] Zhejiang Univ, Key Lab Anim Virol, Minist Agr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Jiyong] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Yongping] Zhejiang A&F Univ, Coll Anim Sci & Technol, Linan, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang A&F University	Wu, YP (corresponding author), Zhejiang A&F Univ, Coll Anim Sci & Technol, Linan, Zhejiang, Peoples R China.	wypzxd2002@163.com; jyzhou@zju.edu.cn			NSFC [31001075]; National Science and Technology Support Program [2010BAD04B01-10]; Key Scientific and Technological Innovation Team of Zhejiang Province [2010R50031]; China Agriculture Research System [CARS-41-K11]; Chinese Universities Scientific Fund; Zhejiang AF University [2012FR021, 2012FR061]; Zhejiang Provincial Natural Science Foundation [LQ12C17001]	NSFC(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program; Key Scientific and Technological Innovation Team of Zhejiang Province; China Agriculture Research System; Chinese Universities Scientific Fund; Zhejiang AF University; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was funded by NSFC (31001075), National Science and Technology Support Program (grant number 2010BAD04B01-10), Key Scientific and Technological Innovation Team of Zhejiang Province (2010R50031), China Agriculture Research System (CARS-41-K11) and Chinese Universities Scientific Fund, Zhejiang A&F University Talent Starting Program (2012FR021, 2012FR061), and Zhejiang Provincial Natural Science Foundation (grant number LQ12C17001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorosi S, 2009, J IMMUNOL, V182, P3304, DOI 10.4049/jimmunol.0802400; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; Crawley AM, 2010, EUR J IMMUNOL, V40, P1396, DOI 10.1002/eji.200940093; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Gu JY, 2010, DEV COMP IMMUNOL, V34, P258, DOI 10.1016/j.dci.2009.10.003; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Liu HW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-364; Marino JH, 2010, HUM IMMUNOL, V71, P329, DOI 10.1016/j.humimm.2010.01.009; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Shi LX, 2009, VIRUS GENES, V39, P46, DOI 10.1007/s11262-008-0313-2; Sun JC, 2009, J IMMUNOL, V183, P2911, DOI 10.4049/jimmunol.0901872; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tanimura N, 1998, J COMP PATHOL, V118, P15, DOI 10.1016/S0021-9975(98)80024-8; Teng QY, 2006, FEBS LETT, V580, P4274, DOI 10.1016/j.febslet.2006.06.044; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wang YZ, 2009, MOL IMMUNOL, V46, P1964, DOI 10.1016/j.molimm.2009.03.011; Wu YP, 2012, PROTEOMICS, V12, P1844, DOI 10.1002/pmic.201100479; Wu YP, 2009, ARCH VIROL, V154, P1873, DOI 10.1007/s00705-009-0524-4; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200; Zheng XJ, 2006, DNA CELL BIOL, V25, P646, DOI 10.1089/dna.2006.25.646; Zhou JY, 2006, J GEN VIROL, V87, P1823, DOI 10.1099/vir.0.81800-0; Zhou JY, 2005, MOL IMMUNOL, V42, P589, DOI 10.1016/j.molimm.2004.09.014	25	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84503	10.1371/journal.pone.0084503	http://dx.doi.org/10.1371/journal.pone.0084503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416239	gold, Green Submitted, Green Published			2022-12-25	WOS:000329866300026
J	Werden, L; Barker, IK; Bowman, J; Gonzales, EK; Leighton, PA; Lindsay, LR; Jardine, CM				Werden, Lisa; Barker, Ian K.; Bowman, Jeff; Gonzales, Emily K.; Leighton, Patrick A.; Lindsay, L. Robbin; Jardine, Claire M.			Geography, Deer, and Host Biodiversity Shape the Pattern of Lyme Disease Emergence in the Thousand Islands Archipelago of Ontario, Canada	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; BLACKLEGGED TICK ACARI; BORRELIA-BURGDORFERI; RANGE EXPANSION; COMMUNITY COMPOSITION; RESERVOIR COMPETENCE; PASSIVE SURVEILLANCE; FOREST FRAGMENTATION; HABITAT DISTRIBUTION; PEROMYSCUS-LEUCOPUS	In the Thousand Islands region of eastern Ontario, Canada, Lyme disease is emerging as a serious health risk. The factors that influence Lyme disease risk, as measured by the number of blacklegged tick (Ixodes scapularis) vectors infected with Borrelia burgdorferi, are complex and vary across eastern North America. Despite study sites in the Thousand Islands being in close geographic proximity, host communities differed and both the abundance of ticks and the prevalence of B. burgdorferi infection in them varied among sites. Using this archipelago in a natural experiment, we examined the relative importance of various biotic and abiotic factors, including air temperature, vegetation, and host communities on Lyme disease risk in this zone of recent invasion. Deer abundance and temperature at ground level were positively associated with tick abundance, whereas the number of ticks in the environment, the prevalence of B. burgdorferi infection, and the number of infected nymphs all decreased with increasing distance from the United States, the presumed source of this new endemic population of ticks. Higher species richness was associated with a lower number of infected nymphs. However, the relative abundance of Peromyscus leucopus was an important factor in modulating the effects of species richness such that high biodiversity did not always reduce the number of nymphs or the prevalence of B. burgdorferi infection. Our study is one of the first to consider the interaction between the relative abundance of small mammal hosts and species richness in the analysis of the effects of biodiversity on disease risk, providing validation for theoretical models showing both dilution and amplification effects. Insights into the B. burgdorferi transmission cycle in this zone of recent invasion will also help in devising management strategies as this important vector-borne disease expands its range in North America.	[Werden, Lisa; Barker, Ian K.; Jardine, Claire M.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Werden, Lisa] Pk Canada Agcy, Mallorytown, ON, Canada; [Barker, Ian K.; Jardine, Claire M.] Canadian Cooperat Wildlife Hlth Ctr, Guelph, ON, Canada; [Bowman, Jeff] Ontario Minist Nat Resources, Peterborough, ON, Canada; [Gonzales, Emily K.] Univ Victoria, Victoria, BC, Canada; [Leighton, Patrick A.] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada; [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Winnipeg, MB, Canada	University of Guelph; Ministry of Natural Resources & Forestry; University of Victoria; Universite de Montreal; Public Health Agency of Canada	Jardine, CM (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	cjardi01@uoguelph.ca	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469; Lindsay, Robbin/0000-0001-7236-2930	University of Guelph; Canadian Cooperative Wildlife Health Centre; Ontario Ministry of Natural Resources; Parks Canada Agency; Public Health Agency of Canada; Natural Sciences and Engineering and Research Council of Canada; Ontario Graduate Scholarship	University of Guelph; Canadian Cooperative Wildlife Health Centre; Ontario Ministry of Natural Resources; Parks Canada Agency; Public Health Agency of Canada; Natural Sciences and Engineering and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	Funding for this study was provided by the University of Guelph (CJ), Canadian Cooperative Wildlife Health Centre (IKB), Ontario Ministry of Natural Resources (JB), Parks Canada Agency (EKG), Public Health Agency of Canada (LRL), Natural Sciences and Engineering and Research Council of Canada (CJ; www.nserc.ca), and an Ontario Graduate Scholarship (LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Employees and/or students with all funding agencies assisted with data collection.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Anderson JM, 2006, APPL ENVIRON MICROB, V72, P5331, DOI 10.1128/AEM.00014-06; [Anonymous], [No title captured]; Bertrand MR, 1996, J MED ENTOMOL, V33, P619, DOI 10.1093/jmedent/33.4.619; Bouchard C, 2013, J MED ENTOMOL, V50, P384, DOI 10.1603/ME12093; Bouchard C, 2011, TICKS TICK-BORNE DIS, V2, P183, DOI 10.1016/j.ttbdis.2011.03.005; Bowman J, 2002, CONSERV ECOL, V6; Brisson D, 2008, P ROY SOC B-BIOL SCI, V275, P227, DOI 10.1098/rspb.2007.1208; Brunner JL, 2008, J MED ENTOMOL, V45, P139, DOI 10.1603/0022-2585(2008)45[139:ERCOBB]2.0.CO;2; DANIELS TJ, 1995, J MED ENTOMOL, V32, P5, DOI 10.1093/jmedent/32.1.5; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Durden L. A., 1996, NYMPHS GENUS IXODES; Eder T., 2002, MAMMALS ONTARIO; Eisen Lars, 2002, P91, DOI 10.1079/9780851996325.0091; Giardina AR, 2000, CAN J ZOOL, V78, P2184, DOI 10.1139/cjz-78-12-2184; Ginsberg HS, 2005, J MED ENTOMOL, V42, P445, DOI 10.1603/0022-2585(2005)042[0445:RCONNA]2.0.CO;2; Ginsberg HS, 1996, EXP APPL ACAROL, V20, P533, DOI 10.1007/BF00048285; Glavanakov S, 2001, AM J TROP MED HYG, V65, P538, DOI 10.4269/ajtmh.2001.65.538; Gray JS, 1998, ZBL BAKT-INT J MED M, V287, P211, DOI 10.1016/S0934-8840(98)80123-0; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Jackson CA, 2002, J CLIN MICROBIOL, V40, P2070, DOI 10.1128/JCM.40.6.2070-2073.2002; Jordan RA, 2005, ENVIRON ENTOMOL, V34, P801, DOI 10.1603/0046-225X-34.4.801; Jordan RA, 2007, J MED ENTOMOL, V44, P752, DOI 10.1603/0022-2585(2007)44[752:EORDDO]2.0.CO;2; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Krohne DT, 1999, CAN J ZOOL, V77, P1247, DOI 10.1139/cjz-77-8-1247; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; LINDSAY LR, 1995, J MED ENTOMOL, V32, P143, DOI 10.1093/jmedent/32.2.143; Lindsay LR, 1998, J MED ENTOMOL, V35, P189, DOI 10.1093/jmedent/35.3.189; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Madhav NK, 2004, J MED ENTOMOL, V41, P842, DOI 10.1603/0022-2585-41.5.842; MATHER TN, 1989, AM J EPIDEMIOL, V130, P143, DOI 10.1093/oxfordjournals.aje.a115306; NEFF DJ, 1968, J WILDLIFE MANAGE, V32, P597, DOI 10.2307/3798941; Nupp TE, 1998, J MAMMAL, V79, P1234, DOI 10.2307/1383014; Ogden N H, 2008, Can Commun Dis Rep, V34, P1; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Ogden NH, 2009, EPIDEMICS-NETH, V1, P196, DOI 10.1016/j.epidem.2009.06.002; Ogden NH, 2004, J MED ENTOMOL, V41, P622, DOI 10.1603/0022-2585-41.4.622; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Ostfeld RS, 2001, VECTOR-BORNE ZOONOT, V1, P55, DOI 10.1089/153036601750137688; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ostfeld RS, 2002, CONSERVATION MEDICINE, P207; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Piesman Joseph, 2002, P223, DOI 10.1079/9780851996325.0223; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2016, R FDN STAT COMP; Rand PW, 2004, J MED ENTOMOL, V41, P779, DOI 10.1603/0022-2585-41.4.779; Rand PW, 2003, J MED ENTOMOL, V40, P179, DOI 10.1603/0022-2585-40.2.179; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Schulze TL, 2009, J MED ENTOMOL, V46, P1025, DOI 10.1603/033.046.0508; SCHULZE TL, 1995, J MED ENTOMOL, V32, P730, DOI 10.1093/jmedent/32.5.730; SPIELMAN A, 1984, YALE J BIOL MED, V57, P507; STAFFORD KC, 1993, J MED ENTOMOL, V30, P986, DOI 10.1093/jmedent/30.6.986; Swei A, 2011, P ROY SOC B-BIOL SCI, V278, P2970, DOI 10.1098/rspb.2010.2402; Talleklint L, 1996, J MED ENTOMOL, V33, P805, DOI 10.1093/jmedent/33.5.805; TELFORD SR, 1988, AM J TROP MED HYG, V39, P105, DOI 10.4269/ajtmh.1988.39.105; Thompson L, 2010, THESIS TRENT U PETER; Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842; Van Wieren J, 2008, ST LAWRENCE ISLANDS; VANBUSKIRK J, 1995, ECOL APPL, V5, P1133, DOI 10.2307/2269360; Werden L, 2012, THESIS U GUELPH GUEL; WHITE DJ, 1991, JAMA-J AM MED ASSOC, V266, P1230, DOI 10.1001/jama.266.9.1230; YUVAL B, 1990, J MED ENTOMOL, V27, P196, DOI 10.1093/jmedent/27.2.196; Zuur Alain F., 2009, P1	80	70	70	0	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85640	10.1371/journal.pone.0085640	http://dx.doi.org/10.1371/journal.pone.0085640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416435	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300094
J	Li, H; Liu, YS; Gong, PH; Zhang, CS; Ye, JP				Li, Han; Liu, Yashu; Gong, Pinghua; Zhang, Changshui; Ye, Jieping		Alzheimers Dis Neuroimaging Initia	Hierarchical Interactions Model for Predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) Conversion	PLOS ONE			English	Article							VARIABLE SELECTION; IMAGING GENETICS; BIOMARKERS; REGRESSION	Identifying patients with Mild Cognitive Impairment (MCI) who are likely to convert to dementia has recently attracted increasing attention in Alzheimer's disease (AD) research. An accurate prediction of conversion from MCI to AD can aid clinicians to initiate treatments at early stage and monitor their effectiveness. However, existing prediction systems based on the original biosignatures are not satisfactory. In this paper, we propose to fit the prediction models using pairwise biosignature interactions, thus capturing higher-order relationship among biosignatures. Specifically, we employ hierarchical constraints and sparsity regularization to prune the high-dimensional input features. Based on the significant biosignatures and underlying interactions identified, we build classifiers to predict the conversion probability based on the selected features. We further analyze the underlying interaction effects of different biosignatures based on the so-called stable expectation scores. We have used 293 MCI subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) database that have MRI measurements at the baseline to evaluate the effectiveness of the proposed method. Our proposed method achieves better classification performance than state-of-the-art methods. Moreover, we discover several significant interactions predictive of MCI-to-AD conversion. These results shed light on improving the prediction performance using interaction features.	[Li, Han; Gong, Pinghua; Zhang, Changshui] Tsinghua Univ, Dept Automat, State Key Lab Intelligent Technol & Syst, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China; [Liu, Yashu; Ye, Jieping] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ USA	Tsinghua University; Arizona State University; Arizona State University-Tempe	Zhang, CS (corresponding author), Tsinghua Univ, Dept Automat, State Key Lab Intelligent Technol & Syst, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China.	zcs@mail.tsinghua.edu.cn			973 Program [2013CB329503]; NSFC [91120301, 61075004, 61021063]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors' research was supported by 973 Program (2013CB329503) and NSFC (Grant No. 91120301, No. 61075004 and No. 61021063). Data collection and sharing for our project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ANDI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research \& Development, LLC.; Johnson \& Johnson Pharmaceutical Research \& Development LLC.; Medpace, Inc.; Merck \& Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Association A.s., 2010, ALZHEIMERS DEMENT, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2010.01.009]; Bien J, 2012, ARXIV12055050; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chipman H, 1996, CAN J STAT, V24, P17, DOI 10.2307/3315687; Choi NH, 2010, J AM STAT ASSOC, V105, P354, DOI 10.1198/jasa.2010.tm08281; COX DR, 1984, INT STAT REV, V52, P1, DOI 10.2307/1403235; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Llano DA, 2011, ALZ DIS ASSOC DIS, V25, P73, DOI 10.1097/WAD.0b013e3181f5b8d8; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; NELDER JA, 1977, J ROY STAT SOC A STA, V140, P48, DOI 10.2307/2344517; Nemirovski A, 2005, LECT NOTES; Nesterov Y, 2004, INTRO LECT CONVEX OP; Oommen T, 2008, MATH GEOSCI, V40, P409, DOI 10.1007/s11004-008-9156-6; PEIXOTO JL, 1987, AM STAT, V41, P311, DOI 10.2307/2684752; Petersen RC, 2003, NAT REV DRUG DISCOV, V2, P646, DOI 10.1038/nrd1155; Radchenko P, 2010, J AM STAT ASSOC, V105, P1541, DOI 10.1198/jasa.2010.tm10130; Tian XM, 2012, ACM T MULTIM COMPUT, V8, DOI 10.1145/2240136.2240139; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Wang H., 2012, P ADV NEUR INF PROC, P1277; Wang H, 2012, BIOINFORMATICS, V28, pI127, DOI 10.1093/bioinformatics/bts228; Wang H, 2012, BIOINFORMATICS, V28, P229, DOI 10.1093/bioinformatics/btr649; Ye JP, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-46; Zhao Peng, 2006, 703 UC BERK DEP STAT; Zhou TY, 2013, IEEE T IMAGE PROCESS, V22, P244, DOI 10.1109/TIP.2012.2202678; Zhou TY, 2011, DATA MIN KNOWL DISC, V22, P340, DOI 10.1007/s10618-010-0182-x	29	41	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82450	10.1371/journal.pone.0082450	http://dx.doi.org/10.1371/journal.pone.0082450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416143	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500016
J	Liu, YH; Wang, LJ; Huang, KM; Wang, WW; Nie, XL; Jiang, Y; Li, PP; Liu, SS; Xu, P; Tang, HZ				Liu, Yanghui; Wang, Lijuan; Huang, Kaiming; Wang, Weiwei; Nie, Xueling; Jiang, Yi; Li, Pengpeng; Liu, Shanshan; Xu, Ping; Tang, Hongzhi			Physiological and Biochemical Characterization of a Novel Nicotine-Degrading Bacterium Pseudomonas geniculata N1	PLOS ONE			English	Article							STRAIN S16; DEGRADATION; PUTIDA; WASTE; BIODEGRADATION; HYDROXYLASE; CATABOLISM; GENE	Management of solid wastes with high nicotine content, such as those accumulated during tobacco manufacturing, poses a major challenge, which can be addressed by using bacteria such as Pseudomonas and Arthrobacter. In this study, a new species of Pseudomonas geniculata, namely strain N1, which is capable of efficiently degrading nicotine, was isolated and identified. The optimal growth conditions for strain N1 are a temperature of 30 degrees C, and a pH 6.5, at a rotation rate of 120 rpm min(-1) with 1 g l(-1) nicotine as the sole source of carbon and nitrogen. Myosmine, cotinine, 6-hydroxynicotine, 6-hydroxy- N-methylmyosmine, and 6-hydroxy-pseudooxynicotine were detected as the five intermediates through gas chromatography-mass and liquid chromatography-mass analyses. The identified metabolites were different from those generated by Pseudomonas putida strains. The analysis also highlighted the bacterial metabolic diversity in relation to nicotine degradation by different Pseudomonas strains.	[Liu, Yanghui; Wang, Lijuan; Huang, Kaiming; Wang, Weiwei; Nie, Xueling; Jiang, Yi; Li, Pengpeng; Xu, Ping; Tang, Hongzhi] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Liu, Yanghui; Wang, Lijuan; Huang, Kaiming; Wang, Weiwei; Nie, Xueling; Jiang, Yi; Li, Pengpeng; Xu, Ping; Tang, Hongzhi] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Liu, Shanshan] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200030, Peoples R China; [Liu, Shanshan] Shanghai Nucl Engn Res & Design Inst, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tang, HZ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	tanghongzhi@sjtu.edu.cn			Chinese National Natural Science Foundation [31270154, 31230002, 31121064]; National Basic Research Program of China [2013CB733901]; "Shanghai Rising-Star Program'' [13QA1401700]; "Chen Xing'' project from Shanghai Jiaotong University	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); "Shanghai Rising-Star Program''; "Chen Xing'' project from Shanghai Jiaotong University	This work was supported in part by grants from the Chinese National Natural Science Foundation (31270154, 31230002, and 31121064), and from the National Basic Research Program of China (2013CB733901). We also acknowledge the "Shanghai Rising-Star Program'' (13QA1401700) and the "Chen Xing'' project from Shanghai Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandsch R, 2006, APPL MICROBIOL BIOT, V69, P493, DOI 10.1007/s00253-005-0226-0; Chen CM, 2008, INT BIODETER BIODEGR, V62, P226, DOI 10.1016/j.ibiod.2008.01.012; Civilini M, 1997, WASTE MANAGE RES, V15, P349, DOI 10.1177/0734242X9701500403; Cobzaru C, 2011, RES MICROBIOL, V162, P285, DOI 10.1016/j.resmic.2011.01.001; Eberhardt Hans-Jochen, 1995, Beitraege zur Tabakforschung International, V16, P119; FRANK HA, 1962, J BACTERIOL, V84, P68, DOI 10.1128/JB.84.1.68-71.1962; Ganas P, 2008, ARCH MICROBIOL, V189, P511, DOI 10.1007/s00203-007-0340-8; Henningfield JE, 1998, TOB CONTROL, V7, P281, DOI 10.1136/tc.7.3.281; Holmstedt B, 1988, ICSU S SERIES, V9; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lei LP, 2009, ANN MICROBIOL, V59, P247, DOI 10.1007/BF03178324; Li HJ, 2010, APPL MICROBIOL BIOT, V86, P11, DOI 10.1007/s00253-009-2427-4; Novotny TE, 1999, TOB CONTROL, V8, P75, DOI 10.1136/tc.8.1.75; Ruan AD, 2005, RES MICROBIOL, V156, P700, DOI 10.1016/j.resmic.2005.02.010; Tang HZ, 2008, APPL ENVIRON MICROB, V74, P1567, DOI 10.1128/AEM.02529-07; Tang HZ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003923; Tang HZ, 2012, J BACTERIOL, V194, P3553, DOI 10.1128/JB.00625-12; Tang HZ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00377; Tang HZ, 2011, J BIOL CHEM, V286, P39179, DOI 10.1074/jbc.M111.283929; Tang HZ, 2009, APPL ENVIRON MICROB, V75, P772, DOI 10.1128/AEM.02300-08; WADA E, 1953, SCIENCE, V117, P152, DOI 10.1126/science.117.3033.152; Wang HH, 2012, J APPL MICROBIOL, V112, P258, DOI 10.1111/j.1365-2672.2011.05208.x; Wang SN, 2007, MICROBIOL-SGM, V153, P1556, DOI 10.1099/mic.0.2006/005223-0; Wang SN, 2012, APPL MICROBIOL BIOT, V95, P1567, DOI 10.1007/s00253-012-4007-2; Wang SN, 2004, BIOTECHNOL LETT, V26, P1493, DOI 10.1023/B:BILE.0000044450.16235.65; Yuan YJ, 2005, INT BIODETER BIODEGR, V56, P45, DOI 10.1016/j.ibiod.2005.04.002	26	5	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84399	10.1371/journal.pone.0084399	http://dx.doi.org/10.1371/journal.pone.0084399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416227	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500124
J	Rauch, DA; Harding, JC; Ratner, L				Rauch, Daniel A.; Harding, John C.; Ratner, Lee			IL-15 Deficient Tax Mice Reveal a Role for IL-1 alpha in Tumor Immunity	PLOS ONE			English	Article							T-CELL LEUKEMIA; VIRUS TYPE-I; NATURAL-KILLER; STERILE INFLAMMATION; ANTI-CD40 ANTIBODY; FIBROSARCOMA CELLS; INTERLEUKIN 15; MYELOID CELLS; COLON-CANCER; EXPRESSION	IL-15 is recognized as a promising candidate for tumor immunotherapy and has been described as both a promoter of cancer and a promoter of anti-cancer immunity. IL-15 was discovered in cells transformed by HTLV-1, the etiologic agent of adult T cell leukemia/lymphoma (ATL) and the human retrovirus that carries the Tax oncogene. We have developed the TAX-LUC mouse model of ATL in which Tax expression drives both malignant transformation and luciferase expression, enabling non-invasive imaging of tumorigenesis in real time. To identify the role of IL-15 in spontaneous development of lymphoma in vivo, an IL-15(-/-) TAX-LUC strain was developed and examined. The absence of IL-15 resulted in aggressive tumor growth and accelerated mortality and demonstrated that IL-15 was not required for Tax-mediated lymphoma but was essential for anti-tumor immunity. Further analysis revealed a unique transcriptional profile in tumor cells that arise in the absence of IL-15 that included a significant increase in the expression of IL-1 alpha and IL-1 alpha-regulated cytokines. Moreover, anti-IL-1 alpha antibodies and an IL-1 receptor antagonist (Anakinra) were used to interrogate the potential of IL-1 alpha targeted therapies in this model. Taken together, these findings identify IL-15 and IL-1 alpha as therapeutic targets in lymphoma.	[Rauch, Daniel A.; Harding, John C.; Ratner, Lee] Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA	Washington University (WUSTL)	Ratner, L (corresponding author), Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA.	lratner@dom.wustl.edu		Ratner, Lee/0000-0003-2744-7294	PHS [CA94056, CA10073, CA63417]; NATIONAL CANCER INSTITUTE [P50CA094056, R01CA063417] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	PHS grants CA94056, CA10073, and CA63417. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte RN, 2000, ADV EXP MED BIOL, V479, P277; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; Bamford RN, 1996, P NATL ACAD SCI USA, V93, P2897, DOI 10.1073/pnas.93.7.2897; Ben-Sasson SZ, 2011, CYTOKINE, V56, P122, DOI 10.1016/j.cyto.2011.07.006; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Buryskova M, 2004, J BIOL CHEM, V279, P4017, DOI 10.1074/jbc.M306342200; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dvorkin T, 2006, J LEUKOCYTE BIOL, V80, P96, DOI 10.1189/jlb.0905509; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Elkabets M, 2009, J IMMUNOL, V182, P4874, DOI 10.4049/jimmunol.0803916; Gao L, 2005, BLOOD, V106, P4294, DOI 10.1182/blood-2005-04-1730; Gillgrass A, 2011, EXPERT REV CLIN IMMU, V7, P367, DOI [10.1586/ECI.10.102, 10.1586/eci.10.102]; Goon PKC, 2004, J INFECT DIS, V189, P2294, DOI 10.1086/420832; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Hodge DL, 2009, CANCER RES, V69, P3986, DOI 10.1158/0008-5472.CAN-08-3735; Hong DS, 2011, MOL CANCER THER, V10, DOI [10.1158/1535-7163.TARG-11-A211, DOI 10.1158/1535-7163.TARG-11-A211]; Jakobisiak M, 2011, CYTOKINE GROWTH F R, V22, P99, DOI 10.1016/j.cytogfr.2011.04.001; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kuniyasu H, 2003, CLIN CANCER RES, V9, P4802; Kurihara K, 2005, INT J CANCER, V114, P257, DOI 10.1002/ijc.20737; Luedke E, 2012, SURGERY, V152, P431, DOI 10.1016/j.surg.2012.05.035; Marhaba R, 2008, INT J CANCER, V123, P134, DOI 10.1002/ijc.23503; Mishra A, 2012, CANCER CELL, V22, P645, DOI 10.1016/j.ccr.2012.09.009; Moga E, 2011, EXP HEMATOL, V39, P1064, DOI 10.1016/j.exphem.2011.08.006; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; Nakayama Y, 2011, J MED MICROBIOL, V60, P1750, DOI 10.1099/jmm.0.033456-0; Nazarenko I, 2008, NEOPLASIA, V10, P549, DOI 10.1593/neo.08286; Pique C, 1996, J VIROL, V70, P4919, DOI 10.1128/JVI.70.8.4919-4926.1996; Portis T, 2001, BLOOD, V98, P1200, DOI 10.1182/blood.V98.4.1200; Rauch D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-116; Rauch D, 2009, BLOOD, V113, P1493, DOI 10.1182/blood-2008-07-166462; Rider P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00290; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Roberti MP, 2012, BREAST CANCER RES TR, V136, P659, DOI 10.1007/s10549-012-2287-y; Rowan Aileen G, 2012, Leuk Res Treatment, V2012, P391953, DOI 10.1155/2012/391953; Sagawa K, 1996, MICROBIOL IMMUNOL, V40, P373, DOI 10.1111/j.1348-0421.1996.tb01082.x; Saijo S, 2002, ARTHRITIS RHEUM-US, V46, P533, DOI 10.1002/art.10172; Sato N, 2011, BLOOD, V117, P4032, DOI 10.1182/blood-2010-09-307504; Shah MV, 2008, BLOOD, V112, P770, DOI 10.1182/blood-2007-11-121871; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Trentin L, 1996, BLOOD, V87, P3327, DOI 10.1182/blood.V87.8.3327.bloodjournal8783327; WANO Y, 1987, J CLIN INVEST, V80, P911, DOI 10.1172/JCI113152; Weiss JM, 2009, P NATL ACAD SCI USA, V106, P19455, DOI 10.1073/pnas.0909474106; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Zhang ML, 2012, J IMMUNOL, V188, P6156, DOI 10.4049/jimmunol.1102604; Zhang ML, 2009, P NATL ACAD SCI USA, V106, P7513, DOI 10.1073/pnas.0902637106	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85028	10.1371/journal.pone.0085028	http://dx.doi.org/10.1371/journal.pone.0085028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416335	Green Published, gold			2022-12-25	WOS:000329862500206
J	Xu, S; Hermanson, DJ; Banerjee, S; Ghebreselasie, K; Clayton, GM; Garavito, RM; Marnett, LJ				Xu, Shu; Hermanson, Daniel J.; Banerjee, Surajit; Ghebreselasie, Kebreab; Clayton, Gina M.; Garavito, R. Michael; Marnett, Lawrence J.			Oxicams Bind in a Novel Mode to the Cyclooxygenase Active Site via a Two-water-mediated H-bonding Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclooxygenase (COX) Pathway; Drug Action; Enzyme Structure; Protein Drug Interactions; X-ray Crystallography	STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ANTIINFLAMMATORY ACTIVITY; SELECTIVE-INHIBITION; ARACHIDONIC-ACID; NSAID BINDING; COX-2; OXYGENATION; MECHANISM; INSIGHTS	Background: The oxicams are anti-inflammatory drugs targeting the cyclooxygenase enzymes. Results: Crystal complexes of mCOX-2isoxicam, mCOX-2meloxicam, and oCOX-1meloxicam are solved. Conclusion: Oxicams bind to the cyclooxygenase active sites in a novel mode. Significance: The first structural description of cyclooxygenase-oxicam complexes reveal a new binding pocket of inhibitors to cyclooxygenases. Oxicams are widely used nonsteroidal anti-inflammatory drugs (NSAIDs), but little is known about the molecular basis of the interaction with their target enzymes, the cyclooxygenases (COX). Isoxicam is a nonselective inhibitor of COX-1 and COX-2 whereas meloxicam displays some selectivity for COX-2. Here we report crystal complexes of COX-2 with isoxicam and meloxicam at 2.0 and 2.45 angstroms, respectively, and a crystal complex of COX-1 with meloxicam at 2.4 angstroms. These structures reveal that the oxicams bind to the active site of COX-2 using a binding pose not seen with other NSAIDs through two highly coordinated water molecules. The 4-hydroxyl group on the thiazine ring partners with Ser-530 via hydrogen bonding, and the heteroatom of the carboxamide ring of the oxicam scaffold interacts with Tyr-385 and Ser-530 through a highly coordinated water molecule. The nitrogen atom of the thiazine and the oxygen atom of the carboxamide bind to Arg-120 and Tyr-355 via another highly ordered water molecule. The rotation of Leu-531 in the structure opens a novel binding pocket, which is not utilized for the binding of other NSAIDs. In addition, a detailed study of meloxicamCOX-2 interactions revealed that mutation of Val-434 to Ile significantly reduces inhibition by meloxicam due to subtle changes around Phe-518, giving rise to the preferential inhibition of COX-2 over COX-1.	[Xu, Shu; Hermanson, Daniel J.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Bi, Nashville, TN 37232 USA; [Xu, Shu; Hermanson, Daniel J.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Ch, Nashville, TN 37232 USA; [Xu, Shu; Hermanson, Daniel J.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Ph, Nashville, TN 37232 USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Banerjee, Surajit] Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA; [Clayton, Gina M.; Garavito, R. Michael] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Michigan State University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Bi, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu	Xu, Shu/K-6089-2013; Xu, Shu/O-6667-2019	Xu, Shu/0000-0002-6876-7991; Xu, Shu/0000-0002-6876-7991; Banerjee, Surajit/0000-0002-9414-7163	National Institutes of Health Research and Training Grants [CA089450, GM15431, DA031572]; National Institutes of Health from the NIGMS [P41 GM103403]; United States DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P41GM103403, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA031572] Funding Source: NIH RePORTER	National Institutes of Health Research and Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Research and Training Grants CA089450 (to L. J. M.), GM15431 (to L. J. M.), and DA031572 (to D. J. H.). This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by National Institutes of Health Grant P41 GM103403 from the NIGMS. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BINDER D, 1987, J MED CHEM, V30, P678, DOI 10.1021/jm00387a017; CARTY TJ, 1993, AGENTS ACTIONS, V39, P157, DOI 10.1007/BF01998969; Davies NM, 1999, CLIN PHARMACOKINET, V36, P115, DOI 10.2165/00003088-199936020-00003; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARRE AJ, 1986, METHOD FIND EXP CLIN, V8, P407; Fleischmann Roy, 2002, Expert Opin Pharmacother, V3, P1501, DOI 10.1517/14656566.3.10.1501; Forli S, 2012, J MED CHEM, V55, P623, DOI 10.1021/jm2005145; Gupta K, 2004, J MOL BIOL, V335, P503, DOI 10.1016/j.jmb.2003.10.073; Harman CA, 2007, J BIOL CHEM, V282, P28096, DOI 10.1074/jbc.M701335200; Ho JM, 2010, J PHYS CHEM A, V114, P11992, DOI 10.1021/jp107890p; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalgutkar AS, 1998, J MED CHEM, V41, P4800, DOI 10.1021/jm980303s; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kothekar V, 2001, INDIAN J BIOCHEM BIO, V38, P56; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Lazer ES, 1997, J MED CHEM, V40, P980, DOI 10.1021/jm9607010; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; LOMBARDINO JG, 1971, J MED CHEM, V14, P1171, DOI 10.1021/jm00294a008; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Marnett LJ, 2002, PROSTAG OTH LIPID M, V68-9, P153, DOI 10.1016/S0090-6980(02)00027-8; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Noble S, 1996, DRUGS, V51, P424, DOI 10.2165/00003495-199651030-00007; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; Park H, 2005, J COMPUT AID MOL DES, V19, P17, DOI 10.1007/s10822-005-0098-5; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wang JL, 2010, BIOORG MED CHEM LETT, V20, P7159, DOI 10.1016/j.bmcl.2010.07.054; Windsor MA, 2012, ACS MED CHEM LETT, V3, P759, DOI 10.1021/ml3001616; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	41	79	81	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6799	6808		10.1074/jbc.M113.517987	http://dx.doi.org/10.1074/jbc.M113.517987			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425867	hybrid, Green Published			2022-12-25	WOS:000332389400040
J	Jannig, PR; Moreira, JBN; Bechara, LRG; Bozi, LHM; Bacurau, AV; Monteiro, AWA; Dourado, PM; Wisloff, U; Brum, PC				Jannig, Paulo R.; Moreira, Jose B. N.; Bechara, Luiz R. G.; Bozi, Luiz H. M.; Bacurau, Aline V.; Monteiro, Alex W. A.; Dourado, Paulo M.; Wisloff, Ulrik; Brum, Patricia C.			Autophagy Signaling in Skeletal Muscle of Infarcted Rats	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; EXERCISE CAPACITY; ATROPHY; HYPERTROPHY; DEGRADATION; PATHWAYS; PROTEINS; FISSION; UPDATE; MICE	Background: Heart failure (HF)-induced skeletal muscle atrophy is often associated to exercise intolerance and poor prognosis. Better understanding of the molecular mechanisms underlying HF-induced muscle atrophy may contribute to the development of pharmacological strategies to prevent or treat such condition. It has been shown that autophagy-lysosome system is an important mechanism for maintenance of muscle mass. However, its role in HF-induced myopathy has not been addressed yet. Therefore, the aim of the present study was to evaluate autophagy signaling in myocardial infarction (MI)-induced muscle atrophy in rats. Methods/Principal Findings: Wistar rats underwent MI or Sham surgeries, and after 12 weeks were submitted to echocardiography, exercise tolerance and histology evaluations. Cathepsin L activity and expression of autophagy-related genes and proteins were assessed in soleus and plantaris muscles by fluorimetric assay, qRT-PCR and immunoblotting, respectively. MI rats displayed exercise intolerance, left ventricular dysfunction and dilation, thereby suggesting the presence of HF. The key findings of the present study were: a) upregulation of autophagy-related genes (GABARAPL1, ATG7, BNIP3, CTSL1 and LAMP2) was observed only in plantaris while muscle atrophy was observed in both soleus and plantaris muscles, and b) Cathepsin L activity, Bnip3 and Fis1 protein levels, and levels of lipid hydroperoxides were increased specifically in plantaris muscle of MI rats. Conclusions: Altogether our results provide evidence for autophagy signaling regulation in HF-induced plantaris atrophy but not soleus atrophy. Therefore, autophagy-lysosome system is differentially regulated in atrophic muscles comprising different fiber-types and metabolic characteristics.	[Jannig, Paulo R.; Brum, Patricia C.] Univ Sao Paulo, Expt Physiopathol Med Sch, Sao Paulo, Brazil; [Jannig, Paulo R.; Moreira, Jose B. N.; Bechara, Luiz R. G.; Bozi, Luiz H. M.; Bacurau, Aline V.; Monteiro, Alex W. A.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Dourado, Paulo M.] Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil; [Moreira, Jose B. N.; Wisloff, Ulrik] Norwegian Univ Sci & Technol, KG Jensen Ctr Exercise Med, N-7034 Trondheim, Norway	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Norwegian University of Science & Technology (NTNU)	Brum, PC (corresponding author), Univ Sao Paulo, Expt Physiopathol Med Sch, Sao Paulo, Brazil.	pcbrum@usp.br	Bozi, Luiz H M/K-5259-2012; Brum, Patricia C/E-6605-2011; Bechara, Luiz R G/K-4095-2012; Bacurau, Aline/F-3293-2012; Bacurau, Aline Villa Nova/AAK-7446-2021; Moreira, Jose/G-1556-2014; Jannig, Paulo Roberto/E-9482-2013; Wisloff, Ulrik/K-2899-2012; Bozi, Luiz/AAT-6126-2020	Bozi, Luiz H M/0000-0002-5698-1181; Brum, Patricia C/0000-0002-4750-6506; Bacurau, Aline/0000-0002-5129-5115; Bacurau, Aline Villa Nova/0000-0002-5129-5115; Jannig, Paulo Roberto/0000-0002-2569-4091; Bechara, Luiz/0000-0002-1642-1008	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP) [2010/14567-4]; FAPESP [2010/50048-1]; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [302201/2011-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	PRJ held a master degree scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP #2010/14567-4). PCB holds grants from FAPESP (#2010/50048-1) and Conselho Nacional de Pesquisa e Desenvolvimento (CNPq #302201/2011-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Attaix Didier, 2008, Curr Opin Support Palliat Care, V2, P262, DOI 10.1097/SPC.0b013e3283196ac2; Bacurau AVN, 2009, J APPL PHYSIOL, V106, P1631, DOI 10.1152/japplphysiol.91067.2008; Bechet D, 2005, INT J BIOCHEM CELL B, V37, P2098, DOI 10.1016/j.biocel.2005.02.029; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Bueno CR, 2010, J APPL PHYSIOL, V109, P702, DOI 10.1152/japplphysiol.00281.2010; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cunha TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041701; Deval C, 2001, BIOCHEM J, V360, P143, DOI 10.1042/0264-6021:3600143; Ferreira JCB, 2008, AM J PHYSIOL-REG I, V294, pR26, DOI 10.1152/ajpregu.00424.2007; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Harrington D, 1997, J AM COLL CARDIOL, V30, P1758, DOI 10.1016/S0735-1097(97)00381-1; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; JONDEAU G, 1992, CIRCULATION, V86, P1351, DOI 10.1161/01.CIR.86.5.1351; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Krum H, 2009, LANCET, V373, P941, DOI 10.1016/S0140-6736(09)60236-1; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li P, 2007, AM J PATHOL, V170, P599, DOI 10.2353/ajpath.2007.060505; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mendes S., 2011, GLOBAL ATLAS CARDIOV; Middlekauff HR, 2010, CIRC-HEART FAIL, V3, P537, DOI 10.1161/CIRCHEARTFAILURE.109.903773; MINOTTI JR, 1993, J APPL PHYSIOL, V75, P373, DOI 10.1152/jappl.1993.75.1.373; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moreira JBN, 2013, J APPL PHYSIOL, V114, P1029, DOI 10.1152/japplphysiol.00760.2012; Musaro A, 2010, CURR OPIN CLIN NUTR, V13, P236, DOI 10.1097/MCO.0b013e3283368188; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; O'Leary MF, 2013, AM J PHYSIOL-CELL PH, V304, pC422, DOI 10.1152/ajpcell.00240.2012; Ogata T, 2010, BIOCHEM BIOPH RES CO, V394, P136, DOI 10.1016/j.bbrc.2010.02.130; Picard MH, 2011, J AM SOC ECHOCARDIOG, V24, P1, DOI 10.1016/j.echo.2010.11.006; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Thomas RL, 2011, AUTOPHAGY, V7, P775, DOI 10.4161/auto.7.7.15536; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	45	36	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85820	10.1371/journal.pone.0085820	http://dx.doi.org/10.1371/journal.pone.0085820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427319	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200060
J	Pereira-Fernandes, A; Dirinck, E; Dirtu, AC; Malarvannan, G; Covaci, A; Van Gaal, L; Vanparys, C; Jorens, PG; Blust, R				Pereira-Fernandes, Anna; Dirinck, Eveline; Dirtu, Alin C.; Malarvannan, Govindan; Covaci, Adrian; Van Gaal, Luc; Vanparys, Caroline; Jorens, Philippe G.; Blust, Ronny			Expression of Obesity Markers and Persistent Organic Pollutants Levels in Adipose Tissue of Obese Patients: Reinforcing the Obesogen Hypothesis?	PLOS ONE			English	Article							GENE-EXPRESSION; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPONECTIN EXPRESSION; ENDOCRINE DISRUPTORS; PERINATAL EXPOSURE; MESSENGER-RNA; ETHER PBDE-99; FACTOR-ALPHA; LEPTIN	Introduction: Persistent Organic Pollutants (POPs) accumulate in adipose tissue and some are described to possess endocrine disrupting capacities. Therefore, it is important to evaluate their effects on key endocrine pathways in adipose tissue (AT), to further evaluate their potential role in metabolic pathologies such as obesity. Objectives: The aim is twofold: (i) evaluate gene expression levels of obesity marker genes, i. e. the adipokines leptin (LEP), adiponectin (ADIPOQ) and Tumor Necrosis Factor alpha (TNF alpha) and the nuclear receptor, Peroxisome Proliferator Activated Receptor gamma (PPAR gamma) in paired subcutaneous (SAT) and visceral (VAT) AT of obese subjects (n = 50) and to relate these values to serum concentrations of LEP and ADIPOQ (ii) evaluate the association of expression levels of marker genes in AT and serum with POP concentrations in AT. Results and Conclusions: Leptin and adiponectin levels in serum were positively correlated to respectively expression levels of leptin in SAT and adiponectin in VAT. Our study shows more significant correlations between gene expression of obesity marker genes and POP concentrations in VAT compared to SAT. Since VAT is more important than SAT in pathologies associated with obesity, this suggests that POPs are able to influence the association between obesity and the development of associated pathologies. Moreover, this finding reveals the importance of VAT when investigating the obesogen hypothesis. Concerning PPAR gamma expression in VAT, negative correlations with polychlorinated biphenyls (PCBs) concentrations were found in non T2D patients. LEP serum concentrations correlated with several PCBs in women whereas in men no correlations were found. This strengthens the potential importance of gender differences in obesity and within the obesogen hypothesis.	[Pereira-Fernandes, Anna; Vanparys, Caroline; Blust, Ronny] Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res SPHERE, B-2020 Antwerp, Belgium; [Dirinck, Eveline; Van Gaal, Luc] Univ Antwerp, Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab, Edegem, Belgium; [Dirtu, Alin C.; Malarvannan, Govindan; Covaci, Adrian] Univ Antwerp, Toxicol Ctr, B-2020 Antwerp, Belgium; [Jorens, Philippe G.] Univ Antwerp, Univ Antwerp Hosp, Dept Clin Pharmacol, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp	Pereira-Fernandes, A (corresponding author), Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res SPHERE, B-2020 Antwerp, Belgium.	Anna.Pereira-Fernandes@ua.ac.be	Covaci, Adrian/A-9058-2008; Malarvannan, Govindan/A-6264-2014; DIRTU, Alin Constantin/P-1525-2014	Covaci, Adrian/0000-0003-0527-1136; Malarvannan, Govindan/0000-0002-2212-8617; DIRTU, Alin Constantin/0000-0002-8144-5807	University of Antwerp (UA) through a GOA project [FA020000/2/3565]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT); UA; Research Scientific Foundation-Flanders (FWO)	University of Antwerp (UA) through a GOA project; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); UA; Research Scientific Foundation-Flanders (FWO)(FWO)	This study was funded by the University of Antwerp (UA) through a GOA project (Endocrine disrupting environmental chemicals: from accumulation to their role in the global 'neuro-endocrine' epidemic of obesity and its metabolic consequences; FA020000/2/3565). APF thanks the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT) for her doctoral scholarship. GM and ACD acknowledge respectively the UA and the Research Scientific Foundation-Flanders (FWO) for their postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Baker NA, 2013, ENVIRON HEALTH PERSP, V121, P105, DOI 10.1289/ehp.1205421; Branchi I, 2002, NEUROTOXICOLOGY, V23, P375, DOI 10.1016/S0161-813X(02)00078-5; Dubois SG, 2006, OBESITY, V14, P1543, DOI 10.1038/oby.2006.178; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elobeid MA, 2010, INT J ENV RES PUB HE, V7, P2988, DOI 10.3390/ijerph7072988; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garaulet M, 2000, EUR J ENDOCRINOL, V143, P657, DOI 10.1530/eje.0.1430657; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Giusti V, 2003, DIABETES, V52, P1673, DOI 10.2337/diabetes.52.7.1673; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Henry RR, 1997, ENDOCRIN METAB CLIN, V26, P553, DOI 10.1016/S0889-8529(05)70267-X; Hoppe AA, 2007, OBESITY, V15, P2942, DOI 10.1038/oby.2007.351; Janesick A, 2011, J STEROID BIOCHEM, V127, P4, DOI 10.1016/j.jsbmb.2011.01.005; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Kim MJ, 2011, ENVIRON HEALTH PERSP, V119, P377, DOI 10.1289/ehp.1002848; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Kouidhi S, 2011, J ENDOCRINOL INVEST, V34, pE16, DOI [10.1007/BF03347056, 10.3275/7204]; La Merrill M, 2013, ENVIRON HEALTH PERSP, V121, P162, DOI 10.1289/ehp.1205485; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; Lee DH, 2006, DIABETES CARE, V29, P2568, DOI 10.2337/dc06-1720; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Lihn AS, 2004, MOL CELL ENDOCRINOL, V219, P9, DOI 10.1016/j.mce.2004.03.002; Lilienthal H, 2006, ENVIRON HEALTH PERSP, V114, P194, DOI 10.1289/ehp.8391; Lyche JL, 2010, J TOXICOL ENV HEAL A, V73, P1032, DOI 10.1080/15287394.2010.481618; Malarvannan G, 2013, ENVIRON INT, V55, P33, DOI 10.1016/j.envint.2013.02.012; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Montague CT, 1998, DIABETES, V47, P1384, DOI 10.2337/diabetes.47.9.1384; Mullerova D, 2007, PHYSIOL RES, V56, P375, DOI 10.33549/physiolres.931022; Mullerova D, 2008, INT J OBESITY, V32, P1875, DOI 10.1038/ijo.2008.169; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pereira-Fernandes A, 2013, MOL CELL ENDOCRINOL, V370, P52, DOI 10.1016/j.mce.2013.02.011; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Samaras K, 2010, OBESITY, V18, P884, DOI 10.1038/oby.2009.443; Suvorov A, 2009, TOXICOLOGY, V260, P126, DOI 10.1016/j.tox.2009.03.018; Tang-Peronard JL, 2011, OBES REV, V12, P622, DOI 10.1111/j.1467-789X.2011.00871.x; Taxvig C, 2012, MOL CELL ENDOCRINOL, V361, P106, DOI 10.1016/j.mce.2012.03.021; Teijeira-Fernandez E, 2011, CYTOKINE, V54, P185, DOI 10.1016/j.cyto.2011.01.016; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VANDERKOOY K, 1993, INT J OBESITY, V17, P187; Wajchenberg BL, 2002, HORM METAB RES, V34, P616, DOI 10.1055/s-2002-38256	44	35	36	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84816	10.1371/journal.pone.0084816	http://dx.doi.org/10.1371/journal.pone.0084816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427296	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200036
J	Aza-Carmona, M; Barca-Tierno, V; Hisado-Oliva, A; Belinchon, A; Gorbenko-del Blanco, D; Rodriguez, JI; Benito-Sanz, S; Campos-Barros, A; Heath, KE				Aza-Carmona, Miriam; Barca-Tierno, Veronica; Hisado-Oliva, Alfonso; Belinchon, Alberta; Gorbenko-del Blanco, Darya; Ignacio Rodriguez, Jose; Benito-Sanz, Sara; Campos-Barros, Angel; Heath, Karen E.			NPPB and ACAN, Two Novel SHOX2 Transcription Targets Implicated in Skeletal Development	PLOS ONE			English	Article							HOMEOBOX GENE SHOX; LERI-WEILL DYSCHONDROSTEOSIS; IDIOPATHIC SHORT STATURE; SINOATRIAL NODE; PAR1 DELETION; EXPRESSION; SOX6; REVEALS; L-SOX5; DIFFERENTIATION	SHOX and SHOX2 transcription factors are highly homologous, with even identical homeodomains. Genetic alterations in SHOX result in two skeletal dysplasias; Leri-Weill dyschondrosteosis (LWD) and Langer mesomelic dysplasia (LMD), while no human genetic disease has been linked to date with SHOX2. SHOX2 is, though, involved in skeletal development, as shown by different knockout mice models. Due to the high homology between SHOX and SHOX2, and their functional redundancy during heart development, we postulated that SHOX2 might have the same transcriptional targets and cofactors as SHOX in limb development. We selected two SHOX transcription targets regulated by different mechanisms: 1) the natriuretic peptide precursor B gene (NPPB) involved in the endochondral ossification signalling and directly activated by SHOX; and 2) Aggrecan (ACAN), a major component of cartilage extracellular matrix, regulated by the cooperation of SHOX with the SOX trio (SOX5, SOX6 and SOX9) via the protein interaction between SOX5/SOX6 and SHOX. Using the luciferase assay we have demonstrated that SHOX2, like SHOX, regulates NPPB directly whilst activates ACAN via its cooperation with the SOX trio. Subsequently, we have identified and characterized the protein domains implicated in the SHOX2 dimerization and also its protein interaction with SOX5/SOX6 and SHOX using the yeast-two hybrid and co-immunoprecipitation assays. Immunohistochemistry of human fetal growth plates from different time points demonstrated that SHOX2 is coexpressed with SHOX and the members of the SOX trio. Despite these findings, no mutation was identified in SHOX2 in a cohort of 83 LWD patients with no known molecular defect, suggesting that SHOX2 alterations do not cause LWD. In conclusion, our work has identified the first cofactors and two new transcription targets of SHOX2 in limb development, and we hypothesize a time-and tissue-specific functional redundancy between SHOX and SHOX2.	[Aza-Carmona, Miriam; Barca-Tierno, Veronica; Hisado-Oliva, Alfonso; Belinchon, Alberta; Benito-Sanz, Sara; Campos-Barros, Angel; Heath, Karen E.] Univ Autonoma Madrid, IdiPAZ, Hosp Univ La Paz, Inst Med & Mol Genet INGEMM, Madrid, Spain; [Aza-Carmona, Miriam; Barca-Tierno, Veronica; Hisado-Oliva, Alfonso; Belinchon, Alberta; Benito-Sanz, Sara; Campos-Barros, Angel; Heath, Karen E.] Inst Salud Carlos III, Ctr Invest Biomed Enfermedades Raras CIBERER, Madrid, Spain; [Gorbenko-del Blanco, Darya] Univ Barcelona, Fac Med, Dept Celular Biol Immunol & Neurosci, Barcelona 7, Spain; [Ignacio Rodriguez, Jose] Hosp Univ La Paz, Dept Pathol, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; Hospital Universitario La Paz	Heath, KE (corresponding author), Univ Autonoma Madrid, IdiPAZ, Hosp Univ La Paz, Inst Med & Mol Genet INGEMM, Madrid, Spain.	karen.heath@salud.madrid.org	Benito-Sanz, Sara/ABB-4188-2021; Heath, Karen Elise/K-7760-2014; Heath, K. E./ABG-4658-2020; del Blanco, Darya Gorbenko/N-6069-2018; Barros, Angel Campos/E-6427-2018	Heath, Karen Elise/0000-0002-5816-7044; Heath, K. E./0000-0002-5816-7044; del Blanco, Darya Gorbenko/0000-0002-9674-2388; Barros, Angel Campos/0000-0003-4649-2971; BENITO-SANZ, SARA/0000-0002-6101-9413; Aza-Carmona, Miriam/0000-0003-4448-9541; Barca Tierno, Veronica/0000-0001-7339-3974	Ministerio de Innovacion y Ciencia [MINECO SAF2012-30871, MICINN SAF2009-08230]; MICINN ("Juan de la Cierva"); CIBERER; Ministerio de Educacion (FPI); Basque Country; MICINN [SAF2009-08230]	Ministerio de Innovacion y Ciencia(Spanish Government); MICINN ("Juan de la Cierva")(Ministry of Science and Innovation, Spain (MICINN)); CIBERER; Ministerio de Educacion (FPI)(National Health and Medical Research Council (NHMRC) of AustraliaGerman Research Foundation (DFG)); Basque Country(Basque Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by the: Ministerio de Innovacion y Ciencia [MINECO SAF2012-30871 y MICINN SAF2009-08230]. Postdoctoral fellowships were awarded from MICINN ("Juan de la Cierva", M. A-C) and CIBERER [S. B-S]. Predoctoral fellowships were awarded from the Ministerio de Educacion (FPI, V. B-T), Basque Country (A. H-S) and MICINN SAF2009-08230 (A. B-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aza-Carmona M, 2011, HUM MOL GENET, V20, P1547, DOI 10.1093/hmg/ddr032; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Benito-Sanz S, 2005, AM J HUM GENET, V77, P533, DOI 10.1086/449313; Benito-Sanz S, 2011, J CLIN ENDOCR METAB, V96, pE404, DOI 10.1210/jc.2010-1689; Benito-Sanz Sara, 2006, Hum Mutat, V27, P1062, DOI 10.1002/humu.9456; Benito-Sanz S, 2012, J MED GENET, V49, P442, DOI 10.1136/jmedgenet-2011-100678; Benito-Sanz S, 2012, EUR J HUM GENET, V20, P125, DOI 10.1038/ejhg.2011.210; Benito-Sanz S, 2006, AM J HUM GENET, V79, P409, DOI 10.1086/506390; Bertorelli R, 2007, CLIN GENET, V72, P490, DOI 10.1111/j.1399-0004.2007.00875.x; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Bobick BE, 2012, J CELL SCI, V125, P6071, DOI 10.1242/jcs.111997; Campos-Barros A, 2007, AM J MED GENET A, V143A, P933, DOI 10.1002/ajmg.a.31676; Chen J, 2009, J MED GENET, V46, P834, DOI 10.1136/jmg.2009.067785; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Decker E, 2011, HUM MOL GENET, V20, P1524, DOI 10.1093/hmg/ddr030; Durand C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045369; Espinoza-Lewis RA, 2011, DEV BIOL, V356, P359, DOI 10.1016/j.ydbio.2011.05.663; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; GRUENEBERG DA, 1995, MOL CELL BIOL, V15, P3318; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Huber C, 2006, J MED GENET, V43, P735, DOI 10.1136/jmg.2006.040998; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; LI T, 1995, SCIENCE, V270, P262, DOI 10.1126/science.270.5234.262; Liu HB, 2011, J BIOL CHEM, V286, P17029, DOI 10.1074/jbc.M111.234252; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Marchini A, 2007, HUM MOL GENET, V16, P3081, DOI 10.1093/hmg/ddm266; Munns CJF, 2004, J CLIN ENDOCR METAB, V89, P4130, DOI 10.1210/jc.2003-032230; NICOLAIDES NC, 1990, BIOTECHNIQUES, V8, P154; Nicolosi A, 2011, J ENDOCRINOL INVES S, V33, P7; Puskaric S, 2010, HUM MOL GENET, V19, P4625, DOI 10.1093/hmg/ddq393; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Schneider KU, 2005, HUM MUTAT, V26, P44, DOI 10.1002/humu.20187; Semina EV, 1998, HUM MOL GENET, V7, P415, DOI 10.1093/hmg/7.3.415; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Sobradillo B, 2002, CURVAS TABLAS CRECIM, P1; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; Tiecke E, 2006, DEV BIOL, V298, P585, DOI 10.1016/j.ydbio.2006.07.008; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Yu L, 2007, DEV BIOL, V306, P549, DOI 10.1016/j.ydbio.2007.03.518; Zinn AR, 2002, AM J MED GENET, V110, P158, DOI 10.1002/ajmg.10422	48	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83104	10.1371/journal.pone.0083104	http://dx.doi.org/10.1371/journal.pone.0083104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421874	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500027
J	Callisaya, ML; Beare, R; Phan, TG; Chen, J; Srikanth, VK				Callisaya, Michele L.; Beare, Richard; Phan, Thanh G.; Chen, Jian; Srikanth, Velandai K.			Global and Regional Associations of Smaller Cerebral Gray and White Matter Volumes with Gait in Older People	PLOS ONE			English	Article							BRAIN; RISK; POPULATION; PARAMETERS; DISORDERS; VELOCITY; ATROPHY; HUMANS; AGE	Background: Gait impairments increase with advancing age and can lead to falls and loss of independence. Brain atrophy also occurs in older age and may contribute to gait decline. We aimed to investigate global and regional relationships of cerebral gray and white matter volumes with gait speed, and its determinants step length and cadence, in older people. Methods: In a population-based study, participants aged >60 years without Parkinson's disease or brain infarcts underwent magnetic resonance imaging and gait measurements using a computerized walkway. Linear regression was used to study associations of total gray and white matter volumes with gait, adjusting for each other, age, sex, height and white matter hyperintensity volume. Other covariates considered in analyses included weight and vascular disease history. Voxel-based morphometry was used to study regional relationships of gray and white matter with gait. Results: There were 305 participants, mean age 71.4 (6.9) years, 54% male, mean gait speed 1.16 (0.22) m/s. Smaller total gray matter volume was independently associated with poorer gait speed (p = 0.001) and step length (p<0.001), but not cadence. Smaller volumes of cortical and subcortical gray matter in bilateral regions important for motor control, vision, perception and memory were independently associated with slower gait speed and shorter steps. No global or regional associations were observed between white matter volume and gait independent of gray matter volume, white matter hyperintensity volume and other covariates. Conclusion: Smaller gray matter volume in bilaterally distributed brain networks serving motor control was associated with slower gait speed and step length, but not cadence.	[Callisaya, Michele L.; Beare, Richard; Phan, Thanh G.; Chen, Jian; Srikanth, Velandai K.] Monash Univ, Dept Med, Southern Clin Sch, Stroke & Ageing Res Grp, Clayton, Vic, Australia; [Callisaya, Michele L.; Srikanth, Velandai K.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia	Monash University; University of Tasmania	Callisaya, ML (corresponding author), Monash Univ, Dept Med, Southern Clin Sch, Stroke & Ageing Res Grp, Clayton, Vic, Australia.	michele.callisaya@monash.edu	Callisaya, Michele/I-2333-2013	Callisaya, Michele/0000-0003-2122-1622; Beare, Richard/0000-0002-7530-5664; Srikanth, Velandai/0000-0002-8442-8981; Chen, Jian/0000-0002-0684-0866	National Health and Medical Research Council (NHMRC) [403000, 491109]; NHMRC/National Heart Foundation [606544]; NHMRC [1034483]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC/National Heart Foundation(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by National Health and Medical Research Council (NHMRC) Grants 403000 and 491109. VS is funded by an NHMRC/National Heart Foundation Career Development Award (606544). MC is funded by an NHMRC Early Career Fellowship (1034483). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Beare R, 2009, NEUROIMAGE, V47, P199, DOI 10.1016/j.neuroimage.2009.03.055; Callisaya ML, 2008, J GERONTOL A-BIOL, V63, P165, DOI 10.1093/gerona/63.2.165; Callisaya ML, 2009, AGE AGEING, V38, P290, DOI 10.1093/ageing/afp017; Cesari M, 2011, JAMA-J AM MED ASSOC, V305, P93, DOI 10.1001/jama.2010.1970; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; de Laat KF, 2012, NEUROIMAGE, V59, P1478, DOI 10.1016/j.neuroimage.2011.08.005; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; de Laat KF, 2010, STROKE, V41, P1652, DOI 10.1161/STROKEAHA.110.583229; Dietz V, 2003, CLIN NEUROPHYSIOL, V114, P1379, DOI 10.1016/S1388-2457(03)00120-2; Fjell AM, 2010, CEREB CORTEX, V20, P2069, DOI 10.1093/cercor/bhp279; Galluzzi S, 2008, NEUROL SCI, V29, pS296, DOI 10.1007/s10072-008-1002-6; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Ikram MA, 2008, NEUROBIOL AGING, V29, P882, DOI 10.1016/j.neurobiolaging.2006.12.012; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Leritz EC, 2011, NEUROIMAGE, V54, P2659, DOI 10.1016/j.neuroimage.2010.10.050; Lord SR, 1996, AGE AGEING, V25, P292, DOI 10.1093/ageing/25.4.292; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Martin KL, 2013, J GERONTOL A-BIOL, V68, P726, DOI 10.1093/gerona/gls224; Meyer JS, 1998, EUR NEUROL, V39, P7, DOI 10.1159/000052064; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Raji CA, 2009, NEUROLOGY, V73, P1899, DOI 10.1212/WNL.0b013e3181c3f293; Rosano C, 2006, NEUROEPIDEMIOLOGY, V26, P52, DOI 10.1159/000089240; Rosano C, 2007, J GERONTOL A-BIOL, V62, P1048, DOI 10.1093/gerona/62.9.1048; Rosano C, 2012, AGE AGEING, V41, P58, DOI 10.1093/ageing/afr113; Rosano C, 2008, J GERONTOL A-BIOL, V63, P1380, DOI 10.1093/gerona/63.12.1380; Rosano C, 2010, NEUROBIOL AGING, V31, P1197, DOI 10.1016/j.neurobiolaging.2008.08.004; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Srikanth V., 2010, AGING HLTH, V6, P123, DOI DOI 10.2217/AHE.09.79; Srikanth V, 2009, STROKE, V40, P175, DOI 10.1161/STROKEAHA.108.524355; Statistics ABo, 2005, POP AG SEX TASM DAT; Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Wang CH, 2008, J NEURAL TRANSM, V115, P1149, DOI 10.1007/s00702-008-0058-z; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005	45	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84909	10.1371/journal.pone.0084909	http://dx.doi.org/10.1371/journal.pone.0084909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416309	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500188
J	Hoffman, MD; Krishnan, E				Hoffman, Martin D.; Krishnan, Eswar			Health and Exercise-Related Medical Issues among 1,212 Ultramarathon Runners: Baseline Findings from the Ultrarunners Longitudinal TRAcking (ULTRA) Study	PLOS ONE			English	Article							STRESS-FRACTURES; 161-KM ULTRAMARATHON; RUNNING INJURIES; HYPONATREMIA; PREVALENCE; PERFORMANCE; STATES; RACE	Regular exercise is associated with substantial health benefits; however, little is known about the health impact of extreme levels of exercise. This study examined the prevalence of chronic diseases, health-care utilization, and risk factors for exercise-related injuries among ultramarathon runners. Retrospective, self-reported enrollment data from an ongoing longitudinal observational study of 1,212 active ultramarathon runners were analyzed. The most prevalent chronic medical conditions were allergies/hay fever (25.1%) and exercise-induced asthma (13.0%), but there was a low prevalence of serious medical issues including cancers (4.5%), coronary artery disease (0.7%), seizure disorders (0.7%), diabetes (0.7%), and human immunodeficiency virus (HIV) infection (0.2%). In the year preceding enrollment, most (64.6%) reported an exercise-related injury that resulted in lost training days (median of 14 days), but little nonattendance of work or school due to illness, injury, or exercise-related medical conditions (medians of 0 days for each). The knee was the most common area of exercise-related injury. Prior year incidence of stress fractures was 5.5% with most (44.5%) involving the foot. Ultramarathon runners who sustained exercise-related injuries were younger (p<0.001) and less experienced (p<0.01) than those without injury. Stress fractures were more common (p<0.01) among women than men. We conclude that, compared with the general population, ultramarathon runners appear healthier and report fewer missed work or school days due to illness or injury. Ultramarathon runners have a higher prevalence of asthma and allergies than the general population, and the prevalence of serious medical issues was nontrivial and should be recognized by those providing medical care to these individuals. Ultramarathon runners, compared with shorter distance runners, have a similar annual incidence of exercise-related injuries but higher proportion of stress fractures involving the foot, and it is the younger and less experienced ultramarathoners who appear most at risk for injury.	[Hoffman, Martin D.] Northern Calif Hlth Care Syst, Dept Vet Affairs, Dept Phys Med & Rehabil, Sacramento, CA USA; [Hoffman, Martin D.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Krishnan, Eswar] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA	University of California System; University of California Davis; Stanford University	Hoffman, MD (corresponding author), Northern Calif Hlth Care Syst, Dept Vet Affairs, Dept Phys Med & Rehabil, Sacramento, CA USA.	martin.hoffman@va.gov	krishnan, Eswar/AAY-1269-2020	Hoffman, Martin/0000-0001-8819-5989	Western States Endurance Run Foundation	Western States Endurance Run Foundation	This material is the result of work supported with resources and the use of facilities at the VA Northern California Health Care System. The work was also partially supported by the Western States Endurance Run Foundation. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ULTRARUNNING     MAR, V2013, P25; Bennell KL, 1996, AM J SPORT MED, V24, P211, DOI 10.1177/036354659602400217; BOVENS AMP, 1989, INT J SPORTS MED, V10, pS186, DOI 10.1055/s-2007-1024970; Brubaker C E, 1974, J Sports Med, V2, P189; Bruckner P, 1996, CLIN J SPORT MED, V6, P85, DOI 10.1097/00042752-199604000-00004; Bruso JR, 2010, WILD ENVIRON MED, V21, P303, DOI 10.1016/j.wem.2010.06.012; Eijkemans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050775; Elers J, 2011, EXPERT REV RESP MED, V5, P343, DOI [10.1586/ERS.11.28, 10.1586/ers.11.28]; FRIZZELL RT, 1986, JAMA-J AM MED ASSOC, V255, P772, DOI 10.1001/jama.255.6.772; Graham SM, 2012, CLIN J SPORT MED, V22, P462, DOI 10.1097/JSM.0b013e3182694734; Hoffman MD, 2013, MED SCI SPORT EXER, V45, P784, DOI 10.1249/MSS.0b013e31827985a8; Hoffman MD, 2012, RES SPORTS MED, V20, P59, DOI 10.1080/15438627.2012.634707; Hoffman MD, 2011, INT J SPORT PHYSIOL, V6, P25, DOI 10.1123/ijspp.6.1.25; Hoffman MD, 2010, INT J HIST SPORT, V27, P1877, DOI 10.1080/09523367.2010.494385; Hoffman MD, 2013, J PHYS ACT IN PRESS; Hoffman MD, 2013, J STRENGTH COND RES; HOLTZHAUSEN LM, 1994, MED SCI SPORT EXER, V26, P1095; James S L, 1978, Am J Sports Med, V6, P40, DOI 10.1177/036354657800600202; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khodaee M, 2012, CURR SPORT MED REP, V11, P290, DOI 10.1249/JSR.0b013e318272c34b; Krabak BJ, 2013, CURR SPORT MED REP, V12, P183, DOI 10.1249/JSR.0b013e3182913c98; Krabak BJ, 2011, MED SCI SPORT EXER, V43, P2314, DOI 10.1249/MSS.0b013e318221bfe3; Lang G., 1984, ULTRARUNNING, V3, P14; LYSHOLM J, 1987, AM J SPORT MED, V15, P168, DOI 10.1177/036354658701500213; MACERA CA, 1989, ARCH INTERN MED, V149, P2565, DOI 10.1001/archinte.149.11.2565; MATHESON GO, 1987, AM J SPORT MED, V15, P46, DOI 10.1177/036354658701500107; MCBRYDE AM, 1985, CLIN SPORT MED, V4, P737; Millet GY, 2012, J APPL PHYSIOL, V113, P507, DOI 10.1152/japplphysiol.00016.2012; RAUCH TM, 1988, J SPORT MED PHYS FIT, V28, P237; Robson-Ansley P, 2012, MED SCI SPORT EXER, V44, P999, DOI 10.1249/MSS.0b013e318243253d; SANDELL RC, 1988, PHYSICIAN SPORTSMED, V16, P86, DOI 10.1080/00913847.1988.11709598; Thompson W, 1983, ULTRARUNNING, V3, P22; Thorpe KE, 2007, HEALTH AFFAIR, V26, pW678, DOI 10.1377/hlthaff.26.6.w678; U.S. Department of Health and Human Services, 2012, VITAL HLTH STAT SERI, V10; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Scheer BV, 2011, CLIN J SPORT MED, V21, P444, DOI 10.1097/JSM.0b013e318225b0df; WALTER SD, 1989, ARCH INTERN MED, V149, P2561, DOI 10.1001/archinte.149.11.2561	37	73	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83867	10.1371/journal.pone.0083867	http://dx.doi.org/10.1371/journal.pone.0083867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416176	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500079
J	Kovjazin, R; Horn, G; Smorodinsky, NI; Shapira, MY; Carmon, L				Kovjazin, Riva; Horn, Galit; Smorodinsky, Nechama I.; Shapira, Michael Y.; Carmon, Lior			Cell Surface-Associated Anti-MUC1-Derived Signal Peptide Antibodies: Implications for Cancer Diagnostics and Therapy	PLOS ONE			English	Article							POLYMORPHIC EPITHELIAL MUCIN; TUMOR-ANTIGEN MUC1; MULTIPLE-MYELOMA; MONOCLONAL-ANTIBODIES; OVARIAN-CANCER; BREAST-CANCER; EXPRESSION; PROTEIN; SEQUENCE; VACCINE	The MUC1 tumor associated antigen is highly expressed on a range of tumors. Its broad distribution on primary tumors and metastases renders it an attractive target for immunotherapy. After synthesis MUC1 is cleaved, yielding a large soluble extracellular alpha subunit containing the tandem repeats array (TRA) domain specifically bound, via non-covalent interaction, to a smaller beta subunit containing the transmembrane and cytoplasmic domains. Thus far, inconclusive efficacy has been reported for anti-MUC1 antibodies directed against the soluble alpha subunit. Targeting the cell bound beta subunit, may bypass limitations posed by circulating TRA domains. MUC1's signal peptide (SP) domain promiscuously binds multiple MHC class II and Class I alleles, which upon vaccination, generated robust T-cell immunity against MUC1-positive tumors. This is a first demonstration of non-MHC associated, MUC1 specific, cell surfaces presence for MUC1 SP domain. Polyclonal and monoclonal antibodies generated against MUC1 SP domain specifically bind a large variety of MUC1-positive human solid and haematological tumor cell lines; MUC1-positive bone marrow derived plasma cells obtained from multiple myeloma (MM)-patients, but not MUC1 negative tumors cells, and normal naive primary blood and epithelial cells. Membranal MUC1 SP appears mainly as an independent entity but also co-localized with the full MUC1 molecule. MUC1-SP specific binding in BM-derived plasma cells can assist in selecting patients to be treated with anti-MUC1 SP therapeutic vaccine, ImMucin. A therapeutic potential of the anti-MUC1 SP antibodies was suggested by their ability to support of complement-mediated lysis of MUC1-positive tumor cells but not MUC1 negative tumor cells and normal naive primary epithelial cells. These findings suggest a novel cell surface presence of MUC1 SP domain, a potential therapeutic benefit for anti-MUC1 SP antibodies in MUC1-positive tumors and a selection tool for MM patients to be treated with the anti-MUC1 SP vaccine, ImMucin.	[Kovjazin, Riva; Carmon, Lior] Vaxil BioTherapeut Ltd, Ness Ziona, Israel; [Horn, Galit; Smorodinsky, Nechama I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Smorodinsky, Nechama I.] Tel Aviv Univ, George S Wise Fac Life Sci, Alec & Myra Marmot Hybridoma Unit, IL-69978 Tel Aviv, Israel; [Shapira, Michael Y.] Hadassah Hebrew Univ Med Ctr, Dept Bone Marrow Transplantat & Canc Immunotherap, Jerusalem, Israel	Tel Aviv University; Tel Aviv University; Hebrew University of Jerusalem	Carmon, L (corresponding author), Vaxil BioTherapeut Ltd, Weizmann Sci Pk, Ness Ziona, Israel.	lior.carmon@vaxilbio.com			Ministry of Industry Trade and Labor [48447]	Ministry of Industry Trade and Labor	This work was supported by a grant No. 48447 from the Israeli Chief Scientist of the Ministry of Industry Trade and Labor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal B, 1998, NAT MED, V4, P43, DOI 10.1038/nm0198-043; ALAUSA OK, 1975, J IMMUNOL METHODS, V8, P117, DOI 10.1016/0022-1759(75)90088-5; APOSTOLOPOULOS V, 1994, CRIT REV IMMUNOL, V14, P293, DOI 10.1615/CritRevImmunol.v14.i3-4.40; Baruch A, 1997, INT J CANCER, V71, P741; Brossart P, 1999, BLOOD, V93, P4309, DOI 10.1182/blood.V93.12.4309.412k19_4309_4317; Brossart P, 2001, CANCER RES, V61, P6846; Carmon L, 2000, INT J CANCER, V85, P391; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; CHEUNG NKV, 1988, J CLIN INVEST, V81, P1122, DOI 10.1172/JCI113426; Correa I, 2005, INT J CANCER, V115, P760, DOI 10.1002/ijc.20949; Danielczyk A, 2006, CANCER IMMUNOL IMMUN, V55, P1337, DOI 10.1007/s00262-006-0135-9; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Fan XN, 2010, PATHOL RES PRACT, V206, P585, DOI 10.1016/j.prp.2010.03.006; Flanders A, 2013, BLOOD, V122, P1088, DOI 10.1182/blood-2013-05-506170; FUNG PYS, 1991, CANCER RES, V51, P1170; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gillespie AM, 2000, ANN ONCOL, V11, P735, DOI 10.1023/A:1008349300781; Graham RA, 1996, CANCER IMMUNOL IMMUN, V42, P71, DOI 10.1007/s002620050254; HAREUVENI M, 1990, EUR J BIOCHEM, V189, P475, DOI 10.1111/j.1432-1033.1990.tb15512.x; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HO SB, 1993, CANCER RES, V53, P641; KEYDAR I, 1989, P NATL ACAD SCI USA, V86, P1362, DOI 10.1073/pnas.86.4.1362; Kovjazin R, 2012, EXP THER MED, V3, P1092, DOI 10.3892/etm.2012.538; Kovjazin R, 2011, VACCINE, V29, P4676, DOI 10.1016/j.vaccine.2011.04.103; Kovjazin R, 2011, MOL IMMUNOL, V48, P1009, DOI 10.1016/j.molimm.2011.01.006; Lacunza E, 2010, CANCER GENET CYTOGEN, V201, P102, DOI 10.1016/j.cancergencyto.2010.05.015; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; LYKO F, 1995, J BIOL CHEM, V270, P19873, DOI 10.1074/jbc.270.34.19873; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; MCGUCKIN MA, 1995, HUM PATHOL, V26, P432, DOI 10.1016/0046-8177(95)90146-9; Nakayama S, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-131; PALMITER RD, 1978, P NATL ACAD SCI USA, V75, P94, DOI 10.1073/pnas.75.1.94; Pichinuk E, 2012, CANCER RES, V72, P3324, DOI 10.1158/0008-5472.CAN-12-0067; Prinssen HM, 1998, CANCER IMMUNOL IMMUN, V47, P39, DOI 10.1007/s002620050502; Rubinstein DB, 2006, CANCER RES, V66, P11247, DOI 10.1158/0008-5472.CAN-06-1486; Schrempf S, 2007, J VIROL, V81, P12515, DOI 10.1128/JVI.01481-07; SEGEV N, 1985, P NATL ACAD SCI USA, V82, P1531, DOI 10.1073/pnas.82.5.1531; Strome SE, 2007, ONCOLOGIST, V12, P1084, DOI 10.1634/theoncologist.12-9-1084; Tang CK, 2008, EXPERT REV VACCINES, V7, P963, DOI 10.1586/14760584.7.7.963; Thie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015921; Treon SP, 2000, SEMIN ONCOL, V27, P598; VANDEWIELVANKEMENADE E, 1993, J IMMUNOL, V151, P767; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x; YE RD, 1988, J BIOL CHEM, V263, P4869	46	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85400	10.1371/journal.pone.0085400	http://dx.doi.org/10.1371/journal.pone.0085400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416403	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500245
J	Nagao, C; Nagano, N; Mizuguchi, K				Nagao, Chioko; Nagano, Nozomi; Mizuguchi, Kenji			Prediction of Detailed Enzyme Functions and Identification of Specificity Determining Residues by Random Forests	PLOS ONE			English	Article							HYDROLASE FOLD ENZYMES; AMINO-ACID-RESIDUES; ACTIVE-SITE GORGE; CRYSTAL-STRUCTURE; PROTEIN FUNCTION; MYCOBACTERIUM-TUBERCULOSIS; TRYPTOPHAN BIOSYNTHESIS; CATALYTIC DOMAIN; LIGAND-BINDING; SEQUENCE	Determining enzyme functions is essential for a thorough understanding of cellular processes. Although many prediction methods have been developed, it remains a significant challenge to predict enzyme functions at the fourth-digit level of the Enzyme Commission numbers. Functional specificity of enzymes often changes drastically by mutations of a small number of residues and therefore, information about these critical residues can potentially help discriminate detailed functions. However, because these residues must be identified by mutagenesis experiments, the available information is limited, and the lack of experimentally verified specificity determining residues (SDRs) has hindered the development of detailed function prediction methods and computational identification of SDRs. Here we present a novel method for predicting enzyme functions by random forests, EFPrf, along with a set of putative SDRs, the random forests derived SDRs (rf-SDRs). EFPrf consists of a set of binary predictors for enzymes in each CATH superfamily and the rf-SDRs are the residue positions corresponding to the most highly contributing attributes obtained from each predictor. EFPrf showed a precision of 0.98 and a recall of 0.89 in a cross-validated benchmark assessment. The rf-SDRs included many residues, whose importance for specificity had been validated experimentally. The analysis of the rf-SDRs revealed both a general tendency that functionally diverged superfamilies tend to include more active site residues in their rf-SDRs than in less diverged superfamilies, and superfamily-specific conservation patterns of each functional residue. EFPrf and the rf-SDRs will be an effective tool for annotating enzyme functions and for understanding how enzyme functions have diverged within each superfamily.	[Nagao, Chioko; Mizuguchi, Kenji] Natl Inst Biomed Innovat, Osaka, Japan; [Nagano, Nozomi] AIST, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan	National Institute of Health Sciences - Japan; National Institute of Advanced Industrial Science & Technology (AIST)	Nagao, C (corresponding author), Natl Inst Biomed Innovat, Osaka, Japan.	chio@nibio.go.jp; kenji@nibio.go.jp	Nagano, Nozomi/A-5717-2017; Mizuguchi, Kenji/GVS-5857-2022	Nagano, Nozomi/0000-0002-2779-685X; Mizuguchi, Kenji/0000-0003-3021-7078	New Energy and Industrial Technology Development Organization (NEDO) of Japan [07C46056a]; Ministry of Education, Culture, Sports, Science, and Technology [25430186, 25293079]; Ministry of Health, Labor, and Welfare; Japan Society for the Promotion of Science (JSPS) [238048, 248047]	New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Industrial Technology Research Grant Program in 2007 (grant number 07C46056a) from New Energy and Industrial Technology Development Organization (NEDO) of Japan, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (grant numbers 25430186 and 25293079) and from the Ministry of Health, Labor, and Welfare to K.M., and also by Grant-in-Aid for Publication of Scientific Research Results (grant numbers 238048 and 248047) from Japan Society for the Promotion of Science (JSPS) to N.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addou S, 2009, J MOL BIOL, V387, P416, DOI 10.1016/j.jmb.2008.12.045; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; Bannert C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-589; Bashton M, 2008, NUCLEIC ACIDS RES, V36, pD618, DOI 10.1093/nar/gkm611; BELAICH A, 1992, J BACTERIOL, V174, P4677, DOI 10.1128/JB.174.14.4677-4682.1992; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; BORTOLIGERMAN I, 1995, J MOL BIOL, V246, P82, DOI 10.1006/jmbi.1994.0068; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Bray T, 2009, J MOL BIOL, V386, P1423, DOI 10.1016/j.jmb.2008.11.057; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cai CZ, 2004, PROTEINS, V55, P66, DOI 10.1002/prot.20045; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Chen XW, 2005, BIOINFORMATICS, V21, P4394, DOI 10.1093/bioinformatics/bti721; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dobson Paul D, 2003, J Mol Biol, V330, P771; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; Dondoshansky I, 2002, BLASTCLUST; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Due AV, 2011, P NATL ACAD SCI USA, V108, P3554, DOI 10.1073/pnas.1015996108; Erdin S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S6; Erskine PT, 1999, BIOCHEMISTRY-US, V38, P4266, DOI 10.1021/bi982137w; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; George RA, 2005, P NATL ACAD SCI USA, V102, P12299, DOI 10.1073/pnas.0504833102; Greenblatt HM, 2004, J AM CHEM SOC, V126, P15405, DOI 10.1021/ja0466154; GRIBSKOV M, 1990, METHOD ENZYMOL, V183, P146; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henn-Sax M, 2002, BIOCHEMISTRY-US, V41, P12032, DOI 10.1021/bi026092h; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Kalinina OV, 2004, NUCLEIC ACIDS RES, V32, pW424, DOI 10.1093/nar/gkh391; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kristensen DM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-17; Kumar C, 2012, EURASIP J BIOINFORM, DOI [10.1186/1687-4153-2012, 10.1186/1687-4153-2012-1]; Kumar N, 2012, BIOINFORMATICS, V28, P2687, DOI 10.1093/bioinformatics/bts510; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lee BJ, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-27; Lees J, 2010, NUCLEIC ACIDS RES, V38, pD296, DOI 10.1093/nar/gkp987; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; List F, 2011, CHEMBIOCHEM, V12, P1487, DOI 10.1002/cbic.201100082; Mertz RW, JANUS PREDICTION RAN; Nagano N, 2005, NUCLEIC ACIDS RES, V33, pD407, DOI 10.1093/nar/gki080; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nagano N, 2001, PROTEIN ENG, V14, P845, DOI 10.1093/protein/14.11.845; Nagao C, 2012, PROTEINS, V80, P2426, DOI 10.1002/prot.24127; Nagao C, 2010, PROTEINS, V78, P2369, DOI 10.1002/prot.22750; Nakanishi T, 2005, BIOCHEMISTRY-US, V44, P1136, DOI 10.1021/bi0484522; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; NAVAS J, 1992, BIOCHEM BIOPH RES CO, V189, P807, DOI 10.1016/0006-291X(92)92274-2; Noda-Garcia L, 2013, MOL BIOL EVOL, V30, P2024, DOI 10.1093/molbev/mst115; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Quinlan JR, 1993, C4 5 PROGRAMS MACHIN; R Core Team, 2021, R LANG ENV STAT COMP; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Redfern OC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000485; Reisinger B, 2012, PROTEIN ENG DES SEL, V25, P751, DOI 10.1093/protein/gzs080; Rost B, 2003, CELL MOL LIFE SCI, V60, P2637, DOI 10.1007/s00018-003-3114-8; Sharma V, 1998, STRUCTURE, V6, P1587, DOI 10.1016/S0969-2126(98)00156-7; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Syed Umar, 2009, V541, P373, DOI 10.1007/978-1-59745-243-4_17; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian WD, 2004, NUCLEIC ACIDS RES, V32, P6226, DOI 10.1093/nar/gkh956; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; Voet D VJ, 1990, BIOCHEMISTRY; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; Wass MN, 2012, NUCLEIC ACIDS RES, V40, pW466, DOI 10.1093/nar/gks489; Webb E. C., 1992, Enzyme nomenclature 1992. Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes.; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101	87	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84623	10.1371/journal.pone.0084623	http://dx.doi.org/10.1371/journal.pone.0084623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416252	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500141
J	Poor, EE; Jakes, A; Loucks, C; Suitor, M				Poor, Erin E.; Jakes, Andrew; Loucks, Colby; Suitor, Mike			Modeling Fence Location and Density at a Regional Scale for Use in Wildlife Management	PLOS ONE			English	Article							WILDEBEEST; MAMMALS; SITE; DEER	Barbed and woven wire fences, common structures across western North America, act as impediments to wildlife movements. In particular, fencing influences pronghorn (Antilocapra americana) daily and seasonal movements, as well as modifying habitat selection. Because of fencing's impacts to pronghorn and other wildlife, it is a potentially important factor in both wildlife movement and habitat selection models. At this time, no geospatial fencing data is available at regional scales. Consequently, we constructed a regional fence model using a series of land tenure assumptions for the Hi-Line region of northern Montana - an area consisting of 13 counties over 103,400 km(2). Randomized 3.2 km long transects (n = 738) on both paved and unpaved roads were driven to collect information on habitat, fence densities and fence type. Using GIS, we constructed a fence location and a density model incorporating ownership, size, neighboring parcels, township boundaries and roads. Local knowledge of land ownership and land use assisted in improving the final models. We predict there is greater than 263,300 km of fencing in the Hi-Line region, with a maximum density of 6.8 km of fencing per km(2) and mean density of 2.4 km of fencing per km(2). Using field data to assess model accuracy, Cohen's Kappa was measured at 0.40. On-the-ground fence modification or removal could be prioritized by identifying high fence densities in critical wildlife areas such as pronghorn migratory pathways or sage grouse lekking habitat. Such novel fence data can assist wildlife and land managers to assess effects of anthropogenic features to wildlife at various scales; which in turn may help conserve declining grassland species and overall ecological functionality.	[Poor, Erin E.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Poor, Erin E.; Loucks, Colby] World Wildlife Fund, Conservat Sci Program, Washington, DC 20037 USA; [Jakes, Andrew; Suitor, Mike] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada	Virginia Polytechnic Institute & State University; World Wildlife Fund; University of Calgary	Poor, EE (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	erinpoor@vt.edu		Poor, Erin/0000-0002-8799-3193	Kathryn Fuller Science for Nature Fund; Alberta Conservation Association [030-00-40-106-4000]; U.S. Bureau of Land Management [090-50778]; Montana Fish, Wildlife Parks [080018]; Saskatchewan Ministry of Environment [08FW111]; University of Calgary	Kathryn Fuller Science for Nature Fund; Alberta Conservation Association; U.S. Bureau of Land Management; Montana Fish, Wildlife Parks; Saskatchewan Ministry of Environment; University of Calgary	The work was supported by: Kathryn Fuller Science for Nature Fund, (no grant number) (http://worldwildlife.org/initiatives/fuller-science-for-nature-fund); Alberta Conservation Association, 030-00-40-106-4000 (http://www.ab-conservation.com/); U.S. Bureau of Land Management, 090-50778 (http://www.blm.gov/wo/st/en.html); Montana Fish, Wildlife & Parks, Cooperative Agreement 080018 (http://fwp.mt.gov/); Saskatchewan Ministry of Environment, Permit 08FW111 (http://www.environment.gov.sk.ca/); University of Calgary, (no grant number) (http://www.ucalgary.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines D, 1997, J APPL ECOL, V34, P941, DOI 10.2307/2405284; BENSHAHAR R, 1993, J TROP ECOL, V9, P249, DOI 10.1017/S0266467400007252; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Berry H. H., 1997, Madoqua, V20, P137; Bolger DT, 2007, ECOL LETT, V10, P1; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Congalton R. G., 1981, THESIS VIRGINIA POLY; Estes R, 1967, ZOOL TIERPSHYCH, V26, P284; Harrington JL, 2006, WILDLIFE SOC B, V34, P1295, DOI 10.2193/0091-7648(2006)34[1295:COUBAM]2.0.CO;2; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hayter EW, 1939, AGR HIST, V13, P189; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; Knick ST, 2011, STUD AVIAN BIOL, P203; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Moss R, 2001, BIOL CONSERV, V101, P255, DOI 10.1016/S0006-3207(01)00066-0; Nakazawa M, 2013, FUNCTIONS MED STAT B; Ockenfels RA, 1994, 13 AR GAM FISH DEP; Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013; Schaefer JA, 2000, LANDSCAPE ECOL, V15, P731, DOI 10.1023/A:1008160408257; Sheldon DP, 2005, PRONGHORN MOVEMENT D; SPINAGE C A, 1992, Oryx, V26, P147; Stevens BS, 2012, J WILDLIFE MANAGE, V76, P1370, DOI 10.1002/jwmg.397; Thirgood S, 2004, ANIM CONSERV, V7, P113, DOI 10.1017/S1367943004001404; Tufford W, 1960, MONTANA, V10, P62; WHYTE IJ, 1988, S AFR J WILDL RES, V18, P78; Williamson D., 1985, Parks, V10, P5	29	14	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83912	10.1371/journal.pone.0083912	http://dx.doi.org/10.1371/journal.pone.0083912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416180	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500083
J	Xu, KD; Huang, XH; Wu, MM; Wang, Y; Chang, YX; Liu, K; Zhang, J; Zhang, Y; Zhang, FL; Yi, LM; Li, TT; Wang, RY; Tan, GX; Li, CW				Xu, Kedong; Huang, Xiaohui; Wu, Manman; Wang, Yan; Chang, Yunxia; Liu, Kun; Zhang, Ju; Zhang, Yi; Zhang, Fuli; Yi, Liming; Li, Tingting; Wang, Ruiyue; Tan, Guangxuan; Li, Chengwei			A Rapid, Highly Efficient and Economical Method of Agrobacterium-Mediated In planta Transient Transformation in Living Onion Epidermis	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; GENE-EXPRESSION; FLUORESCENCE COMPLEMENTATION; SUBCELLULAR-LOCALIZATION; PARTICLE BOMBARDMENT; PROTOPLAST SYSTEM; LEAF PROTOPLASTS; ARABIDOPSIS; OPTIMIZATION; TISSUES	Transient transformation is simpler, more efficient and economical in analyzing protein subcellular localization than stable transformation. Fluorescent fusion proteins were often used in transient transformation to follow the in vivo behavior of proteins. Onion epidermis, which has large, living and transparent cells in a monolayer, is suitable to visualize fluorescent fusion proteins. The often used transient transformation methods included particle bombardment, protoplast transfection and Agrobacterium-mediated transformation. Particle bombardment in onion epidermis was successfully established, however, it was expensive, biolistic equipment dependent and with low transformation efficiency. We developed a highly efficient in planta transient transformation method in onion epidermis by using a special agroinfiltration method, which could be fulfilled within 5 days from the pretreatment of onion bulb to the best time-point for analyzing gene expression. The transformation conditions were optimized to achieve 43.87% transformation efficiency in living onion epidermis. The developed method has advantages in cost, time-consuming, equipment dependency and transformation efficiency in contrast with those methods of particle bombardment in onion epidermal cells, protoplast transfection and Agrobacterium-mediated transient transformation in leaf epidermal cells of other plants. It will facilitate the analysis of protein subcellular localization on a large scale.	[Xu, Kedong; Wang, Yan; Liu, Kun; Zhang, Ju; Zhang, Yi; Zhang, Fuli; Tan, Guangxuan; Li, Chengwei] Zhoukou Normal Univ, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China; [Huang, Xiaohui; Wu, Manman; Chang, Yunxia; Yi, Liming; Li, Tingting; Wang, Ruiyue] Zhoukou Normal Univ, Dept Life Sci, Zhoukou, Peoples R China; [Wang, Yan] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	Zhoukou Normal University; Zhoukou Normal University; Henan Agricultural University	Li, CW (corresponding author), Zhoukou Normal Univ, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China.	lichengweiwau@hotmail.com		Wang, Yan/0000-0003-3262-9930	National Natural Science Foundation of China [31071807, 31272168]; Plan for Scientific Innovation Talent of Henan Province [124100510021]; Doctoral Scientific Research Starting Foundation of Zhoukou Normal University [zksybscx201108]; Scientific Research and Innovation Fund Projects of Zhoukou Normal University [zksykycx201306]; Science and Technology Research Major Projects of Department of Education of Henan Province [13B210270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan for Scientific Innovation Talent of Henan Province; Doctoral Scientific Research Starting Foundation of Zhoukou Normal University; Scientific Research and Innovation Fund Projects of Zhoukou Normal University; Science and Technology Research Major Projects of Department of Education of Henan Province	The research was supported by National Natural Science Foundation of China (31071807, 31272168) (http://www.nsfc.gov.cn), Plan for Scientific Innovation Talent of Henan Province (124100510021) (http://www.hnkjt.gov.cn), Doctoral Scientific Research Starting Foundation of Zhoukou Normal University (zksybscx201108)(http://www.zknu.edu.cn), Scientific Research and Innovation Fund Projects of Zhoukou Normal University (zksykycx201306)(http://www.zknu.edu.cn) and the Science and Technology Research Major Projects of Department of Education of Henan Province (13B210270)(http://www.haedu.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Amoah BK, 2001, J EXP BOT, V52, P1135, DOI 10.1093/jexbot/52.358.1135; Baum K, 1997, PLANT J, V12, P463, DOI 10.1046/j.1365-313X.1997.12020463.x; Bhaskar PB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005812; Blachutzik JO, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-28; Blanvillain R, 2009, PLANT J, V57, P654, DOI 10.1111/j.1365-313X.2008.03717.x; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chen XL, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-9; Eady CC, 1996, PLANT CELL REP, V15, P958, DOI 10.1007/BF00231596; HAMILTON DA, 1992, PLANT MOL BIOL, V18, P211, DOI 10.1007/BF00034950; Han DG, 2013, PLANT MOL BIOL REP, V31, P802, DOI 10.1007/s11105-012-0551-2; Hollender CA, 2010, JOVE-J VIS EXP, V40, P1963, DOI DOI 10.3791/1963; Hosein FN, 2012, J AM SOC HORTIC SCI, V137, P263, DOI 10.21273/JASHS.137.4.263; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Keller ERJ, 1996, THEOR APPL GENET, V92, P417, DOI 10.1007/BF00223688; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; LI YH, 1994, PLANT CELL REP, V13, P661, DOI 10.1007/BF00231619; LIU CN, 1992, PLANT MOL BIOL, V20, P1071, DOI 10.1007/BF00028894; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; Liu QL, 2010, MOL BIOL REP, V37, P1137, DOI 10.1007/s11033-009-9886-7; Manavella PA, 2009, NAT PROTOC, V4, P1699, DOI 10.1038/nprot.2009.178; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; McLusky SR, 1999, PLANT J, V17, P523, DOI 10.1046/j.1365-313X.1999.00403.x; Mitra J, 2012, J FOOD SCI TECH MYS, V49, P267, DOI 10.1007/s13197-011-0369-1; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; OHLROGGE JB, 1979, P NATL ACAD SCI USA, V76, P1194, DOI 10.1073/pnas.76.3.1194; OPARKA KJ, 1994, NEW PHYTOL, V126, P571, DOI 10.1111/j.1469-8137.1994.tb02952.x; Orzaez D, 2006, PLANT PHYSIOL, V140, P3, DOI 10.1104/pp.105.068221; Pommerrenig B, 2013, PLANT J, V73, P392, DOI 10.1111/tpj.12037; Rasco-Gaunt S, 1999, PLANT CELL REP, V19, P118, DOI 10.1007/s002990050721; REGGIARDO MI, 1991, PLANT SCI, V75, P237, DOI 10.1016/0168-9452(91)90239-5; Santarem ER, 1998, PLANT CELL REP, V17, P752, DOI 10.1007/s002990050478; Shah H, 2001, J MOL BIOL, V309, P641, DOI 10.1006/jmbi.2001.4706; Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x; Song SY, 2012, ENVIRON EXP BOT, V80, P1, DOI 10.1016/j.envexpbot.2012.02.001; Takata N, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-30; Trick HN, 1998, PLANT CELL REP, V17, P482, DOI 10.1007/s002990050429; Tsai AYL, 2012, PLANT J, V69, P809, DOI 10.1111/j.1365-313X.2011.04832.x; Tsuda K, 2012, PLANT J, V69, P713, DOI 10.1111/j.1365-313X.2011.04819.x; Ueki S, 2009, NAT PROTOC, V4, P71, DOI 10.1038/nprot.2008.217; Wang GL, 2002, GENE ENG PLANT, P734; WANG YC, 1988, PLANT MOL BIOL, V11, P433, DOI 10.1007/BF00039024; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Xu KD, 2011, AFR J BIOTECHNOL, V10, P4011; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Ye GN, 1999, PLANT J, V19, P249, DOI 10.1046/j.1365-313X.1999.00520.x; Zhang G, 2003, PLANT CELL REP, V21, P860, DOI 10.1007/s00299-003-0585-x; Zhang HC, 2013, PLANT CELL REP, V32, P611, DOI 10.1007/s00299-013-1394-5; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhou C, 2013, PLANT MOL BIOL REP, V31, P783, DOI 10.1007/s11105-012-0545-0	51	92	110	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83556	10.1371/journal.pone.0083556	http://dx.doi.org/10.1371/journal.pone.0083556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416168	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500056
J	Ng, SF; Lin, RCY; Maloney, CA; Youngson, NA; Owens, JA; Morris, MJ				Ng, Sheau-Fang; Lin, Ruby C. Y.; Maloney, Christopher A.; Youngson, Neil A.; Owens, Julie A.; Morris, Margaret J.			Paternal high-fat diet consumption induces common changes in the transcriptomes of retroperitoneal adipose and pancreatic islet tissues in female rat offspring	FASEB JOURNAL			English	Article						chronic degenerative disorder; olfactory receptor genes; obesity; premature aging; developmental programming	PROTEIN-KINASE-C; LOW-BIRTH-WEIGHT; BODY-MASS INDEX; MISSING HERITABILITY; INDUCED OBESITY; OLFACTORY-BULB; EPISTASIS; DISEASE; NORMALIZATION; INFLAMMATION	We previously showed that paternal high-fat diet (HFD) consumption programs beta-cell dysfunction in female rat offspring, together with transcriptome alterations in islets. Here we investigated the retroperitoneal white adipose tissue (RpWAT) transcriptome using gene and pathway enrichment and pathway analysis to determine whether commonly affected network topologies exist between these two metabolically related tissues. In RpWAT, 5108 genes were differentially expressed due to a paternal HFD; the top 5 significantly enriched networks identified by pathway analysis in offspring of HFD fathers compared with those of fathers fed control diet were: mitochondrial and cellular response to stress, telomerase signaling, cell death and survival, cell cycle, cellular growth and proliferation, and cancer. A total of 187 adipose olfactory receptor genes were down-regulated. Interrogation against the islet transcriptome identified specific gene networks and pathways, including olfactory receptor genes that were similarly affected in both tissues (411 common genes, P < 0.05). In particular, we highlight a common molecular network, cell cycle and cancer, with the same hub gene, Myc, suggesting early onset developmental changes that persist, shared responses to programmed systemic factors, or crosstalk between tissues. Thus, paternal HFD consumption triggers unique gene signatures, consistent with premature aging and chronic degenerative disorders, in both RpWAT and pancreatic islets of daughters.-Ng, S.-F., Lin, R. C. Y., Maloney, C. A., Youngson, N. A., Owens, J. A., Morris, M. J. Paternal high-fat diet consumption induces common changes in the transcriptomes of retroperitoneal adipose and pancreatic islet tissues in female rat offspring.	[Ng, Sheau-Fang; Maloney, Christopher A.; Youngson, Neil A.; Morris, Margaret J.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Ramaciotti Ctr Genom, Sydney, NSW 2052, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Ng, Sheau-Fang] Natl Univ Malaysia, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; [Owens, Julie A.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Universiti Kebangsaan Malaysia; University of Adelaide	Morris, MJ (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia.	m.morris@unsw.edu.au	Morris, Margaret J/J-4285-2013; Owens, Julie A/C-9744-2009; Maloney, Christopher/AAG-8599-2019; Lin, Ruby CY/A-1636-2009; Youngson, Neil/AAB-7389-2019	Owens, Julie A/0000-0002-7498-1353; Maloney, Christopher/0000-0002-9193-2369; Lin, Ruby CY/0000-0003-4163-511X; Youngson, Neil/0000-0003-0690-4580; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council (NHMRC) of Australia; New South Innovations [University of New South Wales (UNSW)]; Ministry of Higher Education; National University of Malaysia; UNSW	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Innovations [University of New South Wales (UNSW)]; Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); National University of Malaysia; UNSW	This work was supported by a project grant of the National Health and Medical Research Council (NHMRC) of Australia (to M.J.M) and funding from New South Innovations [University of New South Wales (UNSW)]. S.F.N. was supported by the Ministry of Higher Education and the National University of Malaysia. R.C.Y.L. is supported by the UNSW Vice-Chancellor Postdoctoral Fellowship.	Affymetrix, 2006, AFF GENECHIP EXPR AN; Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Binder NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052304; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Choi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056610; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; FORMAN HJ, 1974, BIOCHEM BIOPH RES CO, V60, P1044, DOI 10.1016/0006-291X(74)90418-5; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gardano L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00146; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hypponen E, 2003, BMJ-BRIT MED J, V326, P19, DOI 10.1136/bmj.326.7379.19; Inoguchi T, 2003, J AM SOC NEPHROL, V14, pS227, DOI 10.1097/01.ASN.0000077407.90309.65; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JENSEN PK, 1966, BIOCHIM BIOPHYS ACTA, V122, P157, DOI 10.1016/0926-6593(66)90057-9; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Le Bacquer O, 2006, M S-MED SCI, V22, P514, DOI 10.1051/medsci/2006225514; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Li PF, 1999, CIRCULATION, V100, P967, DOI 10.1161/01.CIR.100.9.967; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Meseguer M, 2008, FERTIL STERIL, V89, P1191, DOI 10.1016/j.fertnstert.2007.05.005; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Morris Margaret J, 2009, Expert Rev Endocrinol Metab, V4, P625, DOI 10.1586/eem.09.45; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Okser S, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-5; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Power C, 2003, J EPIDEMIOL COMMUN H, V57, P969, DOI 10.1136/jech.57.12.969; Primeaux SD, 2013, DIGEST DIS SCI, V58, P72, DOI 10.1007/s10620-012-2421-z; Pyo CW, 2013, BBA-GEN SUBJECTS, V1830, P5316, DOI 10.1016/j.bbagen.2013.07.030; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Son YO, 2013, TOXICOL APPL PHARM, V271, P239, DOI 10.1016/j.taap.2013.04.036; Tormos AM, 2013, FREE RADICAL RES, V47, P905, DOI 10.3109/10715762.2013.821200; Tucker K, 2012, J NEUROENDOCRINOL, V24, P1087, DOI 10.1111/j.1365-2826.2012.02314.x; Tucker K, 2010, RESULTS PROBL CELL D, V52, P147, DOI 10.1007/978-3-642-14426-4_12; Tzanetakou IP, 2012, AGEING RES REV, V11, P220, DOI 10.1016/j.arr.2011.12.003; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; Wang Y, 2013, AUTOPHAGY, V9, P272, DOI 10.4161/auto.23628; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Youngson NA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0337; Zhang CB, 2013, AM J PHYSIOL-ENDOC M, V305, pE530, DOI 10.1152/ajpendo.00640.2012; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	54	98	103	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1830	1841		10.1096/fj.13-244046	http://dx.doi.org/10.1096/fj.13-244046			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24421403				2022-12-25	WOS:000335344300028
J	Gao, CX; Chen, GM; Romero, G; Moschos, S; Xu, X; Hu, J				Gao, Chenxi; Chen, Guangming; Romero, Guillermo; Moschos, Stergios; Xu, Xiang; Hu, Jing			Induction of Gsk3 beta-beta-TrCP Interaction Is Required for Late Phase Stabilization of beta-Catenin in Canonical Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-catenin; Glycogen Synthase Kinase 3; Ubiquitin Ligase; Ubiquitination; Wnt Signaling	UBIQUITIN LIGASE; CYCLIN D1; KINASE; PHOSPHORYLATION; DEGRADATION; AXIN; EXPRESSION; MECHANISM; PROTEIN; INHIBITION	Background: Despite being a key component of the Wnt pathway, how Gsk3 is regulated in Wnt signaling remains elusive. Results: Wnt simulation induces Gsk3--TrCP interaction and monoubiquitination of Gsk3, leading to inhibition of -catenin recruitment of -TrCP. Conclusion: -Catenin stabilization in late Wnt signaling requires increased Gsk3--TrCP interaction. Significance: First evidence that Gsk3 is regulated by monoubiquitination in Wnt signaling. A pivotal step in canonical Wnt signaling is Wnt-induced -catenin stabilization. In the absence of Wnt, -catenin is targeted for -transducin repeats-containing proteins (-TrCP)-mediated degradation due to phosphorylation by glycogen synthase kinase 3 (Gsk3). How canonical Wnt signaling regulates Gsk3 to inhibit -catenin proteolysis remains largely elusive. This study reveals novel key molecular events in Wnt signaling: induction of Gsk3 ubiquitination and Gsk3--TrCP binding. We found that Wnt stimulation induced prolonged monoubiquitination of Gsk3 and Gsk3--TrCP interaction. Monoubiquitination did not cause Gsk3 degradation nor affects its enzymatic activity. Rather, increased monoubiquitination of Gsk3/Gsk3--TrCP association suppressed -catenin recruitment of -TrCP, leading to long-term inhibition of -catenin ubiquitination and degradation.	[Gao, Chenxi; Chen, Guangming; Romero, Guillermo; Xu, Xiang; Hu, Jing] Univ Pittsburgh Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Gao, Chenxi; Chen, Guangming; Moschos, Stergios; Xu, Xiang; Hu, Jing] Univ Pittsburgh Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA; [Moschos, Stergios] Univ Pittsburgh Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hu, J (corresponding author), Univ Pittsburgh Canc Inst, Dept Pharmacol & Chem Biol, 2-42D Hillman Canc Ctr Res Pavil,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	huj3@upmc.edu	Hu, Jing/M-3130-2014; xu, xiang/L-2579-2014	xu, xiang/0000-0002-1026-2210	United States Public Health Service [CA166197]; NATIONAL CANCER INSTITUTE [R01CA166197] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported in part by United States Public Health Service Grant CA166197 (to J. H.).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carlson ED, 2012, BIOTECHNOL ADV, V30, P1185, DOI 10.1016/j.biotechadv.2011.09.016; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vatsyayan J, 2008, EMBO REP, V9, P885, DOI 10.1038/embor.2008.122; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	34	23	23	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7099	7108		10.1074/jbc.M113.532606	http://dx.doi.org/10.1074/jbc.M113.532606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451375	Green Published, hybrid			2022-12-25	WOS:000332389400069
J	Hartmann, A; Hellmund, M; Lucius, R; Voelker, DR; Gupta, N				Hartmann, Anne; Hellmund, Maria; Lucius, Richard; Voelker, Dennis R.; Gupta, Nishith			Phosphatidylethanolamine Synthesis in the Parasite Mitochondrion Is Required for Efficient Growth but Dispensable for Survival of Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Host-Pathogen Interactions; Membrane Biogenesis; Microbiology; Parasite Metabolism; Parasitology; Phosphatidylethanolamine; Phosphatidylserine Decarboxylase	PHOSPHATIDYLSERINE DECARBOXYLASE ACTIVITY; PHOSPHOLIPID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; GENE; CLONING; MEMBRANE; YEAST; DISRUPTION; EXPRESSION; MARKER	Background:Toxoplasma gondii is a common intracellular parasite of diverse host cells. Results: The parasite can produce phosphatidylethanolamine in its mitochondrion, endoplasmic reticulum, and parasitophorous vacuole, which together allow versatile lipid biogenesis. Conclusion: Multiple routes of lipid synthesis ensure parasite survival in discrete nutrient milieus. Significance:T. gondii offers an instructive model to study membrane biology of parasitic protists. Toxoplasma gondii is a highly prevalent obligate intracellular parasite of the phylum Apicomplexa, which also includes other parasites of clinical and/or veterinary importance, such as Plasmodium, Cryptosporidium, and Eimeria. Acute infection by Toxoplasma is hallmarked by rapid proliferation in its host cells and requires a significant synthesis of parasite membranes. Phosphatidylethanolamine (PtdEtn) is the second major phospholipid class in T. gondii. Here, we reveal that PtdEtn is produced in the parasite mitochondrion and parasitophorous vacuole by decarboxylation of phosphatidylserine (PtdSer) and in the endoplasmic reticulum by fusion of CDP-ethanolamine and diacylglycerol. PtdEtn in the mitochondrion is synthesized by a phosphatidylserine decarboxylase (TgPSD1mt) of the type I class. TgPSD1mt harbors a targeting peptide at its N terminus that is required for the mitochondrial localization but not for the catalytic activity. Ablation of TgPSD1mt expression caused up to 45% growth impairment in the parasite mutant. The PtdEtn content of the mutant was unaffected, however, suggesting the presence of compensatory mechanisms. Indeed, metabolic labeling revealed an increased usage of ethanolamine for PtdEtn synthesis by the mutant. Likewise, depletion of nutrients exacerbated the growth defect (approximate to 56%), which was partially restored by ethanolamine. Besides, the survival and residual growth of the TgPSD1mt mutant in the nutrient-depleted medium also indicated additional routes of PtdEtn biogenesis, such as acquisition of host-derived lipid. Collectively, the work demonstrates a metabolic cooperativity between the parasite organelles, which ensures a sustained lipid synthesis, survival and growth of T. gondii in varying nutritional milieus.	[Hartmann, Anne; Hellmund, Maria; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany; [Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Gupta, Nishith] Max Planck Inst Infect Biol, Dept Parasitol, D-10117 Berlin, Germany	Humboldt University of Berlin; National Jewish Health; Max Planck Society	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Philippstr 13, D-10115 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de		Gupta, Nishith/0000-0003-1452-5126	German Research Foundation (Deutsche Forschungsgemeinschaft; DFG) [SFB618/C7, GU1100/3-1]; Caroline von Humboldt Foundation	German Research Foundation (Deutsche Forschungsgemeinschaft; DFG)(German Research Foundation (DFG)); Caroline von Humboldt Foundation	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft; DFG) Grants SFB618/C7 and GU1100/3-1 (to N. G.) and by a 6-month scholarship from the Caroline von Humboldt Foundation (to A. H.).	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Baunaure F, 2004, MOL MICROBIOL, V51, P33, DOI 10.1046/j.1365-2958.2003.03822.x; Besteiro S., 2011, PLOS PATHOG, V7; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chan EYL, 2012, J BIOL CHEM, V287, P40131, DOI 10.1074/jbc.M112.399428; Charron AJ, 2002, J CELL SCI, V115, P3049; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Dechamps S, 2010, MOL BIOCHEM PARASIT, V173, P69, DOI 10.1016/j.molbiopara.2010.05.006; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Dowhan W, 1997, METHOD ENZYMOL, V280, P81; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kim K., 2014, PERSPECTIVES METHODS, P599; Kuge O, 1996, BIOCHEM J, V319, P33, DOI 10.1042/bj3190033; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Nerlich A, 2007, PLANT PHYSIOL, V144, P904, DOI 10.1104/pp.107.095414; OHTA A, 1981, J BACTERIOL, V147, P552, DOI 10.1128/JB.147.2.552-562.1981; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; PERCY AK, 1983, ARCH BIOCHEM BIOPHYS, V223, P484, DOI 10.1016/0003-9861(83)90613-6; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Rontein D, 2003, PLANT PHYSIOL, V132, P1678, DOI 10.1104/pp.103.023242; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sampels V, 2012, J BIOL CHEM, V287, P16289, DOI 10.1074/jbc.M112.347138; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Signorell A, 2009, MOL MICROBIOL, V72, P1068, DOI 10.1111/j.1365-2958.2009.06713.x; Sinai AP, 1997, J CELL SCI, V110, P2117; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565	50	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6809	6824		10.1074/jbc.M113.509406	http://dx.doi.org/10.1074/jbc.M113.509406			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24429285	Green Published, hybrid			2022-12-25	WOS:000332389400041
J	Matsui, H; Fukuno, N; Kanda, Y; Kantoh, Y; Chida, T; Nagaura, Y; Suzuki, O; Nishitoh, H; Takeda, K; Ichijo, H; Sawada, Y; Sasaki, K; Kobayashi, T; Tamura, S				Matsui, Hiroyuki; Fukuno, Naoto; Kanda, Yoshiaki; Kantoh, Yusuke; Chida, Toko; Nagaura, Yuko; Suzuki, Osamu; Nishitoh, Hideki; Takeda, Kohsuke; Ichijo, Hidenori; Sawada, Yasuhiro; Sasaki, Keiichi; Kobayashi, Takayasu; Tamura, Shinri			The Expression of Fn14 via Mechanical Stress-activated JNK Contributes to Apoptosis Induction in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Jun N-terminal Kinase (JNK); Mechanotransduction; Osteoblasts; p38 MAPK; Fn14	INFLAMMATORY CYTOKINES; BONE-FORMATION; DIFFERENTIATION; TWEAK; HOMEOSTASIS; OSTEOCLASTS; OSTEOCYTES; MOUSE; MAPK; TNF	Background: Fn14 is a highly inducible member of the TNF receptor family. Results: Large-magnitude mechanical stress induced Fn14 expression via JNK in osteoblasts. Conclusion: Expression of Fn14 regulates mechanical stress-induced apoptosis in osteoblasts. Significance: This is the first elucidation of the mechanism of excessive mechanical stress-induced apoptosis mediated by Fn14. Bone mass is maintained by the balance between the activities of bone-forming osteoblasts and bone-resorbing osteoclasts. It is well known that adequate mechanical stress is essential for the maintenance of bone mass, whereas excess mechanical stress induces bone resorption. However, it has not been clarified how osteoblasts respond to different magnitudes of mechanical stress. Here we report that large-magnitude (12%) cyclic stretch induced Ca2+ influx, which activated reactive oxygen species generation in MC3T3-E1 osteoblasts. Reactive oxygen species then activated the ASK1-JNK/p38 pathways. The activated JNK led to transiently enhanced expression of FGF-inducible 14 (Fn14, a member of the TNF receptor superfamily) gene. Cells with enhanced expression of Fn14 subsequently acquired sensitivity to the ligand of Fn14, TNF-related weak inducer of apoptosis, and underwent apoptosis. On the other hand, the ASK1-p38 pathway induced expression of the monocyte chemoattractant protein 3 (MCP-3) gene, which promoted chemotaxis of preosteoclasts. In contrast, the ERK pathway was activated by small-magnitude stretching (1%) and induced expression of two osteogenic genes, collagen Ia (Col1a) and osteopontin (OPN). Moreover, activated JNK suppressed Col1a and OPN induction in large-magnitude mechanical stretch-loaded cells. The enhanced expression of Fn14 and MCP-3 by 12% stretch and the enhanced expression of Col1a and OPN by 1% stretch were also observed in mouse primary osteoblasts. These results suggest that differences in the response of osteoblasts to varying magnitudes of mechanical stress play a key role in switching the mode of bone metabolism between formation and resorption.	[Matsui, Hiroyuki; Fukuno, Naoto; Kantoh, Yusuke; Chida, Toko; Nagaura, Yuko; Kobayashi, Takayasu; Tamura, Shinri] Tohoku Univ, Dept Biochem, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Matsui, Hiroyuki; Fukuno, Naoto; Kanda, Yoshiaki; Kantoh, Yusuke; Sasaki, Keiichi] Tohoku Univ, Dept Adv Prosthet Dent, Sendai, Miyagi 9808575, Japan; [Suzuki, Osamu] Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Sendai, Miyagi 9808575, Japan; [Matsui, Hiroyuki; Sawada, Yasuhiro] Nadogaya Hosp, Locomot Syndrome Res Inst, Lab Mech Med, Kashiwa, Chiba 2770032, Japan; [Nishitoh, Hideki] Miyazaki Univ, Dept Med Sci, Div Biochem & Mol Biol, Kiyotake, Miyazaki 8891692, Japan; [Takeda, Kohsuke] Nagasaki Univ, Div Cell Regulat, Nagasaki 8528521, Japan; [Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, Tokyo 1130033, Japan; [Sawada, Yasuhiro] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore	Tohoku University; Tohoku University; Tohoku University; University of Miyazaki; Nagasaki University; University of Tokyo; National University of Singapore	Tamura, S (corresponding author), Tohoku Univ, Dept Biochem, Inst Dev Aging & Canc, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	tamura@idac.tohoku.ac.jp	Sawada, Yasuhiro/H-8044-2012	Sawada, Yasuhiro/0000-0003-0625-3335; Ichijo, Hidenori/0000-0002-5005-6438; Suzuki, Osamu/0000-0002-3566-5681; Takeda, Kohsuke/0000-0002-8359-8399; Nishitoh, Hideki/0000-0002-8652-4109	Japan Society for Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [25460353, 26861619, 24590339, 24659027] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research from the Japan Society for Promotion of Science and Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Ando T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2038; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Fu JH, 2012, EUR J ORAL IMPLANTOL, V5, pS91; Fukuno N, 2011, BIOCHEM BIOPH RES CO, V408, P202, DOI 10.1016/j.bbrc.2011.02.127; Goga Y, 2006, J DENT RES, V85, P240, DOI 10.1177/154405910608500307; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hay E, 2004, J BIOL CHEM, V279, P1650, DOI 10.1074/jbc.M300969200; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hoshino A, 2010, J BIOL CHEM, V285, P28826, DOI 10.1074/jbc.M109.099424; Jeon YM, 2009, MOL CELL BIOCHEM, V320, P45, DOI 10.1007/s11010-008-9897-z; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Loboa EG, 2001, J ORTHOP RES, V19, P1067, DOI 10.1016/S0736-0266(01)00028-6; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Matsumoto T, 2013, J DENT RES, V92, P340, DOI 10.1177/0022034513476037; Menini M, 2012, J DENT RES, V91, P821, DOI 10.1177/0022034512455802; Menten P, 2001, EUR CYTOKINE NETW, V12, P554; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; Moriishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040143; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006; Suenaga H, 2012, ANN NUCL MED, V26, P817, DOI 10.1007/s12149-012-0648-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeda K, 2011, ANTIOXID REDOX SIGN, V15, P719, DOI 10.1089/ars.2010.3392; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Vincent C, 2009, J BONE MINER RES, V24, P1434, DOI [10.1359/jbmr.090305, 10.1359/JBMR.090305]; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhou HK, 2011, BONE, V49, P404, DOI 10.1016/j.bone.2011.04.020	39	32	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6438	6450		10.1074/jbc.M113.536300	http://dx.doi.org/10.1074/jbc.M113.536300			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24446436	Green Published, hybrid			2022-12-25	WOS:000332389400012
J	Polling, S; Mok, YF; Ramdzan, YM; Turner, BJ; Yerbury, JJ; Hill, AF; Hatters, DM				Polling, Saskia; Mok, Yee-Foong; Ramdzan, Yasmin M.; Turner, Bradley J.; Yerbury, Justin J.; Hill, Andrew F.; Hatters, Danny M.			Misfolded Polyglutamine, Polyalanine, and Superoxide Dismutase 1 Aggregate via Distinct Pathways in the Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Analytical Ultracentrifugation; Flow Cytometry; Polyglutamine; Protein Aggregation; Superoxide Dismutase (SOD); Inclusion; Polyalanine	AMYOTROPHIC-LATERAL-SCLEROSIS; SIZE-DISTRIBUTION ANALYSIS; ANALYTICAL ULTRACENTRIFUGATION; HUNTINGTIN AGGREGATION; MUTANT HUNTINGTIN; GLUTAMINE REPEATS; PROTEIN; SOD1; OLIGOMERIZATION; CHAPERONES	Background: Protein aggregation is associated with neurodegenerative diseases. Results: We defined how the oligomeric state of disease-relevant mutant protein and homopolypeptides relate to clustering into inclusion subtypes IPOD and JUNQ. Conclusion: JUNQ protein and homopolypeptides relate to constitutively disrupted oligomeric states irrespective of inclusion formation. Significance: JUNQ inclusions may arise by cellular failure in degradation of abnormal oligomeric states. Protein aggregation into intracellular inclusions is a key feature of many neurodegenerative disorders. A common theme has emerged that inappropriate self-aggregation of misfolded or mutant polypeptide sequences is detrimental to cell health. Yet protein quality control mechanisms may also deliberately cluster them together into distinct inclusion subtypes, including the insoluble protein deposit (IPOD) and the juxtanuclear quality control (JUNQ). Here we investigated how the intrinsic oligomeric state of three model systems of disease-relevant mutant protein and peptide sequences relates to the IPOD and JUNQ patterns of aggregation using sedimentation velocity analysis. Two of the models (polyalanine (37A) and superoxide dismutase 1 (SOD1) mutants A4V and G85R) accumulated into the same JUNQ-like inclusion whereas the other, polyglutamine (72Q), formed spatially distinct IPOD-like inclusions. Using flow cytometry pulse shape analysis (PulSA) to separate cells with inclusions from those without revealed the SOD1 mutants and 37A to have abruptly altered oligomeric states with respect to the nonaggregating forms, regardless of whether cells had inclusions or not, whereas 72Q was almost exclusively monomeric until inclusions formed. We propose that mutations leading to JUNQ inclusions induce a constitutively misfolded state exposing hydrophobic side chains that attract and ultimately overextend protein quality capacity, which leads to aggregation into JUNQ inclusions. Poly(Q) is not misfolded in this same sense due to universal polar side chains, but is highly prone to forming amyloid fibrils that we propose invoke a different engagement mechanism with quality control.	[Polling, Saskia; Mok, Yee-Foong; Ramdzan, Yasmin M.; Hill, Andrew F.; Hatters, Danny M.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Polling, Saskia; Mok, Yee-Foong; Ramdzan, Yasmin M.; Hill, Andrew F.; Hatters, Danny M.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Turner, Bradley J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Turner, Bradley J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Yerbury, Justin J.] Univ Wollongong, Sch Biol Sci, Fac Sci, Wollongong, NSW 2522, Australia; [Yerbury, Justin J.] Univ Wollongong, Illawarra Hlth & Med Inst, Wollongong, NSW 2522, Australia	University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Wollongong; University of Wollongong	Hatters, DM (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Melbourne, Vic 3010, Australia.	dhatters@unimelb.edu.au	Yerbury, Justin/AAC-7054-2022; Hill, Andrew F/B-4527-2009; Hill, Andrew F./AAH-2854-2020; Hill, Andrew F./GZL-4124-2022	Yerbury, Justin/0000-0003-2528-7039; Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; Turner, Bradley/0000-0001-6580-7655; Hatters, Danny/0000-0002-9965-2847	Australian Research Council (ARC) Discovery Grant [DP120102763]; ARC Future Fellowship Grant [FT120100039, FT100100560]	Australian Research Council (ARC) Discovery Grant(Australian Research Council); ARC Future Fellowship Grant(Australian Research Council)	This work was supported by Australian Research Council (ARC) Discovery Grant DP120102763 and ARC Future Fellowship Grant FT120100039 (to D. M. H.), and ARC Future Fellowship Grant FT100100560 (to A. F. H.).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Berger Z, 2006, HUM MOL GENET, V15, P453, DOI 10.1093/hmg/ddi460; Bernacki JP, 2011, BIOCHEMISTRY-US, V50, P9200, DOI 10.1021/bi201155g; Blondelle SE, 1997, BIOCHEMISTRY-US, V36, P8393, DOI 10.1021/bi963015b; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cecchi C, 2013, BIOPHYS CHEM, V182, P30, DOI 10.1016/j.bpc.2013.06.003; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hatters DM, 2012, CURR TOP MED CHEM, V12, P2611; Hughes J., 2013, TANDEM REPEATS GENES, P135; Irtegun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071035; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Landis D., 1996, HDB INTERCULTURAL TR, V2nd; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lotz GP, 2013, J MOL MED, V91, P653, DOI 10.1007/s00109-013-1025-1; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Nojima J, 2009, J NEUROSCI RES, V87, P2290, DOI 10.1002/jnr.22052; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Ormsby AR, 2013, J BIOL CHEM, V288, P37192, DOI 10.1074/jbc.M113.486944; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Ramdzan YM, 2012, NAT METHODS, V9, P467, DOI [10.1038/NMETH.1930, 10.1038/nmeth.1930]; Ramdzan YM, 2010, CHEM BIOL, V17, P371, DOI 10.1016/j.chembiol.2010.03.011; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Rankin J, 2000, BIOCHEM J, V348, P15, DOI 10.1042/0264-6021:3480015; Robertson AL, 2010, CURR MED CHEM, V17, P3058; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Tsvetkov AS, 2013, NAT CHEM BIOL, V9, P586, DOI [10.1038/NCHEMBIO.1308, 10.1038/nchembio.1308]; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Weisberg SJ, 2012, P NATL ACAD SCI USA, V109, P15811, DOI 10.1073/pnas.1205829109; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	57	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6669	6680		10.1074/jbc.M113.520189	http://dx.doi.org/10.1074/jbc.M113.520189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425868	hybrid, Green Published			2022-12-25	WOS:000332389400030
J	Singh, R; Kraft, C; Jaiswal, R; Sejwal, K; Kasaragod, VB; Kuper, J; Burger, J; Mielke, T; Luirink, J; Bhushan, S				Singh, Rajkumar; Kraft, Christian; Jaiswal, Rahul; Sejwal, Kushal; Kasaragod, Vikram Babu; Kuper, Jochen; Buerger, Joerg; Mielke, Thorsten; Luirink, Joen; Bhushan, Shashi			Cryo-electron Microscopic Structure of SecA Protein Bound to the 70S Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Microscopy (EM); Protein Secretion; Protein Translocation; Ribosomes; Single Particle Analysis; 70S; Cryo-EM; Ribosome; SecA; SecYEG	ION-CHANNEL ACTIVITY; ESCHERICHIA-COLI; SIGNAL-PEPTIDE; DIMERIC SECA; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; BINDING DOMAIN; ATPASE SECA; TRANSLOCATION; COMPLEX	Background: SecA targets preproteins to the protein-conducting channel in bacteria. Results: Both the single and double copies of SecA bind to the 70S ribosome. Conclusion: Two copies of SecA completely surround the polypeptide tunnel exit. Significance: The structures suggest a function of the dimeric form of SecA on the ribosome. SecA is an ATP-dependent molecular motor pumping secretory and outer membrane proteins across the cytoplasmic membrane in bacteria. SecA associates with the protein-conducting channel, the heterotrimeric SecYEG complex, in a so-called posttranslational manner. A recent study further showed binding of a monomeric state of SecA to the ribosome. However, the true oligomeric state of SecA remains controversial because SecA can also form functional dimers, and high-resolution crystal structures exist for both the monomer and the dimer. Here we present the cryo-electron microscopy structures of Escherichia coli SecA bound to the ribosome. We show that not only a monomeric SecA binds to the ribosome but also that two copies of SecA can be observed that form an elongated dimer. Two copies of SecA completely surround the tunnel exit, providing a unique environment to the nascent polypeptides emerging from the ribosome. We identified the N-terminal helix of SecA required for a stable association with the ribosome. The structures indicate a possible function of the dimeric form of SecA at the ribosome.	[Singh, Rajkumar; Kraft, Christian; Sejwal, Kushal; Kasaragod, Vikram Babu; Kuper, Jochen; Bhushan, Shashi] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Jaiswal, Rahul; Bhushan, Shashi] Nanyang Technol Univ, Div Struct Biol & Biochem, Sch Biol Sci, Singapore 637551, Singapore; [Buerger, Joerg; Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Buerger, Joerg; Mielke, Thorsten] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Luirink, Joen] Vrije Univ Amsterdam, Dept Mol Microbiol, Inst Mol Cell Biol, NL-1081 HV Amsterdam, Netherlands	German Research Foundation (DFG); University of Wurzburg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Vrije Universiteit Amsterdam	Bhushan, S (corresponding author), Nanyang Technol Univ, Div Struct Biol & Biochem, Sch Biol Sci, Singapore 639798, Singapore.	sbhushan@ntu.edu.sg	Jaiswal, Rahul/GLS-9380-2022; Luirink, Joen/AAB-8658-2021	Jaiswal, Rahul/0000-0002-4379-3798; Burger, Jorg/0000-0002-4326-5047; Bhushan, Shashi/0000-0002-8514-5959; Luirink, J./0000-0001-8431-0804; Kasaragod, Vikram Babu/0000-0002-1241-4038	Deutsche Forschungsgemeinschaft (Forschungszentrum, Rudolf-Virchow-Zentrum); School of Biological Sciences, Nanyang Technological University, Singapore; Deutsche Forschungsgemeinschaft [SFB740]	Deutsche Forschungsgemeinschaft (Forschungszentrum, Rudolf-Virchow-Zentrum)(German Research Foundation (DFG)); School of Biological Sciences, Nanyang Technological University, Singapore(Nanyang Technological University); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Forschungszentrum, Rudolf-Virchow-Zentrum), by the School of Biological Sciences, Nanyang Technological University, Singapore (to S. B.), and by Grant SFB740, Project Z1 from the Deutsche Forschungsgemeinschaft (to T. M.).	AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; Bhushan S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000581; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; Deville K, 2011, J BIOL CHEM, V286, P4659, DOI 10.1074/jbc.M110.175638; DRIESSEN AJM, 1993, BIOCHEMISTRY-US, V32, P13190, DOI 10.1021/bi00211a030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hsieh YH, 2013, BIOCHEM BIOPH RES CO, V431, P388, DOI 10.1016/j.bbrc.2013.01.042; Hsieh YH, 2011, J BIOL CHEM, V286, P44702, DOI 10.1074/jbc.M111.300111; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Jilaveanu LB, 2006, J BACTERIOL, V188, P335, DOI 10.1128/JB.188.1.335-338.2006; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Karamanou S, 2005, FEBS LETT, V579, P1267, DOI 10.1016/j.febslet.2005.01.025; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; Lin BR, 2012, J MEMBRANE BIOL, V245, P747, DOI 10.1007/s00232-012-9477-8; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morita K, 2012, J BIOL CHEM, V287, P455, DOI 10.1074/jbc.M111.301754; Musial-Siwek M, 2005, BIOCHEMISTRY-US, V44, P13987, DOI 10.1021/bi050882k; Musial-Siwek M, 2007, J MOL BIOL, V365, P637, DOI 10.1016/j.jmb.2006.10.027; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Papanikou E, 2005, J BIOL CHEM, V280, P43209, DOI 10.1074/jbc.M509990200; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; ROLLO EE, 1988, J BACTERIOL, V170, P3281, DOI 10.1128/jb.170.7.3281-3282.1988; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tziatzios C, 2004, J MOL BIOL, V340, P513, DOI 10.1016/j.jmb.2004.04.076; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Whitehouse S, 2012, J CELL BIOL, V199, P919, DOI 10.1083/jcb.201205191; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Wu ZC, 2012, J BIOL CHEM, V287, P7885, DOI 10.1074/jbc.M111.297911; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2006, J MOL BIOL, V364, P259, DOI 10.1016/j.jmb.2006.08.044	53	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7190	7199		10.1074/jbc.M113.506634	http://dx.doi.org/10.1074/jbc.M113.506634			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443566	Green Published, hybrid			2022-12-25	WOS:000332389400077
J	Ran, LY; Su, HN; Zhou, MY; Wang, L; Chen, XL; Xie, BB; Song, XY; Shi, M; Qin, QL; Pang, XH; Zhou, BC; Zhang, YZ; Zhang, XY				Ran, Li-Yuan; Su, Hai-Nan; Zhou, Ming-Yang; Wang, Lei; Chen, Xiu-Lan; Xie, Bin-Bin; Song, Xiao-Yan; Shi, Mei; Qin, Qi-Long; Pang, Xiuhua; Zhou, Bai-Cheng; Zhang, Yu-Zhong; Zhang, Xi-Ying			Characterization of a Novel Subtilisin-like Protease Myroicolsin from Deep Sea Bacterium Myroides profundi D25 and Molecular Insight into Its Collagenolytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Biodegradation; Collagen; Enzyme Mechanisms; Serine Protease; Collagenolytic Mechanism; Deep Sea Sediment; Nitrogen Cycling; Structural Characteristics; Subtilisin-like Protease	PSEUDOALTEROMONAS SP SM9913; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; SERINE PROTEINASE; ORGANIC NITROGEN; STRUCTURAL BASIS; DESEASIN MCP-01; TRIPLE-HELIX; BINDING ABILITY; FIDDLER-CRAB	Background: The mechanism of marine collagen degradation is largely unknown. Results: Myroicolsin, a subtilisin-like protease from a marine bacterium, was characterized, and its collagenolytic mechanism was studied. Conclusion: Myroicolsin has a novel domain structure and a unique collagen degradation mechanism compared with other subtilisin-like proteases. Significance: This study provides new insights into the mechanism of subtilisin-like proteases' collagenolysis and marine nitrogen cycling. Collagen is an insoluble protein that widely distributes in the extracellular matrix of marine animals. Collagen degradation is an important step in the marine nitrogen cycle. However, the mechanism of marine collagen degradation is still largely unknown. Here, a novel subtilisin-like collagenolytic protease, myroicolsin, which is secreted by the deep sea bacterium Myroides profundi D25, was purified and characterized, and its collagenolytic mechanism was studied. Myroicolsin displays low identity (<30%) to previously characterized subtilisin-like proteases, and it contains a novel domain structure. Protein truncation indicated that the Pro secretion system C-terminal sorting domain in the precursor protein is involved in the cleavage of the N-propeptide, and the linker is required for protein folding during myroicolsin maturation. The C-terminal -jelly roll domain did not bind insoluble collagen fiber, suggesting that myroicolsin may degrade collagen without the assistance of a collagen-binding domain. Myroicolsin had broad specificity for various collagens, especially fish-insoluble collagen. The favored residue at the P1 site was basic arginine. Scanning electron microscopy and atomic force microscopy, together with biochemical analyses, confirmed that collagen fiber degradation by myroicolsin begins with the hydrolysis of proteoglycans and telopeptides in collagen fibers and fibrils. Myroicolsin showed strikingly different cleavage patterns between native and denatured collagens. A collagen degradation model of myroicolsin was proposed based on our results. Our study provides molecular insight into the collagen degradation mechanism and structural characterization of a subtilisin-like collagenolytic protease secreted by a deep sea bacterium, shedding light on the degradation mechanism of deep sea sedimentary organic nitrogen.	[Ran, Li-Yuan; Su, Hai-Nan; Zhou, Ming-Yang; Wang, Lei; Chen, Xiu-Lan; Xie, Bin-Bin; Song, Xiao-Yan; Shi, Mei; Qin, Qi-Long; Pang, Xiuhua; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Ran, Li-Yuan; Su, Hai-Nan; Zhou, Ming-Yang; Wang, Lei; Chen, Xiu-Lan; Xie, Bin-Bin; Song, Xiao-Yan; Shi, Mei; Qin, Qi-Long; Pang, Xiuhua; Zhou, Bai-Cheng; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China; [Su, Hai-Nan; Chen, Xiu-Lan; Xie, Bin-Bin; Song, Xiao-Yan; Shi, Mei; Qin, Qi-Long; Pang, Xiuhua; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, Collaborat Innovat Ctr Deep Sea Biol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn; zhangxiying@sdu.edu.cn		Ran, Liyuan/0000-0002-8241-7138	National Natural Science Foundation of China [91228210, 31290231, 31025001, 31170055]; Hi-Tech Research and Development Program of China [2011AA090703, 2012AA092103]; China Ocean Mineral Resources R&D Association (COMRA) Special Foundation [DY125-15-T-05, DY125-15-R-03]; Special Fund of China for Marine-Scientific Research in the Public Interest [201005032-6]; Program of Shandong for Taishan Scholars [2008BS02019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Ocean Mineral Resources R&D Association (COMRA) Special Foundation; Special Fund of China for Marine-Scientific Research in the Public Interest; Program of Shandong for Taishan Scholars	The work was supported by National Natural Science Foundation of China Grants 91228210, 31290231, 31025001, and 31170055; Hi-Tech Research and Development Program of China Grants 2011AA090703 and 2012AA092103; China Ocean Mineral Resources R&D Association (COMRA) Special Foundation Grants DY125-15-T-05 and DY125-15-R-03; Special Fund of China for Marine-Scientific Research in the Public Interest Grant 201005032-6; and Program of Shandong for Taishan Scholars Grant 2008BS02019.	Abraham LD, 1996, ENZYME MICROB TECH, V18, P133, DOI 10.1016/0141-0229(95)00098-4; Aluwihare LI, 2005, SCIENCE, V308, P1007, DOI 10.1126/science.1108925; BALLINGER MD, 1995, BIOCHEMISTRY-US, V34, P13312, DOI 10.1021/bi00041a006; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Brunnegard J, 2004, PROG OCEANOGR, V63, P159, DOI 10.1016/j.pocean.2004.09.004; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; Chen XL, 2009, APPL ENVIRON MICROB, V75, P1838, DOI 10.1128/AEM.02285-08; Chen YJ, 2008, CURR OPIN STRUC BIOL, V18, P765, DOI 10.1016/j.sbi.2008.10.005; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; COWAN PM, 1955, NATURE, V176, P1062, DOI 10.1038/1761062a0; Eckhard U, 2011, NAT STRUCT MOL BIOL, V18, P1109, DOI 10.1038/nsmb.2127; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; EISEN AZ, 1973, BIOCHEMISTRY-US, V12, P1814, DOI 10.1021/bi00733a024; Exposito JY, 2010, INT J MOL SCI, V11, P407, DOI 10.3390/ijms11020407; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Foophow T, 2010, J MOL BIOL, V400, P865, DOI 10.1016/j.jmb.2010.05.064; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; He HL, 2004, FOOD CHEM, V84, P307, DOI 10.1016/S0308-8146(03)00242-5; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Itoi Y, 2006, J BACTERIOL, V188, P6572, DOI 10.1128/JB.00767-06; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kadler KE, 1996, BIOCHEM J, V316, P1; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Kim Hyo-Kyung, 2003, Korean Journal of Parasitology, V41, P189, DOI 10.3347/kjp.2003.41.4.189; Kim Won-Tae, 2006, Korean Journal of Parasitology, V44, P321, DOI 10.3347/kjp.2006.44.4.321; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Kurata A, 2010, APPL MICROBIOL BIOT, V86, P589, DOI 10.1007/s00253-009-2324-x; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; MACIVER B, 1994, APPL ENVIRON MICROB, V60, P3981, DOI 10.1128/AEM.60.11.3981-3988.1994; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Nonaka T, 2004, J BIOL CHEM, V279, P47344, DOI 10.1074/jbc.M409089200; O'Farrell TJ, 2006, BIOCHEMISTRY-US, V45, P15411, DOI 10.1021/bi060849d; Okamoto M, 2001, APPL MICROBIOL BIOT, V57, P103, DOI 10.1007/s002530100731; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Panwar P, 2013, J BIOL CHEM, V288, P5940, DOI 10.1074/jbc.M112.419689; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, BIOCHEMISTRY-US, V36, P5381, DOI 10.1021/bi9617522; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Robinson MW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001012; Sankar S, 2008, INT J BIOL MACROMOL, V42, P6, DOI 10.1016/j.ijbiomac.2007.08.003; Sarkar S, 2010, MAR DRUGS, V8, P1323, DOI 10.3390/md8041323; SCOTT JE, 1981, BIOCHEM J, V195, P573, DOI 10.1042/bj1950573; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; TAKEUCHI H, 1992, BIOCHEM J, V281, P703, DOI 10.1042/bj2810703; Tanaka S, 2008, FEBS LETT, V582, P3875, DOI 10.1016/j.febslet.2008.10.025; Tsu CA, 1997, BIOCHEMISTRY-US, V36, P5393, DOI 10.1021/bi961753u; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Walton RS, 2010, J MATER SCI-MATER M, V21, P451, DOI 10.1007/s10856-009-3910-2; Wang YK, 2010, J BIOL CHEM, V285, P14285, DOI 10.1074/jbc.M109.087023; Windhorst S, 2002, J BIOL CHEM, V277, P11042, DOI 10.1074/jbc.M109525200; Worthington Biochemical Co, 1993, WORTH ENZ MAN; YOSHIDA ETUSUKO, 1965, BIOCHIM BIOPHYSACTA, V105, P562; Zhang XY, 2008, FEMS MICROBIOL LETT, V287, P108, DOI 10.1111/j.1574-6968.2008.01299.x; Zhao GY, 2008, J BIOL CHEM, V283, P36100, DOI 10.1074/jbc.M804438200	56	26	26	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6041	6053		10.1074/jbc.M113.513861	http://dx.doi.org/10.1074/jbc.M113.513861			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24429289	hybrid, Green Published			2022-12-25	WOS:000332015500059
J	Crevecoeur, I; Skinner, MM; Bailey, SE; Gunz, P; Bortoluzzi, S; Brooks, AS; Burlet, C; Cornelissen, E; De Clerck, N; Maureille, B; Semal, P; Vanbrabant, Y; Wood, B				Crevecoeur, Isabelle; Skinner, Matthew M.; Bailey, Shara E.; Gunz, Philipp; Bortoluzzi, Silvia; Brooks, Alison S.; Burlet, Christian; Cornelissen, Els; De Clerck, Nora; Maureille, Bruno; Semal, Patrick; Vanbrabant, Yves; Wood, Bernard			First Early Hominin from Central Africa (Ishango, Democratic Republic of Congo)	PLOS ONE			English	Article							UPPER SEMLIKI VALLEY; ENAMEL THICKNESS; TISSUE PROPORTIONS; MOLARS; AUSTRALOPITHECUS; MORPHOLOGY; EVOLUTION; HOMO; CHALLENGES; FOSSILS	Despite uncontested evidence for fossils belonging to the early hominin genus Australopithecus in East Africa from at least 4.2 million years ago (Ma), and from Chad by 3.5 Ma, thus far there has been no convincing evidence of Australopithecus, Paranthropus or early Homo from the western (Albertine) branch of the Rift Valley. Here we report the discovery of an isolated upper molar (#Ish25) from the Western Rift Valley site of Ishango in Central Africa in a derived context, overlying beds dated to between ca. 2.6 to 2.0 Ma. We used mu CT imaging to compare its external and internal macro-morphology to upper molars of australopiths, and fossil and recent Homo. We show that the size and shape of the enamel-dentine junction (EDJ) surface discriminate between Plio-Pleistocene and post-Lower Pleistocene hominins, and that the Ishango molar clusters with australopiths and early Homo from East and southern Africa. A reassessment of the archaeological context of the specimen is consistent with the morphological evidence and suggest that early hominins were occupying this region by at least 2 Ma.	[Crevecoeur, Isabelle; Maureille, Bruno] Univ Bordeaux, CNRS, Prehist Actuel Culture Environm & Anthropol UMR P, UMR 5199, Talence, France; [Skinner, Matthew M.] UCL, Dept Anthropol, London, England; [Bailey, Shara E.] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Skinner, Matthew M.; Bailey, Shara E.; Gunz, Philipp] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Bortoluzzi, Silvia] Univ Florence, Dipartimento Biol Evoluzionist Leo Pardi, Lab Antropol, Florence, Italy; [Brooks, Alison S.; Wood, Bernard] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC USA; [Burlet, Christian; Vanbrabant, Yves] Royal Belgian Inst Nat Sci, Geol Survey Belgium, Brussels, Belgium; [Cornelissen, Els] Royal Museum Cent Africa, Sect Prehist & Archaeol, Tervuren, Belgium; [De Clerck, Nora] Univ Antwerp, Microtomog CT Res Grp, Antwerp, Belgium; [Semal, Patrick] Royal Belgian Inst Nat Sci, Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of London; University College London; New York University; Max Planck Society; University of Florence; George Washington University; Royal Belgian Institute of Natural Sciences; Royal Museum for Central Africa; University of Antwerp; Royal Belgian Institute of Natural Sciences	Crevecoeur, I (corresponding author), Univ Bordeaux, CNRS, Prehist Actuel Culture Environm & Anthropol UMR P, UMR 5199, Talence, France.	i.crevecoeur@pacea.u-bordeaux1.fr	Skinner, Matthew/D-1104-2010; Gunz, Philipp/C-7748-2009	Skinner, Matthew/0000-0001-8321-3543; Gunz, Philipp/0000-0002-2350-4450; Burlet, Christian/0000-0002-2134-1969; Semal, Patrick/0000-0002-4048-7728; Bailey, Shara/0000-0002-4626-9262; Maureille, Bruno/0000-0002-7616-0073	Brussels Institute for Research and Innovation (IRSIB) [PRFB 2006/CM/IV/52]; Franco-American Commission for Educational Exchange (Fulbright Foreign Scholarship); Centre national de la recherche scientifique (CNRS); Programma Vigoni; Max Planck Society	Brussels Institute for Research and Innovation (IRSIB)(Innoviris); Franco-American Commission for Educational Exchange (Fulbright Foreign Scholarship); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Programma Vigoni; Max Planck Society(Max Planck Society)	Support was provided by the Brussels Institute for Research and Innovation (IRSIB, program Prospective Research for Brussels 2007-2009; PRFB 2006/CM/IV/52; http://www.innoviris.be/site/), the Franco-American Commission for Educational Exchange (Fulbright Foreign Scholarship 2010; http://www.fulbright-france.org/gene/main.php), The Centre national de la recherche scientifique (CNRS; http://www.cnrs.fr/), the Programma Vigoni (bilateral exchange program between Italy and Germany) and the Max Planck Society (http://www.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam W, 1957, MOLLUSQUES QUATERNAI; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Berger LR, 2013, SCIENCE, V340, P163, DOI 10.1126/science.340.6129.163; Boaz N.T., 1990, Virginia Museum of Natural History Memoir, P3; BOAZ NT, 1992, J HUM EVOL, V22, P505, DOI 10.1016/0047-2484(92)90083-L; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Brooks A. S., 1990, WORLD 18000 BP, V2, P121; Brooks A. S., 1987, AFRICAN ARCHAEOL REV, V5, P65, DOI DOI 10.1007/BF01117083; BROOKS AS, 1995, SCIENCE, V268, P548, DOI 10.1126/science.7725099; BROWN FH, 1985, ANCESTORS HARD EVIDE, P82; Clarke RJ, 2012, J HUM EVOL, V63, P418, DOI 10.1016/j.jhevol.2011.11.007; Cleuvenot Emmanuel, 1993, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V5, P245, DOI 10.3406/bmsap.1993.2354; Coleman MN, 2007, AM J PHYS ANTHROPOL, V133, P723, DOI 10.1002/ajpa.20583; Cooke H.B.S., 1990, Virginia Museum of Natural History Memoir, P197; Damas H., 1940, Revue de Zoologie et de Botanique Africaines, V33, P265; de Heinzelin J., 1957, FOUILLES ISHANGO; de Heinzelin J., 1996, REALM UPPER SEMLIKI; de Heinzelin J, 1955, FOSSE TECTONIQUE PAR; de Heinzelin J., 1961, PALEOLITHIQUE ABORDS; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; Dechamps R, 1990, VA MUS NAT, P71; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DEMIRJIAN A, 1973, HUM BIOL, V45, P211; Fuchs V., 1934, GEOL MAG, V71, P97; Fuchs V., 1934, GEOL MAG, V72, P145; Gautier A, 1970, GEOLOGISCHE WETENSCH, V67, P5; Greenwood P. H., 1959, QUATERNARY FISH FOSS; Grine F.E., 1988, P3; Grine FE, 2005, AM J PHYS ANTHROPOL, V126, P14, DOI 10.1002/ajpa.10277; Guatelli-Steinberg D, 2005, AM J PHYS ANTHROPOL, V128, P477, DOI 10.1002/ajpa.20194; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Harris J.W.K., 1990, Virginia Museum of Natural History Memoir, P237; HILLSON S, 1996, DENT ANTHR; Hopwood A. T., 1959, MAMMIFERES FOSSILES; KANAZAWA E, 1990, AM J PHYS ANTHROPOL, V83, P173, DOI 10.1002/ajpa.1330830205; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Kimbel William H., 2007, P1539, DOI 10.1007/978-3-540-33761-4_50; Kingston JD, 2007, YEARB PHYS ANTHROPOL, V50, P20, DOI 10.1002/ajpa.20733; Kirchner MT, 1997, J RAMAN SPECTROSC, V28, P171; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Korenhof C. A. W., 1960, MORPHOGENETICAL ASPE; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Lepersonne J., 1970, Annls Mus r. Afr. cent 8[degrees] Sci. geol., VNo. 67, P171; MACHO GA, 1993, AM J PHYS ANTHROPOL, V92, P189, DOI 10.1002/ajpa.1330920208; Martin, 1983, RELATIONSHIPS LATER; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin Rudolf, 1914, LEHRBUCH ANTHR SYSTE; Mercader J, 2001, J ANTHROPOL RES, V57, P197, DOI 10.1086/jar.57.2.3631567; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Olejniczak A.J., 2006, MICROCOMPUTED TOMOGR; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Olejniczak AJ, 2008, J HUM EVOL, V54, P187, DOI 10.1016/j.jhevol.2007.09.014; Orban Rosine, 2001, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V13, P97; Peters J., 1990, Revue de Paleobiologie, V9, P73; Pickford M., 1993, GEOLOGY PALAEOBIOLOG, V24, P1; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Quam R, 2009, J ANAT, V214, P655, DOI 10.1111/j.1469-7580.2009.01064.x; Robinson JT, 1956, DENTITION AUSTRALOPI; SCOTT GR, 1980, HUM BIOL, V52, P63; SENUT B, 1987, CR ACAD SCI II, V305, P819; Skinner MM, 2009, AM J PHYS ANTHROPOL, V140, P234, DOI 10.1002/ajpa.21057; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Smith TM, 2005, J HUM EVOL, V48, P575, DOI 10.1016/j.jhevol.2005.02.004; Stanley SM, 1995, STUDIES GEOPHYSICS E, P233; Stewart K. M., 1989, BAR INT SERIES; SUZUKI M, 1991, J DENT RES, V70, P1092, DOI 10.1177/00220345910700071501; Tafforeau P, 2004, ASPECTS PHYLOGENETIQ; Tsuda H, 1996, EUR J ORAL SCI, V104, P123, DOI 10.1111/j.1600-0722.1996.tb00056.x; Twiesselmann F, 1958, EXPLORATION PARC NAT; ULLRICH CG, 1980, RADIOLOGY, V134, P137, DOI 10.1148/radiology.134.1.7350593; Van Damme D., 1994, GEOLOGY PALAEOBIOLOG, V2, P71; VANNEER W, 1994, GEOLOGY PALAEOBIOLOG, V2, P89; Verheyen W., 1959, OISEAUX FOSSILES; Vrba E.S., 1988, P405; WALKER A, 1986, NATURE, V322, P517, DOI 10.1038/322517a0; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1988, J ANAT, V161, P1; Wood B, 2010, P NATL ACAD SCI USA, V107, P8902, DOI 10.1073/pnas.1001649107; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100; Zanolli C, 2010, CR PALEVOL, V9, P341, DOI 10.1016/j.crpv.2010.07.019	85	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84652	10.1371/journal.pone.0084652	http://dx.doi.org/10.1371/journal.pone.0084652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24427292	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000329868200032
J	Torgersen, JS; Koppang, EO; Stien, LH; Kohler, A; Pedersen, ME; Morkore, T				Torgersen, Jacob S.; Koppang, Erling Olaf; Stien, Lars H.; Kohler, Achim; Pedersen, Mona E.; Morkore, Turid			Soft Texture of Atlantic Salmon Fillets Is Associated with Glycogen Accumulation	PLOS ONE			English	Article							CONNECTIVE TISSUES; MUSCLE; COLLAGEN; FISH; EXPRESSION; PERLECAN; FLESH; COLOR	Atlantic salmon (Salmo salar L.) with soft fillets are not suited for manufacturing high quality products. Therefore fillets with insufficient firmness are downgraded, leading to severe economic losses to the farming and processing industries. In the current study, morphological characteristics of salmon fillets ranging from soft to hard were analysed. Different microscopic techniques were applied, including novel methods in this field of research: morphometric image analysis, periodic acid Schiff staining, immunofluorescence microscopy, transmission electron microscopy and fourier transform infrared microscopy. The results showed that the myocytes of soft muscle had detached cells with mitochondrial dysfunctions, large glycogen aggregates and enlarged inter cellular areas, void of extracellular matrix proteins, including lower amounts of sulfated glycoproteins. Myofibre-myofibre detachment and disappearance of the endomysium in soft muscles coincided with deterioration of important connective tissue constituents such as Collagen type I (Col I), Perlecan and Aggrecan. In summary our investigations show for the first time an association between soft flesh of Atlantic salmon and massive intracellular glycogen accumulation coinciding with degenerated mitochondria, myocyte detachment and altered extracellular matrix protein distribution. The results are important for further understanding the etiology of soft salmon.	[Torgersen, Jacob S.; Kohler, Achim; Pedersen, Mona E.; Morkore, Turid] Nofima AS, As, Norway; [Koppang, Erling Olaf] Norwegian Sch Vet Sci, Inst Basic Sci & Aquat Med, Oslo, Norway; [Stien, Lars H.] Inst Marine Res, N-5024 Bergen, Norway; [Kohler, Achim] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway	Nofima; Norwegian University of Life Sciences; Institute of Marine Research - Norway; Norwegian University of Life Sciences	Morkore, T (corresponding author), Nofima AS, As, Norway.	turid.morkore@nofima.no		Kohler, Achim/0000-0001-5759-1989	Norwegian Research Council (NFR) [190479/E40]; Norwegian Seafood Research Fund (FHF)	Norwegian Research Council (NFR)(Research Council of Norway); Norwegian Seafood Research Fund (FHF)	This project (Project number 190479/E40) was funded by the Norwegian Research Council (NFR) (http://www.forskningsradet.no/) and The Norwegian Seafood Research Fund (FHF) (http://www.fiskerifond.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2008, NEUROMUSCULAR DISORD, V18, P277, DOI 10.1016/j.nmd.2008.01.001; Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; ANG JF, 1985, J FOOD BIOCHEM, V9, P49, DOI 10.1111/j.1745-4514.1985.tb00338.x; Bahuaud D, 2010, AQUACULTURE, V310, P213, DOI 10.1016/j.aquaculture.2010.10.008; Bancroft JD, 2002, THEORY PRACTICE HIST, V5th; BREMNER HA, 1992, DEV FOOD SCI, V30, P39; Caballero MJ, 2009, AQUACULTURE, V291, P210, DOI 10.1016/j.aquaculture.2009.03.032; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; Di Mauro S, 2007, Acta Myol, V26, P35; Hanifi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064822; HATAE K, 1986, B JPN SOC SCI FISH, V52, P2001; Hurling R, 1996, J TEXTURE STUD, V27, P679, DOI 10.1111/j.1745-4603.1996.tb01001.x; Johnston IA, 2000, AQUACULTURE, V189, P335, DOI 10.1016/S0044-8486(00)00373-2; Johnston IA, 2006, AQUACULTURE, V256, P323, DOI 10.1016/j.aquaculture.2006.02.048; Jonsson A, 2001, AQUACULT NUTR, V7, P81, DOI 10.1046/j.1365-2095.2001.00152.x; Kiessling A, 2004, AQUACULTURE, V236, P645, DOI 10.1016/j.aquaculture.2004.02.030; Kim YJ, 2007, CYTOM PART A, V71A, P8, DOI 10.1002/cyto.a.20334; Koppang EO, 2005, J FISH DIS, V28, P13, DOI 10.1111/j.1365-2761.2004.00583.x; Larsson T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039219; LAVETY J, 1988, INT J FOOD SCI TECH, V23, P23; Long DJ, 2008, J MOL HISTOL, V39, P1, DOI 10.1007/s10735-007-9093-6; Martinez I, 2011, FOOD CHEM, V126, P140, DOI 10.1016/j.foodchem.2010.10.090; Mitchie I., 2001, FARMED FISH QUALITY, V4, P129; Moreno HM, 2012, FOOD CHEM, V134, P678, DOI 10.1016/j.foodchem.2012.02.160; Morkore T, 2003, J FOOD SCI, V68, P1492, DOI 10.1111/j.1365-2621.2003.tb09672.x; Morkore T, 2009, J TEXTURE STUD, V40, P1, DOI 10.1111/j.1745-4603.2008.00166.x; Olsen BR, 1999, J CELL BIOL, V147, P909, DOI 10.1083/jcb.147.5.909; Periago Ma.J., 2005, Aquaculture, V249, P175, DOI 10.1016/j.aquaculture.2005.02.047; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Salem M, 2006, PHYSIOL GENOMICS, V28, P33, DOI 10.1152/physiolgenomics.00114.2006; SATO K, 1986, B JPN SOC SCI FISH, V52, P1595; Sertel O, 2011, COMPUT MED IMAG GRAP, V35, P616, DOI 10.1016/j.compmedimag.2011.01.009; Taylor RG, 2002, J FOOD SCI, V67, P2067, DOI 10.1111/j.1365-2621.2002.tb09502.x; Xu Z, 2010, MATRIX BIOL, V29, P461, DOI 10.1016/j.matbio.2010.06.001; Ytteborg E, 2010, CELL TISSUE RES, V342, P363, DOI 10.1007/s00441-010-1069-2; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022	37	36	37	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85551	10.1371/journal.pone.0085551	http://dx.doi.org/10.1371/journal.pone.0085551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416425	gold, Green Submitted, Green Published			2022-12-25	WOS:000329866300087
J	Ganapathy, A; Pandey, N; Srisailapathy, CRS; Jalvi, R; Malhotra, V; Venkatappa, M; Chatterjee, A; Sharma, M; Santhanam, R; Chadha, S; Ramesh, A; Agarwal, AK; Rangasayee, RR; Anand, A				Ganapathy, Aparna; Pandey, Nishtha; Srisailapathy, C. R. Srikumari; Jalvi, Rajeev; Malhotra, Vikas; Venkatappa, Mohan; Chatterjee, Arunima; Sharma, Meenakshi; Santhanam, Rekha; Chadha, Shelly; Ramesh, Arabandi; Agarwal, Arun K.; Rangasayee, Raghunath R.; Anand, Anuranjan			Non-Syndromic Hearing Impairment in India: High Allelic Heterogeneity among Mutations in TMPRSS3, TMC1, USHIC, CDH23 and TMIE	PLOS ONE			English	Article							USHER-SYNDROME; GENE; DEAFNESS; FAMILIES; PROTEIN; IDENTIFICATION; FREQUENCIES; VARIANTS	Mutations in the autosomal genes TMPRSS3, TMC1, USHIC, CDH23 and TMIE are known to cause hereditary hearing loss. To study the contribution of these genes to autosomal recessive, non-syndromic hearing loss (ARNSHL) in India, we examined 374 families with the disorder to identify potential mutations. We found four mutations in TMPRSS3, eight in TMC1, ten in USHIC, eight in CDH23 and three in TMIE. Of the 33 potentially pathogenic variants identified in these genes, 23 were new and the remaining have been previously reported. Collectively, mutations in these five genes contribute to about one-tenth of ARNSHL among the families examined. New mutations detected in this study extend the allelic heterogeneity of the genes and provide several additional variants for structure-function correlation studies. These findings have implications for early DNA-based detection of deafness and genetic counseling of affected families in the Indian subcontinent.	[Ganapathy, Aparna; Pandey, Nishtha; Venkatappa, Mohan; Chatterjee, Arunima; Sharma, Meenakshi; Santhanam, Rekha; Anand, Anuranjan] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India; [Srisailapathy, C. R. Srikumari; Ramesh, Arabandi] Dr ALM Post Grad Inst Basic Med Sci, Dept Genet, Madras, Tamil Nadu, India; [Jalvi, Rajeev; Rangasayee, Raghunath R.] Ali Yavar Jung Natl Inst Hearing Handicapped, Dept Audiol, Bombay, Maharashtra, India; [Malhotra, Vikas; Chadha, Shelly; Agarwal, Arun K.] Maulana Azad Med Coll, Dept ENT, New Delhi, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore; Maulana Azad Medical College	Anand, A (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India.	anand@jncasr.ac.in	Chadha, Shelly/AAS-8147-2021; Santhanam, Rekha/AAU-3964-2021	Chadha, Shelly/0000-0001-5789-7259; 	Department of Biotechnology, New Delhi [BT/PR4449/Med/12/172/2003]; JNCASR, Bangalore; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); JNCASR, Bangalore; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Funds for this work were provided by Department of Biotechnology, New Delhi (BT/PR4449/Med/12/172/2003) and JNCASR, Bangalore. AG and NP received research fellowships from Council of Scientific and Industrial Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Ahmed Zubair M, 2004, BMC Med Genet, V5, P24, DOI 10.1186/1471-2350-5-24; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Ben Said M, 2010, GENET TEST MOL BIOMA, V14, P307, DOI 10.1089/gtmb.2009.0174; Ben-Yosef T, 2001, J MED GENET, V38, P396, DOI 10.1136/jmg.38.6.396; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Blaydon DC, 2003, CLIN GENET, V63, P303, DOI 10.1034/j.1399-0004.2003.00058.x; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Ceroni A, 2001, NUCLEIC ACIDS RES, V34, pW177; Davoudi-Dehaghani E, 2013, INT J PEDIATR OTORHI, V77, P821, DOI 10.1016/j.ijporl.2013.02.021; Duman D, 2011, GENET TEST MOL BIOMA, V15, P29, DOI 10.1089/gtmb.2010.0120; Guipponi M, 2008, FRONT BIOSCI-LANDMRK, V13, P1557, DOI 10.2741/2780; Hebsgaard SM, 1994, NUCLEIC ACIDS RES, V24, P3439; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Kalay E, 2005, Hum Mutat, V26, P591, DOI 10.1002/humu.9384; Kitajiri SI, 2007, CLIN GENET, V72, P546, DOI 10.1111/j.1399-0004.2007.00895.x; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lee JW, 2013, GENE; LEE K, 2012, CLIN GENET, V82, P82, DOI DOI 10.1111/J.2044-8279.2010.02016.X; Masmoudi S, 2001, HUM MUTAT, V18, P101, DOI 10.1002/humu.1159; Miyagawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040366; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Naz S, 2002, AM J HUM GENET, V71, P632, DOI 10.1086/342193; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Ouyang XM, 2002, HUM GENET, V111, P26, DOI 10.1007/s00439-002-0736-0; Ramshankar M, 2008, EUR J HUM GENET, V10, P502; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J, 2001, MOL CLONING LAB MANU; Santos Regie Lyn P, 2005, Hum Mutat, V26, P396, DOI 10.1002/humu.9374; Santos RLP, 2006, J MOL MED, V84, P226, DOI 10.1007/s00109-005-0015-3; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Sirmaci A, 2009, INT J PEDIATR OTORHI, V73, P699, DOI 10.1016/j.ijporl.2009.01.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wagatsuma M, 2007, CLIN GENET, V72, P339, DOI 10.1111/j.1399-0004.2007.00833.x; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wattenhofer M, 2005, HUM GENET, V117, P528, DOI 10.1007/s00439-005-1332-x; Wattenhofer M, 2002, J MOL MED-JMM, V80, P124, DOI 10.1007/s00109-001-0310-6; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Yan D, 2008, FRONT BIOSCI-LANDMRK, V13, P4972, DOI 10.2741/3056; Yang JJ, 2010, INT J PEDIATR OTORHI, V74, P489, DOI 10.1016/j.ijporl.2010.02.001	45	43	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84773	10.1371/journal.pone.0084773	http://dx.doi.org/10.1371/journal.pone.0084773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416283	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000329862500166
J	Ito, M; Kim, YG; Tsuji, H; Takahashi, T; Kiwaki, M; Nomoto, K; Danbara, H; Okada, N				Ito, Masahiro; Kim, Yun-Gi; Tsuji, Hirokazu; Takahashi, Takuya; Kiwaki, Mayumi; Nomoto, Koji; Danbara, Hirofumi; Okada, Nobuhiko			Transposon Mutagenesis of Probiotic Lactobacillus casei Identifies asnH, an Asparagine Synthetase Gene Involved in Its Immune-Activating Capacity	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; NF-KAPPA-B; LEWIS LUNG-CARCINOMA; ANTI-TUMOR ACTIVITY; ESCHERICHIA-COLI; PEPTIDOGLYCAN STRUCTURE; BLADDER-CANCER; STRAIN SHIROTA; CELL ACTIVITY; MICE	Lactobacillus casei ATCC 27139 enhances host innate immunity, and the J1 phage-resistant mutants of this strain lose the activity. A transposon insertion mutant library of L. casei ATCC 27139 was constructed, and nine J1 phage-resistant mutants out of them were obtained. Cloning and sequencing analyses identified three independent genes that were disrupted by insertion of the transposon element: asnH, encoding asparagine synthetase, and dnaJ and dnaK, encoding the molecular chaperones DnaJ and DnaK, respectively. Using an in vivo mouse model of Listeria infection, only asnH mutant showed deficiency in their ability to enhance host innate immunity, and complementation of the mutation by introduction of the wild-type asnH in the mutant strain recovered the immuno-augmenting activity. AsnH protein exhibited asparagine synthetase activity when the lysozyme-treated cell wall extracts of L. casei ATCC 27139 was added as substrate. The asnH mutants lost the thick and rigid peptidoglycan features that are characteristic to the wild-type cells, indicating that AsnH of L. casei is involved in peptidoglycan biosynthesis. These results indicate that asnH is required for the construction of the peptidoglycan composition involved in the immune-activating capacity of L. casei ATCC 27139.	[Ito, Masahiro; Kim, Yun-Gi; Danbara, Hirofumi; Okada, Nobuhiko] Kitasato Univ, Sch Pharm, Dept Microbiol, Minato Ku, Tokyo, Japan; [Tsuji, Hirokazu; Takahashi, Takuya; Kiwaki, Mayumi; Nomoto, Koji] Yakult Cent Inst Microbiol Res, Kunitachi, Tokyo 186, Japan	Kitasato University; Yakult Honsha Company, Limited	Okada, N (corresponding author), Kitasato Univ, Sch Pharm, Dept Microbiol, Minato Ku, Tokyo, Japan.	okadan@pharm.kitasato-u.ac.jp		Hirokazu, Tsuji/0000-0003-2856-6447	Japanese Ministry of Education, Culture, Sports, Science, and Technology [23790485]; Kitasato University Research Grant for Young Researchers	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kitasato University Research Grant for Young Researchers	This study was supported in part by a Grant-in-Aid for Young Scientists B (23790485 to MI) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. This work was also funded in part by a Kitasato University Research Grant for Young Researchers (2012 to MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANG D, 1991, J BIOL CHEM, V266, P24233; ASO Y, 1995, EUR UROL, V27, P104, DOI 10.1159/000475138; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BillotKlein D, 1997, J BACTERIOL, V179, P6208, DOI 10.1128/jb.179.19.6208-6212.1997; BOEHLEIN SK, 1994, J BIOL CHEM, V269, P26789; BYEON WH, 1984, J BACTERIOL, V158, P543, DOI 10.1128/JB.158.2.543-550.1984; Capra ML, 2006, J APPL MICROBIOL, V100, P334, DOI 10.1111/j.1365-2672.2005.02767.x; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; HASHIMOTO S, 1987, CANCER IMMUNOL IMMUN, V24, P1; Hirasawa T, 2000, J BACTERIOL, V182, P2696, DOI 10.1128/JB.182.10.2696-2701.2000; Hughes CA, 1997, PLANT MOL BIOL, V33, P301, DOI 10.1023/A:1005784202450; HUMBERT R, 1980, J BACTERIOL, V142, P212, DOI 10.1128/JB.142.1.212-220.1980; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Ito M, 2010, J APPL MICROBIOL, V109, P657, DOI 10.1111/j.1365-2672.2010.04690.x; KATO I, 1981, GANN, V72, P517; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Fernandez EM, 2011, GUT, V60, P1444, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Matsuguchi T, 2000, BLOOD, V95, P1378, DOI 10.1182/blood.V95.4.1378.004k08_1378_1385; MATSUZAKI T, 1987, CANCER IMMUNOL IMMUN, V24, P99; Matsuzaki T, 1996, MED MICROBIOL IMMUN, V185, P157; MATSUZAKI T, 1987, CANCER IMMUNOL IMMUN, V25, P100; MATSUZAKI T, 1985, CANCER IMMUNOL IMMUN, V20, P18; MEI B, 1989, J BIOL CHEM, V264, P16613; MIAKE S, 1985, INFECT IMMUN, V48, P480, DOI 10.1128/IAI.48.2.480-485.1985; Miller MT, 2001, NAT STRUCT BIOL, V8, P684, DOI 10.1038/90394; Mitani Y, 2005, J BACTERIOL, V187, P2582, DOI 10.1128/JB.187.8.2582-2591.2005; NOMOTO K, 1985, J CLIN LAB IMMUNOL, V17, P91; OHASHI T, 1989, Biotherapy (Dordrecht), V1, P89, DOI 10.1007/BF02170139; Ohashi Y, 2002, UROL INT, V68, P273, DOI 10.1159/000058450; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Ren H, 2006, ANTIMICROB AGENTS CH, V50, P250, DOI 10.1128/AAC.50.1.250-255.2006; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shida K, 2008, TRENDS IMMUNOL, V29, P565, DOI 10.1016/j.it.2008.07.011; Shimizu-Kadota M, 2000, GENE, V249, P127, DOI 10.1016/S0378-1119(00)00154-2; Smelt MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063099; Takeda K, 2006, CLIN EXP IMMUNOL, V146, P109, DOI 10.1111/j.1365-2249.2006.03165.x; Takeda K, 2007, J NUTR, V137, p791S, DOI 10.1093/jn/137.3.791S; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; YOKOKURA T, 1977, J GEN MICROBIOL, V100, P139, DOI 10.1099/00221287-100-1-139; YOKOKURA T, 1986, INFECT IMMUN, V52, P156, DOI 10.1128/IAI.52.1.156-160.1986; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203	47	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83876	10.1371/journal.pone.0083876	http://dx.doi.org/10.1371/journal.pone.0083876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416179	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500082
J	Laugel-Haushalter, V; Paschaki, M; Marangoni, P; Pilgram, C; Langer, A; Kuntz, T; Demassue, J; Morkmued, S; Choquet, P; Constantinesco, A; Bornert, F; Schmittbuhl, M; Pannetier, S; Viriot, L; Hanauer, A; Dolle, P; Bloch-Zupan, A				Laugel-Haushalter, Virginie; Paschaki, Marie; Marangoni, Pauline; Pilgram, Coralie; Langer, Arnaud; Kuntz, Thibaut; Demassue, Julie; Morkmued, Supawich; Choquet, Philippe; Constantinesco, Andre; Bornert, Fabien; Schmittbuhl, Matthieu; Pannetier, Solange; Viriot, Laurent; Hanauer, Andre; Dolle, Pascal; Bloch-Zupan, Agnes			RSK2 Is a Modulator of Craniofacial Development	PLOS ONE			English	Article							COFFIN-LOWRY-SYNDROME; RIBOSOMAL S6 KINASE; KAPPA-B-ALPHA; TOOTH DEVELOPMENT; RETINOIC ACID; IN-VITRO; TABBY/EDA MICE; SPROUTY GENES; MOUSE MOLAR; MORPHOGENESIS	Background: The RSK2 gene is responsible for Coffin-Lowry syndrome, an X-linked dominant genetic disorder causing mental retardation, skeletal growth delays, with craniofacial and digital abnormalities typically associated with this syndrome. Craniofacial and dental anomalies encountered in this rare disease have been poorly characterized. Methodology/Principal Findings: We examined, using X-Ray microtomographic analysis, the variable craniofacial dysmorphism and dental anomalies present in Rsk2 knockout mice, a model of Coffin-Lowry syndrome, as well as in triple Rsk1,2,3 knockout mutants. We report Rsk mutation produces surpernumerary teeth midline/mesial to the first molar. This highly penetrant phenotype recapitulates more ancestral tooth structures lost with evolution. Most likely this leads to a reduction of the maxillary diastema. Abnormalities of molar shape were generally restricted to the mesial part of both upper and lower first molars (M1). Expression analysis of the four Rsk genes (Rsk1, 2, 3 and 4) was performed at various stages of odontogenesis in wild-type (WT) mice. Rsk2 is expressed in the mesenchymal, neural crest-derived compartment, correlating with proliferative areas of the developing teeth. This is consistent with RSK2 functioning in cell cycle control and growth regulation, functions potentially responsible for severe dental phenotypes. To uncover molecular pathways involved in the etiology of these defects, we performed a comparative transcriptomic (DNA microarray) analysis of mandibular wild-type versus Rsk2-/Y molars. We further demonstrated a misregulation of several critical genes, using a Rsk2 shRNA knock-down strategy in molar tooth germs cultured in vitro. Conclusions: This study reveals RSK2 regulates craniofacial development including tooth development and patterning via novel transcriptional targets.	[Laugel-Haushalter, Virginie; Paschaki, Marie; Morkmued, Supawich; Pannetier, Solange; Hanauer, Andre; Dolle, Pascal; Bloch-Zupan, Agnes] Univ Strasbourg, INSERM, CNRS,U964, Inst Genet & Mol & Cellular Biol IGBMC,UMR 7104, Illkirch Graffenstaden, France; [Marangoni, Pauline; Viriot, Laurent] Univ Lyon 1, Ecole Normale Super Lyon, CNRS,UMR 5242,CNRS, Team Evodevo Vertebrate Dentit,Inst Genom Fonct L, F-69365 Lyon, France; [Pilgram, Coralie; Langer, Arnaud; Kuntz, Thibaut; Demassue, Julie; Morkmued, Supawich; Bornert, Fabien; Schmittbuhl, Matthieu; Bloch-Zupan, Agnes] Univ Strasbourg, Fac Dent, Strasbourg, France; [Choquet, Philippe; Constantinesco, Andre] HUS, Preclin Imaging Lab UF6237, Strasbourg, France; [Choquet, Philippe; Constantinesco, Andre] Univ Strasbourg, CNRS, ICube, Strasbourg, France; [Schmittbuhl, Matthieu; Bloch-Zupan, Agnes] HUS, Reference Ctr Orodental Manifestat Rare Dis, Strasbourg, France; [Bornert, Fabien; Schmittbuhl, Matthieu] Univ Strasbourg, INSERM, U1121, Strasbourg, France; [Morkmued, Supawich] Khon Kaen Univ, Fac Dent, Khon Kaen, Thailand	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Khon Kaen University	Bloch-Zupan, A (corresponding author), Univ Strasbourg, INSERM, CNRS,U964, Inst Genet & Mol & Cellular Biol IGBMC,UMR 7104, Illkirch Graffenstaden, France.	agnes.bloch-zupan@unistra.fr	Dolle, Pascal/A-8037-2010; CHOQUET, Philippe/H-5868-2019; Morkmued, Supawich/AAP-1112-2021; Bloch-Zupan, Agnes/N-7822-2016	Dolle, Pascal/0000-0002-9294-9090; CHOQUET, Philippe/0000-0003-0514-0726; Bloch-Zupan, Agnes/0000-0002-6511-2615; Viriot, Laurent/0000-0003-2092-588X; Paschaki, Marie/0000-0002-9490-8997	University of Strasbourg, the Hopitaux Universitaires de Strasbourg (API); IFRO (Institut Francais pour la Recherche Odontologique); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); European Regional Development Fund (ERDF) of the European Union; Ministere Francais de la Recherche; Agence Nationale de la Recherche	University of Strasbourg, the Hopitaux Universitaires de Strasbourg (API); IFRO (Institut Francais pour la Recherche Odontologique); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Regional Development Fund (ERDF) of the European Union; Ministere Francais de la Recherche(Ministry of Research, France); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants (to AB-Z) from the University of Strasbourg, the Hopitaux Universitaires de Strasbourg (API, 2009-2012, "Development of the oral cavity: from gene to clinical phenotype in Human''), IFRO (Institut Francais pour la Recherche Odontologique), by institutional funds from the Centre National de la Recherche Scientifique (CNRS) and Institut National de la Sante et de la Recherche Medicale (INSERM). This project, A27 "Orodental manifestations of rare diseases'', selected by the Offensive Sciences of the Trinational Metropolitan Area Upper Rhine (TMR), is co-financed by the European Regional Development Fund (ERDF) of the European Union, in the framework of the INTERREG IV Upper Rhine programme. VL-H was the recipient of a PhD fellowship from the Ministere Francais de la Recherche. MP was supported by a grant from the Agence Nationale de la Recherche (to PD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 2004, J HISTOCHEM CYTOCHEM, V52, P131, DOI 10.1177/002215540405200113; BLOCHZUPAN A, 1994, DIFFERENTIATION, V57, P195, DOI 10.1046/j.1432-0436.1994.5730195.x; BlochZupan A, 2012, ELSEV INSIGHT, P1; BLOCHZUPAN A, 1994, ARCH ORAL BIOL, V39, P891, DOI 10.1016/0003-9969(94)90021-3; Boran T, 2005, J DENT RES, V84, P228, DOI 10.1177/154405910508400304; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; Charles C, 2009, ANAT REC, V292, P299, DOI 10.1002/ar.20804; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Chotteau-Lelievre Anne, 2006, Methods Mol Biol, V326, P61; Coin R, 1999, INT J DEV BIOL, V43, P261; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Day P, 2000, J DENT CHILD, V67, P148; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fleischmannova J, 2008, EUR J ORAL SCI, V116, P1, DOI 10.1111/j.1600-0722.2007.00504.x; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; Guimiot F, 2004, GENE EXPR PATTERNS, V4, P111, DOI 10.1016/j.modgep.2003.06.001; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanauer A, 2002, J MED GENET, V39, P705, DOI 10.1136/jmg.39.10.705; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Igari K, 2006, INT J PAEDIATR DENT, V16, P213, DOI 10.1111/j.1365-263X.2006.00698.x; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kohn M, 2003, GENE EXPR PATTERNS, V3, P173, DOI 10.1016/S1567-133X(03)00004-8; Kristenova P, 2002, Orthod Craniofac Res, V5, P205, DOI 10.1034/j.1600-0544.2002.02225.x; Lagronova-Churava S, 2013, J EXP ZOOL PART B, V320B, P307, DOI 10.1002/jez.b.22502; Laugel-Haushalter Virginie, 2013, BMC Res Notes, V6, P113, DOI 10.1186/1756-0500-6-113; Lesot H, 1998, EUR J ORAL SCI, V106, P64, DOI 10.1111/j.1600-0722.1998.tb02155.x; Lesot H, 2003, Bull Group Int Rech Sci Stomatol Odontol, V45, P1; Liu Z, 2012, ONCOGENE; MARK MP, 1991, DIFFERENTIATION, V48, P89, DOI 10.1111/j.1432-0436.1991.tb00247.x; MARK MP, 1992, INT J DEV BIOL, V36, P517; MITSIADIS TA, 1995, INT J DEV BIOL, V39, P195; Murashima-Suginami A, 2008, BIOCHEM BIOPH RES CO, V369, P1012, DOI 10.1016/j.bbrc.2008.02.135; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Ohazama A, 2010, P NATL ACAD SCI USA, V107, P92, DOI 10.1073/pnas.0907236107; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Ohazama A, 2009, DEVELOPMENT, V136, P897, DOI 10.1242/dev.027979; Peterka M, 2000, J CRAN GENET DEV BIO, V20, P35; Peterkova R, 2005, ARCH ORAL BIOL, V50, P219, DOI 10.1016/j.archoralbio.2004.10.020; Peterkova R, 2002, Orthod Craniofac Res, V5, P215, DOI 10.1034/j.1600-0544.2002.02226.x; Peterkova R, 2003, ANN NY ACAD SCI, V1010, P453, DOI 10.1196/annals.1299.083; Pispa J, 2003, GENE EXPR PATTERNS, V3, P675, DOI 10.1016/S1567-133X(03)00092-9; Poirier R, 2007, BEHAV GENET, V37, P31, DOI 10.1007/s10519-006-9116-1; Porntaveetus T, 2011, EUR J ORTHOD; RICHTSMEIER JT, 1995, CLEFT PALATE-CRAN J, V32, P217, DOI 10.1597/1545-1569(1995)032<0217:PRAVOT>2.3.CO;2; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Schneider A, 2011, J NEUROCHEM, V119, P447, DOI 10.1111/j.1471-4159.2011.07423.x; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Temtamy S A, 1975, Birth Defects Orig Artic Ser, V11, P133; TEMTAMY SA, 1975, J PEDIATR-US, V86, P724, DOI 10.1016/S0022-3476(75)80357-X; Tucker AS, 2004, DEV BIOL, V268, P185, DOI 10.1016/j.ydbio.2003.12.019; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Viriot L, 2000, INT J DEV BIOL, V44, P233; Viriot L, 2002, CONNECT TISSUE RES, V43, P129, DOI 10.1080/03008200290001168; Viriot L, 1997, INT J DEV BIOL, V41, P679; Wan XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009118; Wise GE, 2011, EUR J ORAL SCI, V119, P333, DOI 10.1111/j.1600-0722.2011.00854.x; Wright TJ, 2004, DEV BIOL, V269, P264, DOI 10.1016/j.ydbio.2004.02.003; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zeniou M, 2002, HUM MOL GENET, V11, P2929, DOI 10.1093/hmg/11.23.2929; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200	68	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84343	10.1371/journal.pone.0084343	http://dx.doi.org/10.1371/journal.pone.0084343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416220	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500117
J	Lee, SH; Lee, SM; Goo, JM; Kim, KG; Kim, YJ; Park, CM				Lee, Sang Hwan; Lee, Sang Min; Goo, Jin Mo; Kim, Kwang-Gi; Kim, Young Jae; Park, Chang Min			Usefulness of Texture Analysis in Differentiating Transient from Persistent Part-solid Nodules(PSNs): A Retrospective Study	PLOS ONE			English	Article							GROUND-GLASS OPACITY; SUBSOLID PULMONARY NODULES; THIN-SECTION CT; LUNG-CANCER; MANAGEMENT; BIOMARKER; KURTOSIS; SKEWNESS	Background: Early discrimination between transient and persistent par-solid ground-glass nodules (PSNs) at CT is essential for patient management. The objective of our study was to retrospectively investigate the value of texture analysis in differentiating pulmonary transient and persistent PSNs in addition to clinical and CT features. Methods: This retrospective study was performed with IRB approval and a waiver of the requirement for patients' informed consent. From January 2007 to October 2009, we identified 77 individuals (39 men and 38 women; mean age, 55 years) with 86 PSNs on thin-section chest CT. Thirty-nine PSNs in 31 individuals were transient and 47 PSNs in 46 patients were persistent. The clinical, CT, and texture features of PSNs were evaluated. To investigate the additional value of texture analysis in differentiating transient from persistent PSNs, logistic regression analysis and C-statistics were performed. Results: Between transient and persistent PSNs, there were significant differences in age, gender, smoking history, and eosinophil count among the clinical features. As for thin-section CT features, there were significant differences in lesion size, solid portion size, and lesion multiplicity. In terms of texture features, there were significant differences in mean attenuation, skewness of whole PSN, attenuation ratio of whole PSN to inner solid portion, and 5-, 10-, 25-, 50-percentile CT numbers of whole PSN. Multivariate analysis revealed eosinophilia, lesion size, lesion multiplicity, mean attenuation of whole PSN, skewness of whole PSN, and 5-percentile CT number were significant independent predictors of transient PSNs. (P < 0.05) C-statistics revealed that texture analysis incorporating clinical and CT features (AUC, 92.9%) showed significantly higher differentiating performance of transient from persistent PSNs compared with the clinical and CT features alone (AUC, 79.0%). (P = 0.004) Conclusion: Texture analysis of PSNs in addition to clinical and CT features analysis has the potential to improve the differentiation of transient from persistent PSNs.	[Lee, Sang Hwan; Lee, Sang Min; Goo, Jin Mo; Park, Chang Min] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Lee, Sang Hwan; Lee, Sang Min; Goo, Jin Mo; Park, Chang Min] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Goo, Jin Mo; Park, Chang Min] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Kim, Kwang-Gi; Kim, Young Jae] Natl Canc Ctr, Dept Biomed Engn, Div Basic & Appl Sci, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC)	Park, CM (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.	cmpark@radiol.snu.ac.kr			Korean Society of Radiology	Korean Society of Radiology	This study was supported by a Bayer-Schering Radiological Research Fund of the Korean Society of Radiology from 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asamura H, 2010, PRINCIPLES PRACTICE; Baek HJ, 2012, RADIOLOGY, V264, P834, DOI 10.1148/radiol.12112120; Godoy MCB, 2009, RADIOLOGY, V253, P606, DOI 10.1148/radiol.2533090179; Goh V, 2011, RADIOLOGY, V261, P165, DOI 10.1148/radiol.11110264; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Kim HY, 2008, J COMPUT ASSIST TOMO, V32, P101, DOI 10.1097/RCT.0b013e31806535e5; Lee SM, 2012, EUR RADIOL, V22, P1556, DOI 10.1007/s00330-012-2395-4; Lee SM, 2010, RADIOLOGY, V255, P242, DOI 10.1148/radiol.09090547; Lee SM, 2013, RADIOLOGY; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.1093/biomet/57.3.519; Moon WK, 2010, AM J ROENTGENOL, V195, P1460, DOI 10.2214/AJR.09.3140; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nakata M, 2002, CHEST, V121, P1464, DOI 10.1378/chest.121.5.1464; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Oh JY, 2007, LUNG CANCER, V55, P67, DOI 10.1016/j.lungcan.2006.09.009; Park CM, 2007, RADIOGRAPHICS, V27, P391, DOI 10.1148/rg.272065061	18	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85167	10.1371/journal.pone.0085167	http://dx.doi.org/10.1371/journal.pone.0085167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416357	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500223
J	Lin, WH; Yeh, TK; Jiaang, WT; Yen, KJ; Chen, CH; Huang, CT; Yen, SC; Hsieh, SY; Chou, LH; Chen, CP; Chiu, CH; Kao, LC; Chao, YS; Chen, CT; Hsu, JTA				Lin, Wen-Hsing; Yeh, Teng-Kuang; Jiaang, Weir-Torn; Yen, Kuei-Jung; Chen, Chun-Hwa; Huang, Chin-Ting; Yen, Shih-Chieh; Hsieh, Shu-Yi; Chou, Ling-Hui; Chen, Ching-Ping; Chiu, Chun-Hsien; Kao, Li-Chun; Chao, Yu-Sheng; Chen, Chiung-Tong; Hsu, John T. -A.			Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITOR; INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITOR; ACTIVATING MUTATION; APOPTOSIS INDUCTION; IN-VITRO; CELLS; PKC412	Overexpression or/and activating mutation of FLT3 kinase play a major driving role in the pathogenesis of acute myeloid leukemia (AML). Hence, pharmacologic inhibitors of FLT3 are of therapeutic potential for AML treatment. In this study, BPR1J-340 was identified as a novel potent FLT3 inhibitor by biochemical kinase activity (IC50 approximately 25 nM) and cellular proliferation (GC(50) approximately 5 nM) assays. BPR1J-340 inhibited the phosphorylation of FLT3 and STAT5 and triggered apoptosis in FLT3-ITD+ AML cells. The pharmacokinetic parameters of BPR1J-340 in rats were determined. BPR1J-340 also demonstrated pronounced tumor growth inhibition and regression in FLT3-ITD+ AML murine xenograft models. The combination treatment of the HDAC inhibitor vorinostat (SAHA) with BPR1J-340 synergistically induced apoptosis via Mcl-1 down-regulation in MOLM-13 AML cells, indicating that the combination of selective FLT3 kinase inhibitors and HDAC inhibitors could exhibit clinical benefit in AML therapy. Our results suggest that BPR1J-340 may be further developed in the preclinical and clinical studies as therapeutics in AML treatments.	[Lin, Wen-Hsing; Yeh, Teng-Kuang; Jiaang, Weir-Torn; Yen, Kuei-Jung; Chen, Chun-Hwa; Huang, Chin-Ting; Yen, Shih-Chieh; Hsieh, Shu-Yi; Chou, Ling-Hui; Chen, Ching-Ping; Chiu, Chun-Hsien; Kao, Li-Chun; Chao, Yu-Sheng; Chen, Chiung-Tong; Hsu, John T. -A.] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Taiwan; [Hsu, John T. -A.] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University	Chen, CT (corresponding author), Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Taiwan.	ctchen@nhri.org.tw; tsuanhsu@nhri.org.tw	Hsieh, Shu Yi/GLV-4929-2022; Hsu, John Tsu-An/C-1199-2010; Chen, Chiung-Tong/D-2075-2010; Hsieh, Shu Yi/AAT-9884-2021; Jiaang, Weir-Torn/D-2072-2010; Chao, Yu-Sheng/D-2074-2010	Hsieh, Shu Yi/0000-0003-0962-1236; 	National Health Research Institutes; National Science Council of Taiwan [NSC 100-2325-B-400-002-]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The National Health Research Institutes and National Science Council of Taiwan (NSC 100-2325-B-400-002-) financially supported this study.	Al-Yacoub N, 2012, J INVEST DERMATOL, V132, P2263, DOI 10.1038/jid.2012.125; Bali P, 2004, CLIN CANCER RES, V10, P4991, DOI 10.1158/1078-0432.CCR-04-0210; Buchwald M, 2010, LEUKEMIA, V24, P1412, DOI 10.1038/leu.2010.114; Chu SH, 2009, DRUG RESIST UPDATE, V12, P8, DOI 10.1016/j.drup.2008.12.001; Coumar MS, 2008, BIOORG MED CHEM LETT, V18, P1623, DOI 10.1016/j.bmcl.2008.01.068; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; George P, 2005, BLOOD, V105, P1768, DOI 10.1182/blood-2004-09-3413; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grundler R, 2003, BLOOD, V102, P646, DOI 10.1182/blood-2002-11-3441; Hart S, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.43; Kasper S, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.5; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kiyoi H, 2005, INT J HEMATOL, V82, P85, DOI 10.1532/IJH97.05066; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kosugi H, 1999, LEUKEMIA, V13, P1316, DOI 10.1038/sj.leu.2401508; Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61; Levis M, 2004, BLOOD, V104, P1145, DOI 10.1182/blood-2004-01-0388; Lin WH, 2012, BRIT J CANCER, V106, P475, DOI 10.1038/bjc.2011.564; Lin WH, 2013, BIOORGAN MED CHEM, V21, P2856, DOI 10.1016/j.bmc.2013.03.083; Lin WH, 2011, BIOORGAN MED CHEM, V19, P4173, DOI 10.1016/j.bmc.2011.06.016; Liu DP, 2007, ONCOL REP, V18, P673; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Markovic A, 2005, INT J BIOCHEM CELL B, V37, P1168, DOI 10.1016/j.biocel.2004.12.005; Mollgard L, 2008, CANCER CHEMOTH PHARM, V62, P439, DOI 10.1007/s00280-007-0623-4; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Nakao M, 1996, LEUKEMIA, V10, P1911; Nishioka C, 2008, LEUKEMIA RES, V32, P1382, DOI 10.1016/j.leukres.2008.02.018; Odgerel T, 2008, ONCOGENE, V27, P3102, DOI 10.1038/sj.onc.1210980; Pallis M, 2003, LEUKEMIA RES, V27, P803, DOI 10.1016/S0145-2126(03)00012-2; Pietschmann K, 2012, MOL CANCER THER, V11, P2373, DOI 10.1158/1535-7163.MCT-12-0129; Schaefer EW, 2009, HAEMATOL-HEMATOL J, V94, P1375, DOI 10.3324/haematol.2009.009217; Scheijen B, 2002, ONCOGENE, V21, P3314, DOI 10.1038/sj.onc.1205317; Shankar DB, 2007, BLOOD, V109, P3400, DOI 10.1182/blood-2006-06-029579; Shiotsu Y, 2009, BLOOD, V114, P1607, DOI 10.1182/blood-2009-01-199307; Shipley JL, 2009, EXP HEMATOL, V37, P649, DOI 10.1016/j.exphem.2009.04.002; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stone RM, 2012, LEUKEMIA, V26, P2061, DOI 10.1038/leu.2012.115; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Weeraratna AT, 2000, PROSTATE, V45, P140, DOI 10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#; Wei Y, 2010, CLIN CANCER RES, V16, P3923, DOI 10.1158/1078-0432.CCR-10-0032; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wiernik Peter H, 2010, Clin Adv Hematol Oncol, V8, P429; Wiernik PH, 2010, CLIN ADV HEMATOL ONC, V8, P444; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yanada M, 2005, LEUKEMIA, V19, P1345, DOI 10.1038/sj.leu.2403838; Yee KWH, 2002, BLOOD, V100, P2941, DOI 10.1182/blood-2002-02-0531; Zhou JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019798	50	11	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83160	10.1371/journal.pone.0083160	http://dx.doi.org/10.1371/journal.pone.0083160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416160	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500033
J	Scholz, F; Badgley, BD; Sadowsky, MJ; Kaplan, DH				Scholz, Felix; Badgley, Brian D.; Sadowsky, Michael J.; Kaplan, Daniel H.			Immune Mediated Shaping of Microflora Community Composition Depends on Barrier Site	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; T-CELL DEVELOPMENT; INTESTINAL MICROBIOTA; GUT MICROBIOME; DEFICIENT MICE; INDIGENOUS CLOSTRIDIUM; SKIN MICROBIOME; RARE BIOSPHERE; INFLAMMATION; OBESITY	Barrier surfaces, such as the intestinal lining and the skin, are colonized by a diverse community of commensal microorganisms. Although commensal microorganisms clearly impact the host immune system, whether the immune system also shapes the commensal community is poorly understood. We used 16S rDNA deep sequencing to test whether mice with specific immune defects have an altered commensal microflora. Initially, skin swabs were obtained from wild-type and Langerhans Cell (LC) deficient mice. Despite the intimate contacts that LC make with the upper epidermis, no significant differences were observed in microbial community composition. Similarly, the skin of MyD88/TRIF-/-, Rag1(-/-) and heterozygous littermate controls showed no alteration in their commensal communities. Next we examined mouth swabs and feces. We did not find a difference in the MyD88/TRIF-/- mice. However, we did observe a significant shift in the microbial composition in the feces and mouths of Rag1(-/-) mice. Thus, we conclude that the adaptive immune system modulates the microbial composition at mucosal surfaces in the steady-state but LC, adaptive immunity, and MyD88-dependent innate responses do not affect the skin microbiome revealing a major distinction between barrier sites.	[Scholz, Felix; Kaplan, Daniel H.] Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA; [Badgley, Brian D.; Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kaplan, DH (corresponding author), Univ Minnesota, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA.	dankaplan@umn.edu	Kaplan, Daniel H/N-2779-2013; Sadowsky, Michael/J-2507-2016	Kaplan, Daniel H/0000-0002-7851-7320; Sadowsky, Michael/0000-0001-8779-2781	National Institute of Health NIDCR [T32DE07288]; NIAMS [AR056632]; University of Minnesota; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER	National Institute of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by the National Institute of Health NIDCR (T32DE07288, FS), NIAMS (AR056632, DHK), and a seed development grant from the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Chiba Tsutomu, 2011, Gastroenterology, V141, P1114, DOI 10.1053/j.gastro.2011.07.013; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cummings JH, 1997, NUTRITION, V13, P476, DOI 10.1016/S0899-9007(97)00114-7; Dave M, 2012, TRANSL RES, V160, P246, DOI 10.1016/j.trsl.2012.05.003; Dimitriu PA, 2013, ENV MICROBIOL REP, V5, P200, DOI 10.1111/j.1758-2229.2012.00393.x; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Flores GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044563; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2009, CYTOKINE, V48, P144, DOI 10.1016/j.cyto.2009.07.007; Gorbachev AV, 2004, J IMMUNOL, V172, P2286, DOI 10.4049/jimmunol.172.4.2286; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Marchesi JR, 2011, ENVIRON MICROBIOL, V13, P3088, DOI 10.1111/j.1462-2920.2011.02574.x; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Nagano Y, 2012, CURR OPIN IMMUNOL, V24, P392, DOI 10.1016/j.coi.2012.05.007; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Scharschmidt TC, 2009, J INVEST DERMATOL, V129, P2435, DOI 10.1038/jid.2009.104; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Talham GL, 1999, INFECT IMMUN, V67, P1992; Thompson CL, 2013, MUCOSAL IMMUNOL, V6, P200, DOI 10.1038/mi.2012.91; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352	59	24	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84019	10.1371/journal.pone.0084019	http://dx.doi.org/10.1371/journal.pone.0084019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416190	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500090
J	Yun, HC; Fugate, WH; Murray, CK; Cropper, TL; Lott, L; McDonald, JM				Yun, Heather C.; Fugate, William H.; Murray, Clinton K.; Cropper, Thomas L.; Lott, Lisa; McDonald, J. Matthew			Pandemic Influenza Virus 2009 H1N1 and Adenovirus in a High Risk Population of Young Adults: Epidemiology, Comparison of Clinical Presentations, and Coinfection	PLOS ONE			English	Article							REAL-TIME PCR; RESPIRATORY-DISEASE; UNITED-STATES; US MILITARY; INFECTIONS; ILLNESS; ASSAY; SAMPLES	Background: In 2009, pandemic H1N1 influenza virus (2009 H1N1) emerged worldwide, causing morbidity and mortality that disproportionately affected young adults. Upper respiratory infection (URI), largely due to adenovirus, is an endemic cause of morbidity in military training. Whether clinical presentations differ or excess morbidity results from coinfection is unclear. Methods: The Center for Advanced Molecular Detection evaluates epidemiology and rapid diagnostics of respiratory pathogens in trainees with URI. From May 1, 2009, to November 30, 2009, demographic, clinical, and PCR data from throat and nasal specimens for adenovirus and 2009 H1N1 were prospectively collected. Results: 375 trainees with URI enrolled and were tested for both adenovirus and 2009 H1N1 by PCR (median age 20; 89% male). Adenovirus PCR was positive in 72% (96% serotype E-4) and 2009 H1N1 in 20%. Males were more likely to have adenovirus and females more likely to have 2009 H1N1 (p = 0.047). Subjects with 2009 H1N1 presented an average of 1 week earlier in training, had shorter illness duration before enrollment, less sore throat, diarrhea, and fewer abnormal findings on throat exam. Coryza and cough were more common with 2009 H1N1 compared to adenovirus. Subjects with 2009 H1N1 were less likely to have adenovirus than those without, despite persistently high frequencies of adenovirus detections during peak 2009 H1N1 weeks (15% vs. 83%, p < 0.01). Coinfection with adenovirus and 2009 H1N1 was rare (4%). Rates of hospitalization and pneumonia did not differ between the adenovirus, 2009 H1N1, or coinfected groups. Conclusion: Military trainees with 2009 H1N1 vs. adenovirus have differing clinical presentations, and males are more likely to have adenovirus. Despite high frequencies of adenovirus infection, coinfection with adenovirus and 2009 H1N1 is rare and apparently does not result in increased morbidity.	[Yun, Heather C.; Murray, Clinton K.] San Antonio Mil Med Ctr, Joint Base San Antonio F, TX USA; [Fugate, William H.; Lott, Lisa; McDonald, J. Matthew] Joint Base San Antonio Lackland, Ctr Adv Mol Detect, Joint Base San Antonio L, TX USA; [Cropper, Thomas L.] Trainee Hlth Surveillance, Joint Base San Antonio L, TX USA; [Yun, Heather C.; Murray, Clinton K.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	San Antonio Military Medical Center; Uniformed Services University of the Health Sciences - USA	Yun, HC (corresponding author), San Antonio Mil Med Ctr, Joint Base San Antonio F, TX USA.	heather.c.yun.mil@mail.mil			Center for Advanced Molecular Detection	Center for Advanced Molecular Detection	The funding source of the Center for Advanced Molecular Detection's work, including this study, originates with the United States Air Force. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, FEBR RESP ILLN FRI S; [Anonymous], 2009, CDC 38 MILL DOS H1N1; [Anonymous], 2009, CDC PROT REALT RTPCR; Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Butler D, 2010, NATURE, V464, P1112, DOI 10.1038/4641112a; Camargo C, 2012, BRAZ J INFECT DIS, V16, P180, DOI [10.1016/S1413-8670(12)70302-1, 10.1590/S1413-86702012000200013]; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P37; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; DUDDING BA, 1973, AM J EPIDEMIOL, V97, P187, DOI 10.1093/oxfordjournals.aje.a121499; Esper FP, 2011, J INFECTION, V63, P260, DOI 10.1016/j.jinf.2011.04.004; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Gray GC, 2000, CLIN INFECT DIS, V31, P663, DOI 10.1086/313999; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Metzgar D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007081; Potter RN, 2012, EMERG INFECT DIS, V18, P507, DOI 10.3201/eid1803.111238; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Russell KL, 2006, J INFECT DIS, V194, P877, DOI 10.1086/507426; Sanchez JL, 2001, J MED VIROL, V65, P710, DOI 10.1002/jmv.2095; Schnepf N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023514; Tanner H, 2012, EUR J CLIN MICROBIOL, V31, P3001, DOI 10.1007/s10096-012-1653-3; Tate JE, 2009, J INFECT DIS, V199, P1419, DOI 10.1086/598520; Viboud C, 2010, PLOS CURR, V2; Walter EA, 2000, MIL MED, V165, P941, DOI 10.1093/milmed/165.12.941	27	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85094	10.1371/journal.pone.0085094	http://dx.doi.org/10.1371/journal.pone.0085094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416345	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500214
J	Bolt, MJ; Stossi, F; Callison, AM; Mancini, MG; Dandekar, R; Mancini, MA				Bolt, M. J.; Stossi, F.; Callison, A. M.; Mancini, M. G.; Dandekar, R.; Mancini, M. A.			Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-alpha protein levels and activity	ONCOGENE			English	Article						estrogen receptor; UBR5; high content screening; high throughput microscopy; ubiquitin ligase	BREAST-CANCER; ER-ALPHA; GENE-EXPRESSION; CHROMATIN DYNAMICS; POLYMERASE-II; CELLS; TRANSCRIPTION; ACTIVATION; PROMOTER; DEGRADATION	Estrogen receptor-alpha (ER alpha) is a central transcription factor that regulates mammary gland physiology and a key driver in breast cancer. In the present study, we aimed to identify novel modulators of ER alpha-mediated transcriptional regulation via a custom-built siRNA library screen. This screen was directed against a variety of coregulators, transcription modifiers, signaling molecules and DNA damage response proteins. By utilizing a microscopy-based, multi-end point, estrogen responsive biosensor cell line platform, the primary screen identified a wide range of factors that altered ER alpha protein levels, chromatin remodeling and mRNA output. We then focused on UBR5, a ubiquitin ligase and known oncogene that modulates ER alpha protein levels and transcriptional output. Finally, we demonstrated that UBR5 also affects endogenous ER alpha target genes and E2-mediated cell proliferation in breast cancer cells. In conclusion, our multi-end point RNAi screen identified novel modulators of ER alpha levels and activity, and provided a robust systems level view of factors involved in mechanisms of nuclear receptor action and pathophysiology. Utilizing a high throughput RNAi screening approach we identified UBR5, a protein commonly amplified in breast cancer, as a novel regulator of ER alpha protein levels and transcriptional activity.	[Bolt, M. J.; Stossi, F.; Callison, A. M.; Mancini, M. G.; Dandekar, R.; Mancini, M. A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Mancini, MA (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza,DeBakey Bldg,Room 132C, Houston, TX 77030 USA.	mancini@bcm.edu			NIEHS [7RC2ES018789]; Keck Foundation; Keck Center NLM Training Program in Biomedical Informatics of the Gulf Coast Consortia National Library of Medicine [T15LM007093]; Integrated Microscopy Core at Baylor College of Medicine; NIH [HD007495, DK56338, CA125123]; Dan L Duncan Cancer Center; John S Dunn Gulf Coast Consortium for Chemical Genomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018789] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Keck Foundation(W.M. Keck Foundation); Keck Center NLM Training Program in Biomedical Informatics of the Gulf Coast Consortia National Library of Medicine; Integrated Microscopy Core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L Duncan Cancer Center; John S Dunn Gulf Coast Consortium for Chemical Genomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We gratefully acknowledge ZD Sharp for aid in the development of the PRL-HeLA cell line, FJ Ashcroft for creation of the GFP-ERa:PRL-HeLa cells, and I Mikic, TJ Moran and JY Newberg for help in developing the automated high-content analysis tools used in this study. We also acknowledge R Lanz and C Stephan for curation, handling and upkeep of the RNAi library. We acknowledge NIEHS funding from 7RC2ES018789 (MAM), the Keck Foundation pre-doctoral fellowship and imaging/automation resource support from the John S Dunn Gulf Coast for Chemical Genomics (PJ Davies and MAM), Dan L Duncan Baylor Cancer Center (K Osborne), Center for Reproductive Biology (FJ Demayo), Keck Center NLM Training Program in Biomedical Informatics of the Gulf Coast Consortia National Library of Medicine (T15LM007093 to MB), and the Diana Helis Henry Medical Research Foundation (MAM) through its direct engagement in the continuous active conduct of medical research in conjunction with Baylor College of Medicine and the Cancer Program. This project was supported by the Integrated Microscopy Core at Baylor College of Medicine with funding from the NIH (HD007495, DK56338 and CA125123), the Dan L Duncan Cancer Center, and the John S Dunn Gulf Coast Consortium for Chemical Genomics.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Ansari SA, 2013, CELL MOL LIFE SCI, V70, P2743, DOI 10.1007/s00018-013-1265-9; Ashcroft FJ, 2011, GENE, V477, P42, DOI 10.1016/j.gene.2011.01.009; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Berno V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002286; Bhatt S, 2012, MOL CELL BIOL, V32, P1928, DOI 10.1128/MCB.06561-11; Bolt MJ, 2013, NUCLEIC ACIDS RES, V41, P4036, DOI 10.1093/nar/gkt100; Bourdoncle A, 2005, J MOL BIOL, V347, P921, DOI 10.1016/j.jmb.2005.01.048; Burandt E, 2013, BREAST CANCER RES TR, V137, P745, DOI 10.1007/s10549-013-2406-4; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen YJ, 2008, ENDOCRINOLOGY, V149, P4658, DOI 10.1210/en.2008-0063; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Cojocaru M, 2011, J BIOL CHEM, V286, P5012, DOI 10.1074/jbc.M110.176628; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dickson R B, 1988, Cancer Treat Res, V40, P119; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; DUBIK D, 1992, ONCOGENE, V7, P1587; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Esslimani-Sahla M, 2004, CLIN CANCER RES, V10, P5769, DOI 10.1158/1078-0432.CCR-04-0389; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Garcia-Becerra R, 2010, GENE, V458, P37, DOI 10.1016/j.gene.2010.03.007; Giamas G, 2011, NAT MED, V17, P715, DOI 10.1038/nm.2351; Gonzalez-Arenas A, 2012, BBA-MOL CELL RES, V1823, P379, DOI 10.1016/j.bbamcr.2011.11.004; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gururaj AE, 2007, MOL ENDOCRINOL, V21, P1847, DOI 10.1210/me.2006-0514; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Horner-Glister E, 2005, J MOL ENDOCRINOL, V35, P421, DOI 10.1677/jme.1.01784; JACQUEMIER JD, 1990, BREAST CANCER RES TR, V15, P109, DOI 10.1007/BF01810783; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; La Rosa P, 2011, CELL SIGNAL, V23, P1128, DOI 10.1016/j.cellsig.2011.02.006; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Li XF, 2013, CYTOKINE, V61, P876, DOI 10.1016/j.cyto.2012.12.017; Long XH, 2006, J BIOL CHEM, V281, P9607, DOI 10.1074/jbc.M510809200; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mook ORF, 2009, CANCER GENE THER, V16, P532, DOI 10.1038/cgt.2008.104; Prapapanich V, 1996, MOL ENDOCRINOL, V10, P420, DOI 10.1210/me.10.4.420; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rudnik V, 2008, J CELL BIOCHEM, V103, P896, DOI 10.1002/jcb.21459; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schaufele F, 1999, MOL ENDOCRINOL, V13, P935, DOI 10.1210/me.13.6.935; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Smits VAJ, 2012, CELL CYCLE, V11, P715, DOI 10.4161/cc.11.4.19154; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Stanlie A, 2012, PLOS GENET, V8; Stokes K, 2004, J MOL ENDOCRINOL, V33, P315, DOI 10.1677/jme.1.01456; Sun J, 2012, MOL ENDOCRINOL, V26, P1567, DOI 10.1210/me.2012-1140; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Willis IM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000112; Wu Q, 2004, J BIOL CHEM, V279, P53602, DOI 10.1074/jbc.M409778200; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zwart W, 2010, J CELL SCI, V123, P1253, DOI 10.1242/jcs.061135	61	19	21	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					154	164		10.1038/onc.2013.550	http://dx.doi.org/10.1038/onc.2013.550			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24441042	Green Accepted			2022-12-25	WOS:000347790500003
J	Serrano, S; Araujo, A; Apellaniz, B; Bryson, S; Carravilla, P; de la Arada, I; Huarte, N; Rujas, E; Pai, EF; Arrondo, JLR; Domene, C; Jimenez, MA; Nieva, JL				Serrano, Soraya; Araujo, Aitziber; Apellaniz, Beatriz; Bryson, Steve; Carravilla, Pablo; de la Arada, Igor; Huarte, Nerea; Rujas, Edurne; Pai, Emil F.; Arrondo, Jose L. R.; Domene, Carmen; Angeles Jimenez, Maria; Nieva, Jose L.			Structure and Immunogenicity of a Peptide Vaccine, Including the Complete HIV-1 gp41 2F5 Epitope IMPLICATIONS FOR ANTIBODY RECOGNITION MECHANISM AND IMMUNOGEN DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fourier Transform IR (FTIR); HIV-1; Liposomes; Nuclear Magnetic Resonance; Peptide Conformation; Vaccine Development	IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; HUMAN MONOCLONAL-ANTIBODY; BROADLY NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; MOLECULAR-DYNAMICS; MEDIATED FUSION; NMR STRUCTURE; FORCE-FIELD; MEMBRANE	Background: HIV-1 vaccines should elicit broadly neutralizing antibodies as the gp41 membrane-proximal external region targeting MAb2F5. Results: NMR disclosed unprecedented 2F5 peptide-epitope structures. Although overall conformation was preserved in different adjuvants, recovered antibodies after vaccination were functionally different. Conclusion: Membrane-inserted helical oligomers may encompass effective 2F5 peptide vaccines. Significance: Disclosing the structures that generate 2F5-like antibodies may guide future vaccine development. The membrane-proximal external region (MPER) of gp41 harbors the epitope recognized by the broadly neutralizing anti-HIV 2F5 antibody, a research focus in HIV-1 vaccine development. In this work, we analyze the structure and immunogenic properties of MPERp, a peptide vaccine that includes the following: (i) the complete sequence protected from proteolysis by the 2F5 paratope; (ii) downstream residues postulated to establish weak contacts with the CDR-H3 loop of the antibody, which are believed to be crucial for neutralization; and (iii) an aromatic rich anchor to the membrane interface. MPERp structures solved in dodecylphosphocholine micelles and 25% 1,1,1,3,3,3-hexafluoro-2-propanol (v/v) confirmed folding of the complete 2F5 epitope within continuous kinked helices. Infrared spectroscopy (IR) measurements demonstrated the retention of main helical conformations in immunogenic formulations based on alum, Freund's adjuvant, or two different types of liposomes. Binding to membrane-inserted MPERp, IR, molecular dynamics simulations, and characterization of the immune responses further suggested that packed helical bundles partially inserted into the lipid bilayer, rather than monomeric helices adsorbed to the membrane interface, could encompass effective MPER peptide vaccines. Together, our data constitute a proof-of-concept to support MPER-based peptides in combination with liposomes as stand-alone immunogens and suggest new approaches for structure-aided MPER vaccine development.	[Serrano, Soraya; Angeles Jimenez, Maria] Consejo Super Invest Cient IQFR CSIC, Inst Phys Chem Rocasolano, E-28006 Madrid, Spain; [Araujo, Aitziber; Apellaniz, Beatriz; Carravilla, Pablo; de la Arada, Igor; Huarte, Nerea; Rujas, Edurne; Arrondo, Jose L. R.; Nieva, Jose L.] CSIC, Biophys Unit, Bilbao 48080, Spain; [Araujo, Aitziber; Apellaniz, Beatriz; Carravilla, Pablo; de la Arada, Igor; Huarte, Nerea; Rujas, Edurne; Arrondo, Jose L. R.; Nieva, Jose L.] Univ Basque Country, CSIC, UPV EHU, Bilbao 48080, Spain; [Araujo, Aitziber; Apellaniz, Beatriz; Carravilla, Pablo; de la Arada, Igor; Huarte, Nerea; Rujas, Edurne; Arrondo, Jose L. R.; Nieva, Jose L.] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao 48080, Spain; [Bryson, Steve; Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Bryson, Steve; Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Bryson, Steve; Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Bryson, Steve; Pai, Emil F.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON M5G 1L7, Canada; [Domene, Carmen] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Domene, Carmen] Kings Coll London, Dept Chem, London SE1 9NH, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; University of Basque Country; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Oxford; University of London; King's College London	Jimenez, MA (corresponding author), Consejo Super Invest Cient IQFR CSIC, Inst Phys Chem Rocasolano, Serrano 119, E-28006 Madrid, Spain.	majimenez@iqfr.csic.es; gbpniesj@lg.ehu.es	Apellaniz, Beatriz/E-9291-2012; de la Arada, Igor/L-9036-2014; Rujas, Edurne/P-1969-2018; Nieva, Jose L/Q-2063-2019; Pai, Emil/R-8908-2019; Carravilla, Pablo/AAV-9168-2020; Rujas, Edurne/GXG-7368-2022; Jimenez, M. Angeles/C-7193-2008; Rujas, Edurne/AGV-1475-2022; Domene, Carmen/A-2711-2019	de la Arada, Igor/0000-0001-6777-1238; Nieva, Jose L/0000-0001-6446-5649; Pai, Emil/0000-0002-1162-7242; Jimenez, M. Angeles/0000-0001-6835-5850; HUARTE ARRAYAGO, NEREA/0000-0002-6675-4150; APELLANIZ, BEATRIZ/0000-0003-1573-5440; Domene, Carmen/0000-0001-7115-4232; Rujas, Edurne/0000-0002-4465-5071; Bryson, Steve/0000-0001-8924-4201; Carravilla Palomanes, Pablo/0000-0001-6592-7630	Spanish MINECO [BIO2011-29792, BFU2010-22103, CTQ2011-22514]; Basque Government [IT838-13, IT852-13]; Canadian Institutes for Health Research [NRF-126638]; Canada Research Chairs Program; National Science Foundation [CNS-09-58854]	Spanish MINECO(Spanish Government); Basque Government(Basque Government); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Spanish MINECO Grants BIO2011-29792 (to J. L. N.), BFU2010-22103 (to J. L. R. A.), and CTQ2011-22514 (to M. A. J.) and Basque Government Grants IT838-13 and IT852-13 (to J. L. N. and J. L. R. A., respectively).; Recipient of a predoctoral fellowship from Spanish MINECO.; Recipients of predoctoral fellowships from the Basque Government.; Supported by Canadian Institutes for Health Research Grant NRF-126638 and the Canada Research Chairs Program.; Supported in part by the National Science Foundation through Major Research Instrumentation Grant CNS-09-58854.	Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Alving CR, 2012, EXPERT REV VACCINES, V11, P733, DOI [10.1586/ERV.12.35, 10.1586/erv.12.35]; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Biron Z, 2002, BIOCHEMISTRY-US, V41, P12687, DOI 10.1021/bi026261y; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Bryson S, 2009, J VIROL, V83, P11862, DOI 10.1128/JVI.01604-09; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; CONLEY AJ, 1994, P NATL ACAD SCI USA, V91, P3348, DOI 10.1073/pnas.91.8.3348; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cournia Z, 2005, J COMPUT CHEM, V26, P1383, DOI 10.1002/jcc.20277; Coutant J, 2008, FASEB J, V22, P4338, DOI 10.1096/fj.08-113142; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; Dokter AM, 2006, P NATL ACAD SCI USA, V103, P15355, DOI 10.1073/pnas.0603239103; DREESMAN GR, 1982, NATURE, V295, P158, DOI 10.1038/295158a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gulzar N., 2013, AIDS RES HUM RETROV, V29, P13; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HARIS PI, 1994, FEBS LETT, V349, P371, DOI 10.1016/0014-5793(94)00704-7; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huarte N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052740; Jones LS, 2005, J BIOL CHEM, V280, P13406, DOI 10.1074/jbc.M500687200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lorizate M, 2008, BBA-BIOMEMBRANES, V1778, P1624, DOI 10.1016/j.bbamem.2007.12.018; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maeso R, 2011, AIDS RES HUM RETROV, V27, P863, DOI [10.1089/AID.2010.0265, 10.1089/aid.2010.0265]; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Matyas GR, 2009, AIDS, V23, P2069, DOI 10.1097/QAD.0b013e32832faea5; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Menendez A, 2004, J MOL BIOL, V338, P311, DOI 10.1016/j.jmb.2004.02.051; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Mirassou Y, 2009, CHEMBIOCHEM, V10, P902, DOI 10.1002/cbic.200800834; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; Mukherjee S, 2007, LANGMUIR, V23, P11174, DOI 10.1021/la701686g; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Reisdorf WC, 1996, BIOCHEMISTRY-US, V35, P1383, DOI 10.1021/bi951589v; Sanchez-Martinez S, 2006, AIDS RES HUM RETROV, V22, P998, DOI 10.1089/aid.2006.22.998; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Vu DM, 2004, BIOCHEMISTRY-US, V43, P3582, DOI 10.1021/bi036203s; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walsh STR, 2003, PROTEIN SCI, V12, P520, DOI 10.1110/ps.0223003; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	86	22	23	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6565	6580		10.1074/jbc.M113.527747	http://dx.doi.org/10.1074/jbc.M113.527747			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24429284	Green Published, hybrid			2022-12-25	WOS:000332389400022
J	Schoebel, CN; Stewart, J; Gruenwald, NJ; Rigling, D; Prospero, S				Schoebel, Corine N.; Stewart, Jane; Gruenwald, Niklaus J.; Rigling, Daniel; Prospero, Simone			Population History and Pathways of Spread of the Plant Pathogen Phytophthora plurivora	PLOS ONE			English	Article							STATISTICAL PROPERTIES; SELF-FERTILIZATION; GENETIC DIVERSITY; POWER ANALYSIS; NORTH-AMERICA; 2 TESTS; MIGRATION; INFERENCE; EVOLUTION; EXPANSION	Human activity has been shown to considerably affect the spread of dangerous pests and pathogens worldwide. Therefore, strict regulations of international trade exist for particularly harmful pathogenic organisms. Phytophthora plurivora, which is not subject to regulations, is a plant pathogen frequently found on a broad range of host species, both in natural and artificial environments. It is supposed to be native to Europe while resident populations are also present in the US. We characterized a hierarchical sample of isolates from Europe and the US and conducted coalescent-, migration, and population genetic analysis of sequence and microsatellite data, to determine the pathways of spread and the demographic history of this pathogen. We found P. plurivora populations to be moderately diverse but not geographically structured. High levels of gene flow were observed within Europe and unidirectional from Europe to the US. Coalescent analyses revealed a signal of a recent expansion of the global P. plurivora population. Our study shows that P. plurivora has most likely been spread around the world by nursery trade of diseased plant material. In particular, P. plurivora was introduced into the US from Europe. International trade has allowed the pathogen to colonize new environments and/or hosts, resulting in population growth.	[Schoebel, Corine N.; Rigling, Daniel; Prospero, Simone] Swiss Fed Inst Forest Snow & Landscape Res WSL, Dept Biodivers & Conservat Biol, Birmensdorf, Switzerland; [Stewart, Jane; Gruenwald, Niklaus J.] ARS, USDA, Hort Crops Res Lab, Corvallis, OR USA; [Stewart, Jane; Gruenwald, Niklaus J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; United States Department of Agriculture (USDA); Oregon State University	Schoebel, CN (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Dept Biodivers & Conservat Biol, Birmensdorf, Switzerland.	corine.schoebel@wsl.ch	Grunwald, Niklaus` J/K-6041-2013; Schoebel, Corine/D-2801-2013; Prospero, Simone/B-7942-2018	Grunwald, Niklaus` J/0000-0003-1656-7602; Schoebel, Corine/0000-0001-9254-140X; Prospero, Simone/0000-0002-9129-8556; Rigling, Daniel/0000-0002-4338-5364	COST Switzerland [SER C10.0129]; Swiss National Science Foundation	COST Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by COST Switzerland (project SER C10.0129) and supported by an international short visit grant of the Swiss National Science Foundation to CNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aguayo J, 2013, PHYTOPATHOLOGY, V103, P190, DOI 10.1094/PHYTO-05-12-0116-R; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; [Anonymous], POPPR R PACKAGE GENE; [Anonymous], 1997, TFPGA TOOLS POPULATI; [Anonymous], 2004, GENETIX 4 05 LOGICIE; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Balci Y, 2007, PLANT DIS, V91, P705, DOI 10.1094/PDIS-91-6-0705; Banke S, 2005, MOL ECOL, V14, P1881, DOI 10.1111/j.1365-294X.2005.02536.x; Bhat RG, 2007, PLANT DIS, V91, P1556, DOI 10.1094/PDIS-91-12-1556; Bilgin R, 2007, MOL ECOL NOTES, V7, P416, DOI 10.1111/j.1471-8286.2006.01671.x; Billiard S, 2011, BIOL REV, V86, P421, DOI 10.1111/j.1469-185X.2010.00153.x; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Brelsfoard CL, 2012, PARASITE VECTOR, P5; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coetzee MPA, 2001, MOL ECOL, V10, P387, DOI 10.1046/j.1365-294x.2001.01187.x; Cornuet JM, 1996, GENETICS, V144, P2001; Dean MD, 2004, MOL PHYLOGENET EVOL, V32, P998, DOI 10.1016/j.ympev.2004.03.013; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Dorrance A., 2009, OOMYCETES GENETICS G; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubey S, 2011, ECOL EVOL, V1, P218, DOI 10.1002/ece3.25; Dutech C, 2012, MOL ECOL, V21, P3931, DOI 10.1111/j.1365-294X.2012.05575.x; Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; FORSTER H, 1994, MOL PLANT MICROBE IN, V7, P780, DOI 10.1094/MPMI-7-0780; FRANCIS DM, 1993, CURR GENET, V24, P100, DOI 10.1007/BF00324672; Gijzen M., 2008, OOMYCETE GENETICS GE, P303, DOI [10.1002/9780470475898.ch15, DOI 10.1002/9780470475898.CH15]; Gladieux P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001455; Gomez-Alpizar L, 2007, PNAS, V104, P462; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P462, DOI 10.1094/PHYTO.1997.87.4.462; Goss EM, 2009, MOL ECOL, V18, P1161, DOI 10.1111/j.1365-294X.2009.04089.x; Goss EM, 2011, PHYTOPATHOLOGY, V101, P166, DOI 10.1094/PHYTO-05-10-0133; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Hansen EM, 2012, ANNU REV PHYTOPATHOL, V50, P359, DOI 10.1146/annurev-phyto-081211-172946; Hey J, 1997, GENETICS, V145, P833; Hoerner GR, 1940, J AGRIC RES, V61, P0331; HUDSON RR, 1985, GENETICS, V111, P147; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Igic B, 2013, NEW PHYTOL, V198, P386, DOI 10.1111/nph.12182; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Jung T, 2009, PERSOONIA, V22, P95, DOI 10.3767/003158509X442612; Jung T, 2009, FOREST PATHOL, V39, P73, DOI 10.1111/j.1439-0329.2008.00566.x; Jung T, 2000, PLANT PATHOL, V49, P706, DOI 10.1046/j.1365-3059.2000.00521.x; King JP, 2000, MOL BIOL EVOL, V17, P1859, DOI 10.1093/oxfordjournals.molbev.a026287; Lawson R. H., 1996, Acta Horticulturae, P226; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Lilja A, 2011, AGR FOOD SCI, V20, P74, DOI 10.2137/145960611795163051; Martin FN, 2003, MYCOLOGIA, V95, P269, DOI 10.2307/3762038; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; McKinney LV, 2012, FOREST PATHOL, V42, P69, DOI 10.1111/j.1439-0329.2011.00725.x; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Moralejo E, 2009, PLANT PATHOL, V58, P100, DOI 10.1111/j.1365-3059.2008.01930.x; Muscarella RA, 2011, PLOS ONE, V6; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Ni M, 2011, ANNU REV GENET, V45, P405, DOI 10.1146/annurev-genet-110410-132536; OU SH, 1980, ANNU REV PHYTOPATHOL, V18, P167, DOI 10.1146/annurev.py.18.090180.001123; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Pritchard JK, 2000, GENETICS, V155, P945; Prospero S, 2013, PLANT PATHOL, V62, P1063, DOI 10.1111/ppa.12027; Prospero S, 2013, INFECTIOUS FOREST DISEASES, P318, DOI 10.1079/9781780640402.0318; R Development Core Team, 2012, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Reich DE, 1999, MOL BIOL EVOL, V16, P453, DOI 10.1093/oxfordjournals.molbev.a026127; Salinari F, 2006, GLOBAL CHANGE BIOL, V12, P1299, DOI 10.1111/j.1365-2486.2006.01175.x; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Schoebel CN, 2013, J EVOLUTION BIOL, V26, P600, DOI 10.1111/jeb.12077; Schoebel CN, 2013, PHYTOPATHOLOGY, V103, P1020, DOI 10.1094/PHYTO-01-13-0026-R; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Warfield CY, 2008, PLANT DIS, V92, P474, DOI 10.1094/PDIS-92-3-0474; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wilson GA, 2003, GENETICS, V163, P1177	87	44	45	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85368	10.1371/journal.pone.0085368	http://dx.doi.org/10.1371/journal.pone.0085368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427303	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000329868200044
J	Wang, Z; Ko, JH; Challis, JH; Newell, KM				Wang, Zheng; Ko, Ji Hyun; Challis, John H.; Newell, Karl M.			The Degrees of Freedom Problem in Human Standing Posture: Collective and Component Dynamics	PLOS ONE			English	Article							QUIET; SYNERGIES; STANCE	The experiment was setup to investigate the coordination and control of the degrees of freedom (DFs) of human standing posture with particular reference to the identification of the collective and component variables. Subjects stood in 3 postural tasks: feet side by side, single left foot quiet stance and single left foot stance with body rocking at the ankle joint in the sagittal plane. All three postural tasks showed very high coherence (similar to 1) of center of pressure (COP) - center of mass (COM) in the low frequency range. The ankle and hip coherence was mid range (similar to.5) with the tasks having different ankle/hip compensatory cophase patterns. The findings support the view that the in-phase relation of the low frequency components of the COP-COM dynamic is the collective variable in the postural tasks investigated. The motions of the individual joints (ankle, knee, hip, neck) and couplings of pair wise joint synergies (e. g., ankle-hip) provide a supporting cooperative role to the preservation of the collective variable in maintaining the COM within the stability region of the base of support (BOS) and minimizing the amount of body motion consistent with the task constraint.	[Wang, Zheng; Ko, Ji Hyun; Challis, John H.; Newell, Karl M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Wang, Zheng] Univ Texas SW Med Ctr Dallas, Dept Psychiat & Pediat, Dallas, TX 75390 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, Z (corresponding author), Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA.	Zheng.Wang@utsouthwestern.edu	Wang, Zheng/F-9345-2015; Wang, Zheng/F-8001-2017	Wang, Zheng/0000-0003-2265-0891; Wang, Zheng/0000-0003-2265-0891	 [NSF 0848339]		The study was supported by Grant NSF 0848339 (KMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 1998, EXP BRAIN RES, V118, P210, DOI 10.1007/s002210050274; Aramaki Y, 2001, EXP BRAIN RES, V136, P463, DOI 10.1007/s002210000603; Babinski F, 1899, REV NEUROLOGIQUE, V7, P806; Bardy BG, 1999, J EXP PSYCHOL HUMAN, V25, P1284, DOI 10.1037/0096-1523.25.5.1284; Batschelet E, 1981, CIRCULAR STAT BIOL; BEEK PJ, 1992, J MOTOR BEHAV, V24, P85, DOI 10.1080/00222895.1992.9941604; Benaim C, 1999, STROKE, V30, P1862, DOI 10.1161/01.STR.30.9.1862; Bernstein N.A., 1967, COORDINATION REGULAT; Bernstein N.A., 1996, RES ECOL PS; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Corriveau H, 2004, ARCH GERONTOL GERIAT, V39, P163, DOI 10.1016/j.archger.2004.03.001; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; Dempster W.T., 1955, 55159 WADC, P55; Dubousset J, 1992, [No title captured], Patent No. [US Patent No 5147360 A, 5147360]; GREGORIC M, 1981, ACTA ORTHOP SCAND, V52, P59, DOI 10.3109/17453678108991759; GURFINKEL VS, 1995, NEUROSCIENCE, V68, P229, DOI 10.1016/0306-4522(95)00136-7; Hof AL, 2007, J BIOMECH, V40, P451, DOI 10.1016/j.jbiomech.2005.12.016; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horak FB, 2005, EXP NEUROL, V193, P504, DOI 10.1016/j.expneurol.2004.12.008; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Ihlen EAF, 2013, J BIOMECH, V46, P484, DOI 10.1016/j.jbiomech.2012.10.016; James EG, 2014, GAIT POSTURE, V39, P194, DOI 10.1016/j.gaitpost.2013.07.005; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Kelso S., 1995, DYNAMIC PATTERNS SEL; King DL, 1997, GAIT POSTURE, V6, P27, DOI 10.1016/S0966-6362(96)01101-0; Kuznetsov NA, 2012, J MOTOR BEHAV, V44, P241, DOI 10.1080/00222895.2012.688894; Minshew NJ, 2004, NEUROLOGY, V63, P2056, DOI 10.1212/01.WNL.0000145771.98657.62; Mitra S, 1998, HUM MOVEMENT SCI, V17, P17, DOI 10.1016/S0167-9457(97)00023-7; Morasso PG, 1999, J NEUROPHYSIOL, V82, P1622, DOI 10.1152/jn.1999.82.3.1622; Otten E, 1999, PHILOS T ROY SOC B, V354, P869, DOI 10.1098/rstb.1999.0439; Pinter IJ, 2008, J NEUROPHYSIOL, V100, P3197, DOI 10.1152/jn.01312.2007; THELEN E, 1991, MONOGR SOC RES CHILD, V56, pR1, DOI 10.2307/1166099; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Zatsiorsky VM, 1999, MOTOR CONTROL, V3, P28, DOI 10.1123/mcj.3.1.28	37	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85414	10.1371/journal.pone.0085414	http://dx.doi.org/10.1371/journal.pone.0085414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427307	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200048
J	Chen, X; Yang, Y; Zhou, Q; Weiss, JM; Howard, OZ; McPherson, JM; Wakefield, LM; Oppenheim, JJ				Chen, Xin; Yang, Yuan; Zhou, Qiong; Weiss, Jonathan M.; Howard, OlaMae Zack; McPherson, John M.; Wakefield, Lalage M.; Oppenheim, Joost J.			Effective Chemoimmunotherapy with Anti-TGF beta Antibody and Cyclophosphamide in a Mouse Model of Breast Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TUMOR-NECROSIS-FACTOR; SUPPRESSOR-CELLS; IMMUNITY; IMMUNOSUPPRESSION; METASTASIS; EXPRESSION; INDUCTION; CARCINOMA	TGF beta is reportedly responsible for accumulation of CD4(+)Foxp3(+) regulatory T cells (Tregs) in tumor. Thus, we treated mouse 4T1 mammary carcinoma with 1D11, a neutralizing anti-TGF beta (1,2,3) antibody. The treatment delayed tumor growth, but unexpectedly increased the proportion of Tregs in tumor. In vitro, 1D11 enhanced while TGF beta potently inhibited the proliferation of Tregs. To enhance the anti-tumor effects, 1D11 was administered with cyclophosphamide which was reported to eliminate intratumoral Tregs. This combination resulted in long term tumor-free survival of up to 80% of mice, and the tumor-free mice were more resistant to re-challenge with tumor. To examine the phenotype of tumor infiltrating immune cells, 4T1-tumor bearing mice were treated with 1D11 and a lower dose of cyclophosphamide. This treatment markedly inhibited tumor growth, and was accompanied by massive infiltration of IFN gamma-producing T cells. Furthermore, this combination markedly decreased the number of splenic CD11b(+)Gr1(+) cells, and increased their expression levels of MHC II and CD80. In a spontaneous 4T1 lung metastasis model with resection of primary tumor, this combination therapy markedly increased the survival of mice, indicating it was effective in reducing lethal metastasis burden. Taken together, our data show that anti-TGF beta antibody and cyclophosphamide represents an effective chemoimmunotherapeutic combination.	[Chen, Xin] Leidos Biomed Res Inc, Frederick Natl Lab, Basic Sci Program, Frederick, MD 21702 USA; [Yang, Yuan; Wakefield, Lalage M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Frederick, MD 21701 USA; [Chen, Xin; Zhou, Qiong; Howard, OlaMae Zack; Oppenheim, Joost J.] NCI, Mol Immunoregulat Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Weiss, Jonathan M.] NCI, Expt Immunol Lab, Ctr Canc Res, Frederick, MD 21701 USA; [McPherson, John M.] Genzyme Corp, Framingham, MA 01701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanofi-Aventis; Genzyme Corporation	Chen, X (corresponding author), Leidos Biomed Res Inc, Frederick Natl Lab, Basic Sci Program, Frederick, MD 21702 USA.	chenxin@mail.nih.gov; oppenhej@mail.nih.gov	Chen, Xin n/a/I-6601-2015; Wakefield, Lalage M/M-1963-2017	Chen, Xin n/a/0000-0002-2628-4027; Wakefield, Lalage M/0000-0003-4124-5250	National Cancer Institute, National Institutes of Health [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010881] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This Research was supported [in part] by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo I, 2000, BLOOD, V95, P212; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chopra M, 2013, CARCINOGENESIS, V34, P1296, DOI 10.1093/carcin/bgt038; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Emadi A, 2009, NAT REV CLIN ONCOL, V6, P638, DOI 10.1038/nrclinonc.2009.146; Fulton Amy, 2006, Breast Dis, V26, P115; Ge YZ, 2012, CANCER IMMUNOL IMMUN, V61, P353, DOI 10.1007/s00262-011-1106-3; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Horwitz DA, 2013, CLIN IMMUNOL, V149, P450, DOI 10.1016/j.clim.2013.08.007; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Le DT, 2012, CANCER RES, V72, P3439, DOI 10.1158/0008-5472.CAN-11-3912; Li Zhaoyang, 2012, Int J Cancer, V131, P2584, DOI 10.1002/ijc.27572; Liu JQ, 2012, P NATL ACAD SCI USA, V109, P16618, DOI 10.1073/pnas.1117610109; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Mikyskova R, 2012, J IMMUNOTHER, V35, P374, DOI 10.1097/CJI.0b013e318255585a; Moschella F, 2011, CANCER RES, V71, P3528, DOI 10.1158/0008-5472.CAN-10-4523; Nagorsen D, 2003, CLIN CANCER RES, V9, P4296; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Ostrand-Rosenberg S, 2012, CANCER IMMUNOL IMMUN, V61, P1319, DOI 10.1007/s00262-012-1269-6; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Radojcic V, 2010, CANCER IMMUNOL IMMUN, V59, P137, DOI 10.1007/s00262-009-0734-3; Rentzsch C, 2003, CLIN CANCER RES, V9, P4376; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Salem ML, 2007, J IMMUNOTHER, V30, P40, DOI 10.1097/01.cji.0000211311.28739.e3; Sistigu A, 2011, SEMIN IMMUNOPATHOL, V33, P369, DOI 10.1007/s00281-011-0245-0; van der Most RG, 2009, CANCER IMMUNOL IMMUN, V58, P1219, DOI 10.1007/s00262-008-0628-9; Wada S, 2009, CANCER RES, V69, P4309, DOI 10.1158/0008-5472.CAN-08-4102; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yang L, 2008, CANCER RES, V68, P9107, DOI 10.1158/0008-5472.CAN-08-2556; Zhong ZJ, 2010, CLIN CANCER RES, V16, P1191, DOI 10.1158/1078-0432.CCR-09-1634; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	41	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85398	10.1371/journal.pone.0085398	http://dx.doi.org/10.1371/journal.pone.0085398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416401	gold, Green Submitted, Green Published			2022-12-25	WOS:000329866300075
J	Rouhigharabaei, L; Ferreiro, JF; Tousseyn, T; van der Krogt, JA; Put, N; Haralambieva, E; Graux, C; Maes, B; Vicente, C; Vandenberghe, P; Cools, J; Wlodarska, I				Rouhigharabaei, Leila; Ferreiro, Julio Finalet; Tousseyn, Thomas; van der Krogt, Jo-Anne; Put, Natalie; Haralambieva, Eugenia; Graux, Carlos; Maes, Brigitte; Vicente, Carmen; Vandenberghe, Peter; Cools, Jan; Wlodarska, Iwona			Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1	PLOS ONE			English	Article							LYMPHOID-TISSUE LYMPHOMAS; ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR FOXP1; CARDIOMYOCYTE PROLIFERATION; CHROMOSOMAL-ABERRATION; PROSTATE-CANCER; DOWN-REGULATION; POOR-PROGNOSIS; MALT LYMPHOMA; GENE	The transcription factor FOXP1 is implicated in the pathogenesis of B-cell lymphomas through chromosomal translocations involving either immunoglobulin heavy chain (IGH) locus or non-IG sequences. The former translocation, t(3; 14)(p13; q32), results in dysregulated expression of FOXP1 juxtaposed with strong regulatory elements of IGH. Thus far, molecular consequences of rare non-IG aberrations of FOXP1 remain undetermined. Here, using molecular cytogenetics and molecular biology studies, we comprehensively analyzed four lymphoma cases with non-IG rearrangements of FOXP1 and compared these with cases harboring t(3; 14)(p13; q32)/IGH-FOXP1 and FOXP1-expressing lymphomas with no apparent structural aberrations of the gene. Our study revealed that non-IG rearrangements of FOXP1 are usually acquired during clinical course of various lymphoma subtypes, including diffuse large B cell lymphoma, marginal zone lymphoma and chronic lymphocytic leukemia, and correlate with a poor prognosis. Importantly, these aberrations constantly target the coding region of FOXP1, promiscuously fusing with coding and non-coding gene sequences at various reciprocal breakpoints (2q36, 10q24 and 3q11). The non-IG rearrangements of FOXP1, however, do not generate functional chimeric genes but commonly disrupt the full-length FOXP1 transcript leading to an aberrant expression of N-truncated FOXP1 isoforms (FOXP1NT), as shown by QRT-PCR and Western blot analysis. In contrast, t(3; 14)(p13; q32)/IGH-FOXP1 affects the 59 untranslated region of FOXP1 and results in overexpress the full-length FOXP1 protein (FOXP1FL). RNA-sequencing of a few lymphoma cases expressing FOXP1NT and FOXP1FL detected neither FOXP1-related fusions nor FOXP1 mutations. Further bioinformatic analysis of RNA-sequencing data retrieved a set of genes, which may comprise direct or non-direct targets of FOXP1NT, potentially implicated in disease progression. In summary, our findings point to a dual mechanism through which FOXP1 is implicated in B-cell lymphomagenesis. We hypothesize that the primary t(3; 14)(p13; q32)/IGH-FOXP1 activates expression of the FOXP1FL protein with potent oncogenic activity, whereas the secondary non-IG rearrangements of FOXP1 promote expression of the FOXP1NT proteins, likely driving progression of disease.	[Rouhigharabaei, Leila; Ferreiro, Julio Finalet; van der Krogt, Jo-Anne; Put, Natalie; Vicente, Carmen; Vandenberghe, Peter; Cools, Jan; Wlodarska, Iwona] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Tousseyn, Thomas] UZ Leuven, Translat Cell & Tissue Res KU Leuven, Dept Pathol, Louvain, Belgium; [Haralambieva, Eugenia] Univ Wurzburg, Dept Pathol, Wurzburg, Germany; [Graux, Carlos] Mont Godinne Univ Hosp, Yvoir, Belgium; [Maes, Brigitte] Virga Jesse Hosp, Hasselt, Belgium; [Vicente, Carmen; Cools, Jan] VIB, Ctr Biol Dis, Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; University of Wurzburg; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Flanders Institute for Biotechnology (VIB)	Wlodarska, I (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium.	iwona.wlodarska@uzleuven.be	Maes, Brigitte/AFP-8088-2022; Vicente, Carmen/AAA-7098-2021	Vicente, Carmen/0000-0002-3363-3459; Cools, Jan/0000-0001-6626-5843; Vandenberghe, Peter/0000-0003-4719-1935; Rouhi, M.D., Ph.D., Leila/0000-0001-7997-5254; Tousseyn, Thomas/0000-0002-0397-1086	K.U.Leuven [3M040406]	K.U.Leuven(KU Leuven)	This study was supported by the concerted action grant from the K.U.Leuven no. 3M040406 (www.Kuleuven.be). PV is a senior clinical investigator of the FWO-Vlaanderen (www.FWO.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Banham AH, 2005, CLIN CANCER RES, V11, P1065; Banham AH, 2001, CANCER RES, V61, P8820; Barrans SL, 2004, BLOOD, V104, P2933, DOI 10.1182/blood-2004-03-1209; Brown PJ, 2008, BLOOD, V111, P2816, DOI 10.1182/blood-2007-09-115113; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Courts C, 2009, J NEUROPATH EXP NEUR, V68, P972, DOI 10.1097/NEN.0b013e3181b31cd6; Coyaud E, 2010, BLOOD, V115, P3089, DOI 10.1182/blood-2009-07-234229; Craig VJ, 2011, BLOOD, V117, P6227, DOI 10.1182/blood-2010-10-312231; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Fenton JAL, 2006, GENE CHROMOSOME CANC, V45, P164, DOI 10.1002/gcc.20278; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Goatly A, 2008, MODERN PATHOL, V21, P902, DOI 10.1038/modpathol.2008.74; Green MR, 2009, LEUKEMIA RES, V33, P1699, DOI 10.1016/j.leukres.2009.05.004; Hall DC, 2008, UROL ONCOL-SEMIN ORI, V26, P652, DOI 10.1016/j.urolonc.2007.07.017; Han SL, 2009, DIGEST SURG, V26, P156, DOI 10.1159/000212058; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Haralambieva E, 2006, LEUKEMIA, V20, P1300, DOI 10.1038/sj.leu.2404244; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Hoeller S, 2010, HISTOPATHOLOGY, V57, P73, DOI 10.1111/j.1365-2559.2010.03600.x; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Ishikawa ET, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2645; Jais JP, 2008, LEUKEMIA, V22, P1917, DOI 10.1038/leu.2008.188; Jiang W, 2012, MED ONCOL, V29, P3352, DOI 10.1007/s12032-012-0288-7; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Krohn A, 2013, J PATHOL, V231, P130, DOI 10.1002/path.4223; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Mao X, 2013, TUMOUR BIOL IN PRESS; Motegi M, 2000, AM J PATHOL, V156, P807, DOI 10.1016/S0002-9440(10)64948-6; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; NUNEZ G, 1989, P NATL ACAD SCI USA, V86, P4589, DOI 10.1073/pnas.86.12.4589; Pajer P, 2006, CANCER RES, V66, P78, DOI 10.1158/0008-5472.CAN-05-1728; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Sagaert X, 2006, J CLIN ONCOL, V24, P2490, DOI 10.1200/JCO.2006.05.6150; Sagardoy A, 2013, BLOOD, V121, P4311, DOI 10.1182/blood-2012-10-462846; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Streubel B, 2005, LEUKEMIA, V19, P652, DOI 10.1038/sj.leu.2403644; Streubel B, 2003, BLOOD, V101, P2335, DOI 10.1182/blood-2002-09-2963; Tuteja G, 2007, CELL, V130, DOI 10.1016/j.cell.2007.09.005; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wang YZ, 2010, CELL CYCLE, V9, P4251, DOI 10.4161/cc.9.21.13924; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Wong KK, 2013, LEUKEMIA IN PRESS; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Zhai LZ, 2011, TUMOR BIOL, V32, P913, DOI 10.1007/s13277-011-0192-3; Zhang YZ, 2010, GENE DEV, V24, P1746, DOI 10.1101/gad.1929210	59	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85851	10.1371/journal.pone.0085851	http://dx.doi.org/10.1371/journal.pone.0085851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416450	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300102
J	Craddock, TJA; Fritsch, P; Rice, MA; del Rosario, RM; Miller, DB; Fletcher, MA; Klimas, NG; Broderick, G				Craddock, Travis J. A.; Fritsch, Paul; Rice, Mark A., Jr.; del Rosario, Ryan M.; Miller, Diane B.; Fletcher, Mary Ann; Klimas, Nancy G.; Broderick, Gordon			A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: Gulf War Illness and Chronic Fatigue Syndrome	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REGULATORY NETWORKS; IMMUNE-SYSTEM; HPA AXIS; GLUCOCORTICOID-RECEPTOR; GONADAL AXIS; PRIMARY-CARE; T-CELLS; STRESS	A key component in the body's stress response, the hypothalamic-pituitary-adrenal (HPA) axis orchestrates changes across a broad range of major biological systems. Its dysfunction has been associated with numerous chronic diseases including Gulf War Illness (GWI) and chronic fatigue syndrome (CFS). Though tightly coupled with other components of endocrine and immune function, few models of HPA function account for these interactions. Here we extend conventional models of HPA function by including feed-forward and feedback interaction with sex hormone regulation and immune response. We use this multi-axis model to explore the role of homeostatic regulation in perpetuating chronic conditions, specifically GWI and CFS. An important obstacle in building these models across regulatory systems remains the scarcity of detailed human in vivo kinetic data as its collection can present significant health risks to subjects. We circumvented this using a discrete logic representation based solely on literature of physiological and biochemical connectivity to provide a qualitative description of system behavior. This connectivity model linked molecular variables across the HPA axis, hypothalamic-pituitary-gonadal (HPG) axis in men and women, as well as a simple immune network. Inclusion of these interactions produced multiple alternate homeostatic states and sexually dimorphic responses. Experimental data for endocrine-immune markers measured in male GWI subjects showed the greatest alignment with predictions of a naturally occurring alternate steady state presenting with hypercortisolism, low testosterone and a shift towards a Th1 immune response. In female CFS subjects, expression of these markers aligned with an alternate homeostatic state displaying hypocortisolism, high estradiol, and a shift towards an anti-inflammatory Th2 activation. These results support a role for homeostatic drive in perpetuating dysfunctional cortisol levels through persistent interaction with the immune system and HPG axis. Though coarse, these models may nonetheless support the design of robust treatments that might exploit these regulatory regimes.	[Craddock, Travis J. A.; Broderick, Gordon] Nova SE Univ, Ctr Psychol Studies, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.] Nova SE Univ, Grad Sch Comp & Informat Sci, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.; Rice, Mark A., Jr.; del Rosario, Ryan M.; Klimas, Nancy G.; Broderick, Gordon] Nova SE Univ, Inst Neuroimmune Med, Ft Lauderdale, FL 33314 USA; [Fritsch, Paul; Broderick, Gordon] Univ Alberta, Dept Med, Fac Dent & Med, Edmonton, AB, Canada; [Miller, Diane B.] NIOSH, Ctr Dis Control & Prevent, Morgantown, WV USA; [Fletcher, Mary Ann] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Klimas, Nancy G.] Nova SE Univ, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA; [Broderick, Gordon] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA	Nova Southeastern University; Nova Southeastern University; Nova Southeastern University; University of Alberta; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of Miami; Nova Southeastern University; Nova Southeastern University	Craddock, TJA (corresponding author), Nova SE Univ, Ctr Psychol Studies, Ft Lauderdale, FL 33314 USA.	tcraddock@nova.edu		Craddock, Travis/0000-0001-7244-6317	US Department of Defense Congressionally Directed Medical Research Program (CDMRP) [GW093042, GW080152]; National Institutes of Health [RES0008852]	US Department of Defense Congressionally Directed Medical Research Program (CDMRP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding came from the US Department of Defense Congressionally Directed Medical Research Program (CDMRP) awards (http://cdmrp.army.mil/) GW093042 (Broderick - PI) and GW080152 (Klimas - PI) as well as the National Institutes of Health (NIH)(http://www.nih.gov/) R01 award RES0008852 (Klimas - PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gonzalez DA, 2010, IMMUNOL LETT, V133, P6, DOI 10.1016/j.imlet.2010.07.001; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Aschbacher K, 2012, BRAIN BEHAV IMMUN, V26, P1047, DOI 10.1016/j.bbi.2012.06.002; Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; Beacher FDCC, 2009, NEUROIMAGE, V47, P937, DOI 10.1016/j.neuroimage.2009.05.038; Ben-Zvi A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000273; Berczi I, 2003, NEUROIMMUNE BIOL, V3, P495; Boneva RS, 2011, J WOMENS HEALTH, V20, P21, DOI 10.1089/jwh.2009.1900; Brenu EW, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-81; Broderick G, 2006, PHARMACOGENOMICS, V7, P407, DOI 10.2217/14622416.7.3.407; Broderick G, 2012, METHODS MOL BIOL; Broderick G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-191; Broderick G, 2011, BRAIN BEHAV IMMUN, V25, P302, DOI 10.1016/j.bbi.2010.10.011; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Bush KA, 2012, CELL IMMUNOL, V275, P80, DOI 10.1016/j.cellimm.2012.02.014; Chrousos GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3143pe36; Cleare AJ, 2003, ENDOCR REV, V24, P236, DOI 10.1210/er.2002-0014; Collins JF, 2002, CONTROL CLIN TRIALS, V23, P333, DOI 10.1016/S0197-2456(02)00192-7; Crofford LJ, 2004, BRAIN BEHAV IMMUN, V18, P314, DOI 10.1016/j.bbi.2003.12.011; Cutolo M, 2004, ENCY ENDOCRINE DIS, V2, P755; Dallman MF, 2002, HORMONES BRAIN BEHAV, P571; Doyle P, 2006, PHILOS T R SOC B, V361, P571, DOI 10.1098/rstb.2006.1817; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Evengard B, 2005, PSYCHOL MED, V35, P1317, DOI 10.1017/S0033291705005052; Fletcher MA, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-76; Folcik VA, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-1; Foster SC, 2003, J NEUROIMMUNOL, V140, P78, DOI 10.1016/S0165-5728(03)00177-2; Frankenstein Z, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-32; Fuite J, 2008, GENOMICS, V92, P393, DOI 10.1016/j.ygeno.2008.08.008; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Gagliardi L, 2010, MOL CELL ENDOCRINOL, V316, P24, DOI 10.1016/j.mce.2009.07.015; Gallagher AM, 2004, J ROY SOC MED, V97, P571, DOI 10.1258/jrsm.97.12.571; Gangestad SW, 2012, BIOL REV, V87, P856, DOI 10.1111/j.1469-185X.2012.00226.x; Gerritsen L, 2011, BIOL PSYCHIAT, V70, P373, DOI 10.1016/j.biopsych.2011.01.029; Gil-Bea FJ, 2010, J ALZHEIMERS DIS, V22, P829, DOI 10.3233/JAD-2010-100663; Golier JA, 2006, PSYCHONEUROENDOCRINO, V31, P1181, DOI 10.1016/j.psyneuen.2006.08.005; Golier JA, 2007, BIOL PSYCHIAT, V62, P1175, DOI 10.1016/j.biopsych.2007.04.027; Golier JA, 2009, PSYCHONEUROENDOCRINO, V34, P1338, DOI 10.1016/j.psyneuen.2009.04.004; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Gupta S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-8; Hernando H, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r3; Hiller-Sturmhofel S, 1998, ALCOHOL HEALTH RES W, V22, P153; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jerjes WK, 2006, J PSYCHOSOM RES, V60, P145, DOI 10.1016/j.jpsychores.2005.07.008; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; Kin NW, 2006, J LEUKOCYTE BIOL, V79, P1093, DOI 10.1189/jlb.1105625; Lelu K, 2011, J IMMUNOL, V187, P2386, DOI 10.4049/jimmunol.1101578; Liberman AC, 2009, FASEB J, V23, P1558, DOI 10.1096/fj.08-121236; Lindal E, 2002, NORD J PSYCHIAT, V56, P273, DOI 10.1080/08039480260242769; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mehta D, 2012, NEUROPHARMACOLOGY, V62, P654, DOI 10.1016/j.neuropharm.2011.03.009; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Mikics E, 2004, PSYCHONEUROENDOCRINO, V29, P618, DOI 10.1016/S0306-4530(03)00090-8; Nacul LC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-91; Nakamura T, 2010, CLIN VACCINE IMMUNOL, V17, P582, DOI 10.1128/CVI.00379-09; Natelson BH, 2005, CLIN DIAGN LAB IMMUN, V12, P52, DOI 10.1128/CDLI.12.1.52-55.2005; Papadopoulos AS, 2012, NAT REV ENDOCRINOL, V8, P22, DOI 10.1038/nrendo.2011.153; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pinon R, 2001, BIOL HUMAN REPROD; Queen KJ, 2013, INT J CANCER, V132, P2076, DOI 10.1002/ijc.27893; Rankin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030978; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; RIVIER C, 1991, BIOL REPROD, V45, P523, DOI 10.1095/biolreprod45.4.523; Schacterle RS, 2004, ARCH INTERN MED, V164, P401, DOI 10.1001/archinte.164.4.401; Silverman MN, 2005, VIRAL IMMUNOL, V18, P41, DOI 10.1089/vim.2005.18.41; Skowera A, 2004, J CLIN IMMUNOL, V24, P66, DOI 10.1023/B:JOCI.0000018065.64685.82; Tarin JJ, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-53; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/revreprod/5.2.105; Torpy DJ, 2007, CLIN ENDOCRINOL, V67, P161, DOI 10.1111/j.1365-2265.2007.02890.x; Torpy DJ, 1996, BAILLIERE CLIN RHEUM, V10, P181; Van Den Eede F, 2007, NEUROPSYCHOBIOLOGY, V55, P112, DOI 10.1159/000104468; Vernon SD, 2006, PHARMACOGENOMICS, V7, P345, DOI 10.2217/14622416.7.3.345; Viau V, 2002, J NEUROENDOCRINOL, V14, P506, DOI 10.1046/j.1365-2826.2002.00798.x; Vinther F, 2011, J MATH BIOL, V63, P663, DOI 10.1007/s00285-010-0384-2; Walker JJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001341; Walker JJ, 2010, P ROY SOC B-BIOL SCI, V277, P1627, DOI 10.1098/rspb.2009.2148; Watanobe H, 2003, ENDOCRINOLOGY, V144, P4868, DOI 10.1210/en.2003-0644; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12; Wolfram M, 2011, PSYCHONEUROENDOCRINO, V36, P905, DOI 10.1016/j.psyneuen.2010.12.006; Yehuda R, 2009, STRESS CONSEQUENCES, P125; Young E.A., 2007, SEX DIFFERENCES BRAI, P95; Young EA, 2009, UNDERSTANDING DEPRES, P193; Zen M, 2011, AUTOIMMUN REV, V10, P305, DOI 10.1016/j.autrev.2010.11.009	91	48	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84839	10.1371/journal.pone.0084839	http://dx.doi.org/10.1371/journal.pone.0084839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416298	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500178
J	Finch, C; Al-Damluji, MS; Krause, PJ; Niccolai, L; Steeves, T; O'Keefe, CF; Diuk-Wasser, MA				Finch, Casey; Al-Damluji, Mohammed Salim; Krause, Peter J.; Niccolai, Linda; Steeves, Tanner; O'Keefe, Corrine Folsom; Diuk-Wasser, Maria A.			Integrated Assessment of Behavioral and Environmental Risk Factors for Lyme Disease Infection on Block Island, Rhode Island	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; IXODES-DAMMINI ACARI; TICK-BORNE DISEASES; BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; IXODIDAE NYMPHS; UNITED-STATES; FOREST FRAGMENTATION; MODEL SELECTION; LEAF-LITTER	Peridomestic exposure to Borrelia burgdorferi-infected Ixodes scapularis nymphs is considered the dominant means of infection with black-legged tick-borne pathogens in the eastern United States. Population level studies have detected a positive association between the density of infected nymphs and Lyme disease incidence. At a finer spatial scale within endemic communities, studies have focused on individual level risk behaviors, without accounting for differences in peridomestic nymphal density. This study simultaneously assessed the influence of peridomestic tick exposure risk and human behavior risk factors for Lyme disease infection on Block Island, Rhode Island. Tick exposure risk on Block Island properties was estimated using remotely sensed landscape metrics that strongly correlated with tick density at the individual property level. Behavioral risk factors and Lyme disease serology were assessed using a longitudinal serosurvey study. Significant factors associated with Lyme disease positive serology included one or more self-reported previous Lyme disease episodes, wearing protective clothing during outdoor activities, the average number of hours spent daily in tick habitat, the subject's age and the density of shrub edges on the subject's property. The best fit multivariate model included previous Lyme diagnoses and age. The strength of this association with previous Lyme disease suggests that the same sector of the population tends to be repeatedly infected. The second best multivariate model included a combination of environmental and behavioral factors, namely hours spent in vegetation, subject's age, shrub edge density (increase risk) and wearing protective clothing (decrease risk). Our findings highlight the importance of concurrent evaluation of both environmental and behavioral factors to design interventions to reduce the risk of tick-borne infections.	[Finch, Casey; Al-Damluji, Mohammed Salim; Krause, Peter J.; Niccolai, Linda; Steeves, Tanner; O'Keefe, Corrine Folsom; Diuk-Wasser, Maria A.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Al-Damluji, Mohammed Salim] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [O'Keefe, Corrine Folsom] Audubon Connecticut, Southbury, CT USA	Yale University; Yale University	Diuk-Wasser, MA (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	maria.diuk@yale.edu			Environmental Protection Agency [EPA 835120]; National Institutes of Health [NIH 1RO3AI076856-01, NIH RO1AI042402-01]; Gordon and Llaura Gund Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042402, R03AI076856] Funding Source: NIH RePORTER	Environmental Protection Agency(United States Environmental Protection Agency); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Llaura Gund Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Environmental Protection Agency grant EPA 835120 (MAD), the National Institutes of Health grant NIH 1RO3AI076856-01 (MAD), The National Institutes of Health grant NIH RO1AI042402-01 (PJK), and the Gordon and Llaura Gund Foundation (PJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Beyer HL, 2011, GEOSPATIAL MODELLING; Branda JA, 2011, CLIN INFECT DIS, V53, P541, DOI 10.1093/cid/cir464; Brei B, 2009, VECTOR-BORNE ZOONOT, V9, P423, DOI 10.1089/vbz.2008.0150; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; Centers for Disease Control and Prevention (CDC), 1995, MMWR MORB MORTAL WKL, V44, P590; Cliff A, 1973, SPATIAL AUTOCORRELAT; Cliff A. D., 1981, SPATIAL PROCESSES MO; Connally NP, 2006, J VECTOR ECOL, V31, P364, DOI 10.3376/1081-1710(2006)31[364:APEFAP]2.0.CO;2; Connally NP, 2009, AM J PREV MED, V37, P201, DOI 10.1016/j.amepre.2009.04.026; CURRAN KL, 1993, J MED ENTOMOL, V30, P107, DOI 10.1093/jmedent/30.1.107; Daltroy LH, 2007, HEALTH EDUC BEHAV, V34, P531, DOI 10.1177/1090198106294646; Daniels TJ, 2000, J MED ENTOMOL, V37, P357, DOI 10.1603/0022-2585(2000)037[0357:EPSADS]2.0.CO;2; DANIELS TJ, 1991, J MED ENTOMOL, V28, P537, DOI 10.1093/jmedent/28.4.537; Dister SW, 1997, AM J TROP MED HYG, V57, P687, DOI 10.4269/ajtmh.1997.57.687; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Durden L. A., 1996, NYMPHS GENUS IXODES; Eisen RJ, 2006, AM J TROP MED HYG, V75, P669, DOI 10.4269/ajtmh.2006.75.669; Enser R, 2000, ECOLOGY BLOCK ISLAND, P183; FALCO RC, 1989, AM J PUBLIC HEALTH, V79, P12, DOI 10.2105/AJPH.79.1.12; FALCO RC, 1988, AM J EPIDEMIOL, V127, P826, DOI 10.1093/oxfordjournals.aje.a114865; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; Gatewood AG, 2009, APPL ENVIRON MICROB, V75, P2476, DOI 10.1128/AEM.02633-08; Gould LH, 2008, VECTOR-BORNE ZOONOT, V8, P769, DOI 10.1089/vbz.2007.0221; HAMMERSBERGGREN S, 1994, J CLIN MICROBIOL, V32, P1519, DOI 10.1128/JCM.32.6.1519-1525.1994; Hayes EB, 2003, NEW ENGL J MED, V348, P2424, DOI 10.1056/NEJMra021397; HOSMER DW, 1989, APPL LOGISTIC REGRES; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Jackson LE, 2006, COMMUNITY ECOL, V7, P189, DOI 10.1556/ComEc.7.2006.2.6; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kitron U, 1997, AM J EPIDEMIOL, V145, P558, DOI 10.1093/oxfordjournals.aje.a009145; Klein JD, 1996, CLIN PEDIATR, V35, P359, DOI 10.1177/000992289603500705; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; Lillesand T., 1987, REMOTE SENSING IMAGE; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Meek J I, 1996, J Public Health Manag Pract, V2, P61; Nigrovic LE, 2007, EPIDEMIOL INFECT, V135, P1, DOI 10.1017/S0950268806007096; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Piesman J, 2012, J ENVIRON HEALTH, V74, P30; Rosenzweig C, 2000, ECOLOGY BLOCK ISLAND, P183; Schulze TL, 1997, J MED ENTOMOL, V34, P615, DOI 10.1093/jmedent/34.6.615; SCHULZE TL, 1995, J MED ENTOMOL, V32, P730, DOI 10.1093/jmedent/32.5.730; Schulze TL, 2001, J MED ENTOMOL, V38, P344, DOI 10.1603/0022-2585-38.2.344; Skogman BH, 2010, ARCH DIS CHILD, V95, P1013, DOI 10.1136/adc.2010.183624; STAFFORD KC, 1991, J MED ENTOMOL, V28, P32, DOI 10.1093/jmedent/28.1.32; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; Stafford KC., 2004, TICK MANAGEMENT HDB; Talleklint-Eisen L, 2000, J MED ENTOMOL, V37, P484, DOI 10.1603/0022-2585(2000)037[0484:EODSFE]2.0.CO;2; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Updike T., 2010, RADIOMETRIC USE WORL; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Voordouw MJ, 2013, VECTOR-BORNE ZOONOT, V13, P203, DOI 10.1089/vbz.2012.1003; Young JD, 1998, NEW ENGL J MED, V338, P1629, DOI 10.1056/NEJM199805283382216	60	63	63	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84758	10.1371/journal.pone.0084758	http://dx.doi.org/10.1371/journal.pone.0084758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416278	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500161
J	Hao, PP; Liu, YP; Yang, CY; Liang, T; Zhang, C; Song, J; Han, JK; Hou, GH				Hao, Pan-Pan; Liu, Yan-Ping; Yang, Chang-Ya; Liang, Ting; Zhang, Chao; Song, Jing; Han, Jian-Kui; Hou, Gui-Hua			Evaluation of I-131-Anti-Angiotensin II Type 1 Receptor Monoclonal Antibody as a Reporter for Hepatocellular Carcinoma	PLOS ONE			English	Article							5-LIPOXYGENASE ACTIVATING PROTEIN; ANXIETY-LIKE BEHAVIOR; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTOR; MICE; INHIBITOR; MK-886; MAZE	Background: Finding a specific agent is useful for early detection of tumor. Angiotensin II type 1 receptor (AT(1)R) was reported to be elevated in a variety of tumors and participate in tumor progression. The aim of our study was to evaluate whether I-131-anti-AT(1)R monoclonal antibody (mAb) is an efficient imaging reporter for the detection of hepatocellular carcinoma. Methodology/Principal Findings: AT(1)R mAb or isotype IgG was radioiodinated with I-131 and the radiochemical purity and stability of the two imaging agents and the affinity of I-131-anti-AT(1)R mAb against AT(1)R were measured. 3.7 MBq I-131-anti-AT(1)R mAb or isotype I-131-IgG was intravenously injected to mice with hepatocellular carcinoma through tail vein, and then the whole-body autoradiography and biodistribution of the two imaging agents and the pharmacokinetics of I-131-anti-AT(1)R mAb were studied. I-131-anti-AT(1)R mAb and I-131-IgG were successfully radioiodinated and both maintained more stable in serum than in saline. The I-131-anti-AT(1)R mAb group showed much clearer whole-body images for observing hepatocellular carcinoma than the I-131-IgG group. The biodistributions of the two imaging agents suggested that hepatocellular carcinoma tissue uptook more I-131-anti-AT(1)R mAb than other tissues (%ID/g = 1.82 +/- 0.40 and T/NT ratio = 7.67 +/- 0.64 at 48 h), whereas hepatocellular carcinoma tissue did not selectively uptake I-131-IgG (%ID/g = 0.42 +/- 0.06 and T/NT ratio = 1.33 +/- 0.08 at 48 h). The pharmacokinetics of I-131-anti-AT(1)R mAb was in accordance with the two-compartment model, with a rapid distribution phase and a slow decline phase. These results were further verified by real-time RT-PCR, immunohistochemistry staining and Western blot. Conclusions/Significance: I-131-anti-AT(1)R mAb may be a potential target for early detection of tumor.	[Hao, Pan-Pan; Liu, Yan-Ping; Yang, Chang-Ya; Liang, Ting; Zhang, Chao; Song, Jing; Hou, Gui-Hua] Shandong Univ, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Peoples R China; [Hao, Pan-Pan; Liu, Yan-Ping; Yang, Chang-Ya; Liang, Ting; Zhang, Chao; Song, Jing; Hou, Gui-Hua] Shandong Univ, Inst Expt Nucl Med, Sch Med, Jinan 250100, Peoples R China; [Hao, Pan-Pan] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China; [Hao, Pan-Pan] Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan 250100, Peoples R China; [Han, Jian-Kui] Shandong Univ, Qilu Hosp, Dept Nucl Med, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Hou, GH (corresponding author), Shandong Univ, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Peoples R China.	ghhou1@hotmail.com	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022		National Natural Science Foundation of China [81071172]; Natural Science Foundation of Shandong Province [ZR2010CM025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by grants from the National Natural Science Foundation of China (81071172, JK Han) and the Natural Science Foundation of Shandong Province (ZR2010CM025, GH Hou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biserni A, 2008, MOL PHARMACOL, V73, P1434, DOI 10.1124/mol.107.042689; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Joshi YB, 2013, J PSYCHIATR RES, V47, P694, DOI 10.1016/j.jpsychires.2012.12.011; Joshi YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029448; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Lourenco J, 2011, J NEUROSCI, V31, P3243, DOI 10.1523/JNEUROSCI.3512-10.2011; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Naidu PS, 2007, PSYCHOPHARMACOLOGY, V192, P61, DOI 10.1007/s00213-006-0689-4; Pamplona FA, 2012, P NATL ACAD SCI USA, V109, P21134, DOI 10.1073/pnas.1202906109; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Ruehle S, 2012, J PSYCHOPHARMACOL, V26, P23, DOI 10.1177/0269881111408958; Shryock N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061882; Singh VP, 2005, PHARMACOL BIOCHEM BE, V81, P433, DOI 10.1016/j.pbb.2005.03.015; Takahashi RN, 2005, NEUROSCI LETT, V380, P270, DOI 10.1016/j.neulet.2005.01.049; Uz T, 2002, RESTOR NEUROL NEUROS, V20, P15; Uz T, 2008, NEUROSCI LETT, V436, P269, DOI 10.1016/j.neulet.2008.03.041; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	18	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85002	10.1371/journal.pone.0085002	http://dx.doi.org/10.1371/journal.pone.0085002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416333	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500205
J	Hoffmann, D; Mussolin, C; Martin, R; Schiltz, C				Hoffmann, Danielle; Mussolin, Christophe; Martin, Romain; Schiltz, Christine			The Impact of Mathematical Proficiency on the Number-Space Association	PLOS ONE			English	Article							WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; DEVELOPMENTAL DYSCALCULIA; MENTAL REPRESENTATION; NUMERICAL ESTIMATION; ARITHMETIC FACTS; FUNCTIONAL LOCUS; ANGULAR GYRUS; MATH ANXIETY; SNARC	A specific instance of the association between numerical and spatial representations is the SNARC (Spatial Numerical Association of Response Codes) effect. The SNARC effect describes the finding that during binary classification of numbers participants are faster to respond to small/large numbers with the left/right hand respectively. Even though it has been frequently replicated, important inter-individual variability has also been reported. Mathematical proficiency is an obvious candidate source for inter-individual variability in numerical judgments, but studies investigating its influence on the SNARC effect remain scarce. The present experiment included a total of 95 University students, divided into three groups differing significantly in their mathematical proficiency levels. Using group analyses, it appeared that the three groups differed significantly in the strength of their number-space associations in a parity judgment task. This result was further confirmed on an individual level, with higher levels in arithmetic leading to relatively weaker SNARC effects. To explain this negative relationship we propose accounts based on differences in access to qualitatively different numerical representations and also consider more domain general factors, with a focus on inhibition capacities.	[Hoffmann, Danielle; Martin, Romain; Schiltz, Christine] Univ Luxembourg, Walferdange, Luxembourg; [Mussolin, Christophe] Univ Libre Bruxelles, Brussels, Belgium	University of Luxembourg; Universite Libre de Bruxelles	Hoffmann, D (corresponding author), Univ Luxembourg, Walferdange, Luxembourg.	danielle.hoffmann@uni.lu	Hoffmann, Danielle/J-7197-2019	Hoffmann, Danielle/0000-0001-7039-5587; Schiltz, Christine/0000-0002-1055-3878	University of Luxembourg [F3R-EMA-PUL-09NSP2]; National Research Fund, Luxembourg [AFR PHD-09-160]	University of Luxembourg; National Research Fund, Luxembourg(Luxembourg National Research Fund)	This work was funded by the University of Luxembourg (F3R-EMA-PUL-09NSP2; www.uni.lu) and the National Research Fund (AFR PHD-09-160; www.fnr.lu), Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 1999, J EXP PSYCHOL GEN, V128, P186, DOI 10.1037/0096-3445.128.2.186; ASHCRAFT MH, 1994, COGNITION EMOTION, V8, P97, DOI 10.1080/02699939408408931; Ashcraft MH, 2002, CURR DIR PSYCHOL SCI, V11, P181, DOI 10.1111/1467-8721.00196; Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; Ashkenazi S, 2010, NEUROPSYCHOLOGIA, V48, P2861, DOI 10.1016/j.neuropsychologia.2010.05.028; Bachot J., 2005, PSYCHOL SCI, V47, P172, DOI DOI 10.1016/0010-0277(92)90049-N; Bonato M, 2007, J EXP PSYCHOL HUMAN, V33, P1410, DOI 10.1037/0096-1523.33.6.1410; Bonato M, 2009, J COGNITIVE NEUROSCI, V21, P745, DOI 10.1162/jocn.2009.21054; Booth JL, 2006, DEV PSYCHOL, V42, P189, DOI 10.1037/0012-1649.41.6.189; Booth JL, 2008, CHILD DEV, V79, P1016, DOI 10.1111/j.1467-8624.2008.01173.x; Bull R, 2013, J EXP PSYCHOL GEN, V142, P181, DOI 10.1037/a0028387; Butterworth B., 2005, HDB MATH COGNITION, V1st, P455; Casarotti M, 2007, COGNITION, V102, P101, DOI 10.1016/j.cognition.2006.09.001; Castronovo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033832; Censabella S, 2004, CAH PSYCHOL COGN, V22, P635; Chen Q, 2010, COGNITIVE PSYCHOL, V60, P218, DOI 10.1016/j.cogpsych.2010.01.001; Cipora K, 2013, Q J EXP PSYCHOL, V66, P1974, DOI 10.1080/17470218.2013.772215; Cutini S, 2014, CEREB CORTEX, V24, P444, DOI 10.1093/cercor/bhs321; de Hevia MD, 2008, NEUROSCI BIOBEHAV R, V32, P1361, DOI 10.1016/j.neubiorev.2008.05.015; De Smedt B, 2011, J EXP CHILD PSYCHOL, V108, P278, DOI 10.1016/j.jecp.2010.09.003; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; De Visscher A, 2013, CORTEX, V49, P50, DOI 10.1016/j.cortex.2012.01.003; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Dehaene S, 1997, NUMBER SENSE MIND CR; Delazer M, 2003, COGNITIVE BRAIN RES, V18, P76, DOI 10.1016/j.cogbrainres.2003.09.005; Della Sala S, 1999, NEUROPSYCHOLOGIA, V37, P1189, DOI 10.1016/S0028-3932(98)00159-6; Della Sala S, 1997, VISUAL PATTERN TEST; DeWind NK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00068; Di Luca S, 2006, Q J EXP PSYCHOL, V59, P1648, DOI 10.1080/17470210500256839; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Faust M. W., 1996, MATH COGNITION, V2, P25, DOI DOI 10.1080/135467996387534; Fias W., 2005, HDB MATH COGNITION, P43; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fias W, 2011, ATTENTION PERFORM, P133, DOI 10.1016/B978-0-12-385948-8.00010-4; Fischer MH, 2008, CORTEX, V44, P386, DOI 10.1016/j.cortex.2007.08.004; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; FISCHER MH, 2005, PSYCHOL SCI, V47, P22; Fischer U, 2011, PSYCHON B REV, V18, P177, DOI 10.3758/s13423-010-0031-3; Galfano G, 2006, PSYCHON B REV, V13, P869, DOI 10.3758/BF03194011; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Geary DC, 2004, J LEARN DISABIL-US, V37, P4, DOI 10.1177/00222194040370010201; Gevers W, 2006, EXP PSYCHOL, V53, P58, DOI 10.1027/1618-3169.53.1.58; Gevers W, 2006, J EXP PSYCHOL HUMAN, V32, P32, DOI 10.1037/0096-1523.32.1.32; Gevers W, 2005, EUR J COGN PSYCHOL, V17, P659, DOI 10.1080/09541440540000112; Gevers W, 2010, J EXP PSYCHOL GEN, V139, P180, DOI 10.1037/a0017688; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Gobel SM, 2011, J CROSS CULT PSYCHOL, V42, P543, DOI 10.1177/0022022111406251; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Grabner RH, 2009, HUM BRAIN MAPP, V30, P2936, DOI 10.1002/hbm.20720; Grabner RH, 2009, NEUROPSYCHOLOGIA, V47, P604, DOI 10.1016/j.neuropsychologia.2008.10.013; Gut M, 2012, INT J PSYCHOPHYSIOL, V85, P7, DOI 10.1016/j.ijpsycho.2012.02.007; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Herrera A, 2008, ACTA PSYCHOL, V128, P225, DOI 10.1016/j.actpsy.2008.01.002; Hoffmann D, IMPACT INHI IN PRESS; Hoffmann D, 2013, J EXP CHILD PSYCHOL, V116, P775, DOI 10.1016/j.jecp.2013.07.013; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Imbo I, 2012, J EXP CHILD PSYCHOL, V111, P671, DOI 10.1016/j.jecp.2011.09.002; Kadosh RC, 2007, TRENDS COGN SCI, V11, P177, DOI 10.1016/j.tics.2007.01.003; Keus IM, 2005, MEM COGNITION, V33, P681, DOI 10.3758/BF03195335; Keus IM, 2005, COGNITIVE BRAIN RES, V24, P48, DOI 10.1016/j.cogbrainres.2004.12.005; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Koten JW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00115; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LORCH RF, 1990, J EXP PSYCHOL LEARN, V16, P149, DOI 10.1037/0278-7393.16.1.149; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; Mejias S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00518; Mejias S, 2012, CHILD NEUROPSYCHOL, V18, P550, DOI 10.1080/09297049.2011.625355; Mejias S, 2012, LEARN INDIVID DIFFER, V22, P164, DOI 10.1016/j.lindif.2011.09.013; Mussolin C, 2012, TRENDS NEUROSCI EDUC, V1, P21, DOI 10.1016/j.tine.2012.09.003; Mussolin C, 2011, ACTA PSYCHOL, V138, P193, DOI 10.1016/j.actpsy.2011.06.004; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Nuerk HC, 2004, Q J EXP PSYCHOL-A, V57, P835, DOI 10.1080/02724980343000512; Nys J, 2013, TRENDS NEUROSCI EDUC, V2, P13, DOI 10.1016/j.tine.2013.01.001; Passolunghi MC, 2004, J EXP CHILD PSYCHOL, V88, P348, DOI 10.1016/j.jecp.2004.04.002; Piazza M, 2013, PSYCHOL SCI, V24, P1037, DOI 10.1177/0956797612464057; Pinhas M, 2012, J EXP PSYCHOL LEARN, V38, P1187, DOI 10.1037/a0027390; Pinhas M, 2012, BEHAV RES METHODS, V44, P788, DOI 10.3758/s13428-011-0172-y; Previtali P, 2010, EXP BRAIN RES, V201, P599, DOI 10.1007/s00221-009-2063-3; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023553; RESTLE F, 1970, J EXP PSYCHOL, V83, P274, DOI 10.1037/h0028573; Ristic J, 2006, PSYCHON B REV, V13, P862, DOI 10.3758/BF03194010; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Rubinsten O, 2005, NEUROPSYCHOLOGY, V19, P641, DOI 10.1037/0894-4105.19.5.641; Rubinsten O, 2006, J EDUC PSYCHOL, V98, P854, DOI 10.1037/0022-0663.98.4.854; Santens S, 2008, COGNITION, V108, P263, DOI 10.1016/j.cognition.2008.01.002; Schneider M, 2009, J EDUC PSYCHOL, V101, P359, DOI 10.1037/a0013840; Schneider W., 2002, E PRIME USERS GUIDE; Schweiter M., 2005, Z NEUROPSYCHOL, V16, P105, DOI DOI 10.1024/1016-264X.16.2.105; Shaki S, 2009, PSYCHON B REV, V16, P328, DOI 10.3758/PBR.16.2.328; Shalev RS, 2001, J LEARN DISABIL-US, V34, P59, DOI 10.1177/002221940103400105; Siegler RS, 2004, CHILD DEV, V75, P428, DOI 10.1111/j.1467-8624.2004.00684.x; Tschentscher N, 2012, NEUROIMAGE, V59, P3139, DOI 10.1016/j.neuroimage.2011.11.037; Tzelgov J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00302; van Dijck Jean-Philippe, 2011, Front Hum Neurosci, V5, P182, DOI 10.3389/fnhum.2011.00182; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; van Dijck JP, 2009, COGNITION, V113, P248, DOI 10.1016/j.cognition.2009.08.005; Wood G., 2008, PSYCHOL SCI Q, V50, P489; Wood G, 2010, COMMUNICATION; Wood G, 2008, CORTEX, V44, P353, DOI 10.1016/j.cortex.2008.01.002; Wood G, 2006, CORTEX, V42, P1069, DOI 10.1016/S0010-9452(08)70219-3; Wood G, 2006, CORTEX, V42, P1119, DOI 10.1016/S0010-9452(08)70223-5; ZBRODOFF NJ, 1995, MEM COGNITION, V23, P689, DOI 10.3758/BF03200922; Zhang HY, 2011, J HUAZHONG U SCI-MED, V31, P131, DOI 10.1007/s11596-011-0164-2	111	42	43	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85048	10.1371/journal.pone.0085048	http://dx.doi.org/10.1371/journal.pone.0085048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416338	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500208
J	Howbert, JJ; Patterson, EE; Stead, SM; Brinkmann, B; Vasoli, V; Crepeau, D; Vite, CH; Sturges, B; Ruedebusch, V; Mavoori, J; Leyde, K; Sheffield, WD; Litt, B; Worrell, GA				Howbert, J. Jeffry; Patterson, Edward E.; Stead, S. Matt; Brinkmann, Ben; Vasoli, Vincent; Crepeau, Daniel; Vite, Charles H.; Sturges, Beverly; Ruedebusch, Vanessa; Mavoori, Jaideep; Leyde, Kent; Sheffield, W. Douglas; Litt, Brian; Worrell, Gregory A.			Forecasting Seizures in Dogs with Naturally Occurring Epilepsy	PLOS ONE			English	Article							REFRACTORY IDIOPATHIC EPILEPSY; CEREBRAL-BLOOD-FLOW; PREICTAL STATE; ZONISAMIDE THERAPY; CANINE EPILEPSY; EEG; PREDICTION; ONSET; ELECTROENCEPHALOGRAPHY; PERSPECTIVE	Seizure forecasting has the potential to create new therapeutic strategies for epilepsy, such as providing patient warnings and delivering preemptive therapy. Progress on seizure forecasting, however, has been hindered by lack of sufficient data to rigorously evaluate the hypothesis that seizures are preceded by physiological changes, and are not simply random events. We investigated seizure forecasting in three dogs with naturally occurring focal epilepsy implanted with a device recording continuous intracranial EEG (iEEG). The iEEG spectral power in six frequency bands: delta (0.1-4 Hz), theta (4-8 Hz), alpha (8-12 Hz), beta (12-30 Hz), low-gamma (30-70 Hz), and high-gamma (70-180 Hz), were used as features. Logistic regression classifiers were trained to discriminate labeled pre-ictal and inter-ictal data segments using combinations of the band spectral power features. Performance was assessed on separate test data sets via 10-fold cross-validation. A total of 125 spontaneous seizures were detected in continuous iEEG recordings spanning 6.5 to 15 months from 3 dogs. When considering all seizures, the seizure forecasting algorithm performed significantly better than a Poisson-model chance predictor constrained to have the same time in warning for all 3 dogs over a range of total warning times. Seizure clusters were observed in all 3 dogs, and when the effect of seizure clusters was decreased by considering the subset of seizures separated by at least 4 hours, the forecasting performance remained better than chance for a subset of algorithm parameters. These results demonstrate that seizures in canine epilepsy are not randomly occurring events, and highlight the feasibility of long-term seizure forecasting using iEEG monitoring.	[Howbert, J. Jeffry; Ruedebusch, Vanessa; Mavoori, Jaideep; Leyde, Kent; Sheffield, W. Douglas] NeuroVista Corp, Seattle, WA USA; [Patterson, Edward E.] Univ Minnesota, Ctr Vet Med, St Paul, MN 55108 USA; [Stead, S. Matt; Brinkmann, Ben; Vasoli, Vincent; Crepeau, Daniel; Worrell, Gregory A.] Mayo Clin, Mayo Syst Electrophysiol Lab, Rochester, MN 55905 USA; [Vite, Charles H.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Sturges, Beverly] Univ Calif Davis, Sch Vet, Davis, CA 95616 USA; [Litt, Brian] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Pennsylvania; University of California System; University of California Davis; University of Pennsylvania	Worrell, GA (corresponding author), Mayo Clin, Mayo Syst Electrophysiol Lab, Rochester, MN 55905 USA.	Worrell.Gregory@mayo.edu		Brinkmann, Benjamin/0000-0002-2392-8608; Vasoli, Vincent/0000-0001-8004-748X	National Institute of Neurological Disorders and Stroke NIH [U01-NS073557, R01- NS630391, U24-NS063930]; Mayo Clinic; NeuroVista Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS073557, U24NS063930] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic; NeuroVista Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NeuroVista Inc. had a role in study design, analysis, decision to publish, and preparation of the manuscript. The National Institute of Neurological Disorders and Stroke NIH (U01-NS073557, R01- NS630391, U24-NS063930), Mayo Clinic, and NeuroVista Inc. supported this work. No additional external funding received for this study.	Adelson PD, 1999, EPILEPSIA, V40, P1484, DOI 10.1111/j.1528-1157.1999.tb02030.x; ALARCON G, 1995, ELECTROEN CLIN NEURO, V94, P326, DOI 10.1016/0013-4694(94)00286-T; Andrzejak RG, 2009, CLIN NEUROPHYSIOL, V120, P1465, DOI 10.1016/j.clinph.2009.05.019; Andrzejak RG, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.010901; Badawy RA, 2013, ANN NEUROL IN PRESS; Badawy R, 2009, BRAIN, V132, P1013, DOI 10.1093/brain/awp017; Baumgartner C, 1998, J NUCL MED, V39, P978; Berendt M, 1999, J VET INTERN MED, V13, P14, DOI 10.1892/0891-6640(1999)013&lt;0014:EASCID&gt;2.3.CO;2; Berendt M, 1999, ACTA NEUROL SCAND, V99, P276, DOI 10.1111/j.1600-0404.1999.tb00676.x; Chandler K, 2006, VET J, V172, P207, DOI 10.1016/j.tvjl.2005.07.001; Coles L, 2013, EPILEPSY BE IN PRESS; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; Davis KA, 2011, EPILEPSY RES, V96, P116, DOI 10.1016/j.eplepsyres.2011.05.011; Dewey CW, 2004, J AM ANIM HOSP ASSOC, V40, P285, DOI 10.5326/0400285; Dudek FE, 2011, EPILEPSY RES, V97, P324, DOI 10.1016/j.eplepsyres.2011.10.017; Durazzo TS, 2008, NEUROLOGY, V70, P1265, DOI 10.1212/01.wnl.0000308938.84918.3f; Eiger CE, 2013, LANCET NEUROL, V12, P531, DOI 10.1016/S1474-4422(13)70092-9; Engel J, 2007, EPILEPSY COMPREHENSI; Federico P, 2005, BRAIN, V128, P1811, DOI 10.1093/brain/awh533; Fisher RS, 2012, ANN NEUROL, V71, P157, DOI 10.1002/ana.22621; Fisher RS, 2000, EPILEPSY BEHAV, V1, pS9, DOI 10.1006/ebeh.2000.0107; Gardner AB, 2006, J MACH LEARN RES, V7, P1025; Gowers S, 1885, EPILEPSY OTHER CHRON; Haut SR, 2007, NEUROLOGY, V68, P262, DOI 10.1212/01.wnl.0000252352.26421.13; Haut SR, 2006, EPILEPSY BEHAV, V8, P50, DOI 10.1016/j.yebeh.2005.08.018; Haut SR, 2005, NEUROLOGY, V65, P1313, DOI 10.1212/01.wnl.0000180685.84547.7f; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lee SA, 2000, EPILEPSIA, V41, P297, DOI 10.1111/j.1528-1157.2000.tb00159.x; Linehan J, 2011, TREATMENT EPILEPSY P, P165; Main I, 1999, NATURE DEBATES; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Murray, 1994, GLOBAL COMP ASSESSME; Park Y, 2011, EPILEPSIA, V52, P1761, DOI 10.1111/j.1528-1167.2011.03138.x; Pellegrino FC, 2004, CLIN NEUROPHYSIOL, V115, P477, DOI 10.1016/S1388-2457(03)00347-X; Platt SR, 2006, VET REC, V159, P881; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; Schulze-Bonhage A., 2008, SEIZURE PREDICTION E, DOI [10.1002/9783527625192.ch1, DOI 10.1002/9783527625192.CH1]; Schulze-Bonhage A, 2010, EPILEPSY BEHAV, V18, P388, DOI 10.1016/j.yebeh.2010.05.008; Snyder DE, 2008, J NEURAL ENG, V5, P392, DOI 10.1088/1741-2560/5/4/004; Stacey W, 2011, EPILEPSY RES, V97, P243, DOI 10.1016/j.eplepsyres.2011.07.012; Volk HA, 2008, VET J, V176, P310, DOI 10.1016/j.tvjl.2007.03.002; von Klopmann T, 2007, J SMALL ANIM PRACT, V48, P134, DOI 10.1111/j.1748-5827.2006.00290.x; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Weinand ME, 1997, J NEUROSURG, V86, P226, DOI 10.3171/jns.1997.86.2.0226; Worrell GA, 2012, PROG NEUROBIOL, V98, P265, DOI 10.1016/j.pneurobio.2012.02.006	46	90	91	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e81920	10.1371/journal.pone.0081920	http://dx.doi.org/10.1371/journal.pone.0081920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416133	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500010
J	Sancataldo, G; Vetri, V; Fodera, V; Di Cara, G; Militello, V; Leone, M				Sancataldo, Giuseppe; Vetri, Valeria; Fodera, Vito; Di Cara, Gianluca; Militello, Valeria; Leone, Maurizio			Oxidation Enhances Human Serum Albumin Thermal Stability and Changes the Routes of Amyloid Fibril Formation	PLOS ONE			English	Article							METHIONINE RESIDUES; PROTEIN OXIDATION; AGGREGATION; BOVINE; FLUORESCENCE; OLIGOMERS; ANTIOXIDANTS; POLYMORPHISM; MEMBRANE; REVEALS	Oxidative damages are linked to several aging-related diseases and are among the chemical pathways determining protein degradation. Specifically, interplay of oxidative stress and protein aggregation is recognized to have a link to the loss of cellular function in pathologies like Alzheimer's and Parkinson's diseases. Interaction between protein and reactive oxygen species may indeed induce small changes in protein structure and lead to the inhibition/modification of protein aggregation process, potentially determining the formation of species with different inherent toxicity. Understanding the temperate relationship between these events can be of utmost importance in unraveling the molecular basis of neurodegeneration. In this work, we investigated the effect of hydrogen peroxide oxidation on Human Serum Albumin (HSA) structure, thermal stability and aggregation properties. In the selected conditions, HSA forms fibrillar aggregates, while the oxidized protein undergoes aggregation via new routes involving, in different extents, specific domains of the molecule. Minute variations due to oxidation of single residues affect HSA tertiary structure leading to protein compaction, increased thermal stability, and reduced association propensity.	[Sancataldo, Giuseppe; Vetri, Valeria; Militello, Valeria; Leone, Maurizio] Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy; [Vetri, Valeria; Militello, Valeria; Leone, Maurizio] CNR, IBF Uo, Palermo, Italy; [Fodera, Vito] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Fodera, Vito] Univ Cambridge, Cavendish Lab, Dept Phys, Sect Biol & Soft Syst, Cambridge CB3 0HE, England; [Di Cara, Gianluca] Ctr Oncobiol Sperimentale, Palermo, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Copenhagen; University of Cambridge	Vetri, V (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy.	valeria.vetri@unipa.it	Foderà, Vito/F-9029-2010; Fodera, Vito/C-1966-2014; Sancataldo, Giuseppe/AAK-5326-2020; Foderà, Vito/AAZ-9925-2020; Leone, Maurizio/F-2353-2010; Vetri, Valeria/F-2314-2010	Foderà, Vito/0000-0003-2855-0568; Foderà, Vito/0000-0003-2855-0568; Leone, Maurizio/0000-0002-0292-7657; Vetri, Valeria/0000-0002-2307-1165; militello, valeria/0000-0001-8022-8547; DI CARA, Gianluca/0000-0003-3928-7072; sancataldo, giuseppe/0000-0002-8661-5895	FP7 Marie-Curie Actions Intra European Fellowship (IEF) for Career Development [299385]	FP7 Marie-Curie Actions Intra European Fellowship (IEF) for Career Development	V.F. acknowledges support from the FP7 Marie-Curie Actions Intra European Fellowship (IEF) for Career Development 2012-2014, project nr. 299385 "FibCat'' (University of Copenhagen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bagatolli L A, 1996, J Fluoresc, V6, P33, DOI 10.1007/BF00726724; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Beal MF, 2002, FREE RADICAL BIO MED, V32; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Binger KJ, 2008, BIOCHEMISTRY-US, V47, P10208, DOI 10.1021/bi8009339; Bismuto E, 1996, PROTEIN SCI, V5, P121; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bourdon E, 2005, FREE RADICAL RES, V39, P15, DOI 10.1080/10715760400024935; Bourdon E, 2001, ANTIOXID REDOX SIGN, V3, P293, DOI 10.1089/152308601300185241; Browne SE, 1999, BRAIN PATHOL, V9, P147; Carrotta R, 2011, J PHYS CHEM B, V115, P2691, DOI 10.1021/jp1042409; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; FINCH JW, 1993, ARCH BIOCHEM BIOPHYS, V305, P595, DOI 10.1006/abbi.1993.1466; Fleming PJ, 2000, J MOL BIOL, V299, P487, DOI 10.1006/jmbi.2000.3750; Fodera V, 2008, J PHYS CHEM B, V112, P3853, DOI 10.1021/jp710131u; Fodera V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.108105; Fodera V, 2012, J PHYS CHEM LETT, V3, P2803, DOI 10.1021/jz301375d; Fodera V, 2008, J PHYS CHEM B, V112, P15174, DOI 10.1021/jp805560c; Goswami N, 2010, J PHYS CHEM B, V114, P15236, DOI 10.1021/jp105943d; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Heegaard NHH, 2005, BIOCHEMISTRY-US, V44, P4397, DOI 10.1021/bi047594t; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Iwao Y, 2006, DRUG METAB PHARMACOK, V21, P140, DOI 10.2133/dmpk.21.140; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Juarez J, 2009, J PHYS CHEM B, V113, P12391, DOI 10.1021/jp904167e; Juarez J, 2009, J PHYS CHEM B, V113, P10521, DOI 10.1021/jp902224d; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; KATCHALSKI E, 1957, J AM CHEM SOC, V79, P4096, DOI 10.1021/ja01572a034; Kay MS, 1996, NAT STRUCT BIOL, V3, P439, DOI 10.1038/nsb0596-439; Koudelka T, 2012, J AGR FOOD CHEM, V60, P4144, DOI 10.1021/jf205168t; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040845; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lasch P, 2001, J BIOL CHEM, V276, P9492, DOI 10.1074/jbc.M008528200; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; Maleknia SD, 2006, FEBS J, V273, P5400, DOI 10.1111/j.1742-4658.2006.05532.x; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; MEUCCI E, 1991, J BIOL CHEM, V266, P4692; Militello V, 2003, BIOPHYS CHEM, V105, P133, DOI 10.1016/S0301-4622(03)00153-4; Moriyama Y, 1996, J PROTEIN CHEM, V15, P265, DOI 10.1007/BF01887115; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Peters T., 1996, ALL ALBUMIN BIOCH GE; Ravi J, 2011, EUR BIOPHYS J BIOPHY, V40, P339, DOI 10.1007/s00249-010-0656-1; Robbins KJ, 2012, LANGMUIR, V28, P16490, DOI 10.1021/la303677t; Robbins KJ, 2011, J PHYS CHEM LETT, V2, P735, DOI 10.1021/jz200066b; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Scheinost J.C., 2010, PROTEIN MISFOLDING D, P615; Schmit JD, 2011, BIOPHYS J, V100, P450, DOI 10.1016/j.bpj.2010.11.041; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; SHECHTER Y, 1975, BIOCHEMISTRY-US, V14, P4497, DOI 10.1021/bi00691a025; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith MI, 2012, COLLOID SURFACE B, V89, P216, DOI 10.1016/j.colsurfb.2011.09.018; Souillac PO, 2003, BIOCHEMISTRY-US, V42, P8094, DOI 10.1021/bi034652m; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; Stadtman E R, 1992, EXS, V62, P64; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stadtman ER, 2005, BIOCHIM BIOPHYS ACTA, P1703; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sun HY, 1999, BIOCHEMISTRY-US, V38, P105, DOI 10.1021/bi981295k; Taboada P, 2006, J PHYS CHEM B, V110, P20733, DOI 10.1021/jp064861r; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Vetri V, 2005, BIOPHYS CHEM, V113, P83, DOI 10.1016/j.bpc.2004.07.042; Vetri V, 2007, EUR BIOPHYS J BIOPHY, V36, P717, DOI 10.1007/s00249-007-0196-5; Vetri V, 2007, BIOPHYS CHEM, V125, P184, DOI 10.1016/j.bpc.2006.07.012; Vetri V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068912; Vetri V, 2011, ARCH BIOCHEM BIOPHYS, V508, P13, DOI 10.1016/j.abb.2011.01.024; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Xie H, 2013, PNAS; Zolese G, 2000, PROTEINS, V40, P39, DOI 10.1002/(SICI)1097-0134(20000701)40:1<39::AID-PROT60>3.0.CO;2-N	90	48	48	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84552	10.1371/journal.pone.0084552	http://dx.doi.org/10.1371/journal.pone.0084552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416244	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500136
J	van Rijn, S; Barendse, M; van Goozen, S; Swaab, H				van Rijn, Sophie; Barendse, Marjolein; van Goozen, Stephanie; Swaab, Hanna			Social Attention, Affective Arousal and Empathy in Men with Klinefelter Syndrome (47,XXY): Evidence from Eyetracking and Skin Conductance	PLOS ONE			English	Article							EMOTION REGULATION ABILITIES; MALE BRAIN THEORY; FACE RECOGNITION; CHILDREN; INTELLIGENCE; INDIVIDUALS; ALEXITHYMIA; FIXATION; DISORDER; QUALITY	Individuals with an extra X chromosome (Klinefelter syndrome) are at risk for problems in social functioning and have an increased vulnerability for autism traits. In the search for underlying mechanisms driving this increased risk, this study focused on social attention, affective arousal and empathy. Seventeen adults with XXY and 20 non-clinical controls participated in this study. Eyetracking was used to investigate social attention, as expressed in visual scanning patterns in response to the viewing of empathy evoking video clips. Skin conductance levels, reflecting affective arousal, were recorded continuously during the clips as well. Empathic skills, i.e. participants' understanding of own and others' emotions in response to the clips was also assessed. Results showed reduced empathic understanding, decreased visual fixation to the eye region, but increased affective arousal in individuals with Klinefelter syndrome. We conclude that individuals with XXY tend to avoid the eye region. Considering the increased affective arousal, we speculate that this attentional deployment strategy may not be sufficient to successfully downregulate affective hyper-responsivity. As increased affective arousal was related to reduced empathic ability, we hypothesize that own affective responses to social cues play an important role in difficulties in understanding the feelings and intentions of others. This knowledge may help in the identification of risk factors for psychopathology and targets for treatment.	[van Rijn, Sophie; Barendse, Marjolein; van Goozen, Stephanie; Swaab, Hanna] Leiden Univ, Leiden, Netherlands; [van Rijn, Sophie; Swaab, Hanna] Leiden Inst Brain & Cognit, Leiden, Netherlands; [van Goozen, Stephanie] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Cardiff University	van Rijn, S (corresponding author), Leiden Univ, Leiden, Netherlands.	srijn@fsw.leidenuniv.nl	Swaab, Hanna/AAD-2555-2019	Swaab, Hanna/0000-0003-3697-060X; van rijn, sophie/0000-0002-9179-7515	Netherlands Organization for Scientific Research [016.095.060]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a Veni grant (grant number 016.095.060 to SVR) from the Netherlands Organization for Scientific Research (www.NWO.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal E, 2010, J AUTISM DEV DISORD, V40, P358, DOI 10.1007/s10803-009-0884-3; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2010, PROG BRAIN RES, V186, P167, DOI 10.1016/B978-0-444-53630-3.00011-7; Bebko GM, 2011, EMOTION, V11, P732, DOI 10.1037/a0024009; Berthoz S, 2005, EUR PSYCHIAT, V20, P291, DOI 10.1016/j.eurpsy.2004.06.013; Bird G, 2006, HUMAN BRAIN MAPPING; Bird G, 2011, J AUTISM DEV DISORD, V41, P1556, DOI 10.1007/s10803-011-1183-3; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Bishop DVM, 2011, ARCH DIS CHILD, V96, P954, DOI 10.1136/adc.2009.179747; Boada R, 2009, DEV DISABIL RES REV, V15, P284, DOI 10.1002/ddrr.83; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Boone KB, 2001, J INT NEUROPSYCH SOC, V7, P446, DOI 10.1017/S1355617701744013; BOOTHBUTTERFIELD M, 1990, HUM COMMUN RES, V16, P451, DOI 10.1111/j.1468-2958.1990.tb00219.x; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Braaten EB, 2000, J CONSULT CLIN PSYCH, V68, P313, DOI [10.1037/0022-006X.68.2.313, 10.1037//0022-006X.68.2.313]; Bruining H, 2009, PEDIATRICS, V123, pE865, DOI 10.1542/peds.2008-1954; Campbell JM, 1998, PSYCHOL ASSESSMENT, V10, P431, DOI 10.1037/1040-3590.10.4.431; Connelly M, 2007, J PSYCHOSOM RES, V62, P649, DOI 10.1016/j.jpsychores.2006.12.008; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Eisenberg N, 2000, J PERS SOC PSYCHOL, V78, P136, DOI 10.1037//0022-3514.66.4.776; Fitzgerald M, 2006, J AUTISM DEV DISORD, V36, P573, DOI 10.1007/s10803-006-0096-z; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Fusar-Poli P, 2009, J CLIN NEUROSCI, V16, P981, DOI 10.1016/j.jocn.2008.09.022; Geschwind D., 2004, LEARN DISABIL RES PR, V19, P166, DOI [DOI 10.1111/J.1540-5826.2004.00100.X, 10.1111/j.1540-5826.2004.00100.x]; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ, 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Halberstadt AG, 2001, SOC DEV, V10, P79, DOI 10.1111/1467-9507.00150; HerreraGraf M, 1996, EDUC PSYCHOL MEAS, V56, P522, DOI 10.1177/0013164496056003014; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Hirstein W, 2001, P ROY SOC B-BIOL SCI, V268, P1883, DOI 10.1098/rspb.2001.1724; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Hubert BE, 2009, AUTISM, V13, P9, DOI 10.1177/1362361308091649; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Jonsson P, 2003, BIOL PSYCHOL, V62, P157, DOI 10.1016/S0301-0511(02)00114-X; Joseph RM, 2008, J INT NEUROPSYCH SOC, V14, P947, DOI 10.1017/S1355617708081344; Kirchner JC, 2011, J AUTISM DEV DISORD, V41, P158, DOI 10.1007/s10803-010-1032-9; Klein JT, 2009, CURR BIOL, V19, pR958, DOI 10.1016/j.cub.2009.08.010; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Konstantareas MM, 2006, J AUTISM DEV DISORD, V36, P143, DOI 10.1007/s10803-005-0051-4; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Lee NR, 2011, J INT NEUROPSYCH SOC, V17, P522, DOI 10.1017/S1355617711000312; Leggett V, 2010, DEV MED CHILD NEUROL, V52, P119, DOI 10.1111/j.1469-8749.2009.03545.x; Lopes PN, 2005, EMOTION, V5, P113, DOI 10.1037/1528-3542.5.1.113; Lopes PN, 2004, PERS SOC PSYCHOL B, V30, P1018, DOI 10.1177/0146167204264762; Lopes PN, 2003, PERS INDIV DIFFER, V35, P641, DOI 10.1016/S0191-8869(02)00242-8; Main K, 2012, DEV NEW EMPATHY PARA; Mazefsky CA, 2013, J AM ACAD CHILD PSY, V52, P679, DOI 10.1016/j.jaac.2013.05.006; Mestre JM, 2006, PSICOTHEMA, V18, P112; Myers D. G., 2004, THEORIES EMOTION; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Pinkham AE, 2006, PSYCHIAT RES, V143, P167, DOI 10.1016/j.psychres.2005.09.005; Ratcliffe S, 1999, ARCH DIS CHILD, V80, P192, DOI 10.1136/adc.80.2.192; RATCLIFFE SG, 1991, BIRTH DEF, V26, P1; ROBINSON A, 1991, BIRTH DEF, V26, P59; Samson AC, 2012, EMOTION, V12, P659, DOI 10.1037/a0027975; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; STEWART DA, 1991, BIRTH DEF, V26, P131; Sze JA, 2010, EMOTION, V10, P803, DOI 10.1037/a0020146; Tani P, 2004, NEUROPSYCHOBIOLOGY, V49, P64, DOI 10.1159/000076412; Tartaglia Nicole, 2010, Pediatr Endocrinol Rev, V8 Suppl 1, P151; van Rijn S, 2006, SCHIZOPHR RES, V84, P194, DOI 10.1016/j.schres.2006.02.020; van Rijn S, J AUTISM DE IN PRESS; van Rijn S, 2008, J AUTISM DEV DISORD, V38, P1634, DOI 10.1007/s10803-008-0542-1; van Rijn S, 2007, J INT NEUROPSYCH SOC, V13, P1065, DOI 10.1017/S1355617707071044; van 't Wout M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005581; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Visootsak J, 2009, DEV DISABIL RES REV, V15, P328, DOI 10.1002/ddrr.76; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; Wechsler D., 1997, WECHSLER ADULT INTEL; Wechsler D., 2005, WECHSLER ADULT INTEL; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5	77	28	28	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84721	10.1371/journal.pone.0084721	http://dx.doi.org/10.1371/journal.pone.0084721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416272	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000329862500155
J	Kuhn, ML; Prachi, P; Minasov, G; Shuvalova, L; Ruan, J; Dubrovska, I; Winsor, J; Giraldi, M; Biagini, M; Liberatori, S; Savino, S; Bagnoli, F; Anderson, WF; Grandi, G				Kuhn, Misty L.; Prachi, Prachi; Minasov, George; Shuvalova, Ludmilla; Ruan, Jiapeng; Dubrovska, Ievgeniia; Winsor, James; Giraldi, Monica; Biagini, Massimiliano; Liberatori, Sabrina; Savino, Silvana; Bagnoli, Fabio; Anderson, Wayne F.; Grandi, Guido			Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP	FASEB JOURNAL			English	Article						immunogenicity; lantibiotic; abscess; pathogenesis; epidermin leader peptide processing serine protease; vaccine	LANTIBIOTIC GENE CLUSTERS; GROUP-B STREPTOCOCCI; SERINE-PROTEASE; GROUP-A; METHICILLIN-RESISTANT; LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURE; C5A PEPTIDASE; ANTIMICROBIAL RESISTANCE; REVERSE VACCINOLOGY	Despite the global medical needs associated with Staphylococcus aureus infections, no licensed vaccines are currently available. We identified and characterized a protein annotated as an epidermin leader peptide processing serine protease (EpiP), as a novel S. aureus vaccine candidate. In addition, we determined the structure of the recombinant protein (rEpiP) by X-ray crystallography. The crystal structure revealed that rEpiP was cleaved somewhere between residues 95 and 100, and we found that the cleavage occurs through an autocatalytic intramolecular mechanism. The protein expressed by S. aureus cells also appeared to undergo a similar processing event. To determine whether the protein acts as a serine protease, we mutated the hypothesized catalytic serine 393 residue to alanine, generating rEpiP-S393A. The crystal structure of this mutant protein showed that the polypeptide chain was not cleaved and was not interacting stably with the active site. Indeed, rEpiP-S393A was shown to be impaired in its protease activity. Mice vaccinated with rEpiP were protected from S. aureus infection (34% survival, P=0.0054). Moreover, the protective efficacy generated by rEpiP and rEpiP-S393A was comparable, implying that the noncleaving mutant could be used for vaccination purposes.-Kuhn, M. L., Prachi, P., Minasov, G., Shuvalova, L., Ruan, J., Dubrovska, I., Winsor, J., Giraldi, M., Biagini, M., Liberatori, S., Savino, S., Bagnoli, F., Anderson, W. F., Grandi, G. Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP.	[Kuhn, Misty L.; Minasov, George; Shuvalova, Ludmilla; Ruan, Jiapeng; Dubrovska, Ievgeniia; Winsor, James; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Prachi, Prachi; Giraldi, Monica; Biagini, Massimiliano; Liberatori, Sabrina; Savino, Silvana; Bagnoli, Fabio; Grandi, Guido] Novartis Vaccines & Diagnost, Res Ctr, Siena, Italy	Northwestern University; Feinberg School of Medicine; Novartis	Grandi, G (corresponding author), Novartis Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	wf-anderson@northwestern.edu; guido.grandi@novartis.com	Liberatori, Sabrina/GYU-1878-2022	Liberatori, Sabrina/0000-0003-3524-0429; Minasov, George/0000-0001-5460-3462; Grandi, Guido/0000-0001-9724-2185; Winsor, James/0000-0002-9673-4839	U.S. DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P100817]; U.S. National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health, U.S. Department of Health and Human Services [HHSN272200700058C, HHSN272201200026C]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	U.S. DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; U.S. National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health, U.S. Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Elisabetta Sabini for her tireless efforts and organization to enable a productive collaboration between our groups. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory (Argonne, IL, USA), was supported by the U.S. DOE under contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and Michigan Technology Tri-Corridor (grant 085P100817). This project has been funded in whole or in part with federal funds from the U.S. National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health, U.S. Department of Health and Human Services, under contracts HHSN272200700058C and HHSN272201200026C. The authors are grateful to Dr. Ravi P. N Mishra, Dr. Luigi Fiaschi, and Dr. Fabiana Falugi for their contribution in antigen identification and cloning and RNA extraction and real-time PCR experiments.	Andrews T, 2003, CLIN MICROBIOL REV, V16, P597, DOI 10.1128/CMR.16.4.597-621.2003; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Atkins KL, 2008, MOL IMMUNOL, V45, P1600, DOI 10.1016/j.molimm.2007.10.021; AUGUSTIN J, 1992, EUR J BIOCHEM, V204, P1149, DOI 10.1111/j.1432-1033.1992.tb16740.x; Bagnoli F, 2011, OMICS, V15, P545, DOI 10.1089/omi.2010.0127; Bethe G, 2001, FEMS MICROBIOL LETT, V205, P99, DOI 10.1016/S0378-1097(01)00453-0; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; CHAVIRA R, 1984, ANAL BIOCHEM, V136, P446, DOI 10.1016/0003-2697(84)90242-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng Q, 2002, INFECT IMMUN, V70, P6409, DOI 10.1128/IAI.70.11.6409-6415.2002; Cleary PP, 2004, VACCINE, V22, P4332, DOI 10.1016/j.vaccine.2004.04.030; Comellas-Bigler M, 2004, STRUCTURE, V12, P1313, DOI 10.1016/j.str.2004.04.013; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Daly KM, 2010, J BACTERIOL, V192, P1131, DOI 10.1128/JB.01375-09; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGELKE G, 1994, APPL ENVIRON MICROB, V60, P814, DOI 10.1128/AEM.60.3.814-825.1994; Foophow T, 2010, J MOL BIOL, V400, P865, DOI 10.1016/j.jmb.2010.05.064; Geissler S, 1996, J BACTERIOL, V178, P284, DOI 10.1128/jb.178.1.284-288.1996; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Houssen WE, 2012, CHEMBIOCHEM, V13, P2683, DOI 10.1002/cbic.201200661; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Ji YD, 1997, INFECT IMMUN, V65, P2080, DOI 10.1128/IAI.65.6.2080-2087.1997; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kennan RM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001210; Kies S, 2003, PEPTIDES, V24, P329, DOI 10.1016/S0196-9781(03)00046-9; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kuhn ML, 2013, PROTEIN SCI, V22, P222, DOI 10.1002/pro.2199; Kuhn P, 1998, BIOCHEMISTRY-US, V37, P13446, DOI 10.1021/bi9813983; KUIPERS OP, 1993, FEBS LETT, V330, P23, DOI 10.1016/0014-5793(93)80911-D; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marsh AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-679; Maskalyk J, 2002, CAN MED ASSOC J, V167, P375; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Millard CS, 2003, PROTEIN EXPRES PURIF, V29, P311, DOI 10.1016/S1046-5928(03)00063-9; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mishra RPN, 2012, J INFECT DIS, V206, P1041, DOI 10.1093/infdis/jis463; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otto M, 2001, RES MICROBIOL, V152, P351, DOI 10.1016/S0923-2508(01)01206-2; Palumbo E, 2012, METHODS MOL BIOL, V799, P361, DOI 10.1007/978-1-61779-346-2_21; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Patti JM, 2011, EXPERT REV ANTI-INFE, V9, P845, DOI [10.1586/ERI.11.99, 10.1586/eri.11.99]; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Rybak MJ, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161010-00001; SAHAI J, 1989, NEW ENGL J MED, V321, P1342; Santillan DA, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.003; SCHNELL N, 1992, EUR J BIOCHEM, V204, P57, DOI 10.1111/j.1432-1033.1992.tb16605.x; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Shorr AF, 2007, PHARMACOECONOMICS, V25, P751, DOI 10.2165/00019053-200725090-00004; Siezen RJ, 1996, ANTON LEEUW INT J G, V69, P171, DOI 10.1007/BF00399422; Smith L, 2008, CURR OPIN MICROBIOL, V11, P401, DOI 10.1016/j.mib.2008.09.008; Smith TL, 1999, MICROBES INFECT, V1, P795, DOI 10.1016/S1286-4579(99)80082-3; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tanaka SI, 2007, J MOL BIOL, V372, P1055, DOI 10.1016/j.jmb.2007.07.027; ten Broeke-Smits NJP, 2010, NUCLEIC ACIDS RES, V38, P3263, DOI 10.1093/nar/gkq058; Turner CE, 2009, VACCINE, V27, P4923, DOI 10.1016/j.vaccine.2009.06.042; Turner DPJ, 2002, INFECT IMMUN, V70, P4447, DOI 10.1128/IAI.70.8.4447-4461.2002; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VANDERMEER JR, 1993, J BACTERIOL, V175, P2578, DOI 10.1128/JB.175.9.2578-2588.1993; Webb Glenn F., 2010, Journal of Biological Dynamics, V4, P115, DOI 10.1080/17513750903026411; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9; Zingaretti C, 2010, FASEB J, V24, P2839, DOI 10.1096/fj.09-145631; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	75	13	14	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1780	1793		10.1096/fj.13-241737	http://dx.doi.org/10.1096/fj.13-241737			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24421400	Green Published			2022-12-25	WOS:000335344300024
J	Stewart, A; Maity, B; Wunsch, AM; Meng, FT; Wu, Q; Wemmie, JA; Fisher, RA				Stewart, Adele; Maity, Biswanath; Wunsch, Amanda M.; Meng, Fantao; Wu, Qi; Wemmie, John A.; Fisher, Rory A.			Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT1A receptor-adenylyl cyclase axis	FASEB JOURNAL			English	Article						cAMP; animal behavior; mood disorders; SSRIs; GPCRs	ANIMAL-MODELS; EXPRESSION; COORDINATION; ASSOCIATION; HIPPOCAMPUS; INHIBITION; MODULATOR; BEHAVIOR; AGONISTS; BRAIN	Targeting serotonin (5-HT) bioavailability with selective 5-HT reuptake inhibitors (SSRIs) remains the most widely used treatment for mood disorders. However, their limited efficacy, delayed onset of action, and side effects restrict their clinical utility. Endogenous regulator of G-protein signaling (RGS) proteins have been implicated as key inhibitors of 5-HT(1A)Rs, whose activation is believed to underlie the beneficial effects of SSRIs, but the identity of the specific RGS proteins involved remains unknown. We identify RGS6 as the critical negative regulator of 5-HT1AR-dependent antidepressant actions. RGS6 is enriched in hippocampal and cortical neurons, 5-HT1AR-expressing cells implicated in mood disorders. RGS6(-/-) mice exhibit spontaneous anxiolytic and antidepressant behavior rapidly and completely reversibly by 5-HT1AR blockade. Effects of the SSRI fluvoxamine and 5-HT1AR agonist 8-OH-DPAT were also potentiated in RGS6(+/-) mice. The phenotype of RGS6(-/-) mice was associated with decreased CREB phosphorylation in the hippocampus and cortex, implicating enhanced G alpha(i)-dependent adenylyl cyclase inhibition as a possible causative factor in the behavior observed in RGS6(-/-) animals. Our results demonstrate that by inhibiting serotonergic innervation of the cortical-limbic neuronal circuit, RGS6 exerts powerful anxiogenic and prodepressant actions. These findings indicate that RGS6 inhibition may represent a viable means to treat mood disorders or enhance the efficacy of serotonergic agents.-Stewart, A., Maity, B., Wunsch, A. M., Meng, F., Wu, Q., Wemmie, J. A., Fisher, R. A. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT1A receptor-adenylyl cyclase axis.	[Stewart, Adele; Maity, Biswanath; Meng, Fantao; Wu, Qi; Fisher, Rory A.] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Wunsch, Amanda M.; Wemmie, John A.] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Wemmie, John A.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Fisher, RA (corresponding author), Univ Iowa, Carver Coll Med, Dept Pharmacol, 51 Newton Rd,BSB 2-512, Iowa City, IA 52242 USA.	rory-fisher@uiowa.edu		Fisher, Rory/0000-0003-3108-4836; Wemmie, John/0000-0001-7531-9065; Wunsch, Amanda/0000-0002-2292-439X; Stewart, Adele/0000-0003-4968-2471	U.S. National Institutes of Health [CA-161882]; U.S. Department of Veterans Affairs (Merit Award); U.S. National Institute of Mental Health [1R01MH085724-01]; U.S. National Heart, Lung, and Blood Institute [5 R01 HL113863-01]; McKnight Neuroscience of Brain Disorders Award; PhRMA Foundation; University of Iowa Graduate College; NATIONAL CANCER INSTITUTE [R01CA161882] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085724] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000741] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs (Merit Award)(US Department of Veterans Affairs); U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); McKnight Neuroscience of Brain Disorders Award; PhRMA Foundation; University of Iowa Graduate College; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Chantal Allamargot and the University of Iowa Central Microscopy Research Facility for their assistance with acquisition of confocal microscopy images. This work was supported by U.S. National Institutes of Health grant CA-161882 (R.A.F.). J.A.W. was supported by the U.S. Department of Veterans Affairs (Merit Award), the U.S. National Institute of Mental Health (1R01MH085724-01), the U.S. National Heart, Lung, and Blood Institute (5 R01 HL113863-01), and a McKnight Neuroscience of Brain Disorders Award. A.S. is the recipient of a Predoctoral Fellowship in Pharmacology/Toxicology from the PhRMA Foundation and a Presidential Fellowship from the University of Iowa Graduate College. The authors declare no conflicts of interest.	Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Beyer CE, 2004, BRAIN RES, V1022, P214, DOI 10.1016/j.brainres.2004.06.073; Blendy JA, 2006, BIOL PSYCHIAT, V59, P1144, DOI 10.1016/j.biopsych.2005.11.003; Blundell J, 2008, BRAIN RES, V1190, P78, DOI 10.1016/j.brainres.2007.11.017; Chao PT, 2011, CELL METAB, V13, P573, DOI 10.1016/j.cmet.2011.02.019; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; Clarke WP, 1996, J PHARMACOL EXP THER, V277, P1259; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; DUNN RW, 1989, EUR J PHARMACOL, V169, P1, DOI 10.1016/0014-2999(89)90811-X; Gao XJ, 2008, GENOMICS, V92, P457, DOI 10.1016/j.ygeno.2008.08.013; Ghavami A, 2004, CELL SIGNAL, V16, P711, DOI 10.1016/j.cellsig.2003.11.006; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gu ZL, 2007, MOL PHARMACOL, V71, P1030, DOI 10.1124/mol.106.032490; Hettema JM, 2013, PSYCHIAT GENET, V23, P92, DOI 10.1097/YPG.0b013e32835d70b3; Hohoff C, 2009, J NEURAL TRANSM, V116, P1523, DOI 10.1007/s00702-008-0097-5; Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06; KOSTOWSKI W, 1992, PHARMACOL TOXICOL, V71, P24, DOI 10.1111/j.1600-0773.1992.tb00515.x; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Leygraf A, 2006, J NEURAL TRANSM, V113, P1921, DOI 10.1007/s00702-006-0484-8; Lifschytz T, 2012, INT J NEUROPSYCHOPH, V15, P1307, DOI 10.1017/S1461145711001453; Maity B, 2012, J BIOL CHEM, V287, P4972, DOI 10.1074/jbc.M111.297218; MATSUDA T, 1995, EUR J PHARMACOL, V280, P235, DOI 10.1016/0014-2999(95)00254-I; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; POMPEIANO M, 1992, J NEUROSCI, V12, P440; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Richardson-Jones JW, 2011, J NEUROSCI, V31, P6008, DOI 10.1523/JNEUROSCI.5836-10.2011; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stratinaki M, 2013, P NATL ACAD SCI USA, V110, P8254, DOI 10.1073/pnas.1214696110; Talbot JN, 2010, P NATL ACAD SCI USA, V107, P11086, DOI 10.1073/pnas.1000003107; Terzi D, 2009, PROG MOL BIOL TRANSL, V86, P299, DOI 10.1016/S1877-1173(09)86010-9; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220	38	35	37	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1735	1744		10.1096/fj.13-235648	http://dx.doi.org/10.1096/fj.13-235648			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24421401	Green Published			2022-12-25	WOS:000335344300020
J	Jia, XY; Schulte, L; Loukas, A; Pickering, D; Pearson, M; Mobli, M; Jones, A; Rosengren, KJ; Daly, NL; Gobert, GN; Jones, MK; Craik, DJ; Mulvenna, J				Jia, Xinying; Schulte, Leigh; Loukas, Alex; Pickering, Darren; Pearson, Mark; Mobli, Mehdi; Jones, Alun; Rosengren, Karl J.; Daly, Norelle L.; Gobert, Geoffrey N.; Jones, Malcolm K.; Craik, David J.; Mulvenna, Jason			Solution Structure, Membrane Interactions, and Protein Binding Partners of the Tetraspanin Sm-TSP-2, a Vaccine Antigen from the Human Blood Fluke Schistosoma mansoni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Proteins; Protein Structure; Proteomics; Tetraspanins; Vaccines; Schistosoma mansoni; Schistosomiasis	EXTRACELLULAR DOMAIN; CALPAIN; CELL; INFECTION; EXOSOMES; SURFACE; FUSION; REPAIR	Background: Schistosome tetraspanin Sm-TSP-2 is a vaccine antigen. Results: We describe the structure of the large extracellular domain of Sm-TSP-2, develop a model of its interactions with Tetraspanin-enriched-microdomain proteins and plasma membrane, and identify TEM constituents. Conclusion: Structural conservation of the domain means this model is likely applicable to TSPs in general. Significance: Tetraspanin-enriched-microdomain proteins provide further targets for multiplex vaccines and/or novel drug targets. The tetraspanins (TSPs) are a family of integral membrane proteins that are ubiquitously expressed at the surface of eukaryotic cells. TSPs mediate a range of processes at the surface of the plasma membrane by providing a scaffold for the assembly of protein complexes known as tetraspanin-enriched microdomains (TEMs). We report here the structure of the surface-exposed EC2 domain from Sm-TSP-2, a TSP from Schistosoma mansoni and one of the better prospects for the development of a vaccine against schistosomiasis. This is the first solution structure of this domain, and our investigations of its interactions with lipid micelles provide a general model for interactions between TSPs, membranes, and other proteins. Using chemical cross-linking, eight potential protein constituents of Sm-TSP-2-mediated TEMs were also identified. These include proteins important for membrane maintenance and repair, providing further evidence for the functional role of Sm-TSP-2- and Sm-TSP-2-mediated TEMs. The identification of calpain, Sm29, and fructose-bisphosphate aldolase, themselves potential vaccine antigens, suggests that the Sm-TSP-2-mediated TEMs could be disrupted via multiple targets. The identification of further Sm-TSP-2-mediated TEM proteins increases the available candidates for multiplex vaccines and/or novel drugs targeting TEMs in the schistosome tegument.	[Jia, Xinying; Schulte, Leigh; Gobert, Geoffrey N.; Jones, Malcolm K.; Mulvenna, Jason] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Schulte, Leigh; Jones, Malcolm K.] Univ Queensland, Sch Vet Sci, Gatton, Qld 4343, Australia; [Loukas, Alex; Pickering, Darren; Pearson, Mark; Daly, Norelle L.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Queensland Trop Hlth Alliance, Cairns, Qld 4878, Australia; [Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [Jones, Alun; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Rosengren, Karl J.; Mulvenna, Jason] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; James Cook University; University of Queensland; University of Queensland; University of Queensland	Mulvenna, J (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia.	Jason.Mulvenna@qimrberghofer.edu.au	Jia, Xinying/B-8949-2016; Gobert, Geoffrey/V-2985-2019; Craik, David/B-1695-2010; Mobli, Mehdi/O-7244-2014; Daly, Norelle L/D-4302-2013; Mulvenna, Jason/H-7110-2014; Rosengren, K. Johan/P-4450-2016; Pearson, Mark S/O-5636-2014; Jones, Malcolm K/A-1097-2009; Loukas, Alex/B-7355-2014	Jia, Xinying/0000-0003-0133-8321; Craik, David/0000-0003-0007-6796; Mobli, Mehdi/0000-0003-2420-4262; Daly, Norelle L/0000-0002-4697-6602; Mulvenna, Jason/0000-0003-3521-8061; Rosengren, K. Johan/0000-0002-5007-8434; Jones, Malcolm K/0000-0002-0035-6141; Pearson, Mark/0000-0002-0002-1544; Gobert, Geoffrey/0000-0001-5884-6453; Loukas, Alex/0000-0002-0896-8441	National Health and Medical Research Council, Australia (NHMRC) [613682]; National Health and Medical Research Council	National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council, Australia (NHMRC) Project Grant 613682.; Supported by Career Development Fellowships from the National Health and Medical Research Council.	ALLAN D, 1987, MOL BIOCHEM PARASIT, V23, P123, DOI 10.1016/0166-6851(87)90147-2; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Bader R., 2008, PROTEIN SCI ENCY, P95; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bax Ad, 2011, J Magn Reson, V213, P442, DOI 10.1016/j.jmr.2011.08.003; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; Cardoso FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000308; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Drummer HE, 2005, BIOCHEM BIOPH RES CO, V328, P251, DOI 10.1016/j.bbrc.2004.12.160; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gobert GN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000600; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hofmann A, 2010, BIOESSAYS, V32, P967, DOI 10.1002/bies.200900195; Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kovalenko OV, 2004, BIOCHEM J, V377, P407, DOI 10.1042/BJ20031037; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lohr F, 2007, J BIOMOL NMR, V37, P205, DOI 10.1007/s10858-006-9128-4; Loukas A, 2007, INT J PARASITOL, V37, P257, DOI 10.1016/j.ijpara.2006.12.001; Loukas A, 2011, OMICS, V15, P567, DOI 10.1089/omi.2010.0150; Marcilla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045974; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marques HH, 2008, IMMUNOBIOLOGY, V213, P437, DOI 10.1016/j.imbio.2007.10.002; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mobli M, 2007, NAT METHODS, V4, P467, DOI 10.1038/nmeth0607-467; Mobli M, 2010, J MAGN RESON, V204, P160, DOI 10.1016/j.jmr.2010.02.012; Mulvenna J, 2010, INT J PARASITOL, V40, P543, DOI 10.1016/j.ijpara.2009.10.002; PARTEARROYO MA, 1988, BIOCHEM INT, V16, P259; Rajesh S, 2012, J VIROL, V86, P9606, DOI 10.1128/JVI.00559-12; Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SIDDIQUI AA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P37, DOI 10.1016/0925-4439(93)90087-H; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tao H, 2010, BIOTECHNIQUES, V48, P61, DOI 10.2144/000113304; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Tran MH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000840; van Balkom BWM, 2005, J PROTEOME RES, V4, P958, DOI 10.1021/pr050036w; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Zhang RL, 2001, INFECT IMMUN, V69, P386, DOI 10.1128/IAI.69.1.386-391.2001; Zoller M, 2006, Z GASTROENTEROL, V44, P573, DOI 10.1055/s-2006-926795	60	23	24	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7151	7163		10.1074/jbc.M113.531558	http://dx.doi.org/10.1074/jbc.M113.531558			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24429291	Green Published, hybrid			2022-12-25	WOS:000332389400074
J	Dorval, V; Mandemakers, W; Jolivette, F; Coudert, L; Mazroui, R; De Strooper, B; Hebert, SS				Dorval, Veronique; Mandemakers, Wim; Jolivette, Francis; Coudert, Laetitia; Mazroui, Rachid; De Strooper, Bart; Hebert, Sebastien S.			Gene and MicroRNA Transcriptome Analysis of Parkinson's Related LRRK2 Mouse Models	PLOS ONE			English	Article							KINASE 2 LRRK2; TRANSLATIONAL REPRESSION; EXPRESSION; PROTEIN; ASSOCIATION; BRAIN; MUTATIONS; RESPONSES; DISEASE	Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most frequent cause of genetic Parkinson's disease (PD). The biological function of LRRK2 and how mutations lead to disease remain poorly defined. It has been proposed that LRRK2 could function in gene transcription regulation; however, this issue remains controversial. Here, we investigated in parallel gene and microRNA (miRNA) transcriptome profiles of three different LRRK2 mouse models. Striatal tissue was isolated from adult LRRK2 knockout (KO) mice, as well as mice expressing human LRRK2 wildtype (hLRRK2-WT) or the PD-associated R1441G mutation (hLRRK2-R1441G). We identified a total of 761 genes and 24 miRNAs that were misregulated in the absence of LRRK2 when a false discovery rate of 0.2 was applied. Notably, most changes in gene expression were modest (i.e., <2 fold). By real-time quantitative RT-PCR, we confirmed the variations of selected genes (e. g., adra2, syt2, opalin) and miRNAs (e. g., miR-16, miR-25). Surprisingly, little or no changes in gene expression were observed in mice expressing hLRRK2-WT or hLRRK2-R1441G when compared to non-transgenic controls. Nevertheless, a number of miRNAs were misexpressed in these models. Bioinformatics analysis identified several miRNA-dependent and independent networks dysregulated in LRRK2-deficient mice, including PD-related pathways. These results suggest that brain LRRK2 plays an overall modest role in gene transcription regulation in mammals; however, these effects seem context and RNA type-dependent. Our data thus set the stage for future investigations regarding LRRK2 function in PD development.	[Dorval, Veronique; Jolivette, Francis; Coudert, Laetitia; Mazroui, Rachid; Hebert, Sebastien S.] CHUL, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada; [Dorval, Veronique; Jolivette, Francis; Hebert, Sebastien S.] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Coudert, Laetitia; Mazroui, Rachid] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Quebec City, PQ, Canada; [Mandemakers, Wim; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Mandemakers, Wim; De Strooper, Bart] VIB, Dept Mol & Dev Genet, Louvain, Belgium	Laval University; Laval University; Laval University; KU Leuven; Flanders Institute for Biotechnology (VIB)	Dorval, V (corresponding author), CHUL, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada.	veronique.dorval@crchul.ulaval.ca; Sebastien.hebert@neurosciences.ulaval.ca	de+Strooper, Bart/Z-1638-2019; Hébert, Sébastien S./Q-2729-2017	Mandemakers, Wim/0000-0003-2673-5972; Hebert, Sebastien/0000-0002-0391-9325	Natural Sciences and Engineering Research Council of Canada; Fonds de recherche du Quebec - Sante; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Fonds de recherche du Quebec - Sante, and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bailey RM, 2013, ACTA NEUROPATHOL; Bandmann O, 2012, NEUROLOGY, V78, P772, DOI 10.1212/WNL.0b013e318249f744; Baptista MAS, 2013, DIS MODEL MECH, V6, P1316, DOI 10.1242/dmm.011940; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Chartier-Harlin MC, 2011, AM J HUM GENET, V89, P398, DOI 10.1016/j.ajhg.2011.08.009; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Davies P, 2013, BIOCHEM J, V453, P101, DOI 10.1042/BJ20121742; Devine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022489; Dickson D. W., 2012, COLD SPRING HARB PER, V2; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dorval V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044060; Dorval Veronique, 2012, Front Neurol, V3, P12, DOI 10.3389/fneur.2012.00012; Ferree A, 2012, NEURODEGENER DIS, V10, P238, DOI 10.1159/000332599; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Funayama M, 2005, ANN NEUROL, V57, P918, DOI 10.1002/ana.20484; Gareau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055342; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Granic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060718; Habig K, 2008, NEUROGENETICS, V9, P83, DOI 10.1007/s10048-007-0114-0; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80; Kawakami F, 2013, FEBS J; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li TX, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/942412; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mandemakers W, 2012, NEUROBIOL DIS, V48, P582, DOI 10.1016/j.nbd.2012.07.017; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Meister G, 2013, NAT REV GENET; Molotski N, 2012, RNA, V18, P1612, DOI 10.1261/rna.033142.112; Nadler JJ, 2006, GENETICS, V174, P1229, DOI 10.1534/genetics.106.061481; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Nikonova EV, 2012, HUM MOL GENET, V21, P163, DOI 10.1093/hmg/ddr451; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Schulz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020820; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smith PY, 2011, HUM MOL GENET, V20, P4016, DOI 10.1093/hmg/ddr330; Trancikova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047784; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062	47	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85510	10.1371/journal.pone.0085510	http://dx.doi.org/10.1371/journal.pone.0085510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427314	gold, Green Published, Green Submitted			2022-12-25	WOS:000329868200055
J	Xu, YJ; Gong, W; Peng, J; Wang, HR; Huang, J; Ding, H; Wang, DW				Xu, Yujun; Gong, Wei; Peng, Jia; Wang, Haoran; Huang, Jin; Ding, Hu; Wang, Dao Wen			Functional Analysis LRP6 Novel Mutations in Patients with Coronary Artery Disease	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; MUSCLE-CELL PROLIFERATION; LOW-DENSITY-LIPOPROTEIN; BETA-CATENIN; ATHEROSCLEROSIS; ANGIOGENESIS; MECHANISMS; VARIANTS; PATHWAYS; FAMILY	Background: Genetic architecture of coronary artery disease (CAD) is still to be defined. Since low density lipoprotein receptor-related protein 6 (LRP6) gene play critical roles in Wnt signal transduction which are important for vascular development and endodermis specification, we therefore resequenced it to search for mutations in CAD patients. Methods: We systemically sequenced all the exons and promoter region of LRP6 gene in a sample of 380 early onset CAD patients and 380 control subjects in Chinese. Results: In total, we identified 5 patient-specific mutations including K82N (two patients), S488Y (one patient), P1066T (two patients), P1206H (two patients) and I1264V (one patient) All these mutations located at the extracellular domain of LRP6 gene. In vitro functional analysis of patient-specific mutations demonstrated that these mutations resulted in a significant reduction in both protein level transporting to cell membrane and downstream Wnt signal activity. Furthermore, we found that LRP6 novel mutations attenuated proliferation and migration of human umbilical vein endothelial cells (HUVECs) when compared with wild type (WT) LRP6. Conclusion: Our results demonstrated that these loss-of-function variants might contribute to disease liability in a subset of CAD and defects in Wnt signal activation might be important contributing factors for the onset of CAD.	[Xu, Yujun; Gong, Wei; Peng, Jia; Wang, Haoran; Huang, Jin; Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Hypertens, Wuhan 430074, Peoples R China; [Xu, Yujun; Gong, Wei; Peng, Jia; Wang, Haoran; Huang, Jin; Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China; [Xu, Yujun] Sichuan Univ, West China Hosp, Intens Care Unit, Chengdu 610064, Peoples R China; [Peng, Jia] Sichuan Prov Hosp, Echocardiog Lab, Chengdu, Peoples R China; [Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Genet Diag Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Sichuan University; Huazhong University of Science & Technology	Ding, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Hypertens, Wuhan 430074, Peoples R China.	dingo8369@163.com; dwwang@tjh.tjmu.edu.cn	Wang, Haoran/ABC-6993-2021; huang, jin/GRY-1978-2022	Wang, Haoran/0000-0002-5534-6610; Wang, Dao Wen/0000-0002-9774-3980; ding, hu/0000-0002-1814-1552	973 program [2012CB518004]; 863 program [2012AA02A510]; National Nature Science Foundation of China [81100066]; Key Project of Health Ministration	973 program(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Health Ministration	This work was supported by 973 program (No. 2012CB518004), 863 program (No. 2012AA02A510), National Nature Science Foundation of China (No. 81100066) and Key Project of Health Ministration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedel A, 2008, CIRC RES, V103, P694, DOI 10.1161/CIRCRESAHA.107.166405; Bilkovski R, 2011, INT J OBESITY, V35, P1450, DOI 10.1038/ijo.2011.6; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Ding H, 2010, CIRC RES, V106, P1145, DOI 10.1161/CIRCRESAHA.109.215616; Francis AA, 2011, EXP CLIN CARDIOL, V16, P77; Gelfand BD, 2011, ARTERIOSCL THROM VAS, V31, P1625, DOI 10.1161/ATVBAHA.111.227827; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Keramati AR, 2011, P NATL ACAD SCI USA, V108, P1914, DOI 10.1073/pnas.1019443108; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Sarzani R, 2011, NUTR METAB CARDIOVAS, V21, P150, DOI 10.1016/j.numecd.2009.08.004; Schunkert H, 2010, EUR HEART J, V31, P918, DOI 10.1093/eurheartj/ehq038; Smadja DM, 2010, ARTERIOSCL THROM VAS, V30, P2544, DOI 10.1161/ATVBAHA.110.213751; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tsaousi A, 2011, CURR OPIN LIPIDOL, V22, P350, DOI 10.1097/MOL.0b013e32834aa701; Tsaousi A, 2011, CIRC RES, V108, P427, DOI 10.1161/CIRCRESAHA.110.233999; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhu XF, 2010, GENET EPIDEMIOL, V34, P171, DOI 10.1002/gepi.20449	29	18	21	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84345	10.1371/journal.pone.0084345	http://dx.doi.org/10.1371/journal.pone.0084345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427284	gold, Green Submitted, Green Published			2022-12-25	WOS:000329868200024
J	Assefa, Z; Lavens, A; Steyaert, C; Stange, G; Martens, GA; Ling, ZD; Hellemans, K; Pipeleers, D				Assefa, Zerihun; Lavens, Astrid; Steyaert, Christophe; Stange, Geert; Martens, Geert A.; Ling, Zhidong; Hellemans, Karine; Pipeleers, Daniel			Glucose Regulates Rat Beta Cell Number through Age-Dependent Effects on Beta Cell Survival and Proliferation	PLOS ONE			English	Article							PANCREATIC B-CELLS; INSULIN-RESISTANCE; POTENTIAL ROLE; GROWTH-FACTORS; REPLICATION; CAPACITY; MICE; REGENERATION; GLUCOKINASE; SECRETION	Background: Glucose effects on beta cell survival and DNA-synthesis suggest a role as regulator of beta cell mass but data on beta cell numbers are lacking. We examined outcome of these influences on the number of beta cells isolated at different growth stages in their population. Methods: Beta cells from neonatal, young-adult and old rats were cultured serum-free for 15 days. Their number was counted by automated whole-well imaging distinguishing influences on cell survival and on proliferative activity. Results: Elevated glucose (10-20 versus 5 mmol/l) increased the number of living beta cells from 8-week rats to 30%, following a time-and concentration-dependent recruitment of quiescent cells into DNA-synthesis; a glucokinase-activator lowered the threshold but did not raise total numbers of glucose-recruitable cells. No glucose-induced increase occurred in beta cells from 40-week rats. Neonatal beta cells doubled in number at 5 mmol/l involving a larger activated fraction that did not increase at higher concentrations; however, their higher susceptibility to glucose toxicity at 20 mmol/l resulted in 20% lower living cell numbers than at start. None of the age groups exhibited a repetitively proliferating subpopulation. Conclusions: Chronically elevated glucose levels increased the number of beta cells from young-adult but not from old rats; they interfered with expansion of neonatal beta cells and reduced their number. These effects are attributed to age-dependent differences in basal and glucose-induced proliferative activity and in cellular susceptibility to glucose toxicity. They also reflect age-dependent variations in the functional heterogeneity of the rat beta cell population.	[Pipeleers, Daniel] Brussels Free Univ VUB, Diabet Res Ctr, Diabet Pathol & Therapy Unit, Brussels, Belgium; Brussels Free Univ VUB, Ctr Beta Cell Therapy, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel	Pipeleers, D (corresponding author), Brussels Free Univ VUB, Diabet Res Ctr, Diabet Pathol & Therapy Unit, Brussels, Belgium.	daniel.pipeleers@vub.ac.be	Assefa, Zerihun/V-5641-2017; Martens, Geert/ABA-6297-2020; Hellemans, Karine/B-7573-2013; stange, geert m/C-1092-2009; Martens, Geert A./F-6920-2015	Assefa, Zerihun/0000-0001-7803-5228; Martens, Geert/0000-0003-1208-6289; Hellemans, Karine/0000-0001-9306-4369; stange, geert m/0000-0003-3148-1372; Martens, Geert A./0000-0003-1208-6289; Pipeleers, Daniel/0000-0002-6440-2485	Belgian Science Policy (Interuniversity Attraction Poles phase VI) [IAP P6/40]; Agency for Innovation by Science and Technology in Flanders (IWT) [SBO/040084]; Research Foundation Flanders (FWO) [G.0428.09N, G.0400.07N]; VUB Research Council [IOF742]; IWT PhD fellowship; IWT Innovation Mandate	Belgian Science Policy (Interuniversity Attraction Poles phase VI); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); VUB Research Council; IWT PhD fellowship; IWT Innovation Mandate	This study was supported by grants from the Belgian Science Policy (Interuniversity Attraction Poles phase VI, IAP P6/40), the Agency for Innovation by Science and Technology in Flanders (IWT; SBO/040084), the Research Foundation Flanders (FWO; G.0428.09N, and G.0400.07N) and the VUB Research Council (IOF742). Z. A. is a recipient of an IWT Innovation Mandate and A. L. was supported by an IWT PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002; CHICK WL, 1973, DIABETES, V22, P687, DOI 10.2337/diab.22.9.687; Chintinne M, 2010, DIABETOLOGIA, V53, P2380, DOI 10.1007/s00125-010-1851-4; Dadon D, 2012, DIABETES OBES METAB, V14, P101, DOI 10.1111/j.1463-1326.2012.01646.x; Ferrer J, 2011, CELL METAB, V13, P357, DOI 10.1016/j.cmet.2011.03.014; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Gunasekaran U, 2012, CELL CYCLE, V11, P2431, DOI 10.4161/cc.20545; HEIMBERG H, 1993, EMBO J, V12, P2873, DOI 10.1002/j.1460-2075.1993.tb05949.x; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Hellemans KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007266; HELLERSTROM C, 1991, DIABETES, V40, P89, DOI 10.2337/diab.40.2.S89; Hija A, 2013, DIABETES IN PRESS; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; Jermendy A, 2011, DIABETOLOGIA, V54, P594, DOI 10.1007/s00125-010-2036-x; JETTON TL, 1992, P NATL ACAD SCI USA, V89, P2619, DOI 10.1073/pnas.89.7.2619; KIEKENS R, 1992, J CLIN INVEST, V89, P117, DOI 10.1172/JCI115551; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kwon G, 2006, J BIOL CHEM, V281, P3261, DOI 10.1074/jbc.M508821200; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; LING Z, 1994, DIABETOLOGIA, V37, P15; LING ZD, 1994, ENDOCRINOLOGY, V134, P2614, DOI 10.1210/en.134.6.2614; Liu YM, 2009, DIABETES OBES METAB, V11, P54, DOI 10.1111/j.1463-1326.2009.01107.x; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Martens GA, 2013, J MOL ENDOC IN PRESS; Martens GA, 2009, VITAM HORM, V80, P507, DOI 10.1016/S0083-6729(08)00617-1; Metukuri MR, 2012, DIABETES, V61, P2004, DOI 10.2337/db11-0802; Navarro-Tableros V, 2007, AM J PHYSIOL-ENDOC M, V292, pE1018, DOI 10.1152/ajpendo.00457.2006; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Parnaud G, 2009, MOL ENDOCRINOL, V23, P1264, DOI 10.1210/me.2009-0008; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P824, DOI 10.1210/endo-117-3-824; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Salpeter SJ, 2010, DEVELOPMENT, V137, P3205, DOI 10.1242/dev.054304; Stolovich-Rain M, 2012, J BIOL CHEM, V287, P27407, DOI 10.1074/jbc.M112.350736; SWENNE I, 1983, DIABETES, V32, P14, DOI 10.2337/diabetes.32.1.14; SWENNE I, 1982, DIABETES, V31, P754, DOI 10.2337/diab.31.9.754; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Wei P, 2009, DIABETOLOGIA, V52, P2142, DOI 10.1007/s00125-009-1446-0; Weir GC, 2007, J CLIN INVEST, V117, P81, DOI 10.1172/JCI30862	56	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85174	10.1371/journal.pone.0085174	http://dx.doi.org/10.1371/journal.pone.0085174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416358	gold, Green Published, Green Submitted			2022-12-25	WOS:000329866300053
J	Cui, F; Arnstein, D; Thomas, RM; Maurits, NM; Keysers, C; Gazzola, V				Cui, Fang; Arnstein, Dan; Thomas, Rajat Mani; Maurits, Natasha M.; Keysers, Christian; Gazzola, Valeria			Functional Magnetic Resonance Imaging Connectivity Analyses Reveal Efference-Copy to Primary Somatosensory Area, BA2	PLOS ONE			English	Article							INFERIOR PARIETAL; INTERINDIVIDUAL VARIABILITY; CYTOARCHITECTONIC MAPS; MOTOR CONTROL; CORTEX; MOVEMENTS; BRAIN; SUPPRESSION; PERCEPTION; PREDICTION	Some theories of motor control suggest efference-copies of motor commands reach somatosensory cortices. Here we used functional magnetic resonance imaging to test these models. We varied the amount of efference-copy signal by making participants squeeze a soft material either actively or passively. We found electromyographical recordings, an efference-copy proxy, to predict activity in primary somatosensory regions, in particular Brodmann Area (BA) 2. Partial correlation analyses confirmed that brain activity in cortical structures associated with motor control (premotor and supplementary motor cortices, the parietal area PF and the cerebellum) predicts brain activity in BA2 without being entirely mediated by activity in early somatosensory (BA3b) cortex. Our study therefore provides valuable empirical evidence for efference-copy models of motor control, and shows that signals in BA2 can indeed reflect an input from motor cortices and suggests that we should interpret activations in BA2 as evidence for somatosensory-motor rather than somatosensory coding alone.	[Cui, Fang; Arnstein, Dan; Keysers, Christian; Gazzola, Valeria] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Cui, Fang; Arnstein, Dan; Keysers, Christian; Gazzola, Valeria] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Cui, Fang; Thomas, Rajat Mani; Keysers, Christian; Gazzola, Valeria] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Groningen	Gazzola, V (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands.	v.gazzola@nin.knaw.nl	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467; Maurits, Natasha/0000-0001-6231-7044; Gazzola, Valeria/0000-0003-0324-0619	European Commission; Dutch science foundation; N.W.O; Fulbright scholarship; China Scholarship Council for State Scholarship Fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch science foundation(Netherlands Organization for Scientific Research (NWO)); N.W.O(Netherlands Organization for Scientific Research (NWO)); Fulbright scholarship; China Scholarship Council for State Scholarship Fund(China Scholarship Council)	The work was supported by a Marie Curie Excellence Grant of the European Commission and a VIDI grant of the Dutch science foundation to CK (N.W.O.), a VENI grant of N.W.O.to VG, Fulbright scholarship to DA and the China Scholarship Council for State Scholarship Fund to FC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew Z, 2008, J NEUROSCI, V28, P12268, DOI 10.1523/JNEUROSCI.2836-08.2008; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Arnstein D, 2011, J NEUROSCI, V31, P14243, DOI 10.1523/JNEUROSCI.0963-11.2011; Banerjee O, 2006, CONVEX OPTIMIZATION; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Christensen MS, 2007, NAT NEUROSCI, V10, P417, DOI 10.1038/nn1873; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Geyer S, 2000, NEUROIMAGE, V11, P684, DOI 10.1006/nimg.2000.0548; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Geyer S, 2004, ADV ANATOMY EMBRYOLO, V174, pI; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; London BM, 2013, J NEUROPHYSIOL, V109, P1505, DOI 10.1152/jn.00372.2012; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MISTLIN AJ, 1990, EXP BRAIN RES, V82, P437; Myers LJ, 2003, J NEUROSCI METH, V124, P157, DOI 10.1016/S0165-0270(03)00004-9; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; PONS TP, 1986, J COMP NEUROL, V248, P313, DOI 10.1002/cne.902480303; Ramnani N, 2012, CEREBELLUM, V11, P366, DOI 10.1007/s12311-011-0272-3; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; van Duinen H, 2005, NEUROIMAGE, V27, P240, DOI 10.1016/j.neuroimage.2005.04.003; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; Van Rootselaar AF, 2007, HUM BRAIN MAPP, V28, P1117, DOI 10.1002/hbm.20336; Weber DJ, 2011, IEEE T NEUR SYS REH, V19, P501, DOI 10.1109/TNSRE.2011.2163145; Weiller C, 1996, NEUROIMAGE, V4, P105, DOI 10.1006/nimg.1996.0034; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	49	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84367	10.1371/journal.pone.0084367	http://dx.doi.org/10.1371/journal.pone.0084367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416222	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500119
J	de Boer, HJ; Ouarghidi, A; Martin, G; Abbad, A; Kool, A				de Boer, Hugo J.; Ouarghidi, Abderrahim; Martin, Gary; Abbad, Abdelaziz; Kool, Anneleen			DNA Barcoding Reveals Limited Accuracy of Identifications Based on Folk Taxonomy	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR-IDENTIFICATION; RETICULATE EVOLUTION; SEQUENCE; PLANTS; GENUS; BIOGEOGRAPHY; SELECTION	Background: The trade of plant roots as traditional medicine is an important source of income for many people around the world. Destructive harvesting practices threaten the existence of some plant species. Harvesters of medicinal roots identify the collected species according to their own folk taxonomies, but once the dried or powdered roots enter the chain of commercialization, accurate identification becomes more challenging. Methodology: A survey of morphological diversity among four root products traded in the medina of Marrakech was conducted. Fifty-one root samples were selected for molecular identification using DNA barcoding using three markers, trnH-psbA, rpoC1, and ITS. Sequences were searched using BLAST against a tailored reference database of Moroccan medicinal plants and their closest relatives submitted to NCBI GenBank. Principal Findings: Combining psbA-trnH, rpoC1, and ITS allowed the majority of the market samples to be identified to species level. Few of the species level barcoding identifications matched the scientific names given in the literature, including the most authoritative and widely cited pharmacopeia. Conclusions/Significance: The four root complexes selected from the medicinal plant products traded in Marrakech all comprise more than one species, but not those previously asserted. The findings have major implications for the monitoring of trade in endangered plant species as morphology-based species identifications alone may not be accurate. As a result, trade in certain species may be overestimated, whereas the commercialization of other species may not be recorded at all.	[de Boer, Hugo J.] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [de Boer, Hugo J.] Nat Biodivers Ctr, Leiden, Netherlands; [de Boer, Hugo J.; Kool, Anneleen] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Ouarghidi, Abderrahim; Abbad, Abdelaziz] Cadi Ayyad Univ, Fac Sci Semlalia, Marrakech, Morocco; [Ouarghidi, Abderrahim; Abbad, Abdelaziz] Global Div Fdn, Marrakech, Morocco	Uppsala University; Naturalis Biodiversity Center; University of Oslo; Cadi Ayyad University of Marrakech	Kool, A (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	anneleen.kool@nhm.uio.no	de Boer, Hugo/B-5640-2015; de Boer, Hugo Joris/AAS-7585-2020	de Boer, Hugo/0000-0003-1985-7859; de Boer, Hugo Joris/0000-0003-1985-7859	SRL-MENA grant from the Swedish Research Council; Sida; Formas	SRL-MENA grant from the Swedish Research Council(Swedish Research Council); Sida; Formas(Swedish Research Council Formas)	This study was funded through a SRL-MENA grant from the Swedish Research Council, Sida and Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARNASON U, 1991, HEREDITAS, V115, P183, DOI 10.1111/j.1601-5223.1991.tb03554.x; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Barthelson RA, 2006, AM J BOT, V93, P566, DOI 10.3732/ajb.93.4.566; BELLAKHDAR J, 1991, J ETHNOPHARMACOL, V35, P123, DOI 10.1016/0378-8741(91)90064-K; Bellakhdar J, 1997, PHARM MEROCAINE TRAD; Bellakhdar J, 1982, HERB DRUGS HERBALIST; BERLIN B, 1992, ETHNOBIOLOGICAL CLAS; Bertolazzi P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S7; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Boulos L., 1983, Medicinal plants of North Africa.; Brysting AK, 2007, SYST BIOL, V56, P467, DOI 10.1080/10635150701424553; Caldeira RL, 1998, MEM I OSWALDO CRUZ, V93, P219, DOI 10.1590/S0074-02761998000700039; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Cunningham AB, 1993, PEOPLE PLANTS WORKIN, V1, P1; DasGupa B, 2005, BIOINFORMATICS, V21, P3424, DOI 10.1093/bioinformatics/bti547; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dondoshansky I, 2002, BLASTCLUST NCBI SOFT; El-Hilaly J, 2003, J ETHNOPHARMACOL, V86, P149, DOI 10.1016/S0378-8741(03)00012-6; Eurlings MCM, 2010, FORENSIC SCI INT, V197, P30, DOI 10.1016/j.forsciint.2009.12.017; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fennane M., 1998, BOCCONEA, V8, P1; Fennane M, 2007, FLORE PRATIQUE MAROC, V2; Fennane M, 2005, FLORE VASCULAIRE MAR; Fennane M, 1999, TRAV I SCI RABAT, V1, P1; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GarnockJones PJ, 1996, PLANT SYST EVOL, V202, P211, DOI 10.1007/BF00983383; Hanelt P, 2001, MANSFELDS ENCY AGR H, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Humphries CJ, 1979, B BRIT MUS NAT HIST, V7, P83; Ibn Tattou M, 2008, FLORE VASCULAIRE MAR, V2; IUCN Centre for Mediterranean Cooperation, 2005, GUID MED PLANTS N AF; Ize-Ludlow D, 2004, PEDIATRICS, V114, pE653, DOI 10.1542/peds.2004-0058; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; LINARES E, 1987, J ETHNOPHARMACOL, V19, P153, DOI 10.1016/0378-8741(87)90039-0; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Munch K, 2008, SYSTEMATIC BIOL; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Ouarghidi A, 2007, THESIS CADI AYYAD U; Ouarghidi A, 2012, ECON BOT, V66, P370, DOI 10.1007/s12231-012-9215-2; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; RASMUSSEN U, 1981, PLANTA MED, V43, P336, DOI 10.1055/s-2007-971521; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RBG-K, 2007, ROYAL BOT GARD KEW D; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; SANG T, 1995, P NATL ACAD SCI USA, V92, P6813, DOI 10.1073/pnas.92.15.6813; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stull GW, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200497; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Valdes B, 2002, CATALOGUE PLANTES VA, V2; Valdes B, 2002, CATALOGUE PLANTES VA, V1; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Vanhaecke D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032939; White T., 1990, PCR PROTOCOLS GUIDE, P315; YOON CS, 1991, MYCOLOGIA, V83, P835, DOI 10.2307/3760446	70	37	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84291	10.1371/journal.pone.0084291	http://dx.doi.org/10.1371/journal.pone.0084291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416210	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500108
J	Gherasim, C; Yadav, PK; Kabil, O; Niu, WN; Banerjee, R				Gherasim, Carmen; Yadav, Pramod K.; Kabil, Omer; Niu, Wei-Ning; Banerjee, Ruma			Nitrite Reductase Activity and Inhibition of H2S Biogenesis by Human Cystathionine beta-Synthase	PLOS ONE			English	Article							HYDROGEN-SULFIDE; TRANSSULFURATION PATHWAY; HEME; OXIDE; NO; SYSTEMS; METHEMOGLOBIN; HEMOGLOBIN; CYTOGLOBIN; MAGNITUDE	Nitrite was recognized as a potent vasodilator >130 years and has more recently emerged as an endogenous signaling molecule and modulator of gene expression. Understanding the molecular mechanisms that regulate nitrite metabolism is essential for its use as a potential diagnostic marker as well as therapeutic agent for cardiovascular diseases. In this study, we have identified human cystathionine beta-synthase (CBS) as a new player in nitrite reduction with implications for the nitrite-dependent control of H2S production. This novel activity of CBS exploits the catalytic property of its unusual heme cofactor to reduce nitrite and generate NO. Evidence for the possible physiological relevance of this reaction is provided by the formation of ferrous-nitrosyl (Fe-II-NO) CBS in the presence of NADPH, the human diflavin methionine synthase reductase (MSR) and nitrite. Formation of Fe-II-NO CBS via its nitrite reductase activity inhibits CBS, providing an avenue for regulating biogenesis of H2S and cysteine, the limiting reagent for synthesis of glutathione, a major antioxidant. Our results also suggest a possible role for CBS in intracellular NO biogenesis particularly under hypoxic conditions. The participation of a regulatory heme cofactor in CBS in nitrite reduction is unexpected and expands the repertoire of proteins that can liberate NO from the intracellular nitrite pool. Our results reveal a potential molecular mechanism for cross-talk between nitrite, NO and H2S biology.	[Gherasim, Carmen; Yadav, Pramod K.; Kabil, Omer; Niu, Wei-Ning; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Niu, Wei-Ning] Northwestern Polytech Univ, Sch Life Sci, Xian 710072, Peoples R China	University of Michigan System; University of Michigan; Northwestern Polytechnical University	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Kabil, Omer/AAJ-1435-2020; Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684	National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a grant from the National Institutes of Health (HL58984). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; Basu S, 2008, J BIOL CHEM, V283, P32590, DOI 10.1074/jbc.M806934200; Benarroch EE, 2011, NEUROLOGY, V77, P1568, DOI 10.1212/WNL.0b013e318233b3e4; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Carballal S, 2013, BIOCHEMISTRY-US, V52, P4553, DOI 10.1021/bi4004556; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Fago A, 2012, COMP BIOCHEM PHYS A, V162, P1, DOI 10.1016/j.cbpa.2012.01.011; Filipovic MR, 2012, J AM CHEM SOC, V134, P12016, DOI 10.1021/ja3009693; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gherasim CG, 2008, BIOCHEMISTRY-US, V47, P12515, DOI 10.1021/bi8008328; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Hon YY, 2010, DRUG METAB DISPOS, V38, P1707, DOI 10.1124/dmd.110.034355; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Kabil O, 2013, ANTIOXID REDOX SIGNA; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; KERY V, 1994, J BIOL CHEM, V269, P25283; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kraus JP, 1999, HUM MUTAT, V13, P362; Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Sturms R, 2011, BIOCHEMISTRY-US, V50, P3873, DOI 10.1021/bi2004312; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1999, BIOCHEMISTRY-US, V38, P7406, DOI 10.1021/bi995077i; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2001, J INORG BIOCHEM, V87, P253, DOI 10.1016/S0162-0134(01)00336-1; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Vega-Villa K, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.35; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Yadav PK, 2013, J BIOL CHEM; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yi J, 2011, ACTA CRYSTALLOGR F, V67, P647, DOI 10.1107/S1744309111012528; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	60	36	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85544	10.1371/journal.pone.0085544	http://dx.doi.org/10.1371/journal.pone.0085544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416422	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500255
J	Jacobsen, PE; Henriksen, TB; Haubek, D; Ostergaard, JR				Jacobsen, Pernille E.; Henriksen, Tine B.; Haubek, Dorte; Ostergaard, John R.			Prenatal Exposure to Antiepileptic Drugs and Dental Agenesis	PLOS ONE			English	Article							GENETIC-BASIS; PREGNANCY; HYPODONTIA; PREVALENCE; ANOMALIES; MALFORMATIONS; TEETH	Objective: The aim of the study was to investigate the association between prenatal exposure to AEDs and the risk of dental agenesis and to differentiate between the possible effects of the different drugs used. Methods: Data on 214 exposed and 255 unexposed children, aged 12-18 years, were extracted from the Prescription Database of the Central Denmark Region and North Denmark Region and the Danish Medical Birth Registry. The children's dental charts were examined for the presence of dental agenesis. Results: Overall, children exposed to AED in utero had an increased risk of developing dental agenesis, but as a group, the difference was not significant (OR = 1.7; [95% CI: 0.8-3.6]). The risk of developing dental agenesis was three-fold increased (OR = 3.1; [95% CI: 1.3-7.4]) in children exposed to valproate in mono-or in poly-therapy with other AEDs than carbamazepine or oxcarbazepine. The risk was further increased (OR = 11.2; [95% CI: 2.4-51.9]) in children exposed to valproate and carbamazepine or oxcarbazepine in combination. Conclusions: The present study shows that dental agenesis is a potential congenital abnormality that is related to prenatal exposure to valproate, and dental agenesis may be considered a sensitive marker for the teratogenicity of valproate.	[Jacobsen, Pernille E.; Haubek, Dorte] Aarhus Univ, Dept Dent, Sect Pediat Dent, Aarhus, Denmark; [Henriksen, Tine B.] Aarhus Univ Hosp, Dept Pediat, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark; [Ostergaard, John R.] Aarhus Univ Hosp, Dept Pediat, Ctr Rare Dis, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Jacobsen, PE (corresponding author), Aarhus Univ, Dept Dent, Sect Pediat Dent, Aarhus, Denmark.	pej@odontologi.au.dk			Calcin Foundation from the Danish Dental Association; DOFT Foundation from the Association of Community Dental Service; Aarhus University Research Foundation	Calcin Foundation from the Danish Dental Association; DOFT Foundation from the Association of Community Dental Service; Aarhus University Research Foundation	The study was financially supported by the Calcin Foundation from the Danish Dental Association, the DOFT Foundation from the Association of Community Dental Service and the Aarhus University Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaluusua S, 2006, INT DENT J, V56, P323, DOI 10.1111/j.1875-595X.2006.tb00336.x; Andersen TF, 1999, DAN MED BULL, V46, P263; Bailleul-Forestier I, 2008, EUR J MED GENET, V51, P383, DOI 10.1016/j.ejmg.2008.05.003; BLAYNEY JR, 1967, J AM DENT ASSOC, V74, P233; Chuang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043692; CLAYTONSMITH J, 1995, J MED GENET, V32, P724, DOI 10.1136/jmg.32.9.724; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; Gaist D, 1997, DAN MED BULL, V44, P445; GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651; Helm S, 1973, Community Dent Oral Epidemiol, V1, P3, DOI 10.1111/j.1600-0528.1973.tb01055.x; Hvas CL, 2000, BRIT J OBSTET GYNAEC, V107, P896, DOI 10.1111/j.1471-0528.2000.tb11089.x; Jacobsen PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058213; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Jheon AH, 2013, WIRES DEV BIOL, V2, P165, DOI 10.1002/wdev.63; Kapdan A., 2012, EUROPEAN J DENT, V06, P178; KJAER I, 1994, EUR J ORTHODONT, V16, P371, DOI 10.1093/ejo/16.5.371; Kjaer I, 2012, INT J DENT, V2012, DOI 10.1155/2012/145749; Knudsen LB, 1998, DAN MED BULL, V45, P320; Knudsen P A, 1967, Tandlaegebladet, V71, P199; KNUDSEN PA, 1967, ACTA ODONTOL SCAND, V25, P267, DOI 10.3109/00016356709104023; Koo J, 2012, ORAL DIS, DOI [10.1111/odi.12061, DOI 10.1111/0DI.12061]; Kulkarni G, 2011, DENT HYPOTHESES, V2, P63; Lapter M, 1998, COLLEGIUM ANTROPOL, V22, P291; MAGNUSSON TE, 1984, ACTA ODONTOL SCAND, V42, P137, DOI 10.3109/00016358408993864; Marinelli A, 2012, ODONTOLOGY, V100, P22, DOI 10.1007/s10266-011-0021-6; Molgaard-Nielsen D, 2011, JAMA-J AM MED ASSOC, V305, P1996, DOI 10.1001/jama.2011.624; MULLER TP, 1970, J AM DENT ASSOC, V81, P101, DOI 10.14219/jada.archive.1970.0151; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Nik-Hussein N N, 1996, J Clin Pediatr Dent, V21, P15; Orup H I Jr, 2003, Orthod Craniofac Res, V6, P2, DOI 10.1046/j.1439-0280.2003.2o212.x; Orup HI, 1998, J CRAN GENET DEV BIO, V18, P129; Pedersen LB, 2012, INT J PAEDIATR DENT, V22, P239, DOI 10.1111/j.1365-263X.2011.01199.x; Pennell PB, 2008, EPILEPSIA, V49, P43, DOI 10.1111/j.1528-1167.2008.01926.x; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Rolling S, 2009, INT J PAEDIATR DENT, V19, P172, DOI 10.1111/j.1365-263X.2008.00958.x; Sabers Anne, 2009, Ugeskr Laeger, V171, P221; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Tomson T, 2012, LANCET NEUROL, V11, P803, DOI 10.1016/S1474-4422(12)70103-5; Townsend GC, 2005, AUST DENT J, V50, P95, DOI 10.1111/j.1834-7819.2005.tb00347.x; Vajda FJ, 2013, NEUROLOGY, V81, P999, DOI 10.1212/WNL.0b013e3182a43e81; Veiby G, 2009, EPILEPSIA, V50, P2130, DOI 10.1111/j.1528-1167.2009.02147.x; Wlodarczyk BJ, 2012, AM J MED GENET A, V158A, P2071, DOI 10.1002/ajmg.a.35438	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84420	10.1371/journal.pone.0084420	http://dx.doi.org/10.1371/journal.pone.0084420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416231	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500126
J	Sabarinathan, R; Wenzel, A; Novotny, P; Tang, XJ; Kalari, KR; Gorodkin, J				Sabarinathan, Radhakrishnan; Wenzel, Anne; Novotny, Peter; Tang, Xiaojia; Kalari, Krishna R.; Gorodkin, Jan			Transcriptome-Wide Analysis of UTRs in Non-Small Cell Lung Cancer Reveals Cancer-Related Genes with SNV-Induced Changes on RNA Secondary Structure and miRNA Target Sites	PLOS ONE			English	Article							DISEASE-ASSOCIATED SNPS; SOMATIC MUTATIONS; MICRORNA FUNCTION; KRAS MUTATIONS; GENOME; EXPRESSION; DATABASE; IDENTIFICATION; POLYMORPHISMS; DETERMINANTS	Traditional mutation assessment methods generally focus on predicting disruptive changes in protein-coding regions rather than non-coding regulatory regions like untranslated regions (UTRs) of mRNAs. The UTRs, however, are known to have many sequence and structural motifs that can regulate translational and transcriptional efficiency and stability of mRNAs through interaction with RNA-binding proteins and other non-coding RNAs like microRNAs (miRNAs). In a recent study, transcriptomes of tumor cells harboring mutant and wild-type KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) genes in patients with non-small cell lung cancer (NSCLC) have been sequenced to identify single nucleotide variations (SNVs). About 40% of the total SNVs (73,717) identified were mapped to UTRs, but omitted in the previous analysis. To meet this obvious demand for analysis of the UTRs, we designed a comprehensive pipeline to predict the effect of SNVs on two major regulatory elements, secondary structure and miRNA target sites. Out of 29,290 SNVs in 6462 genes, we predict 472 SNVs (in 408 genes) affecting local RNA secondary structure, 490 SNVs (in 447 genes) affecting miRNA target sites and 48 that do both. Together these disruptive SNVs were present in 803 different genes, out of which 188 (23.4%) were previously known to be cancer-associated. Notably, this ratio is significantly higher (one-sided Fisher's exact test p-value = 0.032) than the ratio (20.8%) of known cancer-associated genes (n = 1347) in our initial data set (n = 6462). Network analysis shows that the genes harboring disruptive SNVs were involved in molecular mechanisms of cancer, and the signaling pathways of LPS-stimulated MAPK, IL-6, iNOS, EIF2 and mTOR. In conclusion, we have found hundreds of SNVs which are highly disruptive with respect to changes in the secondary structure and miRNA target sites within UTRs. These changes hold the potential to alter the expression of known cancer genes or genes linked to cancer-associated pathways.	[Sabarinathan, Radhakrishnan; Wenzel, Anne; Gorodkin, Jan] Univ Copenhagen, Sect Anim Genet Bioinformat & Breeding, IKVH, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark; [Novotny, Peter] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Novotny, Peter] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Tang, Xiaojia; Kalari, Krishna R.] Mayo Clin, Dept Hlth Sci Res, Div Biostat & Bioinformat, Rochester, MN USA; [Kalari, Krishna R.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; Mayo Clinic; Mayo Clinic	Gorodkin, J (corresponding author), Univ Copenhagen, Sect Anim Genet Bioinformat & Breeding, IKVH, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark.	gorodkin@rth.dk	Jensen, Betina W/J-2207-2015	Tang, Xiaojia/0000-0003-2457-9953; Wenzel, Anne/0000-0001-6187-4156; Gorodkin, Jan/0000-0001-5823-4000; Kalari, Krishna/0000-0001-8944-8378; Sabarinathan, Radhakrishnan/0000-0001-8916-3954	Danish Center for Scientific Computing (DCSC, DeiC); Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies); Danish Council for Independent Research (Technology and Production Sciences)	Danish Center for Scientific Computing (DCSC, DeiC); Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies); Danish Council for Independent Research (Technology and Production Sciences)(Det Frie Forskningsrad (DFF))	Danish Center for Scientific Computing (DCSC, DeiC); Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies); Danish Council for Independent Research (Technology and Production Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Aouacheria A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-2; Arikawa E, 2011, SABIOSCIENCES; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya A, 2013, NUCLEIC ACIDS RES, V41, pD977, DOI 10.1093/nar/gks1138; Bruno AE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-44; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chen XS, 2012, NUCLEIC ACIDS RES, V40, P8862, DOI 10.1093/nar/gks684; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Croft L, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-90; Diwa A, 2000, GENE DEV, V14, P1249; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Enright AJ, 2004, GENOME BIOL, V5; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; FONTANA W, 1993, BIOPOLYMERS, V33, P1389, DOI 10.1002/bip.360330909; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gochhait S, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1780; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Grover R, 2011, RNA BIOL, V8, P132, DOI 10.4161/rna.8.1.14260; Haas U, 2012, RNA BIOL, V9, P924, DOI 10.4161/rna.20497; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Ingenuity Systems, 2005, IPA NETW GEN ALG; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kalari KR, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00012; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Martin JS, 2012, RNA, V18, P77, DOI 10.1261/rna.029900.111; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mwenifumbo JC, 2013, NAT REV GENET, V14, P321, DOI 10.1038/nrg3445; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pesole G, 2000, Brief Bioinform, V1, P236, DOI 10.1093/bib/1.3.236; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Reveal B, 2010, DEV CELL, V18, P496, DOI 10.1016/j.devcel.2009.12.021; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Rollin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004158; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sabarinathan R, 2013, NUCLEIC ACIDS RES, V41, pW475, DOI 10.1093/nar/gkt291; Sabarinathan R, 2013, HUM MUTAT, V34, P546, DOI 10.1002/humu.22273; Seemann SE, 2013, UNPUB; Teresi RE, 2007, AM J HUM GENET, V81, P756, DOI 10.1086/521051; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Walczak R, 1996, RNA, V2, P367; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wenzel A, 2012, BIOINFORMATICS, V28, P2738, DOI 10.1093/bioinformatics/bts519; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Zhu QQ, 2011, AM J HUM GENET, V88, P458, DOI 10.1016/j.ajhg.2011.03.008; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	66	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82699	10.1371/journal.pone.0082699	http://dx.doi.org/10.1371/journal.pone.0082699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416147	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500019
J	Zou, JJ; Chen, SL; Tan, J; Lin, L; Zhao, YY; Xu, HM; Lin, S; Zhang, J; Fan, HW; Xie, HG				Zou, Jian-Jun; Chen, Shao-Liang; Tan, Jie; Lin, Ling; Zhao, Ying-Ying; Xu, Hai-Mei; Lin, Song; Zhang, Juan; Fan, Hong-Wei; Xie, Hong-Guang			Increased Risk for Developing Major Adverse Cardiovascular Events in Stented Chinese Patients Treated with Dual Antiplatelet Therapy after Concomitant Use of the Proton Pump Inhibitor	PLOS ONE			English	Article							TASK-FORCE; CLOPIDOGREL; OMEPRAZOLE; PHARMACOKINETICS; PHARMACODYNAMICS; OUTCOMES; LANSOPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE; CROSSOVER	Background: Some clinical studies have demonstrated that the proton pump inhibitor (PPI) could decrease clopidogrel platelet response and increase major adverse cardiovascular events (MACE) in white or black subjects. However, that remains to be determined in Chinese patients. In this study, we sought to determine whether there could be an increased risk for developing MACE after concomitant use of dual antiplatelet therapy (DAT) and a PPI in Chinese patients treated with percutaneous coronary intervention (PCI) and stenting. Methods: This study was a 5-year, single-center, retrospective cohort analysis of eligible patients (n = 6188) who received DAT and a PPI concomitantly (defined as PPI users) before discharge and/or 12-month follow-up after discharge as compared with those who received DAT alone (also defined as non-PPI users, n = 1465). The incidence of recurrent MACE, such as myocardial infarction (MI), definite stent thromboses (ST), or cardiovascular death, was compared between the PPI users and non-users. Results: PPI users had a significantly higher incidence of the MACE than non-users (13.9% vs. 10.6%; adjusted HR: 1.33; 95% CI: 1.12 - 1.57, P = 0.007). Stratified analysis revealed that concurrent use of DAT and a PPI was associated with a significantly increased risk for developing ST compared with DAT alone (1% vs. 0.4%; adjusted HR: 2.66, 95% CI: 1.16 - 5.87, P = 0.012). However, there were no significant differences in the risk of MI, cardiovascular death and other adverse events, regardless of combination of clopidogrel and a PPI. Conclusions: The study further suggests that concomitant use of DAT and a PPI may be associated with an increased risk for developing MACE, in particular definite ST, in Chinese PCI patients after discharge as compared with use of DAT alone.	[Zou, Jian-Jun; Tan, Jie; Fan, Hong-Wei; Xie, Hong-Guang] Nanjing Med Univ, Nanjing Hosp 1, Gen Clin Res Ctr, Div Clin Pharmacol, Nanjing, Jiangsu, Peoples R China; [Chen, Shao-Liang; Lin, Ling; Zhao, Ying-Ying; Xu, Hai-Mei; Lin, Song; Zhang, Juan] Nanjing Med Univ, Nanjing Hosp 1, Div Cardiovasc Med, Dept Med, Nanjing, Jiangsu, Peoples R China; [Xie, Hong-Guang] Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Gen Clin Res Ctr, Nanjing, Jiangsu, Peoples R China; [Xie, Hong-Guang] Nanjing Med Univ, Sch Pharm, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Chen, SL (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Div Cardiovasc Med, Dept Med, Nanjing, Jiangsu, Peoples R China.	chmengx126@gmail.com; hongg.xie@gmail.com			National Natural Science Foundation of China [30901380]; Nanjing Bureau of Health [QYK10142, QYK11168]; Nanjing Bureau of Science and Technology [201001098]; Jiangsu (Province) Natural Science Foundation [BK 2012525]; Ministry of Human Resource and Social Security, China [2012-258]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Bureau of Health; Nanjing Bureau of Science and Technology; Jiangsu (Province) Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Ministry of Human Resource and Social Security, China	This study was supported, in part, by a grant from the National Natural Science Foundation of China (No. 30901380) and a grant from Nanjing Bureau of Health (No. QYK10142, and QYK11168) (all to J-JZ), a grant from Nanjing Bureau of Science and Technology (No. 201001098, to S-LC), and grants from the Jiangsu (Province) Natural Science Foundation (No. BK 2012525) and the Ministry of Human Resource and Social Security, China (No. 2012-258) (both to H-GX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; Angiolillo DJ, 2011, CLIN PHARMACOL THER, V89, P65, DOI 10.1038/clpt.2010.219; Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Charlot M, 2010, ANN INTERN MED, V153, P378, DOI 10.7326/0003-4819-153-6-201009210-00005; Chen SL, 2011, J AM COLL CARDIOL, V57, P914, DOI 10.1016/j.jacc.2010.10.023; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Ferreiro JL, 2010, CIRC-CARDIOVASC INTE, V3, P436, DOI 10.1161/CIRCINTERVENTIONS.110.957829; Furuta T, 2010, BRIT J CLIN PHARMACO, V70, P383, DOI 10.1111/j.1365-2125.2010.03717.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Huang CC, 2010, AM J CARDIOL, V105, P1705, DOI 10.1016/j.amjcard.2010.01.348; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Lim PWY, 2005, J GASTROEN HEPATOL, V20, pS22, DOI 10.1111/j.1440-1746.2005.04167.x; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Pezalla E, 2008, J AM COLL CARDIOL, V52, P1038, DOI 10.1016/j.jacc.2008.05.053; Pham CQD, 2006, ANN PHARMACOTHER, V40, P1261, DOI 10.1345/aph.1G703; Rassen JA, 2009, CIRCULATION, V120, P2322, DOI 10.1161/CIRCULATIONAHA.109.873497; Ray WA, 2010, ANN INTERN MED, V152, P337, DOI 10.7326/0003-4819-152-6-201003160-00003; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Small DS, 2008, J CLIN PHARMACOL, V48, P475, DOI 10.1177/0091270008315310; Stockl KM, 2010, ARCH INTERN MED, V170, P704, DOI 10.1001/archinternmed.2010.34; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Xie HG, 2011, PHARMACOL THERAPEUT, V129, P267, DOI 10.1016/j.pharmthera.2010.10.001; Zuern CS, 2010, THROMB RES, V125, pE51, DOI 10.1016/j.thromres.2009.08.016	30	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84985	10.1371/journal.pone.0084985	http://dx.doi.org/10.1371/journal.pone.0084985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416326	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500200
C	Wang, LC; Chen, R; Kong, DH		Datta, A		Wang Lichun; Chen Ran; Kong Dehui			An Improved Patch based Multi-View Stereo (PMVS) Algorithm	PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND SERVICE SYSTEM (CSSS)	Advances in Intelligent Systems Research		English	Proceedings Paper	3rd International Conference on Computer Science and Service System (CSSS)	JUN 13-15, 2014	Bangkok, THAILAND			Multi-view reconstruction; PMVS; quasi-dense matching		Multi-view based reconstruction is always focused in computer graphics and many excellent algorithms have been reported these years. According to Middlebury benchmark, PMVS(Patch based Multi-View Stereo) outperforms all the other submitted algorithms [1]. In this paper, we propose an improved PMVS algorithm based on quasi-dense matching to save time cost of the original algorithm. Improved algorithm reduces running time for patch expansion through building a quasi-dense set of initial patches and depresses time complexity of the algorithm. The experiments demonstrate effectiveness of improved algorithm.	[Wang Lichun; Chen Ran; Kong Dehui] Beijing Univ Technol, Coll Metropolitan Transportat, Beijing Key Lab Multimedia & Intelligent Software, Beijing, Peoples R China	Beijing University of Technology	Wang, LC (corresponding author), Beijing Univ Technol, Coll Metropolitan Transportat, Beijing Key Lab Multimedia & Intelligent Software, Beijing, Peoples R China.			Wang, Lin/0000-0001-6911-0660				BAUMGART BG, 1974, THESIS STANFORD U; BRADLEY D, 2008, P IEEE C COMP VIS PA; Esteban CH, 2004, COMPUT VIS IMAGE UND, V96, P367, DOI 10.1016/j.cviu.2004.03.016; Faugeras O, 1998, IEEE T IMAGE PROCESS, V7, P336, DOI 10.1109/83.661183; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Furukawa Y, 2009, INT J COMPUT VISION, V81, P53, DOI 10.1007/s11263-008-0134-8; Goesele M., 2006, PROC IEEE COMPUT SOC, V2, P2402, DOI [10.1109/CVPR.2006.199, DOI 10.1109/CVPR.2006.199]; Habbecke M., 2006, INT FALL WORKSH VIS, P73; Hartley R., 2000, MULTIPLE VIEW GEOMET, V2; HEYDEN A, 1995, THESIS LUND I TECHNO; Hiep VH, 2009, PROC CVPR IEEE, P1430, DOI 10.1109/CVPRW.2009.5206617; KOLMOGOROV V, 2002, P 7 EUR C COMP VIS; Lhuillier M, 2005, IEEE T PATTERN ANAL, V27, P418, DOI 10.1109/TPAMI.2005.44; Lhuillier M, 2002, IEEE T PATTERN ANAL, V24, P1140, DOI 10.1109/TPAMI.2002.1023810; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Paris S., 2004, P AS C COMP VIS; Seitz S. M., 2010, MULTIVIEW STEREO EVA; Seitz Steven M., 2006, IEEE C COMP VIS PATT; SINHA SN, 2007, P INT C COMP VIS; Strecha C., 2006, COMP VIS PATT REC 20, P2394, DOI [DOI 10.1109/CVPR.2006.78, 10.1109/CVPR.2006.78]; Torr PHS, 1997, INT J COMPUT VISION, V24, P271, DOI 10.1023/A:1007927408552; Tran S., 2006, P EUR C COMP VIS; Vogiatzis G., 2005, P IEEE C COMP VIS PA; Zaharescu A, 2007, LECT NOTES COMPUT SC, V4844, P166	24	14	16	0	15	ATLANTIS PRESS	PARIS	29 AVENUE LAVMIERE, PARIS, 75019, FRANCE	1951-6851		978-94-6252-012-7	ADV INTEL SYS RES			2014	109						9	12						4	Automation & Control Systems; Computer Science, Artificial Intelligence; Computer Science, Theory & Methods	Conference Proceedings Citation Index - Science (CPCI-S)	Automation & Control Systems; Computer Science	BC3ZP	24416438	Green Published, gold, Green Submitted			2022-12-25	WOS:000352132500007
J	Satoyoshi, R; Kuriyama, S; Aiba, N; Yashiro, M; Tanaka, M				Satoyoshi, R.; Kuriyama, S.; Aiba, N.; Yashiro, M.; Tanaka, M.			Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts	ONCOGENE			English	Article						aspirin; CAF; rac1; scirrhous gastric cancer; SLRP	GROWTH-FACTOR RECEPTOR; DOWN-REGULATION; DECORIN; PROTEOGLYCANS; EXPRESSION; PROTEIN; MYOFIBROBLASTS; METASTASIS; ROLES; CELLS	Scirrhous gastric cancer, which has the worst prognosis among the various types of gastric cancer, is highly invasive and associated with abundant stromal fibroblasts. Although cancer-associated fibroblasts (CAFs) have been proposed to generate a tumor-supportive extracellular matrix that promotes the expansion of this type of cancer, the molecular mechanisms by which CAFs assist cancer cells are not yet fully understood. Here, we show for the first time that Asporin, a small leucine-rich proteoglycan (SLRP), is predominantly expressed in CAFs, and has essential roles in promoting co-invasion of CAFs and cancer cells. CAFs of scirrhous gastric cancer possess high potential for invasion, and invasion by CAFs frequently proceeded invasion by cancer cells, both in vitro and in vivo. Expression of Asporin was induced in fibroblasts by exposure to gastric cancer cells. Asporin secreted from CAFs activates Rac1 via an interaction with CD44 and promotes invasion by CAFs themselves. Moreover, Asporin promoted invasion by neighboring cancer cells, via paracrine effects mediated by activation of the CD44-Rac1 pathway. These results suggest that Asporin is a unique SLRP that promotes progression of scirrhous gastric cancer and is required for coordinated invasion by CAFs and cancer cells. Therefore, Asporin may represent a new therapeutic target molecule for the development of drugs aimed at manipulating the cancer microenvironment.	[Satoyoshi, R.; Kuriyama, S.; Aiba, N.; Tanaka, M.] Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, Akita 0108543, Japan; [Yashiro, M.] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 558, Japan	Akita University; Osaka Metropolitan University	Tanaka, M (corresponding author), Akita Univ, 1-1-1 Hondo, Akita 0108543, Japan.	mastanak@med.akita-u.ac.jp	Kuriyama, Sei/AAV-2368-2020	Kuriyama, Sei/0000-0002-5502-7177	JSPS KAKENHI [22300324, 25290042, 24700962]; MEXT KAKENHI [25111702]; National Cancer Center Research and Development Fund [23-A-9]; Grants-in-Aid for Scientific Research [24700962] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grant Nos. 22300324 and 25290042; to MT, 24700962 to SK), MEXT KAKENHI 25111702 to SK and the National Cancer Center Research and Development Fund (Grant No. 23-A-9; to MT).	Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Chong HC, 2012, J ONCOL, V2012, DOI 10.1155/2012/351089; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Duval E, 2011, MOL MED, V17, P816, DOI 10.2119/molmed.2011.00052; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Fuyuhiro Y, 2011, BRIT J CANCER, V105, P996, DOI 10.1038/bjc.2011.330; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gruber HE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2660; Hagiyama M, 2009, AM J PATHOL, V174, P2278, DOI 10.2353/ajpath.2009.080743; Horie M, 2012, BIOCHEM BIOPH RES CO, V423, P158, DOI 10.1016/j.bbrc.2012.05.104; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Klee EW, 2012, CLIN CHEM, V58, P599, DOI 10.1373/clinchem.2011.171637; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Pena C, 2013, CANCER RES, V73, P1287, DOI 10.1158/0008-5472.CAN-12-1875; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Shimamura S, 2013, J BIOL CHEM, V288, P1171, DOI 10.1074/jbc.M112.386722; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Ungefroren H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-18; Yashiro M, 2010, CANCER MICROENVIRON, V3, P127, DOI 10.1007/s12307-010-0036-5; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	31	70	71	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 29	2015	34	5					650	660		10.1038/onc.2013.584	http://dx.doi.org/10.1038/onc.2013.584			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DD	24441039				2022-12-25	WOS:000348853500012
J	Calco, GN; Stephens, OR; Donahue, LM; Tsui, CC; Pierchala, BA				Calco, Gina N.; Stephens, Olivia R.; Donahue, Laura M.; Tsui, Cynthia C.; Pierchala, Brian A.			CD2-associated Protein (CD2AP) Enhances Casitas B Lineage Lymphoma-3/c (Cbl-3/c)-mediated Ret Isoform-specific Ubiquitination and Degradation via Its Amino-terminal Src Homology 3 Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Neurodevelopment; Neurotrophic Factor; Protein Degradation; Receptor Tyrosine Kinase; Ubiquitination	DOWN-REGULATION; C-CBL; NEUROTROPHIC FACTOR; GDNF FAMILY; ALZHEIMERS-DISEASE; NEURONAL SURVIVAL; COMMON VARIANTS; LIGASE ACTIVITY; COMPLEX; RING	Background: Ubiquitination and degradation promote signal termination of the Ret receptor. Results: Cbl-3/c and CD2AP are both required for the ubiquitination of Ret51 on Lys(1060) and Lys(1107). Conclusion: The Ret51 isoform-specific ubiquitination on Lys(1060) and Lys(1107) may underlie its rapid degradation. Significance: Regulation of CD2APCbl-3/c activity may underlie the diversity of functional outcomes of Ret signal transduction. Ret is the receptor tyrosine kinase for the glial cell line-derived neurotrophic factor (GDNF) family of neuronal growth factors. Upon activation by GDNF, Ret is rapidly polyubiquitinated and degraded. This degradation process is isoform-selective, with the longer Ret51 isoform exhibiting different degradation kinetics than the shorter isoform, Ret9. In sympathetic neurons, Ret degradation is induced, at least in part, by a complex consisting of the adaptor protein CD2AP and the E3-ligase Cbl-3/c. Knockdown of Cbl-3/c using siRNA reduced the GDNF-induced ubiquitination and degradation of Ret51 in neurons and podocytes, suggesting that Cbl-3/c was a predominant E3 ligase for Ret. Coexpression of CD2AP with Cbl-3/c augmented the ubiquitination of Ret51 as compared with the expression of Cbl-3/c alone. Ret51 ubiquitination by the CD2APCbl-3/c complex required a functional ring finger and TKB domain in Cbl-3/c. The SH3 domains of CD2AP were sufficient to drive the Cbl-3/c-dependent ubiquitination of Ret51, whereas the carboxyl-terminal coiled-coil domain of CD2AP was dispensable. Interestingly, activated Ret induced the degradation of CD2AP, but not Cbl-3/c, suggesting a potential inhibitory feedback mechanism. There were only two major ubiquitination sites in Ret51, Lys(1060) and Lys(1107), and the combined mutation of these lysines almost completely eliminated both the ubiquitination and degradation of Ret51. Ret9 was not ubiquitinated by the CD2APCbl-3/c complex, suggesting that Ret9 was down-regulated by a fundamentally different mechanism. Taken together, these results suggest that only the SH3 domains of CD2AP were necessary to enhance the E3 ligase activity of Cbl-3/c toward Ret51.	[Calco, Gina N.; Stephens, Olivia R.; Donahue, Laura M.; Pierchala, Brian A.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Tsui, Cynthia C.] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tsui, CC (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, 1150 West Med Ctr Dr,MSRB 1 A520D, Ann Arbor, MI 48109 USA.	cyntsui@umich.edu; pierchal@umich.edu			National Institutes of Health [NS058510, DK084210]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01, NS058510 (B. A. P.) and National Institutes of Health Career Development Award K08, DK084210 (to C. C. T.).	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bonanomi D, 2012, CELL, V148, P568, DOI 10.1016/j.cell.2012.01.024; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; Kim M, 1999, GENE, V239, P145, DOI 10.1016/S0378-1119(99)00356-X; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kobayashi S, 2004, FASEB J, V18, P929, DOI 10.1096/fj.03-0767fje; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pierchala BA, 2006, J NEUROSCI, V26, P2777, DOI 10.1523/JNEUROSCI.3420-05.2006; Pierchala BA, 2010, KIDNEY INT, V78, P868, DOI 10.1038/ki.2010.212; Richardson DS, 2012, MOL BIOL CELL, V23, P3838, DOI 10.1091/mbc.E12-02-0114; Ryan PE, 2010, J BIOL CHEM, V285, P23687, DOI 10.1074/jbc.M109.091157; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Scott RP, 2005, J BIOL CHEM, V280, P13442, DOI 10.1074/jbc.M500507200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Tossidou I, 2007, J BIOL CHEM, V282, P7457, DOI 10.1074/jbc.M608519200; Tsui CC, 2006, J AM SOC NEPHROL, V17, P1543, DOI 10.1681/ASN.2005080835; Tsui CC, 2008, J NEUROSCI, V28, P8789, DOI 10.1523/JNEUROSCI.2738-08.2008; Tsui CC, 2010, J NEUROSCI, V30, P5149, DOI 10.1523/JNEUROSCI.5246-09.2010; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Tsui-Pierchala BA, 2002, J BIOL CHEM, V277, P34618, DOI 10.1074/jbc.M203580200; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742	40	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7307	7319		10.1074/jbc.M113.537878	http://dx.doi.org/10.1074/jbc.M113.537878			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24425877	hybrid, Green Published			2022-12-25	WOS:000332761500005
J	Kubota, S; Fukumoto, Y; Ishibashi, K; Soeda, S; Kubota, S; Yuki, R; Nakayama, Y; Aoyama, K; Yamaguchi, N; Yamaguchi, N				Kubota, Shoichi; Fukumoto, Yasunori; Ishibashi, Kenichi; Soeda, Shuhei; Kubota, Sho; Yuki, Ryuzaburo; Nakayama, Yuji; Aoyama, Kazumasa; Yamaguchi, Noritaka; Yamaguchi, Naoto			Activation of the Prereplication Complex Is Blocked by Mimosine through Reactive Oxygen Species-activated Ataxia Telangiectasia Mutated (ATM) Protein without DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Checkpoint Control; DNA Damage Response; DNA Replication; Oxidative Stress	CHK TYROSINE KINASE; CELL-CYCLE; S-PHASE; CENTROSOME DUPLICATION; NUCLEAR-LOCALIZATION; A RPA; C-SRC; REPLICATION; PHOSPHORYLATION; LYN	Background: Mimosine is a cell synchronization reagent used for arresting cells in late G(1) and S phases. Results: Replication fork assembly is reversibly blocked by ATM activation through mimosine-generated reactive oxygen species. Conclusion: Mimosine induces cell cycle arrest strictly at the G(1)-S phase boundary, which prevents replication fork stalling-induced DNA damage. Significance: These findings provide a novel mechanism of the mimosine-induced G(1) checkpoint. Mimosine is an effective cell synchronization reagent used for arresting cells in late G(1) phase. However, the mechanism underlying mimosine-induced G(1) cell cycle arrest remains unclear. Using highly synchronous cell populations, we show here that mimosine blocks S phase entry through ATM activation. HeLa S3 cells are exposed to thymidine for 15 h, released for 9 h by washing out the thymidine, and subsequently treated with 1 mm mimosine for a further 15 h (thymidine mimosine). In contrast to thymidine-induced S phase arrest, mimosine treatment synchronizes >90% of cells at the G(1)-S phase boundary by inhibiting the transition of the prereplication complex to the preinitiation complex. Mimosine treatment activates ataxia telangiectasia mutated (ATM)/ataxia telangiectasia and Rad3-related (ATR)-mediated checkpoint signaling without inducing DNA damage. Inhibition of ATM activity is found to induce mimosine-arrested cells to enter S phase. In addition, ATM activation by mimosine treatment is mediated by reactive oxygen species (ROS). These results suggest that, upon mimosine treatment, ATM blocks S phase entry in response to ROS, which prevents replication fork stalling-induced DNA damage.	[Kubota, Shoichi; Fukumoto, Yasunori; Ishibashi, Kenichi; Soeda, Shuhei; Kubota, Sho; Yuki, Ryuzaburo; Nakayama, Yuji; Aoyama, Kazumasa; Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba 2608675, Japan	Chiba University	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp		Kubota, Sho/0000-0001-6119-1259; Nakayama, Yuji/0000-0001-7882-0066	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research, Global Center of Excellence (COE) Program (Global Center for Education and Research in Immune Regulation and Treatment) and Special Funds for Education and Research (Development of single photon emission computed tomography (SPECT) probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Aoyama K, 2013, EXP CELL RES, V319, P3251, DOI 10.1016/j.yexcr.2013.09.003; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Ben-Yehoyada M, 2007, DNA REPAIR, V6, P914, DOI 10.1016/j.dnarep.2007.02.005; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bolderson E, 2004, HUM MOL GENET, V13, P2937, DOI 10.1093/hmg/ddh316; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cardoso M. C., 1995, CELL CYCLE MAT METHO, P15; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Correia SC, 2010, J NEUROCHEM, V112, P1, DOI 10.1111/j.1471-4159.2009.06443.x; DAI YM, 1994, VIROLOGY, V205, P210, DOI 10.1006/viro.1994.1636; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Durcan TM, 2008, J CELL PHYSIOL, V215, P182, DOI 10.1002/jcp.21298; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gagou ME, 2010, MOL BIOL CELL, V21, P739, DOI 10.1091/mbc.E09-07-0618; GILBERT DM, 1995, J BIOL CHEM, V270, P9597, DOI 10.1074/jbc.270.16.9597; Hallak M, 2008, APOPTOSIS, V13, P147, DOI 10.1007/s10495-007-0156-7; Harper Jane V., 2004, V296, P157; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Jones RM, 2012, BIOCHEM J, V443, P13, DOI 10.1042/BJ20112100; Julias JG, 1998, J VIROL, V72, P7941, DOI 10.1128/JVI.72.10.7941-7949.1998; Kalejta RF, 1997, EXP CELL RES, V231, P173, DOI 10.1006/excr.1996.3444; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kikuchi I, 2010, CELL BIOL INT, V34, P645, DOI 10.1042/CBI20090398; KNEHR M, 1995, EXP CELL RES, V217, P546, DOI 10.1006/excr.1995.1121; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kuga T, 2007, ARCH BIOCHEM BIOPHYS, V466, P116, DOI 10.1016/j.abb.2007.07.002; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; LEVENSON V, 1993, NUCLEIC ACIDS RES, V21, P3997, DOI 10.1093/nar/21.17.3997; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Matsui Y, 2012, EUR J CELL BIOL, V91, P413, DOI 10.1016/j.ejcb.2011.12.008; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Mikhailov I, 2000, MUTAT RES-DNA REPAIR, V459, P299, DOI 10.1016/S0921-8777(00)00007-0; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Paddenberg R, 2003, AM J PHYSIOL-LUNG C, V284, pL710, DOI 10.1152/ajplung.00149.2002; Panopoulos A, 2005, J BIOL CHEM, V280, P2912, DOI 10.1074/jbc.M409524200; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Swingle Mark, 2007, V365, P23; Szuts D, 2004, J CELL SCI, V117, P4897, DOI 10.1242/jcs.01374; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Yamaguchi N, 2001, J CELL SCI, V114, P1631; Yang YT, 2005, J NEUROCHEM, V93, P513, DOI 10.1111/j.1471-4159.2005.03032.x; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	73	28	28	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5730	5746		10.1074/jbc.M113.546655	http://dx.doi.org/10.1074/jbc.M113.546655			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24421316	hybrid, Green Published			2022-12-25	WOS:000332015500034
J	Science, M; Maguire, JL; Russell, ML; Smieja, M; Walter, SD; Loeb, M				Science, Michelle; Maguire, Jonathon L.; Russell, Margaret L.; Smieja, Marek; Walter, Stephen D.; Loeb, Mark			Serum 25-Hydroxyvitamin D Level and Influenza Vaccine Immunogenicity in Children and Adolescents	PLOS ONE			English	Article							VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; ADULTS; TRIAL; DIFFERENTIATION; PREVALENCE; EXPRESSION; IMMUNITY; ENHANCE; SYSTEM	Background: Vaccination is an important strategy in the prevention of influenza, but immunologic response to vaccination can vary widely. Recent studies have shown an association between serum 25-hydroxyvitamin D (25[OH]D) levels and immune function. The purpose of this study was to determine if serum 25(OH)D level correlates with influenza vaccine immunogenicity in children and adolescents. Methods: We conducted a prospective cohort study of children age 3 to 15 years of age vaccinated with trivalent influenza vaccine (A/Brisbane/59/2007[H1N1]-like virus, A/Brisbane/10/2007 [H3N2]-like virus and B/Florida/4/2006-like virus) in Hutterite communities in Alberta, Saskatchewan and Manitoba. Serum 25(OH)D levels were measured at baseline and immunogenicity was assessed using hemagluttination inhibition (HAI) titers done at baseline and 3-5 weeks post vaccination. Logistic regression was used to assess the relationship between serum 25(OH)D level as both a continuous and dichotomous variable and seroprotection, seroconversion, fold increase in geometric mean titer (GMT) and post vaccination titer. Results: A total of 391 children and adolescents were included in the study and 221 (57% had post-vaccination HAI titers. The median serum 25(OH)D level was 61.0 nmol/L (Interquartile range [IQR] 50.0, 71.0). No relationship was found between serum 25(OH)D level and seroprotection (post-vaccination titer >= 40 and >= 320) or seroconversion (post-vaccination titer >= 40 for participants with pre-vaccine titer,10 or four-fold rise in post-vaccination titer for those with a pre-vaccine titer >= 10). Conclusion: Serum 25(OH)D level was not associated with influenza vaccine immunogenicity in otherwise healthy children and adolescents. Other strategies to enhance influenza vaccine response should continue to be evaluated in this population. The role of serum 25(OH)D level in vaccine responsiveness in other populations, especially those hyporesponsive to influenza vaccination, requires further study.	[Science, Michelle] Hosp Sick Children, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Science, Michelle; Smieja, Marek; Walter, Stephen D.; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Maguire, Jonathon L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada; [Maguire, Jonathon L.] St Michaels Hosp, Dept Paediat, Toronto, ON M5B 1W8, Canada; [Maguire, Jonathon L.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Maguire, Jonathon L.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Russell, Margaret L.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Smieja, Marek; Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Loeb, Mark] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Calgary; McMaster University; McMaster University	Loeb, M (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	loebm@mcmaster.ca	Walter, Stephen/AAB-5548-2022	Walter, Stephen/0000-0003-4157-8928	Canadian Institutes for Health Research [MCT-88113]; National Institute for Allergy and Infectious Diseases [1 U01 AI 76208-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI076208] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Canadian Institutes for Health Research [grant number MCT-88113] and the National Institute for Allergy and Infectious Diseases [grant number #1 U01 AI 76208-01A1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AH, 1996, REV MED MICROBIOL, V7, P23; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; BLACK SC, 2011, AM POETRY REV, V40, P30; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Chadha MK, 2011, PROSTATE, V71, P368, DOI 10.1002/pros.21250; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Committee for Proprietary Medicinal Products, 1997, NOT GUID HARM REQ IN; Cooper C, 2011, HIV CLIN TRIALS, V12, P275, DOI 10.1310/hct1205-275; Daynes RA, 1996, INFECT IMMUN, V64, P1100, DOI 10.1128/IAI.64.4.1100-1109.1996; DAYNES RA, 1994, ANN NY ACAD SCI, V730, P144, DOI 10.1111/j.1749-6632.1994.tb44246.x; Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; Food and Drug Administration, 2007, CLIN DAT NEED SUPP L; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Holland D, 2008, J INFECT DIS, V198, P650, DOI 10.1086/590434; Jackson LA, 2012, J INFECT DIS, V206, P811, DOI 10.1093/infdis/jis427; Kriesel JD, 1999, VACCINE, V17, P1883, DOI 10.1016/S0264-410X(98)00476-9; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Langlois Kellie, 2010, Health Rep, V21, P47; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Maguire JL, 2013, JAMA PEDIATR, V167, P230, DOI 10.1001/2013.jamapediatrics.226; Maguire JL, 2011, PAED CHILD HEALT-CAN, V16, pE11, DOI 10.1093/pch/16.2.e11; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; OBERG F, 1993, J IMMUNOL, V150, P3487; Principi N, 2013, HUM VACCIN IN PRESS, P9; Public Health Agency of Canada, 2009, FLU WATCH       0531; Sundaram ME, 2013, VACCINE, V31, P2057, DOI 10.1016/j.vaccine.2013.02.028; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909	29	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83553	10.1371/journal.pone.0083553	http://dx.doi.org/10.1371/journal.pone.0083553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427274	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200014
J	Zhou, LP; Salvado, O; Dore, V; Bourgeat, P; Raniga, P; Macaulay, SL; Ames, D; Masters, CL; Ellis, KA; Villemagne, VL; Rowe, CC; Fripp, J				Zhou, Luping; Salvado, Olivier; Dore, Vincent; Bourgeat, Pierrick; Raniga, Parnesh; Macaulay, S. Lance; Ames, David; Masters, Colin L.; Ellis, Kathryn A.; Villemagne, Victor L.; Rowe, Christopher C.; Fripp, Jurgen		AIBL Res Grp	MR-Less Surface-Based Amyloid Assessment Based on C-11 PiB PET	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; HUMAN BRAIN; NONRIGID REGISTRATION; A-BETA; IMAGES; SEGMENTATION; DEPOSITION; ATLAS; INFORMATION	Background: beta-amyloid (A beta) plaques in brain's grey matter (GM) are one of the pathological hallmarks of Alzheimer's disease (AD), and can be imaged in vivo using Positron Emission Tomography (PET) with C-11 or F-18 radiotracers. Estimating A beta burden in cortical GM has been shown to improve diagnosis and monitoring of AD. However, lacking structural information in PET images requires such assessments to be performed with anatomical MRI scans, which may not be available at different clinical settings or being contraindicated for particular reasons. This study aimed to develop an MR-less A beta imaging quantification method that requires only PET images for reliable A beta burden estimations. Materials and Methods: The proposed method has been developed using a multi-atlas based approach on C-11-PiB scans from 143 subjects (75 PiB+ and 68 PiB- subjects) in AIBL study. A subset of 20 subjects (PET and MRI) were used as atlases: 1) MRI images were co-registered with tissue segmentation; 2) 3D surface at the GM-WM interfacing was extracted and registered to a canonical space; 3) Mean PiB retention within GM was estimated and mapped to the surface. For other participants, each atlas PET image (and surface) was registered to the subject's PET image for PiB estimation within GM. The results are combined by subject-specific atlas selection and Bayesian fusion to generate estimated surface values. Results: All PiB+ subjects (N = 75) were highly correlated between the MR-dependent and the PET-only methods with Intraclass Correlation (ICC) of 0.94, and an average relative difference error of 13% (or 0.23 SUVR) per surface vertex. All PiB-subjects (N = 68) revealed visually akin patterns with a relative difference error of 16% (or 0.19 SUVR) per surface vertex. Conclusion: The demonstrated accuracy suggests that the proposed method could be an effective clinical inspection tool for A beta imaging scans when MRI images are unavaila ble.	[Zhou, Luping; Salvado, Olivier; Dore, Vincent; Bourgeat, Pierrick; Raniga, Parnesh; Fripp, Jurgen] CSIRO Preventat Hlth Flagship, CSIRO Computat Informat, Australian E Hlth Res Ctr, Herston, Qld, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hosp, Dept Nucl Med, Heidelberg, Vic 3084, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hosp, Ctr PET, Heidelberg, Vic 3084, Australia; [Zhou, Luping] Univ Wollongong, Dept Comp Sci & Software Engn, Wollongong, NSW, Australia; [Macaulay, S. Lance] CSIRO Preventat Hlth Natl Res Flagship, Parkville, Vic, Australia; [Masters, Colin L.; Ellis, Kathryn A.] Univ Melbourne, Mental Hlth Res Inst, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Ames, David] Natl Ageing Res Inst, Parkville, Vic, Australia; [Ames, David; Ellis, Kathryn A.] Univ Melbourne, Dept Psychiat, Acad Unit Psychiat Old Age, Parkville, Vic 3052, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Wollongong; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Florey Institute of Neuroscience & Mental Health; University of Melbourne; National Ageing Research Institute; University of Melbourne	Zhou, LP (corresponding author), CSIRO Preventat Hlth Flagship, CSIRO Computat Informat, Australian E Hlth Res Ctr, Herston, Qld, Australia.	lupingz@uow.edu.au	Raniga, Parnesh/A-8620-2011; Dore, Vincent/A-7750-2011; Duesing, Konsta/H-2802-2013; Maruff, Paul/AAD-2454-2021; Fripp, Jurgen/A-8763-2011; Macaulay, Stuart Lance/A-6086-2008; Salvado, Olivier/C-8910-2009; Bourgeat, Pierrick T/A-1419-2010; Zhou, Luping/AAD-6045-2020; Villemagne, Victor/AAC-5406-2019; Rowe, Christopher/AAX-8748-2021	Dore, Vincent/0000-0002-8051-0558; Duesing, Konsta/0000-0003-3103-0600; Maruff, Paul/0000-0002-6947-9537; Fripp, Jurgen/0000-0001-9705-0079; Macaulay, Stuart Lance/0000-0001-5069-9516; Salvado, Olivier/0000-0002-2720-8739; Bourgeat, Pierrick T/0000-0002-2605-4766; Villemagne, Victor/0000-0002-5832-9875; Ellis, Kathryn/0000-0001-9097-9037; Savage, Gregory/0000-0002-5895-1947; Raniga, Parnesh/0000-0002-0106-6322	CSIRO; Science and Industry Endowment Fund (SIEF); Edith Cowan University; Florey neuro-sciences and Mental Health Research institutes; Alzheimer's Australia; National Age-ing Research Institute; Austin Health; CogState Ltd.; Hollywood Private Hospital; Sir Charles Gardner Hospital; National Health and Medical Research Council; Dementia Collaborative Research Centers program; McCusker Alzheimer's Research Foundation; Government of Victoria, Australia; Pfizer International	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Science and Industry Endowment Fund (SIEF); Edith Cowan University; Florey neuro-sciences and Mental Health Research institutes; Alzheimer's Australia; National Age-ing Research Institute; Austin Health; CogState Ltd.(CogState Limited); Hollywood Private Hospital; Sir Charles Gardner Hospital; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Dementia Collaborative Research Centers program; McCusker Alzheimer's Research Foundation; Government of Victoria, Australia; Pfizer International(Pfizer)	Core funding for the AIBL study was provided by the CSIRO (http://www.csiro.au/) Flagship Collaboration Fund and the Science and Industry Endowment Fund (SIEF http://www.sief.org.au/) in partnership with Edith Cowan University (https://www.ecu.edu.au/), Florey neuro-sciences and Mental Health Research institutes (http://www.florey.edu.au/), Alzheimer's Australia (http://www.fightdementia.org.au/), National Age-ing Research Institute (http://www.mednwh.unimelb.edu.au/), Austin Health (http://www.austin.org.au/), CogState Ltd. (http://cogstate.com/), Hollywood Private Hospital (http://www.hollywood.ramsayhealth.com.au/), Sir Charles Gardner Hospital (http://www.scgh.health.wa.gov.au/). The AIBL study also receives funding from the National Health and Medical Research Council (http://www.nhmrc.gov.au/), the Dementia Collaborative Research Centers program (http://www.fightdementia.org.au/victoria/dementia-collaborative-research-centres-1.aspx), The McCusker Alzheimer's Research Foundation (http://alzheimers.com.au/) and Operational Infrastructure Support from the Government of Victoria (http://www.vic.gov.au/), Australia. Pfizer International (http://www.pfizer.com.au/default.aspx) has contributed financial support to AIBL to assist with analysis of blood samples and to further the AIBL research program. The funders had no role in study design and data analysis, decision to publish, or preparation of this manuscript.	Aalto S, 2009, EUR J NUCL MED MOL I, V36, P1651, DOI 10.1007/s00259-009-1174-1; Acosta O, 2012, J NEUROSCI METH, V205, P96, DOI 10.1016/j.jneumeth.2011.12.011; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Bourgeat P, 2012, MICCAI 2012 WORKSH N; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Dore V., 2011, Proceedings of the 2011 International Conference on Digital Image Computing: Techniques and Applications (DICTA 2011), P13, DOI 10.1109/DICTA.2011.11; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Fodero-Tavoletti MT, 2009, J NUCL MED, V50, P198, DOI 10.2967/jnumed.108.057984; Fripp J, 2008, NEUROIMAGE, V43, P430, DOI 10.1016/j.neuroimage.2008.07.053; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; JOACHIM CL, 1989, AM J PATHOL, V135, P309; Kemppainen NM, 2007, NEUROLOGY, V68, P1603, DOI 10.1212/01.wnl.0000260969.94695.56; Kemppainen NM, 2006, NEUROLOGY, V67, P1575, DOI 10.1212/01.wnl.0000240117.55680.0a; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Li Y, 2008, EUR J NUCL MED MOL I, V35, P2169, DOI 10.1007/s00259-008-0833-y; Lilja A., 2010, TOOLS AIDING DIAGNOS; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Ng S, 2007, J NUCL MED, V48, P547, DOI 10.2967/jnumed.106.037762; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Raniga P, 2009, SPIE MED IM 2009; Raniga P, 2007, I S BIOMED IMAGING, P348, DOI 10.1109/ISBI.2007.356860; Rousset OG, 1998, J NUCL MED, V39, P904; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rueda A, 2010, J NEUROSCI METH, V188, P305, DOI 10.1016/j.jneumeth.2010.02.020; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Thal DR, 2006, SCI AGING KNOWLEDGE, V2006; Tolboom N, 2009, EUR J NUCL MED MOL I, V36, P1629, DOI 10.1007/s00259-009-1129-6; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Villemagne VL, 2011, J NUCL MED, V52, P1210, DOI 10.2967/jnumed.111.089730; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Yasuno F, 2002, NEUROIMAGE, V16, P577, DOI 10.1006/nimg.2002.1120; Yotter RA, 2013, NEUROBIOL AGING, V34, P2835, DOI 10.1016/j.neurobiolaging.2013.05.030; Ziolko SK, 2006, NEUROIMAGE, V33, P94, DOI 10.1016/j.neuroimage.2006.05.063	40	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84777	10.1371/journal.pone.0084777	http://dx.doi.org/10.1371/journal.pone.0084777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427295	Green Published, gold			2022-12-25	WOS:000329868200035
J	Boyce, SE; Tirunagari, N; Niedziela-Majka, A; Perry, J; Wong, M; Kan, E; Lagpacan, L; Barauskas, O; Hung, M; Fenaux, M; Appleby, T; Watkins, WJ; Schmitz, U; Sakowicz, R				Boyce, Sarah E.; Tirunagari, Neeraj; Niedziela-Majka, Anita; Perry, Jason; Wong, Melanie; Kan, Elaine; Lagpacan, Leanna; Barauskas, Ona; Hung, Magdeleine; Fenaux, Martijn; Appleby, Todd; Watkins, William J.; Schmitz, Uli; Sakowicz, Roman			Structural and Regulatory Elements of HCV NS5B Polymerase - beta-Loop and C-Terminal Tail - Are Required for Activity of Allosteric Thumb Site II Inhibitors	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; VIRUS POLYMERASE; PRECLINICAL CHARACTERIZATION; DE-NOVO; MECHANISM; BINDING; COMPLEXES; SELECTION; STEPS	Elucidation of the mechanism of action of the HCV NS5B polymerase thumb site II inhibitors has presented a challenge. Current opinion holds that these allosteric inhibitors stabilize the closed, inactive enzyme conformation, but how this inhibition is accomplished mechanistically is not well understood. Here, using a panel of NS5B proteins with mutations in key regulatory motifs of NS5B - the C-terminal tail and beta-loop - in conjunction with a diverse set of NS5B allosteric inhibitors, we show that thumb site II inhibitors possess a distinct mechanism of action. A combination of enzyme activity studies and direct binding assays reveals that these inhibitors require both regulatory elements to maintain the polymerase inhibitory activity. Removal of either element has little impact on the binding affinity of thumb site II inhibitors, but significantly reduces their potency. NS5B in complex with a thumb site II inhibitor displays a characteristic melting profile that suggests stabilization not only of the thumb domain but also the whole polymerase. Successive truncations of the C-terminal tail and/or removal of the beta-loop lead to progressive destabilization of the protein. Furthermore, the thermal unfolding transitions characteristic for thumb site II inhibitor - NS5B complex are absent in the inhibitor - bound constructs in which interactions between C-terminal tail and beta-loop are abolished, pointing to the pivotal role of both regulatory elements in communication between domains. Taken together, a comprehensive picture of inhibition by compounds binding to thumb site II emerges: inhibitor binding provides stabilization of the entire polymerase in an inactive, closed conformation, propagated via coupled interactions between the C-terminal tail and beta-loop.	[Boyce, Sarah E.; Tirunagari, Neeraj; Niedziela-Majka, Anita; Perry, Jason; Wong, Melanie; Kan, Elaine; Lagpacan, Leanna; Barauskas, Ona; Hung, Magdeleine; Fenaux, Martijn; Appleby, Todd; Watkins, William J.; Schmitz, Uli; Sakowicz, Roman] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Sakowicz, R (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	roman.sakowicz@gilead.com						Adachi T, 2002, BBA-PROTEINS PROTEOM, V1601, P38, DOI 10.1016/S1570-9639(02)00433-8; Aghemo A, 2013, NEW HORIZONS HEPATIT; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Ando I, 2012, ANTIMICROB AGENTS CH, V56, P4250, DOI 10.1128/AAC.00312-12; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Caillet-Saguy C, 2011, J MOL BIOL, V414, P370, DOI 10.1016/j.jmb.2011.10.001; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Davis BC, 2013, PROTEINS, V81, P40, DOI 10.1002/prot.24154; De Clercq E, 2005, J MED CHEM, V48, P1297, DOI 10.1021/jm040158k; Delang L, 2013, CURR TOP MICROBIOL, V369, P289, DOI 10.1007/978-3-642-27340-7_12; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Ellis DA, 2009, BIOORG MED CHEM LETT, V19, P6047, DOI 10.1016/j.bmcl.2009.09.051; Fenaux M, 2013, ANTIMICROB AGENTS CH, V57, P804, DOI 10.1128/AAC.02052-12; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Hang JQ, 2009, J BIOL CHEM, V284, P15517, DOI 10.1074/jbc.M808889200; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Howe AYM, 2006, ANTIMICROB AGENTS CH, V50, P4103, DOI 10.1128/AAC.00365-06; Hung M, 2002, ANTIVIR RES, V56, P99, DOI 10.1016/S0166-3542(02)00101-8; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Johnson CM, 2013, ARCH BIOCHEM BIOPHYS, V531, P100, DOI 10.1016/j.abb.2012.09.008; Kong CC, 2008, THIOPHENE ANALOGUES; Le Pogam S, 2006, J VIROL, V80, P6146, DOI 10.1128/JVI.02628-05; Lea WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036219; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li H, 2009, J MED CHEM, V52, P1255, DOI 10.1021/jm8014537; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu YY, 2006, BIOCHEMISTRY-US, V45, P11312, DOI 10.1021/bi060511j; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 2013, CURR TOP MICROBIOL, V369, P167, DOI 10.1007/978-3-642-27340-7_7; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Pouliot J, 2008, ANN M AM ASS STUD LI; Reich S, 2010, J BIOL CHEM, V285, P13685, DOI 10.1074/jbc.M109.082206; Ruebsam F, 2009, BIOORG MED CHEM LETT, V19, P6404, DOI 10.1016/j.bmcl.2009.09.045; Ruebsam F, 2009, BIOORG MED CHEM LETT, V19, P451, DOI 10.1016/j.bmcl.2008.11.048; Scrima N, 2012, J VIROL, V86, P7107, DOI 10.1128/JVI.00459-12; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shim JH, 2002, J VIROL, V76, P7030, DOI 10.1128/JVI.76.14.7030-7039.2002; SHRAKE A, 1990, J BIOL CHEM, V265, P5055; Sivaraja M, 2008, 15 INT S HEP C VIR R; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Weber PC, 2003, CURR OPIN STRUC BIOL, V13, P115, DOI 10.1016/S0959-440X(03)00003-4; Winquist J, 2013, ANTIVIR RES, V97, P356, DOI 10.1016/j.antiviral.2012.12.027; Yi GH, 2012, ANTIMICROB AGENTS CH, V56, P830, DOI 10.1128/AAC.05438-11; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	49	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84808	10.1371/journal.pone.0084808	http://dx.doi.org/10.1371/journal.pone.0084808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416288	Green Submitted, gold, Green Published			2022-12-25	WOS:000329866300037
J	Dhakal, S; Joshi, DD; Ale, A; Sharma, M; Dahal, M; Shah, Y; Pant, DK; Stephen, C				Dhakal, Santosh; Joshi, Durga Datt; Ale, Anita; Sharma, Minu; Dahal, Meena; Shah, Yogendra; Pant, Dhan Kumar; Stephen, Craig			Regional Variation in Pig Farmer Awareness and Actions Regarding Japanese Encephalitis in Nepal: Implications for Public Health Education	PLOS ONE			English	Article							VECTOR CONTROL; KNOWLEDGE; PREVENTION; IMPACT; VIRUS; INSECTICIDE; MALARIA; DISEASE; DENGUE	Japanese encephalitis (JE) is a mosquito-borne zoonotic disease that has pigs as the major amplifying hosts. It is the most important cause of viral encephalitis in people in Nepal and is spreading in its geographic distribution in that country. Pig farming is increasing in Nepal due to reducing cultural biases against pigs and government programs to support pig farming for poverty alleviation. Major strategies for JE prevention and control include education, vector control, and immunization of people and pigs. This study used a survey of 400 pig farmers in 4 areas of Nepal with different JE and pig farming histories to explore regional variations in farmer awareness and actions towards JE, the association of awareness and actions with farm and farmer variables, and the implications of these associations for public health education. Exposure to JE risk factors was common across pig farms and pig farming districts but there were significant district level differences in knowledge and practices related to on-farm JE risk reduction. Social factors such as literacy, gender, and cultural practices were associated with farmer attitudes, knowledge and practices for JE control. JE vaccine uptake was almost non-existent and mosquito control steps were inconsistently applied across all 4 districts. Income was not a determining factor of the differences, but all farmers were very poor. The low uptake of vaccine and lack of infrastructure or financial capacity to house pigs indoors or away from people suggest that farmer personal protection should be a priority target for education in Nepal. This study re-enforces the need to attack root causes of people's personal disease prevention behaviours and take into account local variation in needs and capacities when designing health or agriculture education programs.	[Dhakal, Santosh; Joshi, Durga Datt; Ale, Anita; Sharma, Minu; Dahal, Meena; Shah, Yogendra; Pant, Dhan Kumar] Natl Zoonoses & Food Hyg Res Ctr, Kathmandu, Nepal; [Stephen, Craig] Ctr Coastal Hlth, Nanaimo, BC, Canada; [Stephen, Craig] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Stephen, Craig] Univ Calgary, Fac Med, Calgary, AB, Canada	University of Calgary; University of Calgary	Stephen, C (corresponding author), Ctr Coastal Hlth, Nanaimo, BC, Canada.	cstephen@ucalgary.ca	Pant, Dhan/HHN-2817-2022; Shah, Yogendra/AAU-7395-2020; Dhakal, Santosh/J-2906-2019	Shah, Yogendra/0000-0002-0820-4556; Dhakal, Santosh/0000-0002-4494-8608	International Development Research Centre, Ottawa, Canada	International Development Research Centre, Ottawa, Canada	This work was funded by a grant from the International Development Research Centre, Ottawa, Canada (www.idrc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, STAND CHINA; [Anonymous], STAT INF NEP AGR 201; Bista M B, 2005, JNMA J Nepal Med Assoc, V44, P51; dataset] National Institute of Statistics (NIS), 2011, POPULATION HOUSING C; Dhakal S, 2012, ZOONOSES PUBLIC HLTH, V59, P568, DOI 10.1111/j.1863-2378.2012.01498.x; Dutta P, 2011, AM J TROP MED HYG, V84, P466, DOI 10.4269/ajtmh.2011.10-0270; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Henrich TJ, 2003, MICROBES INFECT, V5, P603, DOI 10.1016/S1286-4579(03)00100-X; Houston R, 2003, NEPAL ANAL BASELINE; Igarashi A, 2002, CURR TOP MICROBIOL, V267, P139; Joshi D., 1983, NEPAS J, V2, P18; KLEIN RE, 1995, AM J TROP MED HYG, V52, P383, DOI 10.4269/ajtmh.1995.52.383; LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1; LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247; LUO DP, 1994, T ROY SOC TROP MED H, V88, P629, DOI 10.1016/0035-9203(94)90200-3; Nandha B, 2012, HEALTH EDUC RES, V27, P585, DOI 10.1093/her/cyr045; Obara M, 2011, AM J TROP MED HYG, V84, P695, DOI 10.4269/ajtmh.2011.10-0188; Pant S. D., 2009, Journal of Nepal Paediatric Society, V29, P35, DOI 10.3126/jnps.v29i1.1600; Parajuli MB, 1992, J NEPAL MED ASSOC, V30, P7; Rayamajhi A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-294; SEARO/WHO, 2002, REG COMM PROV AG IT; Sohn YM, 2000, EMERG INFECT DIS; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Subedi G, 2012, NEPAL POPULATION J, V17, P91; UMENAI T, 1985, B WORLD HEALTH ORGAN, V63, P625; van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; WHO-IPD, 2012, REC JE CAS UNPUB; Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x; Yasuoka J, 2006, AM J TROP MED HYG, V74, P1034, DOI 10.4269/ajtmh.2006.74.1034	31	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85399	10.1371/journal.pone.0085399	http://dx.doi.org/10.1371/journal.pone.0085399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416402	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300076
J	Ku, HC; Su, MJ				Ku, Hui-Chun; Su, Ming-Jai			DPP4 Deficiency Preserved Cardiac Function in Abdominal Aortic Banding Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; ANGIOTENSIN-ALDOSTERONE SYSTEM; LEFT-VENTRICULAR PERFORMANCE; MYOCARDIAL GLUCOSE-UPTAKE; HEART-FAILURE; CONSCIOUS DOGS; FAILING HEART; GLP-1; DISEASE	Dipeptidyl peptidase-4 (DPP4) enzyme inhibition has been reported to increase plasma glucagon-like peptide-1 (GLP-1) level for controlling postprandial glucose concentration. A prominent GLP-1 level in DPP4-deficient rats contributed to the resistance of endotoxemia and myocardial infarction. DPP4 deficiency also increased the capability against H2O2-induced stress in cardiomyocyte. However, long term effect of loss DPP4 activity on cardiac performance remained unclear. We used abdominal aortic banding (AAB) to induce pressure overload in wild-type and DPP4-deficient rats, and investigated the progression of heart failure. Cardiac histology and function were determined. Blood sample was collected for the plasma biochemical marker measurement. Heart weight to body weight ratio increased 1.2-fold after 6 weeks of AAB surgery. Cardiac function was compensated against pressure overload after 6 weeks of AAB surgery, but progressed to deterioration after 10 weeks of AAB surgery. AAB induced cardiac dysfunction was alleviated in DPP4-deficient rats. DPP4 activity increased significantly in wild-type rats after 10 weeks of AAB surgery, but remained unchanged in DPP4-deficient rats. In contrast, GLP-1 concentration was elevated by AAB after 6 weeks of surgery in DPP4-deficient rats, and remained high after 10 weeks of surgery. Ang II level markedly increased after 6 weeks of AAB surgery, but were less in DPP4-deficient rats. Massive collagen deposits in wild-type rat hearts appeared after 10 weeks of AAB surgery, which were alleviated in DPP4-deficient rats. Long term deficiency of DPP4 activity improved cardiac performance against pressure overload in rat, which may be attributed to a great quantity of GLP-1 accumulation during AAB.	[Ku, Hui-Chun; Su, Ming-Jai] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan	National Taiwan University	Su, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	mingja@ntu.edu.tw		SU, MING-JAI/0000-0001-8887-6899	National Science Council, Taiwan [NSC 101-2325-B-002 -058, NSC 102-2325-B-002 -056, NSC 102-2325-B-002 -086]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Taiwan (NSC 101-2325-B-002 -058, NSC 102-2325-B-002 -056, and NSC 102-2325-B-002 -086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafian H, 2011, CIRC RES, V109, P86, DOI 10.1161/CIRCRESAHA.111.242974; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Biernacka A, 2011, AGING DIS, V2, P158; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Bouzegrhane F, 2002, CARDIOVASC RES, V53, P304, DOI 10.1016/S0008-6363(01)00448-5; Brilla CG, 2000, CARDIOVASC RES, V47, P1, DOI 10.1016/S0008-6363(00)00092-4; Capuano A, 2013, DRUG DES DEV THER, V7, P989, DOI 10.2147/DDDT.S37647; Carley AN, 2005, BBA-MOL CELL BIOL L, V1734, P112, DOI 10.1016/j.bbalip.2005.03.005; Chaykovska L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027861; Chen WP, 2010, N-S ARCH PHARMACOL, V382, P441, DOI 10.1007/s00210-010-0562-1; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; Dos Santos L, 2013, CIRC HEART FAIL; Doupis J, 2008, ADV THER, V25, P627, DOI 10.1007/s12325-008-0076-1; East JM, 2000, MOL MEMBR BIOL, V17, P189, DOI 10.1080/09687680010009646; FEHMANN HC, 1995, ENDOCR REV, V16, P390, DOI 10.1210/er.16.3.390; Fisman EZ, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-38; Gros R, 2003, ENDOCRINOLOGY, V144, P2242, DOI 10.1210/en.2003-0007; Guinto PJ, 2009, AM J PHYSIOL-HEART C, V297, pH614, DOI 10.1152/ajpheart.01143.2008; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Hirata K, 2009, BIOCHEM BIOPH RES CO, V380, P44, DOI 10.1016/j.bbrc.2009.01.003; Kappe C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-276; Khan MA, 2013, HEART FAIL REV, V18, P141, DOI 10.1007/s10741-012-9318-y; Klemann C, 2009, CLIN EXP IMMUNOL, V155, P357, DOI 10.1111/j.1365-2249.2008.03839.x; Ku HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054518; Ku HC, 2011, N-S ARCH PHARMACOL, V384, P197, DOI 10.1007/s00210-011-0665-3; Ku HC, 2010, N-S ARCH PHARMACOL, V382, P463, DOI 10.1007/s00210-010-0559-9; Lee SA, 2011, J CLIN ENDOCR METAB, V98, P2553; Liao RL, 2002, CIRCULATION, V106, P2125, DOI 10.1161/01.CIR.0000034049.61181.F3; Liu JY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/630537; Liu Q, 2010, CARDIOVASC DIABETOL, V9, DOI [10.1186/1475-2840-9-76, 10.1186/1475-2840-9-32]; Michel MC, 2008, N-S ARCH PHARMACOL, V377, P205, DOI 10.1007/s00210-008-0280-0; Monami M, 2013, DIABETES OBES METAB, V15, P112, DOI 10.1111/dom.12000; Monji A, 2013, AM J PHYSIOL-HEART C, V305, pH295, DOI 10.1152/ajpheart.00990.2012; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ni L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027294; Nikolaidis LA, 2005, AM J PHYSIOL-HEART C, V289, pH2401, DOI 10.1152/ajpheart.00347.2005; Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD; Noyan-Ashraf MH, 2013, CIRCULATION, V127, P74, DOI 10.1161/CIRCULATIONAHA.112.091215; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Patten RD, 2009, CIRC-HEART FAIL, V2, P138, DOI 10.1161/CIRCHEARTFAILURE.108.839761; Rijzewijk LJ, 2009, J AM COLL CARDIOL, V54, P1524, DOI 10.1016/j.jacc.2009.04.074; Sabbah HN, 2000, CARDIOVASC RES, V45, P704, DOI 10.1016/S0008-6363(99)00348-X; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Scheen AJ, 2013, NAT REV CARDIOL, V10, P73, DOI 10.1038/nrcardio.2012.183; Scirica BM, 2013, N ENGL J MED; Skov J, 2013, J CLIN ENDOCR METAB, V98, pE664, DOI 10.1210/jc.2012-3855; Stefan N, 2005, JAMA-J AM MED ASSOC, V294, P2578, DOI 10.1001/jama.294.20.2578-a; Takahashi A, 2013, AM J PHYSIOL-HEART C, V304, pH1361, DOI 10.1152/ajpheart.00454.2012; Thompson MA, 2007, MINI-REV MED CHEM, V7, P253, DOI 10.2174/138955707780059853; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282; Vyas AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017178; Wang XM, 2013, CARDIOVASC DRUG THER, V27, P297, DOI 10.1007/s10557-013-6459-8; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Zhao TC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-90	56	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85634	10.1371/journal.pone.0085634	http://dx.doi.org/10.1371/journal.pone.0085634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416433	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300092
J	Mendes, SO; dos Santos, M; Peterle, GT; Maia, LD; Stur, E; Agostini, LP; de Carvalho, MB; Tajara, EH; Louro, ID; Trivilin, LO; da Silva-Conforti, AMA				Mendes, Suzanny Oliveira; dos Santos, Marcelo; Peterle, Gabriela Tonini; Maia, Lucas de Lima; Stur, Elaine; Agostini, Lidiane Pignaton; de Carvalho, Marcos Brasilino; Tajara, Eloiza Helena; Louro, Iuri Drumond; Trivilin, Leonardo Oliveira; Alvares da Silva-Conforti, Adriana Madeira			HIF-1alpha Expression Profile in Intratumoral and Peritumoral Inflammatory Cells as a Prognostic Marker for Squamous Cell Carcinoma of the Oral Cavity	PLOS ONE			English	Article							SURVIVAL; TARGETS; HEAD	The HIF-1 transcriptional complex is responsible for controlling transcription of over 100 genes involved in cell hypoxia response. HIF-1alpha subunit is stabilized in hypoxia conditions, creating the HIF-1 nuclear transcription factor. In inflammatory cells, high HIF-1alpha expression induces lymphocytic immunosuppression, decreasing tumoral antigen recognition, which promotes tumor growth. The present work investigated the relationship between HIF-1alpha expression in lymphocytes populating the intratumoral and peritumoral region of 56 patients with oral cancer. Our data indicates a prognostic value for this expression. High HIF-1alpha expression in peritumoral inflammatory cells is significantly related to worse patient outcome, whereas high expression in the intratumoral lymphoid cells correlates with a better prognosis. A risk profile indicating the chance of disease relapse and death was designed based on HIF-1alpha expression in tumoral inflammatory cells, defining low, intermediate and high risks. This risk profile was able to determine that high HIF-1alpha expression in peritumoral cells correlates with worse prognosis, independently of intratumoral expression. Low HIF-1alpha in tumor margins and high expression in the tumor was considered a low risk profile, showing no cases of disease relapse and disease related death. Intermediate risk was associated with low expression in tumor and tumor margins. Our results suggest that HIF-1alpha expression in tumor and peritumoral inflammatory cells may play an important role as prognostic tumor marker.	[Mendes, Suzanny Oliveira; dos Santos, Marcelo; Peterle, Gabriela Tonini; Maia, Lucas de Lima; Stur, Elaine; Agostini, Lidiane Pignaton; Louro, Iuri Drumond; Trivilin, Leonardo Oliveira; Alvares da Silva-Conforti, Adriana Madeira] Univ Fed Espirito Santo, Programa Pos Grad Biotecnol Renorbio, Vitoria, ES, Brazil; [dos Santos, Marcelo] Univ Fed Rio Grande do Norte, Dept Med, Caico, RN, Brazil; [de Carvalho, Marcos Brasilino] Hosp Heliopolis, Lab Biol Mol, Sao Paulo, Brazil; [Tajara, Eloiza Helena] Fac Med Sao Jose do Rio Preto, Dept Biol Mol, Sao Paulo, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Rio Grande do Norte	da Silva-Conforti, AMA (corresponding author), Univ Fed Espirito Santo, Programa Pos Grad Biotecnol Renorbio, Vitoria, ES, Brazil.	adriana.biomol@gmail.com	Álvares-da-Silva, Adriana M/J-2912-2018; Louro, Iuri D/I-8641-2012; Tajara, Eloiza H/G-7586-2012; dos Santos, Marcelo/K-2582-2012; Tonini Peterle, Gabriela/GWU-6986-2022; Brasilino de Carvalho, Marcos/C-1869-2014	Álvares-da-Silva, Adriana M/0000-0002-8078-0304; Tajara, Eloiza H/0000-0002-2603-2057; dos Santos, Marcelo/0000-0001-7321-7479; Brasilino de Carvalho, Marcos/0000-0001-6854-2680; Louro, Iuri/0000-0001-5160-9615; STUR, ELAINE/0000-0001-5962-0050	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/12054-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES) [54653363]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grant 04/12054-9), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES grant 54653363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GLOBOCAN 2008 V2 0 C; Bauman JE, 2012, CURR OPIN ONCOL, V24, P235, DOI 10.1097/CCO.0b013e3283517920; Binahmed A, 2007, ORAL ONCOL, V43, P780, DOI 10.1016/j.oraloncology.2006.10.001; Campos AHJFM, 2009, MOL CELL BIOCHEM, V321, P95, DOI 10.1007/s11010-008-9923-1; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Deschler DG, 2008, POCKET GUIDE NECK DI; Dong M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0355-0; Kaya AO, 2012, J BUON, V17, P663; Kim JH, 2012, ONCOL REP, V28, P1701, DOI 10.3892/or.2012.2012; Lim YC, 2008, ACTA OTO-LARYNGOL, V128, P1132, DOI 10.1080/00016480801901691; Macarthur M, 2004, AM J PHYSIOL-GASTR L, V286, pG515, DOI 10.1152/ajpgi.00475.2003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mohammed ZMA, 2012, CANCER TREAT REV, V38, P943, DOI 10.1016/j.ctrv.2012.04.011; Palazon A, 2012, CANCER DISCOV, V2, P608, DOI 10.1158/2159-8290.CD-11-0314; SANTOS MD, 2012, PLOS ONE, V0007; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Soini Y, 2000, BRIT J CANCER, V83, P880, DOI 10.1054/bjoc.2000.1384; Thiel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000853; Tougeron D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061001; Yadav GS, 2013, ACTA CYTOL, V57, P75, DOI 10.1159/000342916	23	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84923	10.1371/journal.pone.0084923	http://dx.doi.org/10.1371/journal.pone.0084923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416312	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300042
J	Messing, J; Thole, C; Niehues, M; Shevtsova, A; Glocker, E; Boren, T; Hensel, A				Messing, Jutta; Thoele, Christian; Niehues, Michael; Shevtsova, Anna; Glocker, Erik; Boren, Thomas; Hensel, Andreas			Antiadhesive Properties of Abelmoschus esculentus (Okra) Immature Fruit Extract against Helicobacter pylori Adhesion	PLOS ONE			English	Article							INHIBIT ADHESION; BINDING; INFECTION; LIPOPOLYSACCHARIDE; POLYSACCHARIDES; RECURRENCE; LAMININ; PROTEIN; MILK	Background: Traditional Asian and African medicine use immature okra fruits (Abelmoschus esculentus) as mucilaginous food to combat gastritis. Its effectiveness is due to polysaccharides that inhibit the adhesion of Helicobacter pylori to stomach tissue. The present study investigates the antiadhesive effect in mechanistic detail. Methodology: A standardized aqueous fresh extract (Okra FE) from immature okra fruits was used for a quantitative in vitro adhesion assay with FITC-labled H. pylori J99, 2 clinical isolates, AGS cells, and fluorescence-activated cell sorting. Bacterial adhesins affected by FE were pinpointed using a dot-blot overlay assay with immobilized Lewis(b), sialyl-Lewis(a), H-1, laminin, and fibronectin. I-125-radiolabeled Okra FE polymer served for binding studies to different H. pylori strains and interaction experiments with BabA and SabA. Iron nanoparticles with different coatings were used to investigate the influence of the charge-dependence of an interaction on the H. pylori surface. Principal findings: Okra FE dose-dependently (0.2 to 2 mg/mL) inhibited H. pylori binding to AGS cells. FE inhibited the adhesive binding of membrane proteins BabA, SabA, and HpA to its specific ligands. Radiolabeled compounds from FE bound non-specifically to different strains of H. pylori, as well as to BabA/SabA deficient mutants, indicating an interaction with a still-unknown membrane structure in the vicinity of the adhesins. The binding depended on the charge of the inhibitors. Okra FE did not lead to subsequent feedback regulation or increased expression of adhesins or virulence factors. Conclusion: Non-specific interactions between high molecular compounds from okra fruits and the H. pylori surface lead to strong antiadhesive effects.	[Messing, Jutta; Thoele, Christian; Niehues, Michael; Hensel, Andreas] Univ Munster, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany; [Shevtsova, Anna; Boren, Thomas] Umea Univ, Umea, Sweden; [Glocker, Erik] Univ Hosp Freiburg, Dept Med Microbiol & Hyg, Reference Ctr Helicobacter Pylori, Freiburg, Germany	University of Munster; Umea University; University of Freiburg	Hensel, A (corresponding author), Univ Munster, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany.	ahensel@uni-muenster.de			German Research Foundation, DFG (International Research Training Group 1549 Molecular and Cellular Glyco-Sciences MCGS, Munster Hyderabad); Vetenskapsradet/VR(M), Cancerfonden	German Research Foundation, DFG (International Research Training Group 1549 Molecular and Cellular Glyco-Sciences MCGS, Munster Hyderabad)(German Research Foundation (DFG)); Vetenskapsradet/VR(M), Cancerfonden	Financial support by the German Research Foundation, DFG (International Research Training Group 1549 Molecular and Cellular Glyco-Sciences MCGS, Munster Hyderabad), to AH, JM, and CT and from Vetenskapsradet/VR(M), Cancerfonden to TB is acknowledged, and was in part performed within the Umea Centre for Microbial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Dubois A, 1999, GASTROENTEROLOGY, V116, P90, DOI 10.1016/S0016-5085(99)70232-5; Gisbert JP, 2005, AM J GASTROENTEROL, V100, P2083, DOI 10.1111/j.1572-0241.2005.50043.x; Gloaguen V, 2007, PLANTA MED, V73, P1402, DOI 10.1055/s-2007-990237; Hirmo S, 1998, FEMS IMMUNOL MED MIC, V20, P275, DOI 10.1111/j.1574-695X.1998.tb01137.x; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Khamri W, 2005, INFECT IMMUN, V73, P7677, DOI 10.1128/IAI.73.11.7677-7686.2005; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Lengsfeld C, 2004, PLANTA MED, V70, P620, DOI 10.1055/s-2004-827184; Lengsfeld C, 2004, J AGR FOOD CHEM, V52, P1495, DOI 10.1021/jf030666n; Lengsfeld C, 2007, ANIM FEED SCI TECH, V135, P113, DOI 10.1016/j.anifeedsci.2006.11.017; Linden S, 2002, GASTROENTEROLOGY, V123, P1923, DOI 10.1053/gast.2002.37076; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Mysore JV, 1999, GASTROENTEROLOGY, V117, P1316, DOI 10.1016/S0016-5085(99)70282-9; Niehues A., 2010, MOL NUTR FOOD RES, V54, P1; Niehues M, 2010, International Patent application, Patent No. [PCT/NL2010/050158, 2010050158]; Niv Y, 2008, WORLD J GASTROENTERO, V14, P1477, DOI 10.3748/wjg.14.1477; Odenbreit S, 2002, INT J MED MICROBIOL, V292, P247, DOI 10.1078/1438-4221-00204; Odenbreit S, 1999, MOL MICROBIOL, V31, P1537, DOI 10.1046/j.1365-2958.1999.01300.x; Parente F, 2003, HELICOBACTER, V8, P252, DOI 10.1046/j.1523-5378.2003.00152.x; Selgrad M, 2011, CURR OPIN GASTROEN, V27, P565, DOI 10.1097/MOG.0b013e32834bb818; Sengkhamparn N, 2009, CARBOHYD RES, V344, P1824, DOI 10.1016/j.carres.2008.10.012; Sengkhamparn N, 2009, CARBOHYD RES, V344, P1842, DOI 10.1016/j.carres.2008.11.022; Shmuely H, 2004, DIAGN MICR INFEC DIS, V50, P231, DOI 10.1016/j.diagmicrobio.2004.08.011; Simon PM, 1997, INFECT IMMUN, V65, P750, DOI 10.1128/IAI.65.2.750-757.1997; Stingl K, 2005, INT J MED MICROBIOL, V295, P307, DOI 10.1016/j.ijmm.2005.06.006; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; VALKONEN KH, 1993, FEMS IMMUNOL MED MIC, V7, P29, DOI 10.1111/j.1574-695X.1993.tb00378.x; Valkonen KH, 1997, INFECT IMMUN, V65, P916, DOI 10.1128/IAI.65.3.916-923.1997; Van de Bovenkamp JHB, 2003, HELICOBACTER, V8, P521, DOI 10.1046/j.1523-5378.2003.00173.x; Wittschier N, 2007, PHYTOMEDICINE, V14, P285, DOI 10.1016/j.phymed.2006.12.008; Wittschier N, 2009, J ETHNOPHARMACOL, V125, P218, DOI 10.1016/j.jep.2009.07.009; Yamaoka Yoshio, 2008, P37	37	44	50	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84836	10.1371/journal.pone.0084836	http://dx.doi.org/10.1371/journal.pone.0084836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416297	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300039
J	Finucane, MM; Sharpton, TJ; Laurent, TJ; Pollard, KS				Finucane, Mariel M.; Sharpton, Thomas J.; Laurent, Timothy J.; Pollard, Katherine S.			A Taxonomic Signature of Obesity in the Microbiome? Getting to the Guts of the Matter	PLOS ONE			English	Article							ECOLOGY	Obesity is an important and intractable public health problem. In addition to the well-known risk factors of behavior, diet, and genetics, gut microbial communities were recently identified as another possible source of risk and a potential therapeutic target. However, human and animal-model studies have yielded conflicting results about the precise nature of associations between microbiome composition and obesity. In this paper, we use publicly available data from the Human Microbiome Project (HMP) and MetaHIT, both surveys of healthy adults that include obese individuals, plus two smaller studies that specifically examined lean versus obese adults. We find that inter-study variability in the taxonomic composition of stool microbiomes far exceeds differences between lean and obese individuals within studies. Our analyses further reveal a high degree of variability in stool microbiome composition and diversity across individuals. While we confirm the previously published small, but statistically significant, differences in phylum-level taxonomic composition between lean and obese individuals in several cohorts, we find no association between BMI and taxonomic composition of stool microbiomes in the larger HMP and MetaHIT datasets. We explore a range of different statistical techniques and show that this result is robust to the choice of methodology. Differences between studies are likely due to a combination of technical and clinical factors. We conclude that there is no simple taxonomic signature of obesity in the microbiota of the human gut.	[Finucane, Mariel M.; Sharpton, Thomas J.; Laurent, Timothy J.; Pollard, Katherine S.] J David Gladstone Inst, San Francisco, CA USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pollard, KS (corresponding author), J David Gladstone Inst, San Francisco, CA USA.	kpollard@gladstone.ucsf.edu		Sharpton, Thomas/0000-0002-5996-7764	National Science Foundation [DMS-1069303]; NIH Roadmap for Medical Research	National Science Foundation(National Science Foundation (NSF)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation (grant #DMS-1069303) and a gift from the San Simeon Fund. Funding support for the development of NIH Human Microbiome Project - Core Microbiome Sampling Protocol A (HMP-A) was provided by the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO; Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Davidsen T, 2010, NUCLEIC ACIDS RES, V38, pD340, DOI 10.1093/nar/gkp912; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Graessler J, 2012, PHARMACOGENOMICS J, V2012, P1; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Sweeney TE, 2013, JAMA SURG, P1; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Zimmer C, 2010, NY TIMES, pD1	31	212	217	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84689	10.1371/journal.pone.0084689	http://dx.doi.org/10.1371/journal.pone.0084689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416266	gold, Green Published			2022-12-25	WOS:000329862500149
J	Gao, Q; Ju, ZH; Zhang, Y; Huang, JM; Zhang, XJ; Qi, C; Li, JB; Zhong, JF; Li, GR; Wang, CF				Gao, Qing; Ju, Zhihua; Zhang, Yan; Huang, Jinming; Zhang, Xiaojian; Qi, Chao; Li, Jianbin; Zhong, Jifeng; Li, Guorong; Wang, Changfa			Association of TNP2 Gene Polymorphisms of the bta-miR-154 Target Site with the Semen Quality Traits of Chinese Holstein Bulls	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SPERMATIDAL PROTEIN TP2; DAIRY-CATTLE; MICRORNAS; EXPRESSION; SEQUENCE; MOUSE; PRM1; IDENTIFICATION; LOCALIZATION	Transition protein 2 (TNP2) participates in removing nucleohistones and the initial condensation of spermatid nucleus during spermiogenesis. This study investigated the relationship between the variants of the bovine TNP2 gene and the semen quality traits of Chinese Holstein bulls. We detected three single nucleotide polymorphisms (SNPs) of the TNP2 gene in 392 Chinese Holstein bulls, namely, g.269 G>A (exon 1), g.480 C>T (intron 1), and g.1536 C>T (3'-UTR). Association analysis showed that the semen quality traits of the Chinese Holstein bulls was significantly affected by the three SNPs. The bulls with the haplotypic combinations H6H4, H6H6, and H6H8 had higher initial semen motility than those with the H7H8 and H8H4 haplotypic combinations (P<0.05). SNPs in the microRNA (miRNA) binding region of the TNP2 gene 3'-UTR may have contributed to the phenotypic differences. The phenotypic differences are caused by the altered expression of the miRNAs and their targets. Bioinformatics analysis predicted that the g.1536 C>T site in the TNP2 3'-UTR is located in the bta-miR-154 binding region. The quantitative real-time polymerase chain reaction results showed that the TNP2 mRNA relative expression in bulls with the CT and CC genotypes was significantly higher than those with the TT genotype (P<0.05) in the g.1536 C>T site. The luciferase assay also indicated that bta-miR-154 directly targets TNP2 in a murine Leydig cell tumor cell line. The SNP g.1536 C>T in the TNP2 3'-UTR, which altered the binding of TNP2 with bta-miR-154, was found to be associated with the semen quality traits of Chinese Holstein bulls.	[Gao, Qing; Ju, Zhihua; Zhang, Yan; Huang, Jinming; Zhang, Xiaojian; Qi, Chao; Li, Jianbin; Zhong, Jifeng; Wang, Changfa] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Peoples R China; [Gao, Qing; Li, Guorong] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Normal University	Li, GR (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China.	liguorong66@hotmail.com		Li, Jianbin/0000-0002-9587-2666	National Science and Technology Pillar Program during the 12th Five-Year Plan of China [2011BAD19B02, 2011BAD19B04]; Modern Agro-industry Technology Research System [CARS-37]; State Major Project of Transgenic [2011ZX08007-004]; National Natural Science Foundation of China [31271328, 31371255]; Well-bred Program of Shandong Province [2012LZ10-06]; Key Scientific and Technological Project of Shandong Province [2009GG20002033]	National Science and Technology Pillar Program during the 12th Five-Year Plan of China; Modern Agro-industry Technology Research System; State Major Project of Transgenic; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Well-bred Program of Shandong Province; Key Scientific and Technological Project of Shandong Province	This work was partially supported by grants the National Science and Technology Pillar Program during the 12th Five-Year Plan of China (Grant no. 2011BAD19B02 and 2011BAD19B04), the Modern Agro-industry Technology Research System (Grant no. CARS-37), State Major Project of Transgenic (2011ZX08007-004), the National Natural Science Foundation of China (31271328 and 31371255), the Well-bred Program of Shandong Province (Grant no. 2012LZ10-06), and the Key Scientific and Technological Project of Shandong Province (Gran' no. 2009GG20002033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carletti MZ, 2009, J ANIM SCI, V87, pE29, DOI 10.2527/jas.2008-1331; Chandra V, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S2; COLE KD, 1987, BIOCHEM BIOPH RES CO, V147, P437, DOI 10.1016/S0006-291X(87)80140-7; ENGEL W, 1992, CYTOGENET CELL GENET, V61, P158, DOI 10.1159/000133397; Fridel R, 1994, MAMM GENOME, V5, P523; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hou QL, 2012, DNA CELL BIOL, V31, P739, DOI 10.1089/dna.2011.1402; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; KIERSZENBAUM AL, 1975, J CELL BIOL, V65, P258, DOI 10.1083/jcb.65.2.258; KLEENE KC, 1989, DEVELOPMENT, V106, P367; Kramer JA, 1998, COMP BIOCHEM PHYS C, V120, P467, DOI 10.1016/S0742-8413(98)10062-2; Kundu TK, 1996, BIOCHEMISTRY-US, V35, P15626, DOI 10.1021/bi961271i; Li LM, 2012, IMMUNOGENETICS, V64, P817, DOI 10.1007/s00251-012-0641-1; Liao Y, 2010, INT J BIOCHEM CELL B, V42, P1363, DOI 10.1016/j.biocel.2009.07.019; LUERSSEN H, 1990, GENOMICS, V8, P324, DOI 10.1016/0888-7543(90)90289-7; Meetei AR, 2000, J BIOL CHEM, V275, P38500, DOI 10.1074/jbc.M002734200; Meistrich M., 1989, HISTONES OTHER BASIC, P165; Meistrich ML, 1993, MOL BIOL MALE REPROD, P67; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; REBOIS RV, 1982, J CELL BIOL, V94, P70, DOI 10.1083/jcb.94.1.70; REINHART N, 1991, BIOL CHEM H-S, V372, P431, DOI 10.1515/bchm3.1991.372.1.431; Reshmi G, 2011, GENOMICS, V98, P189, DOI 10.1016/j.ygeno.2011.06.005; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Tseden K, 2007, MOL REPROD DEV, V74, P273, DOI 10.1002/mrd.20570; WYKES SM, 1995, DNA CELL BIOL, V14, P155, DOI 10.1089/dna.1995.14.155; Wykes SM, 2003, DNA SEQUENCE, V14, P359, DOI 10.1080/10425170310001599453; Yan NH, 2009, J ASSIST REPROD GEN, V26, P179, DOI 10.1007/s10815-009-9305-y; Zan LinSen, 2007, Scientia Agricultura Sinica, V40, P1498; Zhang CL, 2007, ANAL BIOCHEM, V365, P286, DOI 10.1016/j.ab.2007.03.023; Zhao Chun-Jiang, 2003, Yichuan, V25, P327; Zhao M, 2001, MOL CELL BIOL, V21, P7243, DOI 10.1128/MCB.21.21.7243-7255.2001	34	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84355	10.1371/journal.pone.0084355	http://dx.doi.org/10.1371/journal.pone.0084355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416221	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500118
J	McGowan, NE; Marks, NJ; McInnes, CJ; Deane, D; Maule, AG; Scantlebury, M				McGowan, Natasha E.; Marks, Nikki J.; McInnes, Colin J.; Deane, David; Maule, Aaron G.; Scantlebury, Michael			Effects of Parasitism and Morphology on Squirrelpox Virus Seroprevalence in Grey Squirrels (Sciurus carolinensis)	PLOS ONE			English	Article							RED SQUIRRELS; LANDSCAPE SCALE; SPLEEN SIZE; POXVIRUS; TESTOSTERONE; VULGARIS; DISEASE; DOMINANCE; DYNAMICS; DECLINE	Invasive species have been cited as major causes of population extinctions in several animal and plant classes worldwide. The North American grey squirrel (Sciurus carolinensis) has a major detrimental effect on native red squirrel (Sciurus vulgaris) populations across Britain and Ireland, in part because it can be a reservoir host for the deadly squirrelpox virus (SQPV). Whilst various researchers have investigated the epizootiology of SQPV disease in grey squirrels and have modelled the consequent effects on red squirrel populations, less work has examined morphological and physiological characteristics that might make individual grey squirrels more susceptible to contracting SQPV. The current study investigated the putative relationships between morphology, parasitism, and SQPV exposure in grey squirrels. We found geographical, sex, and morphological differences in SQPV seroprevalence. In particular, larger animals, those with wide zygomatic arch widths (ZAW), males with large testes, and individuals with concurrent nematode and/or coccidial infections had an increased seroprevalence of SQPV. In addition, males with larger spleens, particularly those with narrow ZAW, were more likely to be exposed to SQPV. Overall these results show that there is variation in SQPV seroprevalence in grey squirrels and that, consequently, certain individual, or populations of, grey squirrels might be more responsible for transmitting SQPV to native red squirrel populations.	[McGowan, Natasha E.; Marks, Nikki J.; Maule, Aaron G.; Scantlebury, Michael] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [McInnes, Colin J.; Deane, David] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland	Queens University Belfast; Moredun Research Institute	Scantlebury, M (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	m.scantlebury@qub.ac.uk		Maule, Aaron/0000-0003-0862-2667; McInnes, Colin/0000-0002-1465-9901	Scottish Government	Scottish Government	The research was supported by Queen's University Belfast and by the Northern Ireland Forest Service, which provided the specimens. CJM and DD were funded by the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basekim CC, 2000, ABDOM IMAGING, V25, P322; Bell BD, 2004, BIOL CONSERV, V120, P189, DOI 10.1016/j.biocon.2004.02.011; Bertolino S, 2003, BIOL CONSERV, V109, P351, DOI 10.1016/S0006-3207(02)00161-1; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; BOAG B, 1988, J WILDLIFE DIS, V24, P450, DOI 10.7589/0090-3558-24.3.450; Boonstra R, 2008, GEN COMP ENDOCR, V158, P61, DOI 10.1016/j.ygcen.2008.05.004; BOOTS M, 1994, ECOL ENTOMOL, V19, P319, DOI 10.1111/j.1365-2311.1994.tb00248.x; Burbidge AA, 2002, J BIOGEOGR, V29, P465, DOI 10.1046/j.1365-2699.2002.00699.x; Cattadori IM, 2008, INT J PARASITOL, V38, P371, DOI 10.1016/j.ijpara.2007.08.004; Chandra R.K., 1977, NUTR IMMUNITY INFECT; Crawley MJ, 2005, STAT INTRO USING R; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Crump JA, 2001, EMERG INFECT DIS, V7, P767; Denk AG, 2006, J ORNITHOL, V147, P436, DOI 10.1007/s10336-005-0031-7; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Gurnell J, 2006, BIOL CONSERV, V131, P287, DOI 10.1016/j.biocon.2006.04.009; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hojesjo J, 2007, J FISH BIOL, V70, P257, DOI 10.1111/j.1095-8649.2006.01299.x; Hopkins GHE, 1971, NAT HIST, V5, P530; JOYNER LP, 1966, PARASITOLOGY, V56, P531, DOI 10.1017/S0031182000069018; Kenward RE, 1985, S BR ECOL SOC, V25, P319; Kirkpatrick A, 2010, NATURE ED KNOWLEDGE, V1, P13; Koprowski JL, 1996, J MAMMAL, V77, P1006, DOI 10.2307/1382781; Koprowski JL, 2007, RODENT SOC; Lo CM, 1998, INT J PARASITOL, V28, P1695, DOI 10.1016/S0020-7519(98)00140-4; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; McCurdy DG, 1998, OIKOS, V82, P303, DOI 10.2307/3546970; McInnes CJ, 2013, ANIM CONSERV, V16, P51, DOI 10.1111/j.1469-1795.2012.00570.x; McInnes CJ, 2006, J GEN VIROL, V87, P2115, DOI 10.1099/vir.0.81966-0; Morand S, 2000, CAN J ZOOL, V78, P1356, DOI 10.1139/cjz-78-8-1356; Obon E, 2011, VET REC, V168, P86, DOI 10.1136/vr.d204; Poole A, 2009, BIODIVERS CONSERV, V18, P3205, DOI 10.1007/s10531-009-9637-z; R Development Core Team R, 2009, R LANG ENV STAT COMP; Rettew JA, 2008, BIOL REPROD, V78, P432, DOI 10.1095/biolreprod.107.063545; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Rushton SP, 1997, J APPL ECOL, V34, P1137, DOI 10.2307/2405227; Russell AF, 2004, EVOLUTION, V58, P1600; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; Scantlebury M, 2010, J ZOOL, V282, P246, DOI 10.1111/j.1469-7998.2010.00734.x; Shutler D, 1999, CAN J ZOOL, V77, P351, DOI 10.1139/cjz-77-3-351; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39; Thomas K, 2003, J GEN VIROL, V84, P3337, DOI 10.1099/vir.0.19464-0; Tompkins DM, 2002, P ROY SOC B-BIOL SCI, V269, P529, DOI 10.1098/rspb.2001.1897; Vicente J, 2007, NATURWISSENSCHAFTEN, V94, P581, DOI 10.1007/s00114-007-0231-5; Wang LJ, 2008, WORLD J GASTROENTERO, V14, P5125, DOI 10.3748/wjg.14.5125; WAUTERS LA, 1995, OIKOS, V72, P402, DOI 10.2307/3546126; WEBLEY GE, 1983, MAMMAL REV, V13, P149, DOI 10.1111/j.1365-2907.1983.tb00275.x; WEBLEY GE, 1985, GEN COMP ENDOCR, V59, P15, DOI 10.1016/0016-6480(85)90414-9; WICKINGS EJ, 1992, PHYSIOL BEHAV, V52, P909, DOI 10.1016/0031-9384(92)90370-H; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; YAN GY, 1995, AM NAT, V146, P795, DOI 10.1086/285825; [No title captured]; [No title captured]	54	3	3	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83106	10.1371/journal.pone.0083106	http://dx.doi.org/10.1371/journal.pone.0083106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416155	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500028
J	Semmineh, NB; Xu, JZ; Boxerman, JL; Delaney, GW; Cleary, PW; Gore, JC; Quarles, CC				Semmineh, Natenael B.; Xu, Junzhong; Boxerman, Jerrold L.; Delaney, Gary W.; Cleary, Paul W.; Gore, John C.; Quarles, C. Chad			An Efficient Computational Approach to Characterize DSC-MRI Signals Arising from Three-Dimensional Heterogeneous Tissue Structures	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; BRAIN-TUMOR; CONTRAST AGENTS; GRADIENT-ECHO; MAGNETIC-SUSCEPTIBILITY; PERFUSION MEASUREMENTS; TRANSVERSE RELAXATION; FIELD INHOMOGENEITY; KINASE INHIBITOR; FRACTAL MODELS	The systematic investigation of susceptibility-induced contrast in MRI is important to better interpret the influence of microvascular and microcellular morphology on DSC-MRI derived perfusion data. Recently, a novel computational approach called the Finite Perturber Method (FPM), which enables the study of susceptibility-induced contrast in MRI arising from arbitrary microvascular morphologies in 3D has been developed. However, the FPM has lower efficiency in simulating water diffusion especially for complex tissues. In this work, an improved computational approach that combines the FPM with a matrix-based finite difference method (FDM), which we call the Finite Perturber the Finite Difference Method (FPFDM), has been developed in order to efficiently investigate the influence of vascular and extravascular morphological features on susceptibility-induced transverse relaxation. The current work provides a framework for better interpreting how DSC-MRI data depend on various phenomena, including contrast agent leakage in cancerous tissues and water diffusion rates. In addition, we illustrate using simulated and micro-CT extracted tissue structures the improved FPFDM along with its potential applications and limitations.	[Semmineh, Natenael B.; Xu, Junzhong; Gore, John C.; Quarles, C. Chad] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Semmineh, Natenael B.; Gore, John C.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Xu, Junzhong; Gore, John C.; Quarles, C. Chad] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Boxerman, Jerrold L.] Rhode Isl Hosp, Dept Diagnost Imaging, Providence, RI USA; [Boxerman, Jerrold L.] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Providence, RI 02903 USA; [Delaney, Gary W.; Cleary, Paul W.] CSIRO Math & Informat Sci, Clayton, Vic, Australia; [Gore, John C.; Quarles, C. Chad] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Quarles, C. Chad] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Vanderbilt University; Vanderbilt University	Quarles, CC (corresponding author), Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	chad.quarles@vanderbilt.edu	Cleary, Paul W/E-3965-2010; Quarles, Chad/V-1168-2019; Boxerman, Jerrold/AAH-3471-2020; Delaney, Gary W/B-3728-2009; Xu, junzhong/E-6731-2010	Cleary, Paul W/0000-0002-6481-3284; Boxerman, Jerrold/0000-0002-0594-1542; Xu, junzhong/0000-0001-7895-4232	National Institutes of Health [NIH/NCI K99/R00 CA127599, NIH/NCI R01 CA158079, P30 CA068485, NCI U24 CA126588]; NATIONAL CANCER INSTITUTE [K99CA127599, P30CA068485, R01CA158079, U24CA126588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health through NIH/NCI K99/R00 CA127599, NIH/NCI R01 CA158079, P30 CA068485, NCI U24 CA126588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Aronen HJ, 2000, CLIN CANCER RES, V6, P2189; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Beaumont M, 2009, J CEREBR BLOOD F MET, V29, P1714, DOI 10.1038/jcbfm.2009.86; Bjornerud A, 2011, J CEREBR BLOOD F MET, V31, P2041, DOI 10.1038/jcbfm.2011.52; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Boxerman JL, 2013, AJNR AM J NEURORADIO; Brix G, 1999, RADIOLOGY, V210, P269, DOI 10.1148/radiology.210.1.r99ja46269; Bruening R, 1996, AM J NEURORADIOL, V17, P831; Christen T, 2012, MAGN RESON MED, V67, P1458, DOI 10.1002/mrm.23094; Delaney GW, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/34002; Donahue KM, 2000, MAGNET RESON MED, V43, P845, DOI 10.1002/1522-2594(200006)43:6<845::AID-MRM10>3.0.CO;2-J; FISEL CR, 1991, MAGNET RESON MED, V17, P336, DOI 10.1002/mrm.1910170206; Frohlich AF, 2005, MAGN RESON MED, V53, P564, DOI 10.1002/mrm.20394; Gabrys E, 2006, CHAOS SOLITON FRACT, V27, P1, DOI 10.1016/j.chaos.2005.02.009; Gabrys E, 2005, CHAOS SOLITON FRACT, V24, P707, DOI 10.1016/j.chaos.2004.09.087; Hall MG, 2009, IEEE T MED IMAGING, V28, P1354, DOI 10.1109/TMI.2009.2015756; Hwang SN, 2003, MAGNET RESON MED, V50, P373, DOI 10.1002/mrm.10536; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Karshafian R, 2003, PHYS MED BIOL, V48, P3225, DOI 10.1088/0031-9155/48/19/009; KENNAN RP, 1994, MAGNET RESON MED, V31, P9, DOI 10.1002/mrm.1910310103; Kiselev VG, 1999, MAGN RESON MED, V41, P499, DOI 10.1002/(SICI)1522-2594(199903)41:3<499::AID-MRM12>3.0.CO;2-O; Kiselev VG, 2001, MAGN RESON MED, V46, P1113, DOI 10.1002/mrm.1307; Kjolby BF, 2006, MAGN RESON MED, V56, P187, DOI 10.1002/mrm.20920; Klassen LM, 2007, BIOPHYS J, V92, P1014, DOI 10.1529/biophysj.106.087965; Lemasson B, 2010, RADIOLOGY, V257, P342, DOI 10.1148/radiol.10092343; MAEDA M, 1993, RADIOLOGY, V189, P233, DOI 10.1148/radiology.189.1.8372199; Mangla R, 2011, AM J NEURORADIOL, V32, P1004, DOI 10.3174/ajnr.A2441; Marques JP, 2005, CONCEPT MAGN RESON B, V25B, P65, DOI 10.1002/cmr.b.20034; Marty B, 2013, CONTRAST MEDIA MOL I, V8, P12, DOI 10.1002/cmmi.1489; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Newman GC, 2006, J CEREBR BLOOD F MET, V26, P760, DOI 10.1038/sj.jcbfm.9600242; OGAWA S, 1990, MAGNET RESON MED, V16, P9, DOI 10.1002/mrm.1910160103; Pannetier NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057636; Pathak AP, 2003, J MAGN RESON IMAGING, V18, P397, DOI 10.1002/jmri.10371; Pathak AP, 2008, NEUROIMAGE, V40, P1130, DOI 10.1016/j.neuroimage.2008.01.022; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Pintaske J, 2006, INVEST RADIOL, V41, P213, DOI 10.1097/01.rli.0000197668.44926.f7; Quarles CC, 2009, PHYS MED BIOL, V54, P5749, DOI 10.1088/0031-9155/54/19/006; ROSEN BR, 1991, MAGNET RESON MED, V19, P285, DOI 10.1002/mrm.1910190216; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Rybaczuk Marek, 2002, Med Sci Monit, V8, pMT145; Salomir R, 2003, CONCEPT MAGN RESON B, V19B, P26, DOI 10.1002/cmr.b.10083; Schreiner W, 1996, J THEOR BIOL, V180, P161, DOI 10.1006/jtbi.1996.0092; Siegal T, 1997, J NEUROSURG, V86, P22, DOI 10.3171/jns.1997.86.1.0022; Simpson NE, 1999, MAGN RESON MED, V42, P42, DOI 10.1002/(SICI)1522-2594(199907)42:1<42::AID-MRM8>3.0.CO;2-Z; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Sourbron S, 2009, MAGN RESON MED, V62, P672, DOI 10.1002/mrm.22042; Sourbron S, 2013, MAGN RESON MED, V69, P1430, DOI 10.1002/mrm.24383; Stables LA, 1998, MAGNET RESON MED, V40, P432, DOI 10.1002/mrm.1910400314; Sugahara T, 2001, AM J NEURORADIOL, V22, P1306; Sugahara T, 2000, AM J NEURORADIOL, V21, P901; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; WEISSKOFF RM, 1992, MAGNET RESON MED, V24, P375, DOI 10.1002/mrm.1910240219; Xu JZ, 2007, PHYS MED BIOL, V52, pN111, DOI 10.1088/0031-9155/52/7/N01; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610	58	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84764	10.1371/journal.pone.0084764	http://dx.doi.org/10.1371/journal.pone.0084764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416281	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500164
J	Wolf, W; Meese, K; Seedorf, M				Wolf, Wendelin; Meese, Klaus; Seedorf, Matthias			Ist2 in the Yeast Cortical Endoplasmic Reticulum Promotes Trafficking of the Amino Acid Transporter Bap2 to the Plasma Membrane	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; H+-ATPASE; TRYPTOPHAN PERMEASE; CYTOSOLIC PH; FLUORESCENT PROTEINS; INTRACELLULAR PH; CONTACT SITES; PROTON PUMPS; ER; VACUOLAR	The equipment of the plasma membrane in Saccharomyces cerevisiae with specific nutrient transporters is highly regulated by transcription, translation and protein trafficking allowing growth in changing environments. The activity of these transporters depends on a H+ gradient across the plasma membrane generated by the H+-ATPase Pma1. We found that the polytopic membrane protein Ist2 in the cortical endoplasmic reticulum (ER) is required for efficient leucine uptake during the transition from fermentation to respiration. Experiments employing tandem fluorescence timer protein tag showed that Ist2 was necessary for efficient trafficking of newly synthesized leucine transporter Bap2 from the ER to the plasma membrane. This finding explains the growth defect of ist2 Delta mutants during nutritional challenges and illustrates the important role of physical coupling between cortical ER and plasma membrane.	[Wolf, Wendelin; Meese, Klaus; Seedorf, Matthias] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Seedorf, M (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Allianz, Heidelberg, Germany.	m.seedorf@zmbh.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SE811/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SE811/5-2; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Ayer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044278; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Brachmann CB, 1998, YEAST, V14, P115; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cohen R, 2007, FEMS MICROBIOL LETT, V273, P239, DOI 10.1111/j.1574-6968.2007.00798.x; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; ENTIAN KD, 1986, MICROBIOL SCI, V3, P366; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; Fernandes AR, 2003, YEAST, V20, P207, DOI 10.1002/yea.957; Fischer MA, 2009, TRAFFIC, V10, P1084, DOI 10.1111/j.1600-0854.2009.00926.x; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johansen Jesper, 2012, Cell Logist, V2, P151; Khmelinskii A, 2012, NAT BIOTECHNOL; Khmelinskii A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023794; Kim Y, 2005, EUKARYOT CELL, V4, P281, DOI 10.1128/EC.4.2.281-288.2005; Kim Y, 2003, P NATL ACAD SCI USA, V100, P15458, DOI 10.1073/pnas.2136651100; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Peters LZ, 2013, J CELL BIOL, V201, P663, DOI 10.1083/jcb.201211146; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Rubio-Texeira M, 2012, NAT CHEM BIOL, V8, P400, DOI [10.1038/NCHEMBIO.910, 10.1038/nchembio.910]; Samarao SS, 2009, BBA-BIOMEMBRANES, V1788, P303, DOI 10.1016/j.bbamem.2008.11.006; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Stradalova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035132; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; VALLEJO CG, 1989, YEAST, V5, P307, DOI 10.1002/yea.320050411; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Wolf W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039703; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026	65	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85418	10.1371/journal.pone.0085418	http://dx.doi.org/10.1371/journal.pone.0085418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416406	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500247
J	Xiang, Q; Chen, L; Hou, SP; Fang, J; Zhou, Y; Bai, L; Liu, YJ; Kijlstra, A; Yang, PZ				Xiang, Qin; Chen, Lu; Hou, Shengping; Fang, Jing; Zhou, Yan; Bai, Lin; Liu, Yunjia; Kijlstra, Aize; Yang, Peizeng			TRAF5 and TRAF3IP2 Gene Polymorphisms Are Associated with Behcet's Disease and Vogt-Koyanagi-Harada Syndrome: A Case-Control Study	PLOS ONE			English	Article							CHINESE HAN POPULATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; CD4(+) T-CELLS; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; CONFER RISK; KAPPA-B; SUSCEPTIBILITY; IL-17	Background: TRAF5 and TRAF3IP2 have been reported to be associated with several autoimmune diseases. Behcet's disease (BD) and Vogt-Koyanagi-Harada (VKH) syndrome are two autoimmune uveitis entities whereby both genetic and environmental factors are thought to be involved. Objective: The role of TRAF5 and TRAF3IP2 in BD and VKH has not yet been reported and was therefore the subject of this study. Methods: The study included 789 BD patients, 940 VKH patients and 1601 healthy unrelated individuals. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or TaqMan (R) SNP Genotyping Assay. Real-Time PCR was used to detect mRNA expression from PBMCs obtained from healthy controls with (n = 22) or without (n = 79) stimulation. Levels of TNF-alpha, IL-6 and IL-8 in culture supernatants were measured by ELISA (n = 22). Results: Three SNPs (rs6540679, rs12569232, rs10863888) of TRAF5 and rs13210247 of TRAF3IP2 were significantly associated with Behcet's disease and VKH syndrome (corrected P values ranging from 9.45x10(-12) to 0.027). TRAF3IP2 rs33980500 and rs13190932 were not polymorphic in Han Chinese. Following stimulation by lipopolysaccharide (LPS), carriers of the GG genotype of rs6540679/ TRAF5 had a higher TRAF5 mRNA expression (p = 0.004) and an increased TNF-alpha (p = 0.0052) and IL-6 (p = 0.0014) level compared with AA and AG genotype carriers. Conclusion: This study provides evidence that TRAF5 and TRAF3IP2 genes are involved in the development of BD and VKH syndrome. Functional research suggested that TRAF5 gene polymorphisms may regulate TRAF5 expression and downstream inflammatory cytokines such as TNF-alpha and IL-6.	[Xiang, Qin; Chen, Lu; Hou, Shengping; Fang, Jing; Zhou, Yan; Bai, Lin; Liu, Yunjia; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Xiang, Qin; Chen, Lu; Hou, Shengping; Fang, Jing; Zhou, Yan; Bai, Lin; Liu, Yunjia; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Eye Clin Maastricht, Maastricht, Netherlands	Chongqing Medical University; Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Lauschner, Flavia H/P-2457-2018		National Basic Research Program of China (973 Program) [2011CB510200]; Key Project of Natural Science Foundation [81130019]; Clinic Key Project of Ministry of Health, Basic Research Program of Chongqing, Research Fund for the Doctoral Program of Higher Education of China [20115503110002]; Research Fund for the Doctoral Program of Higher Education of China [20115503110002]; Chongqing Key Laboratory of Ophthalmology [CSTC,2008CA5003]; Key Project of Health Bureau of Chongqing [2012-1-003]; PAR-EU Scholars Program	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Project of Natural Science Foundation; Clinic Key Project of Ministry of Health, Basic Research Program of Chongqing, Research Fund for the Doctoral Program of Higher Education of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Chongqing Key Laboratory of Ophthalmology; Key Project of Health Bureau of Chongqing; PAR-EU Scholars Program	This work was supported by National Basic Research Program of China (973 Program) (2011CB510200), Key Project of Natural Science Foundation (81130019), Clinic Key Project of Ministry of Health, Basic Research Program of Chongqing, Research Fund for the Doctoral Program of Higher Education of China (20115503110002), Research Fund for the Doctoral Program of Higher Education of China (20115503110002), Chongqing Key Laboratory of Ophthalmology (CSTC,2008CA5003), Key Project of Health Bureau of Chongqing (2012-1-003) and Fund for PAR-EU Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergholdt R, 2012, DIABETES, V61, P954, DOI 10.2337/db11-1263; Billie Au PY, 2007, ADV EXP MED BIOL, V597, P32; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Cerhan JR, 2008, CANCER EPIDEM BIOMAR, V17, P3161, DOI 10.1158/1055-9965.EPI-08-0536; Chen FL, 2012, RHEUMATOLOGY, V51, P47, DOI 10.1093/rheumatology/ker345; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Chu ML, 2011, INVEST OPHTH VIS SCI, V52, P7084, DOI 10.1167/iovs.11-7539; Ciccacci C, 2012, J CROHNS COLITIS; Ciccacci C, 2013, J CROHNS COLITIS, V7, P44, DOI 10.1016/j.crohns.2012.02.020; DAVIS JL, 1990, OPHTHALMOLOGY, V97, P1137; Dolcino M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/198956; Doyle MS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4071; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Fang W, 2008, CURR EYE RES, V33, P517, DOI 10.1080/02713680802233968; Han TU, 2009, ARTHRITIS RHEUM-US, V60, P2577, DOI 10.1002/art.24759; Hou S, 2012, ARTHRITIS RHEUM; Hu K, 2012, INVEST OPHTH VIS SCI, V53, P538, DOI 10.1167/iovs.11-8440; Hu K, 2010, HUM IMMUNOL, V71, P723, DOI 10.1016/j.humimm.2010.04.007; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hunter CA, 2007, NAT IMMUNOL, V8, P232, DOI 10.1038/ni0307-232; Ideguchi H, 2011, MEDICINE, V90, P125, DOI 10.1097/MD.0b013e318211bf28; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Jiang ZX, 2010, HUM IMMUNOL, V71, P414, DOI 10.1016/j.humimm.2010.01.026; Jorgensen TN, 2009, EPIGENETICS AUTOIMMU, P55; Keino H, 2007, BRIT J OPHTHALMOL, V91, P1573, DOI 10.1136/bjo.2007.124875; Kitamei H, 2006, J LEUKOCYTE BIOL, V79, P1193, DOI 10.1189/jlb.0805453; Kraus ZJ, 2009, P NATL ACAD SCI USA, V106, P17140, DOI 10.1073/pnas.0903786106; Li H, 2013, HUM GENET, V132, P293, DOI 10.1007/s00439-012-1250-7; Ma AI, 2012, NAT IMMUNOL, V13, P1034, DOI 10.1038/ni.2448; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Namjou B, 2012, ARTHRITIS RHEUM-US, V64, P1960, DOI 10.1002/art.34361; Niccoli L, 2007, RHEUMATOLOGY, V46, P1161, DOI 10.1093/rheumatology/kem101; Nishimoto K, 2010, ANN RHEUM DIS, V69, P368, DOI 10.1136/ard.2008.104315; O'Rielly DD, 2011, NAT REV RHEUMATOL, V7, P718, DOI 10.1038/nrrheum.2011.169; OHNO S, 1981, T OPHTHAL SOC UK, V101, P335; Okada AA, 2012, ARCH OPHTHALMOL-CHIC, V130, P592, DOI 10.1001/archophthalmol.2011.2698; Perricone C, 2013, IMMUNOGENETICS, V65, P703, DOI 10.1007/s00251-013-0717-6; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Potter C, 2007, ANN RHEUM DIS, V66, P1322, DOI 10.1136/ard.2006.065706; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rassi DM, 2008, ANN NY ACAD SCI, V1150, P282, DOI 10.1196/annals.1447.064; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Shu QM, 2010, HUM IMMUNOL, V71, P988, DOI 10.1016/j.humimm.2010.06.020; SILMAN AJ, 1990, LANCET, V335, P1078; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; Sugita S, 2006, INVEST OPHTH VIS SCI, V47, P2547, DOI 10.1167/iovs.05-1547; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Yang PZ, 2008, OPHTHALMOLOGY, V115, P312, DOI 10.1016/j.ophtha.2007.04.056; Yang PZ, 2007, OPHTHALMOLOGY, V114, P606, DOI 10.1016/j.ophtha.2006.07.040; Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606; Zhang DY, 2011, AM J NEPHROL, V34, P483, DOI 10.1159/000333006; Zhang Z, 2006, INT J RHEUM DIS, V9, P244; ZHAO M, 1991, ARCH OPHTHALMOL-CHIC, V109, P368, DOI 10.1001/archopht.1991.01080030070041; Zhou Q, 2012, ANN RHEUM DIS; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566	56	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84214	10.1371/journal.pone.0084214	http://dx.doi.org/10.1371/journal.pone.0084214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416204	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500103
J	Zhang, Q; Du, Y; Xue, ZW; Chi, CW; Jia, XH; Tian, J				Zhang, Qian; Du, Yang; Xue, Zhenwen; Chi, Chongwei; Jia, Xiaohua; Tian, Jie			Comprehensive Evaluation of the Anti-Angiogenic and Anti-Neoplastic Effects of Endostar on Liver Cancer through Optical Molecular Imaging	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TUMOR ANGIOGENESIS; ORTHOTOPIC MODELS; METASTASIS; THERAPY; GROWTH	Molecular imaging enables non-invasive monitoring of tumor growth, progression, and drug treatment response, and it has become an important tool to promote biological studies in recent years. In this study, we comprehensively evaluated the in vivo anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer based on the optical molecular imaging systems including micro-computer tomography (Micro-CT), bioluminescence molecular imaging (BLI) and fluorescence molecular tomography (FMT). Firefly luciferase (fLuc) and green fluorescent protein (GFP) dual labeled human hepatocellular carcinoma cells (HCC-LM3-fLuc-GFP cells) were used to establish the subcutaneous and orthotopic liver tumor model. After the tumor cells were implanted 14 similar to 18 days, Endostar (5 mg/kg/day) was administered through an intravenous tail vein injection for continuous 14 days. The computer tomography angiography (CTA) and BLI were carried out for the subcutaneous tumor model. FMT was executed for the orthotopic tumor model. The CTA data showed that tumor vessel formation and the peritumoral vasculature of subcutaneous tumor in the Endostar treatment group was significantly inhibited compared to the control group. The BLI data exhibited the obvious tumor inhibition day 8 post-treatment. The FMT detected the tumor suppression effects of Endostar as early as day 4 post-treatment and measured the tumor location. The above data confirmed the effects of Endostar on anti-angiogenesis and tumor suppression on liver cancer. Our system combined CTA, BLI, and FMT to offer more comprehensive information about the effects of Endostar on the suppression of vessel and tumor formation. Optical molecular imaging system enabled the non-invasive and reliable assessment of anti-tumor drug efficacy on liver cancer.	[Zhang, Qian; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Zhang, Qian; Du, Yang; Xue, Zhenwen; Chi, Chongwei; Jia, Xiaohua; Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Chinese Academy of Sciences; Institute of Automation, CAS	Tian, J (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	tian@ieee.org	du, yang/V-1086-2019; Tian, Jie/H-1190-2011	Tian, Jie/0000-0003-0498-0432	National Basic Research Program of China (973 Program) [2011CB707700]; National Natural Science Foundation of China (NSFC) [81227901]; Academy of Sciences Fellowship for Young International Scientists [2013Y1GB0005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Academy of Sciences Fellowship for Young International Scientists	This paper is supported by the National Basic Research Program of China (973 Program) under Grant No. 2011CB707700, the National Natural Science Foundation of China (NSFC) under Grant No. 81227901 and the Academy of Sciences Fellowship for Young International Scientists (2013Y1GB0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avella DM, 2012, HEPATOLOGY, V55, P141, DOI 10.1002/hep.24652; Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Blow N, 2009, NAT METHODS, V6, P465, DOI 10.1038/nmeth0609-465; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cai WB, 2008, METHOD ENZYMOL, V445, P141, DOI 10.1016/S0076-6879(08)03007-3; Cai WB, 2008, J NUCL MED, V49, p113S, DOI 10.2967/jnumed.107.045922; Cheong SJ, 2011, NUCL MED BIOL, V38, P93, DOI 10.1016/j.nucmedbio.2010.05.009; Dong X, 2011, THORAC CARDIOV SURG, V59, P133, DOI 10.1055/s-0030-1250152; Feng YX, 2011, HEPATOLOGY, V53, P483, DOI 10.1002/hep.24075; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Folkman Judah, 2006, Sci STKE, V2006, ppe35, DOI 10.1126/stke.3542006pe35; Han D, 2010, APPL OPTICS, V49, P6930, DOI 10.1364/AO.49.006930; Han D, 2010, OPT EXPRESS, V18, P8630, DOI 10.1364/OE.18.008630; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hu H, 1937, ONCOL REP, V27, P1937; Jaffer FA, 2009, ARTERIOSCL THROM VAS, V29, P1017, DOI 10.1161/ATVBAHA.108.165530; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Ling Y, 2009, ANTICANCER RES, V29, P411; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; [马喜波 Ma Xibo], 2011, [生物物理学报, Acta Biophysica Sinica], V27, P355; Ma XB, 2011, MOL IMAGING, V10, P278, DOI 10.2310/7290.2010.00041; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Tam K, 2013, ADMET DMPK, V1, P29, DOI 10.5599/admet.1.3.7; Tian J, 2013, OPTICAL MULTIMODALIT, P389; Tian J, 2008, IEEE T INF TECHNOL B, V12, P800, DOI 10.1109/TITB.2008.926395; Virostko J, 2007, APPL OPTICS, V46, P2540, DOI 10.1364/AO.46.002540; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Xu W, 2010, MOL BIOL+, V44, P585, DOI 10.1134/S0026893310040138; Xue ZW, 2013, APPL OPTICS, V52, P2374, DOI 10.1364/AO.52.002374; Zhu SP, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/960573	36	27	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85559	10.1371/journal.pone.0085559	http://dx.doi.org/10.1371/journal.pone.0085559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416426	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500257
J	Bedi, U; Scheel, AH; Hennion, M; Begus-Nahrmann, Y; Ruschoff, J; Johnsen, SA				Bedi, U.; Scheel, A. H.; Hennion, M.; Begus-Nahrmann, Y.; Rueschoff, J.; Johnsen, S. A.			SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms	ONCOGENE			English	Article						estrogen receptor; breast cancer; differentiation; chromatin	HUMAN BREAST-CANCER; GENE-EXPRESSION; HISTONE H2B; TRANSCRIPTIONAL ELONGATION; CHROMATIN MODIFICATIONS; HUMAN-CELLS; P-TEFB; MONOUBIQUITINATION; SPT6; ALPHA	The estrogen receptor alpha (ER alpha) is the central transcriptional regulator of ductal mammary epithelial lineage specification and is an important prognostic marker in human breast cancer. Although antiestrogen therapies are initially highly effective at treating ER alpha-positive tumors, a large number of tumors progress to a refractory, more poorly differentiated phenotype accompanied by reduced survival. A better understanding of the molecular mechanisms involved in the progression from estrogen-dependent to hormone-resistant breast cancer may uncover new targets for treatment and the discovery of new predictive markers. Recent studies have uncovered an important role for transcriptional elongation and chromatin modifications in controlling ER alpha activity and estrogen responsiveness. The human Suppressor of Ty Homologue-6 (SUPT6H) is a histone chaperone that links transcriptional elongation to changes in chromatin structure. We show that SUPT6H is required for estrogen-regulated transcription and the maintenance of chromatin structure in breast cancer cells, possibly in part through interaction with RNF40 and regulation of histone H2B monoubiquitination (H2Bub1). Moreover, we demonstrate that SUPT6H protein levels decrease with malignancy in breast cancer. Consistently, SUPT6H, similar to H2Bub1, is required for cellular differentiation and suppression of the repressive histone mark H3K27me3 on lineage-specific genes. Together, these data identify SUPT6H as a new epigenetic regulator of ER alpha activity and cellular differentiation.	[Bedi, U.; Johnsen, S. A.] Univ Med Ctr Hamburg Eppendorf UKE, Dept Tumor Biol, Ctr Med Expt, D-20251 Hamburg, Germany; [Bedi, U.; Hennion, M.; Begus-Nahrmann, Y.; Johnsen, S. A.] Univ Med Ctr Gottingen, Inst Mol Oncol, Gottingen, Germany; [Scheel, A. H.; Rueschoff, J.] Inst Pathol Nordhessen, Kassel, Germany; [Scheel, A. H.] Univ Med Ctr Gottinngen, Dept Pathol, Ctr Pathol & Forens Med, Gottingen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen	Johnsen, SA (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Dept Tumor Biol, Ctr Med Expt, D-20251 Hamburg, Germany.	sjohnsen@alumni.mayo.edu	Johnsen, Steven/AAX-2322-2020	Johnsen, Steven/0000-0003-1198-5805; Hennion, Magali/0000-0002-0352-2790	Erasmus Mundus External Cooperation Window EURINDIA; Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences; Deutsche Krebshilfe [109088]; Deutsche Forschungsgemeinschaft [JO 815/3]	Erasmus Mundus External Cooperation Window EURINDIA; Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank L Schreiber, J Schiller and CR Schlegel for initial efforts in establishing SUPT6H knockdown. UB was supported by doctoral fellowships from the Erasmus Mundus External Cooperation Window EURINDIA and the Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences. This work was supported by grants from the Deutsche Krebshilfe (109088) and the Deutsche Forschungsgemeinschaft (JO 815/3) to SAJ.	Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; BANIAHMAD C, 1995, MOL ENDOCRINOL, V9, P34, DOI 10.1210/me.9.1.34; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen SZ, 2012, GENE DEV, V26, P1364, DOI 10.1101/gad.186056.111; Chen S, 2012, CELL RES, V22, P1402, DOI 10.1038/cr.2012.114; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Diebold ML, 2010, J BIOL CHEM, V285, P38389, DOI 10.1074/jbc.M110.146696; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Johnsen S A, 2006, Ernst Schering Found Symp Proc, P1; Johnsen SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002860; Johnsen SA, 2012, FEBS LETT, V586, P1592, DOI 10.1016/j.febslet.2012.04.002; Kari V, 2011, CELL CYCLE, V10, P3495, DOI 10.4161/cc.10.20.17769; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; Ketchart W, 2011, ONCOGENE, V30, P3563, DOI 10.1038/onc.2011.76; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Ogba N, 2008, CANCER RES, V68, P7015, DOI 10.1158/0008-5472.CAN-08-0814; Pirngruber J, 2010, ONCOGENE, V29, P2853, DOI 10.1038/onc.2010.42; Pirngruber J, 2009, CELL CYCLE, V8, P3636, DOI 10.4161/cc.8.22.9890; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Raaphorst FM, 2003, NEOPLASIA, V5, P481, DOI 10.1016/S1476-5586(03)80032-5; Reijm EA, 2011, BREAST CANCER RES TR, V125, P387, DOI 10.1007/s10549-010-0836-9; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Wang AHJ, 2013, EMBO J, V32, P1075, DOI 10.1038/emboj.2013.54; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Zhang F, 2011, MOL CELL, V41, P384, DOI 10.1016/j.molcel.2011.01.024	46	29	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					465	473		10.1038/onc.2013.558	http://dx.doi.org/10.1038/onc.2013.558			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24441044				2022-12-25	WOS:000348451300007
J	David, M; Machuca-Gayet, I; Kikuta, J; Ottewell, P; Mima, F; Leblanc, R; Bonnelye, E; Ribeiro, J; Holen, I; Vales, RL; Jurdic, P; Chun, J; Clezardin, P; Ishii, M; Peyruchaud, O				David, Marion; Machuca-Gayet, Irma; Kikuta, Junichi; Ottewell, Penelope; Mima, Fuka; Leblanc, Raphael; Bonnelye, Edith; Ribeiro, Johnny; Holen, Ingunn; Lopez Vales, Ruben; Jurdic, Pierre; Chun, Jerold; Clezardin, Philippe; Ishii, Masaru; Peyruchaud, Olivier			Lysophosphatidic Acid Receptor Type 1 (LPA(1)) Plays a Functional Role in Osteoclast Differentiation and Bone Resorption Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Differentiation; Lysophospholipid; Osteoclast; Osteoporosis; Receptors	PROTEIN-COUPLED RECEPTOR; PARATHYROID-HORMONE; TARGETED DELETION; SEALING ZONE; EXPRESSION; MICE; RESPONSES; GENE; REQUIREMENT; ACTIVATION	Background: Lysophosphatidic acid (LPA) is a bioactive lipid with pleiotropic activities due to activation of six receptors (LPA(1-6)). Results: Genetic deletion and pharmacological blockade of LPA(1) inhibit differentiation and bone degradation activity of osteoclasts. Conclusion: LPA controls bone homeostasis through the activation of LPA(1) expressed by osteoclasts. Significance: LPA(1) is a new therapeutic target of diseases with excess bone degradation. Lysophosphatidic acid (LPA) is a natural bioactive lipid that acts through six different G protein-coupled receptors (LPA(1-6)) with pleiotropic activities on multiple cell types. We have previously demonstrated that LPA is necessary for successful in vitro osteoclastogenesis of bone marrow cells. Bone cells controlling bone remodeling (i.e. osteoblasts, osteoclasts, and osteocytes) express LPA(1), but delineating the role of this receptor in bone remodeling is still pending. Despite Lpar1(-/-) mice displaying a low bone mass phenotype, we demonstrated that bone marrow cell-induced osteoclastogenesis was reduced in Lpar1(-/-) mice but not in Lpar2(-/-) and Lpar3(-/-) animals. Expression of LPA(1) was up-regulated during osteoclastogenesis, and LPA(1) antagonists (Ki16425, Debio0719, and VPC12249) inhibited osteoclast differentiation. Blocking LPA(1) activity with Ki16425 inhibited expression of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1) and dendritic cell-specific transmembrane protein and interfered with the fusion but not the proliferation of osteoclast precursors. Similar to wild type osteoclasts treated with Ki16425, mature Lpar1(-/-) osteoclasts had reduced podosome belt and sealing zone resulting in reduced mineralized matrix resorption. Additionally, LPA(1) expression markedly increased in the bone of ovariectomized mice, which was blocked by bisphosphonate treatment. Conversely, systemic treatment with Debio0719 prevented ovariectomy-induced cancellous bone loss. Moreover, intravital multiphoton microscopy revealed that Debio0719 reduced the retention of CX(3)CR1-EGFP(+) osteoclast precursors in bone by increasing their mobility in the bone marrow cavity. Overall, our results demonstrate that LPA(1) is essential for in vitro and in vivo osteoclast activities. Therefore, LPA(1) emerges as a new target for the treatment of diseases associated with excess bone loss.	[David, Marion; Leblanc, Raphael; Bonnelye, Edith; Ribeiro, Johnny; Clezardin, Philippe; Peyruchaud, Olivier] UCB Lyon 1, INSERM, UMR1033, Fac Med Lyon Est, F-69732 Lyon, France; [Machuca-Gayet, Irma; Jurdic, Pierre] UCB Lyon 1, Equipe Biol Cellulaire & Physiopathol Osseuse, Inst Genom Fonct Lyon, CNRS,UMR5242,ENS, F-69007 Lyon, France; [Kikuta, Junichi; Mima, Fuka; Ishii, Masaru] Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, Osaka 5650871, Japan; [Kikuta, Junichi; Mima, Fuka; Ishii, Masaru] Japan Sci & Technol Agcy, CREST, Tokyo 1020076, Japan; [Ottewell, Penelope; Holen, Ingunn] Univ Sheffield, Sch Med, Acad Unit Clin Oncol, Sheffield S10 2RX, S Yorkshire, England; [Lopez Vales, Ruben] Univ Autonoma Barcelona, Fac Med, Unitat Fisiol Med, Grp Neuroplasticitat & Regeneracio, E-08193 Barcelona, Spain; [Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol Biol, La Jolla, CA 92037 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Osaka University; Japan Science & Technology Agency (JST); University of Sheffield; Autonomous University of Barcelona; University of Barcelona; Scripps Research Institute	Peyruchaud, O (corresponding author), Fac Med Lyon Est, INSERM, U1033, Rue Guillaume Paradin, F-69372 Lyon 08, France.	olivier.peyruchaud@inserm.fr	Kikuta, Junichi/HHS-8875-2022; Lopez-Vales, Ruben/E-2150-2011; Clezardin, Philippe/M-8071-2014; Chun, Jerold/Y-4670-2019; Bonnelye, Edith/AAT-9134-2021	Lopez-Vales, Ruben/0000-0001-7615-9550; Clezardin, Philippe/0000-0003-0149-4463; Peyruchaud, Olivier/0000-0002-5393-4945; Leblanc, Raphael/0000-0002-1976-9587; Machuca- Gayet, irma/0000-0002-3010-9774; Holen, Ingunn/0000-0002-8759-6913; Ottewell, Penelope/0000-0002-4826-0771	INSERM; Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer; French Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer; French Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from INSERM (to O. P. and P. C.), the Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer (to O. P.), and the French Association pour la Recherche sur le Cancer (to O. P.).; Recipient of a fellowship from the French Association pour la Recherche sur le Cancer.; Recipients of a fellowship from the Ligue Nationale Contre le Cancer.	An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Boucharaba A, 2009, ONCOL RES, V18, P173, DOI 10.3727/096504009790217399; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Choi KU, 2011, INT J CANCER, V128, P332, DOI 10.1002/ijc.25341; Coleman R, 2011, ANN NY ACAD SCI, V1218, P3, DOI 10.1111/j.1749-6632.2010.05766.x; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Daaka Y, 2002, BBA-MOL CELL BIOL L, V1582, P265, DOI 10.1016/S1388-1981(02)00180-4; David M, 2012, INT J ONCOL, V40, P1133, DOI 10.3892/ijo.2011.1309; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; DELMAS PD, 1995, BONE, V16, P603, DOI 10.1016/8756-3282(95)00113-R; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; Dusaulcy R, 2009, J PHYSIOL BIOCHEM, V65, P345, DOI 10.1007/BF03185929; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Fueller M, 2003, CELL SIGNAL, V15, P367, DOI 10.1016/S0898-6568(02)00117-1; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Gennero I, 2011, BONE, V49, P395, DOI 10.1016/j.bone.2011.04.018; Gidley J, 2006, PROSTAG OTH LIPID M, V80, P46, DOI 10.1016/j.prostaglandins.2006.04.001; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Heise CE, 2001, MOL PHARMACOL, V60, P1173, DOI 10.1124/mol.60.6.1173; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jacobs CR, 2010, ANNU REV BIOMED ENG, V12, P369, DOI 10.1146/annurev-bioeng-070909-105302; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Karagiosis SA, 2007, BIOCHEM BIOPH RES CO, V357, P194, DOI 10.1016/j.bbrc.2007.03.121; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Lapierre DM, 2010, J BIOL CHEM, V285, P25792, DOI 10.1074/jbc.M110.109322; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Liu YB, 2010, J CELL BIOCHEM, V109, P794, DOI 10.1002/jcb.22471; Mansell JP, 2011, PROSTAG OTH LIPID M, V95, P45, DOI [10.1016/j.prostaglandins.2011.05.003, 10.1016/j.prostaglandins.2011.05.002]; Marx UC, 2000, BIOCHEM BIOPH RES CO, V267, P213, DOI 10.1006/bbrc.1999.1958; McMichael BK, 2010, J BIOL CHEM, V285, P26641, DOI 10.1074/jbc.M110.119909; Miyabe Y, 2013, ARTHRITIS RHEUM-US, V65, P2037, DOI 10.1002/art.37991; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Peyruchaud O, 2013, BBA-MOL CELL BIOL L, V1831, P99, DOI 10.1016/j.bbalip.2012.06.004; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sims SM, 2013, BBA-MOL CELL BIOL L, V1831, P109, DOI 10.1016/j.bbalip.2012.08.001; Spencer JA, 1999, ONCOGENE, V18, P7319, DOI 10.1038/sj.onc.1203121; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeda S, 2001, J BONE MINER METAB, V19, P195, DOI 10.1007/s007740170042; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Wysolmerski JJ, 2012, J CLIN ENDOCR METAB, V97, P2947, DOI 10.1210/jc.2012-2142; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Ye XQ, 2008, BIOL REPROD, V79, P328, DOI 10.1095/biolreprod.108.068783; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415	75	37	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6551	6564		10.1074/jbc.M113.533232	http://dx.doi.org/10.1074/jbc.M113.533232			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24429286	Green Published, hybrid			2022-12-25	WOS:000332389400021
J	Berko, D; Herkon, O; Braunstein, I; Isakov, E; David, Y; Ziv, T; Navon, A; Stanhill, A				Berko, Dikla; Herkon, Ora; Braunstein, Ilana; Isakov, Elada; David, Yael; Ziv, Tamar; Navon, Ami; Stanhill, Ariel			Inherent Asymmetry in the 26S Proteasome Is Defined by the Ubiquitin Receptor RPN13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proteasome; Protein Complexes; Protein Degradation; Proteolytic Enzymes; Ubiquitin; S5a; Ubiquitin Receptor; rpn13; Stoichiometry	REGULATORY PARTICLE; 20S PROTEASOME; ABSOLUTE QUANTIFICATION; DEUBIQUITINATING ENZYME; TRANSCRIPTION FACTOR; SUBUNIT; PROTEINS; BINDING; ARCHITECTURE; RECOGNITION	Background: The double-capped 26S proteasome complex is viewed as a symmetrical particle. Results: The ubiquitin receptor subunit Rpn13 is found in an asymmetrical ratio. Conclusion: Rpn13 ubiquitin receptor may dictate preference in substrate recruitment and processing. Significance: The ubiquitin receptor Rpn13 defines asymmetry and thus imposes directionality in the 26S proteasome. The 26S double-capped proteasome is assembled in a hierarchic event that is orchestrated by dedicated set of chaperons. To date, all stoichiometric subunits are considered to be present in equal ratios, thus providing symmetry to the double-capped complex. Here, we show that although the vast majority (if not all) of the double-capped 26S proteasomes, both 19S complexes, contain the ubiquitin receptor Rpn10/S5a, only one of these 19S particles contains the additional ubiquitin receptor Rpn13, thereby defining asymmetry in the 26S proteasome. These results were validated in yeast and mammals, utilizing biochemical and unbiased AQUA-MS methodologies. Thus, the double-capped 26S proteasomes are asymmetric in their polyubiquitin binding capacity. Our data point to a potential new role for ubiquitin receptors as directionality factors that may participate in the prevention of simultaneous substrates translocation into the 20S from both 19S caps.	[Berko, Dikla; Herkon, Ora; Braunstein, Ilana; Isakov, Elada; Stanhill, Ariel] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel; [Berko, Dikla; David, Yael; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Smoler Prote Ctr, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Weizmann Institute of Science; Technion Israel Institute of Technology	Stanhill, A (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel.	ami.navon@weizmann.ac.il; stanhill@tx.technion.ac.il		Ziv, Tamar/0000-0003-4299-7454; stanhill, ariel/0000-0002-0318-2212	Israel Science Foundation [ISF 497/08]; Minerva Foundation (Munich, Germany); German-Israeli Foundation for Scientific Research and Development; Technion-Israel Institute of Technology	Israel Science Foundation(Israel Science Foundation); Minerva Foundation (Munich, Germany); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Technion-Israel Institute of Technology	An incumbent of the Recanati career development chair of cancer research and supported by the Israel Science Foundation, the Minerva Foundation (Munich, Germany), the German-Israeli Foundation for Scientific Research and Development, and a special gift from Rolando Uziel. To whom correspondence may be addressed. Tel.: 972-8-9343719; Fax: 972-8-9344116; E-mail: ami.navon@weizmann.ac.il.; Supported in part by the Israel Science Foundation (ISF 497/08) and the Technion-Israel Institute of Technology. To whom correspondence may be addressed. Tel.: 972-4-8295306; Fax: 972-4-8535245; E-mail: stanhill@tx.technion.ac.il.	AHN JY, 1995, FEBS LETT, V366, P37, DOI 10.1016/0014-5793(95)00492-R; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lin YL, 2011, PLANT CELL, V23, P2754, DOI 10.1105/tpc.111.086702; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010	39	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5609	5618		10.1074/jbc.M113.509380	http://dx.doi.org/10.1074/jbc.M113.509380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24429290	Green Published, hybrid			2022-12-25	WOS:000332015500025
J	D'Hertefeldt, T; Enestrom, JM; Pettersson, LB				D'Hertefeldt, Tina; Enestrom, Johanna M.; Pettersson, Lars B.			Geographic and Habitat Origin Influence Biomass Production and Storage Translocation in the Clonal Plant Aegopodium podagraria	PLOS ONE			English	Article							RELATIVE GROWTH-RATE; EXTENSIVE PHYSIOLOGICAL INTEGRATION; LIFE-HISTORY VARIATION; FRAGARIA-CHILOENSIS; EVOLUTIONARY SIGNIFICANCE; LATITUDINAL GRADIENT; RANUNCULUS-REPTANS; GLECHOMA-HEDERACEA; CAREX-BIGELOWII; PERENNIAL HERB	Through physiological integration, clonal plants can support ramets in unfavourable patches, exploit heterogeneously distributed resources and distribute resources that are taken up over large areas. Physiological integration generally increases in adverse conditions, but it is not well known which factors determine the evolution of physiological integration. The aim of this study was to investigate if clonal plants from Southern and Northern populations of the clonal herb Aegopodium podagraria differed in physiological integration in terms of translocation of carbon to the rhizomes, and in biomass production using a reciprocal transplant experiment. Aegopodium podagraria from shaded conditions have been suggested to share more resources than clones from open conditions and therefore, plants from forest and open populations within the Southern and Northern regions were included. The regional growing conditions greatly affected biomass production. Plants grown in North Sweden produced more biomass and allocated more biomass to shoots, while plants grown in South Sweden allocated more biomass to rhizomes. There was a regional origin effect as plants originating from North Sweden produced more biomass in both regions. Within the Northern region, plants from shaded habitats translocated more C-14 to the rhizomes, suggesting more storage there than in plants from open habitats. In addition to genetic differentiation in biomass production between Northern and Southern populations, probably as a response to a shorter growing season in the North, there appeared to be genetic differentiation in physiological integration within the Northern region. This shows that both regional and local conditions need to be taken into account in future studies of genetic differentiation of physiological integration in clonal plants.	[D'Hertefeldt, Tina; Enestrom, Johanna M.; Pettersson, Lars B.] Lund Univ, Dept Biol, Biodivers Unit, Lund, Sweden	Lund University	D'Hertefeldt, T (corresponding author), Lund Univ, Dept Biol, Biodivers Unit, Lund, Sweden.	tina.dhertefeldt@biol.lu.se	Pettersson, Lars/AAX-3948-2020	Pettersson, Lars/0000-0001-5745-508X	C. Tryggers Foundation; Swedish Research council FORMAS; Gyllenstiernska Krapperupsiftelsen; Royal Physiographic Society Lund	C. Tryggers Foundation; Swedish Research council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Gyllenstiernska Krapperupsiftelsen; Royal Physiographic Society Lund	This study was financed by the C. Tryggers Foundation and the Swedish Research council FORMAS (TD'H), Gyllenstiernska Krapperupsiftelsen (JE and TD'H) and the Royal Physiographic Society Lund (JE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; ASHMUN JW, 1982, ANN BOT-LONDON, V49, P403, DOI 10.1093/oxfordjournals.aob.a086264; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; CHAPIN FS, 1981, ARCTIC ALPINE RES, V13, P83; Chen JS, 2004, FLORA, V199, P342, DOI 10.1078/0367-2530-00162; Clausen JC, 1940, CARNEGIE I WASHINGTO, V520; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; D'Hertefeldt T, 1999, J ECOL, V87, P258, DOI 10.1046/j.1365-2745.1999.00345.x; D'Hertefeldt T, 2002, NEW PHYTOL, V156, P469, DOI 10.1046/j.1469-8137.2002.00529.x; Dawson W, 2012, NEW PHYTOL, V194, P859, DOI 10.1111/j.1469-8137.2012.04104.x; De Frenne P, 2011, GLOBAL CHANGE BIOL, V17, P3240, DOI 10.1111/j.1365-2486.2011.02449.x; Dong BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013631; DOUST LL, 1987, J ECOL, V75, P555, DOI 10.2307/2260434; Enestrom J, 2008, THESIS LUND U LUNDSW; Enestrom J, 2009, NORD J BOT, V27, P437, DOI 10.1111/j.1756-1051.2009.00495.x; Ericsson S, 1991, NATUR NORR, V10, P77; Garske S, 2005, WEEDS GONE WILD ALIE; Ida TY, 2009, J PLANT RES, V122, P171, DOI 10.1007/s10265-008-0212-6; Jia X, 2010, PLANT SPEC BIOL, V25, P85, DOI 10.1111/j.1442-1984.2010.00271.x; Jonsdottir IS, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P109; JONSDOTTIR IS, 1988, OIKOS, V52, P120, DOI 10.2307/3565991; JONSDOTTIR IS, 1990, NEW PHYTOL, V114, P419, DOI 10.1111/j.1469-8137.1990.tb00409.x; Keble Martin W, 1965, CONCISE BRIT FLORA C; KIK C, 1990, J ECOL, V78, P962, DOI 10.2307/2260946; Klimesova J, 2006, CLO PLA3 DATABASE CO; Korsmo E, 1986, KORSMOS UGRASPLANSJE; LANDA K, 1992, OIKOS, V63, P348, DOI 10.2307/3544960; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Lotscher M, 1997, J ECOL, V85, P341, DOI 10.2307/2960506; Loveys BR, 2002, PLANT CELL ENVIRON, V25, P975, DOI 10.1046/j.1365-3040.2002.00879.x; MATTHEIS PJ, 1976, ANN BOT-LONDON, V40, P179, DOI 10.1093/oxfordjournals.aob.a085121; Meyer K, 1997, FLORA, V192, P335; Mossberg B, 2010, NYA NORDISKA FLORAN; NEWELL SJ, 1982, B TORREY BOT CLUB, V109, P306; Nilsson J, 2008, EVOL ECOL, V22, P437, DOI 10.1007/s10682-007-9199-z; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; Prati D, 2000, OIKOS, V90, P442, DOI 10.1034/j.1600-0706.2000.900303.x; Price EAC, 2001, EVOL ECOL, V15, P347, DOI 10.1023/A:1016036916017; Raven P. H., 1999, BIOL PLANTS, V6th; REINARTZ JA, 1984, J ECOL, V72, P913, DOI 10.2307/2259540; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Roiloa SR, 2013, PLANT ECOL, V214, P521, DOI 10.1007/s11258-013-0186-x; Salisbury E. J ., 1942, REPROD CAPACITY PLAN; SAWADA S, 1994, FUNCT ECOL, V8, P400, DOI 10.2307/2389834; Schultz ET, 1997, OECOLOGIA, V109, P516, DOI 10.1007/s004420050112; Sjors H, 2007, SWEDISH PLANT GEOGRA, P5; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; STUEFER JF, 1994, OECOLOGIA, V100, P302, DOI 10.1007/BF00316958; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; Swedish Metrological and Hydrological Institute (SMHI), 2013, STRANG MES MOD SOL R; Swedish Metrological and Hydrological Institute (SMHI), 2011, PTHBV VERS 3 NAT MAP; Van Kleunen M, 2000, J EVOLUTION BIOL, V13, P237; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Zar JH, 1999, BIOSTATISTICAL ANAL; ZEEVAART JA, 1971, PLANT PHYSIOL, V47, P821, DOI 10.1104/pp.47.6.821	59	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85407	10.1371/journal.pone.0085407	http://dx.doi.org/10.1371/journal.pone.0085407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427305	Green Submitted, Green Published, gold			2022-12-25	WOS:000329868200046
J	Liang, W; Dai, CM; Zhou, XF; Zhang, YL				Liang, Wen; Dai, Chaomeng; Zhou, Xuefei; Zhang, Yalei			Application of Zero-Valent Iron Nanoparticles for the Removal of Aqueous Zinc Ions under Various Experimental Conditions	PLOS ONE			English	Article							GRANULAR FERRIC HYDROXIDE; ZEROVALENT IRON; HEAVY-METALS; WATER; ADSORPTION; DEGRADATION; REDUCTION; TOXICITY; SHELL; XPS	Application of zero-valent iron nanoparticles (nZVI) for Zn2+ removal and its mechanism were discussed. It demonstrated that the uptake of Zn2+ by nZVI was efficient. With the solids concentration of 1 g/L nZVI, more than 85% of Zn2+ could be removed within 2 h. The pH value and dissolved oxygen (DO) were the important factors of Zn2+ removal by nZVI. The DO enhanced the removal efficiency of Zn2+. Under the oxygen-contained condition, oxygen corrosion gave the nZVI surface a shell of iron (oxy) hydroxide, which could show high adsorption affinity. The removal efficiency of Zn2+ increased with the increasing of the pH. Acidic condition reduced the removal efficiency of Zn2+ by nZVI because the existing H+ inhibited the formation of iron (oxy) hydroxide. Adsorption and co-precipitation were the most likely mechanism of Zn2+ removal by nZVI. The FeOOH-shell could enhance the adsorption efficiency of nZVI. The removal efficiency and selectivity of nZVI particles for Zn2+ were higher than Cd2+. Furthermore, a continuous flow reactor for engineering application of nZVI was designed and exhibited high removal efficiency for Zn2+.	[Liang, Wen; Dai, Chaomeng; Zhou, Xuefei; Zhang, Yalei] Tongji Univ, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China; [Dai, Chaomeng] Tongji Univ, Coll Civil Engn, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Dai, CM (corresponding author), Tongji Univ, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China.	daichaomeng@tongji.edu.cn; zhangyalei@tongji.edu.cn	ZHOU, XUE/F-6129-2013	Zhang, Yalei/0000-0002-3254-8965	National Key Technologies R&D Program of China [2012BAJ25B04]; New Century Excellent Talents in University [NCET-11-0391]; Shanghai Science and Technology Commission [11QH1402600]; National Natural Science Foundation of China [21246001, 51138009, 41101480]	National Key Technologies R&D Program of China(National Key Technology R&D Program); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Key Technologies R&D Program of China (No. 2012BAJ25B04), New Century Excellent Talents in University (NCET-11-0391), the Project of Shanghai Science and Technology Commission (No. 11QH1402600), and the National Natural Science Foundation of China (key program No. 21246001, 51138009, 41101480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambashta RD, 2011, IND ENG CHEM RES, V50, P11771, DOI 10.1021/ie102121e; Badruzzaman M, 2004, WATER RES, V38, P4002, DOI 10.1016/j.watres.2004.07.007; Boparai HK, 2011, J HAZARD MATER, V186, P458, DOI 10.1016/j.jhazmat.2010.11.029; Celebi O, 2007, J HAZARD MATER, V148, P761, DOI 10.1016/j.jhazmat.2007.06.122; Chastain J, 1992, PERKIN ELMER CORP, V40, P221; Choe S, 2001, CHEMOSPHERE, V42, P367, DOI 10.1016/S0045-6535(00)00147-8; Committee SDW, 1977, DRINK WAT HLTH; Elliott DW, 2009, J ENVIRON ENG, V135, P317, DOI 10.1061/(ASCE)0733-9372(2009)135:5(317); Emsley J, 1989, ELEMENTS; EPA US, 2005, TOX REV ZINC COMP, P6; Fan J, 2009, J HAZARD MATER, V166, P904, DOI 10.1016/j.jhazmat.2008.11.091; Fang ZQ, 2011, DESALINATION, V268, P60, DOI 10.1016/j.desal.2010.09.051; Giller KE, 1998, SOIL BIOL BIOCHEM, V30, P1389, DOI 10.1016/S0038-0717(97)00270-8; Gordon RB, 2006, P NATL ACAD SCI USA, V103, P1209, DOI 10.1073/pnas.0509498103; Guan XH, 2008, J HAZARD MATER, V156, P178, DOI 10.1016/j.jhazmat.2007.12.012; Hafez H., 2012, INT J ENG SCI TECHNO, V4, P3018; Hoerle S, 2004, CORROS SCI, V46, P1431, DOI 10.1016/j.corsci.2003.09.028; Iwasaki Y, 2009, ENVIRON TOXICOL CHEM, V28, P354, DOI 10.1897/08-200.1; Katsou E, 2011, CHEMOSPHERE, V82, P557, DOI 10.1016/j.chemosphere.2010.10.022; Kishimoto N, 2011, WATER AIR SOIL POLL, V221, P183, DOI 10.1007/s11270-011-0781-1; Klimkova S, 2011, CHEMOSPHERE, V82, P1178, DOI 10.1016/j.chemosphere.2010.11.075; Kwon JS, 2005, CHEMOSPHERE, V60, P1416, DOI 10.1016/j.chemosphere.2005.01.078; Li XQ, 2007, J PHYS CHEM C, V111, P6939, DOI 10.1021/jp0702189; Liu F., 2009, ANAL TEST TECHNOL IN, V15, P1; Lu SG, 2007, J HAZARD MATER, V149, P208, DOI 10.1016/j.jhazmat.2007.03.070; Miehr R, 2004, ENVIRON SCI TECHNOL, V38, P139, DOI 10.1021/es034237h; Naja G, 2008, ENVIRON SCI TECHNOL, V42, P4364, DOI 10.1021/es7028153; Otte K, 2012, SURF SCI, V606, P1623, DOI 10.1016/j.susc.2012.07.009; Rangsivek R, 2005, WATER RES, V39, P4153, DOI 10.1016/j.watres.2005.07.040; Sadowski Z, 2001, MINER ENG, V14, P547, DOI 10.1016/S0892-6875(01)00043-7; Salim R, 2003, PROCESS SAF ENVIRON, V81, P236, DOI 10.1205/095758203322299752; Signorini L, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.195423; Sun YP, 2006, ADV COLLOID INTERFAC, V120, P47, DOI 10.1016/j.cis.2006.03.001; WAGEMANN R, 1979, WATER RES, V13, P515, DOI 10.1016/0043-1354(79)90047-2; Wang CM, 2009, J AM CHEM SOC, V131, P8824, DOI 10.1021/ja900353f; Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065282; Yamashita T, 2008, APPL SURF SCI, V254, P2441, DOI 10.1016/j.apsusc.2007.09.063; Yan WL, 2010, J CONTAM HYDROL, V118, P96, DOI 10.1016/j.jconhyd.2010.09.003	38	39	44	9	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85686	10.1371/journal.pone.0085686	http://dx.doi.org/10.1371/journal.pone.0085686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416439	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300097
J	Piscianz, E; Valencic, E; Cuzzoni, E; De Iudicibus, S; De Lorenzo, E; Decorti, G; Tommasini, A				Piscianz, Elisa; Valencic, Erica; Cuzzoni, Eva; De Iudicibus, Sara; De Lorenzo, Elisa; Decorti, Giuliana; Tommasini, Alberto			Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; JAK INHIBITOR; LYMPHOID DEVELOPMENT; JANUS KINASE; CP-690,550; ACTIVATION; RECIPIENTS; PLACEBO; DRUGS; CELLS	Tofacitinib (Tofa) is an inhibitor of Janus Kinase 3, developed for the treatment of autoimmune diseases and for the prevention of transplant rejection. Due to its selective action on proliferating cells, Tofa can offer a way to block T cell activation, without toxic effects on resting cells. However, few studies have investigated the effects of Tofa on lymphocyte activation in vitro. Our aim was to study the action of Tofa on different lymphocyte subsets after in vitro stimulation and to track the behaviour of treated cells after interruption of the treatment. Peripheral blood lymphocytes were stimulated in vitro with mitogen and treated with two concentrations of Tofa. After a first period in culture, cells were washed and further incubated for an additional time. Lymphocyte subsets, activation phenotype and proliferation were assessed at the different time frames. As expected, Tofa was able to reduce the activation and proliferation of lymphocytes in the first four days of treatment. In addition the drug led to a relative decrease of Natural Killer, B cells and CD8 T cells compared to CD4 T cells. However, treated cells were still viable after the first period in culture and begun to proliferate, strikingly, in a dose dependent manner when the drug was removed from the environment by replacing the culture medium. This novel data does not necessarily predict a similar behaviour in vivo, but can warn about the clinical use of this drug when a discontinuation of treatment with Tofa is considered for any reason.	[Piscianz, Elisa; Valencic, Erica] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Diagnost Med, Trieste, Italy; [Cuzzoni, Eva] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [De Iudicibus, Sara; Tommasini, Alberto] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Paediat, Trieste, Italy; [De Lorenzo, Elisa] IRCCS, Natl Canc Inst CRO, Dept Translat Res, Aviano, Italy; [Decorti, Giuliana] Univ Trieste, Dept Life Sci, Trieste, Italy	IRCCS Burlo Garofolo; University of Trieste; IRCCS Burlo Garofolo; IRCCS Aviano (CRO); University of Trieste	Piscianz, E (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Diagnost Med, Trieste, Italy.	elisa.piscianz@gmail.com	Tommasini, Alberto/AAE-3882-2020; Valencic, Erica/G-3067-2014	Tommasini, Alberto/0000-0002-6943-7927; Valencic, Erica/0000-0002-7380-8014; Piscianz, Elisa/0000-0001-7374-1684; Decorti, Giuliana/0000-0002-9714-6246				Conklyn M, 2004, J LEUKOCYTE BIOL, V76, P1248, DOI 10.1189/jlb.0504282; Egli A, 2013, TRANSPLANTATION, V95, P448, DOI 10.1097/TP.0b013e318276a19f; Flanagan ME, 2010, J MED CHEM, V53, P8468, DOI 10.1021/jm1004286; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Kalluri Hari Varun, 2012, World J Transplant, V2, P51, DOI 10.5500/wjt.v2.i4.51; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; Kyttaris VC, 2012, DRUG DES DEV THER, V6, P245, DOI 10.2147/DDDT.S25426; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; O'Shea JJ, 2004, ANN RHEUM DIS, V63, P67, DOI 10.1136/ard.2004.028290; Paniagua R, 2005, TRANSPLANTATION, V80, P1283, DOI 10.1097/01.tp.0000177643.05739.cd; Pinchuk LM, 1996, J IMMUNOL, V157, P4363; Piscianz E, 2011, INT IMMUNOPHARMACOL, V11, P2242, DOI 10.1016/j.intimp.2011.09.009; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Soto H, 2008, SCAND J IMMUNOL, V68, P43, DOI 10.1111/j.1365-3083.2008.02117.x; Vafadari R, 2012, TRANSPLANTATION, V94, P465, DOI 10.1097/TP.0b013e3182626b5a; van Gurp EAFJ, 2009, TRANSPLANTATION, V87, P79, DOI 10.1097/TP.0b013e31818bbea7; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Vincenti F, 2012, AM J TRANSPLANT, V12, P2446, DOI 10.1111/j.1600-6143.2012.04127.x; Yoshida H, 2012, BIOCHEM BIOPH RES CO, V418, P234, DOI 10.1016/j.bbrc.2011.12.156	21	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85463	10.1371/journal.pone.0085463	http://dx.doi.org/10.1371/journal.pone.0085463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416411	gold, Green Published, Green Submitted			2022-12-25	WOS:000329866300080
J	Fikru, R; Hagos, A; Roge, S; Reyna-Bello, A; Gonzatti, MI; Merga, B; Goddeeris, BM; Buscher, P				Fikru, Regassa; Hagos, Ashenafi; Roge, Stijn; Reyna-Bello, Armando; Isabel Gonzatti, Mary; Merga, Bekana; Goddeeris, Bruno Maria; Buscher, Philippe			A Proline Racemase Based PCR for Identification of Trypanosoma vivax in Cattle Blood	PLOS ONE			English	Article							SOUTH-AMERICA; TSETSE; AMPLIFICATION; DIAGNOSIS; REVEALS	A study was conducted to develop a Trypanosoma vivax (T. vivax) specific PCR based on the T. vivax proline racemase (TvPRAC) gene. Forward and reverse primers were designed that bind at 764-783 bp and 983-1002 bp of the gene. To assess its specificity, TvPRAC PCR was conducted on DNA extracted from different haemotropic pathogens: T. vivax from Nigeria, Ethiopia and Venezuela, T. congolense Savannah type, T. brucei brucei, T. evansi, T. equiperdum, T. theileri, Theileria parva, Anaplasma marginale, Babesia bovis and Babesia bigemina and from bovine, goat, mouse, camel and human blood. The analytical sensitivity of the TvPRAC PCR was compared with that of the ITS-1 PCR and the 18S PCR-RFLP on a dilution series of T. vivax DNA in water. The diagnostic performance of the three PCRs was compared on 411 Ethiopian bovine blood specimens collected in a former study. TvPRAC PCR proved to be fully specific for T. vivax, irrespective of its geographical origin. Its analytical sensitivity was lower than that of ITS-1 PCR. On these bovine specimens, TvPRAC PCR detected 8.3% T. vivax infections while ITS-1 PCR and 18S PCR-RFLP detected respectively 22.6 and 6.1% T. vivax infections. The study demonstrates that a proline racemase based PCR could be used, preferably in combination with ITS-1 PCR, as a species-specific diagnostic test for T. vivax infections worldwide.	[Fikru, Regassa; Hagos, Ashenafi; Merga, Bekana] Univ Addis Ababa, Coll Vet Med & Agr, Debre Zeit, Ethiopia; [Fikru, Regassa; Roge, Stijn; Buscher, Philippe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Fikru, Regassa; Goddeeris, Bruno Maria] Katholieke Univ Leuven, Dept Biosyst, Fac Biosci Engn, Louvain, Belgium; [Reyna-Bello, Armando] Univ Ac Expt Simon Rodriguez, Grp Inmunobiol, Ctr Estudios Biomed & Vet, Caracas, Venezuela; [Isabel Gonzatti, Mary] Univ Simon Bolivar, Dept Biol Celular, Grp Bioquim & Inmunol Hemoparasitos, Caracas, Venezuela	Addis Ababa University; Institute of Tropical Medicine (ITM); KU Leuven; Simon Bolivar University	Fikru, R (corresponding author), Univ Addis Ababa, Coll Vet Med & Agr, Debre Zeit, Ethiopia.	fikruregassa@yahoo.com	caputo, carlo/N-3747-2014; Goddeeris, Bruno Maria/L-2440-2015; Reyna-Bello, Armando/G-1117-2019; Büscher, Philippe/B-9956-2012	Goddeeris, Bruno Maria/0000-0003-3729-7592; Reyna-Bello, Armando/0000-0003-0846-5745; Büscher, Philippe/0000-0002-1926-7472; Gonzatti, Mary Isabel/0000-0003-4266-2988	Belgian Directorate General for Development Cooperation	Belgian Directorate General for Development Cooperation	The PhD fellowship of Fikru Regassa was financed by the Belgian Directorate General for Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe G, 1996, REV MED VET-TOULOUSE, V147, P897; Adams ER, 2006, ACTA TROP, V100, P103, DOI 10.1016/j.actatropica.2006.10.002; Barrowman PR, 1976, J VET RES, V43, P55; Chamond N, 2009, MOL BIOCHEM PARASIT, V165, P170, DOI 10.1016/j.molbiopara.2009.02.002; Cortez AP, 2009, MOL CELL PROBE, V23, P44, DOI 10.1016/j.mcp.2008.11.003; Davila AMR, 2000, ANN NY ACAD SCI, V916, P199, DOI 10.1111/j.1749-6632.2000.tb05291.x; Deborggraeve S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000972; Delespaux V, 2008, TRENDS PARASITOL, V24, P236, DOI 10.1016/j.pt.2008.02.006; Desquesnes M, 2001, INT J PARASITOL, V31, P610, DOI 10.1016/S0020-7519(01)00161-8; DICKIN SK, 1989, MOL BIOCHEM PARASIT, V33, P135, DOI 10.1016/0166-6851(89)90027-3; Fikru R, 2012, VET PARASITOL, V190, P355, DOI 10.1016/j.vetpar.2012.07.010; Geysen D, 2003, VET PARASITOL, V110, P171, DOI 10.1016/S0304-4017(02)00313-8; Geysen D, 2000, THESIS BRUNEL U UK; Gibson W, 2007, INT J PARASITOL, V37, P829, DOI 10.1016/j.ijpara.2007.03.002; Gonzalez LE, 2005, EXP PARASITOL, V111, P126, DOI 10.1016/j.exppara.2005.05.008; Hamilton PB, 2008, INFECT GENET EVOL, V8, P26, DOI 10.1016/j.meegid.2007.09.003; Hoare C, 1972, TRYPANOSOMES MAMMALS; LEEFLANG P, 1976, INT J PARASITOL, V6, P413, DOI 10.1016/0020-7519(76)90027-8; Masake RA, 1997, EXP PARASITOL, V85, P193, DOI 10.1006/expr.1996.4124; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; Morlais I, 2001, ACTA TROP, V80, P207, DOI 10.1016/S0001-706X(01)00160-7; Nakayima J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-217; Njiru ZK, 2005, PARASITOL RES, V95, P186, DOI 10.1007/s00436-004-1267-5; Oluwafemi RA, 2007, SCI RES ESSAYS, V2, P380; Silva RAMS, 1998, MEM I OSWALDO CRUZ, V93, P29, DOI 10.1590/S0074-02761998000100006; SONGA EB, 1988, ANN SOC BELG MED TR, V68, P233; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Thumbi Samuel M, 2010, BMC Res Notes, V3, P6, DOI 10.1186/1756-0500-3-6; van Meirvenne N., 1975, Annales Soc belge Med trop, V55, P1; Ventura RM, 2001, EXP PARASITOL, V99, P37, DOI 10.1006/expr.2001.4641; Verloo D, 2000, VET PARASITOL, V89, P129, DOI 10.1016/S0304-4017(00)00191-6; Viera AJ, 2005, FAM MED, V37, P360	32	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84819	10.1371/journal.pone.0084819	http://dx.doi.org/10.1371/journal.pone.0084819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416292	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500174
J	Ghosh, D; Dey, SK; Saha, C				Ghosh, Debjani; Dey, Subrata Kumar; Saha, Chabita			Mutation Induced Conformational Changes in Genomic DNA from Cancerous K562 Cells Influence Drug-DNA Binding Modes	PLOS ONE			English	Article							CALF-THYMUS DNA; RAMAN-SPECTROSCOPY; FREE-ENERGY; MOLECULAR-MECHANISM; MYELOID-LEUKEMIA; IONIC LIQUID; DAUNOMYCIN; INTERCALATION; COMPLEX; RECOGNITION	Normal human genomic DNA (N-DNA) and mutated DNA (M-DNA) from K562 leukemic cells show different thermodynamic properties and binding affinities on interaction with anticancer drugs; adriamycin (ADR) and daunomycin (DNM). Isothermal calorimetric thermograms representing titration of ADR/DNM with N-DNA and M-DNA on analysis best fitted with sequential model of four and three events respectively. From Raman spectroscopy it has been identified that M-DNA is partially transformed to A form owing to mutations and N-DNA on binding of drugs too undergoes transition to A form of DNA. A correlation of thermodynamic contribution and structural data reveal the presence of different binding events in drug and DNA interactions. These events are assumed to be representative of minor groove complexation, reorientation of the drug in the complex, DNA deformation to accommodate the drugs and finally intercalation. Dynamic light scattering and zeta potential data also support differences in structure and mode of binding of N and M DNA. This study highlights that mutations can manifest structural changes in DNA, which may influence the binding efficacy of the drugs. New generation of drugs can be designed which recognize the difference in DNA structure in the cancerous cells instead of their biochemical manifestation.	[Ghosh, Debjani; Dey, Subrata Kumar; Saha, Chabita] West Bengal Univ Technol, Sch Biotechnol & Biol Sci, Kolkata, India	Maulana Abul Kalam Azad University of Technology	Saha, C (corresponding author), West Bengal Univ Technol, Sch Biotechnol & Biol Sci, Kolkata, India.	k.chabita@gmail.com	Saha, chabita/AAW-5020-2021		Department of Science and Technology (DST), Government of India; Council of Scientific and Industrial Research (CSIR), India	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Dr. Chabita Saha is thankful to Department of Science and Technology (DST), Government of India, for the financial support. Ms. Debjani Ghosh is financially supported by Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2008, J PHYS CHEM B, V112, P8151, DOI 10.1021/jp711608y; BENEVIDES JM, 1983, NUCLEIC ACIDS RES, V11, P5747, DOI 10.1093/nar/11.16.5747; Benevides JM, 2005, J RAMAN SPECTROSC, V36, P279, DOI 10.1002/jrs.1324; CHAIRES JB, 1990, BIOCHEMISTRY-US, V29, P6145, DOI 10.1021/bi00478a006; CHAIRES JB, 1987, BIOCHEMISTRY-US, V26, P8227, DOI 10.1021/bi00399a031; Chaires JB, 1996, BIOCHEMISTRY-US, V35, P2047, DOI 10.1021/bi952812r; CHAIRES JB, 1985, BIOCHEMISTRY-US, V24, P260, DOI 10.1021/bi00323a004; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Couzin J, 2002, SCIENCE, V298, P522, DOI 10.1126/science.298.5593.522; Ding YH, 2010, J PHYS CHEM B, V114, P2033, DOI 10.1021/jp9104757; Dong J, 2000, BIOCHEMISTRY-US, V39, P13241, DOI 10.1021/bi001437m; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Frantz S, 2006, NAT REV DRUG DISCOV, V5, P91, DOI 10.1038/nrd1972; Ghosh D, 2013, J BIOMOL STRUCT DYN, V31, P331, DOI 10.1080/07391102.2012.698190; Ghosh D, 2012, DNA CELL BIOL, V31, P377, DOI 10.1089/dna.2011.1299; He YF, 2013, COLLOID SURFACE B, V101, P398, DOI 10.1016/j.colsurfb.2012.07.027; Kabiri M, 2012, MOLECULES, V17, P3114, DOI 10.3390/molecules17033114; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; KRISHNAMOORTHY CR, 1986, BIOCHEMISTRY-US, V25, P5933, DOI 10.1021/bi00368a015; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li G, 2002, SCI CHINA SER C, V45, P397, DOI 10.1360/02yc9044; Ling JY, 2005, CHINESE CHEM LETT, V16, P71; MACGREGOR RB, 1987, BIOCHEMISTRY-US, V26, P4008, DOI 10.1021/bi00387a040; Mady MM, 2004, J DRUG TARGET, V12, P11, DOI 10.1080/10611860410001683059; Majumder P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026486; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Movileanu L, 1999, J RAMAN SPECTROSC, V30, P637, DOI 10.1002/(SICI)1097-4555(199908)30:8<637::AID-JRS431>3.0.CO;2-B; Mukherjee A, 2008, J AM CHEM SOC, V130, P9747, DOI 10.1021/ja8001666; NEAULT JF, 1995, J BIOMOL STRUCT DYN, V13, P387, DOI 10.1080/07391102.1995.10508847; Neault JF, 1996, J BIOL CHEM, V271, P8140, DOI 10.1074/jbc.271.14.8140; NISHIMURA Y, 1983, NUCLEIC ACIDS RES, V11, P1579, DOI 10.1093/nar/11.5.1579; Qu XG, 2001, P NATL ACAD SCI USA, V98, P14212, DOI 10.1073/pnas.241509698; QUIGLEY GJ, 1980, P NATL ACAD SCI-BIOL, V77, P7204, DOI 10.1073/pnas.77.12.7204; REMETA DP, 1993, BIOCHEMISTRY-US, V32, P5064, DOI 10.1021/bi00070a014; RIZZO V, 1989, BIOCHEMISTRY-US, V28, P274, DOI 10.1021/bi00427a038; Salvia MV, 2013, BIOPHYS CHEM, V179, P1, DOI 10.1016/j.bpc.2013.04.001; Serban D, 2002, BIOCHEMISTRY-US, V41, P847, DOI 10.1021/bi011004z; SKOROBOGATY A, 1988, FEBS LETT, V227, P103, DOI 10.1016/0014-5793(88)80877-9; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; WARTELL RM, 1982, P NATL ACAD SCI-BIOL, V79, P2549, DOI 10.1073/pnas.79.8.2549; Wilhelm M, 2012, J AM CHEM SOC, V134, P8588, DOI 10.1021/ja301649k; Yoshikawa Y, 1996, BIOPHYS CHEM, V61, P93, DOI 10.1016/S0301-4622(96)02184-9	44	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84880	10.1371/journal.pone.0084880	http://dx.doi.org/10.1371/journal.pone.0084880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416304	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500183
J	Jaceldo-Siegl, K; Haddad, E; Oda, K; Fraser, GE; Sabate, J				Jaceldo-Siegl, Karen; Haddad, Ella; Oda, Keiji; Fraser, Gary E.; Sabate, Joan			Tree Nuts Are Inversely Associated with Metabolic Syndrome and Obesity: The Adventist Health Study-2	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-WEIGHT; CARDIOVASCULAR EVENTS; NUTRIENT INTAKE; CONSUMPTION; RISK; PEANUTS; NUTRITION; ALMONDS; ADULTS	Objective: To examine the relationships of nut consumption, metabolic syndrome (MetS), and obesity in the Adventist Health Study-2, a relatively healthy population with a wide range of nut intake. Research Design and Methods: Cross-sectional analysis was conducted on clinical, dietary, anthropometric, and demographic data of 803 adults. MetS was defined according to the American Heart Association and the National Heart, Lung, and Blood Institute diagnostic criteria. We assessed intake of total nuts, tree nuts and peanuts, and also classified subjects into low tree nut/low peanut (LT/LP), low tree/high peanut (LT/HP), high tree nut/high peanut (HT/HP), and high tree/low peanut (HT/LP) consumers. Odds ratios were estimated using multivariable logistic regression. Results: 32% of subjects had MetS. Compared to LT/LP consumers, obesity was lower in LT/HP (OR = 0.89; 95% CI = 0.53, 1.48), HT/HP (OR = 0.63; 95% CI = 0.40, 0.99) and HT/LP (OR = 0.54; 95% CI = 0.34, 0.88) consumers, p for trend = 0.006. For MetS, odds ratios (95% CI) were 0.77 (0.47, 1.28), 0.65 (0.42, 1.00) and 0.68 (0.43, 1.07), respectively (p for trend = 0.056). Frequency of nut intake (once/week) had significant inverse associations with MetS (3% less for tree nuts and 2% less for total nuts) and obesity (7% less for tree nuts and 3% less for total nuts). Conclusions: Tree nuts appear to have strong inverse association with obesity, and favorable though weaker association with MetS independent of demographic, lifestyle and dietary factors.	[Jaceldo-Siegl, Karen; Haddad, Ella; Sabate, Joan] Loma Linda Univ, Sch Publ Hlth, Dept Nutr, Loma Linda, CA 92350 USA; [Oda, Keiji; Fraser, Gary E.; Sabate, Joan] Loma Linda Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Loma Linda, CA 92350 USA; [Jaceldo-Siegl, Karen; Fraser, Gary E.] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA	Loma Linda University; Loma Linda University; Loma Linda University	Jaceldo-Siegl, K (corresponding author), Loma Linda Univ, Sch Publ Hlth, Dept Nutr, Loma Linda, CA 92350 USA.	kjaceldo@llu.edu	Oda, Keiji/Q-6822-2019	Oda, Keiji/0000-0001-7631-6085; Sabate, Joan/0000-0002-9063-9785	National Institutes of Health/National Cancer Institute [UO1CA152939]; International Tree Nut Council Nutrition Research and Education Foundation; NATIONAL CANCER INSTITUTE [U01CA152939] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); International Tree Nut Council Nutrition Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge support from the National Institutes of Health/National Cancer Institute (UO1CA152939), and a grant from The International Tree Nut Council Nutrition Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, ARCH INTERN MED, V162, P1382, DOI 10.1001/archinte.162.12.1382; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Bes-Rastrollo M, 2009, AM J CLIN NUTR, V89, P1913, DOI 10.3945/ajcn.2008.27276; Butler TL, 2008, INT J EPIDEMIOL, V37, P260, DOI 10.1093/ije/dym165; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, P518, DOI 10.1016/j.numecd.2009.11.010; Cassady BA, 2009, AM J CLIN NUTR, V89, P794, DOI 10.3945/ajcn.2008.26669; Crichton GE, 2011, OBES REV, V12, pe190, DOI 10.1111/j.1467-789X.2010.00837.x; Deshmukh-Taskar PR, 2009, PUBLIC HEALTH NUTR, V12, P2493, DOI 10.1017/S1368980009991261; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Fernandez-Montero A, 2012, PUBLIC HEALTH NUTR, V23, P1; Flores-Mateo G, 2013, AM J CLIN NUTR, V97, P1346, DOI 10.3945/ajcn.111.031484; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hollis J, 2007, BRIT J NUTR, V98, P651, DOI 10.1017/S0007114507734608; Ibarrola-Jurado N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057367; Jaceldo-Siegl K, 2004, BRIT J NUTR, V92, P533, DOI 10.1079/BJN20041223; Jaceldo-Siegl K, 2011, PUBLIC HEALTH NUTR, V14, P1988, DOI 10.1017/S1368980011000735; Jaceldo-Siegl K, 2010, PUBLIC HEALTH NUTR, V13, P812, DOI 10.1017/S1368980009992072; Jenab M, 2006, BRIT J NUTR, V96, pS12, DOI 10.1017/BJN20061859; Kafonek SD, 1996, CLIN CHEM, V42, P2002; Kelly JH, 2006, BRIT J NUTR, V96, pS61, DOI 10.1017/BJN20061865; King JG, 2008, J NUTR, V138, p1736S, DOI 10.1093/jn/138.9.1736S; Kouki R, 2011, EUR J CLIN NUTR, V65, P368, DOI 10.1038/ejcn.2010.262; Kris-Etherton PN, 2008, J NUTR, V138, p1746S; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Martinez-Gonzalez MA, 2011, NUTR METAB CARDIOVAS, V21, pS40, DOI 10.1016/j.numecd.2010.11.005; Mattes RD, 2008, J NUTR, V138, p1741S, DOI 10.1093/jn/138.9.1741S; Mattes RD, 2010, ASIA PAC J CLIN NUTR, V19, P137; McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538; Novotny JA, 2012, AM J CLIN NUTR, V96, P296, DOI 10.3945/ajcn.112.035782; O'Neil CE, 2012, NUTR RES, V32, P185, DOI 10.1016/j.nutres.2012.01.005; O'Neil CE, 2011, J AM COLL NUTR, V30, P502, DOI 10.1080/07315724.2011.10719996; Organization WH, 2006, GLOB DAT BOD MASS IN; Pan A, 2013, J NUTR, V143, P512, DOI 10.3945/jn.112.172171; Rajaram S, 2006, BRIT J NUTR, V96, pS79, DOI 10.1017/BJN20061867; Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79; Salas-Salvado J, 2008, ARCH INTERN MED, V168, P2449, DOI 10.1001/archinte.168.22.2449; Schmidt C, 2012, METAB SYNDR RELAT D, V10, P394, DOI 10.1089/met.2012.0048; Vadivel V, 2012, NUTRITION, V28, P1089, DOI 10.1016/j.nut.2012.01.004	42	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85133	10.1371/journal.pone.0085133	http://dx.doi.org/10.1371/journal.pone.0085133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416351	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500219
J	Liu, RL; Jiang, Y; Li, Q; Hammond, SK				Liu, Ruiling; Jiang, Yuan; Li, Qiang; Hammond, S. Katharine			An Assessment of Health Risks and Mortality from Exposure to Secondhand Smoke in Chinese Restaurants and Bars	PLOS ONE			English	Article							LUNG-CANCER; TOBACCO-SMOKE; HEART-DISEASE; PASSIVE SMOKING; PUBLIC PLACES; WORKERS; PREVALENCE; BURDEN; EXCESS	Introduction: Smoking is generally not regulated in restaurants or bars in China, or the restrictions are not fully implemented if there are any, while the related hazard health effects are not recognized by the majority of the Chinese population. Objectives: This study aims to assess the excess health risks and mortality attributed to secondhand smoke (SHS) exposure in restaurants and bars for both servers and patrons to provide necessary evidence for advancing tobacco control in this microenvironment. Methods: Two approaches were used for the assessment. One is a continuous approach based on existing field measurements and Repace and Lowrey's dose-response model, and the other is a categorical approach based on exposure or not and epidemiological studies. Results: Based on the continuous approach, servers were estimated to have a lifetime excess risk (LER) of lung cancer death (LCD) of 730 to 1,831x10(-6) for working five days a week for 45 years in smoking restaurants and 1,862 to 8,136x10(-6) in smoking bars, and patrons could have a LER of LCD of 47 to 117x10(-6) due to visiting smoking restaurants for an average of 13 minutes a day for 60 years, and 119 to 522x10(-6) due to visiting smoking bars. The categorical approach estimated that SHS exposure in restaurants and bars alone caused 84 LCD and 57 ischemic heart disease (IHD) deaths among nonsmoking servers and 1,2419 LCDs and 1,689 IHD deaths among the nonsmoking patron population. Conclusions: SHS exposure in restaurants and bars alone can impose high lifetime excess risks of lung cancer death and ischemic heart disease deaths to both servers and patrons, and can cause a significant number of deaths each year in China. These health risks and deaths can be prevented by banning smoking in restaurants and bars and effectively implementing these smoking bans.	[Liu, Ruiling; Hammond, S. Katharine] Univ Calif Berkeley, Dept Environm Hlth Sci, Berkeley, CA 94720 USA; [Jiang, Yuan] Chinese Ctr Dis Control & Prevent, Natl Tobacco Control Off, Beijing, Peoples R China; [Li, Qiang] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	University of California System; University of California Berkeley; Chinese Center for Disease Control & Prevention; University of Waterloo	Hammond, SK (corresponding author), Univ Calif Berkeley, Dept Environm Hlth Sci, Berkeley, CA 94720 USA.	hammondk@berkeley.edu			Flight Attendants Medical Research Institute	Flight Attendants Medical Research Institute	This research project was supported by Dr. William Cahan Distinguished Professor Award to SKH from the Flight Attendants Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; [Anonymous], 2004, IARC MON, V83; [Anonymous], 1997, EXP FACT HDB; California Environmental Protection Agency Office of Environmental Health Hazard Assessment Office of Air Resources Board, 2005, PROP ID ENV TOB SMOK; Chen M, 1997, 1996 NATL PREVALENCE; Chinese Centers for Disease Control and Prevention, 2012, 2011 CHIN TOB CONTR; Crouch T, 1987, ENVIRON SCI TECHNOL, V21, P415; Cui X, 2009, J CARDIOVASCULAR PUL, V28, P50; El-Hougeiri N, 2002, INDOOR BUILT ENVIRON, V11, P83; Gan Q, 2008, J OCCUP ENVIRON MED, V50, P570, DOI 10.1097/JOM.0b013e3181638640; Gan Q, 2007, TOB CONTROL, V16, P417, DOI 10.1136/tc.2007.021477; Hammond SK, 1999, ENVIRON HEALTH PERSP, V107, P329, DOI 10.2307/3434425; Hammond SK, 1999, ENV TOBACCO SMOKE EX, P973; Hedley AJ, 2006, TOXICOL SCI, V90, P539, DOI 10.1093/toxsci/kfj110; Jamrozik K, 2005, BRIT MED J, V330, P812, DOI 10.1136/bmj.38370.496632.8F; Klepeis N., 1996, ANAL NATL HUMAN ACTI; Lee J, 2010, INT J HYG ENVIR HEAL, V213, P348, DOI 10.1016/j.ijheh.2010.05.007; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Liu H, 2011, PREVENTIVE MED TRIBU, V17, P210; Liu R, 2013, INT J HYGIE IN PRESS; Liu R, 2013, ASSESSMENT RISK ASTH; Liu R, 2013, INT J HYG ENV HLTH; Liu RL, 2011, TOB CONTROL, V20, P397, DOI 10.1136/tc.2009.033233; Lopez MJ, 2006, MED CLIN-BARCELONA, V126, P13; Lv J, 2011, TOB CONTROL, V20, P309, DOI 10.1136/tc.2010.040352; Ma GuanSheng, 2005, Acta Nutrimenta Sinica, V27, P272; [康纪明 KANG Jiming], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P738; National Bureau of Statistics Ministry of Labour and Social Security of China, 2005, CHIN LAB STAT YB 200; National Bureau of Statistics of China, 2009, B 3 NAT EC CENS KEY; National Bureau of Statistics of China, 2008, TIM ACT PATT CHIN PE; National Bureau of Statistics of China, 2005, B 1 NAT EC CENS KEY, V3; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; REPACE JL, 1985, ENVIRON INT, V11, P3, DOI 10.1016/0160-4120(85)90098-4; REPACE JL, 1985, NEW YORK STATE J MED, V85, P381; Siegel M, 2003, TOB CONTROL, V12, P333, DOI 10.1136/tc.12.3.333; Steenland K, 1999, ENVIRON HEALTH PERSP, V107, P859, DOI 10.2307/3434566; Stillman F, 2007, TOB CONTROL, V16, P229, DOI 10.1136/tc.2006.018333; Sugimura H, 2006, CHEST, V129, P1088, DOI 10.1378/chest.129.4.1088; USDHHS, 2006, HLTH CONS INV EXP TO; Weng X, 1986, J CARDIOVASCULAR PUL, V02, P44; Xiao L, 2010, BIOMED ENVIRON SCI, V23, P430, DOI 10.1016/S0895-3988(11)60003-2; Yang G, 2010, TOBACCO CONTROL FUTU; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; Yang Y, 2008, CHINESE J HLTH ED, V24, p[657, 660]; Zheng PP, 2009, HEALTH POLICY, V89, P216, DOI 10.1016/j.healthpol.2008.06.002	46	8	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84811	10.1371/journal.pone.0084811	http://dx.doi.org/10.1371/journal.pone.0084811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416289	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500171
J	McCracken, SF; Forstner, MRJ				McCracken, Shawn F.; Forstner, Michael R. J.			Oil Road Effects on the Anuran Community of a High Canopy Tank Bromeliad (Aechmea zebrina) in the Upper Amazon Basin, Ecuador	PLOS ONE			English	Article							RAIN-FOREST; SPECIES-DIVERSITY; FROG ASSEMBLAGES; WESTERN AMAZON; HERPETOFAUNA; BIRDS; DEFORESTATION; FRAGMENTATION; MICROCLIMATE; MIGRATION	Tropical forest canopies are among the most species-rich terrestrial habitats on earth and one of the remaining relatively unexplored biotic frontiers. Epiphytic bromeliads provide microhabitat for a high diversity of organisms in tropical forest canopies and are considered a keystone resource. A number of amphibians inhabit these phytotelmata, yet their ecological role and status in forest canopies remains unknown. For this study, anurans were collected from an upper canopy tank bromeliad (Aechmea zebrina) at similar to 20-45 m ((x) over bar = 33 m) above the forest floor. Bromeliads were sampled from trees located near trails in undisturbed primary rainforest and oil access roads in the Yasuni Biosphere Reserve of Amazonian Ecuador. We collected 95 anurans representing 10 species from 160 bromeliads in 32 trees. We used generalized linear mixed models to assess the effects of disturbance and habitat factors on the occupancy and abundance of anurans collected. Bromeliads in forest along oil roads had a lower occupancy and abundance of anurans than those in undisturbed forest, a somewhat unexpected result due to the intactness and quality of forest adjacent to the roads. Recorded habitat variables had no relationship with occupancy or abundance of anurans, and did not differ significantly between treatments. Our findings reveal that even the minimal footprint of natural resource extraction operations, primarily roads, in rainforest environments can have significant negative impacts on the unique upper canopy anuran community. Based on these results, we recommend that natural resource development treat rainforest habitat as an offshore system where roads are not used, employ industry best practice guidelines, and current access roads be protected from colonization and further deforestation.	[McCracken, Shawn F.; Forstner, Michael R. J.] SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [McCracken, Shawn F.] TADPOLE Org, San Marcos, TX USA	Texas State University System; Texas State University San Marcos	McCracken, SF (corresponding author), SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	smccracken@txstate.edu		McCracken, Shawn/0000-0001-6455-537X	National Science Foundation [0742306]; Texas State University - Department of Biology; TADPOLE Organization; Sigma Xi - The Scientific Research Society; Explorer's Club	National Science Foundation(National Science Foundation (NSF)); Texas State University - Department of Biology; TADPOLE Organization; Sigma Xi - The Scientific Research Society; Explorer's Club	This research was supported by the National Science Foundation (Graduate Research Fellowship Program and a GK-12 grant No. 0742306), Texas State University - Department of Biology, the TADPOLE Organization, Sigma Xi - The Scientific Research Society, and The Explorer's Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews Kimberly M., 2008, P121; Armbruster P, 2002, OIKOS, V96, P225, DOI 10.1034/j.1600-0706.2002.960204.x; Balslev H., 1987, OPERA BOT, V92, P37; Barbieri AF, 2009, POPUL RES POLICY REV, V28, P291, DOI 10.1007/s11113-008-9100-y; Barthlott W, 2001, PLANT ECOL, V152, P145, DOI 10.1023/A:1011483901452; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P7; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P394; Basset Y, 2004, BIODIVERS CONSERV, V13, P709, DOI 10.1023/B:BIOC.0000011722.44714.a4; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P4; Bell KE, 2006, CONSERV BIOL, V20, P1750, DOI 10.1111/j.1523-1739.2006.00522.x; Benzing DH, 1998, CLIMATIC CHANGE, V39, P519, DOI 10.1023/A:1005312307709; BENZING DH, 2000, BROMELIACEAE PROFILE; Blandin LC, 1976, CLIMA SUS CARACTERIS; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brighigna L, 2002, REV BIOL TROP, V50, P577; Buchanan Bryant W., 2006, P192; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Canaday C, 2001, BIODIVERS CONSERV, V10, P567, DOI 10.1023/A:1016651827287; Carr D, 2009, PROG HUM GEOG, V33, P355, DOI 10.1177/0309132508096031; CIA, 2007, WORLD FACT BOOK 2007; Develey PF, 2001, CONSERV BIOL, V15, P1416, DOI 10.1046/j.1523-1739.2001.00170.x; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; Dew JL, 2003, AM J PHYS ANTHROPOL, P89; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Ernst R, 2005, ECOLOGY, V86, P3111, DOI 10.1890/04-0800; Ernst R, 2008, J TROP ECOL, V24, P111, DOI 10.1017/S0266467407004737; Ernst Raffael, 2006, Ecotropica-Bonn, V12, P113; FAO, 2010, GLOBAL FOREST RESOUR; Finer M, 2009, ENVIRON RES LETT, V4, P1; Finer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063022; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Foley JA, 2003, FRONT ECOL ENVIRON, V1, P38, DOI 10.1890/1540-9295(2003)001[0038:GSHTEC]2.0.CO;2; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Freiberg M, 2001, PLANT ECOL, V153, P241, DOI 10.1023/A:1017540629725; Gao Z., 1998, ENV REGULATION OIL G; Godfray HCJ, 1999, PHILOS T R SOC B, V354, P1811, DOI 10.1098/rstb.1999.0523; Goosem M, 2002, WILDLIFE RES, V29, P277, DOI 10.1071/WR01058; Goosem Miriam, 1997, P241; Guayasamin JM, 2006, HERPETOLOGICA, V62, P191, DOI 10.1655/05-40.1; HEINEN JT, 1992, BIOTROPICA, V24, P431, DOI 10.2307/2388614; Hietz P, 1998, PURE APPL CHEM, V70, P1; Jabiol J, 2009, FOREST ECOL MANAG, V257, P351, DOI 10.1016/j.foreco.2008.09.010; Keller A, 2009, J ANIM ECOL, V78, P305, DOI 10.1111/j.1365-2656.2008.01457.x; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kitching RL, 2001, ANNU REV ENTOMOL, V46, P729, DOI 10.1146/annurev.ento.46.1.729; Krebs C., 2008, ECOLOGICAL WORLD VIE; Laurance SGW, 2004, ECOL APPL, V14, P1344, DOI 10.1890/03-5194; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2008, LIVING DYNAMIC TROPI, P295, DOI DOI 10.1002/9781444300321.CH23; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Linden A, 2011, ECOLOGY, V92, P1414, DOI 10.1890/10-1831.1; Lowman MD, 2012, NEW PHYTOL, V194, P12, DOI 10.1111/j.1469-8137.2012.04076.x; McCracken Shawn, 2009, Herpetological Review, V40, P190; McCracken Shawn F., 2008, Herpetological Review, V39, P170; McCracken Shawn F., 2006, Phyllomedusa, V5, P135; Menin M, 2007, J TROP ECOL, V23, P539, DOI 10.1017/S0266467407004269; Moffett M. W., 1994, HIGH FRONTIER EXPLOR; MORAN VC, 1982, J ANIM ECOL, V51, P289, DOI 10.2307/4325; NADKARNI NM, 1994, AM ZOOL, V34, P70; O'Rourke D, 2003, ANNU REV ENV RESOUR, V28, P587, DOI 10.1146/annurev.energy.28.050302.105617; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Ozanne CMP, 2003, SCIENCE, V301, P183, DOI 10.1126/science.1084507; Parris KM, 2004, ECOGRAPHY, V27, P392, DOI 10.1111/j.0906-7590.2004.03711.x; Pearman PB, 1997, CONSERV BIOL, V11, P1211, DOI 10.1046/j.1523-1739.1997.96202.x; PERRY DR, 1978, BIOTROPICA, V10, P155, DOI 10.2307/2388019; Pinheiro J. C., 2002, MIXED EFFECTS MODELS; Pohlman CL, 2009, AGR FOREST METEOROL, V149, P84, DOI 10.1016/j.agrformet.2008.07.003; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Richardson BA, 1999, BIOTROPICA, V31, P321, DOI 10.1111/j.1744-7429.1999.tb00144.x; Schiesari L, 2003, COPEIA, P263, DOI 10.1643/0045-8511(2003)003[0263:TACBAD]2.0.CO;2; Schlaepfer MA, 2001, CONSERV BIOL, V15, P1079, DOI 10.1046/j.1523-1739.2001.0150041079.x; Semlitsch RD, 2007, CONSERV BIOL, V21, P159, DOI 10.1111/j.1523-1739.2006.00571.x; Sierra R, 2000, APPL GEOGR, V20, P1, DOI 10.1016/S0143-6228(99)00014-4; Skaug H., 2011, GLMMADMB GEN LINEAR; Southwood T.R.E., 1987, P3; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Stuntz S, 2002, INT J BIOMETEOROL, V46, P53, DOI 10.1007/s00484-001-0117-8; Suarez E, 2009, ANIM CONSERV, V12, P364, DOI 10.1111/j.1469-1795.2009.00262.x; Terborgh JW, 1986, CONSERVATION BIOL SC; Urbina-Cardona JN, 2006, BIOL CONSERV, V132, P61, DOI 10.1016/j.biocon.2006.03.014; von Arx G, 2012, AGR FOREST METEOROL, V166, P144, DOI 10.1016/j.agrformet.2012.07.018; Wardhaugh CW, 2013, BIOL J LINN SOC, V109, P215, DOI 10.1111/bij.12029; WUNDER S, 2003, OIL WEALTH FATE FORE; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	88	16	17	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85470	10.1371/journal.pone.0085470	http://dx.doi.org/10.1371/journal.pone.0085470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416414	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500251
J	Osth, M; Ost, A; Kjolhede, P; Stralfors, P				Osth, Martin; Ost, Anita; Kjolhede, Preben; Stralfors, Peter			The Concentration of beta-Carotene in Human Adipocytes, but Not the Whole-Body Adipocyte Stores, Is Reduced in Obesity	PLOS ONE			English	Article							VITAMIN-A METABOLISM; ADIPOSE-TISSUE; INSULIN-RESISTANCE; SERUM CAROTENOIDS; DIETARY; PLASMA; RETINOL-BINDING-PROTEIN-4; PHOSPHORYLATION; QUEENSLAND; TRANSPORT	We have examined the concentration of beta-carotene in the fat of isolated abdominal subcutaneous adipocytes obtained from lean (BMI<23 kg/m(2)), non-obese with higher BMI (23 <= BMI<28 kg/m(2)), obese (BMI >= 28 kg/m(2)), and from a group of obese subjects with type 2 diabetes. The concentration of b-carotene was 50% lower in the adipocytes from the obese and obese/diabetic groups compared with the lean and non-obese groups. Interestingly, the total amount of beta-carotene in the adipocyte stores of each subject was constant among all groups. Triacylglycerol constituted 92 +/- 1% (by weight) of the adipocyte lipids in the lean group and this was increased to 99 +/- 2% in the obese group with diabetes (p<0.05). The concentration of cholesteryl esters was in all cases <0.1 g per 100 g of total lipids, demonstrating that mature human adipocytes have negligible stores of cholesteryl ester. Our findings demonstrate that adipocyte concentrations of beta-carotene are reduced in obese subjects. The lower concentrations in adipocytes from subjects with type 2 diabetes apparently reflect subjects obesity. Our finding that whole-body stores of beta-carotene in adipocytes are constant raises new questions regarding what function it serves, as well as the mechanisms for maintaining constant levels in the face of varied adipose tissue mass among individuals over a period of time.	[Osth, Martin; Ost, Anita; Kjolhede, Preben; Stralfors, Peter] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Stralfors, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	peter.stralfors@liu.se		Stralfors, Peter/0000-0002-1196-1806	Swedish Diabetes Fund; Novo Nordic Foundation; University of Linkoping; Swedish Research Council	Swedish Diabetes Fund; Novo Nordic Foundation(Novo Nordisk Foundation); University of Linkoping; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Diabetes Fund, Novo Nordic Foundation, University of Linkoping, and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2009, BRIT J NUTR, V101, P86, DOI 10.1017/S0007114508998445; Amengual J, 2013, PLOS ONE, V6; Beydoun MA, 2012, J NUTR, V142, P1693, DOI 10.3945/jn.112.160416; BJORNSON LK, 1976, J LIPID RES, V17, P343; Brady WE, 1996, J NUTR, V126, P129, DOI 10.1093/jn/126.1.129; Chung HY, 2009, AM J CLIN NUTR, V90, P533, DOI 10.3945/ajcn.2009.27712; Coyne T, 2005, AM J CLIN NUTR, V82, P685, DOI 10.1093/ajcn/82.3.685; Coyne T, 2009, BRIT J NUTR, V102, P1668, DOI 10.1017/S000711450999081X; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; El-Sohemy A, 2002, AM J CLIN NUTR, V76, P172, DOI 10.1093/ajcn/76.1.172; Ford ES, 2003, EUR J CLIN NUTR, V57, P1157, DOI 10.1038/sj.ejcn.1601667; Frey SK, 2011, NUTRIENTS, V3, P27, DOI 10.3390/nu3010027; Gouranton E, 2008, FOOD CHEM TOXICOL, V46, P3832, DOI 10.1016/j.fct.2008.10.006; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; JOHNSON EJ, 1995, AM J CLIN NUTR, V62, P598, DOI 10.1093/ajcn/62.3.598; Kabagambe EK, 2005, J NUTR, V135, P1763, DOI 10.1093/jn/135.7.1763; KAPLAN LA, 1990, CLIN PHYSIOL BIOCH, V8, P1; Kritchevsky SB, 2000, AM J EPIDEMIOL, V152, P1065, DOI 10.1093/aje/152.11.1065; Lee MJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1230, DOI 10.1152/ajpendo.90927.2008; Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moussa M, 2011, MOL NUTR FOOD RES, V55, P578, DOI 10.1002/mnfr.201000399; Ost A, 2007, FASEB J, V21, P3696, DOI 10.1096/fj.07-8173com; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Parker RS, 1999, P NUTR SOC, V58, P155, DOI 10.1079/PNS19990021; PARKER RS, 1989, J NUTR, V119, P101, DOI 10.1093/jn/119.1.101; Ryden M, 2012, J INTERN MED, V272, P371, DOI [10.1111/j.1365-2796.2012.2534.x, 10.1111/j.1365-2796.2012.2534x.x]; SCHREIBMAN PH, 1975, J CLIN INVEST, V55, P986, DOI 10.1172/JCI108028; Sluijs I, 2009, J NUTR, V139, P987, DOI 10.3945/jn.108.101451; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; TOKUNAGA M, 1981, TOHOKU J EXP MED, V133, P451, DOI 10.1620/tjem.133.451; Virtanen SM, 1996, AM J EPIDEMIOL, V144, P968, DOI 10.1093/oxfordjournals.aje.a008867; von Lintig J, 2001, ARCH BIOCHEM BIOPHYS, V385, P47, DOI 10.1006/abbi.2000.2096; von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629; Voutilainen S, 2006, AM J CLIN NUTR, V83, P1265; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	38	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85610	10.1371/journal.pone.0085610	http://dx.doi.org/10.1371/journal.pone.0085610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416432	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500259
J	Pfattheicher, S; Keller, J				Pfattheicher, Stefan; Keller, Johannes			Towards a Biopsychological Understanding of Costly Punishment: The Role of Basal Cortisol	PLOS ONE			English	Article							PRECONSCIOUS SELECTIVE ATTENTION; ECONOMIC DECISION-MAKING; SALIVARY CORTISOL; AGGRESSIVE-BEHAVIOR; SEX-DIFFERENCES; ALTRUISTIC PUNISHMENT; PROACTIVE AGGRESSION; 3RD-PARTY PUNISHMENT; SELF-REGULATION; HPA AXIS	Recent findings have documented a negative relation of basal endogenous cortisol and aggression after a provocation (i.e., reactive aggression) in humans. We build on these findings and investigated the relation of endogenous cortisol and reactive aggression in a social dilemma situation, that is, costly punishment of individuals who did not appropriately contribute to a common group project. Specifically, we predicted that basal cortisol is negatively related to costly punishment of uncooperative individuals. In the present study, basal cortisol was assessed prior to a public goods game with the option to punish other group members. In line with previous research on reactive aggression and basal cortisol, we found that basal cortisol was indeed negatively related to costly punishment. The findings are important for understanding costly punishment because this tendency has been documented as a possible basis for the evolution of cooperation.	[Pfattheicher, Stefan; Keller, Johannes] Univ Ulm, Dept Social Psychol, D-89069 Ulm, Germany	Ulm University	Pfattheicher, S (corresponding author), Univ Ulm, Dept Social Psychol, D-89069 Ulm, Germany.	stefan.pfattheicher@uni-ulm.de		Pfattheicher, Stefan/0000-0002-0161-1570	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	The reported research has been partially supported by a grant from the German Research Foundation to Johannes Keller. The authors received no additional external funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Balliet D, 2013, PERSPECT PSYCHOL SCI, V8, P363, DOI 10.1177/1745691613488533; Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Batson CD, 1997, J PERS SOC PSYCHOL, V72, P105, DOI 10.1037/0022-3514.72.1.105; Baumeister RF, 2002, J CONSUM RES, V28, P670, DOI 10.1086/338209; Baumeister RF, 2000, SOC COGNITION, V18, P130, DOI 10.1521/soco.2000.18.2.130; Bertsch K, 2011, HORM BEHAV, V59, P428, DOI 10.1016/j.yhbeh.2010.12.010; Blair C, 2004, DEV PSYCHOBIOL, V45, P113, DOI 10.1002/dev.20022; Bohnke R, 2010, PSYCHONEUROENDOCRINO, V35, P1034, DOI 10.1016/j.psyneuen.2010.01.004; Bohnke R, 2010, J NEURAL TRANSM, V117, P629, DOI 10.1007/s00702-010-0391-x; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Brown LL, 1996, J PERS SOC PSYCHOL, V70, P362, DOI 10.1037/0022-3514.70.2.362; Brune M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073519; Bullock JG, 2010, J PERS SOC PSYCHOL, V98, P550, DOI 10.1037/a0018933; Chan ME, 2011, PERS INDIV DIFFER, V50, P700, DOI 10.1016/j.paid.2010.12.021; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Connor DF, 2003, CHILD PSYCHIAT HUM D, V33, P279, DOI 10.1023/A:1023084112561; Cook RD, 1982, RESIDUALS INFLUENCE; Crick NR, 1996, CHILD DEV, V67, P993, DOI 10.2307/1131875; Crockett MJ, 2010, EMOTION, V10, P855, DOI 10.1037/a0019861; Cubitt RP, 2011, J PUBLIC ECON, V95, P253, DOI 10.1016/j.jpubeco.2010.10.011; Cunningham WA, 2005, COGN AFFECT BEHAV NE, V5, P202, DOI 10.3758/CABN.5.2.202; Denson TF, 2006, J PERS SOC PSYCHOL, V90, P1032, DOI 10.1037/0022-3514.90.6.1032; Denson TF, 2013, PSYCHONEUROENDOCRINO, V38, P416, DOI 10.1016/j.psyneuen.2012.07.003; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Emanuele E, 2008, NEUROSCI LETT, V437, P158, DOI 10.1016/j.neulet.2008.04.006; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; Eysenck HJ, 1970, BIOL BASIS PERSONALI; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Feilhauer J, 2013, PSYCHONEUROENDOCRINO, V38, P1586, DOI 10.1016/j.psyneuen.2013.01.005; Fiedler K, 2011, J EXP SOC PSYCHOL, V47, P1231, DOI 10.1016/j.jesp.2011.05.007; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Goetz J., 2010, PSYCHOL BULL, V136, P274; Halali E, 2013, J EXP PSYCH IN PRESS; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hayes A.F, 2013, MEDIATION MODERATION; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Hinkelmann K, 2009, BIOL PSYCHIAT, V66, P879, DOI 10.1016/j.biopsych.2009.06.023; KING RJ, 1990, PERS INDIV DIFFER, V11, P287, DOI 10.1016/0191-8869(90)90242-J; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; Knoch D, 2010, PSYCHOL SCI, V21, P337, DOI 10.1177/0956797609360750; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Leliveld MC, 2012, EUR J SOC PSYCHOL, V42, P135, DOI 10.1002/ejsp.872; Lockwood P, 2002, J PERS SOC PSYCHOL, V83, P854, DOI 10.1037//0022-3514.83.4.854; Lopez-Duran NL, 2009, J ABNORM CHILD PSYCH, V37, P169, DOI 10.1007/s10802-008-9263-3; McBurnett K, 2000, ARCH GEN PSYCHIAT, V57, P38, DOI 10.1001/archpsyc.57.1.38; McCullough M., 2008, REVENGE EVOLUTION FO; MCDONALD JF, 1980, REV ECON STAT, V62, P318, DOI 10.2307/1924766; Montoya ER, 2012, MOTIV EMOTION, V36, P65, DOI 10.1007/s11031-011-9264-3; Nava F, 2006, J ADDICT DIS, V25, P9, DOI 10.1300/J069v25n02_02; Nelissen RMA, 2009, JUDGM DECIS MAK, V4, P543; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E., 1990, GOVERNING COMMONS EV; Osumi T, 2012, J AFFECT DISORDERS, V142, P331, DOI 10.1016/j.jad.2012.05.012; Pfattheicher S, 2013, J BEHAV DEC IN PRESS; Pfattheicher S, 2013, EUR J PERSONALITY, V27, P346, DOI 10.1002/per.1909; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Platje E, 2013, BIOL PSYCHOL, V93, P132, DOI 10.1016/j.biopsycho.2013.01.002; Poustka L, 2010, J NEURAL TRANSM, V117, P621, DOI 10.1007/s00702-010-0386-7; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schmidt B, 2013, PSYCHOPHYSIOLOGY, V50, P498, DOI 10.1111/psyp.12032; Shoal GD, 2003, J AM ACAD CHILD PSY, V42, P1101, DOI 10.1097/01.CHI.0000070246.24125.6D; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Stroud LR, 2002, BIOL PSYCHIAT, V52, P318, DOI 10.1016/S0006-3223(02)01333-1; Sylwester K, 2013, J NEUROSCI PSYCHOL E, V6, P167, DOI 10.1037/npe0000009; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Tops M, 2011, PSYCHOPHYSIOLOGY, V48, P723, DOI 10.1111/j.1469-8986.2010.01131.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Bokhoven I, 2005, J NEURAL TRANSM, V112, P1083, DOI 10.1007/s00702-004-0253-5; van Goozen SHM, 2008, CURR DIR PSYCHOL SCI, V17, P224, DOI 10.1111/j.1467-8721.2008.00579.x; van Goozen SHM, 2007, PSYCHOL BULL, V133, P149, DOI 10.1037/0033-2909.133.1.149; van Honk J, 1998, PSYCHONEUROENDOCRINO, V23, P741, DOI 10.1016/S0306-4530(98)00047-X; van Honk J, 2000, PSYCHONEUROENDOCRINO, V25, P577, DOI 10.1016/S0306-4530(00)00011-1; van Honk J, 2010, J PERS, V78, P67, DOI 10.1111/j.1467-6494.2009.00609.x; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wang CS, 2011, ORGAN BEHAV HUM DEC, V116, P46, DOI 10.1016/j.obhdp.2011.05.007; WINDLE M, 1994, PERS INDIV DIFFER, V17, P61, DOI 10.1016/0191-8869(94)90262-3; Zimmer C, 2003, CLIN J PAIN, V19, P233, DOI 10.1097/00002508-200307000-00006	87	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85691	10.1371/journal.pone.0085691	http://dx.doi.org/10.1371/journal.pone.0085691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416441	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500262
J	Tian, YM; Huang, ZF; Wang, ZX; Yin, CX; Zhou, LL; Zhang, LX; Huang, KK; Zhou, HS; Jiang, XJ; Li, JM; Liao, LB; Yang, M; Meng, FY				Tian, Yiming; Huang, Zoufang; Wang, Zhixiang; Yin, Changxin; Zhou, Lanlan; Zhang, Lingxiu; Huang, Kaikai; Zhou, Hongsheng; Jiang, Xuejie; Li, Jinming; Liao, Libin; Yang, Mo; Meng, Fanyi			Identification of Novel Molecular Markers for Prognosis Estimation of Acute Myeloid Leukemia: Over-Expression of PDCD7, FIS1 and Ang2 May Indicate Poor Prognosis in Pretreatment Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							MITOCHONDRIAL DYNAMICS; GROWTH-FACTORS; ANGIOPOIETIN-2; CELLS; RECOMMENDATIONS; ANGIOGENESIS; DIAGNOSIS; OUTCOMES; FISSION; PROTEIN	Numerous factors impact on the prognosis of acute myeloid leukemia (AML), among which molecular genetic abnormalities are developed increasingly, however, accurate prediction for newly diagnosed AML patients remains unsatisfied. For further improving the prognosis evaluation system, we investigated the transcripts levels of PDCD7, FIS1, FAM3A, CA6, APP, KLRF1, ATCAY, GGT5 and Ang2 in 97 AML patients and 30 non-malignant controls, and validated using the published microarray data from 225 cytogenetically normal AML (CN-AML) patients treated according to the German AMLCG-1999 protocol. Real-time quantitative polymerase chain reaction and western blot were carried out, and clinical data were collected and analyzed. High Ang2 and FIS1 expression discriminated the CR rate of AML patients (62.5% versus 82.9% for Ang2, P = 0.011; 61.4% versus 82.2% for FIS1, P = 0.029). In CN-AML, patients with high FIS1 expression were more likely to be resistant to two courses of induction (P = 0.035). Overall survival (OS) and relapse-free survival (RFS) were shorter in CN-AML patients with high PDCD7 expression (P, < 000.01; P = 0.006), and PDCD7 was revealed to be an independent risk factor for OS in CN-AML (P = 0.004). In the analysis of published data from 225 CN-AML patients, PDCD7 remained independently predicting OS in CN-AML (P = 0.039). As a conclusion, Ang2 and FIS1 seem related to decreased CR rate of AML patients, and PDCD7 is associated with shorter OS and RFS in CN-AML. Hence, PDCD7, Ang2 and FIS1 may indicate a more aggressive form and poor prognosis of AML.	[Tian, Yiming; Huang, Zoufang; Wang, Zhixiang; Yin, Changxin; Zhou, Lanlan; Zhang, Lingxiu; Huang, Kaikai; Zhou, Hongsheng; Jiang, Xuejie; Liao, Libin; Yang, Mo; Meng, Fanyi] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China; [Li, Jinming] Southern Med Univ, Bioinformat Dept, Guangzhou, Guangdong, Peoples R China; [Yang, Mo] Univ Hong Kong, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; Southern Medical University - China; University of Hong Kong	Meng, FY (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	mengfu@medmail.com.cn			National Science Foundation of Guangdong Province, China [S20110100003807]	National Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work is supported by grants from the National Science Foundation of Guangdong Province, China ( S20110100003807), the funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benecke H, 2005, EMBO J, V24, P3057, DOI 10.1038/sj.emboj.7600765; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Damm F, 2011, BLOOD, V117, P4561, DOI 10.1182/blood-2010-08-303479; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Estey E, 1996, LEUKEMIA, V10, P932; Hou HA, 2008, LEUKEMIA RES, V32, P904, DOI 10.1016/j.leukres.2007.08.010; Huang HH, 2010, IMMUNOL INVEST, V39, P587, DOI 10.3109/08820131003720702; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Jaffe ES, 2001, WHO CLASSIFICATION T; Jiang XJ, 2012, CANCER LETT, V326, P135, DOI 10.1016/j.canlet.2012.07.030; Juliusson G, 2009, BLOOD, V113, P4179, DOI 10.1182/blood-2008-07-172007; Kaddour-Djebbar I, 2010, INT J ONCOL, V36, P1437, DOI 10.3892/ijo_00000629; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Loges S, 2005, J CLIN ONCOL, V23, P1109, DOI 10.1200/JCO.2005.05.058; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Manczak M, 2010, J ALZHEIMERS DIS JAD, P20; O'Donnell MR, 2011, NATL COMPREHENSIVE C; O'Donnell MR, 2005, NATL COMPREHENSIVE C; Park EJ, 1999, NUCLEIC ACIDS RES, V27, P1524, DOI 10.1093/nar/27.6.1524; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Sastre-Serra J, 2012, INT J BIOCHEM CELL B, V44, P1901, DOI 10.1016/j.biocel.2012.07.012; Schliemann C, 2007, LEUKEMIA, V21, P1901, DOI 10.1038/sj.leu.2404820; Schliemann C, 2006, HAEMATOLOGICA, V91, P1203; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Tang J, 2006, GUO JI SHU XUE JI XU, V29, P297; Tang Jia-ming, 2005, Zhonghua Xue Ye Xue Za Zhi, V26, P653; Turunen JJ, 2008, MOL CELL BIOL, V28, P3548, DOI 10.1128/MCB.01928-07; Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.0.CO;2-4; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang W, 2009, NAN FANG YI KE DA XU, V29, P2259; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604	38	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84150	10.1371/journal.pone.0084150	http://dx.doi.org/10.1371/journal.pone.0084150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416201	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500102
J	Werry, JM; Planes, S; Berumen, ML; Lee, KA; Braun, CD; Clua, E				Werry, Jonathan M.; Planes, Serge; Berumen, Michael L.; Lee, Kate A.; Braun, Camrin D.; Clua, Eric			Reef-Fidelity and Migration of Tiger Sharks, Galeocerdo cuvier, across the Coral Sea	PLOS ONE			English	Article							MARINE PROTECTED AREAS; FRENCH FRIGATE SHOALS; MOVEMENT PATTERNS; TELEMETRY; TRACKING; TRENDS; SCALE; CONSERVATION; SEGREGATION; PREDATORS	Knowledge of the habitat use and migration patterns of large sharks is important for assessing the effectiveness of large predator Marine Protected Areas (MPAs), vulnerability to fisheries and environmental influences, and management of shark-human interactions. Here we compare movement, reef-fidelity, and ocean migration for tiger sharks, Galeocerdo cuvier, across the Coral Sea, with an emphasis on New Caledonia. Thirty-three tiger sharks (1.54 to 3.9 m total length) were tagged with passive acoustic transmitters and their localised movements monitored on receiver arrays in New Caledonia, the Chesterfield and Lord Howe Islands in the Coral Sea, and the east coast of Queensland, Australia. Satellite tags were also used to determine habitat use and movements among habitats across the Coral Sea. Sub-adults and one male adult tiger shark displayed year-round residency in the Chesterfields with two females tagged in the Chesterfields and detected on the Great Barrier Reef, Australia, after 591 and 842 days respectively. In coastal barrier reefs, tiger sharks were transient at acoustic arrays and each individual demonstrated a unique pattern of occurrence. From 2009 to 2013, fourteen sharks with satellite and acoustic tags undertook wide-ranging movements up to 1114 km across the Coral Sea with eight detected back on acoustic arrays up to 405 days after being tagged. Tiger sharks dove 1136 m and utilised three-dimensional activity spaces averaged at 2360 km(3). The Chesterfield Islands appear to be important habitat for sub-adults and adult male tiger sharks. Management strategies need to consider the wide-ranging movements of large (sub-adult and adult) male and female tiger sharks at the individual level, whereas fidelity to specific coastal reefs may be consistent across groups of individuals. Coastal barrier reef MPAs, however, only afford brief protection for large tiger sharks, therefore determining the importance of other oceanic Coral Sea reefs should be a priority for future research.	[Werry, Jonathan M.] Griffith Univ, Australian Rivers Inst, Gold Coast, Qld, Australia; [Werry, Jonathan M.] Griffith Univ, Sch Environm, Gold Coast, Qld, Australia; [Werry, Jonathan M.] Ocean & Coast Res, Gold Coast, Qld, Australia; [Planes, Serge] Ctr Rech Insulaires & Observ Environm CRIOBE, Moorea, France; [Berumen, Michael L.; Braun, Camrin D.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Berumen, Michael L.] Woods Hole Oceanog Dept, Dept Biol, Woods Hole, MA USA; [Lee, Kate A.] Macquarie Univ, Grad Sch Environm, Marine Mammal Res Grp, N Ryde, NSW 2109, Australia; [Clua, Eric] CRISP Programme, Secretariat Pacific Community, Noumea, New Caledonia; [Clua, Eric] French Minist Agr & Fisheries, Paris, France	Griffith University; Griffith University; King Abdullah University of Science & Technology; Macquarie University	Werry, JM (corresponding author), Griffith Univ, Australian Rivers Inst, Gold Coast, Qld, Australia.	jwerry@oc-research.com	Berumen, Michael L/F-7745-2011; Clua, Eric EG/D-7820-2013; PLANES, Serge/ABF-1360-2021	Berumen, Michael L/0000-0003-2463-2742; Clua, Eric EG/0000-0001-7629-2685; Braun, Camrin/0000-0002-9317-9489	Agence Francaise de Developpement; French Pacific Fund; CRISP program; QLD Fisheries	Agence Francaise de Developpement; French Pacific Fund; CRISP program; QLD Fisheries	Funding was provided by the the Agence Francaise de Developpement (http://www.afd.fr), French Pacific Fund, the CRISP program (www.crisponline.info) and QLD Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JC, 1989, DEEP-SEA RES, V36, P957, DOI 10.1016/0198-0149(89)90037-X; [Anonymous], 2013, JOINT STATEMENT STRA; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Borsa P, 2010, PAC SCI, V64, P297, DOI 10.2984/64.2.297; Clarke S, 2007, MAR RESOUR ECON, V22, P305, DOI 10.1086/mre.22.3.42629561; Clua E, 2011, MAR FRESHWATER RES, V62, P764, DOI 10.1071/MF10163; Clua E, 2011, CONTRIBUTION BIOL IN; Clua E, 2013, MAR FRESHW BEHAV PHY, V46, P1, DOI 10.1080/10236244.2013.773127; Clua Eric, 2010, Am J Forensic Med Pathol, V31, P281, DOI 10.1097/PAF.0b013e3181ec7cb8; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; del Monte-Luna P, 2007, FISH FISH, V8, P107; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Driggers WB, 2008, AQUAT BIOL, V2, P161, DOI 10.3354/ab00045; Duffy Clinton A.J., 2012, P301; Dulvy NK, 2006, CAN J FISH AQUAT SCI, V63, P1267, DOI 10.1139/F06-035; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Duong T, 2012, KS KERNEL SMOOTHING; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Fitzpatrick R, 2013, PLOS ONE, V7; Francis Malcolm P., 2012, P319; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Galuardi B, 2010, ANALYZEPSAT; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garla RC, 2006, MAR BIOL, V149, P189, DOI 10.1007/s00227-005-0201-4; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Heap AD, 2008, AUST J EARTH SCI, V55, P555, DOI 10.1080/08120090801888669; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2006, J ANIM ECOL, V75, P666, DOI 10.1111/j.1365-2656.2006.01087.x; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Hill RD, 2001, P S TAGG TRACK MAR F, P315; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Knip DM, 2012, BIOL CONSERV, V148, P200, DOI 10.1016/j.biocon.2012.01.008; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Kohler NE, 1998, MAR FISH REV, V60, P87; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Last PR, 2009, SHARKS RAYS AUSTR; Lowe Christopher G., 2006, Atoll Research Bulletin, P281; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Mourier J, 2013, MOL ECOL, V22, P201, DOI 10.1111/mec.12103; Mourier J, 2012, ANIM BEHAV, V83, P389, DOI 10.1016/j.anbehav.2011.11.008; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Natanson LJ, 1999, FISH B-NOAA, V97, P944; Nielsen A, 2011, CANADIAN J FISH AQUA, V64, P1055; Noriega R, 2011, FISH RES, V110, P472, DOI 10.1016/j.fishres.2011.06.005; O'Connell MT, 2007, ESTUAR COAST, V30, P567, DOI 10.1007/BF02841954; Otway NM, 2011, MAR FRESHWATER RES, V62, P607, DOI 10.1071/MF10139; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; PATERSON R A, 1991, Memoirs of the Queensland Museum, V30, P333; Polidoro BA, 2011, J MAR BIOL; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Revill AT, 2009, MAR BIOL, V156, P1241, DOI 10.1007/s00227-009-1166-5; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sandin Stuart A., 2010, P71; Simpfendorfer CA, 2009, IUCN RED LIST THREAT; Simpfendorfer CA, 2012, CAN J FISH AQUAT SCI, V69, P565, DOI 10.1139/F2011-179; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; Werry JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049796; Whitney NM, 2007, MAR BIOL, V151, P63, DOI 10.1007/s00227-006-0476-0	77	76	77	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83249	10.1371/journal.pone.0083249	http://dx.doi.org/10.1371/journal.pone.0083249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421879	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500039
J	Farah, BL; Madden, L; Li, ST; Nance, S; Bird, A; Bursac, N; Yen, PM; Young, SP; Koeberl, DD				Farah, Benjamin L.; Madden, Lauran; Li, Songtao; Nance, Sierra; Bird, Andrew; Bursac, Nenad; Yen, Paul M.; Young, Sarah P.; Koeberl, Dwight D.			Adjunctive beta(2)-agonist treatment reduces glycogen independently of receptor-mediated acid alpha-glucosidase uptake in the limb muscles of mice with Pompe disease	FASEB JOURNAL			English	Article						mannose-6-phosphate receptor; gene therapy; adeno-associated virus; acid maltase; autophagy; enzyme replacement therapy	ENZYME REPLACEMENT THERAPY; ADENOASSOCIATED VIRUS VECTOR; MTORC1 SUPPRESSION; IMMUNE-RESPONSES; GENE-THERAPY; MOUSE MODEL; AUTOPHAGY; CLENBUTEROL; RECOMBINANT; EXPRESSION	Enzyme or gene replacement therapy with acid -glucosidase (GAA) has achieved only partial efficacy in Pompe disease. We evaluated the effect of adjunctive clenbuterol treatment on cation-independent mannose-6-phosphate receptor (CI-MPR)-mediated uptake and intracellular trafficking of GAA during muscle-specific GAA expression with an adeno-associated virus (AAV) vector in GAA-knockout (KO) mice. Clenbuterol, which increases expression of CI-MPR in muscle, was administered with the AAV vector. This combination therapy increased latency during rotarod and wirehang testing at 12 wk, in comparison with vector alone. The mean urinary glucose tetrasaccharide (Glc4), a urinary biomarker, was lower in GAA-KO mice following combination therapy, compared with vector alone. Similarly, glycogen content was lower in cardiac and skeletal muscle following 12 wk of combination therapy in heart, quadriceps, diaphragm, and soleus, compared with vector alone. These data suggested that clenbuterol treatment enhanced trafficking of GAA to lysosomes, given that GAA was expressed within myofibers. The integral role of CI-MPR was demonstrated by the lack of effectiveness from clenbuterol in GAA-KO mice that lacked CI-MPR in muscle, where it failed to reverse the high glycogen content of the heart and diaphragm or impaired wirehang performance. However, the glycogen content of skeletal muscle was reduced by the addition of clenbuterol in the absence of CI-MPR, as was lysosomal vacuolation, which correlated with increased AKT signaling. In summary, (2)-agonist treatment enhanced CI-MPR-mediated uptake and trafficking of GAA in mice with Pompe disease, and a similarly enhanced benefit might be expected in other lysosomal storage disorders.Farah, B. L., Madden, L., Li, S., Nance, S., Bird, A., Bursac, N., Yen, P. M., Young, S. P., Koeberl, D. D. Adjunctive 2-agonist treatment reduces glycogen independently of receptor-mediated acid -glucosidase uptake in the limb muscles of mice with Pompe disease.	[Farah, Benjamin L.; Yen, Paul M.] Duke Natl Univ Singapore Grad Med Sch, Cardiovasc & Metab Dis Program, Singapore, Singapore; [Madden, Lauran; Bursac, Nenad] Duke Univ Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA; [Li, Songtao; Nance, Sierra; Bird, Andrew; Young, Sarah P.; Koeberl, Dwight D.] Duke Univ Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Yen, Paul M.] Duke Univ Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Yen, Paul M.] Duke Univ Med Ctr, Dept Med & Pharmacol, Durham, NC 27710 USA; [Yen, Paul M.] Duke Univ Med Ctr, Dept Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Koeberl, DD (corresponding author), Duke Univ Med Ctr, Box 103856, Durham, NC 27710 USA.	koebe001@mc.duke.edu	Bursac, Nenad/AAU-5548-2021; Yen, Paul M/V-9857-2019	Bursac, Nenad/0000-0002-5688-6061; Yen, Paul/0000-0002-3790-8114	U.S. National Institutes of Health (NIH) from the National Heart, Lung, and Blood Institute [R01 HL081122]; NIH from the National Institute of Arthritis and Musculoskeletal and Skin Disorders [R01AR065873]; Singapore National Medical Research Council (NMRC) [NMRC/CIRG/1340/2012]; Genzyme Corp.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065873] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) from the National Heart, Lung, and Blood Institute; NIH from the National Institute of Arthritis and Musculoskeletal and Skin Disorders; Singapore National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Genzyme Corp.(Sanofi-AventisGenzyme Corporation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Institutes of Health (NIH) grant R01 HL081122 from the National Heart, Lung, and Blood Institute, by NIH grant R01AR065873 from the National Institute of Arthritis and Musculoskeletal and Skin Disorders, and by Singapore National Medical Research Council (NMRC) grant NMRC/CIRG/1340/2012 to P.M.Y. Muscle-specific CI-MPR-KO mice were provided courtesy of Dr. Randy Jirtle (Duke University, Durham, NC, USA). RhGAA was provided under agreement with Genzyme Corp. (Cambridge, MA, USA). The AAV8 packaging plasmid was provided courtesy of Dr. James M. Wilson (University of Pennsylvania, Philadelphia, PA, USA). D. B., D. D. K., and S.P.Y. have received research/grant support from Genzyme Corp. in the past.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Ashe KM, 2010, MOL GENET METAB, V100, P309, DOI 10.1016/j.ymgme.2010.05.001; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; ENGEL AG, 1970, BRAIN, V93, P599, DOI 10.1093/brain/93.3.599; Franco LM, 2005, MOL THER, V12, P876, DOI 10.1016/j.ymthe.2005.04.024; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Iizuka Hiroyuki, 1998, Journal of Smooth Muscle Research, V34, P139; Kamalakkannan G, 2008, J HEART LUNG TRANSPL, V27, P457, DOI 10.1016/j.healun.2008.01.013; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koeberl DD, 2012, MOL GENET METAB, V105, P221, DOI 10.1016/j.ymgme.2011.11.005; Koeberl DD, 2011, MOL GENET METAB, V103, P107, DOI 10.1016/j.ymgme.2011.02.006; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Li ST, 2013, FASEB J, V27, P34, DOI 10.1096/fj.12-207472; MARTEL RR, 1977, CAN J PHYSIOL PHARM, V55, P48, DOI 10.1139/y77-007; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Nascimbeni AC, 2012, AUTOPHAGY, V8, P1697, DOI 10.4161/auto.21691; NIALS AT, 1993, BRIT J PHARMACOL, V110, P1112, DOI 10.1111/j.1476-5381.1993.tb13929.x; Nishiyama Y, 2012, MOL GENET METAB, V107, P490, DOI 10.1016/j.ymgme.2012.09.011; Oya Y, 2001, Rinsho Shinkeigaku, V41, P390; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schnepp BC, 2003, J VIROL, V77, P3495, DOI 10.1128/JVI.77.6.3495-3504.2003; Soraru G, 2006, AMYOTROPH LATERAL SC, V7, P246, DOI 10.1080/14660820600600558; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176; Sun BD, 2008, MOL THER, V16, P1366, DOI 10.1038/mt.2008.133; Sun BD, 2005, MOL THER, V11, P889, DOI 10.1016/j.ymthe.2005.01.012; Sun BD, 2005, MOL THER, V11, P57, DOI 10.1016/j.ymthe.2004.10.004; Taksir TV, 2007, J HISTOCHEM CYTOCHEM, V55, P991, DOI 10.1369/jhc.7A7239.2007; Torneke K, 1998, J VET PHARMACOL THER, V21, P388, DOI 10.1046/j.1365-2885.1998.00156.x; Wylie AA, 2003, AM J PATHOL, V162, P321, DOI 10.1016/S0002-9440(10)63823-0; Ye Lan, 2012, Frontiers in Genetics, V3, P177, DOI 10.3389/fgene.2012.00177; Young SP, 2009, GENET MED, V11, P536, DOI 10.1097/GIM.0b013e3181a87867; Zhang P, 2012, HUM GENE THER, V23, P460, DOI 10.1089/hum.2011.063; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	38	14	14	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2272	2280		10.1096/fj.13-244202	http://dx.doi.org/10.1096/fj.13-244202			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24448824	Green Published, Green Submitted			2022-12-25	WOS:000335336000029
J	Rasmussen, JE; Sheridan, JT; Polk, W; Davies, CM; Tarran, R				Rasmussen, Julia E.; Sheridan, John T.; Polk, William; Davies, Catrin M.; Tarran, Robert			Cigarette Smoke-induced Ca2+ Release Leads to Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Epithelium; Ion Channels; Lysosomes	CALCIUM-ENTRY; AIRWAY; TRAFFICKING; INTERNALIZATION; MECHANISMS; STIM	Background: COPD is the 4th leading cause of death worldwide, yet little is known about its pathogenesis. Results: Exposure to cigarette smoke elevated intracellular Ca2+ levels, which triggered CFTR internalization/inhibition. Conclusion: Cigarette smoke-induced Ca2+ release and CFTR inhibition may be involved in COPD pathogenesis. Significance: Our data provide novel information regarding the underlying mechanism of cigarette smoke-induced lung injury. Chronic obstructive pulmonary disease affects 64 million people and is currently the fourth leading cause of death worldwide. Chronic obstructive pulmonary disease includes both emphysema and chronic bronchitis, and in the case of chronic bronchitis represents an inflammatory response of the airways that is associated with mucus hypersecretion and obstruction of small airways. Recently, it has emerged that exposure to cigarette smoke (CS) leads to an inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel, causing airway surface liquid dehydration, which may play a role in the development of chronic bronchitis. CS rapidly clears CFTR from the plasma membrane and causes it to be deposited into aggresome-like compartments. However, little is known about the mechanism(s) responsible for the internalization of CFTR following CS exposure. Our studies revealed that CS triggered a rise in cytoplasmic Ca2+ that may have emanated from lysosomes. Furthermore, chelation of cytoplasmic Ca2+, but not inhibition of protein kinases/phosphatases, prevented CS-induced CFTR internalization. The macrolide antibiotic bafilomycin A1 inhibited CS-induced Ca2+ release and prevented CFTR clearance from the plasma membrane, further linking cytoplasmic Ca2+ and CFTR internalization. We hypothesize that CS-induced Ca2+ release prevents normal sorting/degradation of CFTR and causes internalized CFTR to reroute to aggresomes. Our data provide mechanistic insight into the potentially deleterious effects of CS on airway epithelia and outline a hitherto unrecognized signaling event triggered by CS that may affect the long term transition of the lung into a hyper-inflammatory/dehydrated environment.	[Rasmussen, Julia E.; Polk, William; Davies, Catrin M.; Tarran, Robert] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Sheridan, John T.; Tarran, Robert] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tarran, R (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA.	robert_tarran@med.unc.edu			National Institutes of Health [RO1 HL108927, PPG P01 HL034322, P30 ES10126]; British American Tobacco Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322, R01HL108927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British American Tobacco Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL108927, PPG P01 HL034322, and P30 ES10126. This work was also supported by a British American Tobacco Research Grant.	Agopyan N, 2004, AM J PHYSIOL-LUNG C, V286, pL563, DOI 10.1152/ajplung.00299.2003; Bartlett Jennifer A., 2008, V15, P147, DOI 10.1159/000136349; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Cantin AM, 2006, AM J PHYSIOL-CELL PH, V290, pC262, DOI 10.1152/ajpcell.00070.2005; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Cheung KL, 2011, CHEM RES TOXICOL, V24, P670, DOI 10.1021/tx1004369; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Christensen KA, 2002, J CELL SCI, V115, P599; Clunes LA, 2008, J ANAL TOXICOL, V32, P201, DOI 10.1093/jat/32.3.201; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Com Gulnur, 2009, Handb Exp Pharmacol, P363, DOI 10.1007/978-3-540-89615-9_12; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Davis CW, 2008, RESP PHYSIOL NEUROBI, V163, P208, DOI 10.1016/j.resp.2008.05.015; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Fukumori R, 2010, NEUROCHEM INT, V57, P730, DOI 10.1016/j.neuint.2010.08.009; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Haggie PM, 2002, J BIOL CHEM, V277, P16419, DOI 10.1074/jbc.M112361200; Hogg J C, 2005, Exp Lung Res, V31 Suppl 1, P72; Homolya L, 1999, J BIOL CHEM, V274, P26454, DOI 10.1074/jbc.274.37.26454; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kiselyov K, 2010, CELL CALCIUM, V47, P103, DOI 10.1016/j.ceca.2009.12.007; Korngreen A, 1996, J PHYSIOL-LONDON, V497, P53, DOI 10.1113/jphysiol.1996.sp021749; Lazarowski ER, 2001, NEWS PHYSIOL SCI, V16, P1; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mccue HV, 2013, BIOCHEM J, V449, P449, DOI 10.1042/BJ20120898; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Okiyoneda T, 2007, BBA-MOL CELL RES, V1773, P476, DOI 10.1016/j.bbamcr.2007.01.004; Okiyoneda T, 2006, BBA-MOL CELL RES, V1763, P1017, DOI 10.1016/j.bbamcr.2006.08.032; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Petty TL, 2002, CHEST, V121, p116S, DOI 10.1378/chest.121.5_suppl.116S; Ribeiro CMP, 2003, J GEN PHYSIOL, V122, P377, DOI 10.1085/jgp.200308893; RUBIN BK, 1992, AM REV RESPIR DIS, V145, P545, DOI 10.1164/ajrccm/145.3.545; Ryter SW, 2012, ANNU REV PHYSIOL, V74, P377, DOI 10.1146/annurev-physiol-020911-153348; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Schmid A, 2011, SUBCELL BIOCHEM, V55, P95, DOI 10.1007/978-94-007-1217-1_5; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; TAKEMURA H, 1989, BIOCHEM J, V258, P409, DOI 10.1042/bj2580409; Thelin WR, 2005, J BIOL CHEM, V280, P41512, DOI 10.1074/jbc.M507308200; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Yates LL, 2006, ACTA BIOCHIM POL, V53, P651, DOI 10.18388/abp.2006_3293; Young GS, 2006, COMB CHEM HIGH T SCR, V9, P633, DOI 10.2174/138620706778249749; Zhang Q, 2006, J BIOL CHEM, V281, P10174, DOI 10.1074/jbc.M513008200	55	72	74	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7671	7681		10.1074/jbc.M113.545137	http://dx.doi.org/10.1074/jbc.M113.545137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24448802	Green Published, hybrid			2022-12-25	WOS:000332761500035
J	Herve, V; Meudal, H; Labas, V; Rehault-Godbert, S; Gautron, J; Berges, M; Guyot, N; Delmas, AF; Nys, Y; Landon, C				Herve, Virginie; Meudal, Herve; Labas, Valerie; Rehault-Godbert, Sophie; Gautron, Joel; Berges, Magali; Guyot, Nicolas; Delmas, Agnes F.; Nys, Yves; Landon, Celine			Three-dimensional NMR Structure of Hen Egg Gallin (Chicken Ovodefensin) Reveals a New Variation of the beta-Defensin Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptides; Defensins; Host Defense; NMR; Protein Structure; AvBD; SPPS; Ovodefensin	ANTIMICROBIAL PEPTIDES; PROTEOMIC ANALYSIS; PROTEIN; RESISTANCE; SEQUENCE; PROGRAM; MECHANISMS; EXPRESSION; PENGUIN; LEAD	Background: Ovodefensins are small peptides from eggs, related to avian antimicrobial defensins. Results: The first three-dimensional structure of ovodefensins (gallin) is solved, and its antimicrobial properties are screened. Conclusion: Gallin adopts a -defensin fold, with significant variations. Its antibacterial spectrum was restricted to E. coli. Significance: The first structural features may be related to E. coli specificity and/or other yet unknown functions. Gallin is a 41-residue protein, first identified as a minor component of hen egg white and found to be antimicrobial against Escherichia coli. Gallin may participate in the protection of the embryo during its development in the egg. Its sequence is related to antimicrobial -defensin peptides. In the present study, gallin was chemically synthesized 1) to further investigate its antimicrobial spectrum and 2) to solve its three-dimensional NMR structure and thus gain insight into structure-function relationships, a prerequisite to understanding its mode(s) of action. Antibacterial assays confirmed that gallin was active against Escherichia coli, but no additional antibacterial activity was observed against the other Gram-positive or Gram-negative bacteria tested. The three-dimensional structure of gallin, which is the first ovodefensin structure to have been solved to date, displays a new five-stranded arrangement. The gallin three-dimensional fold contains the three-stranded antiparallel -sheet and the disulfide bridge array typical of vertebrate -defensins. Gallin can therefore be unambiguously classified as a -defensin. However, an additional short two-stranded -sheet reveals that gallin and presumably the other ovodefensins form a new structural subfamily of -defensins. Moreover, gallin and the other ovodefensins calculated by homology modeling exhibit atypical hydrophobic surface properties, compared with the already known vertebrate -defensins. These specific structural features of gallin might be related to its restricted activity against E. coli and/or to other yet unknown functions. This work provides initial understanding of a critical sequence-structure-function relationship for the ovodefensin family.	[Herve, Virginie; Rehault-Godbert, Sophie; Gautron, Joel; Berges, Magali; Guyot, Nicolas; Nys, Yves] INRA, Rech Avicoles Fonct & Regulat Proteines Oeuf, F-37380 Nouzilly, France; [Herve, Virginie] Univ Tours, UMR 1100, F-37032 Tours, France; [Herve, Virginie] INSERM, Ctr Etud Pathol Resp, UMR EA6305 1100, F-37032 Tours, France; [Meudal, Herve; Delmas, Agnes F.; Landon, Celine] Univ Orleans, Ctr Biophys Mol, CNRS UPR 4301, F-45071 Orleans, France; [Labas, Valerie] Univ Tours, Plate Forme Anal Integrat Biomol, UMR INRA CNRS 7247 85, IFCE, F-37380 Nouzilly, France	INRAE; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans; INRAE; Universite de Tours	Nys, Y (corresponding author), INRA, F-37380 Nouzilly, France.	Yves.Nys@tours.inra.fr; celine.landon@cnrs-orleans.fr	GAUTRON, Joël/A-1753-2017; Meudal, Hervé/B-5851-2016; REHAULT-GODBERT, Sophie/Y-3890-2019	GAUTRON, Joël/0000-0001-7800-0578; Meudal, Hervé/0000-0002-9642-3643; Rehault-Godbert, Sophie/0000-0003-2800-3417	French National Research Agency (OVO-mining) [ANR-09-BLAN-0136]	French National Research Agency (OVO-mining)(French National Research Agency (ANR))	This work was supported by the French National Research Agency (OVO-mining, ANR-09-BLAN-0136).	Alba A, 2012, BIOPOLYMERS, V98, P251, DOI 10.1002/bip.22076; Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cremer GA, 2006, J PEPT SCI, V12, P437, DOI 10.1002/psc.746; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derache C, 2012, J BIOL CHEM, V287, P7746, DOI 10.1074/jbc.M111.312108; Derache C, 2009, ANTIMICROB AGENTS CH, V53, P4647, DOI 10.1128/AAC.00301-09; Ebers KL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-153; Evans EW, 1995, VET MICROBIOL, V47, P295, DOI 10.1016/0378-1135(95)00126-3; Gong DQ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-12; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Harmon BG, 1998, POULTRY SCI, V77, P972, DOI 10.1093/ps/77.7.972; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Hellgren Olof, 2010, Immunome Res, V6, P3, DOI 10.1186/1745-7580-6-3; Herve-Grepinet V, 2010, ANTIMICROB AGENTS CH, V54, P4401, DOI 10.1128/AAC.00204-10; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Landon C, 2004, J BIOL CHEM, V279, P30433, DOI 10.1074/jbc.M401338200; Landon C, 2004, PROTEIN SCI, V13, P703, DOI 10.1110/ps.03404404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Mann K, 2008, WORLD POULTRY SCI J, V64, P209, DOI 10.1017/S0043933907001808; Mann K, 2008, PROTEOMICS, V8, P2322, DOI 10.1002/pmic.200800032; Mann K, 2008, PROTEOMICS, V8, P178, DOI 10.1002/pmic.200700790; Mann K, 2007, PROTEOMICS, V7, P3558, DOI 10.1002/pmic.200700397; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; Master RN, 2013, ANN NY ACAD SCI, V1277, P1, DOI 10.1111/nyas.12022; Meade KG, 2009, DEV COMP IMMUNOL, V33, P516, DOI 10.1016/j.dci.2008.10.003; Naknukool S, 2008, BIOSCI BIOTECH BIOCH, V72, P2082, DOI 10.1271/bbb.80178; Naknukool S, 2011, J AGR FOOD CHEM, V59, P5081, DOI 10.1021/jf2004404; ODANI S, 1989, J BIOCHEM, V105, P660, DOI 10.1093/oxfordjournals.jbchem.a122721; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SIMPSON RJ, 1983, INT J PEPT PROT RES, V22, P476; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Subedi K, 2007, REPRODUCTION, V133, P127, DOI 10.1530/REP-06-0083; Sugiarto H, 2004, BIOCHEM BIOPH RES CO, V323, P721, DOI 10.1016/j.bbrc.2004.08.162; Thouzeau C, 2003, J BIOL CHEM, V278, P51053, DOI 10.1074/jbc.M306839200; van Dijk A, 2008, VET IMMUNOL IMMUNOP, V124, P1, DOI 10.1016/j.vetimm.2007.12.006; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yount NY, 2013, ANN NY ACAD SCI, V1277, P127, DOI 10.1111/nyas.12005; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	52	21	21	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7211	7220		10.1074/jbc.M113.507046	http://dx.doi.org/10.1074/jbc.M113.507046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443564	Green Published, hybrid			2022-12-25	WOS:000332389400079
J	Wang, Q; Chen, WS; Bai, L; Chen, WJ; Padilla, MT; Lin, AS; Shi, SQ; Wang, X; Lin, Y				Wang, Qiong; Chen, Wenshu; Bai, Lang; Chen, Wenjie; Padilla, Mabel T.; Lin, Amy S.; Shi, Shaoqing; Wang, Xia; Lin, Yong			Receptor-interacting Protein 1 Increases Chemoresistance by Maintaining Inhibitor of Apoptosis Protein Levels and Reducing Reactive Oxygen Species through a microRNA-146a-mediated Catalase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Chemoresistance; Lung Cancer; Reactive Oxygen Species (ROS); RIP	NF-KAPPA-B; DEATH DOMAIN KINASE; MEDIATED SENSITIZATION; CANCER PREVENTION; ACTIVATION; RIP1; CELLS; ROS; CHEMOTHERAPY; LUTEOLIN	Background: Whether RIP1 directly contributes to chemotherapy response in cancer has not been determined. Results: RIP1 knockdown resulted in miR-146a-mediated catalase reduction, ROS induction, IAP degradation, and increased cisplatin cytotoxicity. Conclusion: RIP1 blunts the anticancer activity of cisplatin by releasing miR-146a-mediated catalase suppression. Significance: Our results establish a chemoresistant role for RIP1, and intervention within the RIP1-mediated pathway may be exploited for chemosensitization. Although receptor-interacting protein 1 (RIP1) is well known as a key mediator in cell survival and death signaling, whether RIP1 directly contributes to chemotherapy response in cancer has not been determined. In this report, we found that, in human lung cancer cells, knockdown of RIP1 substantially increased cytotoxicity induced by the frontline anticancer therapeutic drug cisplatin, which has been associated with robust cellular reactive oxygen species (ROS) accumulation and enhanced apoptosis. Scavenging ROS dramatically protected RIP1 knockdown cells against cisplatin-induced cytotoxicity. Furthermore, we found that, in RIP1 knockdown cells, the expression of the hydrogen peroxide-reducing enzyme catalase was dramatically reduced, which was associated with increased miR-146a expression. Inhibition of microRNA-146a restored catalase expression, suppressed ROS induction, and protected against cytotoxicity in cisplatin-treated RIP1 knockdown cells, suggesting that RIP1 maintains catalase expression to restrain ROS levels in therapy response in cancer cells. Additionally, cisplatin significantly triggered the proteasomal degradation of cellular inhibitor of apoptosis protein 1 and 2 (c-IAP1 and c-IAP2), and X-linked inhibitor of apoptosis (XIAP) in a ROS-dependent manner, and in RIP1 knockdown cells, ectopic expression of c-IAP2 attenuated cisplatin-induced cytotoxicity. Thus, our results establish a chemoresistant role for RIP1 that maintains inhibitor of apoptosis protein (IAP) expression by release of microRNA-146a-mediated catalase suppression, where intervention within this pathway may be exploited for chemosensitization.	[Wang, Qiong; Chen, Wenshu; Bai, Lang; Chen, Wenjie; Padilla, Mabel T.; Lin, Amy S.; Shi, Shaoqing; Lin, Yong] Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, Albuquerque, NM 87108 USA; [Wang, Qiong; Shi, Shaoqing; Wang, Xia] Sichuan Univ, West China Univ Hosp 2, Minist Educ,Dept Obstet & Gynecol, Lab Mol & Translat Med,Key Lab Birth Defects & Re, Chengdu 610041, Peoples R China	Lovelace Respiratory Research Institute; Sichuan University	Lin, Y (corresponding author), Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	ylin@lrri.org			NIEHS, National Institutes of Health [R01ES017328]; Department of Energy Low Dose Radiation Research Program [DE-SC0001173]; National Natural Science Foundation of China [30973403]	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Energy Low Dose Radiation Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by NIEHS, National Institutes of Health Grant R01ES017328. This work was also supported by Department of Energy Low Dose Radiation Research Program Grant DE-SC0001173 and by National Natural Science Foundation of China Grant 30973403.	Bai L, 2012, MOL PHARMACOL, V81, P549, DOI 10.1124/mol.111.076653; Basit F, 2012, J BIOL CHEM, V287, P38767, DOI 10.1074/jbc.M112.398966; Bauer G, 2012, ANTICANCER RES, V32, P2599; Caputo F, 2012, BIOCHEM PHARMACOL, V84, P1292, DOI 10.1016/j.bcp.2012.07.022; Chang A, 2011, LUNG CANCER, V71, P3, DOI 10.1016/j.lungcan.2010.08.022; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Epperly MW, 2009, RADIAT RES, V171, P588, DOI 10.1667/RR1424.1; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He WY, 2012, AUTOPHAGY, V8, P1811, DOI 10.4161/auto.22145; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Ju W, 2007, MOL PHARMACOL, V71, P1381, DOI 10.1124/mol.106.032185; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Krepler C, 2013, CLIN CANCER RES, V19, P1784, DOI 10.1158/1078-0432.CCR-12-2518; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lai L, 2009, MOL CANCER THER, V8, P1636, DOI 10.1158/1535-7163.MCT-09-0068; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Loder S, 2012, LEUKEMIA, V26, P1020, DOI 10.1038/leu.2011.353; Maione P, 2010, EXPERT OPIN PHARMACO, V11, P2997, DOI 10.1517/14656566.2010.511615; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Park J, 2012, BIOCHEM BIOPH RES CO, V422, P291, DOI 10.1016/j.bbrc.2012.04.150; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Ulahannan SV, 2011, CANCER INVEST, V29, P325, DOI 10.3109/07357907.2011.554476; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang Q, 2013, CARCINOGENESIS, V34, P2119, DOI 10.1093/carcin/bgt143; Wang X, 2007, BIOCHEM BIOPH RES CO, V355, P807, DOI 10.1016/j.bbrc.2007.02.030; Yang L, 2013, APOPTOSIS, V18, P618, DOI 10.1007/s10495-013-0808-8; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10	40	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5654	5663		10.1074/jbc.M113.526152	http://dx.doi.org/10.1074/jbc.M113.526152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425875	Green Published, hybrid			2022-12-25	WOS:000332015500028
J	Fujiwara, M; Mohr, MS; Greenberg, A				Fujiwara, Masami; Mohr, Michael S.; Greenberg, Aaron			The Effects of Disease-Induced Juvenile Mortality on the Transient and Asymptotic Population Dynamics of Chinook Salmon (Oncorhynchus tshawytscha)	PLOS ONE			English	Article							PARASITE CERATOMYXA-SHASTA; BACTERIAL KIDNEY-DISEASE; KLAMATH RIVER-BASIN; PACIFIC SALMON; OREGON-CALIFORNIA; STRUCTURED POPULATIONS; FISH; RESISTANCE; RESPONSES; HISTORY	The effects of an increased disease mortality rate on the transient and asymptotic dynamics of Chinook salmon (Oncorhynchus tshawytscha) were investigated. Disease-induced mortality of juvenile salmon has become a serious concern in recent years. However, the overall effects of disease mortality on the asymptotic and transient dynamics of adult spawning abundance are still largely unknown. We explored various scenarios with regard to the density-dependent process, the distribution of survivorship over the juvenile phase, the disease mortality rate, and the infusion of stray hatchery fish. Our results suggest that the sensitivity to the disease mortality rate of the equilibrium adult spawning abundance and resilience (asymptotic return rate toward this equilibrium following a small perturbation) varied widely and differently depending on the scenario. The resilience and coefficient of variation of adult spawning abundance following a large perturbation were consistent with each other under the scenarios investigated. We conclude that the increase in disease mortality likely has an effect on fishery yield under a fluctuating environment, not only because the mean equilibrium adult spawning abundance has likely been reduced, but also because the resilience has likely decreased and the variance in adult spawning abundance has likely increased. We also infer the importance of incorporating finer-scale spatiotemporal information into population models and demonstrate a means for doing so within a matrix population modeling framework.	[Fujiwara, Masami] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Mohr, Michael S.] NOAA, Fisheries Ecol Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Santa Cruz, CA USA; [Greenberg, Aaron] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	Texas A&M University System; Texas A&M University College Station; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz	Fujiwara, M (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	fujiwara@tamu.edu	Fujiwara, Masami/C-3115-2012	Fujiwara, Masami/0000-0002-9255-6043	U. S. National Oceanic and Atmospheric Administration, National 468 Marine Fisheries Service (NOAA/NMFS) [NA07NMF4540337]	U. S. National Oceanic and Atmospheric Administration, National 468 Marine Fisheries Service (NOAA/NMFS)	This research was supported by the U. S. National Oceanic and Atmospheric Administration, National 468 Marine Fisheries Service (NOAA/NMFS), grant NA07NMF4540337. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkoosh MR, 1998, T AM FISH SOC, V127, P360, DOI 10.1577/1548-8659(1998)127&lt;0360:ISOJCS&gt;2.0.CO;2; Arkush KD, 2002, CAN J FISH AQUAT SCI, V59, P966, DOI [10.1139/f02-066, 10.1139/F02-066]; Bartholomew JL, 2007, DIS AQUAT ORGAN, V78, P137, DOI 10.3354/dao01877; Bartholomew JL, 1997, J PARASITOL, V83, P859, DOI 10.2307/3284281; BEDDINGTON JR, 1977, SCIENCE, V197, P463, DOI 10.1126/science.197.4302.463; BEVERTON RJH, 1957, UK MINISTRY AGR FISH, V2; Bjork SJ, 2009, DIS AQUAT ORGAN, V86, P29, DOI 10.3354/dao02092; California Hatchery Scientific Review Group, 2012, CAL HATCH REV STAT R; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caswell H, 2008, DEMOGR RES, V18, P59, DOI 10.4054/DemRes.2008.18.3; Caswell H, 2009, J DIFFER EQU APPL, V15, P349, DOI 10.1080/10236190802282669; Foott JS, 1992, DIS SURVEY TRINITY R; Foott JS, 2003, FY 2002 INVESTIGATIO; Ford JS, 2008, PLOS BIOL, V6, P411, DOI 10.1371/journal.pbio.0060033; FRYER JL, 1981, ANNU REV MICROBIOL, V35, P273, DOI 10.1146/annurev.mi.35.100181.001421; FRYER JL, 1993, FISH RES, V17, P15, DOI 10.1016/0165-7836(93)90004-Q; Fujiwara M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00107; Fujiwara M, 2011, T AM FISH SOC, V140, P1380, DOI 10.1080/00028487.2011.621811; Goldwasser L, 2001, SUPPORTING DATABASE; Hallett SL, 2006, DIS AQUAT ORGAN, V71, P109, DOI 10.3354/dao071109; HEALEY MC, 1984, CAN J FISH AQUAT SCI, V41, P476, DOI 10.1139/f84-057; Jacobson KC, 2003, J AQUAT ANIM HEALTH, V15, P1, DOI 10.1577/1548-8667(2003)015&lt;0001:CEONAA&gt;2.0.CO;2; Jacobson KC, 2008, MAR ECOL PROG SER, V354, P235, DOI 10.3354/meps07232; Klamath River Technical Advisory Team, 2002, KLAM RIV FALL CHIN A; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Krkosek M, 2009, P ROY SOC B-BIOL SCI, V276, P2819, DOI 10.1098/rspb.2009.0317; LICHATOWICH J, 1995, FISHERIES, V20, P10, DOI 10.1577/1548-8446(1995)020<0010:AATTDA>2.0.CO;2; Neubert MG, 1997, ECOLOGY, V78, P653, DOI 10.1890/0012-9658(1997)078[0653:ATRFMT]2.0.CO;2; Nicholas JW, 1988, FISH DIVISION INFORM; Nichols K, 2005, FY 2004 INVESTIGATIO; Nichols K, 2009, FY 2008 INVESTIGATIO; Nichols K., 2007, FY 2006 INVESTIGATIO; Nichols K, 2003, FY 2002 INVESTIGATIO; NICHOLS K, 2007, FY 2005 INVESTIGATIO; Nichols K., 2008, FY 2007 INVESTIGATIO; *PAC FISH MAN COUN, 2008, 1 PAC FISH MAN COUNC; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; Pimm SL, 1991, BALANCE NATURE ECOLO; Ralston S, 2008, CAN J FISH AQUAT SCI, V65, P588, DOI 10.1139/F07-174; Ray RA, 2010, DIS AQUAT ORGAN, V93, P63, DOI 10.3354/dao02281; Scheuerell MD, 2006, CAN J FISH AQUAT SCI, V63, P1596, DOI 10.1139/F06-056; Stocking RW, 2007, J PARASITOL, V93, P78, DOI 10.1645/GE-939R.1; Stocking RW, 2006, J AQUAT ANIM HEALTH, V18, P194, DOI 10.1577/H05-036.1; Stone R, 2008, FY 2006 INVESTIGATIO; Walker RL, 1993, DIS SURVEY KLAMATH R; Worden L, 2010, THEOR POPUL BIOL, V78, P239, DOI 10.1016/j.tpb.2010.07.004	46	3	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85464	10.1371/journal.pone.0085464	http://dx.doi.org/10.1371/journal.pone.0085464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427310	Green Submitted, Green Published, gold			2022-12-25	WOS:000329868200051
J	Kong, LT; Wu, F; Tang, YQ; Ren, L; Kong, DY; Liu, Y; Xu, K; Wang, F				Kong, Lingtao; Wu, Feng; Tang, Yanqing; Ren, Ling; Kong, Dongyan; Liu, Ying; Xu, Ke; Wang, Fei			Frontal-Subcortical Volumetric Deficits in Single Episode, Medication-Naive Depressed Patients and the Effects of 8 Weeks Fluoxetine Treatment: A VBM-DARTEL Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; LATE-LIFE DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; GRAY-MATTER REDUCTION; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; UNIPOLAR DEPRESSION; MOOD DISORDERS; FUNCTIONAL CONNECTIVITY; COGNITIVE DEFICITS	Background: Convergent studies suggest that morphological abnormalities of frontal-subcortical circuits which involved with emotional and cognitive processing may contribute to the pathophysiology of major depressive disorder (MDD). Antidepressant treatment which has been reported to reverse the functional abnormalities of frontal-subcortical circuits in MDD may have treating effects to related brain morphological abnormalities. In this study, we used voxel-based morphometry method to investigate whole brain structural abnormalities in single episode, medication-naive MDD patients. Furthermore, we investigated the effects of an 8 weeks pharmacotherapy with fluoxetine. Methods: 28 single episode, medication-naive MDD participants and 28 healthy controls (HC) acquired the baseline high-resolution structural magnetic resonance imaging (sMRI) scan. 24 MDD participants acquired a follow-up sMRI scan after 8 weeks antidepressant treatment. Gray matter volumetric (GMV) difference between groups was examined. Results: Medication-naive MDD had significantly decreased GMV in the right dorsolateral prefrontal cortex and left middle frontal gyrus as well as increased GMV in the left thalamus and right insula compared to HC (P<0.05, corrected). Moreover, treated MDD had significantly increased GMV in the left middle frontal gyrus and right orbitofrontal cortex compared to HC (P<0.05, corrected). No difference on GMV was detected between medication-naive MDD group and treated MDD group. Conclusions: This study of single episode, medication-naive MDD subjects demonstrated structural abnormalities of frontal-subcortical circuitsin the early stage of MDD and the effects of 8 weeks successful antidepressant treatment, suggesting these abnormalities may play an important role in the neuropathophysiology of MDD at its onset.	[Kong, Lingtao; Wu, Feng; Tang, Yanqing; Liu, Ying] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China; [Ren, Ling; Xu, Ke; Wang, Fei] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Liaoning, Peoples R China; [Kong, Dongyan] Quanzhou First Hosp, Dept Psychol, Quanzhou, Fujian, Peoples R China; [Wang, Fei] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	China Medical University; China Medical University; Yale University	Liu, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China.	liuyingpsy@yahoo.com.cn; kexu@vip.sina.com			National Natural Science Foundation of China [81101012, 81071099]; Liaoning Doctor Scientific Foundation [20111099]; Liaoning Science and Technology Foundation [2008225010-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Doctor Scientific Foundation; Liaoning Science and Technology Foundation	This study was supported by the National Natural Science Foundation of China (Grant No 81101012, 81071099), the Liaoning Doctor Scientific Foundation (Grant No 20111099), the Liaoning Science and Technology Foundation (Grant No 2008225010-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2005, BIOL PSYCHIAT, V58, P151, DOI 10.1016/j.biopsych.2005.03.022; Ahdidan J, 2011, ACTA PSYCHIAT SCAND, V123, P211, DOI 10.1111/j.1600-0447.2010.01644.x; Amico F, 2011, J PSYCHIATR NEUROSCI, V36, P15, DOI 10.1503/jpn.090186; Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Chang CC, 2011, PSYCHIAT RES-NEUROIM, V193, P1, DOI 10.1016/j.pscychresns.2011.01.003; Chen SN, 2009, HUM BRAIN MAPP, V30, P2304, DOI 10.1002/hbm.20669; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Fales CL, 2009, J AFFECT DISORDERS, V112, P206, DOI 10.1016/j.jad.2008.04.027; First M. B., 2002, STRUCTURED CLIN INTE; Fossati P, 2004, EUR NEUROPSYCHOPHARM, V14, pS503, DOI 10.1016/j.euroneuro.2004.09.001; Frodl T, 2008, J PSYCHIATR NEUROSCI, V33, P423; Frodl T, 2010, J PSYCHIATR RES, V44, P799, DOI 10.1016/j.jpsychires.2010.01.006; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Hajek T, 2008, J PSYCHIATR NEUROSCI, V33, P91; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hoflich A, 2012, REV NEUROSCIENCE, V23, P227, DOI 10.1515/revneuro-2012-0038; Janssen J, 2007, INT J GERIATR PSYCH, V22, P468, DOI 10.1002/gps.1790; Kerestes R, 2012, PSYCHOL MED, V42, P29, DOI 10.1017/S0033291711001097; Kim AJ, 2008, PSYCHIAT RES-NEUROIM, V164, P114, DOI 10.1016/j.pscychresns.2007.12.020; Kong LT, 2013, J PSYCHIATR RES, V47, P733, DOI 10.1016/j.jpsychires.2013.02.003; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Li CT, 2010, NEUROIMAGE, V50, P347, DOI 10.1016/j.neuroimage.2009.11.021; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; Marchand WR, 2012, NEUROSCI LETT, V514, P86, DOI 10.1016/j.neulet.2012.02.063; Marchand WR, 2010, BRAIN STRUCT FUNCT, V215, P73, DOI 10.1007/s00429-010-0280-y; Ohira K, 2013, NEUROPSYCHOPHARMACOL, V38, P909, DOI 10.1038/npp.2013.2; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Remijnse PL, 2009, PSYCHOL MED, V39, P1503, DOI 10.1017/S0033291708005072; Salvadore G, 2011, NEUROIMAGE, V54, P2643, DOI 10.1016/j.neuroimage.2010.11.011; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Soriano-Mas C, 2011, BIOL PSYCHIAT, V69, P318, DOI 10.1016/j.biopsych.2010.07.029; Tang YQ, 2007, PSYCHIAT RES-NEUROIM, V156, P83, DOI 10.1016/j.pscychresns.2007.03.005; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Turner AD, 2012, NEUROPSYCHOLOGIA, V50, P2348, DOI 10.1016/j.neuropsychologia.2012.06.003; Vasic N, 2008, J AFFECT DISORDERS, V109, P107, DOI 10.1016/j.jad.2007.11.011; Vythilingam M, 2004, BIOL PSYCHIAT, V56, P101, DOI 10.1016/j.biopsych.2004.04.002; Wu F, 2011, PSYCHIAT RES-NEUROIM, V191, P80, DOI 10.1016/j.pscychresns.2010.09.002; Yuan YG, 2008, BIOL PSYCHIAT, V64, P541, DOI 10.1016/j.biopsych.2008.04.032; Zhang XC, 2012, J AFFECT DISORDERS, V136, P443, DOI 10.1016/j.jad.2011.11.005; Zou K, 2010, BIOL PSYCHIAT, V67, P186, DOI 10.1016/j.biopsych.2009.09.014	53	58	63	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e79055	10.1371/journal.pone.0079055	http://dx.doi.org/10.1371/journal.pone.0079055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427263	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200003
J	Brinkmann, M; Blenkle, H; Salowsky, H; Bluhm, K; Schiwy, S; Tiehm, A; Hollert, H				Brinkmann, Markus; Blenkle, Henning; Salowsky, Helena; Bluhm, Kerstin; Schiwy, Sabrina; Tiehm, Andreas; Hollert, Henner			Genotoxicity of Heterocyclic PAHs in the Micronucleus Assay with the Fish Liver Cell Line RTL-W1	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; POLYCYCLIC AROMATIC-HYDROCARBONS; SISTER-CHROMATID EXCHANGES; EFFECT-DIRECTED ANALYSIS; LIFE-CYCLE TEST; COMET ASSAY; IN-VITRO; NATURAL ATTENUATION; DNA-DAMAGE; SALMONELLA-TYPHIMURIUM	Heterocyclic aromatic hydrocarbons are, together with their un-substituted analogues, widely distributed throughout all environmental compartments. While fate and effects of homocyclic PAHs are well-understood, there are still data gaps concerning the ecotoxicology of heterocyclic PAHs: Only few publications are available investigating these substances using in vitro bioassays. Here, we present a study focusing on the identification and quantification of clastogenic and aneugenic effects in the micronucleus assay with the fish liver cell line RTL-W1 that was originally derived from rainbow trout (Oncorhynchus mykiss). Real concentrations of the test items after incubation without cells were determined to assess chemical losses due to, e. g., sorption or volatilization, by means of gas chromatography-mass spectrometry. We were able to show genotoxic effects for six compounds that have not been reported in vertebrate systems before. Out of the tested substances, 2,3-dimethylbenzofuran, benzothiophene, quinoline and 6-methylquinoline did not cause substantial induction of micronuclei in the cell line. Acridine caused the highest absolute induction. Carbazole, acridine and dibenzothiophene were the most potent substances compared with 4-nitroquinoline oxide, a well characterized genotoxicant with high potency used as standard. Dibenzofuran was positive in our investigation and tested negative before in a mammalian system. Chemical losses during incubation ranged from 29.3% (acridine) to 91.7% (benzofuran) and may be a confounding factor in studies without chemical analyses, leading to an underestimation of the real potency. The relative potency of the investigated substances was high compared with their un-substituted PAH analogues, only the latter being typically monitored as priority or indicator pollutants. Hetero-PAHs are widely distributed in the environment and even more mobile, e. g. in ground water, than homocyclic PAHs due to the higher water solubility. We conclude that this substance class poses a high risk to water quality and should be included in international monitoring programs.	[Brinkmann, Markus; Blenkle, Henning; Bluhm, Kerstin; Schiwy, Sabrina; Hollert, Henner] Rhein Westfal TH Aachen, Inst Environm Res, Dept Ecosyst Anal, Aachen, Germany; [Salowsky, Helena; Tiehm, Andreas] Water Technol Ctr, Dept Environm Biotechnol, Karlsruhe, Germany	RWTH Aachen University	Brinkmann, M (corresponding author), Rhein Westfal TH Aachen, Inst Environm Res, Dept Ecosyst Anal, Aachen, Germany.	markus.brinkmann@bio5.rwth-aachen.de	Schiwy, Sabrina/AAM-6459-2020; Brinkmann, Markus/L-3879-2013; Hollert, Henner/A-1027-2009	Brinkmann, Markus/0000-0002-4985-263X; Hollert, Henner/0000-0001-5776-5619	Seed funds project of RWTH Aachen University; German Excellence Initiative; German National Academic Foundation ("Studienstiftung des deutschen Volkes")	Seed funds project of RWTH Aachen University; German Excellence Initiative; German National Academic Foundation ("Studienstiftung des deutschen Volkes")	The authors acknowledge financial support by a Seed funds project of RWTH Aachen University supported by the German Excellence Initiative. M. B. received a personal stipend from the German National Academic Foundation ("Studienstiftung des deutschen Volkes"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, 2142722006 ISO; Asakura S, 1997, ENVIRON MOL MUTAGEN, V30, P459, DOI 10.1002/(SICI)1098-2280(1997)30:4<459::AID-EM11>3.0.CO;2-C; Bartos T, 2006, ENVIRON TOXICOL, V21, P343, DOI 10.1002/tox.20190; Benisek M, 2011, TOXICOL LETT, V200, P169, DOI 10.1016/j.toxlet.2010.11.011; Blotevogel J, 2008, GRUNDWASSER, V13, P147, DOI 10.1007/s00767-008-0077-6; Blum P, 2011, J CONTAM HYDROL, V126, P181, DOI 10.1016/j.jconhyd.2011.08.004; Boettcher M, 2011, MUTAT RES-GEN TOX EN, V723, P152, DOI 10.1016/j.mrgentox.2011.04.012; Boettcher M, 2010, MUTAT RES-GEN TOX EN, V700, P11, DOI 10.1016/j.mrgentox.2010.04.016; Brack W, 2000, ENVIRON TOXICOL CHEM, V19, P2493, DOI 10.1002/etc.5620191015; Brack Werner, 2012, Environmental Sciences Europe, V24, P29, DOI 10.1186/2190-4715-24-29; BROWN BR, 1980, MUTAT RES, V72, P373, DOI 10.1016/0027-5107(80)90112-8; DEBNATH AK, 1992, MUTAT RES, V280, P55, DOI 10.1016/0165-1218(92)90018-U; Diekmann M, 2004, AQUAT TOXICOL, V68, P27, DOI 10.1016/j.aquatox.2004.01.019; Diekmann M, 2004, AQUAT TOXICOL, V68, P13, DOI 10.1016/j.aquatox.2004.01.020; Douben P.E.T., 2003, PAHS ECOTOXICOLOGICA; Dutson Sheryl M., 1997, Environmental Toxicology and Chemistry, V16, P2113, DOI 10.1897/1551-5028(1997)016<2113:CDDTAM>2.3.CO;2; Dyreborg S, 1997, J CONTAM HYDROL, V25, P177, DOI 10.1016/S0169-7722(96)00042-3; Eisentraeger A, 2008, ENVIRON TOXICOL CHEM, V27, P1590, DOI [10.1897/07-201.1, 10.1897/07-201]; Frank D, 2010, ABLEITUNG GERINGFUGI; GALLOWAY SM, 1987, ENVIRON MOL MUTAGEN, V10, P1, DOI 10.1002/em.2850100502; Grummt Tamara, 2013, Environmental Sciences Europe, V25, P27, DOI 10.1186/2190-4715-25-27; Hakura A, 2007, J HEALTH SCI, V53, P470, DOI 10.1248/jhs.53.470; Hallare AV, 2011, J SOIL SEDIMENT, V11, P141, DOI 10.1007/s11368-010-0302-7; Hawliczek A, 2012, REPROD TOXICOL, V33, P213, DOI 10.1016/j.reprotox.2011.11.001; Higley E, 2012, ENVIRON TOXICOL CHEM, V31, P1053, DOI 10.1002/etc.1777; Hinger G, 2011, ENVIRON SCI POLLUT R, V18, P1297, DOI 10.1007/s11356-011-0483-7; HIRAO K, 1976, CANCER RES, V36, P329; Jernbro S, 2007, ENVIRON SCI POLLUT R, V14, P85, DOI 10.1065/espr2007.01.384; Jha AA, 2002, MUTAT RES-GEN TOX EN, V521, P11, DOI 10.1016/S1383-5718(02)00210-3; Johnston WT, 2008, BIOTECH HISTOCHEM, V83, P83, DOI 10.1080/10520290802136793; Kirpnick Z, 2005, MUTAT RES-GEN TOX EN, V582, P116, DOI 10.1016/j.mrgentox.2005.01.005; Klee N, 2004, ENVIRON SCI POLLUT R, V11, P313, DOI 10.1007/BF02979645; Kosmehl T, 2008, MUTAT RES-GEN TOX EN, V650, P1, DOI 10.1016/j.mrgentox.2007.09.009; Kosmehl Thomas, 2004, Journal of Soils and Sediments, V4, P84, DOI 10.1007/BF02991050; Larsson M, 2012, ENVIRON TOXICOL CHEM, V31, P1149, DOI 10.1002/etc.1776; LAVOIE EJ, 1988, FOOD CHEM TOXICOL, V26, P625, DOI 10.1016/0278-6915(88)90233-5; LAVOIE EJ, 1982, MUTAT RES, V101, P141, DOI 10.1016/0165-1218(82)90004-0; LEE LEJ, 1993, CELL BIOL TOXICOL, V9, P279, DOI 10.1007/BF00755606; Mackay D, 2000, ENVIRON POLLUT, V110, P375, DOI 10.1016/S0269-7491(00)00162-7; Meyer S, 2000, CHEMOSPHERE, V40, P359, DOI 10.1016/S0045-6535(99)00237-4; Moir D, 1997, J ENVIRON SCI HEAL B, V32, P545, DOI 10.1080/03601239709373102; OCHIAI M, 1986, MUTAT RES, V172, P189, DOI 10.1016/0165-1218(86)90056-X; Peddinghaus S, 2012, REPROD TOXICOL, V33, P224, DOI 10.1016/j.reprotox.2011.12.005; Phelps JB, 2002, MUTAT RES-GEN TOX EN, V521, P103, DOI 10.1016/S1383-5718(02)00221-8; Reifferscheid G, 2008, MUTAT RES-GEN TOX EN, V649, P15, DOI 10.1016/j.mrgentox.2007.07.015; Reineke AK, 2007, ENVIRON SCI TECHNOL, V41, P5314, DOI 10.1021/es070405k; Robbiano L, 2004, TOXICOLOGY, V204, P187, DOI 10.1016/j.tox.2004.06.057; Rocha PS, 2009, ECOTOX ENVIRON SAFE, V72, P1842, DOI 10.1016/j.ecoenv.2009.04.013; Schnurstein A, 2001, ECOTOX ENVIRON SAFE, V49, P187, DOI 10.1006/eesa.2001.2050; Schuettrumpf Holger, 2011, Environmental Sciences Europe, V23, P39, DOI 10.1186/2190-4715-23-39; Schulze S, 2004, WATER SCI TECHNOL, V50, P347, DOI 10.2166/wst.2004.0348; Seitz N, 2008, MUTAT RES-GEN TOX EN, V652, P38, DOI 10.1016/j.mrgentox.2007.12.004; Sovadinova I, 2006, ENVIRON TOXICOL CHEM, V25, P1291, DOI 10.1897/05-388R.1; Suzuki H, 2009, MUTAGENESIS, V24, P9, DOI 10.1093/mutage/gen047; Suzuki T, 2007, J HEALTH SCI, V53, P325, DOI 10.1248/jhs.53.325; Tiehm A, 2008, WATER SCI TECHNOL, V58, P1349, DOI 10.2166/wst.2008.730; Tiehm A, 2003, OIL GAS SCI TECHNOL, V58, P449, DOI 10.2516/ogst:2003028; WEILLTHEVENET N, 1981, MUTAT RES, V88, P355, DOI 10.1016/0165-1218(81)90027-6; WEYAND EH, 1993, FOOD CHEM TOXICOL, V31, P707, DOI 10.1016/0278-6915(93)90141-K; WILD D, 1983, FOOD CHEM TOXICOL, V21, P707, DOI 10.1016/0278-6915(83)90202-8; Wolz J, 2011, J SOIL SEDIMENT, V11, P82, DOI 10.1007/s11368-010-0267-6; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006	62	36	36	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85692	10.1371/journal.pone.0085692	http://dx.doi.org/10.1371/journal.pone.0085692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416442	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300098
J	Buri, P; Humbert, JY; Arlettaz, R				Buri, Pierrick; Humbert, Jean-Yves; Arlettaz, Raphael			Promoting Pollinating Insects in Intensive Agricultural Matrices: Field-Scale Experimental Manipulation of Hay-Meadow Mowing Regimes and Its Effects on Bees	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; DIVERSITY; BIODIVERSITY; CONSERVATION; HYMENOPTERA; ABUNDANCE; COMMUNITIES; COMPONENTS; RESOURCES; APIFORMES	Bees are a key component of biodiversity as they ensure a crucial ecosystem service: pollination. This ecosystem service is nowadays threatened, because bees suffer from agricultural intensification. Yet, bees rarely benefit from the measures established to promote biodiversity in farmland, such as agri-environment schemes (AES). We experimentally tested if the spatio-temporal modification of mowing regimes within extensively managed hay meadows, a widespread AES, can promote bees. We applied a randomized block design, replicated 12 times across the Swiss lowlands, that consisted of three different mowing treatments: 1) first cut not before 15 June (conventional regime for meadows within Swiss AES); 2) first cut not before 15 June, as treatment 1 but with 15% of area left uncut serving as a refuge; 3) first cut not before 15 July. Bees were collected with pan traps, twice during the vegetation season (before and after mowing). Wild bee abundance and species richness significantly increased in meadows where uncut refuges were left, in comparison to meadows without refuges: there was both an immediate (within year) and cumulative (from one year to the following) positive effect of the uncut refuge treatment. An immediate positive effect of delayed mowing was also evidenced in both wild bees and honey bees. Conventional AES could easily accommodate such a simple management prescription that promotes farmland biodiversity and is likely to enhance pollination services.	[Buri, Pierrick; Humbert, Jean-Yves; Arlettaz, Raphael] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Arlettaz, Raphael] Swiss Ornithol Inst, Valais Field Stn, Sion, Switzerland	University of Bern; Swiss Ornithological Institute	Buri, P (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland.	pierrick.buri@iee.unibe.ch	Arlettaz, Raphaël/O-2182-2016; Buri, Pierrick/I-3749-2019	Arlettaz, Raphaël/0000-0001-6360-5339; Buri, Pierrick/0000-0003-1038-9550; Humbert, Jean-Yves/0000-0002-5756-6748	Swiss National Science Foundation [31003A_125398/1]; Federal Office of Environment; cantonal office of environment, Bern; cantonal office of environment, Vaud; cantonal office of environment, Basel-Landschaft; cantonal office of environment, Aargau; cantonal office of environment, Neuchatel; cantonal office of environment, Fribourg; cantonal office of environment, Valais; cantonal office of environment, Graubunden; cantonal office of agriculture, Bern; cantonal office of agriculture, Vaud; cantonal office of agriculture, Basel-Landschaft; cantonal office of agriculture, Aargau; cantonal office of agriculture, Neuchatel; cantonal office of agriculture, Fribourg; cantonal office of agriculture, Valais; cantonal office of agriculture, Graubunden	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office of Environment; cantonal office of environment, Bern; cantonal office of environment, Vaud; cantonal office of environment, Basel-Landschaft; cantonal office of environment, Aargau; cantonal office of environment, Neuchatel; cantonal office of environment, Fribourg; cantonal office of environment, Valais; cantonal office of environment, Graubunden; cantonal office of agriculture, Bern; cantonal office of agriculture, Vaud; cantonal office of agriculture, Basel-Landschaft; cantonal office of agriculture, Aargau; cantonal office of agriculture, Neuchatel; cantonal office of agriculture, Fribourg; cantonal office of agriculture, Valais; cantonal office of agriculture, Graubunden	This project was supported by a grant of the Swiss National Science Foundation to R. A. (No. 31003A_125398/1), the Federal Office of Environment, and the following cantonal offices of environment and/or agriculture: Bern,Vaud, Basel-Landschaft, Aargau, Neuchatel, Fribourg, Valais and Graubunden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Albrecht M, 2007, J APPL ECOL, V44, P813, DOI 10.1111/j.1365-2664.2007.01306.x; Amiet F, 1999, APIDAE 2 COLLETES DU; Amiet F., 2004, APIDAE 4 ANTHIDIUM C; Amiet F., 2007, APIDAE 5 AMMOBATES A; Amiet F., 1996, APIDAE; [Anonymous], 1998, VERORDNUNG DIREKTZAH, P229; [Anonymous], 2009, BEWIRTSCHAFTUNGSVERT, P1; Bates D, 2012, PACKAGE LME4; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Burel F, 1998, ACTA OECOL, V19, P47, DOI 10.1016/S1146-609X(98)80007-6; C. suisse de cartographie de la Faune, 2001, APIDAE 3 HALICTUS LA; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Droege S, 2010, INSECT CONSERV DIVER, V3, P15, DOI 10.1111/j.1752-4598.2009.00074.x; FOAG, 2012, RAPP AGR 2011; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; Furieri A., 2008, SPATIALITE COMPLETE; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gotelli NJ, 2013, ECOSIMR 1 00; Haaland C, 2011, INSECT CONSERV DIVER, V4, P60, DOI 10.1111/j.1752-4598.2010.00098.x; Hart K., 2011, GREENING CAP DELIVER; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Heneberg P, 2013, J INSECT CONSERV, V17, P473, DOI 10.1007/s10841-012-9529-5; Humbert JY, 2012, ENVIRON EVID, V1, DOI 10.1186/2047-2382-1-9; Humbert JY, 2012, BIOL CONSERV, V152, P96, DOI 10.1016/j.biocon.2012.03.015; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kindt R., 2005, WORLD; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knop E, 2006, J APPL ECOL, V43, P120, DOI 10.1111/j.1365-2664.2005.01113.x; Kohler F, 2008, J APPL ECOL, V45, P753, DOI 10.1111/j.1365-2664.2007.01394.x; Kwaiser KS, 2008, AGR ECOSYST ENVIRON, V124, P200, DOI 10.1016/j.agee.2007.09.012; Le Feon V, 2013, AGR ECOSYST ENVIRON, V166, P94, DOI 10.1016/j.agee.2011.06.020; Littlewood NA, 2012, INSECT CONSERV DIVER, V5, P1, DOI 10.1111/j.1752-4598.2011.00174.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Murray TE, 2012, J APPL ECOL, V49, P998, DOI 10.1111/j.1365-2664.2012.02175.x; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Potts SG, 2009, J APPL ECOL, V46, P369, DOI 10.1111/j.1365-2664.2009.01609.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pywell RF, 2011, J INSECT CONSERV, V15, P853, DOI 10.1007/s10841-011-9383-x; Pywell RF, 2006, BIOL CONSERV, V129, P192, DOI 10.1016/j.biocon.2005.10.034; Quantum GIS Development Team, 2012, QGIS QUANT GIS GEOGR; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasmont P, 2010, CATALOGUE SOUS GENRE, P1; Roulston TH, 2007, J KANSAS ENTOMOL SOC, V80, P179, DOI 10.2317/0022-8567(2007)80[179:ACOPTA]2.0.CO;2; Russell KN, 2005, BIOL CONSERV, V124, P133, DOI 10.1016/j.biocon.2005.01.022; SchmidEgger C., 1997, ILLUSTRIERTE BESTIMM, VIII; Schmidt MH, 2008, BIODIVERS CONSERV, V17, P3003, DOI 10.1007/s10531-008-9412-6; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Swisstopo, 2012, VECT 25; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Valtonen A., 2006, Animal Biodiversity and Conservation, V29, P133; Veddeler D, 2006, OIKOS, V112, P594, DOI 10.1111/j.0030-1299.2006.14111.x; Warren J, 2008, AGRI-ENVIRONMENT, P1; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1	66	46	50	3	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85635	10.1371/journal.pone.0085635	http://dx.doi.org/10.1371/journal.pone.0085635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416434	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300093
J	Khoo, HE; Azlan, A; Ismail, A; Abas, F; Hamid, M				Khoo, Hock Eng; Azlan, Azrina; Ismail, Amin; Abas, Faridah; Hamid, Muhajir			Inhibition of Oxidative Stress and Lipid Peroxidation by Anthocyanins from Defatted Canarium odontophyllum Pericarp and Peel Using In Vitro Bioassays	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; B SCAVENGER RECEPTOR; OXIDIZED LDL; PHENOLIC-COMPOUNDS; PPAR-GAMMA; ANTIOXIDANT CAPACITY; ENDOTHELIAL-CELLS; CD36; DABAI; ATHEROSCLEROSIS	Canarium odontophyllum, also known as CO, is a highly nutritious fruit. Defatted parts of CO fruit are potent sources of nutraceutical. This study aimed to determine oxidative stress and lipid peroxidation effects of defatted CO pericarp and peel extracts using in vitro bioassays. Cell cytotoxic effect of the CO pericarp and peel extracts were also evaluated using HUVEC and Chang liver cell lines. The crude extracts of defatted CO peel and pericarp showed cytoprotective effects in t-BHP and 40% methanol-induced cell death. The crude extracts also showed no toxic effect to Chang liver cell line. Using CD36 ELISA, NAD+ and LDL inhibition assays, inhibition of oxidative stress were found higher in the crude extract of defatted CO peel compared to the pericarp extract. Hemoglobin and LDL oxidation assays revealed both crude extracts had significantly reduced lipid peroxidation as compared to control. TBARS values among defatted CO pericarp, peel, and cyanidin-3-glucoside showed no significant differences for hemoglobin and LDL oxidation assays. The protective effects of defatted CO parts, especially its peel is related to the presence of high anthocyanin that potentially offers as a pharmaceutical ingredient for cardioprotection.	[Khoo, Hock Eng; Azlan, Azrina; Ismail, Amin] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang, Malaysia; [Azlan, Azrina; Ismail, Amin] Univ Putra Malaysia, Lab Halal Sci Res, Halal Prod Res Inst, Serdang, Malaysia; [Abas, Faridah] Univ Putra Malaysia, Dept Food Sci, Fac Food Sci & Technol, Serdang, Malaysia; [Hamid, Muhajir] Univ Putra Malaysia, Dept Microbiol, Fac Biotechnol & Biomol Sci, Serdang, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Azlan, A (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang, Malaysia.	azrina@upm.edu.my	Abas, Faridah/B-9229-2015; Khoo, Hock Eng/F-4007-2011; bin Ismail, Amin/J-8725-2015	Abas, Faridah/0000-0002-8110-9424; Khoo, Hock Eng/0000-0002-7686-6092; bin Ismail, Amin/0000-0002-9427-2028; Hamid, Muhajir/0000-0002-2475-7628	Research Management Center, Universiti Putra Malaysia [04-02-10-0921RU, 9192600]	Research Management Center, Universiti Putra Malaysia	This study was funded by the Research University Grant Scheme (04-02-10-0921RU, 9192600) from Research Management Center, Universiti Putra Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azlan A, 2010, J FOOD COMPOS ANAL, V23, P772, DOI 10.1016/j.jfca.2010.03.026; Azlan A, 2009, J FOOD AGRIC ENVIRON, V7, P55; BLANK F, 1947, BOT REV, V13, P241, DOI 10.1007/BF02861798; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Buege J A, 1978, Methods Enzymol, V52, P302; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Calvo D, 1998, J LIPID RES, V39, P777; Chang YC, 2006, FOOD CHEM TOXICOL, V44, P1015, DOI 10.1016/j.fct.2005.12.006; Chew LY, 2011, J FOOD COMPOS ANAL, V24, P670, DOI 10.1016/j.jfca.2011.01.006; Chew LY, 2012, FOOD ANAL METHOD, V5, P126, DOI 10.1007/s12161-011-9217-1; Cominacini L, 2001, J BIOL CHEM, V276, P13750, DOI 10.1074/jbc.M010612200; DASHTI N, 1984, BIOCHIM BIOPHYS ACTA, V794, P373, DOI 10.1016/0005-2760(84)90003-1; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng JW, 2000, J LIPID RES, V41, P688; Gabius HJ, 2001, CANCER INVEST, V19, P114, DOI 10.1081/CNV-100000146; Galeano NF, 1998, J LIPID RES, V39, P1263; Geraets L, 2006, BIOCHEM PHARMACOL, V72, P902, DOI 10.1016/j.bcp.2006.06.023; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Heo HJ, 2005, J AGR FOOD CHEM, V53, P1984, DOI 10.1021/jf048616l; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; Khoo H.E., 2012, POLYPHENOLS CHEM DIE, P133; Khoo HE, 2013, SAINS MALAYS, V42, P949; Khoo HE, 2012, MOLECULES, V17, P9754, DOI 10.3390/molecules17089754; Khoo HE, 2012, FOOD ANAL METHOD, V5, P339, DOI 10.1007/s12161-011-9250-0; Kita T, 2001, ANN NY ACAD SCI, V947, P199; Kong KW, 2010, FOOD CHEM, V123, P1142, DOI 10.1016/j.foodchem.2010.05.077; Lima CF, 2006, LIFE SCI, V79, P2056, DOI 10.1016/j.lfs.2006.06.042; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lyall KA, 2009, AM J PHYSIOL-REG I, V297, pR70, DOI 10.1152/ajpregu.90740.2008; Meyer AS, 1998, FOOD CHEM, V61, P71, DOI 10.1016/S0308-8146(97)00100-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez J, 2006, BBA-GEN SUBJECTS, V1760, P1333, DOI 10.1016/j.bbagen.2006.04.005; Rotich, 2011, J TOXICOLOGY ENV HLT, V3, P367, DOI 10.5897/JTEHS.9000008; Rubic T, 2004, BIOCHEM PHARMACOL, V67, P411, DOI 10.1016/j.bcp.2003.09.014; Tan PH, 2004, ATHEROSCLEROSIS, V173, P171, DOI 10.1016/j.atherosclerosis.2003.12.011; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tsoukatos DC, 1997, ARTERIOSCL THROM VAS, V17, P3505, DOI 10.1161/01.ATV.17.12.3505; TSUDA T, 1994, J AGR FOOD CHEM, V42, P2407, DOI 10.1021/jf00047a009; Uchide N, 2009, INTERVIROLOGY, V52, P164, DOI 10.1159/000224644; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Visavadiya NP, 2009, FOOD CHEM TOXICOL, V47, P2507, DOI 10.1016/j.fct.2009.07.009; Wang L, 2010, J BIOMOL SCREEN, V15, P239, DOI 10.1177/1087057109359686; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; Yi W, 2006, FOOD RES INT, V39, P628, DOI 10.1016/j.foodres.2006.01.001	46	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e81447	10.1371/journal.pone.0081447	http://dx.doi.org/10.1371/journal.pone.0081447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416130	gold, Green Published, Green Submitted			2022-12-25	WOS:000329866300004
J	Shabnam, N; Pardha-Saradhi, P; Sharmila, P				Shabnam, Nisha; Pardha-Saradhi, P.; Sharmila, P.			Phenolics Impart Au3+-Stress Tolerance to Cowpea by Generating Nanoparticles	PLOS ONE			English	Article							GOLD NANOPARTICLES; ANTIOXIDANT ACTIVITY; AU NANOPARTICLES; IN-VITRO; PLANTS; METAL; DETOXIFICATION; PROLINE; SEED; PEROXIDATION	While evaluating impact of Au nanoparticles on seed germination and early seedling growth of cowpea, HAuCl4 was used as control. Seedlings of cowpea raised in HAuCl4, even at concentration as high as 1 mM, did not show any suppression in growth. Accordingly, Au3+, despite being a heavy metal, did not alter levels of stress markers (viz. proline and malondialdehyde) in cowpea. Interestingly, cowpea turned clear pale yellow HAuCl4 solutions colloidal purple during the course of seed germination and seedling growth. These purple colloidal suspensions showed Au-nanoparticle specific surface plasmon resonance band in absorption spectra. Transmission electron microscopic and powder X-ray diffraction investigations confirmed presence of crystalline Au-nanoparticles in these purple suspensions. Each germinating seed of cowpea released similar to 35 nmoles of GAE of phenolics and since phenolics promote generation of Au-nanoparticles, which are less/non toxic compared to Au3+, it was contemplated that potential of cowpea to withstand Au3+ is linked to phenolics. Of the different components of germinating seed of cowpea tested, seed coat possessed immense power to generate Au-nanoparticles, as it was the key source of phenolics. To establish role of phenolics in generation of Au-nanoparticles (i) seed coat and (ii) the incubation medium in which phenolics were released by germinating seeds, were tested for their efficacy to generate Au-nanoparticles. Interestingly, incubation of either of these components with Au3+ triggered increase in generation of Au-nanoparticles with concomitant decrease in phenolics. Accordingly, with increase in concentration of Au3+, a proportionate increase in generation of Au-nanoparticles and decrease in phenolics was recorded. In summary, our findings clearly established that cowpea possessed potential to withstand Au3+-stress as the phenolics released by seed coat of germinating seeds possess potential to reduce toxic Au3+ to form non/less toxic Au-nanoparticles. Our investigations also pave a novel, simple, green and economically viable protocol for generation of Au-nanoparticles.	[Shabnam, Nisha; Pardha-Saradhi, P.] Univ Delhi, Dept Environm Studies, Delhi 110007, India; [Sharmila, P.] Indian Inst Technol, Dept Chem, Delhi, India	University of Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Sharmila, P (corresponding author), Indian Inst Technol, Dept Chem, Delhi, India.	sharmilaps91@gmail.com	Shabnam, Nisha/J-7470-2019	Shabnam, Nisha/0000-0002-1855-8497	University Grants Commission (Govt. of India); Department of Biotechnology (Govt. of India) under Bio-CARe Women Scientist Scheme	University Grants Commission (Govt. of India)(University Grants Commission, India); Department of Biotechnology (Govt. of India) under Bio-CARe Women Scientist Scheme	Financial assistance provided to (i) Nisha Shabnam by University Grants Commission (Govt. of India); and (ii) P. Sharmila by Department of Biotechnology (Govt. of India) under Bio-CARe Women Scientist Scheme is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Ainsworth SK, 1981, ARCH PATHOL LAB MED, V105, P73; Alia, 1997, J PHOTOCH PHOTOBIO B, V38, P253, DOI 10.1016/S1011-1344(96)07470-2; ALIA, 1995, PHYTOCHEMISTRY, V39, P45, DOI 10.1016/0031-9422(94)00919-K; ALIA, 1993, BIOCHEM BIOPH RES CO, V193, P54; ALIA, 1991, J PLANT PHYSIOL, V138, P554, DOI 10.1016/S0176-1617(11)80240-3; Anderson CWN, 1998, NATURE, V395, P553, DOI 10.1038/26875; Baba A.A., 2011, CHEM B, V1, P1; Bali R, 2010, IND ENG CHEM RES, V49, P12762, DOI 10.1021/ie101600m; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Beattie IR, 2011, METALLOMICS, V3, P628, DOI 10.1039/c1mt00044f; Bekkara F, 1998, PLANT SOIL, V203, P27, DOI 10.1023/A:1004365913726; Bringezu K, 1999, J PLANT PHYSIOL, V154, P536, DOI 10.1016/S0176-1617(99)80295-8; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Duenas M, 2006, FOOD CHEM, V98, P95, DOI 10.1016/j.foodchem.2005.05.052; Duncan DB, 1955, BIOMETRICS, V39, P205; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Ishikawa S, 2002, BIORESOURCE TECHNOL, V81, P201, DOI 10.1016/S0960-8524(01)00134-1; Jung C, 2003, PLANT SOIL, V252, P301, DOI 10.1023/A:1024775803759; Klaus-Joerger T, 2001, TRENDS BIOTECHNOL, V19, P15, DOI 10.1016/S0167-7799(00)01514-6; Lavid N, 2001, PLANTA, V212, P323, DOI 10.1007/s004250000400; Lengke MF, 2005, GEOCHIM COSMOCHIM AC, V69, P3759, DOI 10.1016/j.gca.2005.03.012; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Maestri E, 2010, ENVIRON EXP BOT, V68, P1, DOI 10.1016/j.envexpbot.2009.10.011; Michalak A, 2006, POL J ENVIRON STUD, V15, P523; Migocka M, 2011, J EXP BOT, V62, P4903, DOI 10.1093/jxb/err180; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nune SK, 2009, J MATER CHEM, V19, P2912, DOI 10.1039/b822015h; Pardha Saradhi P, 2008, HDB NEW TECHNOLOGIES, P577; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; SARADHI PP, 1995, BIOCHEM BIOPH RES CO, V209, P1, DOI 10.1006/bbrc.1995.1461; Shabnam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071123; Sharma NC, 2007, ENVIRON SCI TECHNOL, V41, P5137, DOI 10.1021/es062929a; Siddhuraju P, 2007, FOOD CHEM, V101, P10, DOI 10.1016/j.foodchem.2006.01.004; Sivakumar P, 1998, BIOCHEM BIOPH RES CO, V252, P428, DOI 10.1006/bbrc.1998.9666; Syed S, 2012, HYDROMETALLURGY, V115, P30, DOI 10.1016/j.hydromet.2011.12.012; Wang WX, 2007, COLLOID SURFACE A, V301, P73, DOI 10.1016/j.colsurfa.2006.12.037; Wenzl P, 2001, PLANT PHYSIOL, V125, P1473, DOI 10.1104/pp.125.3.1473; Yamal G, 2013, PROCESS BIOCHEM, V48, P532, DOI 10.1016/j.procbio.2013.02.011	40	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85242	10.1371/journal.pone.0085242	http://dx.doi.org/10.1371/journal.pone.0085242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416368	gold, Green Submitted, Green Published			2022-12-25	WOS:000329866300058
J	Zheng, N; Chai, Z; Fu, F; Jiang, FC; Wang, XL; Zhang, XY; Wang, Z; Li, X				Zheng, Nan; Chai, Zheng; Fu, Fang; Jiang, Fucheng; Wang, Xiangling; Zhang, Xueyun; Wang, Zhuo; Li, Xi			Identification of a Novel Haemophilus parasuis-Specific B Cell Epitope Using Monoclonal Antibody against the OppA Protein	PLOS ONE			English	Article							PEPTIDE LIBRARY; VIRUS; SWINE; INFECTION; DIAGNOSIS; SEROVARS; DISEASE; ANTIGEN; MICE; PCR	Monoclonal antibody (MAb) 1B3 against Haemophilus parasuis (H. parasuis) was generated by fusing SP2/0 murine myeloma cells and spleen cells from BALB/c mice immunized with the whole-bacterial-cell suspension of H. parasuis HS80 (serotype 5). The MAb 1B3 showed strong reactivity with 15 serotype reference strains of H. parasuis using Dot blot and Western blot analysis. Immunoprecipitation and protein spectral analysis indicated that MAb 1B3 recognized by Oligopeptide permease A (OppA) belongs to the ATP binding cassette transporter family. In addition, a linear B-cell epitope recognized by MAb 1B3 was identified by the screening of a phage-displayed 12-mer random peptide library. Sequence analysis showed that MAb 1B3 was recognized by phages-displaying peptides with the consensus motif KTPSEXR (X means variable amino acids). Its amino acid sequence matched (469)KTPAEAR(475) of H. parasuis OppA protein. A series of progressively truncated peptides were synthesized to define the minimal region that was required for MAb 1B3 binding. The epitope was highly conserved in OppA protein sequences from the isolated H. parasuis strains, which was confirmed by alignment analysis. Furthermore, the minimal linear epitope was highly specific among 75 different bacterial strains as shown in sequence alignments. These results indicated MAb 1B3 might be potentially used to develop serological diagnostic tools for H. parasuis.	[Zheng, Nan; Chai, Zheng; Fu, Fang; Jiang, Fucheng; Wang, Xiangling; Zhang, Xueyun; Wang, Zhuo; Li, Xi] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Li, X (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	lx2005@126.com	Chai, Zheng/Q-5121-2019		Special Fund for Agro-scientific Research in the Public Interest [201203056]	Special Fund for Agro-scientific Research in the Public Interest	This study was supported by Special Fund for Agro-scientific Research in the Public Interest (201203056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackall PJ, 1997, VET MICROBIOL, V56, P125, DOI 10.1016/S0378-1135(96)01342-9; del Rio ML, 2006, RES VET SCI, V80, P55, DOI 10.1016/j.rvsc.2005.03.004; Del Rio ML, 2003, J CLIN MICROBIOL, V41, P880, DOI 10.1128/JCM.41.2.880-882.2003; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Kaneko N, 2013, ANAL CHEM, V85, P3152, DOI 10.1021/ac303344h; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Kouzmitcheva GA, 2001, CLIN DIAGN LAB IMMUN, V8, P150, DOI 10.1128/CDLI.8.1.150-160.2001; Li XS, 2011, J VIROL METHODS, V176, P46, DOI 10.1016/j.jviromet.2011.05.034; Lin XA, 2010, CLIN VACCINE IMMUNOL, V17, P778, DOI 10.1128/CVI.00405-09; MacInnes JI, 1999, CAN J VET RES, V63, P83; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Olvera A, 2007, VET J, V174, P522, DOI 10.1016/j.tvjl.2006.10.017; Peng WP, 2008, VIRUS RES, V135, P267, DOI 10.1016/j.virusres.2008.04.003; Rafiee M, 2000, AUST VET J, V78, P846, DOI 10.1111/j.1751-0813.2000.tb10507.x; RAPPGABRIELSON VJ, 1992, AM J VET RES, V53, P659; Sun EC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-100; Tadjine M, 2004, MICROBIOL-SGM, V150, P3935, DOI 10.1099/mic.0.27443-0; Tanabe M, 2006, INFECT IMMUN, V74, P3687, DOI 10.1128/IAI.01837-05; Tian HB, 2011, CLIN VACCINE IMMUNOL, V18, P1695, DOI 10.1128/CVI.05223-11; Wang HW, 2011, VET MICROBIOL, V148, P189, DOI 10.1016/j.vetmic.2010.09.013; Wang WS, 2013, APPL MICROBIOL BIOT, V97, P5933, DOI 10.1007/s00253-013-4779-z; Xue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049842; Yang M, 2011, INFECT IMMUN, V79, P846, DOI 10.1128/IAI.00314-10	23	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84516	10.1371/journal.pone.0084516	http://dx.doi.org/10.1371/journal.pone.0084516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416241	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300027
J	McElgunn, CJ; Pereira, CR; Parham, NJ; Smythe, JE; Wigglesworth, MJ; Smielewska, A; Parmar, SA; Gandelman, OA; Brown, NM; Tisi, LC; Curran, MD				McElgunn, Cathal J.; Pereira, Clint R.; Parham, Nicholas J.; Smythe, James E.; Wigglesworth, Michael J.; Smielewska, Anna; Parmar, Surendra A.; Gandelman, Olga A.; Brown, Nicholas M.; Tisi, Laurence C.; Curran, Martin D.			A Low Complexity Rapid Molecular Method for Detection of Clostridium difficile in Stool	PLOS ONE			English	Article							REAL-TIME PCR; XPERT C.-DIFFICILE; BD GENEOHM CDIFF; TOXIN; CULTURE; DIAGNOSIS; FECES; COLONIZATION; TRANSMISSION; INHIBITION	Here we describe a method for the detection of Clostridium difficile from stool using a novel low-complexity and rapid extraction process called Heat Elution (HE). The HE method is two-step and takes just 10 minutes, no specialist instruments are required and there is minimal hands-on time. A test method using HE was developed in conjunction with Loop-mediated Isothermal Amplification (LAMP) combined with the real-time bioluminescent reporter system known as BART targeting the toxin B gene (tcdB). The HE-LAMP-BART method was evaluated in a pilot study on clinical fecal samples (tcdB(+), n = 111; tcdB(-), n = 107). The HE-LAMP-BART method showed 95.5% sensitivity and 100% specificity against a gold standard reference method using cytotoxigenic culture and also a silica-based robotic extraction followed by tcdB PCR to control for storage. From sample to result, the HE-LAMP-BART method typically took 50 minutes, whereas the PCR method took >2.5 hours. In a further study (tcdB(+), n = 47; tcdB(-), n = 28) HE-LAMP-BART was compared to an alternative commercially available LAMP-based method, Illumigene (Meridian Bioscience, OH), and yielded 87.2% sensitivity and 100% specificity for the HE-LAMP-BART method compared to 76.6% and 100%, respectively, for Illumigene against the reference method. A subset of 27 samples (tcdB(+), n = 25; tcdB(-), n = 2) were further compared between HE-LAMP-BART, Illumigene, GeneXpert (Cepheid, Sunnyvale, CA) and RIDA (R) QUICK C. difficile Toxin A/B lateral flow rapid test (R-Biopharm, Darmstadt, Germany) resulting in sensitivities of HE-LAMP-BART 92%, Illumigene 72% GeneXpert 96% and RIDAQuick 76% against the reference method. The HE-LAMP-BART method offers the advantages of molecular based approaches without the cost and complexity usually associated with molecular tests. Further, the rapid time-to-result and simple protocol means the method can be applied away from the centralized laboratory settings.	[McElgunn, Cathal J.; Pereira, Clint R.; Smythe, James E.; Wigglesworth, Michael J.; Gandelman, Olga A.; Tisi, Laurence C.] Lumora Ltd, Ely, Cambs, England; [Parham, Nicholas J.; Smielewska, Anna; Parmar, Surendra A.; Brown, Nicholas M.; Curran, Martin D.] Addenbrookes Hosp, Publ Hlth England, Clin Microbiol & Publ Hlth Lab, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Public Health England; University of Cambridge	McElgunn, CJ (corresponding author), Lumora Ltd, Ely, Cambs, England.	c.mcelgunn@lumora.co.uk		Brown, Nicholas/0000-0002-6657-300X; Smielewska, Anna/0000-0002-6200-6876				Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Abu Al-Soud W, 1998, APPL ENVIRON MICROB, V64, P3748; AKANE A, 1994, J FORENSIC SCI, V39, P362; Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Antunes A, 2010, METHODS MOL BIOL, V646, P93, DOI 10.1007/978-1-60327-365-7_7; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; Bartlett JG, 2010, ANN NY ACAD SCI, V1213, P62, DOI 10.1111/j.1749-6632.2010.05863.x; Bartlett JG, 2010, INFECT CONT HOSP EP, V31, pS35, DOI 10.1086/655999; Belanger SD, 2003, J CLIN MICROBIOL, V41, P730, DOI 10.1128/JCM.41.2.730-734.2003; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bossuyt P., 2006, NAT REV MICROBIOL, V4, P20, DOI [DOI 10.1038/nrmicro1523, DOI 10.1038/nrmico1523]; Brouwer MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023014; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; de Jong E, 2012, EUR J CLIN MICROBIOL, V31, P2219, DOI 10.1007/s10096-012-1558-1; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Gandelman OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014155; Health Protection Agency, 2013, VOL SURV CLOSTR DIFF; Health Protection Agency, 2012, ANN REPORT; Huang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060059; Jones AM, 2013, J INFECTION, V66, P115, DOI 10.1016/j.jinf.2012.10.019; Kato H, 2001, J MED MICROBIOL, V50, P720, DOI 10.1099/0022-1317-50-8-720; Kiddle G, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-15; Knetsch CW, 2011, J CLIN MICROBIOL, V49, P227, DOI 10.1128/JCM.01743-10; Kozak K, 2011, J CLIN MICROBIOL, V49, P2383, DOI 10.1128/JCM.00523-11; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kvach EJ, 2010, J CLIN MICROBIOL, V48, P109, DOI 10.1128/JCM.01630-09; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lalande V, 2011, J CLIN MICROBIOL, V49, P2714, DOI 10.1128/JCM.01835-10; Lantz PG, 1997, J MICROBIOL METH, V28, P159, DOI 10.1016/S0167-7012(97)00979-2; Lawson AJ, 1997, J APPL MICROBIOL, V83, P375, DOI 10.1046/j.1365-2672.1997.00240.x; Monteiro L, 1997, J CLIN MICROBIOL, V35, P995, DOI 10.1128/JCM.35.4.995-998.1997; Novak-Weekley SM, 2010, J CLIN MICROBIOL, V48, P889, DOI 10.1128/JCM.01801-09; Oikarinen S, 2009, J CLIN VIROL, V44, P211, DOI 10.1016/j.jcv.2008.12.017; Pancholi P, 2012, J CLIN MICROBIOL, V50, P1331, DOI 10.1128/JCM.06597-11; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Quinn CD, 2010, J CLIN MICROBIOL, V48, P603, DOI 10.1128/JCM.01614-09; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rupnik M, 2010, METHODS MOL BIOL, V646, P67, DOI 10.1007/978-1-60327-365-7_5; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Ryan J, 2010, IRISH J MED SCI, V179, P245, DOI 10.1007/s11845-009-0361-1; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Simor AE, 2002, INFECT CONT HOSP EP, V23, P696, DOI 10.1086/501997; Sloan LM, 2008, J CLIN MICROBIOL, V46, P1996, DOI 10.1128/JCM.00032-08; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Stanley JD, 2013, CURR PROB SURG, V50, P302, DOI 10.1067/j.cpsurg.2013.02.004; Tenover FC, 2010, J CLIN MICROBIOL, V48, P3719, DOI 10.1128/JCM.00427-10; Thornton CG, 2004, J MICROBIOL METH, V59, P43, DOI 10.1016/j.mimet.2004.06.001; TSAI YL, 1992, APPL ENVIRON MICROB, V58, P2292, DOI 10.1128/AEM.58.7.2292-2295.1992; Viala C, 2012, J MICROBIOL METH, V90, P83, DOI 10.1016/j.mimet.2012.04.017; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	51	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83808	10.1371/journal.pone.0083808	http://dx.doi.org/10.1371/journal.pone.0083808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416173	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500075
J	Park, YH; Shin, JA; Han, K; Yim, HW; Lee, WC; Park, YM				Park, Young-Hoon; Shin, Jeong Ah; Han, Kyungdo; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon			Gender Difference in the Association of Metabolic Syndrome and Its Components with Age-Related Cataract: The Korea National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							BEAVER DAM EYE; RETINAL MICROVASCULAR SIGNS; DISEASE RISK-FACTORS; BLUE MOUNTAINS EYE; BODY-MASS INDEX; LENS OPACITIES; CARDIOVASCULAR-DISEASE; DIABETIC CATARACT; ALDOSE REDUCTASE; 5-YEAR INCIDENCE	Purpose: To explore the relationship of the metabolic syndrome (MetS) and its components with age-related cataract in a representative Korean population. Methods: We analyzed the data from the Korea National Health and Nutrition Examination Surveys (2008-2010). A total of 11,076 adults (4,811 men and 6,265 women) aged 40 and over who completed ophthalmologic examination were evaluated. Cataract was defined as the presence of cortical, nuclear, anterior (sub) capsular or posterior subcapsular cataract, from slit-lamp examination or previous cataract surgery. MetS was defined according to the Joint Interim Statement proposed in 2009 from the International Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute. Results: The prevalence of cataract and MetS in this population was 39.4% (37.1% for men and 41.6% for women) and 38.5% (37.6% for men and 39.4% for women), respectively. Cataract prevalence tended to increase with the number of MetS components in both genders (both P < 0.001). After being controlled for confounders, however, MetS was significantly associated with cataract only in women (adjusted odds ratio (aOR), 1.24; 95% confidence interval (CI), 1.02-1.50]. Reduced HDL cholesterol, elevated fasting glucose, and elevated triglycerides were also significantly associated with cataract in women (aOR, 95% CI; 1.27 (1.07-1.50), 1.23 (1.01-1.50), and 1.26 (1.04-1.52), respectively). In the subgroup analysis for cataract subtype, MetS and reduced HDL cholesterol were significantly associated with nuclear cataract in women (aOR, 95% CI; 1.25 (1.07-1.55) and 1.25 (1.03-1.52), respectively). However, such associations were not found in men. Conclusions: Our results suggest that MetS and its components appear to be associated with age-related cataract only among Korean women, especially in nuclear cataract.	[Park, Young-Hoon; Shin, Jeong Ah] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Han, Kyungdo; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Park, YM (corresponding author), Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea.	markYMpark@gmail.com	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation	This work was financially supported by research grants from the Catholic Medical Center Research Foundation made in the program year of 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Alison G, 2006, Ophthalmol Clin North Am, V19, P415; Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Banos G., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P137; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; Delcourt C, 2000, AM J EPIDEMIOL, V151, P497; Di Benedetto A, 1999, J DIABETES COMPLICAT, V13, P159, DOI 10.1016/S1056-8727(98)00023-3; Galeone C, 2010, ANN EPIDEMIOL, V20, P380, DOI 10.1016/j.annepidem.2010.01.009; Goodrich M E, 1999, Ophthalmic Epidemiol, V6, P279, DOI 10.1076/opep.6.4.279.4188; Hennis A, 2004, ARCH OPHTHALMOL-CHIC, V122, P525, DOI 10.1001/archopht.122.4.525; Hiller R, 1998, OPHTHALMOLOGY, V105, P1244, DOI 10.1016/S0161-6420(98)97029-4; Hiller R, 2003, OPHTHALMOLOGY, V110, P578, DOI 10.1016/S0161-6420(02)01762-1; Hodge WG, 1995, EPIDEMIOL REV, V17, P336, DOI 10.1093/oxfordjournals.epirev.a036197; Jacques PF, 2003, AM J CLIN NUTR, V78, P400, DOI 10.1093/ajcn/78.3.400; Kawasaki R, 2008, BRIT J OPHTHALMOL, V92, P161, DOI 10.1136/bjo.2007.127449; KINOSHITA JH, 1979, METABOLISM, V28, P462, DOI 10.1016/0026-0495(79)90057-X; Klein B E, 2001, Ophthalmic Epidemiol, V8, P251, DOI 10.1076/opep.8.4.251.1612; Klein BEK, 2007, AM J OPHTHALMOL, V144, P961, DOI 10.1016/j.ajo.2007.08.016; Klein BEK, 1998, AM J OPHTHALMOL, V126, P782, DOI 10.1016/S0002-9394(98)00280-3; Klein BEK, 1997, AM J OPHTHALMOL, V123, P338, DOI 10.1016/S0002-9394(14)70129-1; KLEIN BEK, 1995, AM J OPHTHALMOL, V119, P640, DOI 10.1016/S0002-9394(14)70223-5; KLIMOV AN, 1993, ATHEROSCLEROSIS, V100, P13, DOI 10.1016/0021-9150(93)90063-Z; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Lee DH, 2013, DIABETES METAB J, V37, P132, DOI 10.4093/dmj.2013.37.2.132; Leske MC, 1999, OPHTHALMOLOGY, V106, P1893, DOI 10.1016/S0161-6420(99)90398-6; Lim LS, 2009, AM J EPIDEMIOL, V169, P1267, DOI 10.1093/aje/kwp045; Lindblad BE, 2008, OPHTHALMOLOGY, V115, P1687, DOI 10.1016/j.ophtha.2008.04.004; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meyer D, 2003, Cardiovasc J S Afr, V14, P60; Paunksnis A, 2007, EUR J OPHTHALMOL, V17, P605, DOI 10.1177/112067210701700420; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rowe N G, 2000, Ophthalmic Epidemiol, V7, P103; Sabanayagam C, 2011, INVEST OPHTH VIS SCI, V52, P2397, DOI 10.1167/iovs.10-6373; Saxena S, 2004, OPHTHAL EPIDEMIOL, V11, P271, DOI 10.1080/09286580490510733; Schaumberg DA, 2001, ANN EPIDEMIOL, V11, P104, DOI 10.1016/S1047-2797(00)00178-2; Seah SKL, 2002, OPHTHALMOLOGY, V109, P2058, DOI 10.1016/S0161-6420(02)01221-6; STEVENS VJ, 1978, P NATL ACAD SCI USA, V75, P2918, DOI 10.1073/pnas.75.6.2918; Stitt AW, 2001, BRIT J OPHTHALMOL, V85, P746, DOI 10.1136/bjo.85.6.746; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Tan JSL, 2008, OPHTHAL EPIDEMIOL, V15, P317, DOI 10.1080/09286580802105806; Tavani Alessandra, 1995, Annals of Epidemiology, V5, P234, DOI 10.1016/1047-2797(94)00111-6; Tsutsumi K, 1999, BIOL PHARM BULL, V22, P37, DOI 10.1248/bpb.22.37; VARMA SD, 1984, CURR EYE RES, V3, P35, DOI 10.3109/02713688408997186; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Weintraub JM, 2002, INT J OBESITY, V26, P1588, DOI 10.1038/sj.ijo.0802158; West S, 2007, OPHTHAL EPIDEMIOL, V14, P173, DOI 10.1080/09286580701423151; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; Wu SY, 2000, INT OPHTHALMOL CLIN, V40, P71, DOI 10.1097/00004397-200010000-00006; Younan C, 2003, OPHTHALMIC EPIDEMIOL, V10, P227, DOI 10.1076/opep.10.4.227.15905	51	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85068	10.1371/journal.pone.0085068	http://dx.doi.org/10.1371/journal.pone.0085068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416342	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500212
J	Rodrigues Hoffmann, A; Patterson, AP; Diesel, A; Lawhon, SD; Ly, HJ; Stephenson, CE; Mansell, J; Steiner, JM; Dowd, SE; Olivry, T; Suchodolski, JS				Rodrigues Hoffmann, Aline; Patterson, Adam P.; Diesel, Alison; Lawhon, Sara D.; Ly, Hoai Jaclyn; Stephenson, Christine Elkins; Mansell, Joanne; Steiner, Joerg M.; Dowd, Scot E.; Olivry, Thierry; Suchodolski, Jan S.			The Skin Microbiome in Healthy and Allergic Dogs	PLOS ONE			English	Article							CANINE ATOPIC-DERMATITIS; STAPHYLOCOCCUS-INTERMEDIUS; TASK-FORCE; BACTERIAL; DIVERSITY; IDENTIFICATION; COLONIZATION; EXPRESSION; SEARCH; NASAL	Background: Changes in the microbial populations on the skin of animals have traditionally been evaluated using conventional microbiology techniques. The sequencing of bacterial 16S rRNA genes has revealed that the human skin is inhabited by a highly diverse and variable microbiome that had previously not been demonstrated by culture-based methods. The goals of this study were to describe the microbiome inhabiting different areas of the canine skin, and to compare the skin microbiome of healthy and allergic dogs. Methodology/Principal Findings: DNA extracted from superficial skin swabs from healthy (n = 12) and allergic dogs (n = 6) from different regions of haired skin and mucosal surfaces were used for 454-pyrosequencing of the 16S rRNA gene. Principal coordinates analysis revealed clustering for the different skin sites across all dogs, with some mucosal sites and the perianal regions clustering separately from the haired skin sites. The rarefaction analysis revealed high individual variability between samples collected from healthy dogs and between the different skin sites. Higher species richness and microbial diversity were observed in the samples from haired skin when compared to mucosal surfaces or mucocutaneous junctions. In all examined regions, the most abundant phylum and family identified in the different regions of skin and mucosal surfaces were Proteobacteria and Oxalobacteriaceae. The skin of allergic dogs had lower species richness when compared to the healthy dogs. The allergic dogs had lower proportions of the Betaproteobacteria Ralstonia spp. when compared to the healthy dogs. Conclusions/Significance: The study demonstrates that the skin of dogs is inhabited by much more rich and diverse microbial communities than previously thought using culture-based methods. Our sequence data reveal high individual variability between samples collected from different patients. Differences in species richness was also seen between healthy and allergic dogs, with allergic dogs having lower species richness when compared to healthy dogs.	[Rodrigues Hoffmann, Aline; Ly, Hoai Jaclyn; Mansell, Joanne] Texas A&M Univ, Dept Vet Pathol, Coll Vet Med & Biomed Sci, Dermatopathol Specialty Serv, College Stn, TX 77843 USA; [Patterson, Adam P.; Diesel, Alison] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Clin Dermatol Serv, College Stn, TX USA; [Stephenson, Christine Elkins; Steiner, Joerg M.; Suchodolski, Jan S.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX USA; [Lawhon, Sara D.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Clin Microbiol Lab, College Stn, TX USA; [Dowd, Scot E.] MR DNA Lab, Shallowater, TX USA; [Olivry, Thierry] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA; [Olivry, Thierry] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Rodrigues Hoffmann, A (corresponding author), Texas A&M Univ, Dept Vet Pathol, Coll Vet Med & Biomed Sci, Dermatopathol Specialty Serv, College Stn, TX 77843 USA.	arodrigues@cvm.tamu.edu	Olivry, Thierry/AAV-7869-2021; rodrigues hoffmann, aline/L-6859-2017; Lawhon, Sara D./G-5147-2011; Diesel, Alison/H-7256-2019; Dowd, Scot E/M-5386-2017	Olivry, Thierry/0000-0003-1399-0034; rodrigues hoffmann, aline/0000-0001-6148-2531; Lawhon, Sara D./0000-0001-9154-8909; Diesel, Alison/0000-0002-8688-7495; Dowd, Scot E/0000-0002-6296-1427				ALLAKER RP, 1992, VET REC, V130, P303, DOI 10.1136/vr.130.14.303; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Favrot C, 2010, VET DERMATOL, V21, P23, DOI 10.1111/j.1365-3164.2009.00758.x; Fazakerley J, 2009, VET DERMATOL, V20, P179, DOI 10.1111/j.1365-3164.2009.00745.x; Furiani N, 2011, VET DERMATOL, V22, P490, DOI 10.1111/j.1365-3164.2011.00979.x; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; Grahn N, 2003, FEMS MICROBIOL LETT, V219, P87, DOI 10.1016/S0378-1097(02)01190-4; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Harvey RG, 1998, VET DERMATOL, V9, P99, DOI 10.1046/j.1365-3164.1998.00093.x; HARVEY RG, 1995, VET DERMATOL, V6, P79, DOI [10.1111/j.1365-3164.1995.tb00047.x, 10.1111/j.1365-3164.1994.tb00015.x]; Hata TR, 2008, SEMIN CUTAN MED SURG, V27, P144, DOI 10.1016/j.sder.2008.04.002; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Herz U, 1998, INT ARCH ALLERGY IMM, V115, P179, DOI 10.1159/000023899; Hillier A, 2001, VET IMMUNOL IMMUNOP, V81, P147, DOI 10.1016/S0165-2427(01)00296-3; Johnson LR, 2001, J AM VET MED ASSOC, V219, P1247, DOI 10.2460/javma.2001.219.1247; Kasempimolporn Songsri, 2003, Journal of the Medical Association of Thailand, V86, P1162; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Lynch K, 2011, MOL DETECTION HUMAN; Marsella R, 2006, VET DERMATOL, V17, P306, DOI 10.1111/j.1365-3164.2006.00541.x; Miller WH, 2012, MULLER KIRKS SMALL A, P184; Olivry T, 1996, ARCH DERMATOL RES, V288, P579, DOI 10.1007/BF02505260; Olivry T, 1997, AM J DERMATOPATH, V19, P477, DOI 10.1097/00000372-199710000-00008; Olivry T, 2013, VET DERMATOL, V24, P97, DOI 10.1111/j.1365-3164.2012.01088.x; Olivry T, 2012, CHEM IMMUNOL ALLERGY, V96, P61, DOI 10.1159/000331884; Olivry T, 2010, VET DERMATOL, V21, P233, DOI 10.1111/j.1365-3164.2010.00889.x; PUGH GW, 1986, AM J VET RES, V47, P2343; SaijonmaaKoulumies LE, 1996, VET DERMATOL, V7, P153, DOI 10.1111/j.1365-3164.1996.tb00240.x; Sasaki T, 2007, J CLIN MICROBIOL, V45, P2770, DOI 10.1128/JCM.00360-07; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Sturgeon A, 2012, VET DERMATOL, V23, P68; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Wanke I, 2011, J INVEST DERMATOL, V131, P382, DOI 10.1038/jid.2010.328; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zeeuwen PLJM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r101	45	74	76	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83197	10.1371/journal.pone.0083197	http://dx.doi.org/10.1371/journal.pone.0083197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421875	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500035
J	Papa, L; Hahn, M; Marsh, EL; Evans, BS; Germain, D				Papa, Luena; Hahn, Mary; Marsh, Ellen L.; Evans, Bradley S.; Germain, Doris			SOD2 to SOD1 Switch in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Glucose Metabolism; Mitochondria; Reactive Oxygen Species (ROS); Superoxide Dismutase (SOD); ROS	AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; MITOCHONDRIA; SIRT3; METABOLISM; STRESS	Background: Cancer cells are characterized by elevated mitochondrial ROS. The dismutases SOD1 and SOD2 regulate ROS. Results: SOD2 is down-regulated following oncogenic activation in breast cancers. However, SOD1 is overexpressed, and its inhibition by LCS-1 leads to mitochondrial fragmentation. Conclusion: In the absence of SOD2, inhibition of SOD1 abolishes the integrity of the mitochondria. Significance: Our data suggest a SOD switch during transformation. Cancer cells are characterized by elevated levels of reactive oxygen species, which are produced mainly by the mitochondria. The dismutase SOD2 localizes in the matrix and is a major antioxidant. The activity of SOD2 is regulated by the deacetylase SIRT3. Recent studies indicated that SIRT3 is decreased in 87% of breast cancers, implying that the activity of SOD2 is compromised. The resulting elevation in reactive oxygen species was shown to be essential for the metabolic reprograming toward glycolysis. Here, we show that SOD2 itself is down-regulated in breast cancer cell lines. Further, activation of oncogenes, such as Ras, promotes the rapid down-regulation of SOD2. Because in the absence of SOD2, superoxide levels are elevated in the matrix, we reasoned that mechanisms must exist to retain low levels of superoxide in other cellular compartments especially in the intermembrane space of the mitochondrial to avoid irreversible damage. The dismutase SOD1 also acts as an antioxidant, but it localizes to the cytoplasm and the intermembrane space of the mitochondria. We report here that loss of SOD2 correlates with the overexpression of SOD1. Further, we show that mitochondrial SOD1 is the main dismutase activity in breast cancer cells but not in non-transformed cells. In addition, we show that the SOD1 inhibitor LCS-1 leads to a drastic fragmentation and swelling of the matrix, suggesting that in the absence of SOD2, SOD1 is required to maintain the integrity of the organelle. We propose that by analogy to the cadherin switch during epithelial-mesenchymal transition, cancer cells also undergo a SOD switch during transformation.	[Papa, Luena; Hahn, Mary; Germain, Doris] Mt Sinai Sch Med, Dept Med, Tisch Canc Inst, Div Hematol Oncol, New York, NY 10029 USA; [Marsh, Ellen L.; Evans, Bradley S.] Donald Danforth Plant Sci Ctr, Prote & Mass Spectrometry Core Facil, St Louis, MO 63132 USA	Icahn School of Medicine at Mount Sinai; Donald Danforth Plant Science Center	Germain, D (corresponding author), Gustave L Levy Pl,Box 1079, New York, NY 10029 USA.	doris.germain@mssm.edu	Evans, Bradley S/M-2842-2013	Evans, Bradley S/0000-0002-1207-9006	National Institutes of Health [5R24 CA095823-04, 1 S10RRO 9145-01]; National Science Foundation [DBI-9724504]; NATIONAL CANCER INSTITUTE [R01CA109482, R24CA095823, T32CA078207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Tumor sections from the MMTV mouse models were obtained from the laboratory of Dr. Rafael Mira-Lopez. Electron microscopy was performed by the shared facility at Mount Sinai, which is supported by National Institutes of Health shared resources Grant 5R24 CA095823-04, National Science Foundation Major Research Instrumentation Grant DBI-9724504, and National Institutes of Health shared instrumentation Grant 1 S10RRO 9145-01. HPLC analysis of 2-hydroxyethidium was performed at the Donald Danforth Plant Science Center, Proteomics and Mass Spectrometry Core Facility, St. Louis, MO under the supervision of Dr. Bradley S. Evans through Science Exchange.	Bellot GL, 2013, MITOCHONDRION, V13, P155, DOI 10.1016/j.mito.2012.06.007; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fischer LR, 2011, BRAIN, V134, P196, DOI 10.1093/brain/awq314; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Lu Weiqin, 2007, Drug Discov Today Dis Models, V4, P67, DOI 10.1016/j.ddmod.2007.10.005; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Somwar R, 2011, P NATL ACAD SCI USA, V108, P16375, DOI 10.1073/pnas.1113554108; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	17	82	88	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5412	5416		10.1074/jbc.C113.526475	http://dx.doi.org/10.1074/jbc.C113.526475			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24448804	Green Published, hybrid			2022-12-25	WOS:000332015500006
J	Ramakrishnan, G; Davaakhuu, G; Kaplun, L; Chung, WC; Rana, A; Atfi, A; Miele, L; Tzivion, G				Ramakrishnan, Gopalakrishnan; Davaakhuu, Gantulga; Kaplun, Ludmila; Chung, Wen-Cheng; Rana, Ajay; Atfi, Azeddine; Miele, Lucio; Tzivion, Guri			Sirt2 Deacetylase Is a Novel AKT Binding Partner Critical for AKT Activation by Insulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; AMP-activated Kinase (AMPK); Insulin; Phosphorylation; Sirtuins	SIRTUINS; PATHWAY; TARGET; TUMORIGENESIS; LOCALIZATION; DEFICIENCY; INSIGHTS; 3-KINASE; KINASES; GLUCOSE	Background: AKT kinases mediate insulin signaling downstream of phosphatidylinositol-3 kinase (PI3K). Results: AKT binds Sirt2 in insulin-responsive cells and Sirt2 inhibition blocks AKT activation, whereas Sirt2 overexpression sensitizes cells to insulin. Conclusion: Sirt2 deacetylase is an essential factor in AKT activation. Significance: Sirt2 modulators could be useful in treatment of diseases involving AKT, such as type 2 diabetes and cancer. AKT/PKB kinases transmit insulin and growth factor signals downstream of phosphatidylinositol 3-kinase (PI3K). AKT activation involves phosphorylation at two residues, Thr(308) and Ser(473), mediated by PDK1 and the mammalian target of rapamycin complex 2 (mTORC2), respectively. Impaired AKT activation is a key factor in metabolic disorders involving insulin resistance, whereas hyperactivation of AKT is linked to cancer pathogenesis. Here, we identify the cytoplasmic NAD(+)-dependent deacetylase, Sirt2, as a novel AKT interactor, required for optimal AKT activation. Pharmacological inhibition or genetic down-regulation of Sirt2 diminished AKT activation in insulin and growth factor-responsive cells, whereas Sirt2 overexpression enhanced the activation of AKT and its downstream targets. AKT was prebound with Sirt2 in serum or glucose-deprived cells, and the complex dissociated following insulin treatment. The binding was mediated by the pleckstrin homology and the kinase domains of AKT and was dependent on AMP-activated kinase. This regulation involved a novel AMP-activated kinase-dependent Sirt2 phosphorylation at Thr(101). In cells with constitutive PI3K activation, we found that AKT also associated with a nuclear sirtuin, Sirt1; however, inhibition of PI3K resulted in dissociation from Sirt1 and increased association with Sirt2. Sirt1 and Sirt2 inhibitors additively inhibited the constitutive AKT activity in these cells. Our results suggest potential usefulness of Sirt1 and Sirt2 inhibitors in the treatment of cancer cells with up-regulated PI3K activity and of Sirt2 activators in the treatment of insulin-resistant metabolic disorders.	[Ramakrishnan, Gopalakrishnan; Davaakhuu, Gantulga; Chung, Wen-Cheng; Atfi, Azeddine; Miele, Lucio; Tzivion, Guri] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Ramakrishnan, Gopalakrishnan; Davaakhuu, Gantulga; Chung, Wen-Cheng; Atfi, Azeddine; Miele, Lucio; Tzivion, Guri] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Kaplun, Ludmila; Tzivion, Guri] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Barbara Ann Karmanos Cancer Institute; Wayne State University; Loyola University Chicago	Tzivion, G (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, 2500 N State St,Rm G759, Jackson, MS 39216 USA.	gtzivion@umc.edu	Rana, Ajay/ABE-3739-2020	Rana, Ajay/0000-0003-0951-2566; Davaakhuu, Gantulga/0000-0003-3792-7101; Miele, Lucio/0000-0002-5853-7287	National Institutes of Health [R01 GM067134, R01 CA176846]; NATIONAL CANCER INSTITUTE [R01CA176846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM067134 (to G. T.) and R01 CA176846 (to A. R.).	Ahn JY, 2004, J BIOL CHEM, V279, P16441, DOI 10.1074/jbc.M312175200; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheung M, 2013, CURR CANCER DRUG TAR, V13, P234, DOI 10.2174/1568009611313030002; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; de Oliveira RM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00082; Dobson M, 2011, BBA-MOL CELL RES, V1813, P1453, DOI 10.1016/j.bbamcr.2011.05.001; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Horio Y, 2012, NAT REV ENDOCRINOL, V8, P131, DOI 10.1038/nrendo.2011.208; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Ishfaq M, 2012, FEBS LETT, V586, P3236, DOI 10.1016/j.febslet.2012.06.042; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Lu M, 2013, J BIOL CHEM, V288, P10722, DOI 10.1074/jbc.M112.443606; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Martini M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00108; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Park SH, 2012, TRANSL CANCER RES, V1, P15, DOI 10.3978/j.issn.2218-676X.2012.05.01; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Roth M., 2013, ONCOGENE, DOI 10. 1038/onc. 2013. 120; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Snider NT, 2013, J CELL BIOL, V200, P241, DOI 10.1083/jcb.201209028; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Zhu J, 2005, MOL BIOL CELL, V16, P4733, DOI 10.1091/mbc.E05-02-0090	48	81	85	3	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6054	6066		10.1074/jbc.M113.537266	http://dx.doi.org/10.1074/jbc.M113.537266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24446434	Green Published, hybrid			2022-12-25	WOS:000332015500060
J	Jones, AM; Berkelmans, R				Jones, Alison M.; Berkelmans, Ray			Flood Impacts in Keppel Bay, Southern Great Barrier Reef in the Aftermath of Cyclonic Rainfall	PLOS ONE			English	Article							PHOTOSYSTEM-II HERBICIDES; SUSPENDED SEDIMENTS; CORAL RECRUITMENT; CLIMATE-CHANGE; WATER-QUALITY; SALINITY; EXPOSURE; LAGOON; FERTILIZATION; COMMUNITIES	In December 2010, the highest recorded Queensland rainfall associated with Tropical Cyclone 'Tasha' caused flooding of the Fitzroy River in Queensland, Australia. A massive flood plume inundated coral reefs lying 12 km offshore of the Central Queensland coast near Yeppoon and caused 40-100% mortality to coral fringing many of the islands of Keppel Bay down to a depth of similar to 8 m. The severity of coral mortality was influenced by the level of exposure to low salinity seawater as a result of the reef's distance from the flood plume and to a lesser extent, water depth and whether or not the reef faced the plume source. There was no evidence in this study of mortality resulting from pollutants derived from the nearby Fitzroy Catchment, at least in the short term, suggesting that during a major flood, the impact of low salinity on corals outweighs that of pollutants. Recovery of the reefs in Keppel Bay from the 2010/2011 Fitzroy River flood is likely to take 10-15 years based on historical recovery periods from a similar event in 1991; potentially impacting visitor numbers for tourism and recreational usage. In the meantime, activities like snorkeling, diving and coral viewing will be focused on the few shallow reefs that survived the flood, placing even further pressure on their recovery. Reef regeneration, restoration and rehabilitation are measures that may be needed to support tourism in the short term. However, predictions of a warming climate, lower rainfall and higher intensity summer rain events in the Central and Coastal regions of Australia over the next decade, combined with the current anthropogenic influences on water quality, are likely to slow regeneration with consequent impact on long-term reef resilience.	[Jones, Alison M.] Cent Queensland Univ, Rockhampton, Qld 4702, Australia; [Berkelmans, Ray] Townsville Mail Ctr, Australian Inst Marine Sci, Townsville, Qld, Australia	Central Queensland University; Australian Institute of Marine Science	Jones, AM (corresponding author), Cent Queensland Univ, Rockhampton, Qld 4702, Australia.	a.jones@cqu.edu.au	Jones, Alison/AAF-5530-2020		Centre for Environmental Management at Central Queensland University	Centre for Environmental Management at Central Queensland University	This study was made possible by funding provided by the Centre for Environmental Management at Central Queensland University and permitted by the Great Barrier Reef Marine Park Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2006, AUSTR BUR STAT QUEEN; ABS, 2011, AUSTR BUR STAT QUEEN; AIMS, 2011, AUSTR I MAR SCI SQUR; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2011, EXTREME WEATHER GREA; Ayling AL, 1998, EFFECTS DAINTREE RIV; Berkelmans R, 2012, CORAL REEFS, V31, P1103, DOI 10.1007/s00338-012-0930-z; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bostock H, 2006, 50 COOP RES CTR COAS; Brodie J, 2010, MAR FRESHWATER RES, V61, P651, DOI 10.1071/MF08030; Brown BE, 2002, MAR BIOL, V141, P21, DOI 10.1007/s00227-002-0810-0; Butler IR, 2013, CORAL REEFS, V32, P1149, DOI 10.1007/s00338-013-1064-7; Byron GT, 1992, WORKSH IMP FLOOD; Cantin NE, 2007, MAR ECOL PROG SER, V344, P81, DOI 10.3354/meps07059; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Furnas M., 2003, CATCHMENT CORALS TER; Gallant AJE, 2007, AUST METEOROL MAG, V56, P223; GBRMPA, 2013, VESS REG LEV GREAT B; GBRMPA, 2013, ENV MAN CHARG EMC DA; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harrington L, 2005, MAR POLLUT BULL, V51, P415, DOI 10.1016/j.marpolbul.2004.10.042; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Herzfeld M, 2006, 38 CRC COAST ZON EST; Heyward AJ, 2002, MAR ECOL PROG SER, V230, P113, DOI 10.3354/meps230113; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; IBISWorld, 2011, QUEENSL FLOODS EC IM; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones Alison M., 2011, Diversity, V3, P329, DOI 10.3390/d3030329; Jones R, 2005, MAR POLLUT BULL, V51, P495, DOI 10.1016/j.marpolbul.2005.06.027; Kennedy K, 2010, REEF RESC MAR MON PR; Kennedy K, 2012, MAR POLLUT BULL, V64, P1495, DOI 10.1016/j.marpolbul.2012.05.014; Kennedy K, 2012, MAR POLLUT BULL, V65, P292, DOI 10.1016/j.marpolbul.2011.10.029; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; LEWIS EL, 1980, IEEE J OCEANIC ENG, V5, P3, DOI 10.1109/JOE.1980.1145448; Magnusson M, 2010, MAR POLLUT BULL, V60, P1978, DOI 10.1016/j.marpolbul.2010.07.031; O'Neill JP, 1992, WORKSHOP SERIES, V17, P36; Packett B, 2007, P 5 AUSTR STREAM MAN, P294; Packett R, 2009, MAR POLLUT BULL, V58, P976, DOI 10.1016/j.marpolbul.2009.02.017; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; Roelfsema C, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3430107; Saltzer R, 2002, UNDERSTANDING GREAT; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Scott A, 2013, MAR ENVIRON RES, V92, P10, DOI 10.1016/j.marenvres.2013.08.001; Tamelander J, 2002, AMBIO, V31, P551, DOI 10.1639/0044-7447(2002)031[0551:CRFAMM]2.0.CO;2; Thompson A., 2011, REEF RESCUE MARINE P, P127; TISCHER W, 1977, BIOCHIM BIOPHYS ACTA, V460, P113, DOI 10.1016/0005-2728(77)90157-8; VanWoesik R, 1995, MAR ECOL PROG SER, V128, P261, DOI 10.3354/meps128261; Walsh KJE, 2004, CLIM DYNAM, V22, P47, DOI 10.1007/s00382-003-0362-0; Wolanski E, 1996, CONT SHELF RES, V16, P1437, DOI 10.1016/0278-4343(95)00087-9; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009	58	42	42	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84739	10.1371/journal.pone.0084739	http://dx.doi.org/10.1371/journal.pone.0084739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427294	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200034
J	Rao, C; Lin, SL; Ruan, WJ; Wen, H; Wu, DJ; Deng, H				Rao, Cui; Lin, Shan-Li; Ruan, Wen-Jing; Wen, Huan; Wu, Dan-Ju; Deng, Hong			High Expression of IGFBP7 in Fibroblasts Induced by Colorectal Cancer Cells Is Co-Regulated by TGF-beta and Wnt Signaling in a Smad2/3-Dvl2/3-Dependent Manner	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-7; EPITHELIAL-CELLS; PROSTATE-CANCER; CARCINOMA-CELLS; BREAST-CANCER; TUMOR STROMA; IN-SITU; INSULIN; CATENIN; IDENTIFICATION	Fibroblasts in the tumor microenvironment are a key determinant in cancer progression and may be a promising target for cancer therapy. Insulin-like growth factor binding protein 7 (IGFBP7) is known as a tumor suppressor in colorectal cancer (CRC). The present study investigated the inductive mechanism of IGFBP7 expression in fibroblasts by supernatant from the CRC cell line, SW620. The results showed that the expression of IGFBP7 was up-regulated in the fibroblasts when treated with SW620 supernatant and exogenous TGF-beta 1. The IGFBP7 induced by SW620 supernatant or TGF-beta 1 was partially inhibited by the TGF-beta 1 specific antibody AF and TGF-beta 1 receptor antagonist SB431542. The Wnt signaling-targeted genes, c-Myc, CCND1 and the proteins Dvl2/3, were all up-regulated in fibroblasts expressing high levels of IGFBP7, and the upregulation could be inhibited both by the Wnt signaling antagonist Dickkopf-1 (DKK1) and by the TGF-beta 1 receptor antagonist SB431542. In conclusion, CRC cells promote the high expression of IGFBP7 in fibroblasts, most likely through the co-regulation of TGF-beta and Wnt signaling in a Smad2/3-Dvl2/3 dependent manner. Taken together, these data suggest that the fibroblasts could be a novel therapeutic target in tumor therapy.	[Rao, Cui; Lin, Shan-Li; Ruan, Wen-Jing; Wen, Huan; Deng, Hong] Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Dan-Ju] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Deng, H (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China.	hongdeng@zju.edu.cn			Natural Science Foundation of Zhejiang Province [LY12H16027]; National Natural Science Foundation of China [30870971]; Major Program of the National Natural Science Foundation of China [81090420, 81090421]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of Zhejiang Province (LY12H16027), the National Natural Science Foundation of China (30870971) and the Major Program of the National Natural Science Foundation of China (81090420, 81090421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi K, 1996, CELL GROWTH DIFFER, V7, P1671; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; An W, 2012, ANN SURG ONCOL, V19, P3971, DOI 10.1245/s10434-012-2407-2; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Benatar T, 2012, BREAST CANCER RES TR, V133, P563, DOI 10.1007/s10549-011-1816-4; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Degeorges A, 1999, CANCER RES, V59, P2787; Denys H, 2008, CANCER LETT, V266, P263, DOI 10.1016/j.canlet.2008.02.068; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Georges RB, 2011, CANCER BIOL THER, V12, P69, DOI 10.4161/cbt.12.1.15719; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Guo Y, 2012, PHYSIOL RES, V61, P337, DOI 10.33549/physiolres.932289; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kim HA, 2012, J CLIN INVEST, V122, P3248, DOI 10.1172/JCI61216; Kishibe J, 2000, J BIOL CHEM, V275, P15321, DOI 10.1074/jbc.275.20.15321; Komatsu S, 2000, BIOCHEM BIOPH RES CO, V267, P109, DOI 10.1006/bbrc.1999.1937; Liu M, 2011, INT J CANCER, V129, P1795, DOI 10.1002/ijc.26116; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Mamidi A, 2012, CELL DEATH DIFFER, V19, P1689, DOI 10.1038/cdd.2012.50; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Okamura J, 2012, CANCER BIOL THER, V13, P148, DOI 10.4161/cbt.13.3.18695; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; Pen A, 2007, GLIA, V55, P559, DOI 10.1002/glia.20481; Pen A, 2011, CANCER BIOL THER, V12, P634, DOI 10.4161/cbt.12.7.17171; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Sato J, 1999, J CELL BIOCHEM, V75, P187, DOI 10.1002/(SICI)1097-4644(19991101)75:2<187::AID-JCB1>3.0.CO;2-R; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Seth A, 2003, ANTICANCER RES, V23, P2043; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sprenger CC, 1999, CANCER RES, V59, P2370; SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tomimaru Y, 2012, INT J CANCER, V130, P319, DOI 10.1002/ijc.25994; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wajapeyee N, 2009, MOL CANCER THER, V8, P3009, DOI 10.1158/1535-7163.MCT-09-0470; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908	51	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85340	10.1371/journal.pone.0085340	http://dx.doi.org/10.1371/journal.pone.0085340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427302	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200043
J	He, ZJ; Wang, XL; Wu, Y; Jia, J; Hu, YS; Yang, XJ; Li, JQ; Fan, MX; Zhang, L; Guo, JC; Leung, MCP				He, Zhijie; Wang, Xiaolou; Wu, Yi; Jia, Jie; Hu, Yongshan; Yang, Xiaojiao; Li, Jianqi; Fan, Mingxia; Zhang, Li; Guo, Jinchun; Leung, Mason C. P.			Treadmill Pre-Training Ameliorates Brain Edema in Ischemic Stroke via Down-Regulation of Aquaporin-4: An MRI Study in Rats	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; BARRIER DYSFUNCTION; TRANSGENIC MICE; GENE DELETION; BLOOD; EXPRESSION; INJURY; GLUTAMATE; ANGIOGENESIS; REPERFUSION	Objective: Treadmill pre-training can ameliorate blood brain barrier (BBB) dysfunction in ischemia-reperfusion injury, however, its role in ischemic brain edema remains unclear. This study assessed the neuroprotective effects induced by treadmill pre-training, particularly on brain edema in transient middle cerebral artery occluded model. Methods: Transient middle cerebral artery occlusion to induce stroke was performed on rats after 2 weeks of treadmill pre-training. Magnetic resonance imaging (MRI) was used to evaluate the dynamic impairment of cerebral edema after ischemia-reperfusion injury. In addition, measurements of wet and dry brain weight, Evans Blue assay and Garcia scores were performed to investigate the cerebral water content, BBB permeability and neurologic deficit, respectively. Moreover, during ischemia-reperfusion injury, the expression of Aquaporin 4 (AQP4) was detected using immunofluorescence and Western bloting analyses. Results: Treadmill pre-training improved the relative apparent diffusion coefficient (rADC) loss in the ipsilateral cortex and striatum at 1 hour and 2.5 hours after cerebral ischemia. In the treadmill pre-training group, T2W1 values of the ipsilateral cortex and striatum increased less at 7.5 hours, 1 day, and 2 days after stroke while the brain water content decreased at 2 days after ischemia. Regarding the BBB permeability, the semi-quantitative amount of contrast agent leakage of treadmill pre-training group significantly decreased. Less Evans Blue exudation was also observed in treadmill pre-training group at 2 days after stroke. In addition, treadmill pre-training mitigated the Garcia score deficits at 2 days after stroke. Immunofluorescence staining and Western blotting results showed a significant decrease in the expression of AQP4 after treadmill ischemia following pre-training. Conclusions: Treadmill pre-training may reduce cerebral edema and BBB dysfunction during cerebral ischemia/reperfusion injury via the down-regulation of AQP4.	[He, Zhijie; Wang, Xiaolou; Wu, Yi; Jia, Jie; Hu, Yongshan; Yang, Xiaojiao; Zhang, Li] Fudan Univ, Huashan Hosp, Dept Rehabil, Shanghai 200433, Peoples R China; [Li, Jianqi; Fan, Mingxia] E China Normal Univ, Dept Phys, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Hu, Yongshan; Guo, Jinchun] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Leung, Mason C. P.] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China	Fudan University; East China Normal University; Fudan University; Hong Kong Polytechnic University	Jia, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Rehabil, Shanghai 200433, Peoples R China.	shannonjj@126.com; jingchunguo@shmu.edu.cn			National Natural Science Foundation of China [81171855, 81171856, 81272169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study is supported by the National Natural Science Foundation of China (grant NO. 81171855, 81171856 and 81272169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Aoki K, 2003, ACTA NEUROPATHOL, V106, P121, DOI 10.1007/s00401-003-0709-y; Badaut J, 2007, PEDIATR RES, V62, P248, DOI 10.1203/PDR.0b013e3180db291b; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Ding YH, 2005, ACTA NEUROPATHOL, V109, P237, DOI 10.1007/s00401-004-0943-y; Francesca B, 2010, CURR NEUROPHARMACOL, V8, P92, DOI 10.2174/157015910791233132; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Guo M, 2008, NEUROSCIENCE, V151, P340, DOI 10.1016/j.neuroscience.2007.10.006; Guo M, 2008, J CEREBR BLOOD F MET, V28, P1422, DOI 10.1038/jcbfm.2008.29; Hoshi A, 2011, EXP NEUROL, V227, P89, DOI 10.1016/j.expneurol.2010.09.016; Huang CX, 2013, NEUROSCIENCE, V233, P139, DOI 10.1016/j.neuroscience.2012.12.046; Igarashi H, 2011, NEUROL SCI, V32, P113, DOI 10.1007/s10072-010-0431-1; Israeli D, 2011, INT J BIOL SCI, V7, P1; Jia J, 2010, EXP BRAIN RES, V204, P173, DOI 10.1007/s00221-010-2320-5; Jia J, 2009, LIFE SCI, V84, P505, DOI 10.1016/j.lfs.2009.01.015; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Liu XQ, 2008, J CEREBR BLOOD F MET, V28, P1898, DOI 10.1038/jcbfm.2008.83; Liu YQ, 2002, PEDIATR RES, V51, P25, DOI 10.1203/00006450-200201000-00007; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Phillips MD, 1999, NEUROIMAG CLIN N AM, V9, P41; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Stoll G, 2009, J CEREBR BLOOD F MET, V29, P331, DOI 10.1038/jcbfm.2008.129; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang Che-Chuan, 2010, BMC Pharmacology, V10, P11, DOI 10.1186/1471-2210-10-11; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zeng XN, 2007, MOL CELL NEUROSCI, V34, P34, DOI 10.1016/j.mcn.2006.09.008; Zhang F, 2010, MOLECULES, V15, P5246, DOI 10.3390/molecules15085246; Zhang F, 2010, INT J MOL SCI, V11, P2658, DOI 10.3390/ijms11072658; Zhang PY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-43	47	30	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84602	10.1371/journal.pone.0084602	http://dx.doi.org/10.1371/journal.pone.0084602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416250	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300030
J	Hedd, A; Montevecchi, WA; Phillips, RA; Fifield, DA				Hedd, April; Montevecchi, William A.; Phillips, Richard A.; Fifield, David A.			Seasonal Sexual Segregation by Monomorphic Sooty Shearwaters Puffinus griseus Reflects Different Reproductive Roles during the Pre-Laying Period	PLOS ONE			English	Article							TRANS-EQUATORIAL MIGRATION; PELAGIC SEABIRD; CORYS SHEARWATERS; FORAGING STRATEGIES; ROUND DISTRIBUTION; ACTIVITY PATTERNS; HABITAT USE; BEHAVIOR; ALBATROSSES; OCEAN	Tracking technology has revolutionized knowledge of seabird movements; yet, few studies have examined sex differences in distribution and behavior of small to medium-sized, sexually-monomorphic seabirds. Application of bird-borne geolocation-immersion loggers revealed seasonal segregation in the sexually-monomorphic Sooty Shearwater Puffinus griseus, mainly in the pre-laying period, when there were clear differences in reproductive roles. Shearwaters first returned to the Falkland Islands on 27 Sept +/- 8 d; males, on average, 8 d earlier than females. Prior to egg-laying, distribution at sea, colony attendance and behaviour depended on sex. Males foraged locally over the southern Patagonian Shelf and Burdwood Bank, spending mainly single days at sea and intervening nights in the burrow. Females, who flew for more of the day during this time, foraged in more distant areas of the northern Patagonian Shelf and Argentine Basin that were deeper, warmer and relatively more productive. Attendance of females at the colony was also more variable than that of males and, overall, males were present for significantly more of the pre-laying period (38 vs. 19% of time). Sex differences were reduced following egg-laying, with males and females using similar foraging areas and making trips of similar mean duration in incubation (7.6 +/- 2.7 d) and chick-rearing (1.4 +/- 1.3 d). Congruence continued into the non-breeding period, with both sexes showing similar patterns of activity and areas of occupancy in the NW Atlantic. Thus, seasonal changes in reproductive roles influenced patterns of sexual segregation; this occurred only early in the season, when male Sooty Shearwaters foraged locally, returning regularly to the colony to defend (or maintain) the burrow or the mate, while females concentrated on building resources for egg development in distant and relatively more productive waters.	[Hedd, April; Montevecchi, William A.; Fifield, David A.] Mem Univ Newfoundland, Dept Psychol, Cognit & Behav Ecol Program, St John, NF, Canada; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Memorial University Newfoundland; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hedd, A (corresponding author), Mem Univ Newfoundland, Dept Psychol, Cognit & Behav Ecol Program, St John, NF, Canada.	ahedd@mun.ca		Hedd, April/0000-0003-2222-2627	NSERC Discovery Grant; Government of Canada's Program for International Polar Year; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Canada's Program for International Polar Year; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was supported by an NSERC Discovery Grant and the Government of Canada's Program for International Polar Year to WAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bugoni L, 2011, J ORNITHOL, V152, P261, DOI 10.1007/s10336-010-0577-x; Campagna C, 2007, DEEP-SEA RES PT I, V54, P1792, DOI 10.1016/j.dsr.2007.06.006; Catry Paulo, 2005, P351; Catry T, 2009, MAR ECOL PROG SER, V391, P231, DOI 10.3354/meps07717; Copello S, 2011, MAR BIOL, V158, P1247, DOI 10.1007/s00227-011-1645-3; Croxall JP, 2002, AQUAT CONSERV, V12, P101, DOI 10.1002/aqc.480; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; FAO (Food and Agriculture Organization), 2010, FISH AQ STAT 2008; Fifield DA, 2013, ORNITHOL MO IN PRESS; Fraser GS, 2002, CONDOR, V104, P413, DOI 10.1650/0010-5422(2002)104[0413:MFDIPC]2.0.CO;2; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gaston AJ, 2011, MAR BIOL, V158, P1929, DOI 10.1007/s00227-011-1704-9; Gonzalez-Solis J, 2007, AQUAT CONSERV, V17, pS22, DOI 10.1002/aqc.911; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gonzalez-Solis Jacob, 2005, P92; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guilford T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033753; Harris MP, 2010, MAR BIOL, V157, P827, DOI 10.1007/s00227-009-1365-0; Hedd A, 2012, MAR ECOL PROG SER, V449, P277, DOI 10.3354/meps09538; Hill RD, 1994, ELEPHANT SEALS POPUL; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Mackley EK, 2010, MAR ECOL PROG SER, V406, P291, DOI 10.3354/meps08532; Magalhaes MC, 2008, MAR ECOL PROG SER, V359, P283, DOI 10.3354/meps07340; Navarro J, 2009, MAR ECOL PROG SER, V378, P259, DOI 10.3354/meps07880; Paiva VH, 2010, MAR BIOL, V157, P1385, DOI 10.1007/s00227-010-1417-5; Paiva VH, 2010, MAR ECOL PROG SER, V398, P259, DOI 10.3354/meps08319; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2011, MAR BIOL, V158, P2199, DOI 10.1007/s00227-011-1725-4; Phillips RA, 2009, MAR ECOL PROG SER, V391, P279, DOI 10.3354/meps08028; Pinet P, 2012, ANIM BEHAV, V83, P979, DOI 10.1016/j.anbehav.2012.01.019; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Rayner MJ, 2012, EMU, V112, P107, DOI 10.1071/MU11066; Rivas AL, 2006, CONT SHELF RES, V26, P703, DOI 10.1016/j.csr.2006.01.013; Rodhouse P. G., 1995, ICES Marine Science Symposia, V199, P425; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; Stauss C, 2012, MAR ECOL PROG SER, V457, P151, DOI 10.3354/meps09734; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Tranquilla LAM, 2013, MAR ECOL PROG SER, V472, P287, DOI 10.3354/meps10053; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Weimerskirch H, 2000, ECOLOGY, V81, P309, DOI 10.1890/0012-9658(2000)081[0309:SDIPIA]2.0.CO;2; Weimerskirch H, 1998, J ANIM ECOL, V67, P99, DOI 10.1046/j.1365-2656.1998.00180.x; Weimerskirch H, 1997, ECOLOGY, V78, P2051; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Welcker J, 2009, IBIS, V151, P502, DOI 10.1111/j.1474-919X.2009.00931.x; Woods R, 2006, IMPORTANT BIRD AREAS, P99; Yamamoto T, 2011, MAR ECOL PROG SER, V424, P191, DOI 10.3354/meps08973	55	50	52	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85572	10.1371/journal.pone.0085572	http://dx.doi.org/10.1371/journal.pone.0085572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416429	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000329866300090
J	Iqbal, MS; Rahman, M; Islam, R; Banik, A; Amin, MB; Akter, F; Talukder, KA				Iqbal, Mohd S.; Rahman, Mostafizur; Islam, Rafiad; Banik, Atanu; Amin, M. Badrul; Akter, Fatema; Talukder, Kaisar Ali			Plasmid-Mediated Sulfamethoxazole Resistance Encoded by the sul2 Gene in the Multidrug-Resistant Shigella flexneri 2a Isolated from Patients with Acute Diarrhea in Dhaka, Bangladesh	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; GENOTYPIC CHARACTERIZATION; STRAINS; SUSCEPTIBILITY; SONNEI; AZITHROMYCIN; SALMONELLA; PREVALENCE	In this study, mechanisms of plasmid-mediated sulfamethoxazole resistances in the clinical strains of multi-drug resistant (MDR) Shigella flexneri 2a were elucidated for the first time in Bangladesh. From 2006 to 2011, a total of 200 S. flexneri 2a strains were randomly selected from the stock of the Enteric and Food Microbiology Laboratory of icddr, b. Antimicrobial susceptibility of the strains showed 73%, 98%, 93%, 58%, 98%, 64% and 4% resistance to trimethoprim-sulfamethoxazole, nalidixic acid, ampicillin, erythromycin, tetracycline, ciprofloxacin and ceftriaxone respectively. Plasmid profiling revealed heterogeneous patterns and interestingly, all the trimethoprim-sulfamethoxazole resistant (SXTR) strains yielded a distinct 4.3 MDa plasmid compared to that of the trimethoprim-sulfamethoxazole susceptible (SXTS) strains. Curing of this 4.3 MDa plasmid resulted in the susceptibility to sulfamethoxazole alone suggesting the involvement of this plasmid in the resistance of sulfamethoxazole. Moreover, PCR analysis showed the presence of sul2 gene in SXTR strains which is absent in SXTS strains as well as in the 4.3 MDa plasmid-cured derivatives, confirming the involvement of sul2 in the resistance of sulfamethoxazole. Furthermore, pulsed-field gel electrophoresis (PFGE) analysis revealed that both the SXTR and SXTS strains were clonal. This study will significantly contributes to the knowledge on acquired drug resistance of the mostly prevalent S. flexneri 2a and further warrants continuous monitoring of the prevalence and correlation of this resistance determinants amongst the clinical isolates of Shigella and other enteric pathogens around the world to provide effective clinical management of the disease.	[Iqbal, Mohd S.; Rahman, Mostafizur; Islam, Rafiad; Banik, Atanu; Amin, M. Badrul; Akter, Fatema; Talukder, Kaisar Ali] Icddr B, Ctr Food & Waterborne Dis CFWD, Dhaka, Bangladesh; [Iqbal, Mohd S.] Icddr B, Ctr Control Chron Dis CCCD, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Iqbal, MS (corresponding author), Icddr B, Ctr Food & Waterborne Dis CFWD, Dhaka, Bangladesh.	msiqbal@icddrb.org	Islam, Rafiad/ABD-8068-2021	Islam, Rafiad/0000-0001-5039-6240; amin, mansour/0000-0003-4207-9522; Amin, Mohammed Badrul/0000-0002-7181-6432; Rahman, Md Mostafizur/0000-0002-7890-6342	icddr,b; Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	icddr,b; Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This study was funded by icddr,b (www.icddrb.org) and its donors which provide unrestricted support to icddr, b for its operations and research. Current donors providing unrestricted support include: Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The authors gratefully acknowledge these donors for their support and commitment to icddr, b research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes P, 2005, ANTIMICROB AGENTS CH, V49, P836, DOI 10.1128/AAC.49.2.836-839.2005; Barman S, 2010, INT J ANTIMICROB AG, V36, P348, DOI 10.1016/j.ijantimicag.2010.06.037; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Faiz M. A., 2011, Regional Health Forum, V15, P1; Ghosh S, 2011, J MED MICROBIOL, V60, P1460, DOI 10.1099/jmm.0.032920-0; HAIDER K, 1989, EPIDEMIOL INFECT, V102, P421, DOI 10.1017/S0950268800030132; Howie RL, 2010, MICROB DRUG RESIST, V16, P245, DOI 10.1089/mdr.2010.0028; Hu LF, 2011, INT J ANTIMICROB AG, V37, P230, DOI 10.1016/j.ijantimicag.2010.10.025; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Nigro SJ, 2011, J ANTIMICROB CHEMOTH, V66, P2175, DOI 10.1093/jac/dkr230; Rahman M, 2007, J HEALTH POPUL NUTR, V25, P158; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rowe-Magnus DA, 2002, MOL MICROBIOL, V43, P1657, DOI 10.1046/j.1365-2958.2002.02861.x; Schultsz C, 2012, DRUGS, V72, P1, DOI 10.2165/11597960-000000000-00000; Talukder KA, 2003, J CLIN MICROBIOL, V41, P110, DOI 10.1128/JCM.41.1.110-117.2003; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; Talukder KA, 2006, J MED MICROBIOL, V55, P1257, DOI 10.1099/jmm.0.46641-0; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; Vrints M, 2009, J CLIN MICROBIOL, V47, P1379, DOI 10.1128/JCM.02460-08	21	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85338	10.1371/journal.pone.0085338	http://dx.doi.org/10.1371/journal.pone.0085338			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416393	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300071
J	Khattar, M; Miyahara, Y; Schroder, PM; Xie, AN; Chen, WH; Stepkowski, SM				Khattar, Mithun; Miyahara, Yoshihiro; Schroder, Paul M.; Xie, Aini; Chen, Wenhao; Stepkowski, Stanislaw M.			Interleukin-21 Is a Critical Regulator of CD4 and CD8 T Cell Survival during Priming under Interleukin-2 Deprivation Conditions	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; IL-2 RECEPTOR; MICE; ACTIVATION; INDUCTION; TOLERANCE; RESPONSES; LOCUS; DIFFERENTIATION; AUTOIMMUNITY	Optimal T cell activation and expansion require binding of the common gamma-chain (gamma c) cytokine Interleukin-2 (IL-2) to its cognate receptor that in turn engages a gamma c/Janus tyrosine kinase (Jak) 3 signaling pathway. Because of its restricted expression by antigen-activated T cells and its obligatory role in promoting their survival and proliferation, IL-2 has been considered as a selective therapeutic target for preventing T cell mediated diseases. However, in order to further explore IL2 targeted therapy, it is critical to precisely understand its role during early events of T cell activation. In this study, we delineate the role of IL-2 and other gamma c cytokines in promoting the survival of CD4 and CD8 T cells during early phases of priming. Under IL-2 inhibitory conditions (by neutralizing anti-IL-2 mAbs), the survival of activated CD8(+) T cells was reduced, whereas CD4(+) T cells remained much more resistant. These results correlated with reduced Bcl-2 expression, and mitochondrial membrane potential in CD8(+) T cells in comparison to CD4(+) T cells. However, using transwell co-culture assays we have found that CD4(+) T cells could rescue the survival of CD8(+) T cells even under IL-2 deprived conditions via secretion of soluble factors. A cytokine screen performed on CD8+ T cells cultured alone revealed that IL-21, another cc cytokine, was capable of rescuing their survival under IL-2 deprivation. Indeed, blocking the IL-21 signaling pathway along with IL-2 neutralization resulted in significantly reduced survival of both CD4(+) and CD8+ T cells. Taken together, we have shown that under IL-2 deprivation conditions, IL-21 may act as the major survival factor promoting T cell immune responses. Thus, investigation of IL-2 targeted therapies may need to be revisited to consider blockade of the IL-21 signaling pathways as an adjunct to provide more effective control of T cell immune responses.	[Khattar, Mithun; Miyahara, Yoshihiro; Schroder, Paul M.; Stepkowski, Stanislaw M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, Toledo, OH 43606 USA; [Xie, Aini; Chen, Wenhao] Houston Methodist Res Inst, Transplant Immunol Ctr, Houston, TX USA	University System of Ohio; University of Toledo; The Methodist Hospital System; The Methodist Hospital - Houston	Stepkowski, SM (corresponding author), Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	Stanislaw.Stepkowski@utoledo.edu	Khattar, Mithun/AAD-4760-2020; Chen, Wenhao/J-6553-2019; Khattar, Mithun/O-4415-2014	Chen, Wenhao/0000-0002-0626-3739; Khattar, Mithun/0000-0002-4355-4623	National Institutes of Health [5RO1AI090244]; American Heart Association [11SDG7690000]; UT-Biomedical Science Innovation Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); UT-Biomedical Science Innovation Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the National Institutes of Health (grant number 5RO1AI090244), the American Heart Association (grant number 11SDG7690000) and the UT-Biomedical Science Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Borie DC, 2005, TRANSPLANTATION, V79, P791, DOI 10.1097/01.TP.0000157117.30290.6F; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Campara M, 2010, EXPERT OPIN BIOL TH, V10, P959, DOI 10.1517/14712598.2010.485187; Castro I, 2012, J IMMUNOL, V189, P4321, DOI 10.4049/jimmunol.1202067; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Guo ZY, 2013, J IMMUNOL, V190, P3153, DOI 10.4049/jimmunol.1200751; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Johnson LDS, 2009, SCIENCE, V324, P1525, DOI 10.1126/science.1176487; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Matarrese P, 2003, CELL DEATH DIFFER, V10, P609, DOI 10.1038/sj.cdd.4401212; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; McGuire HM, 2011, IMMUNITY, V34, P602, DOI 10.1016/j.immuni.2011.01.021; McGuire HM, 2011, DIABETES, V60, P867, DOI 10.2337/db10-1157; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Petrelli A, 2011, DIABETES, V60, P3223, DOI 10.2337/db11-0880; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Quaedackers ME, 2009, TRANSPLANTATION, V88, P1002, DOI 10.1097/TP.0b013e3181b9ced7; Rojas Monica A, 2009, Ther Adv Neurol Disord, V2, P291, DOI 10.1177/1756285609337992; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Spolski R, 2008, P NATL ACAD SCI USA, V105, P14028, DOI 10.1073/pnas.0804358105; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Stepkowski SM, 2005, J IMMUNOL, V175, P4236, DOI 10.4049/jimmunol.175.7.4236; Stepkowski SM, 2006, TRANSPLANTATION, V82, P295, DOI 10.1097/01.tp.0000228903.03118.be; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; Sutherland APR, 2009, DIABETES, V58, P1144, DOI 10.2337/db08-0882; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Wang GH, 2010, IMMUNOL LETT, V132, P61, DOI 10.1016/j.imlet.2010.06.001; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu AX, 2003, J IMMUNOL, V170, P236, DOI 10.4049/jimmunol.170.1.236; ZIER KS, 1984, DIABETES, V33, P552, DOI 10.2337/diabetes.33.6.552; ZURAWSKI SM, 1986, J IMMUNOL, V137, P3354; Zurgil N, 2002, BIOCHEM BIOPH RES CO, V290, P1573, DOI 10.1006/bbrc.2002.6382	56	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85882	10.1371/journal.pone.0085882	http://dx.doi.org/10.1371/journal.pone.0085882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416451	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300103
J	Liu, YJ; Yan, BB; Huang, ZY; Guo, R; Wu, JX; Liu, X; Yao, KQ; Lv, FJ; Deng, HS				Liu, Yijun; Yan, Bingbing; Huang, Ziyang; Guo, Rui; Wu, Jingxing; Liu, Xun; Yao, Kaiqing; Lv, Fajin; Deng, Huisheng			Feasibility and Safety of Fiber Optic Micro-Imaging in Canine Peripheral Airways	PLOS ONE			English	Article							BRONCHOSCOPY; DUCTOSCOPY; DIAGNOSIS	Purpose: To assess the feasibility and safety of imaging canine peripheral airways (<1 mm) with an experimental micro-imaging fiber optic bronchoscope. Methods: Twenty healthy dogs were scoped with a micro-imaging fiber optic bronchoscope (0.8 mm outer diameter). Images at various levels of the bronchioles, mucosal color, and tracheal secretions were recorded. The apparatus was stopped once it was difficult to insert. CT imaging was performed simultaneously to monitor progression. The safety of the device was evaluated by monitoring heart rate (HR), respiratory rate (RR), mean artery pressure (MAP), peripheral oxygen saturation (SpO(2)) and arterial blood gases (partial pressure of arterial carbon-dioxide, PaCO2, partial pressure of arterial oxygen, PaO2, and blood pH). Results: (1) According to the CT scan, the micro-imaging fiber was able to access the peripheral airways (<1 mm) in canines. (2) There was no significant change in the values of HR, MAP, pH and PaCO2 during the procedure (P > 0.05). Comparing pre-manipulation and post-manipulation values, SpO(2) (F = 13.06, P < 0.05) and PaO2 (F = 3.01, P = 0.01) were decreased, whereas RR (F = 3.85, P < 0.05) was elevated during the manipulation. (3) Self-limited bleeding was observed in one dog; severe bleeding or other complications did not occur. Conclusion: Although the new apparatus had little effect on SpO(2), PaO2 and RR, it can probe into small peripheral airways (<1 mm), which may provide a new platform for the early diagnosis of bronchiolar diseases.	[Liu, Yijun; Yan, Bingbing; Huang, Ziyang; Liu, Xun; Deng, Huisheng] Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing, Peoples R China; [Guo, Rui] Chongqing Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Chongqing, Peoples R China; [Yao, Kaiqing; Lv, Fajin] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China; [Wu, Jingxing] Chongqing Med Univ, Affiliated Hosp 1, Dept Resp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Deng, HS (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing, Peoples R China.	denghuisheng_2004@163.com			Chongqing Science & Technology Commission (CSTC) [2009ab5218]; National Nature Science Foundation of China [81201173]	Chongqing Science & Technology Commission (CSTC)(Natural Science Foundation Project of CQ CSTC); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chongqing Science & Technology Commission (CSTC, 2009ab5218) and the National Nature Science Foundation of China (No, 81201173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brims FJH, 2012, CLIN RESPIR J, V6, P144, DOI 10.1111/j.1752-699X.2011.00254.x; Chung Kian Fan, 2013, Cough, V9, P6, DOI 10.1186/1745-9974-9-6; Colby TV, 1998, AM J CLIN PATHOL, V109, P101; Eberhardt R, 2010, J THORAC ONCOL, V5, P1559, DOI 10.1097/JTO.0b013e3181e8b308; Kaneko M, 2010, JPN J CLIN ONCOL, V40, P838, DOI 10.1093/jjco/hyq136; Liu GY, 2008, BREAST CANCER RES TR, V108, P271, DOI 10.1007/s10549-007-9598-4; Lv JJ, 2013, RESP CARE, V58, P1637, DOI 10.4187/respcare.01982; Martin-Loeches I, 2012, MED INTENSIVA, V36, P644, DOI 10.1016/j.medin.2012.09.001; MEAD J, 1970, NEW ENGL J MED, V282, P1318, DOI 10.1056/NEJM197006042822311; Nair A, 2012, RADIOGRAPHICS, V32, pE201, DOI 10.1148/rg.325115133; O JH, 2007, J NUCL MED, V48, P15; Rice A, 2009, HISTOPATHOLOGY, V54, P117, DOI 10.1111/j.1365-2559.2008.03175.x; Rooney CP, 2002, RESPIRATION, V69, P63, DOI 10.1159/000049372; Ryu JH, 2006, CURR OPIN PULM MED, V12, P145, DOI 10.1097/01.mcp.0000208455.80725.2a; Ryu JH, 2003, AM J RESP CRIT CARE, V168, P1277, DOI 10.1164/rccm.200301-053SO; Simpson JS, 2009, CAN J SURG, V52, pE245; Sriram KB, 2011, FUTURE ONCOL, V7, P737, DOI [10.2217/fon.11.45, 10.2217/FON.11.45]; TANAKA M, 1988, CHEST, V93, P228, DOI 10.1378/chest.93.2.228	18	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84829	10.1371/journal.pone.0084829	http://dx.doi.org/10.1371/journal.pone.0084829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416294	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300038
J	Liu, ZQ; Li, T; Jiang, KS; Huang, QL; Chen, YC; Qian, F				Liu, Zhiqiang; Li, Tao; Jiang, Kesheng; Huang, Qiaoli; Chen, Yicheng; Qian, Feng			Induction of Chemoresistance by All-Trans Retinoic Acid via a Noncanonical Signaling in Multiple Myeloma Cells	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; AP-ENDONUCLEASE APE1/REF-1; DRUG-RESISTANCE GENE; UP-REGULATION; GROWTH-INHIBITION; BINDING PROTEIN; DOWN-REGULATION; DNA-DAMAGE; EXPRESSION; CREB	Despite the successful application of all-trans retinoic acid (ATRA) in multiple myeloma treatment, ATRA-induced chemoresistance in the myeloma patients is very common in clinic. In this study, we evaluated the effect of ATRA on the expression of apurinic endonuclease/redox factor-1 (Ape/Ref-1) in the U266 and RPMI-8226 myeloma cells to explore the chemoresistance mechanism involved. ATRA treatment induced upregulation of Ape/Ref-1 via a noncanonical signaling pathway, leading to enhanced pro-survival activity counteracting melphalan (an alkylating agent). ATRA rapidly activated p38-MSK (mitogen- and stress activated protein kinase) cascade to phosphorylate cAMP response element-binding protein (CREB). Phosphorylated CREB was recruited to the Ape/Ref-1 promoter to evoke the gene expression. The stimulation of ATRA on Ape/Ref-1 expression was attenuated by either p38-MSK inhibitors or overexpression of dominant-negative MSK1 mutants. Moreover, ATRA-mediated Ape/Ref-1 upregulation was correlated with histone modification and activation of CBP/p300, an important cofactors for CREB transcriptional activity. C646, a competitive CBP/p300 inhibitor, abolished the upregulation of Ape/Ref-1 induced by ATRA. Intriguingly, CBP rather than p300 played a dominant role in the expression of Ape/Ref-1. Hence, our study suggests the existence of a noncanonical mechanism involving p38-MSK-CREB cascade and CBP induction to mediate ATRA-induced Ape/Ref-1 expression and acquired chemoresistance in myeloma cells.	[Liu, Zhiqiang] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Div Canc Med, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Li, Tao; Jiang, Kesheng; Huang, Qiaoli] Zhejiang Normal Univ, Coll Chem & Life Sci, Dept Biol, Jinhua, Zhejiang, Peoples R China; [Chen, Yicheng] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [Qian, Feng] Yangtze Univ, Sch Med, Dept Med Funct, Jinzhou, Hubei, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Zhejiang Normal University; Zhejiang University; Yangtze University	Li, T (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Dept Biol, Jinhua, Zhejiang, Peoples R China.	litao@zjnu.cn	Liu, Zhiqiang/E-6950-2014	Liu, Zhiqiang/0000-0002-0677-8097	National Natural Sciences Foundation of China [31101057, 81101929]; Sciences Foundation of Jinhua City [2010-3-071]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Sciences Foundation of Jinhua City	This work was supported by the National Natural Sciences Foundation of China (31101057, 81101929), and the Sciences Foundation of Jinhua City (2010-3-071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Apostolatos H, 2010, J BIOL CHEM, V285, P25987, DOI 10.1074/jbc.M110.100735; BATES SE, 1989, MOL CELL BIOL, V9, P4337, DOI 10.1128/MCB.9.10.4337; Bjorklund CC, 2013, LEUKEMIA; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Chattopadhyay R, 2008, MOL CELL BIOL, V28, P7066, DOI 10.1128/MCB.00244-08; Chen YH, 1999, BLOOD, V94, P251, DOI 10.1182/blood.V94.1.251.413k42_251_259; De Genaro P, 2013, INVEST OPHTH VIS SCI, V54, P3143, DOI 10.1167/iovs.12-11049; Dietze EC, 2003, BIOCHEM BIOPH RES CO, V302, P841, DOI 10.1016/S0006-291X(03)00266-3; Falco P, 2007, EXPERT REV ANTICANC, V7, P945, DOI 10.1586/14737140.7.7.945; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Friedmann Y, 2006, MOL PHARMACOL, V70, P1395, DOI 10.1124/mol.106.022962; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Giltaire S, 2009, BRIT J DERMATOL, V160, P505, DOI 10.1111/j.1365-2133.2008.08960.x; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Grosch S, 1999, BIOCHEM BIOPH RES CO, V261, P859, DOI 10.1006/bbrc.1999.1125; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Huang HW, 2009, LEUKEMIA LYMPHOMA, V50, P966, DOI 10.1080/10428190902866724; Huang HW, 2009, EUR J HAEMATOL, V83, P191, DOI 10.1111/j.1600-0609.2009.01277.x; Kast RE, 2008, CANCER BIOL THER, V7, P1515, DOI 10.4161/cbt.7.10.6573; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Koskela K, 2004, LEUKEMIA LYMPHOMA, V45, P749, DOI 10.1080/10428190310001628158; Levy Y, 1996, CLIN EXP IMMUNOL, V104, P167, DOI 10.1046/j.1365-2249.1996.d01-637.x; Liu Z, 2013, ONCOGENE; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Matsushita H, 1998, BLOOD, V91, P2452, DOI 10.1182/blood.V91.7.2452.2452_2452_2458; Musto P, 1997, HAEMATOLOGICA, V82, P354; Okamura T, 1998, EXP HEMATOL, V26, P501; Oliveira AMM, 2006, BEHAV NEUROSCI, V120, P724, DOI 10.1037/0735-7044.120.3.724; Otsuki T, 2003, LEUKEMIA LYMPHOMA, V44, P1651, DOI 10.1080/1042819031000099652; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Saeki K, 2003, J LEUKOCYTE BIOL, V73, P673, DOI 10.1189/jlb.1002512; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Stromskaya TP, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-15; Tabe Y, 2006, BLOOD, V107, P1546, DOI 10.1182/blood-2004-10-4126; Tokura Y, 2002, LEUKEMIA RES, V26, P29, DOI 10.1016/S0145-2126(01)00094-7; Trocoli A, 2011, AUTOPHAGY, V7, P1108, DOI 10.4161/auto.7.10.16623; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Wong JC, 2012, J CELL BIOCHEM, V113, P3587, DOI 10.1002/jcb.24237; Xiong JJ, 2008, BIOSCI BIOTECH BIOCH, V72, P3206, DOI 10.1271/bbb.80415; Yang JL, 2010, J BIOL CHEM, V285, P28191, DOI 10.1074/jbc.M109.082883; Youn H, 2013, CANCER LETT, V331, P192, DOI 10.1016/j.canlet.2012.12.019; Zhang Ya-Ping, 2010, Zoological Research, V31, P1	45	8	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85571	10.1371/journal.pone.0085571	http://dx.doi.org/10.1371/journal.pone.0085571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416428	Green Submitted, gold, Green Published			2022-12-25	WOS:000329866300089
J	Zhang, LF; Zhang, YQ; Shi, XC; Zhang, Y; Deng, GH; Lalvani, A; Liu, XQ				Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Zhang, Yao; Deng, Guohua; Lalvani, Ajit; Liu, Xiaoqing			Utility of T-Cell Interferon-gamma Release Assays for Diagnosing Tuberculous Serositis: A Prospective Study in Beijing, China	PLOS ONE			English	Article							LINKED IMMUNOSPOT ASSAY; PLEURAL TUBERCULOSIS; LATENT TUBERCULOSIS; ELISPOT ASSAY; PERICARDITIS; RESPONSES; DISEASE; FLUID; AREA	Background: Diagnosis of tuberculous serositis remains a challenge. The aim of this study was to evaluate the diagnostic efficiency of T-SPOT.TB on serous effusion mononuclear cells (SEMC) for diagnosing tuberculous serositis in a high TB burden area. Methods: The present prospective study enrolled patients with suspected tuberculous serositis in a tertiary referral hospital in Beijing, China, to investigate the diagnostic sensitivity, specificity, predictive value (PV), and likelihood ratio(LR) of these tests. Clinical assessment, T-SPOT.TB on SEMC, and T-SPOT.TB on PBMC were performed. Test results were compared with the final confirmed diagnosis. Results: Of the 187 participants, 74 (39.6%) were microbiologically or clinically diagnosed as tuberculous serositis and 93(49.7%) were ruled out. The remaining 20 (10.7%) patients were clinically indeterminate and excluded from the final analysis. Compared to that on PBMC, T-SPOT.TB on SEMC showed higher sensitivity (91.9% vs 73.0%, P = 0.002), specificity (87.1% vs. 73.1%, P = 0.017), PPV (85.0% vs. 68.4%, P = 0.013), NPV (93.1% vs. 77.3%, P = 0.003), LR+ (7.12 vs. 2.72) and LR- (0.09 vs. 0.37), respectively. The frequencies of spot forming cells (SFCs) for T-SPOT.TB on SEMC were 636 per million SEMC (IQR, 143-3443) in patients with tuberculous serositis, which were 4.6-fold (IQR, 1.3-14.3) higher than those of PBMC. By ROC curve analysis, a cut-off value of 56 SFCs per million SEMC for T-SPOT.TB on SEMC showed a sensitivity of 90.5% and specificity of 89.2% for the diagnosis of tuberculous serositis. Conclusions: T-SPOT.TB on SEMC could be an accurate diagnostic method for tuberculous serositis in TB endemic settings. And 56 SFCs per million SEMC might be the optimal cut-off value to diagnose tuberculous serositis.	[Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Deng, Guohua; Liu, Xiaoqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China; [Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Deng, Guohua; Liu, Xiaoqing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Lifan; Zhang, Yao; Liu, Xiaoqing] Int Clin Epidemiol Network, Peking Union Med Coll, Clin Epidemiol Unit, Beijing, Peoples R China; [Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Dept Resp Med, Natl Heart & Lung Inst, London, England	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Imperial College London	Liu, XQ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China.	liuxqpumch@126.com		Lalvani, Ajit/0000-0002-2396-246X	Capital Medical Development Scientific Research Fund [2005-2030]; Applied Research of the Clinical Characteristics in Capital Project [Z111107058811105]	Capital Medical Development Scientific Research Fund; Applied Research of the Clinical Characteristics in Capital Project	This study was funded by grants from the Capital Medical Development Scientific Research Fund [2005-2030 to Xiaoqing Liu] and the Applied Research of the Clinical Characteristics in Capital Project [Z111107058811105 to Xiaoqing Liu]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IM, 2010, PLOS ONE, V5; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Ariga H, 2007, CLIN INFECT DIS, V45, P1559, DOI 10.1086/523591; Baba K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-35; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Bathoorn E, 2011, CLIN VACCINE IMMUNOL, V18, P874, DOI 10.1128/CVI.00031-11; Biglino A, 2008, INFECTION, V36, P601, DOI 10.1007/s15010-008-7402-y; Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Chegou NN, 2008, RESPIRATION, V76, P131, DOI 10.1159/000128575; Dheda K, 2009, EUR RESPIR J, V34, P1118, DOI 10.1183/09031936.00005309; Huo Fei-Fei, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P449; Janssens JP, 2007, EUR RESPIR J, V30, P722, DOI 10.1183/09031936.00028507; Jian-sheng H, 2000, CHINESE J TUBERCULOS, V23; Kobashi Y, 2010, SCAND J INFECT DIS, V42, P712, DOI 10.3109/00365541003705768; Lee LN, 2009, CLIN MICROBIOL INFEC, V15, P173, DOI 10.1111/j.1469-0691.2008.02655.x; Liao CH, 2009, J INFECTION, V59, P402, DOI 10.1016/j.jinf.2009.10.001; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Macaskill P, 2002, STAT MED, V21, P2527, DOI 10.1002/sim.1227; MacHin D, 2008, SAMPLE SIZE TABLES C, V3rd; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Ruan SY, 2012, THORAX, V67, P822, DOI 10.1136/thoraxjnl-2011-201363; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Souza MC, 2008, INFECT IMMUN, V76, P5686, DOI 10.1128/IAI.00133-08; TGGotFNTE Survey, 2012, CHINESE J ANTITUBERC, V34; Valdes L, 1996, CHEST, V109, P158, DOI 10.1378/chest.109.1.158; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139; Xi-rong W, 2012, CHINESE J EVIDENCE B, V07; Zhang Li-Fan, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P438	29	15	23	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85030	10.1371/journal.pone.0085030	http://dx.doi.org/10.1371/journal.pone.0085030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416336	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300048
J	Fu, RH; Harn, HJ; Liu, SP; Chen, CS; Chang, WL; Chen, YM; Huang, JE; Li, RJ; Tsai, SY; Hung, HS; Shyu, WC; Lin, SZ; Wang, YC				Fu, Ru-Huei; Harn, Horng-Jyh; Liu, Shih-Ping; Chen, Chang-Shi; Chang, Wen-Lin; Chen, Yue-Mi; Huang, Jing-En; Li, Rong-Jhu; Tsai, Sung-Yu; Hung, Huey-Shan; Shyu, Woei-Cherng; Lin, Shinn-Zong; Wang, Yu-Chi			n-Butylidenephthalide Protects against Dopaminergic Neuron Degeneration and alpha-Synuclein Accumulation in Caenorhabditis elegans Models of Parkinson's Disease	PLOS ONE			English	Article							LIGUSTICUM-CHUANXIONG; GENE-EXPRESSION; ANIMAL-MODELS; IN-VITRO; DYSFUNCTION; INHIBITION; APOPTOSIS; CELLS; NEUROINFLAMMATION; NEURODEGENERATION	Background: Parkinson's disease (PD) is the second most common degenerative disorder of the central nervous system that impairs motor skills and cognitive function. To date, the disease has no effective therapies. The identification of new drugs that provide benefit in arresting the decline seen in PD patients is the focus of much recent study. However, the lengthy time frame for the progression of neurodegeneration in PD increases both the time and cost of examining potential therapeutic compounds in mammalian models. An alternative is to first evaluate the efficacy of compounds in Caenorhabditis elegans models, which reduces examination time from months to days. n-Butylidenephthalide is the naturally-occurring component derived from the chloroform extract of Angelica sinensis. It has been shown to have antitumor and anti-inflammatory properties, but no reports have yet described the effects of n-butylidenephthalide on PD. The aim of this study was to assess the potential for n-butylidenephthalide to improve PD in C. elegans models. Methodology/Principal Findings: In the current study, we employed a pharmacological strain that expresses green fluorescent protein specifically in dopaminergic neurons (BZ555) and a transgenic strain that expresses human alpha-synuclein in muscle cells (OW13) to investigate the antiparkinsonian activities of n-butylidenephthalide. Our results demonstrate that in PD animal models, n-butylidenephthalide significantly attenuates dopaminergic neuron degeneration induced by 6-hydroxydopamine; reduces alpha-synuclein accumulation; recovers lipid content, food-sensing behavior, and dopamine levels; and prolongs life-span of 6-hydroxydopamine treatment, thus revealing its potential as a possible antiparkinsonian drug. n-Butylidenephthalide may exert its effects by blocking egl-1 expression to inhibit apoptosis pathways and by raising rpn-6 expression to enhance the activity of proteasomes. Conclusions/Significance: n-Butylidenephthalide may be one of the effective neuroprotective agents for PD.	[Fu, Ru-Huei; Chang, Wen-Lin; Chen, Yue-Mi; Huang, Jing-En; Li, Rong-Jhu; Tsai, Sung-Yu; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Fu, Ru-Huei; Liu, Shih-Ping; Hung, Huey-Shan; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Harn, Horng-Jyh] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Liu, Shih-Ping; Hung, Huey-Shan] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chen, Chang-Shi] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigang Hosp, Dept Neurosurg, Yunlin, Taiwan; [Lin, Shinn-Zong] China Med Univ, Tainan Municipal An Nan Hosp, Dept Neurosurg, Tainan, Taiwan; [Wang, Yu-Chi] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Cheng Kung University; China Medical University Taiwan; China Medical University Taiwan; Industrial Technology Research Institute - Taiwan	Fu, RH (corresponding author), China Med Univ, Grad Inst Immunol, Taichung, Taiwan.	rhfu@mail.cmu.edu.tw; yuchiw@itri.org.tw	Lin, Shinn-Zong/AAX-2379-2020; Chen, Chang-Shi/B-9251-2009	Chen, Chang-Shi/0000-0002-8201-3635; Fu, Ru-Huei/0000-0001-9367-1759; Liu, Shih-Ping/0000-0002-5803-4460	National Science Council in Taiwan [101-2314-B-039-010-MY2]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]; China Medical University [DMR-102-054]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence; China Medical University(China Medical University)	This work was supported by the National Science Council in Taiwan (101-2314-B-039-010-MY2), the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004) and China Medical University (DMR-102-054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Asikainen S, 2010, J MOL NEUROSCI, V41, P210, DOI 10.1007/s12031-009-9325-1; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI [DOI 10.1126/SCIENCE.282.5396.2028, DOI 10.1126/science.282.5396.2028]; Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; Binukumar BK, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-35; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; BRENNER S, 1974, GENETICS, V77, P71; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Caldwell KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007227; Cao PX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009312; Castro EMC, 2010, J NEURAL TRANSM, V117, P599, DOI 10.1007/s00702-010-0397-4; Chan SSK, 2006, EUR J PHARMACOL, V537, P111, DOI 10.1016/j.ejphar.2006.03.015; Chan SSK, 2009, J ETHNOPHARMACOL, V122, P308, DOI 10.1016/j.jep.2009.01.002; Charriaut-Marlangue C, 2004, THERAPIE, V59, P185, DOI 10.2515/therapie:2004035; Chen YL, 2008, MOL PHARMACOL, V74, P1046, DOI 10.1124/mol.107.044800; Chiu SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033742; Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333; Coelho M, 2012, NAT REV NEUROL, V8, P435, DOI 10.1038/nrneurol.2012.126; Collins LM, 2012, NEUROPHARMACOLOGY, V62, P2154, DOI 10.1016/j.neuropharm.2012.01.028; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; Du XX, 2012, NEUROSCI BULL, V28, P253, DOI 10.1007/s12264-012-1238-2; Etminan M, 2005, LANCET NEUROL, V4, P362, DOI 10.1016/S1474-4422(05)70097-1; Fu RH, 2013, NEUROPHARMACOLOGY, DOI [10.1016/j.neuropharm.2013.08.007, DOI 10.1016/J.NEUR0PHARM.2013.08.007]; Fu RH, 2011, BIOTECHNOL LETT, V33, P903, DOI 10.1007/s10529-011-0528-5; Fu RH, 2010, ACTA BIOMATER, V6, P3621, DOI 10.1016/j.actbio.2010.03.005; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Hansen C, 2012, TRENDS MOL MED, V18, P248, DOI 10.1016/j.molmed.2012.03.002; Harrington AJ, 2012, J NEUROSCI, V32, P2142, DOI 10.1523/JNEUROSCI.2606-11.2012; Harrington AJ, 2011, METHODS, V53, P220, DOI 10.1016/j.ymeth.2010.12.036; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hwang CK, 2012, BIOSCI BIOTECH BIOCH, V76, P536, DOI 10.1271/bbb.110842; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P605, DOI 10.1016/j.bbrc.2011.09.010; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P306, DOI 10.1016/j.bbrc.2011.08.092; Jankovic J, 2012, CURR OPIN NEUROL, V25, P433, DOI 10.1097/WCO.0b013e3283542fc2; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kim HG, 2012, BIOL PHARM BULL, V35, P1287, DOI 10.1248/bpb.b12-00127; Ko WC, 2002, PLANTA MED, V68, P1004, DOI 10.1055/s-2002-35671; Ko WC, 1998, J PHARM PHARMACOL, V50, P1365, DOI 10.1111/j.2042-7158.1998.tb03361.x; Ko WC, 1998, PLANTA MED, V64, P229, DOI 10.1055/s-2006-957415; KUMAR H, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/514095; Kuwahara T, 2006, J BIOL CHEM, V281, P334, DOI 10.1074/jbc.M504860200; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Liu ZH, 2011, HUM MOL GENET, V20, P3933, DOI 10.1093/hmg/ddr312; Locke CJ, 2008, NEUROSCI LETT, V439, P129, DOI 10.1016/j.neulet.2008.05.003; Lu JH, 2012, AUTOPHAGY, V8, P98, DOI 10.4161/auto.8.1.18313; Maccarrone M, 2011, BRIT J PHARMACOL, V163, P1379, DOI 10.1111/j.1476-5381.2011.01277.x; Martinez-Finley EJ, 2011, METALLOMICS, V3, P271, DOI 10.1039/c0mt00064g; MIMURA Y, 1995, BIOL PHARM BULL, V18, P1203; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Onishi Hiraku, 2005, Curr Drug Discov Technol, V2, P169, DOI 10.2174/1570163054866891; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; Pourkarimi E, 2012, CELL DEATH DIFFER, V19, P406, DOI 10.1038/cdd.2011.104; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Rogers J, 2007, INT REV NEUROBIOL, V82, P235, DOI 10.1016/S0074-7742(07)82012-5; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; Saw CLL, 2013, BIOPHARM DRUG DISPOS, V34, P303, DOI 10.1002/bdd.1846; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schreiber MA, 2011, NEUROSCI LETT, V498, P99, DOI 10.1016/j.neulet.2011.04.071; Sebastiao AM, 2013, NEUROPHARMACOLOGY, V64, P97, DOI 10.1016/j.neuropharm.2012.06.053; Shvadchak VV, 2011, FEBS LETT, V585, P3513, DOI 10.1016/j.febslet.2011.10.006; Slone SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021720; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; TENG CM, 1987, BIOCHIM BIOPHYS ACTA, V924, P375; Tsai NM, 2006, J NEUROCHEM, V99, P1251, DOI 10.1111/j.1471-4159.2006.04151.x; Tucci ML, 2011, METHODS MOL BIOL, V793, P129, DOI 10.1007/978-1-61779-328-8_9; Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206; van der Goot AT, 2012, P NATL ACAD SCI USA, V109, P14912, DOI 10.1073/pnas.1203083109; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; van Ham TJ, 2010, CELL, V142, P601, DOI 10.1016/j.cell.2010.07.020; Vidal-Gadea Andres G., 2012, Communicative & Integrative Biology, V5, P440; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Voisine C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000504; Wei CW, 2009, ACTA PHARMACOL SIN, V30, P1297, DOI 10.1038/aps.2009.124; Yacoubian TA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.4; Yang XL, 2012, J ETHNOPHARMACOL, V141, P41, DOI 10.1016/j.jep.2012.01.025; Yao C, 2010, NEUROBIOL DIS, V40, P73, DOI 10.1016/j.nbd.2010.04.002; Yeh JC, 2011, ANGIOGENESIS, V14, P187, DOI 10.1007/s10456-011-9202-8; Yi LZ, 2009, J CHROMATOGR A, V1216, P1991, DOI 10.1016/j.chroma.2008.07.033; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu ZL, 2011, MOL BIOL CELL, V22, P911, DOI 10.1091/mbc.E10-08-0655; Zbarsky V, 2005, FREE RADICAL RES, V39, P1119, DOI 10.1080/10715760500233113; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zheng MH, 2012, J NEUROSCI METH, V204, P234, DOI 10.1016/j.jneumeth.2011.11.015	96	52	55	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85305	10.1371/journal.pone.0085305	http://dx.doi.org/10.1371/journal.pone.0085305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416384	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500236
J	Scuteri, A; Donzelli, E; Rodriguez-Menendez, V; Ravasi, M; Monfrini, M; Bonandrini, B; Figliuzzi, M; Remuzzi, A; Tredici, G				Scuteri, Arianna; Donzelli, Elisabetta; Rodriguez-Menendez, Virginia; Ravasi, Maddalena; Monfrini, Marianna; Bonandrini, Barbara; Figliuzzi, Marina; Remuzzi, Andrea; Tredici, Giovanni			A Double Mechanism for the Mesenchymal Stem Cells' Positive Effect on Pancreatic Islets	PLOS ONE			English	Article							HUMAN BONE-MARROW; STROMAL CELLS; SURVIVAL; INSULIN; DIFFERENTIATION; TRANSPLANTATION; MOLECULES; THERAPY; EXPRESS; TISSUE	The clinical usability of pancreatic islet transplantation for the treatment of type I diabetes, despite some encouraging results, is currently hampered by the short lifespan of the transplanted tissue. In vivo studies have demonstrated that co-transplantation of Mesenchymal Stem Cells (MSCs) with transplanted pancreatic islets is more effective with respect to pancreatic islets alone in ensuring glycemia control in diabetic rats, but the molecular mechanisms of this action are still unclear. The aim of this study was to elucidate the molecular mechanisms of the positive effect of MSCs on pancreatic islet functionality by setting up direct, indirect and mixed co-cultures. MSCs were both able to prolong the survival of pancreatic islets, and to directly differentiate into an "insulin-releasing'' phenotype. Two distinct mechanisms mediated these effects: i) the survival increase was observed in pancreatic islets indirectly co-cultured with MSCs, probably mediated by the trophic factors released by MSCs; ii) MSCs in direct contact with pancreatic islets started to express Pdx1, a pivotal gene of insulin production, and then differentiated into insulin releasing cells. These results demonstrate that MSCs may be useful for potentiating pancreatic islets' functionality and feasibility.	[Scuteri, Arianna; Donzelli, Elisabetta; Rodriguez-Menendez, Virginia; Ravasi, Maddalena; Monfrini, Marianna; Tredici, Giovanni] Univ Milano Bicocca, Dipartimento Chirurg & Med Interdisciplinare, Monza, Italy; [Bonandrini, Barbara; Figliuzzi, Marina] IRCCS Ist Ric Farmacol Mario Negri, Dept Biomed Engn, Bergamo, Italy; [Remuzzi, Andrea] Univ Bergamo, Dept Ind Engn, Dalmine, BG, Italy	University of Milano-Bicocca; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Bergamo	Scuteri, A (corresponding author), Univ Milano Bicocca, Dipartimento Chirurg & Med Interdisciplinare, Monza, Italy.	arianna.scuteri@unimib.it	Scuteri, Arianna/L-4946-2016; Figliuzzi, Marina/ABB-6409-2020; Donzelli, Elisabetta/J-6837-2015; Remuzzi, Andrea/F-2409-2015	Scuteri, Arianna/0000-0003-0240-313X; Figliuzzi, Marina/0000-0002-3239-2585; Donzelli, Elisabetta/0000-0002-9495-4256; Remuzzi, Andrea/0000-0002-4301-8927	MIUR - FIRB Futuro in Ricerca [RBFR08VSVI_001]	MIUR - FIRB Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by MIUR - FIRB Futuro in Ricerca 2008 Prot. N<SUP>o</SUP> RBFR08VSVI_001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LB, 2004, WORLD J GASTROENTERO, V10, P3016; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Daoud JT, 2011, BIOMATERIALS, V32, P1536, DOI 10.1016/j.biomaterials.2010.10.036; Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007; Duprez IR, 2011, UPSALA J MED SCI, V116, P8, DOI 10.3109/03009734.2010.524320; Figliuzzi M, 2009, TRANSPL P, V41, P1797, DOI 10.1016/j.transproceed.2008.11.015; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Hou Y, 2009, DIABETES RES CLIN PR, V86, P11, DOI 10.1016/j.diabres.2009.07.010; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Jung EJ, 2011, CYTOTHERAPY, V13, P19, DOI 10.3109/14653249.2010.518608; Jurewicz M, 2010, DIABETES, V59, P3139, DOI 10.2337/db10-0542; Karaoz E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.14; Karaoz E, 2011, J TISSUE ENG REGEN M, V5, P491, DOI 10.1002/term.342; Ludwig B, 2010, CURR DIABETES REP, V10, P506, DOI 10.1007/s11892-010-0146-y; Marappagounder D, 2013, CELL MOL BIOL LETT, V18, P75, DOI 10.2478/s11658-012-0040-5; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Remuzzi A, 2009, DIABETOLOGIA, V52, P2653, DOI 10.1007/s00125-009-1537-y; Rezende LF, 2007, J ENDOCRINOL, V195, P157, DOI 10.1677/JOE-07-0016; Rossignol J, 2011, BEHAV BRAIN RES, V217, P369, DOI 10.1016/j.bbr.2010.11.006; Ryan EA, 2006, DIABETES OBES METAB, V8, P1, DOI 10.1111/j.1463-1326.2004.00460.x; Sakata N, 2010, TRANSPLANTATION, V89, P686, DOI 10.1097/TP.0b013e3181cb3e8d; Satija NK, 2009, J CELL MOL MED, V13, P4385, DOI 10.1111/j.1582-4934.2009.00857.x; Scuteri A, 2011, NEUROSCIENCE, V172, P12, DOI 10.1016/j.neuroscience.2010.10.065; Scuteri A, 2006, BRAIN RES, V1116, P75, DOI 10.1016/j.brainres.2006.07.127; Solari MG, 2009, J AUTOIMMUN, V32, P116, DOI 10.1016/j.jaut.2009.01.003; Wang QW, 2012, AM J STEM CELLS, V1, P128; Yuan HJ, 2012, MOL BIOL REP, V39, P7777, DOI 10.1007/s11033-012-1619-7; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	32	41	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84309	10.1371/journal.pone.0084309	http://dx.doi.org/10.1371/journal.pone.0084309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416216	Green Published, gold			2022-12-25	WOS:000329862500114
J	Simon, TD; Pope, CE; Browd, SR; Ojemann, JG; Riva-Cambrin, J; Mayer-Hamblett, N; Rosenfeld, M; Zerr, DM; Hoffman, L				Simon, Tamara D.; Pope, Christopher E.; Browd, Samuel R.; Ojemann, Jeffrey G.; Riva-Cambrin, Jay; Mayer-Hamblett, Nicole; Rosenfeld, Margaret; Zerr, Danielle M.; Hoffman, Lucas			Evaluation of Microbial Bacterial and Fungal Diversity in Cerebrospinal Fluid Shunt Infection	PLOS ONE			English	Article							VENTRICULOPERITONEAL SHUNTS; CLINICAL MICROBIOLOGY; CHRONIC WOUNDS; MANAGEMENT; IDENTIFICATION; HYDROCEPHALUS; BIOFILMS; PATHOGENICITY; EXPERIENCE; CHILDREN	Background: Cerebrospinal fluid shunt infection can be recalcitrant. Recurrence is common despite appropriate therapy for the pathogens identified by culture. Improved diagnostic and therapeutic approaches are required, and culture-independent molecular approaches to cerebrospinal fluid shunt infections have not been described. Objectives: To identify the bacteria and fungi present in cerebrospinal fluid from children with cerebrospinal fluid shunt infection using a high-throughput sequencing approach, and to compare those results to those from negative controls and conventional culture. Methods: This descriptive study included eight children <= 18 years old undergoing treatment for culture-identified cerebrospinal fluid shunt infection. After routine aerobic culture of each cerebrospinal fluid sample, deoxyribonucleic acid (DNA) extraction was followed by amplification of the bacterial 16S rRNA gene and the fungal ITS DNA region tag-encoded FLX-Titanium amplicon pyrosequencing and microbial phylogenetic analysis. Results: The microbiota analyses for the initial cerebrospinal fluid samples from all eight infections identified a variety of bacteria and fungi, many of which did not grow in conventional culture. Detection by conventional culture did not predict the relative abundance of an organism by pyrosequencing, but in all cases, at least one bacterial taxon was detected by both conventional culture and pyrosequencing. Individual bacterial species fluctuated in relative abundance but remained above the limits of detection during infection treatment. Conclusions: Numerous bacterial and fungal organisms were detected in these cerebrospinal fluid shunt infections, even during and after treatment, indicating diverse and recalcitrant shunt microbiota. In evaluating cerebrospinal fluid shunt infection, fungal and anaerobic bacterial cultures should be considered in addition to aerobic bacterial cultures, and culture-independent approaches offer a promising alternative diagnostic approach. More effective treatment of cerebrospinal fluid shunt infections is needed to reduce unacceptably high rates of reinfection, and this work suggests that one effective strategy may be reduction of the diverse microbiota present in infection.	[Simon, Tamara D.; Pope, Christopher E.; Mayer-Hamblett, Nicole; Rosenfeld, Margaret; Zerr, Danielle M.; Hoffman, Lucas] Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Simon, Tamara D.; Mayer-Hamblett, Nicole; Rosenfeld, Margaret; Zerr, Danielle M.; Hoffman, Lucas] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Seattle, WA USA; [Browd, Samuel R.; Ojemann, Jeffrey G.] Univ Washington, Dept Neurol Surg, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Riva-Cambrin, Jay] Univ Utah, Primary Childrens Med Ctr, Div Pediat Neurosurg, Dept Neurosurg, Salt Lake City, UT USA; [Hoffman, Lucas] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Hoffman, Lucas] Seattle Childrens Res Inst, Ctr Infect & Prematur Res, Seattle, WA USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Simon, TD (corresponding author), Univ Washington, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA.	Tamara.Simon@seattlechildrens.org	Hoffman, Lucas/AAX-1853-2021	Rosenfeld, Margaret/0000-0002-8105-614X; Ojemann, Jeffrey/0000-0001-7580-8934	Seattle Children's Center for Clinical and Translational Research; CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [ULI RR025014]; STARS-kids; Clinical and Translational Science Award (CTSA) pilot funds at the University of Utah; CTSA from the NCRR [ULI RR025014]; National Institute of Neurological Disorders And Stroke [K23NS062900]; Children's Hospital Association via the Pediatric Research in Inpatient Setting Network Executive Council; NIH [1R01HL098084, 1K02HL105543]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL105543, R01HL098084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS062900] Funding Source: NIH RePORTER	Seattle Children's Center for Clinical and Translational Research; CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); STARS-kids; Clinical and Translational Science Award (CTSA) pilot funds at the University of Utah; CTSA from the NCRR; National Institute of Neurological Disorders And Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Children's Hospital Association via the Pediatric Research in Inpatient Setting Network Executive Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This publication was supported by Seattle Children's Center for Clinical and Translational Research, and CTSA Grant Number ULI RR025014 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). Collection of CSF specimens from patients was supported by STARS-kids, Clinical and Translational Science Award (CTSA) pilot funds at the University of Utah, Seattle Children's Center for Clinical and Translational Research, and CTSA Grant Number ULI RR025014 from the NCRR. TDS is supported by Award K23NS062900 from the National Institute of Neurological Disorders And Stroke, the Children's Hospital Association via the Pediatric Research in Inpatient Setting Network Executive Council, and Seattle Children's Center for Clinical and Translational Research. LH is supported by NIH grants 1R01HL098084 and 1K02HL105543. None of the sponsors participated in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NCRR or NIH.	Bayston R, 2012, ANTIMICROB AGENTS CH, V56, P2842, DOI 10.1128/AAC.06326-11; CHIOU CC, 1994, CLIN INFECT DIS, V19, P1049, DOI 10.1093/clinids/19.6.1049; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; FANHAVARD P, 1987, CLIN PHARMACY, V6, P866; Fux CA, 2006, CLIN MICROBIOL INFEC, V12, P331, DOI 10.1111/j.1469-0691.2006.01361.x; Gardner P, 1988, Curr Clin Top Infect Dis, V9, P185; GARDNER P, 1985, MED CLIN N AM, V69, P297; GUEVARA JA, 1987, J NEUROSURG, V67, P438, DOI 10.3171/jns.1987.67.3.0438; Han A, 2011, WOUND REPAIR REGEN, V19, P532, DOI 10.1111/j.1524-475X.2011.00720.x; He ZG, 2007, APPL ENVIRON MICROB, V73, P168, DOI 10.1128/AEM.02023-06; Kanev PM, 2003, PEDIATR NEUROSURG, V39, P285, DOI 10.1159/000075255; Kestle JRW, 2006, J NEUROSURG, V105, P177, DOI 10.3171/ped.2006.105.3.177; Kestle JRW, 2003, NEUROL CLIN, V21, P883, DOI 10.1016/S0733-8619(03)00016-1; Kulkarni AV, 2001, PEDIATR NEUROSURG, V35, P66, DOI 10.1159/000050393; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; MORISSETTE I, 1993, CAN J NEUROL SCI, V20, P118, DOI 10.1017/S0317167100047661; NELSON JD, 1984, PEDIATR INFECT DIS J, V3, pS30, DOI 10.1097/00006454-198405001-00011; ODIO C, 1984, AM J DIS CHILD, V138, P1103, DOI 10.1001/archpedi.1984.02140500009004; Rhoads DD, 2012, INT J MOL SCI, V13, P2535, DOI 10.3390/ijms13032535; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; SELLS CJ, 1977, PEDIATRICS, V59, P614; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI 10.2217/FMB.10.127; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Tuan TJ, 2011, PEDIATR INFECT DIS J, V30, P731, DOI 10.1097/INF.0b013e318218ac0e; Venes J L, 1989, Infect Dis Clin North Am, V3, P289; Vinchon M, 2006, CHILD NERV SYST, V22, P692, DOI 10.1007/s00381-005-0037-8; WALTERS BC, 1984, J NEUROSURG, V60, P1014, DOI 10.3171/jns.1984.60.5.1014; Williams MA, 2007, J NEUROSURG, V107, P345, DOI 10.3171/PED-07/11/345; YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548	32	8	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83229	10.1371/journal.pone.0083229	http://dx.doi.org/10.1371/journal.pone.0083229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421877	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500037
J	Sovada, MA; Igl, LD; Pietz, PJ; Bartos, AJ				Sovada, Marsha A.; Igl, Lawrence D.; Pietz, Pamela J.; Bartos, Alisa J.			Influence of Climate Change on Productivity of American White Pelicans, Pelecanus erythrorhynchos	PLOS ONE			English	Article							NATIONAL-WILDLIFE-REFUGE; LONG-TERM; TIGER SALAMANDERS; PRAIRIE WETLANDS; NORTH-DAKOTA; PHENOLOGY; YOUNG; CONSEQUENCES; MISMATCH; WEATHER	In the past decade, severe weather and West Nile virus were major causes of chick mortality at American white pelican (Pelecanus erythrorhynchos) colonies in the northern plains of North America. At one of these colonies, Chase Lake National Wildlife Refuge in North Dakota, spring arrival by pelicans has advanced approximately 16 days over a period of 44 years (1965-2008). We examined phenology patterns of pelicans and timing of inclement weather through the 44-year period, and evaluated the consequence of earlier breeding relative to weather-related chick mortality. We found severe weather patterns to be random through time, rather than concurrently shifting with the advanced arrival of pelicans. In recent years, if nest initiations had followed the phenology patterns of 1965 (i.e., nesting initiated 16 days later), fewer chicks likely would have died from weather-related causes. That is, there would be fewer chicks exposed to severe weather during a vulnerable transition period that occurs between the stage when chicks are being brooded by adults and the stage when chicks from multiple nests become part of a thermally protective creche.	[Sovada, Marsha A.; Igl, Lawrence D.; Pietz, Pamela J.; Bartos, Alisa J.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA	United States Department of the Interior; United States Geological Survey	Sovada, MA (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA.	msovada@usgs.gov	Igl, Lawrence D./ABG-5135-2021	Igl, Lawrence D./0000-0003-0530-7266	US Geological Survey's Northern Prairie Wildlife Research Center, the North Dakota Game and Fish Department; South Dakota Game, Fish and Parks Department through State Wildlife Grant [T-27-R]	US Geological Survey's Northern Prairie Wildlife Research Center, the North Dakota Game and Fish Department; South Dakota Game, Fish and Parks Department through State Wildlife Grant	Funding for this study was provided by US Geological Survey's Northern Prairie Wildlife Research Center, the North Dakota Game and Fish Department; and the South Dakota Game, Fish and Parks Department through State Wildlife Grant T-27-R, Study 2427 (administered by the US Fish and Wildlife Service). The outside funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CL, 1999, CONDOR, V101, P832, DOI 10.2307/1370071; BARTHOLOMEW GA, 1953, ECOLOGY, V34, P554, DOI 10.2307/1929727; Benoy GA, 2008, WETLANDS, V28, P464, DOI 10.1672/07-07.1; Bluemle JP, 1991, FACE N DAKOTA; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; DEUTSCHMAN MR, 1988, CAN J FISH AQUAT SCI, V45, P691, DOI 10.1139/f88-083; DIEM KL, 1994, COLON WATERBIRD, V17, P130, DOI 10.2307/1521291; Drever MC, 2007, J ANIM ECOL, V76, P139, DOI 10.1111/j.1365-2656.2006.01183.x; Dunbar DL, 1982, BREEDING ECOLOGY MAN; Dunnell KL, 2011, AM J BOT, V98, P935, DOI 10.3732/ajb.1000363; EVANS RM, 1984, CAN J ZOOL, V62, P808, DOI 10.1139/z84-117; EVANS RM, 1985, CONDOR, V87, P252, DOI 10.2307/1366890; EVANS RM, 1984, CAN J ZOOL, V62, P814, DOI 10.1139/z84-118; EVANS RM, 1994, BEHAVIOUR, V129, P13, DOI 10.1163/156853994X00334; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Gordo O, 2006, GLOBAL CHANGE BIOL, V12, P1993, DOI 10.1111/j.1365-2486.2006.01178.x; Higgins K.F., 1980, Prairie Naturalist, V12, P89; Institute SAS, 2010, SAS ONLINEDOC 9 2; JOHNSON RF, 1978, WILSON BULL, V90, P346; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; King DT, 2005, WATERBIRDS, V28, P48, DOI 10.1675/1524-4695(2005)28[48:RPSOTA]2.0.CO;2; Knopf F.L., 2004, BIRDS N AM, P1; Larson D.L., 1998, STATUS TRENDS NATION, V2, P450; LARSON DL, 1994, AM MIDL NAT, V131, P330, DOI 10.2307/2426259; Le Bohec C, 2005, ANIM BEHAV, V70, P527, DOI 10.1016/j.anbehav.2004.11.012; Lehikoinen A, 2009, OIKOS, V118, P829, DOI 10.1111/j.1600-0706.2008.17440.x; Lingle GR, 1977, FOOD HABITS SEXING A; Ludwig GX, 2006, P ROY SOC B-BIOL SCI, V273, P2009, DOI 10.1098/rspb.2006.3538; Madden EM, 2005, WATERBIRDS, V28, P23, DOI 10.1675/1524-4695(2005)28[23:HABEOT]2.0.CO;2; Murphy-Klassen HM, 2005, AUK, V122, P1130, DOI 10.1642/0004-8038(2005)122[1130:LTISAD]2.0.CO;2; Niemuth ND, 2010, WETLANDS, V30, P1053, DOI 10.1007/s13157-010-0111-1; POIANI KA, 1991, BIOSCIENCE, V41, P611, DOI 10.2307/1311698; POIANI KA, 1993, CLIMATIC CHANGE, V24, P213, DOI 10.1007/BF01091830; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; SCHALLER GEORGE B., 1964, CONDOR, V66, P3, DOI 10.2307/1365232; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; SIDLE J G, 1984, Prairie Naturalist, V16, P131; Skagen SK, 2012, ECOL APPL, V22, P1131, DOI 10.1890/11-0291.1; Sovada MA, 2005, WATERBIRDS, V28, P27, DOI 10.1675/1524-4695(2005)28[27:HACSOT]2.0.CO;2; Sovada MA, 2013, 20135105 US DEP INT, P117; Sovada MA, 2008, BIOL CONSERV, V141, P1021, DOI 10.1016/j.biocon.2008.01.019; Strait LE, 1973, THESIS MICHIGAN TECH; Todhunter PE, 1993, P N DAK ACAD SCI, V47, P5; Tourenq C, 1995, COLON WATERBIRD, V18, P216, DOI 10.2307/1521484; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	47	6	6	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83430	10.1371/journal.pone.0083430	http://dx.doi.org/10.1371/journal.pone.0083430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416165	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500047
J	van Harmelen, AL; Hauber, K; Moor, BG; Spinhoven, P; Boon, AE; Crone, EA; Elzinga, BM				van Harmelen, Anne-Laura; Hauber, Kirsten; Moor, Bregtje Gunther; Spinhoven, Philip; Boon, Albert E.; Crone, Eveline A.; Elzinga, Bernet M.			Childhood Emotional Maltreatment Severity Is Associated with Dorsal Medial Prefrontal Cortex Responsivity to Social Exclusion in Young Adults	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; PEER REJECTION; SELF-ESTEEM; OSTRACISM; STRESS; ADOLESCENTS; DEPRESSION; BRAIN; ABUSE; RISK	Children who have experienced chronic parental rejection and exclusion during childhood, as is the case in childhood emotional maltreatment, may become especially sensitive to social exclusion. This study investigated the neural and emotional responses to social exclusion (with the Cyberball task) in young adults reporting childhood emotional maltreatment. Using functional magnetic resonance imaging, we investigated brain responses and self-reported distress to social exclusion in 46 young adult patients and healthy controls (mean age = 19.2 +/- 2.16) reporting low to extreme childhood emotional maltreatment. Consistent with prior studies, social exclusion was associated with activity in the ventral medial prefrontal cortex and posterior cingulate cortex. In addition, severity of childhood emotional maltreatment was positively associated with increased dorsal medial prefrontal cortex responsivity to social exclusion. The dorsal medial prefrontal cortex plays a crucial role in self-and other-referential processing, suggesting that the more individuals have been rejected and maltreated in childhood, the more self-and other-processing is elicited by social exclusion in adulthood. Negative self-referential thinking, in itself, enhances cognitive vulnerability for the development of psychiatric disorders. Therefore, our findings may underlie the emotional and behavioural difficulties that have been reported in adults reporting childhood emotional maltreatment.	[van Harmelen, Anne-Laura; Moor, Bregtje Gunther; Spinhoven, Philip; Crone, Eveline A.; Elzinga, Bernet M.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van Harmelen, Anne-Laura; Moor, Bregtje Gunther; Spinhoven, Philip; Crone, Eveline A.; Elzinga, Bernet M.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [van Harmelen, Anne-Laura] Univ Cambridge, Dept Dev Psychiat, Cambridge, England; [Hauber, Kirsten] Youth Mental Hlth Care Ctr, The Hague, Netherlands; [Spinhoven, Philip] Leiden Univ Med Ctr, Dept Psychiat, Leiden, Netherlands; [Boon, Albert E.] Ctr Orthopsychiat & Forens Youth Psychiat, Fjord Lucertis, Capelle Aan Den IJssel, Netherlands; [Boon, Albert E.] Curium Leiden Univ Med Ctr, Dept Child & Adolescent Psychiat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Cambridge; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	van Harmelen, AL (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	avanharmelen@gmail.com		Crone, Eveline/0000-0002-7508-6078; van Harmelen, Anne-Laura/0000-0003-1108-2921; Boon, Albert/0000-0001-8667-6930	VIDI grant [016N085N353]; Netherlands Wetenschaps Organisatie (NWO)	VIDI grant; Netherlands Wetenschaps Organisatie (NWO)	This work was supported by a VIDI grant (grant number 016N085N353) awarded by the Netherlands Wetenschaps Organisatie (NWO) to the principal investigator BME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MANUAL CHILD BEHAV C; APSAC APS on the A of C, 1995, GUID PSYCH EV SUSP P; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Arntz A., 1996, JEUGD TRAUMA VRAGENL; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blair KS, 2012, BIOL PSYCHIAT, V72, P476, DOI 10.1016/j.biopsych.2012.04.013; Bolling DZ, 2011, DEV COGN NEUROS-NETH, V1, P280, DOI 10.1016/j.dcn.2011.02.002; Boyes ME, 2009, PERS INDIV DIFFER, V47, P396, DOI 10.1016/j.paid.2009.04.005; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Burklund LJ, 2007, SOC NEUROSCI-UK, V2, P238, DOI 10.1080/17470910701391711; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; DeWall CN, 2012, SOC COGN AFFECT NEUR, V7, P184, DOI 10.1093/scan/nsq107; DeWall CN, 2011, CURR DIR PSYCHOL SCI, V20, P256, DOI 10.1177/0963721411417545; Duijsens IJ, 1996, PERS INDIV DIFFER, V20, P171, DOI 10.1016/0191-8869(95)00161-1; Egeland B, 2009, CHILD ABUSE NEGLECT, V33, P22, DOI 10.1016/j.chiabu.2008.12.004; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; First MB., 1997, USERS GUIDE STRUCTUR; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Iffland B, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-49; Lemogne C, 2009, SOC COGN AFFECT NEUR, V4, P305, DOI 10.1093/scan/nsp008; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Masten CL, 2011, DEV PSYCHOPATHOL, V23, P283, DOI 10.1017/S0954579410000799; Masten CL, 2010, SOC NEUROSCI-UK, V5, P496, DOI 10.1080/17470919.2010.490673; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; Meyer ML, 2012, SOC COGN AFFECT NEUR; Moor BG, 2012, NEUROIMAGE, V59, P708, DOI 10.1016/j.neuroimage.2011.07.028; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosenbach C, 2011, VERHALTENSTHERAPIE, V21, P87, DOI 10.1159/000328839; Sanchez MM, 2007, MOL PSYCHIATR, V12, P895, DOI 10.1038/sj.mp.4002025; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sebastian C, 2010, BRAIN COGNITION, V72, P134, DOI 10.1016/j.bandc.2009.06.008; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Sebastian CL, 2011, NEUROIMAGE, V57, P686, DOI 10.1016/j.neuroimage.2010.09.063; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Spinhoven P, 2010, J AFFECT DISORDERS, V126, P103, DOI 10.1016/j.jad.2010.02.132; Spitzer RL, 1990, STRUCTURED CLIN INTE; Themanson JR, 2012, SOC COGN AFFECT NEUR, P1; Thombs BD, 2009, CHILD ABUSE NEGLECT, V33, P518, DOI 10.1016/j.chiabu.2009.03.001; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; Tonmyr L, 2011, CHILD ABUSE NEGLECT, V35, P767, DOI 10.1016/j.chiabu.2011.04.011; Trickett PK, 2009, CHILD ABUSE NEGLECT, V33, P27, DOI 10.1016/j.chiabu.2008.12.003; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; van Harmelen AL, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.7336; van Harmelen AL, 2010, BIOL PSYCHIAT, V68, P832, DOI 10.1016/j.biopsych.2010.06.011; van Harmelen AL, 2010, BEHAV RES THER, V48, P486, DOI 10.1016/j.brat.2010.02.003; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Weschler D., 1991, WECHSLER INTELLIGENC; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Yoshimura S, 2009, BRAIN COGNITION, V69, P218, DOI 10.1016/j.bandc.2008.07.010; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	69	66	66	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85107	10.1371/journal.pone.0085107	http://dx.doi.org/10.1371/journal.pone.0085107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416347	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500216
J	Willemoes, M; Strandberg, R; Klaassen, RHG; Tottrup, AP; Vardanis, Y; Howey, PW; Thorup, K; Wikelski, M; Alerstam, T				Willemoes, Mikkel; Strandberg, Roine; Klaassen, Raymond H. G.; Tottrup, Anders P.; Vardanis, Yannis; Howey, Paul W.; Thorup, Kasper; Wikelski, Martin; Alerstam, Thomas			Narrow-Front Loop Migration in a Population of the Common Cuckoo Cuculus canorus, as Revealed by Satellite Telemetry	PLOS ONE			English	Article							ORIENTATION SYSTEM; RING RECOVERIES; BIRDS; NAVIGATION; TRACKING; MODEL; SONGBIRDS; PATTERNS; MIGRANTS; OSPREYS	Narrow migration corridors known in diurnal, social migrants such as raptors, storks and geese are thought to be caused by topographical leading line effects in combination with learning detailed routes across generations. Here, we document narrow-front migration in a nocturnal, solitary migrant, the common cuckoo Cuculus canorus, using satellite telemetry. We tracked the migration of adult cuckoos from the breeding grounds in southern Scandinavia (n = 8), to wintering sites in south-western Central Africa (n = 6) and back to the breeding grounds (n = 3). Migration patterns were very complex; in addition to the breeding and wintering sites, six different stopover sites were identified during the 16,000 km annual route that formed a large-scale clockwise loop. Despite this complexity, individuals showed surprisingly similar migration patterns, with very little variation between routes. We compared observed tracks with simulated routes based on vector orientation (with and without effects of barriers on orientation and survival). Observed distances between routes were often significantly smaller than expected if the routes were established on the basis of an innate vector orientation programme. Average distance between individuals in eastern Sahel after having migrated more than 5,000 km for example, was merely 164 km. This implies that more sophisticated inherent guiding mechanisms, possibly involving elements of intermediate goal area navigation or more elaborate external cues, are necessary to explain the complex narrow-front migration pattern observed for the cuckoos in this study.	[Willemoes, Mikkel; Tottrup, Anders P.; Thorup, Kasper] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Strandberg, Roine; Klaassen, Raymond H. G.; Vardanis, Yannis; Alerstam, Thomas] Lund Univ, Dept Biol, Lund, Sweden; [Klaassen, Raymond H. G.] Univ Groningen, Dutch Montagus Harrier Fdn, Groningen, Netherlands; [Klaassen, Raymond H. G.] Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Howey, Paul W.] Microwave Telemetry Inc, Columbia, MD USA; [Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Wikelski, Martin] Univ Konstanz, Dept Biol, Constance, Germany	University of Copenhagen; Lund University; University of Groningen; University of Groningen; Max Planck Society; University of Konstanz	Willemoes, M (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark.	mwkristensen@snm.ku.dk	Willemoes, Mikkel/J-9391-2012; Klaassen, Raymond/K-3027-2013; Tøttrup, Anders P/N-3836-2013; Thorup, Kasper/A-4835-2013	Willemoes, Mikkel/0000-0001-9363-6304; Tøttrup, Anders P/0000-0001-8776-9629; Thorup, Kasper/0000-0002-0320-0601	Danish National Research Foundation; Swedish Research Council	Danish National Research Foundation(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by the Danish National Research Foundation http://dg.dk/en/and Swedish Research Council http://www.vr.se/inenglish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C, 2009, CIRCSTATS CIRCULAR S; Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 2000, EXPTL BIOL REV, P105; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; [Anonymous], 2008, SVENSK RINGMARKNINGS; Argos, 2011, ARG US MAN; Berthold P., 2001, BIRD MIGRATION; Berthold P, 1996, CONTROL BIRD MIGRATI; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; BTO, 2012, TRACK CUCK AFR BACK; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Cramp S., 1985, HDB BIRDS EUROPE MID; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; ESRI, 2011, ARCGIS; Essen Lv, 1982, AQUILA, V89, P103; Fisher N., 1995, STAT ANAL CIRCULAR D; Fransson T, 2005, J AVIAN BIOL, V36, P6, DOI 10.1111/j.0908-8857.2005.03471.x; Fransson T, 2008, SVENSK RINGMARKNINGS, V2; Hahn S, 2009, OIKOS, V118, P624, DOI 10.1111/j.1600-0706.2009.17309.x; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; Hijmans RJ, 2012, GEOSPHERE SPHERICAL; Julliard R, 2006, IBIS, V148, P735, DOI 10.1111/j.1474-919X.2006.00573.x; Lewin-Koh N.J., 2012, MAPTOOLS TOOLS READI; Telleria JL, 2009, BIRD CONSERV INT, V19, P131, DOI 10.1017/S0959270908008137; Mellone U, 2011, J AVIAN BIOL, V42, P468, DOI 10.1111/j.1600-048X.2011.05454.x; Microwave Telemetry Inc, 2005, MICR TEL INC NEWSL; Moreau R. E., 1961, Ibis, V103a, P373, DOI 10.1111/j.1474-919X.1961.tb02454.x; Moreau R. E., 1972, PALEARCTIC AFRICAN B; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Mouritsen H, 1998, ANIM BEHAV, V56, P899, DOI 10.1006/anbe.1998.0826; Pebesma E.I., 2005, CLASSES METHODS SPAT, V5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RABOL J, 1978, OIKOS, V30, P216, DOI 10.2307/3543481; Rahbek, 2006, DANSK TRAEKFUGLEATLA; Rappe A, 1965, AVES, V2, P27; Royal Society for the Protection of Birds, 2009, HUNT DANG ON WORLDS; Schuz E., 1951, HORSTADIUS SEDITOR, P249; SEEL DC, 1977, IBIS, V119, P309, DOI 10.1111/j.1474-919X.1977.tb08250.x; STERBETZ I, 1968, Vogelwarte, V24, P266; Strandberg R, 2009, P ROY SOC B-BIOL SCI, V276, P727, DOI 10.1098/rspb.2008.1202; Thorup K, 2003, OIKOS, V103, P350, DOI 10.1034/j.1600-0706.2003.12163.x; Thorup K, 2001, J AVIAN BIOL, V32, P111, DOI 10.1034/j.1600-048X.2001.320203.x; Thorup Kasper, 2000, Animal Behaviour Forum, V60, pF3; Tottrup AP, 2012, SCIENCE, V338, P1307, DOI 10.1126/science.1227548; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; WALLRAFF HG, 1978, OIKOS, V30, P401, DOI 10.2307/3543490; Wiltschko R, 2001, ANIM BEHAV, V62, P245, DOI 10.1006/anbe.2001.1751	48	65	67	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83515	10.1371/journal.pone.0083515	http://dx.doi.org/10.1371/journal.pone.0083515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421890	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500053
J	Zhang, B; Chen, J; Cheng, ASL; Ko, BCB				Zhang, Bin; Chen, Juan; Cheng, Alfred S. L.; Ko, Ben C. B.			Depletion of Sirtuin 1 (SIRT1) Leads to Epigenetic Modifications of Telomerase (TERT) Gene in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							MAMMALIAN SIRTUINS; SKELETAL-MUSCLE; DNA METHYLATION; PROSTATE-CANCER; MESSENGER-RNA; HTERT GENE; TRANSCRIPTION; MAINTENANCE; EXPRESSION; HETEROCHROMATIN	Sirtuin 1 (SIRT1) is a nicotinamide adenine dinucleotide (NAD)-dependent deacetylase that is implicated in plethora of biological processes, including metabolism, aging, stress response, and tumorigenesis. Telomerase (TERT) is essential for telomere maintenance. Activation of TERT is considered a crucial step in tumorigenesis, and therefore it is a potential therapeutic target against cancer. We have recently found that SIRT1 expression is highly elevated in hepatocellular carcinoma, and the depletion of SIRT1 leads to substantial reduction in TERT mRNA and protein expression. However, the underlying molecular mechanism of SIRT1-dependent TERT expression remains uncharacterized. Here, we elucidated if SIRT1 regulates TERT expression via transcriptional, epigenetic and post-transcriptional mechanisms. We report that depletion of SIRT1 does not lead to significant change in transcriptional activity and CpG methylation patterns of the TERT promoter, nor does it affect mRNA stability or 3'-UTR regulation of TERT. Intriguingly, depletion of SIRT1 is associated with substantial induction of acetylated histone H3-K9 and reduction of trimethyl H3-K9 at the TERT gene, which are known to be associated with gene activation. Our data revealed that SIRT1 regulates histone acetylation and methylation at the TERT promoter. We postulated that SIRT1 may regulate TERT expression via long-range interaction, or via yet unidentified histone modifications.	[Zhang, Bin] Chinese Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Zhang, Bin] Chinese Univ Hong Kong, Dept Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Chen, Juan] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Affiliated Hosp 2, Chongqing, Peoples R China; [Cheng, Alfred S. L.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Ko, Ben C. B.] Hong Kong Polytech Univ, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China; [Ko, Ben C. B.] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chongqing Medical University; Chinese University of Hong Kong; Hong Kong Polytechnic University; Hong Kong Polytechnic University	Ko, BCB (corresponding author), Hong Kong Polytech Univ, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China.	ben.ko@polyu.edu.hk	Ko, Chi-bun/ACH-7514-2022; Cheng, Alfred SL/C-3327-2014	Cheng, Alfred SL/0000-0003-2345-6951; Ko, Ben Chi Bun/0000-0003-2027-5899	Research Grant Council Grants; National Natural Science Foundation of China	Research Grant Council Grants; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Research Grant Council Grants and National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Choi HN, 2011, ONCOL REP, V26, P503, DOI 10.3892/or.2011.1301; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; El Ramy R, 2009, CELL MOL LIFE SCI, V66, P3219, DOI 10.1007/s00018-009-0105-4; Emerald BS, 2007, J BIOL CHEM, V282, P680, DOI 10.1074/jbc.M600224200; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Horikawa I, 1999, CANCER RES, V59, P826; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lopatina NG, 2003, BIOCHEM BIOPH RES CO, V306, P650, DOI 10.1016/S0006-291X(03)01033-7; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160; Portmann S, 2013, MOL CANCER THER, V12, P499, DOI 10.1158/1535-7163.MCT-12-0700; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Tong EHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008435; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhu QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001446; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	37	30	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84931	10.1371/journal.pone.0084931	http://dx.doi.org/10.1371/journal.pone.0084931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416313	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500190
J	Shao, D; Fry, JL; Han, JY; Hou, XY; Pimentel, DR; Matsui, R; Cohen, RA; Bachschmid, MM				Shao, Di; Fry, Jessica L.; Han, Jingyan; Hou, Xiuyun; Pimentel, David R.; Matsui, Reiko; Cohen, Richard A.; Bachschmid, Markus M.			A Redox-resistant Sirtuin-1 Mutant Protects against Hepatic Metabolic and Oxidant Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutathionylation; Metabolic Diseases; Oxidative Stress; Polyphenols; Resveratrol; Glutathiolation; High Fat High Sucrose Diet; Reactive Oxygen and Nitrogen Species	HIGH-FAT DIET; NF-KAPPA-B; REGULATES SIRT1; CELL-SURVIVAL; HEPATOCYTE APOPTOSIS; ANTIOXIDANT STATUS; LIVER; P53; EXPRESSION; PHOSPHORYLATION	Background: Sirtuin-1 improves metabolic disease, but oxidants may inhibit it. Results: Metabolic stress increased glutathione adducts, inactivated endogenous Sirtuin-1, and promoted apoptosis. A novel Sirtuin-1 oxidation-insensitive mutant or glutaredoxin-1 prevented metabolic dysregulation and apoptosis. Conclusion: A novel Sirtuin-1 mutant circumvents oxidation and more effectively inhibits metabolic dysregulation and apoptosis. Significance: Oxidative inactivation of Sirtuin-1 contributes to metabolic disease. Sirtuin-1 (SirT1), a member of the NAD(+)-dependent class III histone deacetylase family, is inactivated in vitro by oxidation of critical cysteine thiols. In a model of metabolic syndrome, SirT1 activation attenuated apoptosis of hepatocytes and improved liver function including lipid metabolism. We show in SirT1-overexpressing HepG2 cells that oxidants (nitrosocysteine and hydrogen peroxide) or metabolic stress (high palmitate and high glucose) inactivated SirT1 by reversible oxidative post-translational modifications (OPTMs) on three cysteines. Mutating these oxidation-sensitive cysteines to serine preserved SirT1 activity and abolished reversible OPTMs. Overexpressed mutant SirT1 maintained deacetylase activity and attenuated proapoptotic signaling, whereas overexpressed wild type SirT1 was less protective in metabolically or oxidant-stressed cells. To prove that OPTMs of SirT1 are glutathione (GSH) adducts, glutaredoxin-1 was overexpressed to remove this modification. Glutaredoxin-1 overexpression maintained endogenous SirT1 activity and prevented proapoptotic signaling in metabolically stressed HepG2 cells. The in vivo significance of oxidative inactivation of SirT1 was investigated in livers of high fat diet-fed C57/B6J mice. SirT1 deacetylase activity was decreased in the absence of changes in SirT1 expression and associated with a marked increase in OPTMs. These results indicate that glutathione adducts on specific SirT1 thiols may be responsible for dysfunctional SirT1 associated with liver disease in metabolic syndrome.	[Shao, Di; Fry, Jessica L.; Han, Jingyan; Hou, Xiuyun; Matsui, Reiko; Cohen, Richard A.; Bachschmid, Markus M.] Boston Univ, Sch Med, Vasc Biol Sect, Boston, MA 02118 USA; [Pimentel, David R.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Myocardial Biol Unit, Boston, MA 02118 USA; [Cohen, Richard A.; Bachschmid, Markus M.] Boston Univ, Sch Med, Cardiovasc Proteom Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Bachschmid, MM (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect, Boston, MA 02118 USA.	bach@bu.edu	Shao, Di/F-9758-2016	/0000-0002-1070-6408; Bachschmid, Markus Michael/0000-0002-0748-5528; Fry, Jessica/0000-0003-2748-0334	National Institutes of Health [PO1 HL 068758, R37 HL104017]; NHLBI, National Institutes of Health, Department of Health and Human Services [HHSN268201000031C]; National Institutes of Health Cardiovascular Post-doctoral Training Grant [HL007224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758, T32HL007224, R37HL104017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, National Institutes of Health, Department of Health and Human Services; National Institutes of Health Cardiovascular Post-doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL 068758 and R37 HL104017 and the NHLBI, National Institutes of Health, Department of Health and Human Services under Contract HHSN268201000031C.; Supported by National Institutes of Health Cardiovascular Post-doctoral Training Grant HL007224.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Costantini S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-60; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Haeussler DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023160; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Ishikawa S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-187; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Jung SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080115; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Koruk M, 2004, ANN CLIN LAB SCI, V34, P57; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Li S., 2010, PLOS ONE, V5; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Madan K, 2006, J CLIN GASTROENTEROL, V40, P930, DOI 10.1097/01.mcg.0000212608.59090.08; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nin V, 2012, J BIOL CHEM, V287, P23489, DOI 10.1074/jbc.M112.365874; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Olmos Y, 2013, ANTIOXID REDOX SIGN, V19, P1507, DOI 10.1089/ars.2012.4713; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Potente M, 2008, CELL CYCLE, V7, P2117, DOI 10.4161/cc.7.14.6267; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Ruiz-Ramirez A, 2011, AM J PHYSIOL-ENDOC M, V301, pE1198, DOI 10.1152/ajpendo.00631.2010; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Xu SQ, 2011, J CARDIOVASC PHARM, V58, P263, DOI 10.1097/FJC.0b013e3182239eb7; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Yu JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02806; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	72	52	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7293	7306		10.1074/jbc.M113.520403	http://dx.doi.org/10.1074/jbc.M113.520403			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24451382	Green Published, hybrid			2022-12-25	WOS:000332761500004
J	Dickson, CF; Kumar, KK; Jacques, DA; Malmirchegini, GR; Spirig, T; Mackay, JP; Clubb, RT; Guss, JM; Gell, DA				Dickson, Claire F.; Kumar, Kaavya Krishna; Jacques, David A.; Malmirchegini, G. Reza; Spirig, Thomas; Mackay, Joel P.; Clubb, Robert T.; Guss, J. Mitchell; Gell, David A.			Structure of the Hemoglobin-IsdH Complex Reveals the Molecular Basis of Iron Capture by Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystallography; Heme; Hemoglobin; Protein Domains; Staphylococcus aureus; NEAT Domain; Heme; Iron-regulated Surface Determinant	SMALL-ANGLE SCATTERING; SURFACE PROTEIN; NEAT DOMAIN; HEME-IRON; INFECTIVE ENDOCARDITIS; QUATERNARY STRUCTURE; ANTHRAX HEMOPHORE; EXTRACT HEME; NATIVE VALVE; CELL-WALL	Background: IsdB and IsdH proteins from Staphylococcus aureus strip heme iron from human hemoglobin. Results: The IsdHhemoglobin complex shows how globin-binding and heme-binding NEAT domains of IsdH cooperate to remove heme from both chains of hemoglobin. Conclusion: The supradomain architecture of IsdH confers activity by precisely positioning the heme acceptor domain. Significance: Multiple IsdHhemoglobin interfaces may be targets for new antibiotics. Staphylococcus aureus causes life-threatening disease in humans. The S. aureus surface protein iron-regulated surface determinant H (IsdH) binds to mammalian hemoglobin (Hb) and extracts heme as a source of iron, which is an essential nutrient for the bacteria. However, the process of heme transfer from Hb is poorly understood. We have determined the structure of IsdH bound to human Hb by x-ray crystallography at 4.2 resolution, revealing the structural basis for heme transfer. One IsdH molecule is bound to each and Hb subunit, suggesting that the receptor acquires iron from both chains by a similar mechanism. Remarkably, two near iron transporter (NEAT) domains in IsdH perform very different functions. An N-terminal NEAT domain binds / globin through a site distant from the globin heme pocket and, via an intervening structural domain, positions the C-terminal heme-binding NEAT domain perfectly for heme transfer. These data, together with a 2.3 resolution crystal structure of the isolated N-terminal domain bound to Hb and small-angle x-ray scattering of free IsdH, reveal how multiple domains of IsdH cooperate to strip heme from Hb. Many bacterial pathogens obtain iron from human hemoglobin using proteins that contain multiple NEAT domains and other domains whose functions are poorly understood. Our results suggest that, rather than acting as isolated units, NEAT domains may be integrated into higher order architectures that employ multiple interaction interfaces to efficiently extract heme from host proteins.	[Dickson, Claire F.; Gell, David A.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Kumar, Kaavya Krishna; Jacques, David A.; Mackay, Joel P.; Guss, J. Mitchell] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Malmirchegini, G. Reza; Spirig, Thomas; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Tasmania; University of Sydney; University of California System; University of California Los Angeles	Gell, DA (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, 17 Liverpool St, Hobart, Tas 7000, Australia.	david.gell@utas.edu.au	Mackay, Joel P/D-6834-2011; Guss, Jules Mitchell/N-1387-2019	Mackay, Joel P/0000-0001-7508-8033; Guss, Jules Mitchell/0000-0003-4259-6079; Jacques, David/0000-0002-6426-4510; Gell, David/0000-0003-0382-1181; Spirig, Thomas/0000-0001-8936-238X	National Institutes of Health Grant [AI52217]; University of Tasmania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tasmania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI52217 (to R. T. C.). This work was also supported by the University of Tasmania (to D. A. G.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Anguera I, 2005, HEART, V91, DOI 10.1136/hrt.2004.040659; Ascoli F, 1981, Methods Enzymol, V76, P72; Balderas MA, 2012, J BACTERIOL, V194, P5513, DOI 10.1128/JB.00685-12; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Bauer J, 2013, MOL PLANT, V6, P959, DOI 10.1093/mp/sss126; Bricogne G., 2011, BUSTER VERSION 2 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Crowley PB, 2003, ACCOUNTS CHEM RES, V36, P723, DOI 10.1021/ar0200955; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; del Rio A, 2009, CLIN INFECT DIS, V48, pS246, DOI 10.1086/598187; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Dukic VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052722; Ekworomadu MT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002559; Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fusco WG, 2013, J BACTERIOL, V195, P3115, DOI 10.1128/JB.00199-13; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Hempel K, 2011, J PROTEOME RES, V10, P1657, DOI 10.1021/pr1009838; Honsa ES, 2013, J BIOL CHEM, V288, P8479, DOI 10.1074/jbc.M112.430009; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miro JM, 2005, CLIN INFECT DIS, V41, P507, DOI 10.1086/431979; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Morrissey JA, 2002, INFECT IMMUN, V70, P2399, DOI 10.1128/IAI.70.5.2399-2407.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Nepluev I, 2009, INFECT IMMUN, V77, P3065, DOI 10.1128/IAI.00034-09; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouattara M, 2013, ARCH BIOCHEM BIOPHYS, V538, P71, DOI 10.1016/j.abb.2013.08.009; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; SILVA MM, 1992, J BIOL CHEM, V267, P17248; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tiedemann MT, 2012, J AM CHEM SOC, V134, P16578, DOI 10.1021/ja305115y; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vu NT, 2013, PROTEIN SCI, V22, P942, DOI 10.1002/pro.2276; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Yi J, 2011, ACTA CRYSTALLOGR F, V67, P647, DOI 10.1107/S1744309111012528; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X; Zapotoczna M, 2012, J BACTERIOL, V194, P6453, DOI 10.1128/JB.01195-12; Zhao XD, 2008, J MOL BIOL, V375, P1141, DOI 10.1016/j.jmb.2007.11.045; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	72	36	37	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6728	6738		10.1074/jbc.M113.545566	http://dx.doi.org/10.1074/jbc.M113.545566			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425866	Green Published, hybrid			2022-12-25	WOS:000332389400034
J	Walker, RG; Deng, XD; Melchior, JT; Morris, J; Tso, P; Jones, MK; Segrest, JP; Thompson, TB; Davidson, WS				Walker, Ryan G.; Deng, Xiaodi; Melchior, John T.; Morris, Jamie; Tso, Patrick; Jones, Martin K.; Segrest, Jere P.; Thompson, Thomas B.; Davidson, W. Sean			The Structure of Human Apolipoprotein A-IV as Revealed by Stable Isotope-assisted Cross-linking, Molecular Dynamics, and Small Angle X-ray Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Lipid-binding Protein; Mass Spectrometry (MS); Molecular Dynamics; Protein Cross-linking; Protein Structure; Apolipoprotein A-IV; Lipid-free; Small Angle X-ray Scattering	HIGH-DENSITY-LIPOPROTEINS; INTERFACIAL PROPERTIES; LIPID-BINDING; SEQUENCE; PROTEIN; MODEL; IDENTIFICATION; CONFORMATION; FLEXIBILITY; SECRETION	Background: Apolipoprotein (apo)A-IV is involved in lipid and glucose metabolism, but its full-length structure is not known. Results: Stable isotope-assisted cross-linking combined with molecular modeling produced new models of the full-length protein. Conclusion: At least three hydrophobic residues participate in a unique clasp mechanism that regulates apoA-IV function. Significance: We report the most detailed models of lipid-free apoA-IV to date and demonstrate their utility in terms of functional predictions. Apolipoprotein (apo)A-IV plays important roles in dietary lipid and glucose metabolism, and knowledge of its structure is required to fully understand the molecular basis of these functions. However, typical of the entire class of exchangeable apolipoproteins, its dynamic nature and affinity for lipid has posed challenges to traditional high resolution structural approaches. We previously reported an x-ray crystal structure of a dimeric truncation mutant of apoA-IV, which showed a unique helix-swapping molecular interface. Unfortunately, the structures of the N and C termini that are important for lipid binding were not visualized. To build a more complete model, we used chemical cross-linking to derive distance constraints across the full-length protein. The approach was enhanced with stable isotope labeling to overcome ambiguities in determining molecular span of the cross-links given the remarkable similarities in the monomeric and dimeric apoA-IV structures. Using 51 distance constraints, we created a starting model for full-length monomeric apoA-IV and then subjected it to two modeling approaches: (i) molecular dynamics simulations and (ii) fitting to small angle x-ray scattering data. This resulted in the most detailed models yet for lipid-free monomeric or dimeric apoA-IV. Importantly, these models were of sufficient detail to direct the experimental identification of new functional residues that participate in a clasp mechanism to modulate apoA-IV lipid affinity. The isotope-assisted cross-linking approach should prove useful for further study of this family of apolipoproteins in both the lipid-free and -bound states.	[Walker, Ryan G.; Deng, Xiaodi; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45237 USA; [Melchior, John T.; Morris, Jamie; Tso, Patrick; Davidson, W. Sean] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; [Jones, Martin K.; Segrest, Jere P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Jones, Martin K.; Segrest, Jere P.] Univ Alabama Birmingham, Atherosclerosis Res Unit, Birmingham, AL 35294 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Thompson, TB (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45237 USA.	Tom.Thompson@uc.edu; Sean.Davidson@UC.edu		Thompson, Thomas/0000-0002-7041-5047; Davidson, William/0000-0003-2756-2989; Walker, Ryan/0000-0001-6160-8026	National Institutes of Health [RO1 GM098458, HL67093]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM098458 (to W. S. D. and T. B. T.) and HL67093 (to W. S. D.).	Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; BOGUSKI MS, 1985, P NATL ACAD SCI USA, V82, P992, DOI 10.1073/pnas.82.4.992; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Deng XD, 2013, J BIOL CHEM, V288, P4854, DOI 10.1074/jbc.M112.436709; Deng XD, 2012, STRUCTURE, V20, P767, DOI 10.1016/j.str.2012.02.020; DUVERGER N, 1994, BBA-LIPID LIPID MET, V1211, P23, DOI 10.1016/0005-2760(94)90134-1; DVORIN E, 1985, J LIPID RES, V26, P38; ELSHOURBAGY NA, 1987, J BIOL CHEM, V262, P7973; EMMANUEL F, 1994, J BIOL CHEM, V269, P29883; FUJIMOTO K, 1992, AM J PHYSIOL, V262, pG1002, DOI 10.1152/ajpgi.1992.262.6.G1002; Gallagher JW, 2004, J LIPID RES, V45, P1826, DOI 10.1194/jlr.M400188-JLR200; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; HAYASHI H, 1990, J LIPID RES, V31, P1613; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONAS A, 1993, J BIOL CHEM, V268, P1596; Jones MK, 2009, BIOPHYS J, V96, P354, DOI 10.1016/j.bpj.2008.09.041; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KARATHANASIS SK, 1986, P NATL ACAD SCI USA, V83, P8457, DOI 10.1073/pnas.83.22.8457; Kratz M, 2003, J NUTR, V133, P1821, DOI 10.1093/jn/133.6.1821; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Main LA, 1996, BBA-LIPID LIPID MET, V1300, P17, DOI 10.1016/0005-2760(95)00228-6; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Nema V, 2013, BIOINFORMATION, V9, P796, DOI 10.6026/97320630009796; Okumura T, 1996, AM J PHYSIOL-GASTR L, V270, pG49, DOI 10.1152/ajpgi.1996.270.1.G49; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Pearson K, 2004, BIOCHEMISTRY-US, V43, P10719, DOI 10.1021/bi048978m; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Raybould HE, 1998, AM J PHYSIOL-REG I, V274, pR1834, DOI 10.1152/ajpregu.1998.274.6.R1834; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Silva RAGD, 2007, J BIOL CHEM, V282, P9713, DOI 10.1074/jbc.M610380200; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Tubb MR, 2008, J BIOL CHEM, V283, P17314, DOI 10.1074/jbc.M800036200; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; Tubb MR, 2009, J LIPID RES, V50, P1497, DOI 10.1194/jlr.D900003-JLR200; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; WEINBERG RB, 1985, J BIOL CHEM, V260, P4914; WEINBERG RB, 1985, J BIOL CHEM, V260, P4279; WEINBERG RB, 1994, J LIPID RES, V35, P2212; WEINBERG RB, 1990, J BIOL CHEM, V265, P8081; Weinberg RB, 2000, J LIPID RES, V41, P1419; Weinberg RB, 2000, J LIPID RES, V41, P1410; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130	54	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5596	5608		10.1074/jbc.M113.541037	http://dx.doi.org/10.1074/jbc.M113.541037			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425874	Green Published, hybrid			2022-12-25	WOS:000332015500024
J	Sankella, S; Garg, A; Horton, JD; Agarwal, AK				Sankella, Shireesha; Garg, Abhimanyu; Horton, Jay D.; Agarwal, Anil K.			Hepatic Gluconeogenesis Is Enhanced by Phosphatidic Acid Which Remains Uninhibited by Insulin in Lipodystrophic Agpat2 Mice*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gluconeogenesis; Insulin Resistance; Lipids; Lipodystrophy; Phosphatidic Acid	3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; CONGENITAL GENERALIZED LIPODYSTROPHY; QUANTITATIVE-ANALYSIS; ACYLTRANSFERASE-BETA; NEGATIVE REGULATION; BINDING DOMAIN; PHOSPHORYLATION; PDK1; ACTIVATION; MEMBRANE	Background: Lipodystrophic Agpat2(-/-) mice are severely diabetic and insulin resistant. Results: Livers of Agpat2(-/-) mice have elevated levels of phosphatidic acids (PAs), which enhance gluconeogenesis. Conclusion: PA enhanced hepatic gluconeogenesis contributes to the hyperglycemia present in Agpat2(-/-) mice. Significance: PA enhanced hepatic gluconeogenesis might have wider implications in understanding the development of hyperglycemia in type 2 diabetes. In this study we examined the role of phosphatidic acid (PA) in hepatic glucose production (HGP) and development of hepatic insulin resistance in mice that lack 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2). Liver lysophosphatidic acid and PA levels were increased approximate to 2- and approximate to 5-fold, respectively, in male Agpat2(-/-) mice compared with wild type mice. In the absence of AGPAT2, the liver can synthesize PAs by activating diacylglycerol kinase or phospholipase D, both of which were elevated in the livers of Agpat2(-/-) mice. We found that PAs C16:0/18:1 and C18:1/20:4 enhanced HGP in primary WT hepatocytes, an effect that was further enhanced in primary hepatocytes from Agpat2(-/-) mice. Lysophosphatidic acids C16:0 and C18:1 failed to increase HGP in primary hepatocytes. The activation of HGP was accompanied by an up-regulation of the key gluconeogenic enzymes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase. This activation was suppressed by insulin in the WT primary hepatocytes but not in the Agpat2(-/-) primary hepatocytes. Thus, the lack of normal insulin signaling in Agpat2(-/-) livers allows unrestricted PA-induced gluconeogenesis significantly contributing to the development of hyperglycemia in these mice.	[Sankella, Shireesha; Garg, Abhimanyu; Agarwal, Anil K.] Univ Texas SW Med Ctr Dallas, Div Nutr & Metab Dis, Dept Internal Med, Dallas, TX 75390 USA; [Sankella, Shireesha; Garg, Abhimanyu; Agarwal, Anil K.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Agarwal, AK (corresponding author), Univ Texas SW Med Ctr Dallas, Div Nutr & Metab Dis, Dept Internal Med, Dallas, TX 75390 USA.	Anil.Agarwal@utsouthwestern.edu			National Science Foundation [EPS 0236913, MCB 0455318, 0920663, DBI 0521587]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Bio-medical Research Excellence (INBRE) by National Institute of Health [P20RR16475]; Kansas State University; Div Of Molecular and Cellular Bioscience [0920663] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054387] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Bio-medical Research Excellence (INBRE) by National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Katie Tunison M.S. from the University of Texas Southwestern Medical Center for technical assistance and copyediting, Anh Nguyen for assistance with gas chromatography, and Baris Akinci for help with immunoblotting. The mass spectrometry analysis described in this work was performed at the Kansas Lipidomics Research Center Analytical Laboratory. The method of development and instrument acquisition at the Kansas Lipidomics Research Center were supported by National Science Foundation Grants EPS 0236913, MCB 0455318, 0920663 and DBI 0521587, Kansas Technology Enterprise Corporation, K-IDeA Networks of Bio-medical Research Excellence (INBRE) by National Institute of Health Grant P20RR16475, and the Kansas State University.	Agarwal AK, 2003, TRENDS ENDOCRIN MET, V14, P214, DOI 10.1016/S1043-2760(03)00078-X; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2012, CURR OPIN LIPIDOL, V23, P290, DOI 10.1097/MOL.0b013e328354fcf4; Agarwal AK, 2011, J BIOL CHEM, V286, P37676, DOI 10.1074/jbc.M111.250449; Alessi DR, 2001, BIOCHEM SOC T, V29, P1, DOI 10.1042/bst029a059; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; BECART J, 1990, HRC-J HIGH RES CHROM, V13, P126; Camargo DCR, 2012, BIOCHEMISTRY-US, V51, P4909, DOI 10.1021/bi3002133; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Finley L. W., 2013, CELL METAB, V17; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; HENRY RA, 1995, AM J PHYSIOL-CELL PH, V269, pC349, DOI 10.1152/ajpcell.1995.269.2.C349; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; LEPAGE G, 1986, J LIPID RES, V27, P114; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Martelli AM, 2000, CANCER RES, V60, P815; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seong HA, 2012, J BIOL CHEM, V287, P20811, DOI 10.1074/jbc.M111.331827; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shin JJH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-85; Springett GM, 2005, CANCER RES, V65, P9415, DOI 10.1158/0008-5472.CAN-05-0516; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Vantyghem MC, 2012, ANN ENDOCRINOL-PARIS, V73, P170, DOI 10.1016/j.ando.2012.04.010; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wu XD, 2012, ARTERIOSCL THROM VAS, V32, P1236, DOI 10.1161/ATVBAHA.111.244525; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109	45	10	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4762	4777		10.1074/jbc.M113.530998	http://dx.doi.org/10.1074/jbc.M113.530998			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24425876	Green Published, hybrid			2022-12-25	WOS:000331607900023
J	Faggi, F; Mitola, S; Sorci, G; Riuzzi, F; Donato, R; Codenotti, S; Poliani, PL; Cominelli, M; Vescovi, R; Rossi, S; Calza, S; Colombi, M; Penna, F; Costelli, P; Perini, I; Sampaolesi, M; Monti, E; Fanzani, A				Faggi, Fiorella; Mitola, Stefania; Sorci, Guglielmo; Riuzzi, Francesca; Donato, Rosario; Codenotti, Silvia; Poliani, Pietro Luigi; Cominelli, Manuela; Vescovi, Raffaella; Rossi, Stefania; Calza, Stefano; Colombi, Marina; Penna, Fabio; Costelli, Paola; Perini, Ilaria; Sampaolesi, Maurilio; Monti, Eugenio; Fanzani, Alessandro			Phosphocaveolin-1 Enforces Tumor Growth and Chemoresistance in Rhabdomyosarcoma	PLOS ONE			English	Article							CARCINOMA CELL-LINES; EMBRYONAL RHABDOMYOSARCOMA; ALVEOLAR RHABDOMYOSARCOMA; DOWN-REGULATION; IN-VIVO; CHILDHOOD RHABDOMYOSARCOMA; TYROSINE PHOSPHORYLATION; THERAPEUTIC TARGET; GENE-EXPRESSION; BREAST-CANCER	Caveolin-1 (Cav-1) can ambiguously behave as either tumor suppressor or oncogene depending on its phosphorylation state and the type of cancer. In this study we show that Cav-1 was phosphorylated on tyrosine 14 (pCav-1) by Src-kinase family members in various human cell lines and primary mouse cultures of rhabdomyosarcoma (RMS), the most frequent soft-tissue sarcoma affecting childhood. Cav-1 overexpression in the human embryonal RD or alveolar RH30 cells yielded increased pCav-1 levels and reinforced the phosphorylation state of either ERK or AKT kinase, respectively, in turn enhancing in vitro cell proliferation, migration, invasiveness and chemoresistance. In contrast, reducing the pCav-1 levels by administration of a Src-kinase inhibitor or through targeted Cav-1 silencing counteracted the malignant in vitro phenotype of RMS cells. Consistent with these results, xenotransplantation of Cav-1 overexpressing RD cells into nude mice resulted in substantial tumor growth in comparison to control cells. Taken together, these data point to pCav-1 as an important and therapeutically valuable target for overcoming the progression and multidrug resistance of RMS.	[Faggi, Fiorella; Mitola, Stefania; Codenotti, Silvia; Poliani, Pietro Luigi; Cominelli, Manuela; Vescovi, Raffaella; Rossi, Stefania; Calza, Stefano; Colombi, Marina; Monti, Eugenio; Fanzani, Alessandro] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Sorci, Guglielmo; Riuzzi, Francesca; Donato, Rosario] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Penna, Fabio; Costelli, Paola] Univ Turin, Dept Expt Med & Oncol, Turin, Italy; [Perini, Ilaria; Sampaolesi, Maurilio] Univ Hosp Gasthuisberg, Stem Cell Res Inst, B-3000 Louvain, Belgium; [Sampaolesi, Maurilio] Univ Pavia, Human Anat Sect, I-27100 Pavia, Italy	University of Brescia; University of Perugia; University of Turin; KU Leuven; University Hospital Leuven; University of Pavia	Fanzani, A (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.	fanzani@med.unibs.it	Penna, Fabio/K-5090-2016; Sampaolesi, Maurilio/H-6509-2013; Calza, Stefano/AAM-9790-2021; Cominelli, Manuela/J-9988-2016; Donato, Rosario/I-3943-2019; POLIANI, Pietro Luigi/E-8145-2010	Penna, Fabio/0000-0002-2774-6027; Sampaolesi, Maurilio/0000-0002-2422-3757; Calza, Stefano/0000-0003-4996-7995; Cominelli, Manuela/0000-0002-4520-6104; FANZANI, Alessandro/0000-0001-7475-2668; MONTI, Eugenio/0000-0002-4742-7445; MITOLA, Stefania/0000-0002-5557-738X; Colombi, Marina/0000-0002-3105-5990; POLIANI, Pietro Luigi/0000-0002-5662-8978; Riuzzi, Francesca/0000-0001-7908-3379	Fondazione Cariplo grant; Grant NEDD - Network Enabled Drug Design, Regione Lombardia; "Associazione Italiana per la Ricerca sul Cancro" (MFAG) [9161, 6021]; University of Brescia research fund	Fondazione Cariplo grant(Fondazione Cariplo); Grant NEDD - Network Enabled Drug Design, Regione Lombardia; "Associazione Italiana per la Ricerca sul Cancro" (MFAG)(Fondazione AIRC per la ricerca sul cancro); University of Brescia research fund	This work was supported by the Fondazione Cariplo grant to EM, Grant NEDD - Network Enabled Drug Design, Regione Lombardia to EM, "Associazione Italiana per la Ricerca sul Cancro" (MFAG Project n. 9161 to SM and Project 6021 to RD) and University of Brescia research fund (ex 60%) to AF and EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2012, BIOCHEM BIOPH RES CO, V426, P363, DOI 10.1016/j.bbrc.2012.08.092; Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Astolfi A, 2001, GENE, V274, P139, DOI 10.1016/S0378-1119(01)00619-9; Aung CS, 2011, EUR J CELL BIOL, V90, P136, DOI 10.1016/j.ejcb.2010.06.004; Bai L, 2012, J CELL BIOCHEM, V113, P322, DOI 10.1002/jcb.23358; Bai Y, 2012, CANCER RES, V72, P2501, DOI 10.1158/0008-5472.CAN-11-3015; Bender FC, 2000, CANCER RES, V60, P5870; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; Burgermeister E, 2008, CANCER LETT, V268, P187, DOI 10.1016/j.canlet.2008.03.055; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; CHARDIN P, 1985, INT J CANCER, V35, P647, DOI 10.1002/ijc.2910350513; Charytonowicz E, 2009, CANCER LETT, V279, P126, DOI 10.1016/j.canlet.2008.09.039; Crose Lisa E. S., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/756982; De Giovanni C, 2009, FUTURE ONCOL, V5, P1449, DOI 10.2217/fon.09.97; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engelman JA, 1998, FEBS LETT, V436, P403, DOI 10.1016/S0014-5793(98)01134-X; Fanzani A, 2013, TRENDS MOL MED, V19, P546, DOI 10.1016/j.molmed.2013.07.001; FELIX CA, 1992, CANCER RES, V52, P2243; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gamez-Pozo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033752; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Guenther MK, 2013, CANCER LETT, V337, P200, DOI 10.1016/j.canlet.2013.05.010; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hanson CA, 2013, TRAFFIC, V14, P663, DOI 10.1111/tra.12066; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hehlgans S, 2011, AM J CANCER RES, V1, P521; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hill MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043041; Hinson ARP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00183; Inder KL, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012245; Jankowski K, 2003, CANCER RES, V63, P7926; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Joshi B, 2012, J CELL BIOL, V199, P425, DOI 10.1083/jcb.201207089; Jothi M, 2012, CELL CYCLE, V11, P895, DOI 10.4161/cc.11.5.19346; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Keller C, 2013, FEBS J, V280, P4323, DOI 10.1111/febs.12421; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li SW, 1996, J BIOL CHEM, V271, P3863; Lin MI, 2007, CANCER RES, V67, P2849, DOI 10.1158/0008-5472.CAN-06-4082; Linardic CM, 2005, CANCER RES, V65, P4490, DOI 10.1158/0008-5472.CAN-04-3194; Liu L, 2013, ONCOGENE; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; LOLLINI PL, 1991, INVAS METAST, V11, P116; Madaro L, 2013, J CELL BIOCHEM, V114, P1843, DOI 10.1002/jcb.24526; Marampon F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-31; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Marshall AD, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-25; Matveev SV, 2002, AM J PHYSIOL-CELL PH, V282, pC935, DOI 10.1152/ajpcell.00349.2001; Olanich ME, 2013, EXPERT OPIN THER TAR, V17, P607, DOI 10.1517/14728222.2013.772136; Onisto M, 2005, INT J ONCOL, V27, P791; Parham DM, 2013, ADV ANAT PATHOL, V20, P387, DOI 10.1097/PAP.0b013e3182a92d0d; Parham DM, 2012, PEDIATR DEVEL PATHOL, V15, P211, DOI 10.2350/10-12-0953-PB.1; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Perez EA, 2011, J SURG RES, V170, pE243, DOI 10.1016/j.jss.2011.03.001; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Quest AFG, 2013, CURR MOL MED, V13, P266; Quest AFG, 2008, J CELL MOL MED, V12, P1130, DOI 10.1111/j.1582-4934.2008.00331.x; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Rodriguez R, 2012, CELL RES, V22, P62, DOI 10.1038/cr.2011.157; Rossi S, 2011, J CELL MOL MED, V15, P2553, DOI 10.1111/j.1582-4934.2011.01364.x; Rossi S, 2011, EUR J CANCER, V47, P761, DOI 10.1016/j.ejca.2010.10.018; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Sainz-Jaspeado M, 2011, ONCOTARGET, V2, P305; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Schaaf G, 2010, CANCER RES, V70, P762, DOI 10.1158/0008-5472.CAN-09-2532; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Storer NY, 2013, DEVELOPMENT, V140, P3040, DOI 10.1242/dev.087858; STRATTON MR, 1989, CANCER RES, V49, P6324; Taniguchi E, 2008, ONCOGENE, V27, P6550, DOI 10.1038/onc.2008.255; Taulli R, 2006, CANCER RES, V66, P4742, DOI 10.1158/0008-5472.CAN-05-4292; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51; Yi JS, 2013, J PROTEOME RES; Zanola A, 2012, J CELL MOL MED	91	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84618	10.1371/journal.pone.0084618	http://dx.doi.org/10.1371/journal.pone.0084618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427291	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200031
J	Monchamp, ME; Pick, FR; Beisner, BE; Maranger, R				Monchamp, Marie-Eve; Pick, Frances R.; Beisner, Beatrix E.; Maranger, Roxane			Nitrogen Forms Influence Microcystin Concentration and Composition via Changes in Cyanobacterial Community Structure	PLOS ONE			English	Article							BLUE-GREEN-ALGAE; DISSOLVED ORGANIC NITROGEN; FRESH-WATER; PHOSPHORUS; EUTROPHICATION; DOMINANCE; LAKES; GROWTH; PHYTOPLANKTON; AERUGINOSA	The eutrophication of freshwaters is a global health concern as lakes with excess nutrients are often subject to toxic cyanobacterial blooms. Although phosphorus is considered the main element regulating cyanobacterial biomass, nitrogen (N) concentration and more specifically the availability of different N forms may influence the overall toxicity of blooms. In this study of three eutrophic lakes prone to cyanobacterial blooms, we examined the effects of nitrogen species and concentrations and other environmental factors in influencing cyanobacterial community structure, microcystin (MC) concentrations and MC congener composition. The identification of specific MC congeners was of particular interest as they vary widely in toxicity. Different nitrogen forms appeared to influence cyanobacterial community structure leading to corresponding effects on MC concentrations and composition. Total MC concentrations across the lakes were largely explained by a combination of abiotic factors: dissolved organic nitrogen, water temperature and ammonium, but Microcystis spp. biomass was overall the best predictor of MC concentrations. Environmental factors did not appear to affect MC congener composition directly but there were significant associations between specific MC congeners and particular species. Based on redundancy analyses (RDA), the relative biomass of Microcystis aeruginosa was associated with MC-RR, M. wesenbergii with MC-LA and Aphanizomenon flos-aquae with MC-YR. The latter two species are not generally considered capable of MC production. Total nitrogen, water temperature, ammonium and dissolved organic nitrogen influenced the cyanobacterial community structure, which in turn resulted in differences in the dominant MC congener and the overall toxicity.	[Monchamp, Marie-Eve; Maranger, Roxane] Univ Montreal, Dept Sci Biol, Grp Rech Interuniv Limnol & Environm Aquat GRIL, Montreal, PQ H3C 3J7, Canada; [Pick, Frances R.] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Beisner, Beatrix E.] Univ Quebec, Dept Biol Sci, Grp Rech Interuniv Limnol & Environm Aquat GRIL, Montreal, PQ H3C 3P8, Canada	Universite de Montreal; University of Ottawa; University of Quebec; University of Quebec Montreal	Maranger, R (corresponding author), Univ Montreal, Dept Sci Biol, Grp Rech Interuniv Limnol & Environm Aquat GRIL, CP 6128, Montreal, PQ H3C 3J7, Canada.	r.maranger@umontreal.ca	Beisner, Beatrix/ABG-7855-2020; Pick, Frances R/AAD-6379-2021; Pick, Frances/P-2473-2017	Beisner, Beatrix/0000-0001-6972-6887; Pick, Frances/0000-0002-5486-4061; Maranger, Roxane/0000-0002-2509-4678; Monchamp, Marie-Eve/0000-0001-5361-5162	Fonds de Recherche Quebecois sur la Nature et les Technologies FQRNT; Groupe de Recherche Interuniversitaire en Limnologie et Ecologie Aquatique (GRIL)	Fonds de Recherche Quebecois sur la Nature et les Technologies FQRNT; Groupe de Recherche Interuniversitaire en Limnologie et Ecologie Aquatique (GRIL)	Funding was provided by a Fonds de Recherche Quebecois sur la Nature et les Technologies FQRNT-Team grant to RM, BB and FP and the Groupe de Recherche Interuniversitaire en Limnologie et Ecologie Aquatique (GRIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, STANDARD METHODS EXA; Aranda-Rodriguez R, 2005, ENVIRON TOXICOL, V20, P390, DOI 10.1002/tox.20116; Berman T, 2003, AQUAT MICROB ECOL, V31, P279, DOI 10.3354/ame031279; Berman T, 1999, J PLANKTON RES, V21, P1423, DOI 10.1093/plankt/21.8.1423; Beversdorf LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056103; BLOMQVIST P, 1994, ARCH HYDROBIOL, V132, P141; Bronk D, 2007, BIOGEOSCIENCES, V3, P1247; Bronk DA, 2000, MAR CHEM, V69, P163, DOI 10.1016/S0304-4203(99)00103-6; CARMICHAEL WW, 1994, SCI AM, V270, P78, DOI 10.1038/scientificamerican0194-78; Cerasino L, 2012, OCEANOL HYDROBIOL ST, V41, P54, DOI 10.2478/s13545-012-0028-9; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Cronberg G., 2006, MANUAL AQUATIC CYANO; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dolman AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038757; Donald DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053277; Donald DB, 2011, LIMNOL OCEANOGR, V56, P2161, DOI 10.4319/lo.2011.56.6.2161; Downing JA, 2001, CAN J FISH AQUAT SCI, V58, P1905, DOI 10.1139/cjfas-58-10-1905; DOWNING JA, 1992, LIMNOL OCEANOGR, V37, P936, DOI 10.4319/lo.1992.37.5.0936; Downing TG, 2005, ENVIRON TOXICOL, V20, P257, DOI 10.1002/tox.20106; Falconer IR, 1999, ENVIRON TOXICOL, V14, P5, DOI 10.1002/(SICI)1522-7278(199902)14:1<5::AID-TOX3>3.3.CO;2-S; Fastner J, 1999, ENVIRON TOXICOL, V14, P13, DOI 10.1002/(SICI)1522-7278(199902)14:1<13::AID-TOX4>3.0.CO;2-D; Ferber LR, 2004, FRESHWATER BIOL, V49, P690, DOI 10.1111/j.1365-2427.2004.01218.x; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1213, DOI 10.4319/lo.2010.55.3.1213; Flores E, 2005, BIOCHEM SOC T, V33, P164, DOI 10.1042/BST0330164; Giani A, 2005, CAN J FISH AQUAT SCI, V62, P2100, DOI 10.1139/F05-124; Glibert PM, 2004, MAR ECOL PROG SER, V280, P73, DOI 10.3354/meps280073; Gosselain V, 2000, HYDROBIOLOGIA, V438, P139, DOI 10.1023/A:1004122331683; Graham JL, 2004, WATER RES, V38, P4395, DOI 10.1016/j.watres.2004.08.004; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P669, DOI 10.4319/lo.1988.33.4_part_2.0669; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; KOTAK BG, 1995, J PHYCOL, V31, P248, DOI 10.1111/j.0022-3646.1995.00248.x; Lee SJ, 2000, J APPL MICROBIOL, V89, P323, DOI 10.1046/j.1365-2672.2000.01112.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; McCarthy MJ, 2007, HYDROBIOLOGIA, V581, P195, DOI 10.1007/s10750-006-0496-2; McCarthy MJ, 2009, LIMNOLOGY, V10, P215, DOI 10.1007/s10201-009-0277-5; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; OECD, 1982, EUTR WAT MON ASS CON, DOI DOI 10.1002/IROH.19840690206; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; Otsuka S, 1999, FEMS MICROBIOL LETT, V172, P15, DOI 10.1111/j.1574-6968.1999.tb13443.x; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; PICK FR, 1987, NEW ZEAL J MAR FRESH, V21, P425, DOI 10.1080/00288330.1987.9516238; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Reynolds CS, 2000, HYDROBIOLOGIA, V424, P91, DOI 10.1023/A:1003901012233; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; Rolland A, 2005, J PLANKTON RES, V27, P683, DOI 10.1093/plankt/fbi042; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Scott JT, 2010, LIMNOL OCEANOGR, V55, P1265, DOI 10.4319/lo.2010.55.3.1265; SHAPIRO J, 1973, SCIENCE, V179, P382, DOI 10.1126/science.179.4071.382; SIVONEN K, 1999, TOXIC CYANOBACTERIA, P44; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Tillmanns AR, 2011, LAKE RESERV MANAGE, V27, P183, DOI 10.1080/07438141.2011.587095; Tonk L, 2008, FEMS MICROBIOL ECOL, V65, P383, DOI 10.1111/j.1574-6941.2008.00541.x; Van de Waal DB, 2009, ECOL LETT, V12, P1326, DOI 10.1111/j.1461-0248.2009.01383.x; Via-Ordorika L, 2004, SYST APPL MICROBIOL, V27, P592, DOI 10.1078/0723202041748163; WATANABE MM, 1992, J PHYCOL, V28, P761, DOI 10.1111/j.0022-3646.1992.00761.x; Watson SB, 1997, LIMNOL OCEANOGR, V42, P487, DOI 10.4319/lo.1997.42.3.0487; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x; Wetzel R. G., 1983, LIMNOLOGY, V2nd; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3; Xu Y, 2008, ENVIRON POLLUT, V156, P162, DOI 10.1016/j.envpol.2007.12.027	70	99	102	5	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85573	10.1371/journal.pone.0085573	http://dx.doi.org/10.1371/journal.pone.0085573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427318	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200059
J	Sivagangabalan, G; Nazzari, H; Bignolais, O; Maguy, A; Naud, P; Farid, T; Masse, S; Gaborit, N; Varro, A; Nair, K; Backx, P; Vigmond, E; Nattel, S; Demolombe, S; Nanthakumar, K				Sivagangabalan, Gopal; Nazzari, Hamed; Bignolais, Olivier; Maguy, Ange; Naud, Patrice; Farid, Talha; Masse, Stephane; Gaborit, Nathalie; Varro, Andras; Nair, Krishnakumar; Backx, Peter; Vigmond, Edward; Nattel, Stanley; Demolombe, Sophie; Nanthakumar, Kumaraswamy			Regional Ion Channel Gene Expression Heterogeneity and Ventricular Fibrillation Dynamics in Human Hearts	PLOS ONE			English	Article							POTASSIUM CURRENT; IN-VIVO; TRANSMURAL HETEROGENEITY; MYOCYTES; CHANNELOPATHIES; CALSEQUESTRIN; MECHANISMS; CURRENTS; FAILURE	Rationale: Structural differences between ventricular regions may not be the sole determinant of local ventricular fibrillation (VF) dynamics and molecular remodeling may play a role. Objectives: To define regional ion channel expression in myopathic hearts compared to normal hearts, and correlate expression to regional VF dynamics. Methods and Results: High throughput real-time RT-PCR was used to quantify the expression patterns of 84 ion-channel, calcium cycling, connexin and related gene transcripts from sites in the LV, septum, and RV in 8 patients undergoing transplantation. An additional eight non-diseased donor human hearts served as controls. To relate local ion channel expression change to VF dynamics localized VF mapping was performed on the explanted myopathic hearts right adjacent to sampled regions. Compared to non-diseased ventricles, significant differences (p<0.05) were identified in the expression of 23 genes in the myopathic LV and 32 genes in the myopathic RV. Within the myopathic hearts significant regional (LV vs septum vs RV) expression differences were observed for 13 subunits: Nav1.1, Cx43, Ca3.1, Cav alpha 2 delta 2, Cav beta 2, HCN2, Na/K ATPase-1, CASQ1, CASQ2, RYR2, Kir2.3, Kir3.4, SUR2 (p<0.05). In a subset of genes we demonstrated differences in protein expression between control and myopathic hearts, which were concordant with the mRNA expression profiles for these genes. Variability in the expression of Cx43, hERG, Na+/K+ ATPase beta 1 and Kir2.1 correlated to variability in local VF dynamics (p<0.001). To better understand the contribution of multiple ion channel changes on VF frequency, simulations of a human myocyte model were conducted. These simulations demonstrated the complex nature by which VF dynamics are regulated when multi-channel changes are occurring simultaneously, compared to known linear relationships. Conclusions: Ion channel expression profile in myopathic human hearts is significantly altered compared to normal hearts. Multi-channel ion changes influence VF dynamic in a complex manner not predicted by known single channel linear relationships.	[Sivagangabalan, Gopal; Nazzari, Hamed; Farid, Talha; Masse, Stephane; Nair, Krishnakumar; Backx, Peter; Nanthakumar, Kumaraswamy] Toronto Gen Hosp, Toronto, ON, Canada; [Bignolais, Olivier; Gaborit, Nathalie; Demolombe, Sophie] INSERM, UMR915, Inst Thorax, Nantes, France; [Bignolais, Olivier; Gaborit, Nathalie; Demolombe, Sophie] CNRS, ERL3147, Nantes, France; [Bignolais, Olivier; Gaborit, Nathalie; Demolombe, Sophie] Univ Nantes, Nantes, France; [Varro, Andras] Univ Szeged, Szeged, Hungary; [Varro, Andras] Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary; [Maguy, Ange; Naud, Patrice; Vigmond, Edward] IHU LIRYC, Electrophysiol & Heart Modeling Inst, Pessac, France; [Maguy, Ange; Naud, Patrice; Vigmond, Edward] Univ Bordeaux 1, Lab IMB, F-33405 Talence, France; [Nattel, Stanley] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Nattel, Stanley] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Szeged University; Hungarian Academy of Sciences; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universite de Montreal; Universite de Montreal	Nanthakumar, K (corresponding author), Toronto Gen Hosp, Toronto, ON, Canada.	k.nanthakumar@uhn.on.ca	, Nanthakumar/AAA-9943-2020; Varro, Andras/M-2647-2016; Maguy, Ange/ABG-9298-2021; Gaborit, Nathalie/D-4977-2015; Nair, Krishnakumar/AAU-7806-2020	Gaborit, Nathalie/0000-0002-5231-6555; Maguy, Ange/0000-0003-0170-7430; Nattel, Stanley/0000-0002-5565-3311	CIHR [MOP777687]; Heart and Stroke Foundation of Canada Research Fellowship; government of France through the ANR Investissements d'Avenir grant [ANR-10-IAHU-04]	CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada Research Fellowship(Heart & Stroke Foundation of Canada); government of France through the ANR Investissements d'Avenir grant(French National Research Agency (ANR))	This research was funded by grants from CIHR MOP777687 to Dr. Nanthakumar. Dr. Sivagangabalan is a recipient of a Heart and Stroke Foundation of Canada Research Fellowship. Part of this work was supported by the government of France through the ANR Investissements d'Avenir grant ANR-10-IAHU-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2013, GENE, V517, P1, DOI 10.1016/j.gene.2012.12.061; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Chugh SS, 2003, CARDIOVASC RES, V57, P477, DOI 10.1016/S0008-6363(02)00703-4; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Evans FG, 1999, IEEE T BIO-MED ENG, V46, P1090, DOI 10.1109/10.784140; Farid TA, 2011, CIRC RES, V109, P1309, DOI 10.1161/CIRCRESAHA.110.232918; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Glukhov AV, 2012, CIRCULATION, V125, P1835, DOI 10.1161/CIRCULATIONAHA.111.047274; Hashimoto N, 2008, J CARDIOVASC PHARM, V51, P162, DOI 10.1097/FJC.0b013e31815e854c; Kaynak B, 2003, CIRCULATION, V107, P2467, DOI 10.1161/01.CIR.0000066694.21510.E2; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Kieken F, 2009, CIRC RES, V104, P1103, DOI 10.1161/CIRCRESAHA.108.190454; KOUMI S, 1995, CIRCULATION, V92, P164, DOI 10.1161/01.CIR.92.2.164; Laurita KR, 2003, CIRC RES, V92, P668, DOI 10.1161/01.RES.0000062468.25308.27; Lebeche D, 2004, CIRCULATION, V110, P3435, DOI 10.1161/01.CIR.0000148176.33730.3F; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Lou Q, 2011, CIRCULATION, V123, P1881, DOI 10.1161/CIRCULATIONAHA.110.989707; Masse S, 2007, AM J PHYSIOL-HEART C, V292, pH2589, DOI 10.1152/ajpheart.01336.2006; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; NAIR K, 2009, CIRCULATION S2, V120, pS630; Nanthakumar K, 2005, J CARDIOVASC ELECTR, V16, P425, DOI 10.1046/j.1540-8167.2005.40517.x; Nanthakumar K, 2002, CIRC RES, V91, P733, DOI 10.1161/01.RES.0000038945.66661.21; Nanthakumar K, 2007, AM J PHYSIOL-HEART C, V293, pH875, DOI 10.1152/ajpheart.01415.2006; Sah R, 2003, J PHYSIOL-LONDON, V546, P5, DOI 10.1113/jphysiol.2002.026468; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; Sato Y, 1998, J BIOL CHEM, V273, P28470, DOI 10.1074/jbc.273.43.28470; Sekar RB, 2009, CIRC RES, V104, P355, DOI 10.1161/CIRCRESAHA.108.178335; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Sridhar A, 2006, AM J PHYSIOL-HEART C, V291, pH2192, DOI 10.1152/ajpheart.01146.2005; Tabibiazar R, 2003, CIRC RES, V93, P1193, DOI 10.1161/01.RES.0000103171.42654.DD; Thomas SP, 2005, CIRCULATION, V112, P157, DOI 10.1161/CIRCULATIONAHA.104.503631; Tung L, 2007, J ELECTROCARDIOL, V40, pS62, DOI 10.1016/j.jelectrocard.2007.06.018; Umapathy K, 2009, MED ENG PHYS, V31, P964, DOI 10.1016/j.medengphy.2009.05.009; Umapathy K, 2009, IEEE T BIO-MED ENG, V56, P328, DOI 10.1109/TBME.2008.2006031; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Warren M, 2003, J CARDIOVASC ELECTR, V14, P621, DOI 10.1046/j.1540-8167.2003.03006.x; Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571; Wu TJ, 1998, J AM COLL CARDIOL, V32, P187, DOI 10.1016/S0735-1097(98)00184-3; Zhao XS, 2002, PHYSIOL GENOMICS, V12, P53, DOI 10.1152/physiolgenomics.00086.2002	40	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e82179	10.1371/journal.pone.0082179	http://dx.doi.org/10.1371/journal.pone.0082179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427266	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000329868200006
J	Zhou, ZM; Zhou, B; Ren, LP; Meng, QX				Zhou, Zhenming; Zhou, Bo; Ren, Liping; Meng, Qingxiang			Effect of Ensiled Mulberry Leaves and Sun-Dried Mulberry Fruit Pomace on Finishing Steer Growth Performance, Blood Biochemical Parameters, and Carcass Characteristics	PLOS ONE			English	Article							MORUS-ALBA; RUMINAL FERMENTATION; ANTIOXIDANT ACTIVITY; LOTUS-CORNICULATUS; CONDENSED TANNINS; FORAGE DIGESTION; UREA KINETICS; RUMEN; INSULIN; GLUCOSE	Fifty-one Simmental crossbred steers (357.0+/-16.5 kg) were used to compare a standard total mix ration (TMR) with variants on animal performance, ruminal fermentation, blood biochemical parameters, and carcass characteristics. Corn grain and cotton seed meal were partially replaced by ensiled mulberry leaves (EML) or sun-dried mulberry fruit pomace (SMFP). Experimental diets had similar amounts of crude protein (CP), acid detergent fiber (ADF), and metabolizable energy (ME). Animals were divided into three groups: control group (CONT), 8% EML group, and 6.3% SMFP group. Performance, including average daily weight gain (ADG), and dry matter intake (DMI), was measured. Blood and rumen samples were collected at the end of the experiment (16 weeks). There were no differences in final body weight (P = 0.743), ADG (P = 0.425), DMI (P = 0.642), or ADG/DMI (P = 0.236) between the groups. There were no differences (P = 0.2024) in rumen pH values; ammonia N was lower (P = 0.0076) in SMFP than in the EML and CONT groups. There were differences in the concentrations of total and individual volatile fatty acids, while no differences were determined in blood biochemical parameters (i.e., plasma glucose, urea concentrations, triglycerides, total protein, insulin, IgG, alanine transaminase, and aspartate aminotransferase, P >= 0.098). No differences were observed in carcass characteristics (P >= 0.513), tenderness (P = 0.844), adipose and lean color values (P >= 0.149), and chemical composition (P >= 0.400); however, intramuscular fat was lower in the EML and SMFP groups compared to the CONT animals (P = 0.034). In conclusion, diets supplemented with these two mulberry products in an isocaloric and isonitrogenous manner have similar effects to corn grain and cotton seed meals on steer performance, blood biochemical parameters and carcass characteristics, with the exception of ruminal VFA concentrations and lower intramuscular fat content.	[Zhou, Zhenming; Zhou, Bo; Ren, Liping; Meng, Qingxiang] China Agr Univ, State Key Lab Anim Nutr, Beijing 100094, Peoples R China; [Zhou, Zhenming; Zhou, Bo; Ren, Liping; Meng, Qingxiang] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Meng, QX (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Beijing 100094, Peoples R China.	qxmeng@cau.edu.cn	Meng, Q./GSI-6185-2022		National Nature Science Foundation of China [31101738]; China Agricultural Research System [CARS-38]; Chinese Universities Scientific Fund [2013QJ071, 2012 QJ108]; National Scientific Programme [2011CB302705]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural Research System; Chinese Universities Scientific Fund; National Scientific Programme	This study was funded by the National Nature Science Foundation of China (31101738), China Agricultural Research System (CARS-38), Chinese Universities Scientific Fund (2013QJ071, 2012 QJ108) and National Scientific Programme (2011CB302705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett EJ, 2012, J ANIM SCI, V90, P960, DOI 10.2527/jas.2011-4027; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Bailey EA, 2012, J ANIM SCI, V90, P3492, DOI 10.2527/jas.2011-4458; Bailey EA, 2012, J ANIM SCI, V90, P3505, DOI 10.2527/jas.2011-4459; Butkhup L, 2013, INT J FOOD SCI TECH, V48, P934, DOI 10.1111/ijfs.12044; Chen JJ, 2007, ASIA PAC J CLIN NUTR, V16, P290; Cheong SH, 2012, ANIM PROD SCI, V52, P240, DOI 10.1071/AN11087; Choi J, 2013, ARCH PHARM RES; Deshmukh S. V., 1993, World Rabbit Science, V1, P67; Doran MP, 2007, ANIM FEED SCI TECH, V138, P239, DOI 10.1016/j.anifeedsci.2006.11.016; Hogan S, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-71; Isabelile M, 2008, J AGR FOOD CHEM, V56, P9410, DOI 10.1021/jf801527a; JOHNSON DD, 1982, J ANIM SCI, V55, P1224, DOI 10.2527/jas1982.5551224x; LAARVELD B, 1981, ENDOCRINOLOGY, V108, P2217, DOI 10.1210/endo-108-6-2217; Li YL, 2006, ARCH ANIM NUTR, V60, P402, DOI 10.1080/17450390600884401; Liu JX, 2001, SMALL RUMINANT RES, V39, P131, DOI 10.1016/S0921-4488(00)00180-2; Lopez-Campos O, 2011, J ANIM SCI, V89, P1153, DOI 10.2527/jas.2010-2977; Mao SY, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-237; Min BR, 2012, J ANIM SCI, V90, P3556, DOI 10.2527/jas.2011-4931; Min BR, 2000, J AGR SCI, V134, P305, DOI 10.1017/S0021859699007698; Min BR, 2002, CAN J MICROBIOL, V48, P911, DOI 10.1139/W02-087; *MIN CO LTD, 1994, PREC COL COMM COL CO; Price BD, 2011, J ANIM SCI, V89, P809, DOI 10.2527/jas.2010-3187; Romero-Huelva M, 2012, J DAIRY SCI, V95, P6015, DOI 10.3168/jds.2012-5573; Sagdic O, 2011, J FOOD SCI, V76, pM515, DOI 10.1111/j.1750-3841.2011.02323.x; Salinas-Chavira J, 2011, TROP ANIM HEALTH PRO, V43, P995, DOI 10.1007/s11250-011-9797-1; Sami AS, 2004, J ANIM PHYSIOL AN N, V88, P179, DOI 10.1111/j.1439-0396.2004.00455.x; Taasoli G, 2008, Pak J Biol Sci, V11, P294, DOI 10.3923/pjbs.2008.294.297; Tesseraud S, 2007, DOMEST ANIM ENDOCRIN, V33, P123, DOI 10.1016/j.domaniend.2006.06.002; Todaro M, 2007, J ANIM VET ADV, V6, P509; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vu CC, 2011, ASIAN AUSTRAL J ANIM, V24, P1233, DOI 10.5713/ajas.2011.90328; Wang W, 2012, AM J CHINESE MED, V40, P349, DOI 10.1142/S0192415X12500279; Weiss WP, 1997, J DAIRY SCI, V80, P2896, DOI 10.3168/jds.S0022-0302(97)76254-4; Winkelman LA, 2012, J DAIRY SCI, V95, P6974, DOI 10.3168/jds.2011-5045; Xue F, 2011, ANIM FEED SCI TECH, V169, P61, DOI 10.1016/j.anifeedsci.2011.05.011; Yang WZ, 2012, J ANIM SCI, V90, P1301, DOI 10.2527/jas.2011-4372; Zhou B, 2012, J ANIM FEED SCI, V21, P188, DOI 10.22358/jafs/66063/2012; Zou YX, 2012, INT J MOL SCI, V13, P16544, DOI 10.3390/ijms131216544	39	18	25	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85406	10.1371/journal.pone.0085406	http://dx.doi.org/10.1371/journal.pone.0085406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427304	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200045
J	Parker, HJ; Sauka-Spengler, T; Bronner, M; Elgar, G				Parker, Hugo J.; Sauka-Spengler, Tatjana; Bronner, Marianne; Elgar, Greg			A Reporter Assay in Lamprey Embryos Reveals Both Functional Conservation and Elaboration of Vertebrate Enhancers	PLOS ONE			English	Article							HOX GENE-REGULATION; EVOLUTIONARY ORIGIN; EXPRESSION; TRANSGENESIS; INSIGHTS; CLONING; IDENTIFICATION; GENOME	The sea lamprey is an important model organism for investigating the evolutionary origins of vertebrates. As more vertebrate genome sequences are obtained, evolutionary developmental biologists are becoming increasingly able to identify putative gene regulatory elements across the breadth of the vertebrate taxa. The identification of these regions makes it possible to address how changes at the genomic level have led to changes in developmental gene regulatory networks and ultimately to the evolution of morphological diversity. Comparative genomics approaches using sea lamprey have already predicted a number of such regulatory elements in the lamprey genome. Functional characterisation of these sequences and other similar elements requires efficient reporter assays in lamprey. In this report, we describe the development of a transient transgenesis method for lamprey embryos. Focusing on conserved non-coding elements (CNEs), we use this method to investigate their functional conservation across the vertebrate subphylum. We find instances of both functional conservation and lineage-specific functional evolution of CNEs across vertebrates, emphasising the utility of functionally testing homologous CNEs in their host species.	[Parker, Hugo J.; Elgar, Greg] Natl Inst Med Res, MRC, Div Syst Biol, London NW7 1AA, England; [Sauka-Spengler, Tatjana; Bronner, Marianne] CALTECH, Div Biol, Pasadena, CA 91125 USA	MRC National Institute for Medical Research; California Institute of Technology	Elgar, G (corresponding author), Natl Inst Med Res, MRC, Div Syst Biol, London NW7 1AA, England.	gelgar@nimr.mrc.ac.uk		Elgar, Greg/0000-0001-7323-1596; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Parker, Hugo/0000-0001-7646-2007; Bronner, Marianne/0000-0003-4274-1862	MRC [U117597141, GM090049, DE017911]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090049] Funding Source: NIH RePORTER; Medical Research Council [MC_U117597141, G0902418] Funding Source: researchfish; MRC [G0902418, MC_U117597141] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by MRC core funding (U117597141) to GE and grants GM090049 and DE017911 to MEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biemar F, 2001, MECH DEVELOP, V109, P427, DOI 10.1016/S0925-4773(01)00554-8; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Carr JL, 1998, J EXP ZOOL, V280, P73, DOI 10.1002/(SICI)1097-010X(19980101)280:1<73::AID-JEZ9>3.0.CO;2-E; Cerny R, 2010, P NATL ACAD SCI USA, V107, P17262, DOI 10.1073/pnas.1009304107; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Goode DK, 2011, DEVELOPMENT, V138, P879, DOI 10.1242/dev.055996; Guerin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005374; Haming D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026543; Irvine SQ, 2002, J EXP ZOOL, V294, P47, DOI 10.1002/jez.10090; Kano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013332; Kusakabe R, 2003, J EXP ZOOL PART B, V296B, P87, DOI 10.1002/jez.b.00011; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Murakami Y, 2004, DEVELOPMENT, V131, P983, DOI 10.1242/dev.00986; Murakami Y, 2001, DEVELOPMENT, V128, P3521; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Nikitina N, 2009, COLD SPRING HARB, V15; Ogino H, 2006, NAT PROTOC, V1, P1703, DOI 10.1038/nprot.2006.208; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Parker HJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-637; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Ritter DI, 2010, MOL BIOL EVOL, V27, P2322, DOI 10.1093/molbev/msq128; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Sugahara F, 2011, DEVELOPMENT, V138, P1217, DOI 10.1242/dev.059360; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yu JK, 2008, GENOME RES, V18, P1127, DOI 10.1101/gr.076208.108; Zerucha T, 2001, MECH DEVELOP, V102, P247, DOI 10.1016/S0925-4773(01)00299-4	37	14	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85492	10.1371/journal.pone.0085492	http://dx.doi.org/10.1371/journal.pone.0085492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416417	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000329866300083
J	Yang, F; Zhou, YL; Yin, LH; Zhu, GC; Liang, GY; Pu, YP				Yang, Fei; Zhou, Yuanlong; Yin, Lihong; Zhu, Guangcan; Liang, Geyu; Pu, Yuepu			Microcystin-Degrading Activity of an Indigenous Bacterial Strain Stenotrophomonas acidaminiphila MC-LTH2 Isolated from Lake Taihu	PLOS ONE			English	Article							ENZYMATIC PATHWAY; FRESH-WATER; DEGRADATION; LR; RR; BIODEGRADATION; GENE	Microcystin-LR (MC-LR) and microcystin-RR (MC-RR) produced by harmful cyanobacterial blooms (HCBs) pose substantial threats to the ecosystem and public health due to their potential hepatotoxicity. Degradation of microcystins (MCs) by indigenous bacteria represents a promising method for removing MCs from fresh water without harming the aquatic environment, but only a few microcystin (MC)-degrading bacteria have been isolated and had their mechanisms reported. This study aimed to isolate indigenous bacteria from Lake Taihu, and investigate the capability and mechanism of MC degradation by these bacteria. During a Microcystis bloom, an indigenous MC-degrading bacterium designated MC-LTH2 was successfully isolated from Lake Taihu, and identified as Stenotrophomonas acidaminiphila based on phylogenetic analysis. In the presence of MC-LR together with MC-RR, the strain MC-LTH2 was capable of totally degrading both simultaneously in 8 days, at rates of 3.0 mg/(L-d) and 5.6 mg/(L-d), respectively. The degradation rates of MCs were dependent on temperature, pH, and initial MC concentration. Adda (3-amino-9-methoxy-2, 6, 8-trimethyl-10-phenyldeca-4, 6-dienoic acid) was detected as an intermediate degradation product of MCs using high performance liquid chromatography coupled with time-of-flight mass spectrometry (HPLC-TOF-MS). To the best of our knowledge, this is the first report of Stenotrophomonas acidaminiphila capable of degrading two MC analogues and other compounds containing Adda residue completely under various conditions, although the mlrA gene in the strain was not detected. These results indicate the Stenotrophomonas acidaminiphila strain MC-LTH2 possesses a significant potential to be used in bioremediation of water bodies contaminated by MC-LR and MC-RR, and is potentially involved in the degradation of MCs during the disappearance of the HCBs in Lake Taihu.	[Yang, Fei; Zhou, Yuanlong; Yin, Lihong; Zhu, Guangcan; Liang, Geyu; Pu, Yuepu] SE Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing 210018, Peoples R China	Southeast University - China	Pu, YP (corresponding author), SE Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing 210018, Peoples R China.	yppu@seu.edu.cn		Yang, Fei/0000-0001-5687-0556	National Natural Science Foundation of China [30972440]; National Science and Technology Major Project [2012ZX07101-005, 2012ZX07403-001]; Jiangsu Province postgraduate Innovation Project [CX10B-087Z]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Jiangsu Province postgraduate Innovation Project	This research was supported by National Natural Science Foundation of China (30972440), the National Science and Technology Major Project (2012ZX07101-005, 2012ZX07403-001), and the Jiangsu Province postgraduate Innovation Project (CX10B-087Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamri SA, 2012, SAUDI J BIOL SCI, V19, P435, DOI 10.1016/j.sjbs.2012.06.006; Bourne DG, 1996, APPL ENVIRON MICROB, V62, P4086, DOI 10.1128/AEM.62.11.4086-4094.1996; Bourne DG, 2001, ENVIRON TOXICOL, V16, P523, DOI 10.1002/tox.10013; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Chen J, 2010, INT J MOL SCI, V11, P896, DOI 10.3390/ijms11030896; Chen P, 2012, ENVIRON SCI TECHNOL, V46, P2345, DOI 10.1021/es2036338; Chen XG, 2010, WATER RES, V44, P1884, DOI 10.1016/j.watres.2009.11.025; Codd GA, 1999, EUR J PHYCOL, V34, P405, DOI 10.1080/09670269910001736462; Duan HT, 2009, ENVIRON SCI TECHNOL, V43, P3522, DOI 10.1021/es8031852; Gagala I, 2012, POL J ENVIRON STUD, V21, P1125; Harada K, 2004, TOXICON, V44, P107, DOI 10.1016/j.toxicon.2004.04.003; Ho L, 2007, WATER RES, V41, P4685, DOI 10.1016/j.watres.2007.06.057; Hu LB, 2009, NEW BIOTECHNOL, V26, P205, DOI 10.1016/j.nbt.2009.09.001; Imanishi S, 2005, CHEM RES TOXICOL, V18, P591, DOI 10.1021/tx049677g; Ito E, 2002, TOXICON, V40, P1017, DOI 10.1016/S0041-0101(02)00099-5; Jones Gary J., 1994, Natural Toxins, V2, P228, DOI 10.1002/nt.2620020412; Li Xiaoqin, 2010, Journal of Southeast University (English Edition), V26, P96; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Manage PM, 2009, APPL ENVIRON MICROB, V75, P6924, DOI 10.1128/AEM.01928-09; Mou XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061890; Okano K, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/954291; Park HD, 2001, ENVIRON TOXICOL, V16, P337, DOI 10.1002/tox.1041; Saito T, 2003, FEMS MICROBIOL LETT, V229, P271, DOI 10.1016/S0378-1097(03)00847-4; Saitou T, 2003, J WATER SUPPLY RES T, V52, P13, DOI 10.2166/aqua.2003.0002; Shimizu K, 2012, J BIOSCI BIOENG, V114, P630, DOI 10.1016/j.jbiosc.2012.07.004; Song LR, 2007, WATER RES, V41, P2853, DOI 10.1016/j.watres.2007.02.013; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Stone R, 2011, SCIENCE, V333, P1210, DOI 10.1126/science.333.6047.1210; Takenaka S, 1997, CHEMOSPHERE, V34, P749, DOI 10.1016/S0045-6535(97)00002-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang JF, 2010, CHINESE J CHEM ENG, V18, P108, DOI 10.1016/S1004-9541(08)60330-4; Wang SC, 2012, ENVIRON SCI TECHNOL, V46, P3442, DOI 10.1021/es203675y; WHO, 1998, GUID DRINK WAT QUAL, V2nd, P95; Yan H, 2012, J ENVIRON SCI-CHINA, V24, P1816, DOI 10.1016/S1001-0742(11)61016-4; Yang F, 2013, BIOMED ENVIRON SCI, V26, P148, DOI 10.3967/0895-3988.2013.02.009; Yang H, 2006, B ENVIRON CONTAM TOX, V77, P367, DOI 10.1007/s00128-006-1075-y	36	44	47	4	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e86216	10.1371/journal.pone.0086216	http://dx.doi.org/10.1371/journal.pone.0086216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416455	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300104
J	Frank-Fahle, BA; Yergeau, E; Greer, CW; Lantuit, H; Wagner, D				Frank-Fahle, Beatrice A.; Yergeau, Etienne; Greer, Charles W.; Lantuit, Hugues; Wagner, Dirk			Microbial Functional Potential and Community Composition in Permafrost-Affected Soils of the NW Canadian Arctic	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; METHANE-OXIDIZING BACTERIA; LENA DELTA; METHANOTROPHIC BACTERIA; CARBON TURNOVER; METHANOGENIC PATHWAYS; POLYGONAL TUNDRA; LAPTEV SEA; GEN. NOV.; DIVERSITY	Permafrost-affected soils are among the most obvious ecosystems in which current microbial controls on organic matter decomposition are changing as a result of global warming. Warmer conditions in polygonal tundra will lead to a deepening of the seasonal active layer, provoking changes in microbial processes and possibly resulting in exacerbated carbon degradation under increasing anoxic conditions. To identify current microbial assemblages in carbon rich, water saturated permafrost environments, four polygonal tundra sites were investigated on Herschel Island and the Yukon Coast, Western Canadian Arctic. Ion Torrent sequencing of bacterial and archaeal 16S rRNA amplicons revealed the presence of all major microbial soil groups and indicated a local, vertical heterogeneity of the polygonal tundra soil community with increasing depth. Microbial diversity was found to be highest in the surface layers, decreasing towards the permafrost table. Quantitative PCR analysis of functional genes involved in carbon and nitrogen-cycling revealed a high functional potential in the surface layers, decreasing with increasing active layer depth. We observed that soil properties driving microbial diversity and functional potential varied in each study site. These results highlight the small-scale heterogeneity of geomorphologically comparable sites, greatly restricting generalizations about the fate of permafrost-affected environments in a warming Arctic.	[Frank-Fahle, Beatrice A.; Lantuit, Hugues] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Unit Potsdam, Potsdam, Germany; [Yergeau, Etienne; Greer, Charles W.] Natl Res Council Canada, Montreal, PQ, Canada; [Lantuit, Hugues] Univ Potsdam, Potsdam, Germany; [Wagner, Dirk] GFZ German Ctr Geosci, Sect Geomicrobiol 4 5, Potsdam, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Potsdam; National Research Council Canada; University of Potsdam; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Wagner, D (corresponding author), GFZ German Ctr Geosci, Sect Geomicrobiol 4 5, Potsdam, Germany.	dirk.wagner@gfz-potsdam.de	Lantuit, Hugues/ABC-8692-2020; Yergeau, Etienne/B-5344-2008; Yergeau, Etienne/AAZ-6145-2020; Wagner, Dirk/C-3932-2012	Lantuit, Hugues/0000-0003-1497-6760; Yergeau, Etienne/0000-0002-7112-3425; Wagner, Dirk/0000-0001-5064-497X	"International Cooperation in Education and Research" program of the International Bureau of the German Federal Ministry of Education and Research (BMBF); German Environmental Foundation (DBU)	"International Cooperation in Education and Research" program of the International Bureau of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Environmental Foundation (DBU)	This study was funded by the "International Cooperation in Education and Research" program of the International Bureau of the German Federal Ministry of Education and Research (BMBF) and through a doctoral scholarship to Beatrice A. Frank-Fahle from the German Environmental Foundation (DBU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aislabie JM, 2006, SOIL BIOL BIOCHEM, V38, P3041, DOI 10.1016/j.soilbio.2006.02.018; Barbier BA, 2012, FEMS MICROBIOL ECOL, V82, P287, DOI 10.1111/j.1574-6941.2012.01332.x; Bell TH, 2013, ISME J, V7, P1200, DOI 10.1038/ismej.2013.1; Bischoff J, 2013, GLOBAL BIOGEOCHEM CY, V27, P305, DOI 10.1029/2011GB004238; Brauer SL, 2011, INT J SYST EVOL MICR, V61, P45, DOI 10.1099/ijs.0.021782-0; Burn CR, 2009, CAN J GEOPHYS RES, V114, P1; Cadillo-Quiroz H, 2009, INT J SYST EVOL MICR, V59, P928, DOI 10.1099/ijs.0.006890-0; CHANTON JP, 1995, GEOCHIM COSMOCHIM AC, V59, P3663, DOI 10.1016/0016-7037(95)00240-Z; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; CONRAD R, 1987, FEMS MICROBIOL ECOL, V45, P281, DOI 10.1016/0378-1097(87)90005-X; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; EDMEADES DC, 1985, NEW ZEAL J EXP AGR, V13, P47, DOI 10.1080/03015521.1985.10426058; Fiedler S, 2004, SOIL SCI SOC AM J, V68, P1002, DOI 10.2136/sssaj2004.1002; Ganzert L, 2007, FEMS MICROBIOL ECOL, V59, P476, DOI 10.1111/j.1574-6941.2006.00205.x; Graef C, 2011, ENV MICROBIOL REP, V3, P466, DOI 10.1111/j.1758-2229.2010.00237.x; Graham DE, 2012, ISME J, V6, P709, DOI 10.1038/ismej.2011.163; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hartley IP, 2008, ECOL LETT, V11, P1092, DOI 10.1111/j.1461-0248.2008.01223.x; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Hoj L, 2005, FEMS MICROBIOL ECOL, V53, P89, DOI 10.1016/j.femsec.2005.01.004; Hoj L, 2008, ISME J, V2, P37, DOI 10.1038/ismej.2007.84; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Knoblauch C, 2013, GLOBAL CHANGE BIOL, V19, P985; Knoblauch C, 2008, SOIL BIOL BIOCHEM, V40, P3004, DOI 10.1016/j.soilbio.2008.08.020; Koch K, 2009, ENVIRON MICROBIOL, V11, P657, DOI 10.1111/j.1462-2920.2008.01836.x; Kolb S, 2003, APPL ENVIRON MICROB, V69, P2423, DOI 10.1128/AEM.69.5.2423-2429.2003; Kotsyurbenko OR, 2005, FEMS MICROBIOL ECOL, V53, P3, DOI 10.1016/j.femsec.2004.12.009; Kuhry P, 2010, PERMAFROST PERIGLAC, V21, P208, DOI 10.1002/ppp.684; Lawton J. H., 1993, REDUNDANCY ECOSYSTEM, P255; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Le Roux X, 2008, ISME J, V2, P221, DOI 10.1038/ismej.2007.109; Lee CK, 2012, ISME J, V6, P1046, DOI 10.1038/ismej.2011.170; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liebner S, 2009, MICROB ECOL, V57, P25, DOI 10.1007/s00248-008-9411-x; Liebner S, 2008, INT MICROBIOL, V11, P195, DOI 10.2436/20.1501.01.60; Liebner S, 2007, ENVIRON MICROBIOL, V9, P107, DOI 10.1111/j.1462-2920.2006.01120.x; Liebner S, 2011, J ECOL, V99, P914, DOI 10.1111/j.1365-2745.2011.01823.x; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Martineau C, 2010, APPL ENVIRON MICROB, V76, P5773, DOI 10.1128/AEM.03094-09; Metje M, 2007, ENVIRON MICROBIOL, V9, P954, DOI 10.1111/j.1462-2920.2006.01217.x; Minke M, 2007, PEATLANDS INT, V1, P36; Morozova D, 2007, FEMS MICROBIOL ECOL, V61, P16, DOI 10.1111/j.1574-6941.2007.00316.x; Nicolaisen MH, 2002, J MICROBIOL METH, V50, P189, DOI 10.1016/S0167-7012(02)00026-X; Poly F, 2001, RES MICROBIOL, V152, P95, DOI 10.1016/S0923-2508(00)01172-4; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rivkina E, 2007, FEMS MICROBIOL ECOL, V61, P1, DOI 10.1111/j.1574-6941.2007.00315.x; Schimel JP., 1996, LANDSCAPE FUNCTION D, P203, DOI [DOI 10.1007/978-3-662-01145-4_10, 10.1007/978-3-662-01145-4_10]; Shaver G. R., 1992, ARCTIC ECOSYSTEMS CH, P193; SHIVAJI S, 1992, INT J SYST BACTERIOL, V42, P102, DOI 10.1099/00207713-42-1-102; Soil Survey Staff, 1998, KEYS SOIL TAX; Steven B, 2008, ENVIRON MICROBIOL, V10, P3388, DOI 10.1111/j.1462-2920.2008.01746.x; Strom L, 2003, GLOBAL CHANGE BIOL, V9, P1185, DOI 10.1046/j.1365-2486.2003.00655.x; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; van Everdingen RO, 2005, MULTILANGUAGE GLOSSA; van Wijk MT, 2005, OECOLOGIA, V142, P421, DOI 10.1007/s00442-004-1733-x; Wagner D, 2005, ENVIRON MICROBIOL, V7, P1582, DOI 10.1111/j.1462-2920.2005.00849.x; Wagner D., 2009, SOIL BIOL, P219; Wagner D, 2007, GLOBAL CHANGE BIOL, V13, P1089, DOI 10.1111/j.1365-2486.2007.01331.x; Wagner D, 2013, INT J SYST EVOL MICR, V63, P2986, DOI 10.1099/ijs.0.046565-0; Wagner D, 2009, CAN J MICROBIOL, V55, P73, DOI 10.1139/W08-121; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weintraub MN, 2005, BIOSCIENCE, V55, P408, DOI 10.1641/0006-3568(2005)055[0408:NCATSO]2.0.CO;2; Whalen SC, 1992, GLOBAL BIOGEOCHEM CY, V6, P139, DOI 10.1029/92GB00430; WynnWilliams DD, 1996, BIODIVERS CONSERV, V5, P1271, DOI 10.1007/BF00051979; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Yergeau E, 2009, APPL ENVIRON MICROB, V75, P6258, DOI 10.1128/AEM.01029-09	71	62	63	6	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84761	10.1371/journal.pone.0084761	http://dx.doi.org/10.1371/journal.pone.0084761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416279	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500162
J	Hong, H; Xiao, WB; Maitta, RW				Hong, Hong; Xiao, Wenbin; Maitta, Robert W.			Steady Increment of Immature Platelet Fraction Is Suppressed by Irradiation in Single-Donor Platelet Components during Storage	PLOS ONE			English	Article							THROMBOCYTOPENIA; RADIATION; IPF	Circulating immature platelet fraction (IPF) reflects real-time thrombopoiesis and correlates with platelet recovery from thrombocytopenic presentations. To understand the dynamics of IPF in platelet transfusions, we quantified the %-IPF in single-donor platelet components (SDP) during prolonged storage. %-IPF significantly increased from baseline by day 5 post-donation. Absolute IPF counts (A-IPC) had similar significant increments. However, gamma-irradiation suppressed the increments of %-IPF and A-IPC by >50%. Ultrastructural analysis of SDP units at day 10 showed well preserved morphology of immature platelets. Our findings suggest that IPF might actively expand ex-vivo and may have a longer shelf life than their mature counterparts. Closer study of IPF may be of critical clinical importance for transfusion practices.	[Hong, Hong; Xiao, Wenbin; Maitta, Robert W.] Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH USA; [Hong, Hong; Xiao, Wenbin; Maitta, Robert W.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University	Maitta, RW (corresponding author), Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH USA.	robert.maitta@uhhospitals.org	Maitta, Robert/J-9318-2019	Maitta, Robert/0000-0002-5424-5519; Hong, Hong/0000-0002-1009-3621; Xiao, Wenbin/0000-0001-8586-8500	Office of Diversity and Inclusion of the University Hospitals Case Medical Center, Cleveland, Ohio	Office of Diversity and Inclusion of the University Hospitals Case Medical Center, Cleveland, Ohio	This study was fully supported by a grant from the Office of Diversity and Inclusion of the University Hospitals Case Medical Center, Cleveland, Ohio, awarded to RWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2006, THROMB RES, V118, P463, DOI 10.1016/j.thromres.2005.09.007; Barsam SJ, 2011, BLOOD, V117, P5723, DOI 10.1182/blood-2010-11-321398; Bat T, 2013, TRANSFUSION, V53, P1201, DOI 10.1111/j.1537-2995.2012.03918.x; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Fuentes R, 2010, J CLIN INVEST, V120, P3917, DOI 10.1172/JCI43326; Harrison P, 1997, PLATELETS, V8, P379; Jung H, 2010, KOREAN J LAB MED, V30, P451, DOI 10.3343/kjlm.2010.30.5.451; KALOVIDOURIS AE, 1981, ACTA RADIOL ONCOL, V20, P333, DOI 10.3109/02841868109130218; Kickler TS, 2006, AM J CLIN PATHOL, V125, P282, DOI 10.1309/50H8JYHN9JWCKAM7; KUCAN Z, 1971, BIOPHYS J, V11, P237; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Maurer-Spurej E, 2010, INT J LAB HEMATOL, V32, pE1, DOI 10.1111/j.1751-553X.2008.01097.x; MURPHY S, 1969, NEW ENGL J MED, V280, P1094, DOI 10.1056/NEJM196905152802004; Parco S, 2012, ONCOTARGETS THER, V5, DOI 10.2147/OTT.S27883; Sandgren P, 2013, TRANSFUSION; Shanwell A, 2006, TRANSFUSION, V46, P973, DOI 10.1111/j.1537-2995.2006.00830.x; SWEENEY JD, 1994, TRANSFUSION, V34, P779, DOI 10.1046/j.1537-2995.1994.34994378279.x; Zucker Marjorie L, 2006, Lab Hematol, V12, P125, DOI 10.1532/LH96.06012	19	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85465	10.1371/journal.pone.0085465	http://dx.doi.org/10.1371/journal.pone.0085465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416412	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500250
J	Li, JM; Lu, CL; Cheng, MC; Luu, SU; Hsu, SH; Hu, TM; Tsai, HY; Chen, CH				Li, Jun-Ming; Lu, Chao-Lin; Cheng, Min-Chih; Luu, Sy-Ueng; Hsu, Shih-Hsin; Hu, Tsung-Ming; Tsai, Hsin-Yao; Chen, Chia-Hsiang			Role of the DLGAP2 Gene Encoding the SAP90/PSD-95-Associated Protein 2 in Schizophrenia	PLOS ONE			English	Article							CANDIDATE GENE; PSYCHOSIS; FAMILY; MODEL	Aberrant synaptic dysfunction is implicated in the pathogenesis of schizophrenia. The DLGAP2 gene encoding the SAP90/PSD-95-associated protein 2 (SAPAP2) located at the post-synaptic density of neuronal cells is involved in the neuronal synaptic function. This study aimed to investigate whether the DLGAP2 gene is associated with schizophrenia. We resequenced the putative promoter region and all the exons of the DLGAP2 gene in 523 patients with schizophrenia and 596 non-psychotic controls from Taiwan and conducted a case-control association analysis. We identified 19 known SNPs in this sample. Association analysis of 9 SNPs with minor allele frequency greater than 5% showed no association with schizophrenia. However, we found a haplotype (CCACCAACT) significantly associated with schizophrenia (odds ratio: 2.5, p<0.001). We also detected 16 missense mutations and 1 amino acid-insertion mutation in this sample. Bioinformatic analysis showed some of these mutations were damaging or pathological to the protein function, but we did not find increased burden of these mutations in the patient group. Notably, we identified 5 private rare variants in 5 unrelated patients, respectively, including c.269+9C>T, c.269+13C>T, c.269+47C>T, c.269+55C>T at intron 1 and c.-232A>G at untranslated exon 2 of the DLGAP2 gene. These rare variants were not detected in 559 control subjects. Further reporter gene assay of these rare variants except c.-269+13C>T showed significantly elevated promoter activity than the wild type, suggesting increased DLGAP2 gene expression may contribute to the pathogenesis of schizophrenia. Our results indicate that DLGAP2 is a susceptible gene of schizophrenia.	[Li, Jun-Ming; Luu, Sy-Ueng] Taoyuan Armed Forces Gen Hosp, Dept Psychiat, Tao Yuan, Taiwan; [Lu, Chao-Lin] Hualien Armed Forces Gen Hosp, Dept Psychiat, Hualien, Taiwan; [Cheng, Min-Chih; Hsu, Shih-Hsin; Hu, Tsung-Ming; Tsai, Hsin-Yao] Taipei Vet Gen Hosp, Yuli Branch, Yuli Mental Hlth Res Ctr, Dept Psychiat, Hualien, Taiwan; [Chen, Chia-Hsiang] Chang Gung Mem Hosp Linkou, Dept Psychiat, Tao Yuan, Taiwan; [Chen, Chia-Hsiang] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan	Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University	Cheng, MC (corresponding author), Taipei Vet Gen Hosp, Yuli Branch, Yuli Mental Hlth Res Ctr, Dept Psychiat, Hualien, Taiwan.	cmc@vhyl.gov.tw; cchen3801@gmail.com	Cheng, Min-Chih/B-1363-2013	Cheng, Min-Chih/0000-0002-2962-0911; Chen, Chia-Hsiang/0000-0002-8232-2403	Taoyuan Armed Forces General Hospital; Hualien Armed Forces General Hospital in Taiwan	Taoyuan Armed Forces General Hospital; Hualien Armed Forces General Hospital in Taiwan	Funding for this study was provided by the Taoyuan Armed Forces General Hospital, and the Hualien Armed Forces General Hospital in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boardman L, 2011, COMPR PSYCHIAT, V52, P181, DOI 10.1016/j.comppsych.2010.05.007; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Chien WH, 2010, CLIN GENET, V78, P449, DOI 10.1111/j.1399-0004.2010.01395.x; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-26; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; Crane J, 2011, AM J MED GENET B, V156B, P108, DOI 10.1002/ajmg.b.31134; den Dunnen Johan T, 2003, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0713s37; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kumar RA, 2010, CLIN GENET, V78, P517, DOI 10.1111/j.1399-0004.2010.01530_1.x; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Li JM, 2013, PSYCHIAT RES, V208, P84, DOI 10.1016/j.psychres.2012.12.015; Li JM, 2013, PSYCHIAT RES, V205, P13, DOI 10.1016/j.psychres.2012.08.014; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Ozgen HM, 2009, CLIN GENET, V76, P348, DOI 10.1111/j.1399-0004.2009.01254.x; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ranta S, 2000, EUR J HUM GENET, V8, P381, DOI 10.1038/sj.ejhg.5200440; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Verpelli C, 2012, ADV EXP MED BIOL, V970, P29, DOI 10.1007/978-3-7091-0932-8_2; Waltereit R, 2013, WORLD J BIO IN PRESS; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Zuchner S, 2009, MOL PSYCHIATR, V14, P6, DOI 10.1038/mp.2008.83	30	14	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85373	10.1371/journal.pone.0085373	http://dx.doi.org/10.1371/journal.pone.0085373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416398	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500243
J	Lian, IB; Wu, HDI; Chang, WT; Chao, DY				Lian, Ie-Bin; Wu, Hong-Dar Isaac; Chang, Wan-Tzu; Chao, Day-Yu			The Temporal Trend of Influenza-Associated Morbidity and the Impact of Early Appearance of Antigenic Drifted Strains in a Southeast Asian Country	PLOS ONE			English	Article							PROPENSITY SCORE; IMMUNE-RESPONSE; ELDERLY-PEOPLE; META-ANALYSIS; OLDER-ADULTS; VACCINATION; MORTALITY; VACCINES; TAIWAN; VIRUS	Globally, influenza infection is a major cause of morbidity and mortality in the elderly, who are suggested to be the major target group for trivalent influenza vaccine (TIV) vaccination by World Health Organization. In spite of an increasing trend in vaccine coverage rates in many countries, the effect of vaccination among the elderly in reducing hospitalization and mortality remains controversial. In this study, we conducted a historical cohort study to evaluate the temporal pattern of influenza-associated morbidity among persons older than 64 years over a decade. The temporal patterns of influenza-associated morbidity rates among the elderly older than 64 years indicated that Taiwan's elderly P&I outpatient visits have been decreasing since the beginning of the 1999-2000 influenza season; however, hospitalization has been increasing despite significant increases in vaccine coverage. The propensity score logistic regression model was implemented to evaluate the source of bias and it was found that the TIV-receiving group had a higher propensity score than the non-receiving group (P<0.0001). In order to investigate the major factors affecting the temporal pattern of influenza-associated morbidity, we then used the propensity score as a summary confounder in a multivariate Poisson regression model based on the trimmed data. Our final models suggested that the factors affected the temporal pattern of morbidity differently. The variables including co-morbidity, vaccination rate, influenza virus type A and B isolation rate were associated with increased outpatient visits and hospitalization (p<0.05). In contrast, variables including high propensity score, increased 1 degrees C in temperature, matching vaccine strains of type A/H1N1 and type B were associated with decreased outpatient visits and hospitalization (p<0.05). Finally, we assessed the impact of early appearance of antigenic-drifted strains and concluded that an excess influenza-associated morbidity substantial trends toward higher P&I hospitalization, but not outpatient visits, during the influenza season with early appearance of antigenic-drifted strains.	[Lian, Ie-Bin; Chang, Wan-Tzu] Natl Changhua Univ Educ, Grad Inst Stat & Informat Sci, Changhua, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Dept Appl Math, Taichung 40227, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Inst Stat, Taichung 40227, Taiwan; [Chao, Day-Yu] Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan	National Changhua University of Education; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Chao, DY (corresponding author), Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan.	dychao@nchu.edu.tw	Lian, Ie-Bin/AAE-3368-2021; Chao, Day-Yu/AFH-8360-2022	Chao, Day-Yu/0000-0001-7139-026X; Lian, Ie-bin/0000-0003-3992-6049				Baxter R, 2010, VACCINE, V28, P7267, DOI 10.1016/j.vaccine.2010.08.088; Baxter R, 2010, J INFECT DIS, V201, P186, DOI 10.1086/649568; Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; Beyer WEP, 1999, ARCH INTERN MED, V159, P182, DOI 10.1001/archinte.159.2.182; Blank PR, 2009, INFECTION, V37, P390, DOI 10.1007/s15010-009-8467-y; Brydak LB, 2003, J CLIN IMMUNOL, V23, P214, DOI 10.1023/A:1023314029788; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Chan TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011317; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; de Bruijn IA, 1999, J INFECT DIS, V179, P31, DOI 10.1086/314540; Dean AS, 2010, VACCINE, V28, P864, DOI 10.1016/j.vaccine.2009.03.024; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Gorina Y, 2008, AGING TRENDS, V8, P1; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ho TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050337; Hurwitz ES, 2000, JAMA-J AM MED ASSOC, V284, P1677, DOI 10.1001/jama.284.13.1677; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jian JW, 2008, J CLIN MICROBIOL, V46, P1426, DOI 10.1128/JCM.01560-07; Kim SA, 2011, J HEALTH POPUL NUTR, V29, P574; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Lang PO, 2012, CLIN INTERV AGING, V7, P55, DOI 10.2147/CIA.S25215; Li DJ, 2008, J CLIN MICROBIOL, V46, P399, DOI 10.1128/JCM.01549-07; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; Mannino S, 2012, AM J EPIDEMIOL, V176, P527, DOI 10.1093/aje/kws313; Michiels B, 2011, VACCINE, V29, P9159, DOI 10.1016/j.vaccine.2011.08.008; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nicholson KG, 1999, EPIDEMIOL INFECT, V123, P103, DOI 10.1017/S095026889900271X; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Talbot HK, 2012, VACCINE, V30, P3937, DOI 10.1016/j.vaccine.2012.03.071; Vu T, 2002, VACCINE, V20, P1831, DOI 10.1016/S0264-410X(02)00041-5; Wang SF, 2009, J MED VIROL, V81, P1457, DOI 10.1002/jmv.21531; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049343	47	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84239	10.1371/journal.pone.0084239	http://dx.doi.org/10.1371/journal.pone.0084239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416205	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500104
J	Lu, JW; Liao, CY; Yang, WY; Lin, YM; Jin, SLC; Wang, HD; Yuh, CH				Lu, Jeng-Wei; Liao, Chung-Yi; Yang, Wan-Yu; Lin, Yueh-Min; Jin, Shiow-Lian Catherine; Wang, Horng-Dar; Yuh, Chiou-Hwa			Overexpression of Endothelin 1 Triggers Hepatocarcinogenesis in Zebrafish and Promotes Cell Proliferation and Migration through the AKT Pathway	PLOS ONE			English	Article							B-VIRUS X; HUMAN HEPATOCELLULAR-CARCINOMA; LIVER-SPECIFIC EXPRESSION; HEPATITIS-B; TRANSGENIC ZEBRAFISH; COLORECTAL-CANCER; GENE-EXPRESSION; MYC EXPRESSION; GROWTH-FACTOR; IN-VITRO	Hepatocarcinogenesis commonly involves the gradual progression from hepatitis to fibrosis and cirrhosis, and ultimately to hepatocellular carcinoma (HCC). Endothelin 1 (Edn1) has been identified as a gene that is significantly up-regulated in HBx-induced HCC in mice. In this study, we further investigated the role of edn1 in hepatocarcinogenesis using a transgenic zebrafish model and a cell culture system. Liver-specific edn1 expression caused steatosis, fibrosis, glycogen accumulation, bile duct dilation, hyperplasia, and HCC in zebrafish. Overexpression of EDN1 in 293T cells enhanced cell proliferation and cell migration in in vitro and xenotransplantation assays and was accompanied with up-regulation of several cell cycle/proliferation- and migration-specific genes. Furthermore, expression of the unfolded protein response (UPR) pathway-related mediators, such as spliced XBP1, ATF6, IRE1, and PERK, was also up-regulated at both the RNA and protein levels. In the presence of an EDN1 inhibitor or an AKT inhibitor, these increases were diminished and the EDN1-induced migration ability also was disappeared, suggesting that the EDN1 effects act through activation of the AKT pathway to enhance the UPR and subsequently activate the expression of downstream genes. Additionally, p-AKT is enhanced in the edn1 transgenic fish compared to the GFP-mCherry control. The micro RNA miR-1 was found to inhibit the expression of EDN1. We also observed an inverse correlation between EDN1 and miR-1 expression in HCC patients. In conclusion, our data suggest that EDN1 plays an important role in HCC progression by activating the PI3K/AKT pathway and is regulated by miR-1.	[Lu, Jeng-Wei; Liao, Chung-Yi; Yang, Wan-Yu; Yuh, Chiou-Hwa] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan; [Lu, Jeng-Wei; Jin, Shiow-Lian Catherine] Natl Cent Univ, Dept Life Sci, Tao Yuan, Taiwan; [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Changhua County, Taiwan; [Lin, Yueh-Min] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Yuh, Chiou-Hwa] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yuh, Chiou-Hwa] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Health Research Institutes - Taiwan; National Central University; Changhua Christian Hospital; National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University	Yuh, CH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan.	chyuh@nhri.org.tw	Yuh, Chiou-Hwa/E-3972-2010; Yuh, Chiou-Hwa/AAL-2938-2020; Yuh, Chiou-Hwa/AAL-3531-2020	Wang, Horng-Dar/0000-0001-9570-3611; Lu, Jeng-Wei/0000-0003-2128-2046	National Research Program for Genomic Medicine (NRPGM) [99-3112-B-400-010]; National Science Council (NSC) [101-2321-B-400-017]; National Health Research Institute; Liver Disease Prevention & Treatment Research Foundation (Taiwan); NSC [101-2321-B-400-014]	National Research Program for Genomic Medicine (NRPGM)(Ministry of Science and Technology, Taiwan); National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Liver Disease Prevention & Treatment Research Foundation (Taiwan); NSC(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Research Program for Genomic Medicine (NRPGM) (99-3112-B-400-010) and the National Science Council (NSC) (101-2321-B-400-017) to CHY. Additional funding from the National Health Research Institute provided to CHY is gratefully acknowledged. The fellowship and funding to Jeng-Wei Lu and Dr. Chiou-Hwa Yuh, respectively, from the Liver Disease Prevention & Treatment Research Foundation (Taiwan) is also highly acknowledged. The authors would like to thank the Taiwan Zebrafish Core Facility at NTHU-NHRI for providing the fish lines and resources; TZeTH is supported by a grant from the NSC (101-2321-B-400-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2000, GUT, V47, P685, DOI 10.1136/gut.47.5.685; Nguyen AT, 2012, DIS MODEL MECH, V5, P63, DOI 10.1242/dmm.008367; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Arai M, 2006, FEBS LETT, V580, P184, DOI 10.1016/j.febslet.2005.11.072; Asham E, 2001, BRIT J CANCER, V85, P1759, DOI 10.1054/bjoc.2001.2193; Boorman GA, 1997, TOXICOL PATHOL, V25, P202, DOI 10.1177/019262339702500210; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002; Grant K, 2007, BRIT J SURG, V94, P106, DOI 10.1002/bjs.5536; Her GM, 2013, BBA-MOL CELL BIOL L, V1831, P1037, DOI 10.1016/j.bbalip.2013.02.002; Her GM, 2011, BBA-MOL CELL BIOL L, V1811, P536, DOI 10.1016/j.bbalip.2011.06.011; Hobbie KR, 2012, VET PATHOL, V49, P372, DOI 10.1177/0300985811409443; ISHIBASHI M, 1993, J CLIN ENDOCR METAB, V76, P378, DOI 10.1210/jc.76.2.378; Jain S, 2010, AM J TRANSL RES, V2, P105; KAR S, 1995, BIOCHEM BIOPH RES CO, V216, P514, DOI 10.1006/bbrc.1995.2652; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kojima K, 1995, SURG ONCOL, V4, P309, DOI 10.1016/S0960-7404(10)80043-X; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Li Z, 2013, DIS MODEL MECH, V6, P414, DOI 10.1242/dmm.010462; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; LIN TY, 1987, BRIT J SURG, V74, P839, DOI 10.1002/bjs.1800740931; Liu WT, 2012, HEPATOLOGY, V56, P2268, DOI 10.1002/hep.25914; Lu JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076951; Lu JW, 2013, ACTA HISTOCHEM, V115, P728, DOI 10.1016/j.acthis.2013.02.012; Lu JW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0379-5; Lu JW, 2012, CARCINOGENESIS, V33, P209, DOI 10.1093/carcin/bgr224; Marrero CR, 2007, ARCH MED RES, V38, P612, DOI 10.1016/j.arcmed.2006.09.004; Matsuura A, 1998, HYPERTENSION, V32, P89, DOI 10.1161/01.HYP.32.1.89; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; NAKAMUTA M, 1993, AM J GASTROENTEROL, V88, P248; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; OIKAWA T, 1994, BRIT J CANCER, V69, P1059, DOI 10.1038/bjc.1994.208; Pedram A, 1997, J BIOL CHEM, V272, P17097, DOI 10.1074/jbc.272.27.17097; Pfab T, 2004, BRIT J PHARMACOL, V141, P215, DOI 10.1038/sj.bjp.0705601; Rosano L, 2001, CANCER RES, V61, P8340; Seeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560; Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002; Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008; Tseng WF, 2011, DEV BIOL, V357, P541, DOI 10.1016/j.ydbio.2011.06.040; van Malensteina H, 2012, CANCER LETT, V315, P178, DOI 10.1016/j.canlet.2011.09.039; Wu MH, 2012, J CELL PHYSIOL, V227, P3016, DOI 10.1002/jcp.23043; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhao YT, 2011, CLIN ORTHOP RELAT R, V469, P3190, DOI 10.1007/s11999-011-1939-2; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	51	57	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85318	10.1371/journal.pone.0085318	http://dx.doi.org/10.1371/journal.pone.0085318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416389	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500238
J	Prior, A; Laursen, TM; Larsen, KK; Johnsen, SP; Christensen, J; Andersen, G; Vestergaard, M				Prior, Anders; Laursen, Thomas Munk; Larsen, Karen Kjaer; Johnsen, Soren Paaske; Christensen, Jakob; Andersen, Grethe; Vestergaard, Mogens			Post-Stroke Mortality, Stroke Severity, and Preadmission Antipsychotic Medicine Use - A Population-Based Cohort Study	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ATTENUATES BRAIN-DAMAGE; ISCHEMIA IN-VIVO; TREATMENT STRATEGIES; RELATIVE RISK; SCHIZOPHRENIA; SURVIVAL; POLYPHARMACY; MEDICATIONS; OLANZAPINE	Background and Purpose: It has been suggested that antipsychotic medication may be neuroprotective and may reduce post-stroke mortality, but studies are few and ambiguous. We aimed to investigate the post-stroke effects of preadmission antipsychotic use. Methods: We conducted a nationwide, population-based cohort study of 81,143 persons admitted with stroke in Denmark from 2003-2010. Using Danish health care databases, we extracted data on preadmission use of antipsychotics and confounding factors. We examined the association between current, former, and never use of antipsychotics and stroke severity, length of hospital stay, and 30-day post-stroke mortality using logistic regression analysis, survival analysis, and propensity score matching. Results: Current users of antipsychotics had a higher risk of severe or very severe stroke on The Scandinavian Stroke Scale than never users of antipsychotics (adjusted odds ratios, 1.43; 95% CI, 1.29-1.58). Current users were less likely to be discharged from hospital within 30 days of admission than never users (probability of non-discharge, 27.0% vs. 21.9%). Antipsychotics was associated with an increased 30-day post-stroke mortality among current users (adjusted mortality rate ratios, 1.42; 95% CI, 1.29-1.55), but not among former users (adjusted mortality rate ratios, 1.05; 95% CI, 0.98-1.14). Conclusions: Preadmission use of antipsychotics was associated with a higher risk of severe stroke, a longer duration of hospital stay, and a higher post-stroke mortality, even after adjustment for known confounders. Antipsychotics play an important role in the treatment of many psychiatric conditions, but our findings do not support the hypothesis that they reduce stroke severity or post-stroke mortality.	[Prior, Anders; Larsen, Karen Kjaer; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Prior, Anders; Larsen, Karen Kjaer; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Laursen, Thomas Munk] Aarhus Univ, Natl Ctr Register Based Res, iPSYCH, Aarhus, Denmark; [Johnsen, Soren Paaske] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Christensen, Jakob; Andersen, Grethe] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Aarhus University	Prior, A (corresponding author), Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark.	anders.prior@alm.au.dk	Vestergaard, Mogens/M-9333-2014; Laursen, Thomas Munk/AFQ-8066-2022; Prior, Anders/P-8628-2014	Vestergaard, Mogens/0000-0001-8830-2174; Prior, Anders/0000-0003-4053-3701; Laursen, Thomas Munk/0000-0001-6934-1784; Christensen, Jakob/0000-0002-9385-6435; Andersen, Grethe/0000-0001-6807-2500	Danish Heart Association; Lundbeck Foundation; Lundbeck Foundation [R155-2012-11280, R155-2014-1724] Funding Source: researchfish	Danish Heart Association; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This study was funded by unrestricted grants from the Danish Heart Association (http://www.hjerteforeningen.dk/om_os/in_english/) and The Lundbeck Foundation (http://www.lundbeckfoundation.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2011, STROKE, V42, P2806, DOI 10.1161/STROKEAHA.111.619049; Andersen P. K., 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; ASPLUND K, 1985, STROKE, V16, P885; Baandrup L, 2010, J CLIN PSYCHIAT, V71, P103, DOI 10.4088/JCP.08m04818yel; Bushe CJ, 2010, J PSYCHOPHARMACOL, V24, P17, DOI 10.1177/1359786810382468; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doehner W, 2013, EUR HEART J, V34, P268, DOI 10.1093/eurheartj/ehs340; GLOBUS MYT, 1987, NEUROLOGY, V37, P1712, DOI 10.1212/WNL.37.11.1712; Goldstein LB, 1997, CURR OPIN NEUROL, V10, P52, DOI 10.1097/00019052-199702000-00011; Goldstein LB, 1990, NEUROREHABILITATION, V4, P137; Haberg A, 2006, NEUROCHEM INT, V48, P531, DOI 10.1016/j.neuint.2005.12.025; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; John M Eisenberg Center for Clinical Decisions and Communications Science, 2012, COMP EFFECTIVENESS R; Kam KY, 2012, PROG NEURO-PSYCHOPH, V39, P69, DOI 10.1016/j.pnpbp.2012.05.010; Kang JH, 2011, PSYCHOSOM MED, V73, P106, DOI 10.1097/PSY.0b013e3181fdc2c9; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kisely S, 2009, BRIT J PSYCHIAT, V195, P545, DOI 10.1192/bjp.bp.109.067082; Leucht S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008016.pub2; LINDENSTROM E, 1991, CEREBROVASC DIS, V1, P103, DOI 10.1159/000108825; Maher AR, 2011, JAMA-J AM MED ASSOC, V306, P1359, DOI 10.1001/jama.2011.1360; Mainz J, 2004, INT J QUAL HEALTH C, V16, pI45, DOI 10.1093/intqhc/mzh031; Mittal V, 2011, AM J ALZHEIMERS DIS, V26, P10, DOI 10.1177/1533317510390351; Montout C, 2002, SCHIZOPHR RES, V57, P147, DOI 10.1016/S0920-9964(01)00325-5; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rosthoj S, 2004, COMPUT METH PROG BIO, V74, P69, DOI 10.1016/S0169-2607(03)00069-5; Tiihonen J, 2012, ARCH GEN PSYCHIAT, V69, P476, DOI 10.1001/archgenpsychiatry.2011.1532; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Tsai KY, 2012, SCHIZOPHR RES, V138, P41, DOI 10.1016/j.schres.2012.02.013; VANHASSELT P, 1973, NEUROPHARMACOLOGY, V12, P245, DOI 10.1016/0028-3908(73)90109-3; Vargo JM, 1996, BEHAV BRAIN RES, V72, P39; VARGO JM, 1989, BEHAV NEUROSCI, V103, P1017, DOI 10.1037/0735-7044.103.5.1017; Vemmos K, 2011, STROKE, V42, P30, DOI 10.1161/STROKEAHA.110.593434; World Health Organization and Alzheimers Disease International, 2012, DEM PUBL HLTH PRIOR; Yulug B, 2008, J NEUROPSYCH CLIN N, V20, P107, DOI 10.1176/jnp.2008.20.1.107a; Yulug B, 2006, BRAIN RES BULL, V69, P656, DOI 10.1016/j.brainresbull.2006.03.017; Yulug B, 2006, BRAIN RES BULL, V71, P296, DOI 10.1016/j.brainresbull.2006.09.018; Yulug B, 2009, BRAIN RES BULL, V80, P95, DOI 10.1016/j.brainresbull.2009.06.013	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84103	10.1371/journal.pone.0084103	http://dx.doi.org/10.1371/journal.pone.0084103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416196	Green Published, gold			2022-12-25	WOS:000329862500097
J	Schmitt, AK; Danisik, M; Aydar, E; Sen, E; Ulusoy, I; Lovera, OM				Schmitt, Axel K.; Danisik, Martin; Aydar, Erkan; Sen, Erdal; Ulusoy, Inan; Lovera, Oscar M.			Identifying the Volcanic Eruption Depicted in a Neolithic Painting at Catalhoyuk, Central Anatolia, Turkey	PLOS ONE			English	Article							ZIRCON; DISEQUILIBRIUM; STRATOVOLCANO; EVOLUTION; BASIN; AGES	A mural excavated at the Neolithic Catalhoyuk site (Central Anatolia, Turkey) has been interpreted as the oldest known map. Dating to similar to 6600 BCE, it putatively depicts an explosive summit eruption of the Hasan Dagi twin-peaks volcano located similar to 130 km northeast of Catalhoyuk, and a birds-eye view of a town plan in the foreground. This interpretation, however, has remained controversial not least because independent evidence for a contemporaneous explosive volcanic eruption of Hasan Dagi has been lacking. Here, we document the presence of andesitic pumice veneer on the summit of Hasan Dagi, which we dated using (U-Th)/He zircon geochronology. The (U-Th)/He zircon eruption age of 8.97 +/- 0.64 ka (or 6960 +/- 640 BCE; uncertainties 2 sigma) overlaps closely with C-14 ages for cultural strata at Catalhoyuk, including level VII containing the "map'' mural. A second pumice sample from a surficial deposit near the base of Hasan Dagi records an older explosive eruption at 28.9 +/- 1.5 ka. U-Th zircon crystallization ages in both samples range from near-eruption to secular equilibrium (>80 ka). Collectively, our results reveal protracted intrusive activity at Hasan Dagi punctuated by explosive venting, and provide the first radiometric ages for a Holocene explosive eruption which was most likely witnessed by humans in the area. Geologic and geochronologic lines of evidence thus support previous interpretations that residents of Catalhoyuk artistically represented an explosive eruption of Hasan Dagi volcano. The magmatic longevity recorded by quasi-continuous zircon crystallization coupled with new evidence for late-Pleistocene and Holocene explosive eruptions implicates Hasan Dagi as a potential volcanic hazard.	[Schmitt, Axel K.; Lovera, Oscar M.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90024 USA; [Danisik, Martin] Univ Waikato, Hamilton, New Zealand; [Aydar, Erkan] ATERRA R&D, Ankara, Turkey; [Sen, Erdal; Ulusoy, Inan] Hacettepe Univ, Dept Geol Engn, Ankara, Turkey	University of California System; University of California Los Angeles; University of Waikato; Hacettepe University	Schmitt, AK (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90024 USA.	axel@argon.ess.ucla.edu	Danisik, Martin/GQY-6103-2022; ULUSOY, İNAN/G-5968-2013; ŞEN, ERDAL/G-5964-2013	ULUSOY, İNAN/0000-0002-6343-9921; ŞEN, ERDAL/0000-0002-9172-9926; Schmitt, Axel/0000-0002-9029-4211; Danisik, Martin/0000-0002-0885-4938	NSF EAR [1029193]	NSF EAR(National Science Foundation (NSF))	Partial support for this study comes from NSF EAR 1029193 "Facility Support: The UCLA National Ion Microprobe''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aydar E, 1998, J VOLCANOL GEOTH RES, V85, P69, DOI 10.1016/S0377-0273(98)00050-X; Aydar E, 1998, J VOLCANOL GEOTH RES, V85, P129, DOI 10.1016/S0377-0273(98)00053-5; Aydar E, 2012, J VOLCANOL GEOTH RES, V213, P83, DOI 10.1016/j.jvolgeores.2011.11.005; Barber EJW, 2010, AM J ARCHAEOL, V114, P343; Carter T, 2011, ANATOL STUD, V61, P1, DOI 10.1017/S0066154600008759; Cessford C., 2005, CHANGING MAT CATALHO, P65; Claiborne LL, 2010, GEOLOGY, V38, P1011, DOI 10.1130/G31285.1; Clarke KC, 2013, CARTOGR J, V50, P136, DOI 10.1179/0008704113Z.00000000079; Danisik M, 2012, EARTH PLANET SC LETT, V349, P240, DOI 10.1016/j.epsl.2012.06.041; Deniel C, 1998, J VOLCANOL GEOTH RES, V87, P275, DOI 10.1016/S0377-0273(98)00097-3; Ercan T., 1990, JEOMORFOLOJI DERGISI, V18, P39; Farley KA, 2002, EARTH PLANET SC LETT, V201, P117, DOI 10.1016/S0012-821X(02)00659-3; Harris SL, 2000, ARCHAEOLOGY VOLCANIS; Hodder I, 2007, ANNU REV ANTHROPOL, V36, P105, DOI 10.1146/annurev.anthro.36.081406.094308; INNOCENTI F, 1975, GEOL MAG, V112, P349, DOI 10.1017/S0016756800046744; Kuzucuoglu C, 1998, J VOLCANOL GEOTH RES, V85, P153, DOI 10.1016/S0377-0273(98)00054-7; Meece S., 2006, ANATOL STUD, V56, P1; Mellaart J., 1967, CATAL HUYUK NEOLITHI; Mellaart J., 1964, ANATOL STUD, V14, P39, DOI [DOI 10.2307/3642466, 10.2307/3642466]; Mellaart J, 1964, ILLUSTRATED LONDON N, P194; NOTSU K, 1995, J VOLCANOL GEOTH RES, V64, P171, DOI 10.1016/0377-0273(94)00077-T; Pastre JF, 1998, QUATERNAIRE, V9, P169; Schmitt AK, 2011, ANNU REV EARTH PL SC, V39, P321, DOI 10.1146/annurev-earth-040610-133330; Schmitt AK, 2010, EARTH PLANET SC LETT, V295, P91, DOI 10.1016/j.epsl.2010.03.028; Sigurdsson H, 2000, VOLCANOES ART; Ulkekul C, 1999, OXFORD HDB ANCIENT A, P99; Zanchetta G, 2011, HOLOCENE, V21, P33, DOI 10.1177/0959683610377531	27	55	57	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84711	10.1371/journal.pone.0084711	http://dx.doi.org/10.1371/journal.pone.0084711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	291WL	24416270	Green Published, gold			2022-12-25	WOS:000329862500153
J	Hou, SK; Ge, KK; Zheng, XD; Wei, HM; Sun, R; Tian, ZG				Hou, Shengke; Ge, Kuikui; Zheng, Xiaodong; Wei, Haiming; Sun, Rui; Tian, Zhigang			CD226 Protein Is Involved in Immune Synapse Formation and Triggers Natural Killer (NK) Cell Activation via Its First Extracellular Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Junctions; ERK; Natural Killer (NK) Cell; Phosphorylation	IMMUNOGLOBULIN SUPERFAMILY; NECTIN-2 CD112; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; T-LYMPHOCYTES; PVR CD155; ADHESION; RECEPTOR; DNAM-1; MOLECULE	Background: CD226 is an activating receptor on NK cells that mediates NK cell cytotoxicity. Results: The first extracellular domain of CD226 (CD226-ECD1) mediates NK cell recognition, adhesion, immune synapse formation, and cytotoxicity against target cells. Conclusion: CD226-ECD1 retains almost all functions of the full-length CD226 protein. Significance: The conclusion is helpful to understand the mechanism by which CD226 recognizes its ligands. CD226, an activating receptor that interacts with the ligands CD155 and CD112, activates natural killer (NK) cells via its immunoreceptor tyrosine-based activatory motif (ITAM). There are two extracellular domains of CD226; however, the comparative functional relevance of these domains remains unknown. In this study, two different deletion mutants, rCD226-ECD1 (the first extracellular domain) and rCD226-ECD (full extracellular domains), were recombinantly expressed. We observed that rCD226-ECD1, similar to rCD226-ECD, specifically bound to ligand-positive cell lines and that this interaction could be competitively blocked by an anti-CD226 mAb. In addition, rCD226-ECD1 was able to block the binding of CD112 mAb to tumor cells in a competitive binding assay. Importantly, based on surface plasmon resonance (SPR), we determined that rCD226-ECD1, similar to rCD226-ECD, directly bound to its ligand CD155 on a protein chip. Functionally, NK cell cytotoxicity against K562 or HeLa cells was blocked by rCD226-ECD1 by reducing the expression of CD69 and granzyme B, indicating the critical role of ECD1 in NK cell activation. We also examined the role of rCD226-ECD1 in effector/target interactions by using rCD226-ECD to block these interactions. Using flow cytometry, we found that the number of conjugates between IL-2-dependent NKL cells and HeLa cells was reduced and observed that the formation of immune synapses was also decreased under confocal microscopy. In addition, we prepared two anti-rCD226-ECD1 agonistic antibodies, 2E6 and 3B9. Both 2E6 and 3B9 antibodies could induce the phosphorylation of ERK in NK-92 cells. Taken together, our results show that CD226 functions via its first extracellular domain.	[Hou, Shengke; Ge, Kuikui; Zheng, Xiaodong; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230027, Anhui, Peoples R China; [Wei, Haiming; Sun, Rui; Tian, Zhigang] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Sun, R (corresponding author), Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230027, Anhui, Peoples R China.	sunr@ustc.edu.cn; tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Zheng, Xiaodong/N-2830-2013		Ministry of Science and Technology of China (973 Basic Science Project) [2010CB911901, 2013CB530506]; Natural Science Foundation of China [91029303, 31021061]	Ministry of Science and Technology of China (973 Basic Science Project)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (973 Basic Science Project; Grants 2010CB911901 and 2013CB530506) and the Natural Science Foundation of China (Grants 91029303 and 31021061).	Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Bachelet I, 2006, J BIOL CHEM, V281, P27190, DOI 10.1074/jbc.M602359200; Barber DF, 2003, J IMMUNOL, V170, P294, DOI 10.4049/jimmunol.170.1.294; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; BURNS GF, 1985, J EXP MED, V161, P1063, DOI 10.1084/jem.161.5.1063; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; Castriconi R, 2007, BLOOD, V109, P4873, DOI 10.1182/blood-2006-08-038760; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; Chen LH, 2003, LIFE SCI, V73, P2373, DOI 10.1016/S0024-3205(03)00606-4; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Djeu JY, 2002, CLIN CANCER RES, V8, P636; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; Elishmereni M, 2008, CURR OPIN INVEST DR, V9, P491; Friberg Diana D., 1996, Methods (Orlando), V9, P316, DOI 10.1006/meth.1996.0037; Kojima H, 2003, J BIOL CHEM, V278, P36748, DOI 10.1074/jbc.M300702200; Krzewski K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00335; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu J, 2012, J IMMUNOL, V188, P5511, DOI 10.4049/jimmunol.1200324; Ma DC, 2005, EUR J HAEMATOL, V74, P228, DOI 10.1111/j.1600-0609.2004.00345.x; McVicar D W, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.75.re1; Meyer D, 2009, J BIOL CHEM, V284, P2235, DOI 10.1074/jbc.M807698200; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Pala P, 2000, J IMMUNOL METHODS, V243, P107, DOI 10.1016/S0022-1759(00)00230-1; Peggs KS, 2005, BRIT J HAEMATOL, V130, P809, DOI 10.1111/j.1365-2141.2005.05627.x; Pende D, 2005, MOL IMMUNOL, V42, P463, DOI 10.1016/j.molimm.2004.07.028; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; SchartonKersten TM, 1997, CURR OPIN IMMUNOL, V9, P44, DOI 10.1016/S0952-7915(97)80157-4; Seth S, 2009, J LEUKOCYTE BIOL, V86, P91, DOI [10.1189/JLB.1208745, 10.1189/jlb.1208745]; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Stengel KF, 2012, P NATL ACAD SCI USA, V109, P5399, DOI 10.1073/pnas.1120606109; TALMADGE JE, 1980, J NATL CANCER I, V65, P929; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Ye XH, 2006, VIRAL IMMUNOL, V19, P576, DOI 10.1089/vim.2006.19.576; Zhang P, 2008, P NATL ACAD SCI USA, V105, P18284, DOI 10.1073/pnas.0807848105; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	39	19	23	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6969	6977		10.1074/jbc.M113.498253	http://dx.doi.org/10.1074/jbc.M113.498253			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451371	hybrid, Green Published			2022-12-25	WOS:000332389400057
J	Morrison, EA; Henzler-Wildman, KA				Morrison, Emma A.; Henzler-Wildman, Katherine A.			Transported Substrate Determines Exchange Rate in the Multidrug Resistance Transporter EmrE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Transport; Multidrug Transporters; NMR; Protein Drug Interactions; Protein Dynamics	INDUCED CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; ETHIDIUM-BROMIDE; BINDING; DYNAMICS; MODEL; MECHANISM; PROTEINS; DOMAIN; STATE	Background: EmrE transports a broad range of compounds. Results: EmrE converts between open-in and open-out states with rates that vary over 3 orders of magnitude, depending on substrate. Conclusion: Substrate affects both ground-state and transition-state energies for conformational exchange, emphasizing the coupling between substrate binding and transport. Significance: Drug identity determines its own rate of transport by EmrE. EmrE, a small multidrug resistance transporter, serves as an ideal model to study coupling between multidrug recognition and protein function. EmrE has a single small binding pocket that must accommodate the full range of diverse substrates recognized by this transporter. We have studied a series of tetrahedral compounds, as well as several planar substrates, to examine multidrug recognition and transport by EmrE. Here we show that even within this limited series, the rate of interconversion between the inward- and outward-facing states of EmrE varies over 3 orders of magnitude. Thus, the identity of the bound substrate controls the rate of this critical step in the transport process. The binding affinity also varies over a similar range and is correlated with substrate hydrophobicity within the tetrahedral substrate series. Substrate identity influences both the ground-state and transition-state energies for the conformational exchange process, highlighting the coupling between substrate binding and transport required for alternating access antiport.	[Morrison, Emma A.; Henzler-Wildman, Katherine A.] Washington Univ, St Louis Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL)	Henzler-Wildman, KA (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	khenzler@biochem.wustl.edu		Morrison, Emma/0000-0001-6722-7961; Henzler-Wildman, Katherine/0000-0002-5295-2121	National Institutes of Health [P41RR02301, P41GM66326, RR02781, RR08438]; University of Wisconsin; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301, S10RR002781, S10RR008438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095839, P41GM066326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Scott Wildman for medicinal chemistry advice, Tim Lohman and Jim Janetka for the use of the fluorimeter and HPLC, and G. Chang for the EmrE expression plasmid. We thank Greg DeKoster, Marco Tonelli (NMRFAM), and Geoffrey Armstrong (Rocky Mountain NMR Facility) for assistance with NMR acquisition. This study made use of the Rocky Mountain NMR Facility and the National Magnetic Resonance Facility at Madison (NMRFAM). NMRFAM is supported by National Institutes of Health Grants P41RR02301 (BRTP/NCRR) and P41GM66326 (NIGMS), the University of Wisconsin, National Institutes of Health Grant RR02781 and RR08438, National Science Foundation Grants DMB-8415048, OIA-9977486, and BIR-9214394, and the USDA.	Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Akke M, 2002, CURR OPIN STRUC BIOL, V12, P642, DOI 10.1016/S0959-440X(02)00369-X; Amadi ST, 2010, J BIOL CHEM, V285, P26710, DOI 10.1074/jbc.M110.132621; Bachas S, 2011, P NATL ACAD SCI USA, V108, P11046, DOI 10.1073/pnas.1104850108; Brill S, 2012, P NATL ACAD SCI USA, V109, P16894, DOI 10.1073/pnas.1211831109; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Garbett NC, 2004, BIOPHYS J, V87, P3974, DOI 10.1529/biophysj.104.047415; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Gayen A, 2013, ANGEW CHEM INT EDIT, V52, P10321, DOI 10.1002/anie.201303091; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman K, 2012, CURR OPIN STRUC BIOL, V22, P38, DOI 10.1016/j.sbi.2011.10.004; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Korkhov VM, 2008, J MOL BIOL, V377, P1094, DOI 10.1016/j.jmb.2008.01.056; Kovrigin EL, 2012, J BIOMOL NMR, V53, P257, DOI 10.1007/s10858-012-9636-3; Labeikovsky W, 2007, J MOL BIOL, V367, P1370, DOI 10.1016/j.jmb.2007.01.049; LAMBERT B, 1984, BIOCHEMISTRY-US, V23, P166, DOI 10.1021/bi00296a027; Li Y, 2009, J BIOMOL NMR, V45, P357, DOI 10.1007/s10858-009-9385-0; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Miloushev VZ, 2008, STRUCTURE, V16, P1195, DOI 10.1016/j.str.2008.05.009; Morrison EA, 2012, BBA-BIOMEMBRANES, V1818, P814, DOI 10.1016/j.bbamem.2011.12.020; Neyfakh AA, 2002, MOL MICROBIOL, V44, P1123, DOI 10.1046/j.1365-2958.2002.02965.x; OECD, 2009, OECD GUID TEST CHEM, V2, DOI [10.1787/9789264070264-en, DOI 10.1787/9789264069947-EN, 10.1787/9789264076228-en]; Ong YS, 2013, J AM CHEM SOC, V135, P15754, DOI 10.1021/ja402605s; Poulsen BE, 2011, J BACTERIOL, V193, P5929, DOI 10.1128/JB.05846-11; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Rotem D, 2006, J BIOL CHEM, V281, P18715, DOI 10.1074/jbc.M602088200; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tugarinov V, 2003, J MOL BIOL, V327, P1121, DOI 10.1016/S0022-2836(03)00238-9; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Veglia G, 2013, FEBS J, V280, P5608, DOI 10.1111/febs.12462; Velyvis A, 2007, P NATL ACAD SCI USA, V104, P8815, DOI 10.1073/pnas.0703347104; Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wade H, 2010, CURR OPIN STRUC BIOL, V20, P489, DOI 10.1016/j.sbi.2010.06.003; WRIGHT RGM, 1980, BIOCHEMISTRY-US, V19, P5825, DOI 10.1021/bi00566a026; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971	50	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6825	6836		10.1074/jbc.M113.535328	http://dx.doi.org/10.1074/jbc.M113.535328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24448799	hybrid, Green Published			2022-12-25	WOS:000332389400042
J	Vandersickel, N; Kazbanov, IV; Nuitermans, A; Weise, LD; Pandit, R; Panfilov, AV				Vandersickel, Nele; Kazbanov, Ivan V.; Nuitermans, Anita; Weise, Louis D.; Pandit, Rahul; Panfilov, Alexander V.			A Study of Early Afterdepolarizations in a Model for Human Ventricular Tissue	PLOS ONE			English	Article							TORSADES-DE-POINTES; SPIRAL BREAKUP; LONG; MECHANISMS; PROLONGATION; TURBULENCE; SYNCHRONIZATION; PROPAGATION; CALCIUM; VOLTAGE	Sudden cardiac death is often caused by cardiac arrhythmias. Recently, special attention has been given to a certain arrhythmogenic condition, the long-QT syndrome, which occurs as a result of genetic mutations or drug toxicity. The underlying mechanisms of arrhythmias, caused by the long-QT syndrome, are not fully understood. However, arrhythmias are often connected to special excitations of cardiac cells, called early afterdepolarizations (EADs), which are depolarizations during the repolarizing phase of the action potential. So far, EADs have been studied mainly in isolated cardiac cells. However, the question on how EADs at the single-cell level can result in fibrillation at the tissue level, especially in human cell models, has not been widely studied yet. In this paper, we study wave patterns that result from single-cell EAD dynamics in a mathematical model for human ventricular cardiac tissue. We induce EADs by modeling experimental conditions which have been shown to evoke EADs at a single-cell level: by an increase of L-type Ca currents and a decrease of the delayed rectifier potassium currents. We show that, at the tissue level and depending on these parameters, three types of abnormal wave patterns emerge. We classify them into two types of spiral fibrillation and one type of oscillatory dynamics. Moreover, we find that the emergent wave patterns can be driven by calcium or sodium currents and we find phase waves in the oscillatory excitation regime. From our simulations we predict that arrhythmias caused by EADs can occur during normal wave propagation and do not require tissue heterogeneities. Experimental verification of our results is possible for experiments at the cell-culture level, where EADs can be induced by an increase of the L-type calcium conductance and by the application of I-Kr blockers, and the properties of the emergent patterns can be studied by optical mapping of the voltage and calcium.	[Vandersickel, Nele; Kazbanov, Ivan V.; Weise, Louis D.; Panfilov, Alexander V.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium; [Nuitermans, Anita; Weise, Louis D.] Univ Utrecht, Dept Theoret Biol, Utrecht, Netherlands; [Pandit, Rahul] Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India	Ghent University; Utrecht University; Indian Institute of Science (IISC) - Bangalore	Vandersickel, N (corresponding author), Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium.	nele.vandersickel@ugent.be	Panfilov, Alexander/G-8459-2016; Vandersickel, Nele/B-2984-2016	Panfilov, Alexander/0000-0003-2643-642X; 	Research-Foundation Flanders (FWO Vlaanderen); Department of Science and Technology (DST), India; University Grants Commission (UGC), India; Robert Bosch Centre for Cyber Physical Systems (IISc); Research-Foundation Flanders (FWO)	Research-Foundation Flanders (FWO Vlaanderen)(FWO); Department of Science and Technology (DST), India(Department of Science & Technology (India)); University Grants Commission (UGC), India(University Grants Commission, India); Robert Bosch Centre for Cyber Physical Systems (IISc); Research-Foundation Flanders (FWO)(FWO)	N.similar to Vandersickel and I. Kazbanov are supported by the Research-Foundation Flanders (FWO Vlaanderen). The computational resources (STEVIN Supercomputer Infrastructure) and services used in this work were kindly provided by Ghent University, the Flemish Supercomputer Center (VSC), the Hercules Foundation and the Flemish Government - department EWI. R. Pandit acknowledges support from the research grants from the Department of Science and Technology (DST), India, the University Grants Commission (UGC), India, and the Robert Bosch Centre for Cyber Physical Systems (IISc). AV Panfilov also acknowledges the support of the Research-Foundation Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2007, EUROPACE, V9, P4, DOI 10.1093/europace/eum166; Asano Y, 1997, J AM COLL CARDIOL, V29, P831, DOI 10.1016/S0735-1097(96)00588-8; Askar SFA, 2013, CARDIOVASC RES, V97, P171, DOI 10.1093/cvr/cvs290; Brosch SF, 1998, CLIN EXP PHARMACOL P, V25, P225, DOI 10.1111/j.1440-1681.1998.t01-11-.x; Chang MG, 2012, HEART RHYTHM, V9, P115, DOI 10.1016/j.hrthm.2011.08.014; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; CRANEFIELD PF, 1977, CIRC RES, V41, P415, DOI 10.1161/01.RES.41.4.415; de Lange E, 2012, BIOPHYS J, V103, P365, DOI 10.1016/j.bpj.2012.06.007; Fink M, 2010, BASIC CLIN PHARMACOL, V106, P243, DOI 10.1111/j.1742-7843.2009.00534.x; Gallacher DJ, 2007, CARDIOVASC RES, V76, P247, DOI 10.1016/j.cardiores.2007.06.019; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; JANUARY CT, 1988, CIRC RES, V62, P563, DOI 10.1161/01.RES.62.3.563; Kadota S, 2013, EUR HEART J, V34, P1147, DOI 10.1093/eurheartj/ehs418; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Lee P, 2012, CIRC RES, V110, P1556, DOI 10.1161/CIRCRESAHA.111.262535; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Liu GX, 2012, J PHYSIOL-LONDON, V590, P1171, DOI 10.1113/jphysiol.2011.218164; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Majumder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018052; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; Maree AFM, 1997, PHYS REV LETT, V78, P1819, DOI 10.1103/PhysRevLett.78.1819; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; Noda T, 2004, EUR HEART J, V25, P2149, DOI 10.1016/j.ehj.2004.08.020; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Panfilov AV, 1998, CHAOS, V8, P57, DOI 10.1063/1.166287; Panfilov AV, 1999, PHYS REV E, V59, pR6251, DOI 10.1103/PhysRevE.59.R6251; PANFILOV AV, 1990, PHYS LETT A, V151, P23, DOI 10.1016/0375-9601(90)90840-K; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; PRIORI SG, 1990, AM J PHYSIOL, V258, pH1796, DOI 10.1152/ajpheart.1990.258.6.H1796; Qi X, 2009, CIRC-ARRHYTHMIA ELEC, V2, P295, DOI 10.1161/CIRCEP.108.815654; Qu Z, 2013, CARDIOVASC RES; Roden DM, 2005, J CLIN INVEST, V115, P2025, DOI 10.1172/JCI25539; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Sinha S, 2001, PHYS REV LETT, V86, P3678, DOI 10.1103/PhysRevLett.86.3678; Sipido KR, 2007, ANN NY ACAD SCI, V1099, P339, DOI 10.1196/annals.1387.066; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Ten Tusscher KHWJ, 2003, AM J PHYSIOL-HEART C, V284, pH542, DOI 10.1152/ajpheart.00608.2002; Ten Tusscher KHWJ, 2007, CIRC RES, V100, pE87, DOI 10.1161/CIRCRESAHA.107.150730; Tran DX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258103; Trayanova NA, 2011, CIRC RES, V108, P113, DOI 10.1161/CIRCRESAHA.110.223610; TYSON JJ, 1988, PHYSICA D, V32, P327, DOI 10.1016/0167-2789(88)90062-0; Viswanathan PC, 1999, CARDIOVASC RES, V42, P530, DOI 10.1016/S0008-6363(99)00035-8; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; Volders PGA, 1997, CARDIOVASC RES, V34, P348, DOI 10.1016/S0008-6363(96)00270-2; Vos MA, 2008, BRIT J PHARMACOL, V154, P1523, DOI 10.1038/bjp.2008.277; Weiss JN, 2010, HEART RHYTHM, V7, P1891, DOI 10.1016/j.hrthm.2010.09.017; Yang PC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000658; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	57	52	54	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84595	10.1371/journal.pone.0084595	http://dx.doi.org/10.1371/journal.pone.0084595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427289	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000329868200029
J	Borengasser, SJ; Kang, P; Faske, J; Gomez-Acevedo, H; Blackburn, ML; Badger, TM; Shankar, K				Borengasser, Sarah J.; Kang, Ping; Faske, Jennifer; Gomez-Acevedo, Horacio; Blackburn, Michael L.; Badger, Thomas M.; Shankar, Kartik			High Fat Diet and In Utero Exposure to Maternal Obesity Disrupts Circadian Rhythm and Leads to Metabolic Programming of Liver in Rat Offspring	PLOS ONE			English	Article							HEPATIC GENE-EXPRESSION; BODY-MASS INDEX; INSULIN-RESISTANCE; PPAR-ALPHA; DEVELOPMENTAL ORIGINS; SENSITIVITY-ANALYSIS; CHRONIC ETHANOL; ANIMAL-MODELS; PREGNANT RATS; WEIGHT-GAIN	The risk of obesity in adulthood is subject to programming beginning at conception. In animal models, exposure to maternal obesity and high fat diets influences the risk of obesity in the offspring. Among other long-term changes, offspring from obese rats develop hyperinsulinemia, hepatic steatosis, and lipogenic gene expression in the liver at weaning. However, the precise underlying mechanisms leading to metabolic dysregulation in the offspring remains unclear. Using a rat model of overfeeding-induced obesity, we previously demonstrated that exposure to maternal obesity from preconception to birth, is sufficient to program increased obesity risk in the offspring. Offspring of obese rat dams gain greater body weight and fat mass when fed high fat diet (HFD) as compared to lean dam. Since, disruptions of diurnal circadian rhythm are known to detrimentally impact metabolically active tissues such as liver, we examined the hypothesis that maternal obesity leads to perturbations of core clock components and thus energy metabolism in offspring liver. Offspring from lean and obese dams were examined at post-natal day 35, following a short (2 wk) HFD challenge. Hepatic mRNA expression of circadian (CLOCK, BMAL1, REV-ERB alpha, CRY, PER) and metabolic (PPAR alpha, SIRT1) genes were strongly suppressed in offspring exposed to both maternal obesity and HFD. Using a mathematical model, we identified two distinct biological mechanisms that modulate PPAR alpha mRNA expression: i) decreased mRNA synthesis rates; and ii) increased non-specific mRNA degradation rate. Moreover, our findings demonstrate that changes in PPAR alpha transcription were associated with epigenomic alterations in H3K4me3 and H3K27me3 histone marks near the PPAR alpha transcription start site. Our findings indicated that offspring from obese rat dams have detrimental alternations to circadian machinery that may contribute to impaired liver metabolism in response to HFD, specifically via reduced PPAR alpha expression prior to obesity development.	[Borengasser, Sarah J.; Kang, Ping; Faske, Jennifer; Gomez-Acevedo, Horacio; Blackburn, Michael L.; Badger, Thomas M.; Shankar, Kartik] Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA; [Borengasser, Sarah J.; Gomez-Acevedo, Horacio; Badger, Thomas M.; Shankar, Kartik] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Shankar, K (corresponding author), Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA.	ShankarKartik@uams.edu	Gomez-Acevedo, Horacio/AAR-8783-2021	Gomez-Acevedo, Horacio/0000-0002-1570-1606; Borengasser, Sarah/0000-0002-9984-0178; Shankar, Kartik/0000-0002-7964-9026	National Institutes of Health [R01-DK084225]; USDA Agriculture Research Service CRIS [6251-51000-007-04S]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Agriculture Research Service CRIS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the National Institutes of Health-R01-DK084225 (K.S.) and USDA Agriculture Research Service CRIS 6251-51000-007-04S. The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025; Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; BADGER TM, 1993, J PHARMACOL EXP THER, V264, P938; BADGER TM, 1993, J PHARMACOL EXP THER, V264, P438; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Baumgardner JN, 2008, AM J PHYSIOL-GASTR L, V294, pG27, DOI 10.1152/ajpgi.00296.2007; Bayol SA, 2008, J PHYSIOL-LONDON, V586, P3219, DOI 10.1113/jphysiol.2008.153817; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Coomans CP, 2013, FASEB J, V27, P1721, DOI 10.1096/fj.12-210898; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Deckelbaum RJ, 2001, OBES RES, V9, p239S, DOI 10.1038/oby.2001.125; Delezie J, 2011, ANN NY ACAD SCI, V1243, P30, DOI 10.1111/j.1749-6632.2011.06246.x; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gallou-Kabani C, 2007, EPIGENETICS-US, V2, P137, DOI 10.4161/epi.2.3.4897; Haimovich G, 2013, BBA-GENE REGUL MECH, V1829, P643, DOI 10.1016/j.bbagrm.2013.01.004; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Jaaskelainen A, 2011, INT J OBESITY, V35, P1289, DOI 10.1038/ijo.2011.150; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Korourian S, 1999, TOXICOL SCI, V47, P110, DOI 10.1093/toxsci/47.1.110; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lu Lu, 2011, Chinese Medical Sciences Journal, V26, P77; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Masri S, 2012, ANN NY ACAD SCI, V1264, P103, DOI 10.1111/j.1749-6632.2012.06649.x; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Nathanielsz PW, 2007, OBSTET GYN CLIN N AM, V34, P201, DOI 10.1016/j.ogc.2007.03.006; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; O'Meara MM, 2012, CHROMOSOMA, V121, P221, DOI 10.1007/s00412-012-0361-1; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Oishi K, 2008, NEUROREPORT, V19, P487, DOI 10.1097/WNR.0b013e3282f7968f; Olson CM, 2009, MATERN CHILD HLTH J, V13, P839, DOI 10.1007/s10995-008-0413-6; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Saben J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1, DOI 10.1152/ajpendo.00076.2013; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schroeder AM, 2012, J PHYSIOL-LONDON, V590, P6213, DOI 10.1113/jphysiol.2012.233676; Shankar K, 2008, ENDOCRINOLOGY, V149, P1748, DOI 10.1210/en.2007-0903; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shankar K, 2006, EXP BIOL MED, V231, P1379, DOI 10.1177/153537020623100812; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Shankar K, 2010, ENDOCRINOLOGY, V151, P153, DOI 10.1210/en.2009-0840; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Singhal R, 2008, CARCINOGENESIS, V29, P227, DOI 10.1093/carcin/bgm288; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith J, 2009, J CLIN ENDOCR METAB, V94, P4275, DOI 10.1210/jc.2009-0709; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Suter M, 2011, FASEB J, V25, P714, DOI 10.1096/fj.10-172080; Suter MA, 2012, FASEB J, V26, P5106, DOI 10.1096/fj.12-212878; Sutton GM, 2010, ENDOCRINOLOGY, V151, P1570, DOI 10.1210/en.2009-1133; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Wolff G, 2012, MED SCI SPORT EXER, V44, P1663, DOI 10.1249/MSS.0b013e318255cf4c; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	82	69	73	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84209	10.1371/journal.pone.0084209	http://dx.doi.org/10.1371/journal.pone.0084209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416203	gold, Green Submitted, Green Published			2022-12-25	WOS:000329866300020
J	Liu, JP; Chen, L; Zhou, Y; Liu, XZ; Tang, KL				Liu, Junpeng; Chen, Lei; Zhou, You; Liu, Xiangzhou; Tang, Kanglai			Insulin-Like Growth Factor-1 and Bone Morphogenetic Protein-2 Jointly Mediate Prostaglandin E2-Induced Adipogenic Differentiation of Rat Tendon Stem Cells	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; REPETITIVE MOTION; GENE-EXPRESSION; FIBROBLASTS; INCREASES; RESPONSES; MATRIX; ROLES; E-2	Tendinopathy is characterized histopathologically by lipid accumulation and tissue calcification. Adipogenic and osteogenic differentiation of tendon stem cells (TSCs) are believed to play key roles in these processes. The major inflammatory mediator prostaglandin E2 (PGE2) has been shown to induce osteogenic differentiation of TSCs via bone morphogenetic protein-2 (BMP-2), and BMP-2 has also been implicated in adipogenic differentiation of stem cells. We therefore examined the mechanisms responsible for PGE2-induced adipogenesis in rat TSCs in vitro. Insulin-like growth factor-1 (IGF-1) mRNA and protein were significantly up-regulated in PGE2-stimulated TSCs, measured by quantitative reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. Incubation with specific inhibitors of cAMP, cAMP-dependent protein kinase A (PKA), and CCAAT/enhancer binding protein-delta (CEBP delta) demonstrated that IGF-1 up-regulation occurred via a cAMP/PKA/CEBP delta pathway. Furthermore, neither IGF-1 nor BMP-2 alone was able to mediate adipogenic differentiation of TSCs, but IGF-1 together with BMP-2 significantly increased adipogenesis, indicated by Oil Red O staining. Moreover, knock-down of endogenous IGF-1 and BMP2 abolished PGE2-induced adipogenic differentiation. Phosphorylation of CREB and Smad by IGF-1 and BMP-2, respectively, were required for induction of the adipogenesis-related peroxisome proliferator-activated receptor gamma 2 (PPAR gamma 2) gene and for adipogenic differentiation. In conclusion, IGF-1 and BMP-2 together mediate PGE2-induced adipogenic differentiation of TSCs in vitro via a CREB-and Smad-dependent mechanism. This improved understanding of the mechanisms responsible for tendinopathies may help the development of more effective therapies.	[Liu, Junpeng; Zhou, You; Liu, Xiangzhou; Tang, Kanglai] Third Mil Med Univ, Southwest Hosp, Dept Orthopaed, Chongqing, Peoples R China; [Chen, Lei] Wuhan Gen Hosp Guangzhou Mil Reg, Dept Orthopaed, Wuhan, Peoples R China	Army Medical University	Tang, KL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthopaed, Chongqing, Peoples R China.	tangkanglai@126.com			National Nature Science Foundation of China [81230040]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (grant nos. 81230040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEKINDERS LC, 1993, MED SCI SPORT EXER, V25, P603; ALMEKINDERS LC, 1995, AM J SPORT MED, V23, P119, DOI 10.1177/036354659502300120; ARCHAMBAULT JM, 1995, SPORTS MED, V20, P77, DOI 10.2165/00007256-199520020-00003; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; CHARD MD, 1994, ANN RHEUM DIS, V53, P30, DOI 10.1136/ard.53.1.30; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chen TL, 2001, J CELL BIOCHEM, V82, P187, DOI 10.1002/jcb.1145; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; de Mos M, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-16; Devkota AC, 2007, J ORTHOP RES, V25, P1078, DOI 10.1002/jor.20389; Devkota AC, 2010, CONNECT TISSUE RES, V51, P306, DOI 10.3109/03008200903318261; Fenwick S, 2002, RHEUMATOLOGY, V41, pA474, DOI 10.1093/rheumatology/41.4.474; GIMBLE JM, 1995, J CELL BIOCHEM, V58, P393, DOI 10.1002/jcb.240580312; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Ji CH, 2003, MOL ENDOCRINOL, V17, P1834, DOI 10.1210/me.2002-0235; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Li ZZ, 2004, AM J SPORT MED, V32, P435, DOI 10.1177/0095399703258680; Liu JP, 2013, BIOCHEM BIOPH RES CO, V435, P514, DOI 10.1016/j.bbrc.2012.11.083; Lui Pauline Po Yee, 2009, J Orthop Surg Res, V4, P27, DOI 10.1186/1749-799X-4-27; Maffulli N, 1998, ARTHROSCOPY, V14, P840, DOI 10.1016/S0749-8063(98)70021-0; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Riley GP, 1996, ANN RHEUM DIS, V55, P109, DOI 10.1136/ard.55.2.109; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rui YF, 2013, J ORTHOP RES, V31, P746, DOI 10.1002/jor.22290; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Zhang JY, 2012, J ORTHOP RES, V30, P47, DOI 10.1002/jor.21485; Zhang JY, 2010, J ORTHOP RES, V28, P1178, DOI 10.1002/jor.21123; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang JY, 2010, J ORTHOP RES, V28, P198, DOI 10.1002/jor.20962	36	10	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85469	10.1371/journal.pone.0085469	http://dx.doi.org/10.1371/journal.pone.0085469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416413	gold, Green Submitted, Green Published			2022-12-25	WOS:000329866300081
J	Luo, L; Li, L				Luo, Le; Li, Li			Defining and Evaluating Classification Algorithm for High-Dimensional Data Based on Latent Topics	PLOS ONE			English	Article								Automatic text categorization is one of the key techniques in information retrieval and the data mining field. The classification is usually time-consuming when the training dataset is large and high-dimensional. Many methods have been proposed to solve this problem, but few can achieve satisfactory efficiency. In this paper, we present a method which combines the Latent Dirichlet Allocation (LDA) algorithm and the Support Vector Machine (SVM). LDA is first used to generate reduced dimensional representation of topics as feature in VSM. It is able to reduce features dramatically but keeps the necessary semantic information. The Support Vector Machine (SVM) is then employed to classify the data based on the generated features. We evaluate the algorithm on 20 Newsgroups and Reuters-21578 datasets, respectively. The experimental results show that the classification based on our proposed LDA+SVM model achieves high performance in terms of precision, recall and F1 measure. Further, it can achieve this within a much shorter time-frame. Our process improves greatly upon the previous work in this field and displays strong potential to achieve a streamlined classification process for a wide range of applications.	[Luo, Le; Li, Li] Southwest Univ, Fac Comp & Informat Sci, Chongqing, Peoples R China	Southwest University - China	Li, L (corresponding author), Southwest Univ, Fac Comp & Informat Sci, Chongqing, Peoples R China.	lily@swu.edu.cn			National Natural Science Foundation of China [61170192]; Natural Science Foundation Project of CQ [CSTC2012JJB40012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ(Natural Science Foundation Project of CQ CSTC)	This work was supported by National Natural Science Foundation of China (No. 61170192) and Natural Science Foundation Project of CQ (No. CSTC2012JJB40012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellman R. E., 2003, DYNAMIC PROGRAMMING; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Cai J., 2007, P EMNLP CONLL; Christopher J., 2009, MACH LEARN, V2, P275; Debole F, 2005, J AM SOC INF SCI TEC, V56, P584, DOI 10.1002/asi.20147; Di Nunzio GM, 2004, LECT NOTES COMPUT SC, V2997, P112; Forman G, 2004, LECT NOTES ARTIF INT, V3202, P161; Forman G, 2003, J MACHINE LEARNING R, V3, P1533; Guo L., 2004, INT C CONTROL, P1; Hao PY, 2007, EXPERT SYST APPL, V33, P627, DOI 10.1016/j.eswa.2006.06.009; Heinrich G., 2009, PARAMETER ESTIMATION; Kazama J, 2005, MACH LEARN, V60, P159, DOI 10.1007/s10994-005-0911-3; Kim H, 2005, J MACH LEARN RES, V6, P37; Lewis DD, 2004, J MACH LEARN RES, V5, P361; Minh HQ, 2006, LECT NOTES ARTIF INT, V4005, P154, DOI 10.1007/11776420_14; Phan Xuan-Hieu, 2008, P 17 INT C WORLD WID, P91, DOI [DOI 10.1145/1367497.1367510, 10.1145/1367497.1367510]; Schivinski Bruno, 2013, WORKING PAPER SERI A, V12, P2; Tang J., 2012, P 18 ACM SIGKDD INT, P1366, DOI DOI 10.1145/2339530.2339741; Tang J, 2011, MACH LEARN, V82, P211, DOI 10.1007/s10994-010-5212-9; YANG Y, 1997, CMUCS97127	20	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e82119	10.1371/journal.pone.0082119	http://dx.doi.org/10.1371/journal.pone.0082119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416136	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300008
J	Pleger, B; Draganski, B; Schwenkreis, P; Lenz, M; Nicolas, V; Maier, C; Tegenthoff, M				Pleger, Burkhard; Draganski, Bogdan; Schwenkreis, Peter; Lenz, Melanie; Nicolas, Volkmar; Maier, Christoph; Tegenthoff, Martin			Complex Regional Pain Syndrome Type I Affects Brain Structure in Prefrontal and Motor Cortex	PLOS ONE			English	Article							REFLEX SYMPATHETIC DYSTROPHY; MIDBRAIN PERIAQUEDUCTAL GRAY; PRIMARY SOMATOSENSORY CORTEX; CHRONIC BACK-PAIN; CRPS-I; CORTICAL REORGANIZATION; VASCULAR ABNORMALITIES; MACAQUE MONKEYS; MATTER; PROJECTIONS	The complex regional pain syndrome (CRPS) is a rare but debilitating pain disorder that mostly occurs after injuries to the upper limb. A number of studies indicated altered brain function in CRPS, whereas possible influences on brain structure remain poorly investigated. We acquired structural magnetic resonance imaging data from CRPS type I patients and applied voxel-by-voxel statistics to compare white and gray matter brain segments of CRPS patients with matched controls. Patients and controls were statistically compared in two different ways: First, we applied a 2-sample ttest to compare whole brain white and gray matter structure between patients and controls. Second, we aimed to assess structural alterations specifically of the primary somatosensory (S1) and motor cortex (M1) contralateral to the CRPS affected side. To this end, MRI scans of patients with left-sided CRPS (and matched controls) were horizontally flipped before preprocessing and region-of-interest-based group comparison. The unpaired ttest of the "non-flipped" data revealed that CRPS patients presented increased gray matter density in the dorsomedial prefrontal cortex. The same test applied to the "flipped" data showed further increases in gray matter density, not in the S1, but in the M1 contralateral to the CRPS-affected limb which were inversely related to decreased white matter density of the internal capsule within the ipsilateral brain hemisphere. The gray-white matter interaction between motor cortex and internal capsule suggests compensatory mechanisms within the central motor system possibly due to motor dysfunction. Altered gray matter structure in dorsomedial prefrontal cortex may occur in response to emotional processes such as pain-related suffering or elevated analgesic top-down control.	[Pleger, Burkhard] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Pleger, Burkhard] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Draganski, Bogdan] CHU Vaudois, Dept Neurosci Clin, Lab Rech Neuroimagerie LREN, Lausanne, Switzerland; [Schwenkreis, Peter; Lenz, Melanie; Tegenthoff, Martin] Univ Hosp Bergmannsheil, Dept Neurol, Bochum, Germany; [Nicolas, Volkmar] Univ Hosp Bergmannsheil, Dept Radiol, Bochum, Germany; [Maier, Christoph] Univ Hosp Bergmannsheil, Dept Pain Treatment, Bochum, Germany	Max Planck Society; Leipzig University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Pleger, B (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.	bpleger@cbs.mpg.de	Draganski, Bogdan/C-3096-2016	Draganski, Bogdan/0000-0002-5159-5919	BMBF [Bernstein Focus, State Dependencies of Learning] [01GQ0975, 18GL4DW4, 01GQ0963 (TP 4)]	BMBF [Bernstein Focus, State Dependencies of Learning]	This work was supported by the BMBF [Bernstein Focus, State Dependencies of Learning 01GQ0975; Project 18GL4DW4 to B. P. and 01GQ0963 (TP 4) to M. T.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 1999, PAIN, V80, P539, DOI 10.1016/S0304-3959(98)00246-2; An X, 1998, J COMP NEUROL, V401, P455; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Bruehl S, 2010, ANESTHESIOLOGY, V113, P713, DOI 10.1097/ALN.0b013e3181e3db38; Chang LJ, 2011, NEURON, V70, P560, DOI 10.1016/j.neuron.2011.02.056; Di Pietro F, 2013, J PAIN, V14, P1001, DOI 10.1016/j.jpain.2013.04.001; Draganski B, 2006, NEUROIMAGE, V31, P951, DOI 10.1016/j.neuroimage.2006.01.018; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Lamm C, 2010, J COGNITIVE NEUROSCI, V22, P362, DOI 10.1162/jocn.2009.21186; Lenz M, 2011, NEUROLOGY, V77, P1096, DOI 10.1212/WNL.0b013e31822e1436; Lenz M, 2013, PAIN; Macoveanu J, 2013, EUR NEUROPSYCHOPHARM, V23, P919, DOI 10.1016/j.euroneuro.2012.09.006; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MANTYH PW, 1983, J NEUROPHYSIOL, V49, P567, DOI 10.1152/jn.1983.49.3.567; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; Mathur VA, 2010, NEUROIMAGE, V51, P1468, DOI 10.1016/j.neuroimage.2010.03.025; Mechias ML, 2010, NEUROIMAGE, V49, P1760, DOI 10.1016/j.neuroimage.2009.09.040; Napadow V, 2009, NEUROIMAGE, V47, P1055, DOI 10.1016/j.neuroimage.2009.05.079; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ongur D, 1998, J COMP NEUROL, V401, P480; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pleger B, 2004, EXP BRAIN RES, V155, P115, DOI 10.1007/s00221-003-1738-4; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Porro CA, 2003, NEUROIMAGE, V19, P1738, DOI 10.1016/S1053-8119(03)00184-8; Reinersmann A, 2013, PAIN, V154, P1519, DOI 10.1016/j.pain.2013.03.039; Reinersmann A, 2012, PAIN, V153, P2174, DOI 10.1016/j.pain.2012.05.025; Reinersmann A, 2010, NEUROSCI LETT, V486, P240, DOI 10.1016/j.neulet.2010.09.062; Remy F, 2003, NEUROIMAGE, V19, P655, DOI 10.1016/S1053-8119(03)00146-0; Rommel O, 2001, PAIN, V93, P279, DOI 10.1016/S0304-3959(01)00332-3; Rommel O, 1999, PAIN, V80, P95, DOI 10.1016/S0304-3959(98)00202-4; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schwenkreis P, 2003, NEUROLOGY, V61, P515, DOI 10.1212/WNL.61.4.515; Stankewitz A, 2013, PAIN, V154, P1732, DOI 10.1016/j.pain.2013.05.019; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; Tecchio F, 2002, HUM BRAIN MAPP, V17, P28, DOI 10.1002/hbm.10049; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaneker M, 2005, PAIN, V115, P204, DOI 10.1016/j.pain.2005.02.031; Wasner G, 1998, NEUROL CLIN, V16, P851, DOI 10.1016/S0733-8619(05)70101-8; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Wasner G, 1999, ARCH NEUROL-CHICAGO, V56, P613, DOI 10.1001/archneur.56.5.613	53	38	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85372	10.1371/journal.pone.0085372	http://dx.doi.org/10.1371/journal.pone.0085372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416397	gold, Green Published, Green Submitted			2022-12-25	WOS:000329866300073
J	Walentowicz-Sadlecka, M; Sadlecki, P; Bodnar, M; Marszalek, A; Walentowicz, P; Sokup, A; Wilinska-Jankowska, A; Grabiec, M				Walentowicz-Sadlecka, Malgorzata; Sadlecki, Pawel; Bodnar, Magdalena; Marszalek, Andrzej; Walentowicz, Pawel; Sokup, Alina; Wilinska-Jankowska, Arnika; Grabiec, Marek			Stromal Derived Factor-1 (SDF-1) and Its Receptors CXCR4 and CXCR7 in Endometrial Cancer Patients	PLOS ONE			English	Article							TUMOR; CHEMOKINES; EXPRESSION; METASTASIS; CARCINOMA; SURVIVAL; CXCL12; AXIS	Purpose: One of the most important function of stromal derived factor-1 (SDF-1) and its receptors, is regulating the process of metastasis formation. The aim of our study was to investigate the correlation between SDF-1, CXCR4 and CXCR7 protein levels measured by immunohistochemistry with the clinicopathological features and the survival of endometrial cancer patients. Materials and Methods: 92 patients aged 37-84 (mean 65.1 +/- 9.5) were enrolled to our study between January 2000 and December 2007. After the diagnosis of endometrial cancer, all women underwent total abdominal hysterectomy, with bilateral salpingoophorectomy and pelvic lymph node dissection. In all patients clinical stage (according to FIGO classification), histologic grade, myometrial invasion, lymph node and distant metastases were determined. Furthermore, the survival time was assessed. Immunohistochemical analyses of SDF-1, CXCR4 and CXCR7 were performed on archive formalin fixed paraffin embedded tissue sections. Results: Statistically significant correlations (p < 0.01) were reported between SDF-1 and the clinical stage of disease, lymph node metastases, distant metastases, deep myometrial invasion (>= 50%), cervical involvement, involvement of adnexa. Statistically significant correlation (p < 0.01) was found between SDF-1 expression and the risk of the recurrence. Higher SDF-1 expression was associated with ahigher risk of recurrence (p = 0.0001). The results of CXCR4and CXCR7 expression didn't reveal any significant differences(p > 0.05) between the proteins expression in the primary tumor cells and the clinicopathological features. Moreover, the Kaplan-Meier analyses demonstrated a stepwise impairment of cancer overall survival (OS) with increasing SDF-1 expression. Conclusion: The important role of SDF-1 as a predictor of negative clinicopathological characteristics of atumor suggests that the expression of this stromal factor should be included in the panel of accessory pathomorphological tests and could be helpful in establishing a more accurate prognosis in endometrial cancer patients.	[Walentowicz-Sadlecka, Malgorzata; Sadlecki, Pawel; Walentowicz, Pawel; Grabiec, Marek] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Obstet & Gynecol, Bydgoszcz, Poland; [Bodnar, Magdalena; Marszalek, Andrzej] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Clin Pathol, Bydgoszcz, Poland; [Sokup, Alina] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Gastroenterol Angiol & Internal Dis, Bydgoszcz, Poland; [Wilinska-Jankowska, Arnika] Ludwik Rydygier Hosp Torun, Dept Physiotherapy, Torun, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University	Walentowicz-Sadlecka, M (corresponding author), Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Obstet & Gynecol, Bydgoszcz, Poland.	walentowiczm@cm.umk.pl	Sadłecki, Paweł/I-5728-2014; Sokup, Alina/M-5222-2014; Sadlecki, Pawel/AAB-5046-2021; Bodnar, Magdalena/D-6131-2014; Sadlecki, Pawel/AAB-6993-2021	Sadłecki, Paweł/0000-0001-8355-2553; Sokup, Alina/0000-0002-7470-6706; Bodnar, Magdalena/0000-0003-3748-1058; Sadlecki, Pawel/0000-0001-8355-2553; Walentowicz, Pawel/0000-0002-7748-343X				Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bakkum-Gamez JN, 2008, MAYO CLIN PROC, V83, P97, DOI 10.4065/83.1.97; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Felix AS, 2012, INT J CANCER, V131, pE114, DOI 10.1002/ijc.27317; Gelmini S, 2009, CLIN EXP METASTAS, V26, P261, DOI 10.1007/s10585-009-9240-4; Ho TK, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/143209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Kodama J, 2007, ANN ONCOL, V18, P269, DOI 10.1093/annonc/mdl370; Lee E, 2013, PIGM CELL MELANOMA R, V26, P58, DOI 10.1111/pcmr.12024; Liu FF, 2009, HISTOPATHOLOGY, V54, P741, DOI 10.1111/j.1365-2559.2009.03289.x; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Mizokami Y, 2004, INT J CANCER, V110, P652, DOI 10.1002/ijc.20183; REMMELE W, 1987, PATHOLOGE, V8, P138; Salomonnson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051500; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Subramaniam KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068923; Sun QM, 2009, J BIOL CHEM, V284, P32066, DOI 10.1074/jbc.M109.057166; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tsukamoto H, 2007, CLIN EXP METASTAS, V24, P423, DOI 10.1007/s10585-007-9079-5; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069182; Wojcechowskyj JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024918; Zhang SW, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-62	31	22	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84629	10.1371/journal.pone.0084629	http://dx.doi.org/10.1371/journal.pone.0084629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416254	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300031
J	Angus, AA; Agapakis, CM; Fong, S; Yerrapragada, S; Estrada-de los Santos, P; Yang, P; Song, N; Kano, S; Caballero-Mellado, J; de Faria, SM; Dakora, FD; Weinstock, G; Hirsch, AM				Angus, Annette A.; Agapakis, Christina M.; Fong, Stephanie; Yerrapragada, Shailaja; Estrada-de los Santos, Paulina; Yang, Paul; Song, Nannie; Kano, Stephanie; Caballero-Mellado, Jesus; de Faria, Sergio M.; Dakora, Felix D.; Weinstock, George; Hirsch, Ann M.			Plant-Associated Symbiotic Burkholderia Species Lack Hallmark Strategies Required in Mammalian Pathogenesis	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; QUORUM-SENSING SYSTEM; CAENORHABDITIS-ELEGANS; SECRETION SYSTEM; VI SECRETION; PSEUDOMALLEI; VIRULENCE; CEPACIA; INFECTION; NOV	Burkholderia is a diverse and dynamic genus, containing pathogenic species as well as species that form complex interactions with plants. Pathogenic strains, such as B. pseudomallei and B. mallei, can cause serious disease in mammals, while other Burkholderia strains are opportunistic pathogens, infecting humans or animals with a compromised immune system. Although some of the opportunistic Burkholderia pathogens are known to promote plant growth and even fix nitrogen, the risk of infection to infants, the elderly, and people who are immunocompromised has not only resulted in a restriction on their use, but has also limited the application of non-pathogenic, symbiotic species, several of which nodulate legume roots or have positive effects on plant growth. However, recent phylogenetic analyses have demonstrated that Burkholderia species separate into distinct lineages, suggesting the possibility for safe use of certain symbiotic species in agricultural contexts. A number of environmental strains that promote plant growth or degrade xenobiotics are also included in the symbiotic lineage. Many of these species have the potential to enhance agriculture in areas where fertilizers are not readily available and may serve in the future as inocula for crops growing in soils impacted by climate change. Here we address the pathogenic potential of several of the symbiotic Burkholderia strains using bioinformatics and functional tests. A series of infection experiments using Caenorhabditis elegans and HeLa cells, as well as genomic characterization of pathogenic loci, show that the risk of opportunistic infection by symbiotic strains such as B. tuberum is extremely low.	[Angus, Annette A.; Agapakis, Christina M.; Fong, Stephanie; Yang, Paul; Song, Nannie; Kano, Stephanie; Hirsch, Ann M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90047 USA; [Hirsch, Ann M.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Yerrapragada, Shailaja] Baylor Coll Med, Houston, TX 77030 USA; [Estrada-de los Santos, Paulina] Inst Politecn Nacl, Dept Microbiol, Escuela Nacl Ciencias Biol, Mexico City 07738, DF, Mexico; [Caballero-Mellado, Jesus] Univ Nacl Autonoma Mexico, Genom Sci Ctr, Cuernavaca, Morelos, Mexico; [de Faria, Sergio M.] Embrapa Agrobiol, Rio De Janeiro, Brazil; [Dakora, Felix D.] Tshwane Univ Technol, Dept Chem, Pretoria, South Africa; [Weinstock, George] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Tshwane University of Technology; Washington University (WUSTL)	Hirsch, AM (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90047 USA.	ahirsch@ucla.edu	de Faria, Sergio Miana/C-1405-2013; Weinstock, George M/C-6314-2013; de los Santos, Paulina Estrada/AAE-8582-2021; de los Santos, Paulina Estrada/S-1238-2018; Hirsch, Ann M/D-3562-2009; Dakora, Felix/AAI-4090-2020	Weinstock, George M/0000-0002-2997-4592; de los Santos, Paulina Estrada/0000-0003-2407-0284; de los Santos, Paulina Estrada/0000-0003-2407-0284; Hirsch, Ann M/0000-0002-9633-1538; Dakora, Felix/0000-0002-9070-6896; de Faria, Sergio/0000-0001-5066-046X	National Science Foundation (USA) [IOB-0537497]; Shanbrom Family Foundation; University of California Office of The President; L'Oreal USA For Women in Science Fellowship	National Science Foundation (USA)(National Science Foundation (NSF)); Shanbrom Family Foundation; University of California Office of The President(University of California System); L'Oreal USA For Women in Science Fellowship(L'Oreal Group)	This research was supported in part by a grant (IOB-0537497) from the National Science Foundation (USA) to GW and AMH and a Shanbrom Family Foundation grant to AMH. A University of California Office of The President, President's Postdoctoral Fellowship, supported AAA. CMA was supported by the L'Oreal USA For Women in Science Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus AA, 2013, PLANT SOIL, V369, P543, DOI 10.1007/s11104-013-1590-7; [Anonymous], 2003, FED REGISTER, V68, P35315; Araujo R, 2004, J CLIN MICROBIOL, V42, P4335, DOI 10.1128/JCM.42.9.4335-4337.2004; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Caballero-Mellado J, 2004, INT J SYST EVOL MICR, V54, P1165, DOI 10.1099/ijs.0.02951-0; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chen CY, 2008, J HOSP INFECT, V68, P203, DOI 10.1016/j.jhin.2007.11.021; Chiarini L, 2006, TRENDS MICROBIOL, V14, P277, DOI 10.1016/j.tim.2006.04.006; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Coenye T, 2002, J CLIN MICROBIOL, V40, P2062, DOI 10.1128/JCM.40.6.2062-2069.2002; Cooper VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007961; Cunha CD, 2012, J BACTERIOL, V194, P6675, DOI 10.1128/JB.01821-12; de los Santos-Villalobos S, 2012, WORLD J MICROB BIOT, V28, P2615, DOI 10.1007/s11274-012-1071-9; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Essex-Lopresti AE, 2005, INFECT IMMUN, V73, P1260, DOI 10.1128/IAI.73.2.1260-1264.2005; Estrada-de los Santos P, 2013, CURR MICROBIOL, V67, P51, DOI 10.1007/s00284-013-0330-9; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Gyaneshwar P, 2011, MOL PLANT MICROBE IN, V24, P1276, DOI 10.1094/MPMI-06-11-0172; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Holmes A, 1998, EMERG INFECT DIS, V4, P221, DOI 10.3201/eid0402.980209; Kaplan D, 2013, AM J BOT, V100, P1713, DOI 10.3732/ajb.1200615; Kuykendall LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034673; La Scola B, 2002, INT J SYST EVOL MICR, V52, P1773, DOI [10.1099/ijs.0.02149-0, 10.1099/00207713-52-5-1773]; Magalhaes Marcelo, 2002, J Cyst Fibros, V1, P292, DOI 10.1016/S1569-1993(02)00101-7; McCarter LL, 2004, J MOL MICROB BIOTECH, V7, P18, DOI 10.1159/000077866; Mitter B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00120; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; O'Sullivan LA, 2007, ENVIRON MICROBIOL, V9, P1017, DOI 10.1111/j.1462-2920.2006.01228.x; Onofre-Lemus J, 2009, APPL ENVIRON MICROB, V75, P6581, DOI 10.1128/AEM.01240-09; Paphitou NI, 2003, INFECTION, V31, P421, DOI 10.1007/s15010-003-3175-5; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; Perin L, 2006, APPL ENVIRON MICROB, V72, P3103, DOI 10.1128/AEM.72.5.3103-3110.2006; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; Reinke SN, 2010, MOL GENET METAB, V100, P274, DOI 10.1016/j.ymgme.2010.03.013; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Roest HP, 1997, MOL PLANT MICROBE IN, V10, P938, DOI 10.1094/MPMI.1997.10.7.938; Sanchez PA, 2010, NAT GEOSCI, V3, P299, DOI 10.1038/ngeo853; Schmidt MA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-98; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Seo YS, 2011, J BACTERIOL, V193, P3149, DOI 10.1128/JB.00420-11; Stiernagle Theresa, 2006, WormBook, P1; Suarez-Moreno ZR, 2008, MICROBIOL-SGM, V154, P2048, DOI 10.1099/mic.0.2008/017780-0; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Torbeck Lynn, 2011, PDA J Pharm Sci Technol, V65, P535, DOI 10.5731/pdajpst.2011.00793; Ulrich RL, 2004, J MED MICROBIOL, V53, P1053, DOI 10.1099/jmm.0.45661-0; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x; Zachow C, 2009, EUR J PLANT PATHOL, V125, P367, DOI 10.1007/s10658-009-9486-3; Zhang RF, 2009, MICROBIOL-SGM, V155, P4005, DOI 10.1099/mic.0.033043-0	67	76	81	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83779	10.1371/journal.pone.0083779	http://dx.doi.org/10.1371/journal.pone.0083779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416172	Green Published, gold			2022-12-25	WOS:000329862500072
J	Driessen, TM; Zhao, CJ; Whittlinger, A; Williams, H; Gammie, SC				Driessen, Terri M.; Zhao, Changjiu; Whittlinger, Anna; Williams, Horecia; Gammie, Stephen C.			Endogenous CNS Expression of Neurotensin and Neurotensin Receptors Is Altered during the Postpartum Period in Outbred Mice	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; CENTRAL-NERVOUS-SYSTEM; MEDIAL PREOPTIC AREA; MATERNAL-BEHAVIOR; MESSENGER-RNA; GENE-EXPRESSION; LATERAL SEPTUM; NEUROMEDIN-N; BED NUCLEUS; RAT-BRAIN	Neurotensin (NT) is a neuropeptide identical in mice and humans that is produced and released in many CNS regions associated with maternal behavior. NT has been linked to aspects of maternal care and previous studies have indirectly suggested that endogenous NT signaling is altered in the postpartum period. In the present study, we directly examine whether NT and its receptors exhibit altered gene expression in maternal relative to virgin outbred mice using real time quantitative PCR (qPCR) across multiple brain regions. We also examine NT protein levels using anti-NT antibodies and immunohistochemistry in specific brain regions. In the medial preoptic area (MPOA), which is critical for maternal behaviors, mRNA of NT and NT receptor 3 (Sort1) were significantly up-regulated in postpartum mice compared to virgins. NT mRNA was also elevated in postpartum females in the bed nucleus of the stria terminalis dorsal. However, in the lateral septum, NT mRNA was down-regulated in postpartum females. In the paraventricular nucleus of the hypothalamus (PVN), Ntsr1 expression was down-regulated in postpartum females. Neurotensin receptor 2 (Ntsr2) expression was not altered in any brain region tested. In terms of protein expression, NT immunohistochemistry results indicated that NT labeling was elevated in the postpartum brain in the MPOA, lateral hypothalamus, and two subregions of PVN. Together, these findings indicate that endogenous changes occur in NT and its receptors across multiple brain regions, and these likely support the emergence of some maternal behaviors.	[Driessen, Terri M.; Zhao, Changjiu; Whittlinger, Anna; Gammie, Stephen C.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Williams, Horecia] Ft Valley State Univ, Dept Anim Sci, Ft Valley, GA USA; [Gammie, Stephen C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; Fort Valley State University; University of Wisconsin System; University of Wisconsin Madison	Driessen, TM (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	tdriessen@wisc.edu	Zhao, Changjiu/M-8263-2014		National Science Foundation [IOS-0921706]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation grant IOS-0921706 to SCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MJ, 1989, P NATL ACAD SCI USA, V86, P5202, DOI 10.1073/pnas.86.13.5202; Alexander MJ, 1998, J COMP NEUROL, V402, P475; ALLEN GV, 1995, NEUROSCIENCE, V69, P533, DOI 10.1016/0306-4522(95)00261-G; Angelidou A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-48; AXELSON JF, 1992, NEUROSCI LETT, V136, P5, DOI 10.1016/0304-3940(92)90634-J; BERK ML, 1981, NEUROSCIENCE, V6, P1601, DOI 10.1016/0306-4522(81)90227-X; Binder EB, 2001, PHARMACOL REV, V53, P453; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Boudin H, 1996, J COMP NEUROL, V373, P76; BRIDGES RS, 1996, PARENTAL CARE EVOLUT; BROWN KJ, 1995, PHYSIOL BEHAV, V58, P1085, DOI 10.1016/0031-9384(95)02043-8; Byrnes EM, 2002, PHARMACOL BIOCHEM BE, V73, P869, DOI 10.1016/S0091-3057(02)00941-3; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; CONRAD LCA, 1976, J COMP NEUROL, V169, P185, DOI 10.1002/cne.901690205; Consiglio AR, 1996, PHYSIOL BEHAV, V59, P591, DOI 10.1016/0031-9384(95)02117-5; Cui H, 2005, J NEUROSCI, V25, P9497, DOI 10.1523/JNEUROSCI.2269-05.2005; Cullinan WE, 1996, J COMP NEUROL, V368, P88; D'Anna KL, 2006, J NEUROENDOCRINOL, V18, P553, DOI 10.1111/j.1365-2826.2006.01448.x; D'Anna KL, 2009, BEHAV NEUROSCI, V123, P356, DOI 10.1037/a0014987; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dobner PR, 2006, PEPTIDES, V27, P2405, DOI 10.1016/j.peptides.2006.04.025; Dobner PR, 2005, CELL MOL LIFE SCI, V62, P1946, DOI 10.1007/s00018-005-5128-x; DOBNER PR, 1987, P NATL ACAD SCI USA, V84, P3516, DOI 10.1073/pnas.84.10.3516; Dobner PR, 2001, P NATL ACAD SCI USA, V98, P8048, DOI 10.1073/pnas.141042198; DUNN JD, 1987, BRAIN RES, V407, P327, DOI 10.1016/0006-8993(87)91111-5; Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011; Francis DD, 2000, J NEUROENDOCRINOL, V12, P1145, DOI 10.1046/j.1365-2826.2000.00599.x; Gammie SC, 2007, GENES BRAIN BEHAV, V6, P432, DOI 10.1111/j.1601-183X.2006.00271.x; Gammie SC, 2009, NEUROSCIENCE, V158, P1215, DOI 10.1016/j.neuroscience.2008.11.045; Gammie SC, 2005, MOL BRAIN RES, V139, P201, DOI 10.1016/j.molbrainres.2005.05.011; Gammie SC, 2004, BEHAV NEUROSCI, V118, P805, DOI 10.1037/0735-7044.118.4.805; Gammie SC, 2012, BRAIN RES, V1433, P47, DOI 10.1016/j.brainres.2011.11.017; Geerling JC, 2006, J COMP NEUROL, V494, P515, DOI 10.1002/cne.20808; Geisler S, 2006, EUR J NEUROSCI, V24, P116, DOI 10.1111/j.1460-9568.2006.04928.x; HERMAN JP, 1994, J NEUROENDOCRINOL, V6, P433, DOI 10.1111/j.1365-2826.1994.tb00604.x; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; INSEL TR, 1992, ANN NY ACAD SCI, V652, P122, DOI 10.1111/j.1749-6632.1992.tb34350.x; INSEL TR, 1990, J NEUROENDOCRINOL, V2, P539, DOI 10.1111/j.1365-2826.1990.tb00445.x; INSEL TR, 1989, PHYSIOL BEHAV, V45, P1033, DOI 10.1016/0031-9384(89)90234-5; JENNES L, 1982, J COMP NEUROL, V210, P211, DOI 10.1002/cne.902100302; Johnstone LE, 2004, J NEUROENDOCRINOL, V16, P605, DOI 10.1111/j.1365-2826.2004.01208.x; Jurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037060; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; KENDRICK KM, 1992, BRAIN RES, V569, P199, DOI 10.1016/0006-8993(92)90631-I; Kinkead B., 2006, CNS & Neurological Disorders-Drug Targets, V5, P205, DOI 10.2174/187152706776359655; KISLAUSKIS E, 1988, J BIOL CHEM, V263, P4963; KITABGI P, 1992, ANN NY ACAD SCI, V668, P30, DOI 10.1111/j.1749-6632.1992.tb27337.x; Kitabgi P, 2006, PEPTIDES, V27, P2515, DOI 10.1016/j.peptides.2005.12.017; Kitabgi P, 2006, PEPTIDES, V27, P2508, DOI 10.1016/j.peptides.2006.03.038; KOCH M, 1989, BRAIN RES, V489, P101, DOI 10.1016/0006-8993(89)90012-7; Lee G, 2009, BEHAV NEUROSCI, V123, P1169, DOI 10.1037/a0017535; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levine JB, 2008, NEUROSCIENCE, V151, P589, DOI 10.1016/j.neuroscience.2007.10.014; Lonstein JS, 2002, NEUROSCI BIOBEHAV R, V26, P869, DOI 10.1016/S0149-7634(02)00087-8; Lonstein JS, 2000, NEUROENDOCRINOLOGY, V72, P91, DOI 10.1159/000054576; Maeno H, 2004, BRAIN RES, V998, P122, DOI 10.1016/j.brainres.2003.11.039; Maeno H, 1996, MOL BRAIN RES, V40, P97; Maharjan S, 2005, J NEUROCHEM, V93, P1502, DOI 10.1111/j.1471-4159.2005.03142.x; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Mazella J, 1996, J NEUROSCI, V16, P5613; Mazella J, 2006, PEPTIDES, V27, P2488, DOI 10.1016/j.peptides.2006.02.012; Miller SM, 2010, PHARMACOL BIOCHEM BE, V95, P457, DOI 10.1016/j.pbb.2010.03.007; MOOS F, 1989, EXP BRAIN RES, V76, P593, DOI 10.1007/BF00248916; Najimi M, 1998, J BIOL CHEM, V273, P21634, DOI 10.1074/jbc.273.34.21634; Nelissen K, 2010, J NEUROSCI METH, V187, P78, DOI 10.1016/j.jneumeth.2009.12.018; Nelson RJ, 1997, HORM BEHAV, V31, P188, DOI 10.1006/hbeh.1997.1381; NEMEROFF CB, 1977, BRAIN RES, V128, P485, DOI 10.1016/0006-8993(77)90173-1; NEMEROFF CB, 1986, PSYCHONEUROENDOCRINO, V11, P15, DOI 10.1016/0306-4530(86)90029-6; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Nicot A, 1997, J NEUROENDOCRINOL, V9, P263, DOI 10.1046/j.1365-2826.1997.00581.x; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; NIEUWENHUYS R, 1982, J COMP NEUROL, V206, P49, DOI 10.1002/cne.902060106; Numan M, 2005, BEHAV NEUROSCI, V119, P1588, DOI 10.1037/0735-7044.119.6.1588; NUMAN M, 1985, J COMP NEUROL, V237, P552, DOI 10.1002/cne.902370411; Numan M., 2003, HORM BR BEHAV; OCONNOR WT, 1992, BRAIN RES, V573, P209, DOI 10.1016/0006-8993(92)90765-2; Palanza P, 2001, PHYSIOL BEHAV, V73, P411, DOI 10.1016/S0031-9384(01)00494-2; Pawluski JL, 2010, J NEUROENDOCRINOL, V22, P248, DOI 10.1111/j.1365-2826.2010.01960.x; PETRAGLIA F, 1985, J ENDOCRINOL, V105, P239, DOI 10.1677/joe.0.1050239; Pettibone DJ, 2002, J PHARMACOL EXP THER, V300, P305, DOI 10.1124/jpet.300.1.305; Remaury A, 2002, BRAIN RES, V953, P63, DOI 10.1016/S0006-8993(02)03271-7; ROWE W, 1995, J NEUROENDOCRINOL, V7, P109, DOI 10.1111/j.1365-2826.1995.tb00673.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; SAWCHENKO PE, 1983, J COMP NEUROL, V218, P121, DOI 10.1002/cne.902180202; Scotti MAL, 2011, HORM BEHAV, V60, P177, DOI 10.1016/j.yhbeh.2011.04.007; Scotti MAL, 2011, BEHAV NEUROSCI, V125, P434, DOI 10.1037/a0023184; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; SILVERMAN AJ, 1981, BRAIN RES BULL, V6, P47, DOI 10.1016/S0361-9230(81)80068-8; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; SORENSON CA, 1975, PHARMACOL BIOCHEM BE, V3, P331, DOI 10.1016/0091-3057(75)90039-8; Souaze F, 1997, J BIOL CHEM, V272, P10087; Souaze F, 2006, PEPTIDES, V27, P2493, DOI 10.1016/j.peptides.2006.04.029; Sun YJ, 2001, MOL BRAIN RES, V95, P167, DOI 10.1016/S0169-328X(01)00220-0; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; TRIBOLLET E, 1981, NEUROSCIENCE, V6, P1315, DOI 10.1016/0306-4522(81)90190-1; Tsuneoka Y, 2013, J COMP NEUROL, V521, P1633, DOI 10.1002/cne.23251; UHL GR, 1977, P NATL ACAD SCI USA, V74, P4059, DOI 10.1073/pnas.74.9.4059; WAKERLEY JB, 1990, J ENDOCRINOL, V125, P467, DOI 10.1677/joe.0.1250467; Walker N, 1998, MOL BRAIN RES, V57, P193, DOI 10.1016/S0169-328X(98)00074-6; Watters JJ, 1998, J NEUROSCI, V18, P6672; Young LJ, 1997, J NEUROENDOCRINOL, V9, P859, DOI 10.1046/j.1365-2826.1997.00654.x; Zhao CJ, 2012, BRAIN RES, V1470, P35, DOI 10.1016/j.brainres.2012.06.002; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038602; Ziegler DR, 2002, INTEGR COMP BIOL, V42, P541, DOI 10.1093/icb/42.3.541	107	19	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83098	10.1371/journal.pone.0083098	http://dx.doi.org/10.1371/journal.pone.0083098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416154	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500026
J	Garbett, NC; Merchant, ML; Helm, CW; Jenson, AB; Klein, JB; Chaires, JB				Garbett, Nichola C.; Merchant, Michael L.; Helm, C. William; Jenson, Alfred B.; Klein, Jon B.; Chaires, Jonathan B.			Detection of Cervical Cancer Biomarker Patterns in Blood Plasma and Urine by Differential Scanning Calorimetry and Mass Spectrometry	PLOS ONE			English	Article							SERUM PEPTIDOME PATTERNS; INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS; DIAGNOSIS; PROTEOME; EXPRESSION; GUIDELINES; MANAGEMENT; SMEARS; TESTS	Improved methods for the accurate identification of both the presence and severity of cervical intraepithelial neoplasia (CIN) and extent of spread of invasive carcinomas of the cervix (IC) are needed. Differential scanning calorimetry (DSC) has recently been shown to detect specific changes in the thermal behavior of blood plasma proteins in several diseases. This methodology is being explored to provide a complementary approach for screening of cervical disease. The present study evaluated the utility of DSC in differentiating between healthy controls, increasing severity of CIN and early and advanced IC. Significant discrimination was apparent relative to the extent of disease with no clear effect of demographic factors such as age, ethnicity, smoking status and parity. Of most clinical relevance, there was strong differentiation of CIN from healthy controls and IC, and amongst patients with IC between FIGO Stage I and advanced cancer. The observed disease-specific changes in DSC profiles (thermograms) were hypothesized to reflect differential expression of disease biomarkers that subsequently bound to and affected the thermal behavior of the most abundant plasma proteins. The effect of interacting biomarkers can be inferred from the modulation of thermograms but cannot be directly identified by DSC. To investigate the nature of the proposed interactions, mass spectrometry (MS) analyses were employed. Quantitative assessment of the low molecular weight protein fragments of plasma and urine samples revealed a small list of peptides whose abundance was correlated with the extent of cervical disease, with the most striking plasma peptidome data supporting the interactome theory of peptide portioning to abundant plasma proteins. The combined DSC and MS approach in this study was successful in identifying unique biomarker signatures for cervical cancer and demonstrated the utility of DSC plasma profiles as a complementary diagnostic tool to evaluate cervical cancer health.	[Garbett, Nichola C.; Helm, C. William; Jenson, Alfred B.; Klein, Jon B.; Chaires, Jonathan B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Garbett, Nichola C.; Merchant, Michael L.; Helm, C. William; Jenson, Alfred B.; Klein, Jon B.; Chaires, Jonathan B.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Merchant, Michael L.; Klein, Jon B.] Univ Louisville, Ctr Environm Genom & Integrat Biol, Louisville, KY 40292 USA; [Helm, C. William] Univ Louisville, Div Gynecol Oncol, Louisville, KY 40292 USA; [Klein, Jon B.] Robley Rex Vet Affairs Med Ctr, Louisville, KY USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Garbett, NC (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	nichola.garbett@louisville.edu	Merchant, Michael/F-7109-2013; Merchant, Michael/N-7444-2013	Chaires, Jonathan/0000-0001-5477-945X; Merchant, Michael/0000-0003-4128-4057	Office of Research and Development, Medical Research Service, Department of Veterans Affairs, the Department of Energy Office of Science Financial Assistance Program [DE-FG02-05ER6406]; NIEHS [P30ES014443]; National Cancer Institute [R44 CA103437]; Elsa. U. Pardee Foundation; NATIONAL CANCER INSTITUTE [R44CA103437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	Office of Research and Development, Medical Research Service, Department of Veterans Affairs, the Department of Energy Office of Science Financial Assistance Program; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elsa. U. Pardee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This material is based on work supported by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, the Department of Energy Office of Science Financial Assistance Program (DE-FG02-05ER6406 to MLM and JBK), and the NIEHS grant P30ES014443 (to MLM and JBK). This work was also supported by a subcontract awarded to JBC from National Cancer Institute grant R44 CA103437 and by a grant to JBC from the Elsa. U. Pardee Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Chagovetz AA, 2011, J NEURO-ONCOL, V105, P499, DOI 10.1007/s11060-011-0630-5; Chertov O, 2004, PROTEOMICS, V4, P1195, DOI 10.1002/pmic.200300677; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; del Pino M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.046; Diamandis EP, 2006, J PROTEOME RES, V5, P2079, DOI 10.1021/pr060225u; Diamandis EP, 2006, CANCER RES, V66, P5540, DOI 10.1158/0008-5472.CAN-05-4503; Diamands EP, 2006, CLIN CHEM, V52, P771, DOI 10.1373/clinchem.2005.064972; FERENCZ A, 2011, SKIN CANC OVERVIEW I, DOI DOI 10.5772/25606.; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garbett NC, 2008, BIOPHYS J, V94, P1377, DOI 10.1529/biophysj.107.119453; Garbett NC, 2007, SEMIN NEPHROL, V27, P621, DOI 10.1016/j.semnephrol.2007.09.004; Garbett NC, 2007, CLIN CHEM, V53, P2012, DOI 10.1373/clinchem.2007.091165; Garbett NC, 2009, EXP MOL PATHOL, V86, P186, DOI 10.1016/j.yexmp.2008.12.001; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; MCINDOE WA, 1984, OBSTET GYNECOL, V64, P451; Menschaert G, 2010, J PROTEOME RES, V9, P2051, DOI 10.1021/pr900929m; Merchant ML, 2009, J AM SOC NEPHROL, V20, P2065, DOI 10.1681/ASN.2008121233; Michnik A, 2010, J THERM ANAL CALORIM, V102, P57, DOI 10.1007/s10973-009-0602-6; Mitchell M F, 1996, J Natl Cancer Inst Monogr, P17; Moore GD, 2005, DIAGN CYTOPATHOL, V32, P82, DOI 10.1002/dc.20186; Murphy N, 2003, J CLIN PATHOL, V56, P56, DOI 10.1136/jcp.56.1.56; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; No JH, 2009, ANN NY ACAD SCI, V1171, P100, DOI 10.1111/j.1749-6632.2009.04898.x; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Smith C, 2009, NEPHROL DIAL TRANSPL, V24, P1422, DOI 10.1093/ndt/gfn676; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; TEMPST P, 2009, Patent No. 20090208921; Todinova S, 2012, BBA-GEN SUBJECTS, V1820, P1879, DOI 10.1016/j.bbagen.2012.08.001; Todinova S, 2011, ANAL CHEM, V83, P7992, DOI 10.1021/ac202055m; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2005, J PROTEOME RES, V4, P1060, DOI 10.1021/pr050034b; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Villanueva J, 2008, MOL CELL PROTEOMICS, V7, P509, DOI 10.1074/mcp.M700397-MCP200; Villanueva J, 2007, NAT PROTOC, V2, P588, DOI 10.1038/nprot.2007.57; Villanueva J, 2006, MOL CELL PROTEOMICS, V5, P1840, DOI 10.1074/mcp.M600229-MCP200; Zapf I, 2011, THERMOCHIM ACTA, V524, P88, DOI 10.1016/j.tca.2011.06.019; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	41	45	49	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84710	10.1371/journal.pone.0084710	http://dx.doi.org/10.1371/journal.pone.0084710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416269	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500152
J	Islam, MM; Valderas, JM; Yen, L; Dawda, P; Jowsey, T; McRae, IS				Islam, M. Mofizul; Valderas, Jose M.; Yen, Laurann; Dawda, Paresh; Jowsey, Tanisha; McRae, Ian S.			Multimorbidity and Comorbidity of Chronic Diseases among the Senior Australians: Prevalence and Patterns	PLOS ONE			English	Article							BURDEN; HEALTH; CARE	Understanding patterns and identifying common clusters of chronic diseases may help policymakers, researchers, and clinicians to understand the needs of the care process better and potentially save both provider and patient time and cost. However, only limited research has been conducted in this area, and ambiguity remains as those limited previous studies used different approaches to identify common clusters and findings may vary with approaches. This study estimates the prevalence of common chronic diseases and examines co-occurrence of diseases using four approaches: (i) identification of the most occurring pairs and triplets of comorbid diseases; performing (ii) cluster analysis of diseases, (iii) principal component analysis, and (iv) latent class analysis. Data were collected using a questionnaire mailed to a cross-sectional sample of senior Australians, with 4574 responses. Eighty-two percent of respondents reported having at least one chronic disease and over 52% reported having at least two chronic diseases. Respondents suffering from any chronic diseases had an average of 2.4 comorbid diseases. Three defined groups of chronic diseases were identified: (i) asthma, bronchitis, arthritis, osteoporosis and depression; (ii) high blood pressure and diabetes; and (iii) cancer, with heart disease and stroke either making a separate group or "attaching" themselves to different groups in different analyses. The groups were largely consistent across the approaches. Stability and sensitivity analyses also supported the consistency of the groups. The consistency of the findings suggests there is co-occurrence of diseases beyond chance, and patterns of co-occurrence are important for clinicians, patients, policymakers and researchers. Further studies are needed to provide a strong evidence base to identify comorbid groups which would benefit from appropriate guidelines for the care and management of patients with particular disease clusters.	[Islam, M. Mofizul; Yen, Laurann; Dawda, Paresh; Jowsey, Tanisha; McRae, Ian S.] Australian Natl Univ, Australian Primary Hlth Care Res Inst, Canberra, ACT, Australia; [Valderas, Jose M.] Univ Exeter, Sch Med, Exeter, Devon, England	Australian National University; University of Exeter	Islam, MM (corresponding author), Australian Natl Univ, Australian Primary Hlth Care Res Inst, Canberra, ACT, Australia.	mofizul.islam@anu.edu.au	Valderas, Jose M/Y-9814-2019; Valderas, Jose M/G-7967-2014; Dawda, Paresh/I-6947-2015; Islam, M Mofizul/E-8160-2012	Valderas, Jose M/0000-0002-9299-1555; Dawda, Paresh/0000-0003-2727-8320; ibitoye, oluwabunmi/0000-0002-9723-2347; Islam, M Mofizul/0000-0003-1330-863X; Jowsey, Tanisha/0000-0003-1499-9225	National Health and Medical Research Council [402793]; Australian Government Department of Health and Ageing as part of its Primary Health Care Research Evaluation and Development (PHCRED) Strategy; National Institute for Health Research [NIHR/CS/010/024] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing as part of its Primary Health Care Research Evaluation and Development (PHCRED) Strategy(Australian GovernmentDepartment of Health & Ageing); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the National Health and Medical Research Council ID (402793, 2006). The Australian Primary Health Care Research Institute is funded by the Australian Government Department of Health and Ageing as part of its Primary Health Care Research Evaluation and Development (PHCRED) Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspin C, 2010, AUST NZ J PUBL HEAL, V34, P386, DOI 10.1111/j.1753-6405.2010.00571.x; Australian Bureau of Statistics, 2007, NAT HLTH SURV SUMM R; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Calinski T., 1974, COMMUNICATIONS STAT, V3, P1, DOI [DOI 10.1080/03610927408827101, 10.1080/03610927408827101]; Caughey GE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-221; Dickens C, 2001, RHEUMATOLOGY, V40, P1327, DOI 10.1093/rheumatology/40.12.1327; Everitt B. S., 2001, CLUSTER ANAL; Eyre H, 2004, DIABETES CARE, V27, P1812, DOI 10.2337/diacare.27.7.1812; Formiga F, 2013, EUR J INTERN MED, V24, P40, DOI 10.1016/j.ejim.2012.11.003; Fortin M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-52; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Garcia-Olmos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032141; Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Jowsey T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059379; Kaufman L. R., 2005, FINDING GROUPS DATA; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Knox SA, 2008, MED J AUSTRALIA, V189, P66, DOI 10.5694/j.1326-5377.2008.tb01918.x; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Long AN, 2011, J CLIN HYPERTENS, V13, P244, DOI 10.1111/j.1751-7176.2011.00434.x; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; McCarron M, 2013, RES DEV DISABIL, V34, P521, DOI 10.1016/j.ridd.2012.07.029; McCormick WC, 2005, J AM GERIATR SOC, V53, P2227, DOI 10.1111/j.1532-5415.2005.00504.x; McRae I, 2012, AUSTR J PRIMARY HLTH; Parchman ML., 2007, APPL MULTIVAR RES, V12, P163, DOI [DOI 10.22329/AMR.V12I3.658, 10.22329/amr.v12i3.658]; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Starfield B, 2006, ANN FAM MED, V4, P101, DOI 10.1370/afm.524; Steinman MA, 2012, J AM GERIATR SOC, V60, P1872, DOI 10.1111/j.1532-5415.2012.04158.x; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Vu T, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-45; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	35	169	176	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83783	10.1371/journal.pone.0083783	http://dx.doi.org/10.1371/journal.pone.0083783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421905	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500073
J	Michan, S; Juan, AM; Hurst, CG; Cui, ZH; Evans, LP; Hatton, CJ; Pei, DT; Ju, MH; Sinclair, DA; Smith, LEH; Chen, J				Michan, Shaday; Juan, Aimee M.; Hurst, Christian G.; Cui, Zhenghao; Evans, Lucy P.; Hatton, Colman J.; Pei, Dorothy T.; Ju, Meihua; Sinclair, David A.; Smith, Lois E. H.; Chen, Jing			Sirtuin1 Over-Expression Does Not Impact Retinal Vascular and Neuronal Degeneration in a Mouse Model of Oxygen-Induced Retinopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIABETIC-RETINOPATHY; SIRT1 DEACETYLASE; PROLIFERATIVE RETINOPATHY; PATHOLOGICAL ANGIOGENESIS; DEPENDENT REGULATION; RESVERATROL; ACTIVATOR; SRT1720; MICE	Proliferative retinopathy is a leading cause of blindness, including retinopathy of prematurity (ROP) in children and diabetic retinopathy in adults. Retinopathy is characterized by an initial phase of vessel loss, leading to tissue ischemia and hypoxia, followed by sight threatening pathologic neovascularization in the second phase. Previously we found that Sirtuin1 (Sirt1), a metabolically dependent protein deacetylase, regulates vascular regeneration in a mouse model of oxygen-induced proliferative retinopathy (OIR), as neuronal depletion of Sirt1 in retina worsens retinopathy. In this study we assessed whether over-expression of Sirtuin1 in retinal neurons and vessels achieved by crossing Sirt1 over-expressing flox mice with Nestin-Cre mice or Tie2-Cre mice, respectively, may protect against retinopathy. We found that over-expression of Sirt1 in Nestin expressing retinal neurons does not impact vaso-obliteration or pathologic neovascularization in OIR, nor does it influence neuronal degeneration in OIR. Similarly, increased expression of Sirt1 in Tie2 expressing vascular endothelial cells and monocytes/macrophages does not protect retinal vessels in OIR. In addition to the genetic approaches, dietary supplement with Sirt1 activators, resveratrol or SRT1720, were fed to wild type mice with OIR. Neither treatment showed significant vaso-protective effects in retinopathy. Together these results indicate that although endogenous Sirt1 is important as a stress-induced protector in retinopathy, over-expression of Sirt1 or treatment with small molecule activators at the examined doses do not provide additional protection against retinopathy in mice. Further studies are needed to examine in depth whether increasing levels of Sirt1 may serve as a potential therapeutic approach to treat or prevent retinopathy.	[Juan, Aimee M.; Hurst, Christian G.; Cui, Zhenghao; Evans, Lucy P.; Hatton, Colman J.; Pei, Dorothy T.; Ju, Meihua; Smith, Lois E. H.; Chen, Jing] Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA 02114 USA; [Juan, Aimee M.; Chen, Jing] Harvard Univ, Sch Med, Manton Ctr Orphan Dis Res, Boston Childrens Hosp, Boston, MA USA; [Sinclair, David A.] Harvard Univ, Sch Med, Dept Genet, Paul F Glenn Labs Biol Mech Aging, Boston, MA USA; [Sinclair, David A.] Univ New S Wales, Dept Pharmacol, Kensington, NSW 2033, Australia	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of New South Wales Sydney	Chen, J (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA 02114 USA.	jing.chen@childrens.harvard.edu		Juan, Aimee/0000-0002-0221-2280; Sinclair, David/0000-0002-9936-436X	Charles H. Hood Foundation; Boston Children's Hospital (BCH) Ophthalmology Foundation; BCH Manton Center for Orphan Disease Research; Blind Childrens Center; BrightFocus Foundation; Mass Lions Eye Research Fund Inc.; BCH Career Development Award; CONACyT [177819]; National Institutes of Health [EY017017, EY022275, PO1 HD18655]; V. Kann Rasmussen Foundation; RPB Senior Investigator Award; Alcon Research Institute Award; Lowy Medical Research Institute; Paul F. Glenn Foundation; NIH [RO1AG019719]; Juvenile Diabetes Research Foundation; United Mitochondrial Disease Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017017, R01EY022275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019719] Funding Source: NIH RePORTER	Charles H. Hood Foundation; Boston Children's Hospital (BCH) Ophthalmology Foundation; BCH Manton Center for Orphan Disease Research; Blind Childrens Center; BrightFocus Foundation(BrightFocus Foundation); Mass Lions Eye Research Fund Inc.; BCH Career Development Award; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V. Kann Rasmussen Foundation; RPB Senior Investigator Award; Alcon Research Institute Award; Lowy Medical Research Institute; Paul F. Glenn Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); United Mitochondrial Disease Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Charles H. Hood Foundation, Boston Children's Hospital (BCH) Ophthalmology Foundation, BCH Manton Center for Orphan Disease Research, Blind Childrens Center, BrightFocus Foundation, Mass Lions Eye Research Fund Inc., and BCH Career Development Award (to JC). SM is supported by CONACyT (177819). LEHS is supported by National Institutes of Health (EY017017, EY022275, PO1 HD18655), V. Kann Rasmussen Foundation, RPB Senior Investigator Award, Alcon Research Institute Award, and the Lowy Medical Research Institute. DAS is supported by the Paul F. Glenn Foundation, NIH (RO1AG019719), Juvenile Diabetes Research Foundation, and the United Mitochondrial Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chen J, 2013, ANGIOGENESIS    0804, V4; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen J, 2011, CURR OPIN PEDIATR, V23, P173, DOI 10.1097/MOP.0b013e3283423f35; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fulton AB, 2009, PROG RETIN EYE RES, V28, P452, DOI 10.1016/j.preteyeres.2009.06.003; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Hua J, 2011, INVEST OPHTHALMOL VI; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Ichikawa T, 2013, RESPIROLOGY, V18, P332, DOI 10.1111/j.1440-1843.2012.02284.x; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Kadiyala CS, 2012, J BIOL CHEM; Khan AA, 2010, AM J PATHOL, V177, P481, DOI 10.2353/ajpath.2010.090836; Kim Woo Taek, 2010, Korean J Ophthalmol, V24, P108, DOI 10.3341/kjo.2010.24.2.108; King RE, 2005, CHEM-BIOL INTERACT, V151, P143, DOI 10.1016/j.cbi.2004.11.003; Kubota S, 2010, AM J PATHOL, V177, P1725, DOI 10.2353/ajpath.2010.100098; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Michan S, 2013, CURR PHARM DES; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Shindler KS, 2010, J NEURO-OPHTHALMOL, V30, P328, DOI 10.1097/WNO.0b013e3181f7f833; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smoliga JM, 2011, MOL NUTR FOOD RES, V55, P1129, DOI 10.1002/mnfr.201100143; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2012, BLOOD; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Suzuki K, 2012, ONCOL REP, V27, P1726, DOI 10.3892/or.2012.1750; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; Wiejak J, 2013, BIOCHEM J, V454, P283, DOI 10.1042/BJ20130481	53	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85031	10.1371/journal.pone.0085031	http://dx.doi.org/10.1371/journal.pone.0085031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416337	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500207
J	Cruz, JW; Rothenbacher, FP; Maehigashi, T; Lane, WS; Dunham, CM; Woychik, NA				Cruz, Jonathan W.; Rothenbacher, Francesca P.; Maehigashi, Tatsuya; Lane, William S.; Dunham, Christine M.; Woychik, Nancy A.			Doc Toxin Is a Kinase That Inactivates Elongation Factor Tu	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; Phosphorylation; Post-translational Modification; Protein Synthesis; Translation; Translation Elongation Factors; Fic; Adenylylation; Antitoxin	FACTOR-EF-TU; ANTITOXIN SYSTEMS; CRYSTAL-STRUCTURE; TERNARY COMPLEX; PROPHAGE P1; PROTEIN; PHD; AMPYLATION; MECHANISM; SUBSTRATE	Background: Doc toxin, of the phd-doc toxin-antitoxin system, belongs to the Fic protein family found in all domains of life. Results: Doc inactivates elongation factor Tu by phosphorylation of a single amino acid. Conclusion: This phosphorylation event inhibits protein synthesis and thereby arrests cell growth. Significance: The phosphorylation activity of Doc toxin represents a new catalytic activity for members of the Fic protein family. The Doc toxin from bacteriophage P1 (of the phd-doc toxin-antitoxin system) has served as a model for the family of Doc toxins, many of which are harbored in the genomes of pathogens. We have shown previously that the mode of action of this toxin is distinct from the majority derived from toxin-antitoxin systems: it does not cleave RNA; in fact P1 Doc expression leads to mRNA stabilization. However, the molecular triggers that lead to translation arrest are not understood. The presence of a Fic domain, albeit slightly altered in length and at the catalytic site, provided a clue to the mechanism of P1 Doc action, as most proteins with this conserved domain inactivate GTPases through addition of an adenylyl group (also referred to as AMPylation). We demonstrated that P1 Doc added a single phosphate group to the essential translation elongation factor and GTPase, elongation factor (EF)-Tu. The phosphorylation site was at a highly conserved threonine, Thr-382, which was blocked when EF-Tu was treated with the antibiotic kirromycin. Therefore, we have established that Fic domain proteins can function as kinases. This distinct enzymatic activity exhibited by P1 Doc also solves the mystery of the degenerate Fic motif unique to the Doc family of toxins. Moreover, we have established that all characterized Fic domain proteins, even those that phosphorylate, target pivotal GTPases for inactivation through a post-translational modification at a single functionally critical acceptor site.	[Cruz, Jonathan W.; Rothenbacher, Francesca P.; Woychik, Nancy A.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Cruz, Jonathan W.; Rothenbacher, Francesca P.; Woychik, Nancy A.] Rutgers Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Maehigashi, Tatsuya; Dunham, Christine M.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Lane, William S.] Harvard Univ, FAS Ctr Syst Biol, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Emory University; Harvard University	Woychik, NA (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 683 Hoes La, Piscataway, NJ 08854 USA.	nancy.woychik@rutgers.edu			National Institutes of Health from the NIGMS [R01GM093279, R01GM095693]; National Science Foundation CAREER Award [MCB 0953714]; National Institutes of Health from the NIAID [T32AI007403]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095693, R01GM093279, R01GM093278] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation CAREER Award(National Science Foundation (NSF)); National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM093279 (to C. M. D.) and R01GM095693 (to N. A. W.) from the NIGMS, National Science Foundation CAREER Award MCB 0953714 (to C. M. D.), and National Institutes of Health Training Grant T32AI007403, Virus-Host Interactions in Eukaryotic Cells (to J. W. C. and F. P. R., awarded to G. Brewer), from the NIAID.	ALEXANDER C, 1995, J BIOL CHEM, V270, P14541, DOI 10.1074/jbc.270.24.14541; Arbing MA, 2010, STRUCTURE, V18, P996, DOI 10.1016/j.str.2010.04.018; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Dawson CC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002121; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gazit E, 1999, J BIOL CHEM, V274, P16813, DOI 10.1074/jbc.274.24.16813; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Goepfert A, 2013, PROKARYOTIC TOXIN AN, DOI [10.1007/978-3-642-33253-1_10, DOI 10.1007/978-3-642-33253-1_10]; Goepfert A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064901; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Itzen A, 2011, TRENDS BIOCHEM SCI, V36, P219, DOI 10.1016/j.tibs.2010.12.004; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Kint CI, 2012, TRENDS MICROBIOL, V20, P577, DOI 10.1016/j.tim.2012.08.009; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; LIPPMANN C, 1993, J BIOL CHEM, V268, P601; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Magnuson R, 1998, J BACTERIOL, V180, P6342; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Mishra S, 2012, PROTEIN EXPRES PURIF, V86, P58, DOI 10.1016/j.pep.2012.08.020; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; PARMEGGIANI A, 1985, ANNU REV MICROBIOL, V39, P557, DOI 10.1146/annurev.mi.39.100185.003013; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Tan YH, 2011, P NATL ACAD SCI USA, V108, P21212, DOI 10.1073/pnas.1114023109; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; WEIJLAND A, 1992, MOL MICROBIOL, V6, P683, DOI 10.1111/j.1365-2958.1992.tb01516.x; Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005; WOLF H, 1974, P NATL ACAD SCI USA, V71, P4910, DOI 10.1073/pnas.71.12.4910; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	51	50	51	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7788	7798		10.1074/jbc.M113.544429	http://dx.doi.org/10.1074/jbc.M113.544429			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24448800	Green Published, hybrid			2022-12-25	WOS:000332761500045
J	Afroze, T; Yang, G; Khoshbin, A; Tanwir, M; Tabish, T; Momen, A; Husain, M				Afroze, Talat; Yang, Ge; Khoshbin, Amir; Tanwir, Mansoor; Tabish, Taha; Momen, Abdul; Husain, Mansoor			Calcium Efflux Activity of Plasma Membrane Ca2+ ATPase-4 (PMCA4) Mediates Cell Cycle Progression in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Calcium ATPase; Cell Cycle; Cell Proliferation; Vascular Smooth Muscle Cells; AP-2; Decorin; Plasma Membrane Calcium Atpase-4; Rgs16; p15(Ink4b)	EPIDERMAL-GROWTH-FACTOR; MESSENGER-RNA; C-MYB; TRANSCRIPTIONAL ACTIVATION; FUNCTIONAL INTERACTION; CA2+-ATPASE PMCA; FACTOR RECEPTOR; SPERM MOTILITY; UP-REGULATION; KINASE	Background: PMCA4 actions in vascular smooth muscle are not understood. Results: Alternative splicing of PMCA4 changes during vessel injury. Cell cycle arrest and downstream effectors of PMCA4 deletion are rescued by PMCA4a, PMCA4b, and PMCA4b unable to bind PDZ- proteins but not by inactive PMCA4. Conclusion: Ca2+ efflux activity of PMCA4 regulates G(1) progression. Significance: PMCA4 Ca2+ efflux regulates cell cycle. We explored the role played by plasma membrane calcium ATPase-4 (PMCA4) and its alternative splice variants in the cell cycle of vascular smooth muscle cells (VSMC). A novel variant (PMCA4e) was discovered. Quantitative real-time-PCR-quantified PMCA4 splice variant proportions differed in specific organs. The PMCA4a:4b ratio in uninjured carotid arteries (approximate to 1:1) was significantly reduced by wire denudation injury (to approximate to 1:3) by modulation of alternative splicing, as confirmed by novel antibodies against PMCA4a/e and PMCA4b. Laser capture microdissection localized this shift to the media and adventitia. Primary carotid VSMC from PMCA4 knock-out (P4KO) mice showed impaired [H-3]thymidine incorporation and G(1) phase arrest as compared with wild type (P4WT). Electroporation of expression constructs encoding PMCA4a, PMCA4b, and a PMCA4b mutant lacking PDZ binding rescued this phenotype of P4KO cells, whereas a mutant with only 10% of normal Ca2+ efflux activity could not. Microarray of early G(1)-synchronized VSMC showed 39-fold higher Rgs16 (NFAT (nuclear factor of activated T-cells) target; MAPK inhibitor) and 69-fold higher Decorin (G(1) arrest marker) expression in P4KO versus P4WT. Validation by Western blot also revealed decreased levels of Cyclin D1 and NFATc3 in P4KO. Microarrays of P4KO VSMC rescued by PMCA4a or PMCA4b expression showed reversal of perturbed Rgs16, Decorin, and NFATc3 expression levels. However, PMCA4a rescue caused a 44-fold reduction in AP-2, a known anti-proliferative transcription factor, whereas PMCA4b rescue resulted in a 50-fold reduction in p15 (Cyclin D1/Cdk4 inhibitor). We conclude that Ca2+ efflux activity of PMCA4 underlies G(1) progression in VSMC and that PMCA4a and PMCA4b differentially regulate specific downstream mediators.	[Afroze, Talat; Khoshbin, Amir; Tanwir, Mansoor; Tabish, Taha; Momen, Abdul; Husain, Mansoor] Univ Hlth Network, Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON M5G 2C4, Canada; [Yang, Ge; Husain, Mansoor] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Husain, Mansoor] Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON M5G 1L7, Canada; [Husain, Mansoor] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Husain, M (corresponding author), TMDT 3-909,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	mansoor.husain@uhn.ca	; Khoshbin, Amir/V-2276-2018	Husain, Mansoor/0000-0002-3740-6739; Afroze, Talat/0000-0003-2988-1342; Khoshbin, Amir/0000-0002-0891-3424	Canadian Institutes of Health Research [MOP-64352]; Heart and Stroke Foundation of Ontario [T-5254, NA6713]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by operating grants (to M. H.) from the Canadian Institutes of Health Research (MOP-64352) and the Heart and Stroke Foundation of Ontario (T-5254 and NA6713).	Afroze T, 2003, AM J PHYSIOL-CELL PH, V285, pC88, DOI 10.1152/ajpcell.00518.2002; Afroze T, 2000, J BIOL CHEM, V275, P9062, DOI 10.1074/jbc.275.12.9062; Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brandenburger T, 2011, J BIOL CHEM, V286, P7938, DOI 10.1074/jbc.M110.142836; BUETTNER R, 1993, MOL CELL BIOL, V13, P4174, DOI 10.1128/MCB.13.7.4174; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fong CW, 2000, BIOCHEM J, V352, P747, DOI 10.1042/0264-6021:3520747; Frost SJ, 2001, MOL CELL ENDOCRINOL, V176, P29, DOI 10.1016/S0303-7207(01)00477-4; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; Gros R, 2003, CIRC RES, V93, P614, DOI 10.1161/01.RES.0000092142.19896.D9; Han CY, 2008, CANCER SCI, V99, P502, DOI 10.1111/j.1349-7006.2007.00718.x; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Husain M, 1997, AM J PHYSIOL-CELL PH, V272, pC1947, DOI 10.1152/ajpcell.1997.272.6.C1947; Husain M, 1997, CIRC RES, V80, P617, DOI 10.1161/01.RES.80.5.617; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; KEETON TP, 1993, J BIOL CHEM, V268, P2740; Kim DI, 2008, CARCINOGENESIS, V29, P1701, DOI 10.1093/carcin/bgn055; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Liu G, 2011, J HYPERTENS, V29, P696, DOI 10.1097/HJH.0b013e328343c62b; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Oceandy D, 2007, BIOCHEM SOC T, V35, P927, DOI 10.1042/BST0350927; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Pillozzi S, 2010, ADV EXP MED BIOL, V674, P55; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; SantiagoGarcia J, 1996, MOL CELL BIOCHEM, V155, P173; Schonherr E, 2001, J BIOL CHEM, V276, P40687, DOI 10.1074/jbc.M105426200; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Singh NK, 2011, J BIOL CHEM, V286, P22478, DOI 10.1074/jbc.M111.225060; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stander M, 1999, CELL TISSUE RES, V296, P221, DOI 10.1007/s004410051283; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Tharaux PL, 2000, HYPERTENSION, V36, P330, DOI 10.1161/01.HYP.36.3.330; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; You XM, 2003, CIRC RES, V92, P314, DOI 10.1161/01.RES.0000056758.73215.5A; Yucel G, 2013, GENE DEV, V27, P1217, DOI 10.1101/gad.216556.113; Zhang Y, 1999, J BIOL CHEM, V274, P2851, DOI 10.1074/jbc.274.5.2851; ZHAO F, 2011, PLOS ONE, V6	49	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7221	7231		10.1074/jbc.M113.533638	http://dx.doi.org/10.1074/jbc.M113.533638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24448801	Green Published, hybrid			2022-12-25	WOS:000332389400080
J	Dixon, C; Sah, P; Lynch, JW; Keramidas, A				Dixon, Christine; Sah, Pankaj; Lynch, Joseph W.; Keramidas, Angelo			GABA(A) Receptor alpha and gamma Subunits Shape Synaptic Currents via Different Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloride Channels; Cys-loop Receptors; GABA Receptors; Kinetics; Synapses	ACID TYPE-A; FUNCTIONAL GABAERGIC SYNAPSES; INTERMEDIATE STATES; DIRECT BINDING; GEPHYRIN; SUBTYPES; AFFINITY; CHANNELS; ACTIVATIONS; COLLYBISTIN	Background: GABA(A)R 2 and 1 subunits are highly expressed in amygdala but their influence on synaptic currents is unknown. Results: 2 subunits increased GABA affinity thereby slowing current deactivation; 1 subunits reduced synaptic receptor clustering. Conclusion: These subunits may differentially shape synaptic kinetics. Significance: Understanding how 2 and 1 subunits shape synaptic currents may help us understand amygdala processing mechanisms. Synaptic GABA(A) receptors (GABA(A)Rs) mediate most of the inhibitory neurotransmission in the brain. The majority of these receptors are comprised of 1, 2, and 2 subunits. The amygdala, a structure involved in processing emotional stimuli, expresses 2 and 1 subunits at high levels. The effect of these subunits on GABA(A)R-mediated synaptic transmission is not known. Understanding the influence of these subunits on GABA(A)R-mediated synaptic currents may help in identifying the roles and locations of amygdala synapses that contain these subunits. Here, we describe the biophysical and synaptic properties of pure populations of 122, 222, 121 and 221 GABA(A)Rs. Their synaptic properties were examined in engineered synapses, whereas their kinetic properties were studied using rapid agonist application, and single channel recordings. All macropatch currents activated rapidly (<1 ms) and deactivated as a function of the -subunit, with 2-containing GABA(A)Rs consistently deactivating approximate to 10-fold more slowly. Single channel analysis revealed that the slower current decay of 2-containing GABA(A)Rs was due to longer burst durations at low GABA concentrations, corresponding to a approximate to 4-fold higher affinity for GABA. Synaptic currents revealed a different pattern of activation and deactivation to that of macropatch data. The inclusion of 2 and 1 subunits slowed both the activation and deactivation rates, suggesting that receptors containing these subunits cluster more diffusely at synapses. Switching the intracellular domains of the 2 and 1 subunits substantiated this inference. Because this region determines post-synaptic localization, we hypothesize that GABA(A)Rs containing 1 and 2 use different mechanisms for synaptic clustering.	[Dixon, Christine; Sah, Pankaj; Lynch, Joseph W.; Keramidas, Angelo] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland	Keramidas, A (corresponding author), Queensland Brain Inst, QBI Bldg 79, St Lucia, Qld 4072, Australia.	a.keramidas@uq.edu.au	Keramidas, Angelo/I-1704-2013	Keramidas, Angelo/0000-0003-2846-052X; Sah, Pankaj/0000-0001-5063-1589	Australian Research Council [DP120104373]; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian Research Council Grant ID-DP120104373.; Supported by a fellowship from the National Health and Medical Research Council of Australia.	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Buhr A, 1997, P NATL ACAD SCI USA, V94, P8824, DOI 10.1073/pnas.94.16.8824; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D., 1995, SINGLE CHANNEL RECOR, P483; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Delaney AJ, 2001, J NEUROPHYSIOL, V86, P717, DOI 10.1152/jn.2001.86.2.717; Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013; Elenes S, 2006, J GEN PHYSIOL, V128, P615, DOI 10.1085/jgp.200609570; Esmaeili A, 2009, J NEUROPHYSIOL, V101, P341, DOI 10.1152/jn.90991.2008; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Eyre MD, 2012, J NEUROSCI, V32, P5853, DOI 10.1523/JNEUROSCI.6495-11.2012; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gielen MC, 2012, J NEUROSCI, V32, P5707, DOI 10.1523/JNEUROSCI.5663-11.2012; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Jadey S, 2012, J GEN PHYSIOL, V140, P17, DOI 10.1085/jgp.201210801; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Keramidas A, 2008, J GEN PHYSIOL, V131, P163, DOI 10.1085/jgp.200709871; Keramidas A, 2006, J PHYSIOL-LONDON, V575, P11, DOI 10.1113/jphysiol.2005.102756; Keramidas A, 2010, J GEN PHYSIOL, V135, P59, DOI 10.1085/jgp.200910317; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Korber C, 2012, MOL CELL NEUROSCI, V50, P250, DOI 10.1016/j.mcn.2012.05.006; Kowalczyk S, 2013, EUR J NEUROSCI, V37, P544, DOI 10.1111/ejn.12078; Krashia P, 2011, J GEN PHYSIOL, V137, P197, DOI 10.1085/jgp.201010521; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Lavoie AM, 1997, BIOPHYS J, V73, P2518, DOI 10.1016/S0006-3495(97)78280-8; Lema GMC, 2006, J PHYSIOL-LONDON, V572, P183, DOI 10.1113/jphysiol.2005.099093; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Lorez Matthias, 2000, Journal of Physiology (Cambridge), V527, P11, DOI 10.1111/j.1469-7793.2000.t01-1-00011.x; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; McClellan AML, 1999, J PHYSIOL-LONDON, V515, P711, DOI 10.1111/j.1469-7793.1999.711ab.x; Mohler H, 2001, Curr Opin Pharmacol, V1, P22, DOI 10.1016/S1471-4892(01)00008-X; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Okada M, 2000, J NEUROSCI, V20, P2202; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Ribrault C, 2011, NAT REV NEUROSCI, V12, P375, DOI 10.1038/nrn3025; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Schofield CM, 2007, J NEUROSCI, V27, P7954, DOI 10.1523/JNEUROSCI.0377-07.2007; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Thomson AM, 2010, EUR J NEUROSCI, V31, P2193, DOI 10.1111/j.1460-9568.2010.07252.x; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; WAFFORD KA, 1993, MOL PHARMACOL, V43, P240; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; Wu X, 2012, J BIOL CHEM, V287, P27417, DOI 10.1074/jbc.M112.360461; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; YMER S, 1990, EMBO J, V9, P3261, DOI 10.1002/j.1460-2075.1990.tb07525.x	59	60	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5399	5411		10.1074/jbc.M113.514695	http://dx.doi.org/10.1074/jbc.M113.514695			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425869	Green Published, hybrid			2022-12-25	WOS:000332015500005
J	Jardim-Perassi, BV; Arbab, AS; Ferreira, LC; Borin, TF; Varma, NRS; Iskander, ASM; Shankar, A; Ali, MM; Zuccari, DAPD				Jardim-Perassi, Bruna Victorasso; Arbab, Ali S.; Ferreira, Livia Carvalho; Borin, Thaiz Ferraz; Varma, Nadimpalli R. S.; Iskander, A. S. M.; Shankar, Adarsh; Ali, Meser M.; Pires de Campos Zuccari, Debora Aparecida			Effect of Melatonin on Tumor Growth and Angiogenesis in Xenograft Model of Breast Cancer	PLOS ONE			English	Article							STEM-CELLS; VASCULAR-PERMEABILITY; SIGNALING PATHWAYS; IN-VIVO; EXPRESSION; INHIBITION; PROLIFERATION; VEGF; RECRUITMENT; ACTIVATION	As neovascularization is essential for tumor growth and metastasis, controlling angiogenesis is a promising tactic in limiting cancer progression. Melatonin has been studied for their inhibitory properties on angiogenesis in cancer. We performed an in vivo study to evaluate the effects of melatonin treatment on angiogenesis in breast cancer. Cell viability was measured by MTT assay after melatonin treatment in triple-negative breast cancer cells (MDA-MB-231). After, cells were implanted in athymic nude mice and treated with melatonin or vehicle daily, administered intraperitoneally 1 hour before turning the room light off. Volume of the tumors was measured weekly with a digital caliper and at the end of treatments animals underwent single photon emission computed tomography (SPECT) with Technetium-99m tagged vascular endothelial growth factor (VEGF) C to detect in vivo angiogenesis. In addition, expression of pro-angiogenic/growth factors in the tumor extracts was evaluated by membrane antibody array and collected tumor tissues were analyzed with histochemical staining. Melatonin in vitro treatment (1 mM) decreased cell viability (p<0.05). The breast cancer xenografts nude mice treated with melatonin showed reduced tumor size and cell proliferation (Ki-67) compared to control animals after 21 days of treatment (p<0.05). Expression of VEGF receptor 2 decreased significantly in the treated animals compared to that of control when determined by immunohistochemistry (p<0.05) but the changes were not significant on SPECT (p>0.05) images. In addition, there was a decrease of micro-vessel density (Von Willebrand Factor) in melatonin treated mice (p<0.05). However, semiquantitative densitometry analysis of membrane array indicated increased expression of epidermal growth factor receptor and insulin-like growth factor 1 in treated tumors compared to vehicle treated tumors (p<0.05). In conclusion, melatonin treatment showed effectiveness in reducing tumor growth and cell proliferation, as well as in the inhibition of angiogenesis.	[Jardim-Perassi, Bruna Victorasso; Ferreira, Livia Carvalho] Univ Estadual Paulista, Dept Biol, Sao Paulo, Brazil; [Jardim-Perassi, Bruna Victorasso; Ferreira, Livia Carvalho; Borin, Thaiz Ferraz; Pires de Campos Zuccari, Debora Aparecida] Fac Med Sao Jose Rio Preto, Dept Mol Biol, Lab Invest Mol Canc, Sao Paulo, Brazil; [Arbab, Ali S.; Varma, Nadimpalli R. S.; Iskander, A. S. M.; Shankar, Adarsh; Ali, Meser M.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Borin, Thaiz Ferraz; Pires de Campos Zuccari, Debora Aparecida] Fac Med Sao Jose Rio Preto, Dept Mol Biol, Sao Paulo, Brazil	Universidade Estadual Paulista; Henry Ford Health System; Henry Ford Hospital	Zuccari, DAPD (corresponding author), Fac Med Sao Jose Rio Preto, Dept Mol Biol, Lab Invest Mol Canc, Sao Paulo, Brazil.	debora.zuccari@famerp.br	Jardim-Perassi, Bruna V/H-8633-2014; Borin, Thaiz Ferraz/E-8013-2012; de Campos Zuccari, Debora Aparecida Pires/M-3560-2014; Arbab, Ali/AAS-1933-2020	Borin, Thaiz Ferraz/0000-0003-1464-9823; de Campos Zuccari, Debora Aparecida Pires/0000-0002-0146-9041; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP/ Brazil [2011/01052-9, 2011/01054-1, 2012/05065-0]; NIH [R01CA160216, R01CA172048]; NATIONAL CANCER INSTITUTE [R01CA172048, R01CA160216] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP/ Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP/ Brazil (2011/01052-9, 2011/01054-1 and 2012/05065-0) and NIH (R01CA160216 and R01CA172048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MJ, 1990, J NUCL MED, V31, P2022; Ali MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008727; Alvarez-Garcia V, 2013, J PINEAL RES, V54, P373, DOI 10.1111/jpi.12007; Alvarez-Garcia V, 2013, MICROVASC RES, V87, P25, DOI 10.1016/j.mvr.2013.02.008; Ambasta RK, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-26; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Arbab AS, 2012, HISTOL HISTOPATHOL, V27, P549, DOI 10.14670/HH-27.549; Backer MV, 2007, NAT MED, V13, P504, DOI 10.1038/nm1522; Bennett IC, 2000, BREAST, V9, P247, DOI 10.1054/brst.2000.0208; Blankenberg FG, 2006, EUR J NUCL MED MOL I, V33, P841, DOI 10.1007/s00259-006-0099-1; Blask DE, 1997, CANCER RES, V57, P1909; Carpini JD, 2010, ANGIOGENESIS, V13, P43, DOI 10.1007/s10456-010-9163-3; Cos S, 1998, CANCER RES, V58, P4383; Cos S, 2000, FRONT NEUROENDOCRIN, V21, P133, DOI 10.1006/frne.1999.0194; Cui PL, 2008, J PINEAL RES, V44, P107, DOI 10.1111/j.1600-079X.2007.00496.x; Cui PL, 2006, J PINEAL RES, V41, P358, DOI 10.1111/j.1600-079X.2006.00375.x; Cui PL, 2012, J PINEAL RES, V52, P236, DOI 10.1111/j.1600-079X.2011.00933.x; Dai M, 2008, J PINEAL RES, V44, P121, DOI 10.1111/j.1600-079X.2007.00498.x; Di Bella G, 2013, INT J MOL SCI, V14, P2410, DOI 10.3390/ijms14022410; Fic M, 2007, IN VIVO, V21, P513; Finley SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-193; Greenberg S, 2010, CANCER J, V16, P33, DOI 10.1097/PPO.0b013e3181d38514; HILL SM, 1992, CANCER LETT, V64, P249, DOI 10.1016/0304-3835(92)90050-6; Hill SM, 2011, J MAMMARY GLAND BIOL, V16, P235, DOI 10.1007/s10911-011-9222-4; Hill SM, 2009, INTEGR CANCER THER, V8, P337, DOI 10.1177/1534735409353332; Hilmi C, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/162692; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Institut Nacional do Cancer (INCA), 2010, EST INC MORT CANC BR; Instituto Nacional do Cancer (INCA), 2005, INC CANC BRAS; Jablonska K, 2013, J PINEAL RES, V54, P334, DOI 10.1111/jpi.12032; Janic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009173; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Johansson I, 2012, GENE CHROMOSOME CANC, V51, P375, DOI 10.1002/gcc.21922; Jung JH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/879746; Kallergi G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2452; Kaur C, 2007, J PINEAL RES, V42, P338, DOI 10.1111/j.1600-079X.2007.00424.x; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim KJ, 2013, J PINEAL RES, V54, P264, DOI 10.1111/j.1600-079X.2012.01030.x; Leman ES, 2001, BIOELECTROMAGNETICS, V22, P178, DOI 10.1002/bem.36; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; LISSONI P, 1995, BRIT J CANCER, V71, P854, DOI 10.1038/bjc.1995.164; Lissoni P, 2001, NEUROENDOCRINOL LETT, V22, P45; Liu H, 2011, ANAT REC, V294, P781, DOI 10.1002/ar.21361; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Maganhin CC, 2008, REV ASSOC MED BRAS, V54, P267, DOI 10.1590/S0104-42302008000300022; Margheri M, 2012, EUR J PHARMACOL, V681, P34, DOI 10.1016/j.ejphar.2012.02.011; Mediavilla MD, 1999, LIFE SCI, V65, P415, DOI 10.1016/S0024-3205(99)00262-3; MIRUNALINI S, 2010, J APPL SCI RES, V6, P245; Norden AD, 2008, LANCET NEUROL, V7, P1152, DOI 10.1016/S1474-4422(08)70260-6; Oprea-Ilies G, 2013, BREAST CANCER RES TR, V137, P677, DOI 10.1007/s10549-012-2371-3; Park JW, 2009, J PINEAL RES, V46, P415, DOI 10.1111/j.1600-079X.2009.00678.x; Park SY, 2010, J PINEAL RES, V48, P178, DOI 10.1111/j.1600-079X.2009.00742.x; PLATE KH, 1993, CANCER RES, V53, P5822; Proietti S, 2013, CELL MOL LIFE SCI, V70, P2139, DOI 10.1007/s00018-012-1161-8; Rao GN, 2000, BREAST CANCER RES TR, V64, P287, DOI 10.1023/A:1026552405042; Romon R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-157; Sanchez-Barcelo EJ, 2005, J PINEAL RES, V38, P217, DOI 10.1111/j.1600-079X.2004.00207.x; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Silverman MD, 2007, ARTHRITIS RHEUM-US, V56, P1817, DOI 10.1002/art.22706; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Vordermark D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-45; Walker RA, 1997, CANCER METAST REV, V16, P5, DOI 10.1023/A:1005740222307; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yuan L, 2002, MOL CELL ENDOCRINOL, V192, P147, DOI 10.1016/S0303-7207(02)00029-1	66	117	120	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85311	10.1371/journal.pone.0085311	http://dx.doi.org/10.1371/journal.pone.0085311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416386	Green Submitted, gold, Green Published			2022-12-25	WOS:000329866300068
J	Campbell, AH; Marzinelli, EM; Verges, A; Coleman, MA; Steinberg, PD				Campbell, Alexandra H.; Marzinelli, Ezequiel M.; Verges, Adriana; Coleman, Melinda A.; Steinberg, Peter D.			Towards Restoration of Missing Underwater Forests	PLOS ONE			English	Article							CLIMATE-CHANGE; REGIME SHIFTS; BIODIVERSITY; HABITAT; RESILIENCE; CONSEQUENCES; RECRUITMENT; POPULATIONS; PATTERNS; RECOVERY	Degradation of natural habitats due to urbanization is a major cause of biodiversity loss. Anthropogenic impacts can drive phase shifts from productive, complex ecosystems to less desirable, less diverse systems that provide fewer services. Macroalgae are the dominant habitat-forming organisms on temperate coastlines, providing habitat and food to entire communities. In recent decades, there has been a decline in macroalgal cover along some urbanised shorelines, leading to a shift from diverse algal forests to more simple turf algae or barren habitats. Phyllospora comosa, a major habitat forming macroalga in south-eastern Australia, has disappeared from the urban shores of Sydney. Its disappearance is coincident with heavy sewage outfall discharges along the metropolitan coast during 1970s and 1980s. Despite significant improvements in water-quality since that time, Phyllospora has not re-established. We experimentally transplanted adult Phyllospora into two rocky reefs in the Sydney metropolitan region to examine the model that Sydney is now suitable for the survival and recruitment of Phyllospora and thus assess the possibility of restoring Phyllospora back onto reefs where it was once abundant. Survival of transplanted individuals was high overall, but also spatially variable: at one site most individuals were grazed, while at the other site survival was similar to undisturbed algae and procedural controls. Transplanted algae reproduced and recruitment rates were higher than in natural populations at one experimental site, with high survival of new recruits after almost 18 months. Low supply and settlement success of propagules in the absence of adults and herbivory (in some places) emerge as three potential processes that may have been preventing natural re-establishment of this alga. Understanding of the processes and interactions that shape this system are necessary to provide ecologically sensible goals and the information needed to successfully restore these underwater forests.	[Campbell, Alexandra H.; Marzinelli, Ezequiel M.; Verges, Adriana; Steinberg, Peter D.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Campbell, Alexandra H.; Marzinelli, Ezequiel M.; Verges, Adriana; Steinberg, Peter D.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Campbell, Alexandra H.; Marzinelli, Ezequiel M.; Verges, Adriana; Steinberg, Peter D.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Campbell, Alexandra H.; Marzinelli, Ezequiel M.; Verges, Adriana] Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Coleman, Melinda A.] NSW Fisheries, Dept Primary Ind, Coffs Harbour, NSW, Australia; [Steinberg, Peter D.] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Singapore, Singapore	Sydney Institute of Marine Science; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; NSW Department of Primary Industries; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Campbell, AH (corresponding author), Sydney Inst Marine Sci, Mosman, NSW, Australia.	alexandra.campbell@unsw.edu.au	Marzinelli, Ezequiel/AAH-2906-2019; Coleman, Melinda A/R-5563-2016; Verges, Adriana/B-8288-2013	Marzinelli, Ezequiel/0000-0002-3762-3389; Coleman, Melinda A/0000-0003-2623-633X; Verges, Adriana/0000-0002-3507-1234; Steinberg, Peter/0000-0002-1781-0726; Campbell, Alexandra/0000-0002-2322-2840	Australian Research Council [DP1096464]; UNSW	Australian Research Council(Australian Research Council); UNSW	This work was funded by an Australian Research Council Discovery project (DP1096464) awarded to PDS and MAC and a UNSW Early Career Researcher grant awarded to AHC, EMM and AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; ANDERSON M. J., 2007, PERMANOVA PRIMER GUI; Andrew N., 1999, SO SEAS ECOLOGY AUST; Bishop MJ, 2010, OECOLOGIA, V163, P517, DOI 10.1007/s00442-009-1555-y; BODKIN JL, 1988, J EXP MAR BIOL ECOL, V117, P227, DOI 10.1016/0022-0981(88)90059-7; BURRIDGE TR, 1995, B ENVIRON CONTAM TOX, V55, P621; Campbell AH, 2011, GLOBAL CHANGE BIOL, V17, P2958, DOI 10.1111/j.1365-2486.2011.02456.x; Carney LT, 2005, MAR ECOL PROG SER, V302, P49, DOI 10.3354/meps302049; CHAPMAN ARO, 1995, PHYCOLOGIA, V34, P1, DOI 10.2216/i0031-8884-34-1-1.1; CHAPMAN MG, 1986, J EXP MAR BIOL ECOL, V103, P181, DOI 10.1016/0022-0981(86)90140-1; Chapman MG, 1997, FRONTIERS ECOLOGY BU; Coleman MA, 2008, J PHYCOL, V44, P897, DOI 10.1111/j.1529-8817.2008.00541.x; Coleman MA, 2009, MAR ECOL PROG SER, V381, P63, DOI 10.3354/meps07977; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Edwards A.J., 2007, REEF RESTORATION CON; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Field CD, 1998, MAR POLLUT BULL, V37, P383; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Galatowitsch S.M., 2012, ECOLOGICAL RESTORATI; Goodsell PJ, 2009, ECOL STUD-ANAL SYNTH, V206, P333, DOI 10.1007/978-3-540-92704-4_24; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Hernandez-Carmona G, 2005, BOT MAR, V43, P273; Hobbs RJ, 1996, RESTOR ECOL, V4, P93, DOI 10.1111/j.1526-100X.1996.tb00112.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Johnson LE, 1998, OECOLOGIA, V117, P517, DOI 10.1007/s004420050688; KENDRICK GA, 1995, J EXP MAR BIOL ECOL, V192, P273, DOI 10.1016/0022-0981(95)00076-4; KENNELLY SJ, 1987, MAR ECOL PROG SER, V40, P155, DOI 10.3354/meps040155; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Lorentsen SH, 2010, BIOL CONSERV, V143, P2054, DOI 10.1016/j.biocon.2010.05.013; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Marzinelli EM, 2014, J APPL PHYCOL, V26, P1089, DOI 10.1007/s10811-013-0158-5; Marzinelli EM, 2009, ECOLOGY, V90, P2948, DOI 10.1890/08-1893.1; Nielsen HD, 2008, AQUAT BIOL, V3, P121, DOI 10.3354/ab00069; O'Connor KC, 2010, J EXP MAR BIOL ECOL, V386, P1, DOI 10.1016/j.jembe.2010.01.016; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Scanes PR, 1995, MAR POLLUT BULL, V31, P343, DOI 10.1016/0025-326X(96)81926-6; Schiel DR, 1992, RESTORING NATIONAS M; Sheridan P, 2004, ESTUARIES, V27, P781, DOI 10.1007/BF02912040; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Spurgeon J.P.G., 2000, COLLECTED ESSAYS EC, P125; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Sydney-Water, 2007, SYDNEYS DEEPWATER OC; Taylor DI, 2010, ECOLOGY, V91, P201, DOI 10.1890/08-1512.1; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Toohey B, 2004, MAR BIOL, V144, P1019, DOI 10.1007/s00227-003-1267-5; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1991, AUST J ECOL, V16, P231, DOI 10.1111/j.1442-9993.1991.tb01050.x; van Treeck P, 1999, ESTUAR COAST SHELF S, V49, P75, DOI 10.1016/S0272-7714(99)80011-0; WAHL M, 1995, OECOLOGIA, V102, P329, DOI 10.1007/BF00329800; Wernberg T, 2005, AQUAT ECOL, V39, P419, DOI 10.1007/s10452-005-9009-z; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Womersley H.B.S., 1996, MARINE BENTHIC FLORA; WOMERSLEY H.B.S, 1987, MARINE BENTHIC FLO 2; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x; Yu YQ, 2012, ECOL ENG, V44, P10, DOI 10.1016/j.ecoleng.2012.03.016; Zar J. H., 2009, BIOSTATISTICAL ANAL	69	93	94	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84106	10.1371/journal.pone.0084106	http://dx.doi.org/10.1371/journal.pone.0084106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416198	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500099
J	Cao, TT; Thompson, JE				Cao, Tingting; Thompson, Jonathan E.			Remote Sensing of Atmospheric Optical Depth Using a Smartphone Sun Photometer	PLOS ONE			English	Article							CELL-PHONE; SPECTROSCOPY; EXTINCTION; AERONET; NETWORK	In recent years, smart phones have been explored for making a variety of mobile measurements. Smart phones feature many advanced sensors such as cameras, GPS capability, and accelerometers within a handheld device that is portable, inexpensive, and consistently located with an end user. In this work, a smartphone was used as a sun photometer for the remote sensing of atmospheric optical depth. The top-of-the-atmosphere (TOA) irradiance was estimated through the construction of Langley plots on days when the sky was cloudless and clear. Changes in optical depth were monitored on a different day when clouds intermittently blocked the sun. The device demonstrated a measurement precision of 1.2% relative standard deviation for replicate photograph measurements (38 trials, 134 datum). However, when the accuracy of the method was assessed through using optical filters of known transmittance, a more substantial uncertainty was apparent in the data. Roughly 95% of replicate smart phone measured transmittances are expected to lie within +/- 11.6% of the true transmittance value. This uncertainty in transmission corresponds to an optical depth of approx. +/- 0.12-0.13 suggesting the smartphone sun photometer would be useful only in polluted areas that experience significant optical depths. The device can be used as a tool in the classroom to present how aerosols and gases effect atmospheric transmission. If improvements in measurement precision can be achieved, future work may allow monitoring networks to be developed in which citizen scientists submit acquired data from a variety of locations.	[Cao, Tingting; Thompson, Jonathan E.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Thompson, JE (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.	jon.thompson@ttu.edu	Thompson, Jonathan/M-9815-2019	Thompson, Jonathan/0000-0003-1550-2823	State of Texas/Texas Tech University	State of Texas/Texas Tech University	The authors would like to thank the State of Texas/Texas Tech University for financial support of this project through new investigator start-up funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov MD, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010543; ANGSTROM A, 1970, TELLUS, V22, P205; Delaney JL, 2011, ANAL CHEM, V83, P1300, DOI 10.1021/ac102392t; Dial KD, 2010, ANAL CHEM, V82, P7885, DOI 10.1021/ac100617j; Dubovik O, 2000, J GEOPHYS RES-ATMOS, V105, P9791, DOI 10.1029/2000JD900040; Halthore RN, 1997, J GEOPHYS RES-ATMOS, V102, P4343, DOI 10.1029/96JD03247; Holben BN, 1998, REMOTE SENS ENVIRON, V66, P1, DOI 10.1016/S0034-4257(98)00031-5; Ma LL, 2012, ANAL CHEM, V84, P5611, DOI 10.1021/ac3005814; Ma LL, 2011, AEOLIAN RES, V3, P235, DOI 10.1016/j.aeolia.2011.05.002; Madan A, 2010, P ACM UB 2010 COP DE; Perez-Ramirez D, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016450; Redmond H, 2011, PHYS CHEM CHEM PHYS, V13, P6872, DOI 10.1039/c0cp02270e; Redmond HE, 2010, AEOLIAN RES, V2, P5, DOI 10.1016/j.aeolia.2009.09.002; Scheeline A, 2010, APPL SPECTROSC, V64, p256A, DOI 10.1366/000370210792434378; Shaw G. E., 1973, Journal of Applied Meteorology, V12, P374, DOI 10.1175/1520-0450(1973)012<0374:IOAEUD>2.0.CO;2; SHAW GE, 1983, B AM METEOROL SOC, V64, P4, DOI 10.1175/1520-0477(1983)064<0004:SP>2.0.CO;2; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Staehelin J, 1998, J GEOPHYS RES-ATMOS, V103, P5827, DOI 10.1029/97JD02402; Thompson JE, 2006, APPL OPTICS, V45, P2465, DOI 10.1364/AO.45.002465; Thompson JE, 2003, AEROSOL SCI TECH, V37, P221, DOI 10.1080/02786820300942; Thompson JE, 2002, ANAL CHEM, V74, P1962, DOI 10.1021/ac0110505; Thompson JE, 2008, OPT EXPRESS, V16, P2191, DOI 10.1364/OE.16.002191; Thompson JE, 2007, MEAS SCI TECHNOL, V18, P147, DOI 10.1088/0957-0233/18/1/018; Zhu HY, 2012, ANALYST, V137, P2541, DOI 10.1039/c2an35071h; Zhu HY, 2011, ANAL CHEM, V83, P6641, DOI 10.1021/ac201587a	25	11	12	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84119	10.1371/journal.pone.0084119	http://dx.doi.org/10.1371/journal.pone.0084119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416199	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500100
J	de Carvalho, LL; Maltarollo, VG; de Lima, EF; Weber, KC; Honorio, KM; da Silva, ABF				de Carvalho, Luciana L.; Maltarollo, Vinicius G.; de Lima, Emmanuela Ferreira; Weber, Karen C.; Honorio, Kathia M.; da Silva, Alberico B. F.			Molecular Features Related to HIV Integrase Inhibition Obtained from Structure- and Ligand-Based Approaches	PLOS ONE			English	Article							POTENT; RALTEGRAVIR; DISCOVERY; BINDING; DOMAIN	Among several biological targets to treat AIDS, HIV integrase is a promising enzyme that can be employed to develop new anti-HIV agents. The aim of this work is to propose a mechanistic interpretation of HIV-1 integrase inhibition and to rationalize the molecular features related to the binding affinity of studied ligands. A set of 79 HIV-1 integrase inhibitors and its relationship with biological activity are investigated employing 2D and 3D QSAR models, docking analysis and DFT studies. Analyses of docking poses and frontier molecular orbitals revealed important features on the main ligand-receptor interactions. 2D and 3D models presenting good internal consistency, predictive power and stability were obtained in all cases. Significant correlation coefficients (r(2) = 0.908 and q(2) = 0.643 for 2D model; r(2) = 0.904 and q(2) = 0.719 for 3D model) were obtained, indicating the potential of these models for untested compounds. The generated holograms and contribution maps revealed important molecular requirements to HIV-1 IN inhibition and several evidences for molecular modifications. The final models along with information resulting from molecular orbitals, 2D contribution and 3D contour maps should be useful in the design of new inhibitors with increased potency and selectivity within the chemical diversity of the data.	[de Carvalho, Luciana L.; da Silva, Alberico B. F.] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil; [Maltarollo, Vinicius G.; Honorio, Kathia M.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil; [de Lima, Emmanuela Ferreira; Honorio, Kathia M.] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil; [Weber, Karen C.] Univ Fed Paraiba, Ctr Ciencias Exatas & Nat, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Federal da Paraiba	Honorio, KM (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil.	kmhonorio@usp.br; alberico@iqsc.usp.br	da Silva, Alberico Borges Ferreira/AAB-3642-2021; Honorio, Kathia/AAG-9844-2020; Honorio, Kathia M/D-4998-2012; da Silva, Albérico B. F./C-3274-2011; Maltarollo, Vinicius Gonçalves/AAV-6849-2021; Weber, Karen/AAC-2888-2020	da Silva, Alberico Borges Ferreira/0000-0003-2337-1042; Honorio, Kathia/0000-0002-6938-0676; Honorio, Kathia M/0000-0002-6938-0676; Maltarollo, Vinicius Gonçalves/0000-0001-9675-5907; Weber, Karen/0000-0003-4823-5290	CNPq; FAPESP; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This article was supported by CNPq, FAPESP and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SYBYL 8 1; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; DeLano Scientific LLC, 2006, PYMOL MOL GRAPH SYST; Di Francesco ME, 2008, BIOORG MED CHEM LETT, V18, P2709, DOI 10.1016/j.bmcl.2008.03.017; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; FDA notifications, 2009, AIDS ALERT, V24, P106; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Gardelli C, 2007, J MED CHEM, V50, P4953, DOI 10.1021/jm0704705; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Gupta P, 2011, MOL DIVERS, V15, P733, DOI 10.1007/s11030-011-9304-7; Gupta P, 2009, EUR J MED CHEM, V44, P4276, DOI 10.1016/j.ejmech.2009.07.010; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lemmen C, 2000, J COMPUT AID MOL DES, V14, P215, DOI 10.1023/A:1008194019144; Pace P, 2007, J MED CHEM, V50, P2225, DOI 10.1021/jm070027u; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Quashie PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-34; Sharma H, 2012, J CHEM INF MODEL, V52, P515, DOI 10.1021/ci200485a; STEWART JJP, 1990, J COMPUT AID MOL DES, V4, P1, DOI 10.1007/BF00128336; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Summa V, 2006, J MED CHEM, V49, P6646, DOI 10.1021/jm060854f; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Weber KC, 2010, CHEM BIOL DRUG DES, V76, P320, DOI 10.1111/j.1747-0285.2010.01016.x; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052	34	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e81301	10.1371/journal.pone.0081301	http://dx.doi.org/10.1371/journal.pone.0081301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416129	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500009
J	de Gouw, D; Hermans, PWM; Bootsma, HJ; Zomer, A; Heuvelman, K; Diavatopoulos, DA; Mooi, FR				de Gouw, Daan; Hermans, Peter W. M.; Bootsma, Hester J.; Zomer, Aldert; Heuvelman, Kees; Diavatopoulos, Dimitri A.; Mooi, Frits R.			Differentially Expressed Genes in Bordetella pertussis Strains Belonging to a Lineage Which Recently Spread Globally	PLOS ONE			English	Article							RESPIRATORY-TRACT; ESCHERICHIA-COLI; ENVIRONMENTAL-REGULATION; NEUTROPHIL RECRUITMENT; PHOSPHATE GROUPS; TOXIN; INFECTION; VIRULENCE; BRONCHISEPTICA; IDENTIFICATION	Pertussis is a highly contagious, acute respiratory disease in humans caused by the Gram-negative pathogen Bordetella pertussis. Pertussis has resurged in the face of intensive vaccination and this has coincided with the emergence of strains carrying a particular allele for the pertussis toxin promoter, ptxP3, which is associated with higher levels of pertussis toxin (Ptx) production. Within 10 to 20 years, ptxP3 strains have nearly completely replaced the previously dominant ptxP1 strains resulting in a worldwide selective sweep. In order to identify B. pertussis genes associated with the selective sweep, we compared the expression of genes in ptxP1 and ptxP3 strains that are under control of the Bordetella master virulence regulatory locus (bvgASR). The BvgAS proteins comprise a two component sensory transduction system which is regulated by temperature, nicotinic acid and sulfate. By increasing the sulfate concentration, it is possible to change the phase of B. pertussis from virulent to avirulent. Until recently, the only distinctive phenotype of ptxP3 strains was a higher Ptx production. Here we identify additional phenotypic differences between ptxP1 and ptxP3 strains which may have contributed to its global spread by comparing global transcriptional responses under sulfate-modulating conditions. We show that ptxP3 strains are less sensitive to sulfate-mediated gene suppression, resulting in an increased production of the vaccine antigens pertactin (Prn) and Ptx and a number of other virulence genes, including a type III secretion toxin, Vag8, a protein involved in complement resistance, and lpxE involved in lipid A modification. Furthermore, enhanced expression of the vaccine antigens Ptx and Prn by ptxP3 strains was confirmed at the protein level. Identification of genes differentially expressed between ptxP1 and ptxP3 strains may elucidate how B. pertussis has adapted to vaccination and allow the improvement of pertussis vaccines by identifying novel vaccine candidates.	[de Gouw, Daan; Hermans, Peter W. M.; Bootsma, Hester J.; Zomer, Aldert; Diavatopoulos, Dimitri A.; Mooi, Frits R.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat, Nijmegen, Netherlands; [de Gouw, Daan; Hermans, Peter W. M.; Bootsma, Hester J.; Zomer, Aldert; Diavatopoulos, Dimitri A.; Mooi, Frits R.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands; [Heuvelman, Kees; Mooi, Frits R.] Natl Inst Publ Hlth & Environm RIVM, Netherlands Ctr Infect Dis Control, Bilthoven, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment	Mooi, FR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, Dept Pediat, Nijmegen, Netherlands.	frits.mooi@rivm.nl	Diavatopoulos, Dimitri A/L-4269-2015; Hermans, Peter W.M./H-8042-2014; Mooi, prof.F.R./L-4528-2015	Diavatopoulos, Dimitri A/0000-0001-7065-7807; Zomer, Aldert/0000-0002-0758-5190	Netherlands Organization of Scientific Research (ZonMw) [125020001]	Netherlands Organization of Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	D.d.G. is supported by Grant 125020001 from the Netherlands Organization of Scientific Research (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2011, VACCINE, V29, P3438, DOI 10.1016/j.vaccine.2011.02.070; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bottero D, 2012, J APPL MICROBIOL, V112, P1266, DOI 10.1111/j.1365-2672.2012.05299.x; Campbell P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035874; Carbonetti NH, 2004, INFECT IMMUN, V72, P3350, DOI 10.1128/IAI.72.6.3350-3358.2004; Carbonetti NH, 2007, INFECT IMMUN, V75, P1713, DOI 10.1128/IAI.01578-06; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Conyn van Spaendock MAE, 2012, 215121002 RIVM; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Han HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017797; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; HOMMA JY, 1985, J BIOCHEM-TOKYO, V98, P395, DOI 10.1093/oxfordjournals.jbchem.a135294; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Kallonen T, 2012, CLIN MICROBIOL INFEC, V18, pE377, DOI 10.1111/j.1469-0691.2012.04000.x; Kallonen T, 2011, INFECT GENET EVOL, V11, P2034, DOI 10.1016/j.meegid.2011.09.012; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066150; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kong QK, 2011, J IMMUNOL, V187, P412, DOI 10.4049/jimmunol.1100339; Kowalzik F, 2007, PEDIATR INFECT DIS J, V26, P238, DOI 10.1097/01.inf.0000256750.07118.ee; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P514; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marr N, 2008, J BACTERIOL, V190, P4281, DOI 10.1128/JB.01875-07; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Marr N, 2010, J INFECT DIS, V202, P1897, DOI 10.1086/657409; Marr N, 2010, INFECT IMMUN, V78, P2060, DOI 10.1128/IAI.01346-09; MELTON AR, 1989, J BACTERIOL, V171, P6206, DOI 10.1128/jb.171.11.6206-6212.1989; MELTON AR, 1993, INFECT IMMUN, V61, P807, DOI 10.1128/IAI.61.3.807-815.1993; MERKEL TJ, 1995, J BACTERIOL, V177, P2727, DOI 10.1128/jb.177.10.2727-2736.1995; Merkel TJ, 1998, INFECT IMMUN, V66, P4367; Mielcarek N, 1998, NAT BIOTECHNOL, V16, P454, DOI 10.1038/nbt0598-454; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; Nasso M, 2009, J IMMUNOL, V183, P1892, DOI 10.4049/jimmunol.0901071; Neo YL, 2010, MICROBES INFECT, V12, P238, DOI 10.1016/j.micinf.2009.12.002; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Ohtsu I, 2010, J BIOL CHEM, V285, P17479, DOI 10.1074/jbc.M109.081356; Ouellet M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-97; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Petersen RF, 2012, EMERG INFECT DIS, V18, P767, DOI 10.3201/eid1805.110812; PORTER JF, 1993, FEMS MICROBIOL LETT, V110, P33, DOI 10.1111/j.1574-6968.1993.tb06291.x; ROZMAN P, 1992, J CHROMATOGR-BIOMED, V574, P146, DOI 10.1016/0378-4347(92)80110-C; SCARLATO V, 1991, EMBO J, V10, P3971, DOI 10.1002/j.1460-2075.1991.tb04967.x; Schmidtke AJ, 2012, EMERG INFECT DIS, V18, P1248, DOI 10.3201/eid1808.120082; SIRKO A, 1990, J BACTERIOL, V172, P3351, DOI 10.1128/jb.172.6.3351-3357.1990; SPANGRUDE GJ, 1985, J IMMUNOL, V135, P4135; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; Stockbauer KE, 2001, MOL MICROBIOL, V39, P65, DOI 10.1046/j.1365-2958.2001.02191.x; Stocks P, 1932, J HYG, V32, P582; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zurita E, 2013, INFECT IMMUN, V81, P2371, DOI 10.1128/IAI.00336-13	77	49	52	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84523	10.1371/journal.pone.0084523	http://dx.doi.org/10.1371/journal.pone.0084523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416242	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500134
J	Hu, YJ; Tu, PC; Lin, CS; Guo, ST				Hu, Yuh-Jyh; Tu, Po-Chin; Lin, Chun-Sheng; Guo, Szu-Ting			Identification and Chronological Analysis of Genomic Signatures in Influenza A Viruses	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; NS1 PROTEIN; POLYMERASE; BINDING; ORIGIN; SWINE; M1; M2; ADAPTATION; CRITERIA	An increase in the availability of data on the influenza A viruses (IAV) has enabled the identification of the potential determinants of IAV host specificity using computational approaches. In this study, we proposed an alternative approach, based on the adjusted Rand index (ARI), for the evaluation of genomic signatures of IAVs and their ability to distinguish hosts they infected. Our experiments showed that the host-specific signatures identified using the ARI were more characteristic of their hosts than those identified using previous measures. Our results provided updates on the host-specific genomic signatures in the internal proteins of the IAV based on the sequence data as of February 2013 in the National Center for Biotechnology Information (NCBI). Unlike other approaches for signature recognition, our approach considered not only the ability of signatures to distinguish hosts (according to the ARI), but also the chronological relationships among proteins. We identified novel signatures that could be mapped to known functional domains, and introduced a chronological analysis to investigate the changes in host-specific genomic signatures over time. Our chronological analytical approach provided results on the adaptive variability of signatures, which correlated with previous studies' findings, and indicated prospective adaptation trends that warrant further investigation.	[Hu, Yuh-Jyh; Lin, Chun-Sheng] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Hu, Yuh-Jyh; Tu, Po-Chin; Guo, Szu-Ting] Natl Chiao Tung Univ, Dept Comp Sci, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hu, YJ (corresponding author), Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan.	yhu@cs.nctu.edu.tw			National Science Council, Taiwan [NSC 102-2221-E-009-125]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially supported by National Science Council (www.nsc.gov.tw), Taiwan (NSC 102-2221-E-009-125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Babon JAB, 2009, HUM IMMUNOL, V70, P711, DOI 10.1016/j.humimm.2009.06.004; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Deng YP, 1997, J IMMUNOL, V158, P1507; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Forbes NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031839; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hudjetz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002488; HULL JD, 1988, J CELL BIOL, V106, P1489, DOI 10.1083/jcb.106.5.1489; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Manz B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003279; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; MILLIGAN GW, 1986, MULTIVAR BEHAV RES, V21, P441, DOI 10.1207/s15327906mbr2104_5; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Qian XY, 1995, RNA, V1, P948; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; STRANDEN AM, 1993, VIROLOGY, V197, P642, DOI 10.1006/viro.1993.1639; Tamuri AU, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000564; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Thaa B, 2009, VIROLOGY, V383, P150, DOI 10.1016/j.virol.2008.10.001; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	47	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84638	10.1371/journal.pone.0084638	http://dx.doi.org/10.1371/journal.pone.0084638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416256	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500144
J	Johansen, JL				Johansen, Jacob L.			Quantifying Water Flow within Aquatic Ecosystems Using Load Cell Sensors: A Profile of Currents Experienced by Coral Reef Organisms around Lizard Island, Great Barrier Reef, Australia	PLOS ONE			English	Article							WAVE EXPOSURE; FIELD; VELOCITY; MODEL; HYDRODYNAMICS; BREAKAGE; FORCES	Current velocity in aquatic environments has major implications for the diversity, abundance and ecology of aquatic organisms, but quantifying these currents has proven difficult. This study utilises a simple and inexpensive instrument (<$150) to provide a detailed current velocity profile of the coral-reef system around Lizard Island (Great Barrier Reef, Australia) at a spatial and temporal scale relevant to the ecology of individual benthos and fish. The instrument uses load-cell sensors to provide a correlation between sensor output and ambient current velocity of 99%. Each instrument is able to continuously record current velocities to >500 cms(-1) and wave frequency to >100 Hz over several weeks. Sensor data are registered and processed at 16 MHz and 10 bit resolution, with a measuring precision of 0.06+/-0.04%, and accuracy of 0.51+/-0.65% (mean +/-S.D.). Each instrument is also pressure rated to 120 m and shear stresses <= 20 kNm(-2) allowing deployment in harsh environments. The instrument was deployed across 27 coral reef sites covering the crest (3 m), mid-slope (6 m) and deep-slope (9 m depth) of habitats directly exposed, oblique or sheltered from prevailing winds. Measurements demonstrate that currents over the reef slope and crest varies immensely depending on depth and exposure: Currents differ up to 9-fold within habitats only separated by 3 m depth and 15-fold between exposed, oblique and sheltered habitats. Comparisons to ambient weather conditions reveal that currents around Lizard Island are largely wind driven. Zero to 22.5 knot winds correspond directly to currents of 0 to >82 cms(-1), while tidal currents rarely exceed 5.5 cms(-1). Rather, current velocity increases exponentially as a function of wave height (0 to 1.6 m) and frequency (0.54 to 0.20 Hz), emphasizing the enormous effect of wind and waves on organisms in these shallow coral reef habitats.	[Johansen, Jacob L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Johansen, Jacob L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Johansen, JL (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	jacob.johansen@my.jcu.edu.au			Lizard Island Research Station Doctoral Fellowship	Lizard Island Research Station Doctoral Fellowship	This study was funded by the Lizard Island Research Station Doctoral Fellowship. http://australianmuseum.net.au/Lizard-Island-Research-Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL EC, 1994, J EXP MAR BIOL ECOL, V181, P9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Collar P, 2001, ENCY OCEAN SCI, P2796; DONELAN MA, 1978, REV SCI INSTRUM, V49, P298, DOI 10.1063/1.1135395; Figurski JD, 2011, LIMNOL OCEANOGR-METH, V9, P204, DOI 10.4319/lom.2011.9.204; Finelli CM, 2009, CORAL REEFS, V28, P461, DOI 10.1007/s00338-009-0481-0; Fulton CJ, 2005, P ROY SOC B-BIOL SCI, V272, P827, DOI 10.1098/rspb.2004.3029; Fulton CJ, 2005, LIMNOL OCEANOGR, V50, P255, DOI 10.4319/lo.2005.50.1.0255; Gaylord B, 1999, J EXP MAR BIOL ECOL, V239, P85, DOI 10.1016/S0022-0981(99)00031-3; Gaylord B, 2008, BIOL BULL-US, V215, P295, DOI 10.2307/25470713; Grigg RW, 1998, CORAL REEFS, V17, P263, DOI 10.1007/s003380050127; Hearn CJ, 2011, CORAL REEFS, V30, P1, DOI 10.1007/s00338-011-0752-4; Herbers THC, 2010, J ATMOS OCEAN TECH, V27, P210, DOI 10.1175/2009JTECHO681.1; Johansen JL, 2007, CORAL REEFS, V26, P577, DOI 10.1007/s00338-007-0217-y; Kennen JG, 2010, ECOHYDROLOGY, V3, P88, DOI 10.1002/eco.99; Kinsman B, 2002, WIND WAVES THEIR GEN; Lancaster J, 2010, RIVER RES APPL, V26, P385, DOI 10.1002/rra.1274; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002789; Mach KJ, 2011, J EXP BIOL, V214, P1571, DOI 10.1242/jeb.051623; MacVicar BJ, 2007, EARTH SURF PROC LAND, V32, P1412, DOI 10.1002/esp.1497; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Marchant R, IEEE J OCEANIC ENG, DOI [10.1109/JOE.2012.2236151, DOI 10.1109/J0E.2012.2236151]; McIntyre N, 2008, P I CIVIL ENG-WAT M, V161, P199, DOI 10.1680/wama.2008.161.4.199; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Nikora V, 2010, RIVER RES APPL, V26, P367, DOI 10.1002/rra.1291; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; PONTIUS PE, 1982, EXP MECH, V22, P81, DOI 10.1007/BF02325907; Porter ET, 2000, LIMNOL OCEANOGR, V45, P145, DOI 10.4319/lo.2000.45.1.0145; Randall JE, 1997, FISHES GREAT BARRIER; Schutter M, 2010, CORAL REEFS, V29, P737, DOI 10.1007/s00338-010-0617-2; Stone MC, 2007, J HYDRAUL RES, V45, P752, DOI 10.1080/00221686.2007.9521813; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; SWAIN J, 1992, P INDIAN AS-EARTH, V101, P215, DOI 10.1007/BF02878133; Utter BD, 1996, J EXP BIOL, V199, P2645; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vogel S, 2020, LIFE MOVING FLUIDS P	37	28	28	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83240	10.1371/journal.pone.0083240	http://dx.doi.org/10.1371/journal.pone.0083240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421878	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000329862500038
J	Jung, SK; Aleman-Meza, B; Riepe, C; Zhong, WW				Jung, Sang-Kyu; Aleman-Meza, Boanerges; Riepe, Celeste; Zhong, Weiwei			QuantWorm: A Comprehensive Software Package for Caenorhabditis elegans Phenotypic Assays	PLOS ONE			English	Article							EGG-LAYING BEHAVIOR; C-ELEGANS; PLC-BETA; G(Q)ALPHA; CELASTROL; PATHWAY; SYSTEM; G(O)ALPHA; DRUG	Phenotypic assays are crucial in genetics; however, traditional methods that rely on human observation are unsuitable for quantitative, large-scale experiments. Furthermore, there is an increasing need for comprehensive analyses of multiple phenotypes to provide multidimensional information. Here we developed an automated, high-throughput computer imaging system for quantifying multiple Caenorhabditis elegans phenotypes. Our imaging system is composed of a microscope equipped with a digital camera and a motorized stage connected to a computer running the QuantWorm software package. Currently, the software package contains one data acquisition module and four image analysis programs: WormLifespan, WormLocomotion, WormLength, and WormEgg. The data acquisition module collects images and videos. The WormLifespan software counts the number of moving worms by using two time-lapse images; the WormLocomotion software computes the velocity of moving worms; the WormLength software measures worm body size; and the WormEgg software counts the number of eggs. To evaluate the performance of our software, we compared the results of our software with manual measurements. We then demonstrated the application of the QuantWorm software in a drug assay and a genetic assay. Overall, the QuantWorm software provided accurate measurements at a high speed. Software source code, executable programs, and sample images are available at www.quantworm.org. Our software package has several advantages over current imaging systems for C. elegans. It is an all-in-one package for quantifying multiple phenotypes. The QuantWorm software is written in Java and its source code is freely available, so it does not require use of commercial software or libraries. It can be run on multiple platforms and easily customized to cope with new methods and requirements.	[Jung, Sang-Kyu; Aleman-Meza, Boanerges; Riepe, Celeste; Zhong, Weiwei] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University	Zhong, WW (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	Weiwei.Zhong@rice.edu		Riepe, Celeste/0000-0001-8672-5392	National Institutes of Health [HG004724, DA018341]; Kinship foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG004724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinship foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health grants HG004724 and DA018341 and by a Searle Scholar grant from the Kinship foundation to WZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2001, PROG NEURO-PSYCHOPH, V25, P1341, DOI 10.1016/S0278-5846(01)00192-0; Bastiani C, 2006, HETEROTRIMERIC G PRO; Bastiani CA, 2003, GENETICS, V165, P1805; Bradley Derek, 2007, Journal of Graphics Tools, V12, P13; Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029; Ch'ng Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000283; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Daniels SA, 2000, GENETICS, V156, P123; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; He MF, 2009, J ETHNOPHARMACOL, V121, P61, DOI 10.1016/j.jep.2008.09.033; Hu S, 2011, GENETICS, V189, P137, DOI 10.1534/genetics.111.131227; Kawli T, 2010, P NATL ACAD SCI USA, V107, P13788, DOI 10.1073/pnas.0914715107; Kim DH, 2009, EUR J CLIN INVEST, V39, P819, DOI 10.1111/j.1365-2362.2009.02186.x; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lee J, 2004, J MOL BIOL, V344, P585, DOI 10.1016/j.jmb.2004.09.050; Mathew MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033483; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Mohamed M, 2008, IEEE INT SYMP CIRC S, P1072, DOI 10.1109/ISCAS.2008.4541607; Moore BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057142; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Perez-Mansilla B, 2009, ADV GENET, V65, P145, DOI 10.1016/S0065-2660(09)65004-5; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Stiernagle T., 2006, WORMBOOK MAINTENANCE; Stroustrup N, 2013, NAT METHODS, V10, P665, DOI [10.1038/NMETH.2475, 10.1038/nmeth.2475]; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Tsibidis GD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-86; Wahlby C, 2012, NAT METHODS, V9, P714, DOI [10.1038/nmeth.1984, 10.1038/NMETH.1984]; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Yu H, 2013, P NATL ACAD SCI US; Zhang S, 2012, CELL ISOLATION CULTU, P1	35	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84830	10.1371/journal.pone.0084830	http://dx.doi.org/10.1371/journal.pone.0084830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416295	Green Published, gold			2022-12-25	WOS:000329862500176
J	Nielsen, A; Mansson, M; Bojer, MS; Gram, L; Larsen, TO; Novick, RP; Frees, D; Frokiaer, H; Ingmer, H				Nielsen, Anita; Mansson, Maria; Bojer, Martin S.; Gram, Lone; Larsen, Thomas O.; Novick, Richard P.; Frees, Dorte; Frokiaer, Hanne; Ingmer, Hanne			Solonamide B Inhibits Quorum Sensing and Reduces Staphylococcus aureus Mediated Killing of Human Neutrophils	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; ALPHA-HEMOLYSIN; ANTIBIOTIC-RESISTANCE; AUTOINDUCING PEPTIDES; FUTURE-PROSPECTS; AGR; INFECTIONS; STRAINS; DISEASE; TOXIN	Methicillin-resistant Staphylococcus aureus (MRSA) continues to be a serious human pathogen, and particularly the spread of community associated (CA)-MRSA strains such as USA300 is a concern, as these strains can cause severe infections in otherwise healthy adults. Recently, we reported that a cyclodepsipeptide termed Solonamide B isolated from the marine bacterium, Photobacterium halotolerans strongly reduces expression of RNAIII, the effector molecule of the agr quorum sensing system. Here we show that Solonamide B interferes with the binding of S. aureus autoinducing peptides (AIPs) to sensor histidine kinase, AgrC, of the agr two-component system. The hypervirulence of USA300 has been linked to increased expression of central virulence factors like a-hemolysin and the phenol soluble modulins (PSMs). Importantly, in strain USA300 Solonamide B dramatically reduced the activity of a-hemolysin and the transcription of psma encoding PSMs with an 80% reduction in toxicity of supernatants towards human neutrophils and rabbit erythrocytes. To our knowledge this is the first report of a compound produced naturally by a Gram-negative marine bacterium that interferes with agr and affects both RNAIII and AgrA controlled virulence gene expression in S. aureus.	[Nielsen, Anita; Bojer, Martin S.; Frees, Dorte; Frokiaer, Hanne; Ingmer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Mansson, Maria; Gram, Lone; Larsen, Thomas O.] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Novick, Richard P.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY USA	University of Copenhagen; Technical University of Denmark; New York University	Ingmer, H (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark.	hi@sund.ku.dk		Frees, Dorte/0000-0003-4946-2890; Novick, richard/0000-0003-4418-7893; Gram, Lone/0000-0002-1076-5723; Frokiaer, Hanne/0000-0003-1472-9698; Bojer, Martin Saxtorph/0000-0002-8488-9593; Larsen, Thomas Ostenfeld/0000-0002-3362-5707; Ingmer, Hanne/0000-0002-8350-5631	Programme Committee for Food, Health and Welfare under the Danish Strategic Research Council	Programme Committee for Food, Health and Welfare under the Danish Strategic Research Council	This work was supported by funding from the Programme Committee for Food, Health and Welfare under the Danish Strategic Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; BERNHEIMER AW, 1963, J GEN MICROBIOL, V30, P455, DOI 10.1099/00221287-30-3-455; BHAKDI S, 1984, INFECT IMMUN, V46, P318, DOI 10.1128/IAI.46.2.318-323.1984; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469; Chan WC, 2004, J MED CHEM, V47, P4633, DOI 10.1021/jm0400754; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Deresinski S, 2006, DRUGS, V66, P1797, DOI 10.2165/00003495-200666140-00002; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; FIRON N, 1987, INFECT IMMUN, V55, P472, DOI 10.1128/IAI.55.2.472-476.1987; Fischetti V., 2006, GRAM POSITIVE PATHOG, V2nd; Geisinger E, 2009, P NATL ACAD SCI USA, V106, P1216, DOI 10.1073/pnas.0807760106; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; Graves SF, 2010, J MOL MED, V88, P109, DOI 10.1007/s00109-009-0573-x; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Janeway JC, 2005, IMMUNO BIOL IMMUNE S; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Jarry TM, 2008, CELL MICROBIOL, V10, P1801, DOI 10.1111/j.1462-5822.2008.01166.x; Jelsbak L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012752; Jensen RO, 2008, J MOL BIOL, V381, P300, DOI 10.1016/j.jmb.2008.06.018; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Krucke GW, 2009, AM J EMERG MED, V27, P344, DOI 10.1016/j.ajem.2008.03.046; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lowy FD, 2007, NAT MED, V13, P1418, DOI 10.1038/nm1207-1418; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; Lyon GJ, 2002, BIOCHEMISTRY-US, V41, P10095, DOI 10.1021/bi026049u; Mansson M, 2011, MAR DRUGS, V9, P2537, DOI 10.3390/md9122537; Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218; Moran GJ, 2005, EMERG INFECT DIS, V11, P928; Nielsen A, 2010, ANTIMICROB AGENTS CH, V54, P509, DOI 10.1128/AAC.00940-09; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 1967, J EXP MED, V125, P45, DOI 10.1084/jem.125.1.45; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Sakoulas G, 2008, CLIN INFECT DIS, V46, pS360, DOI 10.1086/533592; Shoham M, 2011, FUTURE MED CHEM, V3, P775, DOI [10.4155/FMC.11.43, 10.4155/fmc.11.43]; THOMPSON RL, 1982, ANN INTERN MED, V97, P309, DOI 10.7326/0003-4819-97-3-309; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Werner G, 2008, FUTURE MICROBIOL, V3, P547, DOI 10.2217/17460913.3.5.547	52	66	67	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84992	10.1371/journal.pone.0084992	http://dx.doi.org/10.1371/journal.pone.0084992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416329	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500202
J	Pampeno, C; Derkatch, IL; Meruelo, D				Pampeno, Christine; Derkatch, Irina L.; Meruelo, Daniel			Interaction of Human Laminin Receptor with Sup35, the [PSI+] Prion-Forming Protein from S. cerevisiae: A Yeast Model for Studies of LamR Interactions with Amyloidogenic Proteins	PLOS ONE			English	Article							DE-NOVO APPEARANCE; CELL-SURFACE RECEPTOR; BINDING-PROTEIN; RIBOSOMAL-PROTEIN; PROPAGATION; MODULATION; VIRUS; OVEREXPRESSION; CYTOSKELETON; AGGREGATION	The laminin receptor (LamR) is a cell surface receptor for extracellular matrix laminin, whereas the same protein within the cell interacts with ribosomes, nuclear proteins and cytoskeletal fibers. LamR has been shown to be a receptor for several bacteria and viruses. Furthermore, LamR interacts with both cellular and infectious forms of the prion protein, PrPC and PrPSc. Indeed, LamR is a receptor for PrPC. Whether LamR interacts with PrPSc exclusively in a capacity of the PrP receptor, or LamR specifically recognizes prion determinants of PrPSc, is unclear. In order to explore whether LamR has a propensity to interact with prions and amyloids, we examined LamR interaction with the yeast prion-forming protein, Sup35. Sup35 is a translation termination factor with no homology or functional relationship to PrP. Plasmids expressing LamR or LamR fused with the green fluorescent protein (GFP) were transformed into yeast strain variants differing by the presence or absence of the prion conformation of Sup35, respectively [PSI+] and [psi(-)]. Analyses by immunoprecipitation, centrifugal fractionation and fluorescent microscopy reveal interaction between LamR and Sup35 in [PSI+] strains. The presence of [PSI+] promotes LamR co-precipitation with Sup35 as well as LamR aggregation. In [PSI+] cells, LamR tagged with GFP or mCherry forms bright fluorescent aggregates that co-localize with visible [PSI+] foci. The yeast prion model will facilitate studying the interaction of LamR with amyloidogenic prions in a safe and easily manipulated system that may lead to a better understanding and treatment of amyloid diseases.	[Pampeno, Christine; Meruelo, Daniel] NYU, Sch Med, Gene Therapy Ctr, Inst Canc, New York, NY USA; [Pampeno, Christine; Meruelo, Daniel] NYU, Sch Med, Dept Pathol, New York, NY USA; [Derkatch, Irina L.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10027 USA	New York University; New York University; Columbia University	Derkatch, IL (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10027 USA.	ild2103@columbia.edu; DM01@mac.com			U.S. Public Health Grant from the National Cancer Institute [CA100687]; National Institutes of Health [7 R01 GM070934-06]; NATIONAL CANCER INSTITUTE [R01CA100687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070934] Funding Source: NIH RePORTER	U.S. Public Health Grant from the National Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by U.S. Public Health Grant CA100687 from the National Cancer Institute to D. M., a generous donation from the Litwin foundation and a Research and License agreement between NYU and Cynvec. This work was also supported by National Institutes of Health (grant 7 R01 GM070934-06) to I. L. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Bach S, 2006, METHODS, V39, P72, DOI 10.1016/j.ymeth.2006.04.005; Bagriantsev S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-32; Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870; Chen MS, 1996, BBA-PROTEIN STRUCT M, V1297, P124, DOI 10.1016/S0167-4838(96)00140-9; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; CODY RL, 1986, EXP CELL RES, V165, P107, DOI 10.1016/0014-4827(86)90536-7; Crow ET, 2011, SEMIN CELL DEV BIOL, V22, P452, DOI 10.1016/j.semcdb.2011.03.003; Demianova M, 1996, J BIOL CHEM, V271, P11383, DOI 10.1074/jbc.271.19.11383; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1998, P NATL ACAD SCI USA, V95, P2400, DOI 10.1073/pnas.95.5.2400; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Derkatch IL, 2007, PRION, V1, P161, DOI 10.4161/pri.1.3.4837; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Fujimura Y, 2006, BIOCHEM BIOPH RES CO, V348, P524, DOI 10.1016/j.bbrc.2006.07.086; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; HUNTER I, 1992, J BIOL CHEM, V267, P6006; INGEVECHTOMOV SG, 1988, GENETIKA+, V24, P1159; Jamieson KV, 2008, J BIOL CHEM, V283, P3002, DOI 10.1074/jbc.C700206200; Jamieson KV, 2011, J MOL BIOL, V405, P24, DOI 10.1016/j.jmb.2010.10.028; Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t; KEPPEL E, 1991, J CELL SCI, V100, P789; Kim KJ, 2005, J BIOL CHEM, V280, P1360, DOI 10.1074/jbc.M410176200; Kolodziejczak D, 2010, J MOL BIOL, V402, P293, DOI 10.1016/j.jmb.2010.06.055; Kushnirov VV, 2007, PRION, V1, P179, DOI 10.4161/pri.1.3.4840; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Liebman SW, 2006, METHODS, V39, P23, DOI 10.1016/j.ymeth.2006.04.010; Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765; Morel E, 2005, AM J PATHOL, V167, P1033, DOI 10.1016/S0002-9440(10)61192-3; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Ould-Abeih MB, 2012, BIOCHEMISTRY-US, V51, P4807, DOI 10.1021/bi300335r; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PAULSSON M, 1985, EMBO J, V4, P309, DOI 10.1002/j.1460-2075.1985.tb03630.x; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; Piro JR, 2011, BIOCHEMISTRY-US, V50, P7111, DOI 10.1021/bi200786p; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Serio TR, 2002, ADV PROTEIN CHEM, V59, P391; Sherman F., 1986, METHODS YEAST GENETI; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; SIKORSKI RS, 1989, GENETICS, V122, P19; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Susantad T, 2008, CELL MOL BIOL LETT, V13, P452, DOI 10.2478/s11658-008-0017-6; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tuite MF, 2007, PRION, V1, P101, DOI 10.4161/pri.1.2.4665; Venticinque L, 2012, J PROTEOME RES, V11, P4863, DOI 10.1021/pr300307h; Venticinque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015895; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; WEWER UM, 1987, CANCER RES, V47, P5691; Wickner RB, 2011, SEMIN CELL DEV BIOL, V22, P469, DOI 10.1016/j.semcdb.2011.02.021; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; YANNARIELLOBROWN J, 1988, J CELL BIOL, V106, P1773, DOI 10.1083/jcb.106.5.1773; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	80	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e86013	10.1371/journal.pone.0086013	http://dx.doi.org/10.1371/journal.pone.0086013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416454	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500269
J	Redmond, EM; Liu, WM; Hamm, K; Hatch, E; Cahill, PA; Morrow, D				Redmond, Eileen M.; Liu, Weimin; Hamm, Katie; Hatch, Ekaterina; Cahill, Paul A.; Morrow, David			Perivascular Delivery of Notch 1 siRNA Inhibits Injury-Induced Arterial Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IN-VITRO; GROWTH-FACTOR; EXPRESSION; APOPTOSIS; RESTENOSIS; PROLIFERATION; PATHWAY; INTIMA; ATHEROSCLEROSIS	Objectives: To determine the efficacy of perivascular delivery of Notch 1 siRNA in preventing injury-induced arterial remodeling. Methods and Results: Carotid artery ligation was performed to induce arterial remodeling. After 14 days, morphometric analysis confirmed increased vSMC growth and subsequent media thickening and neointimal formation. Laser capture microdissection, quantitative qRT-PCR and immunoblot analysis of medial tissue revealed a significant increase in Notch1 receptor and notch target gene, Hrt 1 and 2 expression in the injured vessels. Perivascular delivery of Notch 1 siRNA by pluronic gel inhibited the injury-induced increase in Notch 1 receptor and target gene expression when compared to scrambled siRNA controls while concomitantly reducing media thickening and neointimal formation to pre-injury, sham-operated levels. Selective Notch 1 knockdown also reversed the injury-induced inhibition of pro-apoptotic Bax expression while decreasing injury-induced anti-apoptotic Bcl-XL expression to sham-operated control levels. In parallel experiments, proliferative cyclin levels, as measured by PCNA expression, were reversed to sham-operated control levels following selective Notch 1 knockdown. Conclusion: These results suggest that injury-induced arterial remodeling can be successfully inhibited by localized perivascular delivery of Notch 1 siRNA.	[Redmond, Eileen M.; Liu, Weimin; Hamm, Katie; Hatch, Ekaterina; Morrow, David] Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA; [Cahill, Paul A.] Dublin City Univ, Vasc Hlth Res Ctr, Dublin 9, Ireland	University of Rochester; Dublin City University	Morrow, D (corresponding author), Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA.	david_morrow@urmc.rochester.edu	Cahill, Paul A/E-8061-2011	Cahill, Paul A/0000-0002-5385-6502; Redmond, Eileen M/0000-0001-8642-4418	National Institutes of Health [R00HL095650, R21AA020365]; Science Foundation Ireland [SFI-11/PI/1128]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL095650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by funds from the National Institutes of Health (R00HL095650 to D. M.) and (R21AA020365 TO E. R) and Science Foundation Ireland (SFI-11/PI/1128 to PAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora KB, 2010, ANN VASC SURG, V24, P116, DOI 10.1016/j.avsg.2009.07.019; Anderson LM, 2007, J CLIN INVEST, V117, P299, DOI 10.1172/JCI31288; Andres V, 1998, INT J MOL MED, V2, P81; Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Dangas G, 2002, CIRCULATION, V105, P2586, DOI 10.1161/01.CIR.0000019122.00032.DF; Doi H, 2009, BIOCHEM BIOPH RES CO, V381, P654, DOI 10.1016/j.bbrc.2009.02.116; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Goldie LC, 2008, ORGANOGENESIS, V4, P257, DOI [DOI 10.4161/ORG.4.4.7416, DOI 10.4161/org.4.4.7416]; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Korshunov VA, 2008, CURR OPIN HEMATOL, V15, P250, DOI 10.1097/MOH.0b013e3282f97d71; Leng Q, 2009, DRUG FUTURE, V34, P721, DOI 10.1358/dof.2009.034.09.1413267; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; McGrath JC, 2005, EXP PHYSIOL, V90, P469, DOI 10.1113/expphysiol.2005.030130; Morrow D, 2005, ARTERIOSCL THROM VAS, V25, pE86; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Morrow D, 2010, ARTERIOSCL THROM VAS, V30, P2597, DOI 10.1161/ATVBAHA.110.215681; Morrow D, 2009, ARTERIOSCL THROM VAS, V29, P1112, DOI 10.1161/ATVBAHA.109.186890; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Outtz HH, 2010, J IMMUNOL, V185, P4363, DOI 10.4049/jimmunol.1000720; Perumalsamy LR, 2010, P NATL ACAD SCI USA, V107, P6882, DOI 10.1073/pnas.0910060107; Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222; Redmond E, 2013, ATHEROSCLEROSIS THRO; Schwartz S M, 2000, Curr Atheroscler Rep, V2, P422, DOI 10.1007/s11883-000-0081-5; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Smolock EM, 2012, CIRCULATION, V126, P2418, DOI 10.1161/CIRCULATIONAHA.112.125971; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186; Yang Cheng, 2001, Chinese Medical Sciences Journal, V16, P182	35	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84122	10.1371/journal.pone.0084122	http://dx.doi.org/10.1371/journal.pone.0084122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416200	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500101
J	Shitikov, EA; Bespyatykh, JA; Ischenko, DS; Alexeev, DG; Karpova, IY; Kostryukova, ES; Isaeva, YD; Nosova, EY; Mokrousov, IV; Vyazovaya, AA; Narvskaya, OV; Vishnevsky, BI; Otten, TF; Zhuravlev, VY; Yablonsky, PK; Ilina, EN; Govorun, VM				Shitikov, Egor A.; Bespyatykh, Julia A.; Ischenko, Dmitry S.; Alexeev, Dmitry G.; Karpova, Irina Y.; Kostryukova, Elena S.; Isaeva, Yulia D.; Nosova, Elena Y.; Mokrousov, Igor V.; Vyazovaya, Anna A.; Narvskaya, Olga V.; Vishnevsky, Boris I.; Otten, Tatiana F.; Zhuravlev, Valery Y.; Yablonsky, Peter K.; Ilina, Elena N.; Govorun, Vadim M.			Unusual Large-Scale Chromosomal Rearrangements in Mycobacterium tuberculosis Beijing B0/W148 Cluster Isolates	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; GENETIC DIVERSITY; GENOME ANALYSIS; STRAIN; EPIDEMIOLOGY; EVOLUTION; RUSSIA; FAMILY; DELETIONS; ALIGNMENT	The Mycobacterium tuberculosis (MTB) Beijing family isolates are geographically widespread, and there are examples of Beijing isolates that are hypervirulent and associated with drug resistance. One-fourth of Beijing genotype isolates found in Russia belong to the B0/W148 group. The aim of the present study was to investigate features of these endemic strains on a genomic level. Four Russian clinical isolates of this group were sequenced, and the data obtained was compared with published sequences of various MTB strain genomes, including genome of strain W-148 of the same B0/W148 group. The comparison of the W-148 and H37Rv genomes revealed two independent inversions of large segments of the chromosome. The same inversions were found in one of the studied strains after deep sequencing using both the fragment and mate-paired libraries. Additionally, inversions were confirmed by RFLP hybridization analysis. The discovered rearrangements were verified by PCR in all four newly sequenced strains in the study and in four additional strains of the same Beijing B0/W148 group. The other 32 MTB strains from different phylogenetic lineages were tested and revealed no inversions. We suggest that the initial largest inversion changed the orientation of the three megabase (Mb) segment of the chromosome, and the second one occurred in the previously inverted region and partly restored the orientation of the 2.1 Mb inner segment of the region. This is another remarkable example of genomic rearrangements in the MTB in addition to the recently published of large-scale duplications. The described cases suggest that large-scale genomic rearrangements in the currently circulating MTB isolates may occur more frequently than previously considered, and we hope that further studies will help to determine the exact mechanism of such events.	[Shitikov, Egor A.; Bespyatykh, Julia A.; Ischenko, Dmitry S.; Alexeev, Dmitry G.; Karpova, Irina Y.; Kostryukova, Elena S.; Ilina, Elena N.; Govorun, Vadim M.] Res Inst Phys Chem Med, Moscow, Russia; [Ischenko, Dmitry S.; Alexeev, Dmitry G.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Isaeva, Yulia D.; Nosova, Elena Y.] Moscow Sci Pract Ctr Treatment TB Moscow Healthca, Moscow, Russia; [Mokrousov, Igor V.; Vyazovaya, Anna A.; Narvskaya, Olga V.] St Petersburg Pasteur Inst, St Petersburg, Russia; [Vishnevsky, Boris I.; Otten, Tatiana F.; Zhuravlev, Valery Y.; Yablonsky, Peter K.] Res Inst Phthisiopulmonol, St Petersburg, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Moscow Institute of Physics & Technology; Saint-Petersburg Pasteur Institute; St. Petersburg State Research Institute of Phthisiopulmonology	Shitikov, EA (corresponding author), Res Inst Phys Chem Med, Moscow, Russia.	egorshtkv@gmail.com	Shitikov, Egor/AAJ-4171-2021; Alexeev, Dmitry/A-6167-2013; Kostryukova, Elena/D-8064-2014; Narvskaya, Olga/H-1770-2012; Ilina, Elena/ABI-1172-2020; Govorun, Vadim M/A-9043-2018; Zhuravlev, Viacheslav Y./H-1223-2017; Bespyatykh, Julia A/Q-8132-2016; Yablonskiy, Petr/T-8804-2017; Mokrousov, Igor/J-3640-2014; Ilina, Elena N/N-8190-2015; Mokrousov, Igor/Q-5941-2019; Shitikov, Egor/Q-2520-2017	Shitikov, Egor/0000-0002-4865-6004; Alexeev, Dmitry/0000-0003-0783-1176; Kostryukova, Elena/0000-0002-0457-6803; Narvskaya, Olga/0000-0002-0830-5808; Ilina, Elena/0000-0003-0130-5079; Bespyatykh, Julia A/0000-0002-4408-503X; Yablonskiy, Petr/0000-0003-4385-9643; Mokrousov, Igor/0000-0001-5924-0576; Ilina, Elena N/0000-0003-0130-5079; Mokrousov, Igor/0000-0001-5924-0576; Shitikov, Egor/0000-0002-4865-6004; Zhuravlev, Viacheslav/0000-0001-6906-6225	Ministry of Education and Science of the Russian Federation [16.522.11.2003]; European Commission (ORCHID project) [261378]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); European Commission (ORCHID project)(European Commission)	This work was partly supported by 16.522.11.2003 grant of the Ministry of Education and Science of the Russian Federation; and by the European Commission (ORCHID project, Grant Agreement No. 261378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Brosch R, 1999, INFECT IMMUN, V67, P5768, DOI 10.1128/IAI.67.11.5768-5774.1999; Brosch R, 2000, YEAST, V17, P111, DOI 10.1002/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Coyne S, 2010, MICROBIOL-SGM, V156, P1448, DOI 10.1099/mic.0.033639-0; Cui LZ, 2012, P NATL ACAD SCI USA, V109, pE1647, DOI 10.1073/pnas.1204307109; DALE JW, 1995, EUR RESPIR J, V8, pS633; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Domenech P, 2010, J BACTERIOL, V192, P4562, DOI 10.1128/JB.00536-10; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Eisen JA, 2000, GENOME BIOL, V1; Fang Z, 1999, J BACTERIOL, V181, P1014, DOI 10.1128/JB.181.3.1014-1020.1999; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Garcia-Betancur JC, 2012, INFECT GENET EVOL, V12, P819, DOI 10.1016/j.meegid.2011.09.024; Hsu CY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00236; Ilina EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056577; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kurepina NE, 2001, INT J TUBERC LUNG D, V5, pS41; Kurokawa S, 2013, MAR BIOTECHNOL, V15, P596, DOI 10.1007/s10126-013-9511-6; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Mokrousov I, 2013, CLIN MICROBIOL REV, V26, P342, DOI 10.1128/CMR.00087-12; Muttucumaru DGN, 2004, CURR ISSUES MOL BIOL, V6, P145; Nalbantoglu U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009007; Narvskaia O V, 1999, Probl Tuberk, P39; Narvskaya O, 2005, TRENDS IN DNA FINGERPRINTING RESEARCH, P111; Narvskaya O, 2002, EUR J CLIN MICROBIOL, V21, P596, DOI 10.1007/s10096-002-0775-4; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Smirnov G B, 2010, Mol Gen Mikrobiol Virusol, P11; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thomas JM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-21; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wang XM, 2008, TUBERCULOSIS, V88, P399, DOI 10.1016/j.tube.2008.02.003; Weiner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026038	40	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84971	10.1371/journal.pone.0084971	http://dx.doi.org/10.1371/journal.pone.0084971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416324	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500198
J	Vellichirammal, NN; Zera, AJ; Schilder, RJ; Wehrkamp, C; Riethoven, JJM; Brisson, JA				Vellichirammal, Neetha Nanoth; Zera, Anthony J.; Schilder, Rudolf J.; Wehrkamp, Cody; Riethoven, Jean-Jack M.; Brisson, Jennifer A.			De Novo Transcriptome Assembly from Fat Body and Flight Muscles Transcripts to Identify Morph-Specific Gene Expression Profiles in Gryllus firmus	PLOS ONE			English	Article							WING-POLYMORPHIC CRICKET; HISTORY TRADE-OFFS; HEMOLYMPH JH TITER; LIFE-HISTORY; INTERMEDIARY METABOLISM; RNA-SEQ; LIPID BIOSYNTHESIS; REPRODUCTION; DISPERSAL; CAPABILITY	Wing polymorphism is a powerful model for examining many aspects of adaptation. The wing dimorphic cricket species, Gryllus firmus, consists of a long-winged morph with functional flight muscles that is capable of flight, and two flightless morphs. One (obligately) flightless morph emerges as an adult with vestigial wings and vestigial flight muscles. The other (plastic) flightless morph emerges with fully-developed wings but later in adulthood histolyzes its flight muscles. Importantly both flightless morphs have substantially increased reproductive output relative to the flight-capable morph. Much is known about the physiological and biochemical differences between the morphs with respect to adaptations for flight versus reproduction. In contrast, little is known about the molecular genetic basis of these morph-specific adaptations. To address this issue, we assembled a de novo transcriptome of G. firmus using 141.5 million Illumina reads generated from flight muscles and fat body, two organs that play key roles in flight and reproduction. We used the resulting 34,411 transcripts as a reference transcriptome for differential gene expression analyses. A comparison of gene expression profiles from functional flight muscles in the flight-capable morph versus histolyzed flight muscles in the plastic flight incapable morph identified a suite of genes involved in respiration that were highly expressed in pink (functional) flight muscles and genes involved in proteolysis highly expressed in the white (histolyzed) flight muscles. A comparison of fat body transcripts from the obligately flightless versus the flight-capable morphs revealed differential expression of genes involved in triglyceride biosynthesis, lipid transport, immune function and reproduction. These data provide a valuable resource for future molecular genetics research in this and related species and provide insight on the role of gene expression in morph-specific adaptations for flight versus reproduction.	[Vellichirammal, Neetha Nanoth; Zera, Anthony J.; Wehrkamp, Cody; Riethoven, Jean-Jack M.; Brisson, Jennifer A.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Riethoven, Jean-Jack M.] Univ Nebraska, Bioinformat Core Res Facil, Lincoln, NE USA; [Schilder, Rudolf J.] Penn State Univ, Dept Biol, State Coll, PA USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Brisson, JA (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	jennifer.brisson@gmail.com	/M-7215-2019	Riethoven, Jean-Jack/0000-0002-2709-7880; Brisson, Jennifer/0000-0001-7000-0709; Nanoth Vellichirammal, Neetha/0000-0002-5740-7093	School of Biological Sciences, UNL; NSF [IOS-1121960]; Nebraska Research Initiative	School of Biological Sciences, UNL; NSF(National Science Foundation (NSF)); Nebraska Research Initiative	Financial support for this study was provided by start up funds to JAB from the School of Biological Sciences, UNL, and NSF grant IOS-1121960 to AJZ. Part of the bioinformatics analysis was performed by the Bioinformatics research core facility in the UNL Center for Biotechnology and was partially supported by funding from the Nebraska Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Badisco L, 2008, J MOL ENDOCRINOL, V40, P137, DOI 10.1677/JME-07-0161; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brisson JA, 2007, EVOL DEV, V9, P338, DOI 10.1111/j.1525-142X.2007.00170.x; Chen X, 2012, INSECT BIOCHEM MOLEC, V42, P665, DOI 10.1016/j.ibmb.2012.05.004; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Crnokrak P, 2002, J EVOLUTION BIOL, V15, P388, DOI 10.1046/j.1420-9101.2002.00401.x; EDWARDS GA, 1955, Q J MICROSC SCI, V96, P151; Fitzhugh GH, 1997, J EXP BIOL, V200, P1473; FYRBERG C, 1994, BIOCHEM GENET, V32, P119, DOI 10.1007/BF00554420; Ghanim M, 2006, INSECT BIOCHEM MOLEC, V36, P857, DOI 10.1016/j.ibmb.2006.08.007; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guerra PA, 2011, BIOL REV, V86, P813, DOI 10.1111/j.1469-185X.2010.00172.x; Hardie J., 1985, COMPREHENSIVE INSECT, V8, P441; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Herranz R, 2004, GENE EXPR PATTERNS, V4, P183, DOI 10.1016/j.modgep.2003.09.008; Jiang CJ, 2012, EUR J ENTOMOL, V109, P579, DOI 10.14411/eje.2012.072; Kawasaki K, 1996, INSECT BIOCHEM MOLEC, V26, P355, DOI 10.1016/0965-1748(95)00101-8; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maxova A, 2001, EUR J ENTOMOL, V98, P433, DOI 10.14411/eje.2001.063; Maxwell RA, 2002, J BIOL CHEM, V277, P21874, DOI 10.1074/jbc.M201510200; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; ROFF DA, 1986, EVOLUTION, V40, P1009, DOI 10.1111/j.1558-5646.1986.tb00568.x; Roff DA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P358, DOI 10.1086/518012; Schilder RJ, 2011, MOL BIOL EVOL, V28, P3381, DOI 10.1093/molbev/msr171; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang YD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003102; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wilson R, 1999, J IMMUNOL, V162, P1590; Zera A. J., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P609; Zera AJ, 2005, INTEGR COMP BIOL, V45, P511, DOI 10.1093/icb/45.3.511; Zera AJ, 1999, J INSECT PHYSIOL, V45, P275, DOI 10.1016/S0022-1910(98)00123-1; Zera AJ, 1997, PHYSIOL ZOOL, V70, P519, DOI 10.1086/515865; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zera AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P255, DOI 10.1086/383500; Zera AJ, 2003, J INSECT PHYSIOL, V49, P933, DOI 10.1016/S0022-1910(03)00152-5; Zera AJ, 2003, EVOLUTION, V57, P586, DOI 10.1111/j.0014-3820.2003.tb01550.x; Zera AJ, 2001, J INSECT PHYSIOL, V47, P1147, DOI 10.1016/S0022-1910(01)00096-8; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zera AJ, 2006, AM NAT, V167, P889, DOI 10.1086/503578; Zera AJ, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P311; Zera AJ, 2009, EXPERIMENTAL EVOLUTION: CONCEPTS, METHODS, AND APPLICATIONS OF SELECTION EXPERIMENTS, P217; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao ZW, 2004, J INSECT PHYSIOL, V50, P965, DOI 10.1016/j.jinsphys.2004.07.008; Zhao ZW, 2004, J INSECT PHYSIOL, V50, P93, DOI 10.1016/j.jinsphys.2003.10.003; Zhao ZW, 2002, P NATL ACAD SCI USA, V99, P16829, DOI 10.1073/pnas.262533999	58	29	29	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82129	10.1371/journal.pone.0082129	http://dx.doi.org/10.1371/journal.pone.0082129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416137	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500012
J	Zhao, CH; Bu, XM; Wang, W; Ma, TX; Ma, HY				Zhao, Chenghai; Bu, Xianmin; Wang, Wei; Ma, Tingxian; Ma, Haiying			GEC-derived SFRP5 Inhibits Wnt5a-Induced Macrophage Chemotaxis and Activation	PLOS ONE			English	Article							CANCER-RELATED INFLAMMATION; GASTRIC EPITHELIAL-CELLS; HELICOBACTER-PYLORI; INDUCED INVASION; EXPRESSION; CHEMOATTRACTANT; WNT5A; CYCLOOXYGENASE-2; MIGRATION; ANGIOGENESIS	Aberrant macrophage infiltration and activation has been implicated in gastric inflammation and carcinogenesis. Overexpression of Wnt5a and downregulation of SFRP5, a Wnt5a antagonist, were both observed in gastric cancers recently. This study attempted to explore whether Wnt5a/SFRP5 axis was involved in macrophage chemotaxis and activation. It was found that both Wnt5a transfection and recombinant Wnt5a (rWnt5a) treatment upregulated CCL2 expression in macrophages, involving JNK and NF kappa B signals. Conditioned medium from Wnt5a-treated macrophages promoted macrophage chemotaxis mainly dependent on CCL2. SFRP5 from gastric epithelial cells (GECs) inhibited Wnt5a-induced CCL2 expression and macrophage chemotaxis. In addition, Wnt5a treatment stimulated macrophages to produce inflammatory cytokines and COX-2/PGE2, which was also suppressed by SFRP5 from GECs. These results demonstrate that Wnt5a induces macrophage chemotaxis and activation, which can be blocked by GEC-derived SFRP5, suggesting that Wnt5a overproduction and SFRP5 deficiency in gastric mucosa may together play an important role in gastric inflammation and carcinogenesis.	[Zhao, Chenghai; Wang, Wei; Ma, Tingxian; Ma, Haiying] China Med Univ, Dept Pathophysiol, Coll Basic Med Sci, Shenyang, Peoples R China; [Bu, Xianmin] China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Peoples R China	China Medical University; China Medical University	Zhao, CH (corresponding author), China Med Univ, Dept Pathophysiol, Coll Basic Med Sci, Shenyang, Peoples R China.	zhaochenghai1@sina.com			National Natural Science Foundation of China [81370517]; Division of Science and Technology, Liaoning Province, China [20092125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division of Science and Technology, Liaoning Province, China	This work was supported by a grant from National Natural Science Foundation of China (81370517) and a grant from Division of Science and Technology, Liaoning Province, China (20092125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Chang YJ, 2005, J IMMUNOL, V175, P8242, DOI 10.4049/jimmunol.175.12.8242; Chung HY, 2007, ANN NY ACAD SCI, V1095, P220, DOI 10.1196/annals.1397.026; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Futagami S, 2003, GUT, V52, P1257, DOI 10.1136/gut.52.9.1257; Isomoto H, 2004, AM J GASTROENTEROL, V99, P1063, DOI 10.1111/j.1572-0241.2004.30847.x; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Kuroda T, 2005, CLIN CANCER RES, V11, P7629, DOI 10.1158/1078-0432.CCR-05-0798; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Nanbara H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034434; Oshima H, 2011, GASTROENTEROLOGY, V140, P596, DOI 10.1053/j.gastro.2010.11.007; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; REINECKER HC, 1995, GASTROENTEROLOGY, V108, P40, DOI 10.1016/0016-5085(95)90006-3; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Ristimaki A, 1997, CANCER RES, V57, P1276; Saukkonen K, 2001, CLIN CANCER RES, V7, P1923; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Seo JH, 2004, LAB INVEST, V84, P49, DOI 10.1038/labinvest.3700010; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Thiel A, 2011, CANCER METAST REV, V30, P387, DOI 10.1007/s10555-011-9312-1; THUN MJ, 1993, CANCER RES, V53, P1322; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Zhao CH, 2013, CARCINOGENESIS, V34, P146, DOI 10.1093/carcin/bgs309; Zhao CH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-419; Zhao CH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-224	30	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85058	10.1371/journal.pone.0085058	http://dx.doi.org/10.1371/journal.pone.0085058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416340	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500210
J	Zhou, PL; Ren, JZ; Han, XW; Wu, G; Zhang, WG; Ding, PX; Bi, YH				Zhou, Pengli; Ren, Jianzhuang; Han, Xinwei; Wu, Gang; Zhang, Wenguang; Ding, Pengxu; Bi, Yonghua			Initial Imaging Analysis of Budd-Chiari Syndrome in Henan Province of China: Most Cases Have Combined Inferior Vena Cava and Hepatic Veins Involvement	PLOS ONE			English	Article							CLINICAL-FEATURES; SURGICAL ANATOMY; SONOGRAPHY; MANAGEMENT; THROMBOSIS; SPECTRUM	Aim: To evaluate the type of venous involvement in Chinese Budd-Chiari syndrome (BCS) patients and the relative diagnostic accuracy of the different imaging modalities. Methods: Using digital subtraction angiography (DSA) as a reference standard, color Doppler ultrasound (CDUS), computed tomography angiography (CTA), and magnetic resonance angiography (MRA) were performed on 338 patients with BCS. We analyzed the course of the main and any accessory hepatic veins (HVs) and the inferior vena cava (IVC) to assess the etiology of obstructed segments and diagnostic accuracy of CDUS, CTA and MRA. Results: Among the 338 cases, there were 8 cases (2.4%) of isolated IVC membranous obstruction, 45 cases (13.3%) of isolated HV occlusion, and 285 cases (84.3%) with both IVC membranous obstruction and HV occlusion. Comparing with DSA, CDUS, CTA had a diagnostic accuracy of 89.3% and 80.2% in detecting BCS, and 83.4% of cases correctly correlated by MRA. Conclusion: In Henan Province, most patients with BCS have complex lesions combining IVC and HV involvement. The combination of CDUS and CTA or MRI is useful for diagnosis of BCS and guiding therapy.	[Zhou, Pengli; Ren, Jianzhuang; Han, Xinwei; Wu, Gang; Zhang, Wenguang; Ding, Pengxu; Bi, Yonghua] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou 450052, Henan Province, Peoples R China	Zhengzhou University	Han, XW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou 450052, Henan Province, Peoples R China.	hanxinwei2006@163.com	han, wei/ABG-2691-2021					Bargallo X, 2003, AM J ROENTGENOL, V181, P1641, DOI 10.2214/ajr.181.6.1811641; BOLONDI L, 1991, GASTROENTEROLOGY, V100, P1324; Buckley O, 2007, EUR RADIOL, V17, P2071, DOI 10.1007/s00330-006-0537-2; Chawla Y, 1999, J GASTROEN HEPATOL, V14, P904, DOI 10.1046/j.1440-1746.1999.01969.x; Cheng DL, 2013, J GASTROEN HEPATOL, V28, P1061, DOI 10.1111/jgh.12140; Deltenre P, 2001, GUT, V48, P264, DOI 10.1136/gut.48.2.264; Eapen CE, 2006, GUT, V55, P878, DOI 10.1136/gut.2005.071423; ELIAS H, 1952, AM J ANAT, V90, P59, DOI 10.1002/aja.1000900104; Erden A, 2007, EUR J RADIOL, V61, P44, DOI 10.1016/j.ejrad.2006.11.004; GOLDSMITH NA, 1957, SURG GYNECOL OBSTET, V105, P310; Janssen HLA, 2003, J HEPATOL, V38, P364, DOI 10.1016/S0168-8278(02)00434-8; Janssen HLA, 2000, BLOOD, V96, P2364; Kamath PS, 2006, LIVER TRANSPLANT, V12, pS21, DOI 10.1002/lt.20939; Khuroo MS, 2005, J GASTROEN HEPATOL, V20, P1494, DOI 10.1111/j.1440-1746.2005.03878.x; KIMURA C, 1964, Jpn Circ J, V28, P181; Maetani Y, 2002, AM J ROENTGENOL, V178, P869, DOI 10.2214/ajr.178.4.1780869; Mahmoud AEA, 1996, QJM-MON J ASSOC PHYS, V89, P37, DOI 10.1093/oxfordjournals.qjmed.a030135; Meng WCS, 2003, ANZ J SURG, V73, P407, DOI 10.1046/j.1445-2197.2003.t01-1-02633.x; MILLER WJ, 1993, ABDOM IMAGING, V18, P329, DOI 10.1007/BF00201775; Mukund A, 2011, WORLD J RADIOL, V3, P169, DOI 10.4329/wjr.v3.i7.169; Murad SD, 2004, HEPATOLOGY, V39, P500, DOI 10.1002/hep.20064; NAKAMURA S, 1981, SURG GYNECOL OBSTET, V152, P43; Noone TC, 2000, JMRI-J MAGN RESON IM, V11, P44, DOI 10.1002/(SICI)1522-2586(200001)11:1<44::AID-JMRI6>3.3.CO;2-F; OKUDA H, 1995, J HEPATOL, V22, P1, DOI 10.1016/0168-8278(95)80252-5; Okuda Kunio, 2002, Hepatobiliary Pancreat Dis Int, V1, P499; Pemmaraju Naveen, 2012, J Med Case Rep, V6, P102, DOI 10.1186/1752-1947-6-102; Plessier A, 2008, SEMIN LIVER DIS, V28, P259, DOI 10.1055/s-0028-1085094; Plessier A, 2012, J HEPATOL, V56, pS25, DOI 10.1016/S0168-8278(12)60004-X; Qiao T, 2005, SWISS MED WKLY, V135, P318; Rav-Acha M, 2004, Harefuah, V143, P372; Rav-Acha M, 2004, HAREFUAH, V143, P389; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Sato Toshio J, 2002, J Hepatobiliary Pancreat Surg, V9, P55, DOI 10.1007/s005340200005; Singh V, 2000, J GASTROEN HEPATOL, V15, P550, DOI 10.1046/j.1440-1746.2000.02157.x; Smalberg JH, 2012, BLOOD, V120, P4921, DOI 10.1182/blood-2011-09-376517; Valla D, 1997, HEPATOLOGY, V25, P814, DOI 10.1002/hep.510250405; Wang ZG, 2005, ANZ J SURG, V75, P55, DOI 10.1111/j.1445-2197.2005.03135.x; Xue H, 2010, DIGEST DIS SCI, V55, P2659, DOI 10.1007/s10620-009-1087-7; YANAGA K, 1994, SURGERY, V115, P757	39	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85135	10.1371/journal.pone.0085135	http://dx.doi.org/10.1371/journal.pone.0085135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416352	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500220
J	Ravachol, J; Borne, R; Tardif, C; de Philip, P; Fierobe, HP				Ravachol, Julie; Borne, Romain; Tardif, Chantal; de Philip, Pascale; Fierobe, Henri-Pierre			Characterization of All Family-9 Glycoside Hydrolases Synthesized by the Cellulosome-producing Bacterium Clostridium cellulolyticum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Cellulase; Enzyme Kinetics; Enzymes; Protein Complexes; GH9; Cellulose; Cellulosome; Clostridium cellulolyticum; Synergy	SUBSTRATE-SPECIFICITY; ENDOGLUCANASE; THERMOCELLUM; ENZYME; CELLULASE; MODULES; PURIFICATION; MECHANISM; CHIMERAS; GENOME	Background: Family-9 glycoside hydrolases displaying various organizations are plethoric in cellulosome-producing bacteria. Results: The 13 family-9 enzymes synthesized by Clostridium cellulolyticum exhibit different substrate specificities, activities, and relationships with key cellulosomal cellulases in artificial cellulosomes. Conclusion: This variety is required for efficient degradation of crystalline cellulose. Significance: This first global picture provides insights on the multiplicity and diversity of family-9 enzymes in bacterial cellulosomes. The genome of Clostridium cellulolyticum encodes 13 GH9 enzymes that display seven distinct domain organizations. All but one contain a dockerin module and were formerly detected in the cellulosomes, but only three of them were previously studied (Cel9E, Cel9G, and Cel9M). In this study, the 10 uncharacterized GH9 enzymes were overproduced in Escherichia coli and purified, and their activity pattern was investigated in the free state or in cellulosome chimeras with key cellulosomal cellulases. The newly purified GH9 enzymes, including those that share similar organization, all exhibited distinct activity patterns, various binding capacities on cellulosic substrates, and different synergies with pivotal cellulases in mini-cellulosomes. Furthermore, one enzyme (Cel9X) was characterized as the first genuine endoxyloglucanase belonging to this family, with no activity on soluble and insoluble celluloses. Another GH9 enzyme (Cel9V), whose sequence is 78% identical to the cellulosomal cellulase Cel9E, was found inactive in the free and complexed states on all tested substrates. The sole noncellulosomal GH9 (Cel9W) is a cellulase displaying a broad substrate specificity, whose engineered form bearing a dockerin can act synergistically in minicomplexes. Finally, incorporation of all GH9 cellulases in trivalent cellulosome chimera containing Cel48F and Cel9G generated a mixture of heterogeneous mini-cellulosomes that exhibit more activity on crystalline cellulose than the best homogeneous tri-functional complex. Altogether, our data emphasize the importance of GH9 diversity in bacterial cellulosomes, confirm that Cel9G is the most synergistic GH9 with the major endoprocessive cellulase Cel48F, but also identify Cel9U as an important cellulosomal component during cellulose depolymerization.	[Ravachol, Julie; Borne, Romain; Tardif, Chantal; de Philip, Pascale; Fierobe, Henri-Pierre] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, Chim Bacterienne Lab,UMR7283, Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Fierobe, HP (corresponding author), CNRS, Inst Microbiol Mediterranee, Chim Bacterienne Lab, UMR7283, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	hpfierob@imm.cnrs.fr	FIEROBE, Henri-Pierre/P-4372-2019; Borne, Romain/AAC-6453-2019	de philip, pascale/0000-0002-9586-7680	Ministere de l'Enseignement Superieur et de la Recherche	Ministere de l'Enseignement Superieur et de la Recherche	This work was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche (to J. R.).	Abdou L, 2008, J BACTERIOL, V190, P1499, DOI 10.1128/JB.01160-07; Arai T, 2003, J BACTERIOL, V185, P504, DOI 10.1128/JB.185.2.504-512.2003; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Belaich A, 2002, J BACTERIOL, V184, P1378, DOI 10.1128/JB.184.5.1378-1384.2002; Blouzard JC, 2007, J BACTERIOL, V189, P2300, DOI 10.1128/JB.00917-06; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Borne R, 2013, FEBS J, V280, P5764, DOI 10.1111/febs.12497; Burstein T, 2009, FEBS LETT, V583, P879, DOI 10.1016/j.febslet.2009.02.013; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Celik H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056063; Eckert K, 2002, APPL MICROBIOL BIOT, V60, P428, DOI 10.1007/s00253-002-1131-4; Eckert K, 2009, J MOL BIOL, V394, P61, DOI 10.1016/j.jmb.2009.08.060; Eklof JM, 2012, METHOD ENZYMOL, V510, P97, DOI 10.1016/B978-0-12-415931-0.00006-9; Feinberg L, 2011, J BACTERIOL, V193, P2906, DOI 10.1128/JB.00322-11; Fendri I, 2009, FEBS J, V276, P3076, DOI 10.1111/j.1742-4658.2009.07025.x; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; FIEROBE HP, 1993, EUR J BIOCHEM, V217, P557, DOI 10.1111/j.1432-1033.1993.tb18277.x; FIEROBE HP, 1991, J BACTERIOL, V173, P7956, DOI 10.1128/jb.173.24.7956-7962.1991; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gal L, 1997, APPL ENVIRON MICROB, V63, P903, DOI 10.1128/AEM.63.3.903-909.1997; Gal L, 1997, J BACTERIOL, V179, P6595, DOI 10.1128/jb.179.21.6595-6601.1997; Gaudin C, 2000, J BACTERIOL, V182, P1910, DOI 10.1128/JB.182.7.1910-1915.2000; HENRISSAT B, 1989, GENE, V81, P83, DOI 10.1016/0378-1119(89)90339-9; Hirano N, 2013, FEMS MICROBIOL LETT, V344, P25, DOI 10.1111/1574-6968.12149; Honda Y, 2011, GLYCOBIOLOGY, V21, P503, DOI 10.1093/glycob/cwq191; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Jindou S, 2006, FEMS MICROBIOL LETT, V254, P308, DOI 10.1111/j.1574-6968.2005.00040.x; Kataeva IA, 2004, PROTEIN ENG DES SEL, V17, P759, DOI 10.1093/protein/gzh094; Mandelman D, 2003, J BACTERIOL, V185, P4127, DOI 10.1128/JB.185.14.4127-4135.2003; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; PARK JT, 1949, J BIOL CHEM, V181, P149; Pereira JH, 2009, ACTA CRYSTALLOGR D, V65, P744, DOI 10.1107/S0907444909012773; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; Sakka K, 2009, FEMS MICROBIOL LETT, V300, P249, DOI 10.1111/j.1574-6968.2009.01788.x; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Schubot FD, 2004, BIOCHEMISTRY-US, V43, P1163, DOI 10.1021/bi030202i; Tamaru Y, 2011, MICROB BIOTECHNOL, V4, P64, DOI 10.1111/j.1751-7915.2010.00210.x; Warner CD, 2011, ENZYME MICROB TECH, V48, P27, DOI 10.1016/j.enzmictec.2010.08.009; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Yaniv Oren, 2012, Methods Mol Biol, V908, P101, DOI 10.1007/978-1-61779-956-3_10; Zhang XZ, 2010, BIORESOURCE TECHNOL, V101, P5534, DOI 10.1016/j.biortech.2010.01.152; Zverlov VV, 2005, MICROBIOL-SGM, V151, P3395, DOI 10.1099/mic.0.28206-0	44	58	58	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7335	7348		10.1074/jbc.M113.545046	http://dx.doi.org/10.1074/jbc.M113.545046			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24451379	Green Published, hybrid			2022-12-25	WOS:000332761500007
J	Boughattas, S; Ayari, K; Sa, TM; Aoun, K; Bouratbine, A				Boughattas, Sonia; Ayari, Khaled; Sa, Tongmin; Aoun, Karim; Bouratbine, Aida			Survey of the Parasite Toxoplasma gondii in Human Consumed Ovine Meat in Tunis City	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; HUMAN CONSUMPTION; SHEEP; PREVALENCE; INFECTION; SEROPREVALENCE; STRAINS; ANTIBODIES; ANIMALS; TISSUES	Toxoplasmosis has been recognized as parasitic zoonosis with the highest human incidence. The human infection by the parasite can lead to severe clinical manifestations in congenital toxoplasmosis and immunocompromised patients. Contamination occurs mainly by foodborne ways especially consumption of raw or undercooked meat. In contrast to other foodborne infections, toxoplasmosis is a chronic infection which would make its economic and social impact much higher than even previously anticipated. Ovine meat was advanced as a major risk factor, so we investigated its parasite survey, under natural conditions. Serological MAT technique and touchdown PCR approaches were used for prevalence determination of the parasite in slaughtered sheep intended to human consumption in Tunis City. The genotyping was carried by SNPs analysis of SAG3 marker. Anti-Toxoplasma antibodies were present in 38.2% of young sheep and in 73.6% of adult sheep. Molecular detection revealed the contamination of 50% of ewes' tissue. Sequencing and SNPs analysis enabled unambiguous typing of meat isolates and revealed the presence of mixed strains as those previously identified from clinical samples in the same area. Our findings conclude that slaughtered sheep are highly infected, suggesting them as a major risk factor of Toxoplasma gondii transmission by meat consumption. Special aware should target consequently this factor when recommendations have to be established by the health care commanders.	[Boughattas, Sonia; Sa, Tongmin] Chungbuk Natl Univ, Coll Agr Life & Environm Sci, Dept Environm & Biol Chem, Cheongju, Chungbuk, South Korea; [Boughattas, Sonia; Ayari, Khaled; Aoun, Karim; Bouratbine, Aida] Inst Pasteur Tunis, Parasitol Lab, Tunis, Tunisia	Chungbuk National University; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis	Bouratbine, A (corresponding author), Inst Pasteur Tunis, Parasitol Lab, Tunis, Tunisia.	aida.bouratbine@pasteur.rns.tn		Boughattas, Sonia/0000-0001-7216-7852	Ministry of Higher Education Research and Technology in Tunisia	Ministry of Higher Education Research and Technology in Tunisia	This study was supported by the Ministry of Higher Education Research and Technology in Tunisia and carried out within the framework of the Research Lab "Parasitoses emergentes" LR 05SP03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Samra N, 2007, J S AFR VET ASSOC, V78, P116; Alvarado-Esquivel C, 2012, J PARASITOL, V98, P271, DOI 10.1645/GE-2958.1; Andreoletti O., 2007, EFSA J, V583, P1; Bastiaensen P., 1999, Tropicultura, V16/17, P18; BEKELE T, 1989, VET RES COMMUN, V13, P371, DOI 10.1007/BF00346069; Ben Rachid M S, 1970, Tunis Med, V48, P101; Berger F., 2007, TOXOPLASMOSE FRANCE; Berger-Schoch AE, 2011, ZOONOSES PUBLIC HLTH, V58, P472, DOI 10.1111/j.1863-2378.2011.01395.x; Boughattas S, 2011, TROP BIOMED, V28, P615; Boughattas S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-218; Boughattas S, 2010, AM J TROP MED HYG, V82, P1041, DOI 10.4269/ajtmh.2010.09-0691; Cenci-Goga BT, 2011, FOODBORNE PATHOG DIS, V8, P751, DOI 10.1089/fpd.2010.0795; Chabbert E, 2004, J CLIN MICROBIOL, V42, P1719, DOI 10.1128/JCM.42.4.1719-1722.2004; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; Dumetre A, 2006, VET PARASITOL, V142, P376, DOI 10.1016/j.vetpar.2006.07.005; Fakhfakh Najla, 2013, Tunis Med, V91, P188; Gajadhar AA, 2006, REV SCI TECH OIE, V25, P595, DOI 10.20506/rst.25.2.1679; Gharbi M, 2013, Bull Soc Pathol Exot, V106, P184, DOI 10.1007/s13149-013-0290-4; Glor SB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-85; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Halos L, 2010, INT J PARASITOL, V40, P193, DOI 10.1016/j.ijpara.2009.06.009; Hecker YP, 2013, TROP ANIM HLTH PROD; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kamani J, 2010, TROP ANIM HEALTH PRO, V42, P793, DOI 10.1007/s11250-009-9488-3; Khan A, 2005, J CLIN MICROBIOL, V43, P5881, DOI 10.1128/JCM.43.12.5881-5887.2005; Lindstrom I, 2008, PARASITOLOGY, V135, P39, DOI 10.1017/S0031182007003654; Oncel Taraneh, 2005, Turkiye Parazitoloji Dergisi, V29, P10; Opsteegh M, 2010, INT J FOOD MICROBIOL, V139, P193, DOI 10.1016/j.ijfoodmicro.2010.02.027; Preacher KJ, 2001, CALCULATION CHI SQUA; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Sawadogo P, 2005, VET PARASITOL, V130, P89, DOI 10.1016/j.vetpar.2005.03.025; Shaapan RM, 2008, VET PARASITOL, V153, P359, DOI 10.1016/j.vetpar.2008.02.016; Tenter AM, 2009, MEM I OSWALDO CRUZ, V104, P364, DOI 10.1590/S0074-02762009000200033; van der Puije WNA, 2000, ACTA TROP, V76, P21, DOI 10.1016/S0001-706X(00)00084-X; Villena I, 2012, VET PARASITOL, V183, P203, DOI 10.1016/j.vetpar.2011.08.001; WALDELAND H, 1976, ACTA VET SCAND, V17, P432	36	40	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85044	10.1371/journal.pone.0085044	http://dx.doi.org/10.1371/journal.pone.0085044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427300	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200040
J	Hosiner, D; Gerber, S; Lichtenberg-Frate, H; Glaser, W; Schuller, C; Klipp, E				Hosiner, Dagmar; Gerber, Susanne; Lichtenberg-Frate, Hella; Glaser, Walter; Schueller, Christoph; Klipp, Edda			Impact of Acute Metal Stress in Saccharomyces cerevisiae	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; GENE-EXPRESSION; TOXIC METALS; IN-VIVO; CADMIUM; TOLERANCE; ZINC; MICROARRAY; NICKEL; TRANSPORT	Although considered as essential cofactors for a variety of enzymatic reactions and for important structural and functional roles in cell metabolism, metals at high concentrations are potent toxic pollutants and pose complex biochemical problems for cells. We report results of single dose acute toxicity testing in the model organism S. cerevisiae. The effects of moderate toxic concentrations of 10 different human health relevant metals, Ag+, Al3+, As3+, Cd2+, Co2+, Hg2+, Mn2+, Ni2+, V3+, and Zn2+, following short-term exposure were analyzed by transcription profiling to provide the identification of early-on target genes or pathways. In contrast to common acute toxicity tests where defined endpoints are monitored we focused on the entire genomic response. We provide evidence that the induction of central elements of the oxidative stress response by the majority of investigated metals is the basic detoxification process against short-term metal exposure. General detoxification mechanisms also comprised the induction of genes coding for chaperones and those for chelation of metal ions via siderophores and amino acids. Hierarchical clustering, transcription factor analyses, and gene ontology data further revealed activation of genes involved in metal-specific protein catabolism along with repression of growth-related processes such as protein synthesis. Metal ion group specific differences in the expression responses with shared transcriptional regulators for both, up-regulation and repression were also observed. Additionally, some processes unique for individual metals were evident as well. In view of current concerns regarding environmental pollution our results may support ongoing attempts to develop methods to monitor potentially hazardous areas or liquids and to establish standardized tests using suitable eukaryotic a model organism.	[Hosiner, Dagmar; Schueller, Christoph] Univ Nat Resources & Life Sci BOKU, Dept Appl Genet & Cell Biol, Vienna, Austria; [Gerber, Susanne] Univ Svizzera Italiana, Fac Informat, Inst Computat Sci, AG Computat Time Series Anal, Lugano, Switzerland; [Gerber, Susanne; Klipp, Edda] Theoret Biophys Humboldt Univ Berlin, Berlin, Germany; [Lichtenberg-Frate, Hella] Univ Bonn, IZMB, AG Mol Bioenerget, Bonn, Germany; [Glaser, Walter] Med Univ Vienna, Inst Med Biochem, MFPL, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Universita della Svizzera Italiana; University of Bonn; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Klipp, E (corresponding author), Theoret Biophys Humboldt Univ Berlin, Berlin, Germany.	edda.klipp@rz.hu-berlin.de	Gerber, Susanne/I-6352-2018	Gerber, Susanne/0000-0001-9513-0729; Schuller, Christoph/0000-0002-1649-1217	German Ministry for Education and Research (BMBF) [FKZ 0315786A,B]; Swiss HP2C-initiative "Swiss Platform for High-Performance and High-Productivity Computing"; European Commission [201142]; Austrian science fund FWF [P23355]; Austrian Science Fund (FWF) [P 23355] Funding Source: researchfish	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Swiss HP2C-initiative "Swiss Platform for High-Performance and High-Productivity Computing"; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian science fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the German Ministry for Education and Research (BMBF grant for the SysMO project Translucent2, FKZ 0315786A,B to EK and HLF), by the Swiss HP2C-initiative "Swiss Platform for High-Performance and High-Productivity Computing", the European Commission 7th Framework Programme: UNICELLSYS (Contract No. 201142, to EK) and the Austrian science fund FWF grant P23355 (to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas-Terki T, 2001, MOL CELL BIOL, V21, P7569, DOI 10.1128/MCB.21.22.7569-7575.2001; Akache B, 2002, J BIOL CHEM, V277, P21254, DOI 10.1074/jbc.M202566200; Ballatori N, 2002, ENVIRON HEALTH PERSP, V110, P689, DOI 10.1289/ehp.02110s5689; Belcastro M, 2005, J MASS SPECTROM, V40, P300, DOI 10.1002/jms.755; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Boeke J.D., 1991, MOL CELLULAR BIOL YE, V1, P193; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Bozhkov A, 2010, INDIAN J EXP BIOL, V48, P679; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Cao YR, 2012, WORLD J MICROB BIOT, V28, P1727, DOI 10.1007/s11274-011-0983-0; Chen CY, 2003, ARCH TOXICOL, V77, P123, DOI 10.1007/s00204-002-0427-6; Chen F, 2002, CRIT REV ONCOL HEMAT, V42, P105, DOI 10.1016/S1040-8428(01)00211-6; Chen HB, 2005, TOXICOL APPL PHARM, V206, P275, DOI 10.1016/j.taap.2004.11.011; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Dandrea T, 2004, FREE RADICAL BIO MED, V36, P881, DOI 10.1016/j.freeradbiomed.2003.12.014; Dormer UH, 2000, J BIOL CHEM, V275, P32611, DOI 10.1074/jbc.M004167200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Ezaki B, 2005, J EXP BOT, V56, P2661, DOI 10.1093/jxb/eri259; Farcasanu IC, 2005, BIOSCI BIOTECH BIOCH, V69, P2343, DOI 10.1271/bbb.69.2343; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hassinen VH, 2011, PLANT BIOLOGY, V13, P225, DOI 10.1111/j.1438-8677.2010.00398.x; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hosiner D, 2009, MOL BIOL CELL, V20, P1048, DOI 10.1091/mbc.E08-04-0438; Jin YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000053; Khanna S, 2011, TOXICOLOGY, V287, P46, DOI 10.1016/j.tox.2011.05.013; Kim S, 1998, P NATL ACAD SCI USA, V95, P12860, DOI 10.1073/pnas.95.22.12860; Larochelle M, 2006, MOL CELL BIOL, V26, P6690, DOI 10.1128/MCB.02450-05; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; MCLACHLAN GJ, 2004, ANAL MICROARRAY GENE; Momose Y, 2001, ENVIRON TOXICOL CHEM, V20, P2353; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Niazi JH, 2011, APPL BIOCHEM BIOTECH, V164, P1278, DOI 10.1007/s12010-011-9212-4; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Pagani MA, 2007, MOL MICROBIOL, V65, P521, DOI 10.1111/j.1365-2958.2007.05807.x; Pearce DA, 1999, J BACTERIOL, V181, P4774, DOI 10.1128/JB.181.16.4774-4779.1999; Porwol T, 1998, EUR J BIOCHEM, V256, P16, DOI 10.1046/j.1432-1327.1998.2560016.x; Qiu JW, 2005, ARCH ENVIRON CON TOX, V48, P278, DOI 10.1007/s00244-004-0001-8; Rainbow PS, 2005, AQUAT TOXICOL, V72, P45, DOI 10.1016/j.aquatox.2004.11.016; Ralph DM, 2010, FREE RADICAL BIO MED, V49, P649, DOI 10.1016/j.freeradbiomed.2010.05.023; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Richards KD, 1998, PLANT PHYSIOL, V116, P409, DOI 10.1104/pp.116.1.409; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rosen BP, 2002, COMP BIOCHEM PHYS A, V133, P689, DOI 10.1016/S1095-6433(02)00201-5; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saponja JA, 1996, J INORG BIOCHEM, V62, P253, DOI 10.1016/0162-0134(95)00159-X; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth GK., 2005, LIMMA LINEAR MODELS; Stadler JA, 2002, J BIOL CHEM, V277, P39649, DOI 10.1074/jbc.M203924200; Stohs S J, 1995, J Basic Clin Physiol Pharmacol, V6, P205; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Tamas MJ, 2001, CURR GENET, V40, P2, DOI 10.1007/s002940100234; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Thorsen M, 2007, PHYSIOL GENOMICS, V30, P35, DOI 10.1152/physiolgenomics.00236.2006; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Ward RJ, 2001, J INORG BIOCHEM, V87, P9, DOI 10.1016/S0162-0134(01)00308-7; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x	79	59	60	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83330	10.1371/journal.pone.0083330	http://dx.doi.org/10.1371/journal.pone.0083330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416162	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300013
J	Huang, SF; Xie, Y; Yang, P; Chen, P; Zhang, LP				Huang, Shifeng; Xie, Yan; Yang, Ping; Chen, Pu; Zhang, Liping			HCV Core Protein-Induced Down-Regulation of microRNA-152 Promoted Aberrant Proliferation by Regulating Wnt1 in HepG2 Cells	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; UP-REGULATION; EXPRESSION; LIVER; HEPATOCARCINOGENESIS; CANCER; IDENTIFICATION; INFECTION; CIRCUIT	Background: Hepatitis C virus (HCV) has been reported to regulate cellular microRNAs (miRNAs). The HCV core protein is considered to be a potential oncoprotein in HCV-related hepatocellular carcinoma (HCV-HCC), but HCV core-regulated miRNAs are largely unknown. Our preliminary experiments revealed significant down-regulation of microRNA-152 (miR-152) by HCV core protein in HepG2 cells. Through target gene prediction softwares, Wnt1 was predicted to be a potential target of miR-152. The present study was initiated to investigate whether miR-152 is aberrantly regulated by the HCV core protein, and involved in the regulation of the aberrant proliferation of HCV-HCC cells. Methods: MiR-152 levels were examined by stem-loop real-time RT-PCR (SLqRT-PCR). Cell proliferation was analyzed by MTT and colony formation assay. Cell cycle analysis was performed by flow cytometry. Luciferase reporter assay was conducted to confirm miRNA-target association. Wnt1 expression was determined by real-time qPCR and Western blotting. Results: HCV core protein significantly suppressed miR-152 expression, and led to significant Wnt1 up-regulation with a concomitant aberrantly promoted proliferation. Moreover, we validated that miR-152 inhibition promoted, while miR-152 mimics inhibited cell proliferation. Using, qRT-PCR and western blot, Wnt1 was demonstrated to be regulated by miR-152. Luciferase activity assay showed that while miR-152 mimics significantly reduced the luciferase activity by 83.76% (P<0.0001), miR-152 inhibitor showed no effect on luciferase reporter. Most notably, salvage expression of miR-152 after Ad-HCV core infection for 24 h almost totally reversed the proliferation-promoting effect of the HCV core protein, and meanwhile, reduced the expression of both Wnt1 mRNA and protein to basal levels. Conclusion: These findings provide important evidence that the reduced miR-152 expression by HCV core protein can indirectly lose an inhibitory effect on Wnt1, which might, at least partially lead to cell proliferation of liver cancer cells. MiR-152 may have a therapeutic potential to suppress liver cancer proliferation.	[Huang, Shifeng; Xie, Yan; Yang, Ping; Chen, Pu; Zhang, Liping] Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University	Zhang, LP (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China.	liuzhangcq@yahoo.com		Huang, Shifeng/0000-0001-7641-8823	National Science Foundation of China [81071621, 30973378, 81101826, 81272545]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by combined grants from the National Science Foundation of China (No. 81071621, 30973378, 81101826 and 81272545; http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braconi C, 2010, CLIN CANCER RES, V16, P957, DOI 10.1158/1078-0432.CCR-09-2123; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Deng YB, 2010, CANCER SCI, V101, P1501, DOI 10.1111/j.1349-7006.2010.01549.x; Fukutomi T, 2005, HEPATOLOGY, V41, P1096, DOI 10.1002/hep.20668; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Lambert MP, 2011, J HEPATOL, V54, P705, DOI 10.1016/j.jhep.2010.07.027; Lee HH, 2009, CANCER EPIDEM BIOMAR, V18, P1562, DOI 10.1158/1055-9965.EPI-09-0039; Lee TH, 2006, J BIOMED SCI, V13, P27, DOI 10.1007/s11373-005-9030-1; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Peveling-Oberhag J, 2012, LEUKEMIA, V26, P1654, DOI 10.1038/leu.2012.29; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sun BK, 2008, J AM ACAD DERMATOL, V59, P725, DOI 10.1016/j.jaad.2008.08.017; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Vazquez-Del Mercado M, 2010, CLIN EXP RHEUMATOL, V28, P842; Xu Q, 2013, J MOL CELL BIOL, V5, P3, DOI 10.1093/jmcb/mjs049; Zeng B, 2012, FEBS LETT, V586, P3271, DOI 10.1016/j.febslet.2012.06.049; Zhang YL, 2012, HEPATOLOGY, V56, P1631, DOI 10.1002/hep.25849; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zhou X, 2012, ONCOL REP, V27, P447, DOI 10.3892/or.2011.1482	26	55	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e81730	10.1371/journal.pone.0081730	http://dx.doi.org/10.1371/journal.pone.0081730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416131	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300005
J	Li, WJ; Wang, L; Yang, YF				Li, Weijun; Wang, Lin; Yang, Yufang			Chinese Tone and Vowel Processing Exhibits Distinctive Temporal Characteristics: An Electrophysiological Perspective from Classical Chinese Poem Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ERP; COMPREHENSION; VIOLATIONS; MEMORY; WORDS; MODEL; P600	Classical Chinese poems have strict regulations on the acoustic pattern of each syllable and are semantically meaningless. Using such poems, this study characterized the temporal order of tone and vowel processing using event-related potentials (ERPs). The target syllable of the poem was either correct or deviated from the correct syllable at tone, vowel or both levels. Vowel violation elicited a negative effect between 300 and 500 ms regardless of the tone correctness, while tone violation elicited a positive effect between 600 and 1000 ms. The results suggest that the vowel information was available earlier than the tone information. Moreover, there was an interaction between the effect of vowel and tone violations between 600 and 1000 ms, showing that the vowel violation produced a positive effect only when the tone was correct. This indicates that vowel and tone processing interacts in the later processing stage, which involves both error detection and reanalysis of the spoken input. Implications of the present results for models of speech perception are discussed.	[Li, Weijun; Wang, Lin; Yang, Yufang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	wangl@psych.ac.cn; yangyf@psych.ac.cn		Wang, Lin/0000-0001-6911-0660	National Natural Science Foundation of China [31000505, 31070904, 31200849]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Numbers: 31000505, 31070904 and 31200849). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Brown-Schmidt S, 2004, J PSYCHOLINGUIST RES, V33, P103, DOI 10.1023/B:JOPR.0000017223.98667.10; Coch D, 2008, DEVELOPMENTAL SCI, V5, P467; Coch D, 2008, PSYCHOPHYSIOLOGY, V45, P949, DOI 10.1111/j.1469-8986.2008.00701.x; Coch D, 2008, BRAIN LANG, V104, P230, DOI 10.1016/j.bandl.2007.06.003; Cutler A, 1997, PERCEPT PSYCHOPHYS, V59, P165, DOI 10.3758/BF03211886; Duanmu S, 2003, PHONOLOGY STANDARD C, P219; Dumay N, 2001, J COGNITIVE NEUROSCI, V13, P121, DOI 10.1162/089892901564117; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friederici AD, 2002, J PSYCHOLINGUIST RES, V31, P45, DOI 10.1023/A:1014376204525; Friederici AD, 1996, J EXP PSYCHOL LEARN, V22, P1219, DOI 10.1037//0278-7393.22.5.1219; Gandour J, 2003, HUM BRAIN MAPP, V20, P185, DOI 10.1002/hbm.10137; Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526; Gandour J. T, 2006, ENCY LANGUAGE LINGUI, V12, P751, DOI DOI 10.1016/B0-08-044854-2/04796-9; Grossi G, 2001, J COGNITIVE NEUROSCI, V13, P610, DOI 10.1162/089892901750363190; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1531, DOI 10.1016/S0028-3932(00)00053-1; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Hu JH, 2012, PSYCHOPHYSIOLOGY, V49, P1179, DOI 10.1111/j.1469-8986.2012.01406.x; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Liu SY, 2007, LANG COGNITIVE PROC, V22, P566, DOI 10.1080/01690960600989600; Luck S., 2005, INTRO EVENT RELATED, P104; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Perrin F, 2003, COGNITIVE BRAIN RES, V17, P36, DOI 10.1016/S0926-6410(03)00078-8; PRAAMSTRA P, 1993, COGNITIVE BRAIN RES, V1, P73, DOI 10.1016/0926-6410(93)90013-U; Radeau M, 1998, BIOL PSYCHOL, V48, P183, DOI 10.1016/S0301-0511(98)00012-X; Repp B.H., 1990, J ACOUST SOC AM, V87, pS46, DOI [10.1121/1.2028239, DOI 10.1121/1.2028239]; RUGG MD, 1984, BRAIN LANG, V23, P225, DOI 10.1016/0093-934X(84)90065-8; RUGG MD, 1984, NEUROPSYCHOLOGIA, V22, P435, DOI 10.1016/0028-3932(84)90038-1; Schirmer A, 2005, J COGNITIVE NEUROSCI, V17, P1, DOI 10.1162/0898929052880057; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Taft M., 1992, LANGUAGE PROCESSING, P151, DOI DOI 10.1016/S0166-4115(08)61891-9; Tong YX, 2008, LANG COGNITIVE PROC, V23, P689, DOI 10.1080/01690960701728261; van den Brink D, 2001, J COGNITIVE NEUROSCI, V13, P967, DOI 10.1162/089892901753165872; Wagensveld B, 2012, BRAIN RES, V1483, P63, DOI 10.1016/j.brainres.2012.09.018; WANG L, 2005, CHINESE PROSODY; Xu Y, 1998, PHONETICA, V55, P179, DOI 10.1159/000028432; Yao DZ, 2007, COMPUT BIOL MED, V37, P1529, DOI 10.1016/j.compbiomed.2007.02.002; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Ye Y, 1999, LANG COGNITIVE PROC, V14, P609, DOI 10.1080/016909699386202	46	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85683	10.1371/journal.pone.0085683	http://dx.doi.org/10.1371/journal.pone.0085683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291XP	24416438	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300096
J	van Bilsen, M; Daniels, A; Brouwers, O; Janssen, BJA; Derks, WJA; Brouns, AE; Munts, C; Schalkwijk, CG; van der Vusse, GJ; van Nieuwenhoven, FA				van Bilsen, Marc; Daniels, Anneleen; Brouwers, Olaf; Janssen, Ben J. A.; Derks, Wouter J. A.; Brouns, Agnieszka E.; Munts, Chantal; Schalkwijk, Casper G.; van der Vusse, Ger J.; van Nieuwenhoven, Frans A.			Hypertension Is a Conditional Factor for the Development of Cardiac Hypertrophy in Type 2 Diabetic Mice	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; DIASTOLIC DYSFUNCTION; CONTRACTILE DYSFUNCTION; CARDIOVASCULAR-DISEASE; MYOCARDIAL FIBROSIS; INSULIN-RESISTANCE; METABOLIC SYNDROME; GROWTH-FACTOR; DB/DB MICE; CARDIOMYOPATHY	Background: Type 2 diabetes is frequently associated with co-morbidities, including hypertension. Here we investigated if hypertension is a critical factor in myocardial remodeling and the development of cardiac dysfunction in type 2 diabetic db/db mice. Methods: Thereto, 14-wks-old male db/db mice and non-diabetic db/+ mice received vehicle or angiotensin II (AngII) for 4 wks to induce mild hypertension (n = 9-10 per group). Left ventricular (LV) function was assessed by serial echocardiography and during a dobutamine stress test. LV tissue was subjected to molecular and (immuno) histochemical analysis to assess effects on hypertrophy, fibrosis and inflammation. Results: Vehicle-treated diabetic mice neither displayed marked myocardial structural remodeling nor cardiac dysfunction. AngII-treatment did not affect body weight and fasting glucose levels, and induced a comparable increase in blood pressure in diabetic and control mice. Nonetheless, AngII-induced LV hypertrophy was significantly more pronounced in diabetic than in control mice as assessed by LV mass (increase +51% and +34%, respectively, p<0.01) and cardiomyocyte size (+53% and +31%, p<0.001). This was associated with enhanced LV mRNA expression of markers of hypertrophy and fibrosis and reduced activation of AMP-activated protein kinase (AMPK), while accumulation of Advanced Glycation End products (AGEs) and the expression levels of markers of inflammation were not altered. Moreover, AngII-treatment reduced LV fractional shortening and contractility in diabetic mice, but not in control mice. Conclusions: Collectively, the present findings indicate that type 2 diabetes in its early stage is not yet associated with adverse cardiac structural changes, but already renders the heart more susceptible to hypertension-induced hypertrophic remodeling.	[van Bilsen, Marc; Daniels, Anneleen; Munts, Chantal; van der Vusse, Ger J.; van Nieuwenhoven, Frans A.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands; [Brouwers, Olaf; Schalkwijk, Casper G.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Internal Med, Maastricht, Netherlands; [Janssen, Ben J. A.; Brouns, Agnieszka E.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pharmacol, Maastricht, Netherlands; [Derks, Wouter J. A.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	van Bilsen, M (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands.	m.vanbilsen@maastrichtuniversity.nl	van Bilsen, Marc/E-8342-2016	Derks, Wouter/0000-0002-6508-0078; van Nieuwenhoven, Frans/0000-0002-5757-0069; Schalkwijk, Casper G/0000-0003-0190-2690	CARIM; EU-FP6 [LSHM-CT-2005-018833]	CARIM; EU-FP6(European Commission)	This work was supported by grants from CARIM and EU-FP6 (LSHM-CT-2005-018833, EUGeneHeart). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Jorge A, 2004, Diab Vasc Dis Res, V1, P89, DOI 10.3132/dvdr.2004.013; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Ares-Carrasco S, 2009, AM J PHYSIOL-HEART C, V297, pH2109, DOI 10.1152/ajpheart.00157.2009; Bagi Z, 2005, ARTERIOSCL THROM VAS, V25, P1610, DOI 10.1161/01.ATV.0000172688.26838.9f; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Bodiga VL, 2014, HEART FAIL REV, V19, P49, DOI 10.1007/s10741-013-9374-y; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Brouwers O, 2011, J BIOL CHEM, V286, P1374, DOI 10.1074/jbc.M110.144097; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Daniels A, 2010, ACTA PHYSIOL, V200, P11, DOI 10.1111/j.1748-1716.2010.02102.x; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Daniels A, 2012, EUR J HEART FAIL, V14, P193, DOI 10.1093/eurjhf/hfr166; Daugherty Alan, 2009, J Vis Exp, DOI 10.3791/1291; Falcao-Pires I, 2011, CIRCULATION, V124, P1151, DOI 10.1161/CIRCULATIONAHA.111.025270; Falcao-Pires I, 2011, BASIC RES CARDIOL, V106, P801, DOI 10.1007/s00395-011-0184-x; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; FEIN FS, 1990, AM J PHYSIOL, V258, pH793, DOI 10.1152/ajpheart.1990.258.3.H793; Gonzalez-Quesada C, 2013, CIRC RES, V113, P1331, DOI 10.1161/CIRCRESAHA.113.302593; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Hermida N, 2013, CARDIOVASC RES, V99, P44, DOI 10.1093/cvr/cvt070; How OJ, 2006, DIABETES, V55, P466, DOI 10.2337/diabetes.55.02.06.db05-1164; Howard Barbara V, 2002, Circulation, V105, pe132, DOI 10.1161/01.CIR.0000013953.41667.09; Kaplan NM, 2006, LANCET, V367, P168, DOI 10.1016/S0140-6736(06)67965-8; Kelly DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2860, DOI 10.1152/ajpheart.01167.2006; Nguyen Dung V, 2012, Front Endocrinol (Lausanne), V3, P170, DOI 10.3389/fendo.2012.00170; Park CW, 2009, DIABETES, V58, P2666, DOI 10.2337/db09-0136; Reyes M, 2006, AM J PHYSIOL-HEART C, V291, pH1659, DOI 10.1152/ajpheart.00609.2005; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Shah AM, 2012, EUR J HEART FAIL, V14, P185, DOI 10.1093/eurjhf/hfr125; Smeets PJH, 2008, J BIOL CHEM, V283, P29109, DOI 10.1074/jbc.M802143200; Tikellis C, 2012, CLIN SCI, V123, P519, DOI 10.1042/CS20110668; Van den Bergh A, 2006, EUR J HEART FAIL, V8, P777, DOI 10.1016/j.ejheart.2006.03.001; Willemsen S, 2012, AM HEART J, V164, P742, DOI 10.1016/j.ahj.2012.07.027; Yue P, 2007, AM J PHYSIOL-HEART C, V292, pH2106, DOI 10.1152/ajpheart.00856.2006; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702	39	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85078	10.1371/journal.pone.0085078	http://dx.doi.org/10.1371/journal.pone.0085078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416343	gold, Green Submitted, Green Published			2022-12-25	WOS:000329866300049
J	Zauber, P; Bishop, T; Taylor, C; Sabbath-Solitare, M; Marotta, S; Tomlinson, I				Zauber, Peter; Bishop, Timothy; Taylor, Claire; Sabbath-Solitare, Marlene; Marotta, Stephen; Tomlinson, Ian			Colorectal Tumors from APC*I1307K Carriers Principally Harbor Somatic APC Mutations outside the A8 Tract	PLOS ONE			English	Article							POLYPOSIS-COLI GENE; ADENOMATOUS-POLYPOSIS; I1307K VARIANT; ASHKENAZI JEWS; GERMLINE; CANCER; POLYMORPHISMS; CARCINOMAS; NEOPLASIA; ALLELE	Purpose: APC*I1307K (c.3920T>A) is an inherited variant associated with colorectal tumour risk found almost exclusively in those of Ashkenazi Jewish ancestry. A single nucleotide substitution creates an oligo-adenine tract (A8) that appears to be inherently prone to further mis-pairing and slippage. The reported multiple tumor phenotype of carriers is not easily reconciled with molecular and population genetics data. We postulated that some c.3920T>A carriers with multiple adenomas have other unidentified APC germ line or somatic mutations. Methods: DNA from 82 colonic tumours and accompanying normal tissue collected from 29 carriers with multiple colorectal tumors was directly sequenced between codons 716 and 1604. We also assessed APC gene loss of heterozygosity. Results: One patient (3.4%) was found to have an additional APC germ line mutation. Twenty-five of the tumours showed no significant somatic molecular change, 36 showed one change, 20 showed two, and one tumour showed more than 2 changes. Our data suggest a correlation between advancing histology and fewer beta-catenin binding sites remaining in the mutant proteins. Conclusions: There were no other common germ line variants identified within the region of the APC gene examined, suggesting that any effect from this region on tumour production is attributable to the c.3920T>A allele. Our findings further suggest the only somatic genetic change clearly attributable to the c.3920T>A mutation is the c.3924_3925insA.	[Zauber, Peter] St Barnabas Hosp, Dept Med, Livingston, NJ 07039 USA; [Bishop, Timothy] Univ Leeds, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Taylor, Claire] Univ Leeds, Canc Res UK Genom Facil, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Sabbath-Solitare, Marlene; Marotta, Stephen] St Barnabas Hosp, Dept Pathol, Livingston, NJ USA; [Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Oxford, England	University of Leeds; University of Leeds; University of Oxford; Wellcome Centre for Human Genetics	Zauber, P (corresponding author), St Barnabas Hosp, Dept Med, Livingston, NJ 07039 USA.	pzauber@gmail.com		Bishop, Tim/0000-0002-8752-8785	Harvey Nussbaum Foundation of Saint Barnabas Medical Center; June Bleiwise Foundation; Cancer Research UK [C588/A10589]; Cancer Research UK [10589] Funding Source: researchfish	Harvey Nussbaum Foundation of Saint Barnabas Medical Center; June Bleiwise Foundation; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This research was supported by the Harvey Nussbaum Foundation of Saint Barnabas Medical Center, the June Bleiwise Foundation and awards from Cancer Research UK (C588/A10589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 1971, STAT METHODS MED RES, V1; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Beroud C, 1996, NUCLEIC ACIDS RES, V24, P121, DOI 10.1093/nar/24.1.121; Cleary SP, 2008, DIS COLON RECTUM, V51, P1467, DOI 10.1007/s10350-008-9356-7; Crabtree M, 2003, ONCOGENE, V22, P4257, DOI 10.1038/sj.onc.1206471; Fidder HH, 2005, AM J GASTROENTEROL, V100, P1376, DOI 10.1111/j.1572-0241.2005.41580.x; Frayling IM, 1998, P NATL ACAD SCI USA, V95, P10722, DOI 10.1073/pnas.95.18.10722; Gryfe R, 1998, CANCER RES, V58, P4040; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Lamlum H, 2000, HUM MOL GENET, V9, P2215, DOI 10.1093/oxfordjournals.hmg.a018912; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Liang J, 2013, AM J EPIDEMIOL, V177, P1169, DOI 10.1093/aje/kws382; NAKAMURA Y, 1992, TOHOKU J EXP MED, V168, P141, DOI 10.1620/tjem.168.141; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; Rennert G, 2005, DIS COLON RECTUM, V48, P2317, DOI 10.1007/s10350-005-0167-9; Shtoyerman-Chen R, 2001, GENET TEST, V5, P141, DOI 10.1089/109065701753145628; Sieber O, 2003, J PATHOL, V199, P137, DOI 10.1002/path.1272; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; Thirlwell C, 2010, GASTROENTEROLOGY, V138, P1441, DOI 10.1053/j.gastro.2010.01.033; Zauber NP, 2005, CANCER-AM CANCER SOC, V104, P719, DOI 10.1002/cncr.21230; Zauber NP, 2003, J PATHOL, V199, P146, DOI 10.1002/path.1226	22	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84498	10.1371/journal.pone.0084498	http://dx.doi.org/10.1371/journal.pone.0084498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416237	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300025
J	Carlisle, RE; Brimble, E; Werner, KE; Cruz, GL; Ask, K; Ingram, AJ; Dickhout, JG				Carlisle, Rachel E.; Brimble, Elise; Werner, Kaitlyn E.; Cruz, Gaile L.; Ask, Kjetil; Ingram, Alistair J.; Dickhout, Jeffrey G.			4-Phenylbutyrate Inhibits Tunicamycin-Induced Acute Kidney Injury via CHOP/GADD153 Repression	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HISTONE DEACETYLASE INHIBITOR; ORAL SODIUM PHENYLBUTYRATE; PROGRAMMED CELL-DEATH; ER STRESS; CHEMICAL CHAPERONE; APOPTOSIS; CYTOTOXICITY; CONTRIBUTES	Different forms of acute kidney injury (AKI) have been associated with endoplasmic reticulum (ER) stress; these include AKI caused by acetaminophen, antibiotics, cisplatin, and radiocontrast. Tunicamycin (TM) is a nucleoside antibiotic known to induce ER stress and is a commonly used inducer of AKI. 4-phenylbutyrate (4-PBA) is an FDA approved substance used in children who suffer from urea cycle disorders. 4-PBA acts as an ER stress inhibitor by aiding in protein folding at the molecular level and preventing misfolded protein aggregation. The main objective of this study was to determine if 4-PBA could protect from AKI induced by ER stress, as typified by the TM-model, and what mechanism(s) of 4-PBA's action were responsible for protection. C57BL/6 mice were treated with saline, TM or TM plus 4-PBA. 4-PBA partially protected the anatomic segment most susceptible to damage, the outer medullary stripe, from TM-induced AKI. In vitro work showed that 4-PBA protected human proximal tubular cells from apoptosis and TM-induced CHOP expression, an ER stress inducible proapoptotic gene. Further, immunofluorescent staining in the animal model found similar protection by 4-PBA from CHOP nuclear translocation in the tubular epithelium of the medulla. This was accompanied by a reduction in apoptosis and GRP78 expression. CHOP-/- mice were protected from TM-induced AKI. The protective effects of 4-PBA extended to the ultrastructural integrity of proximal tubule cells in the outer medulla. When taken together, these results indicate that 4-PBA acts as an ER stress inhibitor, to partially protect the kidney from TM-induced AKI through the repression of ER stress-induced CHOP expression.	[Carlisle, Rachel E.; Brimble, Elise; Werner, Kaitlyn E.; Cruz, Gaile L.; Ingram, Alistair J.; Dickhout, Jeffrey G.] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada; [Carlisle, Rachel E.; Brimble, Elise; Werner, Kaitlyn E.; Cruz, Gaile L.; Ask, Kjetil; Ingram, Alistair J.; Dickhout, Jeffrey G.] St Josephs Healthcare Hamilton, Hamilton, ON, Canada; [Ask, Kjetil] McMaster Univ, Dept Med, Div Respirol, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Dickhout, JG (corresponding author), McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada.	jdickhou@stjosham.on.ca	Dickhout, Jeffrey/R-2606-2019; Ask, Kjetil/AGE-0063-2022; Ask, Kjetil/B-6833-2015	Brimble, Elise/0000-0002-7238-7342; Carlisle, Rachel/0000-0002-4266-1953; Ask, Kjetil/0000-0002-0202-735X	Canadian Institutes of Health Research [OSO-115895]; St. Joseph's Healthcare Hamilton; McMaster University, Department of Medicine Internal Career Research Award; Father Sean O'Sullivan Research Studentship Award, St. Joseph's Healthcare Hamilton; Department of Medicine, Division of Nephrology, McMaster University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); St. Joseph's Healthcare Hamilton; McMaster University, Department of Medicine Internal Career Research Award; Father Sean O'Sullivan Research Studentship Award, St. Joseph's Healthcare Hamilton; Department of Medicine, Division of Nephrology, McMaster University	This work was supported by a research grant from the Canadian Institutes of Health Research to Jeffrey G. Dickhout (OSO-115895). Financial support from St. Joseph's Healthcare Hamilton is acknowledged. Jeffrey G. Dickhout also acknowledges support from St. Joseph's Healthcare Hamilton and holds a McMaster University, Department of Medicine Internal Career Research Award. Rachel E. Carlisle has been supported by a studentship from a Father Sean O'Sullivan Research Studentship Award, St. Joseph's Healthcare Hamilton. Financial support from the Department of Medicine, Division of Nephrology, McMaster University is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Carducci MA, 1996, CLIN CANCER RES, V2, P379; Carlisle RE, 2012, AM J PHYSIOL-RENAL, V303, pF467, DOI 10.1152/ajprenal.00481.2011; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Dickhout JG, 2009, ANTIOXID REDOX SIGN, V11, P2341, DOI [10.1089/ars.2009.2705, 10.1089/ARS.2009.2705]; Dyer ES, 2002, INT J CANCER, V101, P496, DOI 10.1002/ijc.10609; Hosoi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040144; Hossain GS, 2003, J BIOL CHEM, V278, P30317, DOI 10.1074/jbc.M212897200; Huang LH, 2011, KIDNEY INT, V79, P613, DOI 10.1038/ki.2010.469; Lhotak S, 2012, AM J PHYSIOL-RENAL, V303, pF266, DOI 10.1152/ajprenal.00482.2011; Lichter-Konecki U, 2011, MOL GENET METAB, V103, P323, DOI 10.1016/j.ymgme.2011.04.013; Loffing J, 1999, AM J PHYSIOL-LUNG C, V277, pL700, DOI 10.1152/ajplung.1999.277.4.L700; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Miller AC, 2011, RADIAT ENVIRON BIOPH, V50, P585, DOI 10.1007/s00411-011-0384-7; Mimori S, 2013, BIOORG MED CHEM LETT, V23, P6015, DOI 10.1016/j.bmcl.2013.08.001; Mimori S, 2012, BIOL PHARM BULL, V35, P84, DOI 10.1248/bpb.35.84; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Peyrou M, 2007, TOXICOL SCI, V99, P338, DOI 10.1093/toxsci/kfm105; Peyrou M, 2007, TOXICOL IN VITRO, V21, P878, DOI 10.1016/j.tiv.2007.03.001; Phuphanich S, 2005, NEURO-ONCOLOGY, V7, P177, DOI 10.1215/S1152851704000183; Prachasilchai W, 2008, EUR J PHARMACOL, V592, P138, DOI 10.1016/j.ejphar.2008.06.108; Prachasilchai W, 2009, J PHARMACOL SCI, V109, P311, DOI 10.1254/jphs.08272SC; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wu CT, 2010, TOXICOL SCI, V114, P295, DOI 10.1093/toxsci/kfq006; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Yan K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013297.11876.5B; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	39	71	72	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84663	10.1371/journal.pone.0084663	http://dx.doi.org/10.1371/journal.pone.0084663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416259	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500146
J	Chen, HL; VanBuren, V				Chen, Hailin; VanBuren, Vincent			A Provisional Gene Regulatory Atlas for Mouse Heart Development	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; UNITED-STATES; NETWORKS; DISCOVERY; DISEASE; COMMUNITIES; COMPLEXITY; DATABASE; DEFECTS; MODULES	Congenital Heart Disease (CHD) is one of the most common birth defects. Elucidating the molecular mechanisms underlying normal cardiac development is an important step towards early identification of abnormalities during the developmental program and towards the creation of early intervention strategies. We developed a novel computational strategy for leveraging high-content data sets, including a large selection of microarray data associated with mouse cardiac development, mouse genome sequence, ChIP-seq data of selected mouse transcription factors and Y2H data of mouse protein-protein interactions, to infer the active transcriptional regulatory network of mouse cardiac development. We identified phase-specific expression activity for 765 overlapping gene co-expression modules that were defined for obtained cardiac lineage microarray data. For each co-expression module, we identified the phase of cardiac development where gene expression for that module was higher than other phases. Co-expression modules were found to be consistent with biological pathway knowledge in Wikipathways, and met expectations for enrichment of pathways involved in heart lineage development. Over 359,000 transcription factor-target relationships were inferred by analyzing the promoter sequences within each gene module for overrepresentation against the JASPAR database of Transcription Factor Binding Site (TFBS) motifs. The provisional regulatory network will provide a framework of studying the genetic basis of CHD.	[Chen, Hailin; VanBuren, Vincent] Texas A&M HSC Coll Med, Dept Med Physiol, Temple, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	VanBuren, V (corresponding author), Texas A&M HSC Coll Med, Dept Med Physiol, Temple, TX USA.	vanburen@tamu.edu						Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Boneva RS, 2001, CIRCULATION, V103, P2376; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dewey FE, 2011, CIRC-CARDIOVASC GENE, V4, P26, DOI 10.1161/CIRCGENETICS.110.941757; Donofrio MT, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/359390; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Gupta R, 2011, NUCLEIC ACIDS RES, V39, pD92, DOI 10.1093/nar/gkq1171; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Jupiter D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-332; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Lage K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.36; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Qi Yuan, 2006, PLoS Comput Biol, V2, pe174, DOI 10.1371/journal.pcbi.0020174; Qiu YY, 2009, INT J BIOCHEM CELL B, V41, P531, DOI 10.1016/j.biocel.2008.06.020; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; van Esch JHM, 2010, CARDIOVASC RES, V86, P401, DOI 10.1093/cvr/cvq004; VanBuren V, 2012, SCI REP-UK, V2, DOI 10.1038/srep01011; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weismann CG, 2007, CURR OPIN CARDIOL, V22, P200, DOI 10.1097/HCO.0b013e3280f629c7; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316	43	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83364	10.1371/journal.pone.0083364	http://dx.doi.org/10.1371/journal.pone.0083364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421884	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500044
J	Henschel, P; Coad, L; Burton, C; Chataigner, B; Dunn, A; MacDonald, D; Saidu, Y; Hunter, LTB				Henschel, Philipp; Coad, Lauren; Burton, Cole; Chataigner, Beatrice; Dunn, Andrew; MacDonald, David; Saidu, Yohanna; Hunter, Luke T. B.			The Lion in West Africa Is Critically Endangered	PLOS ONE			English	Article							PANTHERA-LEO; NATIONAL-PARK; CONSERVATION; DECLINES; EXTINCTION; DIVERSITY; PLAYBACKS; MAMMALS; SIZE	The African lion has declined to,35,000 individuals occupying 25% of its historic range. The situation is most critical for the geographically isolated populations in West Africa, where the species is considered regionally endangered. Elevating their conservation significance, recent molecular studies establish the genetic distinctiveness of West and Central African lions from other extant African populations. Interventions to save West African lions are urgently required. However formulating effective conservation strategies has been hampered by a lack of data on the species' current distribution, status, and potential management deficiencies of protected areas (PAs) harboring lions. Our study synthesized available expert opinion and field data to close this knowledge gap, and formulate recommendations for the conservation of West African lions. We undertook lion surveys in 13 large (>500 km(2)) PAs and compiled evidence of lion presence/absence for a further eight PAs. All PAs were situated within Lion Conservation Units, geographical units designated as priority lion areas by wildlife experts at a regional lion conservation workshop in 2005. Lions were confirmed in only 4 PAs, and our results suggest that only 406 (273-605) lions remain in West Africa, representing <250 mature individuals. Confirmed lion range is estimated at 49,000 km(2), or 1.1% of historical range in West Africa. PAs retaining lions were larger than PAs without lions and had significantly higher management budgets. We encourage revision of lion taxonomy, to recognize the genetic distinctiveness of West African lions and highlight their potentially unique conservation value. Further, we call for listing of the lion as critically endangered in West Africa, under criterion C2a(ii) for populations with <250 mature individuals. Finally, considering the relative poverty of lion range states in West Africa, we call for urgent mobilization of investment from the international community to assist range states to increase management effectiveness of PAs retaining lions.	[Henschel, Philipp; Hunter, Luke T. B.] Panthera, New York, NY 10018 USA; [Coad, Lauren] Univ Oxford, Environm Change Inst, Oxford, England; [Coad, Lauren] Univ Queensland, Sch Geog & Environm Planning, Brisbane, Qld, Australia; [Burton, Cole] Univ Alberta, Alberta Biodivers Monitoring Inst, Edmonton, AB, Canada; [Burton, Cole] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Chataigner, Beatrice] IUCN, Protected Area Program, Ouagadougou, Burkina Faso; [Dunn, Andrew] Wildlife Conservat Soc, Nigeria Program, Calabar, Nigeria; [MacDonald, David] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Oxford OX1 3PS, England; [Saidu, Yohanna] Nigeria Natl Pk Serv, Garki Abuja, Nigeria	University of Oxford; University of Queensland; University of Alberta; University of Victoria; University of Oxford	Henschel, P (corresponding author), Panthera, New York, NY 10018 USA.	phenschel@panthera.org	Hunter, Luke T.B./H-3324-2019; Burton, Cole/AAF-9234-2019; Burton, Cole/J-3184-2012	Hunter, Luke T.B./0000-0001-9653-6544; Burton, Cole/0000-0002-8799-3847; Burton, Cole/0000-0002-8799-3847	Panthera; National Geographic's Big Cat Initiative [B1_12]; Oxford Martin School; DWM the Recanati-Kaplan Foundation; Robertson Foundation	Panthera; National Geographic's Big Cat Initiative; Oxford Martin School; DWM the Recanati-Kaplan Foundation; Robertson Foundation	Field survey efforts were funded by Panthera (www.panthera.org), with additional funds from National Geographic's Big Cat Initiative (grant B1_12; http://animals.nationalgeographic.com/animals/big-cats/). LC furthermore acknowledges the support of the Oxford Martin School, and DWM the Recanati-Kaplan Foundation and Robertson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2004, Cat News, V41, P35; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Barnett R, 2009, MOL ECOL, V18, P1668, DOI 10.1111/j.1365-294X.2009.04134.x; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Bauer H, 2003, CR BIOL, V326, pS112, DOI 10.1016/S1631-0691(03)00047-7; Bauer H, 2010, MAMMALIA, V74, P363, DOI 10.1515/MAMM.2010.048; Belbachir F, 2008, IUCN 2011 IUCN RED L; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Blom B, 2010, ENVIRON SCI POLICY, V13, P164, DOI 10.1016/j.envsci.2010.01.002; Bouche P., 2004, RECENSEMENT AERIEN T; Bouche P, 2006, MOLE WILDLIFE SURVEY; Bouche P, 2012, OUAGADOUGOU; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; BREITENMOSER U, 2012, CAT NEWS, V57, P3; Brockington D, 2010, CONSERV LETT, V3, P106, DOI 10.1111/j.1755-263X.2010.00094.x; Brugiere D, 2012, ORYX, V46, P253, DOI 10.1017/S0030605311000391; Burton AC, 2012, BIODIVERS CONSERV, V21, P3079, DOI 10.1007/s10531-012-0355-6; Burton AC, 2011, BIOL CONSERV, V144, P2344, DOI 10.1016/j.biocon.2011.06.014; CENAGREF, 2013, PLAN ACT CONS LION B; Coad L., 2013, PARKS, V19; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Delvingt W, 2007, NAZINGA; Dubach JM, 2013, CONSERV GENET, P1; Dufour S, 2008, PROGRAMME GESTION CO; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Ferreira SM, 2010, WILDLIFE RES, V37, P194, DOI 10.1071/WR09030; Funston PJ, 2010, J ZOOL, V281, P56, DOI 10.1111/j.1469-7998.2009.00682.x; Galat G, 1992, DENOMBREMENT GRANDE; Granier N, 2004, ETUDE CHIMPANZES AIR; Gros PM, 1998, BIOL CONSERV, V85, P137, DOI 10.1016/S0006-3207(97)00135-3; Henschel Philipp, 2010, Cat News, V52, P34; Inah EI, 2005, J SUSTAIN AGR, V27, P125, DOI 10.1300/J064v27n01_08; IUCN, 2006, CONS STRAT LION W CE; IUCN, 2022, IUCN RED LIST THREAT; IUCN/SSC, 2001, IUCN RED LIST CAT CR; IUCN SSC ANTELOPE SPECIALIST GROUP, 2008, IUCN RED LIST THREAT; Jackson P., 1996, BIOL CONSERVATION; Leverington F, 2010, MANAGEMENT EFFECTIVE; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Macdonald DW, 2012, BIOL CONSERV, V147, P107, DOI 10.1016/j.biocon.2011.12.018; Mazak JH, 2010, J ZOOL, V281, P194, DOI 10.1111/j.1469-7998.2010.00694.x; Mole National Park, 2011, MOLE NATL PARK MANAG; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Nyanganji G, 2011, SURVEY LIONS PANTHER; Ogutu JO, 1998, AFR J ECOL, V36, P83, DOI 10.1046/j.1365-2028.1998.113-89113.x; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Pettorelli N, 2010, ANIM CONSERV, V13, P131, DOI 10.1111/j.1469-1795.2009.00309.x; PFNH, 2009, RAPP ACT MAI JUILL 2; R Core Team, 2013, R LANG ENV STAT COMP; Renaud P, 2006, INVENTAIRE AERIEN TE; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Schaller G. B., 1972, SERENGETI LION; Sinsin B, 2002, MAMMALIA, V66, P369, DOI 10.1515/mamm.2002.66.3.369; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; STANDER P E, 1991, Madoqua, V18, P1; Stuart C., 2003, FIELD GUIDE TRACKS S; Thorn M, 2010, S AFR J WILDL RES, V40, P77, DOI 10.3957/056.040.0113; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woodroffe R., 2012, IUCN RED LIST THREAT	63	80	82	8	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83500	10.1371/journal.pone.0083500	http://dx.doi.org/10.1371/journal.pone.0083500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421889	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500052
J	Ino, K; Masuya, M; Tawara, I; Miyata, E; Oda, K; Nakamori, Y; Suzuki, K; Ohishi, K; Katayama, N				Ino, Kazuko; Masuya, Masahiro; Tawara, Isao; Miyata, Eri; Oda, Keiko; Nakamori, Yoshiki; Suzuki, Kei; Ohishi, Kohshi; Katayama, Naoyuki			Monocytes Infiltrate the Pancreas via the MCP-1/CCR2 Pathway and Differentiate into Stellate Cells	PLOS ONE			English	Article							CHEMOATTRACTANT PROTEIN-1 MCP-1; ANGIOTENSIN-II; BONE-MARROW; ENDOTHELIAL-CELLS; HEMATOPOIETIC ORIGIN; INFLAMMATORY SITES; GENE-EXPRESSION; FIBROSIS; MICE; MACROPHAGES	Recent studies have shown that monocytes possess pluripotent plasticity. We previously reported that monocytes could differentiate into hepatic stellate cells. Although stellate cells are also present in the pancreas, their origin remains unclear. An accumulation of enhanced green fluorescent protein (EGFP)(+) CD45(-) cells was observed in the pancreases and livers of chimeric mice, which were transplanted with a single hematopoietic stem cell isolated from EGFP-transgenic mice and treated with carbon tetrachloride (CCl4). Because the vast majority of EGFP(+) CD45(-) cells in the pancreas expressed stellate cell-associated antigens such as vimentin, desmin, glial fibrillary acidic protein, procollagen-I, and alpha-smooth muscle actin, they were characterized as pancreatic stellate cells (PaSCs). EGFP(+) PaSCs were also observed in CCl4-treated mice adoptively transferred with monocytes but not with other cell lineages isolated from EGFP-transgenic mice. The expression of monocyte chemoattractant protein-1 (MCP-1) and angiotensin II (Ang II) increased in the pancreas of CCl4-treated mice and their respective receptors, C-C chemokine receptor 2 (CCR2) and Ang II type 1 receptor (AT1R), were expressed on Ly6C high monocytes isolated from EGFP-transgenic mice. We examined the effect of an AT1R antagonist, irbesartan, which is also a CCR2 antagonist, on the migration of monocytes into the pancreas. Monocytes migrated toward MCP-1 but not Ang II in vitro. Irbesartan inhibited not only their in vitro chemotaxis but also in vivo migration of adoptively transferred monocytes from peripheral blood into the pancreas. Irbesartan treatment significantly reduced the numbers of EGFP(+) F4/80(+) CCR2(+) monocytic cells and EGFP(+) PaSCs in the pancreas of CCl4-treated chimeric mice receiving EGFP(+) bone marrow cells. A specific CCR2 antagonist RS504393 inhibited the occurrence of EGFP(+) PaSCs in injured mice. We propose that CCR2(+) monocytes migrate into the pancreas possibly via the MCP-1/CCR2 pathway and give rise to PaSCs.	[Ino, Kazuko; Masuya, Masahiro; Tawara, Isao; Miyata, Eri; Oda, Keiko; Nakamori, Yoshiki; Suzuki, Kei; Ohishi, Kohshi; Katayama, Naoyuki] Mie Univ, Dept Hematol & Oncol, Grad Sch Med, Tsu, Mie 514, Japan	Mie University	Masuya, M (corresponding author), Mie Univ, Dept Hematol & Oncol, Grad Sch Med, Tsu, Mie 514, Japan.	mmasuya@clin.medic.mie-u.ac.jp; n-kata@clin.medic.mie-u.ac.jp			Japan Society for the Promotion of Science [20591150, 21591200]; Mitsubishi Pharma Research Foundation; Dainippon-Sumitomo Pharmaceutical	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Pharma Research Foundation; Dainippon-Sumitomo Pharmaceutical(Johnson & Johnson)	This work was supported in part by Grants-in-Aid for Scientific Research (C) for 2008-2010 (to M. M., Grant 20591150) and 2009-2011 (to N.K., Grant 21591200) from the Japan Society for the Promotion of Science, and the Mitsubishi Pharma Research Foundation (to M. M.). M. M. has received research funding from Dainippon-Sumitomo Pharmaceutical within the past two years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2004, J HEPATOL, V40, P255, DOI 10.1016/j.jhep.2003.10.012; Bielinski SJ, 2007, GENES IMMUN, V8, P684, DOI 10.1038/sj.gene.6364434; Bush E, 2000, HYPERTENSION, V36, P360, DOI 10.1161/01.HYP.36.3.360; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chipitsyna G, 2007, ENDOCRINOLOGY, V148, P2198, DOI 10.1210/en.2006-1358; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; DOI K, 1991, LAB ANIM, V25, P21, DOI 10.1258/002367791780808121; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goecke H, 2000, SURGERY, V128, P806, DOI 10.1067/msy.2000.108613; Grady T, 1997, GASTROENTEROLOGY, V113, P1966, DOI 10.1016/S0016-5085(97)70017-9; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; Hodge DL, 2012, EUR J IMMUNOL, V42, P2644, DOI 10.1002/eji.201242408; Inoue Masanobu, 2002, Pancreas, V25, pe64, DOI 10.1097/00006676-200211000-00023; Ishibashi T, 2008, J GASTROENTEROL, V43, P79, DOI 10.1007/s00535-007-2126-9; Kanno K, 2005, DIGEST DIS SCI, V50, P942, DOI 10.1007/s10620-005-2669-7; Kintscher U, 2001, HYPERTENSION, V37, P587, DOI 10.1161/01.HYP.37.2.587; Kitagawa K, 2004, AM J PATHOL, V165, P237, DOI 10.1016/S0002-9440(10)63292-0; Leung PS, 2007, J PHYSIOL-LONDON, V580, P31, DOI 10.1113/jphysiol.2006.126193; Marrache F, 2008, GUT, V57, P1113, DOI 10.1136/gut.2007.143271; Marshall TG, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-1; Masuya M, 2003, BLOOD, V101, P2215, DOI 10.1182/blood-2002-04-1076; Masuya M, 2011, EXP HEMATOL, V39, P934, DOI 10.1016/j.exphem.2011.06.001; Mateo T, 2006, J IMMUNOL, V176, P5577, DOI 10.4049/jimmunol.176.9.5577; McIntosh LM, 2009, CLIN EXP IMMUNOL, V155, P295, DOI 10.1111/j.1365-2249.2008.03819.x; Medina A, 2009, WOUND REPAIR REGEN, V17, P268, DOI 10.1111/j.1524-475X.2009.00457.x; Miyata E, 2008, BLOOD, V111, P2427, DOI 10.1182/blood-2007-07-101261; Miyata N, 1999, AM J PHYSIOL-RENAL, V277, pF437, DOI 10.1152/ajprenal.1999.277.3.F437; Nagashio Y, 2004, AM J PHYSIOL-GASTR L, V287, pG170, DOI 10.1152/ajpgi.00005.2004; Naim Y, 2007, ARTERIOSCL THROM VAS, V27, P2370, DOI 10.1161/ATVBAHA.107.147009; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pueyo ME, 1996, BRIT J PHARMACOL, V118, P79, DOI 10.1111/j.1476-5381.1996.tb15369.x; Rasini E, 2006, REGUL PEPTIDES, V134, P69, DOI 10.1016/j.regpep.2006.01.007; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rodgers KE, 2000, STEM CELLS, V18, P287, DOI 10.1634/stemcells.18-4-287; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; Saurer L, 2000, GASTROENTEROLOGY, V118, P356, DOI 10.1016/S0016-5085(00)70218-6; Scarlett CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026088; Sharma M, 1998, AM J PHYSIOL-RENAL, V274, pF623; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; SICA A, 1990, J IMMUNOL, V144, P3034; Sparmann G, 2010, CELL RES, V20, P288, DOI 10.1038/cr.2010.10; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Takai S, 2011, J PHARMACOL SCI, V116, P309, DOI 10.1254/jphs.11053FP; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Vestergaard C, 2004, ACTA DERM-VENEREOL, V84, P353, DOI 10.1080/00015550410034444; Vig P, 2006, HEPATOLOGY, V43, P316, DOI 10.1002/hep.21018; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG1138, DOI 10.1152/ajpgi.00123.2009; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3	54	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84889	10.1371/journal.pone.0084889	http://dx.doi.org/10.1371/journal.pone.0084889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416305	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500184
J	Klenk, J; Rapp, K; Ulmer, H; Concin, H; Nagel, G				Klenk, Jochen; Rapp, Kilian; Ulmer, Hanno; Concin, Hans; Nagel, Gabriele			Changes of Body Mass Index in Relation to Mortality: Results of a Cohort of 42,099 Adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; WEIGHT CHANGE; PHYSICAL-ACTIVITY; HEART-DISEASE; KOREAN MEN; OBESITY; RISK; WOMEN; ASSOCIATION; HEALTH	Background: High Body-Mass-Index (BMI) is associated with increased all-cause mortality, but little is known about the effect of short-and long-term BMI change on mortality. The aim of the study was to determine how long-term weight change affects mortality. Methods and findings: Within a population-based prospective cohort of 42,099 Austrian men and women (mean age 43 years) with at least three BMI measurements we investigated the relationship of BMI at baseline and two subsequent BMI change intervals of five years each with all-cause mortality using Cox proportional Hazard models. During median follow-up of 12 years 4,119 deaths were identified. The lowest mortalities were found in persons with normal weight or overweight at baseline and stable BMI over 10 years. Weight gain (>= 0.10 kg/m(2)/year) during the first five years was associated with increased mortality in overweight and obese people. For weight gain during both time intervals mortality risk remained significantly increased only in overweight (Hazard Ratio (HR): 1.39 (95% confidence interval: 1.01; 1.92)) and obese women (1.85 (95% confidence interval: 1.18; 2.89)). Weight loss (< -0.10 kg/m(2)/year) increased all-cause mortality in men and women consistently. BMI change over time assessed using accepted World Health Organisation BMI categories showed no increased mortality risk for people who remained in the normal or overweight category for all three measurements. In contrast, HRs for stable obese men and women were 1.57 (95% CI: 1.31; 1.87) and 1.46 (95% CI: 1.25; 1.71) respectively. Conclusion: Our findings highlight the importance of weight stability and obesity avoidance in prevention strategy.	[Klenk, Jochen; Rapp, Kilian; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Klenk, Jochen; Rapp, Kilian] Robert Bosch Krankenhaus, Clin Geriatr Rehabil, Stuttgart, Germany; [Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Concin, Hans; Nagel, Gabriele] Agcy Prevent & Social Med, Bregenz, Austria	Ulm University; Bosch; Robert Bosch Krankenhaus; Medical University of Innsbruck	Nagel, G (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.	gabriele.nagel@uni-ulm.de	Ulmer, Hanno/S-6615-2019; Rapp, Kilian/AAJ-3370-2020; Klenk, Jochen/R-3614-2019; Nagel, Gabriele/C-3635-2012; vhmpp, aks/F-9756-2012; Klenk, Jochen/C-2164-2012	Ulmer, Hanno/0000-0001-5911-1002; Rapp, Kilian/0000-0003-1625-2571; Klenk, Jochen/0000-0002-5987-447X; Nagel, Gabriele/0000-0001-6185-8535; 	State of Vorarlberg, Austria	State of Vorarlberg, Austria	Members of the VHM&PP study group are Gunter Diem MD, Guntram Hinteregger MD, Karin Parschalk MD, Wolfgang Metzler MD, Elmar Stimpfl, Raphael Peter (Agency for Preventive-and Social Medicine, Bregenz, Austria) and Stephan K. Weiland dagger MD MSc (Institute of Epidemiology and Medical Biometry, Ulm University, Germany). We thank all physicians and participants in the Vorarlberg Health Monitoring and Prevention Programme (VHM&PP) for completing the study examinations and providing data. The VHM&PP is supported by the State of Vorarlberg, Austria. The VHM&PP is supported by the State of Vorarlberg, Austria. We thank Markus Wallner, Christian Bernhard, Andrea Kaufmann, and Gabriela Dur from the Vorarlberg State Government and Chad Logan from the Institute of Epidemiology and Medical Biometry.	[Anonymous], 2002, WEIGHT CONTR PHYS AC; Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502507, 10.1111/j.1753-4887.2006.tb00183.x]; BLAIR SN, 1993, ANN INTERN MED, V119, P749, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00024; Bosomworth NJ, 2012, CAN FAM PHYSICIAN, V58, P517; Botoseneanu A., 2012, Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, V67, P1075; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Droyvold WB, 2005, J INTERN MED, V257, P338, DOI 10.1111/j.1365-2796.2005.01458.x; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; He JH, 2009, INT J ENV RES PUB HE, V6, P3115, DOI 10.3390/ijerph6123115; Heitmann BL, 2009, OBESITY, V17, P136, DOI 10.1038/oby.2008.479; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Jee SH, 2005, AM J EPIDEMIOL, V162, P42, DOI 10.1093/aje/kwi166; Klenk J, 2009, EUR J EPIDEMIOL, V24, P83, DOI 10.1007/s10654-009-9312-4; LEE IM, 1992, JAMA-J AM MED ASSOC, V268, P2045, DOI 10.1001/jama.268.15.2045; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; PETERS ETJ, 1995, INT J OBESITY, V19, P862; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rapp K, 2005, BRIT J CANCER, V93, P1062, DOI 10.1038/sj.bjc.6602819; Rosengren A, 1999, EUR HEART J, V20, P269, DOI 10.1053/euhj.1998.1235; Stampfer M, 2005, PLOS MED, V2, P476, DOI 10.1371/journal.pmed.0020181; Statistik Austria, METH TOD; Stevens J, 2000, NUTR REV, V58, P129, DOI 10.1111/j.1753-4887.2000.tb01847.x; Travier N, 2009, PREV MED, V49, P365, DOI 10.1016/j.ypmed.2009.08.009; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yarnell JWG, 2000, J EPIDEMIOL COMMUN H, V54, P344, DOI 10.1136/jech.54.5.344; Yun KE, 2010, INT J EPIDEMIOL, V39, P520, DOI 10.1093/ije/dyp282	33	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84817	10.1371/journal.pone.0084817	http://dx.doi.org/10.1371/journal.pone.0084817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416291	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500173
J	Liu, MJ; Bienfait, B; Sacher, O; Gasteiger, J; Siezen, RJ; Nauta, A; Geurts, JMW				Liu, Mengjin; Bienfait, Bruno; Sacher, Oliver; Gasteiger, Johann; Siezen, Roland J.; Nauta, Arjen; Geurts, Jan M. W.			Combining Chemoinformatics with Bioinformatics: In Silico Prediction of Bacterial Flavor-Forming Pathways by a Chemical Systems Biology Approach "Reverse Pathway Engineering''	PLOS ONE			English	Article							VOLATILE SULFUR-COMPOUNDS; LACTIC-ACID BACTERIA; L-LACTATE OXIDASE; ALPHA-KETO ACIDS; AMINO-ACIDS; METABOLISM; ENZYMES; CONVERSION; GENOMICS; RECONSTRUCTION	The incompleteness of genome-scale metabolic models is a major bottleneck for systems biology approaches, which are based on large numbers of metabolites as identified and quantified by metabolomics. Many of the revealed secondary metabolites and/or their derivatives, such as flavor compounds, are non-essential in metabolism, and many of their synthesis pathways are unknown. In this study, we describe a novel approach, Reverse Pathway Engineering (RPE), which combines chemoinformatics and bioinformatics analyses, to predict the "missing links'' between compounds of interest and their possible metabolic precursors by providing plausible chemical and/or enzymatic reactions. We demonstrate the added-value of the approach by using flavor-forming pathways in lactic acid bacteria (LAB) as an example. Established metabolic routes leading to the formation of flavor compounds from leucine were successfully replicated. Novel reactions involved in flavor formation, i.e. the conversion of alpha-hydroxy-isocaproate to 3-methylbutanoic acid and the synthesis of dimethyl sulfide, as well as the involved enzymes were successfully predicted. These new insights into the flavor-formation mechanisms in LAB can have a significant impact on improving the control of aroma formation in fermented food products. Since the input reaction databases and compounds are highly flexible, the RPE approach can be easily extended to a broad spectrum of applications, amongst others health/disease biomarker discovery as well as synthetic biology.	[Liu, Mengjin; Nauta, Arjen; Geurts, Jan M. W.] FrieslandCampina, Dept Nutr Sci, Amersfoort, Netherlands; [Liu, Mengjin; Siezen, Roland J.] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Bienfait, Bruno; Sacher, Oliver; Gasteiger, Johann] Mol Networks GmbH, Erlangen, Germany; [Gasteiger, Johann] Univ Erlangen Nurnberg, Comp Chem Ctr, D-91054 Erlangen, Germany	Radboud University Nijmegen; University of Erlangen Nuremberg	Geurts, JMW (corresponding author), FrieslandCampina, Dept Nutr Sci, Amersfoort, Netherlands.	jan.geurts@frieslandcampina.com	Siezen, Roland J/P-5745-2015		Casimir program of the Ministry of Economic Affairs, The Netherlands [CSI4017]	Casimir program of the Ministry of Economic Affairs, The Netherlands	This work was supported by grant CSI4017 of the Casimir program of the Ministry of Economic Affairs, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardo Y, 2006, BIOTECHNOL ADV, V24, P238, DOI 10.1016/j.biotechadv.2005.11.005; Attieh J, 2002, PLANT MOL BIOL, V50, P511, DOI 10.1023/A:1019865829534; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Bonnarme P, 2004, FEMS MICROBIOL LETT, V236, P85, DOI 10.1016/j.femsle.2004.05.022; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; Chambellon E, 2009, J BACTERIOL, V191, P873, DOI 10.1128/JB.01114-08; COREY EJ, 1985, SCIENCE, V228, P408, DOI 10.1126/science.3838594; de la Plaza M, 2004, FEMS MICROBIOL LETT, V238, P367, DOI 10.1016/j.femsle.2004.07.057; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Furusawa C, 2013, ADV BIOCHEM ENG BIOT, V131, P1, DOI 10.1007/10_2012_137; Ganesan B, 2006, APPL ENVIRON MICROB, V72, P4264, DOI 10.1128/AEM.00448-06; GIEGEL DA, 1990, J BIOL CHEM, V265, P6626; Helinck S, 2004, APPL ENVIRON MICROB, V70, P3855, DOI 10.1128/AEM.70.7.3855-3861.2004; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Ihlenfeldt WD, 1995, ANGEW CHEM INT EDIT, V34, P2613; KADOTA H, 1972, ANNU REV MICROBIOL, V26, P127, DOI 10.1146/annurev.mi.26.100172.001015; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kastenmuller G, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r28; Kinross James M, 2008, Curr Gastroenterol Rep, V10, P396, DOI 10.1007/s11894-008-0075-y; Kumar A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-6; Landaud S, 2008, APPL MICROBIOL BIOT, V77, P1191, DOI 10.1007/s00253-007-1288-y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law J, 2009, J CHEM INF MODEL, V49, P593, DOI 10.1021/ci800228y; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/NCHEMBIO.970, 10.1038/nchembio.970]; Liu M, 2008, APPL ENVIRON MICROB, V74, P4590, DOI 10.1128/AEM.00150-08; Mapelli V, 2008, TRENDS BIOTECHNOL, V26, P490, DOI 10.1016/j.tibtech.2008.05.008; Martin CH, 2009, CHEM BIOL, V16, P277, DOI 10.1016/j.chembiol.2009.01.010; Mashkina AV, 2000, KINET CATAL+, V41, P216, DOI 10.1007/BF02771423; Medema MH, 2012, NAT REV MICROBIOL, V10, P191, DOI 10.1038/nrmicro2717; Michal G, 1999, BIOCH PATHWAYS ATLAS; Morimoto Y, 1998, BIOCHIMIE, V80, P309, DOI 10.1016/S0300-9084(98)80072-2; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Pastink MI, 2008, INT DAIRY J, V18, P781, DOI 10.1016/j.idairyj.2007.07.006; Pettit RK, 2009, APPL MICROBIOL BIOT, V83, P19, DOI 10.1007/s00253-009-1916-9; Pfortner M., 2003, HDB CHEMOINFORMATICS, P1457; Ran NQ, 2007, J AM CHEM SOC, V129, P6130, DOI 10.1021/ja067330p; Ranganathan S, 2012, METAB ENG, V14, P687, DOI 10.1016/j.ymben.2012.08.008; Reitz M, 2004, ORG BIOMOL CHEM, V2, P3226, DOI 10.1039/b410949j; Rezzi S, 2007, J PROTEOME RES, V6, P4469, DOI 10.1021/pr070431h; Sacher O, 2009, J CHEM INF MODEL, V49, P1525, DOI 10.1021/ci800277f; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Simon GM, 2008, NAT CHEM BIOL, V4, P639, DOI 10.1038/nchembio1108-639; Sitzmann M, 2003, CHEMOINFORMATICS TXB, P567; Smit BA, 2004, J AGR FOOD CHEM, V52, P1263, DOI 10.1021/jf035147z; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; Sztajer H, 1996, APPL MICROBIOL BIOT, V45, P600, DOI 10.1007/s002530050736; Takemori S, 1975, Methods Enzymol, V41, P329; Taylor BF, 1989, BIOGENIC SULFUR ENV; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83; Ward DE, 1999, J BACTERIOL, V181, P5433, DOI 10.1128/JB.181.17.5433-5442.1999; Weimer B, 1999, ANTON LEEUW INT J G, V76, P247, DOI 10.1023/A:1002050625344; Xu P, 1996, APPL BIOCHEM BIOTECH, V56, P277, DOI 10.1007/BF02786958; Yorita K, 1996, J BIOL CHEM, V271, P28300, DOI 10.1074/jbc.271.45.28300; Yvon M, 2000, APPL ENVIRON MICROB, V66, P571, DOI 10.1128/AEM.66.2.571-577.2000; Yvon M, 2006, AUST J DAIRY TECHNOL, V61, P88	61	33	35	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84769	10.1371/journal.pone.0084769	http://dx.doi.org/10.1371/journal.pone.0084769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416282	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500165
J	MacIntosh, BJ; Crane, DE; Sage, MD; Rajab, AS; Donahue, MJ; McIlroy, WE; Middleton, LE				MacIntosh, Bradley J.; Crane, David E.; Sage, Michael D.; Rajab, A. Saeed; Donahue, Manus J.; McIlroy, William E.; Middleton, Laura E.			Impact of a Single Bout of Aerobic Exercise on Regional Brain Perfusion and Activation Responses in Healthy Young Adults	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; WHITE-MATTER; PHYSICAL-ACTIVITY; OLDER-ADULTS; FITNESS; STROKE; INTENSITY; HUMANS; TASK; METAANALYSIS	Purpose: Despite the generally accepted view that aerobic exercise can have positive effects on brain health, few studies have measured brain responses to exercise over a short time span. The purpose of this study was to examine the impact within one hour of a single bout of exercise on brain perfusion and neuronal activation. Methods: Healthy adults (n = 16; age range: 20-35 yrs) were scanned using Magnetic Resonance Imaging (MRI) before and after 20 minutes of exercise at 70% of their age-predicted maximal heart rate. Pseudo-continuous arterial spin labeling (pcASL) was used to measure absolute cerebral blood flow (CBF) prior to exercise (pre) and at 10 min (post-10) and 40 min (post-40) post-exercise. Blood oxygenation level dependent (BOLD) functional MRI (fMRI) was performed pre and postexercise to characterize activation differences related to a go/no-go reaction time task. Results: Compared to pre-exercise levels, grey matter CBF was 11% (+/- 9%) lower at post-10 (P < 0.0004) and not different at post-40 (P = 0.12), while global WM CBF was increased at both time points post-exercise (P < 0.0006). Regionally, the hippocampus and insula showed a decrease in perfusion in ROI-analysis at post-10 (P < 0.005, FDR corrected), whereas voxel-wise analysis identified elevated perfusion in the left medial postcentral gyrus at post-40 compared to pre (p(corrected) = 0.05). BOLD activations were consistent between sessions, however, the left parietal operculum showed reduced BOLD activation after exercise. Conclusion: This study provides preliminary evidence of regionalized brain effects associated with a single bout of aerobic exercise. The observed acute cerebrovascular responses may provide some insight into the brain's ability to change in relation to chronic interventions.	[MacIntosh, Bradley J.; Rajab, A. Saeed] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [MacIntosh, Bradley J.; Crane, David E.; Rajab, A. Saeed; McIlroy, William E.; Middleton, Laura E.] Sunnybrook Res Inst, Canadian Partnership Stroke Recovery, Toronto, ON, Canada; [Sage, Michael D.; McIlroy, William E.; Middleton, Laura E.] Univ Toronto, Toronto Rehabil Inst, Toronto, ON, Canada; [Sage, Michael D.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [McIlroy, William E.; Middleton, Laura E.] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Donahue, Manus J.] Vanderbilt Univ, Dept Radiol, Nashville, TN 37235 USA	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Waterloo; Vanderbilt University	MacIntosh, BJ (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	bmac@sri.utoronto.ca	Middleton, Laura/C-6024-2009; Middleton, Laura/ABG-8940-2021	Middleton, Laura/0000-0001-8624-3123; McIlroy, William/0000-0003-2319-1746; MacIntosh, Bradley/0000-0001-7300-2355	Heart and Stroke Foundation Centre for Stroke Recovery; Natural Sciences and Engineering Research Council of Canada (NSERC); Philips Healthcare	Heart and Stroke Foundation Centre for Stroke Recovery(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Philips Healthcare	This study was supported by funding from the Heart and Stroke Foundation Centre for Stroke Recovery and the Natural Sciences and Engineering Research Council of Canada (NSERC). BJM has received funding support from Philips Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2008, J PHYSIOL-LONDON, V586, P4005, DOI 10.1113/jphysiol.2008.158279; [Anonymous], 1984, J CARDIAC REHABIL; Borg G., 1998, BORGS PERCEIVED EXER; Brown AD, 2010, NEUROBIOL AGING, V31, P2047, DOI 10.1016/j.neurobiolaging.2008.11.002; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chen TL, 2010, NEUROIMAGE, V53, P181, DOI 10.1016/j.neuroimage.2010.06.023; Christensen LOD, 2000, EXP BRAIN RES, V135, P66, DOI 10.1007/s002210000493; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Dai W, 2008, STROKE, V39, P349, DOI 10.1161/STROKEAHA.107.495457; Davranche K, 2009, J SPORT EXERCISE PSY, V31, P628, DOI 10.1123/jsep.31.5.628; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hoschneider DP, 2007, BRAIN RES, V1184, P96, DOI 10.1016/j.brainres.2007.09.081; Ivey FM, 2011, STROKE, V42, P1994, DOI 10.1161/STROKEAHA.110.607879; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; MacDonald JR, 2002, J HUM HYPERTENS, V16, P225, DOI 10.1038/sj.jhh.1001377; MacIntosh B, 2007, HUM BRAIN MAPP, V28, P835, DOI 10.1002/hbm.20308; MacIntosh BJ, 2008, J CEREBR BLOOD F MET, V28, P1514, DOI 10.1038/jcbfm.2008.46; Mandell DM, 2008, STROKE, V39, P1993, DOI 10.1161/STROKEAHA.107.501692; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Marks BL, 2011, BRIT J SPORT MED, V45, P1208, DOI 10.1136/bjsm.2009.068114; Martin RE, 2004, J NEUROPHYSIOL, V92, P2428, DOI 10.1152/jn.01144.2003; Middleton LE, 2013, NEUROSCI BIOBEHAV R, V37, P133, DOI 10.1016/j.neubiorev.2012.11.011; Molenberghs P, 2009, NEUROPSYCHOLOGIA, V47, P2866, DOI 10.1016/j.neuropsychologia.2009.06.012; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nybo L, 2002, J APPL PHYSIOL, V93, P58, DOI 10.1152/japplphysiol.00049.2002; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Pescatello LS, 2004, J HYPERTENS, V22, P1881, DOI 10.1097/00004872-200410000-00009; Petruzzello SJ, 1997, PSYCHOPHYSIOLOGY, V34, P527, DOI 10.1111/j.1469-8986.1997.tb01739.x; Rhyu IJ, 2010, NEUROSCIENCE, V167, P1239, DOI 10.1016/j.neuroscience.2010.03.003; Rovio S, 2010, NEUROBIOL AGING, V31, P1927, DOI 10.1016/j.neurobiolaging.2008.10.007; Smith JC, 2010, J NEUROSCI METH, V191, P258, DOI 10.1016/j.jneumeth.2010.06.028; Stroth S, 2009, BRAIN RES, V1269, P114, DOI 10.1016/j.brainres.2009.02.073; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; Williamson JW, 1997, J PHYSIOL-LONDON, V503, P277, DOI 10.1111/j.1469-7793.1997.277bh.x; Yung LM, 2009, SPORTS MED, V39, P45, DOI 10.2165/00007256-200939010-00004	47	66	67	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85163	10.1371/journal.pone.0085163	http://dx.doi.org/10.1371/journal.pone.0085163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416356	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500222
J	Mulero-Pazmany, M; Stolper, R; van Essen, LD; Negro, JJ; Sassen, T				Mulero-Pazmany, Margarita; Stolper, Roel; van Essen, L. D.; Negro, Juan J.; Sassen, Tyrell			Remotely Piloted Aircraft Systems as a Rhinoceros Anti-Poaching Tool in Africa	PLOS ONE			English	Article							AERIAL VEHICLES	Over the last years there has been a massive increase in rhinoceros poaching incidents, with more than two individuals killed per day in South Africa in the first months of 2013. Immediate actions are needed to preserve current populations and the agents involved in their protection are demanding new technologies to increase their efficiency in the field. We assessed the use of remotely piloted aircraft systems (RPAS) to monitor for poaching activities. We performed 20 flights with 3 types of cameras: visual photo, HD video and thermal video, to test the ability of the systems to detect (a) rhinoceros, (b) people acting as poachers and (c) to do fence surveillance. The study area consisted of several large game farms in KwaZulu-Natal province, South Africa. The targets were better detected at the lowest altitudes, but to operate the plane safely and in a discreet way, altitudes between 100 and 180 m were the most convenient. Open areas facilitated target detection, while forest habitats complicated it. Detectability using visual cameras was higher at morning and midday, but the thermal camera provided the best images in the morning and at night. Considering not only the technical capabilities of the systems but also the poachers modus operandi and the current control methods, we propose RPAS usage as a tool for surveillance of sensitive areas, for supporting field anti-poaching operations, as a deterrent tool for poachers and as a complementary method for rhinoceros ecology research. Here, we demonstrate that low cost RPAS can be useful for rhinoceros stakeholders for field control procedures. There are, however, important practical limitations that should be considered for their successful and realistic integration in the anti-poaching battle.	[Mulero-Pazmany, Margarita; Negro, Juan J.] CSIC, Donana Biol Stn, Dept Evolutionary Ecol, E-41080 Seville, Spain; [Stolper, Roel; Sassen, Tyrell] CSIR, Dept Sensor Sci Technol, ZA-0001 Pretoria, South Africa; [van Essen, L. D.] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Council for Scientific & Industrial Research (CSIR) - South Africa; University of Pretoria	Mulero-Pazmany, M (corresponding author), CSIC, Donana Biol Stn, Dept Evolutionary Ecol, E-41080 Seville, Spain.	muleromara@ebd.csic.es	Negro, Juan Jose/I-2653-2015; Mulero-Pazmany, Margarita/M-5596-2013	Negro, Juan Jose/0000-0002-8697-5647; Mulero-Pazmany, Margarita/0000-0002-0303-9360	European Commission [257649]; Donana Biological Station, CSIC; Centre for Wildlife Management (University of Pretoria); CSIR; Aeromab, (Andalusia Government, Project for Excellence) [P07-RNM-03246]	European Commission(European CommissionEuropean Commission Joint Research Centre); Donana Biological Station, CSIC; Centre for Wildlife Management (University of Pretoria); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Aeromab, (Andalusia Government, Project for Excellence)	This study was conducted within the Projects: Aeromab, (Andalusia Government, Project for Excellence, 2007, P07-RNM-03246) and Planet (European Commission 7th FP Grant Agreement 257649) granted to Donana Biological Station, CSIC. Centre for Wildlife Management (University of Pretoria) and CSIR contributed to the study with their own funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chabot D, 2012, WATERBIRDS, V35, P170, DOI 10.1675/063.035.0119; Dublin HT, 2011, PACHYDERM, P1; Emslie R, 2013, 16 M C PART BANGK TH, V51, P1; Emslie R., 1999, STATUS SURVEY CONSER; Emslie R, 2012, CERATOTHERIUM SIMUM; Eustace M, 2012, BUS DAY         0120; Ferreira SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045989; Getzin S, 2012, METHODS ECOL EVOL, V3, P397, DOI 10.1111/j.2041-210X.2011.00158.x; Ingham LA, 2006, AERONAUT J, V110, P695, DOI 10.1017/S0001924000001561; Israel M, 2011, INT ARCH PHOTOGRAMM, V38-1, P51; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Knight M, 2011, PACHYDERM, P7; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Lever C, 2004, ORYX, V38, P13; Loon R, 1997, S AFR J SCI, V93, P237; Mamba A, 2009, REGULATION UNMANNED; Martin E, 2010, PACHYDERM, P48; Milledge SAH, 2007, PACHYDERM, P96; PVan Blyenburgh, 1999, UAVS CURRENT SITUATI; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050336; SACAA, 2008, INT POL CIV UNM AIRC; SAMAA, 2001, MAN PROC MOD AIRCR R; Sarda-Palomera F, 2012, IBIS, V154, P177, DOI 10.1111/j.1474-919X.2011.01177.x; Vermeulen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054700; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; Wild S, 2013, BUSSINES DAY; WWF, 2013, GOOGL HELPS WWF STOP; Zenko M., 2013, REFORMING US DRONE S	28	141	144	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83873	10.1371/journal.pone.0083873	http://dx.doi.org/10.1371/journal.pone.0083873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416177	Green Published, gold			2022-12-25	WOS:000329862500080
J	Pallet, N; Chauvet, S; Chasse, JF; Vincent, M; Avillach, P; Levi, C; Meas-Yedid, V; Olivo-Marin, JC; Nga-Matsogo, D; Beaune, P; Thervet, E; Karras, A				Pallet, Nicolas; Chauvet, Sophie; Chasse, Jean-Francois; Vincent, Marc; Avillach, Paul; Levi, Charlene; Meas-Yedid, Vannary; Olivo-Marin, Jean-Christophe; Nga-Matsogo, Diane; Beaune, Philippe; Thervet, Eric; Karras, Alexandre			Urinary Retinol Binding Protein Is a Marker of the Extent of Interstitial Kidney Fibrosis	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEINS; OXFORD CLASSIFICATION; IMAGE-ANALYSIS; RENAL-DISEASE; NEPHROPATHY; TRANSPLANTATION; QUANTIFICATION; MECHANISMS; HISTOLOGY; SURVIVAL	Currently, a non-invasive method to estimate the degree of interstitial fibrosis (IF) in chronic kidney disease is not available in routine. The aim of our study was to evaluate the diagnostic performance of the measurement of urinary low molecular weight (LMW) protein concentrations as a method to determine the extent of IF. The urines specimen from 162 consecutive patients who underwent renal biopsy were used in the analysis. Numerical quantification software based on the colorimetric analysis of fibrous areas was used to assess the percentage IF. Total proteinuria, albuminuria, and the urinary levels of retinol binding protein (RBP), alpha1-microglobulin (alpha 1MG), beta 2-microglobulin (beta 2MG), transferrin, and IgG immunoglobulins were measured. There was a significant correlation between the degree of IF and the RBP/creatinine (creat) ratio (R2: 0.11, p<0.0001). IF was associated to a lesser extent with urinary beta 2MG and alpha 1MG; however, there was no association with total proteinuria or high molecular weight (HMW) proteinuria. The correlation between IF and RBP/creat remained significant after adjustment to the estimated glomerular filtration rate, age, body mass index, alpha 1MG, and beta 2MG. The specificity of the test for diagnosing a fibrosis score of >25% of the parenchyma was 95% when using a threshold of 20 mg/g creat. In conclusion, RBP appears to be a quantitative and non-invasive marker for the independent prediction of the extent of kidney IF. Because methods for the measurement of urinary RBP are available in most clinical chemistry departments, RBP measurement is appealing for implementation in the routine care of patients with chronic kidney disease.	[Pallet, Nicolas; Chasse, Jean-Francois; Vincent, Marc; Beaune, Philippe] Ctr Univ St Peres, INSERM, U775, Paris, France; [Pallet, Nicolas; Beaune, Philippe] Hop Europeen Georges Pompidou, AP HP, Serv Biochim, Paris, France; [Pallet, Nicolas; Chauvet, Sophie; Levi, Charlene; Nga-Matsogo, Diane; Thervet, Eric; Karras, Alexandre] Hop Europeen Georges Pompidou, AP HP, Serv Nephrol, Paris, France; [Meas-Yedid, Vannary; Olivo-Marin, Jean-Christophe] Inst Pasteur, Unite Anal Image Quantitat, Paris, France; [Avillach, Paul] Hop Europeen Georges Pompidou, AP HP, Dept Informat Med, Paris, France; [Pallet, Nicolas; Chasse, Jean-Francois; Avillach, Paul; Beaune, Philippe; Thervet, Eric] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Pallet, N (corresponding author), Ctr Univ St Peres, INSERM, U775, Paris, France.	npallet@yahoo.fr	Olivo-Marin, Jean-Christophe/K-4428-2015	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Beaune, Philippe/0000-0002-6569-9014; Pallet, Nicolas/0000-0002-8486-3596				Amer H, 2007, AM J TRANSPLANT, V7, P2748, DOI 10.1111/j.1600-6143.2007.02006.x; Amer H, 2013, AM J TRANSPLANT, V13, P676, DOI 10.1111/ajt.12044; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Cravedi P, 2012, NAT REV NEPHROL, V8, P301, DOI 10.1038/nrneph.2012.42; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; El Ghoul B, 2010, CLIN J AM SOC NEPHRO, V5, P205, DOI 10.2215/CJN.06610909; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Gressner A, 1995, PROTEINSTOFFWECHEL; Halimi JM, 2007, AM J TRANSPLANT, V7, P2775, DOI 10.1111/j.1600-6143.2007.02010.x; Hertig A, 2008, J AM SOC NEPHROL, V19, P1584, DOI 10.1681/ASN.2007101160; Iwasawa H, 2013, NEPHROLOGY, V18, P285, DOI 10.1111/nep.12039; Kirsztajn GM, 2002, NEPHRON, V90, P424; Levey AS, 1999, J AM SOC NEPHROL, V10, P2426; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Meas-Yedid V, 2011, TRANSPLANTATION, V92, P890, DOI 10.1097/TP.0b013e31822d879a; Mirkovic K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055887; PARVIAINEN MT, 1983, CLIN CHEM, V29, P853; Post AR, 2013, J BIOMED INFORM, V46, P410, DOI 10.1016/j.jbi.2013.01.005; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Servais A, 2007, TRANSPLANTATION, V84, P1595, DOI 10.1097/01.tp.0000295749.50525.bd; TOMLINSON PA, 1992, PEDIATR NEPHROL, V6, P565, DOI 10.1007/BF00866510; Twyman SJ, 2000, CLIN CHIM ACTA, V297, P155, DOI 10.1016/S0009-8981(00)00242-4; van den Brand JAJG, 2011, CLIN J AM SOC NEPHRO, V6, P2846, DOI 10.2215/CJN.04020411; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	25	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84708	10.1371/journal.pone.0084708	http://dx.doi.org/10.1371/journal.pone.0084708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416268	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500151
J	Rubsamen, D; Kunze, MM; Buderus, V; Brauss, TF; Bajer, MM; Brune, B; Schmid, T				Ruebsamen, Daniela; Kunze, Michael M.; Buderus, Victoria; Brauss, Thilo F.; Bajer, Magdalena M.; Bruene, Bernhard; Schmid, Tobias			Inflammatory Conditions Induce IRES-Dependent Translation of cyp24a1	PLOS ONE			English	Article							INTERNAL RIBOSOME ENTRY; MESSENGER-RNA TRANSLATION; SITE-MEDIATED TRANSLATION; CELL STRESS; CANCER; INITIATION; EXPRESSION; PROTEIN; MTOR; PHOSPHORYLATION	Rapid alterations in protein expression are commonly regulated by adjusting translation. In addition to cap-dependent translation, which is e. g. induced by pro-proliferative signaling via the mammalian target of rapamycin (mTOR)-kinase, alternative modes of translation, such as internal ribosome entry site (IRES)-dependent translation, are often enhanced under stress conditions, even if cap-dependent translation is attenuated. Common stress stimuli comprise nutrient deprivation, hypoxia, but also inflammatory signals supplied by infiltrating immune cells. Yet, the impact of inflammatory microenvironments on translation in tumor cells still remains largely elusive. In the present study, we aimed at identifying translationally deregulated targets in tumor cells under inflammatory conditions. Using polysome profiling and microarray analysis, we identified cyp24a1 (1,25-dihydroxyvitamin D-3 24-hydroxylase) to be translationally upregulated in breast tumor cells co-cultured with conditioned medium of activated monocyte-derived macrophages (CM). Using bicistronic reporter assays, we identified and validated an IRES within the 59 untranslated region (5'UTR) of cyp24a1, which enhances translation of cyp24a1 upon CM treatment. Furthermore, IRES-dependent translation of cyp24a1 by CM was sensitive to phosphatidylinositol-3-kinase (PI3K) inhibition, while constitutive activation of Akt sufficed to induce its IRES activity. Our data provide evidence that cyp24a1 expression is translationally regulated via an IRES element, which is responsive to an inflammatory environment. Considering the negative feedback impact of cyp24a1 on the vitamin D responses, the identification of a novel, translational mechanism of cyp24a1 regulation might open new possibilities to overcome the current limitations of vitamin D as tumor therapeutic option.	[Ruebsamen, Daniela; Kunze, Michael M.; Buderus, Victoria; Brauss, Thilo F.; Bajer, Magdalena M.; Bruene, Bernhard; Schmid, Tobias] Goethe Univ Frankfurt, Inst Biochem 1, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Schmid, T (corresponding author), Goethe Univ Frankfurt, Inst Biochem 1, D-60054 Frankfurt, Germany.	T.Schmid@biochem.uni-frankfurt.de		Schmid, Tobias/0000-0002-1952-5259	DFG [SCHM2663, GRK1172]; LOEWE-Schwerpunkt OSF [III L 4-518/55.004 (2009)]; Hessian Ministry of Higher Education, Research and Arts	DFG(German Research Foundation (DFG)); LOEWE-Schwerpunkt OSF; Hessian Ministry of Higher Education, Research and Arts	This work was supported by the DFG (SCHM2663; GRK1172) and the LOEWE-Schwerpunkt OSF [III L 4-518/55.004 (2009)] funded by the Hessian Ministry of Higher Education, Research and Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Balla B, 2011, THYROID, V21, P459, DOI 10.1089/thy.2010.0420; Blagden SP, 2011, NAT REV CLIN ONCOL, V8, P280, DOI 10.1038/nrclinonc.2011.16; CHEN KS, 1995, BBA-GENE STRUCT EXPR, V1263, P1, DOI 10.1016/0167-4781(95)00060-T; Coldwell MJ, 2000, ONCOGENE, V19, P899, DOI 10.1038/sj.onc.1203407; Dhamija S, 2011, J BIOL CHEM, V286, P33279, DOI 10.1074/jbc.M111.264754; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hobaus J, 2013, INT J CANC; Holcik M, 2004, CURR CANCER DRUG TAR, V4, P299, DOI 10.2174/1568009043333005; Horvath E, 2012, ANTICANCER RES, V32, P4791; Horvath HC, 2010, J HISTOCHEM CYTOCHEM, V58, P277, DOI 10.1369/jhc.2009.954339; Kobayashi N, 2003, BLOOD, V102, P3186, DOI 10.1182/blood-2003-02-0567; Konno Y, 2009, MOL PHARMACOL, V75, P265, DOI 10.1124/mol.108.051904; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Lewis SM, 2005, CELL DEATH DIFFER, V12, P547, DOI 10.1038/sj.cdd.4401602; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Moreau A, 2007, BIOCHEM BIOPH RES CO, V360, P76, DOI 10.1016/j.bbrc.2007.06.003; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Petz M, 2012, NUCLEIC ACIDS RES, V40, P9738, DOI 10.1093/nar/gks760; Rubsamen D, 2012, RNA, V18, P1910, DOI 10.1261/rna.033019.112; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Schmid T, 2011, CARCINOGENESIS, V32, P1427, DOI 10.1093/carcin/bgr131; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2005, BIOCHEM SOC T, V33, P1483, DOI 10.1042/BST0331483; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Yasuda M, 2010, MOL CARCINOGEN, V49, P837, DOI 10.1002/mc.20660	38	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85314	10.1371/journal.pone.0085314	http://dx.doi.org/10.1371/journal.pone.0085314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416388	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500237
J	Kim, Y; Kim, J; Jang, SW; Ko, J				Kim, Y.; Kim, J.; Jang, S-W; Ko, J.			The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer	ONCOGENE			English	Article						prostate cancer; androgen receptor; sLZIP; cyclin D3	CELLS; MECHANISMS; GROWTH; GENE; D3; PROGRESSION; EXPRESSION; RAPAMYCIN; INVASION; COMPLEX	Androgen and the androgen receptor (AR) have important roles in prostate cancer (PCa) development, and androgen ablation has been the main therapeutic option for the treatment of PCa. However, the transition mechanism from androgen-dependent to -independent PCa after androgen depletion remains unclear. We investigated the distinct roles of small leucine zipper protein (sLZIP) in proliferation of androgen-dependent and -independent PCa cells. Cyclin D3 is known to interact with AR and attenuates the ligand-dependent function of AR in PCa cells. sLZIP regulates the transcription of cyclin D3 by binding directly to the AP-1 region in the cyclin D3 promoter. sLZIP represses AR transcriptional activity by interaction with AR that is phosphorylated by cyclin D3/cyclin-dependent kinase11(p58), leading to the suppression of androgen-dependent proliferation of PCa cells. The expression level of sLZIP is elevated in androgen-independent PCa cells and advanced human prostate tumors. Knockdown of endogenous sLZIP suppresses proliferation of androgen-independent PCa cells. LNCaP cells transformed to androgen-independent PCa cells exhibit increased expressions of sLZIP and cyclin D3. Tumor formation is inhibited in nude mouse xenografts from two androgen-independent PCa cells that are stably transfected with sh-sLZIP. Our findings indicate that sLZIP negatively regulates AR transactivation in androgen-dependent PCa cells and functions as a positive regulator in tumor progression of androgen-independent PCa. sLZIP contributes to the malignant phenotype of PCa and constitutes a novel therapeutic target for human PCa.	[Kim, Y.; Kim, J.; Ko, J.] Korea Univ, Div Life Sci, Seoul 136701, South Korea; [Jang, S-W] Univ Ulsan, Grad Sch, Dept Med, Seoul, South Korea	Korea University; University of Ulsan	Ko, J (corresponding author), Korea Univ, Div Life Sci, 5-1 Anam Dong, Seoul 136701, South Korea.	jesangko@korea.ac.kr			Korea University; Basic Research Laboratory Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0087099]	Korea University; Basic Research Laboratory Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by a Korea University Grant and the Basic Research Laboratory Program (2009-0087099) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology.	Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Compagno D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001006; Cui JJ, 2011, CELL MOL LIFE SCI, V68, P1091, DOI 10.1007/s00018-010-0511-7; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Garcia-Morales P, 2006, MOL CANCER THER, V5, P2172, DOI 10.1158/1535-7163.MCT-05-0363; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Henzinger T, 1998, J BIOL CHEM, V273, P14958, DOI 10.1074/jbc.273.24.14958; Hleb M, 2004, J BIOL CHEM, V279, P31948, DOI 10.1074/jbc.M400638200; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Jang SY, 2012, CANCER LETT, V314, P185, DOI 10.1016/j.canlet.2011.09.028; Kang H, 2011, J BIOL CHEM, V286, P42072, DOI 10.1074/jbc.M111.272302; Kang H, 2009, MOL ENDOCRINOL, V23, P1746, DOI 10.1210/me.2009-0009; Li YR, 2009, CANCER RES, V69, P3332, DOI 10.1158/0008-5472.CAN-08-3380; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Lu S, 1999, ENDOCRINOLOGY, V140, P5054, DOI 10.1210/en.140.11.5054; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Olshavsky NA, 2008, ONCOGENE, V27, P3111, DOI 10.1038/sj.onc.1210981; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; REISMAN D, 1995, MOL ENDOCRINOL, V9, P1500, DOI 10.1210/me.9.11.1500; Tilley WD, 1996, CLIN CANCER RES, V2, P277; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Zong HL, 2007, MOL CELL BIOL, V27, P7125, DOI 10.1128/MCB.01753-06	25	14	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 8	2015	34	2					226	236		10.1038/onc.2013.538	http://dx.doi.org/10.1038/onc.2013.538			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AY8FS	24441043				2022-12-25	WOS:000347790500010
J	Fritsch, J; Siebert, E; Priebe, J; Zebger, I; Lendzian, F; Teutloff, C; Friedrich, B; Lenz, O				Fritsch, Johannes; Siebert, Elisabeth; Priebe, Jacqueline; Zebger, Ingo; Lendzian, Friedhelm; Teutloff, Christian; Friedrich, Baerbel; Lenz, Oliver			Rubredoxin-related Maturation Factor Guarantees Metal Cofactor Integrity during Aerobic Biosynthesis of Membrane-bound [NiFe] Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Bioenergetics; Electron Transfer Complex; Biophysics; Electron Paramagnetic Resonance (EPR); Electron Transfer; Energy Metabolism; Enzyme Catalysis; Membrane Enzymes; Metalloproteins; Protein Chemistry	RALSTONIA-EUTROPHA H16; OXYGEN-TOLERANT HYDROGENASE; FE-S CLUSTERS; LOW-LEVEL H-2; ESCHERICHIA-COLI; ACTIVE-SITE; RHIZOBIUM-LEGUMINOSARUM; AQUIFEX-AEOLICUS; OXIDIZED STATES; 4FE-3S CLUSTER	Background: Biosynthesis of complex metal cofactors in [NiFe] hydrogenase is sensitive toward molecular oxygen. Results: A rubredoxin-like protein is required for hydrogenase maturation under aerobic conditions. Conclusion: The rubredoxin-like protein prevents oxidative damage of metallocenters, including the recently discovered [4Fe3S] center. Significance: Dedicated protection mechanisms enable biosynthesis of sophisticated metal centers in the presence of dioxygen. The membrane-bound [NiFe] hydrogenase (MBH) supports growth of Ralstonia eutropha H16 with H-2 as the sole energy source. The enzyme undergoes a complex biosynthesis process that proceeds during cell growth even at ambient O-2 levels and involves 14 specific maturation proteins. One of these is a rubredoxin-like protein, which is essential for biosynthesis of active MBH at high oxygen concentrations but dispensable under microaerobic growth conditions. To obtain insights into the function of HoxR, we investigated the MBH protein purified from the cytoplasmic membrane of hoxR mutant cells. Compared with wild-type MBH, the mutant enzyme displayed severely decreased hydrogenase activity. Electron paramagnetic resonance and infrared spectroscopic analyses revealed features resembling those of O-2-sensitive [NiFe] hydrogenases and/or oxidatively damaged protein. The catalytic center resided partially in an inactive Ni-u-A-like state, and the electron transfer chain consisting of three different Fe-S clusters showed marked alterations compared with wild-type enzyme. Purification of HoxR protein from its original host, R. eutropha, revealed only low protein amounts. Therefore, recombinant HoxR protein was isolated from Escherichia coli. Unlike common rubredoxins, the HoxR protein was colorless, rather unstable, and essentially metal-free. Conversion of the atypical iron-binding motif into a canonical one through genetic engineering led to a stable reddish rubredoxin. Remarkably, the modified HoxR protein did not support MBH-dependent growth at high O-2. Analysis of MBH-associated protein complexes points toward a specific interaction of HoxR with the Fe-S cluster-bearing small subunit. This supports the previously made notion that HoxR avoids oxidative damage of the metal centers of the MBH, in particular the unprecedented Cys(6)[4Fe-3S] cluster.	[Fritsch, Johannes; Friedrich, Baerbel; Lenz, Oliver] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany; [Siebert, Elisabeth; Priebe, Jacqueline; Zebger, Ingo; Lendzian, Friedhelm; Lenz, Oliver] Tech Univ Berlin, Inst Chem, Max Volmer Lab, D-10623 Berlin, Germany; [Teutloff, Christian] Free Univ Berlin, Inst Phys, D-14195 Berlin, Germany	Humboldt University of Berlin; Technical University of Berlin; Free University of Berlin	Lenz, O (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Chausseestr 117, D-10115 Berlin, Germany.	oliver.lenz@tu-berlin.de	Lenz, Oliver/C-1582-2019; Lenz, Oliver/N-5130-2019	Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128	European Union/Energy Network Project FP7 SOLAR-H2 Program [212508]; Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Unifying Concepts in Catalysis"	European Union/Energy Network Project FP7 SOLAR-H2 Program; Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Unifying Concepts in Catalysis"(German Research Foundation (DFG))	This work was supported by the European Union/Energy Network Project FP7 SOLAR-H2 Program Contract 212508 and by the Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Unifying Concepts in Catalysis."	Albareda M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-256; ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Bonomi F, 1998, J BIOL INORG CHEM, V3, P595, DOI 10.1007/s007750050272; Bruska MK, 2013, DALTON T, V42, P8729, DOI 10.1039/c3dt50763g; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Capozzi F, 1998, STRUCT BOND, V90, P127; Cracknell JA, 2009, P NATL ACAD SCI USA, V106, P20681, DOI 10.1073/pnas.0905959106; Cramm R, 2009, J MOL MICROB BIOTECH, V16, P38, DOI 10.1159/000142893; Darensbourg MY, 2011, EUR J INORG CHEM, P994, DOI 10.1002/ejic.201001148; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Frielingsdorf S, 2011, BIOCHEMISTRY-US, V50, P10836, DOI 10.1021/bi201594m; Fritsch J, 2013, NAT REV MICROBIOL, V11, P106, DOI 10.1038/nrmicro2940; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Fritsch J, 2011, BIOCHEMISTRY-US, V50, P5858, DOI 10.1021/bi200367u; Fritsch J, 2011, J BACTERIOL, V193, P2487, DOI 10.1128/JB.01427-10; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; Horch M, 2012, FEBS LETT, V586, P545, DOI 10.1016/j.febslet.2011.10.010; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Lukey MJ, 2011, J AM CHEM SOC, V133, P16881, DOI 10.1021/ja205393w; MA K, 1993, P NATL ACAD SCI USA, V90, P5341, DOI 10.1073/pnas.90.11.5341; Manyani H, 2005, J BACTERIOL, V187, P7018, DOI 10.1128/JB.187.20.7018-7026.2005; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Parish David, 2008, Journal of Structural and Functional Genomics, V9, P41, DOI 10.1007/s10969-008-9050-y; Parkin A, 2012, CURR OPIN CHEM BIOL, V16, P26, DOI 10.1016/j.cbpa.2012.01.012; Parkin A, 2012, FEBS LETT, V586, P536, DOI 10.1016/j.febslet.2011.07.044; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; RAGSDALE SW, 1983, J BACTERIOL, V155, P1224, DOI 10.1128/JB.155.3.1224-1237.1983; Richie KA, 1996, PROTEIN SCI, V5, P883; Rodrigues JV, 2005, BIOCHEM BIOPH RES CO, V329, P1300, DOI 10.1016/j.bbrc.2005.02.114; Roessler MM, 2012, J AM CHEM SOC, V134, P15581, DOI 10.1021/ja307117y; Saggu M, 2010, CHEMPHYSCHEM, V11, P1215, DOI 10.1002/cphc.200900988; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; Schafer C, 2013, APPL ENVIRON MICROB, V79, P5137, DOI 10.1128/AEM.01576-13; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; Schwartz E., 2013, PROKARYOTES PROKARYO, P119, DOI [DOI 10.1007/978-3-642-30141-4_65, 10.1007/978-3-642-30141-4_65]; SEKI S, 1988, J BIOCHEM-TOKYO, V103, P583, DOI 10.1093/oxfordjournals.jbchem.a122310; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; van Beilen JB, 2002, J BACTERIOL, V184, P1722, DOI 10.1128/JB.184.6.1722-1732.2002; van Gastel M, 2006, J BIOL INORG CHEM, V11, P41, DOI 10.1007/s00775-005-0048-7; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; Wait AF, 2010, J PHYS CHEM C, V114, P12003, DOI 10.1021/jp102616m; Zbell AL, 2007, MICROBIOL-SGM, V153, P3508, DOI 10.1099/mic.0.2007/009027-0	64	7	7	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7982	7993		10.1074/jbc.M113.544668	http://dx.doi.org/10.1074/jbc.M113.544668			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24448806	Green Published, hybrid			2022-12-25	WOS:000332761500062
J	Kantamneni, S; Gonzalez-Gonzalez, IM; Luo, J; Cimarosti, H; Jacobs, SC; Jaafari, N; Henley, JM				Kantamneni, Sriharsha; Gonzalez-Gonzalez, Immaculada M.; Luo, Jia; Cimarosti, Helena; Jacobs, Susan C.; Jaafari, Nadia; Henley, Jeremy M.			Differential Regulation of GABA(B) Receptor Trafficking by Different Modes of N-methyl-D-aspartate (NMDA) Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors (GPCR); GABA Receptors; Glutamate Receptor Ionotropic (AMPA; NMDA); Neurodegeneration; Neurotransmitter Receptors; Receptor Endocytosis; Receptor Recycling; GABAB Receptor; Chem-LTP; Oxygen-glucose Deprivation (OGD)	GAMMA-AMINOBUTYRIC-ACID; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; LYSOSOMAL DEGRADATION; RAT HIPPOCAMPUS; AMPA RECEPTORS; SLICE CULTURES; PROTEIN; SUBUNITS; ACTIVATION	Background: Heterodimerization of GABA(B1) and GABA(B2) subunits is required for functional GABA(B)Rs. Results: GABA(B)R subunits are differentially regulated by activation of synaptic or extrasynaptic NMDARs. Conclusion: GABA(B)R trafficking and function is regulated by NMDARs. Significance: GABA(B)Rs are potential targets for treating diseases such as stroke and cerebral ischemia. Inhibitory GABA(B) receptors (GABA(B)Rs) can down-regulate most excitatory synapses in the CNS by reducing postsynaptic excitability. Functional GABA(B)Rs are heterodimers of GABA(B1) and GABA(B2) subunits and here we show that the trafficking and surface expression of GABA(B)Rs is differentially regulated by synaptic or pathophysiological activation of NMDA receptors (NMDARs). Activation of synaptic NMDARs using a chemLTP protocol increases GABA(B)R recycling and surface expression. In contrast, excitotoxic global activation of synaptic and extrasynaptic NMDARs by bath application of NMDA causes the loss of surface GABA(B)Rs. Intriguingly, exposing neurons to extreme metabolic stress using oxygen/glucose deprivation (OGD) increases GABA(B1) but decreases GABA(B2) surface expression. The increase in surface GABA(B1) involves enhanced recycling and is blocked by the NMDAR antagonist AP5. The decrease in surface GABA(B2) is also blocked by AP5 and by inhibiting degradation pathways. These results indicate that NMDAR activity is critical in GABA(B)R trafficking and function and that the individual subunits can be separately controlled to regulate neuronal responsiveness and survival.	[Kantamneni, Sriharsha; Gonzalez-Gonzalez, Immaculada M.; Luo, Jia; Cimarosti, Helena; Jacobs, Susan C.; Jaafari, Nadia; Henley, Jeremy M.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Kantamneni, S (corresponding author), Univ Bradford, Bradford Sch Pharm, Sch Life Sci, Norcroft Bldg, Bradford BD7 1DP, W Yorkshire, England.	s.kantamneni@bradford.ac.uk; J.M.Henley@bristol.ac.uk	Cimarosti, Helena/F-3392-2014; Kantamneni, Sriharsha/G-6504-2012	Kantamneni, Sriharsha/0000-0002-3750-9447; Cimarosti, Helena/0000-0001-5336-480X; Henley, Jeremy/0000-0003-3589-8335; Gonzalez-Gonzalez, Maria Inmaculada/0000-0001-9888-0760	Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); European Research Council; BBSRC [BB/F00723X/1, BB/K014358/1] Funding Source: UKRI; MRC [G0601810] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K014358/1, BB/F00723X/1] Funding Source: researchfish; Medical Research Council [G0601810] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC), and the European Research Council.	Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Calver AR, 2002, NEUROSIGNALS, V11, P299, DOI 10.1159/000068257; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Cimarosti H, 2001, NEUROSCI LETT, V315, P33, DOI 10.1016/S0304-3940(01)02310-2; Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Jaafari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052345; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kantamneni S, 2007, J NEUROCHEM, V100, P1003, DOI 10.1111/j.1471-4159.2006.04271.x; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Laffray S, 2007, EUR J NEUROSCI, V25, P1402, DOI 10.1111/j.1460-9568.2007.05398.x; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lujan R, 2006, EUR J NEUROSCI, V23, P1479, DOI 10.1111/j.1460-9568.2006.04669.x; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; MORRISETT RA, 1991, J NEUROSCI, V11, P203; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Pooler AM, 2007, J BIOL CHEM, V282, P25349, DOI 10.1074/jbc.M702358200; Ramirez OA, 2009, J BIOL CHEM, V284, P13077, DOI 10.1074/jbc.M900575200; Ramoino P, 2005, MICROSC RES TECHNIQ, V68, P290, DOI 10.1002/jemt.20250; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; van der Sluijs P, 2011, SEMIN CELL DEV BIOL, V22, P499, DOI 10.1016/j.semcdb.2011.06.008; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Watanabe M, 2002, INT REV CYTOL, V213, P1; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892	46	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6681	6694		10.1074/jbc.M113.487348	http://dx.doi.org/10.1074/jbc.M113.487348			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425870	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000332389400031
J	Koike, T; Izumikawa, T; Sato, B; Kitagawa, H				Koike, Toshiyasu; Izumikawa, Tomomi; Sato, Ban; Kitagawa, Hiroshi			Identification of Phosphatase That Dephosphorylates Xylose in the Glycosaminoglycan-Protein Linkage Region of Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin Sulfate; Glycosaminoglycan; Glycosyltransferases; Heparan Sulfate; Phosphatase; Phosphorylation; Proteoglycan; Proteoglycan Synthesis	CHONDROITIN SULFATE; MOLECULAR-CLONING; TUMOR SUPPRESSORS; N-ACETYLGALACTOSAMINYLTRANSFERASE; EXT FAMILY; BIOSYNTHESIS; GLUCURONOSYLTRANSFERASE; POLYMERIZATION; EXPRESSION; BETA-1,3-GLUCURONOSYLTRANSFERASE-I	Background: The enzyme responsible for the dephosphorylation of xylose in glycosaminoglycans remains unknown. Results: A protein that removed the phosphate from the phosphorylated linkage trisaccharide and localized in the Golgi was identified. Inhibition of this protein phosphatase resulted in decreased glycosaminoglycan levels in cells. Conclusion: We identified the phosphoxylose phosphatase that regulates glycosaminoglycan synthesis. Significance: Transient phosphorylation of xylose residues controls glycosaminoglycan synthesis. Recently, we demonstrated that FAM20B is a kinase that phosphorylates the xylose (Xyl) residue in the glycosaminoglycan-protein linkage region of proteoglycans. The phosphorylation of Xyl residues by FAM20B enhances the formation of the linkage region. Rapid dephosphorylation is probably induced just after synthesis of the linker and just before polymerization initiates. Indeed, in vitro chondroitin or heparan sulfate polymerization does not occur when the Xyl residue of the tetrasaccharide linkage region is phosphorylated. However, the enzyme responsible for the dephosphorylation of Xyl remains unknown. Here, we identified a novel protein that dephosphorylates the Xyl residue and designated it 2-phosphoxylose phosphatase. The phosphatase efficiently removed the phosphate from the phosphorylated trisaccharide, Gal1-3Gal1-4Xyl(2-O-phosphate), but not from phosphorylated tetrasaccharide, GlcUA1-3Gal1-3Gal1-4Xyl(2-O-phosphate). Additionally, RNA interference-mediated inhibition of 2-phosphoxylose phosphatase resulted in increased amounts of GlcNAc1-4GlcUA1-3Gal1-3Gal1-4Xyl(2-O-phosphate), Gal1-3Gal1-4Xyl(2-O-phosphate), and Gal1-4Xyl(2-O-phosphate) in the cells. Gel filtration analysis of the glycosaminoglycan chains synthesized in the knockdown cells revealed that these cells produced decreased amounts of glycosaminoglycan chains and that the chains had similar lengths to those in the mock-transfected cells. Transcripts encoding this phosphatase were ubiquitously, but differentially, expressed in human tissues. Moreover, the phosphatase localized to the Golgi and interacted with the glucuronyltransferase-I involved in the completion of the glycosaminoglycan-protein linkage region. Based on these findings, we conclude that transient phosphorylation of the Xyl residue in the glycosaminoglycan-protein linkage region controls the formation of glycosaminoglycan chains of proteoglycans.	[Koike, Toshiyasu; Izumikawa, Tomomi; Sato, Ban; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science and Technology, Japan [25293014, 23110003]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research (B) 25293014 (to H. K.) and for Scientific Research on Innovative Areas 23110003 (to H. K.) and by the supported program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.), from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Fansson LA, 2000, MATRIX BIOL, V19, P367, DOI 10.1016/S0945-053X(00)00083-4; FRANSSON LA, 1985, J BIOL CHEM, V260, P4722; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Izumikawa T, 2014, SCI REP-UK, V4, DOI 10.1038/srep03701; Izumikawa T, 2012, BIOCHEM J, V441, P697, DOI 10.1042/BJ20111472; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KITAGAWA H, 1995, J BIOL CHEM, V270, P22190, DOI 10.1074/jbc.270.38.22190; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Mizumoto S, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P289; Moses J, 1999, EUR J BIOCHEM, V260, P879, DOI 10.1046/j.1432-1327.1999.00228.x; Moses J, 1997, EUR J BIOCHEM, V248, P521, DOI 10.1111/j.1432-1033.1997.00521.x; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nadanaka S, 2013, BIOCHEM J, V454, P133, DOI 10.1042/BJ20130323; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; OEGEMA TR, 1984, J BIOL CHEM, V259, P1720; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pedersen LC, 2002, J BIOL CHEM, V277, P21869, DOI 10.1074/jbc.M112343200; Purnomo E, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000405; Sakaguchi H, 2001, J BIOCHEM-TOKYO, V129, P107, DOI 10.1093/oxfordjournals.jbchem.a002820; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Venkatesan N, 2004, P NATL ACAD SCI USA, V101, P18087, DOI 10.1073/pnas.0404504102	35	45	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6695	6708		10.1074/jbc.M113.520536	http://dx.doi.org/10.1074/jbc.M113.520536			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425863	hybrid, Green Published			2022-12-25	WOS:000332389400032
J	Tende, T; Hansson, B; Ottosson, U; Akesson, M; Bensch, S				Tende, Talatu; Hansson, Bengt; Ottosson, Ulf; Akesson, Mikael; Bensch, Staffan			Individual Identification and Genetic Variation of Lions (Panthera leo) from Two Protected Areas in Nigeria	PLOS ONE			English	Article							INBREEDING DEPRESSION; POPULATION-SIZE; CONSERVATION GENETICS; GAME-RESERVE; AFRICAN LION; FECAL DNA; EXTINCTION; SERENGETI; DIVERSITY; TRACKING	This survey was conducted in two protected areas in Nigeria to genetically identify individual lions and to determine the genetic variation within and between the populations. We used faecal sample DNA, a non-invasive alternative to the risky and laborious task of taking samples directly from the animals, often preceded by catching and immobilization. Data collection in Yankari Game Reserve (YGR) spanned through a period of five years (2008 -2012), whereas data in Kainji Lake National Park (KLNP) was gathered for a period of three years (2009, 2010 and 2012). We identified a minimum of eight individuals (2 males, 3 females, 3 unknown) from YGR and a minimum of ten individuals (7 males, 3 females) from KLNP. The two populations were found to be genetically distinct as shown by the relatively high fixation index (F-ST = 0.17) with each population exhibiting signs of inbreeding (YGR F-IS = 0.49, KLNP F-IS = 0.38). The genetic differentiation between the Yankari and Kainji lions is assumed to result from large spatial geographic distance and physical barriers reducing gene flow between these two remaining wild lion populations in Nigeria. To mitigate the probable inbreeding depression in the lion populations within Nigeria it might be important to transfer lions between parks or reserves or to reintroduce lions from the zoos back to the wild.	[Tende, Talatu; Ottosson, Ulf] Univ Jos, Dept Zool, AP Leventis Ornithol Res Inst, Jos, Plateau State, Nigeria; [Tende, Talatu; Hansson, Bengt; Bensch, Staffan] Lund Univ, Dept Biol, Lund, Sweden; [Akesson, Mikael] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	University of Jos; Lund University; Swedish University of Agricultural Sciences	Tende, T (corresponding author), Univ Jos, Dept Zool, AP Leventis Ornithol Res Inst, Jos, Plateau State, Nigeria.	talatu.tende@biol.lu.se	Åkesson, Mikael/K-5370-2014; Hansson, Bengt/L-8874-2013	Hansson, Bengt/0000-0001-6694-8169	Kolmarden zoo conservation fund Sweden; Leventis foundation; Swedish Research Council [621-2009-4945, 621-2010-5277]	Kolmarden zoo conservation fund Sweden; Leventis foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Kolmarden zoo conservation fund Sweden and the Leventis foundation provided the funds for the field and laboratory work. The study was supported by grants from the Swedish Research Council (621-2009-4945 to BH; 621-2010-5277 to SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFOLAYAN TA, 1978, OIKOS, V31, P376, DOI 10.2307/3543665; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Ball SJ, 2000, HEREDITY, V84, P677, DOI 10.1046/j.1365-2540.2000.00721.x; Balme G.A., 2007, J WILDLIFE MANAGE, V73, P433; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Bellemain E, 2004, MOL ECOL NOTES, V4, P519, DOI 10.1111/j.1471-8286.2004.00711.x; Bensch S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000072; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; BROWN EW, 1994, J VIROL, V68, P5953, DOI 10.1128/JVI.68.9.5953-5968.1994; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Coombs JA, 2008, MOL ECOL RESOUR, V8, P578, DOI 10.1111/j.1471-8286.2007.02036.x; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Dunham Jason, 1999, Conservation Ecology, V3, pUnpaginated; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Ernest HB, 2000, MOL ECOL, V9, P433, DOI 10.1046/j.1365-294x.2000.00890.x; Ernest HB, 2003, CONSERV GENET, V4, P353, DOI 10.1023/A:1024069014911; Frankel O. H., 1970, Proceedings of the Linnean Society, New South Wales, V95, P158; FRANKEL OH, 1974, GENETICS, V78, P53; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Frankham R., 2002, INTRO CONSERVATION G; Frankham Richard, 2004, P85, DOI 10.1017/CBO9780511542022.008; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; GILBERT DA, 1991, J HERED, V82, P378, DOI 10.1093/oxfordjournals.jhered.a111107; Goudet J., 2002, FSTAT COMPUTER PROGR; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; Higgins K, 2001, P NATL ACAD SCI USA, V98, P2928, DOI 10.1073/pnas.031358898; Jackson P., 1996, BIOL CONSERVATION; Kays RW, 2002, CAN J ZOOL, V80, P471, DOI 10.1139/Z02-024; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; KENDALL KC, 1992, ECOL APPL, V2, P422, DOI 10.2307/1941877; Kohn MH, 1999, P ROY SOC B-BIOL SCI, V266, P657, DOI 10.1098/rspb.1999.0686; Lacy Robert C., 2000, Ecological Bulletins, V48, P39; Laikre L, 1996, BIOL CONSERV, V76, P69, DOI 10.1016/0006-3207(95)00084-4; Laikre L, 1999, HEREDITAS, V130, P203, DOI 10.1111/j.1601-5223.1999.00203.x; LAIKRE L, 1991, CONSERV BIOL, V5, P33, DOI 10.1111/j.1523-1739.1991.tb00385.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LANDE R, 1995, CONSERV BIOL, V9, P782, DOI 10.1046/j.1523-1739.1995.09040782.x; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lehmann MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003998; Liberg O, 2005, BIOL LETT-UK, V1, P17, DOI 10.1098/rsbl.2004.0266; Lyke MM, 2013, MOL ECOL, V22, P2787, DOI 10.1111/mec.12279; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Morris DW, 2009, ANN NY ACAD SCI, V1162, P334, DOI 10.1111/j.1749-6632.2009.04494.x; Munson L, 1996, J REPROD FERTIL, V108, P11, DOI 10.1530/jrf.0.1080011; Murphy MA, 2002, CONSERV GENET, V3, P435, DOI 10.1023/A:1020503330767; Nyanganji G, 2012, 2011 SURVEY LION PAN; OBRIEN SJ, 1987, NATL GEOGR RES, V3, P114; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piggott MP, 2004, CONSERV GENET, V5, P417, DOI 10.1023/B:COGE.0000031138.67958.44; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Saccheri IJ, 2002, P ROY SOC B-BIOL SCI, V269, P1073, DOI 10.1098/rspb.2002.1963; Sargeant G.A., 2011, WILD1 R TOOLS WILDLI; Schwartz MK, 1998, ANIM CONSERV, V1, P293, DOI 10.1111/j.1469-1795.1998.tb00040.x; Seddon JM, 2005, CONSERV GENET, V6, P147, DOI 10.1007/s10592-004-7734-9; Shankaranarayanan P, 1997, ELECTROPHORESIS, V18, P1693, DOI 10.1002/elps.1150180938; SLATKIN M, 1995, GENETICS, V139, P457; SPIELMAN D, 1992, ZOO BIOL, V11, P343, DOI 10.1002/zoo.1430110506; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; Spong G, 2001, P ROY SOC B-BIOL SCI, V268, P2571, DOI 10.1098/rspb.2001.1835; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tende T, 2010, J AFR ECOL, V59, P7; Uphyrkina O, 2003, CR BIOL, V326, P93, DOI DOI 10.1016/S1631-0691(03)00044-1; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; WILDT DE, 1987, NATURE, V329, P328, DOI 10.1038/329328a0; Wilson DE, 2009, HDB MAMMALS WORLD, V1; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woods JG, 1999, WILDLIFE SOC B, V27, P616; Zhang HM, 2009, CONSERV GENET, V10, P589, DOI 10.1007/s10592-008-9576-3	91	10	10	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84288	10.1371/journal.pone.0084288	http://dx.doi.org/10.1371/journal.pone.0084288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427283	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200023
J	Caldwell, LK; Pierce, AL; Riley, LG; Duncan, CA; Nagler, JJ				Caldwell, Lucius K.; Pierce, Andrew L.; Riley, Larry G.; Duncan, Christine A.; Nagler, James J.			Plasma Nesfatin-1 Is Not Affected by Long-Term Food Restriction and Does Not Predict Rematuration among Iteroparous Female Rainbow Trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; EARLY SEXUAL-MATURATION; SALMON SALMO-SALAR; GROWTH-FACTOR-I; GENE-EXPRESSION; COHO SALMON; FISH GONADOTROPINS; ENDOCRINE FACTORS; METABOLIC-RATE; PUBERTY ONSET	The metabolic peptide hormone nesfatin-1 has been linked to the reproductive axis in fishes. The purpose of this study was to determine how energy availability after spawning affects plasma levels of nesfatin-1, the metabolic peptide hormone ghrelin, and sex steroid hormones in rematuring female rainbow trout (Oncorhynchus mykiss). To limit reproductive maturation, a group of female trout was food-restricted after spawning and compared with a control group that was fed a standard broodstock ration. The experiment was conducted twice, once using two-year-old trout (second-time spawners) and once using three-year-old trout (third-time spawners). During monthly sampling, blood was collected from all fish, and a subset of fish from each treatment was sacrificed for pituitaries. Pituitary follicle-stimulating hormone-beta (fsh-beta) mRNA expression was analyzed with q-RT-PCR; plasma hormone levels were quantified by radioimmunoassay (17 beta-estradiol and ghrelin) and enzyme-linked immunosorbent assay (11-keto-testosterone and nesfatin-1). Although plasma nesfatin-1 levels increased significantly in the months immediately after spawning within both feeding treatments, plasma nesfatin-1 did not differ significantly between the two treatments at any point. Similarly, plasma ghrelin levels did not differ significantly between the two treatments at any point. Food restriction arrested ovarian development by 15-20 weeks after spawning, shown by significantly lower plasma E2 levels among restricted-ration fish. Pituitary fsh-beta mRNA levels were higher among control-ration fish than restricted-ration fish starting at 20 weeks, but did not differ significantly between treatment groups until 30 weeks after spawning. Within both treatment groups, plasma 11-KT was elevated immediately after spawning and rapidly decreased to and persisted at low levels; starting between 20 and 25 weeks after spawning, plasma 11-KT was higher among control-ration fish than restricted-ration fish. The results from these experiments do not provide support for plasma nesfatin-1 as a signal for the initiation of reproductive development in rematuring female rainbow trout.	[Caldwell, Lucius K.; Pierce, Andrew L.; Nagler, James J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Caldwell, Lucius K.; Pierce, Andrew L.; Nagler, James J.] Univ Idaho, Ctr Reprod Biol, Moscow, ID 83843 USA; [Pierce, Andrew L.] Columbia River Intertribal Fish Commiss, Portland, OR USA; [Riley, Larry G.; Duncan, Christine A.] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA	Idaho; University of Idaho; Idaho; University of Idaho; California State University System; California State University Fresno	Caldwell, LK (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	cald0653@vandals.uidaho.edu	Pierce, Andrew/X-2332-2019	Pierce, Andrew/0000-0002-2096-6043	Bonneville Power Administration (CRITFC) [2007-401-00]	Bonneville Power Administration (CRITFC)	This research was funded by the Bonneville Power Administration (www.bpa.gov) (CRITFC (www.critfc.org) Project 2007-401-00, Steelhead Kelt Reconditioning and Reproductive Success Evaluation Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, ZOOL SCI, V14, P1, DOI 10.2108/zsj.14.1; Ando H, 2004, GEN COMP ENDOCR, V137, P109, DOI 10.1016/j.ygcen.2004.02.012; Augustine S, 2011, COMP BIOCHEM PHYS A, V159, P275, DOI 10.1016/j.cbpa.2011.03.016; Baker DM, 2000, BIOL REPROD, V63, P865, DOI 10.1095/biolreprod63.3.865; Banerjee A, 2008, GEN COMP ENDOCR, V155, P827, DOI 10.1016/j.ygcen.2007.09.016; BAROILLER JF, 1987, GEN COMP ENDOCR, V66, P85, DOI 10.1016/0016-6480(87)90353-4; Barreiro ML, 2004, MOL CELL ENDOCRINOL, V226, P1, DOI 10.1016/j.mce.2004.07.015; Bobe J, 2010, MOL CELL ENDOCRINOL, V316, P66, DOI 10.1016/j.mce.2009.09.017; Broggi J, 2007, FUNCT ECOL, V21, P528, DOI 10.1111/j.1365-2435.2007.01255.x; Caldwell LK, 2013, GEN COMP ENDOCR, V194, P124, DOI 10.1016/j.ygcen.2013.09.005; Campbell B, 2003, FISH PHYSIOL BIOCHEM, V28, P287, DOI 10.1023/B:FISH.0000030557.60141.33; Carrillo M, 2009, ANN NY ACAD SCI, V1163, P49, DOI 10.1111/j.1749-6632.2008.03645.x; Castellano JM, 2011, ENDOCRINOLOGY, V152, P3396, DOI 10.1210/en.2010-1415; CHADWICK EMP, 1987, CAN J FISH AQUAT SCI, V44, P1320, DOI 10.1139/f87-156; Davies B, 1999, GEN COMP ENDOCR, V115, P155, DOI 10.1006/gcen.1999.7301; Ebling FJP, 2000, NEUROREPORT, V11, pR23, DOI 10.1097/00001756-200011090-00002; Feng KE, 2013, J EXPT ZOOLOGY A; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254, P127, DOI 10.1016/j.mce.2006.04.026; Forsgren KL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098772; Frantzen M, 2004, J FISH BIOL, V65, P1526, DOI 10.1111/j.0022-1112.2004.00564.x; FUKAGAWA NK, 1990, AM J PHYSIOL, V259, pE233, DOI 10.1152/ajpendo.1990.259.2.E233; Goebel M, 2009, GASTROENTEROLOGY, V136, pA584; Gonzalez R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099630; Gonzalez R, 2012, GEN COMP ENDOCR, V176, P341, DOI 10.1016/j.ygcen.2011.11.021; Gonzalez R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015201; Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593; Hevroy EM, 2012, GEN COMP ENDOCR, V175, P118, DOI 10.1016/j.ygcen.2011.10.007; Hook SE, 2011, ENVIRON TOXICOL CHEM, V30, P309, DOI 10.1002/etc.407; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; James MO, 2011, J STEROID BIOCHEM, V127, P167, DOI 10.1016/j.jsbmb.2010.10.003; Jonsson E, 2013, GEN COMP EN IN PRESS; Jonsson E, 2007, COMP BIOCHEM PHYS A, V147, P1116, DOI 10.1016/j.cbpa.2007.03.024; Jonsson E, 2010, GEN COMP ENDOCR, V166, P39, DOI 10.1016/j.ygcen.2009.11.001; Kah O, 2009, FISH PHYSIOL, V28, P75, DOI 10.1016/S1546-5098(09)28002-2; Kennedy J, 2008, J FISH BIOL, V72, P78, DOI 10.1111/j.1095-8649.2007.01651.x; Kerbel B, 2012, J NEUROENDOCRINOL, V24, P366, DOI 10.1111/j.1365-2826.2011.02246.x; King HR, 2003, AQUACULTURE, V219, P797, DOI 10.1016/S0044-8486(02)00647-6; Kitazawa T, 2012, GEN COMP ENDOCR, V178, P539, DOI 10.1016/j.ygcen.2012.06.025; Kortner TM, 2009, COMP BIOCHEM PHYS A, V152, P304, DOI 10.1016/j.cbpa.2008.11.001; Lents CA, 2013, DOMEST ANIM ENDOCRIN, V45, P89, DOI 10.1016/j.domaniend.2013.06.002; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Lokman PM, 2002, GEN COMP ENDOCR, V129, P1, DOI 10.1016/S0016-6480(02)00562-2; Mateos J, 2002, COMP BIOCHEM PHYS B, V132, P75, DOI 10.1016/S1096-4959(01)00535-8; Matsubara T, 2003, FISH PHYSIOL BIOCHEM, V28, P295, DOI 10.1023/B:FISH.0000030559.71954.37; McMaster ME, 1992, PROTOCOL MEASURING C; Miandare HK, 2013, GEN COMP ENDOCR, V182, P41, DOI 10.1016/j.ygcen.2012.11.013; Mueller CA, 2012, COMP BIOCHEM PHYS A, V163, P95, DOI 10.1016/j.cbpa.2012.05.190; Munakata A, 2012, AQUACULTURE, V362, P158, DOI 10.1016/j.aquaculture.2010.11.027; Nocillado JN, 2008, MOL REPROD DEV, V75, P355, DOI 10.1002/mrd.20744; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Peterson BC, 2012, GEN COMP ENDOCR, V176, P231, DOI 10.1016/j.ygcen.2012.01.022; Picha ME, 2009, GEN COMP ENDOCR, V161, P365, DOI 10.1016/j.ygcen.2009.01.026; Repaci A, 2011, MOL CELL ENDOCRINOL, V340, P70, DOI 10.1016/j.mce.2011.02.022; Rideout RM, 2005, FISH FISH, V6, P50, DOI 10.1111/j.1467-2679.2005.00174.x; Riley L, 2013, FRONTIERS ENDOCRINOL, V4; Riley LG, 2008, ZOOL SCI, V25, P821, DOI 10.2108/zsj.25.821; Roa J, 2010, MOL CELL ENDOCRINOL, V324, P87, DOI 10.1016/j.mce.2009.12.018; Setiawan AN, 2012, GEN COMP ENDOCR, V176, P132, DOI 10.1016/j.ygcen.2011.12.041; Shearer K, 2006, AQUACULTURE, V252, P545, DOI 10.1016/j.aquaculture.2005.06.027; Shearer KD, 2000, AQUACULTURE, V190, P343, DOI 10.1016/S0044-8486(00)00406-3; Shepperd E, 2012, GEN COMP ENDOCR, V176, P426, DOI 10.1016/j.ygcen.2012.01.014; Shimokata H, 1993, Nihon Ronen Igakkai Zasshi, V30, P572; Skillman AD, 2006, ENVIRON TOXICOL CHEM, V25, P2997, DOI 10.1897/05-565R.1; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Tena-Sempere M, 2005, GROWTH HORM IGF RES, V15, P83, DOI 10.1016/j.ghir.2005.02.001; Tena-Sempere M, 2012, EUR J ENDOCRINOL, V167, P733, DOI 10.1530/EJE-12-0669; Unniappan S, 2010, GEN COMP ENDOCR, V167, P340, DOI 10.1016/j.ygcen.2009.12.003; Vacher C, 2002, GEN COMP ENDOCR, V127, P198, DOI 10.1016/S0016-6480(02)00046-1; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; Yamamoto Y, 2011, GEN COMP ENDOCR, V172, P331, DOI 10.1016/j.ygcen.2011.03.017; Yaron Z, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1500; Yaron Z, 2003, INT REV CYTOL, V225, P131, DOI 10.1016/S0074-7696(05)25004-0; You L, 2004, CHEM-BIOL INTERACT, V147, P233, DOI 10.1016/j.cbi.2004.01.006; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	74	24	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85700	10.1371/journal.pone.0085700	http://dx.doi.org/10.1371/journal.pone.0085700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416444	gold, Green Published, Green Submitted			2022-12-25	WOS:000329866300099
J	Katan, M; Moon, YP; Paik, MC; Wolfert, RL; Sacco, RL; Elkind, MSV				Katan, Mira; Moon, Yeseon P.; Paik, Myunghee C.; Wolfert, Robert L.; Sacco, Ralph L.; Elkind, Mitchell S. V.			Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ISCHEMIC-STROKE; CEREBRAL INFARCTION; RECURRENT STROKE; A(2) ACTIVITY; DISEASE; RACE; COHORT; SEX; ETHNICITY	Background: Lipoprotein-associated phospholipase A2 (LpPLA2) levels are associated with stroke, though whether this extends to all populations and stroke subtypes is unknown. Methods: Serum samples from stroke-free community participants in the Northern Manhattan Study were assayed for LpPLA2 mass and activity. Participants were followed annually for stroke. Cox-proportional-hazard models were fitted to estimate hazard-ratios and 95% confidence intervals (HR, 95% CI) for the association of LpPLA2 levels with ischemic stroke (IS), after adjusting for demographic and medical risk factors. Results: Serum samples were available in 1946 participants, of whom 151 (7.8%) experienced a first IS during median followup 11 years. Mean age was 69 (SD 10), 35.6% were men, 20% non-Hispanic Whites, 22% non-Hispanic Blacks, and 55% Hispanics. LpPLA2 mass and activity levels were not associated with overall IS risk. LpPLA2 mass but not activity levels were associated with strokes due to large artery atherosclerosis (LAA; adjusted HR per SD 1.55, 95% CI 1.17-2.04). There was a dose-response relationship with LAA (compared to first quartile, 2nd quartile HR = 1.43, 95% CI 0.23-8.64; 3rd quartile HR = 4.47, 95% CI 0.93-21.54; 4th quartile HR = 5.07, 95% CI 1.07-24.06). The associations between LpPLA2-mass and LAA-stroke risk differed by race-ethnicity (p = 0.01); LpPLA2-mass was associated with increased risk of LAA among non-Hispanic Whites (adjusted HR per SD 1.44, 95% CI 0.98-2.11), but not other race-ethnic groups. Conclusion: LpPLA2-mass levels were associated with risk of atherosclerotic stroke among non-Hispanic White participants, but not in other race-ethnic groups in the cohort. Further study is needed to confirm these race-ethnic differences and the reasons for them.	[Katan, Mira; Moon, Yeseon P.; Elkind, Mitchell S. V.] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Katan, Mira] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Paik, Myunghee C.] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Wolfert, Robert L.] diaDexus Inc, San Francisco, CA USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Epidemiol, Miami, FL 33136 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Elkind, Mitchell S. V.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; University of Zurich; University Zurich Hospital; Columbia University; University of Miami; University of Miami; University of Miami; Columbia University	Katan, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.	mira.katan@usz.ch	Sacco, Ralph/Y-9278-2019	Katan, Mira/0000-0002-9265-8066	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R37 NS 29993, R01 NS 48134]; Swiss National Science Foundation [PBZHP3-130982]; Fondation Leduqc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048134, R37NS029993] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Leduqc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R37 NS 29993 [RLS/MSVE] and R01 NS 48134 [MSVE]) and the Swiss National Science Foundation (PBZHP3-130982 [MK] as well as the Fondation Leduqc [MK]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 1995, LANCET, V346, P1647; Ballantyne CM, 2005, ARCH INTERN MED, V165, P2479, DOI 10.1001/archinte.165.21.2479; Bang OY, 2008, NEUROLOGY, V70, P841, DOI 10.1212/01.wnl.0000294323.48661.a9; Brilakis ES, 2008, ATHEROSCLEROSIS, V199, P110, DOI 10.1016/j.atherosclerosis.2007.10.010; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Cook NR, 2012, CLIN CHEM, V58, P1352, DOI 10.1373/clinchem.2012.188870; De Silva DA, 2007, STROKE, V38, P2592, DOI 10.1161/STROKEAHA.107.484584; Delgado P, 2012, CEREBROVASC DIS, V33, P150, DOI 10.1159/000334193; Elkind MSV, 2006, ARCH INTERN MED, V166, P2073, DOI 10.1001/archinte.166.19.2073; Elkind MSV, 2009, CEREBROVASC DIS, V27, P42, DOI 10.1159/000172633; Elkind MSV, 2005, NEUROLOGY, V64, P2121, DOI 10.1212/01.WNL.0000165989.12122.49; Gan R, 1997, NEUROLOGY, V48, P1204, DOI 10.1212/WNL.48.5.1204; Gentry E M, 1985, Am J Prev Med, V1, P9; Gorelick PB, 2008, AM J CARDIOL, V101, p34F, DOI 10.1016/j.amjcard.2008.04.017; Mannheim D, 2008, STROKE, V39, P1448, DOI 10.1161/STROKEAHA.107.503193; Markus HS, 2007, CIRCULATION, V116, P2157, DOI 10.1161/CIRCULATIONAHA.107.699785; Oei HHS, 2005, CIRCULATION, V111, P570, DOI 10.1161/01.CIR.0000154553.12214.CD; Oliver LK, 2011, CLIN BIOCHEM, V44, P1247, DOI 10.1016/j.clinbiochem.2011.07.005; Persson M, 2008, ATHEROSCLEROSIS, V200, P191, DOI 10.1016/j.atherosclerosis.2007.12.001; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; *WHO, 1983, WHOMNC821; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Willey JZ, 2009, ARCH NEUROL-CHICAGO, V66, P1400, DOI 10.1001/archneurol.2009.210; Wityk RJ, 1996, STROKE, V27, P1974, DOI 10.1161/01.STR.27.11.1974; Wong KS, 1998, NEUROLOGY, V50, P812, DOI 10.1212/WNL.50.3.812	31	42	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83393	10.1371/journal.pone.0083393	http://dx.doi.org/10.1371/journal.pone.0083393			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416164	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000329866300014
J	Lind, A; Brekke, K; Pettersen, FO; Mollnes, TE; Troseid, M; Kvale, D				Lind, Andreas; Brekke, Kristin; Pettersen, Frank Olav; Mollnes, Tom Eirik; Troseid, Marius; Kvale, Dag			A Parameter for IL-10 and TGF-beta Mediated Regulation of HIV-1 Specific T Cell Activation Provides Novel Information and Relates to Progression Markers	PLOS ONE			English	Article							IMMUNE ACTIVATION; LYMPHOCYTE-ACTIVATION; DISEASE PROGRESSION; INFECTION; IMMUNODEFICIENCY; RESPONSES; CD4(+); DIVISION; PD-1; INFLAMMATION	HIV replication is only partially controlled by HIV-specific activated effector T cells in chronic HIV infection and strategies are warranted to improve their efficacy. Chronic T cell activation is generally accompanied by regulation of antigen-specific T cell responses which may impair an effective control of chronic infections. The impact of HIV-induced T cell regulation on individual patients' disease progression is largely unknown, since classical T cell activation assays reflect net activation with regulation as unknown contributing factor. We here explore a quantitative parameter for antigen-induced cytokine-mediated regulation (R-AC) of HIV-specific effector T cell activation by functional antibody-blockade of IL-10 and transforming growth factor-beta. HIV Env- and Gag-specific T cell activation and R-AC were estimated in peripheral blood mononuclear cells from 30 treatment-naive asymptomatic HIV-infected progressors (CD4 count 472/mu l, HIV RNA 37500 copies/ml) stimulated with overlapping peptide panels for 6 days. R-AC was estimated from differences in T cell activation between normal and blocked cultures, and related to annual CD4 loss, immune activation (CD38) and microbial translocation (plasma lipopolysaccharides). R-AC was heterogeneously distributed between individual patients and the two HIV antigens. Notably, RAC did not correlate to corresponding classical activation. Env R-AC correlated with CD38 and CD4 loss rates (r>=0.37, p=<0.046) whereas classical Gag activation tended to correlate with HIV RNA (r = -0.35, p = 0.06). 14 patients (47%) with low R-AC's to both Env and Gag had higher CD8 counts (p = 0.014) and trends towards lower annual CD4 loss (p = 0.056) and later start with antiretroviral treatment (p = 0.07) than the others. In contrast, patients with high R-AC to both Env and Gag (n = 8) had higher annual CD4 loss (p = 0.034) and lower CD8 counts (p = 0.014). R-AC to Env and Gag was not predicted by classical activation parameters and may thus provide additional information on HIV-specific immunity. R-AC and other assessments of regulation deserve further in-depth exploration.	[Lind, Andreas; Brekke, Kristin; Pettersen, Frank Olav; Troseid, Marius; Kvale, Dag] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Lind, Andreas; Mollnes, Tom Eirik; Kvale, Dag] Univ Oslo, Inst Clin Med, Oslo, Norway; [Mollnes, Tom Eirik] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Mollnes, Tom Eirik] Nordland Hosp, Res Lab, Bodo, Norway; [Mollnes, Tom Eirik] Univ Tromso, Tromso, Norway; [Mollnes, Tom Eirik; Kvale, Dag] Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Oslo	Kvale, D (corresponding author), Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway.	dag.kvale@medisin.uio.no	Lind, Andreas/AAN-3730-2021; Mollnes, Tom/ABI-5183-2020	Lind, Andreas/0000-0002-8289-8410; Kvale, Dag/0000-0001-6410-2530	Research Council of Norway (RCN) in the GLOBVAC program, RCN [179389]	Research Council of Norway (RCN) in the GLOBVAC program, RCN(Research Council of Norway)	The study was supported by the Research Council of Norway (RCN) in the GLOBVAC program (http://www.forskningsradet.no/prognett-globvac/Home_page/1224697869238), RCN grant no. 179389. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Chattopadhyay PK, 2010, CYTOM PART A, V77A, P614, DOI 10.1002/cyto.a.20905; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; Holm M, 2008, CURR HIV RES, V6, P49, DOI 10.2174/157016208783571955; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Jin HT, 2011, BMB REP, V44, P217, DOI 10.5483/BMBRep.2011.44.4.217; Kalland ME, 2011, J IMMUNOL, V187, P5233, DOI 10.4049/jimmunol.1101804; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kran AMB, 2004, AIDS, V18, P1875, DOI 10.1097/00002030-200409240-00003; Kvale D, 1999, AIDS, V13, P195, DOI 10.1097/00002030-199902040-00007; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Lind A, 2013, VACCINE IN PRESS, DOI [10.1016/j.vaccine.2013.07.037., DOI 10.1016/J.VACCINE.2013.07.037.PMID:23906886]; Lind A, 2012, SCAND J INFECT DIS, V44, P566, DOI 10.3109/00365548.2011.653581; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; McKarns SC, 2005, J IMMUNOL, V174, P2071, DOI 10.4049/jimmunol.174.4.2071; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Pantaleo G, 2013, CURR OPIN HIV AIDS, V8, P236, DOI 10.1097/COH.0b013e32835fd5cd; Pettersen FO, 2010, CLIN EXP IMMUNOL, V161, P315, DOI 10.1111/j.1365-2249.2010.04179.x; Pettersen FO, 2011, J VIROL, V85, P6557, DOI 10.1128/JVI.00073-11; Reddy M, 2004, J IMMUNOL METHODS, V293, P127, DOI 10.1016/j.jim.2004.07.006; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Thea DM, 1996, ANN INTERN MED, V124, P757, DOI 10.7326/0003-4819-124-8-199604150-00009; Troseid M, 2010, AIDS, V24, P1733, DOI 10.1097/QAD.0b013e32833b254d; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85604	10.1371/journal.pone.0085604	http://dx.doi.org/10.1371/journal.pone.0085604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416431	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300091
J	Neilans, EG; Holfoth, DP; Radziwon, KE; Portfors, CV; Dent, ML				Neilans, Erikson G.; Holfoth, David P.; Radziwon, Kelly E.; Portfors, Christine V.; Dent, Micheal L.			Discrimination of Ultrasonic Vocalizations by CBA/CaJ Mice (Mus musculus) Is Related to Spectrotemporal Dissimilarity of Vocalizations	PLOS ONE			English	Article							COMMUNICATION; ORGANIZATION	The function of ultrasonic vocalizations (USVs) produced by mice (Mus musculus) is a topic of broad interest to many researchers. These USVs differ widely in spectrotemporal characteristics, suggesting different categories of vocalizations, although this has never been behaviorally demonstrated. Although electrophysiological studies indicate that neurons can discriminate among vocalizations at the level of the auditory midbrain, perceptual acuity for vocalizations has yet to be determined. Here, we trained CBA/CaJ mice using operant conditioning to discriminate between different vocalizations and between a spectrotemporally modified vocalization and its original version. Mice were able to discriminate between vocalization types and between manipulated vocalizations, with performance negatively correlating with spectrotemporal similarity. That is, discrimination performance was higher for dissimilar vocalizations and much lower for similar vocalizations. The behavioral data match previous neurophysiological results in the inferior colliculus (IC), using the same stimuli. These findings suggest that the different vocalizations could carry different meanings for the mice. Furthermore, the finding that behavioral discrimination matched neural discrimination in the IC suggests that the IC plays an important role in the perceptual discrimination of vocalizations.	[Neilans, Erikson G.; Holfoth, David P.; Radziwon, Kelly E.; Dent, Micheal L.] SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA; [Portfors, Christine V.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Washington State University	Dent, ML (corresponding author), SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA.	mdent@buffalo.edu			NIH [DC009483, DC012302]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012302, R03DC009483] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH DC009483 and DC012302 to MLD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bregman A.S., 1990, AUDITORY SCENE ANAL; DOOLING RJ, 1987, J COMP PSYCHOL, V101, P367, DOI 10.1037/0735-7036.101.4.367; EHRET G, 1976, J ACOUST SOC AM, V59, P1421, DOI 10.1121/1.381030; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; EHRET G, 1982, J COMP PHYSIOL, V148, P245, DOI 10.1007/BF00619131; Grimsley Jasmine M S, 2012, Front Behav Neurosci, V6, P89, DOI 10.3389/fnbeh.2012.00089; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hammerschmidt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041133; Holmstrom L, 2009, HEARING RES, V247, P1, DOI 10.1016/j.heares.2008.09.012; Holmstrom LA, 2010, J NEUROSCI, V30, P802, DOI 10.1523/JNEUROSCI.1964-09.2010; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Portfors CV, 2011, NEUROSCIENCE, V193, P429, DOI 10.1016/j.neuroscience.2011.07.025; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Radziwon KE, 2009, J COMP PHYSIOL A, V195, P961, DOI 10.1007/s00359-009-0472-1; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Shepard KN, 2011, GENES BRAIN BEHAV, V10, P28, DOI 10.1111/j.1601-183X.2010.00580.x	24	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85405	10.1371/journal.pone.0085405	http://dx.doi.org/10.1371/journal.pone.0085405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416405	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300077
J	Breeze, TD; Vaissiere, BE; Bommarco, R; Petanidou, T; Seraphides, N; Kozak, L; Scheper, J; Biesmeijer, JC; Kleijn, D; Gyldenkaerne, S; Moretti, M; Holzschuh, A; Steffan-Dewenter, I; Stout, JC; Partel, M; Zobel, M; Potts, SG				Breeze, Tom D.; Vaissiere, Bernard E.; Bommarco, Riccardo; Petanidou, Theodora; Seraphides, Nicos; Kozak, Lajos; Scheper, Jeroen; Biesmeijer, Jacobus C.; Kleijn, David; Gyldenkaerne, Steen; Moretti, Marco; Holzschuh, Andrea; Steffan-Dewenter, Ingolf; Stout, Jane C.; Paertel, Meelis; Zobel, Martin; Potts, Simon G.			Agricultural Policies Exacerbate Honeybee Pollination Service Supply-Demand Mismatches Across Europe	PLOS ONE			English	Article							FRUIT-SET; SEQUENTIAL INTRODUCTION; ECOSYSTEM SERVICES; BEES; COLONIES; DECLINES; DENSITY; ENHANCE; BIODIVERSITY; HYMENOPTERA	Declines in insect pollinators across Europe have raised concerns about the supply of pollination services to agriculture. Simultaneously, EU agricultural and biofuel policies have encouraged substantial growth in the cultivated area of insect pollinated crops across the continent. Using data from 41 European countries, this study demonstrates that the recommended number of honeybees required to provide crop pollination across Europe has risen 4.9 times as fast as honeybee stocks between 2005 and 2010. Consequently, honeybee stocks were insufficient to supply >90% of demands in 22 countries studied. These findings raise concerns about the capacity of many countries to cope with major losses of wild pollinators and highlight numerous critical gaps in current understanding of pollination service supplies and demands, pointing to a pressing need for further research into this issue.	[Breeze, Tom D.; Potts, Simon G.] Univ Reading, Ctr Agri Environm Res, Reading, Berks, England; [Vaissiere, Bernard E.] INRA, Avignon, France; [Bommarco, Riccardo] Swedish Univ Agr Sci, Uppsala, Sweden; [Petanidou, Theodora] Univ Aegean, Dept Geog, Mitilini, Greece; [Seraphides, Nicos] Cyprus Agr Res Inst, Nicosia, Cyprus; [Kozak, Lajos] Univ Debrecen, Dept Nat Conservat Zool & Game Management, H-4012 Debrecen, Hungary; [Scheper, Jeroen; Kleijn, David] Alterra, Anim Ecol Team, Wageningen, Netherlands; [Biesmeijer, Jacobus C.] Nat Biodivers Ctr, Darwinweg, Netherlands; [Kleijn, David] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Gyldenkaerne, Steen] Aarhus Univ, Inst Environm Sci, Danish Ctr Environm & Energy, Aarhus, Denmark; [Moretti, Marco] Swiss Fed Inst Forest Snow & Landscape Res, Community Ecol Res Unit, Bellinzona, Switzerland; [Holzschuh, Andrea; Steffan-Dewenter, Ingolf] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany; [Stout, Jane C.] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Zobel, Martin] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia	University of Reading; INRAE; Swedish University of Agricultural Sciences; University of Aegean; University of Debrecen; Wageningen University & Research; Naturalis Biodiversity Center; Wageningen University & Research; Aarhus University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Wurzburg; Trinity College Dublin; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Breeze, TD (corresponding author), Univ Reading, Ctr Agri Environm Res, Reading, Berks, England.	t.d.breeze@reading.ac.uk	Breeze, Tom/AAU-7068-2021; Kleijn, David/HCH-3477-2022; Stout, Jane C/B-1631-2010; Breeze, Tom/ABC-6373-2021; Potts, Simon/ABF-9221-2020; Potts, Simon G/C-7250-2008; Pärtel, Meelis/D-5493-2012; Bommarco, Riccardo/E-7109-2016; Scheper, Jeroen/G-1385-2015; Stout, Jane/AAS-8867-2020; Holzschuh, Andrea/X-8989-2018; Petanidou, Theodora/AAU-3212-2020; Zobel, Martin/H-1336-2015	Breeze, Tom/0000-0002-8929-8354; Stout, Jane C/0000-0002-2027-0863; Potts, Simon/0000-0002-2045-980X; Potts, Simon G/0000-0002-2045-980X; Pärtel, Meelis/0000-0002-5874-0138; Bommarco, Riccardo/0000-0001-8888-0476; Scheper, Jeroen/0000-0002-4314-996X; Stout, Jane/0000-0002-2027-0863; Holzschuh, Andrea/0000-0002-5235-4746; Petanidou, Theodora/0000-0003-1883-0945; Zobel, Martin/0000-0001-7957-6704; Moretti, Marco/0000-0002-5845-3198; Kleijn, David/0000-0003-2500-7164; Biesmeijer, Koos/0000-0003-0328-0573; Steffan-Dewenter, Ingolf/0000-0003-1359-3944	European Community [244090]; Biotechnology and Biological Sciences Research Council [BB/I000275/1, BB/I000348/1] Funding Source: researchfish; BBSRC [BB/I000275/1, BB/I000348/1] Funding Source: UKRI	European Community(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research received funding from the European Community's Seventh Framework Programme(FP7/2007-2013) under grant agreement no 244090, STEP Project (Status and Trends of European Pollinators: www.step-project.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi A, 2011, TRENDS ECOL EVOL, V27, P142; Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Banse M, 2011, BIOMASS BIOENERG, V35, P2385, DOI 10.1016/j.biombioe.2010.09.001; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Brittain C, 2013, GLOBAL CHANGE BIOL, V19, P540, DOI 10.1111/gcb.12043; Britz W, 2011, AGR ECOSYST ENVIRON, V142, P102, DOI 10.1016/j.agee.2009.11.003; Burton RJF, 2008, SOCIOL RURALIS, V48, P16, DOI 10.1111/j.1467-9523.2008.00452.x; Carreck NL, 1997, BEE WORLD, V78, P67, DOI 10.1080/0005772X.1997.11099337; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; CHAGNON M, 1993, J ECON ENTOMOL, V86, P416, DOI 10.1093/jee/86.2.416; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; European Commission, 2011, PROP REG EUR PARL CO; European Parliament, 2013, DIR PAYM FARM SUPP S; Eurostat, 2013, SELL PRIC CROP PROD; Eurostat, 2012, SAL PEST TONN ACT IN; Food and Environment Research Agency, 2012, PEST US STAT; Free J., 1993, CROP POLLINATION INS; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Harper GL, 2008, J INSECT CONSERV, V12, P147, DOI 10.1007/s10841-007-9072-y; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Herzon I, 2007, J NAT CONSERV, V15, P10, DOI 10.1016/j.jnc.2006.08.001; Hodge I, 2010, LAND USE POLICY, V27, P270, DOI 10.1016/j.landusepol.2009.03.005; Holzschuh A, 2013, OECOLOGIA, V172, P477, DOI 10.1007/s00442-012-2515-5; Holzschuh A, 2011, P ROY SOC B-BIOL SCI, V278, P3444, DOI 10.1098/rspb.2011.0268; Hudewenz A, 2013, J AGR SCI FIRSTVIEW, V152, P770, DOI [10.1017/S0021859613000440, DOI 10.1017/80021859613000440]; Ings TC, 2006, J APPL ECOL, V43, P940, DOI 10.1111/j.1365-2664.2006.01199.x; Isbell F, 2013, ECOL LETT, V16, P454, DOI 10.1111/ele.12066; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Jauker F, 2012, BASIC APPL ECOL, V13, P268, DOI 10.1016/j.baae.2012.03.010; Kim IS, 2013, FOOD POLICY, V38, P59, DOI 10.1016/j.foodpol.2012.10.006; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Lebuhn G, 2013, CONSERV BIOL, V27, P113, DOI 10.1111/j.1523-1739.2012.01962.x; Manning R, 2005, AUST J EXP AGR, V45, P1307, DOI 10.1071/EA02170; Marris G, 2011, PEST RISK ASSESSMENT; Meeus I, 2011, CONSERV BIOL, V25, P662, DOI 10.1111/j.1523-1739.2011.01707.x; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pocol CB, 2012, J FOOD AGRIC ENVIRON, V10, P132; Popa AA, 2011, ANALELE U DIN ORADEA, V2011, P297; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rader R, 2011, J APPL ECOL, V46, P1080; Rader R, 2009, J APPL ECOL, V46, P1080, DOI 10.1111/j.1365-2664.2009.01700.x; Rucker RR, 2012, AM J AGR ECON, V94, P956, DOI 10.1093/ajae/aas031; Sabbahi R, 2005, J ECON ENTOMOL, V98, P367, DOI 10.1603/0022-0493-98.2.367; Scheper J, 2013, ECOL LETT, V16, P912, DOI 10.1111/ele.12128; Schulp CJE, 2014, ECOL INDIC, V36, P131, DOI 10.1016/j.ecolind.2013.07.014; Sheffield CS, 2008, CAN ENTOMOL, V140, P589, DOI 10.4039/N08-011; Stern RA, 2004, J HORTIC SCI BIOTECH, V79, P652, DOI 10.1080/14620316.2004.11511821; Stern RA, 2001, J HORTIC SCI BIOTECH, V76, P17, DOI 10.1080/14620316.2001.11511320; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; SUMNER D. A., 2006, AGR RESOURCE EC UPDA, V9, P9; UN, 2011, COMP MACR CONT REG G; Vaissiere B.E, 2011, PROTOCOL DETECT ASSE; Veterinary Medical Directorate, 2011, BEE PROD SIT EUR; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Woodcock BA, 2013, AGR ECOSYST ENVIRON, V171, P1, DOI 10.1016/j.agee.2013.03.005; World Bank, 2013, AGR VAL ADD GDP; World Bank, 2013, GDP PER CAP; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020	72	137	143	6	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82996	10.1371/journal.pone.0082996	http://dx.doi.org/10.1371/journal.pone.0082996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421873	Green Published, Green Accepted, gold			2022-12-25	WOS:000329862500024
J	Choo, MS; Jeong, CW; Jung, JH; Lee, SB; Jeong, H; Son, H; Kim, HH; Oh, SJ; Cho, SY				Choo, Min Soo; Jeong, Chang Wook; Jung, Jae Hyun; Lee, Seung Bae; Jeong, Hyeon; Son, Hwancheol; Kim, Hyeon Hoe; Oh, Seung-june; Cho, Sung Yong			External Validation and Evaluation of Reliability and Validity of the S-ReSC Scoring System to Predict Stone-Free Status after Percutaneous Nephrolithotomy	PLOS ONE			English	Article							ACCESS	Objectives: The Seoul National University Renal Stone Complexity (S-ReSC) scoring system was developed to predict the stone-free rate (SFR) after single-tract percutaneous nephrolithotomy (PCNL). This study is an external validation of this scoring system. Materials and methods: A retrospective review included 327 patients who underwent PCNL at 2 tertiary referral centers. The S-ReSC score was assigned from 1 to 9 based on the number of sites involved. The stone free status was defined as either complete clearance or clinically insignificant residual fragments,4 mm in size at 1 month follow-up imaging. Interobserver and test-retest reliabilities were evaluated. The statistical performance of the prediction model was assessed by its predictive accuracy, predictive probability, and clinical usefulness. Results: The overall SFR was 65.4%. SFRs were 83.9%, 47.6%, and 21.4% in low (1-2), intermediate (3-4), and high (5-9) score groups, respectively, with significant differences (P < 0.001). Inter-observer and test-retest reliabilities revealed almost perfect agreements. External validation of the S-ReSC scoring system revealed an AUC of 0.731 (95% CI 0.675-0.788). The AUC of 3-titered S-ReSC score groups was 0.691 (95% CI, 0.629-0.753). The calibration plot showed that the predicted probability of SFR had a concordance comparable to that of the observed frequency. The Hosmer-Lemeshow goodness-offit statistic revealed an adequate performance of the predictive model (P = 0.10). Inter-observer and test-retest reliability showed a good level of agreement. Conclusions: The S-ReSC scoring system is useful in predicting the post-PCNL SFR and in describing the complexity of renal stones.	[Choo, Min Soo; Jeong, Chang Wook; Jung, Jae Hyun; Kim, Hyeon Hoe; Oh, Seung-june] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Lee, Seung Bae; Jeong, Hyeon; Son, Hwancheol; Cho, Sung Yong] Seoul Natl Univ, Boramae Med Ctr, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Cho, SY (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Urol, Seoul, South Korea.	kmoretry@daum.net	Oh, Seung-June/D-6015-2012	Oh, Seung-June/0000-0002-0322-3539				El-Nahas AR, 2007, J UROLOGY, V177, P576, DOI 10.1016/j.juro.2006.09.048; El-Nahas AR, 2012, UROLOGY, V79, P1236, DOI 10.1016/j.urology.2012.01.026; Ganpule AP, 2009, J ENDOUROL, V23, P1675, DOI 10.1089/end.2009.1535; Jeong CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065888; Kacker R, 2008, J UROLOGY, V180, P958, DOI 10.1016/j.juro.2008.05.031; Mishra S, 2012, CURR OPIN UROL, V22, P148, DOI 10.1097/MOU.0b013e32834fc306; Morris DS, 2006, J UROLOGY, V175, P1731, DOI 10.1016/S0022-5347(05)00994-8; Munver R, 2001, J UROLOGY, V166, P1242, DOI 10.1016/S0022-5347(05)65745-X; Olbert PJ, 2007, UROL RES, V35, P225, DOI 10.1007/s00240-007-0112-6; Osman MM, 2005, EUR UROL, V47, P860, DOI 10.1016/j.eururo.2005.01.005; Romero Victoriano, 2010, Rev Urol, V12, pe86; Rosa M, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-10; Sampaio F J, 2001, Curr Opin Urol, V11, P359, DOI 10.1097/00042307-200107000-00004; Shahrour K, 2012, UROLOGY, V80, P19, DOI 10.1016/j.urology.2011.12.065; Singla M, 2008, UROLOGY, V71, P1039, DOI 10.1016/j.urology.2007.11.072; Thomas K, 2011, UROLOGY, V78, P277, DOI 10.1016/j.urology.2010.12.026; Williams SK, 2008, J ENDOUROL, V22, P1835, DOI 10.1089/end.2008.9795; Yanke BV, 2005, J UROLOGY, V173, P421, DOI 10.1097/01.ju.0000150522.82760.00	18	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83628	10.1371/journal.pone.0083628	http://dx.doi.org/10.1371/journal.pone.0083628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421896	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500060
J	Hannagan, T; Ziegler, JC; Dufau, S; Fagot, J; Grainger, J				Hannagan, Thomas; Ziegler, Johannes C.; Dufau, Stephane; Fagot, Joel; Grainger, Jonathan			Deep Learning of Orthographic Representations in Baboons	PLOS ONE			English	Article							WORD RECOGNITION; FORM; ARCHITECTURE; DYSLEXIA; NETWORK; CODE	What is the origin of our ability to learn orthographic knowledge? We use deep convolutional networks to emulate the primate's ventral visual stream and explore the recent finding that baboons can be trained to discriminate English words from nonwords [1]. The networks were exposed to the exact same sequence of stimuli and reinforcement signals as the baboons in the experiment, and learned to map real visual inputs (pixels) of letter strings onto binary word/nonword responses. We show that the networks' highest levels of representations were indeed sensitive to letter combinations as postulated in our previous research. The model also captured the key empirical findings, such as generalization to novel words, along with some intriguing inter-individual differences. The present work shows the merits of deep learning networks that can simulate the whole processing chain all the way from the visual input to the response while allowing researchers to analyze the complex representations that emerge during the learning process.	[Hannagan, Thomas] Aix Marseille Univ, Lab Psychol Cognit, Marseille, France; CNRS, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Hannagan, T (corresponding author), Aix Marseille Univ, Lab Psychol Cognit, Marseille, France.	thom.hannagan@gmail.com	Dufau, Stephane/B-6349-2008; Grainger, Jonathan/C-9299-2009; Ziegler, Johannes/C-2234-2008	Dufau, Stephane/0000-0002-2692-2084; fagot, joel/0000-0002-9824-9685; Ziegler, Johannes/0000-0002-2061-5729	European Research Council (ERC) [230313]; French government [ANR-11-IDEX-0001-02]	European Research Council (ERC)(European Research Council (ERC)European Commission); French government	This research was supported by a grant from the European Research Council (ERC grant 230313) to Jonathan Grainger. It was carried out within the Labex BLRI (ANR-11-LABX-0036) and has benefited from support from the French government, managed by the French National Agency for Research (ANR), Investments of the Future A*MIDEX (ANR-11-IDEX-0001-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bains W, 2012, SCIENCE, V337, DOI 10.1126/science.1224508; Bergstra J., 2011, P NIPS BIGLEARNING W; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Blaizot X, 2000, J CEREBR BLOOD F MET, V20, P213, DOI 10.1097/00004647-200002000-00001; Brincat SL, 2006, NEURON, V49, P17, DOI 10.1016/j.neuron.2005.11.026; Ciresan D., 2012, IEEE C COMP VIS PATT; Cohen G, 2000, EXPLORING COGNITION; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Di Bono MG, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00635; Erhan D., 2010, 1355 U MONTR; Farabet C., 2013, IEEE T PATTERN ANAL; Frost R, 2013, PSYCHOL SCI, V24, P1868, DOI 10.1177/0956797613482145; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Grainger J, 2003, MENTAL LEXICON: SOME WORDS TO TALK ABOUT WORDS, P1; Grainger J, 2008, LANG COGNITIVE PROC, V23, P1, DOI 10.1080/01690960701578013; Grainger J, 2012, SCIENCE, V336, P245, DOI 10.1126/science.1218152; Hannagan T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003250; Hannagan T, 2012, COGNITIVE SCI, V36, P575, DOI 10.1111/j.1551-6709.2012.01236.x; Hannagan T, 2011, NEURAL COMPUT, V23, P251, DOI 10.1162/NECO_a_00064; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Leveille J, 2013, NEURAL COMPUT, V25, P1261, DOI 10.1162/NECO_a_00435; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; MOZER MC, 1987, ATTENTION PERFORM, P83; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Pegado F, 2011, NEUROIMAGE, V55, P742, DOI 10.1016/j.neuroimage.2010.11.043; Perea M, 2004, J MEM LANG, V51, P231, DOI 10.1016/j.jml.2004.05.005; PLAUT DC, 1993, COGNITIVE NEUROPSYCH, V10, P377, DOI 10.1080/02643299308253469; Rauschecker AM, 2012, P NATL ACAD SCI USA, V109, pE1568, DOI 10.1073/pnas.1121304109; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Stoianov I, 2012, NAT NEUROSCI, V15, P194, DOI 10.1038/nn.2996; Thomas MSC, 2012, BRAIN COGNITION, V78, P38, DOI 10.1016/j.bandc.2011.10.003; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Whitney C, 1999, Prog Brain Res, V121, P143; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Ziegler JC, PHILOS T B IN PRESS; Ziegler JC, 2013, PSYCHOL SCI, V24, P1609, DOI 10.1177/0956797612474322	40	18	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84843	10.1371/journal.pone.0084843	http://dx.doi.org/10.1371/journal.pone.0084843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416300	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500180
J	Penny, D; Chevance, JB; Tang, D; De Greef, S				Penny, Dan; Chevance, Jean-Baptiste; Tang, David; De Greef, Stephane			The Environmental Impact of Cambodia's Ancient City of Mahendraparvata (Phnom Kulen)	PLOS ONE			English	Article							WATER MANAGEMENT; LAND-USE; ANGKOR; CARBONATE; SEDIMENTS; IGNITION; POLLEN	The Khmer kingdom, whose capital was at Angkor from the 9th to the 14th -15th century, was founded in 802 by king Jayavarman II in a city called Mahandraparvata, on Phnom Kulen. Virtually nothing more is known of Mahandraparvata from the epigraphic sources, but systematic archaeological survey and excavation have identified an array of cultural features that point to a more extensive and enduring settlement than the historical record indicates. Recent remote sensing data have revolutionized our view, revealing the remains of a city with a complex and spatially extensive network of urban infrastructure. Here, we present a record of vegetation change and soil erosion from within that urban network, dating from the 8th century CE. Our findings indicate approximately 400 years of intensive land use, punctuated by discrete periods of intense erosion beginning in the mid 9th century and ending in the late 11th century. A marked change in water management practices is apparent from the 12th century CE, with implications for water supply to Angkor itself. This is the first indication that settlement on Mahendraparvata was not only extensive, but also intensive and enduring, with a marked environmental impact.	[Penny, Dan; Tang, David] Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia; [Chevance, Jean-Baptiste; De Greef, Stephane] Archaeol & Dev Fdn, London, England	University of Sydney	Penny, D (corresponding author), Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia.	dan.penny@sydney.edu.au		Penny, Dan/0000-0002-7905-0339	Australian Research Council [DP0558130]; Mohamed S. Farsi Foundation; AINSE Award [ALNGRA11031]	Australian Research Council(Australian Research Council); Mohamed S. Farsi Foundation; AINSE Award	The research is funded by the Australian Research Council (DP0558130) (http://www.arc.gov.au) and the Mohamed S. Farsi Foundation (http://www. themsff.org). Radiocarbon analyses were funded by AINSE Award ALNGRA11031 (http://www.ainse.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ENV MAGNETIC SUSCEPT; [Anonymous], 1998, SOC EC POLITICS PREA; Aymonier E, 1901, CAMBODGE 2 PROVINCES, V2; Boulbet J, 1973, ARTS ASIATIQUES, V27; Boulbet J, 1979, PHNOM KULEN REGION C; Buckley BM, 2010, P NATL ACAD SCI USA, V107, P6748, DOI 10.1073/pnas.0910827107; Carbonnel JP, 1972, QUATERNAIRE CAMBODGI; Chevance JB, 2013, UNEARTHING SE ASIAS, V1, P257; Chevance JB, 2005, U PARIS 3 SORBORNNE; Chevance JB, 2011, THESIS UFR ORIENT MO; Coedes G, 1943, B EC FR EXTR ORIENT, V43, P56; Color Munsell, 1975, MUNSELL SOIL COLOR C; Dan P, 2007, NUCL INSTRUM METH B, V259, P388, DOI 10.1016/j.nimb.2007.02.095; de Lajonquiere EEL, 1902, INVENTAIRE DESCRIPTI, V1; de Lajonquiere EEL, 1911, INVENTAIRE DESCRIPTI, V3; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Desbat A., 2008, PROGRAMME CERANGKOR; Ea D, 2010, ANLONG THOM CULTURAL; Ea D, 2008, INTERPRETING SE ASIA, P275; Evans D, 2007, P NATL ACAD SCI USA, V104, P14277, DOI 10.1073/pnas.0702525104; Evans DH, 2013, P NATL ACAD SCI USA, V110, P12595, DOI 10.1073/pnas.1306539110; Faegri K., 1898, J BIOGEOGR, V12, P238; Fletcher R., 2003, UDAYA, V4, P107; Fletcher R, 2008, ANTIQUITY, V82, P658, DOI 10.1017/S0003598X00097295; Gaughan AE, 2009, APPL GEOGR, V29, P212, DOI 10.1016/j.apgeog.2008.09.007; Glew Jr, 2002, DEV PALEOENVIRON RES, V1, P73; Groslier Bernard-Philippe, 1979, B ECOLE FRANCAISE EX, V66, P161, DOI DOI 10.3406/BEFEO.1979.4014; Hansen E, 1969, CAMBODGE CONSERVATIO, P1; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Higham CFW, 2001, ANGKOR UDAYA, V2, P109; Juggins S, 2007, C2 VERSION 1 5 USER; Kummu M, 2009, J ENVIRON MANAGE, V90, P1413, DOI 10.1016/j.jenvman.2008.08.007; Lefferts L, 2008, SELECTED PAPERS 10 I, P286; Lustig E, 2001, THESIS U SYDNEY; Maxwell AL, 2001, QUATERNARY RES, V56, P390, DOI 10.1006/qres.2001.2271; Miksic J, 2009, ARI WORKING PAPERS, V16, P1; Penny D, 2005, J ARCHAEOL SCI, V32, P69, DOI 10.1016/j.jas.2004.07.002; Penny D., 2005, B ECOLE FRANCAISE EX, V92, P497; Penny D, 2006, ANTIQUITY, V80, P599, DOI 10.1017/S0003598X00094060; Phon D, 2000, DICT PLANTS USED CAM; Pottier C., 2009, ASEANIE, V24, P61; Pottier C, 1999, CARTE ARCHEOLOGIQUE; Pottier C, 2002, UDAYA, V2, P117; Pottier C., 2004, UDAYA J KHMER STUD, V5, P167; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Rollet B, 1972, VEGETATION CAMBODGE; Stern P, 1938, B EC FR EXTR ORIENT, V38, P111; STOCKMARR J, 1971, Pollen et Spores, V13, P615; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Stuiver M, 2010, CALIB 6 0 PROGRAM; Tabata Y., 2008, J SE ASIAN ARCHAEOLO, V28, P61; Theilade I, 2011, NORD J BOT, V29, P71, DOI 10.1111/j.1756-1051.2010.01003.x; Uchida E, 2007, J ARCHAEOL SCI, V34, P924, DOI 10.1016/j.jas.2006.09.015; van Huissteden J, 1999, CLUSTER 3 0 FACULTY; VANLIERE WJ, 1980, WORLD ARCHAEOL, V11, P265, DOI 10.1080/00438243.1980.9979766; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910	56	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84252	10.1371/journal.pone.0084252	http://dx.doi.org/10.1371/journal.pone.0084252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	291WL	24416206	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500105
J	Reichwald, K; Jorgensen, TZ; Tougaard, P; Skov, S				Reichwald, Kirsten; Jorgensen, Tina Z.; Tougaard, Peter; Skov, Soren			TL1A Induces TCR Independent IL-6 and TNF-alpha Production and Growth of PLZF(+) Leukocytes	PLOS ONE			English	Article							REGULATORY T-CELLS; IFN-GAMMA PRODUCTION; CYTOKINE 1A TL1A; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; NATURAL-KILLER; RECEPTOR; PROLIFERATION; ACTIVATION; EXPRESSION	An elevated level of the cytokine TL1A is known to be associated with several autoimmune diseases, e. g. rheumatoid arthritis and inflammatory bowel disease. However, the mode of action of TL1A remains elusive. In this study, we investigated the role of TL1A in a pro-inflammatory setting, using human leukocytes purified from healthy donors. We show that TL1A, together with IL-12, IL-15 and IL-18, directly induces the production of IL-6 and TNF-alpha from leukocytes. Interestingly, TL1A-induced IL-6 was not produced by CD14(+) monocytes. We further show that the produced IL-6 is fully functional, as measured by its ability to signal through the IL-6 receptor, and that the induction of IL-6 is independent of TCR stimulation. Furthermore, the transcription factor PLZF was induced in stimulated cells. These results offer a substantial explanation for the role of TL1A, since TNF-alpha and IL-6 are directly responsible for much of the inflammatory state in many autoimmune diseases. Our study suggests that TL1A is a possible target for the treatment of autoimmune diseases.	[Reichwald, Kirsten; Jorgensen, Tina Z.; Tougaard, Peter; Skov, Soren] Univ Copenhagen, Immunol Lab, Fac Med & Hlth Sci, Frederiksberg C, Denmark	University of Copenhagen	Reichwald, K (corresponding author), Univ Copenhagen, Immunol Lab, Fac Med & Hlth Sci, Frederiksberg C, Denmark.	kire@sund.ku.dk; sosk@sund.ku.dk	Tougaard, Peter/Q-8695-2016	Tougaard, Peter/0000-0003-1304-4152; Jorgensen, Tina Zenia/0000-0003-3586-2332; Skov, Soren/0000-0003-0732-0026	University of Copenhagen	University of Copenhagen	The research was funded by the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MB, 2009, J IMMUNOL, V182, P6763, DOI 10.4049/jimmunol.0801792; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Assier E, 2010, JOINT BONE SPINE, V77, P532, DOI 10.1016/j.jbspin.2010.07.007; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2008, CLIN IMMUNOL, V129, P249, DOI 10.1016/j.clim.2008.07.014; Bamias G, 2012, DIGEST LIVER DIS, V44, P30, DOI 10.1016/j.dld.2011.09.002; Bamias G, 2011, EXP DERMATOL, V20, P725, DOI 10.1111/j.1600-0625.2011.01304.x; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bezbradica JS, 2009, NAT IMMUNOL, V10, P333, DOI 10.1038/ni.1713; Boyman O, 2010, EUR J IMMUNOL, V40, P936, DOI 10.1002/eji.201040466; Buchan SL, 2012, EUR J IMMUNOL, V42, P580, DOI 10.1002/eji.201041950; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Correia MP, 2011, IMMUNOBIOLOGY, V216, P604, DOI 10.1016/j.imbio.2010.09.012; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fleming JO, 2013, INT J PARASITOL, V43, P259, DOI 10.1016/j.ijpara.2012.10.025; Gagnon J, 2008, J IMMUNOL, V180, P7958, DOI 10.4049/jimmunol.180.12.7958; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Harris KM, 2011, J LEUKOCYTE BIOL, V90, P727, DOI 10.1189/jlb.0311132; Itsumi M, 2009, EUR J IMMUNOL, V39, P1784, DOI 10.1002/eji.200839106; Jones GW, 2011, FASEB J, V25, P409, DOI 10.1096/fj.10-166843; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Konsta M, 2012, RHEUMATOLOGY, DOI [10.1093/rheumatology/kes316, DOI 10.1093/RHEUMAT0L0GY/KES316]; Kotaja N, 2004, NAT GENET, V36, P551, DOI 10.1038/ng0604-551; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Lee YJ, 2010, J EXP MED, V207, P237, DOI 10.1084/jem.20091519; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Niedbala W, 2002, EUR J IMMUNOL, V32, P341, DOI 10.1002/1521-4141(200202)32:2<341::AID-IMMU341>3.0.CO;2-X; Niu Q, 2012, RHEUMATOL INT, V32, P2731, DOI 10.1007/s00296-011-1984-x; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Rodrigues L, 2009, MOL IMMUNOL, V46, P1494, DOI 10.1016/j.molimm.2008.12.033; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Rose-John S, 2007, EXPERT OPIN THER TAR, V11, P613, DOI 10.1517/14728222.11.5.613; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schiff MH, 2006, ANN RHEUM DIS, V65, P889, DOI 10.1136/ard.2005.043166; Skov S, 2000, J IMMUNOL, V164, P3500, DOI 10.4049/jimmunol.164.7.3500; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Twohig JP, 2012, FASEB J, V26, P3575, DOI 10.1096/fj.11-200618; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; Vujanovic L, 2010, BLOOD, V116, P575, DOI 10.1182/blood-2009-08-240325; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645	58	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85793	10.1371/journal.pone.0085793	http://dx.doi.org/10.1371/journal.pone.0085793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416448	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500266
J	Rowe, RK; Striz, M; Bachstetter, AD; Van Eldik, LJ; Donohue, KD; O'Hara, BF; Lifshitz, J				Rowe, Rachel K.; Striz, Martin; Bachstetter, Adam D.; Van Eldik, Linda J.; Donohue, Kevin D.; O'Hara, Bruce F.; Lifshitz, Jonathan			Diffuse Brain Injury Induces Acute Post-Traumatic Sleep	PLOS ONE			English	Article							CYTOKINES; WAKE; INTERLEUKIN-1-BETA; PATHOPHYSIOLOGY; ACTIVATION; DISORDERS	Objective: Clinical observations report excessive sleepiness immediately following traumatic brain injury (TBI); however, there is a lack of experimental evidence to support or refute the benefit of sleep following a brain injury. The aim of this study is to investigate acute post-traumatic sleep. Methods: Sham, mild or moderate diffuse TBI was induced by midline fluid percussion injury (mFPI) in male C57BL/6J mice at 9: 00 or 21: 00 to evaluate injury-induced sleep behavior at sleep and wake onset, respectively. Sleep profiles were measured post-injury using a non-invasive, piezoelectric cage system. In separate cohorts of mice, inflammatory cytokines in the neocortex were quantified by immunoassay, and microglial activation was visualized by immunohistochemistry. Results: Immediately after diffuse TBI, quantitative measures of sleep were characterized by a significant increase in sleep (>50%) for the first 6 hours post-injury, resulting from increases in sleep bout length, compared to sham. Acute post-traumatic sleep increased significantly independent of injury severity and time of injury (9: 00 vs 21: 00). The pro-inflammatory cytokine IL-1 beta increased in brain-injured mice compared to sham over the first 9 hours post-injury. Iba-1 positive microglia were evident in brain-injured cortex at 6 hours post-injury. Conclusion: Post-traumatic sleep occurs for up to 6 hours after diffuse brain injury in the mouse regardless of injury severity or time of day. The temporal profile of secondary injury cascades may be driving the significant increase in post-traumatic sleep and contribute to the natural course of recovery through cellular repair.	[Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Lifshitz, Jonathan] Phoenix Veteran Affairs Healthcare Syst, Phoenix, AZ USA; [Rowe, Rachel K.; Van Eldik, Linda J.; Lifshitz, Jonathan] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY USA; [Striz, Martin; O'Hara, Bruce F.] Univ Kentucky, Dept Biol, Coll Arts & Sci, Lexington, KY USA; [Donohue, Kevin D.] Univ Kentucky, Dept Elect & Comp Engn, Coll Engn, Lexington, KY USA; [Lifshitz, Jonathan] Univ Kentucky, Coll Med, Dept Phys Med & Rehabil, Lexington, KY USA; [Rowe, Rachel K.; Van Eldik, Linda J.; O'Hara, Bruce F.; Lifshitz, Jonathan] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [Bachstetter, Adam D.; Van Eldik, Linda J.] Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Lifshitz, J (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA.	jlifshitz@email.arizona.edu		Bachstetter, Adam/0000-0003-4646-6757; Rowe, Rachel/0000-0002-9034-3159	National Institutes of Health (NIH) [R21 NS072611, R01 NS065052, R01 NS064247, KSCHIRT 10-5A, F32 AG037280]; National Institute of Neurological Disorders and Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065052, R21NS072611, R01NS064247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG037280] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support provided by National Institutes of Health (NIH) grants R21 NS072611 (JL/BFO), R01 NS065052 (JL), R01 NS064247 (LVE), KSCHIRT 10-5A, F32 AG037280 (ADB). RKR was supported by a Research Supplement to Promote Diversity by the National Institute of Neurological Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chikahisa Sachiko, 2011, Front Neurol, V2, P87, DOI 10.3389/fneur.2011.00087; Chokroverty S, 2010, INDIAN J MED RES, V131, P126; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; Dworak M, 2010, J NEUROSCI, V30, P9007, DOI 10.1523/JNEUROSCI.1423-10.2010; FAN L, 1995, MOL BRAIN RES, V30, P125; Fang JD, 1998, AM J PHYSIOL-REG I, V274, pR655, DOI 10.1152/ajpregu.1998.274.3.R655; Flores AE, 2007, IEEE T BIO-MED ENG, V54, P225, DOI 10.1109/TBME.2006.886938; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gentleman D, 1999, BRIT MED BULL, V55, P910, DOI 10.1258/0007142991902718; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Krueger JM, 2007, SLEEP MED CLIN, V2, P161, DOI 10.1016/j.jsmc.2007.03.003; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; KRUEGER JM, 1995, INT ARCH ALLERGY IMM, V106, P97, DOI 10.1159/000236827; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCoy JG, 2011, NEUROBIOL LEARN MEM, V96, P564, DOI 10.1016/j.nlm.2011.07.004; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wisor JP, 2011, SLEEP, V34, P261, DOI 10.1093/sleep/34.3.261; Yasuda T, 2005, SLEEP, V28, P177, DOI 10.1093/sleep/28.2.177; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	48	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82507	10.1371/journal.pone.0082507	http://dx.doi.org/10.1371/journal.pone.0082507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416145	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500018
J	Schut, AGT; Wardell-Johnson, GW; Yates, CJ; Keppel, G; Baran, I; Franklin, SE; Hopper, SD; Van Niel, KP; Mucina, L; Byrne, M				Schut, Antonius G. T.; Wardell-Johnson, Grant W.; Yates, Colin J.; Keppel, Gunnar; Baran, Ireneusz; Franklin, Steven E.; Hopper, Stephen D.; Van Niel, Kimberley P.; Mucina, Ladislav; Byrne, Margaret			Rapid Characterisation of Vegetation Structure to Predict Refugia and Climate Change Impacts across a Global Biodiversity Hotspot	PLOS ONE			English	Article							CONSERVATION; FOREST; AUSTRALIA; FUTURE; FIRE; DISTRIBUTIONS; ADAPTATION; ECOSYSTEMS; INSELBERGS; EVOLUTION	Identification of refugia is an increasingly important adaptation strategy in conservation planning under rapid anthropogenic climate change. Granite outcrops (GOs) provide extraordinary diversity, including a wide range of taxa, vegetation types and habitats in the Southwest Australian Floristic Region (SWAFR). However, poor characterization of GOs limits the capacity of conservation planning for refugia under climate change. A novel means for the rapid identification of potential refugia is presented, based on the assessment of local-scale environment and vegetation structure in a wider region. This approach was tested on GOs across the SWAFR. Airborne discrete return Light Detection And Ranging (LiDAR) data and Red Green and Blue (RGB) imagery were acquired. Vertical vegetation profiles were used to derive 54 structural classes. Structural vegetation types were described in three areas for supervised classification of a further 13 GOs across the region. Habitat descriptions based on 494 vegetation plots on and around these GOs were used to quantify relationships between environmental variables, ground cover and canopy height. The vegetation surrounding GOs is strongly related to structural vegetation types (Kappa = 0.8) and to its spatial context. Water gaining sites around GOs are characterized by taller and denser vegetation in all areas. The strong relationship between rainfall, soil-depth, and vegetation structure (R 2 of 0.8-0.9) allowed comparisons of vegetation structure between current and future climate. Significant shifts in vegetation structural types were predicted and mapped for future climates. Water gaining areas below granite outcrops were identified as important putative refugia. A reduction in rainfall may be offset by the occurrence of deeper soil elsewhere on the outcrop. However, climate change interactions with fire and water table declines may render our conclusions conservative. The LiDAR-based mapping approach presented enables the integration of site-based biotic assessment with structural vegetation types for the rapid delineation and prioritization of key refugia.	[Schut, Antonius G. T.] Curtin Univ, Dept Spatial Sci, Bentley, WA, Australia; [Schut, Antonius G. T.; Wardell-Johnson, Grant W.] Curtin Univ, Curtin Inst Biodivers & Climate, Bentley, WA, Australia; [Yates, Colin J.; Byrne, Margaret] Dept Pk & Wildlife, Div Sci, Bentley, WA, Australia; [Keppel, Gunnar] Univ S Australia, Sch Nat & Built Environm, Adelaide, SA 5001, Australia; [Keppel, Gunnar] Univ S Australia, Barbara Hardy Inst, Adelaide, SA 5001, Australia; [Baran, Ireneusz] AAM Pty Ltd, Perth, WA, Australia; [Franklin, Steven E.] Trent Univ, Peterborough, ON K9J 7B8, Canada; [Hopper, Stephen D.] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia; [Van Niel, Kimberley P.] Univ Western Australia, Sch Earth & Environm, Crawley, WA, Australia; [Mucina, Ladislav] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	Curtin University; Curtin University; University of South Australia; University of South Australia; Trent University; University of Western Australia; University of Western Australia; University of Western Australia	Schut, AGT (corresponding author), Curtin Univ, Dept Spatial Sci, Bentley, WA, Australia.	tom.schut@wur.nl	Byrne, Margaret/H-8198-2015; Keppel, Gunnar/F-3767-2013; Mucina, Ladislav/B-6278-2012; Mucina, Ladislav/M-8875-2019; Mucina, Ladislav/A-6275-2019; Hopper, Stephen D/G-4222-2012; Mucina, Laco/H-5490-2014; Keppel, Gunnar/B-3364-2015	Byrne, Margaret/0000-0002-7197-5409; Keppel, Gunnar/0000-0001-7092-6149; Mucina, Ladislav/0000-0003-0317-8886; Mucina, Ladislav/0000-0003-0317-8886; Mucina, Ladislav/0000-0003-0317-8886; Hopper, Stephen D/0000-0002-0364-2856; Mucina, Laco/0000-0003-0317-8886; Schut, Antonius/0000-0002-7512-728X; Franklin, Steven/0000-0003-1886-9153	ARC, Curtin University [LP0990914]	ARC, Curtin University(Australian Research Council)	The paper was supported by ARC Linkage Grant LP0990914, a Targeted Fellowship at Curtin University to G. W. Wardell-Johnson, and in-kind support from AAM Pty. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Climate change in Australia; Ashcroft MB, 2013, AGR FOREST METEOROL, V176, P77, DOI 10.1016/j.agrformet.2013.03.008; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bates BC, 2008, CLIMATIC CHANGE, V89, P339, DOI 10.1007/s10584-007-9390-9; Beard J.S., 1990, PLANT LIFE W AUSTR; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; Bettenay E, 1963, J DEP AGR WA, V4, P216; Bindon P.R., 1997, J ROYAL SOC W AUSTR, V80, P173; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bradstock RA, 2010, GLOBAL ECOL BIOGEOGR, V19, P145, DOI 10.1111/j.1466-8238.2009.00512.x; Brouwers N, 2013, LANDSCAPE ECOL, V28, P69, DOI 10.1007/s10980-012-9815-3; Burke A, 2003, DIVERS DISTRIB, V9, P375, DOI 10.1046/j.1472-4642.2003.00035.x; Burke A, 2002, J ARID ENVIRON, V50, P219, DOI 10.1006/jare.2001.0907; Burrows ND, 2013, AUST J BOT, V61, P81, DOI 10.1071/BT12240; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Croton JT, 2005, SALINITY LAND USE IM; CSIRO BOM, 2007, CLIM CHANG AUSTR OBS; Fernie N, 1930, J I ENG, V2, P198; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Ford KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065008; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Fried JS, 2004, CLIMATIC CHANGE, V64, P169, DOI 10.1023/B:CLIM.0000024667.89579.ed; Game ET, 2011, GLOBAL CHANGE BIOL, V17, P3150, DOI 10.1111/j.1365-2486.2011.02457.x; Goetz S, 2007, REMOTE SENS ENVIRON, V108, P254, DOI 10.1016/j.rse.2006.11.016; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOPKINS AJM, 1981, AUST J ECOL, V6, P177, DOI 10.1111/j.1442-9993.1981.tb01288.x; Hopper S. D., 1997, Journal of the Royal Society of Western Australia, V80, P141; Hopper S. D., 2000, Journal of the Royal Society of Western Australia, V83, P173; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Hughes JD, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050797; Jaskierniak D, 2011, REMOTE SENS ENVIRON, V115, P573, DOI 10.1016/j.rse.2010.10.003; Keppel G, 2012, GLOBAL CHANGE BIOL, V18, P2389, DOI 10.1111/j.1365-2486.2012.02729.x; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Korhonen L, 2011, REMOTE SENS ENVIRON, V115, P1065, DOI 10.1016/j.rse.2010.12.011; Laing I.A.F., 1997, J ROYAL SOC W AUSTR, V80, P181; Lambers H, 2010, PLANT SOIL, V334, P11, DOI 10.1007/s11104-010-0444-9; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Macfarlane C, 2010, FOREST ECOL MANAG, V260, P96, DOI 10.1016/j.foreco.2010.04.005; Mallet C, 2009, ISPRS J PHOTOGRAMM, V64, P1, DOI 10.1016/j.isprsjprs.2008.09.007; Matusick G, 2013, EUR J FOREST RES, V132, P497, DOI 10.1007/s10342-013-0690-5; Michael Damian R., 2010, Ecological Management & Restoration, V11, P43, DOI 10.1111/j.1442-8903.2010.00512.x; Mignaut T, 2010, PLANT ECOL EVOL, V143, P128, DOI 10.5091/plecevo.2010.404; Miura N, 2010, REMOTE SENS ENVIRON, V114, P1069, DOI 10.1016/j.rse.2009.12.017; Morsdorf F, 2010, REMOTE SENS ENVIRON, V114, P1403, DOI 10.1016/j.rse.2010.01.023; Mucina L., 2006, VEGETATION S AFRICA, P801; Mucina L, 2011, PLANT SOIL, V341, P1, DOI 10.1007/s11104-011-0734-x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Orians GH, 2007, BIOL REV, V82, P393, DOI 10.1111/j.1469-185X.2007.00017.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pate J. S., 1984, KWONGAN PLANT LIFE S; Pearce K.B., 2007, CLIMATE CHANGE AUSTR; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Petrone KC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043102; Pinder A. M., 2000, Journal of the Royal Society of Western Australia, V83, P149; Poot P, 2013, PLANT SOIL, V364, P409, DOI 10.1007/s11104-012-1452-8; Poot P, 2012, ANN BOT-LONDON, V110, P291, DOI 10.1093/aob/mcr322; Porembski S., 1997, Journal of the Royal Society of Western Australia, V80, P193; Reed AJ, 2012, FUTURE STREAMFLOWS N; Reitberger J, 2009, ISPRS J PHOTOGRAMM, V64, P561, DOI 10.1016/j.isprsjprs.2009.04.002; Reside A. E., 2013, CLIMATE CHANGE REFUG; Richards J. A., 2006, REMOTE SENSING DIGIT, P267; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rundel Philip W., 2001, P145; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sander J, 2012, PLANT BIOSYST, V146, P451, DOI 10.1080/11263504.2012.656726; Schimper AFW., 1903, PLANT GEOGRAPHY PHYS; Schofield NJ, 1989, JARRAH FOREST, P179; Schut AGT, CANOPY PROFILING VEG; Simonson WD, 2013, ECOL INDIC, V24, P636, DOI 10.1016/j.ecolind.2012.08.024; Simonson WD, 2012, CONSERV BIOL, V26, P840, DOI 10.1111/j.1523-1739.2012.01869.x; Specht RL., 1970, AUSTR ENV, P44; Sun D, 1997, AUST J BOT, V45, P929, DOI 10.1071/BT96121; Twidale C. R., 1997, SPECIAL PUBLICATIONS, V120, P13; Verboom WH, 2003, PLANT SOIL, V248, P321, DOI 10.1023/A:1022358014629; Wardell-Johnson G., 1996, Journal of the Royal Society of Western Australia, V79, P249; Wardell-Johnson Grant W., 2011, Pacific Conservation Biology, V17, P220; Withers P. C., 1997, Journal of the Royal Society of Western Australia, V80, P159; Wulder MA, 2012, REMOTE SENS ENVIRON, V121, P196, DOI 10.1016/j.rse.2012.02.001; Wulder MA, 2008, FOREST CHRON, V84, P807, DOI 10.5558/tfc84807-6; Yates CJ, 2003, J VEG SCI, V14, P185, DOI 10.1111/j.1654-1103.2003.tb02143.x; Yates CJ, 2010, DIVERS DISTRIB, V16, P187, DOI 10.1111/j.1472-4642.2009.00623.x	86	49	53	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82778	10.1371/journal.pone.0082778	http://dx.doi.org/10.1371/journal.pone.0082778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416149	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000329862500021
J	Zhu, J; Zhao, C; Kharman-Biz, A; Zhuang, T; Jonsson, P; Liang, N; Williams, C; Lin, CY; Qiao, Y; Zendehdel, K; Stromblad, S; Treuter, E; Dahlman-Wright, K				Zhu, J.; Zhao, C.; Kharman-Biz, A.; Zhuang, T.; Jonsson, P.; Liang, N.; Williams, C.; Lin, C-Y; Qiao, Y.; Zendehdel, K.; Stroemblad, S.; Treuter, E.; Dahlman-Wright, K.			The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor alpha and modulates estrogen-stimulated breast cancer cell proliferation	ONCOGENE			English	Article						RNF31; ubiquitin; ER alpha; estrogen signaling; breast cancer	TRANSCRIPTIONAL REPRESSION; TUMOR PROGRESSION; ER-ALPHA; P53; DEGRADATION; ACTIVATION; EXPRESSION; COMPLEX; PARKIN; TRANSACTIVATION	Estrogen receptor alpha (ER alpha) is initially expressed in the majority of breast cancers and promotes estrogen-dependent cancer progression by regulating the transcription of genes linked to cell proliferation. ER alpha status is of clinical importance, as ER alpha-positive breast cancers can be successfully treated by adjuvant therapy with antiestrogens or aromatase inhibitors. Complications arise from the frequent development of drug resistance that might be caused by multiple alterations, including components of ER alpha signaling, during tumor progression and metastasis. Therefore, insights into the molecular mechanisms that control ER alpha expression and stability are of utmost importance to improve breast cancer diagnostics and therapeutics. Here we report that the atypical E3 ubiquitin ligase RNF31 stabilizes ER alpha and facilitates ER alpha-stimulated proliferation in breast cancer cell lines. We show that depletion of RNF31 decreases the number of cells in the S phase and reduces the levels of ER alpha and its downstream target genes, including cyclin D1 and c-myc. Analysis of data from clinical samples confirms correlation between RNF31 expression and the expression of ER alpha target genes. Immunoprecipitation indicates that RNF31 associates with ER alpha and increases its stability and mono-ubiquitination, dependent on the ubiquitin ligase activity of RNF31. Our data suggest that association of RNF31 and ER alpha occurs mainly in the cytosol, consistent with the lack of RNF31 recruitment to ER alpha-occupied promoters. In conclusion, our study establishes a non-genomic mechanism by which RNF31 via stabilizing ER alpha levels controls the transcription of estrogen-dependent genes linked to breast cancer cell proliferation.	[Zhu, J.; Zhao, C.; Kharman-Biz, A.; Zhuang, T.; Liang, N.; Qiao, Y.; Stroemblad, S.; Treuter, E.; Dahlman-Wright, K.] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Kharman-Biz, A.; Zendehdel, K.] Univ Tehran Med Sci, Canc Inst Iran, Canc Res Ctr, Tehran, Iran; [Jonsson, P.; Williams, C.; Lin, C-Y] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA	Karolinska Institutet; Tehran University of Medical Sciences; University of Houston System; University of Houston	Dahlman-Wright, K (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden.	karin.dahlman-wright@ki.se	Williams, Cecilia/A-6677-2009; Qiao, yichun/Q-6498-2018; zhu, jian/D-7361-2017	Williams, Cecilia/0000-0002-0602-2062; Jonsson, Philip/0000-0002-1537-0624; Stromblad, Staffan/0000-0002-1236-6339; zhu, jian/0000-0003-0171-4251; zhu, jian/0000-0003-3596-4339; Zendehdel, Kazem/0000-0002-0269-4945; Liang, Ning/0000-0002-7848-2893; Treuter, Eckardt/0000-0002-4147-8989; Zhuang, Ting/0000-0002-6308-1253	China Scholarship Council; KID faculty grant from the Karolinska Institutet; Center for Biosciences; Swedish Cancer Society; Karolinska Institutet; Swedish Research Council; Cancer Institute of Tehran University; Knut & Alice Wallenberg foundation	China Scholarship Council(China Scholarship Council); KID faculty grant from the Karolinska Institutet; Center for Biosciences; Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Institute of Tehran University; Knut & Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	We are grateful to the BEA core facility for performing microarray analysis. We thank Indranil Sinha for uploading the microarray data. This work was supported by scholarship from the China Scholarship Council and by a KID faculty grant from the Karolinska Institutet (Jian Zhu), funding from the Center for Biosciences, the Swedish Cancer Society and the Karolinska Institutet (Karin Dahlman-Wright), and grants from the center for Biosciences, the Swedish Cancer Society and the Swedish Research Council (Eckardt Treuter). Human samples were provided by the Iran National Tumor Bank, which is funded by the Cancer Institute of Tehran University. Imaging, performed at the live cell imaging unit at the Department of Biosciences and Nutrition, was supported by the Knut & Alice Wallenberg foundation, the Swedish Research Council and the Center for Biosciences. This work was supported by scholarship from the China Scholarship Council and by a KID faculty grant from the Karolinska Institutet, funding from the Center for Biosciences, the Swedish Cancer Society, the Swedish Research Council and the Karolinska Institutet. Human samples were provided by the IRAN NATIONAL TUMOR BANK, which is funded by the Cancer Institute of Tehran University. Imaging was performed at the live cell imaging unit at the Department of Biosciences and Nutrition, supported by the Knut & Alice Wallenberg foundation, the Swedish Research Council and the Center for Biosciences.	Berry NB, 2008, MOL ENDOCRINOL, V22, P1535, DOI 10.1210/me.2007-0449; Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804; Brown RJ, 2006, SEMIN ONCOL, V33, P657, DOI 10.1053/j.seminoncol.2006.08.014; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; da Costa CA, 2009, NAT CELL BIOL, V11, P1370, DOI 10.1038/ncb1981; Duong V, 2007, CANCER RES, V67, P5513, DOI 10.1158/0008-5472.CAN-07-0967; Ehrlund A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032080; Ehrlund A, 2009, MOL CELL BIOL, V29, P2230, DOI 10.1128/MCB.00743-08; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Geschickter C F, 1934, Am J Cancer, V21, P828; Gustafsson N, 2010, CANCER RES, V70, P1265, DOI 10.1158/0008-5472.CAN-09-2674; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hicks C, 2012, BREAST CANCER-BASIC, V6, P47, DOI 10.4137/BCBCR.S8652; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kastan MB, 2003, CELL, V112, P1, DOI 10.1016/S0092-8674(02)01281-3; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; La Rosa P, 2011, CELL SIGNAL, V23, P1128, DOI 10.1016/j.cellsig.2011.02.006; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; LECLERCQ G, 1986, CANCER RES, V46, P4233; Lindstrom LS, 2012, J CLIN ONCOL, V30, P2601, DOI 10.1200/JCO.2011.37.2482; Lonard DM, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe16; Ma YX, 2010, MOL ENDOCRINOL, V24, P76, DOI 10.1210/me.2009-0218; Mulhall JP, 2010, BJU INT, V106, P1706, DOI 10.1111/j.1464-410X.2010.09754.x; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Putnik M, 2012, BIOCHEM BIOPH RES CO, V426, P26, DOI 10.1016/j.bbrc.2012.08.007; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shaaban AM, 2002, AM J PATHOL, V160, P597, DOI 10.1016/S0002-9440(10)64879-1; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Stevens TA, 2006, ONCOGENE, V25, P5426, DOI 10.1038/sj.onc.1209529; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Thompson HGR, 2004, EXP CELL RES, V295, P448, DOI 10.1016/j.yexcr.2004.01.019; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wong SCC, 2001, J PATHOL, V194, P35, DOI 10.1002/path.838; Woo MG, 2012, J BIOL CHEM, V287, P3963, DOI 10.1074/jbc.M111.314765; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zwart W, 2011, WIRES SYST BIOL MED, V3, P216, DOI 10.1002/wsbm.109	41	68	70	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 21	2014	33	34					4340	4351		10.1038/onc.2013.573	http://dx.doi.org/10.1038/onc.2013.573			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MK	24441041	Green Published, hybrid			2022-12-25	WOS:000341156900007
J	Jaiswal, M; Dvorsky, R; Amin, E; Risse, SL; Fansa, EK; Zhang, SC; Taha, MS; Gauhar, AR; Nakhaei-Rad, S; Kordes, C; Koessmeier, KT; Cirstea, IC; Olayioye, MA; Haussinger, D; Ahmadian, MR				Jaiswal, Mamta; Dvorsky, Radovan; Amin, Ehsan; Risse, Sarah L.; Fansa, Eyad K.; Zhang, Si-Cai; Taha, Mohamed S.; Gauhar, Aziz R.; Nakhaei-Rad, Saeideh; Kordes, Claus; Koessmeier, Katja T.; Cirstea, Ion C.; Olayioye, Monilola A.; Haeussinger, Dieter; Ahmadian, Mohammad R.			Functional Cross-talk between Ras and Rho Pathways A Ras-SPECIFIC GTPase-ACTIVATING PROTEIN (p120RasGAP) COMPETITIVELY INHIBITS THE RhoGAP ACTIVITY OF DELETED IN LIVER CANCER (DLC) TUMOR SUPPRESSOR BY MASKING THE CATALYTIC ARGININE FINGER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; Kinetics; Molecular Modeling; SH3 Domains; Structural Biology; Arginine Finger; DLC1; Deleted in Liver Cancer; RhoGAP; p120RasGAP	NUCLEOTIDE-EXCHANGE FACTORS; SH3 DOMAIN; HEPATOCELLULAR-CARCINOMA; STRUCTURAL BASIS; ONCOGENIC RAS; AUTOINHIBITORY MECHANISM; INDEPENDENT MECHANISMS; SIGNAL-TRANSDUCTION; HYDROLYSIS REACTION; BINDING PROTEINS	Background: The regulatory mechanism of the DLC1 tumor suppressor protein is unclear. Results: Structure-function analysis revealed determinants for the selectivity, activity, and inhibition of DLC1 RhoGAP function. Conclusion: p120RasGAP competitively and selectively inhibits DLC1 by targeting its catalytic arginine finger. Significance: This mechanistic study emphasizes the importance of the functional inter-relationships of GTPase-activating proteins mediating cross-talk between the Ras and Rho pathways. The three deleted in liver cancer genes (DLC1-3) encode Rho-specific GTPase-activating proteins (RhoGAPs). Their expression is frequently silenced in a variety of cancers. The RhoGAP activity, which is required for full DLC-dependent tumor suppressor activity, can be inhibited by the Src homology 3 (SH3) domain of a Ras-specific GAP (p120RasGAP). Here, we comprehensively investigated the molecular mechanism underlying cross-talk between two distinct regulators of small GTP-binding proteins using structural and biochemical methods. We demonstrate that only the SH3 domain of p120 selectively inhibits the RhoGAP activity of all three DLC isoforms as compared with a large set of other representative SH3 or RhoGAP proteins. Structural and mutational analyses provide new insights into a putative interaction mode of the p120 SH3 domain with the DLC1 RhoGAP domain that is atypical and does not follow the classical PXXP-directed interaction. Hence, p120 associates with the DLC1 RhoGAP domain by targeting the catalytic arginine finger and thus by competitively and very potently inhibiting RhoGAP activity. The novel findings of this study shed light on the molecular mechanisms underlying the DLC inhibitory effects of p120 and suggest a functional cross-talk between Ras and Rho proteins at the level of regulatory proteins.	[Jaiswal, Mamta; Dvorsky, Radovan; Amin, Ehsan; Risse, Sarah L.; Fansa, Eyad K.; Zhang, Si-Cai; Taha, Mohamed S.; Gauhar, Aziz R.; Nakhaei-Rad, Saeideh; Koessmeier, Katja T.; Cirstea, Ion C.; Ahmadian, Mohammad R.] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fak Med, D-40225 Dusseldorf, Germany; [Kordes, Claus; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Fak Med, D-40225 Dusseldorf, Germany; [Cirstea, Ion C.] Leibniz Inst Age Res, D-07745 Jena, Germany; [Olayioye, Monilola A.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Stuttgart	Ahmadian, MR (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fak Med, Univ Str 1,Gebaude 22-03, D-40255 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Dvorsky, Radovan/ABE-3042-2020; Cirstea, Ion Cristian/AAQ-7670-2020; Kordes, Claus/AFM-1775-2022; jaiswal, mamta/E-5148-2016; Nakhaeirad, Saeideh/AAV-1771-2020; taha, mohamed/W-8321-2019	Cirstea, Ion Cristian/0000-0003-3204-1598; Kordes, Claus/0000-0003-0782-1998; jaiswal, mamta/0000-0002-5862-7506; Nakhaeirad, Saeideh/0000-0001-8966-8960; Amin, Ehsan/0000-0003-2995-8864; Taha, Mohamed/0000-0002-7121-9283	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) through the Collaborative Research Center [974 (SFB 974)]; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) through International Research Training Group [1902 (IRGT1902), AH 92/5-1]; National Genome Research Network Plus program of the German Ministry of Science and Education (Bundesministerium fur Bildung und Forschung) [01GS08100]; International North Rhine-Westphalia Research School BioStruct by Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich Heine University of Dusseldorf; Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf; DFG Heisenberg program	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) through the Collaborative Research Center; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) through International Research Training Group(German Research Foundation (DFG)); National Genome Research Network Plus program of the German Ministry of Science and Education (Bundesministerium fur Bildung und Forschung); International North Rhine-Westphalia Research School BioStruct by Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich Heine University of Dusseldorf; Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf; DFG Heisenberg program(German Research Foundation (DFG))	This work was supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) through the Collaborative Research Center 974 (SFB 974) "Communication and Systems Relevance during Liver Injury and Regeneration," the International Research Training Group 1902 (IRGT1902), and Project Grant AH 92/5-1; the National Genome Research Network Plus program of the German Ministry of Science and Education (Bundesministerium fur Bildung und Forschung Grant 01GS08100); and the International North Rhine-Westphalia Research School BioStruct granted by the Ministry of Innovation, Science and Research of the State North Rhine-Westphalia, the Heinrich Heine University of Dusseldorf, and the Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf.; Supported by the DFG Heisenberg program.	Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Asnaghi L, 2010, ONCOGENE, V29, P2760, DOI 10.1038/onc.2010.39; Aznar S, 2001, PROG NUCLEIC ACID RE, V67, P193, DOI 10.1016/S0079-6603(01)67029-6; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chan FKC, 2012, NEUROSIGNALS, V20, P112, DOI 10.1159/000331240; Chan LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005572; Chan PC, 2012, CANCER RES, V72, P2405, DOI 10.1158/0008-5472.CAN-11-3078; Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Clark GJ, 1997, J BIOL CHEM, V272, P1677, DOI 10.1074/jbc.272.3.1677; CLARK GJ, 1995, BREAST CANCER RES TR, V35, P133, DOI 10.1007/BF00694753; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Colon-Gonzalez F, 2008, J BIOL CHEM, V283, P35247, DOI 10.1074/jbc.M806264200; DiNitto JP, 2010, BIOCHEMISTRY-US, V49, P6083, DOI 10.1021/bi1000454; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Eberth A, 2005, BIOL CHEM, V386, P1105, DOI 10.1515/BC.2005.127; Eberth A., 2009, CURR PROTOC CELL BIO, P19; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gigoux V, 2002, J BIOL CHEM, V277, P23742, DOI 10.1074/jbc.C200121200; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Herbrand U, 2006, BIOL CHEM, V387, P311, DOI 10.1515/BC.2006.041; Holeiter G, 2008, CANCER RES, V68, P8743, DOI 10.1158/0008-5472.CAN-08-0984; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kawai K, 2007, BIOCHEM BIOPH RES CO, V364, P783, DOI 10.1016/j.bbrc.2007.10.052; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; Kim TY, 2008, J BIOL CHEM, V283, P32762, DOI 10.1074/jbc.M800617200; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Ligeti E, 2012, PHYSIOL REV, V92, P237, DOI 10.1152/physrev.00045.2010; Lukasik D, 2011, ONCOL LETT, V2, P763, DOI 10.3892/ol.2011.345; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Moskwa P, 2005, J BIOL CHEM, V280, P6716, DOI 10.1074/jbc.M412563200; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Risse SL, 2013, BIOL CHEM, V394, P421, DOI 10.1515/hsz-2012-0246; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Ross B, 2007, BIOCHEM BIOPH RES CO, V353, P463, DOI 10.1016/j.bbrc.2006.12.044; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Scholz RP, 2011, EXP CELL RES, V317, P496, DOI 10.1016/j.yexcr.2010.11.003; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Scouras AD, 2011, PROTEIN SCI, V20, P341, DOI 10.1002/pro.565; Shang X, 2007, J BIOL CHEM, V282, P8801, DOI 10.1074/jbc.M609375200; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tripathi V., 2013, ONCOGENE, V4, P1; Wang ZX, 1996, CELL GROWTH DIFFER, V7, P123; Wong CM, 2003, CANCER RES, V63, P7646; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498; YANG YS, 1994, EMBO J, V13, P1270, DOI 10.1002/j.1460-2075.1994.tb06379.x; Yuan BZ, 1998, CANCER RES, V58, P2196; Zhou YT, 2010, MOL BIOL CELL, V21, P3232, DOI 10.1091/mbc.E09-05-0408; Zimonjic DB, 2012, INT J ONCOL, V41, P393, DOI 10.3892/ijo.2012.1474; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	80	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6839	6849		10.1074/jbc.M113.527655	http://dx.doi.org/10.1074/jbc.M113.527655			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443565	Green Published, hybrid			2022-12-25	WOS:000332389400045
J	Trimbos, KB; Doorenweerd, C; Kraaijeveld, K; Musters, CJM; Groen, NM; de Knijff, P; Piersma, T; de Snoo, GR				Trimbos, Krijn B.; Doorenweerd, Camiel; Kraaijeveld, Ken; Musters, C. J. M.; Groen, Niko M.; de Knijff, Peter; Piersma, Theunis; de Snoo, Geert R.			Patterns in Nuclear and Mitochondrial DNA Reveal Historical and Recent Isolation in the Black-Tailed Godwit (Limosa limosa)	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; STATISTICAL TESTS; SOFTWARE; DIFFERENTIATION; PHYLOGEOGRAPHY; DEMOGRAPHY; NEUTRALITY	On the basis of morphological differences, three subspecies of Black-tailed Godwit (Limosa limosa) have been recognized (L. l. limosa, L. l. islandica and L. l. melanuroides). In previous studies mitochondrial DNA (mtDNA) sequence data showed minimal genetic divergence between the three subspecies and an absence of sub-structuring within L. l. limosa. Here, population genetic structure and phylogeographic patterns have been analyzed using COI, HVR1 and HVR2 mtDNA sequence data as well as 12 microsatellite loci (nuDNA). The nuDNA data suggest genetic differentiation between L. l. limosa from Sweden and The Netherlands, between L. l. limosa and L. l. islandica, but not between L. l. limosa and L. l. melanuroides. However, the mtDNA data were not consistent with the nuDNA pattern. mtDNA did support a split between L. l. melanuroides and L. l. limosa/L. l. islandica and also demonstrated two L. l. limosa haplotype clusters that were not geographically isolated. This genetic structure can be explained by a scenario of isolation of L. l. melanuroides from L. l. limosa in Beringia during the Last Glacial Maximum. During the Pleistocene separation of L. l. islandica from L. l. limosa occurred, followed by colonization of Iceland by the L. l. islandica during the Holocene. Within L. l. limosa founder events, followed by population expansion, took place during the Holocene also. According to the patterns observed in both markers together and their geographic separation, we propose that the three traditional subspecies indeed represent three separate genetic units.	[Trimbos, Krijn B.; Musters, C. J. M.; de Snoo, Geert R.] Leiden Univ, Inst Environm Sci CML, Dept Conservat Biol, Leiden, Netherlands; [Doorenweerd, Camiel] Netherlands Ctr Biodivers, Dept Terr Zool, Leiden, Netherlands; [Kraaijeveld, Ken; de Knijff, Peter] Leiden Univ, Dept Human Genet, Leiden Genome Technol Ctr, Med Ctr, NL-2300 RA Leiden, Netherlands; [Groen, Niko M.; Piersma, Theunis] Univ Groningen, Dept Anim Ecol, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Piersma, Theunis] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Texel, Netherlands	Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Trimbos, KB (corresponding author), Leiden Univ, Inst Environm Sci CML, Dept Conservat Biol, Leiden, Netherlands.	trimbos@cml.leidenuniv.nl	Doorenweerd, Camiel/AAO-4314-2020; Piersma, Theunis/D-1871-2012; Musters, Cornelis/K-7828-2013; de Knijff, Peter/Y-2519-2018	Doorenweerd, Camiel/0000-0002-0418-4439; de Knijff, Peter/0000-0002-0899-771X; Piersma, Theunis/0000-0001-9668-466X; Trimbos, Krijn Baptist/0000-0001-5280-6434; Musters, C.J.M./0000-0003-1321-6786				Adams J. M., 1997, GLOBAL LAND ENV LAST; Beintema A. J., 1995, ECOLOGISCHE ATLAS NE; BirdLife International, 2009, SPEC FACTSH LIM LIM; Birdlife International I., 2004, BIRDS EUR POP EST TR; Buehler DM, 2005, CONDOR, V107, P497, DOI 10.1650/0010-5422(2005)107[0497:PDTAHD]2.0.CO;2; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Cramp S., 1982, BIRDS W PALEARCTIC, V3; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Elbourne R, 2011, THESIS DEP ECOLOGY E; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gill Jennifer A., 2007, Wader Study Group Bulletin, V114, P43; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Haverschmidt F., 1963, BLACK TAILED GODWIT; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hoglund J, 2009, J ORNITHOL, V150, P45, DOI 10.1007/s10336-008-0316-8; Jones KL, 2005, MOL ECOL, V14, P2645, DOI 10.1111/j.1365-294X.2005.02622.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kerr KCR, 2007, MOL ECOL NOTES, V7, P535, DOI 10.1111/j.1471-8286.2006.01670.x; Kleijn D, 2010, IBIS, V152, P475, DOI 10.1111/j.1474-919X.2010.01025.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebers D, 2004, P ROY SOC B-BIOL SCI, V271, P893, DOI 10.1098/rspb.2004.2679; Liebers D, 2001, MOL ECOL, V10, P2447, DOI 10.1046/j.0962-1083.2001.01370.x; Lopes RJ, 2013, J ORNITHOL, V154, P35, DOI 10.1007/s10336-012-0865-8; Mantooth SJ, 2011, GEOGR COMPASS, V5, P1, DOI 10.1111/j.1749-8198.2009.00297.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Mulder T, 1972, NEDERLAND AANTALLEN; Ottvall R, 2005, CONSERV GENET, V6, P321, DOI 10.1007/s10592-005-4973-3; Paton T, 2002, P ROY SOC B-BIOL SCI, V269, P839, DOI 10.1098/rspb.2002.1961; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Qiagen, 2003, DNEASY TISS HDB PROT, P18; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Ronka A, 2008, CONSERV GENET, V9, P29, DOI 10.1007/s10592-007-9299-x; Roselaar C.S., 1991, Dutch Birding, V13, P128; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Schekkerman H, 2008, J APPL ECOL, V45, P1067, DOI 10.1111/j.1365-2664.2008.01506.x; Schindel DE, 2011, ZOOKEYS, P87, DOI 10.3897/zookeys.152.2473; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; TAJIMA F, 1989, GENETICS, V123, P585; Thomas GH, 2004, BMC EVOL BIOL, V28, P1471; Trimbos KB, 2011, CONSERV GENET, V12, P629, DOI 10.1007/s10592-010-0167-8; Trimbos KB, 2009, J ORNITHOL, V150, P915, DOI 10.1007/s10336-009-0422-2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verkuil YI, 2009, MOL ECOL RESOUR, V9, P1415, DOI 10.1111/j.1755-0998.2009.02685.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wenink PW, 1996, AUK, V113, P744, DOI 10.2307/4088854; Wilson John James, 2011, BMC Ecology, V11, P18, DOI 10.1186/1472-6785-11-18; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x; Zwarts L., 2009, LIVING EDGE WETLANDS	61	12	13	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83949	10.1371/journal.pone.0083949	http://dx.doi.org/10.1371/journal.pone.0083949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416186	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300017
J	Hamady, LL; Natanson, LJ; Skomal, GB; Thorrold, SR				Hamady, Li Ling; Natanson, Lisa J.; Skomal, Gregory B.; Thorrold, Simon R.			Vertebral Bomb Radiocarbon Suggests Extreme Longevity in White Sharks	PLOS ONE			English	Article							CARCHARODON-CARCHARIAS; AGE-DETERMINATION; PELAGIC SHARKS; ORANGE ROUGHY; LAMNA-NASUS; VALIDATION; GROWTH; POPULATIONS; CHRONOLOGIES; CONSERVATION	Conservation and management efforts for white sharks (Carcharodon carcharias) remain hampered by a lack of basic demographic information including age and growth rates. Sharks are typically aged by counting growth bands sequentially deposited in their vertebrae, but the assumption of annual deposition of these band pairs requires testing. We compared radiocarbon (Delta C-14) values in vertebrae from four female and four male white sharks from the northwestern Atlantic Ocean (NWA) with reference chronologies documenting the marine uptake of C-14 produced by atmospheric testing of thermonuclear devices to generate the first radiocarbon age estimates for adult white sharks. Age estimates were up to 40 years old for the largest female (fork length [FL]: 526 cm) and 73 years old for the largest male (FL: 493 cm). Our results dramatically extend the maximum age and longevity of white sharks compared to earlier studies, hint at possible sexual dimorphism in growth rates, and raise concerns that white shark populations are considerably more sensitive to human-induced mortality than previously thought.	[Hamady, Li Ling; Thorrold, Simon R.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Hamady, Li Ling] MIT, Woods Hole Oceanog Inst, Joint Program Oceanog Appl Ocean Sci & Engn, Cambridge, MA 02139 USA; [Natanson, Lisa J.] NOAA, Natl Marine Fisheries Serv, Apex Predators Program, Narragansett, RI 02882 USA; [Skomal, Gregory B.] Massachusetts Div Marine Fisheries, New Bedford, MA USA	Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; National Oceanic Atmospheric Admin (NOAA) - USA; Massachusetts Division of Marine Fisheries	Hamady, LL (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	liling@whoi.edu	Thorrold, Simon R/B-7565-2012	Thorrold, Simon R/0000-0002-1533-7517; Hamady, Li Ling/0000-0003-3380-6150	National Science Foundation [OCE 0825148]; National Science Foundation Graduate Research Fellowship Program	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This study was funded by the National Science Foundation (OCE 0825148 was awarded to SRT) and LLH was supported by the National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose S.H., 1993, PREHISTORIC HUMAN BO, P1, DOI 10.1007/978-3-662-02894-0_1; Andrews AH, 2013, CAN J FISH AQUAT SCI, V70, P1131, DOI 10.1139/cjfas-2012-0537; Andrews AH, 2011, FISH B-NOAA, V109, P454; Andrews AH, 2009, CAN J FISH AQUAT SCI, V66, P1130, DOI 10.1139/F09-059; Ardizzone D, 2006, ENVIRON BIOL FISH, V77, P355, DOI 10.1007/s10641-006-9106-4; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Burgess GH, 2005, FISHERIES, V30, P30; Cailliet G.M., 1985, Memoirs of the Southern California Academy of Sciences, V9, P49; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; Campana SE, 2002, CAN J FISH AQUAT SCI, V59, P450, DOI 10.1139/F02-027; Campana SE, 2008, CAN J FISH AQUAT SCI, V65, P733, DOI 10.1139/F08-012; CITES, 2004, PROP INCL CARCH CARC; CMS, 2007, UNEP CMS REC 8 16 MI, V2005; Compagno LJV, 2001, FAO SPECIES CATALOGU, V2, P100; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Domeier Michael L., 2012, P133; DRUFFEL EM, 1978, GEOPHYS RES LETT, V5, P913, DOI 10.1029/GL005i011p00913; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; FENTON GE, 1991, MAR BIOL, V109, P197, DOI 10.1007/BF01319387; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; Goldman KJ, 2012, CRC MAR BIOL SER, P423; IUCN, 2013, IUCN RED LIST THREAT, V1; Kalish J.M., 2001, USE BOMB RADIOCARBON, P116; KALISH JM, 1993, EARTH PLANET SC LETT, V114, P549, DOI 10.1016/0012-821X(93)90082-K; Kerr LA, 2006, ENVIRON BIOL FISH, V77, P337, DOI 10.1007/s10641-006-9125-1; Kim SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045068; Kneebone J, 2008, MAR BIOL, V154, P423, DOI 10.1007/s00227-008-0934-y; McMahon KW, 2013, OCEANOGR MAR BIOL, V51, P327; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Michener R.H., 1994, P138; Mollet HF, 1996, GREAT WHITE SHARKS, P91, DOI 10.1016/B978-012415031-7/50011-2; Natanson LJ, 2014, ENVIRON BIOL FISH, V97, P881, DOI 10.1007/s10641-013-0189-4; Natanson LJ, 2002, FISH B-NOAA, V100, P266; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Passerotti MS, 2010, FISH B-NOAA, V108, P346; Rogers PJ, 2013, MAR FRESHWATER RES, V64, P20, DOI 10.1071/MF11234; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Tanaka S, 2011, MAR FRESHWATER RES, V62, P548, DOI 10.1071/MF10130; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; TUROSS N, 1988, GEOCHIM COSMOCHIM AC, V52, P929, DOI 10.1016/0016-7037(88)90364-X; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Wintner SP, 1999, FISH B-NOAA, V97, P153	48	63	65	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84006	10.1371/journal.pone.0084006	http://dx.doi.org/10.1371/journal.pone.0084006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416189	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500089
J	Jang, MS; Goo, E; An, JH; Kim, J; Hwang, I				Jang, Moon Sun; Goo, Eunhye; An, Jae Hyung; Kim, Jinwoo; Hwang, Ingyu			Quorum Sensing Controls Flagellar Morphogenesis in Burkholderia glumae	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; VIBRIO-CHOLERAE; MOTILITY; FLHF; BACTERIA; POLAR; GENE; PROTEIN; SYSTEM	Burkholderia glumae is a motile plant pathogenic bacterium that has multiple polar flagella and one LuxR/LuxI-type quorum sensing (QS) system, TofR/TofI. A QS-dependent transcriptional regulator, QsmR, activates flagellar master regulator flhDC genes. FlhDC subsequently activates flagellar gene expression in B. glumae at 37 degrees C. Here, we confirm that the interplay between QS and temperature is critical for normal polar flagellar morphogenesis in B. glumae. In the wild-type bacterium, flagellar gene expression and flagellar number were greater at 28 degrees C compared to 37 degrees C. The QS-dependent flhC gene was significantly expressed at 28 degrees C in two QS-defective (tofI::Omega and qsmR::Omega) mutants. Thus, flagella were present in both tofI::Omega and qsmR::Omega mutants at 28 degrees C, but were absent at 37 degrees C. Most tofI::Omega and qsmR::Omega mutant cells possessed polar or nonpolar flagella at 28 degrees C. Nonpolarly flagellated cells processing flagella around cell surface of both tofI::Omega and qsmR::Omega mutants exhibited tumbling and spinning movements. The flhF gene encoding GTPase involved in regulating the correct placement of flagella in other bacteria was expressed in QS mutants in a FlhDC-dependent manner at 28 degrees C. However, FlhF was mislocalized in QS mutants, and was associated with nonpolar flagellar formation in QS mutants at 28 degrees C. These results indicate that QS-independent expression of flagellar genes at 28 degrees C allows flagellar biogenesis, but is not sufficient for normal polar flagellar morphogenesis in B. glumae. Our findings demonstrate that QS functions together with temperature to control flagellar morphogenesis in B. glumae.	[Jang, Moon Sun; Goo, Eunhye; An, Jae Hyung; Hwang, Ingyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Jinwoo] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea; [Kim, Jinwoo] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea	Seoul National University (SNU); Gyeongsang National University; Gyeongsang National University	Hwang, I (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	ingyu@snu.ac.kr	Kim, Jinwoo/AAP-8786-2020; Goo, Eunhye/ERO-2624-2022	Kim, Jinwoo/0000-0003-1104-8088; 	Creative Research Initiatives Program of the National Research Foundation of Korea [2010-0018280]	Creative Research Initiatives Program of the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Creative Research Initiatives Program (2010-0018280) of the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Atkinson S, 2006, J BACTERIOL, V188, P1451, DOI 10.1128/JB.188.4.1451-1461.2006; Balaban M, 2009, J BACTERIOL, V191, P6602, DOI 10.1128/JB.00884-09; Bange G, 2011, NAT STRUCT MOL BIOL, V18, P1376, DOI 10.1038/nsmb.2141; CARPENTER PB, 1992, MOL MICROBIOL, V6, P2705, DOI 10.1111/j.1365-2958.1992.tb01447.x; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Choi KH, 2006, NAT PROTOC, V1, P162, DOI 10.1038/nprot.2006.25; Correa NE, 2005, J BACTERIOL, V187, P6324, DOI 10.1128/JB.187.18.6324-6332.2005; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Fujii M, 2008, J MOL BIOL, V379, P273, DOI 10.1016/j.jmb.2008.04.012; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Goo E, 2010, J PROTEOME RES, V9, P3184, DOI 10.1021/pr100045n; Haya S, 2011, APPL ENVIRON MICROB, V77, P2799, DOI 10.1128/AEM.00286-11; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Hoang HH, 2008, J BACTERIOL, V190, P861, DOI 10.1128/JB.01310-07; Hussain MBBM, 2008, J BACTERIOL, V190, P1045, DOI 10.1128/JB.01472-07; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kim J, 2010, PLANT PATHOLOGY J, V26, P271, DOI 10.5423/PPJ.2010.26.3.271; Kirkpatrick CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006809; Koster DA, 2012, J MOL BIOL, V424, P180, DOI 10.1016/j.jmb.2012.09.005; Kusumoto A, 2008, MICROBIOL-SGM, V154, P1390, DOI 10.1099/mic.0.2007/012641-0; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Matsuda I., 1988, ANN PHYTOPATHOL SOC, V54, P378, DOI DOI 10.3186/JJPHYTOPATH.54.378; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; McCarter LL, 2004, J MOL MICROB BIOTECH, V7, P18, DOI 10.1159/000077866; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; OKINO H, 1989, J BACTERIOL, V171, P2075, DOI 10.1128/jb.171.4.2075-2082.1989; Pandza S, 2000, MOL MICROBIOL, V36, P414, DOI 10.1046/j.1365-2958.2000.01859.x; Rader BA, 2007, J BACTERIOL, V189, P6109, DOI 10.1128/JB.00246-07; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Soutourina OA, 2001, APPL ENVIRON MICROB, V67, P3852, DOI 10.1128/AEM.67.9.3852-3859.2001; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Tsushima Seiya, 1996, Annals of the Phytopathological Society of Japan, V62, P108, DOI 10.3186/jjphytopath.62.108; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Zan JD, 2012, MOL MICROBIOL, V85, P916, DOI 10.1111/j.1365-2958.2012.08149.x	41	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84831	10.1371/journal.pone.0084831	http://dx.doi.org/10.1371/journal.pone.0084831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416296	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500177
J	Li, ZJ; Yang, H; Li, YP; Long, J; Liang, YC				Li, Zhaojun; Yang, Hua; Li, Yupeng; Long, Jian; Liang, Yongchao			Cross-Species Extrapolation of Prediction Model for Lead Transfer from Soil to Corn Grain under Stress of Exogenous Lead	PLOS ONE			English	Article							HEAVY-METALS; TRACE-ELEMENTS; CADMIUM; CD; PH; SORPTION; PB; AVAILABILITY; NICKEL; ZN	There has been increasing concern in recent years regarding lead (Pb) transfer in the soil-plant system. In this study the transfer of Pb (exogenous salts) was investigated from a wide range of Chinese soils to corn grain (Zhengdan 958). Prediction models were developed with combination of the Pb bioconcentration factor (BCF) of Zhengdan 958, and soil pH, organic matter (OM) content, and cation exchange capacity (CEC) through multiple stepwise regressions. Moreover, these prediction models from Zhengdan 958 were applied to other non-model corn species through cross-species extrapolation approach. The results showed that the soil pH and OM were the major factors that controlled Pb transfer from soil to corn grain. The lower pH and OM could improve the bioaccumulation of Pb in corn grain. No significant differences were found between two prediction models derived from the different exogenous Pb contents. When the prediction models were applied to other non-model corn species, the ratio ranges between the predicted BCF values and the measured BCF values were within an interval of 2-fold and close to the solid line of 1: 1 relationship. Moreover, the prediction model i.e. Log[ BCF] = -0.098 pH-0.150 log[OM] -1.894 at the treatment of high Pb can effectively reduce the measured BCF intra-species variability for all non-model corn species. These suggested that this prediction model derived from the high Pb content was more adaptable to be applied to other non-model corn species to predict the Pb bioconcentration in corn grain and assess the ecological risk of Pb in different agricultural soils.	[Li, Zhaojun; Yang, Hua; Li, Yupeng; Liang, Yongchao] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing 100193, Peoples R China; [Yang, Hua; Long, Jian] Guizhou Normal Univ, Guizhou Key Lab Mt Environm, Guiyang, Peoples R China; [Li, Yupeng] Shanxi Normal Univ, Coll City & Environm Sci, Linfen, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Guizhou Normal University; Shanxi Normal University	Li, ZJ (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing 100193, Peoples R China.	lizhaojun@caas.cn	Liang, Yongchao/D-5809-2012; Li, zhaojun/E-5735-2012; Liang, Yongchao/S-9281-2019	Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823	Special Fund of Public Industry in China [200903015]; Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences [2013-9]	Special Fund of Public Industry in China; Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences	This work was jointly supported by the Special Fund of Public Industry in China (Agriculture, project no. 200903015, http://www.moa.gov.cn/) and the Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences (2013-9, http://www.iarrp.cn/SoisWeb/home/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ML, 2004, J ENVIRON QUAL, V33, P532, DOI 10.2134/jeq2004.0532; Allard Patrick, 2010, Integrated Environmental Assessment and Management, V6, P28, DOI 10.1897/IEAM_2009-010.1; Antoniadis V, 2008, CHEMOSPHERE, V71, P759, DOI 10.1016/j.chemosphere.2007.10.015; BAKER AJM, 1994, NEW PHYTOL, V127, P61, DOI 10.1111/j.1469-8137.1994.tb04259.x; BALL DF, 1964, J SOIL SCI, V15, P84, DOI 10.1111/j.1365-2389.1964.tb00247.x; Bang JS, 2004, J ENVIRON QUAL, V33, P891, DOI 10.2134/jeq2004.0891; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Cao Ying, 2009, Journal of Maize Sciences, V17, P80; Cecchi M, 2008, GEODERMA, V144, P287, DOI 10.1016/j.geoderma.2007.11.023; Chapman EEV, 2013, ENVIRON POLLUT, V179, P326, DOI 10.1016/j.envpol.2013.04.027; Chen WP, 2009, AGR ECOSYST ENVIRON, V129, P212, DOI 10.1016/j.agee.2008.09.001; Chien CC, 2008, J ENVIRON SCI, V20, P359, DOI 10.1016/S1001-0742(08)60056-X; Chopin EIB, 2007, WATER AIR SOIL POLL, V182, P245, DOI 10.1007/s11270-007-9336-x; CHRISTENSEN TH, 1984, WATER AIR SOIL POLL, V21, P105, DOI 10.1007/BF00163616; Deleebeeck NME, 2007, AQUAT TOXICOL, V84, P223, DOI 10.1016/j.aquatox.2007.03.025; Deleebeeck NME, 2007, ECOTOX ENVIRON SAFE, V67, P1, DOI 10.1016/j.ecoenv.2006.10.001; Dohrmann R, 2006, APPL CLAY SCI, V34, P38, DOI 10.1016/j.clay.2006.02.009; Gandois L, 2010, EUR J SOIL SCI, V61, P271, DOI 10.1111/j.1365-2389.2009.01215.x; Ge Y, 2005, SOIL SEDIMENT CONTAM, V14, P53, DOI 10.1080/15320380590891817; Ge Y, 2000, ENVIRON POLLUT, V107, P137, DOI 10.1016/S0269-7491(99)00119-0; Grover P, 2010, INT J HYG ENVIR HEAL, V213, P99, DOI 10.1016/j.ijheh.2010.01.005; Hettiarachchi GM, 2003, J ENVIRON QUAL, V32, P1684, DOI 10.2134/jeq2003.1684; Hough RL, 2004, ENVIRON HEALTH PERSP, V112, P215, DOI 10.1289/ehp.5589; Hrudey SE, 1995, BIOAVAILABILITY ENV; Jung MC, 2008, SENSORS-BASEL, V8, P2413, DOI 10.3390/s8042413; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; Kirkham MB, 2006, GEODERMA, V137, P19, DOI 10.1016/j.geoderma.2006.08.024; Kuo S, 2004, SOIL SCI, V169, P363, DOI 10.1097/01.ss.0000128014.15268.d9; Larras F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044458; Li YueFang, 2010, Journal of Agro-Environment Science, V29, P2260; Li ZJ, 2006, CHEMOSPHERE, V62, P1374, DOI 10.1016/j.chemosphere.2005.07.050; Martinez-Villegas N, 2004, CHEMOSPHERE, V57, P1537, DOI 10.1016/j.chemosphere.2004.08.099; Moreno JL, 1996, BIORESOURCE TECHNOL, V55, P251, DOI 10.1016/0960-8524(96)00009-0; Nahmani J, 2007, ENVIRON POLLUT, V145, P402, DOI 10.1016/j.envpol.2006.04.009; NAIDU R, 1994, EUR J SOIL SCI, V45, P419, DOI 10.1111/j.1365-2389.1994.tb00527.x; Puschenreiter M, 2005, PLANT SOIL ENVIRON, V51, P1, DOI 10.17221/3549-PSE; Rainbow PS, 2007, ENVIRON INT, V33, P576, DOI 10.1016/j.envint.2006.05.007; Raskin Ilya, 1994, Current Opinion in Biotechnology, V5, P285, DOI 10.1016/0958-1669(94)90030-2; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Rezvani M., 2011, AUSTR J AGR ENG AJAE, V2, P114; Rodriguez JA, 2008, CHEMOSPHERE, V70, P1085, DOI 10.1016/j.chemosphere.2007.07.056; Sarwar N, 2010, J SCI FOOD AGR, V90, P925, DOI 10.1002/jsfa.3916; Sauve S, 2003, ENVIRON SCI TECHNOL, V37, P5191, DOI 10.1021/es030059g; Schlekat CE, 2010, SCI TOTAL ENVIRON, V408, P6148, DOI 10.1016/j.scitotenv.2010.09.012; Shahid M, 2011, ECOTOX ENVIRON SAFE, V74, P78, DOI 10.1016/j.ecoenv.2010.08.037; Simmons RW, 2008, PLANT SOIL, V302, P125, DOI 10.1007/s11104-007-9460-9; Smical AI, 2008, ENVIRON ENG MANAG J, V7, P609, DOI 10.30638/eemj.2008.085; USEPA, 1992, EPA540R94044; Van Sprang PA, 2009, SCI TOTAL ENVIRON, V407, P5373, DOI 10.1016/j.scitotenv.2009.06.029; Wang AS, 2006, PLANT SOIL, V281, P325, DOI 10.1007/s11104-005-4642-9; Wang J, 2009, GEODERMA, V148, P299, DOI 10.1016/j.geoderma.2008.10.015; Wang Xi, 2012, P1; Wang XP, 2004, CHEMOSPHERE, V55, P811, DOI 10.1016/j.chemosphere.2003.12.003; Yang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080855; Zarcinas BA, 2004, ENVIRON GEOCHEM HLTH, V26, P359, DOI 10.1007/s10653-005-4670-7; Zarcinas BA, 1996, COMMUN SOIL SCI PLAN, V27, P1331, DOI 10.1080/00103629609369636; Zeng F, 2001, ENVIRON POLLUT, V159, P84; Zeng FR, 2011, ENVIRON POLLUT, V159, P84, DOI 10.1016/j.envpol.2010.09.019; Zhang HZ, 2011, J ENVIRON SCI-CHINA, V23, P70, DOI 10.1016/S1001-0742(10)60375-0; Zhao XJ, 2013, RES J CHEM ENVIRON, V17, P74	61	7	7	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85688	10.1371/journal.pone.0085688	http://dx.doi.org/10.1371/journal.pone.0085688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416440	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500261
J	Tang, LL; Cheng, CP; Wan, KY; Li, RH; Wang, DZ; Tao, Y; Pan, JF; Xie, J; Chen, F				Tang, Leilei; Cheng, Chuanpeng; Wan, Kaiyuan; Li, Ruhai; Wang, Daozhong; Tao, Yong; Pan, Junfeng; Xie, Juan; Chen, Fang			Impact of Fertilizing Pattern on the Biodiversity of a Weed Community and Wheat Growth	PLOS ONE			English	Article							WINTER-WHEAT; SPECIES-DIVERSITY; ORGANIC AGRICULTURE; OILSEED RAPE; MANAGEMENT; COMPETITION; CONSERVATION; VEGETATION; FIELDS; CROPS	Weeding and fertilization are important farming practices. Integrated weed management should protect or improve the biodiversity of farmland weed communities for a better ecological environment with not only increased crop yield, but also reduced use of herbicides. This study hypothesized that appropriate fertilization would benefit both crop growth and the biodiversity of farmland weed communities. To study the effects of different fertilizing patterns on the biodiversity of a farmland weed community and their adaptive mechanisms, indices of species diversity and responses of weed species and wheat were investigated in a 17-year field trial with a winter wheat-soybean rotation. This long term field trial includes six fertilizing treatments with different N, P and K application rates. The results indicated that wheat and the four prevalent weed species (Galium aparine, Vicia sativa, Veronica persica and Geranium carolinianum) showed different responses to fertilizer treatment in terms of density, plant height, shoot biomass, and nutrient accumulations. Each individual weed population exhibited its own adaptive mechanisms, such as increased internode length for growth advantages and increased light interception. The PK treatment had higher density, shoot biomass, Shannon-Wiener and Pielou Indices of weed community than N plus P fertilizer treatments. The N1/2PK treatment showed the same weed species number as the PK treatment. It also showed higher Shannon-Wiener and Pielou Indices of the weed community, although it had a lower wheat yield than the NPK treatment. The negative effects of the N1/2PK treatment on wheat yield could be balanced by the simultaneous positive effects on weed communities, which are intermediate in terms of the effects on wheat and weeds.	[Tang, Leilei; Cheng, Chuanpeng; Wan, Kaiyuan; Tao, Yong; Pan, Junfeng; Xie, Juan; Chen, Fang] Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China; [Tang, Leilei] Hainan Modern Agr Inspect & Testing Precaut & Con, Agr Dept Hainan Prov, Haikou, Peoples R China; [Wan, Kaiyuan] Chinese Acad Sci, Ecol Restorat ECORES Lab, Chengdu Inst Biol, Chengdu, Peoples R China; [Li, Ruhai] Hubei Acad Agr Sci, Inst Plant Protect & Soil Sci, Wuhan, Peoples R China; [Wang, Daozhong] Anhui Acad Agr Sci, Inst Soil & Fertilizer Sci, Hefei, Peoples R China; [Chen, Fang] China Program Int Plant Nutr Inst IPNI, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Hubei Academy of Agricultural Sciences; Anhui Academy of Agricultural Sciences	Wan, KY (corresponding author), Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China.	kaiyuanwan@126.com; fchen@ipni.ac.cn			China Program of International Plant Nutrition Institute [IPNI-HB-34]; Opening Project of Hubei Key Laboratory of Wetland Evolution & Ecological Restoration	China Program of International Plant Nutrition Institute; Opening Project of Hubei Key Laboratory of Wetland Evolution & Ecological Restoration	This work was supported by the China Program of International Plant Nutrition Institute (IPNI-HB-34) and the Opening Project of Hubei Key Laboratory of Wetland Evolution & Ecological Restoration(2011-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Angonin C, 1996, WEED RES, V36, P175, DOI 10.1111/j.1365-3180.1996.tb01813.x; [Anonymous], [No title captured]; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Blackshaw RE, 2005, CROP PROT, V24, P971, DOI 10.1016/j.cropro.2005.01.021; Blackshaw RE, 2002, WEED SCI, V50, P634, DOI 10.1614/0043-1745(2002)050[0634:FAMANU]2.0.CO;2; Blackshaw RE, 2009, WEED BIOL MANAG, V9, P46, DOI 10.1111/j.1445-6664.2008.00317.x; Derksen DA, 1996, PHYTOPROTECTION, V77, P29, DOI 10.7202/706098ar; DITOMASO JM, 1995, WEED SCI, V43, P491, DOI 10.1017/S0043174500081522; Forcella F, 2000, FIELD CROP RES, V67, P123, DOI 10.1016/S0378-4290(00)00088-5; Fried G, 2009, BIOL CONSERV, V142, P238, DOI 10.1016/j.biocon.2008.09.029; Fried G, 2008, AGR ECOSYST ENVIRON, V128, P68, DOI 10.1016/j.agee.2008.05.003; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Hanzlik K, 2011, AGR ECOSYST ENVIRON, V141, P323, DOI 10.1016/j.agee.2011.03.010; Kleijn D, 1997, BIOL CONSERV, V81, P57, DOI 10.1016/S0006-3207(96)00153-X; Lamberti-Raverot B, 2012, J EXP BOT, V63, P6115, DOI 10.1093/jxb/ers268; Li Ruhai, 2008, Shengwu Duoyangxing, V16, P118, DOI 10.3724/SP.J.1003.2008.07339; Magurran A E, 1988, ECOLOGICAL DIVERSITY; MAHN E-G, 1988, P71; MARSH SP, 2006, INT ASS AGR EC ITS S; Marshall EJP, 2003, WEED RES, V43, P77, DOI 10.1046/j.1365-3180.2003.00326.x; Murphy CE, 2006, EUPHYTICA, V148, P61, DOI 10.1007/s10681-006-5941-9; Nie J, 2009, WEED SCI, V57, P256, DOI 10.1614/WS-08-106.1; Ochoa-Hueso R, 2010, PLANT ECOL, V210, P263, DOI 10.1007/s11258-010-9755-4; Odero DC, 2011, WEED SCI, V59, P310, DOI 10.1614/WS-D-10-00082.1; Pal RW, 2013, PLANT BIOSYST, V147, P343, DOI 10.1080/11263504.2012.753485; Pinke G, 2012, APPL VEG SCI, V15, P136, DOI 10.1111/j.1654-109X.2011.01158.x; Poggio SL, 2005, AGR ECOSYST ENVIRON, V109, P48, DOI 10.1016/j.agee.2005.02.019; PYSEK P, 1991, J VEG SCI, V2, P237, DOI 10.2307/3235956; Rassam G, 2011, WEED BIOL MANAG, V11, P83, DOI 10.1111/j.1445-6664.2011.00407.x; Silc U, 2009, WEED RES, V49, P602, DOI 10.1111/j.1365-3180.2009.00726.x; Storkey J, 2007, AGR ECOSYST ENVIRON, V122, P173, DOI 10.1016/j.agee.2006.12.031; Tang LL, 2014, J PLANT ECOL, V7, P39, DOI 10.1093/jpe/rtt018; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Tilman David, 1993, P13; van Elsen T, 2000, AGR ECOSYST ENVIRON, V77, P101, DOI 10.1016/S0167-8809(99)00096-1; Vollmann J, 2010, EUR J AGRON, V32, P243, DOI 10.1016/j.eja.2010.01.001; Yin LC, 2005, AGR ECOSYST ENVIRON, V107, P181, DOI 10.1016/j.agee.2004.11.003; Yin LC, 2006, CROP PROT, V25, P910, DOI 10.1016/j.cropro.2005.11.013; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61	41	29	35	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84370	10.1371/journal.pone.0084370	http://dx.doi.org/10.1371/journal.pone.0084370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416223	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500120
J	Thompson, AM; Martin, KA; Rzucidlo, EM				Thompson, Anne Marie; Martin, Kathleen A.; Rzucidlo, Eva M.			Resveratrol Induces Vascular Smooth Muscle Cell Differentiation through Stimulation of SirT1 and AMPK	PLOS ONE			English	Article							SIRTUINS; DISEASE; NAD(+)	Phenotypic plasticity in vascular smooth muscle cells (VSMC) is necessary for vessel maintenance, repair and adaptation to vascular changes associated with aging. De-differentiated VSMC contribute to pathologies including atherosclerosis and intimal hyperplasia. As resveratrol has been reported to have cardio-protective effects, we investigated its role in VSMC phenotypic modulation. We demonstrated the novel finding that resveratrol promoted VSMC differentiation as measured by contractile protein expression, contractile morphology and contraction in collagen gels. Resveratrol induced VSMC differentiation through stimulation of SirT1 and AMPK. We made the novel finding that low or high dose resveratrol had an initially different mechanism on induction of differentiation. We found that low dose resveratrol stimulated differentiation through SirT1-mediated activation of AKT, whereas high dose resveratrol stimulated differentiation through AMPK-mediated inhibition of the mTORC1 pathway, allowing activation of AKT. The health effects of resveratrol in cardiovascular diseases, cancer and longevity are an area of active research. We have demonstrated a supplemental avenue where-by resveratrol may promote health by maintaining and enhancing plasticity of the vasculature.	[Thompson, Anne Marie; Rzucidlo, Eva M.] Dartmouth Med Sch, Vasc Surg Sect, Lebanon, NH USA; [Martin, Kathleen A.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06504 USA	Dartmouth College; Yale University	Rzucidlo, EM (corresponding author), Dartmouth Med Sch, Vasc Surg Sect, Lebanon, NH USA.	eva.m.rzucidlo@hitchcock.org		Martin, Kathleen/0000-0002-1748-0034	Hitchcock Foundation, Dartmouth Department of Surgery Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091013, R01HL118430, R01HL119529] Funding Source: NIH RePORTER	Hitchcock Foundation, Dartmouth Department of Surgery Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Hitchcock Foundation, Dartmouth Department of Surgery Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur J, 2006, NATURE REV, V5; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Borradaile NM, 2009, CURR PHARM DESIGN, V15, P110, DOI 10.2174/138161209787185742; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Chang Z, 2010, FRONTIERS BIOSCIENCE; Ding M, 2011, ARTERIOSCLEROSIS THR, V31; Fullerton MD, 2010, DIABETES, V59, P551, DOI 10.2337/db09-1732; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; KLAR AJS, 1979, GENETICS, V93, P37; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; LI XM, 1994, J BIOL CHEM, V269, P19653; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; MURRAY TR, 1990, J CELL PHYSIOL, V143, P26, DOI 10.1002/jcp.1041430105; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ruderman N, 2010, AM J PHYSL ENDOCRINO, V298; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Westphal C, 2007, TRENDS BIOCH SCI, V32; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343	23	68	71	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85495	10.1371/journal.pone.0085495	http://dx.doi.org/10.1371/journal.pone.0085495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416418	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500253
J	Wang, LX; Liu, X; Liang, M; Tan, FL; Liang, WY; Chen, YY; Lin, YX; Huang, L; Xing, JH; Chen, W				Wang, Lingxia; Liu, Xiao; Liang, Meng; Tan, Fanglin; Liang, Wenyu; Chen, Yiyong; Lin, Yongxiang; Huang, Li; Xing, Jianhong; Chen, Wei			Proteomic Analysis of Salt-Responsive Proteins in the Leaves of Mangrove Kandelia candel during Short-Term Stress	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; NACL STRESS; SUPEROXIDE-DISMUTASE; DEHYDROASCORBATE REDUCTASE; GLUTATHIONE-REDUCTASE; MOLECULAR CHAPERONES; GEL-ELECTROPHORESIS; HYDROGEN-PEROXIDE; SEEDLING ROOTS; BURMA MANGROVE	Salt stress is a major abiotic stress that limits crop productivity in many regions of the world. A comparative proteomic approach to identify salt stress-responsive proteins and to understand the molecular mechanisms was carried out in the woody halophyte Kandelia candel. Four-leaf-old K. candel seedlings were exposed to 150 (control), 300, 450, and 600 mM NaCl for 3 days. Proteins extracted from the leaves of K. candel seedlings were separated by two-dimensional gel electrophoresis (2-DE). More than 900 protein spots were detected on each gel, and 53 differentially expressed protein spots were located with at least two-fold differences in abundance on 2-DE maps, of which 48 were identified by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry (MALDI-TOF-TOF/MS). The results showed that K. candel could withstand up to 450 mM NaCl stress by up-regulating proteins that are mainly involved in photosynthesis, respiration and energy metabolism, Na+ compartmentalization, protein folding and assembly, and signal transduction. Physiological data, including superoxide dismutase (SOD) and dehydroascorbate reductase (DHAR) activities, hydrogen peroxide (H2O2) and superoxide anion radicals (O-2(-)) contents, as well as Na+ content and K+/Na+ ratios all correlated well with our proteomic results. This study provides new global insights into woody halophyte salt stress responses. Identification of differentially expressed proteins promotes better understanding of the molecular basis for salt stress reduction in K. candel.	[Wang, Lingxia; Chen, Wei] Fujian Agr & Forestry Univ, Minist Educ Genet Breeding & Multiple Utilizat Cr, Key Lab, Fuzhou, Fujian, Peoples R China; [Wang, Lingxia; Liu, Xiao; Liang, Meng; Chen, Yiyong; Lin, Yongxiang; Xing, Jianhong; Chen, Wei] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Fujian, Peoples R China; [Tan, Fanglin; Huang, Li] Fujian Acad Forestry, Fuzhou, Fujian, Peoples R China; [Liang, Wenyu] Ningxia Univ, Sch Life Sci, Yinchuan, Ningxia, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Ningxia University	Chen, W (corresponding author), Fujian Agr & Forestry Univ, Minist Educ Genet Breeding & Multiple Utilizat Cr, Key Lab, Fuzhou, Fujian, Peoples R China.	weichen909@163.com	Xing, Jianhong/AAK-1568-2020; xing, jianhong/AAI-2254-2020	Xing, Jianhong/0000-0001-8220-8005; 	National Natural Science Grant of China [31070542]; Provincial Natural Science Grant of Fujian, China [2010J01067]	National Natural Science Grant of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Grant of Fujian, China	This work was supported by the National Natural Science Grant of China (Award no. 31070542) and the Provincial Natural Science Grant of Fujian, China (Award no. 2010J01067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi FM, 2004, PROTEOMICS, V4, P2072, DOI 10.1002/pmic.200300741; Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873; Agarwal GK, 2002, PROTEOMICS, V2, P947, DOI 10.1002/1615-9861(200208)2:8<947::AID-PROT947>3.0.CO;2-J; AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; Allakhverdiev SI, 1999, P NATL ACAD SCI USA, V96, P5862, DOI 10.1073/pnas.96.10.5862; Askari H, 2006, PROTEOMICS, V6, P2542, DOI 10.1002/pmic.200500328; Bandehagh A, 2011, PROTEOMICS, V11, P1965, DOI 10.1002/pmic.201000564; Batelli G, 2007, MOL CELL BIOL, V27, P7781, DOI 10.1128/MCB.00430-07; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Camoni L, 1998, FEBS LETT, V430, P381, DOI 10.1016/S0014-5793(98)00696-6; Chen FG, 2011, J PROTEOME RES, V10, P3944, DOI 10.1021/pr200535r; CHUANG FS, 1973, MIKROCHIM ACTA, P523, DOI 10.1007/BF01217998; Dasgupta N, 2011, TREES-STRUCT FUNCT, V26, P377; Du CX, 2010, PHYTOCHEMISTRY, V71, P1450, DOI 10.1016/j.phytochem.2010.05.020; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fatehi F, 2012, MOL BIOL REP, V39, P6387, DOI 10.1007/s11033-012-1460-z; Finnie C, 1999, PLANT MOL BIOL, V40, P545, DOI 10.1023/A:1006211014713; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Guo GF, 2012, J PROTEOMICS, V75, P1867, DOI 10.1016/j.jprot.2011.12.032; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hoper D, 2006, PROTEOMICS, V6, P1550, DOI 10.1002/pmic.200500197; Hotta M, 2000, PLANT CELL PHYSL S, V41, P79; Huang GJ, 2008, BOT STUD, V49, P1; Huang GY, 2012, TREES-STRUCT FUNCT, V26, P1537, DOI 10.1007/s00468-012-0727-2; Huang W, 2003, BIOL PLANTARUM, V47, P501, DOI 10.1023/B:BIOP.0000041053.39549.2a; HYLAND K, 1983, ANAL BIOCHEM, V135, P280, DOI 10.1016/0003-2697(83)90684-X; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Jithesh MN, 2006, PLANT CELL REP, V25, P865, DOI 10.1007/s00299-006-0127-4; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Katz A, 2007, MOL CELL PROTEOMICS, V6, P1459, DOI 10.1074/mcp.M700002-MCP200; Kim DW, 2005, ELECTROPHORESIS, V26, P4521, DOI 10.1002/elps.200500334; Komatsu S, 2009, AMINO ACIDS, V36, P115, DOI 10.1007/s00726-008-0039-4; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Liang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036499; Liang WY, 2012, J PROTEOMICS, V75, P5604, DOI 10.1016/j.jprot.2012.07.041; Liu H, 2010, PLANTA, V231, P847, DOI 10.1007/s00425-009-1093-1; Ma HY, 2012, J PROTEOMICS, V75, P1529, DOI 10.1016/j.jprot.2011.11.026; Mandhania S, 2006, BIOL PLANTARUM, V50, P227, DOI 10.1007/s10535-006-0011-7; Maserti BE, 2011, J PLANT PHYSIOL, V168, P392, DOI 10.1016/j.jplph.2010.07.026; Mehta PA, 2005, THEOR APPL GENET, V110, P416, DOI 10.1007/s00122-004-1801-y; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Miyama M, 2008, PLANT MOL BIOL, V68, P119, DOI 10.1007/s11103-008-9356-y; Miyama M, 2006, PLANT SCI, V171, P234, DOI 10.1016/j.plantsci.2006.03.015; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Ndimba BK, 2005, PROTEOMICS, V5, P4185, DOI 10.1002/pmic.200401282; Palmgren MG, 1998, ADV BOT RES, V28, P1; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Parida AK, 2003, PHOTOSYNTHETICA, V41, P191, DOI 10.1023/B:PHOT.0000011951.37231.69; Parida AK, 2010, TREES-STRUCT FUNCT, V24, P199, DOI 10.1007/s00468-010-0417-x; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Persson S, 2003, PLANT PHYSIOL, V133, P1385, DOI 10.1104/pp.103.024943; Rasoulnia A, 2011, MOL BIOL REP, V38, P5055, DOI 10.1007/s11033-010-0651-8; Rospert S, 1996, EMBO J, V15, P764, DOI 10.1002/j.1460-2075.1996.tb00412.x; Santiago LS, 2000, INT J PLANT SCI, V161, P99, DOI 10.1086/314236; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sarhadi E, 2012, PLANT PHYSIOL BIOCH, V58, P280, DOI 10.1016/j.plaphy.2012.07.013; Song Y, 2011, J PROTEOMICS, V74, P1045, DOI 10.1016/j.jprot.2011.03.009; Sugihara K, 2000, PLANT CELL PHYSIOL, V41, P1279, DOI 10.1093/pcp/pcd061; Swami AK, 2011, ENVIRON EXP BOT, V71, P321, DOI 10.1016/j.envexpbot.2010.12.017; Tada Y, 2009, PLANT CELL PHYSIOL, V50, P439, DOI 10.1093/pcp/pcp002; Takemura T, 2000, AQUAT BOT, V68, P15, DOI 10.1016/S0304-3770(00)00106-6; Tanaka Y, 2000, PLANT CELL PHYSL, V41, ps27; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wang A. G., 1990, PLANT PHYSL COMMUN, V6, P55, DOI DOI 10.1021/ja00874a010; Wang WF, 1996, J MOL EVOL, V43, P384; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang XC, 2013, MOL CELL PROTEOMICS, V12, P2174, DOI 10.1074/mcp.M112.022475; Wang XC, 2009, J PROTEOME RES, V8, P3331, DOI 10.1021/pr801083a; Weng ZX, 2013, TREES-STRUCT FUNCT, P1; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wong YY, 2007, AQUAT BOT, V86, P117, DOI 10.1016/j.aquabot.2006.09.009; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; You XR, 2012, J PROTEOMICS, V75, P1099, DOI 10.1016/j.jprot.2011.10.023; Yu JJ, 2013, INT J MOL SCI, V14, P1740, DOI 10.3390/ijms14011740; Zhang JL, 2013, PHOTOSYNTH RES, V115, P1, DOI 10.1007/s11120-013-9813-6; Zhang Q, 2011, J PROTEOME RES, V10, P46, DOI 10.1021/pr101052y; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zhu Z, 2012, TREE PHYSIOL, V32, P1378, DOI 10.1093/treephys/tps097	85	54	61	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83141	10.1371/journal.pone.0083141	http://dx.doi.org/10.1371/journal.pone.0083141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416157	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500030
J	Sonkar, VK; Kulkarni, PP; Dash, D				Sonkar, Vijay K.; Kulkarni, Paresh P.; Dash, Debabrata			Amyloid beta peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization	FASEB JOURNAL			English	Article						mitochondrial respiration; clot retraction; myosin light chain; platelet adhesion; thromboembolism	ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; MITOCHONDRIAL DYSFUNCTION; GRAPHENE OXIDE; CORE PROTEIN; KINASE-C; TAU; MECHANISMS; NEURONS; STORAGE	Platelets contribute to 95% of circulating amyloid precursor protein in the body and have widely been employed as a "peripheral" model of neurons in Alzheimer's disease. We sought to analyze the effects of amyloid beta (A beta) on platelets and to understand the underlying molecular mechanism. The A beta active fragment containing amino acid sequence 25-35 (A beta(25-35); 10-20 mu M) was found to induce strong aggregation of human platelets, granule release, and integrin activation, similar to that elicited by physiological agonists. Platelets exposed to A beta(25-35) retracted fibrin clot and displayed augmented adhesion to collagen under arterial shear, reflective of a switch to prothrombotic phenotype. Exposure of platelets to A beta peptide (20 mu M) resulted in a 4.2- and 2.3-fold increase in phosphorylation of myosin light chain (MLC) and MLC phosphatase, respectively, which was reversed by Y27632, an inhibitor of Rho-associated coiled-coil protein kinase (ROCK). A beta(25-35)-induced platelet aggregation and clot retraction were also significantly attenuated by Y27632. Consistent with these findings, A beta(25-35) elicited a significant rise in the level of RhoA-GTP in platelets. Platelets pretreated with reverse-sequenced A beta fragment (A beta(35-25)) and untreated resting platelets served as controls. We conclude that A beta induces cellular activation through RhoA-dependent modulation of actomyosin, and hence, RhoA could be a potential therapeutic target in Alzheimer's disease and cerebral amyloid angiopathy.-Sonkar, V. K., Kulkarni, P. P., Dash, D. Amyloid beta peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization.	[Sonkar, Vijay K.; Kulkarni, Paresh P.; Dash, Debabrata] Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Dash, D (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.	ddass@satyam.net.in	Kulkarni, Paresh P/AAB-3190-2019; DASH, DEBABRATA/AAF-1837-2020	Kulkarni, Paresh P/0000-0002-9108-0485; 	Department of Science and Technology (DST); Department of Biotechnology (DBT), Government of India; Indian Council of Medical Research (ICMR); Council of Scientific and Industrial Research (CSIR); Tata Innovation Fellowship from the DBT; ICMR; Institute of Medical Sciences (IMS), Banaras Hindu University (BHU)	Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Tata Innovation Fellowship from the DBT; ICMR(Indian Council of Medical Research (ICMR)); Institute of Medical Sciences (IMS), Banaras Hindu University (BHU)	This research was supported by grants received by D. D. from the Department of Science and Technology (DST) and the Department of Biotechnology (DBT), Government of India; the Indian Council of Medical Research (ICMR); and the Council of Scientific and Industrial Research (CSIR). D. D. thankfully acknowledges a Tata Innovation Fellowship grant received from the DBT. V. K. S. is the recipient of a research fellowship from ICMR. P. P. K. was supported by residency program of the Institute of Medical Sciences (IMS), Banaras Hindu University (BHU). The authors declare no conflicts of interest. The authors sincerely thank Dr. Mohan Kumar (Department of Pathology, IMS, BHU) for helping with the lung histology study.	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; BUSH AI, 1990, J BIOL CHEM, V265, P15977; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Casoli T, 2008, MECH AGEING DEV, V129, P154, DOI 10.1016/j.mad.2007.11.004; Chacon PJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-14; Chauhan AK, 2006, J EXP MED, V203, P767, DOI 10.1084/jem.20051732; Davis J, 1999, AMYLOID, V6, P157, DOI 10.3109/13506129909007321; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1; Di Luca M, 2000, EUR J PHARMACOL, V405, P277, DOI 10.1016/S0014-2999(00)00559-8; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Gnaiger E, 2000, LIFE IN THE COLD, P431; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; KILKSON H, 1984, BLOOD, V64, P406; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Nayak MK, 2011, THROMB HAEMOSTASIS, V106, P624, DOI 10.1160/TH11-03-0178; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Saller F, 2008, CURR SIGNAL TRANSD T, V3, P22; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Setiadi H, 2003, J CELL BIOL, V163, P1385, DOI 10.1083/jcb.200307178; SHATTIL SJ, 1987, BLOOD, V70, P307; Shen MY, 2008, EUR J PHARMACOL, V588, P259, DOI 10.1016/j.ejphar.2008.04.040; Shen MY, 2008, PHARMACOL RES, V57, P151, DOI 10.1016/j.phrs.2008.01.004; Shrivastava S, 2009, ACS NANO, V3, P1357, DOI 10.1021/nn900277t; Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t; Singh SK, 2011, ACS NANO, V5, P4987, DOI 10.1021/nn201092p; Sjovall F, 2013, MITOCHONDRION, V13, P7, DOI 10.1016/j.mito.2012.11.001; Skovronsky DM, 2001, J BIOL CHEM, V276, P17036, DOI 10.1074/jbc.M006285200; Smith CCT, 1997, NEUROSCI LETT, V235, P157, DOI 10.1016/S0304-3940(97)00738-6; Tang K, 2006, J NEUROL SCI, V240, P53, DOI 10.1016/j.jns.2005.09.002; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Xu J, 2001, J CEREBR BLOOD F MET, V21, P702, DOI 10.1097/00004647-200106000-00008; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668	35	46	47	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1819	1829		10.1096/fj.13-243691	http://dx.doi.org/10.1096/fj.13-243691			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24421399				2022-12-25	WOS:000335344300027
J	Chen, Y; Li, J; Dunn, S; Xiong, S; Chen, W; Zhao, YT; Chen, BB; Mallampalli, RK; Zou, CB				Chen, Yan; Li, Jin; Dunn, Sarah; Xiong, Sheng; Chen, Wei; Zhao, Yutong; Chen, Bill B.; Mallampalli, Rama K.; Zou, Chunbin			Histone Deacetylase 2 (HDAC2) Protein-dependent Deacetylation of Mortality Factor 4-like 1 (MORF4L1) Protein Enhances Its Homodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epigenetics; Histone Acetylase; Histone Deacetylase; Posttranslational Modification; Proliferation; Protein Complexes; Protein Structure; Site-directed Mutagenesis	CHROMODOMAIN PROTEIN; MESSENGER-RNA; DNA-REPAIR; MRG15; COMPLEX; DIFFERENTIATION; DOMAIN; DIMERIZATION; COMPONENT; PROMOTER	Background: Histone acetyltransferase MORF4L1 forms a homodimer to perform its epigenetic function, but the molecular mechanisms for its homodimerization are unknown. Results: Histone deacetylase HDAC2 deacetylates MORF4L1 at Lys-148 to enhance MORF4L1 homodimerization. Conclusion: HDAC2-dependent deacetylation of MORF4L1 enhances MORF4L1 homodimerization, which facilitates complex formation to repress cellular proliferation. Significance: The molecular control of MORF4L1 homodimerization may impact fundamental cellular processes such as proliferation. Histone acetyltransferase mortality factor 4-like 1 (MORF4L1) is a relatively new histone acetyltransferase component that exists as a homodimer to exert its epigenetic function. The mechanism of MORF4L1 self-assembly is unknown. Here we report that Lys-148 deacetylation is indispensable for facilitating MORF4L1 self-assembly into a homodimeric unit. Among a stretch of approximate to 10 amino acids in the NH2 terminus between the chromodomain and MORF4-related gene (MRG) domain within MORF4L1, Lys-148 is normally acetylated. Substitution of Lys-148 with arginine augments MORF4L1 self-assembly. However, acetylation mimics of MORF4L1, including K148L and K148Q, abolished its self-assembly of the histone acetyltransferase component. HDAC2, a deacetylase, interacts with and keeps MORF4L1 in a deacetylation status at Lys(148) that triggers MORF4L1 self-assembly. Knockdown of HDAC2 reduces MORF4L1 self-assembly. HDAC2-dependent deacetylation of MORF4L1 enhances MORF4L1 homodimerization, thus facilitating the functionality of complex formation to repress cell proliferation.	[Chen, Yan; Li, Jin; Dunn, Sarah; Xiong, Sheng; Chen, Wei; Zhao, Yutong; Chen, Bill B.; Mallampalli, Rama K.; Zou, Chunbin] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Zhao, Yutong; Chen, Bill B.; Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Zhao, Yutong; Chen, Bill B.; Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA; [Chen, Yan] Cent S Univ, Xiangya Hosp 2, Dept Resp Med, Changsha 410011, Hunan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Central South University	Chen, Y (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Resp Med, Changsha 410011, Hunan, Peoples R China.	chenyan99727@163.com; zouc@upmc.edu	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	National Institutes of Health [HL096376, HL097376, HL098174, P01 HL114453]; American Heart Association [12SDG12040330]; United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; United States Department of Veterans Affairs; Natural Science Foundation of China [81070039, 81270100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112791, R01HL098174, R01HL116472, R01HL096376, R01HL097376, UH2HL123502, P01HL114453] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); United States Department of Veterans Affairs(US Department of Veterans Affairs); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, National Institutes of Health Grants HL096376, HL097376, HL098174, and P01 HL114453 (to R. K. M.). This work was also supported by American Heart Association Award 12SDG12040330 (to C. Z.); by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; and by a merit review award from the United States Department of Veterans Affairs.; Supported by Natural Science Foundation of China Grants 81070039 and 81270100. To whom correspondence may be addressed: Dept. of Respiratory Medicine, The Second Xiangya Hospital, Central-South University, Changsha, Hunan 410011, China. E-mail: chenyan99727@163.com.	Bertram MJ, 2001, GENE, V266, P111, DOI 10.1016/S0378-1119(01)00372-9; Blus BJ, 2011, CRIT REV BIOCHEM MOL, V46, P507, DOI 10.3109/10409238.2011.619164; Boije H, 2013, J MOL NEUROSCI, V51, P615, DOI 10.1007/s12031-013-0034-4; Bryce SD, 1999, CANCER RES, V59, P2038; Chen M, 2009, J NEUROSCI RES, V87, P1522, DOI 10.1002/jnr.21976; Falvo JV, 2013, ADV IMMUNOL, V118, P37, DOI 10.1016/B978-0-12-407708-9.00002-9; Garcia SN, 2007, FEBS LETT, V581, P5275, DOI 10.1016/j.febslet.2007.10.017; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Khan DH, 2013, J BIOL CHEM, V288, P16518, DOI 10.1074/jbc.M112.440446; Kirkwood KJ, 2013, MOL CELL PROTEOMICS, V12, P3851, DOI 10.1074/mcp.M113.032367; Kumar GS, 2011, J MOL BIOL, V408, P987, DOI 10.1016/j.jmb.2011.03.043; Leung JK, 2001, J BIOL CHEM, V276, P39171, DOI 10.1074/jbc.M103435200; Liang Y, 2010, BBA-GEN SUBJECTS, V1800, P474, DOI 10.1016/j.bbagen.2010.01.010; Martrat G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2862; Matsuoka Y, 2002, NEUROSCI RES, V42, P299, DOI 10.1016/S0168-0102(02)00010-X; Pardo PS, 2002, J BIOL CHEM, V277, P50860, DOI 10.1074/jbc.M203839200; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pena AAN, 2007, ANN NY ACAD SCI, V1100, P299, DOI 10.1196/annals.1395.031; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Smith HF, 2013, GENETICS, V195, P127, DOI 10.1534/genetics.113.153544; Tominaga K, 2005, MOL CELL BIOL, V25, P2924, DOI 10.1128/MCB.25.8.2924-2937.2005; Tominaga K, 2002, GENE, V294, P215, DOI 10.1016/S0378-1119(02)00787-4; Yochum GS, 2002, MOL CELL BIOL, V22, P7868, DOI 10.1128/MCB.22.22.7868-7876.2002; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang HJ, 2010, EXP GERONTOL, V45, P825, DOI 10.1016/j.exger.2010.06.002; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhang P, 2006, PROTEIN SCI, V15, P2423, DOI 10.1110/ps.062397806; Zou CB, 2013, J BIOL CHEM, V288, P6306, DOI 10.1074/jbc.M112.426882; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	30	8	9	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7092	7098		10.1074/jbc.M113.527507	http://dx.doi.org/10.1074/jbc.M113.527507			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451372	Green Published, hybrid			2022-12-25	WOS:000332389400068
J	Stuible, M; Moraitis, A; Fortin, A; Saragosa, S; Kalbakji, A; Filion, M; Tremblay, GB				Stuible, Matthew; Moraitis, Anna; Fortin, Annie; Saragosa, Stefan; Kalbakji, Aida; Filion, Mario; Tremblay, Gilles B.			Mechanism and Function of Monoclonal Antibodies Targeting Siglec-15 for Therapeutic Inhibition of Osteoclastic Bone Resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Bone; Cell Signaling; Osteoclast; Receptor Endocytosis; Siglec-15; Anti-resorptive	DIFFERENTIATION; RECEPTOR; PROTEIN; HISTOMORPHOMETRY; BISPHOSPHONATE; OSTEOPETROSIS; ROLES; CD22	Background: Bone-resorbing osteoclasts express the Siglec-15 receptor on their plasma membrane. Results: Siglec-15 antibodies inhibit osteoclast differentiation and induce receptor endocytosis and degradation. Conclusion: These results establish that Siglec-15 antibodies target osteoclasts in vivo and reveal a likely mechanism of action. Significance: Siglec-15 could serve as a target of novel therapeutics for osteoporosis and cancer-associated bone loss. The use of monoclonal antibodies to target functionally important cell-surface proteins on bone-resorbing osteoclasts represents a promising approach for treatment of cancer-associated bone loss and other skeletal pathologies. Previously, we identified Siglec-15, a little studied sialic acid-binding receptor, as a candidate target that is highly up-regulated during osteoclast differentiation induced by the cytokine receptor activator of NF-B ligand (RANKL). In this report, we confirm that Siglec-15 is localized to the plasma membrane where it can be targeted by monoclonal antibodies to inhibit differentiation of functional osteoclasts in vitro. Furthermore, we found that treatment of mice with these antibodies led to a marked increase in bone mineral density, consistent with inhibition of osteoclast activity. Interestingly, osteoblast numbers were maintained despite the anti-resorptive activity. At the molecular level, Siglec-15 interacts with the adapter protein DAP12 and can induce Akt activation when clustered on the osteoclast cell surface, which likely represents its normal signaling function. Importantly, we discovered that monoclonal antibodies induce rapid internalization, lysosomal targeting, and degradation of Siglec-15 by inducing receptor dimerization. This study defines a key regulatory node that controls osteoclast differentiation and activity downstream of RANKL and supports further development of Siglec-15 antibodies as a novel class of bone loss therapeutics.	[Stuible, Matthew; Moraitis, Anna; Fortin, Annie; Saragosa, Stefan; Kalbakji, Aida; Filion, Mario; Tremblay, Gilles B.] Alethia Biotherapeut Inc, Montreal, PQ H2X 1Y4, Canada		Tremblay, GB (corresponding author), 141 President Kennedy Ave,Suite SB 5100, Montreal, PQ H2X 1Y4, Canada.	gilles.tremblay@alethiabio.com						Angata T, 2007, GLYCOBIOLOGY, V17, P838, DOI 10.1093/glycob/cwm049; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Blasius AL, 2006, TRENDS IMMUNOL, V27, P255, DOI 10.1016/j.it.2006.04.005; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2008, BIOCHEM SOC T, V36, P1467, DOI 10.1042/BST0361467; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Egan KP, 2012, HISTOPATHOLOGY, V61, P1168, DOI 10.1111/j.1365-2559.2012.04333.x; Hiruma Y, 2013, BONE, V53, P87, DOI 10.1016/j.bone.2012.11.036; Hiruma Y, 2011, BIOCHEM BIOPH RES CO, V409, P424, DOI 10.1016/j.bbrc.2011.05.015; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Ishida-Kitagawa N, 2012, J BIOL CHEM, V287, P17493, DOI 10.1074/jbc.M111.324194; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kameda Y, 2013, J BONE MINER RES, V28, P2463, DOI 10.1002/jbmr.1989; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; Liu QY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-286; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; MUHLBAUER RC, 1991, J BONE MINER RES, V6, P1003; O'Reilly MK, 2009, TRENDS PHARMACOL SCI, V30, P240, DOI 10.1016/j.tips.2009.02.005; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Sooknanan R. R, 2011, Alethia Biotherapetuics, United States Patent, Patent No. [7,989,160, 7989160]; Takahata M, 2007, BONE, V41, P77, DOI 10.1016/j.bone.2007.03.016; Taylor VC, 1999, J BIOL CHEM, V274, P11505, DOI 10.1074/jbc.274.17.11505; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Walsh MC, 2003, CYTOKINE GROWTH F R, V14, P251, DOI 10.1016/S1359-6101(03)00027-3	40	45	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6498	6512		10.1074/jbc.M113.494542	http://dx.doi.org/10.1074/jbc.M113.494542			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24446437	Green Published, hybrid			2022-12-25	WOS:000332389400017
J	Rispens, T; Davies, AM; Ooijevaar-de Heer, P; Absalah, S; Bende, O; Sutton, BJ; Vidarsson, G; Aalberse, RC				Rispens, Theo; Davies, Anna M.; Ooijevaar-de Heer, Pleuni; Absalah, Samira; Bende, Onno; Sutton, Brian J.; Vidarsson, Gestur; Aalberse, Rob C.			Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Antibody Engineering; Protein Structure; Structural Biology; Sulfhydryl; Thermodynamics	ANTIBODY DOMAIN C(H)3; HUMAN FC FRAGMENT; STRUCTURAL-CHARACTERIZATION; EFFECTOR FUNCTIONS; CRYSTAL-STRUCTURE; HALF-LIFE; CARBOHYDRATE INTERACTIONS; MONOCLONAL-ANTIBODIES; BIOTIN ANTIBODIES; CH3 DOMAIN	Background: Fab arm exchange requires weak interactions between CH3 domains, such as in human IgG4. Results: CH3-CH3 interactions differ >1,000,000-fold between human subclasses and allotypes due to variations Lys/Asn-392, Val/Met-397, and Lys/Arg-409. Conclusion: For IgG2 and IgG3, but not IgG1, hinge disulfide bonds are essential to prevent half-molecule dissociation. Significance: Subclass/allotype variation in the CH3 domain can alter antibody stability and functionality. Interdomain interactions between the CH3 domains of antibody heavy chains are the first step in antibody assembly and are of prime importance for maintaining the native structure of IgG. For human IgG4 it was shown that CH3-CH3 interactions are weak, resulting in the potential for half-molecule exchange (Fab arm exchange). Here we systematically investigated non-covalent interchain interactions for CH3 domains in the other human subclasses, including polymorphisms (allotypes), using real-time monitoring of Fab arm exchange with a FRET-based kinetic assay. We identified structural variation between human IgG subclasses and allotypes at three amino acid positions (Lys/Asn-392, Val/Met-397, Lys/Arg-409) to alter the strength of inter-domain interactions by >6 orders of magnitude. Each substitution affected the interactions independent from the other substitutions in terms of affinity, but the enthalpic and entropic contributions were non-additive, suggesting a complex interplay. Allotypic variation in IgG3 resulted in widely different CH3 interaction strengths that were even weaker for IgG3 than for IgG4 in the case of allotype G3m(c3c5*/6,24*), whereas G3m(s*/15*) was equally stable to IgG1. These interactions are sufficiently strong to maintain the structural integrity of IgG1 during its normal life span; for IgG2 and IgG3 the inter-heavy chain disulfide bonds are essential to prevent half-molecule dissociation, whereas the labile hinge disulfide bonds favor half-molecule exchange in vivo for IgG4.	[Rispens, Theo; Ooijevaar-de Heer, Pleuni; Absalah, Samira; Bende, Onno; Vidarsson, Gestur; Aalberse, Rob C.] Sanquin Res, NL-1066 CX Amsterdam, Netherlands; [Rispens, Theo; Ooijevaar-de Heer, Pleuni; Absalah, Samira; Bende, Onno; Vidarsson, Gestur; Aalberse, Rob C.] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Davies, Anna M.; Sutton, Brian J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Davies, Anna M.; Sutton, Brian J.] MRC, London SE1 9RT, England; [Davies, Anna M.; Sutton, Brian J.] Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England	University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London; University of London; King's College London	Rispens, T (corresponding author), Sanquin Blood Supply Fdn, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	T.Rispens@sanquin.nl	Davies, Anna Marie/G-4575-2014; Vidarsson, Gestur/A-9909-2009	Davies, Anna Marie/0000-0003-1498-1594; Vidarsson, Gestur/0000-0001-5621-003X; Absalah, Samira/0000-0002-8726-2542	Medical Research Council, UK [G1100090]; MRC [G1100090] Funding Source: UKRI; Medical Research Council [G1000758, G1000758B, G1100090] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	Supported by the Medical Research Council, UK, Grant G1100090.	Aalberse RC, 1999, INT ARCH ALLERGY IMM, V118, P187, DOI 10.1159/000024062; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; BAGCI H, 1993, FEBS LETT, V322, P47, DOI 10.1016/0014-5793(93)81108-C; Baruah K, 2012, J MOL BIOL, V420, P1, DOI 10.1016/j.jmb.2012.04.002; Bertz M, 2013, J AM CHEM SOC, V135, P15085, DOI 10.1021/ja405076j; Bowden TA, 2012, J AM CHEM SOC, V134, P17554, DOI 10.1021/ja306068g; Brusco A, 1998, EUR J IMMUNOGENET, V25, P349, DOI 10.1046/j.1365-2370.1998.00113.x; Chennamsetty N, 2009, J MOL BIOL, V391, P404, DOI 10.1016/j.jmb.2009.06.028; Crispin M, 2009, J MOL BIOL, V387, P1061, DOI 10.1016/j.jmb.2009.02.033; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i; Dard P, 2001, EUR J HUM GENET, V9, P765, DOI 10.1038/sj.ejhg.5200700; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; Davies AM, 2013, MOL IMMUNOL, V54, P1, DOI 10.1016/j.molimm.2012.10.029; DELANGE GG, 1989, EXP CLIN IMMUNOGENET, V6, P7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feige MJ, 2009, J MOL BIOL, V391, P599, DOI 10.1016/j.jmb.2009.06.048; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Goetze AM, 2011, MOL IMMUNOL, V49, P338, DOI 10.1016/j.molimm.2011.09.002; Guhr T, 2012, J PHARM SCI-US, V101, P978, DOI 10.1002/jps.22828; Hougs L, 2003, TISSUE ANTIGENS, V61, P231, DOI 10.1034/j.1399-0039.2003.00048.x; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Ishikawa T, 2010, BIOL PHARM BULL, V33, P1413, DOI 10.1248/bpb.33.1413; Ishino T, 2013, J BIOL CHEM, V288, P16529, DOI 10.1074/jbc.M113.457689; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; Jones DP, 2009, FREE RADICAL BIO MED, V47, P1329, DOI 10.1016/j.freeradbiomed.2009.08.021; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Kohen F, 1997, METHOD ENZYMOL, V279, P451; Kolenko P, 2009, IMMUNOLOGY, V126, P378, DOI 10.1111/j.1365-2567.2008.02904.x; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Lefranc Marie-Paule, 2012, Methods Mol Biol, V882, P635, DOI 10.1007/978-1-61779-842-9_34; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lewis KB, 2009, MOL IMMUNOL, V46, P3488, DOI 10.1016/j.molimm.2009.07.009; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Maskill H., 1986, PHYS BASIS ORGANIC C; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Nomura Y, 2010, NUCLEIC ACIDS RES, V38, P7822, DOI 10.1093/nar/gkq615; Oganesyan V, 2008, ACTA CRYSTALLOGR D, V64, P700, DOI 10.1107/S0907444908007877; Oganesyan V, 2008, MOL IMMUNOL, V45, P1872, DOI 10.1016/j.molimm.2007.10.042; Oganesyan V, 2009, MOL IMMUNOL, V46, P1750, DOI 10.1016/j.molimm.2009.01.026; Rispens T, 2013, J PHARMACEUT BIOMED, V85, P179, DOI 10.1016/j.jpba.2013.07.022; Rispens T, 2013, ANAL BIOCHEM, V437, P118, DOI 10.1016/j.ab.2013.02.027; Rispens T, 2013, MOL IMMUNOL, V53, P35, DOI 10.1016/j.molimm.2012.06.012; Rispens T, 2011, J AM CHEM SOC, V133, P10302, DOI 10.1021/ja203638y; Rispens T, 2010, EUR J PHARM SCI, V40, P62, DOI 10.1016/j.ejps.2010.03.001; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; SCHIFFER M, 1988, J MOL BIOL, V203, P799, DOI 10.1016/0022-2836(88)90210-0; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Shapiro RI, 2011, J PHARMACEUT BIOMED, V55, P168, DOI 10.1016/j.jpba.2011.01.006; Shitara K, 2007, U. S. patent, Patent No. [8,492,526, 8492526]; Siberil S, 2012, IMMUNOL LETT, V143, P60, DOI 10.1016/j.imlet.2012.02.002; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; Stubenrauch K, 2010, DRUG METAB DISPOS, V38, P84, DOI 10.1124/dmd.109.029751; Taylor FR, 2006, ANAL BIOCHEM, V353, P204, DOI 10.1016/j.ab.2006.02.022; Teplyakov A, 2013, MOL IMMUNOL, V56, P131, DOI 10.1016/j.molimm.2013.03.018; Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128; Thies MJW, 2002, J MOL BIOL, V319, P1267, DOI 10.1016/S0022-2836(02)00375-3; Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035; van Schouwenburg PA, 2013, ANN RHEUM DIS, V72, P104, DOI 10.1136/annrheumdis-2012-201445; Wilkinson IC, 2013, MABS-AUSTIN, V5, P406, DOI 10.4161/mabs.23941; Yu XJ, 2013, J AM CHEM SOC, V135, P9723, DOI 10.1021/ja4014375	68	57	78	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6098	6109		10.1074/jbc.M113.541813	http://dx.doi.org/10.1074/jbc.M113.541813			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425871	hybrid, Green Published			2022-12-25	WOS:000332015500064
J	Zhang, QH; Lei, XH; Lu, H				Zhang, Qinghao; Lei, Xiaohong; Lu, Hong			Alterations of Epigenetic Signatures in Hepatocyte Nuclear Factor 4 alpha Deficient Mouse Liver Determined by Improved ChIP-qPCR and (h)MeDIP-qPCR Assays	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; DNA METHYLATION; TRANSCRIPTION FACTORS; HISTONE METHYLATION; MESSENGER-RNAS; IMMUNOPRECIPITATION; EXPRESSION; FACTOR-4-ALPHA; HETEROCHROMATIN; IDENTIFICATION	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a liver-enriched transcription factor essential for liver development and function. In hepatocytes, HNF4 alpha regulates a large number of genes important for nutrient/xenobiotic metabolism and cell differentiation and proliferation. Currently, little is known about the epigenetic mechanism of gene regulation by HNF4 alpha. In this study, the global and specific alterations at the selected gene loci of representative histone modifications and DNA methylations were investigated in Hnf4 alpha-deficient female mouse livers using the improved MeDIP-, hMeDIP- and ChIP-qPCR assay. Hnf4 alpha deficiency significantly increased hepatic total IPed DNA fragments for histone H3 lysine-4 dimethylation (H3K4me2), H3K4me3, H3K9me2, H3K27me3 and H3K4 acetylation, but not for H3K9me3, 5-methylcytosine, or 5-hydroxymethylcytosine. At specific gene loci, the relative enrichments of histone and DNA modifications were changed to different degree in Hnf4 alpha-deficient mouse liver. Among the epigenetic signatures investigated, changes in H3K4me3 correlated the best with mRNA expression. Additionally, Hnf4 alpha-deficient livers had increased mRNA expression of histone H1.2 and H3.3 as well as epigenetic modifiers Dnmt1, Tet3, Setd7, Kmt2c, Ehmt2, and Ezh2. In conclusion, the present study provides convenient improved (h) MeDIP- and ChIP-qPCR assays for epigenetic study. Hnf4 alpha deficiency in young-adult mouse liver markedly alters histone methylation and acetylation, with fewer effects on DNA methylation and 5-hydroxymethylation. The underlying mechanism may be the induction of epigenetic enzymes responsible for the addition/removal of the epigenetic signatures, and/or the loss of HNF4 alpha per se as a key coordinator for epigenetic modifiers.	[Zhang, Qinghao; Lei, Xiaohong; Lu, Hong] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Lu, H (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.	luh@upstate.edu			National Institutes of Health (NIH) [ES019487, CA143656, CA159350]; NATIONAL CANCER INSTITUTE [R03CA159350, R03CA143656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health (NIH) grants: ES019487, CA143656, and CA159350 (http://grants.nih.gov/grants/guide/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Brebi-Mieville P, 2012, EPIGENETICS-US, V7, P106, DOI 10.4161/epi.7.1.18647; Chellappa K, 2012, BIOMARK MED, V6, P297, DOI [10.2217/BMM.12.23, 10.2217/bmm.12.23]; Choudhuri S, 2003, DRUG METAB DISPOS, V31, P1337, DOI 10.1124/dmd.31.11.1337; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Cook AJL, 2011, MOL CELL, V44, P918, DOI 10.1016/j.molcel.2011.11.021; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Elliott GO, 2013, NUCLEIC ACIDS RES, V41, P2228, DOI 10.1093/nar/gks1451; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Hughes JF, 2002, GENOMICS, V80, P453, DOI 10.1006/geno.2002.6856; Hwang-Verslues WW, 2010, CURR OPIN PHARMACOL, V10, P698, DOI 10.1016/j.coph.2010.08.010; Imai S, 2009, MOL PHARMACOL, V75, P568, DOI 10.1124/mol.108.052589; Ishihara S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq203; Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q; Kassner I, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-1; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Liang P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-231; Lim CY, 2013, DEVELOPMENT; Lisanti S, 2012, EPIGENETICS-US, V7, P615, DOI 10.4161/epi.20028; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Lu H, 2012, EPIGENETICS-US, V7, P914, DOI 10.4161/epi.21113; Lu H, 2010, TOXICOL SCI, V118, P380, DOI 10.1093/toxsci/kfq280; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Rollini P, 1999, P NATL ACAD SCI USA, V96, P10308, DOI 10.1073/pnas.96.18.10308; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Sorensen AL, 2009, METHODS MOL BIOL, V567, P249, DOI 10.1007/978-1-60327-414-2_16; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Thomas AM, 2013, PHARM RES; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Walesky C, 2013, AM J PHYSIOL-GASTR L, V304, pG26, DOI 10.1152/ajpgi.00064.2012; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710	48	15	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84925	10.1371/journal.pone.0084925	http://dx.doi.org/10.1371/journal.pone.0084925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427299	Green Published, gold			2022-12-25	WOS:000329868200039
J	Escudero, M; Martin-Bravo, S; Mayrose, I; Fernandez-Mazuecos, M; Fiz-Palacios, O; Hipp, AL; Pimentel, M; Jimenez-Mejias, P; Valcarcel, V; Vargas, P; Luceno, M				Escudero, Marcial; Martin-Bravo, Santiago; Mayrose, Itay; Fernandez-Mazuecos, Mario; Fiz-Palacios, Omar; Hipp, Andrew L.; Pimentel, Manuel; Jimenez-Mejias, Pedro; Valcarcel, Virginia; Vargas, Pablo; Luceno, Modesto			Karyotypic Changes through Dysploidy Persist Longer over Evolutionary Time than Polyploid Changes	PLOS ONE			English	Article							CHROMOSOME-NUMBER; CAREX CYPERACEAE; SEQUENCE DATA; GENOME SIZE; PLANTS; ANGIOSPERMS; SUCCESS; PHYLOGENETICS; EXTINCTION; ANEUPLOIDY	Chromosome evolution has been demonstrated to have profound effects on diversification rates and speciation in angiosperms. While polyploidy has predated some major radiations in plants, it has also been related to decreased diversification rates. There has been comparatively little attention to the evolutionary role of gains and losses of single chromosomes, which may or not entail changes in the DNA content (then called aneuploidy or dysploidy, respectively). In this study we investigate the role of chromosome number transitions and of possible associated genome size changes in angiosperm evolution. We model the tempo and mode of chromosome number evolution and its possible correlation with patterns of cladogenesis in 15 angiosperm clades. Inferred polyploid transitions are distributed more frequently towards recent times than single chromosome gains and losses. This is likely because the latter events do not entail changes in DNA content and are probably due to fission or fusion events (dysploidy), as revealed by an analysis of the relationship between genome size and chromosome number. Our results support the general pattern that recently originated polyploids fail to persist, and suggest that dysploidy may have comparatively longer-term persistence than polyploidy. Changes in chromosome number associated with dysploidy were typically observed across the phylogenies based on a chi-square analysis, consistent with these changes being neutral with respect to diversification.	[Escudero, Marcial; Martin-Bravo, Santiago; Jimenez-Mejias, Pedro; Luceno, Modesto] Pablo de Olavide Univ, Seville, Spain; [Escudero, Marcial; Hipp, Andrew L.] Morton Arboretum, Herbarium, Lisle, IL USA; [Escudero, Marcial; Hipp, Andrew L.] Field Museum, Chicago, IL USA; [Mayrose, Itay] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Fernandez-Mazuecos, Mario; Jimenez-Mejias, Pedro; Vargas, Pablo] Real Jardin Bot CSIC, Madrid, Spain; [Fiz-Palacios, Omar] Uppsala Univ, Uppsala, Sweden; [Pimentel, Manuel] Univ A Coruna, La Coruna, Spain; [Valcarcel, Virginia] Univ Autonoma Madrid, Madrid, Spain	Universidad Pablo de Olavide; Field Museum of Natural History (Chicago); Tel Aviv University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Uppsala University; Universidade da Coruna; Autonomous University of Madrid	Martin-Bravo, S (corresponding author), Pablo de Olavide Univ, Seville, Spain.	smarbra@upo.es	Lirio, Antonio Marcial Escudero/H-2099-2015; Valcárcel, Virginia/L-1795-2014; Luceño, Modesto/H-2753-2015; Fernández-Mazuecos, Mario/F-9699-2011; Martín-Bravo, Santiago/I-3554-2017; Jiménez-Mejías, Pedro/H-7274-2015	Lirio, Antonio Marcial Escudero/0000-0002-2541-5427; Valcárcel, Virginia/0000-0001-7509-5284; Luceño, Modesto/0000-0002-4321-2121; Fernández-Mazuecos, Mario/0000-0003-4027-6477; Martín-Bravo, Santiago/0000-0003-0626-0770; Jiménez-Mejías, Pedro/0000-0003-2815-4477; Pimentel, Manuel/0000-0003-4452-6584; Mayrose, Itay/0000-0002-8460-1502	Spanish Ministry of Economy and Competitivity [CGL2009-09972, CGL2012-38744]; MEC-Fulbright fellowship [FU2009-0946]; MEC Marie Curie (Project HoloChromEvol) fellowship	Spanish Ministry of Economy and Competitivity(Spanish Government); MEC-Fulbright fellowship(Spanish Government); MEC Marie Curie (Project HoloChromEvol) fellowship	This work was supported by the Spanish Ministry of Economy and Competitivity (Project CGL2009-09972 and CGL2012-38744) to M. Luceno (PI), S. Martin-Bravo, M. Escudero, and P. Jimenez-Mejias; by MEC-Fulbright (FU2009-0946); and Marie Curie (Project HoloChromEvol) fellowships to M. Escudero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Chung KS, 2011, AM J BOT, V98, P122, DOI 10.3732/ajb.1000046; Church SA, 2003, MOL PHYLOGENET EVOL, V27, P223, DOI 10.1016/S1055-7903(02)00446-3; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fawcett J.A., 2010, TRENDS ECOL EVOL, V2, P13, DOI DOI 10.4081/EB.2010.E3; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Givnish TJ, 1999, MOL PHYLOGENET EVOL, V12, P360, DOI 10.1006/mpev.1999.0601; Grant V., 1981, PLANT SPECIATION, Vsecond; Guerra M, 2008, CYTOGENET GENOME RES, V120, P339, DOI 10.1159/000121083; Hegarty M, 2007, CURR BIOL, V17, pR927, DOI 10.1016/j.cub.2007.08.060; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Hipp AL, 2009, BOT REV, V75, P96, DOI 10.1007/s12229-008-9022-8; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; LEE KH, 1993, EUPHYTICA, V72, P15; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Lipnerova I, 2013, ANN BOT-LONDON, V111, P79, DOI 10.1093/aob/mcs239; Mayrose I, 2011, SCIENCE, V333, P1257, DOI 10.1126/science.1207205; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Development Core Team, 2012, R LANG ENV STAT COMP; RAY PM, 1957, AM J BOT, V44, P529, DOI 10.2307/2438922; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; Soltis DE, 2001, AM J BOT, V88, P883, DOI 10.2307/2657040; Soltis DE, 2009, P NATL ACAD SCI USA, V106, P5455, DOI 10.1073/pnas.0901994106; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; SOLTIS PS, 1993, NEW ZEAL J BOT, V31, P203, DOI 10.1080/0028825X.1993.10419497; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; STEBBINS GL, 1984, BOT HELV, V94, P1; Van de Peer Y, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-113; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; VICKERY RK, 1995, GREAT BASIN NAT, V55, P174; Wagner W. H. Jun., 1970, Taxon, P146; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106	41	59	61	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85266	10.1371/journal.pone.0085266	http://dx.doi.org/10.1371/journal.pone.0085266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416374	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300061
J	Liebal, K; Vaish, A; Haun, D; Tomasello, M				Liebal, Katja; Vaish, Amrisha; Haun, Daniel; Tomasello, Michael			Does Sympathy Motivate Prosocial Behaviour in Great Apes?	PLOS ONE			English	Article							CHIMPANZEES HELP; YOUNG-CHILDREN; FOOD; ALTRUISM; EMPATHY; HARASSMENT	Prosocial behaviours such as helping, comforting, or sharing are central to human social life. Because they emerge early in ontogeny, it has been proposed that humans are prosocial by nature and that from early on empathy and sympathy motivate such behaviours. The emerging question is whether humans share these abilities to feel with and for someone with our closest relatives, the great apes. Although several studies demonstrated that great apes help others, little is known about their underlying motivations. This study addresses this issue and investigates whether four species of great apes (Pongo pygmaeus, Gorilla gorilla, Pan troglodytes, Pan paniscus) help a conspecific more after observing the conspecific being harmed (a human experimenter steals the conspecific's food) compared to a condition where no harming occurred. Results showed that in regard to the occurrence of prosocial behaviours, only orangutans, but not the African great apes, help others when help is needed, contrasting prior findings on chimpanzees. However, with the exception of one population of orangutans that helped significantly more after a conspecific was harmed than when no harm occurred, prosocial behaviour in great apes was not motivated by concern for others.	[Liebal, Katja] Free Univ Berlin, Excellence Cluster Languages Emot, Dept Educ & Psychol, Berlin, Germany; [Liebal, Katja] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England; [Liebal, Katja; Vaish, Amrisha; Haun, Daniel; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany	Free University of Berlin; University of Portsmouth; Max Planck Society	Liebal, K (corresponding author), Free Univ Berlin, Excellence Cluster Languages Emot, Dept Educ & Psychol, Berlin, Germany.	katja.liebal@fu-berlin.de	Liebal, Katja/AAQ-7910-2020	Liebal, Katja/0000-0003-2447-8327	Volkswagen Foundation; Fritz Thyssen Foundation	Volkswagen Foundation(Volkswagen); Fritz Thyssen Foundation	DFG)/Excellence Cluster3Languages of Emotion2 (EXC 302). Amrisha Vaish was supported by a Dilthey Fellowship provided by the Volkswagen Foundation and the Fritz Thyssen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bates D., 2010, LME4 LINEAR MIXED EF; Batson C.D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; Batson CD., 1991, ALTRUISM QUESTION SO; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Cronin KA, 2012, ANIM BEHAV, V84, P1085, DOI 10.1016/j.anbehav.2012.08.009; Dawkins R, 1976, SELFISH GENE; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Eisenberg N, 2006, HANDBOOK OF MORAL DEVELOPMENT, P517; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Hare B, 2010, CURR BIOL, V20, pR230, DOI 10.1016/j.cub.2009.12.038; Hepach R, 2013, INFANCY, V18, P67, DOI 10.1111/j.1532-7078.2012.00130.x; Hobson JA, 2009, DEVELOPMENTAL SCI, V12, P249, DOI 10.1111/j.1467-7687.2008.00762.x; Hoffman M.L., 2001, EMPATHY MORAL DEV IM; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Koski SE, 2010, EUR J DEV PSYCHOL, V7, P38, DOI 10.1080/17405620902986991; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Li YY, 2013, PSYCHOL SCI, V24, P1686, DOI 10.1177/0956797613479975; Liszkowski U, 2006, J COGN DEV, V7, P173, DOI 10.1207/s15327647jcd0702_2; Massen JJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009734; Melis AP, 2011, P ROY SOC B-BIOL SCI, V278, P1405, DOI 10.1098/rspb.2010.1735; OCONNELL SM, 1995, PRIMATES, V36, P397, DOI 10.1007/BF02382862; Pele M, 2009, J COMP PSYCHOL, V123, P375, DOI 10.1037/a0017253; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; SAGI A, 1976, DEV PSYCHOL, V12, P175, DOI 10.1037/0012-1649.12.2.175; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Silk JB., 2012, OXFORD HDB EVOLUTION, P115; Stevens JR, 2004, P ROY SOC B-BIOL SCI, V271, P451, DOI 10.1098/rspb.2003.2625; Tomasello M, 2009, WHY WE COOPERATE, P1; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Warneken F, 2006, CHILD DEV, V77, P640, DOI 10.1111/j.1467-8624.2006.00895.x; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Warneken F, 2013, COGNITION, V126, P101, DOI 10.1016/j.cognition.2012.09.011; Warneken F, 2009, TRENDS COGN SCI, V13, P397, DOI 10.1016/j.tics.2009.06.008; Warneken F, 2009, BRIT J PSYCHOL, V100, P455, DOI 10.1348/000712608X379061; Yamamoto S, 2012, SOC JUSTICE RES, V25, P233, DOI 10.1007/s11211-012-0160-0; Yamamoto S, 2012, P NATL ACAD SCI USA, V109, P3588, DOI 10.1073/pnas.1108517109; Yamamoto S, 2010, ANIM BEHAV, V79, P595, DOI 10.1016/j.anbehav.2009.11.034; Yamamoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007416; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	49	33	33	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84299	10.1371/journal.pone.0084299	http://dx.doi.org/10.1371/journal.pone.0084299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416212	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500110
J	Meyer, CG; O'Malley, JM; Papastamatiou, YP; Dale, JJ; Hutchinson, MR; Anderson, JM; Royer, MA; Holland, KN				Meyer, Carl G.; O'Malley, Joseph M.; Papastamatiou, Yannis P.; Dale, Jonathan J.; Hutchinson, Melanie R.; Anderson, James M.; Royer, Mark A.; Holland, Kim N.			Growth and Maximum Size of Tiger Sharks (Galeocerdo cuvier) in Hawaii	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; GULF-OF-MEXICO; INDIVIDUAL VARIABILITY; SOUTHWESTERN AUSTRALIA; CARCHARHINUS-OBSCURUS; REPRODUCTIVE-BIOLOGY; MOVEMENT PATTERNS; MARINE PREDATOR; DUSKY SHARKS; CATCH RATES	Tiger sharks (Galecerdo cuvier) are apex predators characterized by their broad diet, large size and rapid growth. Tiger shark maximum size is typically between 380 & 450 cm Total Length (TL), with a few individuals reaching 550 cm TL, but the maximum size of tiger sharks in Hawaii waters remains uncertain. A previous study suggested tiger sharks grow rather slowly in Hawaii compared to other regions, but this may have been an artifact of the method used to estimate growth (unvalidated vertebral ring counts) compounded by small sample size and narrow size range. Since 1993, the University of Hawaii has conducted a research program aimed at elucidating tiger shark biology, and to date 420 tiger sharks have been tagged and 50 recaptured. All recaptures were from Hawaii except a single shark recaptured off Isla Jacques Cousteau (24 degrees 13'17 '' N 109 degrees 52'14 '' W), in the southern Gulf of California (minimum distance between tag and recapture sites = approximately 5,000 km), after 366 days at liberty (DAL). We used these empirical mark-recapture data to estimate growth rates and maximum size for tiger sharks in Hawaii. We found that tiger sharks in Hawaii grow twice as fast as previously thought, on average reaching 340 cm TL by age 5, and attaining a maximum size of 403 cm TL. Our model indicates the fastest growing individuals attain 400 cm TL by age 5, and the largest reach a maximum size of 444 cm TL. The largest shark captured during our study was 464 cm TL but individuals >450 cm TL were extremely rare (0.005% of sharks captured). We conclude that tiger shark growth rates and maximum sizes in Hawaii are generally consistent with those in other regions, and hypothesize that a broad diet may help them to achieve this rapid growth by maximizing prey consumption rates.	[Meyer, Carl G.; Hutchinson, Melanie R.; Anderson, James M.; Royer, Mark A.; Holland, Kim N.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA; [O'Malley, Joseph M.] Natl Marine Fisheries Serv, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Papastamatiou, Yannis P.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Papastamatiou, Yannis P.] Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Dale, Jonathan J.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	University of Hawaii System; University of Hawaii Manoa; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; State University System of Florida; University of Florida; University of St Andrews; Stanford University	Meyer, CG (corresponding author), Univ Hawaii Manoa, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA.	carlm@hawaii.edu	Holland, Kim/ABH-1490-2021	Anderson, James/0000-0002-4900-5916	National Oceanic and Atmospheric Administration (National Marine Sanctuaries Program); University of Hawaii Sea Grant; State of Hawaii (Department of Land and Natural Resources)	National Oceanic and Atmospheric Administration (National Marine Sanctuaries Program); University of Hawaii Sea Grant; State of Hawaii (Department of Land and Natural Resources)	The authors are grateful to National Oceanic and Atmospheric Administration (National Marine Sanctuaries Program), University of Hawaii Sea Grant and the State of Hawaii (Department of Land and Natural Resources) for providing funding to support a variety of shark research projects that collectively made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AS, 2012, J FISH BIOL, V81, P2080, DOI 10.1111/j.1095-8649.2012.03455.x; Bass AJ, 1975, OCEANOGR RES INT DUR, V38, P100; Beerkircher L.R., 2002, MAR FISH REV, V64, P40, DOI DOI 10.1037/0003-066x.59.1.29; BRANSTETTER S, 1987, FISH B-NOAA, V85, P269; BRANSTETTER S, 1981, CONTRIB MAR SCI, V24, P13; Branstetter S, 1981, CONTRIB MAR SCI, V24, P213; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Carlson JK, 1999, COPEIA, P684; DeCrosta MA, 1984, P 2 S RES INV NW HAW, V2, P75; Ebert DA., 2013, FAO SPEC CAT FISH PU, V7, P523; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Fourmanoir P., 1961, Memoires de l'Institut Scientifique de Madagascar, V4F, P1; Francis MP, 1998, NEW ZEAL J MAR FRESH, V32, P427, DOI 10.1080/00288330.1998.9516835; Francis R.I.C.C., 1988, New Zealand Journal of Marine and Freshwater Research, V22, P42; FRANCIS RICC, 1988, CAN J FISH AQUAT SCI, V45, P936, DOI 10.1139/f88-115; GULLAND J. A., 1959, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V25, P47; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; Hussey NE, 2009, MAR FRESHWATER RES, V60, P571, DOI 10.1071/MF08280; Kneebone J, 2008, MAR BIOL, V154, P423, DOI 10.1007/s00227-008-0934-y; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; McGarvey R, 1999, MAR FRESHWATER RES, V50, P333, DOI 10.1071/MF97172; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Natanson LJ, 2006, ENVIRON BIOL FISH, V77, P367, DOI 10.1007/s10641-006-9127-z; Natanson LJ, 1999, FISH B-NOAA, V97, P944; Natanson LJ, 2002, COL VOL SCI PAP ICCA, V54, P1261; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; Papastamatiou YP, 2010, MAR FRESHWATER RES, V61, P1366, DOI 10.1071/MF10056; Romine JG, 2006, ENVIRON BIOL FISH, V77, P229, DOI 10.1007/s10641-006-9113-5; SAINSBURY KJ, 1980, CAN J FISH AQUAT SCI, V37, P241, DOI 10.1139/f80-031; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Simpfendorfer CA, 2000, FISH B-NOAA, V98, P811; Simpfendorfer CA, 2000, ENVIRON BIOL FISH, V58, P335, DOI 10.1023/A:1007624828001; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Skomal GB, 2003, FISH B-NOAA, V101, P627; Smith EB, 1997, CAN J FISH AQUAT SCI, V54, P2025, DOI 10.1139/f97-110; STEVENS JD, 1984, AUST J MAR FRESH RES, V35, P573, DOI 10.1071/MF9840573; STEVENS JD, 1991, AUST J MAR FRESH RES, V42, P151; TYLER JA, 1994, REV FISH BIOL FISHER, V4, P91, DOI 10.1007/BF00043262; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Welsford DC, 2005, FISH B-NOAA, V103, P697; Whitney NM, 2007, MAR BIOL, V151, P63, DOI 10.1007/s00227-006-0476-0; Wintner SP, 2000, MAR FRESHWATER RES, V51, P43, DOI 10.1071/MF99077; Wirsing AJ, 2006, MAR BIOL, V149, P961, DOI 10.1007/s00227-006-0278-4	49	27	27	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84799	10.1371/journal.pone.0084799	http://dx.doi.org/10.1371/journal.pone.0084799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416287	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500170
J	Hagmann, H; Kuczkowski, A; Ruehl, M; Lamkemeyer, T; Brodesser, S; Horke, S; Dryer, S; Schermer, B; Benzing, T; Brinkkoetter, PT				Hagmann, Henning; Kuczkowski, Alexander; Ruehl, Michael; Lamkemeyer, Tobias; Brodesser, Susanne; Horke, Sven; Dryer, Stuart; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul Thomas			Breaking the chain at the membrane: paraoxonase 2 counteracts lipid peroxidation at the plasma membrane	FASEB JOURNAL			English	Article						atherosclerosis; arylesterase; oxidative stress; inflammation	LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; ATHEROSCLEROSIS; DEFICIENCY; EXPRESSION; PRODUCTS; GENE; PHOSPHOLIPIDS; INFLAMMATION; MECHANISMS	Lipid peroxidation through electrophilic molecules of extracellular origin is involved in the pathogenesis of many inflammatory conditions. To counteract free radical actions at the plasma membrane, cells host a variety of antioxidative enzymes. Here we analyzed localization, membrane topology, and trafficking of PON2 a member of the paraoxonase family of 3 enzymatically active proteins (PON1-3) found to have antiatherogenic properties. Immunohistochemistry localized PON2 to the villous tip of human intestinal epithelial cells. Employing membrane preparations, surface biotinylation experiments, and mutational analyses in HEK 293T and HeLa cells, we demonstrate that PON2 is a type II transmembrane protein. A hydrophobic stretch in the N terminus was identified as single transmembrane domain of PON2. The enzymatically active domain faced the extracellular compartment, where it suppressed lipid peroxidation (P < 0.05) and regulated the glucosylceramide content, as demonstrated by mass spectrometry (P < 0.05). PON2 translocation to the plasma membrane was dependent on intracellular calcium responses and could be induced to > 10-fold as compared to baseline (P=0.0001) by oxidative stress. Taken together, these data identify the paraoxonase protein PON2 as a type II transmembrane protein, which is dynamically translocated to the plasma membrane in response to oxidative stress to counteract lipid peroxidation.-Hagmann, H., Kuczkowski, A., Ruehl, M., Lamkemeyer, T., Brodesser, S., Horke, S., Dryer, S., Schermer, B., Benzing, T., Brinkkoetter, P. T. Breaking the chain at the membrane: paraoxonase 2 counteracts lipid peroxidation at the plasma membrane.	[Hagmann, Henning; Kuczkowski, Alexander; Ruehl, Michael; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul Thomas] Univ Cologne, Dept Internal Med 2, D-50937 Cologne, Germany; [Hagmann, Henning; Kuczkowski, Alexander; Ruehl, Michael; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul Thomas] Univ Cologne, Ctr Mol Med Cologne, D-50937 Cologne, Germany; [Lamkemeyer, Tobias; Brodesser, Susanne; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Brodesser, Susanne] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50937 Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas] Univ Cologne, D-50937 Cologne, Germany; [Horke, Sven] Univ Hosp Mainz, Inst Pharmacol, Mainz, Germany; [Dryer, Stuart] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University Hospital Mainz; University of Houston System; University of Houston	Brinkkoetter, PT (corresponding author), Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany.	thomas.benzing@uk-koeln.de; paul.brinkkoetter@uk-koeln.de	Schermer, Bernhard/E-9972-2014; Benzing, Thomas/X-5476-2019	Schermer, Bernhard/0000-0002-5194-9000; 	Marga und Walter Boll-Stiftung [HH 210-05-11]; Deutsche Forschungsgemeinschaft [BR2955/4-1, SCHE1562, SFB832, SFB572, SFB635, SFB829]; Koln Fortune Program of the University of Cologne	Marga und Walter Boll-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Koln Fortune Program of the University of Cologne	The authors thank Angelika Koeser for technical support. This study was funded by the Marga und Walter Boll-Stiftung (HH 210-05-11). P.T.B. received funding from the Deutsche Forschungsgemeinschaft (BR2955/4-1) and Koln Fortune Program of the University of Cologne. B.S. obtained funding from the Deutsche Forschungsgemeinschaft (SCHE1562 and SFB832). T.B. received funding from the Deutsche Forschungsgemeinschaft (SFB572, SFB635, and SFB829).	Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Aviram Michael, 2008, V477, P259, DOI 10.1007/978-1-60327-517-0_20; Barros GP, 2012, INT J GEOPHYS, V2012, DOI [10.1155/2012/459497, 10.5402/2012/137289]; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Goswami B, 2009, CLIN CHIM ACTA, V410, P1, DOI 10.1016/j.cca.2009.09.025; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Jarerattanachat V, 2013, J PHYS CHEM B, V117, P8490, DOI 10.1021/jp4040612; Kawamoto Y, 2000, J BIOL CHEM, V275, P11291, DOI 10.1074/jbc.275.15.11291; Kumagai T, 2004, J BIOL CHEM, V279, P48389, DOI 10.1074/jbc.M409935200; KUNIMOTO M, 1981, BIOCHIM BIOPHYS ACTA, V646, P169, DOI 10.1016/0005-2736(81)90284-4; Levy E, 2007, AM J PHYSIOL-GASTR L, V293, pG1252, DOI 10.1152/ajpgi.00369.2007; Mackness B, 2006, ARTERIOSCL THROM VAS, V26, P1545, DOI 10.1161/01.ATV.0000222924.62641.aa; Mackness B, 2010, IUBMB LIFE, V62, P480, DOI 10.1002/iub.347; MACKNESS MI, 1985, COMP BIOCHEM PHYS B, V82, P675, DOI 10.1016/0305-0491(85)90506-1; Minoguchi K, 2006, EUR RESPIR J, V28, P378, DOI 10.1183/09031936.06.00084905; Mochizuki H, 1998, GENE, V213, P149, DOI 10.1016/S0378-1119(98)00193-0; Musiek ES, 2006, J NEUROCHEM, V97, P1301, DOI 10.1111/j.1471-4159.2006.03797.x; Musiek ES, 2005, BRAIN PATHOL, V15, P149; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Ng CJ, 2006, J BIOL CHEM, V281, P29491, DOI 10.1074/jbc.M605379200; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Ng DS, 2008, CARDIOVASC PATHOL, V17, P226, DOI 10.1016/j.carpath.2007.10.001; Patel BP, 2007, INTEGR CANCER THER, V6, P365, DOI 10.1177/1534735407309760; Patel M, 2008, J NEUROCHEM, V104, P264, DOI 10.1111/j.1471-4159.2007.04974.x; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Quintanar-Escorza MA, 2010, TOXICOL IN VITRO, V24, P1338, DOI 10.1016/j.tiv.2010.05.002; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ravandi A, 2004, LIPIDS, V39, P97, DOI 10.1007/s11745-004-1207-5; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rosenblat M, 2009, J LIPID RES, V50, P870, DOI 10.1194/jlr.M800550-JLR200; Schindler J, 2006, J NEURAL TRANSM, V113, P995, DOI 10.1007/s00702-006-0508-4; Schwamb J, 2012, BLOOD, V120, P3978, DOI 10.1182/blood-2012-05-431783; Signorelli P, 2002, METHOD ENZYMOL, V345, P275; Sorenson RC, 1999, ARTERIOSCL THROM VAS, V19, P2214, DOI 10.1161/01.ATV.19.9.2214; Teiber JF, 2004, J LIPID RES, V45, P2260, DOI 10.1194/jlr.M400213-JLR200; Tsao SM, 2007, NUTR CANCER, V59, P8, DOI 10.1080/01635580701365043; Volkel W, 2006, NEUROCHEM INT, V48, P679, DOI 10.1016/j.neuint.2005.12.003; Waddington EI, 2003, ATHEROSCLEROSIS, V167, P111, DOI 10.1016/S0021-9150(02)00391-X; Wang W., 2001, IN VITRO MUTAGENESIS, P37; Witte I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.91; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565; Yang Y, 2012, FREE RADICAL BIO MED, V53, P437, DOI 10.1016/j.freeradbiomed.2012.05.015; Young O, 2010, HEAD NECK-J SCI SPEC, V32, P750, DOI 10.1002/hed.21247	52	46	50	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	4					1769	1779		10.1096/fj.13-240309	http://dx.doi.org/10.1096/fj.13-240309			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3UC	24421402				2022-12-25	WOS:000335344300023
J	Monette, MY; Somasekharan, S; Forbush, B				Monette, Michelle Y.; Somasekharan, Suma; Forbush, Biff			Molecular Motions Involved in Na-K-Cl Cotransporter-mediated Ion Transport and Transporter Activation Revealed by Internal Cross-linking between Transmembrane Domains 10 and 11/12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloride Transport; Copper; Membrane Proteins; Membrane Transport; Protein Cross-linking; Protein Structure; Na-K-Cl Cotransporter; Iodine; Loop Diuretics; Phenanthroline	AMINO-ACID ANTIPORTER; PROTEIN-STRUCTURE; MECHANISM; PHOSPHORYLATION; NKCC1; CYSTEINE	Background: Na-K-Cl cotransporters (NKCCs) are responsible for volume and chloride homeostasis and chloride transport and are targets of loop diuretic drugs. Results: Cross-links between transmembrane domains (TMs) 10 and 11/12 of NKCC1 are identified as inhibitory and stimulatory. Conclusion: Activation of NKCC1 involves movement of TM12 relative to TM10. Significance: This identifies movement of TM12 as a key step in the molecular mechanism of NKCC activation. We examined the relationship between transmembrane domain (TM) 10 and TM11/12 in NKCC1, testing homology models based on the structure of AdiC in the same transporter superfamily. We hypothesized that introduced cysteine pairs would be close enough for disulfide formation and would alter transport function: indeed, evidence for cross-link formation with low micromolar concentrations of copper phenanthroline or iodine was found in 3 of 8 initially tested pairs and in 1 of 26 additionally tested pairs. Inhibition of transport was observed with copper phenanthroline and iodine treatment of P676C/A734C and I677C/A734C, consistent with the proximity of these residues and with movement of TM10 during the occlusion step of ion transport. We also found Cu2+ inhibition of the single-cysteine mutant A675C, suggesting that this residue and Met(382) of TM3 are involved in a Cu2+-binding site. Surprisingly, cross-linking of P676C/I730C was found to prevent rapid deactivation of the transporter while not affecting the dephosphorylation rate, thus uncoupling the phosphorylation and activation steps. Consistent with this, (a) cross-linking of P676C/I730C was dependent on activation state, and (b) mutants lacking the phosphoregulatory domain could still be activated by cross-linking. These results suggest a model of NKCC activation that involves movement of TM12 relative to TM10, which is likely tied to movement of the large C terminus, a process somehow triggered by phosphorylation of the regulatory domain in the N terminus.	[Monette, Michelle Y.; Somasekharan, Suma; Forbush, Biff] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Forbush, B (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, POB 208026, New Haven, CT 06520 USA.	biff.forbush@yale.edu			National Institutes of Health [P01-DK17433]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-DK17433.	Aronica E, 2007, NEUROSCIENCE, V145, P185, DOI 10.1016/j.neuroscience.2006.11.041; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; Melo F, 2007, PROTEIN SCI, V16, P2412, DOI 10.1110/ps.072895107; Monette Michelle Y, 2012, J Biol Chem, V287, P2210, DOI 10.1074/jbc.M111.309211; Pedersen M, 2008, J BIOL CHEM, V283, P2663, DOI 10.1074/jbc.M708194200; Prudent M, 2009, METALLOMICS, V1, P157, DOI 10.1039/b817061d; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Somasekharan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082060; Somasekharan S, 2012, J BIOL CHEM, V287, P17308, DOI 10.1074/jbc.M112.356014	25	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7569	7579		10.1074/jbc.M113.542258	http://dx.doi.org/10.1074/jbc.M113.542258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24451383	hybrid, Green Published			2022-12-25	WOS:000332761500027
J	Addis, PW; Hall, CJ; Bruton, S; Veverka, V; Wilkinson, IC; Muskett, FW; Renshaw, PS; Prosser, CE; Carrington, B; Lawson, ADG; Griffin, R; Taylor, RJ; Waters, LC; Henry, AJ; Carr, MD				Addis, Philip W.; Hall, Catherine J.; Bruton, Shaun; Veverka, Vaclav; Wilkinson, Ian C.; Muskett, Frederick W.; Renshaw, Philip S.; Prosser, Christine E.; Carrington, Bruce; Lawson, Alastair D. G.; Griffin, Robert; Taylor, Richard J.; Waters, Lorna C.; Henry, Alistair J.; Carr, Mark D.			Conformational Heterogeneity in Antibody-Protein Antigen Recognition IMPLICATIONS FOR HIGH AFFINITY PROTEIN COMPLEX FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; NMR; Protein Conformation; Protein Structure; Protein-Protein Interactions; CDR; Conformational Heterogeneity	TISSUE INHIBITOR; MATRIX-METALLOPROTEINASE; LARGER PROTEINS; NMR METHODS; DOMAIN; SHIFT; TRANSFORMATION; REARRANGEMENTS; RELAXATION; SCLEROSTIN	Background: Antibodies are essential components of the immune system which recognize specific antigens with high affinity. Results: Protein antigen binding sites on antibodies show conformational exchange on a millisecond to second timescale. Conclusion: Conformational heterogeneity at high affinity protein-protein interaction sites may be common and facilitate efficient protein complex formation. Significance: High affinity protein-protein interactions are critical for many biological processes. Specific, high affinity protein-protein interactions lie at the heart of many essential biological processes, including the recognition of an apparently limitless range of foreign proteins by natural antibodies, which has been exploited to develop therapeutic antibodies. To mediate biological processes, high affinity protein complexes need to form on appropriate, relatively rapid timescales, which presents a challenge for the productive engagement of complexes with large and complex contact surfaces (approximate to 600-1800 (2)). We have obtained comprehensive backbone NMR assignments for two distinct, high affinity antibody fragments (single chain variable and antigen-binding (Fab) fragments), which recognize the structurally diverse cytokines interleukin-1 (IL-1, -sheet) and interleukin-6 (IL-6, -helical). NMR studies have revealed that the hearts of the antigen binding sites in both free anti-IL-1 Fab and anti-IL-6 single chain variable exist in multiple conformations, which interconvert on a timescale comparable with the rates of antibody-antigen complex formation. In addition, we have identified a conserved antigen binding-induced change in the orientation of the two variable domains. The observed conformational heterogeneity and slow dynamics at protein antigen binding sites appears to be a conserved feature of many high affinity protein-protein interfaces structurally characterized by NMR, suggesting an essential role in protein complex formation. We propose that this behavior may reflect a soft capture, protein-protein docking mechanism, facilitating formation of high affinity protein complexes on a timescale consistent with biological processes.	[Renshaw, Philip S.; Prosser, Christine E.; Waters, Lorna C.; Carr, Mark D.] Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Prosser, Christine E.; Carrington, Bruce; Lawson, Alastair D. G.; Griffin, Robert; Taylor, Richard J.; Henry, Alistair J.] UCB, Slough SL1 3WE, Berks, England; [Veverka, Vaclav] Inst Organ Chem & Biochem, Flemingovo Namesti 2, Prague 16610 6, Czech Republic	University of Leicester; UCB Pharma SA; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Waters, LC (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	lw83@le.ac.uk; alistair.henry@ucb.com; mdc12@le.ac.uk	Veverka, Vaclav/G-9174-2014; Veverka, Vaclav/P-5251-2019	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996; Addis, Philip/0000-0003-1185-651X				ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; DAVIES D R, 1992, Current Biology, V2, P254, DOI 10.1016/0960-9822(92)90369-L; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; DRISCOLL PC, 1990, BIOCHEMISTRY-US, V29, P3542, DOI 10.1021/bi00466a018; Gao G, 2000, J MOL BIOL, V301, P537, DOI 10.1006/jmbi.2000.3976; Grishaev A, 2008, J BIOMOL NMR, V40, P95, DOI 10.1007/s10858-007-9211-5; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Holdsworth G, 2012, J BIOL CHEM, V287, P26464, DOI 10.1074/jbc.M112.350108; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Marintchev A, 2007, METHOD ENZYMOL, V430, P283, DOI 10.1016/S0076-6879(07)30012-8; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prosser C. E., 2013, BIOMOL NMR ASSIGN, DOI 10.1007/s12104-013-9464-8; Reichert JM, 2010, MABS-AUSTIN, V2, P695, DOI 10.4161/mabs.2.6.13603; Ruschak AM, 2012, P NATL ACAD SCI USA, V109, pE3454, DOI 10.1073/pnas.1213640109; Sela-Culang I, 2012, J IMMUNOL, V189, P4890, DOI 10.4049/jimmunol.1201493; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; STANFIELD RL, 1993, STRUCTURE, V1, P83, DOI 10.1016/0969-2126(93)90024-B; Veverka V, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405597; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Wilkinson IC, 2009, J BIOL CHEM, V284, P31928, DOI 10.1074/jbc.M109.025304; Williamson RA, 2001, J BIOL CHEM, V276, P32966, DOI 10.1074/jbc.M101843200; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Williamson RA, 1999, J BIOL CHEM, V274, P37226, DOI 10.1074/jbc.274.52.37226; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xu GY, 1996, J BIOMOL NMR, V8, P123; Yoon S, 2010, BIOTECHNOL BIOPROC E, V15, P709, DOI 10.1007/s12257-009-3113-1; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519	38	13	13	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7200	7210		10.1074/jbc.M113.492215	http://dx.doi.org/10.1074/jbc.M113.492215			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24436329	Green Published, hybrid			2022-12-25	WOS:000332389400078
J	Dorn, J; Ferrari, E; Imhof, R; Ziegler, N; Hubscher, U				Dorn, Julia; Ferrari, Elena; Imhof, Ralph; Ziegler, Nathalie; Huebscher, Ulrich			Regulation of Human MutYH DNA Glycosylase by the E3 Ubiquitin Ligase Mule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair; DNA Damage; E3 Ubiquitin Ligase; Oxidative Stress; Ubiquitination; 8-Oxo-G; Mule; MutYH	BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; POLYMERASE-LAMBDA; SUBCELLULAR-LOCALIZATION; 8-OXO-GUANINE REPAIR; GENETIC INSTABILITY; DAMAGE; CANCER; PHOSPHORYLATION; MYH	Background: Regulation of MutYH DNA glycosylase is essential for genomic integrity. Results: MutYH is ubiquitinated by the E3 ligase Mule changing its protein levels and recruitment to chromatin. MutYH levels in cancer cells influence the mutagenic potential of reactive oxygen species. Conclusion: Ubiquitination of MutYH is an important regulatory step. Significance: We identified the residues that are targets for ubiquitination by Mule. Oxidation of DNA is a frequent and constantly occurring event. One of the best characterized oxidative DNA lesions is 7,8-dihydro-8-oxoguanine (8-oxo-G). It instructs most DNA polymerases to preferentially insert an adenine (A) opposite 8-oxo-G instead of the appropriate cytosine (C) thus showing miscoding potential. The MutY DNA glycosylase homologue (MutYH) recognizes A:8-oxo-G mispairs and removes the mispaired A giving way to the canonical base excision repair that ultimately restores undamaged guanine (G). Here we characterize for the first time in detail a posttranslational modification of the human MutYH DNA glycosylase. We show that MutYH is ubiquitinated in vitro and in vivo by the E3 ligase Mule between amino acids 475 and 535. Mutation of five lysine residues in this region significantly stabilizes MutYH, suggesting that these are the target sites for ubiquitination. The endogenous MutYH protein levels depend on the amount of expressed Mule. Furthermore, MutYH and Mule physically interact. We found that a ubiquitination-deficient MutYH mutant shows enhanced binding to chromatin. The mutation frequency of the ovarian cancer cell line A2780, analyzed at the HPRT locus can be increased upon oxidative stress and depends on the MutYH levels that are regulated by Mule. This reflects the importance of tightly regulated MutYH levels in the cell. In summary our data show that ubiquitination is an important regulatory mechanism for the essential MutYH DNA glycosylase in human cells.	[Dorn, Julia; Ferrari, Elena; Imhof, Ralph; Huebscher, Ulrich] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Ziegler, Nathalie] ETH, Inst Food Nutr & Hlth, CH-8092 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hubscher, U (corresponding author), Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	hubscher@vetbio.uzh.ch		Ziegler, Nathalie/0000-0003-1152-0645				Blasi MF, 2006, CANCER RES, V66, P9036, DOI 10.1158/0008-5472.CAN-06-1896; Boldogh I, 2001, NUCLEIC ACIDS RES, V29, P2802, DOI 10.1093/nar/29.13.2802; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO;2-3; El-Shemerly M, 2005, CANCER RES, V65, P3604, DOI 10.1158/0008-5472.CAN-04-4069; Friedberg E.C., 2006, DNA REPAIR MUTAGENES, P16; Frouin I, 2005, NUCLEIC ACIDS RES, V33, P5354, DOI 10.1093/nar/gki845; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hirano S, 2003, J BIOL CHEM, V278, P38121, DOI 10.1074/jbc.C300316200; Hwang BJ, 2014, DNA REPAIR, V13, P10, DOI 10.1016/j.dnarep.2013.10.011; Khoronenkova SV, 2013, NUCLEIC ACIDS RES, V41, P1750, DOI 10.1093/nar/gks1359; Khoronenkova SV, 2012, MOL CELL, V45, P801, DOI 10.1016/j.molcel.2012.01.021; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Maga G, 2008, P NATL ACAD SCI USA, V105, P20689, DOI 10.1073/pnas.0811241106; Markkanen Enni, 2013, Frontiers in Genetics, V4, P18, DOI 10.3389/fgene.2013.00018; Markkanen E, 2012, P NATL ACAD SCI USA, V109, P437, DOI 10.1073/pnas.1110449109; Parker AR, 2002, CANCER RES, V62, P7230; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Parsons JL, 2009, EMBO J, V28, P3207, DOI 10.1038/emboj.2009.243; Ruggieri V, 2013, ONCOGENE, V32, P4500, DOI 10.1038/onc.2012.479; Russo MT, 2009, CANCER RES, V69, P4372, DOI 10.1158/0008-5472.CAN-08-3292; Russo MT, 2004, CANCER RES, V64, P4411, DOI 10.1158/0008-5472.CAN-04-0355; Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802; Shinmura K, 2011, J PATHOL, V225, P414, DOI 10.1002/path.2953; Taghizadeh K, 2008, NAT PROTOC, V3, P1287, DOI 10.1038/nprot.2008.119; Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638; van Loon B, 2009, P NATL ACAD SCI USA, V106, P18201, DOI 10.1073/pnas.0907280106; Wimmer U, 2008, EMBO REP, V9, P1027, DOI 10.1038/embor.2008.148; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834	31	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7049	7058		10.1074/jbc.M113.536094	http://dx.doi.org/10.1074/jbc.M113.536094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443563	Green Published, hybrid			2022-12-25	WOS:000332389400064
J	Nikolajsen, CL; Dyrlund, TF; Poulsen, ET; Enghild, JJ; Scavenius, C				Nikolajsen, Camilla Lund; Dyrlund, Thomas F.; Poulsen, Ebbe Toftgaard; Enghild, Jan J.; Scavenius, Carsten			Coagulation Factor XIIIa Substrates in Human Plasma IDENTIFICATION AND INCORPORATION INTO THE CLOT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood Coagulation Factors; Fibrinogenesis; Plasma; Proteomics; Transglutaminases	EXTRACELLULAR-MATRIX PROTEIN-1; COVALENT CROSS-LINKING; COMPLEMENT; INHIBITOR; FIBRIN; TRANSGLUTAMINASES; FIBRONECTIN; SPECIFICITY; PEPTIDE; ECM1	Background: Coagulation factor XIIIa (FXIIIa) catalyzes cross-linking of Gln and Lys residues during coagulation. Results: A total of 147 FXIIIa substrates were identified in human plasma, and 48 of these were incorporated into the clot. Conclusion: These results indicate that FXIIIa is involved in extensive functionalization of the plasma clot. Significance: We present new insights into roles of FXIIIa in physiological and pathological processes. Coagulation factor XIII (FXIII) is a transglutaminase with a well defined role in the final stages of blood coagulation. Active FXIII (FXIIIa) catalyzes the formation of E-(-glutamyl)lysine isopeptide bonds between specific Gln and Lys residues. The primary physiological outcome of this catalytic activity is stabilization of the fibrin clot during coagulation. The stabilization is achieved through the introduction of cross-links between fibrin monomers and through cross-linking of proteins with anti-fibrinolytic activity to fibrin. FXIIIa additionally cross-links several proteins with other functionalities to the clot. Cross-linking of proteins to the clot is generally believed to modify clot characteristics such as proteolytic susceptibility and hereby affect the outcome of tissue damage. In the present study, we use a proteomic approach in combination with transglutaminase-specific labeling to identify FXIIIa plasma protein substrates and their reactive residues. The results revealed a total of 147 FXIIIa substrates, of which 132 have not previously been described. We confirm that 48 of the FXIIIa substrates were indeed incorporated into the insoluble fibrin clot during the coagulation of plasma. The identified substrates are involved in, among other activities, complement activation, coagulation, inflammatory and immune responses, and extracellular matrix organization.	[Nikolajsen, Camilla Lund; Dyrlund, Thomas F.; Poulsen, Ebbe Toftgaard; Enghild, Jan J.; Scavenius, Carsten] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Nikolajsen, Camilla Lund; Enghild, Jan J.] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Enghild, JJ (corresponding author), Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	jje@mb.au.dk; csss@mb.au.dk	; Scavenius, Carsten/Q-5941-2017	Enghild, Jan Johannes/0000-0001-9292-9172; Toftgaard Poulsen, Ebbe/0000-0002-4416-0431; Scavenius, Carsten/0000-0002-4304-0681				Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999; COUSSONS PJ, 1992, BIOCHEM J, V282, P929, DOI 10.1042/bj2820929; Csosz E, 2008, J MOL BIOL, V383, P390, DOI 10.1016/j.jmb.2008.08.026; Csosz E, 2009, AMINO ACIDS, V36, P615, DOI 10.1007/s00726-008-0121-y; Dorum S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014056; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; FRANCIS RT, 1986, J BIOL CHEM, V261, P9787; Fraser SR, 2011, BLOOD, V117, P6371, DOI 10.1182/blood-2011-02-333203; GORMAN JJ, 1984, J BIOL CHEM, V259, P9007; HADA M, 1986, BLOOD, V68, P95; HALKIER T, 1994, BIOCHEM BIOPH RES CO, V200, P78, DOI 10.1006/bbrc.1994.1416; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Hsieh L, 2008, HAEMOPHILIA, V14, P1190, DOI 10.1111/j.1365-2516.2008.01857.x; KRONVALL G, 1979, INFECT IMMUN, V25, P1; Kussmann M, 1997, J MASS SPECTROM, V32, P593; Lippi G, 2011, NAT REV CARDIOL, V8, P502, DOI 10.1038/nrcardio.2011.91; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Lorand L, 2005, J THROMB HAEMOST, V3, P1337, DOI 10.1111/j.1538-7836.2005.01213.x; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Nahrendorf M, 2008, EUR HEART J, V29, P445, DOI 10.1093/eurheartj/ehm558; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Nikolajsen CL, 2012, BIOCHEMISTRY-US, V51, P4735, DOI 10.1021/bi3004022; OKAMOTO M, 1992, BIOCHIM BIOPHYS ACTA, V1138, P53, DOI 10.1016/0925-4439(92)90151-C; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Richardson VR, 2013, CLIN SCI, V124, P123, DOI 10.1042/CS20120233; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ritchie H, 1999, THROMB HAEMOSTASIS, V81, P96; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Robinson BR, 2000, CIRCULATION, V102, P1151, DOI 10.1161/01.CIR.102.10.1151; Ruoppolo M, 2003, PROTEIN SCI, V12, P1290, DOI 10.1110/ps.0239103; SAKATA Y, 1982, J CLIN INVEST, V69, P536, DOI 10.1172/JCI110479; Scavenius C, 2011, BBA-PROTEINS PROTEOM, V1814, P1624, DOI 10.1016/j.bbapap.2011.08.017; Schroeder V, 2013, J THROMB HAEMOST, V11, P234, DOI 10.1111/jth.12074; Sercu S, 2008, J INVEST DERMATOL, V128, P1397, DOI 10.1038/sj.jid.5701231; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Valnickova Z, 1998, J BIOL CHEM, V273, P27220, DOI 10.1074/jbc.273.42.27220; Zhang Y., 2012, PLOS ONE, V7	41	42	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6526	6534		10.1074/jbc.M113.517904	http://dx.doi.org/10.1074/jbc.M113.517904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443567	hybrid, Green Published			2022-12-25	WOS:000332389400019
J	Wang, DR; Hsiao, JC; Wong, CH; Li, GC; Lin, SC; Yu, SSF; Chen, WL; Chang, W; Tzou, DLM				Wang, Da-Rong; Hsiao, Jye-Chian; Wong, Chien-Hsuan; Li, Guo-Chian; Lin, Su-Ching; Yu, Steve S. -F.; Chen, Wenlung; Chang, Wen; Tzou, Der-Lii M.			Vaccinia Viral Protein A27 Is Anchored to the Viral Membrane via a Cooperative Interaction with Viral Membrane Protein A17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pox Viruses; Protein Structure; Protein-Protein Interactions; Viral Protein; Virus Assembly	PLAQUE SIZE PHENOTYPE; ENVELOPE PROTEIN; MATURE VIRIONS; VIRUS ENTRY; SECONDARY STRUCTURE; STABLE COMPLEX; CELL-SURFACES; GENE-PRODUCT; IDENTIFICATION; FUSION	Background: Vaccinia viral protein A27 associates with viral membrane protein A17 for anchoring to the viral membrane. Results: A27 specifically interacts with two binding regions within the N-terminal domain of A17. Conclusion: The A27-A17 interaction is mediated through a specific and cooperative binding mechanism. Significance: As demonstrated, the F1 and F2 bindings are critical for A27 anchoring to the viral membrane and virion assembly. The vaccinia viral protein A27 in mature viruses specifically interacts with heparan sulfate for cell surface attachment. In addition, A27 associates with the viral membrane protein A17 to anchor to the viral membrane; however, the specific interaction between A27 and A17 remains largely unclear. To uncover the active binding sites and the underlying binding mechanism, we expressed and purified the N-terminal (18-50 residues) and C-terminal (162-203 residues) fragments of A17, which are denoted A17-N and A17-C. Through surface plasmon resonance, the binding affinity of A27/A17-N (K-A = 3.40 x 10(8) m(-1)) was determined to be approximately 3 orders of magnitude stronger than that of A27/A17-C (K-A = 3.40 x 10(5) m(-1)), indicating that A27 prefers to interact with A17-N rather than A17-C. Despite the disordered nature of A17-N, the A27-A17 interaction is mediated by a specific and cooperative binding mechanism that includes two active binding sites, namely (SFMPK36)-S-32 (denoted as F1 binding) and (20)LDKDLFTEEQ(29) (F2). Further analysis showed that F1 has stronger binding affinity and is more resistant to acidic conditions than is F2. Furthermore, A27 mutant proteins that retained partial activity to interact with the F1 and F2 sites of the A17 protein were packaged into mature virus particles at a reduced level, demonstrating that the F1/F2 interaction plays a critical role in vivo. Using these results in combination with site-directed mutagenesis data, we established a computer model to explain the specific A27-A17 binding mechanism.	[Wang, Da-Rong; Lin, Su-Ching; Yu, Steve S. -F.; Tzou, Der-Lii M.] Acad Sinica, Inst Chem, Taipei, Taiwan; [Hsiao, Jye-Chian; Chang, Wen] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Wong, Chien-Hsuan; Li, Guo-Chian; Chen, Wenlung] Natl Chia Yi Univ, Dept Appl Chem, Chiayi 60004, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Chiayi University	Tzou, DLM (corresponding author), 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	tzougate@gate.sinica.edu.tw	Yu, Steve Sheng-Fa/E-4866-2015; Tzou, Der-Lii M/E-9499-2015; Lin, Su-Ching/E-3571-2015; Chang, Wen/AAA-5076-2021	Yu, Steve Sheng-Fa/0000-0002-3462-065X; Tzou, Der-Lii M/0000-0002-3755-8230; Chang, Wen/0000-0003-3369-083X	Academia Sinica; National Science Council [NSC 100-2113-M-001-016-MY2, NSC 101-2320-B-001-023-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and the National Science Council Grants NSC 100-2113-M-001-016-MY2 (to D.-L. M. T.) and NSC 101-2320-B-001-023-MY3 (to W.C.).	Adamson A. W., 1960, PHYS CHEM SURFACES, P457; Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; BAX A, 1994, METHOD ENZYMOL, V239, P79; Bengali Z, 2012, VIROLOGY, V433, P506, DOI 10.1016/j.virol.2012.08.044; Betakova T, 1999, J VIROL, V73, P3534, DOI 10.1128/JVI.73.5.3534-3543.1999; Betakova T, 2000, J VIROL, V74, P2438, DOI 10.1128/JVI.74.5.2438-2442.2000; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Chang SJ, 2012, J VIROL, V86, P3809, DOI 10.1128/JVI.06081-11; Chang SJ, 2010, J VIROL, V84, P8422, DOI 10.1128/JVI.00599-10; Chang TH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003563; Charles-Whitbeck J, 2009, VIROLOGY, V385, P383, DOI 10.1016/j.virol.2008.12.029; Ching YC, 2009, J VIROL, V83, P6464, DOI 10.1128/JVI.02295-08; Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Chung CS, 2005, J VIROL, V79, P1623, DOI 10.1128/JVI.79.3.1623-1634.2005; DALLO S, 1987, VIROLOGY, V159, P423, DOI 10.1016/0042-6822(87)90481-8; Derrien M, 1999, J VIROL, V73, P7287, DOI 10.1128/JVI.73.9.7287-7296.1999; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; Fass D, 1996, NAT STRUCT BIOL, V3, P465, DOI 10.1038/nsb0596-465; Foo CH, 2009, VIROLOGY, V385, P368, DOI 10.1016/j.virol.2008.12.019; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; GONG SC, 1989, J VIROL, V63, P4507, DOI 10.1128/JVI.63.11.4507-4514.1989; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; Ho Y, 2005, J MOL BIOL, V349, P1060, DOI 10.1016/j.jmb.2005.04.024; Howard AR, 2008, J VIROL, V82, P12384, DOI 10.1128/JVI.01524-08; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998; Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08; Izmailyan R, 2012, J VIROL, V86, P6677, DOI 10.1128/JVI.06860-11; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kay LE, 1997, BIOCHEM CELL BIOL, V75, P1, DOI 10.1139/o97-023; Kochan G, 2008, CELL MICROBIOL, V10, P149, DOI 10.1111/j.1462-5822.2007.01026.x; KrijnseLocker J, 1996, J BIOL CHEM, V271, P14950, DOI 10.1074/jbc.271.25.14950; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lin TH, 2002, J BIOL CHEM, V277, P20949, DOI 10.1074/jbc.M110403200; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Moss B, 2006, VIROLOGY, V344, P48, DOI 10.1016/j.virol.2005.09.037; Moss B., 1996, FIELDS VIROLOGY, P2637; PAYNE L, 1978, J VIROL, V27, P28, DOI 10.1128/JVI.27.1.28-37.1978; Resch W, 2007, VIROLOGY, V358, P233, DOI 10.1016/j.virol.2006.08.025; RODRIGUEZ D, 1993, J VIROL, V67, P3435, DOI 10.1128/JVI.67.6.3435-3440.1993; RODRIGUEZ D, 1995, J VIROL, V69, P4640; Rodriguez D, 1996, J VIROL, V70, P7641; RODRIGUEZ JF, 1990, NUCLEIC ACIDS RES, V18, P5347, DOI 10.1093/nar/18.18.5347; Schroeder N, 2012, J VIROL, V86, P4868, DOI 10.1128/JVI.06610-11; Shih PC, 2009, J BIOL CHEM, V284, P36535, DOI 10.1074/jbc.M109.037267; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; Unger B, 2013, J VIROL, V87, P1083, DOI 10.1128/JVI.02529-12; Vazquez MI, 1998, J VIROL, V72, P10126; Wallengren K, 2001, VIROLOGY, V290, P143, DOI 10.1006/viro.2001.1131; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WHITEHEAD SS, 1994, J VIROL, V68, P7603, DOI 10.1128/JVI.68.11.7603-7608.1994; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Wolffe EJ, 1996, J VIROL, V70, P2797, DOI 10.1128/JVI.70.5.2797-2808.1996; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yoder JD, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-10	59	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6639	6655		10.1074/jbc.M114.547372	http://dx.doi.org/10.1074/jbc.M114.547372			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451374	hybrid, Green Published			2022-12-25	WOS:000332389400028
J	Kim, SJ; Cheresh, P; Williams, D; Cheng, Y; Ridge, K; Schumacker, PT; Weitzman, S; Bohr, VA; Kamp, DW				Kim, Seok-Jo; Cheresh, Paul; Williams, David; Cheng, Yuan; Ridge, Karen; Schumacker, Paul T.; Weitzman, Sigmund; Bohr, Vilhelm A.; Kamp, David W.			Mitochondria-targeted Ogg1 and Aconitase-2 Prevent Oxidant-induced Mitochondrial DNA Damage in Alveolar Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Repair; Epithelial Cell; Fibrosis; Oxidative Stress; Lung Fibrosis; Mitochondrial DNA Damage; Mitochondrial Aconitase; Mitochondrial hOgg1	OXIDATIVE STRESS; SIGNALING PATHWAY; INDUCED APOPTOSIS; REACTIVE OXYGEN; MTDNA DAMAGE; NUCLEAR-DNA; P53; REPAIR; 8-OXOGUANINE; LUNG	Background: Mitochondrial Ogg1 prevents oxidant (H2O2 and asbestos)-induced Aco-2 degradation and apoptosis. Results: Oxidant stress caused preferential AEC mtDNA > nuclear DNA damage, mt-p53 translocation, and apoptosis; effects were blocked by mt-hOgg1 or Aco-2. Conclusion: mt-hOgg1 and Aco-2 preserve AEC mtDNA, preventing oxidant-induced p53 activation and apoptosis. Significance: mt-hOgg1/Aco-2 effects on mtDNA may be an innovative target for preventing degenerative diseases. Mitochondria-targeted human 8-oxoguanine DNA glycosylase (mt-hOgg1) and aconitase-2 (Aco-2) each reduce oxidant-induced alveolar epithelial cell (AEC) apoptosis, but it is unclear whether protection occurs by preventing AEC mitochondrial DNA (mtDNA) damage. Using quantitative PCR-based measurements of mitochondrial and nuclear DNA damage, mtDNA damage was preferentially noted in AEC after exposure to oxidative stress (e.g. amosite asbestos (5-25 g/cm(2)) or H2O2 (100-250 m)) for 24 h. Overexpression of wild-type mt-hOgg1 or mt-long / 317-323 hOgg1 mutant incapable of DNA repair (mt-hOgg1-Mut) each blocked A549 cell oxidant-induced mtDNA damage, mitochondrial p53 translocation, and intrinsic apoptosis as assessed by DNA fragmentation and cleaved caspase-9. In contrast, compared with controls, knockdown of Ogg1 (using Ogg1 shRNA in A549 cells or primary alveolar type 2 cells from ogg1(-/-) mice) augmented mtDNA lesions and intrinsic apoptosis at base line, and these effects were increased further after exposure to oxidative stress. Notably, overexpression of Aco-2 reduced oxidant-induced mtDNA lesions, mitochondrial p53 translocation, and apoptosis, whereas siRNA for Aco-2 (siAco-2) enhanced mtDNA damage, mitochondrial p53 translocation, and apoptosis. Finally, siAco-2 attenuated the protective effects of mt-hOgg1-Mut but not wild-type mt-hOgg1 against oxidant-induced mtDNA damage and apoptosis. Collectively, these data demonstrate a novel role for mt-hOgg1 and Aco-2 in preserving AEC mtDNA integrity, thereby preventing oxidant-induced mitochondrial dysfunction, p53 mitochondrial translocation, and intrinsic apoptosis. Furthermore, mt-hOgg1 chaperoning of Aco-2 in preventing oxidant-mediated mtDNA damage and apoptosis may afford an innovative target for the molecular events underlying oxidant-induced toxicity.	[Kim, Seok-Jo; Cheresh, Paul; Williams, David; Cheng, Yuan; Ridge, Karen; Kamp, David W.] Jesse Brown Vet Affairs Med Ctr, Div Pulm & Crit Care Med, Dept Med, Chicago, IL 60611 USA; [Kim, Seok-Jo; Cheresh, Paul; Williams, David; Cheng, Yuan; Ridge, Karen; Kamp, David W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Schumacker, Paul T.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Weitzman, Sigmund] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Baltimore, MD 21224 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kamp, DW (corresponding author), Northwestern Univ, Feinberg Sch Med, McGaw M-330,240 E Huron St, Chicago, IL 60611 USA.	d-kamp@northwestern.edu	Bohr, Vilhelm/AAP-5931-2020	Schumacker, Paul T/0000-0001-9591-2034	National Institutes of Health [RO1 ES020357, P01HL071643]; Veterans Affairs Merit Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, R01HL079190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000727, ZIAAG000733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES020357 (to D. W. K.) and P01HL071643 (to K. R.). This work was also supported by a Veterans Affairs Merit Award (to D. W. K.).	Amaral JD, 2010, DISCOV MED, V9, P145; Arai T, 2002, CARCINOGENESIS, V23, P2005, DOI 10.1093/carcin/23.12.2005; Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7; Boldogh I, 2012, J BIOL CHEM, V287, P20769, DOI 10.1074/jbc.C112.364620; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Cheresh P, 2013, BBA-MOL BASIS DIS, V1832, P1028, DOI 10.1016/j.bbadis.2012.11.021; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Ding ZF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01077; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Dobson AW, 2002, AM J PHYSIOL-LUNG C, V283, pL205, DOI 10.1152/ajplung.00443.2001; Essmann F, 2005, J BIOL CHEM, V280, P37169, DOI 10.1074/jbc.M502052200; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Grishko V, 2001, AM J PHYSIOL-LUNG C, V280, pL1300, DOI 10.1152/ajplung.2001.280.6.L1300; Hajas G, 2013, FREE RADICAL BIO MED, V61, P384, DOI 10.1016/j.freeradbiomed.2013.04.011; Hashiguchi K, 2004, NUCLEIC ACIDS RES, V32, P5596, DOI 10.1093/nar/gkh863; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Kamp DW, 2013, AM J RESP CELL MOL, V49, P892, DOI 10.1165/rcmb.2013-0053OC; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Koczor CA, 2013, MITOCHONDRION, V13, P277, DOI 10.1016/j.mito.2013.03.001; Laing S, 2010, AM J PHYSIOL-CELL PH, V299, pC736, DOI 10.1152/ajpcell.00529.2009; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lim S, 2011, CELL PHYSIOL BIOCHEM, V28, P873, DOI 10.1159/000335802; Liu G, 2013, ANNU REV PATHOL-MECH, V8, P161, DOI 10.1146/annurev-pathol-020712-163942; Ma WW, 2013, NEUROCHEM RES, V38, P1315, DOI 10.1007/s11064-013-1019-y; Mambo E, 2005, ONCOGENE, V24, P4496, DOI 10.1038/sj.onc.1208669; Nantajit D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012341; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Panduri V, 2006, AM J RESP CELL MOL, V34, P443, DOI 10.1165/rcmb.2005-0352OC; Panduri V, 2004, AM J PHYSIOL-LUNG C, V286, pL1220, DOI 10.1152/ajplung.00371.2003; Panduri V, 2003, AM J RESP CELL MOL, V28, P241, DOI 10.1165/rcmb.4903; Panduri V, 2009, FREE RADICAL BIO MED, V47, P750, DOI 10.1016/j.freeradbiomed.2009.06.010; Paz-Elizur T, 2003, J NATL CANCER I, V95, P1312, DOI 10.1093/jnci/djg033; Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Roepke M, 2007, CANCER BIOL THER, V6, P160, DOI 10.4161/cbt.6.2.3575; Ruchko M, 2005, AM J PHYSIOL-LUNG C, V288, pL530, DOI 10.1152/ajplung.00255.2004; Ruchko MV, 2011, FREE RADICAL BIO MED, V50, P1107, DOI 10.1016/j.freeradbiomed.2010.10.692; Sakumi K, 2003, CANCER RES, V63, P902; Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Shukla A, 2003, AM J PHYSIOL-LUNG C, V285, pL1018, DOI 10.1152/ajplung.00038.2003; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Tsui KH, 2011, PROSTATE, V71, P62, DOI 10.1002/pros.21222; Tsutsui H, 2001, INTERNAL MED, V40, P1177, DOI 10.2169/internalmedicine.40.1177; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wang JX, 2011, AM J PHYSIOL-HEART C, V301, pH2073, DOI 10.1152/ajpheart.00157.2011; Wang W, 2011, J NEUROSCI, V31, P9746, DOI 10.1523/JNEUROSCI.0852-11.2011; Wu M, 2008, ENVIRON MOL MUTAGEN, V49, P265, DOI 10.1002/em.20381; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Youn CK, 2007, MOL CANCER RES, V5, P1083, DOI 10.1158/1541-7786.MCR-06-0432; Yuzefovych LV, 2013, ENDOCRINOLOGY, V154, P2640, DOI 10.1210/en.2013-1076	60	70	74	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6165	6176		10.1074/jbc.M113.515130	http://dx.doi.org/10.1074/jbc.M113.515130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24429287	Green Published, hybrid			2022-12-25	WOS:000332015500070
J	Sahar, S; Masubuchi, S; Eckel-Mahan, K; Vollmer, S; Galla, L; Ceglia, N; Masri, S; Barth, TK; Grimaldi, B; Oluyemi, O; Astarita, G; Hallows, WC; Piomelli, D; Imhof, A; Baldi, P; Denu, JM; Sassone-Corsi, P				Sahar, Saurabh; Masubuchi, Satoru; Eckel-Mahan, Kristin; Vollmer, Simone; Galla, Luisa; Ceglia, Nicholas; Masri, Selma; Barth, Teresa K.; Grimaldi, Benedetto; Oluyemi, Opeyemi; Astarita, Giuseppe; Hallows, William C.; Piomelli, Daniele; Imhof, Axel; Baldi, Pierre; Denu, John M.; Sassone-Corsi, Paolo			Circadian Control of Fatty Acid Elongation by SIRT1 Protein-mediated Deacetylation of Acetyl-coenzyme A Synthetase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Circadian Clock; Gene Regulation; Post-translational Modification; Signal Transduction; SIRT1	REV-ERB-ALPHA; HISTONE ACETYLATION; CELL-GROWTH; METABOLISM; CLOCK; COA; BEHAVIOR; DISEASE; BETA; PROLIFERATION	Background: Circadian clock regulates various aspects of metabolism. Results: Rhythmic acetylation of AceCS1 controls circadian oscillations in acetyl-CoA levels and in fatty acid elongation. Conclusion: A previously unrecognized regulation of acetyl-CoA provides additional evidence to circadian regulation of metabolism. Significance: Understanding of the role of acetyl-CoA in fatty acid elongation might provide therapeutic benefits for treating metabolic diseases and cancer. The circadian clock regulates a wide range of physiological and metabolic processes, and its disruption leads to metabolic disorders such as diabetes and obesity. Accumulating evidence reveals that the circadian clock regulates levels of metabolites that, in turn, may regulate the clock. Here we demonstrate that the circadian clock regulates the intracellular levels of acetyl-CoA by modulating the enzymatic activity of acetyl-CoA Synthetase 1 (AceCS1). Acetylation of AceCS1 controls the activity of the enzyme. We show that acetylation of AceCS1 is cyclic and that its rhythmicity requires a functional circadian clock and the NAD(+)-dependent deacetylase SIRT1. Cyclic acetylation of AceCS1 contributes to the rhythmicity of acetyl-CoA levels both in vivo and in cultured cells. Down-regulation of AceCS1 causes a significant decrease in the cellular acetyl-CoA pool, leading to reduction in circadian changes in fatty acid elongation. Thus, a nontranscriptional, enzymatic loop is governed by the circadian clock to control acetyl-CoA levels and fatty acid synthesis.	[Sahar, Saurabh; Masubuchi, Satoru; Eckel-Mahan, Kristin; Galla, Luisa; Masri, Selma; Grimaldi, Benedetto; Sassone-Corsi, Paolo] Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Vollmer, Simone; Barth, Teresa K.; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, Munich Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Ceglia, Nicholas; Baldi, Pierre] Univ Calif Irvine, Inst Genom & Bioinformat, Dept Comp Sci, Irvine, CA 92697 USA; [Oluyemi, Opeyemi; Astarita, Giuseppe; Piomelli, Daniele] Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92697 USA; [Hallows, William C.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Astarita, Giuseppe] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA	University of California System; University of California Irvine; University of Munich; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Wisconsin System; University of Wisconsin Madison; Georgetown University	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92697 USA.	psc@uci.edu	Astarita, Giuseppe/AAD-1239-2019; Imhof, Axel/AAU-5313-2021; Astarita, Giuseppe/N-7346-2014	Imhof, Axel/0000-0003-2993-8249; Astarita, Giuseppe/0000-0001-6700-301X; Eckel-Mahan, Kristin/0000-0001-8201-1675; Grimaldi, Benedetto/0000-0002-2589-9302; Galla, Luisa/0000-0001-8160-6052; Masri, Selma/0000-0002-8619-8331	National Institutes of Health; Institut de la Sante et de la Recherche Medicale (France); Sirtris Pharmaceutical Inc.; Bavarian-Californian Technology Center (BaCaTeC); Deutsche Forschungsgemeinschaft; National Institutes of Health Ruth L. Kirschstein postdoctoral fellowships; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, R37GM059785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Sirtris Pharmaceutical Inc.; Bavarian-Californian Technology Center (BaCaTeC); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health Ruth L. Kirschstein postdoctoral fellowships(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Sassone-Corsi laboratory was supported by the National Institutes of Health, the Institut de la Sante et de la Recherche Medicale (France), and Sirtris Pharmaceutical Inc. Work in the Imhof laboratory was supported by the Bavarian-Californian Technology Center (BaCaTeC) and the Deutsche Forschungsgemeinschaft.; Supported by National Institutes of Health Ruth L. Kirschstein postdoctoral fellowships.	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Cen Y, 2011, CURR MED CHEM, V18, P1919, DOI 10.2174/092986711795590084; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chu KY, 2010, J BIOL CHEM, V285, P32606, DOI 10.1074/jbc.M110.157172; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hayashi O, 2006, BIOSCI BIOTECH BIOCH, V70, P2676, DOI 10.1271/bbb.60269; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Langer MR, 2002, J BIOL CHEM, V277, P27337, DOI 10.1074/jbc.M203251200; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Partch CL, 2013, TRENDS CELL BIOL; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Shimazu T, 2010, MECH AGEING DEV, V131, P511, DOI 10.1016/j.mad.2010.05.001; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang QO, 2010, J LIPID RES, V51, P2516, DOI 10.1194/jlr.M003335; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x	40	55	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6091	6097		10.1074/jbc.M113.537191	http://dx.doi.org/10.1074/jbc.M113.537191			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425865	Green Published, hybrid			2022-12-25	WOS:000332015500063
J	Patelis, A; Gunnbjornsdottir, M; Borres, MP; Burney, P; Gislason, T; Toren, K; Forsberg, B; Alving, K; Malinovschi, A; Janson, C				Patelis, Antonios; Gunnbjornsdottir, Maria; Borres, Magnus P.; Burney, Peter; Gislason, Thorarinn; Toren, Kjell; Forsberg, Bertil; Alving, Kjell; Malinovschi, Andrei; Janson, Christer			Natural History of Perceived Food Hypersensitivity and IgE Sensitisation to Food Allergens in a Cohort of Adults	PLOS ONE			English	Article							RESPIRATORY-HEALTH-SURVEY; SKIN-TEST REACTIVITY; HOUSE-DUST MITE; SERUM IGE; CHILDHOOD ASTHMA; IMMUNOGLOBULIN-E; NITRIC-OXIDE; PREVALENCE; POPULATION; CHILDREN	Background: No longitudinal studies exist on the natural history of food hypersensitivity and IgE sensitisation to food allergens in adults. Objective: To examine the natural history of food hypersensitivity, the natural history of IgE sensitisation to food allergens and to investigate the risk factors for new onset food hypersensitivity. Methods: Food hypersensitivity was questionnaire-assessed in 2307 individuals (aged 20-45 years) from Iceland and Sweden during the European Community Respiratory Health Survey both at baseline and follow-up 9 years later. IgE food and aeroallergen sensitisation were assessed in a subgroup of these individuals (n = 807). Values of 0.35 kU/L and above were regarded as positive sensitisation. Results: Food hypersensitivity was reported by 21% of the subjects and this proportion remained unchanged at follow-up (p = 0.58). Fruits, nuts and vegetables were the three most common causes of food hypersensitivity, with a similar prevalence at baseline and follow-up. The prevalence IgE sensitisation to food allergens decreased in general by 56% (p < 0.001) and IgE sensitisation to peanut decreased in particular by 67% (p = 0.003). The prevalence of timothy grass IgE sensitisation decreased by 15% (p = 0.003) while cat, mite and birch IgE sensitisation did not decrease significantly. Female sex, rhinitis, eczema and presence of IgE sensitisation to aeroallergens were independently associated with new onset food hypersensitivity. Conclusion: The prevalence of food hypersensitivity remained unchanged while the prevalence of IgE sensitisation to food allergens decreased in adults over a 9-year follow-up period. The decrease in prevalence of IgE sensitisation to food allergens was considerably larger than the change in prevalence of IgE sensitisation to aeroallergens.	[Patelis, Antonios; Gunnbjornsdottir, Maria; Janson, Christer] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; [Borres, Magnus P.] Thermo Fischer Sci, Immunodiagnost, Uppsala, Sweden; [Gislason, Thorarinn] Univ Iceland, Fac Med, Reykjavik, Iceland; [Gislason, Thorarinn] Landspitali Univ Hosp, Dept Resp Med & Sleep, Reykjavik, Iceland; [Toren, Kjell] Univ Gothenburg, Inst Med, Sect Occupat & Environm Med, Gothenburg, Sweden; [Forsberg, Bertil] Umea Univ, Div Occupat & Environm Med, Umea, Sweden; [Borres, Magnus P.; Alving, Kjell] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Burney, Peter] Univ London Imperial Coll Sci Technol & Med, London, England; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden	Uppsala University; University of Iceland; Landspitali National University Hospital; University of Gothenburg; Umea University; Uppsala University; Imperial College London; Uppsala University	Patelis, A (corresponding author), Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden.	antonios.patelis@medsci.uu.se	; Alving, Kjell/M-4579-2014	Burney, Peter/0000-0001-8635-5678; Patelis, Antonios/0000-0001-7837-1862; Alving, Kjell/0000-0003-0784-0443	Swedish Heart and Lung Foundation; Vardal Foundation for Health Care Science and Allergy Research; Swedish Association against Asthma and Allergy; Agnes and Mac Rudberg's Foundation; Bror Hjerpstedt Foundation	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Vardal Foundation for Health Care Science and Allergy Research; Swedish Association against Asthma and Allergy; Agnes and Mac Rudberg's Foundation; Bror Hjerpstedt Foundation	This study was supported financially by the Swedish Heart and Lung Foundation, the Vardal Foundation for Health Care Science and Allergy Research, the Swedish Association against Asthma and Allergy, Agnes and Mac Rudberg's Foundation and the Bror Hjerpstedt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DR, 1996, J ALLERGY CLIN IMMUN, V97, P1247, DOI 10.1016/S0091-6749(96)70192-6; BARBEE RA, 1987, J ALLERGY CLIN IMMUN, V79, P919, DOI 10.1016/0091-6749(87)90241-7; BARBEE RA, 1987, J ALLERGY CLIN IMMUN, V79, P16, DOI 10.1016/S0091-6749(87)80010-6; Bjornsson E, 1996, ANN ALLERG ASTHMA IM, V77, P327; BOUSQUET J, 1990, J ALLERGY CLIN IMMUN, V85, P1039, DOI 10.1016/0091-6749(90)90048-9; Broadfield E, 2002, J ALLERGY CLIN IMMUN, V109, P969, DOI 10.1067/mai.2002.124772; Burney P, 2010, ALLERGY, V65, P1182, DOI 10.1111/j.1398-9995.2010.02346.x; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Carsin AE, 2013, INT ARCH ALLERGY IMM, V160, P387, DOI 10.1159/000342464; Eggesbo M, 1999, PEDIATR ALLERGY IMMU, V10, P122, DOI 10.1034/j.1399-3038.1999.00022.x; European Community Respiratory Health Survey IISC, 2002, EUR RESP J, V20, P1071; Gislason D, 1999, ALLERGY, V54, P1160, DOI 10.1034/j.1398-9995.1999.00093.x; Hughes JL, 2010, PEDIAT ALLERG IMM-UK, V21, P1107, DOI 10.1111/j.1399-3038.2010.01071.x; Jackola DR, 2004, HUM IMMUNOL, V65, P20, DOI 10.1016/j.humimm.2003.10.012; Jarvis D, 2005, J ALLERGY CLIN IMMUN, V116, P675, DOI 10.1016/j.jaci.2005.05.009; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Karakaya G, 2006, Allergol Immunopathol (Madr), V34, P257; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Linneberg A, 2002, CLIN EXP ALLERGY, V32, P1702, DOI 10.1046/j.1365-2222.2002.01537.x; Linneberg A, 2010, INT ARCH ALLERGY IMM, V151, P142, DOI 10.1159/000236004; Linneberg A, 2000, J ALLERGY CLIN IMMUN, V106, P247, DOI 10.1067/mai.2000.108312; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Malinovschi A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-92; Olafsdottir IS, 2005, THORAX, V60, P451, DOI 10.1136/thx.2004.035774; ORYSZCZYN MP, 1995, AM J RESP CRIT CARE, V151, P663; Paganelli R, 1998, ALLERGY, V53, P763; Patelis A, 2012, J ALLERGY CLIN IMMUN, V130, P397, DOI 10.1016/j.jaci.2012.03.046; Peat JK, 1996, AM J RESP CRIT CARE, V153, P141, DOI 10.1164/ajrccm.153.1.8542107; Ramesh S, 2008, CLIN REV ALLERG IMMU, V34, P217, DOI 10.1007/s12016-007-8034-1; RAWLE FC, 1983, CLIN ALLERGY, V13, P409, DOI 10.1111/j.1365-2222.1983.tb02616.x; Sampson HA, 1996, PEDIAT ALLERG IMM-UK, V7, P42, DOI 10.1111/j.1399-3038.1996.tb00394.x; Schafer T, 2001, ALLERGY, V56, P1172, DOI 10.1034/j.1398-9995.2001.00196.x; SEARS MR, 1989, CLIN EXP ALLERGY, V19, P419, DOI 10.1111/j.1365-2222.1989.tb02408.x; Sherrill DL, 1999, J ALLERGY CLIN IMMUN, V104, P28, DOI 10.1016/S0091-6749(99)70110-7; Sicherer SH, 2013, J ALLERGY CLIN IMMUN, V131, P55, DOI 10.1016/j.jaci.2012.11.007; Skypala I, 2011, J AM DIET ASSOC, V111, P1877, DOI 10.1016/j.jada.2011.09.001; SPORIK R, 1995, AM J RESP CRIT CARE, V151, P1388, DOI 10.1164/ajrccm.151.5.7735590; TAYLOR SL, 1986, J AM DIET ASSOC, V86, P599; Warm K, 2012, J ALLERGY CLIN IMMUN, V129, P136, DOI 10.1016/j.jaci.2011.08.033; Woods RK, 2001, EUR J CLIN NUTR, V55, P298, DOI 10.1038/sj.ejcn.1601159; YOUNG E, 1994, LANCET, V343, P1127, DOI 10.1016/S0140-6736(94)90234-8	41	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85333	10.1371/journal.pone.0085333	http://dx.doi.org/10.1371/journal.pone.0085333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427301	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200042
J	Curciarello, R; Smaldini, PL; Candreva, AM; Gonzalez, V; Parisi, G; Cauerhff, A; Barrios, I; Blanch, LB; Fossati, CA; Petruccelli, S; Docena, GH				Curciarello, Renata; Smaldini, Paola L.; Candreva, Angela M.; Gonzalez, Virginia; Parisi, Gustavo; Cauerhff, Ana; Barrios, Ivana; Bruno Blanch, Luis; Fossati, Carlos A.; Petruccelli, Silvana; Docena, Guillermo H.			Targeting a Cross-Reactive Gly m 5 Soy Peptide as Responsible for Hypersensitivity Reactions in a Milk Allergy Mouse Model	PLOS ONE			English	Article							IGG-BINDING EPITOPES; COWS MILK; BETA-CONGLYCININ; SECONDARY-STRUCTURE; FOOD ALLERGY; ALPHA-SUBUNIT; PROTEIN; PREDICTION; IDENTIFICATION; SEQUENCE	Background: Cross-reactivity between soybean allergens and bovine caseins has been previously reported. In this study we aimed to map epitopes of the major soybean allergen Gly m 5 that are co-recognized by casein specific antibodies, and to identify a peptide responsible for the cross-reactivity. Methods: Cow's milk protein (CMP)-specific antibodies were used in different immunoassays (immunoblotting, ELISA, ELISA inhibition test) to evaluate the in vitro recognition of soybean proteins (SP). Recombinant Gly m 5 (alpha), a truncated fragment containing the C-terminal domain (alpha-T) and peptides of alpha-T were obtained and epitope mapping was performed with an overlapping peptide assay. Bioinformatics tools were used for epitope prediction by sequence alignment, and for modelling the cross-recognized soy proteins and peptides. The binding of SP to a monoclonal antibody was studied by surface Plasmon resonance (SPR). Finally, the in vivo cross-recognition of SP was assessed in a mouse model of milk allergy. Results: Both alpha and alpha-T reacted with the different CMP-specific antibodies. alpha-T contains IgG and IgE epitopes in several peptides, particularly in the peptide named PA. Besides, we found similar values of association and dissociation constants between the alpha-casein specific mAb and the different milk and soy components. The food allergy mouse model showed that SP and PA contain the cross-reactive B and T epitopes, which triggered hypersensitivity reactions and a Th2-mediated response on CMP-sensitized mice. Conclusions: Gly m 5 is a cross-reactive soy allergen and the alpha-T portion of the molecule contains IgG and IgE immunodominant epitopes, confined to PA, a region with enough conformation to be bound by antibodies. These findings contribute to explain the intolerance to SP observed in IgE-mediated CMA patients, primarily not sensitised to SP, as well as it sets the basis to propose a mucosal immunotherapy for milk allergy using this soy peptide.	[Curciarello, Renata; Smaldini, Paola L.; Candreva, Angela M.; Fossati, Carlos A.; Docena, Guillermo H.] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, Buenos Aires, DF, Argentina; [Gonzalez, Virginia; Parisi, Gustavo] Univ Nacl Quilmes, Dept Ciencias & Tecnol, Ctr Estudios & Invest, Buenos Aires, DF, Argentina; [Cauerhff, Ana] UNLP, Ctr Invest & Desarrollo Fermentac Ind, CINDEFI, Buenos Aires, DF, Argentina; [Cauerhff, Ana] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Cauerhff, Ana] Fdn Inst Leloir, CONICET, IIBBA, Buenos Aires, DF, Argentina; [Barrios, Ivana; Bruno Blanch, Luis] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Catedra Quim Med, Buenos Aires, DF, Argentina; [Curciarello, Renata; Candreva, Angela M.; Petruccelli, Silvana; Docena, Guillermo H.] Univ Nacl La Plata, Fac Ciencias Exactas, CIDCA, Buenos Aires, DF, Argentina	National University of La Plata; National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Docena, GH (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, Buenos Aires, DF, Argentina.	guidoc@biol.unlp.edu.ar	Petruccelli, Silvana/A-3083-2012; Petruccelli, Silvana/AAC-6826-2019	Petruccelli, Silvana/0000-0002-7072-0076; Petruccelli, Silvana/0000-0002-7072-0076; parisi, gustavo/0000-0001-7444-1624; Smaldini, Paola/0000-0002-2734-516X; Cauerhff, Ana/0000-0001-9686-9883; Gonzalez, Virginia/0000-0002-1725-001X; Candreva, Angela Maria/0000-0002-3407-9904	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET) [PIP 5475]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2007-0049, PICT 2010-2366, PICT 2008-2202]; Universidad Nacional de La Plata, Argentina [X498, X455]	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de La Plata, Argentina(National University of La Plata)	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET) (grant PIP 5475), by Agencia Nacional de Promocion Cientifica y Tecnologica (grants PICT2007-0049 and PICT 2010-2366 to SP, PICT 2008-2202 to GHD) and by Universidad Nacional de La Plata, Argentina (grants X498 to SP and X455 to CAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2006, J PEDIATR GASTR NUTR, V42, P352, DOI 10.1097/01.mpg.0000189358.38427.cd; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ballmer-Weber BK, 2007, J ALLERGY CLIN IMMUN, V119, P1489, DOI 10.1016/j.jaci.2007.01.049; Bhatia J, 2008, PEDIATRICS, V121, P1062, DOI 10.1542/peds.2008-0564; Cerecedo I, 2008, J ALLERGY CLIN IMMUN, V122, P589, DOI 10.1016/j.jaci.2008.06.040; Ceska M, 1981, Methods Enzymol, V73, P646; Chatchatee P, 2001, J ALLERGY CLIN IMMUN, V107, P379, DOI 10.1067/mai.2001.112372; Chatchatee P, 2001, CLIN EXP ALLERGY, V31, P1256, DOI 10.1046/j.1365-2222.2001.01167.x; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cocco RR, 2003, J ALLERGY CLIN IMMUN, V112, P433, DOI 10.1067/mai.2003.1617; Codina R, 2002, CLIN EXP ALLERGY, V32, P1059, DOI 10.1046/j.1365-2222.2002.01411.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; COOK CD, 1960, NEW ENGL J MED, V263, P1076, DOI 10.1056/NEJM196011242632109; Curciarello R, 2008, CLIN EXP ALLERGY, V38, P1559, DOI 10.1111/j.1365-2222.2008.03062.x; Docena G, 2002, ALLERGY, V57, P83, DOI 10.1034/j.1398-9995.2002.1o3219.x; Docena GH, 1996, ALLERGY, V51, P412, DOI 10.1111/j.1398-9995.1996.tb04639.x; Dupont Christophe, 2011, Ann Nutr Metab, V59 Suppl 1, P8, DOI 10.1159/000334145; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Fiocchi A, 2010, PEDIAT ALLERG IMM-UK, V21, P1, DOI [10.1111/j.1399-3038.2010.01068.x, 10.1097/WOX.0b013e3181defeb9]; Fu CJJ, 2007, J AGR FOOD CHEM, V55, P4014, DOI 10.1021/jf070211o; Handlogten MW, 2012, ACS CHEM BIOL, V7, P1796, DOI 10.1021/cb300193f; Holzhauser T, 2009, J ALLERGY CLIN IMMUN, V123, P452, DOI 10.1016/j.jaci.2008.09.034; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Klemola T, 2002, J PEDIATR-US, V140, P219, DOI 10.1067/mpd.2002.121935; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Koletzko S, 2012, J PEDIATR GASTR NUTR, V55, P221, DOI 10.1097/MPG.0b013e31825c9482; Krishnan HB, 2009, J AGR FOOD CHEM, V57, P938, DOI 10.1021/jf802451g; Marti-Renom MA, 2002, STRUCTURE, V10, P435, DOI 10.1016/S0969-2126(02)00731-1; Mills ENC, 2002, BIOCHEM SOC T, V30, P925, DOI 10.1042/BST0300925; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; OGAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P831, DOI 10.1271/bbb.59.831; Ogawa T, 2000, J NUTR SCI VITAMINOL, V46, P271, DOI 10.3177/jnsv.46.271; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Petrucelli S, FOOD AGR IMMUNOL, V16, P17; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Rozenfeld P, 2002, CLIN EXP IMMUNOL, V130, P49, DOI 10.1046/j.1365-2249.2002.t01-1-01935.x; Sicherer SH, 2011, MT SINAI J MED, V78, P683, DOI 10.1002/msj.20292; Smaldini P, 2012, INT ARCH ALLERGY IMM, V158, P335, DOI 10.1159/000333562; Vila L, 2001, CLIN EXP ALLERGY, V31, P1599, DOI 10.1046/j.1365-2222.2001.01218.x; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zeiger RS, 1999, J PEDIATR-US, V134, P614, DOI 10.1016/S0022-3476(99)70249-0	47	16	16	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e82341	10.1371/journal.pone.0082341	http://dx.doi.org/10.1371/journal.pone.0082341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416141	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300010
J	Cavanagh, DR; Kocken, CHM; White, JH; Cowan, GJM; Samuel, K; Dubbeld, MA; Voorberg-van der Wel, A; Thomas, AW; McBride, JS; Arnot, DE				Cavanagh, David R.; Kocken, Clemens H. M.; White, John H.; Cowan, Graeme J. M.; Samuel, Kay; Dubbeld, Martin A.; Voorberg-van der Wel, Annemarie; Thomas, Alan W.; McBride, Jana S.; Arnot, David E.			Antibody Responses to a Novel Plasmodium falciparum Merozoite Surface Protein Vaccine Correlate with Protection against Experimental Malaria Infection in Aotus Monkeys	PLOS ONE			English	Article							ANTIGENIC POLYMORPHISM; SEQUENCE DIVERSITY; CRITICAL PATH; C-TERMINUS; PARASITE; ADJUVANT; EFFICACY; IMMUNIZATION; IMMUNITY; BLOCK-2	The Block 2 region of the merozoite surface protein-1 (MSP-1) of Plasmodium falciparum has been identified as a target of protective immunity by a combination of seroepidemiology and parasite population genetics. Immunogenicity studies in small animals and Aotus monkeys were used to determine the efficacy of recombinant antigens derived from this region of MSP-1 as a potential vaccine antigen. Aotus lemurinus griseimembra monkeys were immunized three times with a recombinant antigen derived from the Block 2 region of MSP-1 of the monkey-adapted challenge strain, FVO of Plasmodium falciparum, using an adjuvant suitable for use in humans. Immunofluorescent antibody assays (IFA) against erythrocytes infected with P. falciparum using sera from the immunized monkeys showed that the MSP-1 Block 2 antigen induced significant antibody responses to whole malaria parasites. MSP-1 Block 2 antigen-specific enzyme-linked immunosorbent assays (ELISA) showed no significant differences in antibody titers between immunized animals. Immunized animals were challenged with the virulent P. falciparum FVO isolate and monitored for 21 days. Two out of four immunized animals were able to control their parasitaemia during the follow-up period, whereas two out of two controls developed fulminating parasitemia. Parasite-specific serum antibody titers measured by IFA were four-fold higher in protected animals than in unprotected animals. In addition, peptide-based epitope mapping of serum antibodies from immunized Aotus showed distinct differences in epitope specificities between protected and unprotected animals.	[Cavanagh, David R.; White, John H.; Cowan, Graeme J. M.; McBride, Jana S.; Arnot, David E.] Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Kocken, Clemens H. M.; Dubbeld, Martin A.; Voorberg-van der Wel, Annemarie; Thomas, Alan W.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Samuel, Kay] Univ Edinburgh, Scottish Natl Blood Transfus Serv, Cell Therapy Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Cavanagh, DR (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Ashworth Labs, Edinburgh, Midlothian, Scotland.	david.cavanagh@ed.ac.uk	Cowan, Graeme/F-2842-2011; Arnot, David/S-1984-2019	Cowan, Graeme/0000-0002-1949-4253; Arnot, David/0000-0002-3027-1130; Kocken, Clemens/0000-0002-4784-1734; Voorberg - van der Wel, Annemarie/0000-0001-9403-0515; Cavanagh, David/0000-0003-4360-2637	Commission of the European Union [QLK2-CT-2002-01197]	Commission of the European Union(European Commission)	The work was supported by a grant from the Commission of the European Union (QLK2-CT-2002-01197) to the EUROMALVAC2 consortium, coordinated by David Arnot. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aucouturier J, 2006, VACCINE, V24, pS44, DOI 10.1016/j.vaccine.2005.01.116; Baruch DI, 2002, P NATL ACAD SCI USA, V99, P3860, DOI 10.1073/pnas.022018399; Bejon P, 2013, LANCET INFECT DIS, V13, P319, DOI 10.1016/S1473-3099(13)70005-7; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; BREWER JM, 1994, VACCINE, V12, P613, DOI 10.1016/0264-410X(94)90265-8; Burghaus PA, 1996, INFECT IMMUN, V64, P3614, DOI 10.1128/IAI.64.9.3614-3619.1996; Cavanagh DR, 1997, MOL BIOCHEM PARASIT, V85, P197, DOI 10.1016/S0166-6851(96)02826-5; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Cavanagh DR, 2001, INFECT IMMUN, V69, P1207, DOI 10.1128/IAI.69.2.1207-1211.2001; Cavanagh DR, 1998, J IMMUNOL, V161, P347; COLLINS WE, 1992, MEM I OSWALDO CRUZ, V87, P401, DOI 10.1590/S0074-02761992000700068; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; Cowan GJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026616; Dutta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008138; FENTON B, 1991, MOL CELL BIOL, V11, P963, DOI 10.1128/MCB.11.2.963; Galamo CD, 2009, J INFECT DIS, V199, P1151, DOI 10.1086/597426; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Gozalo AS, 2007, COMPARATIVE MED, V57, P396; Heppner DG, 2001, TRENDS PARASITOL, V17, P419, DOI 10.1016/S1471-4922(01)02012-8; HERRERA MA, 1992, INFECT IMMUN, V60, P154, DOI 10.1128/IAI.60.1.154-158.1992; Herrera S, 2002, INT J PARASITOL, V32, P1625, DOI 10.1016/S0020-7519(02)00191-1; HERRERA S, 1992, AM J TROP MED HYG, V47, P682, DOI 10.4269/ajtmh.1992.47.682; Hisaeda H, 2002, J INFECT DIS, V185, P657, DOI 10.1086/339187; HOLDER AA, 1985, NATURE, V317, P270, DOI 10.1038/317270a0; HOLDER AA, 1987, PARASITOLOGY, V94, P199, DOI 10.1017/S0031182000053889; HUI GSN, 1992, INFECT IMMUN, V60, P1422, DOI 10.1128/IAI.60.4.1422-1433.1992; Jiang GF, 2000, ACTA TROP, V74, P51, DOI 10.1016/S0001-706X(99)00045-5; Jones TR, 2001, J INFECT DIS, V183, P303, DOI 10.1086/317933; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; Jouin H, 2001, EUR J IMMUNOL, V31, P539, DOI 10.1002/1521-4141(200102)31:2&lt;539::AID-IMMU539&gt;3.0.CO;2-1; KUMAR S, 1995, MOL MED, V1, P325, DOI 10.1007/BF03401557; Kumar S, 2000, INFECT IMMUN, V68, P2215, DOI 10.1128/IAI.68.4.2215-2223.2000; Locher CP, 1996, EXP PARASITOL, V84, P74, DOI 10.1006/expr.1996.0091; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Makobongo MO, 2006, J INFECT DIS, V193, P731, DOI 10.1086/500150; Malaga CA, 2004, J MED PRIMATOL, V33, P109, DOI 10.1111/j.1600-0684.2004.00060.x; Mawili-Mboumba DP, 2003, J INFECT DIS, V187, P1137, DOI 10.1086/368414; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; MCBRIDE JS, 1985, J EXP MED, V161, P160, DOI 10.1084/jem.161.1.160; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Otsyula N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-29; Pink J Richard, 2004, Vaccine, V22, P2097, DOI 10.1016/j.vaccine.2004.01.021; Polley SD, 2003, INFECT IMMUN, V71, P1833, DOI 10.1128/IAI.71.4.1833-1842.2003; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; PYE D, 1991, INFECT IMMUN, V59, P2403, DOI 10.1128/IAI.59.7.2403-2411.1991; Rono J, 2013, CLIN INFECT DIS, V57, P1409, DOI 10.1093/cid/cit556; SCHMIDT LH, 1978, AM J TROP MED HYG, V27, P671, DOI 10.4269/ajtmh.1978.27.671; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; SIDDIQUI WA, 1986, INFECT IMMUN, V52, P314, DOI 10.1128/IAI.52.1.314-318.1986; SIDDIQUI WA, 1987, P NATL ACAD SCI USA, V84, P3014, DOI 10.1073/pnas.84.9.3014; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stoute JA, 2007, VACCINE, V25, P176, DOI 10.1016/j.vaccine.2005.11.037; Stowers AW, 2002, P NATL ACAD SCI USA, V99, P339, DOI 10.1073/pnas.012590199; Stowers AW, 2001, TRENDS PARASITOL, V17, P415, DOI 10.1016/S1471-4922(01)02011-6; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Tetteh KKA, 2005, INFECT IMMUN, V73, P5928, DOI 10.1128/IAI.73.9.5928-5935.2005; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Tsuji M, 2001, BIOL CHEM, V382, P553, DOI 10.1515/BC.2001.069; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006	67	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83704	10.1371/journal.pone.0083704	http://dx.doi.org/10.1371/journal.pone.0083704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421900	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500066
J	Durso, DF; Bydlowski, SP; Hutz, MH; Suarez-Kurtz, G; Magalhaes, TR; Pena, SDJ				Durso, Danielle Fernandes; Bydlowski, Sergio Paulo; Hutz, Mara Helena; Suarez-Kurtz, Guilherme; Magalhaes, Tiago R.; Junho Pena, Sergio Danilo			Association of Genetic Variants with Self-Assessed Color Categories in Brazilians	PLOS ONE			English	Article							HUMAN PIGMENTATION; GENOMIC ANCESTRY; SKIN COLOR; TRANSPORTER PROTEIN; POPULATION; SLC24A5; PHENOTYPE; GENOTYPE; POLYMORPHISMS; DETERMINANTS	The Brazilian population was formed by extensive admixture of three different ancestral roots: Amerindians, Europeans and Africans. Our previous work has shown that at an individual level, ancestry, as estimated using molecular markers, was a poor predictor of color in Brazilians. We now investigate if SNPs known to be associated with human skin pigmentation can be used to predict color in Brazilians. For that, we studied the association of fifteen SNPs, previously known to be linked with skin color, in 243 unrelated Brazilian individuals self-identified as White, Browns or Blacks from Rio de Janeiro and 212 unrelated Brazilian individuals self-identified as White or Blacks from Sao Paulo. The significance of association of SNP genotypes with self-assessed color was evaluated using partial regression analysis. After controlling for ancestry estimates as covariates, only four SNPs remained significantly associated with skin pigmentation: rs1426654 and rs2555364 within SLC24A5, rs16891982 at SLC45A2 and rs1042602 at TYR. These loci are known to be involved in melanin synthesis or transport of melanosomes. We found that neither genotypes of these SNPs, nor their combination with biogeographical ancestry in principal component analysis, could predict self-assessed color in Brazilians at an individual level. However, significant correlations did emerge at group level, demonstrating that even though elements other than skin, eye and hair pigmentation do influence self-assessed color in Brazilians, the sociological act of self-classification is still substantially dependent of genotype at these four SNPs.	[Durso, Danielle Fernandes; Junho Pena, Sergio Danilo] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Bydlowski, Sergio Paulo] Univ Sao Paulo, Fac Med, Lab Genet & Hematol Mol, Sao Paulo, Brazil; [Hutz, Mara Helena] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Suarez-Kurtz, Guilherme] Inst Nacl Canc INCA, Coordenacao Pesquisa Div Farmacol, Rio De Janeiro, RJ, Brazil; [Magalhaes, Tiago R.; Junho Pena, Sergio Danilo] Univ Fed Minas Gerais, Fac Med, Lab Genom Clin, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; National Cancer Institute (Inca); Universidade Federal de Minas Gerais	Pena, SDJ (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	spena@dcc.ufmg.br	Hutz, Mara H/I-4070-2012; Suarez-Kurtz, Guilherme/P-4620-2019; Suarez-Kurtz, Guilherme/J-6648-2012	Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; R Magalhaes, Tiago/0000-0002-5528-2119; Bydlowski, Sergio Paulo/0000-0002-7582-5942; Hutz, Mara/0000-0002-9146-1229	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Comissao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Comissao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from the following Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Comissao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos João Luiz, 2008, Rev. Saúde Pública, V42, P324, DOI 10.1590/S0034-89102008005000005; Bastos-Rodrigues L, 2006, ANN HUM GENET, V70, P658, DOI 10.1111/j.1469-1809.2006.00287.x; Beleza S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003372; Beleza S, 2013, MOL BIOL EVOL, V30, P24, DOI 10.1093/molbev/mss207; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Branicki W, 2009, ANN HUM GENET, V73, P160, DOI 10.1111/j.1469-1809.2009.00504.x; Bydlowski SP, 2003, FORENSIC SCI INT, V135, P67, DOI 10.1016/S0379-0738(03)00174-9; Cheng KC, 2006, EXP DERMATOL, V15, P836, DOI 10.1111/j.1600-0625.2006.00491.x; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Giardina E, 2008, CURR GENOMICS, V9, P110, DOI 10.2174/138920208784139528; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Guimaraes ASA, 1996, RACA CIENCIA SOCIEDA, P143; Han JS, 2008, CELL MOL NEUROBIOL, V28, P5, DOI 10.1007/s10571-007-9211-8; Inagaki K, 2006, PIGM CELL RES, V19, P451, DOI 10.1111/j.1600-0749.2006.00332.x; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; Nikamo P, 2012, EXP DERMATOL, V21, P221, DOI 10.1111/j.1600-0625.2011.01423.x; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Osorio RG, 2003, SISTEMA CLASSIFICATO, P51; Ossorio PN, 2006, J LAW MED ETHICS, V34, P277, DOI 10.1111/j.1748-720X.2006.00033.x; Park HY, 1999, J BIOL CHEM, V274, P16470, DOI 10.1074/jbc.274.23.16470; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Petruccelli JL, 2007, BRAZILIAN ETHNORACIA; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; Pneuman A, 2012, LEGAL MED-TOKYO, V14, P78, DOI 10.1016/j.legalmed.2011.12.005; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANG ENV STAT COMP; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Spichenok O, 2011, FORENSIC SCI INT-GEN, V5, P472, DOI 10.1016/j.fsigen.2010.10.005; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sturm RA, 2009, PIGM CELL MELANOMA R, V22, P544, DOI 10.1111/j.1755-148X.2009.00606.x; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Suarez-Kurtz G, 2007, PHARMACOGENOMICS, V8, P1299, DOI 10.2217/14622416.8.10.1299; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Telles EE, 2002, ETHNIC RACIAL STUD, V25, P415, DOI 10.1080/01419870252932133; TRIPATHI RK, 1992, J BIOL CHEM, V267, P23707; Tsetskhladze ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047398; Tully G, 2007, FORENSIC SCI INT-GEN, V1, P105, DOI 10.1016/j.fsigen.2007.01.005; Valenzuela RK, 2011, J FORENSIC RES, V2, P1; Valenzuela RK, 2010, J FORENSIC SCI, V55, P315, DOI 10.1111/j.1556-4029.2009.01317.x; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727	51	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83926	10.1371/journal.pone.0083926	http://dx.doi.org/10.1371/journal.pone.0083926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416183	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500085
J	Gaillard, PJ; Appeldoorn, CCM; Dorland, R; van Kregten, J; Manca, F; Vugts, DJ; Windhorst, B; van Dongen, GAMS; de Vries, HE; Maussang, D; van Tellingen, O				Gaillard, Pieter J.; Appeldoorn, Chantal C. M.; Dorland, Rick; van Kregten, Joan; Manca, Francesca; Vugts, Danielle J.; Windhorst, Bert; van Dongen, Guus A. M. S.; de Vries, Helga E.; Maussang, David; van Tellingen, Olaf			Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)	PLOS ONE			English	Article							MALIGNANT GLIOMA; CHEMOTHERAPY; TRANSPORT; BARRIER; CELLS; MODEL; BIODISTRIBUTION; ADRIAMYCIN; PACLITAXEL; METASTASES	Brain cancer is a devastating disease affecting many people worldwide. Effective treatment with chemotherapeutics is limited due to the presence of the blood-brain barrier (BBB) that tightly regulates the diffusion of endogenous molecules but also xenobiotics. Glutathione pegylated liposomal doxorubicin (2B3-101) is being developed as a new treatment option for patients with brain cancer. It is based on already marketed pegylated liposomal doxorubicin (Doxil (R)/Caelyx (R)), with an additional glutathione coating that safely enhances drug delivery across the BBB. Uptake of 2B3-101 by human brain capillary endothelial cells in vitro was time-, concentration-and temperature-dependent, while pegylated liposomal doxorubicin mainly remained bound to the cells. In vivo, 2B3-101 and pegylated liposomal doxorubicin had a comparable plasma exposure in mice, yet brain retention 4 days after administration was higher for 2B3-101. 2B3-101 was overall well tolerated by athymic FVB mice with experimental human glioblastoma (luciferase transfected U87MG). In 2 independent experiments a strong inhibition of brain tumor growth was observed for 2B3-101 as measured by bioluminescence intensity. The effect of weekly administration of 5 mg/kg 2B3-101 was more pronounced compared to pegylated liposomal doxorubicin (p<0.05) and saline (p<0.01). Two out of 9 animals receiving 2B3-101 showed a complete tumor regression. Twice-weekly injections of 5 mg/kg 2B3-101 again had a significant effect in inhibiting brain tumor growth (p<0.001) compared to pegylated liposomal doxorubicin and saline, and a complete regression was observed in 1 animal treated with 2B3-101. In addition, twice-weekly dosing of 2B3-101 significantly increased the median survival time by 38.5% (p<0.001) and 16.1% (p<0.05) compared to saline and pegylated liposomal doxorubicin, respectively. Overall, these data demonstrate that glutathione pegylated liposomal doxorubicin enhances the effective delivery of doxorubicin to brain tumors and could become a promising new therapeutic option for the treatment of brain malignancies.	[Gaillard, Pieter J.; Appeldoorn, Chantal C. M.; Dorland, Rick; van Kregten, Joan; Manca, Francesca; Maussang, David] To BBB Technol BV, Leiden, Netherlands; [Vugts, Danielle J.; Windhorst, Bert; van Dongen, Guus A. M. S.] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [de Vries, Helga E.] Vrije Univ Amsterdam Med Ctr, Blood Brain Barrier Res Grp, Amsterdam, Netherlands; [van Tellingen, Olaf] Antoni van Leeuwenhoek Hosp NKI AvL, Netherlands Canc Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Cancer Institute	Gaillard, PJ (corresponding author), To BBB Technol BV, Leiden, Netherlands.	PieterGaillard@toBBB.com	Van Tellingen, Olaf/A-1344-2014	Van Tellingen, Olaf/0000-0002-1037-6269; de Vries, Helga/0000-0001-7904-7124; Vugts, Danielle/0000-0001-7068-8152; Windhorst, Albert/0000-0002-1250-7656	to-BBB technologies BV; to-BBB technologies	to-BBB technologies BV; to-BBB technologies	All of the work presented in this manuscript was supported by to-BBB technologies BV (http://www.tobbb.com/). DJ Vugts, B Windhorst, GAMS van Dongen, HE de Vries, and O van Tellingen have received research funding from to-BBB technologies for their part of the work. Other than through the scientific input of their participating employees, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, DRUG METAB DISPOS, V41, P33, DOI 10.1124/dmd.112.048322; Anders CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061359; [Anonymous], 2012, Drug Discov Today Technol, V9, pe71, DOI 10.1016/j.ddtec.2011.12.002; Arnold RD, 2005, CLIN CANCER RES, V11, P8856, DOI 10.1158/1078-0432.CCR-05-1365; Aryal M, 2013, J CONTROL RELEASE, V169, P103, DOI 10.1016/j.jconrel.2013.04.007; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Block KI, 2008, INT J CANCER, V123, P1227, DOI 10.1002/ijc.23754; Che C, 2010, J MED CHEM, V53, P2814, DOI 10.1021/jm9016637; Dai HQ, 2003, J PHARMACOL EXP THER, V304, P1085, DOI 10.1124/jpet.102.045260; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; de Vries Nienke A, 2006, Expert Rev Neurother, V6, P1199, DOI 10.1586/14737175.6.8.1199; Fabel K, 2001, CANCER, V92, P1936, DOI 10.1002/1097-0142(20011001)92:7<1936::AID-CNCR1712>3.0.CO;2-H; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Gaillard PJ, 2012, J CONTROL RELEASE, V164, P364, DOI 10.1016/j.jconrel.2012.06.022; Gaillard PJ, 2013, DRUG DELIVERY BRAIN; Glas M, 2007, ONCOLOGY-BASEL, V72, P302, DOI 10.1159/000113052; Hau P, 2004, CANCER, V100, P1199, DOI 10.1002/cncr.20073; Joshi G, 2010, NEUROSCIENCE, V166, P796, DOI 10.1016/j.neuroscience.2010.01.021; Kannan R, 2000, BRAIN RES, V852, P374, DOI 10.1016/S0006-8993(99)02184-8; KANNAN R, 1990, J CLIN INVEST, V85, P2009, DOI 10.1172/JCI114666; Kemper EM, 2006, EUR J CANCER, V42, P3294, DOI 10.1016/j.ejca.2006.07.013; Klerk CPW, 2007, BIOTECHNIQUES, V43, P7, DOI 10.2144/000112515; Kurzrock R, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B168; Kurzrock R, 2012, MOL CANCER THER, V11, P308, DOI 10.1158/1535-7163.MCT-11-0566; La Rocca RV, 2011, EXPERT OPIN PHARMACO, V12, P1325, DOI 10.1517/14656566.2011.580737; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Lesniak MS, 2005, ANTICANCER RES, V25, P3825; Liedtke C, 2010, BREAST CANCER RES TR, V121, P301, DOI 10.1007/s10549-009-0445-7; Lindqvist A, 2013, MOL PHARMACEUT, V10, P1533, DOI 10.1021/mp300272a; Lu-Emerson Christine, 2012, Continuum (Minneap Minn), V18, P295, DOI 10.1212/01.CON.0000413659.12304.a6; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; Palmieri D, 2007, CLIN CANCER RES, V13, P1656, DOI 10.1158/1078-0432.CCR-06-2659; Pardridge WM, 2007, PHARM RES, V24, P1729, DOI 10.1007/s11095-007-9387-0; Perry J, 2007, Curr Oncol, V14, P189, DOI 10.3747/co.2007.147; Regina A, 2008, BRIT J PHARMACOL, V155, P185, DOI 10.1038/bjp.2008.260; Rip J, 2010, PHARM TOX BLOOD BRAI; SIEGAL T, 1995, J NEUROSURG, V83, P1029, DOI 10.3171/jns.1995.83.6.1029; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tardi PG, 1996, J DRUG TARGET, V4, P129, DOI 10.3109/10611869609015970; Tosoni A, 2008, CRIT REV ONCOL HEMAT, V68, P212, DOI 10.1016/j.critrevonc.2008.04.004; van Asperen J, 1998, J CHROMATOGR B, V712, P129, DOI 10.1016/S0378-4347(98)00165-0; VONHOLST H, 1990, ACTA NEUROCHIR, V104, P13, DOI 10.1007/BF01842886; Voulgaris S, 2002, AM J CLIN ONCOL-CANC, V25, P60, DOI 10.1097/00000421-200202000-00013; Walbert T, 2009, INT J CLIN ONCOL, V14, P299, DOI 10.1007/s10147-009-0916-1; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Whitaker G, 2010, J PHARMACEUT BIOMED, V53, P490, DOI 10.1016/j.jpba.2010.05.023; Wolff JEA, 1999, J CANCER RES CLIN, V125, P481, DOI 10.1007/s004320050305; ZLOKOVIC BV, 1994, BIOCHEM BIOPH RES CO, V201, P402, DOI 10.1006/bbrc.1994.1715	48	151	159	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82331	10.1371/journal.pone.0082331	http://dx.doi.org/10.1371/journal.pone.0082331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416140	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500014
J	Kurihara, C; Kusuoka, H; Ono, S; Kakee, N; Saito, K; Takehara, K; Tsujide, K; Nabeoka, Y; Sakuhiro, T; Aoki, H; Morishita, N; Suzuki, C; Kachi, S; Kondo, E; Komori, Y; Isobe, T; Kageyama, S; Watanabe, H				Kurihara, Chieko; Kusuoka, Hideo; Ono, Shunsuke; Kakee, Naoko; Saito, Kazuyuki; Takehara, Kenji; Tsujide, Kiyokazu; Nabeoka, Yuzo; Sakuhiro, Takuya; Aoki, Hiroshi; Morishita, Noriko; Suzuki, Chieko; Kachi, Shigeo; Kondo, Emiko; Komori, Yukiko; Isobe, Tetsu; Kageyama, Shigeru; Watanabe, Hiroshi			High Rate of Awarding Compensation for Claims of Injuries Related to Clinical Trials by Pharmaceutical Companies in Japan: A Questionnaire Survey	PLOS ONE			English	Article							POLICIES	Introduction: International norms and ethical standards have suggested that compensation for research-related injury should be provided to injured research volunteers. However, statistical data of incidence of compensation claims and the rate of awarding them have been rarely reported. Method: Questionnaire surveys were sent to pharmaceutical companies and medical institutions, focusing on industry-initiated clinical trials aiming at new drug applications (NDAs) on patient volunteers in Japan. Results: With the answers from pharmaceutical companies, the incidence of compensation was 0.8%, including 0.06% of monetary compensation. Of the cases of compensation claims, 99% were awarded. In turn, with the answers from medical institutions, the incidence of compensation was 0.6%, including 0.4% of serious but not death cases, and 0.04% of death cases. Furthermore, most claims for compensation were initiated by medical institutions, rather than by the patients. On the other hand, with the answers from clinical trial volunteers, 3% of respondents received compensations. These compensated cases were 25% of the injuries which cannot be ruled out from the scope of compensation. Conclusion: Our study results demonstrated that Japanese pharmaceutical companies have provided a high rate of compensation for clinical trial-related injuries despite the possibility of overestimation. In the era of global clinical development, our study indicates the importance of further surveys to find each country's compensation policy by determining how it is being implemented based on a survey of the actual status of compensation coming from statistical data.	[Kurihara, Chieko] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Kusuoka, Hideo] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan; [Ono, Shunsuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Kakee, Naoko; Takehara, Kenji] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Saito, Kazuyuki] Pharmaceut & Med Devices Agcy, Off OTC Gener Drugs, Tokyo, Japan; [Tsujide, Kiyokazu; Aoki, Hiroshi] Japan Pharmaceut Manufacturers Assoc, Drug Evaluat Comm, Clin Evaluat Expert Comm, Tokyo, Japan; [Nabeoka, Yuzo] Chugai Pharmaceut Co Ltd, Clin Res Coordinat Dept, Tokyo, Japan; [Sakuhiro, Takuya] Mitsubishi Tanabe Pharma Corp, Dev Div, Tokyo, Japan; [Morishita, Noriko] Osaka Natl Hosp, Natl Hosp Org, Adm Ctr Clin Trials, Inst Clin Res, Osaka, Japan; [Suzuki, Chieko; Kachi, Shigeo] Hamamatsu Univ Sch Med, Clin Res Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Kondo, Emiko] Pharmaceut & Med Devices Agcy, Off Conform Audit, Tokyo, Japan; [Komori, Yukiko] Pharmaceut & Med Devices Agcy, Off New Drug CNS PNS Anesthesia 3, Tokyo, Japan; [Isobe, Tetsu] Keio Univ, Keio Law Sch, Tokyo, Japan; [Kageyama, Shigeru] Jikei Univ, Sch Med, Div Clin Pharmacol & Therapeut, Tokyo, Japan; [Watanabe, Hiroshi] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4313192, Japan	National Institutes for Quantum Science & Technology; Osaka National Hospital; University of Tokyo; National Center for Child Health & Development - Japan; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Mitsubishi Tanabe Pharma Corporation; Osaka National Hospital; Hamamatsu University School of Medicine; Keio University; Jikei University; Hamamatsu University School of Medicine	Kurihara, C (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	chieko.kurihara@nifty.ne.jp		Takehara, Kenji/0000-0002-5957-600X	Ministry of Health, Labor and Welfare	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This survey was conducted as the task force titled "Research on protection of human subjects concerning clinical trial-related injuries", in the area of the grant for "General research project on regulatory science for drug and medical device" by the Ministry of Health, Labor and Welfare, in the fiscal year 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, OFFICIAL J EUROPEA L, VL121, P34; [Anonymous], 2004, GUID COMP INJ RES PA; Association of the British Pharmaceutical Industry (ABPI), 1991, CLIN TRIAL COMP GUID; Association of the British Pharmaceutical Industry (ABPI), 1988, GUID MED EXP NONP HU; Bavdekar S B, 2009, Indian J Med Sci, V63, P455; CARDON PV, 1976, NEW ENGL J MED, V295, P650, DOI 10.1056/NEJM197609162951205; *CIOMS, 2002, INT ETH GUID BIOM RE; Council of Europe, 2005, EUR TREAT SER, V195; Department of Health, 2006, GUID GOOD PRACT COND; Gainotti S, 2010, J CLIN RES BIOETH, V1, P101, DOI [10.4172/2155-9627.1000101, DOI 10.4172/2155-9627.1000101]; hhs, 1979, BELM REP ETH PRINC G; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH, 1996, ICH HARM TRIP GUID G; Japanese Pharmaceutical Industry Legal & Business Affairs Association, 2009, LEGAL MIND S, V35, P60; Japanese Pharmaceutical Industry Legal & Business Affairs Association, 2009, LEGAL MIND S, V35, P6; Kurihara C, 2011, RINSHO HYOKA CLIN EV, V39, P31; Ministry of Health and Family Welfare Government of India. The Drugs and Cosmetics (First Amendment) Rules, 2013, INS APP 12 COMP CAS; Ministry of Health and Welfare Japan, 1997, MIN ORD GOOD CLIN PR; Ministry of Health Labour and Welfare Japan, 2008, ETH GUID CLIN RES; Ministry of Health Singapore, 2007, NAT MED ETH COMM GUI; Munshi Renuka, 2013, Perspect Clin Res, V4, P61, DOI 10.4103/2229-3485.106392; Nabeoka Y, 2012, PHARM STAGE, V12, P26; Office for Drug-Induced Damages Pharmaceutical and Food Safety Bureau Ministry of Health Labor and Welfare, 8 STUD COMM REL HLTH; Paasche-Ortow MK, 2005, AM J MED, V118, P175, DOI 10.1016/j.amjmed.2004.03.045; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, COMP RES INJ ETH LEG; Resnik DB, 2006, J LEGAL MED, V27, P263, DOI 10.1080/01947640600870866; ROYLE JM, 1986, BRIT J CLIN PHARMACO, V21, P548, DOI 10.1111/j.1365-2125.1986.tb02842.x; Slack C, 2012, S AFR J BIOETH LAW, V5, P91, DOI 10.7196/SAJBL.211; SPEIRS CJ, 1983, BRIT J CLIN PHARMACO, V15, P649, DOI 10.1111/j.1365-2125.1983.tb01545.x; Thatte UM, 2009, J MED ETHICS, V35, P133, DOI 10.1136/jme.2008.025155; The Association of the British Pharmaceutical Industry (ABPI), 2007, GUID PHAS 1 CLIN TRI; The Association of the British Pharmaceutical Industry (ABPI) BioIndustry Association Clinical Contract Research Association, 2012, INS COMP EV INJ PHAS; The Researched Medicines Industry Association of New Zealand Inc, 2008, RES MED IND GUID CLI; Watanabe H, 2011, RINSHO HYOKA CLIN EV, V39, P5; ZARAFONETIS CJD, 1978, CLIN PHARMACOL THER, V24, P127	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84998	10.1371/journal.pone.0084998	http://dx.doi.org/10.1371/journal.pone.0084998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416332	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500204
J	McFarlin, KM; Prince, RC; Perkins, R; Leigh, MB				McFarlin, Kelly M.; Prince, Roger C.; Perkins, Robert; Leigh, Mary Beth			Biodegradation of Dispersed Oil in Arctic Seawater at-1 degrees C	PLOS ONE			English	Article							CRUDE-OIL; PETROLEUM-HYDROCARBONS; COREXIT 9500; BACTERIAL COMMUNITIES; N-ALKANES; BIOREMEDIATION; SEA; SPILL; DEGRADATION; MICROORGANISMS	As offshore oil and gas exploration expands in the Arctic, it is important to expand the scientific understanding of arctic ecology and environmental impact to mitigate operational risks. Understanding the fate of oil in arctic seawater is a key factor for consideration. Here we report the chemical loss due to the biodegradation of Alaska North Slope (ANS) crude oil that would occur in the water column following the successful dispersion of a surface oil slick. Primary biodegradation and mineralization were measured in mesocosms containing Arctic seawater collected from the Chukchi Sea, Alaska, incubated at -1 degrees C. Indigenous microorganisms degraded both fresh and weathered oil, in both the presence and absence of Corexit 9500, with oil losses ranging from 46-61% and up to 11% mineralization over 60 days. When tested alone, 14% of 50 ppm Corexit 9500 was mineralized within 60 days. Our study reveals that microorganisms indigenous to Arctic seawater are capable of performing extensive biodegradation of chemically and physically dispersed oil at an environmentally relevant temperature (-1 degrees C) without any additional nutrients.	[McFarlin, Kelly M.; Leigh, Mary Beth] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Prince, Roger C.] ExxonMobil Biomed Sci Inc, Annandale, NJ USA; [Perkins, Robert] Univ Alaska Fairbanks, Inst Northern Engn, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks; Exxon Mobil Corporation; University of Alaska System; University of Alaska Fairbanks	McFarlin, KM (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.	kmmcfarlin@alaska.edu		Prince, Roger/0000-0002-5174-4216; McFarlin, Kelly/0000-0002-1543-7649	Shell; ExxonMobil; Statoil; ConocoPhillips; BP; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103395]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103395] Funding Source: NIH RePORTER	Shell(Royal Dutch Shell); ExxonMobil(Exxon Mobil Corporation); Statoil; ConocoPhillips; BP; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was part of a Joint Industry Program funded by Shell, ExxonMobil, Statoil, ConocoPhillips and BP. Additional support was provided by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103395. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATLAS RM, 1981, ESTUAR COAST SHELF S, V12, P589, DOI 10.1016/S0302-3524(81)80085-0; Baelum J, 2012, ENVIRON MICROBIOL, V14, P2405, DOI 10.1111/j.1462-2920.2012.02780.x; Belore R, 2005, SPILL SCI TECHNOL B; Belore RC, 2009, MAR POLLUT BULL, V58, P118, DOI 10.1016/j.marpolbul.2008.08.013; BRAGG JR, 1994, NATURE, V368, P413, DOI 10.1038/368413a0; Brakstad OG, 2006, BIODEGRADATION, V17, P71, DOI 10.1007/s10532-005-3342-8; Bushnell LD, 1941, J BACTERIOL, V41, P653, DOI 10.1128/JB.41.5.653-673.1941; Chakraborty R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00357; Codispoti LA, 2005, DEEP-SEA RES PT II, V52, P3199, DOI 10.1016/j.dsr2.2005.10.007; Davies L, 2001, BIODEGRADABILITY CHE; DAVIS JB, 1964, APPL MICROBIOL, V12, P210, DOI 10.1128/AEM.12.3.210-214.1964; Delille D, 1998, POLAR BIOL, V19, P237, DOI 10.1007/s003000050240; Deppe U, 2005, EXTREMOPHILES, V9, P461, DOI 10.1007/s00792-005-0463-2; Douglas G. S., 1992, Journal of Soil Contamination, V1, P197, DOI 10.1080/15320389209383411; ExxonMobil Corporation, 2013, AL N SLOP CRUD OIL; FOGHT JM, 1983, CAN J MICROBIOL, V29, P623, DOI 10.1139/m83-099; Garrett RM, 2003, SPILL SCI TECHNOL B, V8, P297, DOI 10.1016/S1353-2561(03)00037-9; Gerdes B, 2005, FEMS MICROBIOL ECOL, V53, P129, DOI 10.1016/j.femsec.2004.11.010; Government Accountability Office, 2012, GAO12585; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Lee K, 2013, MAR POLLUT BULL, V73, P314, DOI 10.1016/j.marpolbul.2013.06.005; Lessard RR, 2000, SPILL SCI TECHNOL B, V6, P59, DOI 10.1016/S1353-2561(99)00061-4; Li ZK, 2009, MAR POLLUT BULL, V58, P735, DOI 10.1016/j.marpolbul.2008.12.014; Lindstrom JE, 2002, MAR POLLUT BULL, V44, P739, DOI 10.1016/S0025-326X(02)00050-4; Lunel T, 1997, P 1997 INT OIL SPILL, P185; Mazzella N, 2005, J CHROMATOGR B, V822, P40, DOI 10.1016/j.jchromb.2005.05.014; Mearns AJ, 1997, SPILL SCI TECHNOL B, V4, P209, DOI 10.1016/S1353-2561(98)00026-7; MULKINSPHILLIPS GJ, 1974, CAN J MICROBIOL, V20, P955, DOI 10.1139/m74-147; Nalco, 2011, COREXIT INGREDIENTS; National Research Council, 1993, IN SIT BIOR DOES IT; National Research Council, 2005, OIL SPILL DISPERSANT; National Research Council, 2003, OIL SEA INP FAT EFF; OECD, 1992, TEST 301 READ BIOD O, DOI [10.1787/9789264070349-en, DOI 10.1787/9789264070349-EN]; Pelletier E, 2004, MAR ENVIRON RES, V57, P311, DOI 10.1016/j.marenvres.2003.07.001; PRINCE RC, 1994, ENVIRON SCI TECHNOL, V28, P142, DOI 10.1021/es00050a019; Prince RC, 2003, SPILL SCI TECHNOL B, V8, P303, DOI 10.1016/S1353-2561(03)00036-7; Prince RC., 2010, HDB HYDROCARBON LIPI, P1672; Prince RC, 2014, ENVIRON SCI POLLUT R, V21, P9506, DOI 10.1007/s11356-013-2053-7; Prince RC, 2013, CHEMOSPHERE, V90, P521, DOI 10.1016/j.chemosphere.2012.08.020; Ron EZ, 2002, CURR OPIN BIOTECH, V13, P249, DOI 10.1016/S0958-1669(02)00316-6; Rontani J. F., 2010, HDB HYDROCARBON LIPI, V34, P460; Santas R, 1999, MAR POLLUT BULL, V38, P44, DOI 10.1016/S0025-326X(98)00084-8; SIRON R, 1995, ARCH ENVIRON CON TOX, V28, P406, DOI 10.1007/BF00211621; Swannell RPJ, 1997, PROCEEDINGS OF THE TWENTIETH ARCTIC AND MARINE OILSPILL PROGRAM (AMOP) TECHNICAL SEMINAR, VOLS 1 AND 2, P617; Tavassoli T, 2012, FUEL, V93, P142, DOI 10.1016/j.fuel.2011.10.021; Tissot B.P., 1984, PETROLEUM FORMATION, DOI 10.1007/978-3-642-96446-6; Uribe-Alvarez C, 2011, MICROB BIOTECHNOL, V4, P663, DOI 10.1111/j.1751-7915.2011.00269.x; Venosa AD, 2007, MAR POLLUT BULL, V54, P545, DOI 10.1016/j.marpolbul.2006.12.013; Zahed MA, 2011, J HAZARD MATER, V185, P1027, DOI 10.1016/j.jhazmat.2010.10.009	49	94	95	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84297	10.1371/journal.pone.0084297	http://dx.doi.org/10.1371/journal.pone.0084297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416211	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500109
J	Pacico, N; Mingorance-Le Meur, A				Pacico, Nathalie; Mingorance-Le Meur, Ana			New In Vitro Phenotypic Assay for Epilepsy: Fluorescent Measurement of Synchronized Neuronal Calcium Oscillations	PLOS ONE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; ANTIEPILEPTIC DRUG DEVELOPMENT; HUMAN NEOCORTICAL SLICES; EPILEPTIFORM DISCHARGES; CORTICAL-NEURONS; RAT HIPPOCAMPUS; ANIMAL-MODELS; IDENTIFICATION; LEVETIRACETAM; RETIGABINE	Research in the epilepsy field is moving from a primary focus on controlling seizures to addressing disease pathophysiology. This requires the adoption of resource- and time-consuming animal models of chronic epilepsy which are no longer able to sustain the testing of even moderate numbers of compounds. Therefore, new in vitro functional assays of epilepsy are needed that are able to provide a medium throughput while still preserving sufficient biological context to allow for the identification of compounds with new modes of action. Here we describe a robust and simple fluorescence-based calcium assay to measure epileptiform network activity using rat primary cortical cultures in a 96-well format. The assay measures synchronized intracellular calcium oscillations occurring in the population of primary neurons and is amenable to medium throughput screening. We have adapted this assay format to the low magnesium and the 4-aminopyridine epilepsy models and confirmed the contribution of voltage-gated ion channels and AMPA, NMDA and GABA receptors to epileptiform activity in both models. We have also evaluated its translatability using a panel of antiepileptic drugs with a variety of modes of action. Given its throughput and translatability, the calcium oscillations assay bridges the gap between simplified target-based screenings and compound testing in animal models of epilepsy. This phenotypic assay also has the potential to be used directly as a functional screen to help identify novel antiepileptic compounds with new modes of action, as well as pathways with previously unknown contribution to disease pathophysiology.	[Pacico, Nathalie; Mingorance-Le Meur, Ana] UCB Pharma, Neurosci Therapeut Area, Braine Lalleud, Belgium	UCB Pharma SA	Mingorance-Le Meur, A (corresponding author), UCB Pharma, Neurosci Therapeut Area, Braine Lalleud, Belgium.	ana.mingorance@ucb.com		Mingorance, Ana/0000-0002-6213-6160	UCB Pharma SA	UCB Pharma SA(UCB Pharma SA)	This work was funded by UCB Pharma SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias RL, 2005, BRAIN RES, V1047, P233, DOI 10.1016/j.brainres.2005.04.052; Arkin MR, 2004, NBK92012; AVOLI M, 1993, J NEUROPHYSIOL, V70, P1018, DOI 10.1152/jn.1993.70.3.1018; Bacci A, 1999, EUR J NEUROSCI, V11, P389, DOI 10.1046/j.1460-9568.1999.00440.x; Blair RE, 2009, NEUROPHARMACOLOGY, V57, P208, DOI 10.1016/j.neuropharm.2009.06.007; DeLorenzo RJ, 2000, EPILEPSIA, V41, pS40, DOI 10.1111/j.1528-1157.2000.tb06048.x; Dost R, 2000, EPILEPSY RES, V38, P53; Dravid SM, 2004, BRAIN RES, V1006, P8, DOI 10.1016/j.brainres.2004.01.059; Eggert US, 2013, NAT CHEM BIOL, V9, P206, DOI 10.1038/nchembio.1206; FUETA Y, 1992, EPILEPSY RES, V12, P207, DOI 10.1016/0920-1211(92)90075-5; Galanopoulou AS, 2012, EPILEPSIA, V53, P571, DOI 10.1111/j.1528-1167.2011.03391.x; Gorji A, 2002, EPILEPSIA, V43, P1480, DOI 10.1046/j.1528-1157.2002.23702.x; Heinemann U, 2006, MODELS OF SEIZURES AND EPILEPSY, P35, DOI 10.1016/B978-012088554-1/50006-2; Hemstapat Kamondanai, 2004, Journal of Pharmacological and Toxicological Methods, V49, P81, DOI 10.1016/j.vascn.2003.10.002; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Kupferberg H, 2001, EPILEPSIA, V42, P7, DOI 10.1046/j.1528-1157.2001.0420s4007.x; LaRoche SM, 2004, JAMA-J AM MED ASSOC, V291, P605, DOI 10.1001/jama.291.5.605; Loscher W, 2006, EPILEPSY RES, V69, P183, DOI 10.1016/j.eplepsyres.2006.03.014; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; LOSCHER W, 1988, EPILEPSY RES, V2, P145, DOI 10.1016/0920-1211(88)90054-X; LOSCHER W, 1994, EPILEPSY RES, V17, P95, DOI 10.1016/0920-1211(94)90012-4; Loscher Wolfgang, 2002, Novartis Found Symp, V243, P149; Lucke A, 1998, BRIT J PHARMACOL, V124, P370, DOI 10.1038/sj.bjp.0701825; Mangan PS, 2004, J NEUROPHYSIOL, V91, P946, DOI 10.1152/jn.00547.2003; Mezler M, 2012, COMB CHEM HIGH T SCR, V15, P372, DOI 10.2174/138620712800194503; Pisani A, 2004, EPILEPSIA, V45, P719, DOI 10.1111/j.0013-9580.2004.02204.x; Richards GR, 2006, METHOD ENZYMOL, V414, P335, DOI 10.1016/S0076-6879(06)14019-7; Rogawski MA, 2006, EPILEPSY RES, V68, P22, DOI 10.1016/j.eplepsyres.2005.09.012; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Santos SF, 2009, J NEUROSCI, V29, P4708, DOI 10.1523/JNEUROSCI.4917-08.2009; Shen MX, 1996, J NEUROSCI, V16, P4322; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706, DOI 10.1152/jn.1995.73.4.1706; Straub H, 2001, EPILEPSY RES, V44, P155, DOI 10.1016/S0920-1211(01)00193-0; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Verderio C, 1999, EUR J NEUROSCI, V11, P2793, DOI 10.1046/j.1460-9568.1999.00697.x; Wang XS, 1997, BRAIN RES, V767, P239, DOI 10.1016/S0006-8993(97)00585-4	37	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84755	10.1371/journal.pone.0084755	http://dx.doi.org/10.1371/journal.pone.0084755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416277	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500160
J	Shim, JW; Dodge, TR; Hammond, MA; Wallace, JM; Zhou, FC; Yokota, H				Shim, Joon W.; Dodge, Todd R.; Hammond, Max A.; Wallace, Joseph M.; Zhou, Feng C.; Yokota, Hiroki			Physical Weight Loading Induces Expression of Tryptophan Hydroxylase 2 in the Brain Stem	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; BONE-FORMATION; AFFECTIVE-DISORDER; MICE; EXERCISE; TIBIAE; TARGET; LRP5; RATS	Sustaining brain serotonin is essential in mental health. Physical activities can attenuate mental problems by enhancing serotonin signaling. However, such activity is not always possible in disabled individuals or patients with dementia. Knee loading, a form of physical activity, has been found to mimic effects of voluntary exercise. Focusing on serotonergic signaling, we addressed a question: Does local mechanical loading to the skeleton elevate expression of tryptophan hydroxylase 2 (tph2) that is a rate-limiting enzyme for brain serotonin? A 5 min knee loading was applied to mice using 1 N force at 5 Hz for 1,500 cycles. A 5-min treadmill running was used as an exercise (positive) control, and a 90-min tail suspension was used as a stress (negative) control. Expression of tph2 was determined 30 min -2 h in three brain regions - frontal cortex (FC), ventromedial hypothalamus (VMH), and brain stem (BS). We demonstrated for the first time that knee loading and treadmill exercise upregulated the mRNA level of tph2 in the BS, while tail suspension downregulated it. The protein level of tph2 in the BS was also upregulated by knee loading and downregulated by tail suspension. Furthermore, the downregulation of tph2 mRNA by tail suspension can be partially suppressed by pre-application of knee loading. The expression of tph2 in the FC and VMH was not significantly altered with knee loading. In this study we provided evidence that peripheral mechanical loading can activate central tph2 expression, suggesting that physical cues may mediate tph2-cathalyzed serotonergic signaling in the brain.	[Shim, Joon W.; Dodge, Todd R.; Wallace, Joseph M.; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Hammond, Max A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Wallace, Joseph M.] Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA; [Zhou, Feng C.; Yokota, Hiroki] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Zhou, Feng C.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Shim, JW (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	shimjoon@iupui.edu; hyokota@iupui.edu	Shim, Joon W./AEW-0442-2022; Wallace, Joseph Michael/G-7906-2012	Wallace, Joseph Michael/0000-0001-6077-8058; Hammond, Max/0000-0003-2103-7884	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [AR052144]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052144] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, under Award Number AR052144. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Boldrini M, 2005, BRAIN RES, V1041, P19, DOI 10.1016/j.brainres.2005.01.083; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Chen GL, 2013, BIOCHEM PHARMACOL, V85, P1227, DOI 10.1016/j.bcp.2013.02.018; Dodge T, 2012, BONE, V51, P810, DOI 10.1016/j.bone.2012.07.021; Ganzer PD, 2013, EXP NEUROL, V241, P84, DOI 10.1016/j.expneurol.2012.12.004; Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y; Ilic TV, 2002, NEUROSCI LETT, V319, P116, DOI 10.1016/S0304-3940(01)02563-0; Inose H, 2011, J BONE MINER RES, V26, P2002, DOI 10.1002/jbmr.439; Kumar Vinayak, 2012, J Pain Res, V5, P279, DOI 10.2147/JPR.S33408; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Ma Y, 2008, NEUROSCI BULL, V24, P265; Matthes S, 2010, PHARMACOLOGY, V85, P95, DOI 10.1159/000279322; Mattson Mark P, 2004, NeuroRx, V1, P111, DOI 10.1007/BF03206571; Moon HY, 2012, P NATL ACAD SCI USA, V109, P13094, DOI 10.1073/pnas.1205535109; Osterberg N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019239; Patel PD, 2007, J BIOL CHEM, V282, P26717, DOI 10.1074/jbc.M705120200; Popova NK, 2010, EXPERT OPIN THER TAR, V14, P1259, DOI 10.1517/14728222.2010.524208; Seo HY, 2005, EXP NEUROL, V193, P469, DOI 10.1016/j.expneurol.2004.11.017; Shim JW, 2006, BIOMECH MODEL MECHAN, V5, P247, DOI 10.1007/s10237-005-0013-y; Shim JW, 2013, EXP NEUROL, V247, P703, DOI 10.1016/j.expneurol.2013.03.011; Shim JW, 2013, J MUSCULOSK IN PRESS, V13; Soares DD, 2007, NEUROSCI LETT, V415, P274, DOI 10.1016/j.neulet.2007.01.035; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Wallace JM, 2009, CALCIFIED TISSUE INT, V84, P297, DOI 10.1007/s00223-009-9228-8; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yun Hyung-Mun, 2011, Exp Neurobiol, V20, P159, DOI 10.5607/en.2011.20.4.159; Zhang P, 2006, J APPL PHYSIOL, V100, P1452, DOI 10.1152/japplphysiol.00997.2005; Zhang P, 2011, BONE, V49, P867, DOI 10.1016/j.bone.2011.06.020; Zhang P, 2010, J BONE MINER METAB, V28, P268, DOI 10.1007/s00774-009-0135-x; Zhao LM, 2013, BONE, V54, P35, DOI 10.1016/j.bone.2013.01.033	33	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85095	10.1371/journal.pone.0085095	http://dx.doi.org/10.1371/journal.pone.0085095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416346	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500215
J	Smith, R; Solberg, R; Jacobsen, LL; Voreland, AL; Rustan, AC; Thoresen, GH; Johansen, HT				Smith, Robert; Solberg, Rigmor; Jacobsen, Linn Lokken; Voreland, Anette Larsen; Rustan, Arild Christian; Thoresen, G. Hege; Johansen, Harald Thidemann			Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes	PLOS ONE			English	Article							CATHEPSIN-B; INDUCED MYOTOXICITY; INSULIN-RESISTANCE; ATORVASTATIN; PRAVASTATIN; DEPLETION; STATINS; DEGRADATION; ACTIVATION; TOXICITY	Simvastatin, a HMG-CoA reductase inhibitor, is prescribed worldwide to patients with hypercholesterolemia. Although simvastatin is well tolerated, side effects like myotoxicity are reported. The mechanism for statin-induced myotoxicity is still poorly understood. Reports have suggested impaired mitochondrial dysfunction as a contributor to the observed myotoxicity. In this regard, we wanted to study the effects of simvastatin on glucose metabolism and the activity of legumain, a cysteine protease. Legumain, being the only known asparaginyl endopeptidase, has caspase-like properties and is described to be involved in apoptosis. Recent evidences indicate a regulatory role of both glucose and statins on cysteine proteases in monocytes. Satellite cells were isolated from the Musculus obliquus internus abdominis of healthy human donors, proliferated and differentiated into polynuclear myotubes. Simvastatin with or without mevalonolactone, farnesyl pyrophosphate or geranylgeranyl pyrophosphate were introduced on day 5 of differentiation. After 48 h, cells were either harvested for immunoblotting, ELISA, cell viability assay, confocal imaging or enzyme activity analysis, or placed in a fuel handling system with [C-14] glucose or [H-3] deoxyglucose for uptake and oxidation studies. A dose-dependent decrease in both glucose uptake and oxidation were observed in mature myotubes after exposure to simvastatin in concentrations not influencing cell viability. In addition, simvastatin caused a decrease in maturation and activity of legumain. Dysregulation of glucose metabolism and decreased legumain activity by simvastatin points out new knowledge about the effects of statins on skeletal muscle, and may contribute to the understanding of the myotoxicity observed by statins.	[Smith, Robert; Solberg, Rigmor; Jacobsen, Linn Lokken; Voreland, Anette Larsen; Rustan, Arild Christian; Thoresen, G. Hege] Univ Oslo, Dept Pharmaceut Biosci, Sch Pharm, Fac Math & Nat Sci, Oslo, Norway; [Thoresen, G. Hege; Johansen, Harald Thidemann] Univ Oslo, Dept Pharmacol, Inst Clin Med, Fac Med, Oslo, Norway; [Thoresen, G. Hege; Johansen, Harald Thidemann] Oslo Univ Hosp, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Smith, R (corresponding author), Univ Oslo, Dept Pharmaceut Biosci, Sch Pharm, Oslo, Norway.	robert.smith@farmasi.uio.no		Solberg, Rigmor/0000-0001-7205-4401; Johansen, Harald Thidemann/0000-0001-6617-1732	University of Oslo; Anders Jahres foundation for the Promotion of Science; S.G. Sonneland foundation; Norwegian Pharmaceutical Society	University of Oslo; Anders Jahres foundation for the Promotion of Science; S.G. Sonneland foundation; Norwegian Pharmaceutical Society	This study was supported by The University of Oslo, Anders Jahres foundation for the Promotion of Science, S.G. Sonneland foundation and The Norwegian Pharmaceutical Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas V, 2013, CELL TISSUE RES; Abisi S, 2008, BRIT J SURG, V95, P333, DOI 10.1002/bjs.5989; Arora R, 2006, J CARDIOVASC PHARM T, V11, P105, DOI 10.1177/1074248406288758; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; COLELLA R, 1986, BIOMED BIOCHIM ACTA, V45, P1413; Deng D, 2009, BBA-BIOMEMBRANES, V1788, P470, DOI 10.1016/j.bbamem.2008.11.018; Flint OP, 1997, TOXICOL APPL PHARM, V145, P99, DOI 10.1006/taap.1997.8174; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; GHIRLANDA G, 1993, J CLIN PHARMACOL, V33, P226, DOI 10.1002/j.1552-4604.1993.tb03948.x; Halfon S, 1998, FEBS LETT, V438, P114, DOI 10.1016/S0014-5793(98)01281-2; Haugen MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052980; Itagaki M, 2009, J PHARMACOL SCI, V109, P94, DOI 10.1254/jphs.08238FP; Jadot M, 2001, EUR J BIOCHEM, V268, P1392, DOI 10.1046/j.1432-1327.2001.02006.x; Johansen HT, 1999, ANAL BIOCHEM, V273, P278, DOI 10.1006/abio.1999.4221; Koh KK, 2008, DIABETES CARE, V31, P776, DOI 10.2337/dc07-2199; Koh KK, 2010, J AM COLL CARDIOL, V55, P1209, DOI 10.1016/j.jacc.2009.10.053; Kwak HB, 2012, FREE RADICAL BIO MED, V52, P198, DOI 10.1016/j.freeradbiomed.2011.10.449; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; Liu C, 2003, CANCER RES, V63, P2957; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Malenda A, 2012, NEOPLASIA, V14, P311, DOI 10.1593/neo.12444; Minet AD, 2010, BIOCHEM BIOPH RES CO, V402, P70, DOI 10.1016/j.bbrc.2010.09.115; Minogue S, 2010, J LIPID RES, V51, P2314, DOI 10.1194/jlr.M005751; Moheimani F, 2012, ATHEROSCLEROSIS, V223, P144, DOI 10.1016/j.atherosclerosis.2012.04.026; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; PEDERSEN TR, 1994, LANCET, V344, P1383; Peres C, 2003, FEBS LETT, V534, P164, DOI 10.1016/S0014-5793(02)03832-2; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; QIAN F, 1991, BIOMED BIOCHIM ACTA, V50, P531; Sakamoto K, 2007, FASEB J, V21, P4087, DOI 10.1096/fj.07-8713com; Sakamoto K, 2011, J PHARMACOL EXP THER, V338, P62, DOI 10.1124/jpet.111.179762; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Sinzinger H, 2002, J CARDIOVASC PHARM, V40, P163, DOI 10.1097/00005344-200208000-00001; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V329, P1067, DOI 10.1016/j.bbrc.2005.02.070; Skottheim IB, 2008, EUR J PHARM SCI, V33, P317, DOI 10.1016/j.ejps.2007.12.009; Smith R, 2012, BIOCHIMIE, V94, P2590, DOI 10.1016/j.biochi.2012.07.026; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Takaguri A, 2008, J PHARMACOL SCI, V107, P80, DOI 10.1254/jphs.FP0072403; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Wang ZH, 2010, J CLIN PHARMACOL, V50, P311, DOI 10.1177/0091270009340889; Waugh MG, 2006, J BIOL CHEM, V281, P3757, DOI 10.1074/jbc.M506527200; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; WERLE B, 1995, BIOL CHEM H-S, V376, P157, DOI 10.1515/bchm3.1995.376.3.157; Wu BH, 2010, J BIOL CHEM, V285, P1790, DOI 10.1074/jbc.M109.049064	51	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85721	10.1371/journal.pone.0085721	http://dx.doi.org/10.1371/journal.pone.0085721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416446	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500264
J	Sparks, JS; Schelly, RC; Smith, WL; Davis, MP; Tchernov, D; Pieribone, VA; Gruber, DF				Sparks, John S.; Schelly, Robert C.; Smith, W. Leo; Davis, Matthew P.; Tchernov, Dan; Pieribone, Vincent A.; Gruber, David F.			The Covert World of Fish Biofluorescence: A Phylogenetically Widespread and Phenotypically Variable Phenomenon	PLOS ONE			English	Article							GREEN-FLUORESCENT PROTEIN; FAMILY KNERIIDAE TELEOSTEI; HIGHER-LEVEL RELATIONSHIPS; REEF FISHES; MOLECULAR PHYLOGENY; COLOR-VISION; MITOGENOMIC PERSPECTIVE; MITOCHONDRIAL GENOMES; POLARIZATION VISION; BEHAVIORAL EVIDENCE	The discovery of fluorescent proteins has revolutionized experimental biology. Whereas the majority of fluorescent proteins have been identified from cnidarians, recently several fluorescent proteins have been isolated across the animal tree of life. Here we show that biofluorescence is not only phylogenetically widespread, but is also phenotypically variable across both cartilaginous and bony fishes, highlighting its evolutionary history and the possibility for discovery of numerous novel fluorescent proteins. Fish biofluorescence is especially common and morphologically variable in cryptically patterned coral-reef lineages. We identified 16 orders, 50 families, 105 genera, and more than 180 species of biofluorescent fishes. We have also reconstructed our current understanding of the phylogenetic distribution of biofluorescence for ray-finned fishes. The presence of yellow long-pass intraocular filters in many biofluorescent fish lineages and the substantive color vision capabilities of coral-reef fishes suggest that they are capable of detecting fluoresced light. We present species-specific emission patterns among closely related species, indicating that biofluorescence potentially functions in intraspecific communication and evidence that fluorescence can be used for camouflage. This research provides insight into the distribution, evolution, and phenotypic variability of biofluorescence in marine lineages and examines the role this variation may play.	[Sparks, John S.; Schelly, Robert C.; Pieribone, Vincent A.] Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA; [Sparks, John S.; Schelly, Robert C.; Gruber, David F.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Smith, W. Leo; Davis, Matthew P.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Tchernov, Dan] Univ Haifa, Leon H Charney Sch Marine Sci, Dept Marine Biol, IL-31999 Haifa, Israel; [Pieribone, Vincent A.] Yale Univ, John B Pierce Lab Inc, Dept Cellular & Mol Physiol, New Haven, CT USA; [Gruber, David F.] CUNY Bernard M Baruch Coll, Dept Nat Sci, New York, NY 10010 USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); University of Kansas; University of Haifa; Yale University; The John B Pierce Laboratory, Inc; City University of New York (CUNY) System; Baruch College (CUNY)	Sparks, JS (corresponding author), Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA.	jsparks@amnh.org; davidfgruber@gmail.com	Tchernov, Dan/AAE-2545-2021	Tchernov, Dan/0000-0003-1135-8270; Pieribone, Vincent/0000-0002-5836-5454	American Museum of Natural History; City University of New York; National Science Foundation [DEB-0444842, IOS-0749943, DEB-1258141, MCB-0920572, DRL-1007747, DEB-0732642, DEB-1060869, DEB-1257555]; National Institutes of Health (NIH) [U24NS057631, R01NS083875]; National Geographic Waitt Grants [W101-10, W214-12]; Direct For Biological Sciences [1257555] Funding Source: National Science Foundation; Division Of Environmental Biology [1543654] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1227093] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065110, U24NS057631, R01NS083875] Funding Source: NIH RePORTER	American Museum of Natural History; City University of New York; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Geographic Waitt Grants(National Geographic Society); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Museum of Natural History, City University of New York, National Science Foundation grants DEB-0444842, IOS-0749943, and DEB-1258141 to JSS, MCB-0920572 and DRL-1007747 to DFG, DEB-0732642 and DEB-1060869 to WLS, DEB-1257555 and DEB-1258141 to MPD, WLS, and JSS, National Institutes of Health (NIH) grants U24NS057631 and R01NS083875 to VAP and National Geographic Waitt Grants #W101-10 to DFG and #W214-12 to JSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews K, 2007, BIOL LETTERS, V3, P265, DOI 10.1098/rsbl.2007.0016; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Aquilino SVL, 2011, MOL ECOL RESOUR, V11, P612, DOI 10.1111/j.1755-0998.2011.03000.x; Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; Arnold RJ, 2012, MOL PHYLOGENET EVOL, V62, P117, DOI 10.1016/j.ympev.2011.09.012; Asgharian H, 2011, MOL ECOL RESOUR, V11, P461, DOI 10.1111/j.1755-0998.2011.02989.x; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Davis Matthew P., 2010, P431; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; Douglas RH, 1998, NATURE, V393, P423, DOI 10.1038/30871; Dunlap PV, 2007, CLADISTICS, V23, P507, DOI 10.1111/j.1096-0031.2007.00157.x; Espineira M, 2008, J AGR FOOD CHEM, V56, P10594, DOI 10.1021/jf801728q; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Fu CZ, 2012, MOL PHYLOGENET EVOL, V62, P848, DOI 10.1016/j.ympev.2011.11.031; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gruber DF, 2008, BIOL BULL-US, V215, P143, DOI 10.2307/25470695; Guo Li, 2011, Acta Hydrobiologica Sinica, V35, P449; Haddock SHD, 2005, SCIENCE, V309, P263, DOI 10.1126/science.1110441; Haddock SHD, 2010, P ROY SOC B-BIOL SCI, V277, P1155, DOI 10.1098/rspb.2009.1774; HAWRYSHYN CW, 1992, AM SCI, V80, P164; HEINERMANN PH, 1984, EXP BIOL, V43, P127; Holcroft NI, 2008, ICHTHYOL RES, V55, P274, DOI 10.1007/s10228-007-0026-x; Holcroft NI, 2004, MOL PHYLOGENET EVOL, V32, P749, DOI 10.1016/j.ympev.2004.04.002; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Hubert N, 2010, MOL PHYLOGENET EVOL, V55, P1195, DOI 10.1016/j.ympev.2010.02.023; Ilves KL, 2007, COPEIA, P180, DOI 10.1643/0045-8511(2007)7[180:AHCAHN]2.0.CO;2; Inoue JG, 2004, MOL PHYLOGENET EVOL, V32, P274, DOI 10.1016/j.ympev.2003.11.009; Inoue JG, 2003, MOL BIOL EVOL, V20, P1917, DOI 10.1093/molbev/msg206; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Ishiguro N, 2001, FISHERIES SCI, V67, P474, DOI 10.1046/j.1444-2906.2001.00283.x; Ishiguro NB, 2003, MOL PHYLOGENET EVOL, V27, P476, DOI 10.1016/S1055-7903(02)00418-9; Jaafar TNAM, 2012, PLOS ONE, V7, DOI [DOI 10.1371/journal.pone.0049623, DOI 10.1371/JOURNAL.PONE.0049623]; Jerlov N.G., 1968, OPTICAL OCEANOGRAPHY; Johnsen S. N., 2012, OPTICS LIFE BIOL GUI; Kaeding AJ, 2007, APPL ENVIRON MICROB, V73, P3173, DOI 10.1128/AEM.02212-06; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Lavoue S, 2005, MOL PHYLOGENET EVOL, V37, P165, DOI 10.1016/j.ympev.2005.03.024; Lavoue S, 2008, MOL PHYLOGENET EVOL, V47, P1111, DOI 10.1016/j.ympev.2007.12.002; Lavoue S, 2012, ICHTHYOL RES, V59, P104, DOI 10.1007/s10228-011-0258-7; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Li CH, 2011, MOL PHYLOGENET EVOL, V60, P463, DOI 10.1016/j.ympev.2011.05.004; LOBEL PS, 1978, PAC SCI, V32, P193; Lopez J.A., 2004, COPEIA; Losey GS, 2003, COPEIA, P433, DOI 10.1643/01-053; Marie AD, 2007, CORAL REEFS, V26, P841, DOI 10.1007/s00338-007-0273-3; Marshall J, 1999, CURR BIOL, V9, P755, DOI 10.1016/S0960-9822(99)80336-4; Mathger LM, 2009, J EXP BIOL, V212, P2133, DOI 10.1242/jeb.020800; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; Mecklenburg Catherine W., 2011, Marine Biodiversity, V41, P109, DOI 10.1007/s12526-010-0070-z; Michiels Nico K., 2008, BMC Ecology, V8, P16, DOI 10.1186/1472-6785-8-16; Miya M, 2001, MOL BIOL EVOL, V18, P1993, DOI 10.1093/oxfordjournals.molbev.a003741; Miya M, 2007, ICHTHYOL RES, V54, P323, DOI 10.1007/s10228-007-0408-0; MORIN JG, 1971, J CELL PHYSIOL, V77, P313, DOI 10.1002/jcp.1040770305; Moritz T, 2006, ICHTHYOL EXPLOR FRES, V17, P65; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Near TJ, 2012, MOL PHYLOGENET EVOL, V63, P388, DOI 10.1016/j.ympev.2012.01.011; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quenouille B, 2004, MOL PHYLOGENET EVOL, V31, P66, DOI 10.1016/s1055-7903(03)00278-1; Ribeiro AD, 2012, MOL ECOL RESOUR, V12, P1012, DOI 10.1111/1755-0998.12007; Roa-Varon A, 2009, MOL PHYLOGENET EVOL, V52, P688, DOI 10.1016/j.ympev.2009.03.020; Roth MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01421; Roth MS, 2010, J EXP BIOL, V213, P3644, DOI 10.1242/jeb.040881; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Santini F, 2013, MOL PHYLOGENET EVOL, V66, P153, DOI 10.1016/j.ympev.2012.09.022; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shashar N, 1997, BIOL BULL-US, V193, P207, DOI 10.1086/BBLv193n2p207; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Siebeck UE, 2008, J EXP BIOL, V211, P354, DOI 10.1242/jeb.012880; Smith PJ, 2012, POLAR BIOL, V35, P1297, DOI 10.1007/s00300-012-1173-8; Sparks John S., 2003, Ichthyological Exploration of Freshwaters, V14, P317; Sparks JS, 2005, CLADISTICS, V21, P305, DOI 10.1111/j.1096-0031.2005.00067.x; Sparks JS, 2004, CLADISTICS, V20, P501, DOI 10.1111/j.1096-0031.2004.00038.x; Sparks JS, 2004, MOL PHYLOGENET EVOL, V33, P719, DOI 10.1016/j.ympev.2004.07.002; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Takemura A, 2004, FISH FISH, V5, P317, DOI 10.1111/j.1467-2679.2004.00164.x; Thacker CE, 2005, MOL PHYLOGENET EVOL, V37, P858, DOI 10.1016/j.ympev.2005.05.004; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Theiss SM, 2007, J COMP PHYSIOL A, V193, P67, DOI 10.1007/s00359-006-0171-0; Van-Eyk SM, 2011, J EXP BIOL, V214, P4186, DOI 10.1242/jeb.061853; Varela AI, 2012, MAR BIOL, V159, P1049, DOI 10.1007/s00227-012-1885-x; Vogt A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003766; Vukusic P, 2005, SCIENCE, V310, P1151, DOI 10.1126/science.1116612; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Weigt LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041059; Wucherer MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037913; Yamanoue Y, 2004, ICHTHYOL RES, V51, P269, DOI 10.1007/s10228-004-0218-6; Yamanoue Y, 2007, MOL PHYLOGENET EVOL, V45, P89, DOI 10.1016/j.ympev.2007.03.008; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030621, 10.1371/journal.pone.0039076]; Zhang JB, 2011, BIOCHEM SYST ECOL, V39, P31, DOI 10.1016/j.bse.2010.12.017; Zwickl D., 2006, GARLI GENETIC ALGORI	103	99	99	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83259	10.1371/journal.pone.0083259	http://dx.doi.org/10.1371/journal.pone.0083259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421880	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500040
J	Yoshimura, S; Tsunoda, T; Osawa, R; Harada, M; Watanabe, T; Hikichi, T; Katsuda, M; Miyazawa, M; Tani, M; Iwahashi, M; Takeda, K; Katagiri, T; Nakamura, Y; Yamaue, H				Yoshimura, Sachiko; Tsunoda, Takuya; Osawa, Ryuji; Harada, Makiko; Watanabe, Tomohisa; Hikichi, Tetsuro; Katsuda, Masahiro; Miyazawa, Motoki; Tani, Masaji; Iwahashi, Makoto; Takeda, Kazuyoshi; Katagiri, Toyomasa; Nakamura, Yusuke; Yamaue, Hiroki			Identification of an HLA-A2-Restricted Epitope Peptide Derived from Hypoxia-Inducible Protein 2 (HIG2)	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; CYTOTOXIC T-LYMPHOCYTES; INTERFERON-ALPHA; CLINICAL-TRIAL; DOUBLE-BLIND; HLA-B; CANCER; EXPRESSION; GENE; IMMUNOTHERAPY	We herein report the identification of an HLA-A2 supertype-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2), which is known to be a diagnostic marker and a potential therapeutic target for renal cell carcinoma. Among several candidate peptides predicted by the HLA-binding prediction algorithm, HIG2-9-4 peptide (VLNLYLLGV) was able to effectively induce peptide-specific cytotoxic T lymphocytes (CTLs). The established HIG2-9-4 peptide-specific CTL clone produced interferon-gamma (IFN-gamma) in response to HIG2-9-4 peptide-pulsed HLA-A*02:01-positive cells, as well as to cells in which HLA-A*02:01 and HIG2 were exogenously introduced. Moreover, the HIG2-9-4 peptide-specific CTL clone exerted cytotoxic activity against HIG2-expressing HLA-A*02:01-positive renal cancer cells, thus suggesting that the HIG2-9-4 peptide is naturally presented on HLA-A*02:01 of HIG-2-expressing cancer cells and is recognized by CTLs. Furthermore, we found that the HIG2-9-4 peptide could also induce CTLs under HLA-A*02: 06 restriction. Taken together, these findings indicate that the HIG2-9-4 peptide is a novel HLA-A2 supertype-restricted epitope peptide that could be useful for peptide-based immunotherapy against cancer cells with HIG2 expression.	[Yoshimura, Sachiko; Tsunoda, Takuya; Osawa, Ryuji; Katsuda, Masahiro; Miyazawa, Motoki; Tani, Masaji; Iwahashi, Makoto; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; [Tsunoda, Takuya; Katagiri, Toyomasa; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Takeda, Kazuyoshi] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Katagiri, Toyomasa] Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima 770, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Wakayama Medical University; University of Tokyo; Juntendo University; Tokushima University; University of Chicago	Yamaue, H (corresponding author), Wakayama Med Univ, Dept Surg 2, Wakayama, Japan.	yamaue-h@wakayama-med.ac.jp			Grants-in-Aid for Scientific Research [24791390, 23300355] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amato RJ, 2009, J IMMUNOTHER, V32, P765, DOI 10.1097/CJI.0b013e3181ace876; Atzpodien J, 2004, J CLIN ONCOL, V22, P1188, DOI 10.1200/JCO.2004.06.155; Bleumer I, 2007, J IMMUNOTHER, V30, P116, DOI 10.1097/01.cji.0000211318.22902.ec; BOON T, 1993, INT J CANCER, V54, P177, DOI 10.1002/ijc.2910540202; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; CELIS E, 1994, P NATL ACAD SCI USA, V91, P2105, DOI 10.1073/pnas.91.6.2105; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Denko N, 2000, CLIN CANCER RES, V6, P480; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2009, J CLIN ONCOL, V27, P1280, DOI 10.1200/JCO.2008.19.3342; Fleischhauer K, 1997, J IMMUNOL, V159, P2513; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kono K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-141; McDermott DF, 2009, CANCER-AM CANCER SOC, V115, P2298, DOI 10.1002/cncr.24236; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; National Comprehensive Cancer Network, 2012, NCCN CLIN PRACT GUID; Obara W, 2012, JPN J CLIN ONCOL, V42, P591, DOI 10.1093/jjco/hys069; Okuno K, 2011, EXP THER MED, V2, P73, DOI 10.3892/etm.2010.182; Patil S, 2010, CANCER-AM CANCER SOC, V116, P347, DOI 10.1002/cncr.24713; Pecher G, 2002, CANCER IMMUNOL IMMUN, V51, P669, DOI 10.1007/s00262-002-0317-z; Rimoldi D, 2000, J IMMUNOL, V165, P7253, DOI 10.4049/jimmunol.165.12.7253; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2003, CLIN CANCER RES, V9, P2973; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Seo T, 2010, ONCOL LETT, V1, P697, DOI 10.3892/ol_00000122; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; SPARANO JA, 1993, J CLIN ONCOL, V11, P1969, DOI 10.1200/JCO.1993.11.10.1969; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Suda T, 2007, CANCER SCI, V98, P1803, DOI 10.1111/j.1349-7006.2007.00603.x; Takeda K, 2004, J EXP MED, V199, P437, DOI 10.1084/jem.20031457; Togashi A, 2005, CANCER RES, V65, P4817, DOI 10.1158/0008-5472.CAN-05-0120; TSOMIDES TJ, 1994, J EXP MED, V180, P1283, DOI 10.1084/jem.180.4.1283; Tsuji T, 2011, J IMMUNOL, V186, P1218, DOI 10.4049/jimmunol.1000808; Uchida N, 2004, CLIN CANCER RES, V10, P8577, DOI 10.1158/1078-0432.CCR-04-0104	46	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85267	10.1371/journal.pone.0085267	http://dx.doi.org/10.1371/journal.pone.0085267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416375	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500232
J	Desai, SS; Modali, SD; Parekh, VI; Kebebew, E; Agarwal, SK				Desai, Shruti S.; Modali, Sita D.; Parekh, Vaishali I.; Kebebew, Electron; Agarwal, Sunita K.			GSK-3 beta Protein Phosphorylates and Stabilizes HLXB9 Protein in Insulinoma Cells to Form a Targetable Mechanism of Controlling Insulinoma Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Neuroendocrinology; Pancreatic Islets; Proliferation; Tumor; GSK-3; HLXB9; Insulinoma; MEN1; Menin	MULTIPLE-ENDOCRINE-NEOPLASIA; GLYCOGEN-SYNTHASE KINASE-3-BETA; MOLECULAR PATHOGENESIS; TYPE-1; MENIN; GENE; EXPRESSION; INACTIVATION; SUPPRESSION; PANCREAS	Background: Germ line heterozygous loss of the MEN1 tumor suppressor gene causes tissue-specific tumors such as insulinomas. Results: GSK-3 and GSK-3-mediated phosphorylation of HLXB9, a -cell differentiation factor, is elevated in insulinomas, and GSK-3 inhibition blocks insulinoma cell proliferation. Conclusion: GSK-3 and phospho-HLXB9 form a targetable mechanism of insulinoma pathogenesis. Significance: Reactivation of a tissue-specific differentiation factor accounts for tumor tissue specificity. Insulinomas (pancreatic islet cell tumors) are the most common type of functioning pancreatic neuroendocrine tumors that occur sporadically or as a part of the MEN1 syndrome that is caused by germ line mutations in MEN1. Tissue-specific tumor predisposition from germ line mutations in ubiquitously expressed genes such as MEN1 could occur because of functional consequences on tissue-specific factors. We previously reported the proapoptotic cell differentiation factor HLXB9 as a downstream target of menin (encoded by MEN1). Here we show that GSK-3 inactivates the proapoptotic activity of HLXB9 by phosphorylating HLXB9 at Ser-78/Ser-80 (pHLXB9). Although HLXB9 is found in the nucleus and cytoplasm, pHLXB9 is predominantly nuclear. Both pHLXB9 and active GSK-3 are elevated in cells with menin knockdown, in MEN1-associated cell tumors (insulinomas), and also in human sporadic insulinomas. Pharmacologic inhibition of GSK-3 blocked cell proliferation in three different rodent insulinoma cell lines by arresting the cells in G(2)/M phase and caused apoptosis. Taken together, these data suggest that the combination of GSK-3 and pHLXB9 forms a therapeutically targetable mechanism of insulinoma pathogenesis. Our results reveal that GSK-3 and pHLXB9 can serve as novel targets for insulinoma treatment and have implications for understanding the pathways associated with cell proliferation.	[Desai, Shruti S.; Modali, Sita D.; Parekh, Vaishali I.; Agarwal, Sunita K.] NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; [Kebebew, Electron] NCI, Endocrine Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Agarwal, SK (corresponding author), NIH, Bldg 10,Rm 8C-101, Bethesda, MD 20892 USA.	sunitaa@mail.nih.gov	Agarwal, Sunita K/D-1428-2016	Agarwal, Sunita K/0000-0002-7557-3191; Desai, Shruti/0000-0002-5234-5890	NIDDK, National Institutes of Health [1ZIADK07503503]; NCI, National Institutes of Health [1ZIABC01127503]; NATIONAL CANCER INSTITUTE [ZIABC011286, ZIABC011275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075085] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Intramural Program Grant 1ZIADK07503503 (to S. K. A.) and NCI, National Institutes of Health Grant 1ZIABC01127503 (to E. K.).	Agarwal SK, 2013, FRONT HORM RES, V41, P1, DOI 10.1159/000345666; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Chen G, 2008, MOL CANCER RES, V6, P1894, DOI 10.1158/1541-7786.MCR-07-2206; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217; Greenblatt DY, 2010, AM J TRANSL RES, V2, P248; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Jensen RI, 2008, CANCER-AM CANCER SOC, V113, P1807, DOI 10.1002/cncr.23648; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kunnimalaiyaan M, 2007, MOL CANCER THER, V6, P1151, DOI 10.1158/1535-7163.MCT-06-0665; Li H, 2001, DEV BIOL, V240, P247, DOI 10.1006/dbio.2001.0440; Li H, 1999, NAT GENET, V23, P67; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; O'Dowd JF, 2009, METHODS MOL BIOL, V560, P37, DOI 10.1007/978-1-59745-448-3_3; Oberg K, 2013, CLIN CANCER RES, V19, P2842, DOI 10.1158/1078-0432.CCR-12-3458; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Piret SE, 2011, J ENDOCRINOL, V211, P211, DOI 10.1530/JOE-11-0193; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Scacheri PC, 2004, MAMM GENOME, V15, P872, DOI 10.1007/s00335-004-2395-z; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Semache M, 2013, J BIOL CHEM, V288, P24825, DOI 10.1074/jbc.M113.495945; Shen HCJ, 2010, ENDOCRINOLOGY, V151, P4024, DOI 10.1210/en.2009-1251; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; Shi K, 2013, ENDOCR-RELAT CANCER, V20, P111, DOI 10.1530/ERC-12-0077; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sukhodolets KE, 2003, MOL CELL BIOL, V23, P493, DOI 10.1128/MCB.23.2.493-509.2003; Sutherland C, 2011, INT J ALZHEIMERS DIS; Thakker RV, 2012, J CLIN ENDOCR METAB, V97, P2990, DOI 10.1210/jc.2012-1230; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Zhuang ZP, 1997, CANCER RES, V57, P4682	40	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5386	5398		10.1074/jbc.M113.533612	http://dx.doi.org/10.1074/jbc.M113.533612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425879	Green Published, hybrid			2022-12-25	WOS:000332015500004
J	Liang, T; Xie, L; Chao, C; Kang, YH; Lin, XG; Qin, TR; Xie, HL; Feng, ZP; Gaisano, HY				Liang, Tao; Xie, Li; Chao, Christin; Kang, Youhou; Lin, Xianguang; Qin, Tairan; Xie, Huanli; Feng, Zhong-Ping; Gaisano, Herbert Y.			Phosphatidylinositol 4,5-Biphosphate (PIP2) Modulates Interaction of Syntaxin-1A with Sulfonylurea Receptor 1 to Regulate Pancreatic beta-Cell ATP-sensitive Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Insulin Secretion; Phospholipid; Plasma Membrane; Potassium Channels; SNARE Proteins; ATP-sensitive Potassium Channel; Kir6; 2; PIP2; SUR1; Syntaxin-1A	NUCLEOTIDE-BINDING FOLDS; INSULIN-SECRETION; MEMBRANE-FUSION; PLASMA-MEMBRANE; K+ CHANNELS; PHOSPHOINOSITIDES; 4,5-BISPHOSPHATE; PROTEINS; TRAFFICKING; CHOLESTEROL	In beta-cells, syntaxin (Syn)-1A interacts with SUR1 to inhibit ATP-sensitive potassium channels (K-ATP channels). PIP2 binds the Kir6.2 subunit to open K-ATP channels. PIP2 also modifies Syn-1A clustering in plasma membrane (PM) that may alter Syn-1A actions on PM proteins like SUR1. Here, we assessed whether the actions of PIP2 on activating K-ATP channels is contributed by sequestering Syn-1A from binding SUR1. In vitro binding showed that PIP2 dose-dependently disrupted Syn-1A center dot SUR1 complexes, corroborated by an in vivo Forster resonance energy transfer assay showing disruption of SUR1(-EGFP)/Syn-1A(-mCherry) interaction along with increased Syn-1A cluster formation. Electrophysiological studies of rat beta-cells, INS-1, and SUR1/Kir6.2-expressing HEK293 cells showed that PIP2 dose-dependent activation of K-ATP currents was uniformly reduced by Syn-1A. To unequivocally distinguish between PIP2 actions on Syn-1A and Kir6.2, we employed several strategies. First, we showed that PIP2-insensitive Syn-1A-5RK/A mutant complex with SUR1 could not be disrupted by PIP2, consequently reducing PIP2 activation of K-ATP channels. Next, Syn-1A center dot SUR1 complex modulation of K-ATP channels could be observed at a physiologically low PIP2 concentration that did not disrupt the Syn-1A center dot SUR1 complex, compared with higher PIP2 concentrations acting directly on Kir6.2. These effects were specific to PIP2 and not observed with physiologic concentrations of other phospholipids. Finally, depleting endogenous PIP2 with polyphosphoinositide phosphatase synaptojanin-1, known to disperse Syn-1A clusters, freed Syn-1A from Syn-1A clusters to bind SUR1, causing inhibition of K-ATP channels that could no longer be further inhibited by exogenous Syn-1A. These results taken together indicate that PIP2 affects islet beta-cell K-ATP channels not only by its actions on Kir6.2 but also by sequestering Syn-1A to modulate Syn-1A availability and its interactions with SUR1 on PM.	[Liang, Tao; Xie, Li; Chao, Christin; Kang, Youhou; Lin, Xianguang; Qin, Tairan; Xie, Huanli; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Chao, Christin; Feng, Zhong-Ping; Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Gaisano, HY (corresponding author), Univ Toronto, 1 Kings Coll Circle,Rm 7368, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes of Health Research [MOP 69083]; Canadian Foundation for Innovation; Ontario Research Fund [19442]; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund; Canadian Diabetes Association	This work was supported by Canadian Institutes of Health Research Grant MOP 69083 (to H. Y. G.) and by an equipment grant to the 3D (Diet, Digestive Tract, and Disease) Centre from the Canadian Foundation for Innovation and Ontario Research Fund (Project 19442).; Supported by a fellowship from the Canadian Diabetes Association.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Chang N, 2011, J BIOL CHEM, V286, P23308, DOI 10.1074/jbc.M111.217950; Chao C, 2011, J MOL CELL CARDIOL, V51, P790, DOI 10.1016/j.yjmcc.2011.08.011; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Cremona O, 2001, J CELL SCI, V114, P1041; Cui NG, 2004, J BIOL CHEM, V279, P53259, DOI 10.1074/jbc.M410171200; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Kang YH, 2004, J BIOL CHEM, V279, P47125, DOI 10.1074/jbc.M404954200; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Murray DH, 2011, BIOCHEMISTRY-US, V50, P9014, DOI 10.1021/bi201307u; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Olsen HL, 2003, P NATL ACAD SCI USA, V100, P5187, DOI 10.1073/pnas.0931282100; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Pasyk EA, 2004, J BIOL CHEM, V279, P4234, DOI 10.1074/jbc.M309667200; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545	39	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6028	6040		10.1074/jbc.M113.511808	http://dx.doi.org/10.1074/jbc.M113.511808			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24429282	Green Published, hybrid			2022-12-25	WOS:000332015500058
J	Lalioti, VS; Ilari, A; O'Connell, DJ; Poser, E; Sandoval, IV; Colotti, G				Lalioti, Vasiliki S.; Ilari, Andrea; O'Connell, David J.; Poser, Elena; Sandoval, Ignacio V.; Colotti, Gianni			Sorcin Links Calcium Signaling to Vesicle Trafficking, Regulates Polo-Like Kinase 1 and Is Necessary for Mitosis	PLOS ONE			English	Article							BINDING PROTEIN; ANNEXIN-VII; AURORA-A; MULTIDRUG-RESISTANCE; CRYSTAL-STRUCTURE; UP-REGULATION; CA2+ CURRENT; CELL; IDENTIFICATION; LOCALIZATION	Sorcin, a protein overexpressed in many multi-drug resistant cancers, dynamically localizes to distinct subcellular sites in 3T3-L1 fibroblasts during cell-cycle progression. During interphase sorcin is in the nucleus, in the plasma membrane, in endoplasmic reticulum (ER) cisternae, and in ER-derived vesicles localized along the microtubules. These vesicles are positive to RyR, SERCA, calreticulin and Rab10. At the beginning of mitosis, sorcin-containing vesicles associate with the mitotic spindle, and during telophase are concentrated in the cleavage furrow and, subsequently, in the midbody. Sorcin regulates dimensions and calcium load of the ER vesicles by inhibiting RYR and activating SERCA. Analysis of sorcin interactome reveals calcium-dependent interactions with many proteins, including Polo-like kinase 1 (PLK1), Aurora A and Aurora B kinases. Sorcin interacts physically with PLK1, is phosphorylated by PLK1 and induces PLK1 autophosphorylation, thereby regulating kinase activity. Knockdown of sorcin results in major defects in mitosis and cytokinesis, increase in the number of rounded polynucleated cells, blockage of cell progression in G2/M, apoptosis and cell death. Sorcin regulates calcium homeostasis and is necessary for the activation of mitosis and cytokinesis.	[Lalioti, Vasiliki S.; Sandoval, Ignacio V.] CSIC Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Celular & Inmunol, Cantoblanco Ctr Invest Biomed Red Enfermedades He, Madrid, Spain; [Ilari, Andrea; Colotti, Gianni] Univ Roma La Sapienza, CNR Natl Res Council Italy, Inst Mol Biol & Pathol, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [O'Connell, David J.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Poser, Elena] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; University College Dublin; Sapienza University Rome	Lalioti, VS (corresponding author), CSIC Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Dept Biol Celular & Inmunol, Cantoblanco Ctr Invest Biomed Red Enfermedades He, Madrid, Spain.	vlalioti@cbm.uam.es; gianni.colotti@uniroma1.it	Colotti, Gianni/AAG-4918-2019; Ilari, Andrea/AAC-7670-2022; Colotti, Gianni/D-2015-2010; Ilari, Andrea/T-5501-2017	Ilari, Andrea/0000-0002-7754-399X; Colotti, Gianni/0000-0002-9913-0635; Ilari, Andrea/0000-0002-7754-399X; O'Connell, David/0000-0002-6461-7750; LALIOTI, VASILIKI/0000-0002-4273-6126	Fondo de Investigaciones Sanitarias de Espana [PI11/00922]; PRIN MIUR; Italian Ministry of Economy and Finance; Progetto Bandiera CNR Nanomax Nadine [P2010IT01]	Fondo de Investigaciones Sanitarias de Espana(Spanish Government); PRIN MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Economy and Finance; Progetto Bandiera CNR Nanomax Nadine	This work was supported by grants PI11/00922 Fondo de Investigaciones Sanitarias de Espana, PRIN 2007 MIUR, funds from Italian Ministry of Economy and Finance to the CNR for the Project FaReBio di Qualita (qPMO), Progetto Bandiera CNR Nanomax Nadine, P2010IT01 cooperation CSIC-CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DF, 2007, J MOL CELL CARDIOL, V43, P492, DOI 10.1016/j.yjmcc.2007.07.003; Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Babbey CM, 2010, AM J PHYSIOL-RENAL, V299, P12; Barr FA, 2005, METHOD ENZYMOL, V403, P391, DOI 10.1016/S0076-6879(05)03034-X; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colotti G, 2006, BIOCHEMISTRY-US, V45, P12519, DOI 10.1021/bi060416a; Deng LM, 2010, MED ONCOL, V27, P1102, DOI 10.1007/s12032-009-9342-5; Dickson EJ, 2012, P NATL ACAD SCI USA, V109, pE3539, DOI 10.1073/pnas.1218247109; DWYER N, 1976, J CELL BIOL, V70, P581, DOI 10.1083/jcb.70.3.581; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; English AR, 2013, NAT CELL BIOL, V15, P169, DOI 10.1038/ncb2647; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Fowler MR, 2009, PFLUG ARCH EUR J PHY, V457, P1049, DOI 10.1007/s00424-008-0575-5; Fowler MR, 2008, EXP PHYSIOL, V93, P1233, DOI 10.1113/expphysiol.2008.043497; Franceschini S, 2008, FASEB J, V22, P295, DOI 10.1096/fj.07-8988com; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; He QC, 2011, ONCOL REP, V25, P237, DOI 10.3892/or_00001066; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ilari A, 2002, J MOL BIOL, V317, P447, DOI 10.1006/jmbi.2002.5417; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KAO JPY, 1990, J CELL BIOL, V111, P183, DOI 10.1083/jcb.111.1.183; Kawakami M, 2007, BIOL PHARM BULL, V30, P1065, DOI 10.1248/bpb.30.1065; KEITH CH, 1985, NATURE, V316, P848, DOI 10.1038/316848a0; Lalioti V, 2009, P NATL ACAD SCI USA, V106, P4249, DOI 10.1073/pnas.0900218106; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Landriscina M, 2010, CANCER RES, V70, P6577, DOI 10.1158/0008-5472.CAN-10-1256; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Maddalena F, 2011, CANCER RES, V71, P7659, DOI 10.1158/0008-5472.CAN-11-2172; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Matsumoto T, 2005, BASIC RES CARDIOL, V100, P250, DOI 10.1007/s00395-005-0518-7; Mella M, 2003, J BIOL CHEM, V278, P24921, DOI 10.1074/jbc.M213276200; MEYERS MB, 1987, BIOCHEM PHARMACOL, V36, P2373, DOI 10.1016/0006-2952(87)90606-X; MEYERS MB, 1995, FEBS LETT, V357, P230, DOI 10.1016/0014-5793(94)01338-2; Nagpal JK, 2007, EUR J CLIN INVEST, V37, P658, DOI 10.1111/j.1365-2362.2007.01841.x; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Connell DJ, 2010, MOL CELL PROTEOMICS, V9, P1118, DOI 10.1074/mcp.M900324-MCP200; OHTA Y, 1990, P NATL ACAD SCI USA, V87, P5341, DOI 10.1073/pnas.87.14.5341; Padar S, 2004, BRIT J PHARMACOL, V142, P305, DOI 10.1038/sj.bjp.0705755; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Perales C, 2013, J VIROL, V87, P7593, DOI 10.1128/JVI.02824-12; Pickel VM, 1997, J COMP NEUROL, V386, P625, DOI 10.1002/(SICI)1096-9861(19971006)386:4<625::AID-CNE8>3.0.CO;2-4; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; POENIE M, 1986, SCIENCE, V233, P886, DOI 10.1126/science.3755550; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Qi J, 2006, BIOCHEM BIOPH RES CO, V349, P303, DOI 10.1016/j.bbrc.2006.08.042; Qu YQ, 2010, MED ONCOL, V27, P1303, DOI 10.1007/s12032-009-9379-5; RATAN RR, 1986, P NATL ACAD SCI USA, V83, P5136, DOI 10.1073/pnas.83.14.5136; Salzer U, 2002, BLOOD, V99, P2569, DOI 10.1182/blood.V99.7.2569; Schmit TL, 2012, CANCER RES, V72, P3864, DOI 10.1158/0008-5472.CAN-12-0714; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Suarez J, 2013, AM J PHYSIOL-CELL PH, V304, pC248, DOI 10.1152/ajpcell.00039.2012; Szulc Jolanta, 2008, V434, P291, DOI 10.1007/978-1-60327-248-3_18; Tan YH, 2003, LEUKEMIA RES, V27, P125, DOI 10.1016/S0145-2126(02)00083-8; TOMBES RM, 1989, J CELL BIOL, V109, P627, DOI 10.1083/jcb.109.2.627; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; VANDERBLIEK AM, 1988, CANCER RES, V48, P5927; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yang YX, 2008, J CELL BIOCHEM, V104, P1010, DOI 10.1002/jcb.21687; Yokota T, 2006, ACTA NEUROPATHOL, V111, P29, DOI 10.1007/s00401-005-1085-6; Zamparelli C, 1997, FEBS LETT, V409, P1, DOI 10.1016/S0014-5793(97)00464-X; Zhao P, 2010, CHEM-BIOL INTERACT, V186, P166, DOI 10.1016/j.cbi.2010.04.015; Zhou Y, 2006, LEUKEMIA RES, V30, P469, DOI 10.1016/j.leukres.2005.08.024	71	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85438	10.1371/journal.pone.0085438	http://dx.doi.org/10.1371/journal.pone.0085438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427308	Green Published, gold			2022-12-25	WOS:000329868200049
J	Mahajan, IM; Chen, MD; Muro, I; Robertson, JD; Wright, CW; Bratton, SB				Mahajan, Indra M.; Chen, Miao-Der; Muro, Israel; Robertson, John D.; Wright, Casey W.; Bratton, Shawn B.			BH3-Only Protein BIM Mediates Heat Shock-Induced Apoptosis	PLOS ONE			English	Article							STRESS-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; CELL-DEATH; MITOCHONDRIAL PERMEABILIZATION; MEMBRANE PERMEABILIZATION; BCL-2 PROTEINS; CASPASE-2; BAX; ACTIVATION; COMPLEX	Acute heat shock can induce apoptosis through a canonical pathway involving the upstream activation of caspase-2, followed by BID cleavage and stimulation of the intrinsic pathway. Herein, we report that the BH3-only protein BIM, rather than BID, is essential to heat shock-induced cell death. We observed that BIM-deficient cells were highly resistant to heat shock, exhibiting short and long-term survival equivalent to Bax(-/-)Bak(-/-) cells and better than either Bid(-/-) or dominantnegative caspase-9-expressing cells. Only Bim(-/-) and Bax(-/-)Bak(-/-) cells exhibited resistance to mitochondrial outer membrane permeabilization and loss of mitochondrial inner membrane potential. Moreover, while dimerized caspase-2 failed to induce apoptosis in Bid(-/-) cells, it readily did so in Bim(-/-) cells, implying that caspase-2 kills exclusively through BID, not BIM. Finally, BIM reportedly associates with MCL-1 following heat shock, and Mcl-1(-/-) cells were indeed sensitized to heat shock-induced apoptosis. However, pharmacological inhibition of BCL-2 and BCL-XL with ABT-737 also sensitized cells to heat shock, most likely through liberation of BIM. Thus, BIM mediates heat shock-induced apoptosis through a BAX/BAK-dependent pathway that is antagonized by antiapoptotic BCL-2 family members.	[Mahajan, Indra M.; Chen, Miao-Der; Bratton, Shawn B.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Mahajan, Indra M.; Chen, Miao-Der; Muro, Israel; Wright, Casey W.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Kansas; University of Kansas Medical Center	Bratton, SB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX USA.	sbbratton@mdanderson.org		Wright, Casey/0000-0002-9512-1264; Bratton, Shawn/0000-0003-2895-5020	National Institutes of Health [CA129521, GM096101]; NATIONAL CANCER INSTITUTE [R01CA129521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by R01 grants, CA129521 and GM096101, from the National Institutes of Health (all to SBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Bratton SB, 2001, TRENDS PHARMACOL SCI, V22, P306, DOI 10.1016/S0165-6147(00)01718-1; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chigancas V, 2000, CANCER RES, V60, P2458; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Milleron RS, 2006, J BIOL CHEM, V281, P16991, DOI 10.1074/jbc.M512754200; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Parsons MJ, 2013, CELL DEATH IN PRESS; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Shelton SN, 2010, J BIOL CHEM, V285, P40525, DOI 10.1074/jbc.M110.167635; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Troy CM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.138pe42; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	44	11	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84388	10.1371/journal.pone.0084388	http://dx.doi.org/10.1371/journal.pone.0084388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427286	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200026
J	Rupp, O; Becker, J; Brinkrolf, K; Timmermann, C; Borth, N; Puhler, A; Noll, T; Goesmann, A				Rupp, Oliver; Becker, Jennifer; Brinkrolf, Karina; Timmermann, Christina; Borth, Nicole; Puehler, Alfred; Noll, Thomas; Goesmann, Alexander			Construction of a Public CHO Cell Line Transcript Database Using Versatile Bioinformatics Analysis Pipelines	PLOS ONE			English	Article							RNA; SEQUENCE; GENERATION; ALIGNMENT; PROTEIN; PLATFORM; PROGRAM; BLAST	Chinese hamster ovary (CHO) cell lines represent the most commonly used mammalian expression system for the production of therapeutic proteins. In this context, detailed knowledge of the CHO cell transcriptome might help to improve biotechnological processes conducted by specific cell lines. Nevertheless, very few assembled cDNA sequences of CHO cells were publicly released until recently, which puts a severe limitation on biotechnological research. Two extended annotation systems and web-based tools, one for browsing eukaryotic genomes (GenDBE) and one for viewing eukaryotic transcriptomes (SAMS), were established as the first step towards a publicly usable CHO cell genome/transcriptome analysis platform. This is complemented by the development of a new strategy to assemble the ca. 100 million reads, sequenced from a broad range of diverse transcripts, to a high quality CHO cell transcript set. The cDNA libraries were constructed from different CHO cell lines grown under various culture conditions and sequenced using Roche/454 and Illumina sequencing technologies in addition to sequencing reads from a previous study. Two pipelines to extend and improve the CHO cell line transcripts were established. First, de novo assemblies were carried out with the Trinity and Oases assemblers, using varying k-mer sizes. The resulting contigs were screened for potential CDS using ESTScan. Redundant contigs were filtered out using cd-hit-est. The remaining CDS contigs were re-assembled with CAP3. Second, a reference-based assembly with the TopHat/Cufflinks pipeline was performed, using the recently published draft genome sequence of CHO-K1 as reference. Additionally, the de novo contigs were mapped to the reference genome using GMAP and merged with the Cufflinks assembly using the cuffmerge software. With this approach 28,874 transcripts located on 16,492 gene loci could be assembled. Combining the results of both approaches, 65,561 transcripts were identified for CHO cell lines, which could be clustered by sequence identity into 17,598 gene clusters.	[Rupp, Oliver; Becker, Jennifer; Brinkrolf, Karina; Puehler, Alfred; Noll, Thomas; Goesmann, Alexander] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Rupp, Oliver; Becker, Jennifer; Timmermann, Christina; Noll, Thomas] Univ Bielefeld, D-33615 Bielefeld, Germany; [Borth, Nicole] Univ Bodenkultur Wien, Dept Biotechnol, Vienna, Austria; [Borth, Nicole] ACIB, Graz, Austria; [Borth, Nicole] ACIB, Vienna, Austria; [Rupp, Oliver; Goesmann, Alexander] Univ Giessen, D-35390 Giessen, Germany	University of Bielefeld; University of Bielefeld; University of Natural Resources & Life Sciences, Vienna; Austrian Centre of Industrial Biotechnology; Austrian Centre of Industrial Biotechnology; Justus Liebig University Giessen	Rupp, O (corresponding author), Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany.	oliver@cebitec.uni-bielefeld.de	Noll, Thomas/A-3539-2012	Noll, Thomas/0000-0003-0748-3423; Puhler, Alfred/0000-0003-4723-2960; Borth, Nicole/0000-0001-6324-9338; Rupp, Oliver/0000-0003-2755-6458; Goesmann, Alexander/0000-0002-7086-2568	European Union; German federal state North Rhine-Westphalia (NRW); CLIB Graduate Cluster Industrial Biotechnology; Ziel2.NRW; European Regional Development Fund; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (MIWF); ACIB; COMET K2 center of the Austrian FFG	European Union(European Commission); German federal state North Rhine-Westphalia (NRW); CLIB Graduate Cluster Industrial Biotechnology; Ziel2.NRW; European Regional Development Fund(European Commission); Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (MIWF); ACIB; COMET K2 center of the Austrian FFG	The project is co-funded by the European Union (European Regional Development Fund - Investing in your future) and the German federal state North Rhine-Westphalia (NRW). JB acknowledges the receipt of a scholarship from the CLIB Graduate Cluster Industrial Biotechnology (http://www.graduatecluster.net/). CT is funded by Ziel2.NRW (http://www.ziel2.nrw.de/), the European Regional Development Fund and Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (MIWF). NB acknowledges funding by ACIB (http://lamp3.tugraz.at/similar to acib/index.php/wbindex/start), a COMET K2 center of the Austrian FFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Becker J, 2011, J BIOTECHNOL, V156, P227, DOI 10.1016/j.jbiotec.2011.09.014; Bekel T, 2009, J BIOTECHNOL, V140, P3, DOI 10.1016/j.jbiotec.2009.01.006; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Boutet E, 2007, PLANT BIOINFORMATICS, P89, DOI DOI 10.1007/978-1-59745-535-0_; Brinkrolf K, 2013, NAT BIOTECHNOL, V31, P694, DOI 10.1038/nbt.2645; Clarke K, 2013, SCI CHINA LIFE SCI, V56, P156, DOI 10.1007/s11427-013-4444-x; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Ernst Wolfgang, 2006, Biotechnology Journal, V1, P639, DOI 10.1002/biot.200600010; Gatti MD, 2007, J BIOSCI BIOENG, V103, P82, DOI 10.1263/jbb.103.82; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grasso C, 2004, BIOINFORMATICS, V20, P1546, DOI 10.1093/bioinformatics/bth126; Grasso C, 2003, BIOINFORMATICS, V19, P1446, DOI 10.1093/bioinformatics/btg175; Hammond S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-67; Hassan MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-696; Hazelhurst S, 2008, BIOINFORMATICS, V24, P1542, DOI 10.1093/bioinformatics/btn203; Haznedaroglu BZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-170; Hide W, 1994, J Comput Biol, V1, P199, DOI 10.1089/cmb.1994.1.199; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jacob NM, 2010, BIOTECHNOL BIOENG, V105, P1002, DOI 10.1002/bit.22588; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975; Kantardjieff A, 2009, BIOTECHNOL ADV, V27, P1028, DOI 10.1016/j.biotechadv.2009.05.023; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Lewis NE, 2013, NAT BIOTECH; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu BX, 2013, SCI CHINA LIFE SCI, V56, P143, DOI 10.1007/s11427-013-4442-z; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Schneider J, 2011, J BIOTECHNOL, V155, P118, DOI 10.1016/j.jbiotec.2010.10.076; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yee JC, 2008, BIOTECHNOL BIOENG, V101, P1359, DOI 10.1002/bit.21984; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	45	51	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85568	10.1371/journal.pone.0085568	http://dx.doi.org/10.1371/journal.pone.0085568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427317	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200058
J	Fiorentino, M; Levine, MM; Sztein, MB; Fasano, A				Fiorentino, Maria; Levine, Myron M.; Sztein, Marcelo B.; Fasano, Alessio			Effect of Wild-Type Shigella Species and Attenuated Shigella Vaccine Candidates on Small Intestinal Barrier Function, Antigen Trafficking, and Cytokine Release	PLOS ONE			English	Article							TIGHT JUNCTION; EPITHELIAL-CELLS; OCCLUDIN PHOSPHORYLATION; RHESUS-MONKEYS; HUMAN-COLON; DYSENTERIAE TYPE-1; FLEXNERI INFECTION; TRAVELERS DIARRHEA; DIVERSE SEROTYPES; ESCHERICHIA-COLI	Bacterial dysentery due to Shigella species is a major cause of morbidity and mortality worldwide. The pathogenesis of Shigella is based on the bacteria's ability to invade and replicate within the colonic epithelium, resulting in severe intestinal inflammatory response and epithelial destruction. Although the mechanisms of pathogenesis of Shigella in the colon have been extensively studied, little is known on the effect of wild-type Shigella on the small intestine and the role of the host response in the development of the disease. Moreover, to the best of our knowledge no studies have described the effects of apically administered Shigella flexneri 2a and S. dysenteriae 1 vaccine strains on human small intestinal enterocytes. The aim of this study was to assess the coordinated functional and immunological human epithelial responses evoked by strains of Shigella and candidate vaccines on small intestinal enterocytes. To model the interactions of Shigella with the intestinal mucosa, we apically exposed monolayers of human intestinal Caco2 cells to increasing bacterial inocula. We monitored changes in paracellular permeability, examined the organization of tight-junctions and the pro-inflammatory response of epithelial cells. Shigella infection of Caco2 monolayers caused severe mucosal damage, apparent as a drastic increase in paracellular permeability and disruption of tight junctions at the cell-cell boundary. Secretion of pro-inflammatory IL-8 was independent of epithelial barrier dysfunction. Shigella vaccine strains elicited a pro-inflammatory response without affecting the intestinal barrier integrity. Our data show that wild-type Shigella infection causes a severe alteration of the barrier function of a small intestinal cell monolayer (a proxy for mucosa) and might contribute (along with enterotoxins) to the induction of watery diarrhea. Diarrhea may be a mechanism by which the host attempts to eliminate harmful bacteria and transport them from the small to the large intestine where they invade colonocytes inducing a strong inflammatory response.	[Fiorentino, Maria; Fasano, Alessio] Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Levine, Myron M.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Levine, Myron M.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Levine, Myron M.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	Harvard University; Massachusetts General Hospital; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Fasano, A (corresponding author), Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA.	afasano@mgh.harvard.edu	Fiorentino, Maria/AAV-9514-2020; Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261; Fiorentino, Maria R/0000-0001-5318-7313	NIAID, NIH, DHHS [U19 AI082655]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090873, U19AI082655] Funding Source: NIH RePORTER	NIAID, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded by NIAID, NIH, DHHS grant U19 AI082655 (Cooperative Center for Translational Research in Human Immunology and Biodefense; CCHI) to M. B. S and A. F. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; BLACK RE, 1984, PEDIATRICS, V73, P799; Cersini A, 1998, INFECT IMMUN, V66, P549, DOI 10.1128/IAI.66.2.549-557.1998; COHEN D, 1991, J CLIN MICROBIOL, V29, P386, DOI 10.1128/JCM.29.2.386-389.1991; Coron E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004713; DINARI G, 1987, J INFECT DIS, V155, P1065, DOI 10.1093/infdis/155.5.1065; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dorfel MJ, 2013, CCS, V11; DUPONT HL, 1972, J INFECT DIS, V125, P12, DOI 10.1093/infdis/125.1.12; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; Faherty C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049980; Farfan MJ, 2011, FEMS IMMUNOL MED MIC, V61, P332, DOI 10.1111/j.1574-695X.2011.00778.x; FASANO A, 1995, J CLIN INVEST, V95, P2853, DOI 10.1172/JCI117991; Fasano A, 1997, GUT, V40, P505, DOI 10.1136/gut.40.4.505; Fiorentino M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00017; Flamant M, 2011, GUT, V60, P473, DOI 10.1136/gut.2010.229237; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Gupta A, 2004, CLIN INFECT DIS, V38, P1372, DOI 10.1086/386326; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Jeong KI, 2010, J INFECT DIS, V201, P903, DOI 10.1086/650995; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; KATAKURA S, 1990, APMIS, V98, P313, DOI 10.1111/j.1699-0463.1990.tb01038.x; Kotloff KL, 2007, HUM VACCINES, V3, P268, DOI 10.4161/hv.4746; KOTLOFF KL, 1995, VACCINE, V13, P495, DOI 10.1016/0264-410X(94)00011-B; KOTLOFF KL, 1995, VACCINE, V13, P1488, DOI 10.1016/0264-410X(95)00102-7; Kotloff KL, 2004, J INFECT DIS, V190, P1745, DOI 10.1086/424680; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LEVINE MM, 1973, J INFECT DIS, V127, P261, DOI 10.1093/infdis/127.3.261; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; LINDBERG AA, 1988, VACCINE, V6, P146, DOI 10.1016/S0264-410X(88)80018-5; LINDBERG AA, 1990, MICROB PATHOGENESIS, V8, P433, DOI 10.1016/0882-4010(90)90030-T; McCarthy KM, 1996, J CELL SCI, V109, P2287; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nandakumar NS, 2009, INDIAN J MED RES, V130, P170; NATARO JP, 1995, INFECT IMMUN, V63, P4721, DOI 10.1128/IAI.63.12.4721-4728.1995; Niyogi SK, 2004, CLIN MICROBIOL INFEC, V10, P574, DOI 10.1111/j.1469-0691.2004.00897.x; NORIEGA FR, 1995, J INFECT DIS, V172, P1408, DOI 10.1093/infdis/172.5.1408; OAKS EV, 1986, INFECT IMMUN, V53, P57, DOI 10.1128/IAI.53.1.57-63.1986; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; PIGNATA S, 1994, CELL GROWTH DIFFER, V5, P967; Porter CK, 2012, EPIDEMIOLOGY INFECT, P1; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; ROUT WR, 1975, GASTROENTEROLOGY, V68, P270; Sakaguchi T, 2002, CELL MICROBIOL, V4, P367, DOI 10.1046/j.1462-5822.2002.00197.x; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Shipley ST, 2010, COMPARATIVE MED, V60, P54; Sundstrom JM, 2009, J PROTEOME RES, V8, P808, DOI 10.1021/pr7007913; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; TAYLOR DN, 1988, JAMA-J AM MED ASSOC, V260, P1245, DOI 10.1001/jama.260.9.1245; TAYLOR DN, 1986, REV INFECT DIS, V8, pS136; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; VASSELON T, 1992, INFECT IMMUN, V60, P1031, DOI 10.1128/IAI.60.3.1031-1040.1992; Venkatesan MM, 2002, INFECT IMMUN, V70, P2950, DOI 10.1128/IAI.70.6.2950-2958.2002; Wong V, 1997, AM J PHYSIOL-CELL PH, V273, pC1859, DOI 10.1152/ajpcell.1997.273.6.C1859; Wu T, 2011, INFECT IMMUN, V79, P4912, DOI 10.1128/IAI.05814-11; Yavzori M, 2002, EPIDEMIOL INFECT, V128, P533, DOI 10.1017/S0950268802006866; Zhang Z, 2001, INFECT IMMUN, V69, P3240, DOI 10.1128/IAI.69.5.3240-3247.2001; Zurawski DV, 2009, MOL MICROBIOL, V71, P350, DOI 10.1111/j.1365-2958.2008.06524.x	63	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85211	10.1371/journal.pone.0085211	http://dx.doi.org/10.1371/journal.pone.0085211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416363	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300055
J	Hsiung, YC; Liu, JJ; Hou, YC; Yeh, CL; Yeh, SL				Hsiung, Yuan-Chin; Liu, Jun-Jen; Hou, Yu-Chen; Yeh, Chiu-Li; Yeh, Sung-Ling			Effects of Dietary Glutamine on the Homeostasis of CD4+T Cells in Mice with Dextran Sulfate Sodium-Induced Acute Colitis	PLOS ONE			English	Article							REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; APOPTOSIS; SUPPLEMENTATION; PROLIFERATION; ACTIVATION; BREAKDOWN; PROFILES	This study investigated the effects of dietary glutamine (Gln) on T-helper (Th) and T regulatory (Treg) cell homeostasis and colonic inflammatory mediator expression in mice with dextran sulfate sodium (DSS)-induced colitis. Mice were randomly assigned to 4 groups with 2 normal control (C and G) and 2 DSS-treated groups (DC and DG). The C and DC groups were fed a common semipurified diet, while the G and DG groups received an identical diet except that part of the casein was replaced by Gln, which provided 25% of the total amino acid nitrogen. Mice were fed the diets for 10 days. On day 6, mice in the normal control groups were given distilled water, while those in the DSS groups were given distilled water containing 1.5% DSS for 5 d. At the end of the experiment, the mice were sacrificed for further examination. Results showed that DC group had higher plasma haptoglobin, colonic weight, immunoglobulin G, inflammatory cytokine and nuclear factor (NF)-kappa B protein levels. Gln administration lowered inflammatory mediators and NF-kappa B/I kappa B alpha ratio in colitis. Compared with the DC group, the percentages of interleukin-17F and interferon-gamma in blood and transcription factors, T-bet and RAR-related orphan receptor-gamma t, gene expressions in mesenteric lymph nodes were lower, whereas blood Foxp3 was higher in the DG group. Also, DG group had lower colon injury score. These results suggest that Gln administration suppressed Th1/Th17 and Th-associated cytokine expressions and upregulated the expression of Tregs, which may modulate the balance of Th/Treg and reduce inflammatory reactions in DSS-induced colitis.	[Hsiung, Yuan-Chin; Yeh, Sung-Ling] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Liu, Jun-Jen] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Hou, Yu-Chen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yeh, Chiu-Li] Chinese Culture Univ, Dept Food & Nutr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Chinese Culture University	Yeh, SL (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan.	sangling@tmu.edu.tw	Liu, Jun-Jen/AAP-1788-2021		National Science Council, Taipei, Taiwan [NSC100-2320-B-038-007-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council grant NSC100-2320-B-038-007-MY3, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Benson JM, 2011, TOXICOL SCI, V120, P68, DOI 10.1093/toxsci/kfq360; Boden EK, 2008, CURR OPIN GASTROEN, V24, P733, DOI 10.1097/MOG.0b013e328311f26e; Boirivant M, 2012, ORAL DIS, V18, P1, DOI 10.1111/j.1601-0825.2011.01811.x; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Chang WK, 2002, CLIN IMMUNOL, V104, P151, DOI 10.1006/clim.2002.5257; Chang WK, 1999, CLIN EXP IMMUNOL, V117, P482, DOI 10.1046/j.1365-2249.1999.01009.x; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; CHOUDARI CP, 1993, GASTROENTEROLOGY, V104, P1064, DOI 10.1016/0016-5085(93)90275-H; Chu CC, 2012, J NUTR BIOCHEM, V23, P1092, DOI 10.1016/j.jnutbio.2011.06.002; Cuzzocrea S, 2003, BRIT J PHARMACOL, V138, P678, DOI 10.1038/sj.bjp.0705077; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Hoebler C, 2006, DIGEST DIS SCI, V51, P381, DOI 10.1007/s10620-006-3142-y; Iba Y, 2003, INT IMMUNOPHARMACOL, V3, P485, DOI 10.1016/S1567-5769(02)00299-0; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kew S, 1999, J NUTR, V129, P1524, DOI 10.1093/jn/129.8.1524; Kim H, 2011, YONSEI MED J, V52, P892, DOI 10.3349/ymj.2011.52.6.892; KINDON H, 1995, GASTROENTEROLOGY, V109, P516, DOI 10.1016/0016-5085(95)90340-2; Kretzmann NA, 2008, INFLAMM BOWEL DIS, V14, P1504, DOI 10.1002/ibd.20543; LACEY JM, 1990, NUTR REV, V48, P297, DOI 10.1111/j.1753-4887.1990.tb02967.x; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Leung JM, 2014, MUCOSAL IMMUNOL, V7, P124, DOI 10.1038/mi.2013.31; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Nielsen OH, 1996, DIGEST DIS SCI, V41, P1786, DOI 10.1007/BF02088746; PARRYBILLINGS M, 1990, LANCET, V336, P523, DOI 10.1016/0140-6736(90)92083-T; Renes IB, 2002, INT J COLORECTAL DIS, V17, P317, DOI 10.1007/s00384-002-0409-4; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616; Singh NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023522; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Takahashi M, 2006, DIGEST DIS SCI, V51, P677, DOI 10.1007/s10620-006-3191-2; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wilmore DW, 2001, J NUTR, V131, p2543S, DOI 10.1093/jn/131.9.2543S; Wischmeyer PE, 1997, AM J PHYSIOL-GASTR L, V272, pG879, DOI 10.1152/ajpgi.1997.272.4.G879; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P188, DOI 10.1177/0148607110381407; Yeh CL, 2006, NUTRITION, V22, P408, DOI 10.1016/j.nut.2005.10.007; Yu QT, 2007, INFLAMM BOWEL DIS, V13, P191, DOI 10.1002/ibd.20053; Zhang N, 2011, MOL CELL BIOCHEM, V353, P41, DOI 10.1007/s11010-011-0772-y	52	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84410	10.1371/journal.pone.0084410	http://dx.doi.org/10.1371/journal.pone.0084410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416230	gold, Green Published, Green Submitted			2022-12-25	WOS:000329866300024
J	Li, XH; Han, YH; Wei, YL; Acharya, A; Farmer, AD; Ho, J; Monteros, MJ; Brummer, EC				Li, Xuehui; Han, Yuanhong; Wei, Yanling; Acharya, Ananta; Farmer, Andrew D.; Ho, Julie; Monteros, Maria J.; Brummer, E. Charles			Development of an Alfalfa SNP Array and Its Use to Evaluate Patterns of Population Structure and Linkage Disequilibrium	PLOS ONE			English	Article							GENOMIC SELECTION; WINTER HARDINESS; MEDICAGO-SATIVA; ASSOCIATION; IDENTIFICATION; COMPLEX; POLYMORPHISM; PERSISTENCE; IMPROVEMENT; RESISTANCE	A large set of genome-wide markers and a high-throughput genotyping platform can facilitate the genetic dissection of complex traits and accelerate molecular breeding applications. Previously, we identified about 0.9 million SNP markers by sequencing transcriptomes of 27 diverse alfalfa genotypes. From this SNP set, we developed an Illumina Infinium array containing 9,277 SNPs. Using this array, we genotyped 280 diverse alfalfa genotypes and several genotypes from related species. About 81% (7,476) of the SNPs met the criteria for quality control and showed polymorphisms. The alfalfa SNP array also showed a high level of transferability for several closely related Medicago species. Principal component analysis and model-based clustering showed clear population structure corresponding to subspecies and ploidy levels. Within cultivated tetraploid alfalfa, genotypes from dormant and nondormant cultivars were largely assigned to different clusters; genotypes from semidormant cultivars were split between the groups. The extent of linkage disequilibrium (LD) across all genotypes rapidly decayed to 26 Kbp at r(2) = 0.2, but the rate varied across ploidy levels and subspecies. A high level of consistency in LD was found between and within the two subpopulations of cultivated dormant and nondormant alfalfa suggesting that genome-wide association studies (GWAS) and genomic selection (GS) could be conducted using alfalfa genotypes from throughout the fall dormancy spectrum. However, the relatively low LD levels would require a large number of markers to fully saturate the genome.	[Li, Xuehui; Han, Yuanhong; Wei, Yanling; Acharya, Ananta; Monteros, Maria J.; Brummer, E. Charles] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK 73401 USA; [Farmer, Andrew D.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Ho, Julie] Forage Genet Int, Davis, CA USA	Noble Research Institute; National Center for Genome Resources (NCGR)	Brummer, EC (corresponding author), Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK 73401 USA.	ecbrummer@noble.org	Li, Xuehui/D-4475-2014	Monteros, Maria/0000-0002-6061-3883	USDA-DOE Plant Feedstock Genomics for Bioenergy program [2009-65504-05809]	USDA-DOE Plant Feedstock Genomics for Bioenergy program	This research was funded by the USDA-DOE Plant Feedstock Genomics for Bioenergy program, award # 2009-65504-05809 to ECB and MJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Barnes DK, 1977, ALF GERMPL US GEN VU; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; Brummer EC, 1999, CROP SCI, V39, P943, DOI 10.2135/cropsci1999.0011183X003900040001x; Castonguay Y, 2006, ADV AGRON, V90, P203, DOI 10.1016/S0065-2113(06)90006-6; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Dekkers JCM, 2002, NAT REV GENET, V3, P22, DOI 10.1038/nrg701; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Han YH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-350; Havananda T, 2011, AM J BOT, V98, P1633, DOI 10.3732/ajb.1000318; Hayes BJ, 2013, PLANT BREEDING, V132, P133, DOI 10.1111/pbr.12037; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Herrmann D, 2010, THEOR APPL GENET, V121, P865, DOI 10.1007/s00122-010-1356-z; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; Hirsch CN, 2013, G3-GENES GENOM GENET, V3, P1003, DOI 10.1534/g3.113.005595; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Khu DM, 2013, CROP SCI, V53, P148, DOI 10.2135/cropsci2012.03.0181; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lamb JFS, 2006, CROP SCI, V46, P902, DOI 10.2135/cropsci2005.08-0236; Li XH, 2012, AGRONOMY-BASEL, V2, P40, DOI 10.3390/agronomy2010040; Li XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-568; Li XH, 2011, PLANT GENOME-US, V4, P24, DOI 10.3835/plantgenome2010.09.0022; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; MarquezOrtiz JJ, 1996, CROP SCI, V36, P766, DOI 10.2135/cropsci1996.0011183X003600030039x; McCaslin MH, 2003, N AM ALF IMPR C BELT; Meuwissen THE, 2001, GENETICS, V157, P1819; Muller MH, 2006, MOL ECOL, V15, P1589, DOI 10.1111/j.1365-294X.2006.02851.x; Musial JM, 2007, THEOR APPL GENET, V114, P1427, DOI 10.1007/s00122-007-0528-y; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Robins JG, 2008, CROP SCI, V48, P1780, DOI 10.2135/cropsci2008.02.0101; Robins JG, 2007, CROP SCI, V47, P1, DOI 10.2135/cropsci2005.11.0401; Sakiroglu M, 2012, THEOR APPL GENET, V125, P577, DOI 10.1007/s00122-012-1854-2; Sakiroglu M, 2010, THEOR APPL GENET, V121, P403, DOI 10.1007/s00122-010-1319-4; Schwab PM, 1996, CROP SCI, V36, P418, DOI 10.2135/cropsci1996.0011183X003600020034x; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; SMALL E, 1988, PLANT SYST EVOL, V160, P195, DOI 10.1007/BF00936047; SORENSEN EL, 1994, CROP SCI, V34, P544, DOI 10.2135/cropsci1994.0011183X003400020059x; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; SVED J A, 1971, Theoretical Population Biology, V2, P125; Teuber LR, 1998, N AM ALF IMPR C BELT; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Volenec J, 2000, REPORT STATUS MEDICA; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277; Zuniga BA, 2004, DEV PLANT BREED, V11, P97	51	45	46	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84329	10.1371/journal.pone.0084329	http://dx.doi.org/10.1371/journal.pone.0084329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416217	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300022
J	Cebotaru, L; Rapino, D; Cebotaru, V; Guggino, WB				Cebotaru, Liudmila; Rapino, Daniele; Cebotaru, Valeriu; Guggino, William B.			Correcting the Cystic Fibrosis Disease Mutant, A455E CFTR	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; MUTATIONS; DELTA-F508; DYSFUNCTION; MECHANISMS; PHENOTYPE; GENE	Cystic fibrosis is caused by more than 1000 mutations, the most common being the Delta F508 mutation. These mutations have been divided into five classes [1], with Delta F508 CFTR in class II. Here we have studied the class V mutation A455E. We report that the mature and immature bands of A455E are rapidly degraded primarily by proteasomes; the short protein half-life of this mutant therefore resembles that of Delta F508 CFTR. A455E could be rescued by treatment of the cells with proteasome inhibitors. Furthermore, co-transfection of A455E with the truncation mutant Delta 264 CFTR also rescued the mature C band, indicating that A455E can be rescued by transcomplementation. We found that Delta 264 CFTR bound to A455E, forming a bimolecular complex. Treatment with the compound correctors C3 and C4 also rescued A455E. These results are significant because they show that although Delta F508 belongs to a different class than A455E, it can be rescued by the same strategies, offering therapeutic promise to patients with Class V mutations.	[Cebotaru, Liudmila; Rapino, Daniele] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cebotaru, Liudmila; Rapino, Daniele; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Cebotaru, Valeriu] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	wguggino@jhmi.edu			CFTR Folding Consortium from Cystic Fibrosis Foundation	CFTR Folding Consortium from Cystic Fibrosis Foundation	This work was supported in part by a CFTR Folding Consortium Grant from the Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Boucher RC, 1996, TRENDS GENET, V12, P81, DOI 10.1016/0168-9525(96)81410-7; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cebotaru L, 2013, J BIOL CHEM, V288, P10505, DOI 10.1074/jbc.M112.420489; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; CUTTING GR, 1993, J BIOENERG BIOMEMBR, V25, P7, DOI 10.1007/BF00768062; DeBraekeleer M, 1997, HUM GENET, V101, P208, DOI 10.1007/s004390050616; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Fischer AC, 2007, MOL THER, V15, P756, DOI 10.1038/sj.mt.6300059; FULMER SB, 1995, P NATL ACAD SCI USA, V92, P6832, DOI 10.1073/pnas.92.15.6832; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Kim SJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00201; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; SHEPPARD DN, 1995, EMBO J, V14, P876, DOI 10.1002/j.1460-2075.1995.tb07069.x; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Stansberg PM, 1997, CLIN CHEM, V43, P1083; Sun F, 2008, FASEB J; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Van Oene M, 2000, J BIOL CHEM, V275, P19577, DOI 10.1074/jbc.M002186200; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85183	10.1371/journal.pone.0085183	http://dx.doi.org/10.1371/journal.pone.0085183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416359	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500224
J	Figueira, M; Moschioni, M; De Angelis, G; Barocchi, M; Sabharwal, V; Masignani, V; Pelton, SI				Figueira, Marisol; Moschioni, Monica; De Angelis, Gabriella; Barocchi, Michele; Sabharwal, Vishakha; Masignani, Vega; Pelton, Stephen I.			Variation of Pneumococcal Pilus-1 Expression Results in Vaccine Escape during Experimental Otitis Media [EOM]	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; STREPTOCOCCUS-PNEUMONIAE; VIRULENCE; MICE	The pneumococcal Pilus-1 enhances attachment to epithelial cells in the respiratory tract and subsequent invasion. Pilus-1 expression is bi-stable and positively regulated by the RlrA transcriptional regulator. To delineate the role of pilus-1 in Experimental Otitis Media (EOM), we evaluated colonization and disease due to a Streptococcus pneumoniae (SP) wild type strain (Taiwan19F-14 wt) and its otherwise isogenic pilus-1 and pilus-2 deficient mutant (Taiwan19F-14 Delta PI-1/PI-2-) as well as potential for a chimeric protein (RrgB321) vaccine candidate for prevention of middle ear (ME) disease. Methods: Chinchillas were challenged intranasally with either Taiwan19F-14 wt or Taiwan19F-14PI-1/PI-2 deficient mutant. ME status was assessed and direct cultures performed. New cohorts of animals were immunized with RrgB321 or alum. Intranasal challenge with Taiwan19F-14 wt [erythromycin susceptible E(S)] was performed. Subsequently, a second cohort of animals was immunized and challenged with either Taiwan19F-14 wt or a Pilus-1 over-expressing mutant [Taiwan19F-14+pMU1328_Pc-rlrA mutant; E resistant (R)] strain. Pilus-1 expression was analyzed in SP isolated from nasopharynx (NP) and ME fluids by flow cytometry. Results: Culture positive EOM developed following challenge with either wild type SP (Taiwan19F-14) or its pilus-1 deficient mutant. Culture positive EOM developed following challenge with wild type in both RrgB321 immunized and control animals. Pilus-1 expression in ME fluids was significantly higher in controls compared to immunized chinchillas. In second cohort of immunized and control animals challenged with the over-expressing Pilus-1 mutant, delayed development of EOM in the immunized animals was observed. Pneumococci recovered from ME fluid of immunized animals were no longer E(R) signifying the loss of the pMU1328_Pc-rlrA plasmid. Conclusion: Pneumococcal pilus-1 was not essential for EOM. Regulation of Pilus-1 expression in ME fluids in the presence of anti RrgB321 antibody was essential for survival of S. pneumoniae. Pneumococci have evolved mechanisms of regulation of non-essential surface proteins to evade host defenses.	[Figueira, Marisol; Sabharwal, Vishakha; Pelton, Stephen I.] Boston Med Ctr, Maxwell Finland Lab Infect Dis, Sect Pediat Infect Dis, Boston, MA 02118 USA; [Moschioni, Monica; De Angelis, Gabriella; Barocchi, Michele; Masignani, Vega] Novartis Vaccines & Diagnost, Siena, Italy	Boston Medical Center; Novartis	Figueira, M (corresponding author), Boston Med Ctr, Maxwell Finland Lab Infect Dis, Sect Pediat Infect Dis, Boston, MA 02118 USA.	Marisol.Figuiera@bmc.org	Sabharwal, Vishakha/GXG-8148-2022	Sabharwal, Vishakha/0000-0002-5092-4442; Pelton, Stephen/0000-0003-4862-5344	Novartis Vaccines and Diagnostics, Siena, Italy	Novartis Vaccines and Diagnostics, Siena, Italy	Supported by a research grant from Novartis Vaccines and Diagnostics, Siena, Italy. This manuscript was a collaboration between Drs. Pelton and Figueira at Boston University and Drs. Barocchi, De Angelis, Moschioni and Masignani at Novartis Vaccines. As such all 6 investigators were involved in study design, analysis, and preparation of the manuscript.	ACHEN MG, 1986, GENE, V45, P45, DOI 10.1016/0378-1119(86)90130-7; Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Babl FE, 2002, ANTIMICROB AGENTS CH, V46, P2194, DOI 10.1128/AAC.46.7.2194-2199.2002; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; De Angelis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021269; Figueira MA, 2007, INFECT IMMUN, V75, P325, DOI 10.1128/IAI.01054-06; KARASIC RB, 1989, PEDIATR INFECT DIS J, V8, pS62; Moschioni M, 2010, CLIN MICROBIOL INFEC, V16, P1501, DOI [10.1111/j.1469-0691.2009.03105.x, 10.1111/j.1469-0691.2010.03105.x]; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Moschioni M, 2012, VACCINE, V30, P1349, DOI 10.1016/j.vaccine.2011.12.080; Pancotto L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02040; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Sabharwal V, 2012, MICROBES INFECT, V14, P712, DOI 10.1016/j.micinf.2012.02.008; Sabharwal V, 2009, INFECT IMMUN, V77, P1121, DOI 10.1128/IAI.01148-08; Shi ZY, 1998, J CLIN MICROBIOL, V36, P3514, DOI 10.1128/JCM.36.12.3514-3519.1998	17	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83798	10.1371/journal.pone.0083798	http://dx.doi.org/10.1371/journal.pone.0083798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421906	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500074
J	Gan, HL; Zhang, JQ; Zhou, QW; Feng, L; Chen, F; Yang, Y				Gan, Hui-Li; Zhang, Jian-Qun; Zhou, Qi-Wen; Feng, Lei; Chen, Fei; Yang, Yi			Patients with Congenital Systemic-to-Pulmonary Shunts and Increased Pulmonary Vascular Resistance: What Predicts Postoperative Survival?	PLOS ONE			English	Article							VENTRICULAR SEPTAL-DEFECT; INHALED NITRIC-OXIDE; THORACIC SURGEONS; SURGICAL CLOSURE; RISK MODELS; HYPERTENSION; REPAIR; CHILDREN; SOCIETY; DISEASE	Background: We carried out a retrospective data review of patients with systemic to pulmonary shunts that underwent surgical repair between February 1990 and February 2012 in order to assess preoperative pulmonary vascular dynamic risk factors for predicting early and late deaths due presumably to pulmonary vascular disease. Methods and Results: A total of 1024 cases of congenital systemic-to-pulmonary shunt and advanced pulmonary vascular disease beyond infancy and early childhood were closed surgically. The mean follow up duration was 8.5 +/- 5.5 (range 0.7 to 20) years. Sixty-one in-hospital deaths (5.96%, 61/1024) occurred after the shunt closure procedure and there were 46 late deaths, yielding 107 total deaths. We analyzed preoperative pulmonary vascular resistance index (PVRI), pulmonary vascular resistance index on pure oxygen challenge (PVRIO), difference between PVRI and PVRIO (PVRID), Qp:Qs, and Rp:Rs as individual risk predictors. The results showed that these individual factors all predicted in-hospital death and total death with PVRIO showing better performance than other risk factors. A multivariable Cox regression model was built, and suggested that PVRID and Qp: Qs were informative factors for predicting survival time from late death and closure of congenital septal defects was safe with a PVRIO<10.3 WU.m(2) and PVRID>7.3 WU.m(2) on 100% oxygen. Conclusions: All 4 variables, PVRI, PVRIO, PVRID and Qp:Qs, should be considered in deciding surgical closure of congenital septal defects and a PVRIO<10.3 WU.m(2) and PVRID>7.3 WU.m(2) on 100% oxygen are associated with a favorable risk benefit profile for the procedure.	[Gan, Hui-Li; Zhang, Jian-Qun; Zhou, Qi-Wen; Feng, Lei; Chen, Fei; Yang, Yi] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China	Capital Medical University	Gan, HL (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	ganhuili@hotmail.com			China Nature Science Foundation Committee [81070041]; Beijing health system special foundation [2013-2-002]; Beijing Science and Technology Project [Z121107001012067]	China Nature Science Foundation Committee; Beijing health system special foundation; Beijing Science and Technology Project	This project was supported by of a grant (#81070041) from the China Nature Science Foundation Committee, a grant (#2013-2-002) from the Beijing health system special foundation for building high-level health personnel, and a grant (#Z121107001012067) from the Beijing Science and Technology Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzer DT, 2002, CIRCULATION, V106, pI76, DOI 10.1161/01.cir.0000032875.55215.cb; Beghetti M, 2012, CONGENIT HEART DIS, V7, P3, DOI 10.1111/j.1747-0803.2011.00611.x; Berner M, 1996, AM J CARDIOL, V77, P532, DOI 10.1016/S0002-9149(97)89353-8; BLACKSTONE EH, 1976, J THORAC CARDIOV SUR, V72, P661; BRAUNWALD NS, 1962, CIRCULATION, V26, P1270, DOI 10.1161/01.CIR.26.6.1270; CARTMILL TB, 1966, J THORAC CARDIOV SUR, V52, P486, DOI 10.1016/S0022-5223(19)43393-X; Castaneda A R, 1971, Ann Thorac Surg, V12, P29; DuShane JW, 1976, CHILD CONGENITAL HEA, P299; FRIEDLI B, 1974, AM J CARDIOL, V33, P403, DOI 10.1016/0002-9149(74)90323-3; Gatzoulis MA, 2009, EUR RESPIR REV, V18, P154, DOI 10.1183/09059180.00003309; Giglia TM, 2010, PEDIATR CRIT CARE ME, V11, pS57, DOI 10.1097/PCC.0b013e3181d10cce; HALLIDIESMITH KA, 1969, BRIT HEART J, V31, P246; IKAWA S, 1995, J THORAC CARDIOV SUR, V109, P1218, DOI 10.1016/S0022-5223(95)70206-7; JOHN S, 1983, THORAX, V38, P279, DOI 10.1136/thx.38.4.279; Kannan Bhava R J, 2003, Indian Heart J, V55, P161; LOCK JE, 1982, PEDIATR CARDIOL, V3, P41, DOI 10.1007/BF02082331; MOMMA K, 1981, JPN CIRC J, V45, P230, DOI 10.1253/jcj.45.230; NEUTZE JM, 1989, AM J CARDIOL, V63, P327, DOI 10.1016/0002-9149(89)90340-8; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6	21	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83976	10.1371/journal.pone.0083976	http://dx.doi.org/10.1371/journal.pone.0083976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416187	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500088
J	Groger, A; Kolb, R; Schafer, R; Klose, U				Groeger, Adriane; Kolb, Rupert; Schaefer, Rita; Klose, Uwe			Dopamine Reduction in the Substantia Nigra of Parkinson's Disease Patients Confirmed by In Vivo Magnetic Resonance Spectroscopic Imaging	PLOS ONE			English	Article								Objectives: Metabolic changes in the substantia nigra of patients with Parkinson's disease were previously investigated in different molecular-pathological examinations. The aim of our study was the in vivo measurement of these alterations using three-dimensional magnetic resonance spectroscopic imaging. Methods: 21 patients with Parkinson's disease and 24 controls were examined using magnetic resonance spectroscopic imaging at 3 Tesla. The spectra of rostral and caudal substantia nigra regions were analyzed using LCModel. For spectral fitting, an adjusted basis data set with pathology-specific metabolites and macromolecules was used to better reproduce the in vivo spectra. To assess differences between both groups more accurately, especially in metabolites at lower concentrations, group-averaged spectra were evaluated in addition to the analysis of individual data. Results: We found significantly decreased N-acetylaspartate, choline, creatine, myo-inositol, glutathione and dopamine concentrations in patients with Parkinson's disease compared to controls, whereas glutamine+glutamate, gamma-aminobutyric acid, and homovanillic acid were slightly increased. According to anatomical features, clear differences in the biochemical profiles were found between rostral and caudal substantia nigra voxels in both groups. Conclusions: Reduced N-acetylaspartate and dopamine concentrations result from progressive degeneration of dopamine-producing neurons within the substantia nigra pars compacta. Decreased creatine levels can be interpreted as impaired energy metabolism due to mitochondrial dysfunction. Lower glutathione concentrations might be a cause or consequence of oxidative stress. Furthermore, slightly increased glutamine+glutamate and gamma-aminobutyric acid levels are expected based on post mortem data in Parkinson's disease. To the best of our knowledge, this is the first non-invasive confirmation of these metabolic changes.	[Groeger, Adriane; Kolb, Rupert; Schaefer, Rita; Klose, Uwe] Univ Tubingen Hosp, Magnet Resonance Res Grp, Dept Diagnost & Intervent Neuroradiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Groger, A (corresponding author), Univ Tubingen Hosp, Magnet Resonance Res Grp, Dept Diagnost & Intervent Neuroradiol, Tubingen, Germany.	adriane.groeger@med.uni-tuebingen.de	Klose, Uwe/M-7110-2013	Klose, Uwe/0000-0001-5236-3450	Deutsche Forschungsgemeinschaft; Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	This work was supported by the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal D, 2002, MAGN RESON CHEM, V40, P533, DOI 10.1002/mrc.1053; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Delli Pizzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056501; Emir UE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030918; Fayed N, 2009, NEUROL RES, V31, P472, DOI 10.1179/174313209X395481; Gerlach M, 1996, BRAIN RES, V741, P142, DOI 10.1016/S0006-8993(96)00915-8; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Groger A, 2011, EUR RADIOL, V21, P1962, DOI 10.1007/s00330-011-2123-5; Groger A, 2013, J NEUROL NEUROSURG P; Kirov II, 2012, MAGN RESON MED, V67, P27, DOI 10.1002/mrm.23001; Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443; Massey LA, 2010, NEUROIMAG CLIN N AM, V20, P7, DOI 10.1016/j.nic.2009.10.001; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Provencher SW, 2011, LCMODEL LCMGUI USERS; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Soher BJ, 2011, VESPA INTEGRATED APP; Terpstra M, 2004, MAGN RESON MED, V51, P225, DOI 10.1002/mrm.10715	19	56	59	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84081	10.1371/journal.pone.0084081	http://dx.doi.org/10.1371/journal.pone.0084081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416192	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500093
J	Hong, JY; Labus, JS; Jiang, ZG; Ashe-Mcnalley, C; Dinov, I; Gupta, A; Shi, YG; Stains, J; Heendeniya, N; Smith, SR; Tillisch, K; Mayer, EA				Hong, Jui-Yang; Labus, Jennifer S.; Jiang, Zhiguo; Ashe-Mcnalley, Cody; Dinov, Ivo; Gupta, Arpana; Shi, Yonggang; Stains, Jean; Heendeniya, Nuwanthi; Smith, Suzanne R.; Tillisch, Kirsten; Mayer, Emeran A.			Regional Neuroplastic Brain Changes in Patients with Chronic Inflammatory and Non-Inflammatory Visceral Pain	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GRAY-MATTER DECREASE; CHRONIC BACK-PAIN; SOMATOSENSORY CORTEX; CORTICAL THICKNESS; ANTERIOR INSULA; ANXIETY; HYPERSENSITIVITY; FIBROMYALGIA; VALIDATION	Regional cortical thickness alterations have been reported in many chronic inflammatory and painful conditions, including inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS), even though the mechanisms underlying such neuroplastic changes remain poorly understood. In order to better understand the mechanisms contributing to grey matter changes, the current study sought to identify the differences in regional alterations in cortical thickness between healthy controls and two chronic visceral pain syndromes, with and without chronic gut inflammation. 41 healthy controls, 11 IBS subjects with diarrhea, and 16 subjects with ulcerative colitis (UC) underwent high-resolution T1-weighted magnetization-prepared rapid acquisition gradient echo scans. Structural image preprocessing and cortical thickness analysis within the region of interests were performed by using the Laboratory of Neuroimaging Pipeline. Group differences were determined using the general linear model and linear contrast analysis. The two disease groups differed significantly in several cortical regions. UC subjects showed greater cortical thickness in anterior cingulate cortical subregions, and in primary somatosensory cortex compared with both IBS and healthy subjects. Compared with healthy subjects, UC subjects showed lower cortical thickness in orbitofrontal cortex and in mid and posterior insula, while IBS subjects showed lower cortical thickness in the anterior insula. Large effects of correlations between symptom duration and thickness in the orbitofrontal cortex and postcentral gyrus were only observed in UC subjects. The findings suggest that the mechanisms underlying the observed gray matter changes in UC subjects represent a consequence of peripheral inflammation, while in IBS subjects central mechanisms may play a primary role.	[Hong, Jui-Yang; Labus, Jennifer S.; Ashe-Mcnalley, Cody; Gupta, Arpana; Stains, Jean; Heendeniya, Nuwanthi; Smith, Suzanne R.; Tillisch, Kirsten; Mayer, Emeran A.] Univ Calif Los Angeles, Gail & Gerald Oppenheimer Family Ctr Neurobiol St, Los Angeles, CA 90095 USA; [Labus, Jennifer S.; Ashe-Mcnalley, Cody; Gupta, Arpana; Tillisch, Kirsten; Mayer, Emeran A.] Univ Calif Los Angeles, Pain & Interocept Imaging Network PAIN, Los Angeles, CA USA; [Hong, Jui-Yang; Labus, Jennifer S.; Ashe-Mcnalley, Cody; Gupta, Arpana; Stains, Jean; Heendeniya, Nuwanthi; Smith, Suzanne R.; Tillisch, Kirsten; Mayer, Emeran A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Mayer, Emeran A.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Labus, Jennifer S.; Mayer, Emeran A.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Hong, Jui-Yang; Labus, Jennifer S.; Ashe-Mcnalley, Cody; Gupta, Arpana; Stains, Jean; Heendeniya, Nuwanthi; Smith, Suzanne R.; Tillisch, Kirsten; Mayer, Emeran A.] Univ Calif Los Angeles, Div Digest Dis, Los Angeles, CA USA; [Mayer, Emeran A.] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; [Hong, Jui-Yang] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Dinov, Ivo] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Jiang, Zhiguo] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Jiang, Zhiguo] Kessler Fdn Res Ctr, Human Performance & Engn Lab, W Orange, NJ USA; [Shi, Yonggang] Univ So Calif, Lab Neuroimaging, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; New Jersey Institute of Technology; Kessler Institute for Rehabilitation; University of Southern California	Hong, JY (corresponding author), Univ Calif Los Angeles, Gail & Gerald Oppenheimer Family Ctr Neurobiol St, Los Angeles, CA 90095 USA.	usagilberthong@hotmail.com	Tillisch, Kirsten/ABE-2174-2020; Labus, Jennifer S/M-4567-2017	Labus, Jennifer S/0000-0002-6634-2551; Jiang, Zhiguo/0000-0002-4415-0401	National Institutes of Health through Center for Neurobiology (CNS) [K08 DK071626, R03 DK084169, K23DK073451, R01 AT007137, P50 DK064539, R01 DK048351]; LONI [NIBIB 9P41EB015922-15, NCRR 2-P41-RR-013642-15, NCRR U54 RR021813, U24-RR025736, U24-RR021992]; National Center for Complementary & Integrative Health [R01AT007137] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021992, U54RR021813, P41RR013642, U24RR025736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK084169, P30DK041301, P50DK064539, K08DK071626, R01DK048351, K23DK073451] Funding Source: NIH RePORTER	National Institutes of Health through Center for Neurobiology (CNS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LONI; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by the National Institutes of Health through Center for Neurobiology (CNS) grants: K08 DK071626, R03 DK084169, K23DK073451, R01 AT007137, P50 DK064539, R01 DK048351, and LONI grants: NIBIB 9P41EB015922-15, NCRR 2-P41-RR-013642-15, NCRR U54 RR021813, U24-RR025736, U24-RR021992. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini A, 2013, NEUROGASTROENTEROL M; Agostini A, 2012, NEUROGASTROENTEROL M; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Berman SM, 2008, J NEUROSCI, V28, P349, DOI 10.1523/JNEUROSCI.2500-07.2008; Bernstein CN, 2002, AM J GASTROENTEROL, V97, P319; Bielefeldt K, 2009, INFLAMM BOWEL DIS, V15, P778, DOI 10.1002/ibd.20848; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Chang L, 2001, AM J GASTROENTEROL, V96, P3341; Chang L, 2000, GUT, V47, P497, DOI 10.1136/gut.47.4.497; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Davis KD, 2008, NEUROLOGY, V70, P153, DOI 10.1212/01.wnl.0000295509.30630.10; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; Dinov ID, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-304; Drossman DA, 2000, ROME, Vxxvii; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Erpelding N, 2012, PAIN, V153, P1602, DOI 10.1016/j.pain.2012.03.012; Farb NAS, 2013, CEREB CORTEX, V23, P114, DOI 10.1093/cercor/bhr385; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frokjaer JB, 2012, CLIN GASTROENTEROL H, V10, P434, DOI 10.1016/j.cgh.2011.11.024; Gustin SM, 2012, J NEUROSCI, V32, P14874, DOI 10.1523/JNEUROSCI.1733-12.2012; Gwilym SE, 2010, ARTHRITIS RHEUM-US, V62, P2930, DOI 10.1002/art.27585; Hsu MC, 2009, PAIN, V143, P262, DOI 10.1016/j.pain.2009.03.017; Jarcho JM, 2013, PAIN; Jiang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073932; Jones AKP, 2012, CURR RHEUMATOL REP, V14, P557, DOI 10.1007/s11926-012-0287-x; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Kwan CL, 2005, NEUROLOGY, V65, P1268, DOI 10.1212/01.wnl.0000180971.95473.cc; Labus J, 2013, PAIN; Labus JS, 2007, PSYCHOSOM MED, V69, P89, DOI 10.1097/PSY.0b013e31802e2f24; Labus JS, 2009, NEUROIMAGE, V47, P952, DOI 10.1016/j.neuroimage.2009.05.078; Labus JS, 2004, ALIMENT PHARM THER, V20, P89, DOI 10.1111/j.1365-2036.2004.02007.x; Lallemend F, 2003, J NEUROCHEM, V87, P508, DOI 10.1046/j.1471-4159.2003.02014.x; Leung KTK, 2011, PRINCIPAL RANKING ME; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Lewis M, 2008, HDB EMOTIONS, Vxvi; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mayer E.A., 2009, FUNCTIONAL PAIN SYND; Mayer EA, 2005, PAIN, V115, P398, DOI 10.1016/j.pain.2005.03.023; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meier ML, 2012, J CLIN PERIODONTOL, V39, P441, DOI 10.1111/j.1600-051X.2012.01863.x; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; MULDER W, 1992, J COMPUT PHYS, V100, P209, DOI 10.1016/0021-9991(92)90229-R; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Ray RD, 2005, COGN AFFECT BEHAV NE, V5, P156, DOI 10.3758/CABN.5.2.156; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Schmidt-Wilcke T, 2007, PAIN, V132, pS109, DOI 10.1016/j.pain.2007.05.010; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Shi YG, 2011, LECT NOTES COMPUT SC, V6892, P327, DOI 10.1007/978-3-642-23629-7_40; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Tulloch I, 2011, BRAIN RES, V1399, P33, DOI 10.1016/j.brainres.2011.05.017; Ung H, 2012, CEREB CORTEX; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; Verne GN, 2003, PAIN, V103, P99, DOI 10.1016/S0304-3959(02)00416-5; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Wang J, 2011, BRAIN RES, V1369, P131, DOI 10.1016/j.brainres.2010.11.017; Wartolowska K, 2012, ARTHRITIS RHEUM-US, V64, P371, DOI 10.1002/art.33326; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010	74	42	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84564	10.1371/journal.pone.0084564	http://dx.doi.org/10.1371/journal.pone.0084564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416245	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500137
J	Kansal, S; Bhatnagar, A; Agnihotri, N				Kansal, Shevali; Bhatnagar, Archana; Agnihotri, Navneet			Fish Oil Suppresses Cell Growth and Metastatic Potential by Regulating PTEN and NF-kappa B Signaling in Colorectal Cancer	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; UP-REGULATION; CHEMOPREVENTIVE ACTION; TRANSCRIPTION FACTOR; DIFFERENT RATIOS; CORN-OIL; PATHWAY; APOPTOSIS; EXPRESSION; INHIBITION	Homeostasis in eukaryotic tissues is tightly regulated by an intricate balance of the prosurvival and antisurvival signals. The tumor suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10), a dual-specificity phosphatase, plays a functional role in cell cycle arrest and apoptosis. NF-kappa B and its downstream regulators (such as VEGF) play a central role in prevention of apoptosis, promotion of inflammation and tumor growth. Therefore, we thought to estimate the expression of PTEN, Poly-ADP-ribose polymerase (PARP), NF-kappa Bp50, NF-kBp65 and VEGF to evaluate the effect of supplementation of fish oil on apoptotic and inflammatory signaling in colon carcinoma. Male wistar rats in Group I received purified diet while Group II and III received modified diet supplemented with FO:CO(1:1)&FO:CO(2.5:1) respectively. These were further subdivided into controls receiving ethylenediamine-tetra acetic-acid and treated groups received dimethylhydrazine-dihydrochloride (DMH)/week for 4 weeks. Animals sacrificed 48 hours after last injection constituted initiation phase and that sacrificed after 16 weeks constituted post-initiation phase. We have analysed expression of PTEN, NF-kappa Bp50, NF-kappa Bp65 by flowcytometer and nuclear localization of NF-kB by immunofluorescence. PARP and VEGF were assessed by immunohistochemistry. In the initiation phase, animals receiving DMH have shown increased % of apoptotic cells, PTEN, PARP, NF-kappa Bp50, NF-kappa Bp65 and VEGF however in post-initiation phase no significant alteration in apoptosis with decreased PTEN and increased PARP, NF-kappa Bp50, NF-kappa Bp65 and VEGF were observed as compared to control animals. On treatment with both ratios of fish oil in both the phases, augmentation in % of apoptotic cells, decreased PTEN, PARP, NF-kappa Bp50, NF-kappa Bp65 and VEGF were documented with respect to DMH treated animals with effect being more exerted with higher ration in post-initiation phase. Hence, fish oil activates apoptosis, diminishes DNA damage and inhibits inflammatory signalling in a dose and time dependent manner so as to inhibit progression of colon cancer.	[Kansal, Shevali; Bhatnagar, Archana; Agnihotri, Navneet] Panjab Univ, Dept Biochem, Chandigarh 160014, India	Panjab University	Agnihotri, N (corresponding author), Panjab Univ, Dept Biochem, Chandigarh 160014, India.	agnihotri.navneet@gmail.com		Agnihotri, Navneet/0000-0001-6063-3473	Indian Council of Medical Research [Immuno/18/11/27/2008-ECD-I]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by a grant from the Indian Council of Medical Research (Immuno/18/11/27/2008-ECD-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	21. Committee on Laboratory Animal Diets, 1978, CONTR DIETS LAB AN E; Akinsete JA, 2012, CARCINOGENESIS, V33, P140, DOI 10.1093/carcin/bgr238; American Cancer Society, 2012, CANC FACTS FIG 2012; Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Barber TD, 2004, NEW ENGL J MED, V351, P2883, DOI 10.1056/NEJM200412303512724; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Borghaei RC, 2004, BIOCHEM BIOPH RES CO, V316, P182, DOI 10.1016/j.bbrc.2004.02.030; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; Das R, 2013, APOPTOSIS; Dedes KJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001538; Freshney RI, 1994, CULTURE ANIMAL CELLS, P287; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Goulet AC, 2003, CANCER BIOL THER, V2, P713; Hu YP, 2010, NEOPLASIA, V12, P826, DOI 10.1593/neo.10586; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kansal S, 2012, NUTR CANCER, V64, P559, DOI 10.1080/01635581.2012.675619; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kummar S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-25; Latham P, 1999, CARCINOGENESIS, V20, P645, DOI 10.1093/carcin/20.4.645; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Mangerich A, 2011, INT J CANCER, V128, P251, DOI 10.1002/ijc.25683; Matsuda Satoru, 2013, Open Med Chem J, V7, P23, DOI 10.2174/1874104501307010023; Megnin-Chanet F, 2010, CELL MOL LIFE SCI, V67, P3649, DOI 10.1007/s00018-010-0490-8; Melen-Mucha G, 2002, CANCER INVEST, V20, P700, DOI 10.1081/CNV-120003539; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sanders LM, 2004, J NUTR, V134, P3233, DOI 10.1093/jn/134.12.3233; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Sarotra P, 2010, LIPIDS, V45, P785, DOI 10.1007/s11745-010-3459-3; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Sawai H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-56; Sharma G, 2013, CANCER INVEST, V31, P231, DOI 10.3109/07357907.2013.780076; Shibata A, 2002, BREAST CANCER RES TR, V73, P237, DOI 10.1023/A:1015872531675; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Smith TK, 1998, CARCINOGENESIS, V19, P267, DOI 10.1093/carcin/19.2.267; Steelman LS, 2004, EXPERT OPIN THER TAR, V8, P537, DOI 10.1517/14728222.8.6.537; Wang JT, 2006, BRAIN RES, V1081, P211, DOI 10.1016/j.brainres.2006.01.077; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Zhao GX, 2005, BIOCHEM BIOPH RES CO, V336, P909, DOI 10.1016/j.bbrc.2005.08.204	51	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84627	10.1371/journal.pone.0084627	http://dx.doi.org/10.1371/journal.pone.0084627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416253	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500142
J	Levy, H; Glinert, I; Weiss, S; Sittner, A; Schlomovitz, J; Altboum, Z; Kobiler, D				Levy, Haim; Glinert, Itai; Weiss, Shay; Sittner, Assa; Schlomovitz, Josef; Altboum, Zeev; Kobiler, David			Toxin-Independent Virulence of Bacillus anthracis in Rabbits	PLOS ONE			English	Article							GUINEA-PIGS; PROTECTIVE ANTIGEN; GENE; ANTIBODIES; IDENTIFICATION; PATHOGENICITY; INFECTION; ADHESIN; BSLA	The accepted paradigm states that anthrax is both an invasive and toxinogenic disease and that the toxins play a major role in pathogenicity. In the guinea pig (GP) model we have previously shown that deletion of all three toxin components results in a relatively moderate attenuation in virulence, indicating that B. anthracis possesses an additional toxin-independent virulence mechanism. To characterize this toxin-independent mechanism in anthrax disease, we developed a new rabbit model by intravenous injection (IV) of B. anthracis encapsulated vegetative cells, artificially creating bacteremia. Using this model we were able to demonstrate that also in rabbits, B. anthracis mutants lacking the toxins are capable of killing the host within 24 hours. This virulent trait depends on the activity of AtxA in the presence of pXO2, as, in the absence of the toxin genes, deletion of either component abolishes virulence. Furthermore, this IV virulence depends mainly on AtxA rather than the whole pXO1. A similar pattern was shown in the GP model using subcutaneous (SC) administration of spores of the mutant strains, demonstrating the generality of the phenomenon. The virulent strains showed higher bacteremia levels and more efficient tissue dissemination; however our interpretation is that tissue dissemination per se is not the main determinant of virulence whose exact nature requires further elucidation.	[Levy, Haim; Glinert, Itai; Weiss, Shay; Sittner, Assa; Schlomovitz, Josef; Altboum, Zeev; Kobiler, David] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel		Levy, H (corresponding author), Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel.	haiml@iibr.gov.il		Sittner, Assa/0000-0002-1633-8191				Ariel N, 2003, INFECT IMMUN, V71, P4563, DOI 10.1128/IAI.71.8.4563-4579.2003; Chateau A, 2011, FASEB J, V25, P4445, DOI 10.1096/fj.11-188912; Chen ZC, 2011, TOXINS, V3, P1004, DOI 10.3390/toxins3081004; Cohen S, 2000, INFECT IMMUN, V68, P4549, DOI 10.1128/IAI.68.8.4549-4558.2000; Cote CK, 2011, MICROBES INFECT, V13, P1146, DOI 10.1016/j.micinf.2011.07.005; Ebrahimi CM, 2009, J BACTERIOL, V191, P7165, DOI 10.1128/JB.00903-09; Fouet A, 1996, INFECT IMMUN, V64, P4928, DOI 10.1128/IAI.64.12.4928-4932.1996; Fouet A, 2010, RES MICROBIOL, V161, P735, DOI 10.1016/j.resmic.2010.09.006; Froude JW, 2011, MABS-AUSTIN, V3, P517, DOI 10.4161/mabs.3.6.17621; Froude JW, 2011, TOXINS, V3, P1433, DOI 10.3390/toxins3111433; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Guichard A, 2012, MICROBES INFECT, V14, P97, DOI 10.1016/j.micinf.2011.08.016; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Kobiler D, 2002, INFECT IMMUN, V70, P544, DOI 10.1128/IAI.70.2.544-550.2002; Kobiler D, 2006, INFECT IMMUN, V74, P5871, DOI 10.1128/IAI.00792-06; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Levy H, 2005, FEMS MICROBIOL LETT, V244, P199, DOI 10.1016/j.femsle.2005.01.039; Levy H, 2012, INFECT IMMUN, V80, P2623, DOI 10.1128/IAI.00244-12; Levy H, 2012, MICROB PATHOGENESIS, V52, P55, DOI 10.1016/j.micpath.2011.10.002; Levy H, 2011, MICROB PATHOGENESIS, V51, P345, DOI 10.1016/j.micpath.2011.07.004; Lovchik JA, 2012, INFECT IMMUN, V80, P2414, DOI 10.1128/IAI.06340-11; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sambrook J, 1989, MOL CLOINING LAB MAN; UCHIDA I, 1993, J BACTERIOL, V175, P5329, DOI 10.1128/JB.175.17.5329-5338.1993; Weiss S, 2011, ANTIMICROB AGENTS CH, V55, P1533, DOI 10.1128/AAC.01689-10; Welkos S, 2001, MICROBIOL-SGM, V147, P1677, DOI 10.1099/00221287-147-6-1677; Yoong P, 2006, J BACTERIOL, V188, P2711, DOI 10.1128/JB.188.7.2711-2714.2006	31	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84947	10.1371/journal.pone.0084947	http://dx.doi.org/10.1371/journal.pone.0084947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416317	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500194
J	Maria-Ferreira, D; Da Silva, LM; Mendes, DAGB; Cabrini, DD; Nascimento, AM; Iacomini, M; Cipriani, TR; Santos, ARS; Werner, MFD; Baggio, CH				Maria-Ferreira, Daniele; Da Silva, Luisa Mota; Gasparin Bueno Mendes, Daniel Augusto; Cabrini, Daniela de Almeida; Nascimento, Adamara Machado; Iacomini, Marcello; Cipriani, Thales Ricardo; Soares Santos, Adair Roberto; de Paula Werner, Maria Fernanda; Baggio, Cristiane Hatsuko			Rhamnogalacturonan from Acmella oleracea (L.) RK Jansen: Gastroprotective and Ulcer Healing Properties in Rats	PLOS ONE			English	Article							SPILANTHES-ACMELLA; GASTRIC-ULCER; GASTROINTESTINAL-TRACT; POLYSACCHARIDES; MECHANISMS; EXTRACT; QUALITY; TISSUE; OXYGEN	A rhamnogalacturonan (RGal) isolated from Acmella oleracea (L.) R.K. Jansen administered by oral route showed gastroprotective activity against acute lesions induced by ethanol. In this study, we investigated the gastric ulcer healing effect of RGal and its mechanisms of action. Intraperitoneal treatment of animals with RGal protected the gastric mucosa against acute lesions induced by ethanol, with participation of gastric mucus. Furthermore, in the chronic ulcer model, oral administration of RGal accelerates the gastric ulcer healing, accompanied by increasing of cellular proliferation and gastric mucus content, reducing inflammatory parameters and oxidative stress. In addition, the repeated 7 days-treatment of animals with RGal did not show alterations of clinical and behavioral symptoms, body and organs weights or plasmatic biochemical parameters. Collectively, these results showed that RGal has an interesting antiulcerogenic activity and could constitute an attractive molecule of interest for the development of new antiulcer agents.	[Maria-Ferreira, Daniele; Da Silva, Luisa Mota; Gasparin Bueno Mendes, Daniel Augusto; Cabrini, Daniela de Almeida; de Paula Werner, Maria Fernanda; Baggio, Cristiane Hatsuko] Univ Fed Parana, Dept Pharmacol, Sect Biol Sci, BR-80060000 Curitiba, Parana, Brazil; [Nascimento, Adamara Machado; Iacomini, Marcello; Cipriani, Thales Ricardo] Univ Fed Parana, Dept Biochem & Mol Biol, Sect Biol Sci, BR-80060000 Curitiba, Parana, Brazil; [Soares Santos, Adair Roberto] Univ Fed Santa Catarina, Dept Physiol Sci, Ctr Biol Sci, Florianopolis, SC, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal de Santa Catarina (UFSC)	Baggio, CH (corresponding author), Univ Fed Parana, Dept Pharmacol, Sect Biol Sci, BR-80060000 Curitiba, Parana, Brazil.	crisbaggio@gmail.com	Maria-Ferreira, Daniele/AAE-9373-2020; da+Silva, Luisa/AAQ-1408-2020; Baggio, Cristiane H/C-5633-2013; Nascimento, Adamara/AAQ-4649-2020; Cabrini, Daniela A/I-4652-2014; Maria-Ferreira, Daniele/AAQ-2015-2020; Mendes, Daniel/AAY-4058-2020; Werner, Maria Fernanda P/G-1461-2012; Cipriani, Thales R/I-7195-2015; da Silva, Luisa Mota/P-5201-2018; Santos, Adair/C-5565-2013	Baggio, Cristiane H/0000-0001-5536-7561; Cabrini, Daniela A/0000-0002-7323-6933; Maria-Ferreira, Daniele/0000-0001-7992-510X; Werner, Maria Fernanda P/0000-0001-5979-8676; Santos, Adair/0000-0002-6435-4698	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq [150983/2012-4]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors wish to thank the Brazilian funding agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). C.H. Baggio is recipient of post-doctoral scholarship from the CNPq (no. 150983/2012-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2012, WORLD J GASTROENTERO, V18, P4811, DOI 10.3748/wjg.v18.i35.4811; Baggio CH, 2005, PLANTA MED, V71, P733, DOI 10.1055/s-2005-871286; Baggio CF, 2012, Z NATURFORSCH C, V67, P405; Baggio CH, 2012, INT J BIOL MACROMOL, V50, P872, DOI 10.1016/j.ijbiomac.2011.10.023; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Chakraborty A., 2004, Indian Journal of Pharmacology, V36, P148; Chakraborty A, 2010, INDIAN J PHARMACOL, V42, P277, DOI 10.4103/0253-7613.70106; Chen FA, 2004, FOOD CHEM, V86, P479, DOI 10.1016/j.foodchem.2003.09.020; CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116; Czyzewska J, 2009, FOLIA HISTOCHEM CYTO, V47, P289, DOI 10.2478/v10042-009-0042-y; DeVault KR, 2009, NAT REV GASTRO HEPAT, V6, P524, DOI 10.1038/nrgastro.2009.125; DEYOUNG LM, 1989, AGENTS ACTIONS, V26, P335; Ekanem AP, 2007, PHYTOTHER RES, V21, P1253, DOI 10.1002/ptr.2239; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Gao RM, 1998, BIOELECTROCH BIOENER, V45, P41, DOI 10.1016/S0302-4598(98)00072-5; Gao YH, 2004, J MED FOOD, V7, P417, DOI 10.1089/jmf.2004.7.417; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HIRSCHOWITZ BI, 1983, J CLIN GASTROENTEROL, V5, P115, DOI 10.1097/00004836-198312001-00011; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Ley Jakob P., 2006, V43, P21; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MOWRY RW, 1956, AM J PATHOL, V32, P628; Naito Y, 1995, J CLIN GASTROENTEROL, V21, pS82; Nascimento AM, 2013, PHYTOCHEMISTRY, V85, P137, DOI 10.1016/j.phytochem.2012.08.024; Nergard CS, 2005, J ETHNOPHARMACOL, V96, P255, DOI 10.1016/j.jep.2004.09.018; Okabe S, 2012, FRONT GASTROINT RES, V30, P32; OKABE S, 1971, AM J DIG DIS, V16, P277, DOI 10.1007/BF02235252; Palileo C, 2011, CURR OPIN GASTROEN, V27, P543, DOI 10.1097/MOG.0b013e32834b3fcb; Pereira IT, 2013, PHYTOTHER RES, V27, P1067, DOI 10.1002/ptr.4835; Phillipson M, 2008, AM J PHYSIOL-GASTR L, V295, pG806, DOI 10.1152/ajpgi.90252.2008; Potrich FB, 2010, J ETHNOPHARMACOL, V130, P85, DOI 10.1016/j.jep.2010.04.014; Prachayasittikul S, 2009, MOLECULES, V14, P850, DOI 10.3390/molecules14020850; Ratnasooriya WD, 2004, J ETHNOPHARMACOL, V91, P317, DOI 10.1016/j.jep.2004.01.006; Repetto MG, 2002, BRAZ J MED BIOL RES, V35, P523, DOI 10.1590/S0100-879X2002000500003; ROBERT A, 1979, GASTROENTEROLOGY, V77, P433; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; Srikanta BM, 2010, BIOCHIMIE, V92, P194, DOI 10.1016/j.biochi.2009.10.005; SRIVASTAVA R, 1989, PHYTOCHEMISTRY, V28, P2877, DOI 10.1016/0031-9422(89)80245-6; TAKAGI K, 1969, JPN J PHARMACOL, V19, P418, DOI 10.1254/jjp.19.418; Tarnawski AS, 2012, CURR MED CHEM, V19, P16; Wu LC, 2008, J AGR FOOD CHEM, V56, P2341, DOI 10.1021/jf073057e; YAMADA H, 1994, CARBOHYD POLYM, V25, P269, DOI 10.1016/0144-8617(94)90052-3; Ye YN, 2003, LIFE SCI, V72, P925, DOI 10.1016/S0024-3205(02)02332-9	46	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84762	10.1371/journal.pone.0084762	http://dx.doi.org/10.1371/journal.pone.0084762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416280	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500163
J	Nishio, M; Satoh, M				Nishio, Motohide; Satoh, Masahiro			Including Dominance Effects in the Genomic BLUP Method for Genomic Evaluation	PLOS ONE			English	Article							INFORMATION; PREDICTION; SELECTION; VALUES	We evaluated the performance of GBLUP including dominance genetic effect (GBLUP-D) by estimating variances and predicting genetic merits in a computer simulation and 2 actual traits (T4 and T5) in pigs. In simulation data, GBLUP-D explained more than 50% of dominance genetic variance. Moreover, GBLUP-D yielded estimated total genetic effects over 1.2% more accurate than those yielded by GBLUP. In particular, when the dominance genetic variance was large, the accuracy could be substantially improved by increasing the number of markers. The dominance genetic variances in T4 and T5 accounted for 9.6% and 6.3% of the phenotypic variances, respectively. Estimates of such small dominance genetic variances contributed little to the improvement of the accuracies of estimated total genetic effects. In both simulation and pig data, there were nearly no differences in the estimates of additive genetic effects or their variance between GBLUP-D and GBLUP. Therefore, we conclude GBLUP-D is a feasible approach to improve genetic performance in crossbred populations with large dominance genetic variation and identify mating systems with good combining ability.	[Nishio, Motohide; Satoh, Masahiro] NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan	Nishio, M (corresponding author), NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan.	mtnishio@affrc.go.jp						Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cleveland MA, 2012, G3-GENES GENOM GENET, V2, P429, DOI 10.1534/g3.111.001453; Da Y, 2013, J DAIRY SCI S1, V96, P620; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Falconer D. S, 1996, INTRO QUANTITATIVE G; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; JOHNSON DL, 1995, J DAIRY SCI, V78, P449, DOI 10.3168/jds.S0022-0302(95)76654-1; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mc Hugh N, 2011, J DAIRY SCI, V94, P4109, DOI 10.3168/jds.2010-4016; Meuwissen THE, 2001, GENETICS, V157, P1819; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Sun C, 2013, J DAIRY SCI IN PRESS; Toro MA, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-33; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vitezica ZG, 2013, GENETICS IN PRESS; Wang C, 2013, J DAIRY SCI S1, V96, P620; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Wittenburg D, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-74; Xu S, 2013, GENETICS IN PRESS; Yao C, 2013, J DAIRY SCI, V96, P6716, DOI 10.3168/jds.2012-6237	27	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85792	10.1371/journal.pone.0085792	http://dx.doi.org/10.1371/journal.pone.0085792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416447	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500265
J	Wilkars, W; Wollberg, J; Mohr, E; Han, M; Chetkovich, DM; Bahring, R; Bender, RA				Wilkars, Wiebke; Wollberg, Jessica; Mohr, Evita; Han, Mieri; Chetkovich, Dane M.; Baehring, Robert; Bender, Roland A.			Nedd4-2 regulates surface expression and may affect N-glycosylation of hyperpolarization-activated cyclic nucleotide-gated (HCN)-1 channels	FASEB JOURNAL			English	Article						ion channel; trafficking; TRIP8b; ubiquitination	CARDIAC-PACEMAKER CHANNELS; UBIQUITIN LIGASE NEDD4-2; TEMPORAL-LOBE EPILEPSY; HCN CHANNELS; POTASSIUM CHANNEL; ION CHANNELS; LINKED GLYCOSYLATION; DEPENDENT REGULATION; SODIUM-CHANNELS; PROTEIN	HCN channels are important regulators of neuronal excitability. The proper function of these channels is governed by various mechanisms, including post-translational modifications of channel subunits. Here, we provide evidence that ubiquitination via a ubiquitin ligase, neuronal precursor cell expressed developmentally downregulated (Nedd)-4-2, is involved in the regulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. We identified a PY motif (L/PPxY), the characteristic binding motif for Nedd4-2 in the C terminus of the HCN1 subunit, and showed that HCN1 and Nedd4-2 interacted both in vivo (rat hippocampus, neocortex, and cerebellum) and in vitro [human embryonic kidney 293 (HEK293) cells], resulting in increased HCN1 ubiquitination. Elimination of the PY motif reduced, but did not abolish, Nedd4-2 binding, which further involved a stretch of approximate to 100 aa downstream in the HCN1 C terminus. Coexpression of Nedd4-2 and HCN1 drastically reduced the HCN1-mediated h-current amplitude (85-92%) in Xenopus laevis oocytes and reduced surface expression (34%) of HCN1 channels in HEK293 cells, thereby opposing effects of tetratricopeptide repeat-containing Rab8b interacting protein (TRIP8b)-(1a-4), an auxiliary subunit that promotes HCN1 surface expression. Regulation may further include N-glycosylation of HCN1 channels, which is significantly enhanced by TRIP8b(1a-4), but may be reduced by Nedd4-2. Taken together, our data indicate that Nedd4-2 plays an important role in the regulation of HCN1 trafficking and may compete with TRIP8b(1a-4) in this process.Wilkars, W., Wollberg, J., Mohr, E., Han, M., Chetkovich, D. M., Bahring, R., Bender, R. A. Nedd4-2 regulates surface expression and may affect N-glycosylation of hyperpolarization-activated cyclic nucleotide-gated (HCN)-1 channels.	[Wilkars, Wiebke; Mohr, Evita; Han, Mieri; Bender, Roland A.] Univ Hamburg, Med Ctr, Inst Neuroanat, D-20246 Hamburg, Germany; [Wollberg, Jessica; Baehring, Robert] Univ Hamburg, Med Ctr, Inst Cellular & Integrat Physiol, D-20246 Hamburg, Germany; [Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	University of Hamburg; University of Hamburg; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bender, RA (corresponding author), Univ Hamburg, Med Ctr, Inst Neuroanat, Martinistr 52, D-20246 Hamburg, Germany.	rbender@uke.uni-hamburg.de	Chetkovich, Dane/AAV-5457-2021	Bahring, Robert/0000-0002-0406-5958	Deutsche Forschungsgemeinschaft (DFG) [BE4107/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank Telse Kock and Christiane Schroder-Birkner for excellent technical assistance. This study was supported by Deutsche Forschungsgemeinschaft (DFG; grant: BE4107/2-1).	Albesa M, 2011, J MOL CELL CARDIOL, V51, P90, DOI 10.1016/j.yjmcc.2011.03.015; Baruscotti M, 2010, PFLUG ARCH EUR J PHY, V460, P405, DOI 10.1007/s00424-010-0810-8; Bender RA, 2007, J NEUROSCI, V27, P4697, DOI 10.1523/JNEUROSCI.4699-06.2007; Bender RA, 2008, PROG NEUROBIOL, V86, P129, DOI 10.1016/j.pneurobio.2008.09.007; Bongiorno D, 2011, CHANNELS, V5, P79, DOI 10.4161/chan.5.1.13967; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Gasser A, 2010, J BIOL CHEM, V285, P26149, DOI 10.1074/jbc.M109.098681; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Han Y, 2011, J BIOL CHEM, V286, P20823, DOI 10.1074/jbc.M111.236125; Hardel N, 2008, CARDIOVASC RES, V79, P52, DOI 10.1093/cvr/cvn062; He YW, 2008, J BIOL CHEM, V283, P24000, DOI 10.1074/jbc.M803361200; Hegle AP, 2010, AM J PHYSIOL-CELL PH, V298, pC1066, DOI 10.1152/ajpcell.00389.2009; Herrmann S, 2012, BRIT J PHARMACOL, V166, P501, DOI 10.1111/j.1476-5381.2011.01798.x; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Jung S, 2010, J NEUROSCI, V30, P6678, DOI 10.1523/JNEUROSCI.1290-10.2010; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Lamothe SM, 2013, J BIOL CHEM, V288, P15075, DOI 10.1074/jbc.M113.453670; Lewis AS, 2011, J NEUROSCI, V31, P7424, DOI 10.1523/JNEUROSCI.0936-11.2011; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; McClelland S, 2011, ANN NEUROL, V70, P454, DOI 10.1002/ana.22479; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rotin D, 2011, PFLUG ARCH EUR J PHY, V461, P1, DOI 10.1007/s00424-010-0893-2; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Schafer MKE, 2010, FEBS LETT, V584, P4475, DOI 10.1016/j.febslet.2010.10.011; Schuetz F, 2008, AM J PHYSIOL-CELL PH, V295, pC73, DOI 10.1152/ajpcell.00146.2008; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Tyrrell L, 2001, J NEUROSCI, V21, P9629, DOI 10.1523/JNEUROSCI.21-24-09629.2001; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Whitaker GM, 2007, J BIOL CHEM, V282, P22900, DOI 10.1074/jbc.M610978200; Wilkars W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032181; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zha QQ, 2008, J NEUROCHEM, V105, P68, DOI 10.1111/j.1471-4159.2007.05110.x; Zhang Y, 1999, J MEMBRANE BIOL, V171, P195, DOI 10.1007/s002329900571; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	65	15	15	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2177	2190		10.1096/fj.13-242032	http://dx.doi.org/10.1096/fj.13-242032			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24451387				2022-12-25	WOS:000335336000021
J	Su, MF; Mei, Y; Sanishvili, R; Levine, B; Colbert, CL; Sinha, S				Su, Minfei; Mei, Yang; Sanishvili, Ruslan; Levine, Beth; Colbert, Christopher L.; Sinha, Sangita			Targeting gamma-Herpesvirus 68 Bcl-2-mediated Down-regulation of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Bcl-2 Family Proteins; Crystal Structure; Herpesvirus; Host Defense; Host-Pathogen Interactions; Protein-Protein Interactions	EPSTEIN-BARR-VIRUS; PEPTIDE COMPLEX; MOLECULAR-BASIS; BCL-2 HOMOLOG; BECLIN 1; JNK1-MEDIATED PHOSPHORYLATION; INHIBITS APOPTOSIS; CELL SURVIVAL; BHRF1 PROTEIN; X-RAY	Background: Cellular and -herpesvirus Bcl-2 homologs down-regulate autophagy. Results: A peptide designed to bind to the -herpesvirus68 Bcl-2, M11, but not cellular Bcl-2 homologs, abrogates M11-mediated down-regulation of autophagy. Conclusion: This peptide is a selective M11 inhibitor. Significance: Such selective inhibitors are important for understanding the role of -herpesvirus Bcl-2 homologs in viral reactivation and oncogenic transformation of host cells. -herpesviruses (HVs) are common human pathogens that encode homologs of the anti-apoptotic cellular Bcl-2 proteins, which are critical to viral reactivation and oncogenic transformation. The murine HV68 provides a tractable in vivo model for understanding general features of these important human pathogens. Bcl-X-L, a cellular Bcl-2 homolog, and the murine HV68 Bcl-2 homolog, M11, both bind to a BH3 domain within the key autophagy effector Beclin 1 with comparable affinities, resulting in the down-regulation of Beclin 1-mediated autophagy. Despite this similarity, differences in residues lining the binding site of M11 and Bcl-X-L dictate varying affinities for the different BH3 domain-containing proteins. Here we delineate Beclin 1 differential specificity determinants for binding to M11 or Bcl-X-L by quantifying autophagy levels in cells expressing different Beclin 1 mutants and either M11 or Bcl-X-L, and we show that a G120E/D121A Beclin 1 mutant selectively prevents down-regulation of Beclin 1-mediated autophagy by Bcl-X-L, but not by M11. We use isothermal titration calorimetry to identify a Beclin 1 BH3 domain-derived peptide that selectively binds to M11, but not to Bcl-X-L. The x-ray crystal structure of this peptide bound to M11 reveals the mechanism by which the M11 BH3 domain-binding groove accommodates this M11-specific peptide. This information was used to develop a cell-permeable peptide inhibitor that selectively inhibits M11-mediated, but not Bcl-X-L-mediated, down-regulation of autophagy.	[Su, Minfei; Mei, Yang; Colbert, Christopher L.; Sinha, Sangita] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, GMCA APS, Argonne, IL 60439 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Ctr, Ctr Autophagy Res, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	North Dakota State University Fargo; United States Department of Energy (DOE); Argonne National Laboratory; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sinha, S (corresponding author), N Dakota State Univ, Dept Chem & Biochem, POB 6050,Dept 2710, Fargo, ND 58102 USA.	Sangita.Sinha@ndsu.edu		Mei, Yang/0000-0003-4357-9000	National Institutes of Health [P20 RR015566, P30 GM103332-01, R21 AI078198, RO1 CA109618]; CPRIT [PR120718-P1]; National Science Foundation [EPS-0814442, HRD-0811239]; NATIONAL CANCER INSTITUTE [R01CA109618] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS090939] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1413525] Funding Source: National Science Foundation; EPSCoR [0814442] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR015566 and P30 GM103332-01 (to S. S. and C. L. C.), R21 AI078198 (to S. S.), and RO1 CA109618 and CPRIT PR120718-P1 (to B. L.). This work was also supported by National Science Foundation Grants EPS-0814442 (to S. S. and C. L. C.), HRD-0811239 (to S. S.).	Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeBartolo J, 2012, J MOL BIOL, V422, P124, DOI 10.1016/j.jmb.2012.05.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Foghsgaard L, 1997, J VIROL, V71, P7509, DOI 10.1128/JVI.71.10.7509-7517.1997; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gangappa S, 2002, J EXP MED, V195, P931, DOI 10.1084/jem.20011825; Hardwick JM, 1998, SEMIN CELL DEV BIOL, V9, P339, DOI 10.1006/scdb.1998.0243; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Huang QL, 2003, J MOL BIOL, V332, P1123, DOI 10.1016/j.jmb.2003.08.007; Huang QL, 2002, P NATL ACAD SCI USA, V99, P3428, DOI 10.1073/pnas.062525799; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ku B, 2008, AUTOPHAGY, V4, P519, DOI 10.4161/auto.5846; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Loh J, 2005, PLOS PATHOG, V1, P80, DOI 10.1371/journal.ppat.0010010; Maity A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076837; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Marshall WL, 1999, J VIROL, V73, P5181, DOI 10.1128/JVI.73.6.5181-5185.1999; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Mei Y, 2013, PROTEINS; Moroy G, 2009, J BIOL CHEM, V284, P17499, DOI 10.1074/jbc.M805542200; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ojala PM, 1999, CANCER RES, V59, P4984; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Roizman B, 2001, FIELDS VIROL, P2381; Sarid R, 1997, NAT MED, V3, P293, DOI 10.1038/nm0397-293; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Su MF, 2013, J ONCOL, V2013, DOI 10.1155/2013/102735; Tarakanova VL, 2005, J VIROL, V79, P14668, DOI 10.1128/JVI.79.23.14668-14679.2005; Theodorakis P, 1996, ONCOGENE, V12, P1707; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang GH, 1999, J GEN VIROL, V80, P2737, DOI 10.1099/0022-1317-80-10-2737; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001	56	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8029	8040		10.1074/jbc.M113.515361	http://dx.doi.org/10.1074/jbc.M113.515361			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24443581	hybrid, Green Published			2022-12-25	WOS:000333157500003
J	Lasry, I; Golan, Y; Berman, B; Amram, N; Glaser, F; Assaraf, YG				Lasry, Inbal; Golan, Yarden; Berman, Bluma; Amram, Noy; Glaser, Fabian; Assaraf, Yehuda G.			In Situ Dimerization of Multiple Wild Type and Mutant Zinc Transporters in Live Cells Using Bimolecular Fluorescence Complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Metal Homeostasis; Mutant; Protein-Protein Interactions; Transport Metals; Zinc	DIFFUSION FACILITATOR FAMILY; MAMMALIAN ZINC; FUNCTIONAL-CHARACTERIZATION; ALKALINE-PHOSPHATASES; PROTEIN INTERACTIONS; SLC30 FAMILY; BETA; VISUALIZATION; EXPRESSION; GENE	Background: Zinc transporters (ZnTs) presumably form dimers, thereby modulating zinc transport activity. Results: Bimolecular fluorescence complementation (BiFC) revealed ZnT1-4, ZnT7 homodimers and ZnT5-ZnT6 heterodimers. Conclusion: BiFC pinpointed WT and mutant ZnT2 dimerization in live cells. Significance: BiFC provides the first in situ evidence for the subcellular localization of WT and mutant ZnT2 dimers in live cells, thereby establishing the molecular basis underlying zinc deficiency. Zinc transporters (ZnTs) facilitate zinc efflux and zinc compartmentalization, thereby playing a key role in multiple physiological processes and pathological disorders, presumed to be modulated by transporter dimerization. We recently proposed that ZnT2 homodimerization is the underlying basis for the dominant negative effect of a novel heterozygous G87R mutation identified in women producing zinc-deficient milk. To provide direct visual evidence for the in situ dimerization and function of multiple normal and mutant ZnTs, we applied here the bimolecular fluorescence complementation (BiFC) technique, which enables direct visualization of specific protein-protein interactions. BiFC is based upon reconstitution of an intact fluorescent protein including YFP when its two complementary, non-fluorescent N- and C-terminal fragments (termed YN and YC) are brought together by a pair of specifically interacting proteins. Homodimerization of ZnT1, -2, -3, -4, and -7 was revealed by high subcellular fluorescence observed upon co-transfection of non-fluorescent ZnT-YC and ZnT-YN; this homodimer fluorescence localized in the characteristic compartments of each ZnT. The validity of the BiFC assay in ZnT dimerization was further corroborated when high fluorescence was obtained upon co-transfection of ZnT5-YC and ZnT6-YN, which are known to form heterodimers. We further show that BiFC recapitulated the pathogenic role that ZnT mutations play in transient neonatal zinc deficiency. Zinquin, a fluorescent zinc probe applied along with BiFC, revealed the in situ functionality of ZnT dimers. Hence, the current BiFC-Zinquin technique provides the first in situ evidence for the dimerization and function of wild type and mutant ZnTs in live cells.	[Lasry, Inbal; Golan, Yarden; Berman, Bluma; Amram, Noy; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel; [Glaser, Fabian] Technion Israel Inst Technol, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Bioinformat Knowledge Unit, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il		Golan, Yarden/0000-0002-3043-3638				Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P15; Dempsey C, 2012, J NUTR, V142, P655, DOI 10.3945/jn.111.150623; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005679; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Gustin JL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-76; Haider AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025818; Heroux M, 2007, J BIOL CHEM, V282, P31610, DOI 10.1074/jbc.M701790200; Higuchi T, 2009, PROTEINS, V76, P768, DOI 10.1002/prot.22444; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Itsumura N., 2013, PLOS ONE, V8; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Jirakulaporn T, 2004, J BIOL CHEM, V279, P27807, DOI 10.1074/jbc.M401210200; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kambe Taiho, 2006, Genomics Proteomics & Bioinformatics, V4, P1, DOI 10.1016/S1672-0229(06)60010-7; Kambe T, 2012, CURR TOP MEMBR, V69, P199, DOI 10.1016/B978-0-12-394390-3.00008-2; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; Kelleher SL, 2012, J CELL PHYSIOL, V227, P1761, DOI 10.1002/jcp.22900; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kosel D, 2010, J CELL SCI, V123, P1320, DOI 10.1242/jcs.057919; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Li N, 2007, BIOCHEM J, V407, P363, DOI 10.1042/BJ20070716; Liuzzi JP, 2003, J NUTR, V133, P342, DOI 10.1093/jn/133.2.342; Liuzzi JP, 2001, J NUTR, V131, P46, DOI 10.1093/jn/131.1.46; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin Y, 2009, NEUROSCI LETT, V450, P206, DOI 10.1016/j.neulet.2008.11.069; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Rothem L, 2005, MOL PHARMACOL, V68, P616, DOI 10.1124/mol.105.013540; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Valente T, 2002, MOL CELL NEUROSCI, V21, P189, DOI 10.1006/mcne.2002.1159; Weijers RNM, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-33	60	43	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7275	7292		10.1074/jbc.M113.533786	http://dx.doi.org/10.1074/jbc.M113.533786			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24451381	hybrid, Green Published			2022-12-25	WOS:000332761500003
J	Gilardi, F; Giudici, M; Mitro, N; Maschi, O; Guerrini, U; Rando, G; Maggi, A; Cermenati, G; Laghezza, A; Loiodice, F; Pochetti, G; Lavecchia, A; Caruso, D; De Fabiani, E; Bamberg, K; Crestani, M				Gilardi, Federica; Giudici, Marco; Mitro, Nico; Maschi, Omar; Guerrini, Uliano; Rando, Gianpaolo; Maggi, Adriana; Cermenati, Gaia; Laghezza, Antonio; Loiodice, Fulvio; Pochetti, Giorgio; Lavecchia, Antonio; Caruso, Donatella; De Fabiani, Emma; Bamberg, Krister; Crestani, Maurizio			LT175 Is a Novel PPAR alpha/gamma Ligand with Potent Insulin-sensitizing Effects and Reduced Adipogenic Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Glucose Metabolism; Insulin Resistance; Metabolic Regulation; Peroxisome Proliferator-activated Receptor (PPAR); Transcription Coregulators; Type 2 Diabetes	ACTIVATED-RECEPTOR-GAMMA; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; PARTIAL AGONIST; ALPHA; THIAZOLIDINEDIONES; ROSIGLITAZONE; METABOLISM; OBESITY; PHOSPHORYLATION	Background: PPARs are attractive targets of antidiabetic agents. However, PPAR ligands show side effects that hinder their clinical use. Results: LT175 improves insulin sensitivity and reduces body weight via selective gene activation in adipose tissue. Conclusion: LT175 shows an improved pharmacological profile linked to characteristic binding and differential coregulator recruitment. Significance: LT175 may be a scaffold molecule to design a safer generation of PPAR ligands. Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors regulating lipid and glucose metabolism. Ongoing drug discovery programs aim to develop dual PPAR/ agonists devoid of the side effects of the marketed antidiabetic agents thiazolidinediones and the dual agonists glitazars. Recently, we described a new dual PPAR/ ligand, LT175, with a partial agonist profile against PPAR and interacting with a newly identified region of the PPAR-ligand binding domain (1). Here we show that LT175 differentially activated PPAR target genes involved in fatty acid esterification and storage in 3T3-L1-derived adipocytes. This resulted in a less severe lipid accumulation compared with that triggered by rosiglitazone, suggesting that LT175 may have a lower adipogenic activity. Consistent with this hypothesis, in vivo administration of LT175 to mice fed a high-fat diet decreased body weight, adipocyte size, and white adipose tissue mass, as assessed by magnetic resonance imaging. Furthermore, LT175 significantly reduced plasma glucose, insulin, non-esterified fatty acids, triglycerides, and cholesterol and increased circulating adiponectin and fibroblast growth factor 21 levels. Oral glucose and insulin tolerance tests showed that the compound improves glucose homeostasis and insulin sensitivity. Moreover, we demonstrate that the peculiar interaction of LT175 with PPAR affected the recruitment of the coregulators cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1), fundamentals for the PPAR-mediated adipogenic program. In conclusion, our results describe a new PPAR ligand, modulating lipid and glucose metabolism with reduced adipogenic activity, that may be used as a model for a series of novel molecules with an improved pharmacological profile for the treatment of dyslipidemia and type 2 diabetes.	[Gilardi, Federica; Giudici, Marco; Mitro, Nico; Maschi, Omar; Guerrini, Uliano; Rando, Gianpaolo; Maggi, Adriana; Cermenati, Gaia; Caruso, Donatella; De Fabiani, Emma; Crestani, Maurizio] Univ Milan, Dipartimento Sci Farmacol & Biomol, I-20133 Milan, Italy; [Laghezza, Antonio; Loiodice, Fulvio] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, I-70125 Bari, Italy; [Pochetti, Giorgio] CNR, I-00016 Rome, Italy; [Lavecchia, Antonio] Univ Naples Federico II, Dipartimento Farm, Drug Discovery Lab, I-80131 Naples, Italy; [Bamberg, Krister] AstraZeneca, S-43183 Molndal, Sweden	University of Milan; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; AstraZeneca	Crestani, M (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Giovanni Galli Lab Biochem & Mol Biol Metab, I-20133 Milan, Italy.	maurizio.crestani@unimi.it	Laghezza, Antonio/F-7420-2014; De Fabiani, Emma/B-6936-2015; Lavecchia, Antonio/P-9476-2017; pochetti, giorgio/AAU-7069-2020	De Fabiani, Emma/0000-0003-2406-1468; Lavecchia, Antonio/0000-0002-2181-8026; Gilardi, Federica/0000-0001-5421-2779; Laghezza, Antonio/0000-0001-6221-6155; Maschi, Omar/0000-0002-4879-436X; Maggi, Adriana/0000-0001-5700-5273; Crestani, Maurizio/0000-0001-9230-1078; Mitro, Nico/0000-0002-5000-3619	Universita degli Studi di Milano	Universita degli Studi di Milano	We thank Elda Desiderio Pinto (Universita degli Studi di Milano) for administrative and financial management and Catherine Moret (Center for Integrative Genomics, University of Lausanne) for help with histological analyses.	[Anonymous], 2008, LANCET, V372, P1520, DOI [10.1016/S0140-6736(08)61628-1, 10.2337/dc08-9025]; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Berthou L, 1996, J CLIN INVEST, V97, P2408, DOI 10.1172/JCI118687; Biserni A, 2008, MOL PHARMACOL, V73, P1434, DOI 10.1124/mol.107.042689; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Ciana P, 2007, MOL ENDOCRINOL, V21, P388, DOI 10.1210/me.2006-0152; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Douglas IJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000154; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Fievet C, 2006, CURR OPIN PHARMACOL, V6, P606, DOI 10.1016/j.coph.2006.06.009; Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Henry RR, 2009, LANCET, V374, P126, DOI 10.1016/S0140-6736(09)60870-9; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Li Y, 2008, J BIOL CHEM, V283, P9168, DOI 10.1074/jbc.M800104200; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Liu Y, 2013, J PROTEOME RES, V12, P5634, DOI 10.1021/pr400587y; Mitro N., 2013, PEROXISOME PROLIFERA, P219; Montanari R, 2008, J MED CHEM, V51, P7768, DOI 10.1021/jm800733h; Mudaliar Sunder, 2003, Endocr Pract, V9, P406; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Pochetti G, 2010, J MED CHEM, V53, P4354, DOI 10.1021/jm9013899; Porcelli L, 2012, J MED CHEM, V55, P37, DOI 10.1021/jm201306q; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Qi C, 2003, J BIOL CHEM, V278, P25281, DOI 10.1074/jbc.C300175200; Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shadid S, 2003, DIABETES CARE, V26, P3148, DOI 10.2337/diacare.26.11.3148; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012; Vallon V, 2009, J AM SOC NEPHROL, V20, P721, DOI 10.1681/ASN.2008040415; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wilding J, 2006, INT J CLIN PRACT, V60, P1272, DOI 10.1111/j.1742-1241.2006.01128.x; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102	46	27	27	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6908	6920		10.1074/jbc.M113.506394	http://dx.doi.org/10.1074/jbc.M113.506394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451380	Green Published, hybrid			2022-12-25	WOS:000332389400051
J	Marzahn, MR; Hayner, JN; Finkelstein, J; O'Donnell, M; Bloom, LB				Marzahn, Melissa R.; Hayner, Jaclyn N.; Finkelstein, Jeff; O'Donnell, Mike; Bloom, Linda B.			The ATP Sites of AAA plus Clamp Loaders Work Together as a Switch to Assemble Clamps on DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; DNA Enzymes; DNA Replication; Fluorescence; Nucleic Acid Enzymology; AAA plus ATPase; Proliferating Cell Nuclear Antigen; Replication Factor C; Clamp Loader	REPLICATION-FACTOR-C; CELL NUCLEAR ANTIGEN; POLYMERASE III HOLOENZYME; ESCHERICHIA-COLI; SLIDING CLAMP; COMPLEX-FORMATION; LOADING MACHINE; DISTINCT ROLES; BINDING; PCNA	Background: Replication factor C contains four active AAA+ ATPase sites. Results: Mutation of any one ATP binding site affects clamp loader activities. Conclusion: Although ATP sites may fill sequentially, ATP binding to all four sites is needed for RFC activity. Significance: This provides insight into the ATP-dependent conformational changes in RFC that drive the clamp loading reaction. Clamp loaders belong to a family of proteins known as ATPases associated with various cellular activities (AAA+). These proteins utilize the energy from ATP binding and hydrolysis to perform cellular functions. The clamp loader is required to load the clamp onto DNA for use by DNA polymerases to increase processivity. ATP binding and hydrolysis are coordinated by several key residues, including a conserved Lys located within the Walker A motif (or P-loop). This residue is required for each subunit to bind ATP. The specific function of each ATP molecule bound to the Saccharomyces cerevisiae clamp loader is unknown. A series of point mutants, each lacking a single Walker A Lys residue, was generated to study the effects of abolishing ATP binding in individual clamp loader subunits. A variety of biochemical assays were used to analyze the function of ATP binding during discrete steps of the clamp loading reaction. All mutants reduced clamp binding/opening to different degrees. Decreased clamp binding activity was generally correlated with decreases in the population of open clamps, suggesting that differences in the binding affinities of Walker A mutants stem from differences in stabilization of proliferating cell nuclear antigen in an open conformation. Walker A mutations had a smaller effect on DNA binding than clamp binding/opening. Our data do not support a model in which each ATP site functions independently to regulate a different step in the clamp loading cycle to coordinate these steps. Instead, the ATP sites work in unison to promote conformational changes in the clamp loader that drive clamp loading.	[Marzahn, Melissa R.; Hayner, Jaclyn N.; Bloom, Linda B.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Finkelstein, Jeff; O'Donnell, Mike] Howard Hughes Med Inst, New York, NY 10021 USA; [Finkelstein, Jeff; O'Donnell, Mike] Rockefeller Univ, New York, NY 10021 USA	State University System of Florida; University of Florida; Howard Hughes Medical Institute; Rockefeller University	Bloom, LB (corresponding author), Univ Florida, Dept Biochem & Mol Biol, 1600 SW Archer Rd,JHMHC Rm R3-234, Gainesville, FL 32601 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014	O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM082849, T32 CA009126-32]; GM38839; NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082849, R01GM038839, R37GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GM38839; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM082849 (to L. B. B.), T32 CA009126-32 (to J. N. H. through the University of Florida Shands Cancer Center), and GM38839 (to M. O. D.).	Anderson SG, 2007, J BIOL CHEM, V282, P7035, DOI 10.1074/jbc.M610136200; Anderson SG, 2009, BIOCHEMISTRY-US, V48, P8516, DOI 10.1021/bi900912a; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Cai JS, 1998, P NATL ACAD SCI USA, V95, P11607, DOI 10.1073/pnas.95.20.11607; Chen SY, 2009, J MOL BIOL, V388, P431, DOI 10.1016/j.jmb.2009.03.014; Chiraniya A, 2013, GENES-BASEL, V4, P134, DOI 10.3390/genes4020134; CRONET P, 1995, J MOL BIOL, V249, P654, DOI 10.1006/jmbi.1995.0326; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Downey CD, 2011, J MOL BIOL, V412, P340, DOI 10.1016/j.jmb.2011.07.051; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Grabowski B, 2003, ANNU REV MICROBIOL, V57, P487, DOI 10.1146/annurev.micro.57.030502.090709; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Huebscher Ulrich, 2009, V521, P19, DOI [10.1007/978-1-60327-817-5_2, 10.1007/978-1-60327-815-7_2]; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; Kelch BA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-34; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Marzahn MR, 2012, PROTEIN EXPRES PURIF, V83, P135, DOI 10.1016/j.pep.2012.03.010; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Neuwald AF, 1999, GENOME RES, V9, P27; Podust VN, 1998, J BIOL CHEM, V273, P12935, DOI 10.1074/jbc.273.21.12935; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Sakato M, 2012, J MOL BIOL, V416, P176, DOI 10.1016/j.jmb.2011.12.018; Sakato M, 2012, J MOL BIOL, V416, P163, DOI 10.1016/j.jmb.2011.12.017; Schmidt SLG, 2001, J BIOL CHEM, V276, P34792, DOI 10.1074/jbc.M011671200; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; Seybert A, 2004, EMBO J, V23, P1360, DOI 10.1038/sj.emboj.7600130; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Tainer JA, 2010, J AM CHEM SOC, V132, P7372, DOI 10.1021/ja100365x; Thompson JA, 2012, J BIOL CHEM, V287, P2203, DOI 10.1074/jbc.C111.318899; Thompson JA, 2009, J BIOL CHEM, V284, P32147, DOI 10.1074/jbc.M109.045997; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wieczorek A, 2010, J BIOL CHEM, V285, P29049, DOI 10.1074/jbc.C110.165076; Yao N, 2003, J BIOL CHEM, V278, P50744, DOI 10.1074/jbc.M309206200; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103	53	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5537	5548		10.1074/jbc.M113.541466	http://dx.doi.org/10.1074/jbc.M113.541466			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24436332	Green Published, hybrid			2022-12-25	WOS:000332015500020
J	Luz, M; Spannl-Muller, S; Ozhan, G; Kagermeier-Schenk, B; Rhinn, M; Weidinger, G; Brand, M				Luz, Marta; Spannl-Mueller, Stephanie; Oezhan, Guenes; Kagermeier-Schenk, Birgit; Rhinn, Muriel; Weidinger, Gilbert; Brand, Michael			Dynamic Association with Donor Cell Filopodia and Lipid-Modification Are Essential Features of Wnt8a during Patterning of the Zebrafish Neuroectoderm	PLOS ONE			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; PLASMA-MEMBRANE; SIGNALING PATHWAY; SONIC HEDGEHOG; IN-VIVO; PROTEINS; WINGLESS; DROSOPHILA; SECRETION; POSTERIORIZATION	Background: Wnt proteins are conserved signaling molecules that regulate pattern formation during animal development. Many Wnt proteins are post-translationally modified by addition of lipid adducts. Wnt8a provides a crucial signal for patterning the anteroposterior axis of the developing neural plate in vertebrates. However, it is not clear how this protein propagates from its source, the blastoderm margin, to the target cells in the prospective neural plate, and how lipid-modifications might influence Wnt8a propagation and activity. Results: We have dynamically imaged biologically active, fluorescently tagged Wnt8a in living zebrafish embryos. We find that Wnt8a localizes to membrane-associated, punctate structures in live tissue. In Wnt8a expressing cells, these puncta are found on filopodial cellular processes, from where the protein can be released. In addition, Wnt8a is found colocalized with Frizzled receptor-containing clusters on signal receiving cells. Combining in vitro and in vivo assays, we compare the roles of conserved Wnt8a residues in cell and non-cell-autonomous signaling activity and secretion. Non-signaling Wnt8 variants show these residues can regulate Wnt8a distribution in producing cell membranes and filopodia as well as in the receiving tissue. Conclusions: Together, our results show that Wnt8a forms dynamic clusters found on filopodial donor cell and on signal receiving cell membranes. Moreover, they demonstrate a differential requirement of conserved residues in Wnt8a protein for distribution in producing cells and receiving tissue and signaling activity during neuroectoderm patterning.	[Luz, Marta; Spannl-Mueller, Stephanie; Rhinn, Muriel; Brand, Michael] Tech Univ Dresden, CRTD, D-01062 Dresden, Germany; [Luz, Marta; Spannl-Mueller, Stephanie; Oezhan, Guenes; Kagermeier-Schenk, Birgit; Rhinn, Muriel; Weidinger, Gilbert; Brand, Michael] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Brand, M (corresponding author), Tech Univ Dresden, CRTD, D-01062 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Ozhan, Gunes/HGU-9280-2022; Brand, Michael/A-5509-2010; Weidinger, Gilbert/A-8342-2010; Ozhan, Gunes/Q-3816-2018	Ozhan, Gunes/0000-0002-4806-5917; Brand, Michael/0000-0001-5711-6512; Weidinger, Gilbert/0000-0003-3599-6760; Rhinn, Muriel/0000-0002-1918-0246; Spannl, Stephanie/0000-0001-5999-1564	Deutsche Forschungsgemeinschaft [SFB 655-A3]; EU (Zf-Models and Endotrack)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU (Zf-Models and Endotrack)	This work was supported by grants to M. B. by the Deutsche Forschungsgemeinschaft(SFB 655-A3) and the EU (Zf-Models and Endotrack). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Brand M., 2002, ZEBRAFISH PRACTICAL; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chu MLH, 2013, STRUCTURE, V21, P1235, DOI 10.1016/j.str.2013.05.006; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Erter CE, 2001, DEVELOPMENT, V128, P3571; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Iioka H, 2004, J CELL BIOL, V164, P169, DOI 10.1083/jcb.200310027; Iizuka-Kogo A, 2005, HISTOCHEM CELL BIOL, V123, P67, DOI 10.1007/s00418-004-0729-2; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kagermeier-Schenk B, 2011, DEV CELL; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kiecker C, 2001, DEVELOPMENT, V128, P4189; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Miura GI, 2006, CELL CYCLE, V5, P1184, DOI 10.4161/cc.5.11.2804; Momoi A, 2003, MECH DEVELOP, V120, P477, DOI 10.1016/S0925-4773(03)00003-0; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Ozhan G, 2013, DEV CELL, V26, P331, DOI 10.1016/j.devcel.2013.07.020; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Raible F, 2004, TRENDS NEUROSCI, V27, P727, DOI 10.1016/j.tins.2004.10.003; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Reifers F, 1998, DEVELOPMENT, V125, P2381; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Rhinn M, 2006, CURR OPIN NEUROBIOL, V16, P5, DOI 10.1016/j.conb.2006.01.005; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Rhinn M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-12; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Strzelecka M, 2010, NUCLEUS-PHILA, V1, P96, DOI 10.4161/nucl.1.1.10680; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Tang XF, 2012, DEV BIOL, V364, P32, DOI 10.1016/j.ydbio.2012.01.009; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	57	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84922	10.1371/journal.pone.0084922	http://dx.doi.org/10.1371/journal.pone.0084922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427298	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200038
J	Yamaguchi, H; Yoshida, N; Takanashi, M; Ito, Y; Fukami, K; Yanagihara, K; Yashiro, M; Sakai, R				Yamaguchi, Hideki; Yoshida, Nachi; Takanashi, Miho; Ito, Yuumi; Fukami, Kiyoko; Yanagihara, Kazuyoshi; Yashiro, Masakazu; Sakai, Ryuichi			Stromal Fibroblasts Mediate Extracellular Matrix Remodeling and Invasion of Scirrhous Gastric Carcinoma Cells	PLOS ONE			English	Article							CANCER-CELLS; MYOFIBROBLASTS; GROWTH; PROLIFERATION; METASTASIS; INHIBITOR; BETA; ROCK	Scirrhous gastric carcinoma (SGC) has the worst prognosis of all gastric cancers, owing to its rapid expansion by invasion and frequent peritoneal dissemination. Due to the increased proliferation of stromal fibroblasts (SFs) that occurs within SGC lesions and the peritoneal metastatic sites, SFs have been proposed to support the progression of this disease. However, the biological and molecular basis and the pathological role of the intercellular interaction between SGC cells and SFs remain largely unknown. In this study, we investigated the role of SFs in the invasion of the extracellular matrix (ECM) by SGC cells. When SGC cells were cocultured with SFs derived from SGC tissue on three-dimensional (3D) Matrigel, they were attracted together to form large cellular aggregates that invaded within the Matrigel. Time-lapse imaging revealed that this process was associated with extensive contraction and remodeling of the ECM. Immunofluorescence and biochemical analysis showed that SGC cells stimulate phosphorylation of myosin light chain and actomyosin-mediated mechanical remodeling of the ECM by SFs. By utilizing this assay system for inhibitor library screening, we have identified several inhibitors that potently suppress the cooperation between SGC cells and SFs to form the invasive structures. Among them, a Src inhibitor dasatinib impaired the interaction between SGC cells and SFs both in vitro and in vivo and effectively blocked peritoneal dissemination of SGC cells. These results indicate that SFs mediate mechanical remodeling of the ECM by SGC cells, thereby promoting invasion and peritoneal dissemination of SGC.	[Yamaguchi, Hideki; Yoshida, Nachi; Takanashi, Miho; Ito, Yuumi; Sakai, Ryuichi] Natl Canc Ctr, Res Inst, Div Metastasis & Invas Signaling, Chuo Ku, Tokyo 104, Japan; [Takanashi, Miho; Ito, Yuumi; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Hachioji, Tokyo 19203, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 558, Japan	National Cancer Center - Japan; Tokyo University of Pharmacy & Life Sciences; National Cancer Center - Japan; Osaka Metropolitan University	Sakai, R (corresponding author), Natl Canc Ctr, Res Inst, Div Metastasis & Invas Signaling, Chuo Ku, Tokyo 104, Japan.	rsakai@ncc.go.jp	Sakai, Ryuichi/R-7741-2017; Yamaguchi, Hideki/AAP-1767-2021	Yamaguchi, Hideki/0000-0003-2125-9655; Sakai, Ryuichi/0000-0001-6833-1103	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; National Cancer Center Research and Development Fund [23-A-9]; Tokyo Biochemical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Tokyo Biochemical Research Foundation	This work was supported by Grants-in-Aid for Scientific Research by the Japan Society for the Promotion of Science; by Grants-in-Aid for Scientific Research on Innovative Areas by the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan for the 3rd term Comprehensive 10-year Strategy for Cancer Control. This work was supported in part by the National Cancer Center Research and Development Fund (23-A-9), and also by Grant-in-Aid from the Tokyo Biochemical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Calvo F, 2011, CURR OPIN CELL BIOL, V23, P621, DOI 10.1016/j.ceb.2011.04.010; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Fuyuhiro Y, 2011, BRIT J CANCER, V105, P996, DOI 10.1038/bjc.2011.330; Fuyuhiro Y, 2012, CANCER SCI, V103, P797, DOI 10.1111/j.1349-7006.2012.02209.x; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Ikeguchi M, 2009, SURG TODAY, V39, P290, DOI 10.1007/s00595-008-3860-1; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Nakazawa K, 2003, CANCER RES, V63, P8848; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Parekh A, 2009, CELL ADHES MIGR, V3, P288, DOI 10.4161/cam.3.3.8888; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Schenone S, 2010, EXPERT OPIN INV DRUG, V19, P931, DOI 10.1517/13543784.2010.499898; Semba S, 2009, BRIT J CANCER, V101, P1365, DOI 10.1038/sj.bjc.6605309; Tendo M, 2005, CANCER SCI, V96, P451, DOI 10.1111/j.1349-7006.2005.00066.x; URA H, 1991, CANCER RES, V51, P3550; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Yashiro M, 1996, BRIT J CANCER, V74, P1096, DOI 10.1038/bjc.1996.496; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685; Yashiro M, 2007, INT J CANCER, V120, P686, DOI 10.1002/ijc.22329; Yashiro M, 2010, CANCER MICROENVIRON, V3, P127, DOI 10.1007/s12307-010-0036-5; Zhi KK, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-66	31	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85485	10.1371/journal.pone.0085485	http://dx.doi.org/10.1371/journal.pone.0085485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427313	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200054
J	Ammendolia, MG; Iosi, F; De Berardis, B; Guccione, G; Superti, F; Conte, MP; Longhi, C				Ammendolia, Maria Grazia; Iosi, Francesca; De Berardis, Barbara; Guccione, Giuliana; Superti, Fabiana; Conte, Maria Pia; Longhi, Catia			Listeria monocytogenes Behaviour in Presence of Non-UV-Irradiated Titanium Dioxide Nanoparticles	PLOS ONE			English	Article							FOOD-CONTACT SURFACES; ESCHERICHIA-COLI; BIOFILM FORMATION; FECAL CARRIAGE; TIO2; PARTICLES; PHOTOCATALYSIS; MICROPARTICLES; TRANSLOCATION; DISINFECTION	Listeria monocytogenes is the agent of listeriosis, a food-borne disease. It represents a serious problem for the food industry because of its environmental persistence mainly due to its ability to form biofilm on a variety of surfaces. Microrganisms attached on the surfaces are a potential source of contamination for environment and animals and humans. Titanium dioxide nanoparticles (TiO2 NPs) are used in food industry in a variety of products and it was reported that daily exposure to these nanomaterials is very high. Anti-listerial activity of TiO2 NPs was investigated only with UV-irradiated nanomaterials, based on generation of reactive oxigen species (ROS) with antibacterial effect after UV exposure. Since both Listeria monocytogenes and TiO2 NPs are veicolated with foods, this study explores the interaction between Listeria monocytogenes and non UV-irradiated TiO2 NPs, with special focus on biofilm formation and intestinal cell interaction. Scanning electron microscopy and quantitative measurements of biofilm mass indicate that NPs influence both production and structural architecture of listerial biofilm. Moreover, TiO2 NPs show to interfere with bacterial interaction to intestinal cells. Increased biofilm production due to TiO2 NPs exposure may favour bacterial survival in environment and its transmission to animal and human hosts.	[Ammendolia, Maria Grazia; Iosi, Francesca; Superti, Fabiana] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy; [De Berardis, Barbara] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Guccione, Giuliana; Conte, Maria Pia; Longhi, Catia] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Sapienza University Rome	Ammendolia, MG (corresponding author), Ist Super Sanita, Dept Technol & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	maria.ammendolia@iss.it	AMMENDOLIA, MARIA GRAZIA/F-2101-2015; Superti, Fabiana/F-2100-2015; DE BERARDIS, BARBARA/F-2105-2015; IOSI, FRANCESCA/F-2106-2015	AMMENDOLIA, MARIA GRAZIA/0000-0003-4121-3005; Superti, Fabiana/0000-0003-4909-7598; IOSI, FRANCESCA/0000-0002-5929-6833; De Berardis, Barbara/0000-0001-7857-9620				Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Ashwood P, 2007, EXP BIOL MED, V232, P107; Baan R, 2006, LANCET ONCOL, V7, P295, DOI 10.1016/S1470-2045(06)70651-9; Bae HS, 2003, COLLOID SURFACE A, V220, P169, DOI 10.1016/S0927-7757(03)00077-3; Bockmann J, 2000, PHARMAZIE, V55, P140; Briandet R, 1999, APPL ENVIRON MICROB, V65, P5328; Butler M, 2007, INFLAMM RES, V56, P353, DOI 10.1007/s00011-007-7068-4; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chorianopoulos NG, 2011, FOOD MICROBIOL, V28, P164, DOI 10.1016/j.fm.2010.07.025; Corr S, 2006, MICROB PATHOGENESIS, V41, P241, DOI 10.1016/j.micpath.2006.08.003; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Di Bonaventura G, 2008, J APPL MICROBIOL, V104, P1552, DOI 10.1111/j.1365-2672.2007.03688.x; Doyle MP, 2006, POULTRY SCI, V85, P960, DOI 10.1093/ps/85.6.960; EFSA,, 2004, EFSA J, V163, P1, DOI [10.2903/j.efsa.2005.163, DOI 10.2903/J.EFSA.2005.163]; European Parliament C, 1994, COM94314, P13; Fernandez-Ibanez P, 2003, WATER RES, V37, P3180, DOI 10.1016/S0043-1354(03)00157-X; Folsom JP, 2006, J FOOD PROTECT, V69, P1292, DOI 10.4315/0362-028X-69.6.1292; Garcia-Del Portillo Francisco, 2012, Commun Integr Biol, V5, P160, DOI 10.4161/cib.18678; GARCIADELPORTILLO F, 1995, TRENDS MICROBIOL, V3, P373, DOI 10.1016/S0966-842X(00)88982-9; Gogniat G, 2006, FEMS MICROBIOL LETT, V258, P18, DOI 10.1111/j.1574-6968.2006.00190.x; Gounadaki AS, 2008, FOOD MICROBIOL, V25, P313, DOI 10.1016/j.fm.2007.10.001; Grif K, 2003, EUR J CLIN MICROBIOL, V22, P16, DOI 10.1007/s10096-002-0835-9; Gumy D, 2006, APPL CATAL B-ENVIRON, V63, P76, DOI 10.1016/j.apcatb.2005.09.013; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Ivaneka R, 2007, J THEOR BIOL, V245, P44, DOI 10.1016/j.jtbi.2006.09.031; JANI PU, 1994, INT J PHARM, V105, P157, DOI 10.1016/0378-5173(94)90461-8; Kim B, 2003, CHEMOSPHERE, V52, P277, DOI 10.1016/S0045-6535(03)00051-1; Kim S, 2013, WATER RES, V47, P4403, DOI 10.1016/j.watres.2013.05.009; Kim Y, 2009, J FOOD PROTECT, V72, P1916, DOI 10.4315/0362-028X-72.9.1916; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Koutsoumanis K, 2010, APPL ENVIRON MICROB, V76, P2181, DOI 10.1128/AEM.02430-09; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Lomer MCE, 2004, BRIT J NUTR, V92, P947, DOI 10.1079/BJN20041276; Lomer MCE, 2002, P NUTR SOC, V61, P123, DOI 10.1079/PNS2001134; Longhi C, 2003, INT J IMMUNOPATH PH, V16, P119, DOI 10.1177/039463200301600205; Longhi C, 2008, MICROB PATHOGENESIS, V45, P45, DOI 10.1016/j.micpath.2008.01.007; MACGOWAN AP, 1991, EPIDEMIOL INFECT, V106, P157, DOI 10.1017/S0950268800056521; MAFU AA, 1991, APPL ENVIRON MICROB, V57, P1969, DOI 10.1128/AEM.57.7.1969-1973.1991; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Pigeot-Remy S, 2011, APPL CATAL B-ENVIRON, V104, P390, DOI 10.1016/j.apcatb.2011.03.001; Poimenidou S, 2009, APPL ENVIRON MICROB, V75, P7182, DOI 10.1128/AEM.01359-09; Powell JJ, 2000, J AUTOIMMUN, V14, P99, DOI 10.1006/jaut.1999.0342; Rincon AG, 2004, APPL CATAL B-ENVIRON, V49, P99, DOI 10.1016/j.apcatb.2003.11.013; Simon-Deckers A, 2009, ENVIRON SCI TECHNOL, V43, P8423, DOI 10.1021/es9016975; Tassinari R, 2014, NANOTOXICOLOGY, V8, P654, DOI 10.3109/17435390.2013.822114; Tessema GT, 2009, APPL ENVIRON MICROB, V75, P6973, DOI 10.1128/AEM.00608-09; Travier L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003131; URBANSKI SJ, 1989, MODERN PATHOL, V2, P222; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Weir A, 2012, ENVIRON SCI TECHNOL, V46, P2242, DOI 10.1021/es204168d	54	24	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84986	10.1371/journal.pone.0084986	http://dx.doi.org/10.1371/journal.pone.0084986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416327	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300046
J	Karaca, G; Swiderska-Syn, M; Xie, GH; Syn, WK; Kruger, L; Machado, MV; Garman, K; Choi, SS; Michelotti, GA; Burkly, LC; Ochoa, B; Diehl, AM				Karaca, Gamze; Swiderska-Syn, Marzena; Xie, Guanhua; Syn, Wing-Kin; Krueger, Leandi; Machado, Mariana Verdelho; Garman, Katherine; Choi, Steve S.; Michelotti, Gregory A.; Burkly, Linda C.; Ochoa, Begona; Diehl, Anna Mae			TWEAK/Fn14 Signaling Is Required for Liver Regeneration after Partial Hepatectomy in Mice	PLOS ONE			English	Article							PROGENITOR CELLS; STEM-CELLS; DRIVEN	Background & Aims: Pro-inflammatory cytokines are important for liver regeneration after partial hepatectomy (PH). Expression of Fibroblast growth factor-inducible 14 (Fn14), the receptor for TNF-like weak inducer of apoptosis (TWEAK), is induced rapidly after PH and remains elevated throughout the period of peak hepatocyte replication. The role of Fn14 in post-PH liver regeneration is uncertain because Fn14 is expressed by liver progenitors and TWEAK-Fn14 interactions stimulate progenitor growth, but replication of mature hepatocytes is thought to drive liver regeneration after PH. Methods: To clarify the role of TWEAK-Fn14 after PH, we compared post-PH regenerative responses in wild type (WT) mice, Fn14 knockout (KO) mice, TWEAK KO mice, and WT mice treated with anti-TWEAK antibodies. Results: In WT mice, rare Fn14(+) cells localized with other progenitor markers in peri-portal areas before PH. PH rapidly increased proliferation of Fn14(+) cells; hepatocytic cells that expressed Fn14 and other progenitor markers, such as Lgr5, progressively accumulated from 12-8 h post-PH and then declined to baseline by 96 h. When TWEAK/Fn14 signaling was disrupted, progenitor accumulation, induction of pro-regenerative cytokines, hepatocyte and cholangiocyte proliferation, and over-all survival were inhibited, while post-PH liver damage and bilirubin levels were increased. TWEAK stimulated proliferation and increased Lgr5 expression in cultured liver progenitors, but had no effect on either parameter in cultured primary hepatocytes. Conclusions: TWEAK-FN14 signaling is necessary for the healthy adult liver to regenerate normally after acute partial hepatectomy.	[Karaca, Gamze; Swiderska-Syn, Marzena; Xie, Guanhua; Krueger, Leandi; Machado, Mariana Verdelho; Garman, Katherine; Choi, Steve S.; Michelotti, Gregory A.; Diehl, Anna Mae] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Syn, Wing-Kin] Fdn Liver Res, Inst Hepatol, Regenerat & Repair Grp, London, England; [Syn, Wing-Kin] Barts Hlth NHS Trust, Dept Hepatol, London, England; [Burkly, Linda C.] Biogen Idec Inc, Dept Exploratory Sci, Cambridge, MA USA; [Burkly, Linda C.] Biogen Idec Inc, Dept Discovery Biol, Cambridge, MA USA; [Burkly, Linda C.] Biogen Idec Inc, Dept Validat Biol, Cambridge, MA USA; [Ochoa, Begona] Univ Basque Country, Fac Med, Dept Physiol, Bilbao, Spain	Duke University; University of London; University College London; Barts Health NHS Trust; Biogen; Biogen; Biogen; University of Basque Country	Diehl, AM (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA.	diehl004@mc.duke.edu	Choi, Steve/GZH-1598-2022; Syn, Wing-Kin/AAB-8406-2020; Ochoa, Begona/K-9123-2014	Ochoa, Begona/0000-0002-1580-7160; , Gregory/0000-0002-3936-4675	 [R37 AA010154];  [R01 DK077794]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007568, R01DK077794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA010154] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by R37 AA010154 and R01 DK077794 (to AMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affo S, 2013, GUT, V62, P452, DOI 10.1136/gutjnl-2011-301146; Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Komuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238; Kuramitsu K, 2013, AM J PATHOL, V183, P182, DOI 10.1016/j.ajpath.2013.03.018; Kuramitsu K, 2011, HEPATOLOGY, V53, P2016, DOI 10.1002/hep.24317; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2011, INT J BIOCHEM CELL B, V43, P173, DOI 10.1016/j.biocel.2009.09.014; Michelotti GA, 2013, J CLIN INVEST; Ochoa B, 2010, HEPATOLOGY, V51, P1712, DOI 10.1002/hep.23525; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SWIDERSKASYN M, 2013, GUT; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Xie G, 2013, HEPATOLOGY	19	45	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83987	10.1371/journal.pone.0083987	http://dx.doi.org/10.1371/journal.pone.0083987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416188	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300018
J	Sommer, F; Adam, N; Johansson, MEV; Xia, LJ; Hansson, GC; Backhed, F				Sommer, Felix; Adam, Nina; Johansson, Malin E. V.; Xia, Lijun; Hansson, Gunnar C.; Backhed, Fredrik			Altered Mucus Glycosylation in Core 1 O-Glycan-Deficient Mice Affects Microbiota Composition and Intestinal Architecture	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GUT MICROBIOTA; GERM-FREE; MUCIN; CELLS; EXTRACTION; DNA; INFLAMMATION; EXPRESSION; BACTERIA	A functional mucus layer is a key requirement for gastrointestinal health as it serves as a barrier against bacterial invasion and subsequent inflammation. Recent findings suggest that mucus composition may pose an important selection pressure on the gut microbiota and that altered mucus thickness or properties such as glycosylation lead to intestinal inflammation dependent on bacteria. Here we used TM-IEC C1galt(-/-) mice, which carry an inducible deficiency of core 1-derived O-glycans in intestinal epithelial cells, to investigate the effects of mucus glycosylation on susceptibility to intestinal inflammation, gut microbial ecology and host physiology. We found that TM-IEC C1galt(-/-) mice did not develop spontaneous colitis, but they were more susceptible to dextran sodium sulphate-induced colitis. Furthermore, loss of core 1-derived O-glycans induced inverse shifts in the abundance of the phyla Bacteroidetes and Firmicutes. We also found that mucus glycosylation impacts intestinal architecture as TM-IEC C1galt(-/-) mice had an elongated gastrointestinal tract with deeper ileal crypts, a small increase in the number of proliferative epithelial cells and thicker circular muscle layers in both the ileum and colon. Alterations in the length of the gastrointestinal tract were partly dependent on the microbiota. Thus, the mucus layer plays a role in the regulation of gut microbiota composition, balancing intestinal inflammation, and affects gut architecture.	[Sommer, Felix; Adam, Nina; Backhed, Fredrik] Univ Gothenburg, Wallenberg Lab, Gothenburg, Sweden; [Sommer, Felix; Adam, Nina; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Gothenburg, Sweden; [Sommer, Felix; Johansson, Malin E. V.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Mucin Biol Grp, Gothenburg, Sweden; [Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn, Ctr Basic Metab Res,Sect Metab Receptol & Enteroe, Copenhagen, Denmark	University of Gothenburg; University of Gothenburg; University of Gothenburg; Oklahoma Medical Research Foundation; Novo Nordisk Foundation; University of Copenhagen	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, Mucin Biol Grp, Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se; fredrik.backhed@wlab.gu.se	Hansson, Gunnar C/A-1236-2009; Sommer, Felix/I-1706-2017; Johansson, Malin E. V./HCH-7451-2022; Sommer, Felix/AAL-1746-2020; Hansson, Gunnar C./AAF-7324-2019; Backhed, Fredrik/ABE-6613-2020	Hansson, Gunnar C/0000-0002-1900-1869; Sommer, Felix/0000-0002-6545-3487; Sommer, Felix/0000-0002-6545-3487; Hansson, Gunnar C./0000-0002-1900-1869; Backhed, Fredrik/0000-0002-4871-8818; Johansson, Malin E. V./0000-0002-4237-6677	Swedish Research Council; Torsten Soderberg foundation; Ragnar Soderberg foundation; IngaBritt and Arne Lundberg's foundation; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC); Knut and Alice Wallenberg foundation; National Institute of Health [U01AI095473, R01DK085691]; Region Vastra Gotaland; Sahlgrenska University Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085691] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten Soderberg foundation; Ragnar Soderberg foundation; IngaBritt and Arne Lundberg's foundation; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC)(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region Vastra Gotaland; Sahlgrenska University Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Swedish Research Council, Torsten and Ragnar Soderbergs' foundations, IngaBritt and Arne Lundberg's foundation, Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC), Knut and Alice Wallenberg foundation, National Institute of Health (U01AI095473, R01DK085691), and the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS GD, 1963, LAB INVEST, V12, P355; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Fuhrer A, 2010, J EXP MED, V207, P2843, DOI 10.1084/jem.20101098; Graham ML, 2011, COMPARATIVE MED, V61, P356; GUM JR, 1994, J BIOL CHEM, V269, P2440; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Johansson M. E. V., 2013, NAT REV GASTROENTERO; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Johansson ME, 2013, GUT; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Kim JJ, 2013, J IMMUNOL, V190, P4795, DOI 10.4049/jimmunol.1201887; Kleiveland CR, 2013, APPL ENVIRON MICROB, V79, P48, DOI 10.1128/AEM.02464-12; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; MANDEL U, 1991, J INVEST DERMATOL, V97, P713, DOI 10.1111/1523-1747.ep12484064; Nylund L, 2010, J MICROBIOL METH, V83, P231, DOI 10.1016/j.mimet.2010.09.003; Quigley EMM, 2012, J CLIN GASTROENTEROL, V46, P356, DOI 10.1097/MCG.0b013e318247157c; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sperandio B, 2013, INFECT IMMUN, V81, P3632, DOI 10.1128/IAI.00551-13; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Staubach F, 2012, ISME J, V6, P1345, DOI 10.1038/ismej.2011.204; Thomsson KA, 2012, GLYCOBIOLOGY, V22, P1128, DOI 10.1093/glycob/cws083; Tornblom H, 2002, GASTROENTEROLOGY, V123, P1972, DOI 10.1053/gast.2002.37059; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	42	89	90	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85254	10.1371/journal.pone.0085254	http://dx.doi.org/10.1371/journal.pone.0085254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416370	gold, Green Published, Green Submitted			2022-12-25	WOS:000329866300059
J	Brycki, B; Szulc, A				Brycki, Bogumil; Szulc, Adrianna			Gemini Alkyldeoxy-D-Glucitolammonium Salts as Modern Surfactants and Microbiocides: Synthesis, Antimicrobial and Surface Activity, Biodegradation	PLOS ONE			English	Article							TO-MICELLE TRANSITION; CATIONIC SURFACTANTS; ANTIFUNGAL ACTIVITY; PH; GLUCAMINES; BEHAVIOR	Dimeric quaternary alkylammonium salts possess a favourable surface and antimicrobial activity. In this paper we describe synthesis, spectroscopic analysis, surface and antimicrobial activity as well as biodegradability of polymethylene-alpha, omega-bis(N,N-dialkyl-N-deoxy-D-glucitolammonium iodides), a new group of dimeric quaternary ammonium salts. This new group of gemini surfactants can be produced from chemicals which come from renewable sources. The structure of products has been determined by the FTIR and H-1 and C-13 NMR spectroscopy. The biodegradability, surface activity and antimicrobial efficacy against Escherichia coli, Staphylococcus aureus, Candida albicans, Aspergillus niger and Penicillium chrysogenum were determined. The influence of the number of alkyl chains and their lengths on surface and antimicrobial properties has been shown. In general, dimeric quaternary alkyldeoxy-D-glucitolammonium salts with long alkyl substituents show favourable surface properties and an excellent antimicrobial activity.	[Brycki, Bogumil; Szulc, Adrianna] Adam Mickiewicz Univ, Fac Chem, Lab Microbiocides Chem, PL-60780 Poznan, Poland	Adam Mickiewicz University	Brycki, B (corresponding author), Adam Mickiewicz Univ, Fac Chem, Lab Microbiocides Chem, Grunwaldzka 6, PL-60780 Poznan, Poland.	brycki@amu.edu.pl		Brycki, Bogumil/0000-0002-5659-9847	International Project DPN/N [172/CHINA/2009]	International Project DPN/N	This work was supported by the funds International Project DPN/N 172/CHINA/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, OECD GUIDELINE TESTI; Banno T, 2010, J SURFACTANTS DETERG, V13, P387, DOI 10.1007/s11743-010-1224-5; Banno T, 2009, J SURFACTANTS DETERG, V12, P249, DOI 10.1007/s11743-009-1119-5; Bell PC, 2003, J AM CHEM SOC, V125, P1551, DOI 10.1021/ja020707g; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; Brycki B, 2012, J MOL STRUCT, V1020, P41, DOI 10.1016/j.molstruc.2012.03.035; Brycki B, 2010, POL J MICROBIOL, V59, P227, DOI 10.33073/pjm-2010-035; Brycki B, 2011, MOLECULES, V16, P319, DOI 10.3390/molecules16010319; DIZ M, 1994, J CHEM SOC PERK T 2, P1871, DOI 10.1039/p29940001871; Fielden ML, 2001, EUR J BIOCHEM, V268, P1269, DOI 10.1046/j.1432-1327.2001.01995.x; Hait SK, 2002, CURR SCI INDIA, V82, P1101; Holmberg K., 2003, SURFACTANTS POLYM AQ; In M, 2001, SURF SCI SERIES, V100, P59; Johnsson M, 2003, LANGMUIR, V19, P4609, DOI 10.1021/la0343270; Kirby AJ, 2003, ANGEW CHEM INT EDIT, V42, P1448, DOI 10.1002/anie.200201597; Kuperkar K, 2012, J SURFACTANTS DETERG, V15, P107, DOI 10.1007/s11743-011-1269-0; Laatiris A, 2008, MICROBIOL RES, V163, P645, DOI 10.1016/j.micres.2006.09.006; Lambert PA, 2013, RUSSELL HUGO AYLIFFE; Laska U, 2006, J SURFACTANTS DETERG, V9, P115, DOI 10.1007/s11743-006-0380-0; Mayers D, 2006, SURFACTANT SCI TECHN; Menger FM, 2000, ANGEW CHEM INT EDIT, V39, P1907; MENGER FM, 1991, J AM CHEM SOC, V113, P1451, DOI 10.1021/ja00004a077; Ng CKL, 2006, J MED CHEM, V49, P811, DOI 10.1021/jm0508843; Para G, 2010, COLLOID SURFACE A, V365, P215, DOI 10.1016/j.colsurfa.2010.02.004; Pestman JM, 1997, LANGMUIR, V13, P6857, DOI 10.1021/la970681k; Pisarcik M., 2003, ACTA FACULT PHARM U, V50, P119; Rosen MJ, 2012, SURFACTANTS AND INTERFACIAL PHENOMENA, 4TH EDITION, P1, DOI 10.1002/9781118228920; Schramm LL, 2003, ANN RP CH C, V99, P3, DOI 10.1039/b208499f; Shukla D, 2006, J OLEO SCI, V55, P381, DOI DOI 10.5650/JOS.55.381; Takagi Y, 2004, SURF SCI CRC, V123, P129; Van Ginkel CG, 2004, HDB DETERGENTS B; Wagenaar A, 2007, TETRAHEDRON, V63, P10622, DOI 10.1016/j.tet.2007.08.023; Walker EB, 2003, HDB TOPICAL ANTIMICR; Warwel S, 2004, J SURFACTANTS DETERG, V7, P181, DOI 10.1007/s11743-004-0302-1; Warwel S, 2004, J SURFACTANTS DETERG, V7, P187, DOI 10.1007/s11743-004-0303-0; Wasungu L, 2006, BBA-BIOMEMBRANES, V1758, P1677, DOI 10.1016/j.bbamem.2006.06.019; Wasungu L, 2006, J MOL MED-JMM, V84, P774, DOI 10.1007/s00109-006-0067-z; Zana R., 2003, GEMINI SURFACTANTS S	38	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84936	10.1371/journal.pone.0084936	http://dx.doi.org/10.1371/journal.pone.0084936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416314	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500191
J	Gong, PC; Zhao, M; He, CY				Gong, Pichang; Zhao, Man; He, Chaoying			Slow Co-Evolution of the MAGO and Y14 Protein Families Is Required for the Maintenance of Their Obligate Heterodimerization Mode	PLOS ONE			English	Article							EXON JUNCTION COMPLEX; OSKAR MESSENGER-RNA; EVOLUTIONARY RATE; BINDING PROTEIN; NASHI; GENE; OOCYTE; INTERACTS; SUBSTITUTION; DIFFERENTIATION	The exon junction complex (EJC) plays important roles in RNA metabolisms and the development of eukaryotic organisms. MAGO (short form of MAGO NASHI) and Y14 (also Tsunagi or RBM8) are the EJC core components. Their biological roles have been well investigated in various species, but the evolutionary patterns of the two gene families and their protein-protein interactions are poorly known. Genome-wide survey suggested that the MAGO and Y14 two gene families originated in eukaryotic organisms with the maintenance of a low copy. We found that the two protein families evolved slowly; however, the MAGO family under stringent purifying selection evolved more slowly than the Y14 family that was under relative relaxed purifying selection. MAGO and Y14 were obliged to form heterodimer in a eukaryotic organism, and this obligate mode was plesiomorphic. Lack of binding of MAGO to Y14 as functional barrier was observed only among distantly species, suggesting that a slow co-evolution of the two protein families. Inter-protein co-evolutionary signal was further quantified in analyses of the Tol-MirroTree and co-evolution analysis using protein sequences. About 20% of the 41 significantly correlated mutation groups (involving 97 residues) predicted between the two families was clade-specific. Moreover, around half of the predicted co-evolved groups and nearly all clade-specific residues fell into the minimal interaction domains of the two protein families. The mutagenesis effects of the clade-specific residues strengthened that the co-evolution is required for obligate MAGO-Y14 heterodimerization mode. In turn, the obliged heterodimerization in an organism serves as a strong functional constraint for the co-evolution of the MAGO and Y14 families. Such a co-evolution allows maintaining the interaction between the proteins through large evolutionary time scales. Our work shed a light on functional evolution of the EJC genes in eukaryotes, and facilitates to understand the co-evolutionary processes among protein families.	[Gong, Pichang; Zhao, Man; He, Chaoying] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China; [Gong, Pichang; Zhao, Man] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, CY (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China.	chaoying@ibcas.ac.cn	Gong, Pichang/GVT-9910-2022	Gong, Pichang/0000-0003-3322-9525	Chinese Ministry of Agriculture Transgenic Major Project [2009ZX08009-011B]; Chinese Academy of Sciences	Chinese Ministry of Agriculture Transgenic Major Project; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by a grant (2009ZX08009-011B) from the Chinese Ministry of Agriculture Transgenic Major Project and by Hundred Talents Project of the Chinese Academy of Sciences to CYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi CA, 2012, J GENET GENOMICS, V39, P157, DOI 10.1016/j.jgg.2012.02.008; Ashton-Beaucage D, 2010, CELL, V143, P251, DOI 10.1016/j.cell.2010.09.014; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Boothby TC, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-45; Burton RS, 1999, AM ZOOL, V39, P451; Chen YR, 2007, TREE PHYSIOL, V27, P1261, DOI 10.1093/treephys/27.9.1261; Chu FH, 2009, MYCOL RES, V113, P577, DOI 10.1016/j.mycres.2009.01.012; Clark NL, 2010, MOL BIOL EVOL, V27, P1152, DOI 10.1093/molbev/msp324; Clark NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000570; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Fryxell KJ, 1996, TRENDS GENET, V12, P364, DOI 10.1016/S0168-9525(96)80020-5; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haag ES, 2002, CURR BIOL, V12, P2035, DOI 10.1016/S0960-9822(02)01333-7; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; He CY, 2007, MOL BIOL EVOL, V24, P1229, DOI 10.1093/molbev/msm041; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Inaki M, 2011, GENES CELLS, V16, P166, DOI 10.1111/j.1365-2443.2010.01479.x; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kawano T, 2004, MECH DEVELOP, V121, P27, DOI 10.1016/j.mod.2003.11.003; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Lee HC, 2009, BIOCHEM BIOPH RES CO, V384, P334, DOI 10.1016/j.bbrc.2009.04.123; Lenser T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000264; Lewandowski JP, 2010, DEV BIOL, V339, P307, DOI 10.1016/j.ydbio.2009.12.035; Li WQ, 2000, DEV BIOL, V218, P172, DOI 10.1006/dbio.1999.9593; Liu MA, 2010, PARASITOL RES, V107, P615, DOI 10.1007/s00436-010-1904-0; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Mohr SE, 2001, GENE DEV, V15, P2886; Mufarrege EF, 2011, J EXP BOT, V62, P5025, DOI 10.1093/jxb/err202; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Newmark PA, 1997, DEVELOPMENT, V124, P3197; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Park NI, 2007, PLANTA, V225, P625, DOI 10.1007/s00425-006-0385-y; Park NI, 2009, PLANT SCI, V176, P461, DOI 10.1016/j.plantsci.2008.12.016; Parma DH, 2007, DEV BIOL, V308, P507, DOI 10.1016/j.ydbio.2007.06.007; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Rodionov A, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-17; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Saeed R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-128; Sandler I, 2013, MOL BIOSYST, V9, P175, DOI 10.1039/c2mb25317h; Shi H, 2003, GENE DEV, V17, P971, DOI 10.1101/gad.260403; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JN, 1994, COEVOLUTIONARY PROCE; van der Weele CM, 2007, MOL BIOL CELL, V18, P3711, DOI 10.1091/mbc.E06-11-0979; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Winter KU, 2002, MOL BIOL EVOL, V19, P587, DOI 10.1093/oxfordjournals.molbev.a004118; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zamir L, 2012, P NATL ACAD SCI USA, V109, pE406, DOI 10.1073/pnas.1108633109; Zhao XF, 2000, GENOMICS, V63, P145, DOI 10.1006/geno.1999.6064	64	20	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84842	10.1371/journal.pone.0084842	http://dx.doi.org/10.1371/journal.pone.0084842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416299	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500179
J	Harrop, TWR; Sztal, T; Lumb, C; Good, RT; Daborn, PJ; Batterham, P; Chung, H				Harrop, Thomas W. R.; Sztal, Tamar; Lumb, Christopher; Good, Robert T.; Daborn, Phillip J.; Batterham, Philip; Chung, Henry			Evolutionary Changes in Gene Expression, Coding Sequence and Copy-Number at the Cyp6g1 Locus Contribute to Resistance to Multiple Insecticides in Drosophila	PLOS ONE			English	Article							MELANOGASTER CYTOCHROME-P450 GENES; DETOXIFICATION GENE; CROSS-RESISTANCE; OVER-EXPRESSION; ESTERASE GENE; METABOLISM; AMPLIFICATION; PHYLOGENY; INDUCTION; ELEMENTS	Widespread use of insecticides has led to insecticide resistance in many populations of insects. In some populations, resistance has evolved to multiple pesticides. In Drosophila melanogaster, resistance to multiple classes of insecticide is due to the overexpression of a single cytochrome P450 gene, Cyp6g1. Overexpression of Cyp6g1 appears to have evolved in parallel in Drosophila simulans, a sibling species of D. melanogaster, where it is also associated with insecticide resistance. However, it is not known whether the ability of the CYP6G1 enzyme to provide resistance to multiple insecticides evolved recently in D. melanogaster or if this function is present in all Drosophila species. Here we show that duplication of the Cyp6g1 gene occurred at least four times during the evolution of different Drosophila species, and the ability of CYP6G1 to confer resistance to multiple insecticides exists in D. melanogaster and D. simulans but not in Drosophila willistoni or Drosophila virilis. In D. virilis, which has multiple copies of Cyp6g1, one copy confers resistance to DDT and another to nitenpyram, suggesting that the divergence of protein sequence between copies subsequent to the duplication affected the activity of the enzyme. All orthologs tested conferred resistance to one or more insecticides, suggesting that CYP6G1 had the capacity to provide resistance to anthropogenic chemicals before they existed. Finally, we show that expression of Cyp6g1 in the Malpighian tubules, which contributes to DDT resistance in D. melanogaster, is specific to the D. melanogaster-D. simulans lineage. Our results suggest that a combination of gene duplication, regulatory changes and protein coding changes has taken place at the Cyp6g1 locus during evolution and this locus may play a role in providing resistance to different environmental toxins in different Drosophila species.	[Harrop, Thomas W. R.; Sztal, Tamar; Lumb, Christopher; Good, Robert T.; Daborn, Phillip J.; Batterham, Philip; Chung, Henry] Univ Melbourne, Dept Genet, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Sztal, Tamar] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Chung, Henry] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI USA; [Chung, Henry] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	University of Melbourne; Monash University; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Batterham, P (corresponding author), Univ Melbourne, Dept Genet, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia.	p.batterham@unimelb.edu.au; hwchung@wisc.edu	Harrop, Thomas/G-4024-2016; Chung, Henry/C-9374-2014; Batterham, Philip/G-5914-2012	Harrop, Thomas/0000-0001-6557-0440; Chung, Henry/0000-0001-5056-2755; Batterham, Philip/0000-0001-9840-9119; Sztal, Tamar/0000-0001-9745-3580	Australian Research Council	Australian Research Council(Australian Research Council)	Australian Research Council for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Chung H, 2011, INSECT BIOCHEM MOLEC, V41, P863, DOI 10.1016/j.ibmb.2011.07.002; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2012, INSECT BIOCHEM MOLEC, V42, P918, DOI 10.1016/j.ibmb.2012.09.003; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Feyereisen R., 2005, P1; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; FIELD LM, 1988, BIOCHEM J, V251, P309, DOI 10.1042/bj2510309; Jones RT, 2010, PEST MANAG SCI, V66, P1106, DOI 10.1002/ps.1986; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Kirischian N, 2011, J MOL EVOL, V72, P56, DOI 10.1007/s00239-010-9402-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XC, 2000, J ECON ENTOMOL, V93, P18, DOI 10.1603/0022-0493-93.1.18; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; MOUCHES C, 1986, SCIENCE, V233, P778, DOI 10.1126/science.3755546; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Sen Zeng R, 2007, J CHEM ECOL, V33, P449, DOI 10.1007/s10886-006-9238-1; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107	36	18	18	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84879	10.1371/journal.pone.0084879	http://dx.doi.org/10.1371/journal.pone.0084879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416303	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500182
J	Pendleton, RM; Hoeinghaus, DJ; Gomes, LC; Agostinho, AA				Pendleton, Richard M.; Hoeinghaus, David J.; Gomes, Luiz C.; Agostinho, Angelo A.			Loss of Rare Fish Species from Tropical Floodplain Food Webs Affects Community Structure and Ecosystem Multifunctionality in a Mesocosm Experiment	PLOS ONE			English	Article							TROPHIC CASCADES; PREDATOR DIVERSITY; FRESH-WATERS; CHAIN LENGTH; BIODIVERSITY; CONSEQUENCES; EXTINCTION; RICHNESS; IDENTITY; CONSERVATION	Experiments with realistic scenarios of species loss from multitrophic ecosystems may improve insight into how biodiversity affects ecosystem functioning. Using 1000 L mesocoms, we examined effects of nonrandom species loss on community structure and ecosystem functioning of experimental food webs based on multitrophic tropical floodplain lagoon ecosystems. Realistic biodiversity scenarios were developed based on long-term field surveys, and experimental assemblages replicated sequential loss of rare species which occurred across all trophic levels of these complex food webs. Response variables represented multiple components of ecosystem functioning, including nutrient cycling, primary and secondary production, organic matter accumulation and whole ecosystem metabolism. Species richness significantly affected ecosystem function, even after statistically controlling for potentially confounding factors such as total biomass and direct trophic interactions. Overall, loss of rare species was generally associated with lower nutrient concentrations, phytoplankton and zooplankton densities, and whole ecosystem metabolism when compared with more diverse assemblages. This pattern was also observed for overall ecosystem multifunctionality, a combined metric representing the ability of an ecosystem to simultaneously maintain multiple functions. One key exception was attributed to time-dependent effects of intraguild predation, which initially increased values for most ecosystem response variables, but resulted in decreases over time likely due to reduced nutrient remineralization by surviving predators. At the same time, loss of species did not result in strong trophic cascades, possibly a result of compensation and complexity of these multitrophic ecosystems along with a dominance of bottom-up effects. Our results indicate that although rare species may comprise minor components of communities, their loss can have profound ecosystem consequences across multiple trophic levels due to a combination of direct and indirect effects in diverse multitrophic ecosystems.	[Pendleton, Richard M.; Hoeinghaus, David J.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Pendleton, Richard M.; Hoeinghaus, David J.] Univ N Texas, Inst Appl Sci, Denton, TX 76203 USA; [Gomes, Luiz C.; Agostinho, Angelo A.] Univ Estadual Maringa, Dept Biol, Maringa, Parana, Brazil; [Gomes, Luiz C.; Agostinho, Angelo A.] Univ Estadual Maringa, Nucleo Pesquisas Limnol Ictiol & Aquicultura Nupe, Maringa, Parana, Brazil	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Pendleton, RM (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	rich.pendleton@gmail.com	Agostini, Angelo/D-5888-2013; Gomes, Luiz/D-5886-2013; Agostinho, Angelo Antonio/S-1538-2019	Agostini, Angelo/0000-0002-4707-9444; Agostinho, Angelo Antonio/0000-0002-4707-9444; gomes, Luiz/0000-0001-7295-723X	UNT Office of the Provost and Vice President for Academic Affairs; Charn Uswachoke International Development Fund; Society of Wetland Scientists; CNPq/PELD through the Upper Parana Floodplain LTER	UNT Office of the Provost and Vice President for Academic Affairs; Charn Uswachoke International Development Fund; Society of Wetland Scientists; CNPq/PELD through the Upper Parana Floodplain LTER(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	Financial support was provided by the UNT Office of the Provost and Vice President for Academic Affairs and the Charn Uswachoke International Development Fund, the Society of Wetland Scientists, and CNPq/PELD through support of the Upper Parana Floodplain LTER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho A.A., 2004, ECOHYDROL HYDROBIOL, V4, P255; Agostinho AA., 2013, PELD CNPQ DEZ ANOS P, P163; [Anonymous], 2005, EC HUM WELL BEING SY; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Baranyi C, 2002, FRESHWATER BIOL, V47, P473, DOI 10.1046/j.1365-2427.2002.00822.x; Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bracken MES, 2012, ECOL LETT, V15, P461, DOI 10.1111/j.1461-0248.2012.01758.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; Capps KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054093; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carey MP, 2011, OECOLOGIA, V167, P189, DOI 10.1007/s00442-011-1967-3; Clescheri LS, 1999, STANDARD METHODS EXA; Downing AL, 2005, ECOLOGY, V86, P701, DOI 10.1890/03-0239; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Finke DL, 2005, ECOL LETT, V8, P1299, DOI 10.1111/j.1461-0248.2005.00832.x; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Henry-Silva GG, 2008, HYDROBIOLOGIA, V610, P153, DOI 10.1007/s10750-008-9430-0; Hoeinghaus DJ, 2008, OIKOS, V117, P984, DOI 10.1111/j.0030-1299.2008.16459.x; Hoeinghaus DJ, 2007, ECOSYSTEMS, V10, P1019, DOI 10.1007/s10021-007-9075-2; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Julio HF, 2009, NEOTROP ICHTHYOL, V7, P709, DOI 10.1590/S1679-62252009000400021; KERY M, 2003, B ECOL SOC AM, V84, P92; Lyons KG, 2001, ECOL LETT, V4, P358, DOI 10.1046/j.1461-0248.2001.00235.x; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Naeem S, 2008, TRENDS ECOL EVOL, V23, P414, DOI 10.1016/j.tree.2008.05.003; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Reynolds PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036196; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Schagerl M, 2009, J LIMNOL, V68, P274, DOI 10.4081/jlimnol.2009.274; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Small GE, 2011, ECOLOGY, V92, P386, DOI 10.1890/10-0081.1; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Straub CS, 2006, ECOLOGY, V87, P277, DOI 10.1890/05-0599; THOMAZ S.M, 2004, UPPER PARANA RIVER I; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Vanni MJ, 2002, ECOL LETT, V5, P285, DOI 10.1046/j.1461-0248.2002.00314.x; Wardle DA, 2003, OIKOS, V102, P45, DOI 10.1034/j.1600-0706.2003.12481.x; Winemiller Kirk O., 2005, P10; Woodward G, 2009, FRESHWATER BIOL, V54, P2171, DOI 10.1111/j.1365-2427.2008.02081.x; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	53	29	31	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84568	10.1371/journal.pone.0084568	http://dx.doi.org/10.1371/journal.pone.0084568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416246	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500138
J	Sargoy, A; Sun, XP; Barnes, S; Brecha, NC				Sargoy, Allison; Sun, Xiaoping; Barnes, Steven; Brecha, Nicholas C.			Differential Calcium Signaling Mediated by Voltage-Gated Calcium Channels in Rat Retinal Ganglion Cells and Their Unmyelinated Axons	PLOS ONE			English	Article							DISPLACED AMACRINE CELLS; BIPOLAR CELLS; MOUSE RETINA; OPTIC-NERVE; BETA-SUBUNITS; IN-VIVO; CURRENTS; NEURONS; MIBEFRADIL; EXPRESSION	Aberrant calcium regulation has been implicated as a causative factor in the degeneration of retinal ganglion cells (RGCs) in numerous injury models of optic neuropathy. Since calcium has dual roles in maintaining homeostasis and triggering apoptotic pathways in healthy and injured cells, respectively, investigation of voltage-gated Ca channel (VGCC) regulation as a potential strategy to reduce the loss of RGCs is warranted. The accessibility and structure of the retina provide advantages for the investigation of the mechanisms of calcium signalling in both the somata of ganglion cells as well as their unmyelinated axons. The goal of the present study was to determine the distribution of VGCC subtypes in the cell bodies and axons of ganglion cells in the normal retina and to define their contribution to calcium signals in these cellular compartments. We report L-type Ca channel alpha 1C and alpha 1D subunit immunoreactivity in rat RGC somata and axons. The N-type Ca channel alpha 1B subunit was in RGC somata and axons, while the P/Q-type Ca channel alpha 1A subunit was only in the RGC somata. We patch clamped isolated ganglion cells and biophysically identified T-type Ca channels. Calcium imaging studies of RGCs in wholemounted retinas showed that selective Ca channel antagonists reduced depolarization-evoked calcium signals mediated by L-, N-, P/Q- and T-type Ca channels in the cell bodies but only by L-type Ca channels in the axons. This differential contribution of VGCC subtypes to calcium signals in RGC somata and their axons may provide insight into the development of target-specific strategies to spare the loss of RGCs and their axons following injury.	[Sargoy, Allison; Sun, Xiaoping; Barnes, Steven; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Sargoy, Allison; Sun, Xiaoping; Barnes, Steven; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Barnes, Steven; Brecha, Nicholas C.] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Barnes, Steven] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Barnes, Steven] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Dalhousie University; Dalhousie University	Barnes, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	sbarnes@dal.ca		Barnes, Steven/0000-0003-0496-1645	NIH [EY04067]; VA Merit Review; CIHR; NSHRF Regional Partnership Program; NSERC; U.S. Army Medical Research & Materiel Command (USAMRMC); Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD [W81XWH-10-2-0077]; NATIONAL EYE INSTITUTE [R56EY004067, T32EY007026, R01EY004067] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review(US Department of Veterans Affairs); CIHR(Canadian Institutes of Health Research (CIHR)); NSHRF Regional Partnership Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. Army Medical Research & Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	Support for these studies came from NIH EY04067 (NCB), a VA Merit Review (NCB), a CIHR and NSHRF Regional Partnership Program grant (SB), and NSERC (SB). Part of this work was made possible by a contract agreement awarded to NCB and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD under Contract Number: W81XWH-10-2-0077. NCB is a VA Senior Career Research Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer CS, 2010, CURR OPIN NEUROBIOL, V20, P563, DOI 10.1016/j.conb.2010.05.007; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Crish SD, 2011, NEUROSCIENCE, V176, P1, DOI 10.1016/j.neuroscience.2010.12.036; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; de la Villa P, 1998, EUR J NEUROSCI, V10, P317, DOI 10.1046/j.1460-9568.1998.00051.x; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Eller P, 2000, BRIT J PHARMACOL, V130, P669, DOI 10.1038/sj.bjp.0703352; Farrell SR, 2010, J NEUROPHYSIOL, V104, P1347, DOI 10.1152/jn.00098.2010; Firth SI, 2001, CLIN EXP OPHTHALMOL, V29, P183, DOI 10.1046/j.1442-9071.2001.00401.x; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; FLIEGNER KH, 1991, INT REV CYTOL, V131, P109, DOI 10.1016/S0074-7696(08)62018-5; Forti L, 2000, J PHYSIOL-LONDON, V527, P33, DOI 10.1111/j.1469-7793.2000.00033.x; GUENTHER E, 1994, BRAIN RES, V633, P223, DOI 10.1016/0006-8993(94)91543-1; Habermann CJ, 2003, J NEUROSCI, V23, P6904; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hartwick ATE, 2008, J PHYSIOL-LONDON, V586, P3425, DOI 10.1113/jphysiol.2008.154609; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu CP, 2009, VISUAL NEUROSCI, V26, P177, DOI 10.1017/S0952523809090026; ISHIDA AT, 1991, J NEUROPHYSIOL, V65, P968, DOI 10.1152/jn.1991.65.4.968; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Karim MD, 2006, CURR EYE RES, V31, P273, DOI 10.1080/02713680500536647; Karnas D, 2013, J COMP NEUROL, V521, P912, DOI 10.1002/cne.23210; KARSCHIN A, 1989, J PHYSIOL-LONDON, V418, P379, DOI 10.1113/jphysiol.1989.sp017847; Kawasaki A, 2000, INVEST OPHTH VIS SCI, V41, P3444; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f; Kong WC, 1999, LIFE SCI, V64, P1773, DOI 10.1016/S0024-3205(99)00115-0; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155; LoGiudice L, 2006, MOL VIS, V12, P184; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Margolis DJ, 2010, J NEUROSCI, V30, P7127, DOI 10.1523/JNEUROSCI.5694-09.2010; Mark MD, 2011, J NEUROSCI, V31, P4311, DOI 10.1523/JNEUROSCI.5342-10.2011; McNulty MM, 2004, MOL PHARMACOL, V66, P1652, DOI 10.1124/mol.66.6.1652; Muller LPD, 2007, J COMP NEUROL, V505, P177, DOI 10.1002/cne.21487; Nakano N, 2011, INVEST OPHTH VIS SCI, V52, P8754, DOI 10.1167/iovs.10-6654; Pan ZH, 2000, J NEUROPHYSIOL, V83, P513, DOI 10.1152/jn.2000.83.1.513; Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8; PERRY VH, 1980, PROC R SOC SER B-BIO, V208, P415, DOI 10.1098/rspb.1980.0060; Prilloff S, 2007, EUR J NEUROSCI, V25, P3339, DOI 10.1111/j.1460-9568.2007.05550.x; Quigley HA, 1998, RET EYE RES, V18, P39; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Rodriguez AR, 2013, J COMP NEUROL UNPUB; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Schmid S, 1999, J NEUROSCI, V19, P3486; Schmid S, 1996, NEUROREPORT, V7, P677, DOI 10.1097/00001756-199601310-00070; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Sun BB, 1999, J NEUROSCI, V19, P5185; TASCHENBERGER H, 1995, J NEUROSCI, V15, P2240, DOI 10.1523/JNEUROSCI.15-03-02240.1995; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Viana F, 1997, CELL CALCIUM, V22, P299, DOI 10.1016/S0143-4160(97)90068-3; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Witkovsky P, 2006, J COMP NEUROL, V497, P384, DOI 10.1002/cne.20995; Xu HP, 2003, NEUROSCIENCE, V118, P763, DOI 10.1016/S0306-4522(03)00022-8; Xu HP, 2002, NEUROSCI LETT, V329, P297, DOI 10.1016/S0304-3940(02)00688-2; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang CL, 2006, J NEUROPHYSIOL, V96, P695, DOI 10.1152/jn.00083.2006	65	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84507	10.1371/journal.pone.0084507	http://dx.doi.org/10.1371/journal.pone.0084507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416240	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500133
J	Tang, FY; Cheng, YJ; Bao, CJ; Hu, JL; Liu, WD; Liang, Q; Wu, Y; Norris, J; Peng, ZH; Yu, RB; Shen, HB; Chen, F				Tang, Fenyang; Cheng, Yuejia; Bao, Changjun; Hu, Jianli; Liu, Wendong; Liang, Qi; Wu, Ying; Norris, Jessie; Peng, Zhihang; Yu, Rongbin; Shen, Hongbing; Chen, Feng			Spatio-Temporal Trends and Risk Factors for Shigella from 2001 to 2011 in Jiangsu Province, People's Republic of China	PLOS ONE			English	Article							BACILLARY DYSENTERY; CHILDHOOD DIARRHEA; MODEL; INTERVENTIONS; TEMPERATURE; SALVADOR; HEALTH	Objective: This study aimed to describe the spatial and temporal trends of Shigella incidence rates in Jiangsu Province, People's Republic of China. It also intended to explore complex risk modes facilitating Shigella transmission. Methods: County-level incidence rates were obtained for analysis using geographic information system (GIS) tools. Trend surface and incidence maps were established to describe geographic distributions. Spatio-temporal cluster analysis and autocorrelation analysis were used for detecting clusters. Based on the number of monthly Shigella cases, an autoregressive integrated moving average (ARIMA) model successfully established a time series model. A spatial correlation analysis and a case-control study were conducted to identify risk factors contributing to Shigella transmissions. Results: The far southwestern and northwestern areas of Jiangsu were the most infected. A cluster was detected in southwestern Jiangsu (LLR = 11674.74, P<0.001). The time series model was established as ARIMA (1, 12, 0), which predicted well for cases from August to December, 2011. Highways and water sources potentially caused spatial variation in Shigella development in Jiangsu. The case-control study confirmed not washing hands before dinner (OR = 3.64) and not having access to a safe water source (OR = 2.04) as the main causes of Shigella in Jiangsu Province. Conclusion: Improvement of sanitation and hygiene should be strengthened in economically developed counties, while access to a safe water supply in impoverished areas should be increased at the same time.	[Cheng, Yuejia; Peng, Zhihang; Yu, Rongbin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Tang, Fenyang; Bao, Changjun; Hu, Jianli; Liu, Wendong; Liang, Qi; Wu, Ying] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Norris, Jessie] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Peng, ZH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhihangpeng@njmu.edu.cn			Natural Science Foundation Key Project of Jiangsu Province, China [BK2010079]; "National S&T Major Project Foundation of China" [2011ZX10004-902]; Jiangsu Province Health Development Project with Science and Education [ZX201109]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation Key Project of Jiangsu Province, China; "National S&T Major Project Foundation of China"; Jiangsu Province Health Development Project with Science and Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by Natural Science Foundation Key Project of Jiangsu Province, China (BK2010079), "National S&T Major Project Foundation of China" (2011ZX10004-902), Jiangsu Province Health Development Project with Science and Education (NO. ZX201109), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elyazeed RR, 2004, AM J TROP MED HYG, V71, P367, DOI 10.4269/ajtmh.2004.71.367; Ali Mohammad, 2006, Int J Health Geogr, V5, P45, DOI 10.1186/1476-072X-5-45; Allard R, 1998, B WORLD HEALTH ORGAN, V76, P327; [Anonymous], 2008, MODEL SELECTION MODE; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; Bowerman Bruce L, 2003, FORECASTING TIME SER, P117; Checkley W, 2004, LANCET, V363, P112, DOI 10.1016/S0140-6736(03)15261-0; Cheng YJ, 2012, GEOSPATIAL HEALTH, V7, P63, DOI 10.4081/gh.2012.105; D'Souza RM, 2004, EPIDEMIOLOGY, V15, P86, DOI 10.1097/01.ede.0000101021.03453.3e; Emch M, 1999, SOC SCI MED, V49, P519, DOI 10.1016/S0277-9536(99)00146-X; Ferrer SR, 2008, INT J EPIDEMIOL, V37, P805, DOI 10.1093/ije/dyn093; Forrer A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001481; Gu B, 2012, INT J ANTIMICROB AG, V40, P9, DOI 10.1016/j.ijantimicag.2012.02.005; Hu JianLi, 2011, Chinese Preventive Medicine, V12, P419; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Li LF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-951; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Liu X.N., 2008, SPATIAL ANAL THEORIE, P189; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Loha E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-166; [朋文佳 Peng Wenjia], 2011, [中国卫生统计, Chinese Journal of Health Statistics], V28, P645; Rego RF, 2005, T ROY SOC TROP MED H, V99, P48, DOI 10.1016/j.trstmh.2004.02.008; Strina A, 2003, AM J EPIDEMIOL, V157, P1032, DOI 10.1093/aje/kwg075; Vinceti M, 2012, Ann Ig, V24, P407; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Yang G H, 1997, Biomed Environ Sci, V10, P1; Zhang Y, 2008, PUBLIC HEALTH REP, V123, P61, DOI 10.1177/003335490812300109; Zhang Y, 2012, J ENVIRON MONITOR, V14, P510, DOI 10.1039/c1em10391a; Zhou SD, 2009, JIANGSU SOCIAL SCI, V2, P212; Zhou XN, 2009, SPATIAL EPIDEMIOLOGY, P241	33	27	32	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83487	10.1371/journal.pone.0083487	http://dx.doi.org/10.1371/journal.pone.0083487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416167	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500050
J	Gao, Y; Shen, L; Honzatko, RB				Gao, Yang; Shen, Lu; Honzatko, Richard B.			Central Cavity of Fructose-1,6-bisphosphatase and the Evolution of AMP/Fructose 2,6-bisphosphate Synergism in Eukaryotic Organisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Crystal Structure; Enzyme Inhibitors; Enzyme Kinetics; Evolution; Gluconeogenesis; Metabolism	RECOMBINANT PORCINE FRUCTOSE-1,6-BISPHOSPHATASE; ESCHERICHIA-COLI FRUCTOSE-1,6-BISPHOSPHATASE; RABBIT LIVER FRUCTOSE-1,6-BISPHOSPHATASE; PIG-KIDNEY FRUCTOSE-1,6-BISPHOSPHATASE; NUCLEAR-MAGNETIC-RESONANCE; FRUCTOSE 2,6-BISPHOSPHATE; ALLOSTERIC INHIBITION; AMP INHIBITION; DYNAMIC LOOP; R-STATE	Background: AMP and fructose 2,6-bisphosphate (Fru-2,6-P-2) synergistically inhibit eukaryotic fructose-1,6-bisphosphatase (FBPase). How did this property evolve? Results: Directed mutations, kinetics, and structure determinations link the central cavity of FBPase to AMP/Fru-2,6-P-2 synergism. Conclusion: A central cavity in any FBPase implies AMP/Fru-2,6-P-2 and AMP/Fru-6-P synergism. Significance: AMP/Fru-2,6-P-2 synergism of eukaryotic FBPases probably evolved from AMP/Fru-6-P synergism of an ancestral FBPase. The effects of AMP and fructose 2,6-bisphosphate (Fru-2,6-P-2) on porcine fructose-1,6-bisphosphatase (pFBPase) and Escherichia coli FBPase (eFBPase) differ in three respects. AMP/Fru-2,6-P-2 synergism in pFBPase is absent in eFBPase. Fru-2,6-P-2 induces a 13 degrees subunit pair rotation in pFBPase but no rotation in eFBPase. Hydrophilic side chains in eFBPase occupy what otherwise would be a central aqueous cavity observed in pFBPase. Explored here is the linkage of AMP/Fru-2,6-P-2 synergism to the central cavity and the evolution of synergism in FBPases. The single mutation Ser(45) His substantially fills the central cavity of pFBPase, and the triple mutation Ser(45) His, Thr(46) Arg, and Leu(186) Tyr replaces porcine with E. coli type side chains. Both single and triple mutations significantly reduce synergism while retaining other wild-type kinetic properties. Similar to the effect of Fru-2,6-P-2 on eFBPase, the triple mutant of pFBPase with bound Fru-2,6-P-2 exhibits only a 2 degrees subunit pair rotation as opposed to the 13 degrees rotation exhibited by the Fru-2,6-P-2 complex of wild-type pFBPase. The side chain at position 45 is small in all available eukaryotic FBPases but large and hydrophilic in bacterial FBPases, similar to eFBPase. Sequence information indicates the likelihood of synergism in the FBPase from Leptospira interrogans (lFBPase), and indeed recombinant lFBPase exhibits AMP/Fru-2,6-P-2 synergism. Unexpectedly, however, AMP also enhances Fru-6-P binding to lFBPase. Taken together, these observations suggest the evolution of AMP/Fru-2,6-P-2 synergism in eukaryotic FBPases from an ancestral FBPase having a central aqueous cavity and exhibiting synergistic feedback inhibition by AMP and Fru-6-P.	[Gao, Yang; Shen, Lu; Honzatko, Richard B.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Honzatko, RB (corresponding author), Iowa State Univ, 4206 Mol Biol Bldg, Ames, IA 50011 USA.	honzatko@iastate.edu	Gao, Yang/O-3445-2016		National Institutes of Health [NS 10546]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010546, R01NS010546, R56NS010546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS 10546.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BENKOVIC SJ, 1982, ADV ENZYMOL RAMB, V53, P45; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Choe JY, 1998, BIOCHEMISTRY-US, V37, P11441, DOI 10.1021/bi981112u; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DERR RF, 1972, BIOCHEM BIOPH RES CO, V49, P1385, DOI 10.1016/0006-291X(72)90492-5; ELMAGHRABI MR, 1992, J BIOL CHEM, V267, P6526; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; GANSON NJ, 1985, J BIOL CHEM, V260, P2837; Gao Y, 2013, BIOCHEMISTRY-US, V52, P5206, DOI 10.1021/bi400532n; HAN PF, 1983, EXPERIENTIA, V39, P1305, DOI 10.1007/BF01990383; Hines JK, 2007, J BIOL CHEM, V282, P36121, DOI 10.1074/jbc.M707302200; Hines JK, 2007, J BIOL CHEM, V282, P24697, DOI 10.1074/jbc.M703580200; Hines JK, 2007, J BIOL CHEM, V282, P11696, DOI 10.1074/jbc.M611104200; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; Iancu CV, 2005, J BIOL CHEM, V280, P19737, DOI 10.1074/jbc.M501011200; KE HM, 1990, P NATL ACAD SCI USA, V87, P5243, DOI 10.1073/pnas.87.14.5243; Kelley-Loughnane N, 2002, BBA-PROTEIN STRUCT M, V1594, P6, DOI 10.1016/S0167-4838(01)00261-8; Kelley-Loughnane N, 2001, BBA-PROTEIN STRUCT M, V1548, P66, DOI 10.1016/S0167-4838(01)00218-7; KRUGER NJ, 1984, PLANT PHYSIOL, V76, P49, DOI 10.1104/pp.76.1.49; Kurbanov FT, 1998, J BIOL CHEM, V273, P17511, DOI 10.1074/jbc.273.28.17511; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; LIU F, 1988, J BIOL CHEM, V263, P10035; LIU F, 1988, J BIOL CHEM, V263, P9122; LIU F, 1988, ARCH BIOCHEM BIOPHYS, V260, P609, DOI 10.1016/0003-9861(88)90488-2; MCGRANE MM, 1983, J BIOL CHEM, V258, P445; Michels PAM, 2006, IUBMB LIFE, V58, P133, DOI 10.1080/15216540600688280; Nelson SW, 2004, J BIOL CHEM, V279, P18481, DOI 10.1074/jbc.M308811200; Nelson SW, 2002, J BIOL CHEM, V277, P15539, DOI 10.1074/jbc.M112304200; Nelson SW, 2001, J BIOL CHEM, V276, P6119, DOI 10.1074/jbc.M009485200; Nelson SW, 2000, BIOCHEMISTRY-US, V39, P11100, DOI 10.1021/bi000609c; Nelson SW, 2000, J BIOL CHEM, V275, P29986, DOI 10.1074/jbc.M000473200; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; PILKIS SJ, 1981, J BIOL CHEM, V256, P3619; PILKIS SJ, 1981, J BIOL CHEM, V256, P3171; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; SCHEFFLER JE, 1986, BIOCHEMISTRY-US, V25, P6659, DOI 10.1021/bi00369a050; Shyur LF, 1996, J BIOL CHEM, V271, P33301, DOI 10.1074/jbc.271.52.33301; Shyur LF, 1997, J BIOL CHEM, V272, P26295, DOI 10.1074/jbc.272.42.26295; Shyur LF, 1996, J BIOL CHEM, V271, P3005, DOI 10.1074/jbc.271.6.3005; TAKETA K, 1965, J BIOL CHEM, V240, P651; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; UYEDA K, 1981, J BIOL CHEM, V256, P8394; VANSCHAFTINGEN E, 1981, EUR J BIOCHEM, V117, P319, DOI 10.1111/j.1432-1033.1981.tb06339.x; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P2861; XUE YF, 1994, P NATL ACAD SCI USA, V91, P12482, DOI 10.1073/pnas.91.26.12482; Zhang RL, 1996, BIOCHEMISTRY-US, V35, P3038, DOI 10.1021/bi952188i; ZHANG YP, 1994, J MOL BIOL, V244, P609, DOI 10.1006/jmbi.1994.1755	57	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8450	8461		10.1074/jbc.M114.548586	http://dx.doi.org/10.1074/jbc.M114.548586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24436333	Green Published, hybrid			2022-12-25	WOS:000333157500037
J	Anttonen, M; Pihlajoki, M; Andersson, N; Georges, A; L'Hote, D; Vattulainen, S; Farkkila, A; Unkila-Kallio, L; Veitia, RA; Heikinheimo, M				Anttonen, Mikko; Pihlajoki, Marjut; Andersson, Noora; Georges, Adrien; L'Hote, David; Vattulainen, Sanna; Farkkila, Anniina; Unkila-Kallio, Leila; Veitia, Reiner A.; Heikinheimo, Markku			FOXL2, GATA4, and SMAD3 Co-Operatively Modulate Gene Expression, Cell Viability and Apoptosis in Ovarian Granulosa Cell Tumor Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; SOMATIC-CELLS; ADULT; MUTATION; SIGNALS; LINE; ESTABLISHMENT; ACTIVATION; SURVIVAL; FETAL	Aberrant ovarian granulosa cell proliferation and apoptosis may lead to granulosa cell tumors (GCT), the pathogenesis of which involves transcription factors GATA4, FOXL2, and SMAD3. FOXL2 gene harbors a point mutation (C134W) in a vast majority of GCTs. GATA4 is abundantly expressed in GCTs and its expression correlates with poor prognosis. The TGF-beta mediator SMAD3 promotes GCT cell survival through NF-kappa B activation, and interacts with FOXL2. Here, we find that the expression patterns of these factors overlap in the normal human ovary and 90 GCTs, and positively correlate with each other and with their mutual target gene CCND2, which is a key factor for granulosa cell proliferation. We have explored the molecular interactions of FOXL2, GATA4, and SMAD3 and their roles in the regulation of CCND2 using co-immunoprecipitation, promoter transactivation, and cell viability assays in human GCT cells. We found that not only SMAD3, but also GATA4 physically interact with both wild type and C134W-mutated FOXL2. GATA4 and SMAD3 synergistically induce a 8-fold increase in CCND2 promoter transactivation, which is 50% reduced by both FOXL2 types. We confirmed that wild type FOXL2 significantly decreases cell viability. Interestingly, GATA4 and SMAD3 caused a marked reduction of GCT cell apoptosis induced by wild type FOXL2. Thus, the effects of GATA4 and SMAD3 on both cell viability and apoptosis are distinct from those of wild type FOXL2; a perturbation of this balance due to the oncogenic FOXL2 mutation is likely to contribute to GCT pathogenesis.	[Anttonen, Mikko; Pihlajoki, Marjut; Andersson, Noora; Vattulainen, Sanna; Farkkila, Anniina; Heikinheimo, Markku] Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Helsinki, Finland; [Anttonen, Mikko; Pihlajoki, Marjut; Andersson, Noora; Vattulainen, Sanna; Farkkila, Anniina; Unkila-Kallio, Leila; Heikinheimo, Markku] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Anttonen, Mikko; Farkkila, Anniina; Unkila-Kallio, Leila] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Georges, Adrien; L'Hote, David; Veitia, Reiner A.] Univ Paris Diderot, UMR CNRS 7592, Inst Jacques Monod, Programme Pathol Mol & Cellulaire, Paris, France; [Heikinheimo, Markku] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; UDICE-French Research Universities; Universite Paris Cite; Washington University (WUSTL)	Anttonen, M (corresponding author), Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Helsinki, Finland.	mikko.anttonen@helsinki.fi	Georges, Adrien/ABD-6348-2021; Andersson, Noora/AAW-2030-2020; LHOTE, David/AAD-5390-2020; Färkkilä, Anniina/L-3059-2015; L'Hote, David/L-2653-2017	Andersson, Noora/0000-0003-4708-7273; Färkkilä, Anniina/0000-0002-3558-6617; L'Hote, David/0000-0001-5658-5018; Georges, Adrien/0000-0003-4208-2393	Academy of Finland; Helsinki University Central Hospital Research Funds; Sigrid Juselius Foundation; Institut Universitaire de France; La Ligue Nationale Contre le Cancer (Comite' de Paris); Groupement d'Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); CNRS; Universite' Paris VII	Academy of Finland(Academy of Finland); Helsinki University Central Hospital Research Funds; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Institut Universitaire de France; La Ligue Nationale Contre le Cancer (Comite' de Paris); Groupement d'Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite' Paris VII	Financial support: Academy of Finland, Helsinki University Central Hospital Research Funds, Sigrid Juselius Foundation, Institut Universitaire de France, La Ligue Nationale Contre le Cancer (Comite' de Paris), Groupement d'Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), CNRS and Universite' Paris VII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttonen M, 2006, J MOL ENDOCRINOL, V36, P557, DOI 10.1677/jme.1.01962; Anttonen M, 2005, J CLIN ENDOCR METAB, V90, P6529, DOI 10.1210/jc.2005-0921; Benayoun BA, 2013, ONCOGENE, V32, P2739, DOI 10.1038/onc.2012.298; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Bilandzic M, 2013, MOL ENDOCRINOL, V27, P466, DOI 10.1210/me.2012-1239; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; D'Angelo E, 2011, MODERN PATHOL, V24, P1360, DOI 10.1038/modpathol.2011.95; Duffin K, 2009, MOL HUM REPROD, V15, P771, DOI 10.1093/molehr/gap065; Farkkila A, 2011, EUR J ENDOCRINOL, V164, P115, DOI 10.1530/EJE-10-0849; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Jamieson S, 2012, ENDOCR REV, V33, P109, DOI 10.1210/er.2011-0014; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 10.1038/modpathol.2010.145; Kalfa N, 2008, J UROLOGY, V180, P1810, DOI 10.1016/j.juro.2008.03.097; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Kyronlahti A, 2008, ENDOCRINOLOGY, V149, P5635, DOI 10.1210/en.2008-0148; Kyronlahti A, 2011, BIOL REPROD, V84, P1033, DOI 10.1095/biolreprod.110.086850; Kyronlahti A, 2010, ENDOCR-RELAT CANCER, V17, P709, DOI 10.1677/ERC-10-0041; L'Hote D, 2012, HUM MOL GENET, V21, P3264, DOI 10.1093/hmg/dds170; Lamba P, 2010, ENDOCRINOLOGY, V151, P5456, DOI 10.1210/en.2010-0605; Looyenga BD, 2007, MOL ENDOCRINOL, V21, P2440, DOI 10.1210/me.2006-0402; Middlebrook BS, 2009, ENDOCRINOLOGY, V150, P5208, DOI 10.1210/en.2009-0644; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Nonis D, 2013, MOL CELL ENDOCRINOL, V372, P42, DOI 10.1016/j.mce.2013.02.020; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; Rosario R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046270; Sambrook J, 2001, MOL CLONING LAB MANU; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Suzuki YJ, 2003, J BIOL CHEM, V278, P17525, DOI 10.1074/jbc.M210465200; Tomic D, 2004, MOL ENDOCRINOL, V18, P2224, DOI 10.1210/me.2003-0414; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; VANDENBERGBAKKER CAM, 1993, INT J CANCER, V53, P613, DOI 10.1002/ijc.2910530415; Vaskivuo TE, 2001, J CLIN ENDOCR METAB, V86, P3421, DOI 10.1210/jc.86.7.3421; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513	39	43	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85545	10.1371/journal.pone.0085545	http://dx.doi.org/10.1371/journal.pone.0085545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416423	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300086
J	Antwis, RE; Haworth, RL; Engelmoer, DJP; Ogilvy, V; Fidgett, AL; Preziosi, RF				Antwis, Rachael E.; Haworth, Rachel L.; Engelmoer, Daniel J. P.; Ogilvy, Victoria; Fidgett, Andrea L.; Preziosi, Richard F.			Ex situ Diet Influences the Bacterial Community Associated with the Skin of Red-Eyed Tree Frogs (Agalychnis callidryas)	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CUTANEOUS BACTERIA; BATRACHOCHYTRIUM-DENDROBATIDIS; MICROBIAL COMMUNITY; DIVERSITY; GUT; BIOAUGMENTATION; BIOSYNTHESIS; SALAMANDERS; SELECTION	Amphibians support symbiotic bacterial communities on their skin that protect against a range of infectious pathogens, including the amphibian chytrid fungus. The conditions under which amphibians are maintained in captivity (e. g. diet, substrate, enrichment) in ex situ conservation programmes may affect the composition of the bacterial community. In addition, ex situ amphibian populations may support different bacterial communities in comparison to in situ populations of the same species. This could have implications for the suitability of populations intended for reintroduction, as well as the success of probiotic bacterial inoculations intended to provide amphibians with a bacterial community that resists invasion by the chytrid fungus. We aimed to investigate the effect of a carotenoid-enriched diet on the culturable bacterial community associated with captive red-eyed tree frogs (Agalychnis callidryas) and make comparisons to bacteria isolated from a wild population from the Chiquibul Rainforest in Belize. We successfully showed carotenoid availability influences the overall community composition, species richness and abundance of the bacterial community associated with the skin of captive frogs, with A. callidryas fed a carotenoid-enriched diet supporting a greater species richness and abundance of bacteria than those fed a carotenoid-free diet. Our results suggest that availability of carotenoids in the diet of captive frogs is likely to be beneficial for the bacterial community associated with the skin. We also found wild A. callidryas hosted more than double the number of different bacterial species than captive frogs with very little commonality between species. This suggests frogs in captivity may support a reduced and diverged bacterial community in comparison to wild populations of the same species, which could have particular relevance for ex situ conservation projects.	[Antwis, Rachael E.; Haworth, Rachel L.; Engelmoer, Daniel J. P.; Ogilvy, Victoria; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Engelmoer, Daniel J. P.] Vrije Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Ogilvy, Victoria] FrogLife, Peterborough, Cambs, England; [Fidgett, Andrea L.] Chester Zoo, Chester, Cheshire, England	University of Manchester; Vrije Universiteit Amsterdam	Antwis, RE (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Rachael.Antwis@gmail.com	Preziosi, Richard F/A-8626-2010	Preziosi, Richard F/0000-0003-0468-6655; Antwis, Rachael/0000-0002-8849-8194; Fidgett, Andrea/0000-0001-5036-525X	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [961801] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council studentship to REA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANAS JA, 1988, APPL ENVIRON MICROB, V54, P2305, DOI 10.1128/AEM.54.9.2305-2310.1988; Banning JL, 2008, OECOLOGIA, V156, P423, DOI 10.1007/s00442-008-1002-5; Baruah P., 2012, J RES IBIOL, V2, P114; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Boelsma E, 2003, AM J CLIN NUTR, V77, P348, DOI 10.1093/ajcn/77.2.348; Boyen F, 2009, VET MICROBIOL, V135, P187, DOI 10.1016/j.vetmic.2008.12.025; Brizzi R, 2002, J MORPHOL, V254, P328, DOI 10.1002/jmor.10039; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; CARR A H, 1976, Herpetologica, V32, P239; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Dillon RJ, 2005, DIVERSITY LOCUST GUT; Eisenhauer N, 2013, FUNCT ECOL, V27, P282, DOI 10.1111/j.1365-2435.2012.02060.x; Filocamo A, 2012, PHYTOMEDICINE, V19, P707, DOI 10.1016/j.phymed.2012.02.018; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; HIRD DW, 1983, APPL ENVIRON MICROB, V46, P1423, DOI 10.1128/AEM.46.6.1423-1425.1983; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Klaphake E, 2009, EXOTIC ANIMAL PRACTI, V12, P597, DOI [10.1016/j.cvex.2009.06.005, DOI 10.1016/J.CVEX.2009.06.005]; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Kueneman JG, 2014, MOL ECOL, V23, P1238, DOI 10.1111/mec.12510; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lauer A, 2008, ISME J, V2, P145, DOI 10.1038/ismej.2007.110; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; Lima AP, 2000, J HERPETOL, V34, P40, DOI 10.2307/1565236; Mahan RD, 2007, J HERPETOL, V41, P16, DOI 10.1670/0022-1511(2007)41[16:DOTGTH]2.0.CO;2; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Matos A, 2005, MICROB ECOL, V49, P257, DOI 10.1007/s00248-004-0179-3; Matsui K, 2002, PIGM CELL RES, V15, P265, DOI 10.1034/j.1600-0749.2002.01085.x; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Meyer EA, 2012, DIS AQUAT ORGAN, V101, P235, DOI 10.3354/dao02523; Miller EA, 2001, CONTEMP TOP LAB ANIM, V40, P18; Mendoza GM, 2012, RES VET SCI, V93, P1160, DOI 10.1016/j.rvsc.2012.05.007; Muletz CR, 2012, BIOL CONSERV, V152, P119, DOI 10.1016/j.biocon.2012.03.022; Ogilvy V, 2012, ANIM CONSERV, V15, P480, DOI 10.1111/j.1469-1795.2012.00536.x; Ogilvy V, 2012, ZOO BIOL, V31, P470, DOI 10.1002/zoo.20416; Pasteris SE, 2006, AQUACULTURE, V251, P11, DOI 10.1016/j.aquaculture.2005.05.007; Pasteris SE, 2009, AQUAC RES, V40, P1605, DOI 10.1111/j.1365-2109.2009.02261.x; Pessier AP, 2002, SEMIN AVIAN EXOT PET, V11, P162, DOI 10.1053/saep.2002.123980; SALMOND GPC, 1995, MOL MICROBIOL, V16, P615, DOI 10.1111/j.1365-2958.1995.tb02424.x; Soler JJ, 2009, OPEN ORNITHOLOGY J, V2, P29, DOI DOI 10.1098/8SPB; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Wiggins PJ, 2011, J HERPETOL, V45, P329, DOI 10.1670/10-231.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004	52	75	80	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85563	10.1371/journal.pone.0085563	http://dx.doi.org/10.1371/journal.pone.0085563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416427	Green Published, Green Accepted, gold			2022-12-25	WOS:000329866300088
J	George, S; Paulick, S; Knutter, I; Rober, N; Hiemann, R; Roggenbuck, D; Conrad, K; Kupper, JH				George, Sandra; Paulick, Silvia; Knuetter, Ilka; Roeber, Nadja; Hiemann, Rico; Roggenbuck, Dirk; Conrad, Karsten; Kuepper, Jan-Heiner			Stable Expression of Human Muscle-Specific Kinase in HEp-2 M4 Cells for Automatic Immunofluorescence Diagnostics of Myasthenia Gravis	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR ANTIBODY; MUSK ANTIBODIES; HISTONE DEACETYLASE; AUTOANTIBODIES; FEATURES; IMMUNIZATION; PATTERNS; MECP2; DNA; MG	Muscle-specific kinase (MuSK) belongs to the nicotinic acetylcholine receptor complex which is targeted by pathogenic autoantibodies causing Myasthenia gravis. While up to 95% of patients with generalized Myasthenia gravis were shown to be positive for acetylcholine receptor-specific autoantibodies, up to 70% of the remaining patients develop autoantibodies against MuSK. Discrimination of the autoantibody specificity is important for therapy of Myasthenia gravis. Recently, the new automatic fluorescence assessment platform AKLIDES has been developed for immunofluorescence-based diagnostics of autoimmune diseases. In order to establish an AKLIDES procedure for the detection of MuSK-specific autoantibodies (anti-MuSK), we developed a recombinant HEp-2 cell clone expressing the human MuSK cDNA. Here we show at the mRNA and protein level that the cell clone HEp-2 M4 stably expresses human MuSK. We provide evidence for a localization of MuSK at the cell membrane. Using cell clone HEp-2 M4 on the AKLIDES system, we investigated 34 patient sera that were previously tested anti-MuSK positive by radioimmunoassay as positive controls. As negative controls, we tested 29 acetylcholine receptor-positive but MuSK-negative patient sera, 30 amytrophic lateral sclerosis (ALS) patient sera and 45 blood donors. HEp-2 M4 cells revealed a high specificity for the detection of MuSK autoantibodies from 25 patient sera assessed by a specific pattern on HEp-2 M4 cells. By using appropriate cell culture additives, the fraction of cells stained positive with anti-MuSK containing sera can be increased from 2-16% to 10-48%, depending on the serum. In conclusion, we provide data showing that the novel recombinant cell line HEp-2 M4 can be used to screen for anti-MuSK with the automatic AKLIDES system.	[George, Sandra; Paulick, Silvia; Roggenbuck, Dirk; Kuepper, Jan-Heiner] Brandenburg Univ Technol Cottbus Senftenberg, Fac Sci, Senftenberg, Germany; [Knuetter, Ilka; Hiemann, Rico; Roggenbuck, Dirk] GA Gener Assays GmbH, Dahlewitz Berlin, Germany; [George, Sandra; Roeber, Nadja; Conrad, Karsten] Tech Univ Dresden, Inst Immunol, D-01062 Dresden, Germany	Brandenburg University of Technology Cottbus; Technische Universitat Dresden	Kupper, JH (corresponding author), Brandenburg Univ Technol Cottbus Senftenberg, Fac Sci, Senftenberg, Germany.	Jan-Heiner.Kuepper@HS-Lausitz.de		Roggenbuck, Dirk/0000-0002-6861-6827	ZIM project [KF2088004AJ9]	ZIM project	This work was partially funded by ZIM project KF2088004AJ9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoccioni E, 2006, NEUROLOGY, V67, P505, DOI 10.1212/01.wnl.0000228225.23349.5d; Benatar M, 2012, MUSCLE NERVE, V45, P909, DOI 10.1002/mus.23330; Caress JB, 2005, ARCH NEUROL-CHICAGO, V62, P1002, DOI 10.1001/archneur.62.6.1002; Cavalcante P, 2012, CURR OPIN NEUROL, V25, P621, DOI 10.1097/WCO.0b013e328357a829; Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Deymeer F, 2007, NEUROLOGY, V68, P609, DOI 10.1212/01.wnl.0000254620.45529.97; Egerer K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2949; Evoli A, 2003, BRAIN, V126, P2304, DOI 10.1093/brain/awg223; Evoli A, 2008, ANN NY ACAD SCI, V1132, P76, DOI 10.1196/annals.1405.012; Farrugia ME, 2006, MUSCLE NERVE, V33, P568, DOI 10.1002/mus.20491; Gerhauser C, 2013, BIOMEDICAL RES, V23, P91; Gilhus NE, 2012, CURR OPIN NEUROL, V25, P523, DOI 10.1097/WCO.0b013e3283572588; Grassi G, 2003, CARCINOGENESIS, V24, P1625, DOI 10.1093/carcin/bgg118; Grossmann K, 2011, CYTOM PART A, V79A, P118, DOI 10.1002/cyto.a.21009; Hiemann R, 2007, ANN NY ACAD SCI, V1109, P358, DOI 10.1196/annals.1398.042; Hiemann R, 2009, AUTOIMMUN REV, V9, P17, DOI 10.1016/j.autrev.2009.02.033; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Jacob S, 2012, ARCH NEUROL-CHICAGO, V69, P994, DOI 10.1001/archneurol.2012.437; Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kivity S, 2012, CLIN RHEUMATOL, V31, P503, DOI 10.1007/s10067-011-1884-1; Knutter I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4119; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang B, 2009, CURR OPIN PHARMACOL, V9, P336, DOI 10.1016/j.coph.2009.04.005; Lavrnic D, 2005, J NEUROL NEUROSUR PS, V76, P1099, DOI 10.1136/jnnp.2004.052415; LEFVERT AK, 1978, SCAND J IMMUNOL, V8, P525; Leite MI, 2008, BRAIN, V131, P1940, DOI 10.1093/brain/awn092; Leite MI, 2005, ANN NEUROL, V57, P444, DOI 10.1002/ana.20386; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; McConville J, 2004, ANN NEUROL, V55, P580, DOI 10.1002/ana.20061; Meriggioli MN, 2012, EXPERT REV CLIN IMMU, V8, P427, DOI [10.1586/ECI.12.34, 10.1586/eci.12.34]; Meyer A, 2010, AUTOIMMUN REV, V9, pA383, DOI 10.1016/j.autrev.2009.11.011; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ohta K, 2007, EUR J NEUROL, V14, P1029, DOI 10.1111/j.1468-1331.2007.01870.x; Pasnoor M, 2010, MUSCLE NERVE, V41, P370, DOI 10.1002/mus.21533; Phillips LH, 2003, ANN NY ACAD SCI, V998, P407, DOI 10.1196/annals.1254.053; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Richman DP, 2012, ARCH NEUROL-CHICAGO, V69, P453, DOI 10.1001/archneurol.2011.2200; Rodiger S, 2013, ADV BIOCHEM ENG BIOT, V133, P35, DOI 10.1007/10_2011_132; Romi F, 2005, EUR J NEUROL, V12, P413, DOI 10.1111/j.1468-1331.2005.01137.x; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Sanders DB, 2003, NEUROLOGY, V60, P1978, DOI 10.1212/01.WNL.0000065882.63904.53; SANDERS DB, 1978, MUSCLE NERVE, V1, P146, DOI 10.1002/mus.880010207; Scuderi F, 2002, LAB INVEST, V82, P1139, DOI 10.1097/01.LAB.0000028144.48023.9B; Shigemoto K, 2006, J CLIN INVEST, V116, P1016, DOI 10.1172/JCI21545; Shigemoto K, 2008, ANN NY ACAD SCI, V1132, P93, DOI 10.1196/annals.1405.002; Simpson JA, 1960, SCOT MED J, V5, P419, DOI [10.1177/003693306000501001, DOI 10.1177/003693306000501001]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vincent A, 2003, LANCET NEUROL, V2, P99, DOI 10.1016/S1474-4422(03)00306-5; Vincent A, 2004, SEMIN NEUROL, V24, P125, DOI 10.1055/s-2004-829589; Vincent AC, 2005, NEUROLOGY, V64, P399, DOI 10.1212/WNL.64.2.399; Willitzki A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/284740; Wolfe GI, 2008, ANN NY ACAD SCI, V1132, P71, DOI 10.1196/annals.1405.005	54	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83924	10.1371/journal.pone.0083924	http://dx.doi.org/10.1371/journal.pone.0083924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416182	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300016
J	Gomez-Pinilla, PJ; Farro, G; Di Giovangiulio, M; Stakenborg, N; Nemethova, A; de Vries, A; Liston, A; Feyerabend, TB; Rodewald, HR; Boeckxstaens, GE; Matteoli, G				Gomez-Pinilla, Pedro J.; Farro, Giovanna; Di Giovangiulio, Martina; Stakenborg, Nathalie; Nemethova, Andrea; de Vries, Annick; Liston, Adrian; Feyerabend, Thorsten B.; Rodewald, Hans-Reimwer; Boeckxstaens, Guy E.; Matteoli, Gianluca			Mast Cells Play No Role in the Pathogenesis of Postoperative Ileus Induced by Intestinal Manipulation	PLOS ONE			English	Article							INTERSTITIAL-CELLS; GENE-EXPRESSION; SH MICE; COMPOUND-48/80; STIMULATION; ACTIVATION; KETOTIFEN; CAJAL; DEGRANULATION; INFLAMMATION	Introduction: Intestinal manipulation (IM) during abdominal surgery results in intestinal inflammation leading to hypomotility or ileus. Mast cell activation is thought to play a crucial role in the pathophysiology of postoperative ileus (POI). However, this conclusion was mainly drawn using mast cell-deficient mouse models with abnormal Kit signaling. These mice also lack interstitial cells of Cajal (ICC) resulting in aberrant gastrointestinal motility even prior to surgery, compromising their use as model to study POI. To avoid these experimental weaknesses we took advantage of a newly developed knock-in mouse model, Cpa3(Cre/+), devoid of mast cells but with intact Kit signaling. Design: The role of mast cells in the development of POI and intestinal inflammation was evaluated assessing gastrointestinal transit and muscularis externa inflammation after IM in two strains of mice lacking mast cells, i.e. Kit(W-sh/W-sh) and Cpa3(Cre/+) mice, and by use of the mast cell stabilizer cromolyn. Results: Kit(W-sh/W-sh) mice lack ICC networks and already revealed significantly delayed gastrointestinal transit even before surgery. IM did not further delay intestinal transit, but induced infiltration of myeloperoxidase positive cells, expression of inflammatory cytokines and recruitment of monocytes and neutrophils into the muscularis externa. On the contrary, Cpa3(Cre/+) mice have a normal network of ICC and normal gastrointestinal. Surprisingly, IM in Cpa3(Cre/+) mice caused delay in gut motility and intestinal inflammation as in wild type littermates mice (Cpa3(+/+)). Furthermore, treatment with the mast cell inhibitor cromolyn resulted in an inhibition of mast cells without preventing POI. Conclusions: Here, we confirm that IM induced mast cell degranulation. However, our data demonstrate that mast cells are not required for the pathogenesis of POI in mice. Although there might be species differences between mouse and human, our results argue against mast cell inhibitors as a therapeutic approach to shorten POI.	[Gomez-Pinilla, Pedro J.; Farro, Giovanna; Di Giovangiulio, Martina; Stakenborg, Nathalie; Nemethova, Andrea; de Vries, Annick; Boeckxstaens, Guy E.; Matteoli, Gianluca] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Louvain, Belgium; [Liston, Adrian] Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium; [Liston, Adrian] Vlaams Inst Biotechnol VIB, Autoimmune Genet Lab, Louvain, Belgium; [Feyerabend, Thorsten B.; Rodewald, Hans-Reimwer] German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Helmholtz Association; German Cancer Research Center (DKFZ)	Matteoli, G (corresponding author), Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Louvain, Belgium.	gianluca.matteoli@med.kuleuven.be	Boeckxstaens, Guy/AAP-2502-2020; Liston, Adrian/G-8606-2013	Liston, Adrian/0000-0002-6272-4085; Di Giovangiulio, Martina/0000-0003-3004-578X; Matteoli, Gianluca/0000-0002-2902-4976	Research Foundation - Flanders (FWO) (Odysseus program); FWO postdoctoral research fellowship; FWO PhD fellowship; DFG [SFB 983 project L]; ERC [233074]	Research Foundation - Flanders (FWO) (Odysseus program)(FWO); FWO postdoctoral research fellowship; FWO PhD fellowship(FWO); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	Supported by grants from Research Foundation - Flanders (FWO) (Odysseus program to GEB), by a FWO postdoctoral research fellowship (to GM and PJG) by FWO PhD fellowship (to MDG), by DFG (SFB 983 project L to HRR) and by the ERC (grant no. 233074 to HRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgeirsson T, 2010, J AM COLL SURGEONS, V210, P228, DOI 10.1016/j.jamcollsurg.2009.09.028; Bauer AJ, 2004, NEUROGASTROENT MOTIL, V16, P54, DOI 10.1111/j.1743-3150.2004.00558.x; Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Bouchard JC, 2012, AM J PATHOL, V181, P845, DOI 10.1016/j.ajpath.2012.05.020; Byrne RD, 2007, CELL SIGNAL, V19, P321, DOI 10.1016/j.cellsig.2006.07.004; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Jonge WJ, 2004, GASTROENTEROLOGY, V127, P535, DOI 10.1053/j.gastro.2004.04.017; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Fowler CJ, 2003, INFLAMM RES, V52, P461, DOI 10.1007/s00011-003-1202-8; GALLI SJ, 1984, PROG ALLERGY, V34, P1; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Hung CH, 2007, PEDIAT ALLERG IMM-UK, V18, P378, DOI 10.1111/j.1399-3038.2007.00535.x; Iino S, 2009, NEUROSCI LETT, V459, P123, DOI 10.1016/j.neulet.2009.05.003; Kaida S, 2010, FREE RADICAL RES, V44, P171, DOI 10.3109/10715760903380466; KAKUTA Y, 1988, J ALLERGY CLIN IMMUN, V81, P469, DOI 10.1016/0091-6749(88)90919-0; Kalff JC, 1999, GASTROENTEROLOGY, V117, P378, DOI 10.1053/gast.1999.0029900378; Kalff JC, 1998, J LEUKOCYTE BIOL, V63, P683, DOI 10.1002/jlb.63.6.683; Kalff JC, 2000, GASTROENTEROLOGY, V118, P316, DOI 10.1016/S0016-5085(00)70214-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michel A, 2013, J IMMUNOL, V190, P5534, DOI 10.4049/jimmunol.1203355; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Palomaki VAB, 2006, BRIT J PHARMACOL, V147, P596, DOI 10.1038/sj.bjp.0706671; Ramos L, 2010, J IMMUNOL, V185, P709, DOI 10.4049/jimmunol.1000273; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Schemann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052104; Schwarz NT, 2001, GASTROENTEROLOGY, V121, P1354, DOI 10.1053/gast.2001.29605; Snoek SA, 2012, NEUROGASTROENT MOTIL, V24, P172, DOI 10.1111/j.1365-2982.2011.01820.x; The FO, 2008, GUT, V57, P33, DOI 10.1136/gut.2007.120238; The FO, 2005, BRIT J PHARMACOL, V146, P252, DOI 10.1038/sj.bjp.0706303; van Bree SHW, 2012, NAT REV GASTRO HEPAT, V9, P675, DOI 10.1038/nrgastro.2012.134; van Bree Sjoerd Hw, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P219; Viaro F, 2008, NITRIC OXIDE-BIOL CH, V18, P87, DOI 10.1016/j.niox.2007.11.004; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Yamada Y, 2003, PHARMACOLOGY, V69, P138, DOI 10.1159/000072666; YAMAZAKI M, 1994, BLOOD, V83, P3509; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391	40	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85304	10.1371/journal.pone.0085304	http://dx.doi.org/10.1371/journal.pone.0085304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416383	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000329866300066
J	Pretorius, E; Bester, J; Vermeulen, N; Lipinski, B; Gericke, GS; Kell, DB				Pretorius, Etheresia; Bester, Janette; Vermeulen, Natasha; Lipinski, Boguslaw; Gericke, George S.; Kell, Douglas B.			Profound Morphological Changes in the Erythrocytes and Fibrin Networks of Patients with Hemochromatosis or with Hyperferritinemia, and Their Normalization by Iron Chelators and Other Agents	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; RED-BLOOD-CELL; HFE C282Y HOMOZYGOSITY; SERUM FERRITIN; HEREDITARY HEMOCHROMATOSIS; OXIDATIVE STRESS; SCANNING-ELECTRON; ASYMPTOMATIC SUBJECTS; BIOLOGICAL-MEMBRANES; PARKINSONS-DISEASE	It is well-known that individuals with increased iron levels are more prone to thrombotic diseases, mainly due to the presence of unliganded iron, and thereby the increased production of hydroxyl radicals. It is also known that erythrocytes (RBCs) may play an important role during thrombotic events. Therefore the purpose of the current study was to assess whether RBCs had an altered morphology in individuals with hereditary hemochromatosis (HH), as well as some who displayed hyperferritinemia (HF). Using scanning electron microscopy, we also assessed means by which the RBC and fibrin morphology might be normalized. An important objective was to test the hypothesis that the altered RBC morphology was due to the presence of excess unliganded iron by removing it through chelation. Very striking differences were observed, in that the erythrocytes from HH and HF individuals were distorted and had a much greater axial ratio compared to that accompanying the discoid appearance seen in the normal samples. The response to thrombin, and the appearance of a platelet-rich plasma smear, were also markedly different. These differences could largely be reversed by the iron chelator desferal and to some degree by the iron chelator clioquinol, or by the free radical trapping agents salicylate or selenite (that may themselves also be iron chelators). These findings are consistent with the view that the aberrant morphology of the HH and HF erythrocytes is caused, at least in part, by unliganded ('free') iron, whether derived directly via raised ferritin levels or otherwise, and that lowering it or affecting the consequences of its action may be of therapeutic benefit. The findings also bear on the question of the extent to which accepting blood donations from HH individuals may be desirable or otherwise.	[Pretorius, Etheresia; Bester, Janette; Vermeulen, Natasha] Univ Pretoria, Dept Physiol, Arcadia, South Africa; [Lipinski, Boguslaw] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Gericke, George S.] AMPATH Natl Reference Lab, Centurion, South Africa; [Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Kell, Douglas B.] Univ Manchester, Manchester Inst Biotechnol, Manchester M13 9PL, Lancs, England	University of Pretoria; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Manchester; University of Manchester	Pretorius, E (corresponding author), Univ Pretoria, Dept Physiol, Arcadia, South Africa.	resia.pretorius@up.ac.za	Pretorius, Etheresia/ACH-6368-2022; Pretorius, Etheresia/P-2978-2016; Kell, Douglas/E-8318-2011	Pretorius, Etheresia/0000-0002-9108-2384; Pretorius, Etheresia/0000-0002-9108-2384; Bester, Janette/0000-0002-8931-9194; Kell, Douglas/0000-0001-5838-7963	National Research Foundation of South Africa (NRF); BBSRC [BB/L025752/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L025752/1] Funding Source: researchfish	National Research Foundation of South Africa (NRF)(National Research Foundation - South Africa); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding body: The National Research Foundation of South Africa (NRF): E Pretorius. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel RJ, 2006, J AM CHEM SOC, V128, P8920, DOI 10.1021/ja062046j; Acton RT, 2006, DIABETES CARE, V29, P2084, DOI 10.2337/dc05-1592; Adamkiewicz TV, 2009, BLOOD, V114, P4632, DOI 10.1182/blood-2009-02-203323; Adams PC, 2008, INT J LAB HEMATOL, V30, P300, DOI 10.1111/j.1751-553X.2007.00956.x; Adams Paul, 2008, Gastroenterol Hepatol (N Y), V4, P333; Adams PC, 2006, CLIN GASTROENTEROL H, V4, P918, DOI 10.1016/j.cgh.2006.04.013; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Adams RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1567, DOI 10.1001/archneur.64.11.1567; Ahluwalia N, 2010, J NUTR, V140, P812, DOI 10.3945/jn.109.110353; Akoev VR, 1997, B EXP BIOL MED+, V123, P242, DOI 10.1007/BF02445414; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Altes A, 2009, ANN HEMATOL, V88, P951, DOI 10.1007/s00277-009-0705-y; [Anonymous], 2006, FREE RADICALS BIOL M; Asberg A, 2007, SCAND J GASTROENTERO, V42, P1073, DOI 10.1080/00365520701245488; Ayonrinde OT, 2008, CRIT REV CL LAB SCI, V45, P451, DOI 10.1080/10408360802335716 ; Azizova OA, 2009, B EXP BIOL MED+, V148, P776, DOI 10.1007/s10517-010-0814-6; Babitt JL, 2011, SEMIN LIVER DIS, V31, P280, DOI 10.1055/s-0031-1286059; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bareggi SR, 2012, CNS NEUROSCI THER, V18, P41, DOI 10.1111/j.1755-5949.2010.00231.x; Barton JC, 2012, CLIN GASTROENTEROL H, V10, P412, DOI 10.1016/j.cgh.2011.11.032; Barton JC, 1998, ANN INTERN MED, V129, P932, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00003; Barton JC, 2000, J LAB CLIN MED, V135, P96, DOI 10.1016/S0022-2143(00)70026-6; Bassett ML, 2001, INTERN MED J, V31, P237, DOI 10.1046/j.1445-5994.2001.00050.x; Brandhagen DJ, 2002, AM FAM PHYSICIAN, V65, P853; Brewer GJ, 2007, EXP BIOL MED, V232, P323; Bush AI, 2008, J ALZHEIMERS DIS, V15, P223; Buys AV, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-25; Cahoon L, 2009, NAT MED, V15, P356, DOI 10.1038/nm0409-356; Camaschella C, 2011, CURR OPIN PEDIATR, V23, P14, DOI 10.1097/MOP.0b013e3283425591; Castellani RJ, 2012, BIOFACTORS, V38, P133, DOI 10.1002/biof.1010; Chan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054902; Chen JX, 2012, BBA-GEN SUBJECTS, V1820, P256, DOI 10.1016/j.bbagen.2011.07.015; Choi BY, 2013, NEUROBIOL DIS; Clark Paul, 2010, Clin Biochem Rev, V31, P3; Cooper GJS, 2011, DRUGS, V71, P1281, DOI 10.2165/11591370-000000000-00000; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; Crownover BK, 2013, AM FAM PHYSICIAN, V87, P183; Daniels R., 2010, DELMARS GUIDE LAB DI; Darshan D, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001687; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Day SM, 2003, CIRCULATION, V107, P2601, DOI 10.1161/01.CIR.0000066910.02844.D0; DePalma RG, 2010, J VASC SURG, V51, P1498, DOI 10.1016/j.jvs.2009.12.068; Dhillon BK, 2007, WORLD J GASTROENTERO, V13, P2956, DOI 10.3748/wjg.v13.i21.2956; Double KL, 2008, CELL MOL LIFE SCI, V65, P1669, DOI 10.1007/s00018-008-7581-9; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Ferro E, 2012, FREE RADICAL BIO MED, V53, P1829, DOI 10.1016/j.freeradbiomed.2012.08.592; Finberg KE, 2013, J CLIN INVEST, V123, P1424, DOI 10.1172/JCI68889; Flaten TP, 2012, J TRACE ELEM MED BIO, V26, P127, DOI 10.1016/j.jtemb.2012.03.009; Fleming RE, 2005, SEMIN LIVER DIS, V25, P411, DOI 10.1055/s-2005-923313; Franchini M, 2008, ANN HEMATOL, V87, P167, DOI 10.1007/s00277-007-0416-1; Funke C, 2012, NEUROCHEM INT; Funke C, 2013, NEUROCHEM INT, V62, P637, DOI 10.1016/j.neuint.2012.11.015; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Girasole M, 2012, MICRON, V43, P1273, DOI 10.1016/j.micron.2012.03.019; Gordeuk VR, 2012, CAN J GASTROENTEROL, V26, P345, DOI 10.1155/2012/676824; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Gurrin LC, 2008, GASTROENTEROLOGY, V135, P1945, DOI 10.1053/j.gastro.2008.08.056; Hardy G, 2012, NUTR CLIN PRACT, V27, P21, DOI 10.1177/0884533611434116; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; Inati A, 2011, PEDIATR BLOOD CANCER, V56, P182, DOI 10.1002/pbc.22721; Inati A, 2010, AM J HEMATOL, V85, P782, DOI 10.1002/ajh.21806; Inati A, 2010, BLOOD, V115, P2980, DOI 10.1182/blood-2009-09-243568; Jacobs EMG, 2009, J HEPATOL, V50, P174, DOI 10.1016/j.jhep.2008.08.014; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460, DOI 10.2174/138161211798072463; Kasvosve I, 2013, CLIN CHIM ACTA, V416, P20, DOI 10.1016/j.cca.2012.11.013; Kaur H, 1996, ANN RHEUM DIS, V55, P915, DOI 10.1136/ard.55.12.915; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; KELLNER H, 1992, Z GASTROENTEROL, V30, P779; Kiechl S, 1997, CIRCULATION, V96, P3300; Konz T, 2013, ANAL CHEM, V85, P8334, DOI 10.1021/ac401692k; Kozlova EK, 2012, ANAL NANOSTRUCTURE R; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Kwan T, 1998, CLIN INVEST MED, V21, P251; Lee DH, 2004, DIABETOLOGIA, V47, P185, DOI 10.1007/s00125-003-1307-1; Lee MT, 2006, BLOOD, V108, P847, DOI 10.1182/blood-2005-10-009506; Leitman SF, 2003, TRANSFUSION, V43, P1538, DOI 10.1046/j.1537-2995.2003.00570.x; Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299; Limdi JK, 2004, QJM-INT J MED, V97, P315, DOI 10.1093/qjmed/hch065; Lipinski B, 2012, MICROSC RES TECHNIQ, V75, P1185, DOI 10.1002/jemt.22047; Lipinski B, 2012, ULTRASTRUCT PATHOL, V36, P79, DOI 10.3109/01913123.2011.627491; Lipinski B, 2012, POL ARCH MED WEWN, V122, P115, DOI 10.20452/pamw.1201; Luten M, 2008, TRANSFUSION, V48, P436, DOI 10.1111/j.1537-2995.2007.01547.x; Ma Y, 2012, CURR MED CHEM, V19, P2816, DOI 10.2174/092986712800609724; Madathil KS, 2013, SYNAPSE; Mangasser-Stephan K, 1999, CLIN CHEM, V45, P1875; Martines AM, 2013, NAT REV NEPHROL; Mazumdar M, 2007, PEDIATRICS, V120, pe1107, DOI 10.1542/peds.2006-2002; McCullen MA, 2002, CLIN CHIM ACTA, V315, P169, DOI 10.1016/S0009-8981(01)00711-2; McCune CA, 2006, GUT, V55, P554, DOI 10.1136/gut.2005.070342; McLaren CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017390; McLaren Gordon D, 2009, Hematology Am Soc Hematol Educ Program, P195, DOI 10.1182/asheducation-2009.1.195; Merono T, 2011, EUR J CLIN INVEST, V41, P479, DOI 10.1111/j.1365-2362.2010.02429.x; Mirre E, 2010, EUR J HAEMATOL, V84, P259, DOI 10.1111/j.1600-0609.2009.01379.x; Moczulski DK, 2001, DIABETES CARE, V24, P1187, DOI 10.2337/diacare.24.7.1187; Mohanakumar KP, 2000, BRAIN RES, V864, P281, DOI 10.1016/S0006-8993(00)02189-2; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nagy E, 2010, ARTERIOSCL THROM VAS, V30, P1347, DOI 10.1161/ATVBAHA.110.206433; Nielsen P, 2000, J LAB CLIN MED, V135, P413, DOI 10.1067/mlc.2000.106456; Nunez MT, 2012, BIOMETALS, V25, P761, DOI 10.1007/s10534-012-9523-0; Olynyk JK, 2008, HEPATOLOGY, V48, P991, DOI 10.1002/hep.22507; Oyama TM, 2012, LIFE SCI, V91, P1216, DOI 10.1016/j.lfs.2012.09.014; Pasini EM, 2010, J PROTEOMICS, V73, P403, DOI 10.1016/j.jprot.2009.06.005; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Pra D, 2012, MUTAT RES-FUND MOL M, V733, P92, DOI 10.1016/j.mrfmmm.2012.02.001; Pretorius E, 2013, BLOOD, V121, P9, DOI 10.1182/blood-2012-09-454793; Pretorius E, 2007, PATHOPHYSIOL HAEMO T, V36, P251, DOI 10.1159/000252821; Pretorius E, 2013, TOXICOL MECH METHODS; Pretorius E, 2012, HEART LUNG CIRC; Pretorius E, 2013, TOXICOL MECH METHOD, V23, P352, DOI 10.3109/15376516.2012.762082; Pretorius E, 2013, MICROSC RES TECHNIQ, V76, P268, DOI 10.1002/jemt.22163; Pretorius E, 2013, CURR DRUG TARGETS, V14, P13, DOI 10.2174/138945013804806541; Prus E, 2010, ACTA HAEMATOL-BASEL, V123, P14, DOI 10.1159/000258958; Raghupathy R, 2010, ADV HEMATOL; RAI D, 1995, J SOLUTION CHEM, V24, P735, DOI 10.1007/BF01131042; Rajpathak SN, 2009, DIABETES OBES METAB, V11, P472, DOI 10.1111/j.1463-1326.2008.00985.x; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Roetto A, 2005, BEST PRACT RES CL HA, V18, P235, DOI 10.1016/j.beha.2004.09.004; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; Santos PCJL, 2012, INT J MOL SCI, V13, P1497, DOI 10.3390/ijms13021497; Santos PCJL, 2011, BLOOD CELL MOL DIS, V46, P302, DOI 10.1016/j.bcmd.2011.02.008; Schneider SA, 2012, SEMIN PEDIATR NEUROL, V19, P57, DOI 10.1016/j.spen.2012.03.005; Schneider SA, 2012, MOVEMENT DISORD, V27, P42, DOI 10.1002/mds.23971; SHEETZ MP, 1976, J CELL BIOL, V70, P193, DOI 10.1083/jcb.70.1.193; SHEETZ MP, 1976, J CELL BIOL, V70, P247, DOI 10.1083/jcb.70.1.247; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Shizukuda Y, 2007, AM J HEMATOL, V82, P249, DOI 10.1002/ajh.20743; Shizukuda Y, 2006, AM J CARDIOL, V98, P954, DOI 10.1016/j.amjcard.2006.04.040; SIMON M, 1976, GUT, V17, P332, DOI 10.1136/gut.17.5.332; Smith-Whitley K, 2012, PEDIATR BLOOD CANCER, V59, P358, DOI 10.1002/pbc.24179; Superior Health Council, 2013, SHC PUBL, V8672; Swinkels DW, 2011, HAEMATOL-HEMATOL J, V96, P485, DOI 10.3324/haematol.2011.042036; Switzer JA, 2006, LANCET NEUROL, V5, P501, DOI 10.1016/S1474-4422(06)70469-0; Tachev KD, 2004, COLLOID SURFACE B, V34, P123, DOI 10.1016/j.colsurfb.2003.12.011; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Tsuchiya K, 2013, THER APHER DIAL, V17, P1, DOI 10.1111/1744-9987.12001; Verduzco LA, 2009, BLOOD, V114, P5117, DOI 10.1182/blood-2009-05-220921; Vermeulen E, 2012, ACTA CLIN BELG, V67, P190, DOI 10.2143/ACB.67.3.2062654; Waalen J, 2008, BLOOD, V111, P3373, DOI 10.1182/blood-2007-07-102673; Walter PB, 2009, ACTA HAEMATOL-BASEL, V122, P174, DOI 10.1159/000243802; Wang Y, 2012, SEMIN ARTHRITIS RHEU, V41, P872, DOI 10.1016/j.semarthrit.2011.11.003; Weiss G, 2010, NAT REV GASTRO HEPAT, V7, P50, DOI 10.1038/nrgastro.2009.201; White AR, 2006, EXPERT REV NEUROTHER, V6, P711, DOI 10.1586/14737175.6.5.711; Wilson JG, 2003, AM J MED SCI, V325, P332, DOI 10.1097/00000441-200306000-00004; Wong B, 2011, NAT METHODS, V8, P365, DOI 10.1038/nmeth0511-365; Wood MJ, 2012, HEPATOLOGY, V56, P904, DOI 10.1002/hep.25720; Yamanishi H, 2002, CLIN BIOCHEM, V35, P523, DOI 10.1016/S0009-9120(02)00380-6; Yu Y, 2012, CURR MED CHEM, V19, P2689, DOI 10.2174/092986712800609706; Zeitz M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051904	154	47	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85271	10.1371/journal.pone.0085271	http://dx.doi.org/10.1371/journal.pone.0085271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416376	Green Published, gold			2022-12-25	WOS:000329866300062
J	Xin, H; Wang, K; Hu, G; Xie, FB; Ouyang, KD; Tang, XZ; Wang, MJ; Wen, DY; Zhu, YZ; Qin, XR				Xin, Hong; Wang, Ke; Hu, Gang; Xie, Fubo; Ouyang, Kedong; Tang, Xuzhen; Wang, Minjun; Wen, Danyi; Zhu, Yizhun; Qin, Xiaoran			Establishment and Characterization of 7 Novel Hepatocellular Carcinoma Cell Lines from Patient-Derived Tumor Xenografts	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; SERUM ALPHA-FETOPROTEIN; PRIMARY LIVER-CANCER; HEPATITIS-B-VIRUS; RISK-FACTORS; HETEROGENEITY; EPIDEMIOLOGY; PROGNOSIS; INFECTION; DIAGNOSIS	Hepatocellular carcinoma (HCC) is a common cancer with poor prognosis worldwide and the molecular mechanism is not well understood. This study aimed to establish a collection of human HCC cell lines from patient-derived xenograft (PDX) models. From the 20 surgical HCC sample collections, 7 tumors were successfully developed in immunodeficient mice and further established 7 novel HCC cell lines (LIXC002, LIXC003, LIXC004, LIXC006, LIXC011, LIXC012 and CPL0903) by primary culture. The characterization of cell lines was defined by morphology, growth kinetics, cell cycle, chromosome analysis, short tandem repeat (STR) analysis, molecular profile, and tumorigenicity. Additionally, response to clinical chemotherapeutics was validated both in vitro and in vivo. STR analysis indicated that all cell lines were unique cells different from known cell lines and free of contamination by bacteria or mycoplasma. The other findings were quite heterogeneous between individual lines. Chromosome aberration could be found in all cell lines. Alpha-fetoprotein was overexpressed only in 3 out of 7 cell lines. 4 cell lines expressed high level of vimentin. Ki67 was strongly stained in all cell lines. mRNA level of retinoic acid induced protein 3 (RAI3) was decreased in all cell lines. The 7 novel cell lines showed variable sensitivity to 8 tested compounds. LIXC011 and CPL0903 possessed multiple drug resistance property. Sorafenib inhibited xenograft tumor growth of LIXC006, but not of LIXC012. Our results indicated that the 7 novel cell lines with low passage maintaining their clinical and pathological characters could be good tools for further exploring the molecular mechanism of HCC and anti-cancer drug screening.	[Wang, Ke; Hu, Gang; Xie, Fubo; Ouyang, Kedong; Tang, Xuzhen; Wen, Danyi; Qin, Xiaoran] Shanghai ChemPartner Co LTD, Shanghai, Peoples R China; [Xin, Hong; Wang, Minjun; Zhu, Yizhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China	Fudan University	Qin, XR (corresponding author), Shanghai ChemPartner Co LTD, Shanghai, Peoples R China.	xiaoran_qin@yahoo.com	Zhu, Yi Zhun/ABG-8449-2021; Xin, Hong/AAF-5786-2020	Zhu, Yi Zhun/0000-0001-7700-8041; 	Shanghai Science and Technology Committee [11140901400]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	Shanghai Science and Technology Committee research grant, 2011, No. 11140901400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Carr BI, 2007, DIGEST DIS SCI, V52, P776, DOI 10.1007/s10620-006-9541-2; Chan SL, 2009, J CLIN ONCOL, V27, P446, DOI 10.1200/JCO.2008.18.8151; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Ertle JM, 2013, DIGESTION, V87, P121, DOI 10.1159/000346080; Fransvea E, 2009, CELL ONCOL, V31, P227, DOI 10.3233/CLO-2009-0473; Gao TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062950; Guzman G, 2005, MODERN PATHOL, V18, P1498, DOI 10.1038/modpathol.3800458; Hu G, 2012, INT J ONCOL, V40, P798, DOI 10.3892/ijo.2011.1254; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Ivaska Johanna, 2011, Small GTPases, V2, P51; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; KAWAMATA N, 1995, CANCER RES, V55, P2266; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; LOK ASF, 1989, HEPATOLOGY, V9, P110, DOI 10.1002/hep.1840090119; Maletzki C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052485; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Mizejewski G, 1997, BETA FETOPROTEIN BIO, P333; Mukhopadhyay B, 2010, J BIOL CHEM, V285, P19002, DOI 10.1074/jbc.M109.068460; Naguib A, 2013, TRENDS CELL BIOL; Ni XG, 2005, EJSO-EUR J SURG ONC, V31, P164, DOI 10.1016/j.ejso.2004.09.007; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Polakis P, 2000, GENE DEV, V14, P1837; Reid YA, 2011, METHODS MOL BIOL, V731, P35, DOI 10.1007/978-1-61779-080-5_4; Reig Maria, 2009, Gastroenterology, V137, P1171, DOI 10.1053/j.gastro.2009.07.008; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Siolas D, 2013, CANC RES; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Tao QG, 2004, GENOMICS, V83, P270, DOI 10.1016/S0888-7543(03)00237-4; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Venepalli NK, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/341636; Wiedmann MW, 2011, CURR CANCER DRUG TAR, V11, P714; YU MW, 1995, CANCER RES, V55, P1301	40	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85308	10.1371/journal.pone.0085308	http://dx.doi.org/10.1371/journal.pone.0085308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416385	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300067
J	Farley, JH; Hoyle, SD; Eveson, JP; Williams, AJ; Davies, CR; Nicol, SJ				Farley, Jessica H.; Hoyle, Simon D.; Eveson, J. Paige; Williams, Ashley J.; Davies, Campbell R.; Nicol, Simon J.			Maturity Ogives for South Pacific Albacore Tuna (Thunnus alalunga) That Account for Spatial and Seasonal Variation in the Distributions of Mature and Immature Fish	PLOS ONE			English	Article							BLUEFIN TUNA; AGE; ATRESIA; SIZE; L.	Length and age at maturity are important life history parameters for estimating spawning stock biomass and reproductive potential of fish stocks. Bias in estimates of size and age at maturity can arise when disparate distributions of mature and immature fish within a population are not accounted for in the analysis. Here we investigate the spatial and temporal variability in observed size and age at maturity of female albacore tuna, Thunnus alalunga, using samples collected across the South Pacific. Maturity status was identified using consistent histological criteria that were precise enough to allow for mature but regenerating females to be distinguished from immature females during the non-spawning season, permitting year-round sampling for maturity estimation in albacore. Using generalised linear mixed models, we found that the proportion of mature females at length varied significantly with latitude and time of year. Specifically, females at northern latitudes (similar to 10-20 degrees S, where spawning occurs) were mature at significantly smaller lengths and ages than females at southern latitudes (similar to 20-40 degrees S), particularly during the spawning season (October-March). This variation was due to different geographic distributions of mature and immature fish during the year. We present a method for estimating an unbiased maturity ogive that takes into account the latitudinal variation in proportion mature at length during a given season (spawning or non-spawning). Applying this method to albacore samples from the western region of the South Pacific gave a predicted length at 50% mature of similar to 87 cm fork length (4.5 years).	[Farley, Jessica H.; Eveson, J. Paige; Davies, Campbell R.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia; [Hoyle, Simon D.; Williams, Ashley J.; Nicol, Simon J.] Secretariat Pacific Community, Ocean Fisheries Programme, Noumea, New Caledonia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Farley, JH (corresponding author), CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia.	Jessica.Farley@csiro.au	Hoyle, Simon D/G-1201-2015; Davies, Campbell R/N-8086-2013; Williams, Ashley J/G-2017-2014; Williams, Ashley J/J-7565-2013; Williams, Ashley/ABA-5921-2020; Farley, Jessica/E-4957-2014	Hoyle, Simon D/0000-0002-1787-6565; Davies, Campbell R/0000-0002-2028-1060; Williams, Ashley J/0000-0002-5530-0073; Williams, Ashley/0000-0002-5530-0073; Farley, Jessica/0000-0002-5047-746X; Eveson, Paige/0000-0002-1560-2093; Nicol, Simon/0000-0001-8193-8719	CSIRO Wealth from Oceans Flagship; Australian Fisheries Research and Development Corporation [2009/012]; European Union; Western and Central Pacific Fisheries Commission	CSIRO Wealth from Oceans Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Fisheries Research and Development Corporation; European Union(European Commission); Western and Central Pacific Fisheries Commission	This work was supported by funding from CSIRO Wealth from Oceans Flagship, the Australian Fisheries Research and Development Corporation (Project #2009/012), the 9th European Union Development Fund (SCIFISH project), and the Western and Central Pacific Fisheries Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2000, CAN J FISH AQUAT SCI, V57, P1448, DOI 10.1139/cjfas-57-7-1448; [Anonymous], 2011, REPORT 2011 ICCAT S; Bates D, 2012, LME4 LINEAR MIXED EF; Begg Gavin A., 2009, P230, DOI 10.1002/9781444312133.ch6; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Campbell R, 2011, IMPLEMENTATION ETBF; Chen KS, 2010, J FISH BIOL, V77, P119, DOI 10.1111/j.1095-8649.2010.02662.x; CHEN Y, 1994, AQUAT SCI, V56, P206, DOI 10.1007/BF00879965; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Corriero A, 2003, J FISH BIOL, V63, P108, DOI 10.1046/j.1095-8649.2003.00132.x; Crabtree RE, 1997, FISH B-NOAA, V95, P456; Farley J, 2009, IND BASED SIZE MONIT; Farley JH, 2013, J FISH BIOL, V82, P1523, DOI 10.1111/jfb.12077; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; HILBORN R, 1992; Hillary RM, 2008, IOTC2008WPTE09; Hoyle S, 2012, WCPFCSC82012SAWP04RE; Hoyle S, 2011, 7 SCI COMM M W CENTR; Hoyle S.D., 2008, WCPFCSC4MEWP2; Hunter John Roe, 2003, Fisken og Havet, V12, P57; HUNTER JR, 1985, FISH B-NOAA, V83, P119; ICCAT, 2012, REP 2011 ICCAT S ATL, P491; ICCAT, 2010, ICCAT COLL VOL SCI P, V65, P1113; ICES, 2008, WORKSH MAT OG EST ST; ISC, 2010, REP ISC ALB WORK GRO; Langley A, 2005, 1 M SCI COMM W CENTR; Langley AD, 2006, 37 SECR PAC COMM; Langley AD, 2003, 16 M STAND COMM TUN; McDonough CJ, 2005, FISH B-NOAA, V103, P601; Murray T., 1994, 3362 FAO, V336, P188; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Otsu T., 1959, Fishery Bulletin United States, V59, P287; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramon D, 1996, FISH B-NOAA, V94, P725; Saidapur S K, 1978, Int Rev Cytol, V54, P225, DOI 10.1016/S0074-7696(08)60169-2; Schaefer K. M., 1998, INT AM TROP TUNA COM, V21, P201; Schaefer Kurt M., 2005, Inter-American Tropical Tuna Commission Bulletin, V23, P3; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schmitt CC, 1997, 35 IPHC; Ueyanagi S, 1957, REP NANKAI REG FISH, V6, P113; Williams AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039318	42	25	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83017	10.1371/journal.pone.0083017	http://dx.doi.org/10.1371/journal.pone.0083017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416153	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000329862500025
J	Fenyvesi, F; Reti-Nagy, K; Bacso, Z; Gutay-Toth, Z; Malanga, M; Fenyvesi, E; Szente, L; Varadi, J; Ujhelyi, Z; Feher, P; Szabo, G; Vecsernyes, M; Bacskay, I				Fenyvesi, Ferenc; Reti-Nagy, Katalin; Bacso, Zsolt; Gutay-Toth, Zsuzsanna; Malanga, Milo; Fenyvesi, Eva; Szente, Lajos; Varadi, Judit; Ujhelyi, Zoltan; Feher, Palma; Szabo, Gabor; Vecsernyes, Miklos; Bacskay, Ildiko			Fluorescently Labeled Methyl-Beta-Cyclodextrin Enters Intestinal Epithelial Caco-2 Cells by Fluid-Phase Endocytosis	PLOS ONE			English	Article							P-GLYCOPROTEIN; PHARMACEUTICAL APPLICATIONS; DENDRITIC CELLS; CHOLESTEROL; PERMEATION; MACROPINOCYTOSIS; TRANSPORTER; INHIBITION; SOLUBILITY; MEMBRANE	Cyclodextrins are widely used excipients for increasing the bioavailability of poorly water-soluble drugs. Their effect on drug absorption in the gastrointestinal tract is explained by their solubility- and permeability-enhancement. The aims of this study were to investigate penetration properties of fluorescently labeled randomly methylated-beta-cyclodextrin (FITC-RAMEB) on Caco-2 cell layer and examine the cellular entry of cyclodextrins on intestinal cells. The permeability of FITCRAMEB through Caco-2 monolayers was very limited. Using this compound in 0.05 mM concentration the permeability coefficient was 3.35 +/- 1.29 x 10(-8) cm/s and its permeability did not change in the presence of 5 mM randomly methylated-beta-cyclodextrin. Despite of the low permeability, cellular accumulation of FITC-RAMEB in cytoplasmic vesicles was significant and showed strong time and concentration dependence, similar to the characteristics of the macropinocytosis marker Lucifer Yellow. The internalization process was fully inhibited at 0 degrees C and it was drastically reduced at 37 degrees C applying rottlerin, an inhibitor of macropinocytosis. Notably, FITC-RAMEB colocalized with the early endosome organizer Rab5a. These results have revealed that FITC-RAMEB is able to enter intestinal epithelial cells by fluid-phase endocytosis from the apical side. This mechanism can be an additional process which helps to overcome the intestinal barrier and contributes to the bioavailability enhancement of cyclodextrins.	[Fenyvesi, Ferenc; Reti-Nagy, Katalin; Varadi, Judit; Ujhelyi, Zoltan; Feher, Palma; Vecsernyes, Miklos; Bacskay, Ildiko] Univ Debrecen, Dept Pharmaceut Technol, H-4012 Debrecen, Hungary; [Bacso, Zsolt; Gutay-Toth, Zsuzsanna; Szabo, Gabor] Univ Debrecen, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary; [Malanga, Milo; Fenyvesi, Eva; Szente, Lajos] Cyclolab Cyclodextrin R&D Lab Ltd, Budapest, Hungary	University of Debrecen; University of Debrecen; CycloLab	Fenyvesi, F (corresponding author), Univ Debrecen, Dept Pharmaceut Technol, H-4012 Debrecen, Hungary.	fenyvesi.ferenc@pharm.unideb.hu	Bacso, Zsolt/A-3615-2009; Ujhelyi, Zoltan/AAF-7036-2021; Réti-Nagy, Katalin/AAR-7341-2021	Bacso, Zsolt/0000-0001-6885-3796; Ujhelyi, Zoltan/0000-0001-9724-0614; Varadi, Judit/0000-0003-1885-164X; Fenyvesi, Ferenc/0000-0003-2890-0783	European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]; Marie Curie Program [237962 CYCLON];  [TAMOP-4.2.2.A- 11/1/KONV-2012-0025];  [OTKA 72762];  [OTKA-101337]	European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); Marie Curie Program(European Commission); ; ; 	This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 National Excellence Program. This work was supported by the following grants: TAMOP-4.2.2.A- 11/1/KONV-2012-0025, OTKA 72762 and OTKA-101337. The preparation of FITC-RAMEB was supported by Marie Curie Program # 237962 CYCLON (FP7-PEOPLEITN-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Bacso Z, 2004, CYTOM PART A, V61A, P105, DOI 10.1002/cyto.a.20081; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Deli MA, 2009, BBA-BIOMEMBRANES, V1788, P892, DOI 10.1016/j.bbamem.2008.09.016; Fenyvesi F, 2008, EUR J PHARM SCI, V34, P236, DOI 10.1016/j.ejps.2008.04.005; Garrigues A, 2002, P NATL ACAD SCI USA, V99, P10347, DOI 10.1073/pnas.162366399; Gonzalez-Gaitano G, 2002, J INCL PHENOM MACRO, V44, P101, DOI 10.1023/A:1023065823358; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kiss T, 2010, EUR J PHARM SCI, V40, P376, DOI 10.1016/j.ejps.2010.04.014; Kurkov SV, 2012, INT J PHARM; Lambert D, 2005, BIOCHEM J, V387, P553, DOI 10.1042/BJ20041377; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Loftsson T, 1996, J PHARM SCI, V85, P1017, DOI 10.1021/js950534b; Loftsson Thorsteinn, 2005, Expert Opin Drug Deliv, V2, P335, DOI 10.1517/17425247.2.1.335; Loftsson T, 2011, J PHARM PHARMACOL, V63, P1119, DOI 10.1111/j.2042-7158.2011.01279.x; Matilainen L, 2008, J CONTROL RELEASE, V126, P10, DOI 10.1016/j.jconrel.2007.11.003; Matsuda H, 1999, ADV DRUG DELIVER REV, V36, P81, DOI 10.1016/S0169-409X(98)00056-8; ON MJ, 2011, MECH STUDIES UPTAKE; Plazzo AP, 2012, CHEM PHYS LIPIDS, V165, P505, DOI 10.1016/j.chemphyslip.2012.03.007; Puskas I, 2013, J INCL PHENOM MACRO, V75, P269, DOI 10.1007/s10847-012-0127-7; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sarkar K, 2005, IMMUNOLOGY, V116, P513, DOI 10.1111/j.1365-2567.2005.02253.x; SWANSON JA, 1985, J CELL BIOL, V100, P851, DOI 10.1083/jcb.100.3.851; SZEJTLI J, 1980, ARZNEIMITTEL-FORSCH, V30-1, P808; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Wei H, 2011, INT J PHARMACEUT, V403, P15, DOI 10.1016/j.ijpharm.2010.09.032; Zuhorn IS, 2002, J BIOL CHEM, V277, P18021, DOI 10.1074/jbc.M111257200	32	39	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84856	10.1371/journal.pone.0084856	http://dx.doi.org/10.1371/journal.pone.0084856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416301	Green Submitted, gold, Green Published			2022-12-25	WOS:000329862500181
J	Fortner, KB; Grotegut, CA; Ransom, CE; Bentley, RC; Feng, LP; Lan, L; Heine, RP; Seed, PC; Murtha, AP				Fortner, Kimberly B.; Grotegut, Chad A.; Ransom, Carla E.; Bentley, Rex C.; Feng, Liping; Lan, Lan; Heine, R. Phillips; Seed, Patrick C.; Murtha, Amy P.			Bacteria Localization and Chorion Thinning among Preterm Premature Rupture of Membranes	PLOS ONE			English	Article							HUMAN FETAL MEMBRANES; LOW-BIRTH-WEIGHT; LOWER UTERINE POLE; STRUCTURAL CHARACTERISTICS; ALTERED MORPHOLOGY; IDENTIFICATION; ASSOCIATION; CERVIX; LABOR; ZONE	Objective: Bacterial colonization of the fetal membranes and its role in pathogenesis of membrane rupture is poorly understood. Prior retrospective work revealed chorion layer thinning in preterm premature rupture of membranes (PPROM) subjects. Our objective was to prospectively examine fetal membrane chorion thinning and to correlate to bacterial presence in PPROM, preterm, and term subjects. Study Design: Paired membrane samples (membrane rupture and membrane distant) were prospectively collected from: PPROM = 14, preterm labor (PTL = 8), preterm no labor (PTNL = 8), term labor (TL = 10), and term no labor (TNL = 8), subjects. Sections were probed with cytokeratin to identify fetal trophoblast layer of the chorion using immunohistochemistry. Fluorescence in situ hybridization was performed using broad range 16 s ribosomal RNA probe. Images were evaluated, chorion and choriodecidua were measured, and bacterial fluorescence scored. Chorion thinning and bacterial presence were compared among and between groups using Student's t-test, linear mixed effect model, and Poisson regression model (SAS Cary, NC). Results: In all groups, the fetal chorion cellular layer was thinner at rupture compared to distant site (147.2 vs. 253.7 mm, p<0.0001). Further, chorion thinning was greatest among PPROM subjects compared to all other groups combined, regardless of site sampled [PPROM(114.9) vs. PTL(246.0) vs. PTNL(200.8) vs. TL(217.9) vs. TNL(246.5)]. Bacteria counts were highest among PPROM subjects compared to all other groups regardless of site sampled or histologic infection [PPROM(31) vs. PTL(9) vs. PTNL(7) vs. TL(7) vs. TNL(6)]. Among all subjects at both sites, bacterial counts were inversely correlated with chorion thinning, even excluding histologic chorioamnionitis (p<0.0001 and p = 0.05). Conclusions: Fetal chorion was uniformly thinner at rupture site compared to distant sites. In PPROM fetal chorion, we demonstrated pronounced global thinning. Although cause or consequence is uncertain, bacterial presence is greatest and inversely correlated with chorion thinning among PPROM subjects.	[Fortner, Kimberly B.; Ransom, Carla E.] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Nashville, TN 37232 USA; [Grotegut, Chad A.; Feng, Liping; Heine, R. Phillips; Murtha, Amy P.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Durham, NC 27710 USA; [Bentley, Rex C.] Duke Univ, Dept Pathol, Duke Univ Hosp, Durham, NC 27706 USA; [Seed, Patrick C.] Duke Univ, Dept Pediat, Duke Univ Hosp, Div Infect Dis, Durham, NC 27706 USA; [Seed, Patrick C.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Lan, Lan] Duke Univ, Duke Univ Hosp, Dept Biostat, Durham, NC USA	Vanderbilt University; Duke University; Duke University; Duke University; Duke University; Duke University	Murtha, AP (corresponding author), Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Durham, NC 27710 USA.	amy.murtha@dm.duke.edu	Heine, R. Phillips/AAR-1189-2020		Charles Hammond Foundation; M. Krzyzewski Family	Charles Hammond Foundation; M. Krzyzewski Family	This work was funded by grant from the Charles Hammond Foundation and the M. Krzyzewski Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikat S, 2006, AM J OBSTET GYNECOL, V194, P211, DOI 10.1016/j.ajog.2005.06.083; Avchen RN, 2001, AM J EPIDEMIOL, V154, P895, DOI 10.1093/aje/154.10.895; Cahill RJ, 2005, MOL HUM REPROD, V11, P761, DOI 10.1093/molehr/gah234; Canzoneri BJ FL, 2013, REPROD SCI IN PRESS; Crofts BJ, 1998, BRIT J OPHTHALMOL, V82, P9, DOI 10.1136/bjo.82.1.9; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El Khwad M, 2006, J SOC GYNECOL INVEST, V13, P191, DOI 10.1016/j.jsgi.2005.12.010; El Khwad M, 2005, BIOL REPROD, V72, P720, DOI 10.1095/biolreprod.104.033647; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; George RB, 2008, AM J PERINAT, V25, P29, DOI 10.1055/s-2007-1004828; Hamilton BE, 2010, BIRTHS PRELIMINARY D, V58; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jacobsson B, 2005, PEDIATR RES, V57, P473, DOI 10.1203/01.PDR.0000156475.50488.B0; Jones HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008205; KHONG TY, 1986, CELL TISSUE RES, V246, P189; Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49; Kobaly K, 2008, PEDIATRICS, V121, P73, DOI 10.1542/peds.2007-1444; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6; MALAK TM, 1994, BRIT J OBSTET GYNAEC, V101, P375, DOI 10.1111/j.1471-0528.1994.tb11908.x; MARTIN J, 2013, NY TIMES BK REV 1103, P15; McLaren J, 1999, HUM REPROD, V14, P237, DOI 10.1093/humrep/14.1.237; McParland PC, 2003, AM J OBSTET GYNECOL, V189, P1481, DOI 10.1067/S0002-9378(03)00585-4; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Moore RM, 2009, BIOL REPROD, V80, P781, DOI 10.1095/biolreprod.108.073205; Moutquin JM, 2003, BJOG-INT J OBSTET GY, V110, P30, DOI 10.1016/S1470-0328(03)00021-1; Murtha A P, 2002, Infect Dis Obstet Gynecol, V10, P93, DOI 10.1155/S106474490200008X; Murtha AP, 2006, AM J OBSTET GYNECOL, V195, P1249, DOI 10.1016/j.ajog.2006.09.002; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Saigal S, 2006, JAMA-J AM MED ASSOC, V295, P667, DOI 10.1001/jama.295.6.667; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Uchide N, 2005, MED SCI MONITOR, V11, pRA7; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1130, DOI 10.1067/mob.2000.109036; Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445	38	51	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83338	10.1371/journal.pone.0083338	http://dx.doi.org/10.1371/journal.pone.0083338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421883	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500043
J	Gladue, DP; Baker-Bransetter, R; Holinka, LG; Fernandez-Sainz, IJ; O'Donnell, V; Fletcher, P; Lu, ZQ; Borca, MV				Gladue, Douglas P.; Baker-Bransetter, Ryan; Holinka, Lauren G.; Fernandez-Sainz, Ignacio J.; O'Donnell, Vivian; Fletcher, Paige; Lu, Zhiqiang; Borca, Manuel V.			Interaction of CSFV E2 Protein with Swine Host Factors as Detected by Yeast Two-Hybrid System	PLOS ONE			English	Article							VIRAL-DIARRHEA-VIRUS; ENVELOPE GLYCOPROTEIN E2; FEVER VIRUS; E-RNS; DENDRITIC CELLS; VIRULENCE DETERMINANT; INFLUENZA-VIRUS; STRAIN BRESCIA; CORE PROTEIN; N-PRO	E2 is one of the envelope glycoproteins of pestiviruses, including classical swine fever virus (CSFV) and bovine viral diarrhea virus (BVDV). E2 is involved in several critical functions, including virus entry into target cells, induction of a protective immune response and virulence in swine. However, there is no information regarding any host binding partners for the E2 proteins. Here, we utilized the yeast two-hybrid system and identified fifty-seven host proteins as positive binding partners which bound E2 from both CSFV and BVDV with the exception of two proteins that were found to be positive for binding only to CSFV E2. Alanine scanning of CSFV E2 demonstrated that the binding sites for these cellular proteins on E2 are likely non-linear binding sites. The possible roles of the identified host proteins are discussed as the results presented here will be important for future studies to elucidate mechanisms of host protein-virus interactions during pestivirus infection. However, due to the limitations of the yeast two hybrid system, the proteins identified is not exhaustive and each interaction identified needs to be confirmed by independent experimental approaches in the context of virus-infected cells before any definitive conclusion can be drawn on relevance for the virus life cycle.	[Gladue, Douglas P.; Baker-Bransetter, Ryan; Holinka, Lauren G.; Fernandez-Sainz, Ignacio J.; O'Donnell, Vivian; Fletcher, Paige; Borca, Manuel V.] ARS, Plum Isl Anim Dis Ctr, USDA, Greenport, NY USA; [Gladue, Douglas P.; O'Donnell, Vivian] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA; [Lu, Zhiqiang] USDA ARS, Plum Isl Anim Dis Ctr, Dept Homeland Secur, Greenport, NY 11944 USA	United States Department of Agriculture (USDA); University of Connecticut; United States Department of Agriculture (USDA)	Borca, MV (corresponding author), ARS, Plum Isl Anim Dis Ctr, USDA, Greenport, NY USA.	manuel.borca@ars.usda.gov	Fernandez Sainz, Ignacio/I-3046-2016; Gladue, Douglas/P-6280-2018; O'Donnell, Vivian/ACY-4611-2022	Gladue, Douglas/0000-0002-7894-0233; Borca, Manuel/0000-0002-0888-1178	USDA	USDA(United States Department of Agriculture (USDA))	Funded by the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajamian L, 2008, RNA, V14, P914, DOI 10.1261/rna.829208; Becher P, 2003, VIROLOGY, V311, P96, DOI 10.1016/S0042-6822(03)00192-2; Bennett JA, 2012, J VIROL, V86, P6595, DOI 10.1128/JVI.06755-11; Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Chen LJ, 2012, RES VET SCI, V93, P529, DOI 10.1016/j.rvsc.2011.06.026; Chen WN, 2012, J VIROL, V86, P13533, DOI 10.1128/JVI.02095-12; Chernyy ES, 2011, BIOCHEMISTRY-MOSCOW+, V76, P958, DOI 10.1134/S0006297911080128; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Feng L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-175; Fernandez-Sainz I, 2010, J VIROL, V84, P1536, DOI 10.1128/JVI.02050-09; Fiebach AR, 2011, J VIROL, V85, P8002, DOI 10.1128/JVI.00330-11; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Garcin P, 2013, J PROTEOMICS, V79, P123, DOI 10.1016/j.jprot.2012.12.010; Gladue DP, 2012, J VIROL, V86, P12080, DOI 10.1128/JVI.01610-12; Gladue DP, 2010, VIROLOGY, V407, P129, DOI 10.1016/j.virol.2010.07.040; Gladue DP, 2010, VIRUS RES, V151, P10, DOI 10.1016/j.virusres.2010.03.007; Gladue DP, 2013, J VIROL; Gross H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042106; Ha SD, 2012, ANTIVIR RES, V93, P175, DOI 10.1016/j.antiviral.2011.11.009; Henke A, 2000, J VIROL, V74, P4284, DOI 10.1128/JVI.74.9.4284-4290.2000; Hong S, 2001, J VIROL, V75, P2526, DOI 10.1128/JVI.75.6.2526-2534.2001; Husser L, 2012, J INTERF CYTOK RES, V32, P221, DOI 10.1089/jir.2011.0068; Hulst M, 2013, ARCH VIROL, V158, P325, DOI 10.1007/s00705-012-1491-8; Hulst MM, 1997, J GEN VIROL, V78, P2779, DOI 10.1099/0022-1317-78-11-2779; Inoue Y, 2011, VIROLOGY, V410, P38, DOI 10.1016/j.virol.2010.10.026; Iourin O, 2013, ACTA CRYSTALLOGR F, V69, P35, DOI 10.1107/S1744309112049184; De Giusti CJ, 2011, NEUROSCI LETT, V501, P163, DOI 10.1016/j.neulet.2011.07.007; Kang K, 2012, MOL BIOL REP, V39, P10515, DOI 10.1007/s11033-012-1936-x; Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11; KONIG M, 1995, J VIROL, V69, P6479; Lee JW, 2011, J PROTEOME RES, V10, P4522, DOI 10.1021/pr200338d; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; Li J, 2010, VIRUS RES, V148, P60, DOI 10.1016/j.virusres.2009.12.004; Li Y, 2013, P NATL ACAD SCI USA, V110, P6805, DOI 10.1073/pnas.1300524110; Liang DL, 2003, J GEN VIROL, V84, P1269, DOI 10.1099/vir.0.18557-0; Lindenbach BD, 2007, FIELDS VIROLOGY, P931; Lubinski J, 1999, J EXP MED, V190, P1637, DOI 10.1084/jem.190.11.1637; Maurer K, 2004, J VIROL, V78, P1792, DOI 10.1128/JVI.78.4.1792-1799.2004; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mocquet V, 2012, J VIROL, V86, P7530, DOI 10.1128/JVI.07021-11; Park N, 2010, J BIOL CHEM, V285, P28796, DOI 10.1074/jbc.M110.143404; Py B, 2007, APOPTOSIS, V12, P1879, DOI 10.1007/s10495-007-0106-4; Reimann I, 2004, VIROLOGY, V322, P143, DOI 10.1016/j.virol.2004.01.028; Risatti GR, 2007, VIROLOGY, V364, P371, DOI 10.1016/j.virol.2007.02.025; Risatti GR, 2007, J VIROL, V81, P924, DOI 10.1128/JVI.01824-06; Risatti GR, 2006, VIROLOGY, V355, P94, DOI 10.1016/j.virol.2006.07.005; Risatti GR, 2005, J VIROL, V79, P3787, DOI 10.1128/JVI.79.6.3787-3796.2005; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sato S, 2012, ANN NY ACAD SCI, V1253, P133, DOI 10.1111/j.1749-6632.2012.06475.x; Schmidt T, 2010, FEBS LETT, V584, P4361, DOI 10.1016/j.febslet.2010.09.038; Severino A, 2007, J CELL PHYSIOL, V212, P118, DOI 10.1002/jcp.21011; Shiozaki T, 2011, J GEN VIROL, V92, P315, DOI 10.1099/vir.0.028316-0; Sivan G, 2013, P NATL ACAD SCI USA, V110, P3519, DOI 10.1073/pnas.1300708110; THIEL HJ, 1991, J VIROL, V65, P4705, DOI 10.1128/JVI.65.9.4705-4712.1991; van Gennip HGP, 2000, VACCINE, V19, P447, DOI 10.1016/S0264-410X(00)00198-5; van Gennip HGP, 2004, J VIROL, V78, P8812, DOI 10.1128/JVI.78.16.8812-8823.2004; van Gennip HGP, 2002, VACCINE, V20, P1544, DOI 10.1016/S0264-410X(01)00497-2; Wang Z, 2004, VIROLOGY, V330, P332, DOI 10.1016/j.virol.2004.09.023; WEILAND E, 1990, J VIROL, V64, P3563, DOI 10.1128/JVI.64.8.3563-3569.1990; Weiland F, 1999, J GEN VIROL, V80, P1157, DOI 10.1099/0022-1317-80-5-1157; Woodward AM, 2013, J VIROL, V87, P5841, DOI 10.1128/JVI.00166-13; Yoshii H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019352; Zaichick SV, 2013, CELL HOST MICROBE, V13, P193, DOI 10.1016/j.chom.2013.01.009	67	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85324	10.1371/journal.pone.0085324	http://dx.doi.org/10.1371/journal.pone.0085324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416391	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500240
J	Koolschijn, PCMP; Peper, JS; Crone, EA				Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.			The Influence of Sex Steroids on Structural Brain Maturation in Adolescence	PLOS ONE			English	Article							RIGHT ANTERIOR CINGULATE; HUMAN CEREBRAL-CORTEX; DIURNAL RHYTHM; TESTOSTERONE SECRETION; SALIVARY TESTOSTERONE; CORTICAL MATURATION; MENSTRUAL-CYCLE; HEALTHY GIRLS; WHITE-MATTER; GRAY-MATTER	Puberty reflects a period of hormonal changes, physical maturation and structural brain reorganization. However, little attention has been paid to what extent sex steroids and pituitary hormones are associated with the refinement of brain maturation across adolescent development. Here we used high-resolution structural MRI scans from 215 typically developing individuals between ages 8-25, to examine the association between cortical thickness, surface area and (sub) cortical brain volumes with luteinizing hormone, testosterone and estradiol, and pubertal stage based on self-reports. Our results indicate sex-specific differences in testosterone related influences on gray matter volumes of the anterior cingulate cortex after controlling for age effects. No significant associations between subcortical structures and sex hormones were found. Pubertal stage was not a stronger predictor than chronological age for brain anatomical differences. Our findings indicate that sex steroids are associated with cerebral gray matter morphology in a sex specific manner. These hormonal and morphological differences may explain in part differences in brain development between boys and girls.	[Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.] Leiden Univ, Brain & Dev Lab, Inst Psychol, Leiden, Netherlands; [Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Koolschijn, P. Cedric M. P.] Univ Amsterdam, Amsterdam, Netherlands; [Crone, Eveline A.] Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); University of Amsterdam; University of Amsterdam	Koolschijn, PCMP (corresponding author), Leiden Univ, Brain & Dev Lab, Inst Psychol, Leiden, Netherlands.	koolschijnpcmp@gmail.com		Koolschijn, P Cedric/0000-0002-0625-1447; Crone, Eveline/0000-0002-7508-6078	Netherlands Organization for Scientific Research (NWO) [451-10-007]; European Research Council (ERC) [2010-StG-263234]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by Netherlands Organization for Scientific Research (NWO) Innovational research grant 451-10-007(JSP), and an European Research Council (ERC) starting grant 2010-StG-263234(EAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankarberg C, 1999, J CLIN ENDOCR METAB, V84, P975, DOI 10.1210/jc.84.3.975; Ankarberg-Lindgren C, 2004, EUR J ENDOCRINOL, V151, P747, DOI 10.1530/eje.0.1510747; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Blanton RE, 2012, NEUROSCIENCE, V217, P105, DOI 10.1016/j.neuroscience.2012.04.059; Boes AD, 2008, BEHAV NEUROSCI, V122, P677, DOI 10.1037/0735-7044.122.3.677; Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Bramen JE, 2011, CEREB CORTEX, V21, P636, DOI 10.1093/cercor/bhq137; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Bukovsky Antonin, 2003, Reprod Biol Endocrinol, V1, P13, DOI 10.1186/1477-7827-1-13; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Crone EA, 2011, DEV COGN NEUROS-NETH, V1, P101, DOI 10.1016/j.dcn.2010.12.001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Ronde W, 2011, PHARMACOTHERAPY, V31, P248, DOI 10.1592/phco.31.3.248; de Water E, 2013, HORM BEHAV, V63, P392, DOI 10.1016/j.yhbeh.2012.11.018; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dorn L. D., 2006, APPL DEV SCI, V10, P30, DOI [10.1207/s1532480xads1001_3, DOI 10.1207/S1532480XADS1001_3]; Ducharme S, 2011, BIOL PSYCHIAT, V70, P283, DOI 10.1016/j.biopsych.2011.03.015; Estrada M, 2006, J BIOL CHEM, V281, P25492, DOI 10.1074/jbc.M603193200; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Giedd JN, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-19; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; Granger DA, 2003, DEV PSYCHOPATHOL, V15, P431, DOI 10.1017/S0954579403000233; Haberecht MF, 2001, HUM BRAIN MAPP, V14, P96, DOI 10.1002/hbm.1044; Hagemann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014655; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Josephs RA, 2006, J PERS SOC PSYCHOL, V90, P999, DOI 10.1037/0022-3514.90.6.999; Kesner JS, 1998, HUM REPROD, V13, P15, DOI 10.1093/humrep/13.1.15; Koolschijn PCMP, 2013, DEV COGN NEUROS-NETH, V5, P106, DOI 10.1016/j.dcn.2013.02.003; LEI ZM, 1993, ENDOCRINOLOGY, V132, P2262, DOI 10.1210/en.132.5.2262; Lombardo MV, 2012, J NEUROSCI, V32, P674, DOI 10.1523/JNEUROSCI.4389-11.2012; Luna B, 2009, ADV CHILD DEV BEHAV, V37, P233, DOI 10.1016/S0065-2407(09)03706-9; McCall C, 2012, NAT NEUROSCI, V15, P681, DOI 10.1038/nn.3084; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mehta PH, 2008, J PERS SOC PSYCHOL, V94, P1078, DOI 10.1037/0022-3514.94.6.1078; Mehta PH, 2010, J COGNITIVE NEUROSCI, V22, P2357, DOI 10.1162/jocn.2009.21389; Mihm M, 2011, ANIM REPROD SCI, V124, P229, DOI 10.1016/j.anireprosci.2010.08.030; Mueller SC, 2013, J NEUROENDOCRINOL, V25, P762, DOI 10.1111/jne.12048; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Norjavaara E, 1996, J CLIN ENDOCR METAB, V81, P4095, DOI 10.1210/jc.81.11.4095; Op de Macks ZA, 2011, DEV COGN NEUROS-NETH, V1, P506, DOI 10.1016/j.dcn.2011.06.003; Ossewaarde L, 2013, HUM BRAIN MAPP, V34, P1187, DOI 10.1002/hbm.21502; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Peper JS, 2008, PSYCHONEUROENDOCRINO, V33, P909, DOI 10.1016/j.psyneuen.2008.03.017; Peper JS, 2013, CURR DIR PSYCHOL SCI, V22, P134, DOI 10.1177/0963721412473755; Peper JS, 2012, J NEUROSCI, V32, P6745, DOI 10.1523/JNEUROSCI.1012-12.2012; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Peper JS, 2013, J COGN NEUR IN PRESS; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; PETERSEN AC, 1988, ANNU REV PSYCHOL, V39, P583, DOI 10.1146/annurev.psych.39.1.583; Raznahan A, 2010, P NATL ACAD SCI USA, V107, P16988, DOI 10.1073/pnas.1006025107; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; van Bokhoven I, 2006, HORM BEHAV, V50, P118, DOI 10.1016/j.yhbeh.2006.02.002; Van Leijenhorst L, 2008, DEV NEUROPSYCHOL, V33, P179, DOI 10.1080/87565640701884287; van Wingen G, 2010, PSYCHONEUROENDOCRINO, V35, P105, DOI 10.1016/j.psyneuen.2009.09.007; Veldhuis JD, 1996, PEDIATR NEPHROL, V10, P304; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Witte AV, 2010, NEUROIMAGE, V49, P1205, DOI 10.1016/j.neuroimage.2009.09.046; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358	75	65	68	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83929	10.1371/journal.pone.0083929	http://dx.doi.org/10.1371/journal.pone.0083929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416184	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500086
J	Nagumo, K; Tanaka, M; Chuang, VTG; Setoyama, H; Watanabe, H; Yamada, N; Kubota, K; Tanaka, M; Matsushita, K; Yoshida, A; Jinnouchi, H; Anraku, M; Kadowaki, D; Ishima, Y; Sasaki, Y; Otagiri, M; Maruyama, T				Nagumo, Kohei; Tanaka, Motohiko; Chuang, Victor Tuan Giam; Setoyama, Hiroko; Watanabe, Hiroshi; Yamada, Naoyuki; Kubota, Kazuyuki; Tanaka, Motoko; Matsushita, Kazutaka; Yoshida, Akira; Jinnouchi, Hideaki; Anraku, Makoto; Kadowaki, Daisuke; Ishima, Yu; Sasaki, Yutaka; Otagiri, Masaki; Maruyama, Toru			Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HEMODIALYSIS-PATIENTS; LIGAND-BINDING; SULFENIC ACID; REDOX STATE; PROTEIN; DYSFUNCTION	The degree of oxidized cysteine (Cys) 34 in human serum albumin (HSA), as determined by high performance liquid chromatography (HPLC), is correlated with oxidative stress related pathological conditions. In order to further characterize the oxidation of Cys34-HSA at the molecular level and to develop a suitable analytical method for a rapid and sensitive clinical laboratory analysis, the use of electrospray ionization time-of-flight mass spectrometer (ESI-TOFMS) was evaluated. A marked increase in the cysteinylation of Cys34 occurs in chronic liver and kidney diseases and diabetes mellitus. A significant positive correlation was observed between the Cys-Cys34-HSA fraction of plasma samples obtained from 229 patients, as determined by ESI-TOFMS, and the degree of oxidized Cys34-HSA determined by HPLC. The Cys-Cys34-HSA fraction was significantly increased with the progression of liver cirrhosis, and was reduced by branched chain amino acids (BCAA) treatment. The changes in the Cys-Cys34-HSA fraction were significantly correlated with the alternations of the plasma levels of advanced oxidized protein products, an oxidative stress marker for proteins. The binding ability of endogenous substances (bilirubin and tryptophan) and drugs (warfarin and diazepam) to HSA purified from chronic liver disease patients were significantly suppressed but significantly improved by BCAA supplementation. Interestingly, the changes in this physiological function of HSA in chronic liver disease were correlated with the Cys-Cys34-HSA fraction. In conclusion, ESI-TOFMS is a suitable high throughput method for the rapid and sensitive quantification of Cys-Cys34-HSA in a large number of samples for evaluating oxidative stress related chronic disease progression or in response to a treatment.	[Nagumo, Kohei; Watanabe, Hiroshi; Kadowaki, Daisuke; Ishima, Yu; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, Kumamoto, Japan; [Tanaka, Motohiko; Setoyama, Hiroko; Sasaki, Yutaka] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol & Hepatol, Chuo Ku, Kumamoto, Japan; [Chuang, Victor Tuan Giam] Curtin Univ, Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA 6845, Australia; [Watanabe, Hiroshi; Kadowaki, Daisuke; Ishima, Yu; Maruyama, Toru] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Chuo Ku, Kumamoto, Japan; [Yamada, Naoyuki; Kubota, Kazuyuki] Ajinomoto Co Inc, Inst Innovat, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Tanaka, Motoko; Matsushita, Kazutaka] Akebono Clin, Dept Nephrol, Minami Ku, Kumamoto, Japan; [Yoshida, Akira; Jinnouchi, Hideaki] Diabet Care Ctr, Jinnouchi Clin, Chuo Ku, Kumamoto, Japan; [Anraku, Makoto; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto, Japan; [Otagiri, Masaki] Sojo Univ, DDS Res Inst, Nishi Ku, Kumamoto, Japan	Kumamoto University; Kumamoto University; Curtin University; Kumamoto University; Ajinomoto Co Inc; Sojo University; Sojo University	Maruyama, T (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, Kumamoto, Japan.	tomaru@gpo.kumamoto-u.ac.jp	Chuang, Victor/A-3644-2011; Anraku, Makoto/AAA-3935-2020; Chuang, Victor/A-3644-2011	Chuang, Victor/0000-0002-2141-630X; Chuang, Victor/0000-0003-4543-2256; Kadowaki, Daisuke/0000-0001-5166-7145				Alvarez B, 2010, METHOD ENZYMOL, V473, P117, DOI 10.1016/S0076-6879(10)73005-6; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; Anraku M, 2004, KIDNEY INT, V66, P841, DOI 10.1111/j.1523-1755.2004.00813.x; Anraku M, 2013, BIOCH BIOPHYS ACTA; Anraku M, 2008, CLIN BIOCHEM, V41, P1168, DOI 10.1016/j.clinbiochem.2008.07.007; Anraku M, 2011, J PHARM SCI-US, V100, P3968, DOI 10.1002/jps.22571; Boisvert MR, 2010, ANAL CHEM, V82, P1133, DOI 10.1021/ac902322w; Borges CR, 2011, CLIN CHEM, V57, P719, DOI 10.1373/clinchem.2010.156976; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Descamps-Latscha B, 2001, KIDNEY INT, V59, pS108; Furusyo N, 2013, BIOCH BIOPHYS ACTA; Ichikawa K, 2012, MOL BIOL REP, V39, P10803, DOI 10.1007/s11033-012-1974-4; Iwao Y, 2012, IUBMB LIFE, V64, P450, DOI 10.1002/iub.567; JAGANNATHAN V, 1995, BIOMED CHROMATOGR, V9, P305, DOI 10.1002/bmc.1130090626; Jalan R, 2009, HEPATOLOGY, V50, P555, DOI 10.1002/hep.22913; Kadowaki D, 2007, HYPERTENS RES, V30, P395, DOI 10.1291/hypres.30.395; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Kubota Kazuyuki, 2009, Int J Biomed Sci, V5, P293; Kuwahata M, 2008, J NUTR BIOCHEM, V19, P438, DOI 10.1016/j.jnutbio.2007.05.011; Mera K, 2005, BIOCHEM BIOPH RES CO, V334, P1322, DOI 10.1016/j.bbrc.2005.07.035; Mera K, 2010, J PHARM SCI-US, V99, P1614, DOI 10.1002/jps.21927; Minomo A, 2011, FEBS J, V278, P4100, DOI 10.1111/j.1742-4658.2011.08316.x; Musante L, 2007, J AM SOC NEPHROL, V18, P799, DOI 10.1681/ASN.2006090965; Narazaki R, 1997, PHARMACEUT RES, V14, P351, DOI 10.1023/A:1012006306915; Nishitani S, 2004, BIOCHEM BIOPH RES CO, V313, P387, DOI 10.1016/j.bbrc.2003.11.023; Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251; Oettl K, 2013, J HEPATOL; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Regazzoni L, 2013, FREE RADICAL RES, V47, P172, DOI 10.3109/10715762.2012.756139; Sengupta S, 2001, J BIOL CHEM, V276, P30111, DOI 10.1074/jbc.M104324200; Shimoishi K, 2007, PHARM RES-DORDR, V24, P1283, DOI 10.1007/s11095-007-9248-x; SOGAMI M, 1985, J CHROMATOGR, V332, P19, DOI 10.1016/S0021-9673(01)83283-0; TAKIKAWA H, 1987, BIOCHIM BIOPHYS ACTA, V926, P145, DOI 10.1016/0304-4165(87)90231-5; Terawaki H, 2004, KIDNEY INT, V66, P1988, DOI 10.1111/j.1523-1755.2004.00969.x; Terawaki H, 2012, CLIN EXP NEPHROL, V16, P629, DOI 10.1007/s10157-012-0610-x; Watanabe H, 2000, BIOCHEM J, V349, P813, DOI 10.1042/bj3490813; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Yamasaki K, 2013, BIOCH BIOPHYS ACTA	40	109	113	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85216	10.1371/journal.pone.0085216	http://dx.doi.org/10.1371/journal.pone.0085216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416365	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500228
J	Zhang, WJ; Niu, Y; Bu, SH; Li, M; Feng, JY; Zhang, J; Yang, SX; Odinga, MM; Wei, SP; Liu, XF; Zhang, YM				Zhang, Wen-Jie; Niu, Yuan; Bu, Su-Hong; Li, Meng; Feng, Jian-Ying; Zhang, Jin; Yang, Sheng-Xian; Odinga, Medrine Mmayi; Wei, Shi-Ping; Liu, Xiao-Feng; Zhang, Yuan-Ming			Epistatic Association Mapping for Alkaline and Salinity Tolerance Traits in the Soybean Germination Stage	PLOS ONE			English	Article							GLYCINE-SOJA SIEB.; SALT TOLERANCE; ARABIDOPSIS-THALIANA; LINKAGE DISEQUILIBRIUM; GENETIC ARCHITECTURE; QTL; MAIZE; LOCUS; RICE; PROTEIN	Soil salinity and alkalinity are important abiotic components that frequently have critical effects on crop growth, productivity and quality. Developing soybean cultivars with high salt tolerance is recognized as an efficient way to maintain sustainable soybean production in a salt stress environment. However, the genetic mechanism of the tolerance must first be elucidated. In this study, 257 soybean cultivars with 135 SSR markers were used to perform epistatic association mapping for salt tolerance. Tolerance was evaluated by assessing the main root length (RL), the fresh and dry weights of roots (FWR and DWR), the biomass of seedlings (BS) and the length of hypocotyls (LH) of healthy seedlings after treatments with control, 100 mM NaCl or 10 mM Na2CO3 solutions for approximately one week under greenhouse conditions. A total of 83 QTL-by-environment (QE) interactions for salt tolerance index were detected: 24 for LR, 12 for FWR, 11 for DWR, 15 for LH and 21 for BS, as well as one epistatic QTL for FWR. Furthermore, 86 QE interactions for alkaline tolerance index were found: 17 for LR, 16 for FWR, 17 for DWR, 18 for LH and 18 for BS. A total of 77 QE interactions for the original trait indicator were detected: 17 for LR, 14 for FWR, 4 for DWR, 21 for LH and 21 for BS, as well as 3 epistatic QTL for BS. Small-effect QTL were frequently observed. Several soybean genes with homology to Arabidopsis thaliana and soybean salt tolerance genes were found in close proximity to the above QTL. Using the novel alleles of the QTL detected above, some elite parental combinations were designed, although these QTL need to be further confirmed. The above results provide a valuable foundation for fine mapping, cloning and molecular breeding by design for soybean alkaline and salt tolerance.	[Zhang, Wen-Jie; Niu, Yuan; Bu, Su-Hong; Li, Meng; Feng, Jian-Ying; Zhang, Jin; Yang, Sheng-Xian; Odinga, Medrine Mmayi; Wei, Shi-Ping; Liu, Xiao-Feng; Zhang, Yuan-Ming] Nanjing Agr Univ, Sect Stat Genom, State Key Lab Crop Genet & Germplasm Enhancement, Dept Crop Genet & Breeding, Nanjing, Jiangsu, Peoples R China; [Zhang, Wen-Jie] Ningxia Acad Agr & Forestry Sci, Inst Crop Res, Yinchuan, Ningxia, Peoples R China	Nanjing Agricultural University	Zhang, YM (corresponding author), Nanjing Agr Univ, Sect Stat Genom, State Key Lab Crop Genet & Germplasm Enhancement, Dept Crop Genet & Breeding, Nanjing, Jiangsu, Peoples R China.	soyzhang@njau.edu.cn	Zhang, Yuan-Ming/AFQ-8637-2022; Zhang, Yuan-Ming/AAT-2899-2021	Zhang, Yuan-Ming/0000-0003-2317-2190	National Basic Research Program of China [2011CB109306]; National Natural Science Foundation of China [30971848, 31301004, 31301229]; Fundamental Research Funds for the Central Universities [KYT201002, KYZ201202-9]; Specialized Research Fund for the Doctoral Program of Higher Education [20100097110035, 20120097110023]; 111 project [B08025]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); 111 project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grant 2011CB109306 from the National Basic Research Program of China; grants 30971848, 31301004, and 31301229 from the National Natural Science Foundation of China; grants KYT201002 and KYZ201202-9 from the Fundamental Research Funds for the Central Universities; grants 20100097110035 and 20120097110023 from Specialized Research Fund for the Doctoral Program of Higher Education; 111 project (B08025); and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL GEORGE, 1964, CROP SCI, V4, P157, DOI 10.2135/cropsci1964.0011183X000400020010x; ABEL GH, 1969, CROP SCI, V9, P697, DOI 10.2135/cropsci1969.0011183X000900060006x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bianchi-Hall CM, 2000, CROP SCI, V40, P538, DOI 10.2135/cropsci2000.402538x; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Chen HT, 2008, AUST J AGR RES, V59, P1086, DOI 10.1071/AR08104; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Cho Youngkoo, 2002, Journal of Biomedicine & Biotechnology, V2, P151, DOI 10.1155/S1110724302204039; Clerkx EJM, 2004, PLANT PHYSIOL, V135, P432, DOI 10.1104/pp.103.036814; Cui ZL, 1999, RELEASED CHINESE SOY; DeRose-Wilson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022832; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Foolad MR, 1997, MOL BREEDING, V3, P269, DOI 10.1023/A:1009668325331; Genc Y, 2010, THEOR APPL GENET, V121, P877, DOI 10.1007/s00122-010-1357-y; Hamwieh A, 2011, EUPHYTICA, V179, P451, DOI 10.1007/s10681-011-0347-8; Hamwieh A, 2008, BREEDING SCI, V58, P355, DOI 10.1270/jsbbs.58.355; Hansen M, 2001, GENET RES, V77, P61, DOI 10.1017/S0016672300004857; Hauser MT, 2001, MOL BIOL EVOL, V18, P1754, DOI 10.1093/oxfordjournals.molbev.a003963; He XH, 2011, THEOR APPL GENET, V122, P33, DOI 10.1007/s00122-010-1420-8; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Jun TH, 2008, EUPHYTICA, V162, P179, DOI 10.1007/s10681-007-9491-6; Kaman H, 2011, J FOOD AGRIC ENVIRON, V9, P648; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Lam HM, 2009, RES TOLERANCE STRESS; Lee GJ, 2004, THEOR APPL GENET, V109, P1610, DOI 10.1007/s00122-004-1783-9; Lee JD, 2009, J HERED, V100, P798, DOI 10.1093/jhered/esp027; Li M, 2011, THESIS NANJING AGR U; Li YH, 2011, CONSERV GENET, V12, P1145, DOI 10.1007/s10592-011-0216-y; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Lipp M, 1999, J AOAC INT, V82, P923; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Lu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017773; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Niu Y, 2013, MOL BREEDING, V31, P785, DOI 10.1007/s11032-012-9833-5; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; PARKER MB, 1987, J PLANT NUTR, V10, P517, DOI 10.1080/01904168709363589; Pritchard JK, 2000, GENETICS, V155, P945; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quesada V, 2002, PLANT PHYSIOL, V130, P951, DOI 10.1104/pp.006536; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Ren ZH, 2010, P NATL ACAD SCI USA, V107, P5669, DOI 10.1073/pnas.0910798107; Shao G. H., 1994, Acta Agronomica Sinica, V20, P721; Sharma AD, 2011, THEOR APPL GENET, V122, P687, DOI 10.1007/s00122-010-1478-3; Shi H, 2010, P NATL ACAD SCI USA, V97, P6896; Singh RK, 2008, NATL ACAD SCI LETT, V31, P281; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Thomson MJ, 2010, RICE, V3, P148, DOI 10.1007/s12284-010-9053-8; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tuyen DD, 2010, THEOR APPL GENET, V121, P229, DOI 10.1007/s00122-010-1304-y; Uwatoko N, 2008, EUPHYTICA, V163, P167, DOI 10.1007/s10681-007-9584-2; Wang J, 2008, THEOR APPL GENET, V116, P777, DOI 10.1007/s00122-008-0710-x; Wang ZF, 2011, EUPHYTICA, V178, P297, DOI 10.1007/s10681-010-0287-8; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Xu Y, 2011, THEOR APPL GENET, V122, P581, DOI 10.1007/s00122-010-1471-x; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Zhang YM, 2005, GENETICS, V169, P2267, DOI 10.1534/genetics.104.033217; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	61	19	26	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84750	10.1371/journal.pone.0084750	http://dx.doi.org/10.1371/journal.pone.0084750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416275	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500158
J	Koag, MC; Min, K; Lee, S				Koag, Myong-Chul; Min, Kyungjin; Lee, Seongmin			Structural Basis for Promutagenicity of 8-Halogenated Guanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Polymerase; DNA Repair; Enzyme Structure; Protein Structure; X-ray Crystallography	DNA-POLYMERASE-BETA; ACTIVE-SITE; HYPOCHLOROUS ACID; CRYSTAL-STRUCTURE; INTERMEDIATE; INFLAMMATION; NUCLEOTIDE; SYSTEM; DAMAGE; MYELOPEROXIDASE	Background: 8-Halogenated guanine is a promutagenic lesion that promotes insertion of guanine opposite the lesion during DNA replication. Results: 8-Bromoguanine forms Hoogsteen base pairing with G and Watson-Crick base pairing with C in the active site of pol. Conclusion: 8-Bromoguanine is well accommodated in the nascent base pair binding pocket of pol. Significance: Our structural studies provide insights into potential G to C mutations. 8-Halogenated guanine (haloG), a major DNA adduct formed by reactive halogen species during inflammation, is a promutagenic lesion that promotes misincorporation of G opposite the lesion by various DNA polymerases. Currently, the structural basis for such misincorporation is unknown. To gain insights into the mechanism of misincorporation across haloG by polymerase, we determined seven x-ray structures of human DNA polymerase (pol) bound to DNA bearing 8-bromoguanine (BrG). We determined two pre-catalytic ternary complex structures of pol with an incoming nonhydrolyzable dGTP or dCTP analog paired with templating BrG. We also determined five binary complex structures of pol in complex with DNA containing BrGC/T at post-insertion and post-extension sites. In the BrGdGTP ternary structure, BrG adopts syn conformation and forms Hoogsteen base pairing with the incoming dGTP analog. In the BrGdCTP ternary structure, BrG adopts anti conformation and forms Watson-Crick base pairing with the incoming dCTP analog. In addition, our pol binary post-extension structures show Hoogsteen BrGG base pair and Watson-Crick BrGC base pair. Taken together, the first structures of haloG-containing DNA bound to a protein indicate that both BrGG and BrGC base pairs are accommodated in the active site of pol. Our structures suggest that Hoogsteen-type base pairing between G and C8-modified G could be accommodated in the active site of a DNA polymerase, promoting G to C mutation.	[Koag, Myong-Chul; Min, Kyungjin; Lee, Seongmin] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Lee, S (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, 2409 Univ Ave, Austin, TX 78712 USA.	seongminlee@austin.utexas.edu	Lee, Seongmin/AAR-2499-2021		College of Pharmacy at the University of Texas at Austin; Robert Welch Foundation (Welch Grant) [F-1741]	College of Pharmacy at the University of Texas at Austin; Robert Welch Foundation (Welch Grant)(The Welch Foundation)	This work was supported by grants from a start-up fund from the College of Pharmacy at the University of Texas at Austin and the Robert Welch Foundation (Welch Grant F-1741).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asahi T, 2010, J BIOL CHEM, V285, P9282, DOI 10.1074/jbc.M109.054213; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2013, J AM CHEM SOC, V135, P8078, DOI 10.1021/ja403842j; Batra VK, 2012, P NATL ACAD SCI USA, V109, P113, DOI 10.1073/pnas.1112235108; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Batra VK, 2005, STRUCTURE, V13, P1225, DOI 10.1016/j.str.2005.05.010; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Clausen AR, 2013, P NATL ACAD SCI USA, V110, P16802, DOI 10.1073/pnas.1309119110; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Efrati E, 1999, J BIOL CHEM, V274, P15920, DOI 10.1074/jbc.274.22.15920; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Freudenthal BD, 2013, NUCLEIC ACIDS RES, V41, P1848, DOI 10.1093/nar/gks1276; Freudenthal BD, 2012, STRUCTURE, V20, P1829, DOI 10.1016/j.str.2012.08.008; Fujikawa K, 2002, FEBS LETT, V512, P149, DOI 10.1016/S0014-5793(02)02240-8; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Kino K, 2001, CHEM BIOL, V8, P369, DOI 10.1016/S1074-5521(01)00019-9; Kirby TW, 2012, NUCLEIC ACIDS RES, V40, P2974, DOI 10.1093/nar/gkr1218; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Lin P, 2008, P NATL ACAD SCI USA, V105, P5670, DOI 10.1073/pnas.0801257105; Masuda M, 2001, J BIOL CHEM, V276, P40486, DOI 10.1074/jbc.M102700200; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan B, 2006, P NATL ACAD SCI USA, V103, P3130, DOI 10.1073/pnas.0507730103; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Ravelli RBG, 2003, STRUCTURE, V11, P217, DOI 10.1016/S0969-2126(03)00006-6; Sassa A, 2011, J MOL BIOL, V406, P679, DOI 10.1016/j.jmb.2011.01.005; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Stanley NR, 2010, CHEM RES TOXICOL, V23, P1293, DOI 10.1021/tx100188b; Stathis D, 2012, J AM CHEM SOC, V134, P4925, DOI 10.1021/ja211435d; Suzuki T, 2002, NUCLEIC ACIDS RES, V30, P2555, DOI 10.1093/nar/30.11.2555; Valinluck V, 2007, CANCER RES, V67, P5583, DOI 10.1158/0008-5472.CAN-07-0846; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; Yang LJ, 2004, J AM CHEM SOC, V126, P8441, DOI 10.1021/ja049412o; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109; Zhong XJ, 1998, J AM CHEM SOC, V120, P235, DOI 10.1021/ja973507r	45	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6289	6298		10.1074/jbc.M113.537803	http://dx.doi.org/10.1074/jbc.M113.537803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425881	hybrid, Green Published			2022-12-25	WOS:000332015500080
J	Ahmed, S; Xie, J; Horne, D; Williams, JC				Ahmed, Shubbir; Xie, Jun; Horne, David; Williams, John C.			Photocleavable Dimerizer for the Rapid Reversal of Molecular Trap Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dynein; Endosomes; Microscopy; Microtubules; Signaling; Molecular Trap; Organelle; Photocleavable Antagonist	DYNEIN; DYNACTIN; SPECIFICITY; ACTIVATION; APOPTOSIS; SUBUNITS; PROTEIN; CELLS	Background: The ability to rapidly turn on and off an acute antagonist is helpful to understand the initiation of a cellular program. Results: A photocleavable analog was produced and functionally demonstrated. Conclusion: Fine temporal control of endosome dispersion and restoration was obtained. Significance: The combination of traps and the photocleavable analog permits new avenues to study signaling within a single cell in an organism. Herein, we report the development of a photocleavable analog of AP20187, a cell-permeable molecule used to dimerize FK506-binding protein (FKBP) fusion proteins and initiate biological signaling cascades and gene expression or disrupt protein-protein interactions. We demonstrate that this reagent permits the unique ability to rapidly and specifically antagonize a molecular interaction in vitro and follow a biological process due to this acute antagonism (e.g. endosome dispersion) and to release the trap upon photocleavage to follow the cell's return to homeostasis. In addition, this photocleavable AP20187 analog can be used in other systems where the dimerization of FKBP has been used to initiate signaling pathways, offering the ability to correlate the duration of a signaling event and a cellular response.	[Ahmed, Shubbir; Xie, Jun; Horne, David; Williams, John C.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Williams, JC (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, 1710 Flower Ave, Duarte, CA 91010 USA.	jcwilliams@coh.org	Ahmed, Shubbir/AAC-4289-2019	Ahmed, Shubbir/0000-0003-1655-6735	National Institutes of Health [R21NS071166]; National Institutes of Health from the NCI [P30 CA033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21NS071166 (to J. C. W.) and National Institutes of Health Grant P30 CA033572 from the NCI (to Michael A. Friedman).	Abdel-Azim H, 2008, BLOOD, V111, P4064, DOI 10.1182/blood-2007-08-107466; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Beland M, 2012, J NEUROSCI, V32, P13255, DOI 10.1523/JNEUROSCI.2236-12.2012; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; DeRose R., 2012, J VIS EXP, V61, P3794; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Dixon SJ, 2009, CURR OPIN CHEM BIOL, V13, P549, DOI 10.1016/j.cbpa.2009.08.003; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; HASTINGS RJ, 1983, BRIT J CANCER, V47, P233, DOI 10.1038/bjc.1983.31; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; Piggott AM, 2005, MOLECULES, V10, P1292, DOI 10.3390/10101292; Roostaee A, 2009, J BIOL CHEM, V284, P30907, DOI 10.1074/jbc.M109.057950; Rothman JE, 2010, MOL BIOL CELL, V21, P3776, DOI 10.1091/mbc.E10-05-0418; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Umeda N, 2011, J AM CHEM SOC, V133, P12, DOI 10.1021/ja108258d; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396; Zhapparova ON, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1233, DOI 10.1134/S0006297907110090; Zlatic SA, 2011, MOL BIOL CELL, V22, P1699, DOI 10.1091/mbc.E10-10-0799	23	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4546	4552		10.1074/jbc.C113.513622	http://dx.doi.org/10.1074/jbc.C113.513622			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24421317	Green Published, hybrid			2022-12-25	WOS:000331607900001
J	Lee, MY; Hsiao, PJ; Yang, YH; Lin, KD; Shin, SJ				Lee, Mei-Yueh; Hsiao, Pi-Jung; Yang, Yi-Hsin; Lin, Kun-Der; Shin, Shyi-Jang			The Association of Pioglitazone and Urinary Tract Disease in Type 2 Diabetic Taiwanese: Bladder Cancer and Chronic Kidney Disease	PLOS ONE			English	Article							BLOOD-CELL COUNT; RENAL-INSUFFICIENCY; CARDIOVASCULAR OUTCOMES; INFLAMMATION; PHARMACOKINETICS; DIFFERENTIATION; BIOMARKERS; PREDICTOR; MORTALITY; CORONARY	Objective: Although studies have shown an association between pioglitazone and bladder cancer, the associated factors have not been identified. The aim of this study was to investigate the factors that may link pioglitazone to bladder cancer. Materials and Methods: In total, 34,970 study subjects were identified from the National Health Insurance Research Database in 2003 with follow-up from 2005 to 2009. The demographic characteristics of patients who had used and had never used pioglitazone, including age, sex, diabetes duration, urinary tract disease, nephropathy, bladder cancer, and cumulative dose and duration of pioglitazone therapy, were analyzed using the chi 2 test. Cox proportional hazard regression models were used to determine the independent effects of pioglitazone on bladder cancer and newly developed chronic kidney disease. Results: Among 3,497 ever users and 31,473 never users of pioglitazone, the respective incident cases of bladder cancer were 12 (0.4%) and 72 (0.2%), and for newly developed chronic kidney disease 245 (8.1%) and 663 (2.3%), respectively. Ever use of pioglitazone [1.59(1.32-1.91)], cumulative dose of pioglitazone <10,500 mg [1.69 (1.37-2.01)] and >10,500 mg [1.34 (1.04-1.73)], and duration of therapy <12 months [1.68 (1.36-2.08)] and >12 months [1.39 (1.09-1.76)] were associated with the development of chronic kidney disease. Conclusions: There was no association of pioglitazone use with bladder cancer development, however, there was an association with an increased risk of newly developed chronic kidney disease.	[Lee, Mei-Yueh] Kaohsiung Municipal Hsiaokang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Mei-Yueh; Hsiao, Pi-Jung; Lin, Kun-Der; Shin, Shyi-Jang] Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Mei-Yueh; Hsiao, Pi-Jung; Lin, Kun-Der; Shin, Shyi-Jang] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ, Grad Inst Med Genet, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ Hosp, Dept Clin Res, Stat Anal Lab, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Shin, SJ (corresponding author), Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Kaohsiung, Taiwan.	sjshin@kmu.edu.tw	Yang, Yi-Hsin/D-6471-2012	Yang, Yi-Hsin/0000-0002-9581-2778; Hsiao, Pi-Jung/0000-0001-5024-9371	Department of Internal Medicine, Kaohsiung Medical University Hospital	Department of Internal Medicine, Kaohsiung Medical University Hospital	This study was funded by the Department of Internal Medicine, Kaohsiung Medical University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Cengiz Kuddusi, 2002, International Urology and Nephrology, V33, P121; Chapelsky MC, 2003, J CLIN PHARMACOL, V43, P252, DOI 10.1177/0091270002250602; Cohen SM, 1998, TOXICOL PATHOL, V26, P121, DOI 10.1177/019262339802600114; COHEN SM, 1995, FOOD CHEM TOXICOL, V33, P715, DOI 10.1016/0278-6915(95)00040-9; Cohen SM, 1999, IARC SCI PUBL, P175; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; de Vinuesa SG, 2006, J AM SOC NEPHROL, V17, pS206, DOI 10.1681/ASN.2006080916; El-Hage J., 2005, INT ATH SOC S PPAR M; Fox CS, 2005, DIABETES CARE, V28, P2436, DOI 10.2337/diacare.28.10.2436; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; FRIEDMAN GD, 1991, AM J EPIDEMIOL, V133, P376, DOI 10.1093/oxfordjournals.aje.a115891; GAN SC, 1992, ARCH INTERN MED, V152, P2333, DOI 10.1001/archinte.152.11.2333; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Keller CR, 2007, KIDNEY INT, V71, P239, DOI 10.1038/sj.ki.5002042; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Krepinsky J, 2000, AM J KIDNEY DIS, V35, P500, DOI 10.1016/S0272-6386(00)70204-6; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; McGregor DB, 1999, IARC SCI PUBL, P1; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Perkins BA, 2005, J AM SOC NEPHROL, V16, P1404, DOI 10.1681/ASN.2004100854; Piccinni C, 2011, DIABETES CARE, V34, P1369, DOI 10.2337/dc10-2412; Schneider CA, 2008, J AM SOC NEPHROL, V19, P182, DOI 10.1681/ASN.2007060678; Schumacher S, 2001, EUR J CLIN PHARMACOL, V57, P147, DOI 10.1007/s002280100280; Shankar A, 2006, ARCH INTERN MED, V166, P188, DOI 10.1001/archinte.166.2.188; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; Tachibana K, 2008, PPAR RES, V2008, DOI 10.1155/2008/102737; Takayama S, 1998, JNCI-J NATL CANCER I, V90, P19, DOI 10.1093/jnci/90.1.19; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Varley CL, 2009, CELL DEATH DIFFER, V16, P103, DOI 10.1038/cdd.2008.116; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; Varley CL, 2004, AM J PATHOL, V164, P1789, DOI 10.1016/S0002-9440(10)63737-6; Varley CL, 2008, EXP TOXICOL PATHOL, V60, P435, DOI 10.1016/j.etp.2008.04.009; Wong G, 2009, J AM SOC NEPHROL, V20, P1341, DOI 10.1681/ASN.2008090998; Yale JF, 2005, J AM SOC NEPHROL, V16, pS7, DOI 10.1681/ASN.2004110974	38	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85479	10.1371/journal.pone.0085479	http://dx.doi.org/10.1371/journal.pone.0085479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427312	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200053
J	Chaffey, GS; Lloyd, DJB; Skeldon, AC; Kirkby, NF				Chaffey, Gary S.; Lloyd, David J. B.; Skeldon, Anne C.; Kirkby, Norman F.			The Effect of the G(1) - S transition Checkpoint on an Age Structured Cell Cycle Model	PLOS ONE			English	Article							POPULATION BALANCE MODEL; MATHEMATICAL-MODEL; LINES; PHASE; RADIATION; KINETICS; ARREST; FLOW	Knowledge of how a population of cancerous cells progress through the cell cycle is vital if the population is to be treated effectively, as treatment outcome is dependent on the phase distributions of the population. Estimates on the phase distribution may be obtained experimentally however the errors present in these estimates may effect treatment efficacy and planning. If mathematical models are to be used to make accurate, quantitative predictions concerning treatments, whose efficacy is phase dependent, knowledge of the phase distribution is crucial. In this paper it is shown that two different transition rates at the G(1)-S checkpoint provide a good fit to a growth curve obtained experimentally. However, the different transition functions predict a different phase distribution for the population, but both lying within the bounds of experimental error. Since treatment outcome is effected by the phase distribution of the population this difference may be critical in treatment planning. Using an age-structured population balance approach the cell cycle is modelled with particular emphasis on the G(1)-S checkpoint. By considering the probability of cells transitioning at the G(1)-S checkpoint, different transition functions are obtained. A suitable finite difference scheme for the numerical simulation of the model is derived and shown to be stable. The model is then fitted using the different probability transition functions to experimental data and the effects of the different probability transition functions on the model's results are discussed.	[Chaffey, Gary S.; Lloyd, David J. B.; Skeldon, Anne C.] Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England; [Kirkby, Norman F.] Univ Surrey, Dept Chem Engn, Guildford GU2 5XH, Surrey, England	University of Surrey; University of Surrey	Chaffey, GS (corresponding author), Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England.	g.chaffey@surrey.ac.uk	Kirkby, Norman/M-3739-2015	Kirkby, Norman/0000-0003-3984-0309; Kirkby, Norman/0000-0001-5352-8069; Lloyd, David/0000-0002-1902-0007; Skeldon, Anne/0000-0001-6387-4766	Engineering and Physical Sciences Research Council (EPSRC) [EP/P505755/1]; Engineering and Physical Sciences Research Council [1003347] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	GC's contribution was funded by an Engineering and Physical Sciences Research Council (EPSRC) supported Doctoral Training Centre, funded through EP/P505755/1. There was no other external funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 1994, MOL BIOL CELL; Basse B, 2005, B MATH BIOL, V67, P815, DOI 10.1016/j.bulm.2004.10.003; Basse B, 2004, J MATH BIOL, V49, P329, DOI 10.1007/s00285-003-0254-2; Basse B, 2003, J MATH BIOL, V47, P295, DOI 10.1007/s00285-003-0203-0; Basse B, 2007, B MATH BIOL, V69, P1673, DOI 10.1007/s11538-006-9185-6; Begg RE, 2008, EUR J APPL MATH, V19, P435, DOI 10.1017/S0956792508007535; BHUYAN BK, 1972, CANCER RES, V32, P398; Billy F., 2013, MATH METHODS MODELS; Brugarolas J, 1995, NATURE, V377, P12; Chaffey GS, 2013, SIMPLE MATLAB MODEL; Chapman SJ, 2007, ANZIAM J, V49, P151, DOI 10.1017/S144618110001275X; Darzynkiewicz Z, 2011, CRITICAL ASPECTS ANA; DEAN PN, 1982, CYTOMETRY, V3, P188, DOI 10.1002/cyto.990030309; Eakman J, 1966, CHEM ENG PROGR S SER, V69, P37; Faraday D, 1994, THESIS; Faraday DBF, 2001, BIOCHEM ENG J, V7, P49, DOI 10.1016/S1369-703X(00)00101-7; FREDERICKSON A. G., 1967, MATH BIO SCL, V1, P327, DOI 10.1016/0025-5564(67)90008-9; Fredrickson AG, 1963, AICHE J, V9, P359; Hayter P, 1989, INVESTIGATION FACTOR; Jackiewicz Z, 2009, MATH BIOSCI ENG, V6, P561, DOI 10.3934/mbe.2009.6.561; LACOMBE F, 1988, CYTOMETRY, V9, P245, DOI 10.1002/cyto.990090310; Liou JJ, 1997, CHEM ENG SCI, V52, P1529, DOI 10.1016/S0009-2509(96)00510-6; Liu YH, 2007, BIOTECHNOL PROGR, V23, P1198, DOI 10.1021/bp070152z; LOPES NM, 1993, CANCER CHEMOTH PHARM, V32, P235, DOI 10.1007/BF00685842; Mantzaris NV, 1999, J BIOTECHNOL, V71, P157, DOI 10.1016/S0168-1656(99)00020-6; Marples B, 2004, RADIAT RES, V161, P247, DOI 10.1667/RR3130; Mathworks, MATL R22012A; Novak B, 2004, J THEORETICAL BIOL; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; Powathil GG, 2013, J THEORETICAL BIOL; Slater G.R., 2004, THESIS; Smith GD, 2003, NUMERICAL SOLUTION P; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; Yao KC, 2003, J NEUROSURG, V98, P378, DOI 10.3171/jns.2003.98.2.0378	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83477	10.1371/journal.pone.0083477	http://dx.doi.org/10.1371/journal.pone.0083477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416166	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300015
J	Charaudeau, S; Pakdaman, K; Boelle, PY				Charaudeau, Segolene; Pakdaman, Khashayar; Boelle, Pierre-Yves			Commuter Mobility and the Spread of Infectious Diseases: Application to Influenza in France	PLOS ONE			English	Article							TRANSMISSION; NETWORKS; MODELS	Commuting data is increasingly used to describe population mobility in epidemic models. However, there is little evidence that the spatial spread of observed epidemics agrees with commuting. Here, using data from 25 epidemics for influenza-like illness in France (ILI) as seen by the Sentinelles network, we show that commuting volume is highly correlated with the spread of ILI. Next, we provide a systematic analysis of the spread of epidemics using commuting data in a mathematical model. We extract typical paths in the initial spread, related to the organization of the commuting network. These findings suggest that an alternative geographic distribution of GP accross France to the current one could be proposed. Finally, we show that change in commuting according to age (school or work commuting) impacts epidemic spread, and should be taken into account in realistic models.	[Charaudeau, Segolene; Boelle, Pierre-Yves] INSERM, UMR S 707, Paris, France; [Charaudeau, Segolene; Boelle, Pierre-Yves] Univ Paris 06, Paris, France; [Charaudeau, Segolene; Pakdaman, Khashayar] Inst Jacques Monod, F-75251 Paris, France; [Charaudeau, Segolene; Pakdaman, Khashayar] Univ Paris 07, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Charaudeau, S (corresponding author), INSERM, UMR S 707, Paris, France.	segolene.charaudeau@u707.jussieu.fr		Boelle, Pierre-Yves/0000-0002-5367-8232	Fondation pour la recherche medicale	Fondation pour la recherche medicale(Fondation pour la Recherche Medicale)	This work has been funded by the Fondation pour la recherche medicale (http://www.frm.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-190; Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bavaud F, 1998, GEOGR ANAL, V30, P153; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Crepey P, 2007, AM J EPIDEMIOL, V166, P1244, DOI 10.1093/aje/kwm266; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Lunelli A, 2009, MATH BIOSCI, V220, P24, DOI 10.1016/j.mbs.2009.03.008; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Polgreen PM, 2009, AM J EPIDEMIOL, V170, P1300, DOI 10.1093/aje/kwp270; Truscott J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002699; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237	27	39	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e83002	10.1371/journal.pone.0083002	http://dx.doi.org/10.1371/journal.pone.0083002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416152	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300012
J	Dogan, H; Can, HD; Otu, HH				Dogan, Haluk; Can, Handan; Otu, Hasan H.			Whole Genome Sequence of a Turkish Individual	PLOS ONE			English	Article							MASSIVELY-PARALLEL DNA; PROGRESSION; ALIGNMENT	Although whole human genome sequencing can be done with readily available technical and financial resources, the need for detailed analyses of genomes of certain populations still exists. Here we present, for the first time, sequencing and analysis of a Turkish human genome. We have performed 35x coverage using paired-end sequencing, where over 95% of sequencing reads are mapped to the reference genome covering more than 99% of the bases. The assembly of unmapped reads rendered 11,654 contigs, 2,168 of which did not reveal any homology to known sequences, resulting in similar to 1 Mbp of unmapped sequence. Single nucleotide polymorphism (SNP) discovery resulted in 3,537,794 SNP calls with 29,184 SNPs identified in coding regions, where 106 were nonsense and 259 were categorized as having a high-impact effect. The homo/hetero zygosity (1,415,123:2,122,671 or 1:1.5) and transition/transversion ratios (2,383,204:1,154,590 or 2.06:1) were within expected limits. Of the identified SNPs, 480,396 were potentially novel with 2,925 in coding regions, including 48 nonsense and 95 high-impact SNPs. Functional analysis of novel high-impact SNPs revealed various interaction networks, notably involving hereditary and neurological disorders or diseases. Assembly results indicated 713,640 indels (1:1.09 insertion/deletion ratio), ranging from -52 bp to 34 bp in length and causing about 180 codon insertion/deletions and 246 frame shifts. Using paired-end-and read-depth-based methods, we discovered 9,109 structural variants and compared our variant findings with other populations. Our results suggest that whole genome sequencing is a valuable tool for understanding variations in the human genome across different populations. Detailed analyses of genomes of diverse origins greatly benefits research in genetics and medicine and should be conducted on a larger scale.	[Dogan, Haluk; Can, Handan; Otu, Hasan H.] Istanbul Bilgi Univ, Dept Genet & Bioengn, Istanbul, Turkey	Istanbul Bilgi University	Otu, HH (corresponding author), Istanbul Bilgi Univ, Dept Genet & Bioengn, Istanbul, Turkey.	hasan.otu@bilgi.edu.tr	Dogan, Haluk/AAH-3873-2020	Dogan, Haluk/0000-0002-6547-6638; Otu, Hasan/0000-0002-9253-8152	Istanbul Bilgi University Research Fund	Istanbul Bilgi University Research Fund(Istanbul Bilgi University)	This work is funded by Istanbul Bilgi University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Akin H, 2010, MOL BIOL REP, V37, P93, DOI 10.1007/s11033-009-9543-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Cheng NH, 2011, FEBS J, V278, P2525, DOI 10.1111/j.1742-4658.2011.08178.x; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Erbilgin Y, 2010, DIS MARKERS, V28, P353, DOI [10.3233/DMA-2010-0715, 10.1155/2010/740140]; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lassmann T, 2011, BIOINFORMATICS, V27, P130, DOI 10.1093/bioinformatics/btq614; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marschall T, 2012, BIOINFORMATICS, V28, P2875, DOI 10.1093/bioinformatics/bts566; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Peng Y, 2010, LECT N BIOINFORMAT, V6044, P426, DOI 10.1007/978-3-642-12683-3_28; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2011, NAT GENET, V43, P923, DOI 10.1038/ng.953; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yazici Yusuf, 2010, Curr Rheumatol Rep, V12, P429, DOI 10.1007/s11926-010-0132-z	38	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85233	10.1371/journal.pone.0085233	http://dx.doi.org/10.1371/journal.pone.0085233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416366	Green Published, gold			2022-12-25	WOS:000329866300056
J	Elfrink, K; Liao, WQ; Pieper, U; Oeding, SJ; Bahler, M				Elfrink, Kerstin; Liao, Wanqin; Pieper, Uwe; Oeding, Stefanie J.; Baehler, Martin			The Loop2 Insertion of Type IX Myosin Acts as an Electrostatic Actin Tether that Permits Processive Movement	PLOS ONE			English	Article							KINETIC MECHANISM; PLUS-END; MOTOR; KINESIN; SUPERFAMILY; BINDING; MUSCLE; DOMAIN; RHO	Although class IX myosins are single-headed, they demonstrate characteristics of processive movement along actin filaments. Double-headed myosins that move processively along actin filaments achieve this by successive binding of the two heads in a hand-over-hand mechanism. This mechanism, obviously, cannot operate in single-headed myosins. However, it has been proposed that a long class IX specific insertion in the myosin head domain at loop2 acts as an F-actin tether, allowing for single-headed processive movement. Here, we tested this proposal directly by analysing the movement of deletion constructs of the class IX myosin from Caenorhabditis elegans (Myo IX). Deletion of the large basic loop2 insertion led to a loss of processive behaviour, while deletion of the N-terminal head extension, a second unique domain of class IX myosins, did not influence the motility of Myo IX. The processive behaviour of Myo IX is also abolished with increasing salt concentrations. These observations directly demonstrate that the insertion located in loop2 acts as an electrostatic actin tether during movement of Myo IX along the actin track.	[Elfrink, Kerstin; Liao, Wanqin; Pieper, Uwe; Oeding, Stefanie J.; Baehler, Martin] Univ Munster, Inst Mol Cell Biol, D-48149 Munster, Germany	University of Munster	Bahler, M (corresponding author), Univ Munster, Inst Mol Cell Biol, D-48149 Munster, Germany.	baehler@uni-muenster.de			Deutsche Forschungsgemeinschaft [BA 1354/9-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a grant from the Deutsche Forschungsgemeinschaft to Martin Bahler (Grant number BA 1354/9-2) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouhamed M, 2009, MOL BIOL CELL, V20, P5074, DOI 10.1091/mbc.E09-04-0291; Bahler M, 2000, BBA-MOL CELL RES, V1496, P52, DOI 10.1016/S0167-4889(00)00008-2; Baker JP, 1998, CURR OPIN CELL BIOL, V10, P80, DOI 10.1016/S0955-0674(98)80089-6; CANDE WZ, 1986, METHOD ENZYMOL, V134, P473; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; Inoue A, 2002, NAT CELL BIOL, V4, P302, DOI 10.1038/ncb774; Kalhammer G, 1997, FEBS LETT, V414, P599, DOI 10.1016/S0014-5793(97)01076-4; Kambara T, 2006, J BIOL CHEM, V281, P4949, DOI 10.1074/jbc.M509141200; Liao WQ, 2010, J BIOL CHEM, V285, P24933, DOI 10.1074/jbc.M110.101105; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Nishikawa M, 2006, BIOCHEM BIOPH RES CO, V343, P1159, DOI 10.1016/j.bbrc.2006.03.057; O'Connell CB, 2003, NAT CELL BIOL, V5, P171, DOI 10.1038/ncb924; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Post PL, 1998, J CELL SCI, V111, P941; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; REINHARD J, 1995, EMBO J, V14, P697, DOI 10.1002/j.1460-2075.1995.tb07048.x; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Struchholz S, 2009, J BIOL CHEM, V284, P3663, DOI 10.1074/jbc.M808338200; van den Boom F, 2007, MOL BIOL CELL, V18, P1507, DOI 10.1091/mbc.E06-08-0771; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Watanabe TM, 2004, P NATL ACAD SCI USA, V101, P9630, DOI 10.1073/pnas.0402914101; Xie P, 2010, BIOPHYS CHEM, V151, P71, DOI 10.1016/j.bpc.2010.05.007	35	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84874	10.1371/journal.pone.0084874	http://dx.doi.org/10.1371/journal.pone.0084874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416302	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300040
J	Krishnan, N; Titus, MA; Thapar, R				Krishnan, Nithya; Titus, Mark A.; Thapar, Roopa			The Prolyl Isomerase Pin1 Regulates mRNA Levels of Genes with Short Half-Lives by Targeting Specific RNA Binding Proteins	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-CANCER; PEPTIDYLPROLYL ISOMERASE; BETA-CATENIN; CELL-CYCLE; IN-VIVO; HUR; PHOSPHORYLATION; INHIBITORS; STABILITY	The peptidyl-prolyl isomerase Pin1 is over-expressed in several cancer tissues is a potential prognostic marker in prostate cancer, and Pin1 ablation can suppress tumorigenesis in breast and prostate cancers. Pin1 can co-operate with activated ErbB2 or Ras to enhance tumorigenesis. It does so by regulating the activity of proteins that are essential for gene expression and cell proliferation. Several targets of Pin1 such as c-Myc, the Androgen Receptor, Estrogen Receptor-alpha, Cyclin D1, Cyclin E, p53, RAF kinase and NCOA3 are deregulated in cancer. At the posttranscriptional level, emerging evidence indicates that Pin1 also regulates mRNA decay of histone mRNAs, GM-CSF, Pth, and TGF beta mRNAs by interacting with the histone mRNA specific protein SLBP, and the ARE-binding proteins AUF1 and KSRP, respectively. To understand how Pin1 may affect mRNA abundance on a genome-wide scale in mammalian cells, we used RNAi along with DNA microarrays to identify genes whose abundance is significantly altered in response to a Pin1 knockdown. Functional scoring of differentially expressed genes showed that Pin1 gene targets control cell adhesion, leukocyte migration, the phosphatidylinositol signaling system and DNA replication. Several mRNAs whose abundance was significantly altered by Pin1 knockdown contained AU-rich element (ARE) sequences in their 3' untranslated regions. We identified HuR and AUF1 as Pin1 interacting ARE-binding proteins in vivo. Pin1 was also found to stabilize all core histone mRNAs in this study, thereby validating our results from a previously published study. Statistical analysis suggests that Pin1 may target the decay of essential mRNAs that are inherently unstable and have short to medium half-lives. Thus, this study shows that an important biological role of Pin1 is to regulate mRNA abundance and stability by interacting with specific RNA-binding proteins that may play a role in cancer progression.	[Krishnan, Nithya; Thapar, Roopa] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14260 USA; [Thapar, Roopa] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA; [Thapar, Roopa] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Titus, Mark A.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rice University; University of Texas System; UTMD Anderson Cancer Center	Thapar, R (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	rthapar@rice.edu	Thapar, Roopa/AAC-3419-2021		NIH [1RO1-GM076660]; Department of Defense (DOD) [W81XWH-10-1-0273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076660] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by NIH 1RO1-GM076660 (R. T.) and Department of Defense (DOD) grant W81XWH-10-1-0273 (M. A. T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014656; ALTERMAN RBM, 1984, MOL CELL BIOL, V4, P123, DOI 10.1128/MCB.4.1.123; Anderson P, 2005, NAT IMMUNOL, V6, P1211, DOI 10.1038/ni1205-1211; Avila MA, 2007, GASTROENTEROLOGY, V132, P1180, DOI 10.1053/j.gastro.2007.01.061; Ayala G, 2003, CANCER RES, V63, P6244; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; Chen SY, 2006, MOL CELL BIOL, V26, P929, DOI 10.1128/MCB.26.3.929-939.2006; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Dominski Z, 1999, MOL CELL BIOL, V19, P3561; Dong LM, 2010, BIOORG MED CHEM LETT, V20, P2210, DOI 10.1016/j.bmcl.2010.02.033; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Driver Jane A, 2010, Curr Aging Sci, V3, P158; Duncan KE, 2011, J MED CHEM, V54, P3854, DOI 10.1021/jm200156c; Esnault S, 2008, CRIT REV IMMUNOL, V28, P45, DOI 10.1615/CritRevImmunol.v28.i1.30; Esnault S, 2006, J IMMUNOL, V177, P6999, DOI 10.4049/jimmunol.177.10.6999; Gherzi R, 2010, WIRES RNA, V1, P230, DOI 10.1002/wrna.2; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Guo CX, 2009, BIOORG MED CHEM LETT, V19, P5613, DOI 10.1016/j.bmcl.2009.08.034; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; Jentsch S, 2009, CELL CYCLE, V8, P3800, DOI 10.4161/cc.8.23.9971; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kim HH, 2008, CELL CYCLE, V7, P3124, DOI 10.4161/cc.7.20.6884; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Krishnan N, 2012, MOL CELL BIOL, V32, P4306, DOI 10.1128/MCB.00382-12; Kumar R, 2009, J CLIN INVEST, V119, P2887, DOI 10.1172/JCI40784; La Montagna R, 2012, CELL CYCLE, V11, P3415, DOI 10.4161/cc.21730; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Liu T, 2010, J MED CHEM, V53, P2494, DOI 10.1021/jm901778v; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Moore JD, 2013, BIOORG MED CHEM LETT, V23, P4283, DOI 10.1016/j.bmcl.2013.05.088; Mori T, 2011, BIOCHEM BIOPH RES CO, V406, P439, DOI 10.1016/j.bbrc.2011.02.066; Naveh-Many T, 2010, ENDOCRINOLOGY, V151, P1398, DOI 10.1210/en.2009-1160; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Potter A, 2010, BIOORG MED CHEM LETT, V20, P6483, DOI 10.1016/j.bmcl.2010.09.063; Rajbhandari P, 2013, ONCOGENE; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rudrabhatla P, 2010, J ALZHEIMERS DIS, V19, P389, DOI 10.3233/JAD-2010-1243; Ryo A, 2005, CLIN CANCER RES, V11, P7523, DOI 10.1158/1078-0432.CCR-05-0457; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sanchez R, 2002, MOL CELL BIOL, V22, P7093, DOI 10.1128/MCB.22.20.7093-7104.2002; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2012, J BIOL CHEM, V287, P23294, DOI 10.1074/jbc.M111.313684; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Tatara Y, 2009, BIOCHEM BIOPH RES CO, V384, P394, DOI 10.1016/j.bbrc.2009.04.144; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	62	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85427	10.1371/journal.pone.0085427	http://dx.doi.org/10.1371/journal.pone.0085427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416409	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300079
J	Waschke, N; Hardge, K; Hancock, C; Hilker, M; Obermaier, E; Meiners, T				Waeschke, Nicole; Hardge, Kristin; Hancock, Christine; Hilker, Monika; Obermaier, Elisabeth; Meiners, Torsten			Habitats as Complex Odour Environments: How Does Plant Diversity Affect Herbivore and Parasitoid Orientation?	PLOS ONE			English	Article							DENTICHASMIAS-BUSSEOLAE; INVERTEBRATE HERBIVORY; LOCATION BEHAVIOR; FORAGING BEHAVIOR; NATURAL ENEMIES; BACKGROUND ODOR; NONHOST PLANT; HOST; VOLATILES; SELECTION	Plant diversity is known to affect success of host location by pest insects, but its effect on olfactory orientation of non-pest insect species has hardly been addressed. First, we tested in laboratory experiments the hypothesis that non-host plants, which increase odour complexity in habitats, affect the host location ability of herbivores and parasitoids. Furthermore, we recorded field data of plant diversity in addition to herbivore and parasitoid abundance at 77 grassland sites in three different regions in Germany in order to elucidate whether our laboratory results reflect the field situation. As a model system we used the herb Plantago lanceolata, the herbivorous weevil Mecinus pascuorum, and its larval parasitoid Mesopolobus incultus. The laboratory bioassays revealed that both the herbivorous weevil and its larval parasitoid can locate their host plant and host via olfactory cues even in the presence of non-host odour. In a newly established two-circle olfactometer, the weevils capability to detect host plant odour was not affected by odours from non-host plants. However, addition of non-host plant odours to host plant odour enhanced the weevils foraging activity. The parasitoid was attracted by a combination of host plant and host volatiles in both the absence and presence of non-host plant volatiles in a Y-tube olfactometer. In dual choice tests the parasitoid preferred the blend of host plant and host volatiles over its combination with non-host plant volatiles. In the field, no indication was found that high plant diversity disturbs host (plant) location by the weevil and its parasitoid. In contrast, plant diversity was positively correlated with weevil abundance, whereas parasitoid abundance was independent of plant diversity. Therefore, we conclude that weevils and parasitoids showed the sensory capacity to successfully cope with complex vegetation odours when searching for hosts.	[Waeschke, Nicole; Hardge, Kristin; Hilker, Monika; Meiners, Torsten] Free Univ Berlin, Inst Biol, Berlin, Germany; [Hancock, Christine; Obermaier, Elisabeth] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany	Free University of Berlin; University of Wurzburg	Meiners, T (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	meito@zedat.fu-berlin.de	Meiners, Torsten/C-7290-2013	Meiners, Torsten/0000-0002-6607-8463	Deutsche Forschungsgemeinschaft within the Priority Programme 1374 "Infrastructure-Biodiversity-Exploratories" [ME 1810/5-1, OB 185/2-1]	Deutsche Forschungsgemeinschaft within the Priority Programme 1374 "Infrastructure-Biodiversity-Exploratories"	This work was supported by Deutsche Forschungsgemeinschaft within the Priority Programme 1374 "Infrastructure-Biodiversity-Exploratories" (ME 1810/5-1, OB 185/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri M., 1995, ADV PLANT PATHOL, V11, P191; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; [Anonymous], 2010, R LANG ENV STAT COMP; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Beyaert I, 2014, BIOL REV, V89, P68, DOI 10.1111/brv.12043; Bezemer TM, 2010, ECOL ENTOMOL, V35, P341, DOI 10.1111/j.1365-2311.2010.01184.x; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bukovinszky T, 2007, J ANIM ECOL, V76, P845, DOI 10.1111/j.1365-2656.2007.01259.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Castelo MK, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.5301; Couty A, 2006, PHYSIOL ENTOMOL, V31, P134, DOI 10.1111/j.1365-3032.2006.00499.x; Crawley MJ., 2007, R BOOK; DICKASON E. A., 1968, COLEOPT BULL, V22, P11; Dicke M, 2003, OIKOS, V101, P38, DOI 10.1034/j.1600-0706.2003.12571.x; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Finch S, 2000, ENTOMOL EXP APPL, V96, P91, DOI 10.1023/A:1004058518179; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fontana A, 2009, J CHEM ECOL, V35, P833, DOI 10.1007/s10886-009-9654-0; GILBERT LE, 1975, ANNU REV ECOL SYST, V6, P365, DOI 10.1146/annurev.es.06.110175.002053; GODFRAY HCJ, 1994, PARASITOIDS; Gohole LS, 2003, ENTOMOL EXP APPL, V107, P1, DOI 10.1046/j.1570-7458.2003.00030.x; Gohole LS, 2005, J INSECT BEHAV, V18, P149, DOI 10.1007/s10905-005-0472-0; Hamback PA, 2003, FUNCT ECOL, V17, P87, DOI 10.1046/j.1365-2435.2003.00699.x; Hilker Monika, 2008, P92, DOI 10.1002/9780470696200.ch5; Hori M, 1997, APPL ENTOMOL ZOOL, V32, P303, DOI 10.1303/aez.32.303; Janz N, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P349; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Knudsen GK, 2008, PHYSIOL ENTOMOL, V33, P1, DOI 10.1111/j.1365-3032.2007.00592.x; Kostenko O, 2012, ENTOMOL EXP APPL, V144, P27, DOI 10.1111/j.1570-7458.2012.01251.x; Lotz T, 2012, ECOL INFORM, V8, P10, DOI 10.1016/j.ecoinf.2011.11.004; MACKINNON WJ, 1964, J AM STAT ASSOC, V59, P935, DOI 10.2307/2283112; Mozuraitis R, 2002, CHEM SENSES, V27, P505, DOI 10.1093/chemse/27.6.505; Muller C, 2000, NATURWISSENSCHAFTEN, V87, P216, DOI 10.1007/s001140050706; Mumm R, 2005, CHEM SENSES, V30, P337, DOI 10.1093/chemse/bji028; Norowi HM, 2000, ECOL ENTOMOL, V25, P188, DOI 10.1046/j.1365-2311.2000.00242.x; Pareja M, 2007, J CHEM ECOL, V33, P695, DOI 10.1007/s10886-007-9260-y; Perfecto I, 2003, ENVIRON ENTOMOL, V32, P163, DOI 10.1603/0046-225X-32.1.163; Petermann JS, 2010, J ANIM ECOL, V79, P709, DOI 10.1111/j.1365-2656.2010.01674.x; Pettersson J, 2008, APPL ENTOMOL ZOOL, V43, P315, DOI 10.1303/aez.2008.315; Randlkofer B, 2007, CHEMOECOLOGY, V17, P177, DOI 10.1007/s00049-007-0377-9; Randlkofer B, 2010, BASIC APPL ECOL, V11, P383, DOI 10.1016/j.baae.2010.03.003; Randlkofer B, 2010, ECOL ENTOMOL, V35, P446, DOI 10.1111/j.1365-2311.2010.01200.x; Reinecke A, 2002, NATURWISSENSCHAFTEN, V89, P265, DOI 10.1007/s00114-002-0314-2; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Sachs L., 1984, ANGEW STAT ANWENDUNG, V6, DOI [10.1007/978-3-662-05748-3, DOI 10.1007/978-3-662-05748-3]; Sanon A, 2006, ENVIRON ENTOMOL, V35, P718, DOI 10.1603/0046-225X-35.3.718; Scherber C, 2006, OECOLOGIA, V147, P489, DOI 10.1007/s00442-005-0281-3; Schoonhoven L. M., 2005, Insect-plant biology; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; SCHUBERT R, 1990, EXKURSIONSFLORA DEUT, V4; SHEEHAN W, 1986, ENVIRON ENTOMOL, V15, P456, DOI 10.1093/ee/15.3.456; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; THIERY D, 1986, ENTOMOL EXP APPL, V41, P165, DOI 10.1007/BF00195573; Unsicker SB, 2006, OECOLOGIA, V150, P233, DOI 10.1007/s00442-006-0511-3; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Van Nouhuys S, 1999, HEREDITY, V83, P127, DOI 10.1046/j.1365-2540.1999.00549.x; Vanbergen AJ, 2007, ECOL ENTOMOL, V32, P419, DOI 10.1111/j.1365-2311.2007.00885.x; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vet Louise E.M., 1995, P65; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Waschke N, 2013, RECENT ADV CHEM ECOL, P193; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x	64	29	33	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85152	10.1371/journal.pone.0085152	http://dx.doi.org/10.1371/journal.pone.0085152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416354	gold, Green Published			2022-12-25	WOS:000329866300051
J	Belanger, F; Rajotte, V; Drobetsky, EA				Belanger, Francois; Rajotte, Vincent; Drobetsky, Elliot A.			A Majority of Human Melanoma Cell Lines Exhibits an S Phase-Specific Defect in Excision of UV-Induced DNA Photoproducts	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; REPAIR GENE POLYMORPHISMS; PIGMENTOSUM GROUP-A; XERODERMA-PIGMENTOSUM; ATR KINASE; MICROSATELLITE INSTABILITY; RADIOSENSITIZING AGENT; ATAXIA-TELANGIECTASIA; H2AX PHOSPHORYLATION; DAMAGE	It is well established that efficient removal of highly-promutagenic UV-induced dipyrimidine photoproducts via nucleotide excision repair (NER) is required for protection against sunlight-associated malignant melanoma. Nonetheless, the extent to which reduced NER capacity might contribute to individual melanoma susceptibility in the general population remains unclear. Here we show that among a panel of 14 human melanoma strains, 11 exhibit significant inhibition of DNA photoproduct removal during S phase relative to G0/G1 or G2/M. Evidence is presented that this cell cycle-specific NER defect correlates with enhanced apoptosis and reduced clonogenic survival following UV irradiation. In addition, melanoma strains deficient in S phase-specific DNA photoproduct removal manifest significantly lower levels of phosphorylated histone H2AX at 1 h post-UV, suggesting diminished activation of ataxia telangiectasia and Rad 3-related (ATR) kinase, i.e., a primary orchestrator of the cellular response to UV-induced DNA replication stress. Consistently, in the case of DNA photoproduct excision-proficient melanoma cells, siRNA-mediated depletion of ATR (but not of its immediate downstream effector kinase Chk1) engenders deficient NER specifically during S. On the other hand simultaneous siRNA-mediated depletion of ataxia telangiectasia mutated kinase (ATM) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) exerts no significant effect on either phosphorylation of H2AX at 1 h post-UV or the efficiency of DNA photoproduct removal. Our data suggest that defective NER exclusively during S phase, possibly associated with decreased ATR signaling, may constitute an heretofore unrecognized determinant in melanoma pathogenesis.	[Drobetsky, Elliot A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal	Drobetsky, EA (corresponding author), Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada.	elliot.drobetsky@umontreal.ca			Canadian Cancer Society Research Institute [700749]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	Canadian Cancer Society Research Institute (grant # 700749). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair Y, 2010, DNA REPAIR, V9, P754, DOI 10.1016/j.dnarep.2010.03.013; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; DROBETSKY EA, 1995, P NATL ACAD SCI USA, V92, P2350, DOI 10.1073/pnas.92.6.2350; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Fernandez AA, 2011, PHOTOCHEM PHOTOBIOL, V87, P335, DOI 10.1111/j.1751-1097.2010.00875.x; Ford JM, 2005, MUTAT RES-FUND MOL M, V577, P195, DOI 10.1016/j.mrfmmm.2005.04.005; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gaddameedhi S, 2010, CANCER RES, V70, P4922, DOI 10.1158/0008-5472.CAN-10-0095; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Ho H, 2012, CANCER RES, V72, P5516, DOI 10.1158/0008-5472.CAN-12-0775; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kuluncsics Z, 1999, J PHOTOCH PHOTOBIO B, V49, P71, DOI 10.1016/S1011-1344(99)00034-2; Landi MT, 2002, JNCI-J NATL CANCER I, V94, P94, DOI 10.1093/jnci/94.2.94; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Li CY, 2006, CANCER EPIDEM BIOMAR, V15, P2526, DOI 10.1158/1055-9965.EPI-06-0672; Loignon M, 2002, CARCINOGENESIS, V23, P35, DOI 10.1093/carcin/23.1.35; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Mathonnet R, 2003, P NATL ACAD SCI USA, V100, P7219, DOI 10.1073/pnas.123216100; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Menoyo A, 2001, CANCER RES, V61, P7727; Ming M, 2011, CANCER RES, V71, P5287, DOI 10.1158/0008-5472.CAN-10-4614; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; Mocellin S, 2009, CARCINOGENESIS, V30, P1735, DOI 10.1093/carcin/bgp207; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Neudauer CL, 2003, EXP CELL RES, V286, P128, DOI 10.1016/S0014-4827(03)00049-1; Nogueira C, 2010, ONCOGENE, V29, P6222, DOI 10.1038/onc.2010.349; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ogi T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002945; Papp T, 1996, J CANCER RES CLIN, V122, P541, DOI 10.1007/BF01213550; Paszkowska-Szczur K, 2013, INT J CANCER, V133, P1094, DOI 10.1002/ijc.28123; Povey JE, 2007, CARCINOGENESIS, V28, P1087, DOI 10.1093/carcin/bgl257; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sarkaria JN, 1998, CANCER RES, V58, P4375; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; Vassileva V, 2002, CANCER RES, V62, P4095; Wei QY, 2003, J NATL CANCER I, V95, P308, DOI 10.1093/jnci/95.4.308; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Xu GG, 2000, J INVEST DERMATOL, V114, P628, DOI 10.1046/j.1523-1747.2000.00943.x; Yoon JH, 2000, J MOL BIOL, V299, P681, DOI 10.1006/jmbi.2000.3771; Zighelboim I, 2009, J CLIN ONCOL, V27, P3091, DOI 10.1200/JCO.2008.19.9802	55	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85294	10.1371/journal.pone.0085294	http://dx.doi.org/10.1371/journal.pone.0085294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416382	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500235
J	Chan, MHT; Kim, PS				Chan, Matthew H. T.; Kim, Peter S.			An Age-Structured Approach to Modelling Behavioural Variation Maintained by Life-History Trade-Offs	PLOS ONE			English	Article							INTEGRODIFFERENCE EQUATIONS; ANIMAL PERSONALITIES; BOLDNESS; HERITABILITY; POPULATIONS; AGGRESSION; CONTEXT; SHYNESS; TRAITS	There have been numerous empirical studies on the fitness consequences of behavioural syndromes in various animal taxa; however, the ecological and evolutionary implications on a population level are still poorly understood. To better understand these implications, we develop a non-linear age-structured mathematical model to qualitatively examine the evolutionary consequences of a heritable boldness personality trait within an animal population. We assume that this heritable boldness trait is positively correlated with boldness towards predators and intraspecific aggressiveness. This assumption leads to a growth/reproductive success versus mortality trade-off, which is thoroughly investigated and documented in the literature. Another life-history trade-off we include in the model is future versus current reproduction, which was shown by Wolf et al. [1] to be a possible mechanism for the evolution of behavioural syndromes within an animal population. The stability of the system is analysed, whereby the characteristic equation is in the form of a homogeneous Fredholm equation of the second kind which depends on both the perturbation and equilibrium solution. The system is found to be stable due to the competition between individuals of similar boldness acting as a negative feedback mechanism. Using numerical simulations we examine the qualitative features of the solution to the system. In particular, we investigate the interplay between the mutation and competition strength between two individuals with different boldness, whereby we find that an increasing competition range acts to push individuals to both extremes of the shy-bold axis, while an increasing mutation range counteracts this effect. This qualitative trait of aggregation of individuals around the shy and bold extremes is also found when examining different birth, mortality and competition functions.	[Chan, Matthew H. T.; Kim, Peter S.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia	University of Sydney	Chan, MHT (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia.	M.Chan@maths.usyd.edu.au		Kim, Peter/0000-0002-1492-4744	Australian Postgraduate Award (APA); Australian Research Council Discovery Early Career Research Award	Australian Postgraduate Award (APA)(Australian Government); Australian Research Council Discovery Early Career Research Award(Australian Research Council)	Matthew Chan was supported by the Australian Postgraduate Award (APA). Peter Kim was supported by the Australian Research Council Discovery Early Career Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Castanheira MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062037; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Dzieweczynski TL, 2011, J FISH BIOL, V79, P776, DOI 10.1111/j.1095-8649.2011.03064.x; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; Johnson JC, 2005, BEHAV ECOL SOCIOBIOL, V58, P390, DOI 10.1007/s00265-005-0943-5; Kanda LL, 2012, ETHOLOGY, V118, P518, DOI 10.1111/j.1439-0310.2012.02038.x; Kanwal R. P., 1996, LINEAR INTEGRAL EQUA; Kiesel AL, 2012, BEHAVIOUR, V149, P1155, DOI 10.1163/1568539X-00003015; Kot M, 2008, B MATH BIOL, V70, P1790, DOI 10.1007/s11538-008-9325-2; Lovitt W. V., 1950, LINEAR INTEGRAL EQUA; Medlock J, 2003, MATH BIOSCI, V184, P201, DOI 10.1016/S0025-5564(03)00041-5; Norton WHJ, 2011, J NEUROSCI, V31, P13796, DOI 10.1523/JNEUROSCI.2892-11.2011; Pike TW, 2008, P ROY SOC B-BIOL SCI, V275, P2515, DOI 10.1098/rspb.2008.0744; Reale D, 2009, J EVOLUTION BIOL, V22, P1599, DOI 10.1111/j.1420-9101.2009.01781.x; RIECHERT SE, 1993, ANIM BEHAV, V46, P669, DOI 10.1006/anbe.1993.1243; Shigesada N, 1997, BIOL INVASIONS THEOR; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; van Oers K, 2005, BEHAVIOUR, V142, P1185, DOI 10.1163/156853905774539364; Wang MH, 2002, J MATH BIOL, V44, P150, DOI 10.1007/s002850100116; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wisenden BD, 2011, BEHAVIOUR, V148, P1443, DOI 10.1163/156853911X616530; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	29	2	2	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84774	10.1371/journal.pone.0084774	http://dx.doi.org/10.1371/journal.pone.0084774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416284	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500167
J	Pereira, MG; Baptista, IL; Carlassara, EOC; Moriscot, AS; Aoki, MS; Miyabara, EH				Pereira, Marcelo G.; Baptista, Igor L.; Carlassara, Eduardo O. C.; Moriscot, Anselmo S.; Aoki, Marcelo S.; Miyabara, Elen H.			Leucine Supplementation Improves Skeletal Muscle Regeneration after Cryolesion in Rats	PLOS ONE			English	Article							STIMULATES PROTEIN-SYNTHESIS; NEONATAL PIGS; MTOR; PHOSPHORYLATION; ASSOCIATION; INITIATION; EXERCISE; INJURY; 4E-BP1; EIF4G	This study was undertaken in order to provide further insight into the role of leucine supplementation in the skeletal muscle regeneration process, focusing on myofiber size and strength recovery. Young (2-month-old) rats were subjected or not to leucine supplementation (1.35 g/kg per day) started 3 days prior to cryolesion. Then, soleus muscles were cryolesioned and continued receiving leucine supplementation until 1, 3 and 10 days later. Soleus muscles from leucine-supplemented animals displayed an increase in myofiber size and a reduction in collagen type III expression on post-cryolesion day 10. Leucine was also effective in reducing FOXO3a activation and ubiquitinated protein accumulation in muscles at post-cryolesion days 3 and 10. In addition, leucine supplementation minimized the cryolesion-induced decrease in tetanic strength and increase in fatigue in regenerating muscles at post-cryolesion day 10. These beneficial effects of leucine were not accompanied by activation of any elements of the phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin signalling pathway in the regenerating muscles. Our results show that leucine improves myofiber size gain and strength recovery in regenerating soleus muscles through attenuation of protein ubiquitination. In addition, leucine might have therapeutic effects for muscle recovery following injury and in some muscle diseases.	[Pereira, Marcelo G.; Baptista, Igor L.; Carlassara, Eduardo O. C.; Moriscot, Anselmo S.; Miyabara, Elen H.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Aoki, Marcelo S.] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Miyabara, EH (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil.	elenm@usp.br	Aoki, Marcelo Saldanha/K-5423-2016; Baptista, Igor Luchini/N-6442-2016; de Oliveira Cruz Carlassara, Eduardo/L-2766-2015; Gomes Pereira, Marcelo/D-7324-2015; Baptista, Igor/ABC-1551-2021; Miyabara, Elen H/E-8143-2012; Moriscot, Anselmo S./C-4506-2012	Aoki, Marcelo Saldanha/0000-0001-7803-6829; Baptista, Igor Luchini/0000-0001-5185-0185; Baptista, Igor/0000-0001-5185-0185; Miyabara, Elen H/0000-0002-2325-9571; Moriscot, Anselmo S./0000-0003-3098-4613; Gomes Pereira, Marcelo/0000-0002-6670-8031	FAPESP [2010/52520-0, 2012/15276-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP, grant numbers 2010/52520-0 to MGP and 2012/15276-9 to EHM; URL: www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JC, 2000, J NUTR, V130, P139, DOI 10.1093/jn/130.2.139; Balage M, 2011, J NUTR BIOCH; Baptista IL, 2010, MUSCLE NERVE, V41, P800, DOI 10.1002/mus.21578; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bolster DR, 2004, J NUTR, V134, P1704, DOI 10.1093/jn/134.7.1704; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488; Chan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012345; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Conte TC, 2012, J GERONTOL A; Crozier SJ, 2005, J NUTR, V135, P376, DOI 10.1093/jn/135.3.376; Pinheiro CHDJ, 2012, EUR J APPL PHYSIOL, V112, P2531, DOI 10.1007/s00421-011-2224-5; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1374, DOI 10.1152/japplphysiol.91397.2008; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hornberger TA, 2006, CELL CYCLE, V5, P1391, DOI 10.4161/cc.5.13.2921; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; Lang CH, 2003, AM J PHYSIOL-ENDOC M, V285, pE1205, DOI 10.1152/ajpendo.00177.2003; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Magne H, 2012, J PHYSIOL-LONDON, V590, P2035, DOI 10.1113/jphysiol.2011.226266; MATHIEU O, 1981, J MICROSC-OXFORD, V121, P75, DOI 10.1111/j.1365-2818.1981.tb01200.x; Miyabara EH, 2010, MUSCLE NERVE, V42, P778, DOI 10.1002/mus.21754; Nedergaard A, 2007, J APPL PHYSIOL, V103, P1513, DOI 10.1152/japplphysiol.01445.2006; Nicastro H, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/136937; Perhonen M, 1996, J APPL PHYSIOL, V80, P2226, DOI 10.1152/jappl.1996.80.6.2226; Pizza FX, 2002, J APPL PHYSIOL, V92, P1873, DOI 10.1152/japplphysiol.01055.2001; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Rennie MJ, 2000, ANNU REV NUTR, V20, P457, DOI 10.1146/annurev.nutr.20.1.457; Rogulska A, 1975, Pol Med Sci Hist Bull, V15, P245; Ryall JG, 2004, J PHYSIOL-LONDON, V555, P175, DOI 10.1113/jphysiol.2003.056770; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Stipanuk MH, 2007, NUTR REV, V65, P122, DOI 10.1111/j.1753-4887.2007.tb00289.x; Suryawan A, 2011, J ANIM SCI, V89, P2004, DOI 10.2527/jas.2010-3400; Suryawan A, 2008, AM J PHYSIOL-ENDOC M, V295, pE868, DOI 10.1152/ajpendo.90314.2008; Taillandier D, 2004, P NUTR SOC, V63, P357, DOI 10.1079/PAR2004358; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Torrazza RM, 2010, J NUTR, V140, P2145, DOI 10.3945/jn.110.128421; Toumi H, 2006, J ANAT, V208, P459, DOI 10.1111/j.1469-7580.2006.00543.x; Vary TC, 2007, J NUTR, V137, P2074, DOI 10.1093/jn/137.9.2074; Vary TC, 2007, J NUTR, V137, P1835, DOI 10.1093/jn/137.8.1835; Wu M, 2010, J CELL PHYSL	49	45	45	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85283	10.1371/journal.pone.0085283	http://dx.doi.org/10.1371/journal.pone.0085283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416379	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500233
J	Qi, FZ; Huang, MD; Pan, Y; Liu, Y; Liu, JB; Wen, J; Xie, KP; Shen, HB; Ma, HX; Miao, Y; Hu, ZB				Qi, Fuzhen; Huang, Mingde; Pan, Yun; Liu, Yao; Liu, Jibin; Wen, Juan; Xie, Kaipeng; Shen, Hongbing; Ma, Hongxia; Miao, Yi; Hu, Zhibin			A Genetic Variant in the Promoter Region of miR-106b-25 Cluster Predict Clinical Outcome of HBV-Related Hepatocellular Carcinoma in Chinese	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; LUNG-CANCER; MICRORNA EXPRESSION; CELL-PROLIFERATION; ALPHA-FETOPROTEIN; HUMAN LIVER; CIRRHOSIS; MARKER	Background: MiR-106b-25 cluster, hosted in intron 13 of MCM7, may play integral roles in diverse processes including immune response, tumorigenesis and progression. A single nucleotide polymorphism (SNP), rs999885, is located in the promoter region of MCM7. Our previous study showed that the A to G base change of rs999885 may provide an increased risk for HCC in HBV persistent carriers by altering the expression of the miR-106b-25 cluster. However, it is unknown whether rs999885 is associated with prognosis of intermediate or advanced HBV-related hepatocellular carcinoma (HCC) patients. Methods: The SNP, rs999885, was genotyped by using the TaqMan allelic discrimination Assay in 414 intermediate or advanced HCC patients. Log-rank test and Cox proportional hazard models were used for survival analysis. Results: The variant genotypes of rs999885 were associated with a significantly decreased risk of death for intermediate or advanced HCC [additive model: adjusted hazard ratio (HR) = 0.76,95% confidence intervals (CI) = 0.59-0.97]. Further stepwise regression analysis suggested that rs999885 was an independently protective factor for the prognosis of HCC in the final model (additive model: adjusted HR = 0.72, 95% CI = 0.56-0.91, P = 0.007). Conclusions: These findings indicate that the A to G base change of rs999885 may provide a protective effect on the prognosis of intermediate or advanced HCC in Chinese.	[Qi, Fuzhen] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Hepatopancreatobiliary Surg, Huaian, Jiangsu, Peoples R China; [Huang, Mingde] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Med Oncol, Huaian, Jiangsu, Peoples R China; [Pan, Yun; Liu, Yao; Wen, Juan; Xie, Kaipeng; Shen, Hongbing; Ma, Hongxia; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Epidemiol & Biostat,Canc Ctr, Nanjing, Jiangsu, Peoples R China; [Liu, Jibin] Nantong Tumor Hosp, Dept Hepatobiliary Surg, Nantong, Jiangsu, Peoples R China; [Shen, Hongbing; Ma, Hongxia; Hu, Zhibin] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Miao, Yi] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Ma, HX (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Epidemiol & Biostat,Canc Ctr, Nanjing, Jiangsu, Peoples R China.	hongxiama@njmu.edu.cn; miaoyi@njmu.edu.cn; zhibin_hu@njmu.edu.cn			National Natural Science Foundation of China [81372606, 81072344]; National Key Basic Research Program [2013CB911400]; National Science Foundation for Distinguished Young Scholars of China [81225020]; Foundation of Jiangsu Province for Distinguished Young Scholars [BK2012042]; Foundation for the Program for New Century Excellent Talents in University [NCET-10-0178]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions [122031]; Organization Department of the CPC Central Committee; Author of National Excellent Doctoral Dissertation [201081]; Jiangsu Province Clinical Science and Technology Projects [BL2012008]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Foundation of Jiangsu Province for Distinguished Young Scholars; Foundation for the Program for New Century Excellent Talents in University; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions; Organization Department of the CPC Central Committee; Author of National Excellent Doctoral Dissertation; Jiangsu Province Clinical Science and Technology Projects; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This work was funded by the National Natural Science Foundation of China (81372606 and 81072344), Project supported by the National Key Basic Research Program Grant (2013CB911400), the project supported by the National Science Foundation for Distinguished Young Scholars of China (81225020), Foundation of Jiangsu Province for Distinguished Young Scholars(BK2012042), Foundation for the Program for New Century Excellent Talents in University (NCET-10-0178), the Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions (122031), Young tip-top talents support program by the Organization Department of the CPC Central Committee, the Author of National Excellent Doctoral Dissertation (201081), Jiangsu Province Clinical Science and Technology Projects (BL2012008) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders G, 2012, NUCLEIC ACIDS RES, V40, pD180, DOI 10.1093/nar/gkr1007; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Braconi C, 2011, SEMIN ONCOL, V38, P752, DOI 10.1053/j.seminoncol.2011.08.001; Cai KM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-73; Chan SL, 2009, J CLIN ONCOL, V27, P446, DOI 10.1200/JCO.2008.18.8151; Chen H, 2012, BIOCHEM BIOPH RES CO, V422, P721, DOI 10.1016/j.bbrc.2012.05.066; Chon YE, 2012, INT J CANCER, V131, P2332, DOI 10.1002/ijc.27507; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Rodriguez RG, 2012, REV ESP ENFERM DIG, V104, P298, DOI 10.4321/s1130-01082012000600003; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Hu ZB, 2011, AM J RESP CRIT CARE, V183, P641, DOI 10.1164/rccm.201005-0717OC; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kan T, 2009, CURR OPIN PHARMACOL, V9, P727, DOI 10.1016/j.coph.2009.08.009; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee YK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-5; Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032230; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Savita U, 2013, BIOCHEM BIOPH RES CO, V434, P841, DOI 10.1016/j.bbrc.2013.04.025; Shen G, 2013, CARCINOGENESIS, V34, P211, DOI 10.1093/carcin/bgs320; Slaby O, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-90; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Xie K, 2013, CANC EPIDEMIOL; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Zhong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028839	41	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85394	10.1371/journal.pone.0085394	http://dx.doi.org/10.1371/journal.pone.0085394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416400	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500244
J	McColl, B; Kao, BR; Lourthai, P; Chan, K; Wardan, H; Roosjen, M; Delagneau, O; Gearing, LJ; Blewitt, ME; Svasti, S; Fucharoen, S; Vadolas, J				McColl, Bradley; Kao, Betty R.; Lourthai, Preeyachan; Chan, Kasey; Wardan, Hady; Roosjen, Mark; Delagneau, Orane; Gearing, Linden J.; Blewitt, Marnie E.; Svasti, Saovaros; Fucharoen, Suthat; Vadolas, Jim			An in vivo model for analysis of developmental erythropoiesis and globin gene regulation	FASEB JOURNAL			English	Article						hemoglobin switching; BAC transgenics; epigenetics; chromatin modification	YEAST ARTIFICIAL CHROMOSOME; FETAL-HEMOGLOBIN LEVELS; HUMAN GAMMA-GLOBIN; MOUSE MODEL; NUCLEAR RECEPTORS; BCL11A; LOCUS; EXPRESSION; DECITABINE; PROMOTERS	Expression of fetal -globin in adulthood ameliorates symptoms of -hemoglobinopathies by compensating for the mutant -globin. Reactivation of the silenced -globin gene is therefore of substantial clinical interest. To study the regulation of -globin expression, we created the GG mice, which carry an intact 183-kb human -globin locus modified to express enhanced green fluorescent protein (eGFP) from the G-globin promoter. GG embryos express eGFP first in the yolk sac blood islands and then in the aorta-gonad mesonephros and the fetal liver, the sites of normal embryonic hematopoiesis. eGFP expression in erythroid cells peaks at E9.5 and then is rapidly silenced (>95%) and maintained at low levels into adulthood, demonstrating appropriate developmental regulation of the human -globin locus. In vitro knockdown of the epigenetic regulator DNA methyltransferase-1 in GG primary erythroid cells increases the proportion of eGFP(+) cells in culture from 41.9 to 74.1%. Furthermore, eGFP fluorescence is induced >3-fold after treatment of erythroid precursors with epigenetic drugs known to induce -globin expression, demonstrating the suitability of the G-globin eGFP reporter for evaluation of -globin inducers. The GG mouse model is therefore a valuable model system for genetic and pharmacologic studies of the regulation of the -globin locus and for discovery of novel therapies for the -hemoglobinopathies.McColl, B., Kao, B. R., Lourthai, P., Chan, K., Wardan, H., Roosjen, M., Delagneau, O., Gearing, L. J., Blewitt, M. E., Svasti, S., Fucharoen, S., Vadolas, J. An in vivo model for analysis of developmental erythropoiesis and globin gene regulation.	[McColl, Bradley; Kao, Betty R.; Lourthai, Preeyachan; Chan, Kasey; Wardan, Hady; Roosjen, Mark; Delagneau, Orane; Vadolas, Jim] Royal Childrens Hosp, Murdoch Childrens Res Inst, Cell & Gene Therapy Grp, Parkville, Vic 3052, Australia; [Kao, Betty R.; Vadolas, Jim] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Gearing, Linden J.; Blewitt, Marnie E.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Gearing, Linden J.; Blewitt, Marnie E.] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia; [Lourthai, Preeyachan] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Lourthai, Preeyachan; Svasti, Saovaros; Fucharoen, Suthat] Mahidol Univ, Inst Mol Biosci, Thalassemia Res Ctr, Nakhon Pathom, Thailand; [Blewitt, Marnie E.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3050, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Mahidol University; Mahidol University; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Vadolas, J (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Cell & Gene Therapy Grp, Flemington Rd, Parkville, Vic 3052, Australia.	jim.vadolas@mcri.edu.au	Svasti, Saovaros/AAH-6111-2020	Kao, Betty/0000-0003-0202-8018; Blewitt, Marnie/0000-0002-2984-1474; Gearing, Linden/0000-0003-3508-3056; Vadolas, Jim/0000-0002-3072-3512	National Health and Medical Research Council; Murdoch Childrens Research Institute; Victorian Government; Thalassaemia Australia; Thalassaemia Society of New South Wales; Greek Conference, a Research Chair grant from the Thailand National Science and Technology Development Agency (NSTDA); Mahidol University; Medical Scholars Program, Mahidol University	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Childrens Research Institute; Victorian Government; Thalassaemia Australia; Thalassaemia Society of New South Wales; Greek Conference, a Research Chair grant from the Thailand National Science and Technology Development Agency (NSTDA); Mahidol University; Medical Scholars Program, Mahidol University	The authors thank Chelsea Dunn for assistance with the preparation of figures. This work was supported by the National Health and Medical Research Council, the Murdoch Childrens Research Institute, the Victorian Government's Operational Infrastructure Support Program, Thalassaemia Australia, the Thalassaemia Society of New South Wales, the Greek Conference, a Research Chair grant from the Thailand National Science and Technology Development Agency (NSTDA), and Mahidol University. P. L. was supported by the Medical Scholars Program, Mahidol University. P. L. was a Ph.D. candidate at Mahidol University; this work was submitted in partial fulfilment of the Ph.D. requirements.	Akpan I, 2010, EXP HEMATOL, V38, P989, DOI 10.1016/j.exphem.2010.08.001; Amaya M, 2013, BLOOD, V121, P3493, DOI 10.1182/blood-2012-11-466227; Banzon V, 2011, EXP HEMATOL, V39, P26, DOI 10.1016/j.exphem.2010.10.003; Baron MH, 2012, BLOOD, V119, P4828, DOI 10.1182/blood-2012-01-153486; Bauer DE, 2012, BLOOD, V120, P2945, DOI 10.1182/blood-2012-06-292078; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Chan KSK, 2012, FASEB J, V26, P1736, DOI 10.1096/fj.11-199356; Costa FC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003155; Cui SAY, 2011, MOL CELL BIOL, V31, P3298, DOI 10.1128/MCB.05310-11; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; Fraser ST, 2010, METHOD ENZYMOL, V476, P403, DOI 10.1016/S0076-6879(10)76022-5; Fucharoen S, 2013, BRIT J HAEMATOL, V161, P587, DOI 10.1111/bjh.12304; GAENSLER KML, 1993, P NATL ACAD SCI USA, V90, P11381, DOI 10.1073/pnas.90.23.11381; Harju-Baker S, 2008, MOL CELL BIOL, V28, P3101, DOI 10.1128/MCB.01858-07; Jamsai D, 2005, GENOMICS, V85, P453, DOI 10.1016/j.ygeno.2004.11.016; Jamsai D, 2006, GENOMICS, V88, P309, DOI 10.1016/j.ygeno.2006.03.009; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Lavelle D, 2006, BLOOD CELL MOL DIS, V36, P269, DOI 10.1016/j.bcmd.2006.01.004; Lavelle D, 2012, BLOOD, V119, P1240, DOI 10.1182/blood-2011-08-371690; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; Mabaera R, 2007, BLOOD, V110, P1343, DOI 10.1182/blood-2007-01-068635; MAVILIO F, 1983, P NATL ACAD SCI-BIOL, V80, P6907, DOI 10.1073/pnas.80.22.6907; McCaffrey PG, 1997, BLOOD, V90, P2075, DOI 10.1182/blood.V90.5.2075; McGrath KE, 2003, BLOOD, V101, P1669, DOI 10.1182/blood-2002-08-2531; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Olivieri NF, 2011, BLOOD, V118, P2708, DOI 10.1182/blood-2011-03-341909; Papadopoulos P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051272; Perrine SP, 2010, ANN NY ACAD SCI, V1202, P158, DOI 10.1111/j.1749-6632.2010.05593.x; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips JD, 2007, BLOOD, V109, P2618, DOI 10.1182/blood-2006-06-022848; Porcu S, 1997, BLOOD, V90, P4602, DOI 10.1182/blood.V90.11.4602.4602_4602_4609; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Shi LH, 2013, NAT MED, V19, P291, DOI 10.1038/nm.3101; STAMATOYANNOPOULOS G, 1993, MOL CELL BIOL, V13, P7636, DOI 10.1128/MCB.13.12.7636; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; THORPE SJ, 1994, BRIT J HAEMATOL, V87, P125, DOI 10.1111/j.1365-2141.1994.tb04881.x; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Vadolas J, 2006, J BIOL CHEM, V281, P7399, DOI 10.1074/jbc.M512931200; Vadolas J, 2005, BBA-GENE STRUCT EXPR, V1728, P150, DOI 10.1016/j.bbaexp.2005.02.008; Vadolas J, 2004, HUM MOL GENET, V13, P223, DOI 10.1093/hmg/ddh023; van Dijk TB, 2010, BLOOD, V116, P4349, DOI 10.1182/blood-2010-03-274399; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Wilber A, 2011, BLOOD, V117, P3945, DOI 10.1182/blood-2010-11-316893; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310	51	9	9	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2306	2317		10.1096/fj.13-246637	http://dx.doi.org/10.1096/fj.13-246637			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24443374				2022-12-25	WOS:000335336000032
J	Che, T; Bethel, CR; Pusztai-Carey, M; Bonomo, RA; Carey, PR				Che, Tao; Bethel, Christopher R.; Pusztai-Carey, Marianne; Bonomo, Robert A.; Carey, Paul R.			The Different Inhibition Mechanisms of OXA-1 and OXA-24 beta-Lactamases Are Determined by the Stability of Active Site Carboxylated Lysine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystallography; Enzyme Mechanisms; Physical Methods; Raman Spectroscopy; UV Spectroscopy; OXA-1; OXA-24; Carboxylated Lysine; Penems	RESISTANT STAPHYLOCOCCUS-AUREUS; N-ZETA-DECARBOXYLATION; ACINETOBACTER-BAUMANNII; BLAR1 PROTEIN; SENSOR DOMAIN; CRYSTAL-STRUCTURE; RAMAN CRYSTALLOGRAPHY; SUBSTRATE TURNOVER; CLAVULANIC ACID; CARBON-DIOXIDE	Background: OXA-1 and OXA-24 are class D -lactamases that resist clinically used inhibitors. Results: Spectroscopic methods and kinetic measurements show that penem drug candidates are good inhibitors of OXA-1 but are rapidly hydrolyzed by OXA-24. Conclusion: An active site water in OXA-24 aids the reversible carboxylation of Lys-84, enabling many reaction cycles. Significance: Understanding the mechanism of class D -lactamases is vital for drug development. The catalytic efficiency of class D -lactamases depends critically on an unusual carboxylated lysine as the general base residue for both the acylation and deacylation steps of the enzyme. Microbiological and biochemical studies on the class D -lactamases OXA-1 and OXA-24 showed that the two enzymes behave differently when reacting with two 6-methylidene penems (penem 1 and penem 3): the penems are good inhibitors of OXA-1 but act more like substrates for OXA-24. UV difference and Raman spectroscopy revealed that the respective reaction mechanisms are different. The penems form an unusual intermediate, a 1,4-thiazepine derivative in OXA-1, and undergo deacylation followed by the decarboxylation of Lys-70, rendering OXA-1 inactive. This inactivation could not be reversed by the addition of 100 mm NaHCO3. In OXA-24, under mild conditions (enzyme:inhibitor = 1:4), only hydrolyzed products were detected, and the enzyme remained active. However, under harsh conditions (enzyme:inhibitor = 1:2000), OXA-24 was inhibited via decarboxylation of Lys-84; however, the enzyme could be reactivated by the addition of 100 mm NaHCO3. We conclude that OXA-24 not only decarboxylates with difficulty but also recarboxylates with ease; in contrast, OXA-1 decarboxylates easily but recarboxylates with difficulty. Structural analysis of the active site indicates that a crystallographic water molecule may play an important role in carboxylation in OXA-24 (an analogous water molecule is not found in OXA-1), supporting the suggestion that a water molecule in the active site of OXA-24 can lower the energy barrier for carboxylation significantly.	[Che, Tao; Pusztai-Carey, Marianne; Carey, Paul R.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Bethel, Christopher R.; Bonomo, Robert A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Carey, PR (corresponding author), Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	prc5@case.edu			National Institutes of Health [GM54072, R01-AI100560, R01-AI063517]; Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center; Veterans Health Administration; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100560, R01AI063517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM054072, R01GM054072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center; Veterans Health Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54072 (to P. R. C.) and R01-AI100560 and R01-AI063517 (to R. A. B.).; Supported by the Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center and a merit review award by the Veterans Health Administration.	Altose MD, 2001, P NATL ACAD SCI USA, V98, P3006, DOI 10.1073/pnas.061029598; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Baurin S, 2009, BIOCHEMISTRY-US, V48, P11252, DOI 10.1021/bi901548c; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bethel CR, 2008, ANTIMICROB AGENTS CH, V52, P3135, DOI 10.1128/AAC.01677-07; Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Borbulevych O, 2011, J BIOL CHEM, V286, P31466, DOI 10.1074/jbc.M111.252189; Bou G, 2000, ANTIMICROB AGENTS CH, V44, P1556, DOI 10.1128/AAC.44.6.1556-1561.2000; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; BROOM NJP, 1992, J CHEM SOC CHEM COMM, P1663, DOI 10.1039/c39920001663; Buchman JS, 2012, BIOCHEMISTRY-US, V51, P3143, DOI 10.1021/bi201896k; BUSH K, 1993, ANTIMICROB AGENTS CH, V37, P851, DOI 10.1128/AAC.37.4.851; Carey PR, 2006, ANNU REV PHYS CHEM, V57, P527, DOI 10.1146/annurev.physchem.57.032905.104521; Cha J, 2007, J AM CHEM SOC, V129, P3834, DOI 10.1021/ja070472e; CHARNAS RL, 1978, BIOCHEMISTRY-US, V17, P2185, DOI 10.1021/bi00604a025; Che T, 2012, J AM CHEM SOC, V134, P11206, DOI 10.1021/ja303168n; Dong J, 2001, BIOCHEMISTRY-US, V40, P9751, DOI 10.1021/bi010955+; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Frisch M., 2016, GAUSSIAN 16 REVISION; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; Helfand MS, 2003, BIOCHEMISTRY-US, V42, P13386, DOI 10.1021/bi035716w; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P3198, DOI 10.1128/AAC.49.8.3198-3202.2005; Hujer KM, 2005, ANTIMICROB AGENTS CH, V49, P2941, DOI 10.1128/AAC.49.7.2941-2948.2005; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; Kalp M, 2009, J AM CHEM SOC, V131, P2338, DOI 10.1021/ja808311s; Ke W., 2012, PLOS ONE, V7; Kerff F, 2003, BIOCHEMISTRY-US, V42, P12835, DOI 10.1021/bi034976a; KIM K, 1994, J PHYS CHEM-US, V98, P10089, DOI 10.1021/j100091a024; Leonard DA, 2008, BIOCHEM J, V410, P455, DOI 10.1042/BJ20070573; Leonard DA, 2013, ACCOUNTS CHEM RES, V46, P2407, DOI 10.1021/ar300327a; Li J, 2005, PROTEINS, V61, P246, DOI 10.1002/prot.20596; Llarrull LI, 2011, J BIOL CHEM, V286, P38148, DOI 10.1074/jbc.M111.288985; LORIMER GH, 1976, BIOCHEMISTRY-US, V15, P529, DOI 10.1021/bi00648a012; MACCLEMENT BAE, 1981, BIOCHEMISTRY-US, V20, P3438, DOI 10.1021/bi00515a021; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Naas T, 1999, CURR PHARM DESIGN, V5, P865; National Committee on Clinical Laboratory Standards, 2003, M2A8 NCCLS; National Committee on Clinical Laboratory Standards, 2005, M100S15 NCCLS; Pattanaik P, 2009, J BIOL CHEM, V284, P945, DOI 10.1074/jbc.M806833200; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Schneider KD, 2011, J MOL BIOL, V406, P583, DOI 10.1016/j.jmb.2010.12.042; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P6136, DOI 10.1021/bi900448u; Shim H, 2000, BIOCHEMISTRY-US, V39, P7357, DOI 10.1021/bi000291o; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; Sun T, 2001, ACTA CRYSTALLOGR D, V57, P1912, DOI 10.1107/S0907444901016274; Thumanu K, 2006, P NATL ACAD SCI USA, V103, P10630, DOI 10.1073/pnas.0601971103; Tien M, 1999, P NATL ACAD SCI USA, V96, P7809, DOI 10.1073/pnas.96.14.7809; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Torkabadi HH, 2013, J AM CHEM SOC, V135, P2895, DOI 10.1021/ja311440p; Venkatesan AM, 2004, J MED CHEM, V47, P6556, DOI 10.1021/jm049680x; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200	56	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6152	6164		10.1074/jbc.M113.533562	http://dx.doi.org/10.1074/jbc.M113.533562			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24443569	Green Published, hybrid			2022-12-25	WOS:000332015500069
J	Cui, TZ; Conte, A; Fox, JL; Zara, V; Winge, DR				Cui, Tie-Zhong; Conte, Annalea; Fox, Jennifer L.; Zara, Vincenzo; Winge, Dennis R.			Modulation of the Respiratory Supercomplexes in Yeast ENHANCED FORMATION OF CYTOCHROME OXIDASE INCREASES THE STABILITY AND ABUNDANCE OF RESPIRATORY SUPERCOMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer Complex; Cardiolipin; Cytochrome Oxidase; Mitochondria; Mitochondrial Metabolism	INNER MITOCHONDRIAL-MEMBRANE; RIESKE FE/S PROTEIN; BC(1) COMPLEX; C-OXIDASE; SACCHAROMYCES-CEREVISIAE; CHAIN SUPERCOMPLEXES; CRYSTAL-STRUCTURE; B SYNTHESIS; CARDIOLIPIN; SINGLE	Background: The cytochrome bc(1) complex weakly associates with cytochrome oxidase (CcO) in the absence of the Rieske Rip1 subunit. Results: The N-terminal domain of Rip1 enhances the stabilization of cytochrome bc(1)-CcO supercomplexes in yeast. Conclusion: Induced stabilization of supercomplexes arises from bc(1)-dependent formation of CcO. Significance: The late assembly intermediate of the bc(1) complex can template the maturation of CcO even without cardiolipin. Yeast cells deficient in the Rieske iron-sulfur subunit (Rip1) of ubiquinol-cytochrome c reductase (bc(1)) accumulate a late core assembly intermediate, which weakly associates with cytochrome oxidase (CcO) in a respiratory supercomplex. Expression of the N-terminal half of Rip1, which lacks the C-terminal FeS-containing globular domain (designated N-Rip1), results in a marked stabilization of trimeric and tetrameric bc(1)-CcO supercomplexes. Another bc(1) mutant (qcr9) stalled at the same assembly intermediate is likewise converted to stable supercomplex species by the expression of N-Rip1, but not by expression of intact Rip1. The N-Rip1-induced stabilization of bc(1)-CcO supercomplexes is independent of the Bcs1 translocase, which mediates Rip1 translocation during bc(1) biogenesis. N-Rip1 induces the stabilization of bc(1)-CcO supercomplexes through an enhanced formation of CcO. The association of N-Rip1 with the late core bc(1) assembly intermediate appears to confer stabilization of a CcO assembly intermediate. This induced stabilization of CcO is dependent on the Rcf1 supercomplex stabilization factor and only partially dependent on the presence of cardiolipin. N-Rip1 exerts a related induction of CcO stabilization in WT yeast, resulting in enhanced respiration. Additionally, the impact of CcO stabilization on supercomplexes was observed by means other than expression of N-Rip1 (via overexpression of CcO subunits Cox4 and Cox5a), demonstrating that this is a general phenomenon. This study presents the first evidence showing that supercomplexes can be stabilized by the stimulated formation of CcO.	[Cui, Tie-Zhong; Fox, Jennifer L.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Cui, Tie-Zhong; Fox, Jennifer L.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Conte, Annalea; Zara, Vincenzo] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, I-73100 Lecce, Italy	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Salento	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Zara, Vincenzo/AAC-2900-2019	Conte, Annalea/0000-0002-2833-506X; Zara, Vincenzo/0000-0001-6592-4501	National Institutes of Health from NIEHS [ES03817];  [T32 HL007576-25]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817, R37ES003817] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES03817 from NIEHS (to D. R. W.) and Training Grant T32 HL007576-25 (to J. L. F.).	Atkinson A, 2011, MOL CELL BIOL, V31, P3988, DOI 10.1128/MCB.05673-11; Atkinson A, 2010, J BIOL CHEM, V285, P19450, DOI 10.1074/jbc.M110.109793; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; CRIVELLONE MD, 1988, J BIOL CHEM, V263, P14323; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Ferramosca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038797; Gruschke S, 2012, J CELL BIOL, V199, P137, DOI 10.1083/jcb.201206040; Gruschke S, 2011, J CELL BIOL, V193, P1101, DOI 10.1083/jcb.201103132; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kronekova Z, 2005, CURR GENET, V47, P203, DOI 10.1007/s00294-005-0561-9; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lee SY, 2001, ARCH BIOCHEM BIOPHYS, V393, P215, DOI 10.1006/abbi.2001.2498; McStay GP, 2013, J BIOL CHEM, V288, P26546, DOI 10.1074/jbc.M113.498592; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wegener N, 2011, MOL CELL, V44, P191, DOI 10.1016/j.molcel.2011.07.036; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Winge DR, 2012, MOL CELL BIOL, V32, P2647, DOI 10.1128/MCB.00573-12; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zara V, 2007, FEBS J, V274, P4526, DOI 10.1111/j.1742-4658.2007.05982.x; Zara V, 2009, FEBS J, V276, P1900, DOI 10.1111/j.1742-4658.2009.06916.x; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	46	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6133	6141		10.1074/jbc.M113.523688	http://dx.doi.org/10.1074/jbc.M113.523688			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24421313	hybrid, Green Published			2022-12-25	WOS:000332015500067
J	Zhu, H; Guariglia, S; Li, WJ; Brancho, D; Wang, ZV; Scherer, PE; Chow, CW				Zhu, Hong; Guariglia, Sara; Li, Wenjing; Brancho, Deborah; Wang, Zhao V.; Scherer, Philipp E.; Chow, Chi-Wing			Role of Extracellular Signal- regulated Kinase 5 in Adipocyte Signaling*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose tissue; MAP Kinases (MAPKs); Metabolic Regulation; NFAT Transcription Factor; Protein Kinase A (PKA)	ACTIVATED PROTEIN-KINASES; BETA-ADRENERGIC-RECEPTORS; MAP KINASE; TARGETED DELETION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL REGULATION; INSULIN-RESISTANCE; LEPTIN RESISTANCE; DOWN-REGULATION	Background: Regulation and function of ERK5 in adipose depots is not known. Results: Deletion of ERK5 in adipose depots increases adiposity and adipokine secretion. Reduced phosphorylation and potentiated NFATc4 nuclear localization are found. ERK5 also modulates PKA activation. Conclusion: ERK5 impinges on NFATc4 nucleo-cytoplasmic shuttling and modulates PKA activation in adipocytes. Significance: These results expand the repertoire of ERK5 physiological function and downstream targets. Increased adiposity due to energy imbalance is a critical factor of the epidemic crisis of obesity and type II diabetes. In addition to the obvious role in energy storage, regulatory factors are secreted from adipose depots to control appetite and cellular homeostasis. Complex signaling cross-talks within adipocyte are also evident due to the metabolic and immune nature of adipose depots. Here, we uncover a role of extracellular signal-regulated kinase 5 (ERK5) in adipocyte signaling. We find that deletion of ERK5 in adipose depots (adipo-ERK5(-/-)) increases adiposity, in part, due to increased food intake. Dysregulated secretion of adipokines, leptin resistance, and impaired glucose handling are also found in adipo-ERK5(-/-) mice. Mechanistically, we show that ERK5 impinges on transcription factor NFATc4. Decreased phosphorylation at the conserved gate-keeping Ser residues and increased nuclear localization of NFATc4 are found in adipo-ERK5(-/-) mice. We also find attenuated PKA activation in adipo-ERK5(-/-) mice. In response to stimulation of -adrenergic G-protein-coupled receptor, we find decreased NFATc4 phosphorylation and impaired PKA activation in adipo-ERK5(-/-) mice. Reduced cAMP accumulation and increased phosphodiesterase activity are also found. Together, these results demonstrate integration of ERK5 with NFATc4 nucleo-cytoplasmic shuttling and PKA activation in adipocyte signaling.	[Zhu, Hong; Li, Wenjing; Brancho, Deborah; Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Guariglia, Sara] CUNY Coll Staten Isl, Dept Biol, New York, NY 10314 USA; [Wang, Zhao V.; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dept Internal Med & Cell Biol, Dallas, TX 75390 USA	Yeshiva University; Albert Einstein College of Medicine; City University of New York (CUNY) System; College of Staten Island (CUNY); University of Texas System; University of Texas Southwestern Medical Center Dallas	Chow, CW (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	chi-wing.chow@einstein.yu.edu	Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392; Wang, Zhao/0000-0002-9904-9538	National Institutes of Health [R01-DK0904881, P01-DK088761, R01-DK55758, R01-DK099110]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090481, R01DK099110, R01DK055758, P01DK088761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK0904881 (to C.-W.C.) and P01-DK088761, R01-DK55758, and R01-DK099110 (to P.E.S.).	Ahmad F, 2012, HORM METAB RES, V44, P776, DOI 10.1055/s-0032-1312646; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Ananieva O, 2008, EUR J IMMUNOL, V38, P2534, DOI 10.1002/eji.200737867; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Baillie GS, 2005, CURR OPIN CELL BIOL, V17, P129, DOI 10.1016/j.ceb.2005.01.003; Calabro Paolo, 2007, Subcell Biochem, V42, P63; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Dodge-Kafka KL, 2006, EUR J CELL BIOL, V85, P593, DOI 10.1016/j.ejcb.2006.01.007; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; Dyck DJ, 2009, APPL PHYSIOL NUTR ME, V34, P396, DOI 10.1139/H09-037; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Enriori PJ, 2006, OBESITY, V14, P254; Garaude J, 2006, J IMMUNOL, V177, P7607, DOI 10.4049/jimmunol.177.11.7607; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jin L, 2003, NAT STRUCT BIOL, V10, P807, DOI 10.1038/nsb975; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kim CH, 2006, AM J PHYSIOL-ENDOC M, V291, pE298, DOI 10.1152/ajpendo.00319.2005; Kim HB, 2006, DIABETES, V55, P1342, DOI 10.2337/db05-1507; Kim JJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1694, DOI 10.1152/ajpendo.00430.2006; Kim S, 2000, J NUTR, V130, p3110S; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Lin HV, 2007, DIABETES, V56, P1969, DOI 10.2337/db07-0127; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Niswender KD, 2003, FRONT NEUROENDOCRIN, V24, P1, DOI 10.1016/S0091-3022(02)00105-X; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Pearson GW, 2006, MOL CELL BIOL, V26, P3039, DOI 10.1128/MCB.26.8.3039-3047.2006; Perez-Madrigal D, 2012, CELL SIGNAL, V24, P2360, DOI 10.1016/j.cellsig.2012.08.001; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rao A, 2000, BRIT MED BULL, V56, P969, DOI 10.1258/0007142001903634; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Robidoux J, 2004, ANNU REV PHARMACOL, V44, P297, DOI 10.1146/annurev.pharmtox.44.101802.121659; Rosen ED, 2000, GENE DEV, V14, P1293; Semple RK, 2008, DIABETES CARE, V31, P977, DOI 10.2337/dc07-2194; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Soto-Nieves N, 2009, J EXP MED, V206, P867, DOI 10.1084/jem.20082731; Steppan CM, 2002, TRENDS ENDOCRIN MET, V13, P18, DOI 10.1016/S1043-2760(01)00522-7; Szaszak M, 2008, CELL SIGNAL, V20, P590, DOI 10.1016/j.cellsig.2007.10.020; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Wang X, 2006, CELL DEATH DIFFER, V13, P2099, DOI 10.1038/sj.cdd.4401969; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang X, 2005, MOL CELL BIOL, V25, P336, DOI 10.1128/MCB.25.1.336-345.2005; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07; Yang TTC, 2006, MOL CELL BIOL, V26, P7372, DOI 10.1128/MCB.00580-06; Yang TTC, 2003, J BIOL CHEM, V278, P15874, DOI 10.1074/jbc.M211560200; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zhu H, 2010, MOL CELL BIOL, V30, P4379, DOI 10.1128/MCB.01193-09; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	85	15	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6311	6322		10.1074/jbc.M113.506584	http://dx.doi.org/10.1074/jbc.M113.506584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425864	hybrid, Green Published			2022-12-25	WOS:000332015500082
J	Launders, NJ; Nichols, GL; Cartwright, R; Lawrence, J; Jones, J; Hadjichristodoulou, C				Launders, Naomi J.; Nichols, Gordon L.; Cartwright, Rodney; Lawrence, Joanne; Jones, Jane; Hadjichristodoulou, Christos			Self-Reported Stomach Upset in Travellers on Cruise-Based and Land-Based Package Holidays	PLOS ONE			English	Article							PASSENGER BEHAVIORS; DIARRHEA; EPIDEMIOLOGY; SHIPS; INFECTION; ILLNESS	Background: International travellers are at a risk of infectious diseases not seen in their home country. Stomach upsets are common in travellers, including on cruise ships. This study compares the incidence of stomach upsets on land-and cruise-based holidays. Methods: A major British tour operator has administered a Customer Satisfaction Questionnaire (CSQ) to UK resident travellers aged 16 or more on return flights from their holiday abroad over many years. Data extracted from the CSQ was used to measure self-reported stomach upset in returning travellers. Results: From summer 2000 through winter 2008, 6,863,092 questionnaires were completed; 6.6% were from cruise passengers. A higher percentage of land-based holiday-makers (7.2%) reported stomach upset in comparison to 4.8% of cruise passengers (RR = 1.5, p<0.0005). Reported stomach upset on cruises declined over the study period (7.1% in 2000 to 3.1% in 2008, p<0.0005). Over 25% of travellers on land-based holidays to Egypt and the Dominican Republic reported stomach upset. In comparison, the highest proportion of stomach upset in cruise ship travellers were reported following cruises departing from Egypt (14.8%) and Turkey (8.8%). Conclusions: In this large study of self-reported illness both demographic and holiday choice factors were shown to play a part in determining the likelihood of developing stomach upset while abroad. There is a lower cumulative incidence and declining rates of stomach upset in cruise passengers which suggest that the cruise industry has adopted operations (e. g. hygiene standards) that have reduced illness over recent years.	[Launders, Naomi J.; Nichols, Gordon L.] Publ Hlth England, Gastrointestinal Emerging & Zoonot Infect Dept, London, England; [Launders, Naomi J.; Nichols, Gordon L.; Hadjichristodoulou, Christos] European Agcy Hlth & Consumers, Publ Hlth Program, EU Shipsan Trainet Project, Luxembourg, Luxembourg; [Cartwright, Rodney] Federat Tour Operators, London, England; [Lawrence, Joanne; Jones, Jane] Publ Hlth England, Travel & Migrant Hlth Sect, London, England; [Nichols, Gordon L.; Hadjichristodoulou, Christos] Univ Thessaly, Fac Med, Dept Hyg & Epidemiol, Larisa, Greece; [Nichols, Gordon L.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Public Health England; Public Health England; University of Thessaly; University of East Anglia	Nichols, GL (corresponding author), Publ Hlth England, Gastrointestinal Emerging & Zoonot Infect Dept, London, England.	gordon.nichols@ecdc.europa.eu	Nichols, Gordon L./J-1114-2014; Launders, Naomi/GOG-8003-2022	Nichols, Gordon L./0000-0003-0773-9556; Launders, Naomi/0000-0003-4241-938X; Freedman, Joanne/0000-0002-7840-473X; Hadjichristodoulou, Christos/0000-0002-4769-8376	SHIPSAN TRAINET project (EU Project) [2007206]	SHIPSAN TRAINET project (EU Project)	This study was not formally funded and analysis was performed within the SHIPSAN TRAINET project (EU Project No. 2007206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cartwright RY, 2003, J APPL MICROBIOL, V94, p12S, DOI 10.1046/j.1365-2672.94.s1.2.x; Centers for Disease Control and Prevention, 2005, VESS SAN PROGR OP MA; Centers for Disease Control and Prevention, 2011, OUTBR UPD INT CRUIS; Chimonas MAR, 2008, J TRAVEL MED, V15, P177, DOI 10.1111/j.1708-8305.2008.00200.x; Cramer EH, 2006, AM J PREV MED, V30, P252, DOI 10.1016/j.amepre.2005.10.027; Cramer EH, 2008, J ENVIRON HEALTH, V70, P15; de Jong B, 2006, COMP BURDEN SALMONEL; Dupont HL, 2009, ALIMENT PHARM THER, V30, P187, DOI 10.1111/j.1365-2036.2009.04028.x; EU Shipsan Trainet Project, 2012, EUR MAN HYG STAND CO; Evans MR, 2001, J INFECTION, V43, P140, DOI 10.1053/jinf.2001.0876; Greenwood Z, 2008, J TRAVEL MED, V15, P221, DOI 10.1111/j.1708-8305.2008.00203.x; Health Protection Agency, 2010, FOR TRAV ASS ILLN FO; Mouchtouri VA, 2010, INT MARIT HEALTH, V61, P49; Neri AJ, 2008, J TRAVEL MED, V15, P172, DOI 10.1111/j.1708-8305.2008.00199.x; Northey G, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-126; Office for National Statistics, 2010, INT PASS SURV TRAV T; Peake DE, 1999, ANN EMERG MED, V33, P67, DOI 10.1016/S0196-0644(99)70419-1; Pitzurra R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-231; Redman CA, 2006, J TRAVEL MED, V13, P203, DOI 10.1111/j.1708-8305.2006.00046.x; Schultsz C, 2000, J CLIN MICROBIOL, V38, P3550, DOI 10.1128/JCM.38.10.3550-3554.2000; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Soto SM, 2009, CLIN MICROBIOL INFEC, V15, P26, DOI 10.1111/j.1469-0691.2008.02694.x; Steffen R, 2004, J TRAVEL MED, V11, P231, DOI 10.2310/7060.2004.19007; Swaminathan A, 2009, J INFECTION, V59, P19, DOI 10.1016/j.jinf.2009.05.008; Tomaszewski R, 2008, INT MARIT HEALTH, V59, P61; Verhoef L, 2008, EMERG INFECT DIS, V14, P238, DOI 10.3201/eid1402.061567; World Health Organization, 2001, COMP FOODB WAT DIS L	27	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83425	10.1371/journal.pone.0083425	http://dx.doi.org/10.1371/journal.pone.0083425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427271	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200011
J	Scott, BM; Matochko, WL; Gierczak, RF; Bhakta, V; Derda, R; Sheffield, WP				Scott, Benjamin M.; Matochko, Wadim L.; Gierczak, Richard F.; Bhakta, Varsha; Derda, Ratmir; Sheffield, William P.			Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin	PLOS ONE			English	Article							HEPARIN-COFACTOR-II; ALPHA(1)-PROTEINASE INHIBITOR; PLASMINOGEN-ACTIVATOR; ALPHA-1-PROTEINASE INHIBITOR; ANTI-THROMBIN; HINGE REGION; SITE LOOP; SPECIFICITY; COMPLEX; ALPHA(1)-ANTITRYPSIN	In spite of the power of phage display technology to identify variant proteins with novel properties in large libraries, it has only been previously applied to one member of the serpin superfamily. Here we describe phage display of human alpha-1 proteinase inhibitor (API) in a T7 bacteriophage system. API M358R fused to the C-terminus of T7 capsid protein 10B was directly shown to form denaturation-resistant complexes with thrombin by electrophoresis and immunoblotting following exposure of intact phages to thrombin. We therefore developed a biopanning protocol in which thrombin-reactive phages were selected using biotinylated anti-thrombin antibodies and streptavidin-coated magnetic beads. A library consisting of displayed API randomized at residues 357 and 358 (P2-P1) yielded predominantly Pro-Arg at these positions after five rounds of thrombin selection; in contrast the same degree of mock selection yielded only non-functional variants. A more diverse library of API M358R randomized at residues 352-356 (P7-P3) was also probed, yielding numerous variants fitting a loose consensus of DLTVS as judged by sequencing of the inserts of plaque-purified phages. The thrombin-selected sequences were transferred en masse into bacterial expression plasmids, and lysates from individual colonies were screening for API-thrombin complexing. The most active candidates from this sixth round of screening contained DITMA and AAFVS at P7-P3 and inhibited thrombin 2.1-fold more rapidly than API M358R with no change in reaction stoichiometry. Deep sequencing using the Ion Torrent platform confirmed that over 800 sequences were significantly enriched in the thrombin-panned versus naive phage display library, including some detected using the combined phage display/bacterial lysate screening approach. Our results show that API joins Plasminogen Activator Inhibitor-1 (PAI-1) as a serpin amenable to phage display and suggest the utility of this approach for the selection of "designer serpins" with novel reactivity and/or specificity.	[Scott, Benjamin M.; Gierczak, Richard F.; Sheffield, William P.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Matochko, Wadim L.; Derda, Ratmir] Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB, Canada; [Bhakta, Varsha; Sheffield, William P.] Canadian Blood Serv, Hamilton, ON, Canada	McMaster University; University of Alberta; Canadian Blood Services	Sheffield, WP (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	sheffiel@mcmaster.ca		Scott, Benjamin/0000-0003-4782-7139	Heart and Stroke Foundation of Canada (Ontario Provincial Office) [000267]; Canadian Blood Services	Heart and Stroke Foundation of Canada (Ontario Provincial Office); Canadian Blood Services	This work was made possible by Grant-In-Aid 000267 from the Heart and Stroke Foundation of Canada (Ontario Provincial Office) to WPS. RFG received a competitive Graduate Fellowship Program award from Canadian Blood Services in support of his doctoral research at McMaster University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Bhakta V, 2013, J BIOTECHNOL, V168, P373, DOI 10.1016/j.jbiotec.2013.10.011; Bhunia SS, 2011, J CHEM INF MODEL, V51, P1966, DOI 10.1021/ci200185q; Bottomley SP, 2001, PROTEIN SCI, V10, P2518, DOI 10.1110/ps.ps.24101; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Bratkovic T, 2010, CELL MOL LIFE SCI, V67, P749, DOI 10.1007/s00018-009-0192-2; Chaillan-Huntington CE, 1998, J BIOL CHEM, V273, P4569, DOI 10.1074/jbc.273.8.4569; Ciaccia AV, 1997, J BIOL CHEM, V272, P888, DOI 10.1074/jbc.272.2.888; Cunningham MA, 2002, THROMB HAEMOSTASIS, V88, P89; Dan JH, 1997, J BIOL CHEM, V272, P8243, DOI 10.1074/jbc.272.13.8243; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Djie MZ, 1997, J BIOL CHEM, V272, P16268, DOI 10.1074/jbc.272.26.16268; Djie MZ, 1996, BIOCHEMISTRY-US, V35, P11461, DOI 10.1021/bi952717i; Dufour EK, 2005, PROTEIN SCI, V14, P303, DOI 10.1110/ps.04843305; Dufour EK, 2001, J BIOL CHEM, V276, P38971, DOI 10.1074/jbc.M102959200; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; Filion ML, 2004, BIOCHEMISTRY-US, V43, P14864, DOI 10.1021/bi048833f; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; GEORGE PM, 1989, BLOOD, V73, P490; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gierczak RF, 2011, J THROMB HAEMOST, V9, P2424, DOI 10.1111/j.1538-7836.2011.04524.x; Han JH, 1998, BIOCHEMISTRY-US, V37, P3203, DOI 10.1021/bi9722195; Harper PL, 1998, THROMB HAEMOSTASIS, V80, P816; HEEB MJ, 1990, J BIOL CHEM, V265, P2365; Hopkins PCR, 2000, J MOL EVOL, V51, P507, DOI 10.1007/s002390010114; HOPKINS PCR, 1995, J BIOL CHEM, V270, P11866, DOI 10.1074/jbc.270.20.11866; HOPKINS PCR, 1995, BIOCHEMISTRY-US, V34, P15872, DOI 10.1021/bi00048a033; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matochko WL, 2012, METHODS, V58, P47, DOI 10.1016/j.ymeth.2012.07.006; Matochko WL, 2013, NUCL ACIDS RES; O'Donoghue SI, 2010, NAT METHODS, V7, pS42, DOI [10.1038/NMETH.1427, 10.1038/nmeth.1427]; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PANNEKOEK H, 1993, GENE, V128, P135, DOI 10.1016/0378-1119(93)90164-X; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; RUBIN H, 1994, BIOCHEMISTRY-US, V33, P7627, DOI 10.1021/bi00190a016; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; SCOTT CF, 1986, J CLIN INVEST, V77, P631, DOI 10.1172/JCI112346; Sheffield WP, 2012, THROMB HAEMOSTASIS, V107, P972, DOI 10.1160/TH11-09-0604; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stoop AA, 2000, J MOL BIOL, V301, P1135, DOI 10.1006/jmbi.2000.4035; Stoop AA, 2001, J MOL BIOL, V305, P773, DOI 10.1006/jmbi.2000.4356; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; Sutherland JS, 2007, THROMB HAEMOSTASIS, V98, P1014, DOI 10.1160/TH07-03-0197; Sutherland JS, 2006, BIOCHEMISTRY-US, V45, P11444, DOI 10.1021/bi0609624; Sutherland JS, 2006, THROMB RES, V117, P447, DOI 10.1016/j.thromres.2005.03.004; TOLLEFSEN DM, 1982, J BIOL CHEM, V257, P2162; vanMeijer M, 1996, J BIOL CHEM, V271, P7423, DOI 10.1074/jbc.271.13.7423; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790	60	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e84491	10.1371/journal.pone.0084491	http://dx.doi.org/10.1371/journal.pone.0084491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427287	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200027
J	Cornen, S; Guille, A; Adelaide, J; Addou-Klouche, L; Finetti, P; Saade, MR; Manai, M; Carbuccia, N; Bekhouche, I; Letessier, A; Raynaud, S; Charafe-Jauffret, E; Jacquemier, J; Spicuglia, S; de The, H; Viens, P; Bertucci, F; Birnbaum, D; Chaffanet, M				Cornen, Stephanie; Guille, Arnaud; Adelaide, Jose; Addou-Klouche, Lynda; Finetti, Pascal; Saade, Marie-Rose; Manai, Marwa; Carbuccia, Nadine; Bekhouche, Ismahane; Letessier, Anne; Raynaud, Stephane; Charafe-Jauffret, Emmanuelle; Jacquemier, Jocelyne; Spicuglia, Salvatore; de The, Hugues; Viens, Patrice; Bertucci, Francois; Birnbaum, Daniel; Chaffanet, Max			Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling	PLOS ONE			English	Article							ANTIESTROGEN RESISTANCE; MOLECULAR PORTRAITS; THERAPEUTIC TARGET; CELL-LINES; PATTERNS; MUTATIONS; SUBTYPES; PROTEIN; FOXM1; RISK	Breast cancers (BCs) of the luminal B subtype are estrogen receptor-positive (ER+), highly proliferative, resistant to standard therapies and have a poor prognosis. To better understand this subtype we compared DNA copy number aberrations (CNAs), DNA promoter methylation, gene expression profiles, and somatic mutations in nine selected genes, in 32 luminal B tumors with those observed in 156 BCs of the other molecular subtypes. Frequent CNAs included 8p11-p12 and 11q13.1-q13.2 amplifications, 7q11.22-q34, 8q21.12-q24.23, 12p12.3-p13.1, 12q13.11-q24.11, 14q21.1-q23.1, 17q11.1-q25.1, 20q11.23-q13.33 gains and 6q14.1-q24.2, 9p21.3-p24,3, 9q21.2, 18p11.31-p11.32 losses. A total of 237 and 101 luminal B-specific candidate oncogenes and tumor suppressor genes (TSGs) presented a deregulated expression in relation with their CNAs, including 11 genes previously reported associated with endocrine resistance. Interestingly, 88% of the potential TSGs are located within chromosome arm 6q, and seven candidate oncogenes are potential therapeutic targets. A total of 100 candidate oncogenes were validated in a public series of 5,765 BCs and the overexpression of 67 of these was associated with poor survival in luminal tumors. Twenty-four genes presented a deregulated expression in relation with a high DNA methylation level. FOXO3, PIK3CA and TP53 were the most frequent mutated genes among the nine tested. In a meta-analysis of next-generation sequencing data in 875 BCs, KCNB2 mutations were associated with luminal B cases while candidate TSGs MDN1 (6q15) and UTRN (6q24), were mutated in this subtype. In conclusion, we have reported luminal B candidate genes that may play a role in the development and/or hormone resistance of this aggressive subtype.	[Cornen, Stephanie; Guille, Arnaud; Adelaide, Jose; Addou-Klouche, Lynda; Finetti, Pascal; Saade, Marie-Rose; Manai, Marwa; Carbuccia, Nadine; Bekhouche, Ismahane; Letessier, Anne; Raynaud, Stephane; Charafe-Jauffret, Emmanuelle; Jacquemier, Jocelyne; Bertucci, Francois; Birnbaum, Daniel; Chaffanet, Max] Inst J Paoli I Calmettes, Dept Mol Oncol, Equipe Labellisee Ligue Canc, Marseille Canc Res Ctr,Inserm,UMR1068, F-13009 Marseille, France; [Addou-Klouche, Lynda] Univ Djillali Liabes Sidi Bel Abbes, Biotoxicol Lab, Sidi Bel Abbes, Algeria; [Manai, Marwa] Fac Sci El Manar, Biol Dpt, Biochem & Mol Biol Unit, Tunis, Tunisia; [Charafe-Jauffret, Emmanuelle; Jacquemier, Jocelyne] Inst J Paoli I Calmettes, Dept Biopathol, F-13009 Marseille, France; [Charafe-Jauffret, Emmanuelle; Spicuglia, Salvatore; Viens, Patrice; Bertucci, Francois] Aix Marseille Univ, Marseille, France; [Spicuglia, Salvatore] TAGC, INSERM, U1090, Marseille, France; [de The, Hugues] Univ Paris 07, Hop St Louis, INSERM 7212, CNRS,UMR 944, Paris, France; [Viens, Patrice; Bertucci, Francois] Inst J Paoli I Calmettes, Dept Mol Oncol, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); University Djillali Liabes Sidi Bel Abbes; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Paoli-Calmette (IPC)	Chaffanet, M (corresponding author), Inst J Paoli I Calmettes, Dept Mol Oncol, Equipe Labellisee Ligue Canc, Marseille Canc Res Ctr,Inserm,UMR1068, F-13009 Marseille, France.	chaffanetm@ipc.unicancer.fr	Guille, Arnaud/GZG-1785-2022; Viens, Patrice/Q-8499-2018; Letessier, Anne/M-3431-2017; Spicuglia, Salvatore/L-2268-2016; CHAFFANET, Max/AAU-5743-2020; Carbuccia, Nadine/O-4459-2017; ADELAIDE, José JA/O-4390-2017; Finetti, Pascal/O-8669-2017; Charafe-Jauffret, emmanuelle/P-6009-2017	Guille, Arnaud/0000-0001-5747-562X; Viens, Patrice/0000-0003-1511-1048; Letessier, Anne/0000-0002-1894-4072; Spicuglia, Salvatore/0000-0002-8101-7108; Carbuccia, Nadine/0000-0002-3561-4315; ADELAIDE, José JA/0000-0003-4364-9857; Bertucci, Francois/0000-0002-0157-0959; Finetti, Pascal/0000-0002-2674-3123; MANAI, Marwa/0000-0003-4037-3402; CHAFFANET, Max/0000-0002-2344-1488; Charafe-Jauffret, emmanuelle/0000-0002-0286-1299	Inserm; Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer; GEFLUC; Institut National du Cancer [ACI2007, AO2008, AO/R-TRANS09]; DGOS (SIRIC label) [INCa-DGOS-Inserm 6038]; Franco-Algerian program of high level formation in France (PROFAS); Algerian government; AVEROES European program	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); GEFLUC; Institut National du Cancer(Institut National du Cancer (INCA) France); DGOS (SIRIC label); Franco-Algerian program of high level formation in France (PROFAS); Algerian government; AVEROES European program	Financial support for this study came from Inserm, Institut Paoli-Calmettes, and grants from Ligue Nationale Contre le Cancer (Label DB), GEFLUC (MC), Institut National du Cancer (ACI2007, AO2008, AO/R-TRANS09 "identification, caracterisation et validation clinique de nouvelles cibles cellulaires et moleculaires dans les cancers du sein de mauvais pronostic" IVOIRES (INCA)) and DGOS (SIRIC label: grant INCa-DGOS-Inserm 6038). LAK and IB were supported by a fellowship from the Franco-Algerian program of high level formation in France (PROFAS) and the Algerian government, respectively. MM was supported by a fellowship from the AVEROES European program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Addou-Klouche L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-213; Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Bekhouche I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016950; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bergamaschi A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2913; Bernard-Pierrot I, 2008, CANCER RES, V68, P7165, DOI 10.1158/0008-5472.CAN-08-1360; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; Braun L, 2013, MODERN PATHOL, V26, P1161, DOI 10.1038/modpathol.2013.60; Cancello G, 2013, ANN ONCOL, V24, P661, DOI 10.1093/annonc/mds430; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Cornen S, 2012, ONCOGENE, V31, P4255, DOI 10.1038/onc.2011.598; Dadi S, 2012, CANCER CELL, V21, P563, DOI 10.1016/j.ccr.2012.02.013; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dunn L, 2009, MOL DIAGN THER, V13, P73, DOI 10.2165/01250444-200913020-00002; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069600; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ha KCH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-75; Habashy HO, 2011, BREAST CANCER RES TR, V129, P11, DOI 10.1007/s10549-010-1161-z; Hill VK, 2011, CANCER RES, V71, P2988, DOI 10.1158/0008-5472.CAN-10-4026; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Horlings HM, 2010, CLIN CANCER RES, V16, P651, DOI 10.1158/1078-0432.CCR-09-0709; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang B, 2012, ONCOGENE, V31, P527, DOI 10.1038/onc.2011.252; Ignatiadis M, 2013, NAT REV CLIN ONCOL, V10, P494, DOI 10.1038/nrclinonc.2013.124; Karlsson E, 2011, GENE CHROMOSOME CANC, V50, P775, DOI 10.1002/gcc.20900; Karn T, 2011, BREAST CANCER RES TR, V130, P409, DOI 10.1007/s10549-010-1333-x; KNIGHT WA, 1980, ANN CLIN RES, V12, P202; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwek SS, 2009, ONCOGENE, V28, P1892, DOI 10.1038/onc.2009.34; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mitelman F, 2013, MITELMAN DATABASE CH; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Patel MN, 2013, NAT REV DRUG DISCOV, V12, P35, DOI 10.1038/nrd3913; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sircoulomb F, 2011, EMBO MOL MED, V3, P153, DOI 10.1002/emmm.201100121; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Teh MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034329; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; van Agthoven T, 2009, BRIT J CANCER, V101, P1824, DOI 10.1038/sj.bjc.6605423; van Agthoven T, 2012, INT J CANCER, V131, P1998, DOI 10.1002/ijc.27489; Van der Auwera I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012616; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Wang M, 2011, MOL CANCER THER, V10, P2287, DOI 10.1158/1535-7163.MCT-11-0536; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	68	44	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e81843	10.1371/journal.pone.0081843	http://dx.doi.org/10.1371/journal.pone.0081843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416132	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300006
J	Chang, RY; Jin, TT; Lu, YH; Liu, GH; Fu, BJ				Chang, Ruiying; Jin, Tiantian; Lu, Yihe; Liu, Guohua; Fu, Bojie			Soil Carbon and Nitrogen Changes following Afforestation of Marginal Cropland across a Precipitation Gradient in Loess Plateau of China	PLOS ONE			English	Article							LOCUST ROBINIA-PSEUDOACACIA; LAND-USE CHANGE; ORGANIC-CARBON; LODGEPOLE PINE; TREE DENSITY; STAND AGE; FOREST; MECHANISMS; ECOSYSTEM; SEQUESTRATION	Cropland afforestation has been widely found to increase soil organic carbon (SOC) and soil total nitrogen (STN); however, the magnitudes of SOC and STN accumulation and regulating factors are less studied in dry, marginal lands, and therein the interaction between soil carbon and nitrogen is not well understood. We examined the changes in SOC and STN in younger (5-9-year-old) and older (25-3-year-old) black locust (Robinia pseudoacacia L., an N-fixing species) plantations that were established on former cropland along a precipitation gradient (380 to 650 mm) in the semi-arid Loess Plateau of China. The SOC and STN stocks of cropland and plantations increased linearly with precipitation increase, respectively, accompanying an increase in the plantation net primary productivity and the soil clay content along the increasing precipitation gradient. The SOC stock of cropland decreased in younger plantations and increased in older plantations after afforestation, and the amount of the initial loss of SOC during the younger plantations' establishment increased with precipitation increasing. By contrast, the STN stock of cropland showed no decrease in the initial afforestation while tending to increase with plantation age, and the changes in STN were not related to precipitation. The changes in STN and SOC showed correlated and were precipitation-dependent following afforestation, displaying a higher relative gain of SOC to STN as precipitation decreased. Our results suggest that the afforestation of marginal cropland in Loess Plateau can have a significant effect on the accumulation of SOC and STN, and that precipitation has a significant effect on SOC accumulation but little effect on STN retention. The limitation effect of soil nitrogen on soil carbon accumulation is more limited in the drier area rather than in the wetter sites.	[Chang, Ruiying] Chinese Acad Sci, Inst Mt Hazards & Environm, Key Lab Mt Surface Proc & Ecol Regulat, Chengdu, Sichuan, Peoples R China; [Chang, Ruiying; Jin, Tiantian; Lu, Yihe; Liu, Guohua; Fu, Bojie] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Jin, Tiantian] China Inst Water Resources & Hydropower Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); China Institute of Water Resources & Hydropower Research	Fu, BJ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bfu@rcees.ac.cn	Fu, Bojie/B-1493-2009	chang, rui ying/0000-0002-0534-4502	National Natural Science Foundation of China [41230745]; Chinese Academy of Sciences [XDA05060000]; International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services"	This research was supported the National Natural Science Foundation of China (41230745), the Chinese Academy of Sciences (No. XDA05060000) and the International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashkin MA, 1998, ECOLOGY, V79, P828, DOI 10.1890/0012-9658(1998)079[0828:CISCFA]2.0.CO;2; Berthrong ST, 2012, ECOL APPL, V22, P76, DOI 10.1890/10-2210.1; Binkley D, 2005, NATO SCI S SS IV EAR, V55, P155; BORING LR, 1984, FOREST SCI, V30, P528; Broughton LC, 2000, OECOLOGIA, V125, P420, DOI 10.1007/s004420000456; Callesen I, 2003, GLOBAL CHANGE BIOL, V9, P358, DOI 10.1046/j.1365-2486.2003.00587.x; Chang RY, 2012, ECOL RES, V27, P827, DOI 10.1007/s11284-012-0958-0; Cheng WX, 2009, SOIL BIOL BIOCHEM, V41, P1795, DOI 10.1016/j.soilbio.2008.04.018; Cheng WX, 2005, ROOTS SOIL MANAGEMEN; DAVIDSON EA, 1993, BIOGEOCHEMISTRY, V20, P161, DOI 10.1007/BF00000786; Dijkstra FA, 2007, SOIL BIOL BIOCHEM, V39, P2264, DOI 10.1016/j.soilbio.2007.03.026; [FAO FAO], 2010, STAT WORLDS FOR 2011; Farrar JF, 2000, NEW PHYTOL, V147, P43, DOI 10.1046/j.1469-8137.2000.00688.x; Feng L.X., 1992, SHAANXI SOILS; Forrester DI, 2013, ECOSYSTEMS, V16, P123, DOI 10.1007/s10021-012-9600-9; Fu BJ, 2009, PROG PHYS GEOG, V33, P793, DOI 10.1177/0309133309350264; Galvez L, 2005, J EXP BOT, V56, P2551, DOI 10.1093/jxb/eri249; Gardenas AI, 2011, SOIL BIOL BIOCHEM, V43, P702, DOI 10.1016/j.soilbio.2010.04.006; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hendricks JJ, 2006, J ECOL, V94, P40, DOI 10.1111/j.1365-2745.2005.01067.x; Hooker TD, 2003, ECOL APPL, V13, P299, DOI 10.1890/1051-0761(2003)013[0299:FECANA]2.0.CO;2; Jiao JY, 2010, RESTOR ECOL, V20, P240, DOI DOI 10.1111/J.1526-100X.2010.00756.X; JOHNSON DW, 1992, WATER AIR SOIL POLL, V64, P83, DOI 10.1007/BF00477097; Kirkby CA, 2013, SOIL BIOL BIOCHEM, V60, P77, DOI 10.1016/j.soilbio.2013.01.011; Krull ES, 2003, FUNCT PLANT BIOL, V30, P207, DOI 10.1071/FP02085; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y., 2004, ARCH AGRON SOIL SCI, V50, P115, DOI [10.1080/03650340310001627658, DOI 10.1080/03650340310001627658]; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Li YY, 2005, PEDOSPHERE, V15, P601; Li Z, 2003, INT GEOSCI REMOTE SE, P2275; Litton CM, 2004, ECOL APPL, V14, P460, DOI 10.1890/02-5291; Litton CM, 2003, GLOBAL CHANGE BIOL, V9, P680, DOI 10.1046/j.1365-2486.2003.00626.x; Liu Dong, 2012, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V20, P322, DOI 10.3724/SP.J.1011.2012.00322; Liu SG, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002010; [刘雨 LIU Yu], 2007, [干旱地区农业研究, Agricultural Research in the Arid Areas], V25, P220; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; LUGO AE, 1986, PLANT SOIL, V96, P185, DOI 10.1007/BF02374763; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; McCulley RL, 2009, OECOLOGIA, V159, P571, DOI 10.1007/s00442-008-1229-1; McLauchlan K, 2006, ECOSYSTEMS, V9, P1364, DOI 10.1007/s10021-005-0135-1; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Ogle SM, 2005, BIOGEOCHEMISTRY, V72, P87, DOI 10.1007/s10533-004-0360-2; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Peng L, 1995, J NW U NATURAL SCI E, V25, P117; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Resh SC, 2002, ECOSYSTEMS, V5, P217, DOI 10.1007/s10021-001-0067-3; Rice SK, 2004, PLANT ECOL, V174, P97, DOI 10.1023/B:VEGE.0000046049.21900.5a; Sartori F, 2007, AGR ECOSYST ENVIRON, V122, P325, DOI 10.1016/j.agee.2007.01.026; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Sun Wen-yi, 2010, Huanjing Kexue, V31, P2740; Tian Q., 1997, J BEIJING FOR UNIV, V19, P104; Wang B, 2012, ENVIRON EARTH SCI, V65, P597, DOI 10.1007/s12665-011-1107-8; Wang B, 2011, ENVIRON EARTH SCI, V62, P915, DOI 10.1007/s12665-010-0577-4; [王万忠 Wang Wanzhong], 2002, [地理学报, Acta Geographica Sinica], V57, P210; Wang Xiao-li, 2007, Yingyong Shengtai Xuebao, V18, P1281; Wei XR, 2009, BIOGEOCHEMISTRY, V96, P149, DOI 10.1007/s10533-009-9350-8; Wen Q.Z., 1989, GEOCHEMISTRY CHINESE; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999	66	34	40	6	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85426	10.1371/journal.pone.0085426	http://dx.doi.org/10.1371/journal.pone.0085426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416408	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500248
J	DeRubeis, RJ; Cohen, ZD; Forand, NR; Fournier, JC; Gelfand, LA; Lorenzo-Luaces, L				DeRubeis, Robert J.; Cohen, Zachary D.; Forand, Nicholas R.; Fournier, Jay C.; Gelfand, Lois A.; Lorenzo-Luaces, Lorenzo			The Personalized Advantage Index: Translating Research on Prediction into Individualized Treatment Recommendations. A Demonstration	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIALS; COGNITIVE THERAPY; SEVERE DEPRESSION; COVARIATE-INFORMATION; TREATMENT OUTCOMES; TREATMENT RESPONSE; MEDICINE; PHARMACOGENETICS; MEDICATIONS; MODERATE	Background: Advances in personalized medicine require the identification of variables that predict differential response to treatments as well as the development and refinement of methods to transform predictive information into actionable recommendations. Objective: To illustrate and test a new method for integrating predictive information to aid in treatment selection, using data from a randomized treatment comparison. Method: Data from a trial of antidepressant medications (N = 104) versus cognitive behavioral therapy (N = 50) for Major Depressive Disorder were used to produce predictions of post-treatment scores on the Hamilton Rating Scale for Depression (HRSD) in each of the two treatments for each of the 154 patients. The patient's own data were not used in the models that yielded these predictions. Five pre-randomization variables that predicted differential response (marital status, employment status, life events, comorbid personality disorder, and prior medication trials) were included in regression models, permitting the calculation of each patient's Personalized Advantage Index (PAI), in HRSD units. Results: For 60% of the sample a clinically meaningful advantage (PAI >= 3) was predicted for one of the treatments, relative to the other. When these patients were divided into those randomly assigned to their "Optimal" treatment versus those assigned to their "Non-optimal" treatment, outcomes in the former group were superior (d = 0.58, 95% CI .17-1.01). Conclusions: This approach to treatment selection, implemented in the context of two equally effective treatments, yielded effects that, if obtained prospectively, would rival those routinely observed in comparisons of active versus control treatments.	[DeRubeis, Robert J.; Cohen, Zachary D.; Gelfand, Lois A.; Lorenzo-Luaces, Lorenzo] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Forand, Nicholas R.] Ohio State Univ, Dept Psychiat, Columbus, OH 43210 USA; [Fournier, Jay C.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; University System of Ohio; Ohio State University; University of Pennsylvania	DeRubeis, RJ (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	derubeis@psych.upenn.edu	Cohen, Zachary/A-8946-2013; Fournier, Jay/AAG-8452-2019; Lorenzo-Luaces, Lorenzo/AAA-2070-2020	Cohen, Zachary/0000-0002-4883-1028; Fournier, Jay/0000-0001-8967-1668; Lorenzo-Luaces, Lorenzo/0000-0002-8882-0243; DeRubeis, Robert/0000-0003-3129-0277	NIMH [2-R01-MH-060998-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097889, R01MH060998] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support provided by NIMH grant 2-R01-MH-060998-06, "Prevention of Recurrence in Depression with Drugs and CT" (http://www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, P655; Arranz MJ, 2008, SCHIZOPHRENIA BULL, V34, P1130, DOI 10.1093/schbul/sbn114; Barber JP, 1996, J CONSULT CLIN PSYCH, V64, P951, DOI 10.1037/0022-006X.64.5.951; Baskaran A, 2012, NEUROPHARMACOLOGY, V63, P507, DOI 10.1016/j.neuropharm.2012.04.021; BYAR DP, 1985, STAT MED, V4, P255, DOI 10.1002/sim.4780040304; BYAR DP, 1977, J CHRON DIS, V30, P445, DOI 10.1016/0021-9681(77)90037-6; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Draper N.R., 2003, APPL REGRESSION ANAL; Dunlop BW, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-106; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Fournier JC, 2008, BRIT J PSYCHIAT, V192, P124, DOI 10.1192/bjp.bp.107.037234; Fournier JC, 2009, J CONSULT CLIN PSYCH, V77, P775, DOI 10.1037/a0015401; Gong QY, 2011, NEUROIMAGE, V55, P1497, DOI 10.1016/j.neuroimage.2010.11.079; Guo Y, 2008, HUM BRAIN MAPP, V29, P1092, DOI 10.1002/hbm.20450; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hollon SD, 2005, ARCH GEN PSYCHIAT, V62, P417, DOI 10.1001/archpsyc.62.4.417; Hollon SD, 1986, PREDICTING OUTCOME V; Ising M, 2009, ARCH GEN PSYCHIAT, V66, P966, DOI 10.1001/archgenpsychiatry.2009.95; Jarrett RB, 1999, ARCH GEN PSYCHIAT, V56, P431, DOI 10.1001/archpsyc.56.5.431; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kraemer HC, 2006, JAMA-J AM MED ASSOC, V296, P1286, DOI 10.1001/jama.296.10.1286; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Leykin Y, 2007, J CONSULT CLIN PSYCH, V75, P267, DOI 10.1037/0022-006X.75.2.267; Malhotra AK, 2012, MOL PSYCHIATR, V17, P760, DOI 10.1038/mp.2011.146; McClay JL, 2011, MOL PSYCHIATR, V16, P76, DOI 10.1038/mp.2009.89; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Perlis RH, 2011, MOL PSYCHIATR, V16, P1076, DOI 10.1038/mp.2011.63; Schosser A, 2009, INT CLIN PSYCHOPHARM, V24, P277, DOI 10.1097/YIC.0b013e3283306a2f; Simon GE, 2010, AM J PSYCHIAT, V167, P1445, DOI 10.1176/appi.ajp.2010.09111680; Squassina A, 2010, PHARMACOGENOMICS, V11, P1149, DOI 10.2217/PGS.10.97; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Uher R, 2011, HARVARD REV PSYCHIAT, V19, P109, DOI 10.3109/10673229.2011.586551; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; YAKOVLEV AY, 1994, STAT MED, V13, P1575, DOI 10.1002/sim.4780131508; Zachary RA, 1991, W PSYCHOL SERVICES F	42	259	260	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83875	10.1371/journal.pone.0083875	http://dx.doi.org/10.1371/journal.pone.0083875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416178	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000329862500081
J	Haseleu, J; Omerbasic, D; Frenzel, H; Gross, M; Lewin, GR				Haseleu, Julia; Omerbasic, Damir; Frenzel, Henning; Gross, Manfred; Lewin, Gary R.			Water-Induced Finger Wrinkles Do Not Affect Touch Acuity or Dexterity in Handling Wet Objects	PLOS ONE			English	Article							SYMPATHETIC FUNCTION; REPLANTED FINGERS; NERVE INJURY; IMMERSION; VASOCONSTRICTION; TESTS; EMLA	Human non-hairy (glabrous) skin of the fingers, palms and soles wrinkles after prolonged exposure to water. Wrinkling is a sympathetic nervous system-dependent process but little is known about the physiology and potential functions of water-induced skin wrinkling. Here we investigated the idea that wrinkling might improve handling of wet objects by measuring the performance of a large cohort of human subjects (n = 40) in a manual dexterity task. We also tested the idea that skin wrinkling has an impact on tactile acuity or vibrotactile sensation using two independent sensory tasks. We found that skin wrinkling did not improve dexterity in handling wet objects nor did it affect any aspect of touch sensitivity measured. Thus water-induced wrinkling appears to have no significant impact on tactile driven performance or dexterity in handling wet or dry objects.	[Haseleu, Julia; Omerbasic, Damir; Frenzel, Henning; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany; [Gross, Manfred] Charite, Dept Audiol & Phoniatr, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany.	glewin@mdc-berlin.de	Lewin, Gary R/B-8028-2011	Lewin, Gary/0000-0002-2890-6352; Haseleu, Julia/0000-0002-6827-074X; Omerbasic, Damir/0000-0003-1839-4856	European Research Council (ERC); Deutsche Forschungsgemeinschaft via collaborative research center 665	European Research Council (ERC)(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft via collaborative research center 665	The work was supported by grants from the European Research Council (ERC) and the Deutsche Forschungsgemeinschaft via collaborative research center 665. None of the the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ G, 1980, BRIT MED J, V281, P586, DOI 10.1136/bmj.281.6240.586-a; BRAHAM J, 1979, ARCH NEUROL-CHICAGO, V36, P113, DOI 10.1001/archneur.1979.00500380083013; BULL C, 1977, BRIT MED J, V1, P551, DOI 10.1136/bmj.1.6060.551-a; Cales L, 1997, J HAND SURG-AM, V22, P747, DOI 10.1016/S0363-5023(97)80141-4; Changizi M, 2011, BRAIN BEHAV EVOLUT, V77, P286, DOI 10.1159/000328223; Daanen HAM, 2003, EUR J APPL PHYSIOL, V89, P411, DOI 10.1007/s00421-003-0818-2; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Frenzel H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001318; Heidenreich M, 2012, NAT NEUROSCI, V15, P138, DOI 10.1038/nn.2985; Hsieh CH, 2007, J SURG RES, V143, P265, DOI 10.1016/j.jss.2006.07.042; Hsieh CH, 2006, CLIN AUTON RES, V16, P223, DOI 10.1007/s10286-006-0340-9; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kareklas K, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0999; Lechner SG, 2013, PHYSIOLOGY, V28, P142, DOI 10.1152/physiol.00059.2012; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lewis T, 1936, CLIN SCI, V2, P149; Lumpkin EA, 2010, J CELL BIOL, V191, P237, DOI 10.1083/jcb.201006074; NAGASAKA T, 1986, PFLUG ARCH EUR J PHY, V407, P71, DOI 10.1007/BF00580723; NAGASAKA T, 1990, J APPL PHYSIOL, V68, P71, DOI 10.1152/jappl.1990.68.1.71; NAGASAKA T, 1987, JPN J PHYSIOL, V37, P425, DOI 10.2170/jjphysiol.37.425; ORIAIN S, 1973, BRIT MED J, V3, P615, DOI 10.1136/bmj.3.5881.615; PHELPS PE, 1977, AM J OCCUP THER, V31, P565; POULTON EC, 1966, PSYCHOL BULL, V66, P1, DOI 10.1037/h0023427; Tindall A, 2006, EMERG MED J, V23, P883, DOI 10.1136/emj.2005.031377; Tsai N, 2005, J HAND SURG-BRIT EUR, V30B, P273, DOI 10.1016/j.jhsb.2004.12.010; Vasudevan TM, 2000, AUST NZ J SURG, V70, P57, DOI 10.1046/j.1440-1622.2000.01744.x; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Wilder-Smith E, 2003, MICROVASC RES, V66, P68, DOI 10.1016/S0026-2862(03)00020-7; Wilder-Smith EPV, 2004, CLIN AUTON RES, V14, P125, DOI 10.1007/s10286-004-0172-4; Wilder-Smith EPV, 2003, MUSCLE NERVE, V27, P307, DOI 10.1002/mus.10323; Zwislocki JJ, 2001, P NATL ACAD SCI USA, V98, P4811, DOI 10.1073/pnas.081082598	31	9	9	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84949	10.1371/journal.pone.0084949	http://dx.doi.org/10.1371/journal.pone.0084949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416318	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500195
J	Muniz, S; Lacarta, J; Pata, MP; Jimenez, JJ; Navarro, E				Muniz, Selene; Lacarta, Juan; Pata, Maria P.; Jose Jimenez, Juan; Navarro, Enrique			Analysis of the Diversity of Substrate Utilisation of Soil Bacteria Exposed to Cd and Earthworm Activity Using Generalised Additive Models	PLOS ONE			English	Article							LEVEL PHYSIOLOGICAL PROFILES; MICROBIAL COMMUNITY; HEAVY-METALS; FUNCTIONAL DIVERSITY; UTILIZATION PATTERN; TOLERANCE; BIOMASS; EFFICIENCY; POLLUTION; CADMIUM	Biolog EcoPlates (TM) can be used to measure the carbon substrate utilisation patterns of microbial communities. This method results in a community-level physiological profile (CLPP), which yields a very large amount of data that may be difficult to interpret. In this work, we explore a combination of statistical techniques (particularly the use of generalised additive models [GAMs]) to improve the exploitation of CLPP data. The strength of GAMs lies in their ability to address highly non-linear relationships between the response and the set of explanatory variables. We studied the impact of earthworms (Aporrectodea caliginosa Savigny 1826) and cadmium (Cd) on the CLPP of soil bacteria. The results indicated that both Cd and earthworms modified the CLPP. GAMs were used to assess time-course changes in the diversity of substrate utilisation (DSU) using the Shannon-Wiener index. GAMs revealed significant differences for all treatments (compared to control -S-). The Cd exposed microbial community presented very high metabolic capacities on a few substrata, resulting in an initial acute decrease of DSU (i.e. intense utilization of a few carbon substrata). After 54 h, and over the next 43 h the increase of the DSU suggest that other taxa, less dominant, reached high numbers in the wells containing sources that are less suitable for the Cd-tolerant taxa. Earthworms were a much more determining factor in explaining time course changes in DSU than Cd. Accordingly, Ew and EwCd soils presented similar trends, regardless the presence of Cd. Moreover, both treatments presented similar number of bacteria and higher than Cd-treated soils. This experimental approach, based on the use of DSU and GAMs allowed for a global and statistically relevant interpretation of the changes in carbon source utilisation, highlighting the key role of earthworms on the protection of microbial communities against the Cd.	[Muniz, Selene; Lacarta, Juan; Pata, Maria P.; Jose Jimenez, Juan; Navarro, Enrique] Spanish Natl Res Council, Dept Biodivers & Conservat & Ecosyst Restorat, Pyrenean Inst Ecol, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Navarro, E (corresponding author), Spanish Natl Res Council, Dept Biodivers & Conservat & Ecosyst Restorat, Pyrenean Inst Ecol, Zaragoza, Spain.	enrique.navarro@ipe.csic.es	Navarro, Enrique/A-4869-2009; Jiménez, Juan J./B-9058-2013	Navarro, Enrique/0000-0002-3964-4431; Jiménez, Juan J./0000-0003-2398-0796; Muniz Cabrera, Selene/0000-0002-2741-1331	Spanish Ministry of Economy and Competitiveness (National Research Plan) [BFU2010-22053]; ARAID Foundation	Spanish Ministry of Economy and Competitiveness (National Research Plan); ARAID Foundation	This work was supported by Spanish Ministry of Economy and Competitiveness (National Research Plan, ref. BFU2010-22053, http://www.mineco.gob.es/portal/site/mineco/). The ARAID Foundation (http://www.araid.es/) is also acknowledged for support provided to J.J. JimA (c) nez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmal M, 2005, CHEMOSPHERE, V60, P508, DOI 10.1016/j.chemosphere.2005.01.001; Almas AR, 2004, SOIL BIOL BIOCHEM, V36, P805, DOI 10.1016/j.soilbio.2004.01.010; [Anonymous], 1998, D2216 ASTM INT, DOI [10.1520/D2216-98, http://www.astm.org, DOI 10.1520/D2216-98.AVAILABLE:HTTP://WWW.ASTM.0RG]; Bouche M.B., 1975, BIODEGRADATION HUMIF, P157; Classen AT, 2003, FEMS MICROBIOL ECOL, V44, P319, DOI 10.1016/S0168-6496(03)00068-0; Degens BP, 2001, SOIL BIOL BIOCHEM, V33, P1143, DOI 10.1016/S0038-0717(01)00018-9; DiazRavina M, 1996, APPL ENVIRON MICROB, V62, P2970, DOI 10.1128/AEM.62.8.2970-2977.1996; Dominici F, 2004, J AM STAT ASSOC, V99, P938, DOI 10.1198/016214504000000656; Friendly M, 2013, CANDISC VISUALIZING; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Gomez-Brandon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031895; Gregori G, 2001, APPL ENVIRON MICROB, V67, P4662, DOI 10.1128/AEM.67.10.4662-4670.2001; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Hackett CA, 1997, J MICROBIOL METH, V30, P63, DOI 10.1016/S0167-7012(97)00045-6; HASTIE T, 1990, BIOMETRICS, V46, P1005, DOI 10.2307/2532444; Hobbelen PHF, 2006, ENVIRON POLLUT, V144, P639, DOI 10.1016/j.envpol.2006.01.019; Ikeda H, 2004, P INT S ID US MICR R, P169; Insam H, 1997, MICROBIAL COMMUNITIES, P259; Insam H, 2004, MOL MICROBIAL ECOLOG, P1780; Jegou D, 2001, APPL SOIL ECOL, V17, P165, DOI 10.1016/S0929-1393(00)00136-0; Jiang W, 2010, ENVIRON EARTH SCI, V59, P1717, DOI 10.1007/s12665-009-0153-y; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; JOSCHKO M, 1989, BIOL FERT SOILS, V8, P191, DOI 10.1007/BF00266478; Kamitani T, 2006, WATER AIR SOIL POLL, V172, P185, DOI 10.1007/s11270-005-9073-y; Karaca A, 2010, SOIL BIOL, V19, P237, DOI 10.1007/978-3-642-02436-8_11; Katayama A, 1998, SOIL SCI PLANT NUTR, V44, P245, DOI 10.1080/00380768.1998.10414445; Khalil MA, 1996, PEDOBIOLOGIA, V40, P548; KLINGLER JM, 1992, APPL ENVIRON MICROB, V58, P2089, DOI 10.1128/AEM.58.6.2089-2092.1992; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lavelle P., 2001, SOIL ECOLOGY; MARINISSEN JCY, 1990, BIOL FERT SOILS, V9, P163, DOI 10.1007/BF00335801; McLaughlin M.J., 1999, CADMIUM SOILS PLANTS; Ministry-of-Agriculture, 1975, B OFICIAL ESTADO BOE, V78, P6458; Moret-Fernandez D, 2011, TDR LAB VERSION 1 2; Muller AK, 2001, FEMS MICROBIOL LETT, V204, P49, DOI 10.1016/S0378-1097(01)00376-7; Nakatsu CH, 2005, APPL ENVIRON MICROB, V71, P7679, DOI 10.1128/AEM.71.12.7679-7689.2005; Niklinska M, 2005, SOIL BIOL BIOCHEM, V37, P2185, DOI 10.1016/j.soilbio.2005.03.020; Preston-Mafham J, 2002, FEMS MICROBIOL ECOL, V42, P1, DOI 10.1111/j.1574-6941.2002.tb00990.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Ritz C, 2005, J STAT SOFTW, V12, P1; Rombke J, 2006, HUM ECOL RISK ASSESS, V12, P84, DOI 10.1080/10807030500430427; Rutgers M, 1998, ENVIRON TOXICOL CHEM, V17, P2210, DOI [10.1002/etc.5620171111, 10.1897/1551-5028(1998)017&lt;2210:RMFAPI&gt;2.3.CO;2]; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHIPITALO MJ, 1989, GEODERMA, V45, P357, DOI 10.1016/0016-7061(89)90016-5; Sizmur T, 2009, ENVIRON POLLUT, V157, P1981, DOI 10.1016/j.envpol.2009.02.029; Smalla K, 1998, APPL ENVIRON MICROB, V64, P1220; Tam L, 2001, BIODIVERS CONSERV, V10, P1933, DOI 10.1023/A:1013143503902; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Udovic M, 2007, ENVIRON POLLUT, V148, P663, DOI 10.1016/j.envpol.2006.11.010; van Beelen P, 2004, ENVIRON TOXICOL CHEM, V23, P2769, DOI 10.1897/03-568; Violante A, 2008, WILEY-IUPAC SER BIOP, P1; Wang Y, 2011, J SOIL SEDIMENT, V11, P789, DOI 10.1007/s11368-011-0352-5; Wood SN, 2006, AUST NZ J STAT, V48, P445, DOI 10.1111/j.1467-842X.2006.00450.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Yao HY, 2003, GEODERMA, V115, P139, DOI 10.1016/S0016-7061(03)00083-1; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170; ZHANG H, 1993, BIOL FERT SOILS, V15, P229, DOI 10.1007/BF00361617	58	41	41	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85057	10.1371/journal.pone.0085057	http://dx.doi.org/10.1371/journal.pone.0085057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416339	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500209
J	Sogbohossou, EA; Bauer, H; Loveridge, A; Funston, PJ; De Snoo, GR; Sinsin, B; De Iongh, HH				Sogbohossou, Etotepe A.; Bauer, Hans; Loveridge, Andrew; Funston, Paul J.; De Snoo, Geert R.; Sinsin, Brice; De Iongh, Hans H.			Social Structure of Lions (Panthera leo) Is Affected by Management in Pendjari Biosphere Reserve, Benin	PLOS ONE			English	Article							NATIONAL-PARK; POPULATION; WEST; COALITIONS	Lion populations have undergone a severe decline in West Africa. As baseline for conservation management, we assessed the group structure of lions in the Pendjari Biosphere Reserve in Benin. This reserve, composed of one National Park and two Hunting Zones, is part of the WAP transboundary complex of protected areas. Overall mean group size was 2.6 +/- 1.7 individuals (n = 296), it was significantly higher in the National Park (2.7 +/- 1.7, n = 168) than in the Hunting Zones (2.2 +/- 1.5, n = 128). Overall adult sex ratio was even, but significantly biased towards females (0.67) in the National Park and towards males (1.67) in the Hunting Zones. Our results suggest that the Pendjari lion population is affected by perturbations, such as trophy hunting.	[Sogbohossou, Etotepe A.; Sinsin, Brice] Univ Abomey Calavi, Lab Appl Ecol, Cotonou, Benin; [Funston, Paul J.] Panthera, Kongola, Caprivi Region, Namibia; [De Snoo, Geert R.; De Iongh, Hans H.] Leiden Univ, Inst Environm Sci, Leiden, Netherlands	University of Abomey Calavi; Leiden University; Leiden University - Excl LUMC	Sogbohossou, EA (corresponding author), Univ Abomey Calavi, Lab Appl Ecol, Cotonou, Benin.	etotepe@gmail.com	SOGBOHOSSOU, Etotepe A/HDL-8938-2022	Bauer, Hans/0000-0001-5031-5842	Dutch Organisation for Cooperation in Higher Education (NUFFIC); African Wildlife Foundation (AWF)	Dutch Organisation for Cooperation in Higher Education (NUFFIC); African Wildlife Foundation (AWF)	This study was part of the PhD project of the first author, ES. Her scholarship costs were covered by the Dutch Organisation for Cooperation in Higher Education (NUFFIC). All operational costs for the collection of data for the present paper were covered by the African Wildlife Foundation (AWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2004, Cat News, V41, P35; Bauer H, 2003, MAMM BIOL, V68, P239, DOI 10.1078/1616-5047-00090; Bauer H, 2008, MAMM BIOL, V73, P70, DOI 10.1016/j.mambio.2006.11.006; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Bertram BCR, 1975, J ZOOL LOND, V177, P483; Burton AC, 2011, AFR J ECOL, V49, P122, DOI 10.1111/j.1365-2028.2010.01234.x; BYGOTT JD, 1979, NATURE, V282, P839, DOI 10.1038/282839a0; Clerici N, 2005, C LANDSC EC PATT PRO; Creel S, 1997, AFR J ECOL, V35, P83, DOI 10.1111/j.1365-2028.1997.062-89062.x; Di Silvestre Ilaria, 2013, Cat News, V58, P16; Funston PJ, 2011, S AFR J WILDL RES, V41, P1, DOI 10.3957/056.041.0108; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Henschel Philipp, 2010, Cat News, V52, P34; IUCN, 2012, MOT WORLD CONS C JEJ; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge Andrew J., 2010, P283; Meena V., 2009, Journal of Threatened Taxa, V1, P158; Mills M.G.L., 1978, Koedoe, V21, P163; Mosser A, 2009, ANIM BEHAV, V78, P359, DOI 10.1016/j.anbehav.2009.04.024; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Schaller G. B., 1972, SERENGETI LION; Sinsin B, 2002, MAMMALIA, V66, P369, DOI 10.1515/mamm.2002.66.3.369; SMUTS GL, 1978, CARNIVORE, V1, P17; Sogbohossou EA, 2011, ORYX, V45, P569, DOI 10.1017/S0030605310001109; STANDER P E, 1991, Madoqua, V18, P1; Tumenta PN, 2010, AFR J ECOL, V48, P888, DOI 10.1111/j.1365-2028.2009.01181.x; UICN/PACO, 2009, GRAND CHASS AFR OUES; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6	31	15	15	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84674	10.1371/journal.pone.0084674	http://dx.doi.org/10.1371/journal.pone.0084674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416263	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500148
J	Sproul, AA; Jacob, S; Pre, D; Kim, SH; Nestor, MW; Navarro-Sobrino, M; Santa-Maria, I; Zimmer, M; Aubry, S; Steele, JW; Kahler, DJ; Dranovsky, A; Arancio, O; Crary, JF; Gandy, S; Noggle, SA				Sproul, Andrew A.; Jacob, Samson; Pre, Deborah; Kim, Soong Ho; Nestor, Michael W.; Navarro-Sobrino, Miriam; Santa-Maria, Ismael; Zimmer, Matthew; Aubry, Soline; Steele, John W.; Kahler, David J.; Dranovsky, Alex; Arancio, Ottavio; Crary, John F.; Gandy, Sam; Noggle, Scott A.			Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; 21ST-CENTURY BRAIN BANKING; NEURONAL GENE-EXPRESSION; COLUMBIA-UNIVERSITY; ADULT NEUROGENESIS; TRANSGENIC MICE; HUMAN ES; A-BETA; PRESENILIN-1; ACTIVATION	Presenilin 1 (PSEN1) encodes the catalytic subunit of gamma-secretase, and PSEN1 mutations are the most common cause of early onset familial Alzheimer's disease (FAD). In order to elucidate pathways downstream of PSEN1, we characterized neural progenitor cells (NPCs) derived from FAD mutant PSEN1 subjects. Thus, we generated induced pluripotent stem cells (iPSCs) from affected and unaffected individuals from two families carrying PSEN1 mutations. PSEN1 mutant fibroblasts, and NPCs produced greater ratios of A beta 42 to A beta 40 relative to their control counterparts, with the elevated ratio even more apparent in PSEN1 NPCs than in fibroblasts. Molecular profiling identified 14 genes differentially-regulated in PSEN1 NPCs relative to control NPCs. Five of these targets showed differential expression in late onset AD/Intermediate AD pathology brains. Therefore, in our PSEN1 iPSC model, we have reconstituted an essential feature in the molecular pathogenesis of FAD, increased generation of A beta 42/40, and have characterized novel expression changes.	[Sproul, Andrew A.; Jacob, Samson; Nestor, Michael W.; Zimmer, Matthew; Kahler, David J.; Noggle, Scott A.] New York Stem Cell Fdn, New York, NY 10023 USA; [Pre, Deborah; Santa-Maria, Ismael; Aubry, Soline; Arancio, Ottavio; Crary, John F.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Pre, Deborah; Santa-Maria, Ismael; Aubry, Soline; Arancio, Ottavio; Crary, John F.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Kim, Soong Ho; Steele, John W.; Gandy, Sam] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY USA; [Kim, Soong Ho; Steele, John W.; Gandy, Sam] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Kim, Soong Ho; Steele, John W.; Gandy, Sam] Icahn Sch Med Mt Sinai, Alzheimers Dis Res Ctr, New York, NY USA; [Navarro-Sobrino, Miriam; Dranovsky, Alex] Columbia Univ, Dept Psychiat, New York, NY USA; [Gandy, Sam] James J Peters Vet Adm Med Ctr, Bronx, NY USA	The New York Stem Cell Foundation; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Sproul, AA (corresponding author), New York Stem Cell Fdn, New York, NY 10023 USA.	asproul@nsycf.org; snoggle@nyscf.org	Kahler, David J/I-9275-2019; Dranovsky, Alex/P-4357-2018; Santa-Maria, Ismael/AAI-7630-2020; arancio, ottavio/AAB-7959-2019	Kahler, David J/0000-0002-7144-2215; Dranovsky, Alex/0000-0001-7896-3243; arancio, ottavio/0000-0001-6335-164X; PRE, deborah/0000-0002-0163-9514; Noggle, Scott/0000-0002-0374-2240; Sproul, Andrew/0000-0001-6972-1592; Santa-Maria Perez, Ismael/0000-0003-2801-5020	Charles Evans Foundation; Alzheimer's Drug Discovery Foundation; NY Community Trust; National Institutes of Health (NIH) [R21AG042965, 1U01AG046170-01, NS049442, R01MH091844]; Cure Alzheimer's Fund; BrightFocus Foundation; Taub Institute; Aging Brain at Columbia University [P50AG08702, RO1AG037212, P01AG07232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG046170, P50AG005138, P50AG008702, R01AG037212, P01AG007232] Funding Source: NIH RePORTER	Charles Evans Foundation; Alzheimer's Drug Discovery Foundation; NY Community Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; BrightFocus Foundation(BrightFocus Foundation); Taub Institute; Aging Brain at Columbia University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is generously supported by grants to Scott Noggle by Charles Evans Foundation, Alzheimer's Drug Discovery Foundation, and NY Community Trust. Scott Noggle and Sam Gandy are jointly supported by National Institutes of Health (NIH) grants R21AG042965 and 1U01AG046170-01, and the Cure Alzheimer's Fund. Ottavio Arancio is supported by NIH grant NS049442. Alex Dranovsky is supported by NIH grant R01MH091844. Soong Ho Kim is supported by the BrightFocus Foundation. The authors express their sincerest gratitude to the patients and staff of the Taub Institute for Research on Alzheimer's Disease & the Aging Brain at Columbia University (P50AG08702, RO1AG037212, P01AG07232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SE, 1994, ARCH NEUROL-CHICAGO, V51, P145, DOI 10.1001/archneur.1994.00540140051014; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Beal MF, 2011, AMINO ACIDS, V40, P1305, DOI 10.1007/s00726-011-0851-0; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Braunger BM, 2012, ADV EXP MED BIOL, V723, P679, DOI 10.1007/978-1-4614-0631-0_86; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Castellano JM, 2012, P NATL ACAD SCI USA, V109, P15502, DOI 10.1073/pnas.1206446109; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Dagenais M, 2012, CELL DEATH DIFFER, V19, P5, DOI 10.1038/cdd.2011.159; Debrincat MA, 2007, J BIOL CHEM, V282, P4728, DOI 10.1074/jbc.M609164200; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Elder GA, 2010, BRAIN STRUCT FUNCT, V214, P127, DOI 10.1007/s00429-009-0227-3; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; HENEKA MT, 2012, NATURE, V493, P674, DOI DOI 10.1038/NATURE11729; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim JH, 2012, J NEUROCHEM, V121, P751, DOI 10.1111/j.1471-4159.2012.07725.x; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Kwok JBJ, 2003, J BIOL CHEM, V278, P6748, DOI 10.1074/jbc.M211827200; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2010, NEUROBIOL AGING, V31, P549, DOI 10.1016/j.neurobiolaging.2008.05.013; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; MURPHY TH, 1992, J NEUROSCI, V12, P4834; NIELSEN J, 1976, CLIN GENET, V10, P161; Ozair MZ, 2013, STEM CELLS, V31, P35, DOI 10.1002/stem.1246; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Santa-Maria I, 2012, ACTA NEUROPATHOL, V124, P693, DOI 10.1007/s00401-012-1017-1; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Sproul AA, 2009, CELL RES, V19, P950, DOI 10.1038/cr.2009.74; Thambisetty M, 2013, BIOL PSYCHIAT, V73, P422, DOI 10.1016/j.biopsych.2012.08.015; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Vonsattel JPG, 2008, CELL TISSUE BANK, V9, P247, DOI 10.1007/s10561-008-9079-y; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394	52	120	122	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84547	10.1371/journal.pone.0084547	http://dx.doi.org/10.1371/journal.pone.0084547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416243	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500135
J	Takasawa, K; Kashimada, K; Pelosi, E; Takagi, M; Morio, T; Asahara, H; Schlessinger, D; Mizutani, S; Koopman, P				Takasawa, Kei; Kashimada, Kenichi; Pelosi, Emanuele; Takagi, Masatoshi; Morio, Tomohiro; Asahara, Hiroshi; Schlessinger, David; Mizutani, Shuki; Koopman, Peter			FOXL2 transcriptionally represses Sf1 expression by antagonizing WT1 during ovarian development in mice	FASEB JOURNAL			English	Article						sex determination; reproduction; LHX9	STEROIDOGENIC FACTOR-I; SEX DETERMINATION; NUCLEAR RECEPTOR; GONADAL DEVELOPMENT; FOLLICLE DEVELOPMENT; GENE-EXPRESSION; GRANULOSA-CELLS; MOUSE; FACTOR-1; PROMOTER	Steroidogenic factor 1 (SF1; Ad4BP/NR5A1) plays key roles in gonadal development. Initially, the Sf1 gene is expressed in mouse fetal gonads of both sexes, but later is up-regulated in testes and down-regulated in ovaries. While Sf1 expression is activated and maintained by Wilms tumor 1 (WT1) and LIM homeobox 9 (LHX9), the mechanism of sex-specific regulation remains unclear. We hypothesized that Sf1 is repressed by the transcription factor Forkhead box L2 (FOXL2) during ovarian development. In an in vitro system (TM3 cells), up-regulation of Sf1 by the WT1 splice variant WT1-KTS was antagonized by FOXL2, as determined by quantitative RT-PCR. Using reporter assays, we localized the Sf1 proximal promoter region involved in this antagonism to a 674-bp interval. A conserved FOXL2 binding site was identified in this interval by in vitro chromatin immunoprecipitation. Introducing mutations into this site abolished negative regulation by FOXL2 in reporter assays. Finally, in Foxl2-null mice, Sf1 expression was increased 2-fold relative to wild-type XX fetal gonads. Our results support the hypothesis that FOXL2 negatively regulates Sf1 expression by antagonizing WT1-KTS during early ovarian development in mice.Takasawa, K., Kashimada, K., Pelosi, E., Takagi, M., Morio, T., Asahara, H., Schlessinger, D., Mizutani, S., Koopman, P. FOXL2 transcriptionally represses Sf1 expression by antagonizing WT1 during ovarian development in mice.	[Takasawa, Kei; Kashimada, Kenichi; Takagi, Masatoshi; Morio, Tomohiro; Mizutani, Shuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Asahara, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Syst BioMed, Bunkyo Ku, Tokyo 1138510, Japan; [Pelosi, Emanuele; Schlessinger, David] NIA, Intramural Res Program, Genet Lab, US Natl Inst Hlth Biomed Res Ctr, Baltimore, MD 21224 USA; [Koopman, Peter] Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, Brisbane, Qld, Australia	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Queensland	Kashimada, K (corresponding author), Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138510, Japan.	kkashimada.ped@tmd.ac.jp	Koopman, Peter A/C-9416-2009; Pelosi, Emanuele/D-2015-2017	Koopman, Peter A/0000-0001-6939-0914; Pelosi, Emanuele/0000-0003-1890-9821; Morio, Tomohiro/0000-0002-9259-1025; Takasawa, Kei/0000-0001-6947-4034; Kashimada, Kenichi/0000-0003-2505-5932	Intramural Research Program of the U.S. National Institutes of Health, National Institute on Aging; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [23249071]; Japan Society for the Promotion of Science (JSPS) KAKENHI grant [24115707]; Japan Science and Technology Agency (JST) Core Research for Evolutionary Science and Technology (CREST) [24591503]; NATIONAL INSTITUTE ON AGING [ZIAAG000647] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23249071, 24591503] Funding Source: KAKEN	Intramural Research Program of the U.S. National Institutes of Health, National Institute on Aging; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency (JST) Core Research for Evolutionary Science and Technology (CREST); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dagmar Wilhelm (Monash University, Melbourne, VIC, Australia) for critical reading of the manuscript and Atsushi Kubo (Tokyo Medical and Dental University) for technical support. This research was supported, in part, by the Intramural Research Program of the U.S. National Institutes of Health, National Institute on Aging, for E.P. and D.S.; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Grants-in-Aid for Scientific Research (KAKENHI) grant 23249071, Japan Society for the Promotion of Science (JSPS) KAKENHI grant 24115707, and Japan Science and Technology Agency (JST) Core Research for Evolutionary Science and Technology (CREST), for H.A.; and KAKENHI (C) grant 24591503, for K.K.	Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Beverdam A, 2003, CYTOGENET GENOME RES, V101, P242, DOI 10.1159/000074344; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Caburet S, 2012, MOL CELL ENDOCRINOL, V356, P55, DOI 10.1016/j.mce.2011.06.019; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Gao LY, 2011, BIOL REPROD, V84, P422, DOI 10.1095/biolreprod.110.084590; Georges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025463; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Kashimada K, 2011, FASEB J, V25, P3561, DOI 10.1096/fj.11-184333; Kashimada K, 2011, ENDOCRINOLOGY, V152, P272, DOI 10.1210/en.2010-0636; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Morohashi KI, 1996, FASEB J, V10, P1569, DOI 10.1096/fasebj.10.14.9002548; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Park M, 2010, MOL ENDOCRINOL, V24, P1024, DOI 10.1210/me.2009-0375; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; RICE DA, 1991, MOL ENDOCRINOL, V5, P1552, DOI 10.1210/mend-5-10-1552; Roberts SGE, 2005, CURR OPIN GENET DEV, V15, P542, DOI 10.1016/j.gde.2005.08.004; Schepers G, 2003, J BIOL CHEM, V278, P28101, DOI 10.1074/jbc.M304067200; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shen JHC, 2002, MOL ENDOCRINOL, V16, P529, DOI 10.1210/me.16.3.529; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Wagner KD, 2003, J CELL SCI, V116, P1653, DOI 10.1242/jcs.00405; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; Wilson MJ, 2005, J BIOL CHEM, V280, P5917, DOI 10.1074/jbc.M412806200; Woodson KG, 1997, MOL ENDOCRINOL, V11, P117, DOI 10.1210/me.11.2.117	40	37	40	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2020	2028		10.1096/fj.13-246108	http://dx.doi.org/10.1096/fj.13-246108			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24451388	Green Published, Bronze			2022-12-25	WOS:000335336000007
J	Ghaddar, K; Krammer, EM; Mihajlovic, N; Brohee, S; Andre, B; Prevost, M				Ghaddar, Kassem; Krammer, Eva-Maria; Mihajlovic, Natalija; Brohee, Sylvain; Andre, Bruno; Prevost, Martine			Converting the Yeast Arginine Can1 Permease to a Lysine Permease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Membrane Proteins; Molecular Modeling; Protein Engineering; Proton Transport; Site-directed Mutagenesis; Transporters; Yeast Physiology; Ligand Docking	AMINO-ACID ANTIPORTER; PROTEIN DATA-BANK; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; TRANSPORTING SYSTEM; STRUCTURAL BASIS; LEUT-FOLD; MECHANISM; DOCKING; PREDICTION	Background: Can1 is a yeast plasma membrane permease catalyzing specific uptake of arginine. Results: Two residues in the binding pocket of Can1 affect its selectivity. Conclusion: Subtle amino acid changes can convert Can1 to a lysine-specific permease. Significance: Understanding, at the molecular level, the translocation mechanism(s) of yeast amino acid transporters has bearings on our knowledge of other transporters featuring the same fold. Amino acid uptake in yeast cells is mediated by about 16 plasma membrane permeases, most of which belong to the amino acid-polyamine-organocation (APC) transporter family. These proteins display various substrate specificity ranges. For instance, the general amino acid permease Gap1 transports all amino acids, whereas Can1 and Lyp1 catalyze specific uptake of arginine and lysine, respectively. Although Can1 and Lyp1 have different narrow substrate specificities, they are close homologs. Here we investigated the molecular rules determining the substrate specificity of the H+-driven arginine-specific permease Can1. Using a Can1-Lyp1 sequence alignment as a guideline and a three-dimensional Can1 structural model based on the crystal structure of the bacterial APC family arginine/agmatine antiporter, we introduced amino acid substitutions liable to alter Can1 substrate specificity. We show that the single substitution T456S results in a Can1 variant transporting lysine in addition to arginine and that the combined substitutions T456S and S176N convert Can1 to a Lyp1-like permease. Replacement of a highly conserved glutamate in the Can1 binding site leads to variants (E184Q and E184A) incapable of any amino acid transport, pointing to a potential role for this glutamate in H+ coupling. Measurements of the kinetic parameters of arginine and lysine uptake by the wild-type and mutant Can1 permeases, together with docking calculations for each amino acid in their binding site, suggest a model in which residues at positions 176 and 456 confer substrate selectivity at the ligand-binding stage and/or in the course of conformational changes required for transport.	[Ghaddar, Kassem; Mihajlovic, Natalija; Andre, Bruno] Univ Libre Bruxelles, Lab Physiol Mol Cellule CP300, B-6041 Gosselies, Belgium; [Krammer, Eva-Maria; Prevost, Martine] Univ Libre Bruxelles, Ctr Biol Struct & Bioinformat, B-1050 Brussels, Belgium; [Brohee, Sylvain] Univ Libre Bruxelles, Machine Learning Grp, Dept Comp Sci, Fac Sci, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Andre, B (corresponding author), Univ Libre Bruxelles, Lab Physiol Mol Cellule CP300, 11 Rue Pr Jeener & Brachet, B-6041 Gosselies, Belgium.	bran@ulb.ac.be; mprevost@ulb.ac.be	Krammer, Eva-Maria/H-2543-2013	Krammer, Eva-Maria/0000-0002-4821-2550	Fonds de la Recherche Scientifique Medicale [3.4.592.08.F]; Actions de Recherche Concertees Grant of the Federation Wallonie-Bruxelles [AUWB 2010-15-2]	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees Grant of the Federation Wallonie-Bruxelles	This work was supported by Fonds de la Recherche Scientifique Medicale Grant 3.4.592.08.F and Actions de Recherche Concertees Grant AUWB 2010-15-2 of the Federation Wallonie-Bruxelles.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andre B, 1995, YEAST, V11, P1575, DOI 10.1002/yea.320111605; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Brohee S, 2011, NUCLEIC ACIDS RES, V39, P6340, DOI 10.1093/nar/gkr264; Brohee S, 2010, BBA-BIOMEMBRANES, V1798, P1908, DOI 10.1016/j.bbamem.2010.06.008; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Du J, 2011, J COMPUT CHEM, V32, P2800, DOI 10.1002/jcc.21859; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Graves AP, 2008, J MOL BIOL, V377, P914, DOI 10.1016/j.jmb.2008.01.049; Greenidge PA, 2013, J CHEM INF MODEL, V53, P201, DOI [10.1021/cI300025v, 10.1021/ci300425v]; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P339, DOI 10.1016/0304-4165(66)90388-6; Hayes JM, 2012, IN TECH CH, V9, P171; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; HOFFMANN W, 1985, J BIOL CHEM, V260, P1831; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Jeschke G, 2013, EUR BIOPHYS J BIOPHY, V42, P181, DOI 10.1007/s00249-012-0802-z; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li JN, 2011, PROTEINS, V79, P2794, DOI 10.1002/prot.23106; Liang J, 2012, BBA-BIOMEMBRANES, V1818, P927, DOI 10.1016/j.bbamem.2011.09.026; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; OH BH, 1994, J BIOL CHEM, V269, P26323; Opekarova M, 2002, BBA-BIOMEMBRANES, V1564, P9, DOI 10.1016/S0005-2736(02)00455-8; OPEKAROVA M, 1993, EUR J BIOCHEM, V211, P683, DOI 10.1111/j.1432-1033.1993.tb17596.x; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; SYCHROVA H, 1993, YEAST, V9, P771, DOI 10.1002/yea.320090711; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ullmann RT, 2012, J PHYS CHEM B, V116, P9690, DOI 10.1021/jp305440f; Ullmann RT, 2012, J COMPUT CHEM, V33, P887, DOI 10.1002/jcc.22919; Ullmann RT, 2011, J PHYS CHEM B, V115, P10346, DOI 10.1021/jp204644h; Van Belle D, 2001, CURR OPIN CELL BIOL, V13, P389, DOI 10.1016/S0955-0674(00)00226-X; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	69	32	32	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7232	7246		10.1074/jbc.M113.525915	http://dx.doi.org/10.1074/jbc.M113.525915			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24448798	Green Published, hybrid			2022-12-25	WOS:000332389400081
J	Kumar, P; Tripathi, S; Pandey, KN				Kumar, Prerna; Tripathi, Satyabha; Pandey, Kailash N.			Histone Deacetylase Inhibitors Modulate the Transcriptional Regulation of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Gene INTERACTIVE ROLES OF MODIFIED HISTONES, HISTONE ACETYLTRANSFERASE, p300, AND Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Gene Transcription; Histone Deacetylase Inhibitors; Natriuretic Peptides; p300; Sp1	MEDULLARY COLLECTING DUCT; ATRIAL-NATRIURETIC-PEPTIDE; CGMP-RESPONSE ELEMENT; ESSENTIAL-HYPERTENSION; CARDIAC-HYPERTROPHY; PROMOTER ACTIVITY; PROTEIN-KINASE; ACETYLATION; EXPRESSION; CELLS	Background: Natriuretic peptide receptor-A (NPRA) lowers blood pressure and blood volume. Results: Data show that histone deacetylase inhibitors (HDACi) enhance NPRA expression by blocking HDACs and interacting with Sp1, histone acetyltransferase, and acetylated histones. Conclusion: Results suggest that epigenetic mechanisms regulate NPRA gene transcription. Significance: Findings will help to identify molecular targets regulating NPRA expression and function in vivo. Atrial natriuretic peptide (ANP) binds guanylyl cyclase-A/natriuretic peptide receptor-A (GC-A/NPRA) and produces the intracellular second messenger, cGMP, which regulates cardiovascular homeostasis. We sought to determine the function of histone deacetylases (HDACs) in regulating Npr1 (coding for GC-A/NPRA) gene transcription, using primary mouse mesangial cells treated with class-specific HDAC inhibitors (HDACi). Trichostatin A, a pan inhibitor, and mocetinostat (MGCD0103), a class I HDAC inhibitor, significantly enhanced Npr1 promoter activity (by 8- and 10-fold, respectively), mRNA levels (4- and 5.3-fold, respectively), and NPRA protein (2.7- and 3.5-fold, respectively). However, MC1568 (class II HDAC inhibitor) had no discernible effect. Overexpression of HDAC1 and HDAC2 significantly attenuated Npr1 promoter activity, whereas HDAC3 and HDAC8 had no effect. HDACi-treated cultured cells in vitro and intact animals in vivo showed significantly reduced binding of HDAC1 and -2 and increased accumulation of acetylated H3-K9/14 and H4-K12 at the Npr1 promoter. Deletional analyses of the Npr1 promoter along with ectopic overexpression and inhibition of Sp1 confirmed that HDACi-induced Npr1 gene transcription is accomplished by Sp1 activation. Furthermore, HDACi attenuated the interaction of Sp1 with HDAC1/2 and promoted Sp1 association with p300 and p300/cAMP-binding protein-associated factor; it also promoted the recruitment of p300 and p300/cAMP-binding protein-associated factor to the Npr1 promoter. Our results demonstrate that trichostatin A and MGCD0103 enhanced Npr1 gene expression through inhibition of HDAC1/2 and increased both acetylation of histones (H3-K9/14, H4-K12) and Sp1 by p300, and their recruitment to Npr1 promoter. Our findings define a novel epigenetic regulatory mechanism that governs Npr1 gene transcription.	[Kumar, Prerna; Tripathi, Satyabha; Pandey, Kailash N.] Tulane Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, New Orleans, LA 70112 USA	Tulane University	Pandey, KN (corresponding author), SL-39 1430 Tulane Ave, New Orleans, LA 70112 USA.	kpandey@tulane.edu			National Institutes of Health [HL 57531]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL057531, R01HL057531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 57531.	Andres V, 2001, ARTERIOSCL THROM VAS, V21, P342, DOI 10.1161/01.ATV.21.3.342; Arise KK, 2006, BIOCHEM BIOPH RES CO, V349, P131, DOI 10.1016/j.bbrc.2006.08.003; Buchwald M, 2009, CANCER LETT, V280, P160, DOI 10.1016/j.canlet.2009.02.028; Bush EW, 2010, CIRC RES, V106, P272, DOI 10.1161/CIRCRESAHA.109.209338; Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426; Chen S, 2007, KIDNEY INT, V72, P300, DOI 10.1038/sj.ki.5002274; Chen SC, 2002, J BIOL CHEM, V277, P6037, DOI 10.1074/jbc.M111117200; Colussi C, 2010, PHARMACOL RES, V62, P3, DOI 10.1016/j.phrs.2010.02.014; Cong BH, 2014, MOL CELL ENDOCRINOL, V382, P17, DOI 10.1016/j.mce.2013.09.002; Das S, 2012, PHYSIOL GENOMICS, V44, P430, DOI 10.1152/physiolgenomics.00147.2011; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DEBOLD AJ, 1985, SCIENCE, V230, P767, DOI 10.1126/science.2932797; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; Ellmers LJ, 2007, J MOL ENDOCRINOL, V38, P245, DOI 10.1677/jme.1.02138; Garg R, 2003, HYPERTENSION, V41, P730, DOI 10.1161/01.HYP.0000051890.68573.94; Garg R, 2002, GENE, V291, P123, DOI 10.1016/S0378-1119(02)00589-9; Gaub P, 2010, CELL DEATH DIFFER, V17, P1392, DOI 10.1038/cdd.2009.216; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Hum D, 2004, HYPERTENSION, V43, P1270, DOI 10.1161/01.HYP.0000126920.93207.53; Kim JH, 2011, BIOCHEM J, V436, P253, DOI 10.1042/BJ20110062; Kim SH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2562; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Kumar P, 2006, PEPTIDES, V27, P1762, DOI 10.1016/j.peptides.2006.01.004; Kumar P, 2010, J BIOL CHEM, V285, P37521, DOI 10.1074/jbc.M110.132795; Kumar P, 2009, HYPERTENSION, V54, P172, DOI 10.1161/HYPERTENSIONAHA.109.133033; Levin ER, 1998, NEW ENGL J MED, V339, P321; Liu C, 2011, J PHARMACOL EXP THER, V339, P203, DOI 10.1124/jpet.111.184796; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Martel G, 2010, J BIOL CHEM, V285, P20926, DOI 10.1074/jbc.M109.061622; McKinsey TA, 2004, TRENDS GENET, V20, P206, DOI 10.1016/j.tig.2004.02.002; Nakayama T, 2000, CIRC RES, V86, P841, DOI 10.1161/01.RES.86.8.841; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; Oliver PM, 1998, P NATL ACAD SCI USA, V95, P2547, DOI 10.1073/pnas.95.5.2547; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Pandey KN, 2011, CAN J PHYSIOL PHARM, V89, P557, DOI [10.1139/Y11-054, 10.1139/y11-054]; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; PANDEY KN, 1990, J BIOL CHEM, V265, P12342; Pandey KN, 1999, ENDOCRINOLOGY, V140, P5112, DOI 10.1210/en.140.11.5112; Pandey KN, 2000, BIOCHEM BIOPH RES CO, V271, P374, DOI 10.1006/bbrc.2000.2627; Pascual M, 2012, NEUROPHARMACOLOGY, V62, P2309, DOI 10.1016/j.neuropharm.2012.01.011; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Pitzalis MV, 2003, J HYPERTENS, V21, P1491, DOI 10.1097/00004872-200308000-00012; Rubattu S, 2006, J AM COLL CARDIOL, V48, P499, DOI 10.1016/j.jacc.2005.12.081; Swingler TE, 2010, BIOCHEM J, V427, P391, DOI 10.1042/BJ20091798; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Thakur VS, 2012, CARCINOGENESIS, V33, P377, DOI 10.1093/carcin/bgr277; Tremblay J, 2003, HYPERTENSION, V41, P16, DOI 10.1161/01.HYP.0000042664.75193.1B; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tsai PF, 2011, J VIROL, V85, P2373, DOI 10.1128/JVI.01602-10; Usami S, 2008, HYPERTENS RES, V31, P89, DOI 10.1291/hypres.31.89; Vellaichamy E, 2005, J BIOL CHEM, V280, P19230, DOI 10.1074/jbc.M411373200; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142; Xu YC, 2012, EXP CELL RES, V318, P177, DOI 10.1016/j.yexcr.2011.11.010; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	63	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6991	7002		10.1074/jbc.M113.511444	http://dx.doi.org/10.1074/jbc.M113.511444			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451378	hybrid, Green Published			2022-12-25	WOS:000332389400059
J	Zhang, RW; Wang, YL; Li, JX; Jin, HL; Song, SJ; Huang, CS				Zhang, Ruowen; Wang, Yulei; Li, Jingxia; Jin, Honglei; Song, Shaojiang; Huang, Chuanshu			The Chinese Herb Isolate Yuanhuacine (YHL-14) Induces G(2)/M Arrest in Human Cancer Cells by Up-regulating p21 Protein Expression through an p53 Protein-independent Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Cell Growth; p38; MAPK; Protein Stability; Sp1; p21; Yuanhuacine	STRESS-ACTIVATED CHECKPOINT; POTENT INHIBITORY-ACTIVITY; DAPHNANE DITERPENE ESTERS; NF-KAPPA-B; CYCLE ARREST; TUMOR-GROWTH; DNA-DAMAGE; P38 MAPK; APOPTOSIS; PHOSPHORYLATION	Background: The potential mechanism of YHL-14 against cancer cells has not been explored. Results: YHL-14 induces G(2)/M phase arrest and inhibition of cancer cell growth by up-regulation of p21 transcription and protein expression via modulation of Sp1 protein stability. Conclusion: YHL-14 inhibits bladder and colon cancer cell growth through up-regulation of p21 expression. Significance: This study identifies a novel mechanism underlying the anticancer effect of YHL-14. Yuanhuacine (YHL-14), the major component of daphnane diterpene ester isolated from the flower buds of Daphne genkwa, has been reported to have activity against cell proliferation in various cancer cell lines. Nevertheless, the potential mechanism has not been explored yet. Here we demonstrate that YHL-14 inhibits bladder and colon cancer cell growth through up-regulation of p21 expression in an Sp1-dependent manner. We found that YHL-14 treatment resulted in up-regulation of p21 expression and a significant G(2)/M phase arrest in T24T and HCT116 cells without affecting p53 protein expression and activation. Further studies indicate that p21 induction by YHL-14 occurs at the transcriptional level via up-regulation of Sp1 protein expression. Moreover, our results show that p38 is essential for YHL-14-mediated Sp1 protein stabilization, G(2)/M growth arrest induction, and anchorage-independent growth inhibition of cancer cells. Taken together, our studies demonstrate a novel mechanism of YHL-14 against cancer cell growth in bladder and colon cancer cell lines, which provides valuable information for the design and synthesis of other new conformation-constrained derivatives on the basis of the structure of YHL-14 for cancer therapy.	[Zhang, Ruowen; Wang, Yulei; Li, Jingxia; Jin, Honglei; Huang, Chuanshu] NYU, Nelson Inst Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; [Zhang, Ruowen; Song, Shaojiang] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China	New York University; Shenyang Pharmaceutical University	Song, SJ (corresponding author), Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China.	songsj99@gmail.com; chuanshu.huang@nyumc.org		Zhang, Ruowen/0000-0003-1403-2356; Huang, Chuanshu/0000-0003-4133-5096	NCI, National Institutes of Health [CA177665, CA165980, CA112557]; National Institutes of Health [NSFC81229002, LR2012034]; NATIONAL CANCER INSTITUTE [P01CA165980, R01CA112557, R01CA177665, P30CA016087] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants CA177665, CA165980, and CA112557 and National Institutes of Health Grants NSFC81229002 and LR2012034.	Bhandurge P., 2013, ASIAN J BIOMED PHARM, V3, P1; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Cai T, 2011, CURR CANCER DRUG TAR, V11, P548, DOI 10.2174/156800911795656001; Chadalapaka G, 2012, CARCINOGENESIS, V33, P886, DOI 10.1093/carcin/bgs102; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Cummins Jordan M., 2004, Cancer Research, V64, P3006; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; De Souza CPC, 2007, EUKARYOT CELL, V6, P1521, DOI 10.1128/EC.00178-07; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Eom HJ, 2010, ENVIRON SCI TECHNOL, V44, P8337, DOI 10.1021/es1020668; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; HALL IH, 1986, EUR J CANCER CLIN ON, V22, P45, DOI 10.1016/0277-5379(86)90341-X; Harding MA, 2010, EUR J CANCER, V46, P1252, DOI 10.1016/j.ejca.2010.02.025; HARPER JW, 1993, CELL, V75, P805; Hong JY, 2011, J NAT PROD, V74, P2102, DOI 10.1021/np2003512; Hong JY, 2010, CHEM PHARM BULL, V58, P234, DOI 10.1248/cpb.58.234; Hopkins Maton A., 1997, CELLS BUILDING BLOCK, P76; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Huang CS, 1999, ONCOGENE, V18, P2828, DOI 10.1038/sj.onc.1202639; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Liu JY, 2010, J BIOL CHEM, V285, P26058, DOI 10.1074/jbc.M110.100271; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Mikhailov A, 2005, CELL CYCLE, V4, P57, DOI 10.4161/cc.4.1.1357; Mikhailov A, 2007, CURR BIOL, V17, P2162, DOI 10.1016/j.cub.2007.11.028; Park BY, 2007, J ETHNOPHARMACOL, V111, P496, DOI 10.1016/j.jep.2006.12.023; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Sisodiya D., 2012, IJAPBC, V1, P138; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Vinay K. M., 2004, ROBBINS COTRAN PATHO, P331; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; WHO, 2009, WHO TECH REP SER, V958, P1; WHO Library Cataloguing-in-Publication Data, 2010, WHOHRHHPN103, P18; Wood CD, 2009, INT J BIOL SCI, V5, P428; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhan ZJ, 2005, BIOORGAN MED CHEM, V13, P645, DOI 10.1016/j.bmc.2004.10.054; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang SX, 2006, BIOORGAN MED CHEM, V14, P3888, DOI 10.1016/j.bmc.2006.01.055; Zhang SX, 2009, J DRUG TARGET, V17, P286, DOI 10.1080/10611860902737912; Zhou J. J., 2013, ENCY TRADITIONAL CHI, V5, P227	49	28	30	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6394	6403		10.1074/jbc.M113.513960	http://dx.doi.org/10.1074/jbc.M113.513960			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451377	Green Published, hybrid			2022-12-25	WOS:000332389400008
J	Firon, A; Dinis, M; Raynal, B; Poyart, C; Trieu-Cuot, P; Kaminski, PA				Firon, Arnaud; Dinis, Marcia; Raynal, Bertrand; Poyart, Claire; Trieu-Cuot, Patrick; Kaminski, Pierre Alexandre			Extracellular Nucleotide Catabolism by the Group B Streptococcus Ectonucleotidase NudP Increases Bacterial Survival in Blood	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenosine; Bacterial Pathogenesis; Enzyme Catalysis; Enzymes; Host-Pathogen Interactions; Metalloenzymes; Nucleoside Nucleotide Metabolism; Streptococcus	ECTO-TRIPHOSPHATE DIPHOSPHOHYDROLASE; ESCHERICHIA-COLI; LEGIONELLA-PNEUMOPHILA; SUBSTRATE-SPECIFICITY; ENZYMATIC-PROPERTIES; ATP RELEASE; AGALACTIAE; 5'-NUCLEOTIDASE; PROTEINS; SURFACE	Background: Ectonucleotidases regulate extracellular nucleotide concentration. Results: The NudP ecto-5-nucleotidase of Streptococcus agalactiae has specific substrate specificities necessary for survival in blood and organ colonization. Conclusion: Extracellular nucleotide catabolism is involved in the control of Group B streptococcal pathogenesis. Significance: Bacterial pathogens exploit different enzymatic specificities to subvert extracellular nucleotide signaling. Streptococcus agalactiae (Group B Streptococcus) is a commensal of the human intestine and vagina of adult women but is the leading cause of invasive infection in neonates. This Gram-positive bacterium displays a set of virulence-associated surface proteins involved in the interaction with the host, such as adhesion to host cells, invasion of tissues, or subversion of the immune system. In this study, we characterized a cell wall-localized protein as an ecto-5-nucleoside diphosphate phosphohydrolase (NudP) involved in the degradation of extracellular nucleotides which are central mediators of the immune response. Biochemical characterization of recombinant NudP revealed a Mn2+-dependent ecto-5-nucleotidase activity on ribo- and deoxyribonucleoside 5-mono- and 5-diphosphates with a substrate specificity different from that of known orthologous enzymes. Deletion of the gene coding the housekeeping enzyme sortase A led to the release of NudP into the culture supernatant, confirming that this enzyme is anchored to the cell wall by its non-canonical LPXTN motif. The NudP ecto-5-nucleotidase activity is reminiscent of the reactions performed by the mammalian ectonucleotidases CD39 and CD73 involved in regulating the extracellular level of ATP and adenosine. We further demonstrated that the absence of NudP activity decreases bacterial survival in mouse blood, a process dependent on extracellular adenosine. In vivo assays in animal models of infection showed that NudP activity is critical for virulence. These results demonstrate that Group B Streptococcus expresses a specific ecto-5-nucleotidase necessary for its pathogenicity and highlight the diversity of reactions performed by this enzyme family. These results suggest that bacterial pathogens have developed specialized strategies to subvert the mammalian immune response controlled by the extracellular nucleotide signaling pathways.	[Firon, Arnaud; Dinis, Marcia; Trieu-Cuot, Patrick; Kaminski, Pierre Alexandre] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, F-75015 Paris, France; [Raynal, Bertrand] Inst Pasteur, F-75015 Paris, France; [Firon, Arnaud; Dinis, Marcia; Trieu-Cuot, Patrick; Kaminski, Pierre Alexandre] CNRS, ERL3526, F-75015 Paris, France; [Poyart, Claire] Univ Sorbonne Paris Descartes, Inst Cochin, F-75014 Paris, France; [Poyart, Claire] INSERM, U1016, F-75014 Paris, France; [Poyart, Claire] AP HP, Serv Bacteriol, F-75014 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Kaminski, PA (corresponding author), Inst Pasteur, Dept Microbiol, Unite Biol Bacteries Pathogenes Gram Positif, 25-28 Rue Docteur Roux, F-75015 Paris, France.	pierre-alexandre.kaminski@pasteur.fr	POYART, Claire/P-4225-2017	POYART, Claire/0000-0003-2158-6293; raynal, Bertrand/0000-0001-5634-0408; Dinis, Marcia/0000-0001-8734-4276; FIRON, Arnaud/0000-0002-5323-5212; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Kaminski, Pierre Alexandre/0000-0001-9841-6837	Institut Pasteur; CNRS; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Fondation pour la Recherche Medicale [DEQ20130326538]	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Institut Pasteur, the CNRS, the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" Grant ANR-10-LABX-62-IBEID, and Fondation pour la Recherche Medicale Grant DEQ20130326538.	Betton JM, 1996, J BIOL CHEM, V271, P8046, DOI 10.1074/jbc.271.14.8046; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Derre-Bobillot A, 2013, MOL MICROBIOL, V89, P518, DOI 10.1111/mmi.12295; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Fan J., 2012, PLOS ONE, V7; Firon A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003179; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Henneke P, 2006, INFECT IMMUN, V74, P3085, DOI 10.1128/IAI.01551-05; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Knofel T, 2001, J MOL BIOL, V309, P255, DOI 10.1006/jmbi.2001.4657; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krug U, 2013, FEBS LETT, V587, P460, DOI 10.1016/j.febslet.2013.01.010; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Sansom FM, 2008, J BIOL CHEM, V283, P12909, DOI 10.1074/jbc.M801006200; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Sansom FM, 2008, MICROBIOL MOL BIOL R, V72, P765, DOI 10.1128/MMBR.00013-08; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Thammavongsa V, 2013, SCIENCE, V342, P863, DOI 10.1126/science.1242255; Thammavongsa V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-56; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Trigo G, 2008, CAN J MICROBIOL, V54, P899, DOI [10.1139/W08-083, 10.1139/w08-083]; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; Vivian JP, 2010, STRUCTURE, V18, P228, DOI 10.1016/j.str.2009.11.014; Whidbey C, 2013, J EXP MED, V210, P1265, DOI 10.1084/jem.20122753; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	54	27	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5479	5489		10.1074/jbc.M113.545632	http://dx.doi.org/10.1074/jbc.M113.545632			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24429288	hybrid, Green Published			2022-12-25	WOS:000332015500012
J	Grover, S; Alderwick, LJ; Mishra, AK; Krumbach, K; Marienhagen, J; Eggeling, L; Bhatt, A; Besra, GS				Grover, Shipra; Alderwick, Luke J.; Mishra, Arun K.; Krumbach, Karin; Marienhagen, Jan; Eggeling, Lothar; Bhatt, Apoorva; Besra, Gurdyal S.			Benzothiazinones Mediate Killing of Corynebacterineae by Blocking Decaprenyl Phosphate Recycling Involved in Cell Wall Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Carbohydrate Metabolism; Cell Wall; Drug Resistance; Polysaccharide	MYCOBACTERIUM-TUBERCULOSIS; ARABINAN BIOSYNTHESIS; STRUCTURAL-CHARACTERIZATION; GLUTAMICUM; GENES; IDENTIFICATION; DELETION; STEP; MUTANT; DPRE1	Background: Benzothiazinones inhibit cell wall arabinan biosynthesis, which is lethal for Corynebacterineae.Results:Corynebacteria can evade the action of benzothiazinones in the absence of decaprenyl phosphoribose synthesis by increasing the intracellular decaprenyl phosphate pool. Conclusion: Benzothiazinones induce synthetic lethality in Corynebacterineae by blocking decaprenyl phosphate recycling. Significance: Increased production of decaprenyl phosphate is a new mechanism of resistance to benzothiazinones. Benzothiazinones (BTZs) are a new class of sulfur containing heterocyclic compounds that target DprE1, an oxidoreductase involved in the epimerization of decaprenyl-phosphoribose (DPR) to decaprenyl-phosphoarabinose (DPA) in the Corynebacterineae, such as Corynebacterium glutamicum and Mycobacterium tuberculosis. As a result, BTZ inhibition leads to inhibition of cell wall arabinan biosynthesis. Previous studies have demonstrated the essentiality of dprE1. In contrast, Cg-UbiA a ribosyltransferase, which catalyzes the first step of DPR biosynthesis prior to DprE1, when genetically disrupted, produced a viable mutant, suggesting that although BTZ biochemically targets DprE1, killing also occurs through chemical synthetic lethality, presumably through the lack of decaprenyl phosphate recycling. To test this hypothesis, a derivative of BTZ, BTZ043, was examined in detail against C. glutamicum and C. glutamicum::ubiA. The wild type strain was sensitive to BTZ043; however, C. glutamicum::ubiA was found to be resistant, despite possessing a functional DprE1. When the gene encoding C. glutamicum Z-decaprenyl-diphosphate synthase (NCgl2203) was overexpressed in wild type C. glutamicum, resistance to BTZ043 was further increased. This data demonstrates that in the presence of BTZ, the bacilli accumulate DPR and fail to recycle decaprenyl phosphate, which results in the depletion of decaprenyl phosphate and ultimately leads to cell death.	[Grover, Shipra; Alderwick, Luke J.; Mishra, Arun K.; Bhatt, Apoorva; Besra, Gurdyal S.] Univ Birmingham, Inst Microbiol & Infect, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Krumbach, Karin; Marienhagen, Jan; Eggeling, Lothar] Res Ctr Juelich, Inst Bio & Geosci Biotechnol IBG 1, D-52425 Julich, Germany	University of Birmingham; Helmholtz Association; Research Center Julich	Besra, GS (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	g.besra@bham.ac.uk	Grover, +Shipra/I-6388-2019; Marienhagen, Jan/E-9593-2011	Grover, +Shipra/0000-0001-7094-6879; Marienhagen, Jan/0000-0001-5513-3730; Besra, Gurdyal/0000-0002-5605-0395; Alderwick, Luke/0000-0002-1257-6053	Royal Society; Medical Research Council [MR/K012118/1]; Wellcome Trust [081569/Z/06/Z]; MRC [MR/K012118/1] Funding Source: UKRI	Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Personal Research Chair from James Bardrick, Royal Society Wolfson Research Merit Award, as a former Lister Institute-Jenner Research Fellow, Medical Research Council Grant MR/K012118/1, and Wellcome Trust Grant 081569/Z/06/Z (to G. S. B.).	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, GLYCOBIOLOGY, V16, P1073, DOI 10.1093/glycob/cwl030; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Alderwick LJ, 2011, GLYCOBIOLOGY, V21, P410, DOI 10.1093/glycob/cwq173; Batt SM, 2012, P NATL ACAD SCI USA, V109, P11354, DOI 10.1073/pnas.1205735109; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; Campbell J, 2012, ANTIMICROB AGENTS CH, V56, P1810, DOI 10.1128/AAC.05938-11; Crellin PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016869; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; D'Elia MA, 2009, J BACTERIOL, V191, P4030, DOI 10.1128/JB.00611-08; Dover LG, 2004, FEMS MICROBIOL REV, V28, P225, DOI 10.1016/j.femsre.2003.10.001; Lee YH, 2013, ANTIMICROB AGENTS CH, V57, P4267, DOI 10.1128/AAC.00794-13; Lothar Eggeling M. B., 2005, HDB CORYNEBACTERIUM; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, MOL MICROBIOL, V77, P1172, DOI 10.1111/j.1365-2958.2010.07277.x; Meniche X, 2008, MICROBIOL-SGM, V154, P2315, DOI 10.1099/mic.0.2008/016378-0; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; Minnikin D. E., 1978, LIPID COMPOSITION CL; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mishra AK, 2011, MOL MICROBIOL, V80, P1241, DOI 10.1111/j.1365-2958.2011.07640.x; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Neres J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004395; Pasca MR, 2010, ANTIMICROB AGENTS CH, V54, P1616, DOI 10.1128/AAC.01676-09; Pathak AK, 2002, BIOORGAN MED CHEM, V10, P923, DOI 10.1016/S0968-0896(01)00343-1; Radmacher E, 2005, MICROBIOL-SGM, V151, P1359, DOI 10.1099/mic.0.27804-0; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scherman MS, 1996, J BIOL CHEM, V271, P29652, DOI 10.1074/jbc.271.47.29652; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Tatituri RVV, 2007, MICROBIOL-SGM, V153, P2621, DOI 10.1099/mic.0.2007/008078-0; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Trefzer C, 2012, J AM CHEM SOC, V134, P912, DOI 10.1021/ja211042r; Trefzer C, 2010, J AM CHEM SOC, V132, P13663, DOI 10.1021/ja106357w; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x	36	22	22	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6177	6187		10.1074/jbc.M113.522623	http://dx.doi.org/10.1074/jbc.M113.522623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24446451	Green Published, hybrid			2022-12-25	WOS:000332015500071
J	Suarez-Kurtz, G; Vargens, DD; Santoro, AB; Hutz, MH; de Moraes, ME; Pena, SDJ; Ribeiro-dos-Santos, A; Romano-Silva, MA; Struchiner, CJ				Suarez-Kurtz, Guilherme; Vargens, Daniela D.; Santoro, Ana Beatriz; Hutz, Mara H.; de Moraes, Maria Elisabete; Pena, Sergio D. J.; Ribeiro-dos-Santos, Andrea; Romano-Silva, Marco A.; Struchiner, Claudio Jose			Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population	PLOS ONE			English	Article							GENOTYPE; IMPACT	The influence of self-reported "race/color", geographical origin and genetic ancestry on the distribution of three functional CYP3A5 polymorphisms, their imputed haplotypes and inferred phenotypes was examined in 909 healthy, adult Brazilians, self-identified as White, Brown or Black ("race/color" categories of the Brazilian census). The cohort was genotyped for CYP3A5*3 (rs776746), CYP3A5*6 (rs10264272) and CYP3A5*7 (rs41303343), CYP3A5 haplotypes were imputed and CYP3A5 metabolizer phenotypes were inferred according to the number of defective CYP3A5 alleles. Estimates of the individual proportions of Amerindian, African and European ancestry were available for the entire cohort. Multinomial log-linear regression models were applied to infer the statistical association between the distribution of CYP3A5 alleles, haplotypes and phenotypes (response variables), and self-reported Color, geographical region and ancestry (explanatory variables). We found that Color per se or in combination with geographical region associates significantly with the distribution of CYP3A5 variant alleles and CYP3A5 metabolizer phenotypes, whereas geographical region per se influences the frequency distribution of CYP3A5 variant alleles. The odds of having the default CYP3A5*3 allele and the poor metabolizer phenotype increases continuously with the increase of European ancestry and decrease of African ancestry. The opposite trend is observed in relation to CYP3A5*6, CYP3A5*7, the default CYP3A5*1 allele, and both the extensive and intermediate phenotypes. No significant effect of Amerindian ancestry on the distribution of CYP3A5 alleles or phenotypes was observed. In conclusion, this study strongly supports the notion that the intrinsic heterogeneity of the Brazilian population must be acknowledged in the design and interpretation of pharmacogenomic studies, and dealt with as a continuous variable, rather than proportioned in arbitrary categories that do not capture the diversity of the population. The relevance of this work extrapolates the Brazilian borders, and extends to other admixed peoples of the Americas, with ancestral roots in Europe, Africa and the American continent.	[Suarez-Kurtz, Guilherme; Vargens, Daniela D.; Santoro, Ana Beatriz] Inst Nacl Canc, Programa Farmacol, Rio De Janeiro, RJ, Brazil; [Hutz, Mara H.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [de Moraes, Maria Elisabete] Univ Fed Ceara, Dept Fisiol & Farmacol, Fortaleza, CE, Brazil; [Pena, Sergio D. J.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Ribeiro-dos-Santos, Andrea] Univ Fed Para, Lab Genet Humana & Med, Guama, PA, Brazil; [Romano-Silva, Marco A.] Univ Fed Minas Gerais, Inst Nacl Ciencia & Tecnol Med Mol, Belo Horizonte, MG, Brazil; [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio Grande do Sul; Universidade Federal do Ceara; Universidade Federal de Minas Gerais; Universidade Federal do Para; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Suarez-Kurtz, G (corresponding author), Inst Nacl Canc, Programa Farmacol, Rio De Janeiro, RJ, Brazil.	kurtz@inca.gov.br	Romano-Silva, Marco Aurelio/T-8321-2019; Hutz, Mara H/I-4070-2012; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Suarez-Kurtz, Guilherme/J-6648-2012; Santos, Ândrea Ribeiro dos/B-6061-2013; Struchiner, Claudio Jose/HGB-9492-2022; Suarez-Kurtz, Guilherme/P-4620-2019; Romano-Silva, Marco Aurelio/A-1790-2008; Struchiner, Claudio J/M-9360-2013	Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Struchiner, Claudio J/0000-0003-2114-847X; Hutz, Mara/0000-0002-9146-1229	Financiadora de Estudos e Projetos (Finep); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Financiadora de Estudos e Projetos (Finep)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This research was supported by grants from Financiadora de Estudos e Projetos (Finep), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos-Rodrigues L, 2006, ANN HUM GENET, V70, P658, DOI 10.1111/j.1469-1809.2006.00287.x; Dandara C, 2005, CANCER LETT, V225, P275, DOI 10.1016/j.canlet.2004.11.004; Ferreira PE, 2008, THER DRUG MONIT, V30, P10, DOI 10.1097/FTD.0b013e31815e93c6; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Garsa AA, 2005, BMC MED GENET, V6, DOI 10.1186/1471-23350-6-19; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lamba J, 2012, PHARMACOGENET GENOM, V22, P555, DOI 10.1097/FPC.0b013e328351d47f; Lee SJ, 2005, PHARMACOGENOMICS, V6, P357, DOI 10.1517/14622416.6.4.357; Mirghani RA, 2006, PHARMACOGENET GENOM, V16, P637, DOI 10.1097/01.fpc.0000230411.89973.1b; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2009, R FDN STAT COMP; Salzano FM, 2002, EVOLUTION GENETICS L; Santoro A, 2011, PHARMACOGENOMICS, V12, P1293, DOI [10.2217/PGS.11.70, 10.2217/pgs.11.70]; Sortica VD, 2012, BASIC CLIN PHARMACOL, V110, P460, DOI 10.1111/j.1742-7843.2011.00838.x; Suarez-Kurtz G, 2006, CURR DRUG TARGETS, V7, P1649, DOI 10.2174/138945006779025392; Suarez-Kurtz G, 2012, PHARMACOGENOMICS J, V12, P267, DOI 10.1038/tpj.2010.89; Suarez-Kurtz G, 2007, PHARMACOGENOMICS, V8, P1299, DOI 10.2217/14622416.8.10.1299; Suarez-Kurtz G, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00118; Suarez-Kurtz G, 2010, PHARMACOGENOMICS, V11, P1257, DOI 10.2217/PGS.10.89; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	23	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e83472	10.1371/journal.pone.0083472	http://dx.doi.org/10.1371/journal.pone.0083472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24427273	Green Published, gold, Green Submitted			2022-12-25	WOS:000329868200013
J	Fan, HY; Sun, HW; Wang, Y; Zhang, YL; Wang, XB; Li, DW; Yu, JL; Han, CG				Fan, Huiyan; Sun, Haiwen; Wang, Ying; Zhang, Yongliang; Wang, Xianbing; Li, Dawei; Yu, Jialin; Han, Chenggui			Deep Sequencing-Based Transcriptome Profiling Reveals Comprehensive Insights into the Responses of Nicotiana benthamiana to Beet necrotic yellow vein virus Infections Containing or Lacking RNA4	PLOS ONE			English	Article							P25 PATHOGENICITY FACTOR; GENE-EXPRESSION; 26S PROTEASOME; DWARF VIRUS; PROTEIN; IDENTIFICATION; TARGETS; GIBBERELLINS; TRANSMISSION; SUPPRESSION	Background: Beet necrotic yellow vein virus (BNYVV), encodes either four or five plus-sense single stranded RNAs and is the causal agent of sugar beet rhizomania disease, which is widely distributed in most regions of the world. BNYVV can also infect Nicotiana benthamiana systemically, and causes severe curling and stunting symptoms in the presence of RNA4 or mild symptoms in the absence of RNA4. Results: Confocal laser scanning microscopy (CLSM) analyses showed that the RNA4-encoded p31 protein fused to the red fluorescent protein (RFP) accumulated mainly in the nuclei of N. benthamiana epidermal cells. This suggested that severe RNA4-induced symptoms might result from p31-dependent modifications of the transcriptome. Therefore, we used next-generation sequencing technologies to analyze the transcriptome profile of N. benthamiana in response to infection with different isolates of BNYVV. Comparisons of the transcriptomes of mock, BN3 (RNAs1+2+3), and BN34 (RNAs1+2+3+4) infected plants identified 3,016 differentially expressed transcripts, which provided a list of candidate genes that potentially are elicited in response to virus infection. Our data indicate that modifications in the expression of genes involved in RNA silencing, ubiquitin-proteasome pathway, cellulose synthesis, and metabolism of the plant hormone gibberellin may contribute to the severe symptoms induced by RNA4 from BNYVV. Conclusions: These results expand our understanding of the genetic architecture of N. benthamiana as well as provide valuable clues to identify genes potentially involved in resistance to BNYVV infection. Our global survey of gene expression changes in infected plants reveals new insights into the complicated molecular mechanisms underlying symptom development, and aids research into new strategies to protect crops against viruses.	[Han, Chenggui] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Han, CG (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	hanchenggui@cau.edu.cn	Li, Dawei/CAJ-5076-2022; Wang, Xianbing/E-4831-2013; Li, Dawei/I-8751-2016; Zhang, Yongliang/AAE-7639-2021	Li, Dawei/0000-0003-4133-1263; Zhang, Yongliang/0000-0002-6790-1044; Wang, Xian-Bing/0000-0003-3082-2462	National Natural Science Foundation of China [30471136, 30671359]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was in part supported by the National Natural Science Foundation of China (30471136 and 30671359) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Alvarado V, 2009, SEMIN CELL DEV BIOL, V20, P1032, DOI 10.1016/j.semcdb.2009.06.001; Andika IB, 2005, MOL PLANT MICROBE IN, V18, P194, DOI 10.1094/MPMI-18-0194; Aronson MN, 2000, J VIROL, V74, P2967, DOI 10.1128/JVI.74.7.2967-2972.2000; BAILISS KW, 1968, ANN BOT-LONDON, V32, P543, DOI 10.1093/oxfordjournals.aob.a084228; Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; Burn JE, 2002, PLANT J, V32, P949, DOI 10.1046/j.1365-313X.2002.01483.x; Canto T, 2006, J VIROL, V80, P9064, DOI 10.1128/JVI.00953-06; Cao DN, 2005, PLANTA, V223, P105, DOI 10.1007/s00425-005-0057-3; Catoni M, 2009, MOL PLANT MICROBE IN, V22, P1504, DOI 10.1094/MPMI-22-12-1504; Chiba S, 2011, MOL PLANT MICROBE IN, V24, P207, DOI 10.1094/MPMI-10-10-0241; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dunoyer P, 2002, PLANT J, V29, P555, DOI 10.1046/j.0960-7412.2001.01242.x; Ellis C, 2002, PLANT MOL BIOL, V50, P971, DOI 10.1023/A:1021291522243; Faino L, 2012, PLANT SIGNAL BEHAV, V7, P1065, DOI 10.4161/psb.21014; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Huang J, 2010, J GENET GENOMICS, V37, P23, DOI 10.1016/S1673-8527(09)60022-9; Jia MA, 2012, MOL PLANT PATHOL, V13, P251, DOI 10.1111/j.1364-3703.2011.00743.x; JUPIN I, 1992, EMBO J, V11, P479, DOI 10.1002/j.1460-2075.1992.tb05078.x; KOENIG R, 1991, J GEN VIROL, V72, P2243, DOI 10.1099/0022-1317-72-9-2243; Li M, 2009, PLANT J, V60, P1055, DOI 10.1111/j.1365-313X.2009.04022.x; Link D, 2005, J GEN VIROL, V86, P2115, DOI 10.1099/vir.0.80937-0; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Liu T, 2003, CHINESE SCI BULL, V48, P796, DOI 10.1360/02wc0502; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Lucy AP, 2000, EMBO J, V19, P1672, DOI 10.1093/emboj/19.7.1672; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; McGrann GRD, 2009, MOL PLANT PATHOL, V10, P129, DOI 10.1111/j.1364-3703.2008.00514.x; MOHANTY SK, 1979, PHYSIOL PLANTARUM, V45, P132, DOI 10.1111/j.1399-3054.1979.tb01677.x; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nie QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041645; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Peltier C, 2011, TRANSGENIC RES, V20, P443, DOI 10.1007/s11248-010-9424-3; Rahim MD, 2007, J GEN VIROL, V88, P1611, DOI 10.1099/vir.0.82720-0; RICHARDS KE, 1992, ANNU REV PHYTOPATHOL, V30, P291, DOI 10.1146/annurev.py.30.090192.001451; RUSSELL SL, 1971, ANN BOT-LONDON, V35, P1037, DOI 10.1093/oxfordjournals.aob.a084539; Sakamoto T, 2001, PLANT PHYSIOL, V125, P1508, DOI 10.1104/pp.125.3.1508; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Schmidlin L, 2008, MOL PLANT PATHOL, V9, P741, DOI 10.1111/J.1364-3703.2008.00498.X; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Shaw PJ, 2004, CURR OPIN PLANT BIOL, V7, P614, DOI 10.1016/j.pbi.2004.09.011; Shimizu T, 2007, MOL PLANT MICROBE IN, V20, P247, DOI 10.1094/MPMI-20-3-0247; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; TAMADA T, 1989, J GEN VIROL, V70, P3391, DOI 10.1099/0022-1317-70-12-3391; TAMADA T, 1973, Annals of the Phytopathological Society of Japan, V39, P325, DOI 10.3186/jjphytopath.39.325; Thiel H, 2012, MOL PLANT MICROBE IN, V25, P1058, DOI 10.1094/MPMI-03-12-0057-R; Thiel H, 2009, MOL PLANT MICROBE IN, V22, P999, DOI 10.1094/MPMI-22-8-0999; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valli A., 2009, ENCY LIFE SCI ELS, DOI 10.1002/9780470015902.a978047002126; Vetter G, 2004, J GEN VIROL, V85, P2459, DOI 10.1099/vir.0.80142-0; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wang YN, 2011, STAT BIOPHARM RES, V3, P1, DOI 10.1198/sbr.2011.09051; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Zhang LD, 2005, CHINESE SCI BULL, V50, P305, DOI 10.1360/982004-731; Zhang SC, 2009, PLANT MOL BIOL, V69, P745, DOI 10.1007/s11103-009-9452-7; Zhang YJ, 2011, VIRUS RES, V155, P307, DOI 10.1016/j.virusres.2010.10.029; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306	74	19	22	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85284	10.1371/journal.pone.0085284	http://dx.doi.org/10.1371/journal.pone.0085284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416380	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300065
J	Pisani, F; Livermore, T; Rose, G; Chubb, JR; Gaspari, M; Saiardi, A				Pisani, Francesca; Livermore, Thomas; Rose, Giuseppina; Chubb, Jonathan Robert; Gaspari, Marco; Saiardi, Adolfo			Analysis of Dictyostelium discoideum Inositol Pyrophosphate Metabolism by Gel Electrophoresis	PLOS ONE			English	Article							PHOSPHOLIPASE-C; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE; MYOINOSITOL HEXAKISPHOSPHATE; PHOSPHATES; KINASE; CELLS; IDENTIFICATION; FAMILY; 1,4,5-TRISPHOSPHATE; PHOSPHORYLATION	The social amoeba Dictyostelium discoideum was instrumental in the discovery and early characterization of inositol pyrophosphates, a class of molecules possessing highly-energetic pyrophosphate bonds. Inositol pyrophosphates regulate diverse biological processes and are attracting attention due to their ability to control energy metabolism and insulin signalling. However, inositol pyrophosphate research has been hampered by the lack of simple experimental procedures to study them. The recent development of polyacrylamide gel electrophoresis (PAGE) and simple staining to resolve and detect inositol pyrophosphate species has opened new investigative possibilities. This technology is now commonly applied to study in vitro enzymatic reactions. Here we employ PAGE technology to characterize the D. discoideum inositol pyrophosphate metabolism. Surprisingly, only three major bands are detectable after resolving acidic extract on PAGE. We have demonstrated that these three bands correspond to inositol hexakisphosphate (IP6 or Phytic acid) and its derivative inositol pyrophosphates, IP7 and IP8. Biochemical analyses and genetic evidence were used to establish the genuine inositol phosphate nature of these bands. We also identified IP9 in D. discoideum cells, a molecule so far detected only from in vitro biochemical reactions. Furthermore, we discovered that this amoeba possesses three different inositol pentakisphosphates (IP5) isomers, which are largely metabolised to inositol pyrophosphates. Comparison of PAGE with traditional Sax-HPLC revealed an underestimation of the cellular abundance of inositol pyrophosphates by traditional methods. In fact our study revealed much higher levels of inositol pyrophosphates in D. discoideum in the vegetative state than previously detected. A three-fold increase in IP8 was observed during development of D. discoideum a value lower that previously reported. Analysis of inositol pyrophosphate metabolism using ip6k null amoeba revealed the absence of developmentally-induced synthesis of inositol pyrophosphates, suggesting that the alternative class of enzyme responsible for pyrophosphate synthesis, PP-IP5K, doesn't' play a major role in the IP8 developmental increase.	[Pisani, Francesca; Livermore, Thomas; Chubb, Jonathan Robert; Saiardi, Adolfo] UCL, MRC, Mol Cell Biol Lab, London, England; [Pisani, Francesca; Rose, Giuseppina] Univ Calabria, Dept Biol Ecol & Earth Sci, I-87036 Arcavacata Di Rende, Italy; [Gaspari, Marco] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Lab Prote & Mass Spectrometry, Catanzaro, Italy	University of London; University College London; University of Calabria; Magna Graecia University of Catanzaro	Saiardi, A (corresponding author), UCL, MRC, Mol Cell Biol Lab, London, England.	dmcbado@ucl.ac.uk	Gaspari, Marco/C-2756-2009; Gaspari, Marco/HGB-2399-2022; Gaspari, Marco/ABE-1539-2020	Gaspari, Marco/0000-0002-5411-8800; Gaspari, Marco/0000-0002-5411-8800; Rose, Giuseppina/0000-0002-4264-4184; Livermore, Tom/0000-0003-0283-4597	Medical Research Council; Medical Research Council [1068476, MC_U122680443, MC_UU_12018/4] Funding Source: researchfish; MRC [MC_U122680443, MC_UU_12018/4] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council funding of the Cell Biology Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Dove Stephen K., 2009, V462, P59, DOI 10.1007/978-1-60327-115-8_4; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; DRAYER AL, 1994, EMBO J, V13, P1601, DOI 10.1002/j.1460-2075.1994.tb06423.x; Franca-Koh J, 2006, CURR OPIN GENET DEV, V16, P333, DOI 10.1016/j.gde.2006.06.001; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Zhong G, 2007, ANAL BIOANAL CHEM, V387, P1939, DOI 10.1007/s00216-006-1100-3; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Kilari RS, 2013, FEBS LETT, V587, P3464, DOI 10.1016/j.febslet.2013.08.035; Laussmann T, 2000, EUR J BIOCHEM, V267, P2447, DOI 10.1046/j.1432-1327.2000.01264.x; Laussmann T, 1997, BIOCHEM J, V322, P31, DOI 10.1042/bj3220031; Letcher AJ, 2008, BIOCHEM J, V416, P263, DOI 10.1042/BJ20081417; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; Loss O, 2013, MOL BIOL CELL, V24, P2981, DOI 10.1091/mbc.E13-04-0198; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; MAYR GW, 1988, BIOCHEM J, V254, P585, DOI 10.1042/bj2540585; MCCONNELL FM, 1991, BIOCHEM J, V280, P323, DOI 10.1042/bj2800323; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; NEWELL PC, 1988, J CELL SCI, V89, P123; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A., 2012, SUBCELL BIOCH, V59, P413; Saiardi Adolfo, 2012, Advances in Biological Regulation, V52, P351, DOI 10.1016/j.jbior.2012.03.002; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; STEPHENS LR, 1990, NATURE, V346, P580, DOI 10.1038/346580a0; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; VANDIJKEN P, 1995, J BIOL CHEM, V270, P29724; VanHaastert PJM, 1995, EXPERIENTIA, V51, P1144; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	37	33	38	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85533	10.1371/journal.pone.0085533	http://dx.doi.org/10.1371/journal.pone.0085533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416420	Green Published, Green Submitted, gold			2022-12-25	WOS:000329866300084
J	Antonson, P; Matic, M; Portwood, N; Kuiper, RV; Bryzgalova, G; Gao, H; Windahl, SH; Humire, P; Ohlsson, C; Berggren, PO; Gustafsson, JA; Dahlman-Wright, K				Antonson, Per; Matic, Marko; Portwood, Neil; Kuiper, Raoul V.; Bryzgalova, Galyna; Gao, Hui; Windahl, Sara H.; Humire, Patricia; Ohlsson, Claes; Berggren, Per-Olof; Gustafsson, Jan-Ake; Dahlman-Wright, Karin			aP2-Cre-Mediated Inactivation of Estrogen Receptor Alpha Causes Hydrometra	PLOS ONE			English	Article							ER-ALPHA; HORMONE NEURONS; KNOCKOUT MICE; DELETION; MECHANISMS; GENERATION; RESPONSES; FEMALES; REVEALS; BETA	In this study we describe the reproductive phenotypes of a novel mouse model in which Cre-mediated deletion of ER alpha is regulated by the aP2 (fatty acid binding protein 4) promoter. ER alpha-floxed mice were crossed with transgenic mice expressing Cre-recombinase under the control of the aP2 promoter to generate aP2-Cre/ER alpha(flox/flox) mice. As expected, ER alpha mRNA levels were reduced in adipose tissue, but in addition we also detected an 80% reduction of ER alpha levels in the hypothalamus of aP2-Cre/ER alpha(flox/flox) mice. Phenotypic analysis revealed that aP2-Cre/ER alpha(flox/flox) female mice were infertile. In line with this, aP2-Cre/ER alpha(flox/flox) female mice did not cycle and presented 3.8-fold elevated estrogen levels. That elevated estrogen levels were associated with increased estrogen signaling was evidenced by increased mRNA levels of the estrogen-regulated genes lactoferrin and aquaporin 5 in the uterus. Furthermore, aP2-Cre/ER alpha(flox/flox) female mice showed an accumulation of intra-uterine fluid, hydrometra, without overt indications for causative anatomical anomalies. However, the vagina and cervix displayed advanced keratosis with abnormal quantities of accumulating squamous epithelial cells suggesting functional obstruction by keratin plugs. Importantly, treatment of aP2-Cre/ER alpha(flox/flox) mice with the aromatase inhibitor Letrozole caused regression of the hydrometra phenotype linking increased estrogen levels to the observed phenotype. We propose that in aP2-Cre/ER alpha(flox/flox) mice, increased serum estrogen levels cause over-stimulation in the uterus and genital tracts resulting in hydrometra and vaginal obstruction.	[Antonson, Per; Matic, Marko; Gao, Hui; Humire, Patricia; Gustafsson, Jan-Ake; Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Novum, Huddinge, Sweden; [Portwood, Neil; Bryzgalova, Galyna; Berggren, Per-Olof] Karolinska Inst, Karolinska Univ Hosp L1, Rolf Luft Ctr Diabet & Endocrinol, Stockholm, Sweden; [Kuiper, Raoul V.] Karolinska Inst, Phenotyping Core Facil, Dept Lab Med, Karolinska Univ Hosp, Huddinge, Sweden; [Windahl, Sara H.; Ohlsson, Claes] Univ Gothenburg, Inst Med, Ctr Bone & Arthrit Res, Sahlgrenska Acad, Gothenburg, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg; University of Houston System; University of Houston	Antonson, P (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Novum, Huddinge, Sweden.	per.antonson@ki.se	Ohlsson, Claes/AGP-3544-2022; Gao, Hui/AAF-9770-2019	Ohlsson, Claes/0000-0002-9633-2805; Windahl, Sara/0000-0002-6611-6001; Berggren, Per-Olof/0000-0001-8991-413X; Kuiper, Raoul/0000-0001-5645-2389; Antonson, Per/0000-0001-9335-9941	Swedish Research Council; Cancerfonden [080482, 090678, 100404, 110588, 120435]; Novo Nordisk Foundation; Estrogen signaling in metabolic disease; Molecular mechanisms underlying the regulation of body weight and the anti-diabetic effects of estrogen; Genetic dissection of estrogen signaling in mice; Genetic dissection of estrogen signaling in metabolic disease; Strategic Research Area in Diabetes at the Karolinska Institute (SFO/TM Diabetes); Center for Biosciences; KI Endomet network; King Gustaf V and Queen Victoria's Freemason's Foundation; Molecular Mechanisms Underlying the Antidiabetic Effects of Estrogen;  [K2009-54X-21122-01-3];  [K2008-54X-20640-01-3];  [K2011-54X-20640-04-6]; Novo Nordisk Fonden [NNF14OC0010513, NNF13OC0005785] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Estrogen signaling in metabolic disease; Molecular mechanisms underlying the regulation of body weight and the anti-diabetic effects of estrogen; Genetic dissection of estrogen signaling in mice; Genetic dissection of estrogen signaling in metabolic disease; Strategic Research Area in Diabetes at the Karolinska Institute (SFO/TM Diabetes); Center for Biosciences; KI Endomet network; King Gustaf V and Queen Victoria's Freemason's Foundation; Molecular Mechanisms Underlying the Antidiabetic Effects of Estrogen; ; ; ; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work is supported by the Swedish Research Council (http://www.vr.se/; The involvement of estrogen receptor signaling in insulin resistance and type 2 diabetes (project # K2009-54X-21122-01-3), Estrogen signaling in metabolic disease; a functional genomics approach (project # K2008-54X-20640-01-3) and Tissue-specific estrogen signaling - new insights in metabolic disease development (project # K2011-54X-20640-04-6)), Cancerfonden (http://www.cancerfonden.se; grant # 080482, 090678, 100404, 110588 and 120435), Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en/; Estrogen signaling in metabolic disease (2006), Molecular mechanisms underlying the regulation of body weight and the anti-diabetic effects of estrogen (2008), Genetic dissection of estrogen signaling in mice (2009), Genetic dissection of estrogen signaling in metabolic disease (2011)), the Strategic Research Area in Diabetes at the Karolinska Institute (http://ki.se/srp-diabetes; SFO/TM Diabetes (2010)), Center for Biosciences (http://ki.se/cb; grant # n/a (2009-2011)), the KI Endomet network (http://researchnetworks.ki.se/converis/; grant details n/a), King Gustaf V and Queen Victoria's Freemason's Foundation; Molecular Mechanisms Underlying the Antidiabetic Effects of Estrogen (2008, 2009, 2010, 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonson P, 2012, BIOCHEM BIOPH RES CO, V424, P710, DOI 10.1016/j.bbrc.2012.07.016; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4; Chen M, 2009, MOL CELL BIOCHEM, V321, P145, DOI 10.1007/s11010-008-9928-9; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Dupont S, 2000, DEVELOPMENT, V127, P4277; Gieske MC, 2008, ENDOCRINOLOGY, V149, P20, DOI 10.1210/en.2007-1084; GREENMAN DL, 1986, J TOXICOL ENV HEALTH, V19, P531, DOI 10.1080/15287398609530950; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Herbison AE, 2001, FRONT NEUROENDOCRIN, V22, P292, DOI 10.1006/frne.2001.0219; Hewitt SC, 2005, MOL ENDOCRINOL, V19, P657, DOI 10.1210/me.2004-0142; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2000, BREAST CANCER RES, V2, P345, DOI 10.1186/bcr79; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Katzenellenbogen B S, 1979, Recent Prog Horm Res, V35, P259; Kobayashi M, 2006, GENES CELLS, V11, P1133, DOI 10.1111/j.1365-2443.2006.01009.x; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martens K, 2010, FEBS LETT, V584, P1054, DOI 10.1016/j.febslet.2010.01.061; Matic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057458; Mullican SE, 2013, MOL ENDOCRINOL, V27, P127, DOI 10.1210/me.2012-1267; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Petersen SL, 2003, BIOL REPROD, V69, P1771, DOI 10.1095/biolreprod.103.019745; Radovick Sally, 2012, Front Endocrinol (Lausanne), V3, P52, DOI 10.3389/fendo.2012.00052; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Wintermantel TM, 2006, NEURON, V52, P271, DOI 10.1016/j.neuron.2006.07.023; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Zhang WH, 2000, P NATL ACAD SCI USA, V97, P5936, DOI 10.1073/pnas.97.11.5936	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85581	10.1371/journal.pone.0085581	http://dx.doi.org/10.1371/journal.pone.0085581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416430	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500258
J	Dalton, ARH; Vamos, EP; Harris, MJ; Netuveli, G; Wachter, RM; Majeed, A; Millett, C				Dalton, Andrew R. H.; Vamos, Eszter P.; Harris, Matthew J.; Netuveli, Gopalakrishnan; Wachter, Robert M.; Majeed, Azeem; Millett, Christopher			Impact of Universal Health Insurance Coverage on Hypertension Management: A Cross-National Study in the United States and England	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; PRIMARY-CARE; POPULATION HEALTH; US ADULTS; DISEASE; DISADVANTAGE; MORTALITY; HEART	Background: The Patient Protection and Affordable Care Act (ACA) galvanised debate in the United States (US) over universal health coverage. Comparison with countries providing universal coverage may illustrate whether the ACA can improve health outcomes and reduce disparities. We aimed to compare quality and disparities in hypertension management by socio-economic position in the US and England, the latter of which has universal health care. Method: We used data from the Health and Retirement Survey in the US, and the English Longitudinal Study for Aging from England, including non-Hispanic White respondents aged 50-64 years (US market-based v NHS) and >65 years (US-Medicare v NHS) with diagnosed hypertension. We compared blood pressure control to clinical guideline (140/90 mmHg) and audit (150/90 mmHg) targets; mean systolic and diastolic blood pressure and antihypertensive prescribing, and disparities in each by educational attainment, income and wealth, using regression models. Results: There were no significant differences in aggregate achievement of clinical targets aged 50 to 65 years (US market-based vs. NHS-62.3% vs. 61.3% [p = 0.835]). There was, however, greater control in the US in patients aged 65 years and over (US Medicare vs. NHS-53.5% vs. 58.2% [p = 0.043]). England had no significant socioeconomic disparity in blood pressure control (60.9% vs. 63.5% [p = 0.588], high and low wealth aged >= 65 years). The US had socioeconomic differences in the 5064 years group (71.7% vs. 55.2% [p = 0.003], high and low wealth); these were attenuated but not abolished in Medicare beneficiaries. Conclusion: Moves towards universal health coverage in the US may reduce disparities in hypertension management. The current situation, providing universal coverage for residents aged 65 years and over, may not be sufficient for equality in care.	[Dalton, Andrew R. H.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Vamos, Eszter P.; Harris, Matthew J.; Majeed, Azeem; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Netuveli, Gopalakrishnan] Univ E London, Inst Hlth & Human Dev, London E15 4LZ, England; [Wachter, Robert M.] Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA USA	University of Oxford; Imperial College London; University of East London; University of California System; University of California San Francisco	Dalton, ARH (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	andrew.dalton@phc.ox.ac.uk		Majeed, Azeem/0000-0002-2357-9858; Millett, Christopher/0000-0002-0793-9884; Harris, Matthew/0000-0002-0005-9710	National Institute for Health Research Biomedical Research Centre scheme; National Institute for Health Research Collaboration for Leadership in Applied Health Research Care scheme; Imperial Centre for Patient Safety and Service Quality; Higher Education Funding Council for England; National Institute for Health Research; Economic & Social Research Council [RES-596-28-0001]	National Institute for Health Research Biomedical Research Centre scheme; National Institute for Health Research Collaboration for Leadership in Applied Health Research Care scheme; Imperial Centre for Patient Safety and Service Quality; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); National Institute for Health Research(National Institute for Health Research (NIHR)); Economic & Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	There was no direct external funding for this study. The Department of Primary Care & Public Health at Imperial College is grateful for support from the National Institute for Health Research Biomedical Research Centre scheme, the National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care scheme and the Imperial Centre for Patient Safety and Service Quality. Prof Wachter was a US-UK Fulbright Scholar at Imperial College London in 2011. Dr Millett is funded by the Higher Education Funding Council for England and the National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care scheme. Dr Vamos is partly funded by the National Institute for Health Research. Dr Netuveli is supported by a grant from the Economic & Social Research Council [RES-596-28-0001]. The funders had no part in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Anderson GF, 2005, HEALTH AFFAIR, V24, P903, DOI 10.1377/hlthaff.24.4.903; Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Caminal J, 2004, EUR J PUBLIC HEALTH, V14, P246, DOI 10.1093/eurpub/14.3.246; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Chobanian AV, 2009, NEW ARMEN MED J, V3, P60, DOI 10.1056/NEJMsa0903829; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531; Gilmore I, 2010, 116366 DH; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; *I MED US, 2001, CROSS QUAL CHASM NEW; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Levene LS, 2010, JAMA-J AM MED ASSOC, V304, P2028, DOI 10.1001/jama.2010.1636; Link BG, 2008, J HEALTH SOC BEHAV, V49, P367, DOI 10.1177/002214650804900401; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; Majeed A, 2009, J AMBUL CARE MANAG, V32, P280, DOI 10.1097/JAC.0b013e3181ba6f4b; Mancia G, 2002, ARCH INTERN MED, V162, P582, DOI 10.1001/archinte.162.5.582; Marmot M, 2003, HLTH WEALTH LIFESTYL; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Millett C, 2008, ANN FAM MED, V6, P490, DOI 10.1370/afm.907; Millett C, 2010, ARCH INTERN MED, V170, P1325, DOI 10.1001/archinternmed.2010.208; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Papke LE, 2005, ECON LETT, V86, P413, DOI 10.1016/j.econlet.2004.07.022; Patel R, 2006, J HUM HYPERTENS, V20, P733, DOI 10.1038/sj.jhh.1002064; Roalfe AK, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-275; Schoen C, 2009, HEALTH AFFAIR, V28, pW1, DOI 10.1377/hlthaff.28.1.w1; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Yamey G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1674	36	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83705	10.1371/journal.pone.0083705	http://dx.doi.org/10.1371/journal.pone.0083705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416171	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000329862500067
J	Donaldson, TM; Ting, LM; Zhan, CY; Shi, WX; Zheng, RJ; Almo, SC; Kim, K				Donaldson, Teraya M.; Ting, Li-Min; Zhan, Chenyang; Shi, Wuxian; Zheng, Renjian; Almo, Steven C.; Kim, Kami			Structural Determinants of the 5 '-Methylthioinosine Specificity of Plasmodium Purine Nucleoside Phosphorylase	PLOS ONE			English	Article							TRANSITION-STATE ANALOG; TRICHOMONAS-VAGINALIS; TOXOPLASMA-GONDII; IMMUCILLIN-H; FALCIPARUM; INHIBITORS; PATHWAY	Plasmodium parasites rely upon purine salvage for survival. Plasmodium purine nucleoside phosphorylase is part of the streamlined Plasmodium purine salvage pathway that leads to the phosphorylysis of both purines and 5 '-methylthiopurines, byproducts of polyamine synthesis. We have explored structural features in Plasmodium falciparum purine nucleoside phosphorylase ( PfPNP) that affect efficiency of catalysis as well as those that make it suitable for dual specificity. We used site directed mutagenesis to identify residues critical for PfPNP catalytic activity as well as critical residues within a hydrophobic pocket required for accommodation of the 5 '-methylthio group. Kinetic analysis data shows that several mutants had disrupted binding of the 5 '-methylthio group while retaining activity for inosine. A triple PfPNP mutant that mimics Toxoplasma gondii PNP had significant loss of 5 '-methylthio activity with retention of inosine activity. Crystallographic investigation of the triple mutant PfPNP with Tyr160Phe, Val66Ile, andVal73Ile in complex with the transition state inhibitor immucillin H reveals fewer hydrogen bond interactions for the inhibitor in the hydrophobic pocket.	[Donaldson, Teraya M.; Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Donaldson, Teraya M.; Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Donaldson, Teraya M.; Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Zhan, Chenyang; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Shi, Wuxian] Brookhaven Natl Lab, Natl Synchrotron Light Source, Brookhaven, NY USA; [Zheng, Renjian] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; United States Department of Energy (DOE); Brookhaven National Laboratory; Yeshiva University; Albert Einstein College of Medicine	Kim, K (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	kami.kim@einstein.yu.edu		Kim, Kami/0000-0003-3384-152X; Zucker-Scharff, Thomas/0000-0002-1790-7405; , Teraya/0000-0002-1635-8854	US Army Research [W81XWH-05-2-0025]; National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research; Basic Energy Sciences of the US Department of Energy; National Center for Research Resources of the National Institutes of Health; National Center for Research Resources at the National Institute of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02_06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	US Army Research(United States Department of DefenseUS Army Research Laboratory (ARL)); National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research; Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Part of this work was supported by US Army Research Grant W81XWH-05-2-0025 (to K. K.). Financial support of beamline X29A of the National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy and from the National Center for Research Resources of the National Institutes of Health. The Northeastern Collaborative Access Team beamlines of the Advanced Photon Source are supported by award RR-15301 from the National Center for Research Resources at the National Institute of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract number DE-AC02_06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; Bennett EM, 2003, J BIOL CHEM, V278, P47110, DOI 10.1074/jbc.M304622200; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Chaudhary K, 2004, J BIOL CHEM, V279, P31221, DOI 10.1074/jbc.M404232200; Chaudhary K, 2006, J BIOL CHEM, V281, P25652, DOI 10.1074/jbc.M602624200; Cook T, 2007, MICROBIOL-SGM, V153, P1123, DOI 10.1099/mic.0.2006/001768-0; Das Gupta R, 2005, ANTIMICROB AGENTS CH, V49, P2857, DOI 10.1128/AAC.49.7.2857-2864.2005; DeLano WL, 2002, PYMOL USERS MANUAL; Evans GB, 2004, J MED CHEM, V47, P3275, DOI 10.1021/jm0306475; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Evans GB, 2003, ORG LETT, V5, P3639, DOI 10.1021/ol035293q; Evans GB, 2003, J MED CHEM, V46, P3412, DOI 10.1021/jm030145r; Evans GB, 2003, J MED CHEM, V46, P155, DOI 10.1021/jm0203332; Gherardi A, 2007, TRENDS PARASITOL, V23, P384, DOI 10.1016/j.pt.2007.06.003; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Keithly JS, 1997, MOL BIOCHEM PARASIT, V88, P35, DOI 10.1016/S0166-6851(97)00063-7; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; Kicska GA, 2002, J BIOL CHEM, V277, P3219, DOI 10.1074/jbc.M105905200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Madrid DC, 2008, J BIOL CHEM; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Minor ZOaW, 1997, PROCESSING XRAY DIFF; Munagala N, 2002, BIOCHEMISTRY-US, V41, P10382, DOI 10.1021/bi026025n; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Rinaldo-Matthis A, 2007, BIOCHEMISTRY-US, V46, P659, DOI 10.1021/bi061515r; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; Stoeckler JD, 1997, BIOCHEMISTRY-US, V36, P11749, DOI 10.1021/bi961971n; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SUFRIN JR, 1995, ANTIMICROB AGENTS CH, V39, P2511, DOI 10.1128/AAC.39.11.2511; Takebe S, 2007, EUKARYOT CELL, V6, P584, DOI 10.1128/EC.00376-06; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; Wang F, 2000, PROTEIN SCI, V9, P1660, DOI 10.1110/ps.9.9.1660; WHO, 2012, WORLD MALARIA REPORT 2012, P1	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84384	10.1371/journal.pone.0084384	http://dx.doi.org/10.1371/journal.pone.0084384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416224	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500121
J	Horga, G; Fernandez-Egea, E; Mane, A; Font, M; Schatz, KC; Falcon, C; Lomena, F; Bernardo, M; Parellada, E				Horga, Guillermo; Fernandez-Egea, Emilio; Mane, Anna; Font, Mireia; Schatz, Kelly C.; Falcon, Carles; Lomena, Francisco; Bernardo, Miguel; Parellada, Eduard			Brain Metabolism during Hallucination-Like Auditory Stimulation in Schizophrenia	PLOS ONE			English	Article							FDG-PET; AMYGDALA; ACTIVATION; NETWORKS; FEELINGS; PATTERNS; EMOTION; STATE; FMRI; CONNECTIVITY	Auditory verbal hallucinations (AVH) in schizophrenia are typically characterized by rich emotional content. Despite the prominent role of emotion in regulating normal perception, the neural interface between emotion-processing regions such as the amygdala and auditory regions involved in perception remains relatively unexplored in AVH. Here, we studied brain metabolism using FDG-PET in 9 remitted patients with schizophrenia that previously reported severe AVH during an acute psychotic episode and 8 matched healthy controls. Participants were scanned twice: (1) at rest and (2) during the perception of aversive auditory stimuli mimicking the content of AVH. Compared to controls, remitted patients showed an exaggerated response to the AVH-like stimuli in limbic and paralimbic regions, including the left amygdala. Furthermore, patients displayed abnormally strong connections between the amygdala and auditory regions of the cortex and thalamus, along with abnormally weak connections between the amygdala and medial prefrontal cortex. These results suggest that abnormal modulation of the auditory cortex by limbic-thalamic structures might be involved in the pathophysiology of AVH and may potentially account for the emotional features that characterize hallucinatory percepts in schizophrenia.	[Horga, Guillermo; Schatz, Kelly C.] Columbia Univ Med Ctr, New York State Psychiat Inst, Dept Psychiat, New York, NY USA; [Horga, Guillermo; Font, Mireia; Lomena, Francisco; Bernardo, Miguel; Parellada, Eduard] Hosp Clin Barcelona, Schizophrenia Unit, Neurosci Inst, Barcelona, Spain; [Horga, Guillermo; Bernardo, Miguel; Parellada, Eduard] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Fernandez-Egea, Emilio] Univ Cambridge, Dept Psychiat, Cambridge, England; [Fernandez-Egea, Emilio] Cambridgeshire & Peterborough NHS Fdn Trust, Huntingdon, England; [Fernandez-Egea, Emilio; Mane, Anna; Lomena, Francisco; Bernardo, Miguel; Parellada, Eduard] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain; [Mane, Anna] Ctr Forum, Barcelona, Spain; [Falcon, Carles] CIBER BBN, GIB UB, Barcelona, Spain; [Lomena, Francisco; Bernardo, Miguel; Parellada, Eduard] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	Columbia University; New York State Psychiatry Institute; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Cambridge; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Horga, G (corresponding author), Columbia Univ Med Ctr, New York State Psychiat Inst, Dept Psychiat, New York, NY USA.	guillermo.horga@gmail.com	Bernardo, Miquel/P-3049-2015; Parellada, Eduard/I-2675-2015; Horga, Guillermo/M-8036-2016	Bernardo, Miquel/0000-0001-8748-6717; Parellada, Eduard/0000-0003-1131-4980; Horga, Guillermo/0000-0002-9049-9786; falcon, carles/0000-0001-5564-2025; mane santacana, anna/0000-0003-2127-349X; Fernandez-Egea, Emilio/0000-0003-4128-8955	Fundacio Marato of TV3 [012410]; Janssen-Cilag; Ministerio de Ciencia y Tecnologia [SAF-2002-04270-C02 02]; Fondo de Investigacion Sanitaria [G03/185, C03/06]; DIUE (Government of Catalonia, Comissionat per Universitats I Recerca del Departament d'Innovacio, Universitats I Empresa) [2009SGR1295]; Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM); Medical Research Council [G0001354B, G1000183B, G0001354] Funding Source: researchfish	Fundacio Marato of TV3; Janssen-Cilag; Ministerio de Ciencia y Tecnologia; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); DIUE (Government of Catalonia, Comissionat per Universitats I Recerca del Departament d'Innovacio, Universitats I Empresa); Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM)(Instituto de Salud Carlos III); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Fundacio Marato of TV3 (registered number 012410), Janssen-Cilag; Ministerio de Ciencia y Tecnologia (grant number SAF-2002-04270-C02 02); the Fondo de Investigacion Sanitaria (grant numbers G03/185, C03/06); DIUE (Government of Catalonia, Comissionat per Universitats I Recerca del Departament d'Innovacio, Universitats I Empresa, grant number 2009SGR1295); and the Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Anticevic A, 2012, SCHIZOPHRENIA BULL, V38, P608, DOI 10.1093/schbul/sbq131; Anticevic A, 2012, SCHIZOPHRENIA BULL, V38, P967, DOI 10.1093/schbul/sbq168; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Bentaleb LA, 2006, ENCEPHALE, V32, P27; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Di X, 2012, BRAIN CONNECT, V2, P275, DOI 10.1089/brain.2012.0086; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Fernandez-Egea E, 2010, EUR ARCH PSY CLIN N, V260, P69, DOI 10.1007/s00406-009-0020-6; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Grunder G, 2009, NEUROIMAGE, V45, P258, DOI 10.1016/j.neuroimage.2008.10.042; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Haddock G, 1999, PSYCHOL MED, V29, P879, DOI 10.1017/S0033291799008661; Holt DJ, 2006, SCHIZOPHR RES, V82, P153, DOI 10.1016/j.schres.2005.09.021; Holt DJ, 2005, BIOL PSYCHIAT, V57, P1011, DOI 10.1016/j.biopsych.2005.01.033; Horga G, 2011, J PSYCHIATR NEUROSCI, V36, P312, DOI 10.1503/jpn.100085; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kumar S, 2012, J NEUROSCI, V32, P14184, DOI 10.1523/JNEUROSCI.1759-12.2012; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lee DS, 2008, EUR J NUCL MED MOL I, V35, P1681, DOI 10.1007/s00259-008-0808-z; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Morbelli S, 2012, NEUROBIOL AGING, V33, P2533, DOI 10.1016/j.neurobiolaging.2012.01.005; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Salgado-Pineda P, 2010, J PSYCHIATR NEUROSCI, V35, P41, DOI 10.1503/jpn.090017; Sanjuan J, 2007, PSYCHIAT RES-NEUROIM, V154, P21, DOI 10.1016/j.pscychresns.2006.04.011; Schneider F, 1998, SCHIZOPHR RES, V34, P133, DOI 10.1016/S0920-9964(98)00085-1; Taylor PA, 2012, BRAIN CONNECT, V2, P203, DOI 10.1089/brain.2012.0095; Taylor SF, 2005, NEUROPSYCHOPHARMACOL, V30, P984, DOI 10.1038/sj.npp.1300679; Taylor SF, 2002, SCHIZOPHR RES, V58, P159, DOI 10.1016/S0920-9964(01)00403-0; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P683, DOI 10.1093/schbul/sbs045; Weber WA, 2000, NUCL MED BIOL, V27, P683, DOI 10.1016/S0969-8051(00)00141-4; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zhang ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028817	46	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84987	10.1371/journal.pone.0084987	http://dx.doi.org/10.1371/journal.pone.0084987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416328	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500201
J	Hernandez-Bule, ML; Trillo, MA; Ubeda, A				Luisa Hernandez-Bule, Maria; Angeles Trillo, Maria; Ubeda, Alejandro			Molecular Mechanisms Underlying Antiproliferative and Differentiating Responses of Hepatocarcinoma Cells to Subthermal Electric Stimulation	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY-OUTPUT POWER; PLUS REGIONAL HYPERTHERMIA; HUMAN NEUROBLASTOMA-CELLS; HEPATOCYTE GROWTH-FACTOR; HZ MAGNETIC-FIELD; C-MET; ELECTROMAGNETIC-FIELDS; LUNG-CANCER; P53	Capacitive Resistive Electric Transfer (CRET) therapy applies currents of 0.4-0.6 MHz to treatment of inflammatory and musculoskeletal injuries. Previous studies have shown that intermittent exposure to CRET currents at subthermal doses exert cytotoxic or antiproliferative effects in human neuroblastoma or hepatocarcinoma cells, respectively. It has been proposed that such effects would be mediated by cell cycle arrest and by changes in the expression of cyclins and cyclin-dependent kinase inhibitors. The present work focuses on the study of the molecular mechanisms involved in CRET-induced cytostasis and investigates the possibility that the cellular response to the treatment extends to other phenomena, including induction of apoptosis and/or of changes in the differentiation stage of hepatocarcinoma cells. The obtained results show that the reported antiproliferative action of intermittent stimulation (5 m On/4 h Off) with 0.57 MHz, sine wave signal at a current density of 50 mu A/mm(2), could be mediated by significant increase of the apoptotic rate as well as significant changes in the expression of proteins p53 and Bcl-2. The results also revealed a significantly decreased expression of alpha-fetoprotein in the treated samples, which, together with an increased concentration of albumin released into the medium by the stimulated cells, can be interpreted as evidence of a transient cytodifferentiating response elicited by the current. The fact that this type of electrical stimulation is capable of promoting both, differentiation and cell cycle arrest in human cancer cells, is of potential interest for a possible extension of the applications of CRET therapy towards the field of oncology.	[Luisa Hernandez-Bule, Maria; Angeles Trillo, Maria; Ubeda, Alejandro] Ramon y Cajal Univ Hosp, Ramon y Cajal Inst Med Res, Bioelectromagnet Serv, Madrid, Spain		Hernandez-Bule, ML (corresponding author), Ramon y Cajal Univ Hosp, Ramon y Cajal Inst Med Res, Bioelectromagnet Serv, Madrid, Spain.	mluisa.hernandez@hrc.es	Hernandez-Bule, Maria Luisa/AAE-4403-2022; Hernandez-Bule, Maria Luisa/A-5010-2019	Hernandez-Bule, Maria Luisa/0000-0002-1437-3452; Hernandez-Bule, Maria Luisa/0000-0002-1437-3452	Fundacion para la Investigacion Biomedica del Hospital Ramon y Cajal, through Project FiBio-HRC [2006/0158]	Fundacion para la Investigacion Biomedica del Hospital Ramon y Cajal, through Project FiBio-HRC	This work was financially supported by Fundacion para la Investigacion Biomedica del Hospital Ramon y Cajal, through Project FiBio-HRC No. 2006/0158. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cid MA, 2012, CELL PHYSIOL BIOCHEM, V30, P1502, DOI 10.1159/000343338; Martinez MA, 2012, CELL PHYSIOL BIOCHEM, V29, P675, DOI 10.1159/000178457; Barbault A, 2009, J EXP CLIN CANC RES, V14, P28; Beerheide W, 2000, BIOCHEM BIOPH RES CO, V273, P54, DOI 10.1006/bbrc.2000.2891; BOIX L, 1994, HEPATOLOGY, V19, P88, DOI 10.1016/0270-9139(94)90057-4; Brown L, 2007, CRIT REV EUKAR GENE, V17, P73, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.50; Caldon CE, 2010, CELL CYCLE, V9, P1918, DOI 10.4161/cc.9.10.11474; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Chen H, 2012, J INT MED RES, V40, P85, DOI 10.1177/147323001204000109; Cheuk W, 2004, INT J SURG PATHOL, V12, P185, DOI 10.1177/106689690401200301; Coffman FD, 1999, EXP CELL RES, V248, P58, DOI 10.1006/excr.1999.4457; Costa FP, 2011, BRIT J CANCER, V105, P640, DOI 10.1038/bjc.2011.292; Costin GE, 2012, CURR MOL MED, V12, P14, DOI 10.2174/156652412798376143; Grimnes S., 2000, BIOIMPEDANCE BIOELEC, P71; Gu JJ, 2000, MOL CELL BIOL, V20, P1243, DOI 10.1128/MCB.20.4.1243-1253.2000; Guo LF, 2011, ELECTROMAGN BIOL MED, V30, P21, DOI 10.3109/15368378.2011.566775; Heiser D, 2004, EXP GERONTOL, V39, P1125, DOI 10.1016/j.exger.2004.04.011; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Hernandez-Bule ML, 2004, NEUROCIRUGIA, V15, P366; Hernandez-Bule ML, 2007, INT J ONCOLOGY, V30, P583; Huang HP, 2010, J BIOL CHEM, V285, P33510, DOI 10.1074/jbc.M110.122093; Iseki K, 2000, INT J ONCOL, V16, P1141; Issels RD, 2010, LANCET ONCOL, V11, P561, DOI 10.1016/S1470-2045(10)70071-1; Kato S, 2011, CYTOTECHNOLOGY, V63, P425, DOI 10.1007/s10616-011-9363-8; Kong N, 2013, ASIAN PAC J CANCER P, V14, P747, DOI 10.7314/APJCP.2013.14.2.747; Kotnik T, 2000, BIOELECTROMAGNETICS, V21, P385, DOI 10.1002/1521-186X(200007)21:5<385::AID-BEM7>3.0.CO;2-F; Lee KH, 2008, CLIN EXP METASTAS, V25, P89, DOI 10.1007/s10585-007-9106-6; Li P, 2011, WORLD J GASTROENTERO, V17, P4563, DOI 10.3748/wjg.v17.i41.4563; Liang SH, 2001, EUR J BIOCHEM, V268, P2779, DOI 10.1046/j.1432-1327.2001.02227.x; Hernandez-Bule ML, 2012, INT J ONCOL, V41, P1251, DOI 10.3892/ijo.2012.1569; Hernandez-Bule ML, 2010, INT J ONCOL, V37, P1399, DOI 10.3892/ijo_00000791; Malmlof M, 2007, J BIOL CHEM, V282, P2288, DOI 10.1074/jbc.M604953200; Moon SD, 2011, LUNG CANCER, V71, P338, DOI 10.1016/j.lungcan.2010.06.007; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; Ohguri T, 2012, LUNG CANCER, V77, P140, DOI 10.1016/j.lungcan.2012.02.018; Ohguri T, 2011, INT J HYPERTHER, V27, P20, DOI 10.3109/02656736.2010.500644; Ohguri T, 2009, INT J RADIAT ONCOL, V73, P128, DOI 10.1016/j.ijrobp.2008.03.059; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; San BH, 2013, INT J HYPERTHER, V29, P99, DOI 10.3109/02656736.2012.760137; Sheikh AQ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0548; STECK KD, 1995, CYTOMETRY, V20, P154, DOI 10.1002/cyto.990200208; SUZUKI K, 1994, HEPATOLOGY, V20, P1231; Takahashi K, 2004, J PHYS THER SCI, V11, P45, DOI [DOI 10.1589/JPTS.11.45, 10.1589/jpts.11.45]; Takahashi M, 1999, J HEPATOL, V31, P315, DOI 10.1016/S0168-8278(99)80230-X; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Tomek M, 2012, J PHARM PHARMACOL, V64, P1695, DOI 10.1111/j.2042-7158.2012.01526.x; Wang SY, 2004, J HEPATOL, V41, P267, DOI 10.1016/j.jhep.2004.04.013; Yao DF, 2007, HEPATOB PANCREAT DIS, V6, P241	48	20	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84636	10.1371/journal.pone.0084636	http://dx.doi.org/10.1371/journal.pone.0084636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416255	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500143
J	Notebaert, L; Chrystal, J; Clarke, PJF; Holmes, EA; MacLeod, C				Notebaert, Lies; Chrystal, Jessica; Clarke, Patrick J. F.; Holmes, Emily A.; MacLeod, Colin			When We Should Worry More: Using Cognitive Bias Modification to Drive Adaptive Health Behaviour	PLOS ONE			English	Article							METAANALYSIS; STRESS; FEAR	A lack of behavioural engagement in health promotion or disease prevention is a problem across many health domains. In these cases where people face a genuine danger, a reduced focus on threat and low levels of anxiety or worry are maladaptive in terms of promoting protection or prevention behaviour. Therefore, it is possible that increasing the processing of threat will increase worry and thereby enhance engagement in adaptive behaviour. Laboratory studies have shown that cognitive bias modification (CBM) can increase or decrease anxiety and worry when increased versus decreased processing of threat is encouraged. In the current study, CBM for interpretation (CBM-I) is used to target engagement in sun protection behaviour. The goal was to investigate whether inducing a negative rather than a positive interpretation bias for physical threat information can enhance worry elicited when viewing a health campaign video (warning against melanoma skin cancer), and consequently lead to more adaptive behaviour (sun protection). Participants were successfully trained to either adopt a positive or negative interpretation bias using physical threat scenarios. However, contrary to expectations results showed that participants in the positive training condition reported higher levels of worry elicited by the melanoma video than participants in the negative training condition. Video elicited worry was, however, positively correlated with a measure of engagement in sun protection behaviour, suggesting that higher levels of worry do promote adaptive behaviour. These findings imply that more research is needed to determine under which conditions increased versus decreased processing of threat can drive adaptive worry. Various potential explanations for the current findings and suggestions for future research are discussed.	[Notebaert, Lies; Chrystal, Jessica; Clarke, Patrick J. F.; MacLeod, Colin] Univ Western Australia, Sch Psychol, Crawley, WA, Australia; [Holmes, Emily A.] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England	University of Western Australia; University of Cambridge	Notebaert, L (corresponding author), Univ Western Australia, Sch Psychol, Crawley, WA, Australia.	lies.notebaert@uwa.edu.au	Clarke, Patrick/H-8998-2014; Notebaert, Lies/H-5546-2014; Holmes, Emily/ABD-4367-2020	Clarke, Patrick/0000-0003-0303-4479; Notebaert, Lies/0000-0002-5849-4045; Holmes, Emily/0000-0001-7319-3112; MacLeod, Colin/0000-0003-2407-7339	Australian Bushfire Cooperative Research Centre; Wellcome Trust [WT088217]; Medical Research Council; Lupina Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University; Australian Research Council [DP0879589]; Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PNII-ID-PCCE-2011-2-0045]; Medical Research Council [MC_UP_0901/1] Funding Source: researchfish; MRC [MC_UP_0901/1] Funding Source: UKRI	Australian Bushfire Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lupina Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University; Australian Research Council(Australian Research Council); Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Lies Notebaert is supported by an Australian Bushfire Cooperative Research Centre grant on managing threat through the modification of thought. Emily A. Holmes is supported by a Wellcome Trust Clinical Fellowship (WT088217), The Medical Research Council, The Lupina Foundation, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals Trust Oxford University. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Colin MacLeod is supported in part by Australian Research Council Grant DP0879589, and by a grant from the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, project number PNII-ID-PCCE-2011-2-0045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2006, ACAD EMERG MED, V13, P427, DOI [10.1111/j.1553-2712.2006.tb00321.x, 10.1197/j.aem.2005.11.003]; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; Ciarocco NJ, 2010, J SOC CLIN PSYCHOL, V29, P1057, DOI 10.1521/jscp.2010.29.10.1057; Clarke PJF, 2013, COGNIT THER RES; Dandeneau SD, 2007, J PERS SOC PSYCHOL, V93, P651, DOI 10.1037/0022-3514.93.4.651; deRooij MJM, 1997, ACTA DERM-VENEREOL, V77, P467; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fazio R. H., 1990, REV PERSONALITY SOCI, V11, P74, DOI DOI 10.1037/031329; Hayes S, 2010, BEHAV RES THER, V48, P171, DOI 10.1016/j.brat.2009.10.006; Hirsch CR, 2009, J ABNORM PSYCHOL, V118, P44, DOI 10.1037/a0013473; Hoppitt L, 2010, BEHAV THER, V41, P73, DOI 10.1016/j.beth.2009.01.002; Lange WG, 2010, APPL COGNITIVE PSYCH, V24, P326, DOI 10.1002/acp.1679; Lucas R., 2006, SOLAR ULTRAVIOLET RA; Mackintosh B, 2013, J EXP PSYCHOPATHOL, V4, P133, DOI 10.5127/jep.025711; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MacLeod C, 2013, HDB COGNITION EMOTIO, P540; MacLeod C, 2012, CURR OPIN PSYCHIATR, V25, P114, DOI 10.1097/YCO.0b013e32834fda4a; Mathews A, 2000, J ABNORM PSYCHOL, V109, P602, DOI 10.1037//0021-843X.109.4.602; McCaul KD, 1996, HEALTH PSYCHOL, V15, P423, DOI 10.1037/0278-6133.15.6.423; McCaul KD, 2003, BLACKW SER HLTH PSYC, P137; Mermelstein R, 1999, CANC RES THER CONTR, V8, P69; MIKULINCER M, 1996, LEA SER PER CLIN PSY, P191; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Pictet A, 2011, BEHAV RES THER, V49, P885, DOI 10.1016/j.brat.2011.10.003; Rivkin ID, 1999, PERS SOC PSYCHOL B, V25, P1451, DOI 10.1177/01461672992510002; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stober J, 2001, PERS INDIV DIFFER, V31, P591, DOI 10.1016/S0191-8869(00)00163-X; Teachman BA, 2008, COGNITIVE THER RES, V32, P448, DOI 10.1007/s10608-006-9084-z; Tukey JW, 1977, EXPLORATORY DATA ANA; Verkuil B, 2007, BEHAV RES THER, V45, P1835, DOI 10.1016/j.brat.2007.02.004; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506	32	9	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85092	10.1371/journal.pone.0085092	http://dx.doi.org/10.1371/journal.pone.0085092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24416344	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500213
J	Sanz, G; Leray, I; Dewaele, A; Sobilo, J; Lerondel, S; Bouet, S; Grebert, D; Monnerie, R; Pajot-Augy, E; Mir, LM				Sanz, Guenhael; Leray, Isabelle; Dewaele, Aurelie; Sobilo, Julien; Lerondel, Stephanie; Bouet, Stephan; Grebert, Denise; Monnerie, Regine; Pajot-Augy, Edith; Mir, Lluis M.			Promotion of Cancer Cell Invasiveness and Metastasis Emergence Caused by Olfactory Receptor Stimulation	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; MAMMALIAN ODORANT RECEPTORS; NEUROENDOCRINE CARCINOMAS; ENTEROCHROMAFFIN CELLS; FUNCTIONAL EXPRESSION; SEROTONIN RELEASE; PROTEIN; MOUSE; MODEL; INVASION	Olfactory receptors (ORs) are expressed in the olfactory epithelium, where they detect odorants, but also in other tissues with additional functions. Some ORs are even overexpressed in tumor cells. In this study, we identified ORs expressed in enterochromaffin tumor cells by RT-PCR, showing that single cells can co-express several ORs. Some of the receptors identified were already reported in other tumors, but they are orphan (without known ligand), as it is the case for most of the hundreds of human ORs. Thus, genes coding for human ORs with known ligands were transfected into these cells, expressing functional heterologous ORs. The in vitro stimulation of these cells by the corresponding OR odorant agonists promoted cell invasion of collagen gels. Using LNCaP prostate cancer cells, the stimulation of the PSGR (Prostate Specific G protein-coupled Receptor), an endogenously overexpressed OR, by beta-ionone, its odorant agonist, resulted in the same phenotypic change. We also showed the involvement of a PI3 kinase gamma dependent signaling pathway in this promotion of tumor cell invasiveness triggered by OR stimulation. Finally, after subcutaneous inoculation of LNCaP cells into NSG immunodeficient mice, the in vivo stimulation of these cells by the PSGR agonist beta-ionone significantly enhanced metastasis emergence and spreading.	[Sanz, Guenhael; Dewaele, Aurelie; Grebert, Denise; Monnerie, Regine; Pajot-Augy, Edith] INRA, Neurobiol Olfact & Modelisat Imagerie UR1197, Jouy En Josas, France; [Sanz, Guenhael; Dewaele, Aurelie; Grebert, Denise; Monnerie, Regine; Pajot-Augy, Edith] IFR 144 NeuroSud Paris, Gif Sur Yvette, France; [Leray, Isabelle; Mir, Lluis M.] CNRS, Vectorol & Therapeut Anticancereuses UMR8203, Inst Gustave Roussy, Villejuif, France; [Leray, Isabelle; Mir, Lluis M.] Univ Paris 11, UMR8203, Orsay, France; [Sobilo, Julien; Lerondel, Stephanie] CNRS TAAM, UPS44, Ctr Imagerie Petit Anim, Orleans, France; [Bouet, Stephan] INRA, UMR 1313, Jouy En Josas, France; [Bouet, Stephan] CEA, DSV, IRCM, SREIT,Lab Radiobiol & Etud Genome, Jouy En Josas, France; [Bouet, Stephan] AgroParisTech, UMR 1313, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Sanz, G (corresponding author), INRA, Neurobiol Olfact & Modelisat Imagerie UR1197, Jouy En Josas, France.	Guenhael.Sanz@jouy.inra.fr; Luis.MIR@gustaveroussy.fr	MIR, Lluis M/AAJ-9110-2020		INRA; CNRS (The National Centre for Scientific Research (France)	INRA; CNRS (The National Centre for Scientific Research (France)	This work was supported by INRA and CNRS (The National Centre for Scientific Research (France). This research was conducted in the scope of the LEA EBAM (The European Associated Laboratory (LEA) entitled "Pulsed Electric Fields Applications in Biology and Medicine"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoub S, 2008, ANN NY ACAD SCI, V1138, P204, DOI 10.1196/annals.1414.027; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Brunert D, 2010, CHEM SENSES, V35, P301, DOI 10.1093/chemse/bjq020; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cui T, 2013, EUR J ENDOCRINOL, V168, P253, DOI 10.1530/EJE-12-0814; De Wever O, 2010, INT J DEV BIOL, V54, P887, DOI 10.1387/ijdb.092948ow; EVERS BM, 1994, ANN NY ACAD SCI, V733, P393, DOI 10.1111/j.1749-6632.1994.tb17289.x; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fukuda N, 2006, GENES CELLS, V11, P71, DOI 10.1111/j.1365-2443.2005.00915.x; Gershon MD, 2004, ALIMENT PHARM THER, V20, P3, DOI 10.1111/j.1365-2036.2004.02180.x; Giandomenico V, 2013, J MOL ENDOCRINOL; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Kidd M, 2008, AM J PHYSIOL-GASTR L, V295, pG260, DOI 10.1152/ajpgi.00056.2008; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Modlin IM, 2005, GASTROENTEROLOGY, V128, P1717, DOI 10.1053/j.gastro.2005.03.038; Muranen TA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3015; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Regnauld K, 2002, ONCOGENE, V21, P4020, DOI 10.1038/sj.onc.1205498; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Sanz G, 2008, CHEM SENSES, V33, P639, DOI 10.1093/chemse/bjn032; Sato N, 1997, CANCER RES, V57, P1584; Scatena CD, 2004, PROSTATE, V59, P292, DOI 10.1002/pros.20003; Spehr M, 2004, CURR BIOL, V14, pR832, DOI 10.1016/j.cub.2004.09.034; Thalmann GN, 2000, PROSTATE, V44, P91; Ukhanov K, 2011, J NEUROSCI, V31, P273, DOI 10.1523/JNEUROSCI.3698-10.2011; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; von Mentzer B, 2007, BIOCHEM PHARMACOL, V73, P805, DOI 10.1016/j.bcp.2006.11.019; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; Weng JS, 2005, INT J CANCER, V113, P811, DOI 10.1002/ijc.20635; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	41	77	78	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85110	10.1371/journal.pone.0085110	http://dx.doi.org/10.1371/journal.pone.0085110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416348	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500217
J	Tewari-Singh, N; Jain, AK; Orlicky, DJ; White, CW; Agarwal, R				Tewari-Singh, Neera; Jain, Anil K.; Orlicky, David J.; White, Carl W.; Agarwal, Rajesh			Cutaneous Injury-Related Structural Changes and Their Progression following Topical Nitrogen Mustard Exposure in Hairless and Haired Mice	PLOS ONE			English	Article							SULFUR MUSTARD; SKIN-LESIONS; PIG SKIN; TOXICITY; GAS; TOXICOLOGY; AGENTS; COMPLICATIONS; PROTECTION; FEATURES	To identify effective therapies against sulfur mustard (SM)-induced skin injuries, various animals have been used to assess the cutaneous pathology and related histopathological changes of SM injuries. However, these efforts to establish relevant skin injury endpoints for efficacy studies have been limited mainly due to the restricted assess of SM. Therefore, we employed the SM analog nitrogen mustard (NM), a primary vesicating and bifunctional alkylating agent, to establish relevant endpoints for efficient efficacy studies. Our published studies show that NM (3.2 mg) exposure for 12-120 h in both the hairless SKH-1 and haired C57BL/6 mice caused clinical sequelae of toxicity similar to SM exposure in humans. The NM-induced cutaneous pathology-related structural changes were further analyzed in this study and quantified morphometrically (as percent length or area of epidermis or dermis) of skin sections in mice showing these lesions. H&E stained skin sections of both hairless and haired mice showed that NM (12-120 h) exposure caused epidermal histopathological effects such as increased epidermal thickness, epidermal-dermal separation, necrotic/dead epidermis, epidermal denuding, scab formation, parakeratosis (24-120 h), hyperkeratosis (12-120 h), and acanthosis with hyperplasia (72-120 h). Similar NM exposure in both mice caused dermal changes including necrosis, edema, increase in inflammatory cells, and red blood cell extravasation. These NM-induced cutaneous histopathological features are comparable to the reported lesions from SM exposure in humans and animal models. This study advocates the usefulness of these histopathological parameters observed due to NM exposure in screening and optimization of rescue therapies against NM and SM skin injuries.	[Tewari-Singh, Neera; Jain, Anil K.; Agarwal, Rajesh] Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado Denver, Sch Med, Dept Pathol, Aurora, CO USA; [White, Carl W.] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Agarwal, R (corresponding author), Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	Rajesh.Agarwal@ucdenver.edu			Countermeasures Against Chemical Threats (CounterACT) Program; Office of the Director National Institutes of Health (OD); National Institute of Environmental Health Sciences (NIEHS) [U54 ES015678]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES015678] Funding Source: NIH RePORTER	Countermeasures Against Chemical Threats (CounterACT) Program; Office of the Director National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Countermeasures Against Chemical Threats (CounterACT) Program, Office of the Director National Institutes of Health (OD) and the National Institute of Environmental Health Sciences (NIEHS), [Grant Number U54 ES015678]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER S F, 1947, Mil Surg, V101, P1; Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117; Arroyo CM, 2001, INT J TOXICOL, V20, P281, DOI 10.1080/109158101753253027; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P297, DOI 10.1111/j.1472-8206.2005.00325.x; Benson JM, 2011, WOUND REPAIR REGEN, V19, P348, DOI 10.1111/j.1524-475X.2011.00675.x; Dachir S, 2010, SKIN RES TECHNOL, V16, P114, DOI 10.1111/j.1600-0846.2009.00409.x; Dorandeu F, 2011, HUM EXP TOXICOL, V30, P470, DOI 10.1177/0960327110373615; Emadi SN, 2012, CUTAN OCUL TOXICOL, V31, P214, DOI 10.3109/15569527.2011.641196; Ghabili K, 2011, CRIT REV TOXICOL, V41, P384, DOI 10.3109/10408444.2010.541224; Ghabili K, 2010, J APPL TOXICOL, V30, P627, DOI 10.1002/jat.1581; Ghanei M, 2010, CUTAN OCUL TOXICOL, V29, P269, DOI 10.3109/15569527.2010.511367; Ghasemi H, 2013, CUTAN OCUL TOXICOL, V32, P304, DOI 10.3109/15569527.2013.781615; Graham JS, 2013, CHEM BIOL INTERACT; Hardej D, 2007, TOXICOL IND HEALTH, V23, P209, DOI 10.1177/0748233707083541; Hayden PJ, 2009, TOXICOL IN VITRO; Hess JF, 2007, BIOCHEM BIOPH RES CO, V359, P616, DOI 10.1016/j.bbrc.2007.05.141; Jain AK, 2011, TOXICOLOGY, V282, P129, DOI 10.1016/j.tox.2011.01.021; Joseph LB, 2011, EXP MOL PATHOL, V91, P515, DOI 10.1016/j.yexmp.2011.05.010; Kan RK, 2003, TOXICOL PATHOL, V31, P185, DOI 10.1080/01926230390183661; Kehe K, 2005, TOXICOLOGY, V214, P198, DOI 10.1016/j.tox.2005.06.014; Kehe K, 2009, TOXICOLOGY, V263, P12, DOI 10.1016/j.tox.2009.01.019; Kehe K, 2009, TOXICOLOGY, V263, P3, DOI 10.1016/j.tox.2009.04.060; Lomash V, 2011, BURNS, V37, P851, DOI 10.1016/j.burns.2010.12.010; Mol MAE, 2009, TOXICOLOGY, V258, P39, DOI 10.1016/j.tox.2009.01.004; Naraghi ZS, 2005, EUR J DERMATOL, V15, P140; PAPIRMEISTER B, 1985, FUND APPL TOXICOL, V5, pS134, DOI 10.1016/0272-0590(85)90123-X; Petrali JP, 1997, MICROSC RES TECHNIQ, V37, P221, DOI 10.1002/(SICI)1097-0029(19970501)37:3<221::AID-JEMT7>3.0.CO;2-Q; Poursaleh Z, 2012, CUTAN OCUL TOXICOL, V31, P241, DOI 10.3109/15569527.2011.636119; Sabourin CLK, 2002, J BIOCHEM MOL TOXIC, V16, P263, DOI 10.1002/jbt.10050; Shakarjian MP, 2010, TOXICOL SCI, V114, P5, DOI 10.1093/toxsci/kfp253; Sharma M, 2010, INT J TOXICOL, V29, P391, DOI 10.1177/1091581810365730; Smith KJ, 1997, J DERMATOL SCI, V14, P126, DOI 10.1016/S0923-1811(96)00560-9; Smith KJ, 1998, AM J DERMATOPATH, V20, P22, DOI 10.1097/00000372-199802000-00005; Song J, 2010, MODERN PATHOL, V23, P799, DOI 10.1038/modpathol.2010.52; Tewari-Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067557; Tewari-Singh N, 2009, TOXICOL SCI, V108, P194, DOI 10.1093/toxsci/kfn261; Wang GQ, 2007, BURNS, V33, P923, DOI 10.1016/j.burns.2006.11.004; WATSON AP, 1992, ENVIRON HEALTH PERSP, V98, P259, DOI 10.2307/3431280; Wormser U, 2004, TOXICOL APPL PHARM, V200, P40, DOI 10.1016/j.taap.2004.03.013; Wormser U, 2004, ARCH TOXICOL, V78, P156, DOI 10.1007/s00204-003-0523-2; Wormser U, 2002, ARCH TOXICOL, V76, P119, DOI 10.1007/s00204-001-0307-5; WORMSER U, 1991, TRENDS PHARMACOL SCI, V12, P164, DOI 10.1016/0165-6147(91)90534-Y	42	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85402	10.1371/journal.pone.0085402	http://dx.doi.org/10.1371/journal.pone.0085402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416404	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500246
J	Belcher, J; McLean, KJ; Matthews, S; Woodward, LS; Fisher, K; Rigby, SEJ; Nelson, DR; Potts, D; Baynham, MT; Parker, DA; Leys, D; Munro, AW				Belcher, James; McLean, Kirsty J.; Matthews, Sarah; Woodward, Laura S.; Fisher, Karl; Rigby, Stephen E. J.; Nelson, David R.; Potts, Donna; Baynham, Michael T.; Parker, David A.; Leys, David; Munro, Andrew W.			Structure and Biochemical Properties of the Alkene Producing Cytochrome P450 OleTJE (CYP152L1) from the Jeotgalicoccus sp 8456 Bacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofuel; Crystal Structure; Cytochrome P450; Decarboxylase; Electron Paramagnetic Resonance (EPR); Enzyme Kinetics; Enzyme Mechanisms; Fatty Acid-binding Protein; Hydrogen Peroxide; X-ray Crystallography	ELECTRON-PARAMAGNETIC-RESONANCE; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; OXYGEN ACTIVATION; HYDROGEN-PEROXIDE; BACILLUS-SUBTILIS; LIGAND-BINDING; PURIFICATION; SUBSTRATE; HYDROXYLATION	Background: OleT(JE) oxidatively decarboxylates fatty acids to produce terminal alkenes. Results: OleT(JE) is an efficient peroxide-dependent lipid decarboxylase, with high affinity substrate binding and the capacity to be resolubilized from precipitate in an active form. Conclusion: OleT(JE) has key differences in active site structure and substrate binding/mechanistic properties from related CYP152 hydroxylases. Significance: OleT(JE) is an efficient and robust biocatalyst with applications in biofuel production. The production of hydrocarbons in nature has been documented for only a limited set of organisms, with many of the molecular components underpinning these processes only recently identified. There is an obvious scope for application of these catalysts and engineered variants thereof in the future production of biofuels. Here we present biochemical characterization and crystal structures of a cytochrome P450 fatty acid peroxygenase: the terminal alkene forming OleT(JE) (CYP152L1) from Jeotgalicoccus sp. 8456. OleT(JE) is stabilized at high ionic strength, but aggregation and precipitation of OleT(JE) in low salt buffer can be turned to advantage for purification, because resolubilized OleT(JE) is fully active and extensively dissociated from lipids. OleT(JE) binds avidly to a range of long chain fatty acids, and structures of both ligand-free and arachidic acid-bound OleT(JE) reveal that the P450 active site is preformed for fatty acid binding. OleT(JE) heme iron has an unusually positive redox potential (-103 mV versus normal hydrogen electrode), which is not significantly affected by substrate binding, despite extensive conversion of the heme iron to a high spin ferric state. Terminal alkenes are produced from a range of saturated fatty acids (C12-C20), and stopped-flow spectroscopy indicates a rapid reaction between peroxide and fatty acid-bound OleT(JE) (167 s(-1) at 200 m H2O2). Surprisingly, the active site is highly similar in structure to the related P450(BS), which catalyzes hydroxylation of fatty acids as opposed to decarboxylation. Our data provide new insights into structural and mechanistic properties of a robust P450 with potential industrial applications.	[Belcher, James; McLean, Kirsty J.; Matthews, Sarah; Woodward, Laura S.; Fisher, Karl; Rigby, Stephen E. J.; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Nelson, David R.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Potts, Donna; Baynham, Michael T.] Agilent Technol UK Ltd, Stockport SK8 3GR, Cheshire, England; [Parker, David A.] Westhollow Technol Ctr, Houston, TX 77028 USA	University of Manchester; University of Tennessee System; University of Tennessee Health Science Center; Agilent Technologies	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022; Fisher, Karl/A-5956-2013	Munro, Andrew/0000-0002-4642-180X; Fisher, Karl/0000-0003-3539-8939; McLean, Kirsty/0000-0002-7193-5044; Woodward, Laura/0000-0001-7880-5325; Nelson, David/0000-0003-0583-5421	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K017802/1]; Agilent Technologies UK Ltd. [BB/J012645/1]; Biotechnology and Biological Sciences Research Council [BB/F002521/1, BB/K017802/1, 1225743, BB/E013007/1] Funding Source: researchfish; BBSRC [BB/E013007/1, BB/K017802/1, BB/F002521/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agilent Technologies UK Ltd.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) Industrial CASE studentship with Agilent Technologies UK Ltd. (BB/J012645/1) (to S. M., A. W. M., and M. T. B.) and Industrial Partnership Award (IPA) BB/K017802/1 (to D. L., A. W. M., and D. P.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; CuppVickery JR, 1997, STEROIDS, V62, P112, DOI 10.1016/S0039-128X(96)00168-7; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; de Montellano P. R. O., 1995, CYTCOCHROME P450 STR, P245; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Dutton P L, 1978, Methods Enzymol, V54, P411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujishiro T, 2011, J BIOL CHEM, V286, P29941, DOI 10.1074/jbc.M111.245225; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Girhard M, 2007, BIOCHEM BIOPH RES CO, V362, P114, DOI 10.1016/j.bbrc.2007.07.155; Girvan HM, 2004, J BIOL CHEM, V279, P23274, DOI 10.1074/jbc.M401716200; GROVES JT, 1976, J AM CHEM SOC, V98, P859, DOI 10.1021/ja00419a049; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Harford-Cross CF, 2000, PROTEIN ENG, V13, P121, DOI 10.1093/protein/13.2.121; HECKER M, 1989, J BIOL CHEM, V264, P141; HOLLENBERG PF, 1980, J BIOL CHEM, V255, P4801; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krest CM, 2013, J BIOL CHEM, V288, P17074, DOI 10.1074/jbc.R113.473108; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; LIPSCOMB JD, 1980, BIOCHEMISTRY-US, V19, P3590, DOI 10.1021/bi00556a027; Matsunaga I, 1999, LIPIDS, V34, P841, DOI 10.1007/s11745-999-0431-3; Matsunaga I, 1997, J BIOL CHEM, V272, P23592, DOI 10.1074/jbc.272.38.23592; Matsunaga I, 2002, BIOCHEMISTRY-US, V41, P1886, DOI 10.1021/bi011883p; Matsunaga I, 2001, ARCH BIOCHEM BIOPHYS, V394, P45, DOI 10.1006/abbi.2001.2512; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Munro AW, 2007, BBA-GEN SUBJECTS, V1770, P345, DOI 10.1016/j.bbagen.2006.08.018; Munro AW, 2013, TRENDS BIOCHEM SCI, V38, P140, DOI 10.1016/j.tibs.2012.11.006; Netto LES, 1996, ARCH BIOCHEM BIOPHYS, V333, P233, DOI 10.1006/abbi.1996.0386; OMURA T, 1964, J BIOL CHEM, V239, P2379; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; PORTER TD, 1991, TRENDS BIOCHEM SCI, V16, P154, DOI 10.1016/0968-0004(91)90059-5; Pylypenko O, 2003, J BIOL CHEM, V278, P46727, DOI 10.1074/jbc.M306486200; Quaroni LG, 2004, BIOCHEMISTRY-US, V43, P16416, DOI 10.1021/bi049163g; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; SONG WC, 1991, SCIENCE, V253, P781, DOI 10.1126/science.1876834; SONO M, 1982, J BIOL CHEM, V257, P8308; TYSON CA, 1972, J BIOL CHEM, V247, P5777; ULLRICH V, 1975, BIOCHEM SOC T, V3, P803, DOI 10.1042/bst0030803; Warman AJ, 2012, FEBS J, V279, P1675, DOI 10.1111/j.1742-4658.2012.08543.x; YEOM H, 1995, BIOCHEMISTRY-US, V34, P14733, DOI 10.1021/bi00045a014	55	112	124	2	90	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6535	6550		10.1074/jbc.M113.527325	http://dx.doi.org/10.1074/jbc.M113.527325			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443585	Green Published, hybrid			2022-12-25	WOS:000332389400020
J	Jia, XY; Kwon, S; Wang, CIA; Huang, YH; Chan, LY; Tan, CC; Rosengren, KJ; Mulvenna, JP; Schroeder, CI; Craik, DJ				Jia, Xinying; Kwon, Soohyun; Wang, Ching-I Anderson; Huang, Yen-Hua; Chan, Lai Y.; Tan, Chia Chia; Rosengren, K. Johan; Mulvenna, Jason P.; Schroeder, Christina I.; Craik, David J.			Semienzymatic Cyclization of Disulfide-rich Peptides Using Sortase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; NMR; Peptide Chemical Synthesis; Peptides; Toxins; Cyclic Peptides; Cyclotides; Enzymatic Cyclization; Kalata B1; Sortase A	CYCLOTIDE KALATA B1; BACKBONE-CYCLIZED PEPTIDES; PLANT CYCLOTIDES; CIRCULAR PROTEIN; STRUCTURAL-CHARACTERIZATION; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; SCANNING MUTAGENESIS; MACROCYCLIC PEPTIDES; STRUCTURE VALIDATION	Background: Sortase A (SrtA) is a transpeptidase capable of catalyzing the formation of amide bonds. Results: SrtA was used to backbone-cyclize disulfide-rich peptides, including kalata B1, -conotoxin Vc1.1, and SFTI-1. Conclusion: SrtA-mediated cyclization is applicable to small disulfide-rich peptides. Significance: SrtA-mediated cyclization is an alternative to native chemical ligation for the cyclization of small peptides of therapeutic interest. Disulfide-rich cyclic peptides have generated great interest in the development of peptide-based therapeutics due to their exceptional stability toward chemical, enzymatic, or thermal attack. In particular, they have been used as scaffolds onto which bioactive epitopes can be grafted to take advantage of the favorable biophysical properties of disulfide-rich cyclic peptides. To date, the most commonly used method for the head-to-tail cyclization of peptides has been native chemical ligation. In recent years, however, enzyme-mediated cyclization has become a promising new technology due to its efficiency, safety, and cost-effectiveness. Sortase A (SrtA) is a bacterial enzyme with transpeptidase activity. It recognizes a C-terminal penta-amino acid motif, LPXTG, and cleaves the amide bond between Thr and Gly to form a thioacyl-linked intermediate. This intermediate undergoes nucleophilic attack by an N-terminal poly-Gly sequence to form an amide bond between the Thr and N-terminal Gly. Here, we demonstrate that sortase A can successfully be used to cyclize a variety of small disulfide-rich peptides, including the cyclotide kalata B1, -conotoxin Vc1.1, and sunflower trypsin inhibitor 1. These peptides range in size from 14 to 29 amino acids and contain three, two, or one disulfide bond, respectively, within their head-to-tail cyclic backbones. Our findings provide proof of concept for the potential broad applicability of enzymatic cyclization of disulfide-rich peptides with therapeutic potential.	[Jia, Xinying; Mulvenna, Jason P.] QIMR Berghofer Med Res, Brisbane, Qld 4000, Australia; [Jia, Xinying; Kwon, Soohyun; Wang, Ching-I Anderson; Huang, Yen-Hua; Chan, Lai Y.; Tan, Chia Chia; Schroeder, Christina I.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Schroeder, CI (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	c.schroeder@imb.uq.edu.au; d.craik@imb.uq.edu.au	Schroeder, Cristina I./K-2042-2014; Rosengren, K. Johan/P-4450-2016; Huang, Yen-Hua/J-9056-2014; Jia, Xinying/B-8949-2016; Mulvenna, Jason/H-7110-2014; CHAN, LAI YUE/C-6489-2014; Craik, David/B-1695-2010	Schroeder, Cristina I./0000-0002-6737-6374; Rosengren, K. Johan/0000-0002-5007-8434; Huang, Yen-Hua/0000-0001-6937-2660; Jia, Xinying/0000-0003-0133-8321; Mulvenna, Jason/0000-0003-3521-8061; CHAN, LAI YUE/0000-0002-9346-2487; Craik, David/0000-0003-0007-6796	Australian National Health and Medical Research Council (NHMRC) [APP1047857]; Queensland State Government; Australian NHMRC	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland State Government; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian National Health and Medical Research Council (NHMRC) Project Grant APP1047857. The Queensland NMR Network facilities at the University of Queensland were supported by the Queensland State Government.; Supported by Career Development Awards from the Australian NHMRC.	Aboye TL, 2012, J BIOL CHEM, V287, P27026, DOI 10.1074/jbc.R111.305508; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Antos JM, 2009, J BIOL CHEM, V284, P16028, DOI 10.1074/jbc.M901752200; Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; Cemazar M, 2012, CURR TOP MED CHEM, V12, P1534, DOI 10.2174/156802612802652484; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Clark RJ, 2010, BIOPOLYMERS, V94, P414, DOI 10.1002/bip.21372; Clark RJ, 2005, P NATL ACAD SCI USA, V102, P13767, DOI 10.1073/pnas.0504613102; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Contreras J, 2011, J CONTROL RELEASE, V155, P134, DOI 10.1016/j.jconrel.2011.08.030; Craik DJ, 2012, EXPERT OPIN DRUG DIS, V7, P179, DOI 10.1517/17460441.2012.661554; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; Gran L., 1970, MEDD NOR FARM SELSK, V12, P173; Greenwood KP, 2007, INT J BIOCHEM CELL B, V39, P2252, DOI 10.1016/j.biocel.2007.06.016; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; Guntert Peter, 2004, Methods Mol Biol, V278, P353; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Ji YB, 2013, J AM CHEM SOC, V135, P11623, DOI 10.1021/ja405108p; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Kawakami T, 2009, NAT CHEM BIOL, V5, P888, DOI 10.1038/nchembio.259; Kimura R, 2005, PROTEIN PEPTIDE LETT, V12, P789, DOI 10.2174/0929866054864274; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Levary DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018342; Lindholm P, 2002, MOL CANCER THER, V1, P365; Ling JJJ, 2012, J AM CHEM SOC, V134, P10749, DOI 10.1021/ja302354v; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Moffatt F, 2000, J CHROMATOGR A, V891, P235, DOI 10.1016/S0021-9673(00)00620-8; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Mulvenna JR, 2005, STRUCTURE, V13, P691, DOI 10.1016/j.str.2005.02.013; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Pattabiraman VR, 2011, NATURE, V480, P471, DOI 10.1038/nature10702; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Popp MW, 2011, P NATL ACAD SCI USA, V108, P3169, DOI 10.1073/pnas.1016863108; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tavassoli A, 2007, NAT PROTOC, V2, P1126, DOI 10.1038/nprot.2007.152; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Witte MD, 2012, P NATL ACAD SCI USA, V109, P11993, DOI 10.1073/pnas.1205427109; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Wong JH, 2007, CURR PROTEIN PEPT SC, V8, P446, DOI 10.2174/138920307782411446; Wu ZM, 2011, CHEM COMMUN, V47, P9218, DOI 10.1039/c1cc13322e; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P16	82	59	64	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6627	6638		10.1074/jbc.M113.539262	http://dx.doi.org/10.1074/jbc.M113.539262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425873	hybrid, Green Published			2022-12-25	WOS:000332389400027
J	Abdul-Ridha, A; Lopez, L; Keov, P; Thal, DM; Mistry, SN; Sexton, PM; Lane, JR; Canals, M; Christopoulos, A				Abdul-Ridha, Alaa; Lopez, Laura; Keov, Peter; Thal, David M.; Mistry, Shailesh N.; Sexton, Patrick M.; Lane, J. Robert; Canals, Meritxell; Christopoulos, Arthur			Molecular Determinants of Allosteric Modulation at the M-1 Muscarinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Drug Discovery; G Protein-coupled Receptors (GPCR); Molecular Dynamics; Site-directed Mutagenesis; Muscarinic Acetylcholine Receptor	PROTEIN-COUPLED RECEPTOR; FUNCTIONAL SELECTIVITY; CRYSTAL-STRUCTURE; GPCR ACTIVATION; CNS DISORDERS; FORCE-FIELD; AMINO-ACIDS; LIGAND; AGONISM; COMPLEX	Background: BQCA is a selective allosteric modulator of the M-1 mAChR. Results: Residues that govern BQCA activity were identified using mutagenesis and molecular modeling. Conclusion: BQCA likely occupies a pocket overlapping prototypical mAChR modulators and gains selectivity through cooperativity with orthosteric ligands. Significance: Understanding the structural basis of BQCA function can provide insight into the design of more tailored allosteric ligands. Benzylquinolone carboxylic acid (BQCA) is an unprecedented example of a selective positive allosteric modulator of acetylcholine at the M-1 muscarinic acetylcholine receptor (mAChR). To probe the structural basis underlying its selectivity, we utilized site-directed mutagenesis, analytical modeling, and molecular dynamics to delineate regions of the M-1 mAChR that govern modulator binding and transmission of cooperativity. We identified Tyr-85(2.64) in transmembrane domain 2 (TMII), Tyr-179 and Phe-182 in the second extracellular loop (ECL2), and Glu-397(7.32) and Trp-400(7.35) in TMVII as residues that contribute to the BQCA binding pocket at the M-1 mAChR, as well as to the transmission of cooperativity with the orthosteric agonist carbachol. As such, the BQCA binding pocket partially overlaps with the previously described common allosteric site in the extracellular vestibule of the M-1 mAChR, suggesting that its high subtype selectivity derives from either additional contacts outside this region or through a subtype-specific cooperativity mechanism. Mutation of amino acid residues that form the orthosteric binding pocket caused a loss of carbachol response that could be rescued by BQCA. Two of these residues (Leu-102(3.29) and Asp-105(3.32)) were also identified as indirect contributors to the binding affinity of the modulator. This new insight into the structural basis of binding and function of BQCA can guide the design of new allosteric ligands with tailored pharmacological properties.	[Abdul-Ridha, Alaa; Lopez, Laura; Keov, Peter; Thal, David M.; Mistry, Shailesh N.; Sexton, Patrick M.; Lane, J. Robert; Canals, Meritxell; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Mistry, Shailesh N.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	Monash University; Monash University	Canals, M (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 399 Royal Parade, Parkville, Vic 3052, Australia.	meri.canals@monash.edu; arthur.christopoulos@monash.edu	Christopoulos, Arthur/B-6207-2013; Thal, David/GXH-4911-2022; Keov, Peter/AGE-7936-2022; Sexton, Patrick M/B-1319-2008; Mistry, Shailesh/O-2697-2014	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Mistry, Shailesh/0000-0002-2252-1689; Thal, David/0000-0002-0325-2524; Lane, J. Robert/0000-0002-7361-7875; Abdul-Ridha, Alaa/0000-0002-1491-3818; Keov, Peter/0000-0002-3829-6455; Canals, Meritxell/0000-0002-7942-5006	National Health and Medical Research Council of Australia [519461, APP1011796, APP1011920]; Victorian Life Sciences Computation Initiative, Peak Computing Facility, University of Melbourne [VR0024]; Australian Postgraduate Award scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative, Peak Computing Facility, University of Melbourne; Australian Postgraduate Award scholarship	This work was supported in part by National Health and Medical Research Council of Australia Program Grant 519461 (to A. C. and P. M. S.), Project Grant APP1011796 (to M. C.), and Grant APP1011920 (to J. R. L.) and computational studies were supported by Resource Allocation Scheme Grant VR0024 from the Victorian Life Sciences Computation Initiative, Peak Computing Facility, University of Melbourne.; Recipient of an Australian Postgraduate Award scholarship.	Abdul-Ridha A, 2013, MOL PHARMACOL, V83, P521, DOI 10.1124/mol.112.083006; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Canals M, 2012, J BIOL CHEM, V287, P650, DOI 10.1074/jbc.M111.314278; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Daval SB, 2013, MOL PHARMACOL, V84, P71, DOI 10.1124/mol.113.085670; Davie BJ, 2013, ACS CHEM NEUROSCI, V4, P1026, DOI 10.1021/cn400086m; De Amici M, 2010, MED RES REV, V30, P463, DOI 10.1002/med.20166; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Goodwin JA, 2007, MOL PHARMACOL, V72, P1484, DOI 10.1124/mol.107.038265; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Hulme EC, 2003, BIOCHEM SOC T, V31, P29, DOI 10.1042/bst0310029; Hulme EC, 2013, TRENDS PHARMACOL SCI, V34, P67, DOI 10.1016/j.tips.2012.11.002; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leach K, 2011, MOL PHARMACOL, V79, P855, DOI 10.1124/mol.111.070938; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Lebois EP, 2010, ACS CHEM NEUROSCI, V1, P104, DOI 10.1021/cn900003h; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Mistry SN, 2013, J MED CHEM, V56, P5151, DOI 10.1021/jm400540b; Motulsky H, 2003, PRACTICAL GUIDE CURV; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Nawaratne V, 2010, J BIOL CHEM, V285, P19012, DOI 10.1074/jbc.M110.125096; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Shonberg J, 2013, J MED CHEM, V56, P9199, DOI 10.1021/jm401318w; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Valant C, 2012, MOL PHARMACOL, V81, P41, DOI 10.1124/mol.111.074872; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P43516, DOI 10.1074/jbc.M112.395137; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	58	47	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6067	6079		10.1074/jbc.M113.539080	http://dx.doi.org/10.1074/jbc.M113.539080			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24443568	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000332015500061
J	Tsuneki, M; Madri, JA				Tsuneki, Masayuki; Madri, Joseph A.			CD44 Regulation of Endothelial Cell Proliferation and Apoptosis via Modulation of CD31 and VE-cadherin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Cd44; Cell Proliferation; Endothelial Cell; Survivin; Vascular Biology; Western Blotting; Cd31	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HIPPO SIGNALING PATHWAY; BETA-CATENIN; CONTACT INHIBITION; GENE-EXPRESSION; CARCINOMA-CELLS; GROWTH-CONTROL; TUMOR-CELLS; T-CELLS; PECAM-1	Background: CD44 mediates vascular barrier integrity via regulation of VE-cadherin and CD31 expression. Results: CD44 regulates cell proliferation and specific caspase-mediated apoptosis via modulation of CD31 and VE-cadherin expression through the Hippo pathway. Conclusion: CD44 modulates proliferation and apoptosis of microvascular endothelial cells. Significance: CD44 regulates endothelial cell survival by modulating specific cell adhesion molecules via the Hippo pathway. CD44 has been implicated in a diverse array of cell behaviors and in a diverse range of signaling pathway activations under physiological and pathophysiological conditions. We have documented a role for CD44 in mediating vascular barrier integrity via regulation of PECAM-1 (CD31) expression. We now report our findings on the roles of CD44 in modulating proliferation and apoptosis of microvascular endothelial cells via its modulation of CD31 and VE-cadherin expression and the Hippo pathway. In this report, we demonstrate persistent increased proliferation and reduced activations of both effector and initiator caspases in high cell density, postconfluent CD44 knock-out (CD44KO), and CD31KO cultures. We found that reconstitution with murine CD44 or CD31 restored the proliferative and caspase activation rates to WT levels. Moreover, we have confirmed that the CD31 ecto-domain plays a key role in specific caspase cascades as well as cell adhesion-mediated cell growth and found that CD31 deficiency results in a reduction in VE-cadherin expression. Last, we have shown that both CD44KO and CD31KO endothelial cells exhibit a reduced VE-cadherin expression correlating with increased survivin expression and YAP nuclear localization, consistent with inactivation of the Hippo pathway, resulting in increased proliferation and decreased apoptosis. These findings support the concept that CD44 mediates several of its effects on endothelia through modulation of adhesion protein expression, which, in addition to its known modulation of junctional integrity, matrix metalloproteinase levels and activation, interactions with cortical membrane proteins, and selected signaling pathways, plays a key role as a critical regulator of vascular function.	[Tsuneki, Masayuki; Madri, Joseph A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Yale University	Madri, JA (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St, New Haven, CT 06520 USA.	joseph.madri@yale.edu	Tsuneki, Masayuki/AAB-6115-2021	Tsuneki, Masayuki/0000-0003-3409-5485	National Institutes of Health [PO1-NS00344738]; Japan Society for the Promotion of Science; Uehara Memorial Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grant PO1-NS00344738 (to J. A. M.). This work was also supported by a grant-in-aid from the Japan Society for the Promotion of Science for Fellows and by the Uehara Memorial Foundation (to M. T.).	Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Badouel C, 2011, CELL, V145, P484, DOI 10.1016/j.cell.2011.04.009; Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769; Bao YJ, 2011, J BIOCHEM, V149, P361, DOI 10.1093/jb/mvr021; Biswas P, 2005, BIOCHEM BIOPH RES CO, V329, P1225, DOI 10.1016/j.bbrc.2005.02.095; Biswas P, 2003, BIOCHEM BIOPH RES CO, V303, P212, DOI 10.1016/S0006-291X(03)00313-9; Biswas P, 2006, AM J PATHOL, V169, P314, DOI 10.2353/ajpath.2006.051112; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Campbell KN, 2013, J BIOL CHEM, V288, P17057, DOI 10.1074/jbc.C113.457390; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Cao GY, 2009, AM J PATHOL, V175, P903, DOI 10.2353/ajpath.2009.090206; Carrithers M, 2005, AM J PATHOL, V166, P185, DOI 10.1016/S0002-9440(10)62243-2; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Enciso JM, 2003, J CELL BIOL, V160, P605, DOI 10.1083/jcb.200209014; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Fedorchenko O, 2013, BLOOD, V121, P4126, DOI 10.1182/blood-2012-11-466250; Feng YM, 2012, CELL BIOCHEM BIOPHYS, V64, P5, DOI 10.1007/s12013-012-9362-1; Flynn KM, 2013, ANGIOGENESIS, V16, P689, DOI 10.1007/s10456-013-9346-9; Flynn KM, 2013, AM J PATHOL, V182, P1322, DOI 10.1016/j.ajpath.2013.01.003; Ghazi-Visser L, 2013, FASEB J, V27, P3683, DOI 10.1096/fj.13-228809; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Gratzinger D, 2003, FASEB J, V17, P1458, DOI 10.1096/fj.02-1040com; Guan HB, 2011, J IMMUNOL, V186, P6955, DOI 10.4049/jimmunol.1004043; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hauptschein RS, 2005, CANCER RES, V65, P1887, DOI 10.1158/0008-5472.CAN-04-3571; Hertweck MK, 2011, ANN HEMATOL, V90, P493, DOI 10.1007/s00277-011-1161-z; Hiraga T, 2013, CANCER RES, V73, P4112, DOI 10.1158/0008-5472.CAN-12-3801; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Huang JM, 2013, ONCOGENE, V32, P2220, DOI 10.1038/onc.2012.231; Ilan N, 2000, J BIOL CHEM, V275, P21435, DOI 10.1074/jbc.M001857200; Ilan N, 2001, FASEB J, V15, P362, DOI 10.1096/fj.00-0372com; Ilan N, 2001, DEV BIOL, V232, P219, DOI 10.1006/dbio.2001.0186; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Ilan N, 1999, J CELL SCI, V112, P3005; Iurlaro M, 2004, AM J PATHOL, V165, P181, DOI 10.1016/S0002-9440(10)63287-7; Jijiwa M, 2011, PLOS ONE, V6; Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390; Ladeda V, 1998, EXP CELL RES, V242, P515, DOI 10.1006/excr.1998.4094; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Marhaba R, 2004, J MOL HISTOL, V35, P211; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; McKallip RJ, 2005, INFECT IMMUN, V73, P50, DOI 10.1128/IAI.73.1.50-61.2005; McKallip RJ, 2002, INT IMMUNOL, V14, P1015, DOI 10.1093/intimm/dxf068; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Perez A, 2013, ORAL ONCOL, V49, P306, DOI 10.1016/j.oraloncology.2012.11.009; Pinter E, 1997, AM J PATHOL, V150, P1523; Qian H, 2012, CANCER BIOL THER, V13, P1276, DOI 10.4161/cbt.21784; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rouschop KMA, 2006, J AM SOC NEPHROL, V17, P746, DOI 10.1681/ASN.2005080808; Sah NK, 2006, CANCER LETT, V244, P164, DOI 10.1016/j.canlet.2006.03.007; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; Seiki M, 2002, CURR OPIN CELL BIOL, V14, P624, DOI 10.1016/S0955-0674(02)00363-0; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Suwan K, 2009, J BIOL CHEM, V284, P8596, DOI 10.1074/jbc.M806927200; Tamm I, 1998, CANCER RES, V58, P5315; Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4; Tsuneki M, 2013, LAB INVEST, V93, P921, DOI 10.1038/labinvest.2013.86; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; Winkler CW, 2012, J BIOL CHEM, V287, P33237, DOI 10.1074/jbc.M112.356287; Wu JQ, 2003, J CELL BIOCHEM, V90, P121, DOI 10.1002/jcb.10600; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Zhang JJ, 2007, J CELL PHYSIOL, V210, P527, DOI 10.1002/jcp.20908; Zhang LS, 2010, CELL PROLIFERAT, V43, P385, DOI 10.1111/j.1365-2184.2010.00689.x; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	76	50	50	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5357	5370		10.1074/jbc.M113.529313	http://dx.doi.org/10.1074/jbc.M113.529313			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425872	Green Published, hybrid			2022-12-25	WOS:000332015500002
J	Chen, Y; Zhou, ZQ; Zhao, G; Li, XH; Song, LY; Yan, N; Weng, JF; Hao, ZF; Zhang, DG; Li, MS; Zhang, SH				Chen, Yan; Zhou, Zhiqiang; Zhao, Gang; Li, Xinhai; Song, Liya; Yan, Na; Weng, Jianfeng; Hao, Zhuanfang; Zhang, Degui; Li, Mingshun; Zhang, Shihuang			Transposable Element rbg Induces the Differential Expression of opaque-2 Mutant Gene in Two Maize o2 NILs Derived from the Same Inbred Line	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; MOLECULAR ANALYSIS; LYSINE CONTENT; GAMMA-ZEIN; PROTEIN; LOCUS; INCREASE; ENCODES; SYSTEM	The recessive opaque-2 mutant gene (o2) reduces alpha-zeins accumulation in maize endosperm, changes the amino acid composition of maize kernels, induces an opaque endosperm, and increases the lysine content of kernels. The quality protein maize (QPM) inbred line CA339 (o2o2) and an elite normal inbred line liao2345 (O2O2) were used to construct o2 near-isogenic lines (NILs) by marker-assisted selection (MAS) using the co-dominant SSR marker phi057. Two specific o2 NILs were constructed, named liao2345/o2-1 and liao2345/o2-2. However, the kernel phenotypes of the two o2 NILs were different from each other. liao2345/o2-1 had the wild-type vitreous endosperm, which is similar to its recurrent parent liao2345, while the endosperm of liao2345/o2-2 was opaque, identical to typical o2 mutant individuals. In comparison to their recurrent parent liao2345, the lysine concentration of liao2345/o2-1 was similar and the lysine concentration in liao2345/o2-2 was doubled. SDS-PAGE analysis indicated that liao2345/o2-1 had the same zeins ratio as liao2345, whereas the zeins concentration of liao2345/o2-2 was markedly lower. Sequence and transcript abundance analyses indicated that the CDS of two o2 NILs are derived from CA339, but they have different promoters. The O2 transcript of liao2345/o2-2 is largely inhibited because of an rbg transposable element inserted between the TATA box and initiator codon of liao2345/o2-2. We concluded that different crossing-over patterns during the process of o2 NIL construction resulted in the different kernel phenotypes of the two o2 NILs. We surmise that the reversion of liao2345/o2-1 to wild type was due to the recombination with the wild type liao2345 promoter during introgression and backcrossing. The o2 mutant gene of donor (CA339) is a null mutant because of low O2 expression. However, its CDS probably encodes a protein with normal function which can maintain the normal accumulation of zeins in maize endosperm.	[Chen, Yan; Zhou, Zhiqiang; Zhao, Gang; Li, Xinhai; Yan, Na; Weng, Jianfeng; Hao, Zhuanfang; Zhang, Degui; Li, Mingshun; Zhang, Shihuang] Chinese Acad Agr Sci, Inst Crop Sci, Dept Crop Genet & Breeding, Beijing 100193, Peoples R China; [Song, Liya] Beijing Technol & Business Univ, Beijing Key Lab Plant Resource Res & Dev, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Beijing Technology & Business University	Li, MS (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Dept Crop Genet & Breeding, Beijing 100193, Peoples R China.	limingshun@caas.cn; zhangshihuang2013@163.com	yan, na/HDM-3747-2022		China Agriculture Research System [CARS-02-01]; Beijing Municipal Natural Science Foundation [6112003]	China Agriculture Research System; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the China Agriculture Research System (CARS-02-01), the Beijing Municipal Natural Science Foundation (6112003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASS HW, 1992, PLANT CELL, V4, P225, DOI 10.1105/tpc.4.2.225; Chin ECL, 1996, GENOME, V39, P866, DOI 10.1139/g96-109; Ciceri P, 2000, PLANT PHYSIOL, V124, P451, DOI 10.1104/pp.124.1.451; Damerval C, 1998, MOL GEN GENET, V257, P354, DOI 10.1007/s004380050657; de Leon DG, 1994, LAB PROTOCOLS CIMMYT, P38; GEETHA KB, 1991, PLANT CELL, V3, P1207, DOI 10.1105/tpc.3.11.1207; Guo XM, 2013, PLANT PHYSIOL, V162, P1359, DOI 10.1104/pp.113.218941; HARTINGS H, 1989, EMBO J, V8, P2795, DOI 10.1002/j.1460-2075.1989.tb08425.x; HARTINGS H, 1991, MOL GEN GENET, V227, P91, DOI 10.1007/BF00260712; Holding DR, 2008, THEOR APPL GENET, V117, P157, DOI 10.1007/s00122-008-0762-y; Hopkins C. G., 1899, J AM CHEM SOC, V21, P1039, DOI [10.1021/ja02061a012, DOI 10.2135/1974]; Hunter BG, 2002, PLANT CELL, V14, P2591, DOI 10.1105/tpc.003905; Jia H, 2007, CROP SCI, V47, pS45, DOI 10.2135/cropsci2006-00025tpg; Jia M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-60; [雷开荣 LEI Kairong], 2006, [玉米科学, Maize Science], V14, P28; [卢振宇 LU Zhenyu], 2008, [玉米科学, Maize Science], V16, P50; Maddaloni M, 1996, MOL GEN GENET, V250, P647, DOI 10.1007/s004380050117; MADDALONI M, 1989, NUCLEIC ACIDS RES, V17, P7532, DOI 10.1093/nar/17.18.7532; McClintock B., 1948, Carnegie Institution of Washington. Yearbook No. 48: 1948-1949, P142; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; MONTANELLI C, 1984, MOL GEN GENET, V197, P209, DOI 10.1007/BF00330965; Moro GL, 1996, CROP SCI, V36, P1651, DOI 10.2135/cropsci1996.0011183X003600060039x; MOTTO M, 1986, GENETICS, V112, P121; SALAMI F, 1980, MOL GEN GENET, V179, P497, DOI 10.1007/BF00271739; SALAMINI F, 1980, COLD SPRING HARB SYM, V45, P467; SCHMIDT RJ, 1987, SCIENCE, V238, P960, DOI 10.1126/science.2823388; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Senior ML, 1997, 39 MAIZ GEN C; TB O, 1914, J BIOL CHEM, V18, P1; van Berloo R, 1999, J HERED, V90, P328, DOI 10.1093/jhered/90.2.328; Vasal SK, 1980, GENETIC MODIFIERS BR, P37; Vivek BS., 2008, BREEDING QUALITY PRO, P1; WALLACE JC, 1990, PLANT PHYSIOL, V92, P191, DOI 10.1104/pp.92.1.191; Wu YR, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-77; Wu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032850; Wu YR, 2010, P NATL ACAD SCI USA, V107, P12810, DOI 10.1073/pnas.1004721107; Wu YR, 2010, PLANT PHYSIOL, V153, P337, DOI 10.1104/pp.110.154690; Wu YR, 2009, THEOR APPL GENET, V119, P721, DOI 10.1007/s00122-009-1083-5; Zhao G, 2012, PLANTA, V235, P205, DOI 10.1007/s00425-011-1491-z; [赵刚 Zhao Gang], 2010, [玉米科学, Maize Science], V40, P11	44	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85159	10.1371/journal.pone.0085159	http://dx.doi.org/10.1371/journal.pone.0085159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24416355	Green Submitted, gold, Green Published			2022-12-25	WOS:000329866300052
J	Johnson, EK; Seidl, A; Tyler, MD				Johnson, Elizabeth K.; Seidl, Amanda; Tyler, Michael D.			The Edge Factor in Early Word Segmentation: Utterance-Level Prosody Enables Word Form Extraction by 6-Month-Olds	PLOS ONE			English	Article							SPEECH SEGMENTATION; INFANTS; BOUNDARIES; LANGUAGE; CUES; STRESS; CONSTRAINTS; VOCABULARY; PREFERENCE; BEGINNINGS	Past research has shown that English learners begin segmenting words from speech by 7.5 months of age. However, more recent research has begun to show that, in some situations, infants may exhibit rudimentary segmentation capabilities at an earlier age. Here, we report on four perceptual experiments and a corpus analysis further investigating the initial emergence of segmentation capabilities. In Experiments 1 and 2, 6-month-olds were familiarized with passages containing target words located either utterance medially or at utterance edges. Only those infants familiarized with passages containing target words aligned with utterance edges exhibited evidence of segmentation. In Experiments 3 and 4, 6-month-olds recognized familiarized words when they were presented in a new acoustically distinct voice (male rather than female), but not when they were presented in a phonologically altered manner (missing the initial segment). Finally, we report corpus analyses examining how often different word types occur at utterance boundaries in different registers. Our findings suggest that edge-aligned words likely play a key role in infants' early segmentation attempts, and also converge with recent reports suggesting that 6-month-olds' have already started building a rudimentary lexicon.	[Johnson, Elizabeth K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Seidl, Amanda] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA; [Tyler, Michael D.] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia; [Tyler, Michael D.] Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia	University of Toronto; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Western Sydney University; Western Sydney University	Johnson, EK (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	elizabeth.johnson@utoronto.ca	Tyler, Michael D/B-2399-2013	Tyler, Michael D/0000-0003-1642-7941; Johnson, Elizabeth Kay/0000-0002-9941-9949	NSERC; SSHRC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was funded by NSERC (www.nserc-crsng.gc.ca/index_eng.asp) and SSHRC (http://www.sshrc-crsh.gc.ca/) grants awarded to EKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, PERCEPTION PRODUCTIO; Aslin RN, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P117; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Bortfeld H, 2005, PSYCHOL SCI, V16, P298, DOI 10.1111/j.0956-7976.2005.01531.x; Brent MR, 2001, COGNITION, V81, pB33, DOI 10.1016/S0010-0277(01)00122-6; Christophe A, 2004, J MEM LANG, V51, P523, DOI 10.1016/j.jml.2004.07.001; CHRISTOPHE A, 1994, J ACOUST SOC AM, V95, P1570, DOI 10.1121/1.408544; Christophe A, 2001, INFANCY, V2, P385, DOI 10.1207/S15327078IN0203_6; CUTLER A, 1988, J EXP PSYCHOL HUMAN, V14, P113, DOI 10.1037/0096-1523.14.1.113; Cutler A., 1987, Computer Speech and Language, V2, P133, DOI 10.1016/0885-2308(87)90004-0; CUTLER A, 1994, LINGUA, V92, P81, DOI 10.1016/0024-3841(94)90338-7; Cutler Anne, 2012, NATIVE LISTENING LAN; Daland R, 2011, COGNITIVE SCI, V35, P119, DOI 10.1111/j.1551-6709.2010.01160.x; Endress AD, 2010, COGNITIVE PSYCHOL, V61, P177, DOI 10.1016/j.cogpsych.2010.05.001; Endress AD, 2010, J EXP PSYCHOL HUMAN, V36, P235, DOI 10.1037/a0017164; FERNALD A, 1991, DEV PSYCHOL, V27, P209, DOI 10.1037/0012-1649.27.2.209; Goldsmith J., 2011, HDB PHONOLOGICAL THE, P164; Gout A, 2004, J MEM LANG, V51, P548, DOI 10.1016/j.jml.2004.07.002; HIRSHPASEK K, 1987, COGNITION, V26, P269, DOI 10.1016/S0010-0277(87)80002-1; Hohle B, 2009, INFANT BEHAV DEV, V32, P262, DOI 10.1016/j.infbeh.2009.03.004; Houston DM, 2000, J EXP PSYCHOL HUMAN, V26, P1570, DOI 10.1037/0096-1523.26.5.1570; Houston DM, 2000, PSYCHON B REV, V7, P504, DOI 10.3758/BF03214363; Hunter M.A., 1988, ADV INFANCY RES, V5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Johnson E.K., 2012, STAT LEARNING LANGUA, P55; Johnson EK, 2005, INFANCY, V7, P99, DOI 10.1207/s15327078in0701_8; Johnson EK, 2003, COGNITIVE PSYCHOL, V46, P65, DOI 10.1016/S0010-0285(02)00507-8; Johnson EK, 2012, 2012 INT C INF STUD; Johnson EK, 2003, THESIS J HOPKINS U; Johnson EK, 2008, INFANCY, V13, P440, DOI 10.1080/15250000802329321; Johnson EK, 2008, J ACOUST SOC AM, V123, pEL144, DOI 10.1121/1.2908407; Johnson EK, 2010, DEVELOPMENTAL SCI, V13, P339, DOI 10.1111/j.1467-7687.2009.00886.x; Johnson EK, 2009, DEVELOPMENTAL SCI, V12, P131, DOI 10.1111/j.1467-7687.2008.00740.x; JUSCZYK PW, 1993, CHILD DEV, V64, P675, DOI 10.2307/1131210; Jusczyk PW, 1999, COGNITIVE PSYCHOL, V39, P159, DOI 10.1006/cogp.1999.0716; Jusczyk PW, 1997, SCIENCE, V277, P1984, DOI 10.1126/science.277.5334.1984; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Kidd C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036399; KUHL PK, 1979, J ACOUST SOC AM, V66, P1668, DOI 10.1121/1.383639; Lew-Williams C, 2012, COGNITION, V122, P241, DOI 10.1016/j.cognition.2011.10.007; Mattys SL, 1999, COGNITIVE PSYCHOL, V38, P465, DOI 10.1006/cogp.1999.0721; Mattys SL, 2001, COGNITION, V78, P91, DOI 10.1016/S0010-0277(00)00109-8; Mattys SL, 2001, J EXP PSYCHOL HUMAN, V27, P644, DOI 10.1037//0096-1523.27.3.644; Nazzi T, 2005, LANG SPEECH, V48, P279, DOI 10.1177/00238309050480030201; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; PHILLIPS JR, 1973, CHILD DEV, V44, P182; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sahni SD, 2010, CHILD DEV, V81, P727, DOI 10.1111/j.1467-8624.2010.01430.x; Schmale R, 2010, INFANCY, V15, P650, DOI 10.1111/j.1532-7078.2010.00032.x; Seidl A, 2008, J CHILD LANG, V35, P1, DOI 10.1017/S0305000907008215; Seidl A, 2006, DEVELOPMENTAL SCI, V9, P565, DOI 10.1111/j.1467-7687.2006.00534.x; Selkirk Elisabeth, 1984, PHONOLOGY SYNTAX REL; Shi RS, 1998, J CHILD LANG, V25, P169, DOI 10.1017/S0305000997003395; Shi RS, 2006, J ACOUST SOC AM, V119, pEL61, DOI 10.1121/1.2198947; Shukla M, 2007, COGNITIVE PSYCHOL, V54, P1, DOI 10.1016/j.cogpsych.2006.04.002; Shukla M, 2011, P NATL ACAD SCI USA, V108, P6038, DOI 10.1073/pnas.1017617108; Singh L, 2004, J MEM LANG, V51, P173, DOI 10.1016/j.jml.2004.04.004; Singh L, 2008, INFANCY, V13, P57, DOI 10.1080/15250000701779386; Soderstrom M, 2003, J MEM LANG, V49, P249, DOI 10.1016/S0749-596X(03)00024-X; Swingley D, 2005, COGNITIVE PSYCHOL, V50, P86, DOI 10.1016/j.cogpsych.2004.06.001; Swingley D, 2009, PHILOS T R SOC B, V364, P3617, DOI 10.1098/rstb.2009.0107; Thiessen ED, 2003, DEV PSYCHOL, V39, P706, DOI 10.1037/0012-1649.39.4.706; Thiessen ED, 2005, INFANCY, V7, P53, DOI 10.1207/s15327078in0701_5; Thiessen ED, 2013, FRONT PSYCHOL, V3, P590, DOI [10.3389/fpsyg.2012.00590, DOI 10.3389/FPSYG.2012.00590]; Thiessen ED, 2007, LANG LEARN DEV, V3, P73, DOI 10.1080/15475440709337001; Tincoff R, 1999, PSYCHOL SCI, V10, P172, DOI 10.1111/1467-9280.00127; Tincoff R, 2012, INFANCY, V17, P432, DOI 10.1111/j.1532-7078.2011.00084.x; Tyler MD, 2009, J ACOUST SOC AM, V126, P367, DOI 10.1121/1.3129127; van Heugten M, 2012, J SPEECH LANG HEAR R, V55, P554, DOI 10.1044/1092-4388(2011/10-0347); Weijer van de J, 1998, MAX PLANCK SERIES PS, P9; Yang CD, 2004, TRENDS COGN SCI, V8, P451, DOI 10.1016/j.tics.2004.08.006	70	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83546	10.1371/journal.pone.0083546	http://dx.doi.org/10.1371/journal.pone.0083546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	24421892	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500055
J	Selig, ER; Turner, WR; Troeng, S; Wallace, BP; Halpern, BS; Kaschner, K; Lascelles, BG; Carpenter, KE; Mittermeier, RA				Selig, Elizabeth R.; Turner, Will R.; Troeng, Sebastian; Wallace, Bryan P.; Halpern, Benjamin S.; Kaschner, Kristin; Lascelles, Ben G.; Carpenter, Kent E.; Mittermeier, Russell A.			Global Priorities for Marine Biodiversity Conservation	PLOS ONE			English	Article							SPECIES RICHNESS; HUMAN IMPACT; HOTSPOTS; AREAS; OCEAN; RESILIENCE; DIVERSITY; SEAMOUNTS; PATTERNS; DECLINE	In recent decades, many marine populations have experienced major declines in abundance, but we still know little about where management interventions may help protect the highest levels of marine biodiversity. We used modeled spatial distribution data for nearly 12,500 species to quantify global patterns of species richness and two measures of endemism. By combining these data with spatial information on cumulative human impacts, we identified priority areas where marine biodiversity is most and least impacted by human activities, both within Exclusive Economic Zones (EEZs) and Areas Beyond National Jurisdiction (ABNJ). Our analyses highlighted places that are both accepted priorities for marine conservation like the Coral Triangle, as well as less well-known locations in the southwest Indian Ocean, western Pacific Ocean, Arctic and Antarctic Oceans, and within semi-enclosed seas like the Mediterranean and Baltic Seas. Within highly impacted priority areas, climate and fishing were the biggest stressors. Although new priorities may arise as we continue to improve marine species range datasets, results from this work are an essential first step in guiding limited resources to regions where investment could best sustain marine biodiversity.	[Selig, Elizabeth R.; Turner, Will R.; Troeng, Sebastian] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA; [Troeng, Sebastian] Lund Univ, Dept Biol, Lund, Sweden; [Wallace, Bryan P.] Ocean Soc, Ross, CA USA; [Wallace, Bryan P.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Halpern, Benjamin S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England; [Kaschner, Kristin] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79106 Freiburg, Germany; [Kaschner, Kristin] Ctr Synth & Anal Biodiversite CESAB, Aix En Provence, France; [Lascelles, Ben G.] Birdlife Int, Global Seabird Programme, Cambridge, England; [Carpenter, Kent E.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Carpenter, Kent E.] Int Union Conservat Nat, Global Species Programme, Gland, Switzerland; [Mittermeier, Russell A.] Conservat Int, Arlington, VA USA	Conservation International; Lund University; Duke University; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Imperial College London; University of Freiburg; BirdLife International; Old Dominion University; Conservation International	Selig, ER (corresponding author), Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA.	eselig@conservation.org	Kaschner, Kristin/GQQ-6475-2022	Kaschner, Kristin/0000-0002-4061-626X	Gordon and Betty Moore Foundation; Cinco Hermanos; Packard Foundation; New Hampshire Charitable Foundation; Thomas W. Haas Foundation; Fondation pour la Recherche en Biodiversite; Fondation Total	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Cinco Hermanos; Packard Foundation(The David & Lucile Packard Foundation); New Hampshire Charitable Foundation; Thomas W. Haas Foundation; Fondation pour la Recherche en Biodiversite(Fondation pour la Recherche Medicale); Fondation Total	Funding for this work was provided by the Gordon and Betty Moore Foundation, Cinco Hermanos, a grant from the Packard Foundation to the National Center for Ecological Analysis and Synthesis and support to the IUCN-GMSA from the New Hampshire Charitable Foundation and the Thomas W. Haas Foundation. K.K.'s work was conducted in part while working on the PELAGIC project co-financed by the Fondation pour la Recherche en Biodiversite and Fondation Total. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; BirdLife International and Nature Serve, 2011, BIRD SPEC DISTR MAPS; Bouchet Philippe, 2006, P31; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CBD, 2011, STRAT PLAN BIOD 2011, DOI DOI 10.1007/978-1-4020-6970-3_5; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Edgar GJ, 2008, AQUAT CONSERV, V18, P969, DOI 10.1002/aqc.902; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Kaschner K, 2010, PREDICTED RANGE MAPS; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Lascelles BG, 2012, BIOL CONSERV, V156, P5, DOI 10.1016/j.biocon.2011.12.008; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lucifora LO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019356; McLeod K., 2009, ECOSYSTEM BASED MANA; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mittermeier Russell A., 1999, P1; Moland E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2679; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pompa S, 2011, P NATL ACAD SCI USA, V108, P13600, DOI 10.1073/pnas.1101525108; Rayner NA, 2006, J CLIMATE, V19, P446, DOI 10.1175/JCLI3637.1; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson DR, 2008, DIVERS DISTRIB, V14; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; Sanciangco JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056245; Secretariat of the Convention on Biological Diversity, 2009, AZ SCI CRIT GUID ID; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Shenkar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020657; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Trebilco R, 2011, BIOL CONSERV, V144, P1758, DOI 10.1016/j.biocon.2011.02.024; Wafar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014613; Williams PH, 1996, BIOL J LINN SOC, V58, P125, DOI 10.1111/j.1095-8312.1996.tb01428.x; Williams R, ECOGRAPHY IN PRESS; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004	55	137	139	1	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82898	10.1371/journal.pone.0082898	http://dx.doi.org/10.1371/journal.pone.0082898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416151	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500023
J	Tettamanti, F; Viblanc, VA				Tettamanti, Federico; Viblanc, Vincent A.			Influences of Mating Group Composition on the Behavioral Time-Budget of Male and Female Alpine Ibex (Capra ibex) during the Rut	PLOS ONE			English	Article							OPERATIONAL SEX-RATIO; PREDATION RISK; GROUP-SIZE; FORAGING BEHAVIOR; SPATIAL-BEHAVIOR; CALVING SUCCESS; BODY CONDITION; AGE; SEGREGATION; VIGILANCE	During the rut, polygynous ungulates gather in mixed groups of individuals of different sex and age. Group social composition, which may vary on a daily basis, is likely to have strong influences on individual's time-budget, with emerging properties at the group-level. To date, few studies have considered the influence of group composition on male and female behavioral time budget in mating groups. Focusing on a wild population of Alpine ibex, we investigated the influence of group composition (adult sex ratio, the proportion of dominant to subordinate males, and group size) on three behavioral axes obtained by Principal Components Analysis, describing male and female group time-budget. For both sexes, the first behavioral axis discerned a trade-off between grazing and standing/vigilance behavior. In females, group vigilance behavior increased with increasingly male-biased sex ratio, whereas in males, the effect of adult sex ratio on standing/vigilance behavior depended on the relative proportion of dominant males in the mating group. The second axis characterized courtship and male-male agonistic behavior in males, and moving and male-directed agonistic behavior in females. Mating group composition did not substantially influence this axis in males. However, moving and male-directed agonistic behavior increased at highly biased sex ratios (quadratic effect) in females. Finally, the third axis highlighted a trade-off between moving and lying behavior in males, and distinguished moving and female-female agonistic behavior from lying behavior in females. For males, those behaviors were influenced by a complex interaction between group size and adult sex ratio, whereas in females, moving and female-female agonistic behaviors increased in a quadratic fashion at highly biased sex ratios, and also increased with increasing group size. Our results reveal complex behavioral trade-offs depending on group composition in the Alpine ibex, and emphasize the importance of social factors in influencing behavioral time-budgets of wild ungulates during the rut.	[Tettamanti, Federico] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Viblanc, Vincent A.] Univ Montpellier 2, Ctr Ecol Fonct & Evolut, Equipe Ecol Comportementale, CNRS,UMR 5175, Montpellier, France	University of Sassari; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Tettamanti, F (corresponding author), Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy.	ftettamanti@bluewin.ch; vincent.viblanc@gmail.com	Viblanc, Vincent Alexandre/A-7455-2014	Viblanc, Vincent Alexandre/0000-0002-4953-659X	University of Sassari; AXA Research Fund	University of Sassari; AXA Research Fund(AXA Research Fund)	Field accommodation was provided by the Swiss National Park (Forschungskommission des Schweizerisches Nationalparks). FT was the recipient of a PhD scholarship from the University of Sassari. VAV was supported by a post-doctoral fellowship from the AXA Research Fund during the time of writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderhalden Walter, 2006, Nationalpark-Forschung in der Schweiz, V93, P171; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Apollonio M, 2013, BEHAV PROCESS, V98, P44, DOI 10.1016/j.beproc.2013.05.001; BERGER J, 1978, BEHAV ECOL SOCIOBIOL, V4, P91, DOI 10.1007/BF00302563; Bergeron P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1299, DOI 10.1007/s00265-010-0944-x; Bon R, 2001, ANIM BEHAV, V62, P495, DOI 10.1006/anbe.2001.1776; BOWYER RT, 1984, J MAMMAL, V65, P410, DOI 10.2307/1381087; Brivio F, 2010, ETHOLOGY, V116, P406, DOI 10.1111/j.1439-0310.2010.01753.x; Bro-Jorgensen J, 2011, EVOL BIOL, V38, P28, DOI 10.1007/s11692-010-9105-4; Cameron EZ, 2005, ANIM BEHAV, V69, P1337, DOI 10.1016/j.anbehav.2004.08.015; CAMERON RD, 1993, CAN J ZOOL, V71, P480, DOI 10.1139/z93-069; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Cote SD, 1997, CAN J ZOOL, V75, P1628, DOI 10.1139/z97-789; Cote SD, 2000, BEHAVIOUR, V137, P1541, DOI 10.1163/156853900502718; de Jong K, 2012, BEHAV ECOL, V23, P1170, DOI 10.1093/beheco/ars094; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; GREENBERGCOHEN D, 1994, ETHOLOGY, V98, P210; Grignolio S, 2004, ETHOL ECOL EVOL, V16, P255; Grignolio S, 2007, J MAMMAL, V88, P1488, DOI 10.1644/06-MAMM-A-351R.1; Hamel S, 2008, ANIM BEHAV, V75, P217, DOI 10.1016/j.anbehav.2007.04.028; Hamel S, 2009, OECOLOGIA, V161, P421, DOI 10.1007/s00442-009-1377-y; Holand O, 2006, BEHAV ECOL SOCIOBIOL, V59, P682, DOI 10.1007/s00265-005-0097-5; Isvaran K, 2005, CURR SCI INDIA, V89, P1192; Komers PE, 1999, AM NAT, V153, P431, DOI 10.1086/303185; L'Italien L, 2012, ETHOLOGY, V118, P783, DOI 10.1111/j.1439-0310.2012.02073.x; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Luaps P., 2007, BEITRAGE JAGD WILDFO, V32, P495; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Marshall HH, 2012, ANIM BEHAV, V84, P1295, DOI 10.1016/j.anbehav.2012.09.030; Neuhaus P, 2002, ETHOL ECOL EVOL, V14, P373; Nievergelt B, 1974, COMP RUTTING BEHAV G, P324; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Parrini F, 2003, ACTA THERIOL, V48, P411, DOI 10.1007/BF03194179; Parrini Francesca, 2009, Mammalian Species, P1, DOI 10.1644/830.1; Pelletier F, 2006, ANIM BEHAV, V71, P649, DOI 10.1016/j.anbehav.2005.07.008; Pelletier F, 2006, BEHAV ECOL SOCIOBIOL, V60, P645, DOI 10.1007/s00265-006-0208-y; R Development Core Team, 2012, R LANG ENV STAT COMP; RASMUSSEN KLR, 1985, BEHAV ECOL SOCIOBIOL, V17, P161; RATTI P, 1977, Z JAGDWISS, V23, P188, DOI 10.1007/BF01905758; REALE D, 1996, CAN J ZOOL, V74, P1812; Robert K, 2013, J ZOOL, V290, P199, DOI 10.1111/jzo.12027; Roed KH, 2002, MOL ECOL, V11, P1239, DOI 10.1046/j.1365-294X.2002.01509.x; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Ruckstuhl KE, 2000, BEHAVIOUR, V137, P361, DOI 10.1163/156853900502123; Ruckstuhl KE, 2001, BEHAVIOUR, V138, P1033, DOI 10.1163/156853901753286551; Saether BE, 2002, ECOLOGY, V83, P3457, DOI 10.2307/3072094; Saunders FC, 2005, ACTA ETHOL, V8, P103, DOI 10.1007/s10211-005-0006-y; Schuett W, 2011, ANIM BEHAV, V81, P609, DOI 10.1016/j.anbehav.2010.12.006; Shargal D, 2008, THERIOGENOLOGY, V69, P673, DOI 10.1016/j.theriogenology.2007.11.017; Tennenhouse EM, 2011, BEHAV ECOL SOCIOBIOL, V65, P287, DOI 10.1007/s00265-010-1043-8; Testa JW, 1998, J MAMMAL, V79, P1345, DOI 10.2307/1383026; THOULESS CR, 1990, ANIM BEHAV, V40, P105, DOI 10.1016/S0003-3472(05)80669-4; Turner WC, 2005, J ZOOL, V267, P291, DOI 10.1017/S095283690500748X; VALDEZ R, 1991, APPL ANIM BEHAV SCI, V29, P165, DOI 10.1016/0168-1591(91)90244-R; Valle S, 1999, IND ENG CHEM RES, V38, P4389, DOI 10.1021/ie990110i; Viera VM, 2011, ANIM BEHAV, V82, P69, DOI 10.1016/j.anbehav.2011.04.001; Villaret JC, 1995, ETHOLOGY, V101, P291; Weir LK, 2011, AM NAT, V177, P167, DOI 10.1086/657918; White RG, 1997, J ZOOL, V243, P13, DOI 10.1111/j.1469-7998.1997.tb05752.x; Willisch CS, 2010, BEHAV ECOL, V21, P372, DOI 10.1093/beheco/arp200; Willisch CS, 2009, J MAMMAL, V90, P1421, DOI 10.1644/08-MAMM-A-316R1.1; [No title captured]	65	7	7	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e86004	10.1371/journal.pone.0086004	http://dx.doi.org/10.1371/journal.pone.0086004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416453	Green Published, Green Submitted, gold			2022-12-25	WOS:000329862500268
J	Xuan, CY; Shamonki, JM; Chung, A; DiNome, ML; Chung, M; Sieling, PA; Lee, DJ				Xuan, Caiyun; Shamonki, Jaime M.; Chung, Alice; DiNome, Maggie L.; Chung, Maureen; Sieling, Peter A.; Lee, Delphine J.			Microbial Dysbiosis Is Associated with Human Breast Cancer	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HELICOBACTER-PYLORI; GUT MICROBIOME; CARCINOMA; RISK; INFECTION; ABSENCE; IMMUNITY	Breast cancer affects one in eight women in their lifetime. Though diet, age and genetic predisposition are established risk factors, the majority of breast cancers have unknown etiology. The human microbiota refers to the collection of microbes inhabiting the human body. Imbalance in microbial communities, or microbial dysbiosis, has been implicated in various human diseases including obesity, diabetes, and colon cancer. Therefore, we investigated the potential role of microbiota in breast cancer by next-generation sequencing using breast tumor tissue and paired normal adjacent tissue from the same patient. In a qualitative survey of the breast microbiota DNA, we found that the bacterium Methylobacterium radiotolerans is relatively enriched in tumor tissue, while the bacterium Sphingomonas yanoikuyae is relatively enriched in paired normal tissue. The relative abundances of these two bacterial species were inversely correlated in paired normal breast tissue but not in tumor tissue, indicating that dysbiosis is associated with breast cancer. Furthermore, the total bacterial DNA load was reduced in tumor versus paired normal and healthy breast tissue as determined by quantitative PCR. Interestingly, bacterial DNA load correlated inversely with advanced disease, a finding that could have broad implications in diagnosis and staging of breast cancer. Lastly, we observed lower basal levels of antibacterial response gene expression in tumor versus healthy breast tissue. Taken together, these data indicate that microbial DNA is present in the breast and that bacteria or their components may influence the local immune microenvironment. Our findings suggest a previously unrecognized link between dysbiosis and breast cancer which has potential diagnostic and therapeutic implications.	[Xuan, Caiyun; Sieling, Peter A.; Lee, Delphine J.] John Wayne Canc Inst, Dirks Dougherty Lab Canc Res, Dept Translat Immunol, Santa Monica, CA 90404 USA; [Shamonki, Jaime M.] St Johns Hlth Ctr, Dept Pathol, Santa Monica, CA USA; [Chung, Alice] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [DiNome, Maggie L.; Chung, Maureen] St Johns Hlth Ctr, Margie Petersen Breast Ctr, Santa Monica, CA USA	John Wayne Cancer Institute; Cedars Sinai Medical Center	Lee, DJ (corresponding author), John Wayne Canc Inst, Dirks Dougherty Lab Canc Res, Dept Translat Immunol, Santa Monica, CA 90404 USA.	leedj@jwci.org	Chung, Alice/AAH-5776-2021	DiNome, Maggie/0000-0002-1926-292X	Joseph B. Gould Foundation; Association of Breast and Prostate Cancer Studies (Los Angeles); Fashion Footwear Association of New York Charitable Foundation (New York)	Joseph B. Gould Foundation; Association of Breast and Prostate Cancer Studies (Los Angeles); Fashion Footwear Association of New York Charitable Foundation (New York)	This work was supported by Carolyn Dirks and Brett Dougherty, the Joseph B. Gould Foundation, the Association of Breast and Prostate Cancer Studies (Los Angeles) and the Fashion Footwear Association of New York Charitable Foundation (New York). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil N, 2008, BRIT J CANCER, V99, P404, DOI 10.1038/sj.bjc.6604503; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bonnet M, 1999, J NATL CANCER I, V91, P1376, DOI 10.1093/jnci/91.16.1376; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Castillo M, 2006, VET MICROBIOL, V114, P165, DOI 10.1016/j.vetmic.2005.11.055; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fina F, 2001, BRIT J CANCER, V84, P783, DOI 10.1054/bjoc.2000.1672; Glaser SL, 1998, INT J CANCER, V75, P555; Gopalkrishna V, 1996, BREAST CANCER RES TR, V39, P197, DOI 10.1007/BF01806186; Heng B, 2009, BRIT J CANCER, V101, P1345, DOI 10.1038/sj.bjc.6605282; Hix LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020702; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kroupis C, 2006, CLIN BIOCHEM, V39, P727, DOI 10.1016/j.clinbiochem.2006.03.005; LESPAGNARD L, 1995, AM J CLIN PATHOL, V103, P449; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lin S-Y, 2011, INT J SYST EVOL MICR, V62, P1581; Lindel K, 2007, BREAST, V16, P172, DOI 10.1016/j.breast.2006.09.001; LUQMANI YA, 1995, INT J ONCOL, V6, P899; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2008, J PEDIAT GASTROENTER, V46, pE12; McCall SA, 2001, JNCI-J NATL CANCER I, V93, P148, DOI 10.1093/jnci/93.2.148; Nishio T, 1997, APPL ENVIRON MICROB, V63, P1594, DOI 10.1128/AEM.63.4.1594-1597.1997; Pittet B, 2005, LANCET INFECT DIS, V5, P94, DOI 10.1016/S1473-3099(05)01281-8; Rossini A, 2006, CANCER RES, V66, P6219, DOI 10.1158/0008-5472.CAN-05-4592; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siman JH, 1997, SCAND J GASTROENTERO, V32, P1215, DOI 10.3109/00365529709028150; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Velicer CM, 2004, JAMA-J AM MED ASSOC, V291, P827, DOI 10.1001/jama.291.7.827; Xiong T, 2020, SENSOR ACTUAT B-CHEM, V304, DOI [10.1016/j.snb.2019.127310, 10.1126/scitranslmed.3009124]	40	240	255	9	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e83744	10.1371/journal.pone.0083744	http://dx.doi.org/10.1371/journal.pone.0083744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24421902	gold, Green Submitted, Green Published			2022-12-25	WOS:000329862500069
J	Zhang, XC; Zhu, XL; Wang, X; Zhu, XZ; Zhong, MT; Yi, JY; Rao, HY; Yao, SQ				Zhang, Xiaocui; Zhu, Xueling; Wang, Xiang; Zhu, Xiongzhao; Zhong, Mingtian; Yi, Jinyao; Rao, Hengyi; Yao, Shuqiao			First-Episode Medication-Naive Major Depressive Disorder Is Associated with Altered Resting Brain Function in the Affective Network	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; POSITRON-EMISSION-TOMOGRAPHY; ORBITOFRONTAL CORTEX; SPONTANEOUS FLUCTUATIONS; TRYPTOPHAN DEPLETION; REGIONAL HOMOGENEITY; NEGATIVE AFFECT; DEFAULT MODE; STATE; CONNECTIVITY	Background: Major depressive disorder (MDD) has been associated with abnormal structure and function of the brain's affective network, including the amygdala and orbitofrontal cortex (OFC). However, it is unclear if alterations of resting-state function in this affective network are present at the initial onset of MDD. Aims: To examine resting-state function of the brain's affective network in first-episode, medication-naive patients with MDD compared to healthy controls (HCs). Methods: Resting-state functional magnetic resonance imaging (rs-fMRI) was performed on 32 first-episode, medication-naive young adult patients with MDD and 35 matched HCs. The amplitude of low-frequency fluctuations (ALFF) of the blood oxygen level-dependent (BOLD) signal and amygdala-seeded functional connectivity (FC) were investigated. Results: Compared to HC, MDD patients showed reduced ALFF in the bilateral OFC and increased ALFF in the bilateral temporal lobe extending to the insular and left fusiform cortices. Enhanced anti-correlation of activity between the left amygdala seed and the left OFC was found in MDD patients but not in HCs. Conclusions: Reduced ALFF in the OFC suggests hypo-functioning of emotion regulation in the affective network. Enhanced anti-correlation of activity between the amygdala and OFC may reflect dysfunction of the amygdala-OFC network and additionally represent a pathological process of MDD.	[Zhang, Xiaocui; Zhu, Xueling; Wang, Xiang; Zhu, Xiongzhao; Yi, Jinyao; Yao, Shuqiao] Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China; [Zhang, Xiaocui; Rao, Hengyi] Univ Penn, Ctr Funct Neuroimaging, Dept Neurol, Philadelphia, PA 19104 USA; [Zhong, Mingtian] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Rao, Hengyi] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China	Central South University; University of Pennsylvania; Pennsylvania Medicine; South China Normal University; Sun Yat Sen University	Yao, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China.	shuqiaoyao@163.com	Rao, Hengyi/K-5152-2019; Rao, Hengyi/AAQ-4919-2020; Rao, Hengyi/A-7064-2009; Zhong, Mingtian/AAA-3305-2022	Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; 	National Natural Science Foundation of China [30670709, 81071104, 30700236, 81301211, 31070984]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (Grant No. 30670709, 81071104 awarded to Shuqiao Yao, Grant No. 30700236 awarded to Xiang Wang, Grant No. 81301211 awarded to Xueling Zhu and Grant No. 31070984 awarded to Hengyi Rao). This work is partly supported by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BIVER F, 1994, BIOL PSYCHIAT, V36, P381, DOI 10.1016/0006-3223(94)91213-0; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Bremner JD, 2003, JAMA-J AM MED ASSOC, V289, P3125, DOI 10.1001/jama.289.23.3125; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P364; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P59, DOI 10.1093/scan/nsn037; Dougherty DD, 2004, ARCH GEN PSYCHIAT, V61, P795, DOI 10.1001/archpsyc.61.8.795; DREVETS WC, 1992, J NEUROSCI, V12, P3628; DREVETS WC, 1995, J CEREB BLOOD FLOW M, V15, pS93; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; First M. B., 2002, STRUCTURED CLIN INTE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Galynker II, 1998, J NUCL MED, V39, P608; Gan ZY, 2011, J AFFECT DISORDERS, V134, P119, DOI 10.1016/j.jad.2011.05.054; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Jiao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025159; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lacerda ALT, 2004, BIOL PSYCHIAT, V55, P353, DOI 10.1016/j.biopsych.2003.08.021; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Monkul ES, 2012, HUM BRAIN MAPP, V33, P272, DOI 10.1002/hbm.21212; Murray EA, 2007, ANN NY ACAD SCI, V1121, P273, DOI 10.1196/annals.1401.021; Nagafusa Y, 2012, J AFFECT DISORDERS, V140, P296, DOI 10.1016/j.jad.2012.03.026; Neumeister A, 2004, ARCH GEN PSYCHIAT, V61, P765, DOI 10.1001/archpsyc.61.8.765; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Scheuerecker J, 2010, J PSYCHIATR NEUROSCI, V35, P311, DOI 10.1503/jpn.090076; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Steingard RJ, 2000, BIOL PSYCHIAT, V48, P1053, DOI 10.1016/S0006-3223(00)00942-2; Tang Y, 2013, PSYCHOL MED, V43, P1921, DOI 10.1017/S0033291712002759; Tao H, 2013, MOL PSYCHIATR, V18, P101, DOI 10.1038/mp.2011.127; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yang HJ, 2004, J AFFECT DISORDERS, V82, P419, DOI 10.1016/j.jad.2004.04.008; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhong MT, 2012, PSYCHIAT RES-NEUROIM, V201, P107, DOI 10.1016/j.pscychresns.2011.06.003; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	69	206	219	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85241	10.1371/journal.pone.0085241	http://dx.doi.org/10.1371/journal.pone.0085241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24933024	Green Submitted, Green Published, gold			2022-12-25	WOS:000329866300057
J	Xie, YH; Chongsuvivatwong, V; Tang, ZZ; McNeil, EB; Tan, Y				Xie, Yi-hong; Chongsuvivatwong, Virasakdi; Tang, Zhenzhu; McNeil, Edward B.; Tan, Yi			Spatio-Temporal Clustering of Hand, Foot, and Mouth Disease at the County Level in Guangxi, China	PLOS ONE			English	Article							ENTEROVIRUS 71; OUTBREAK; EPIDEMIOLOGY; SURVEILLANCE; INFECTION	Background: Amid numerous outbreaks of hand, foot and mouth disease (HFMD) in Asia over the past decade, studies on spatio-temporal clustering are limited. Without this information the distribution of severe cases assumed to be sporadic. We analyzed surveillance data with onset dates between 1 May 2008 to 31 October 2013 with the aim to document the spatio-temporal clustering of HFMD cases and severe cases at the county level. Methods: Purely temporal and purely spatial descriptive analyses were done. These were followed by a space-time scan statistic for the whole study period and by year to detect the high risk clusters based on a discrete Poisson model. Results: The annual incidence rate of HFMD in Guangxi increased whereas the severe cases peaked in 2010 and 2012. EV71 and CoxA16 were alternating viruses. Both HFMD cases and severe cases had a seasonal peak in April to July. The spatio-temporal cluster of HFMD cases were mainly detected in the northeastern, central and southwestern regions, among which three clusters were observed in Nanning, Liuzhou, Guilin city and their neighbouring areas lasting from 1.2 to 2.5 years. The clusters of severe cases were less consistent in location and included around 40-70% of all severe cases in each year. Conclusions: Both HFMD cases and severe cases occur in spatio-temporal clusters. The continuous epidemic in Nanning, Liuzhou, Guilin cities and their neighbouring areas and the clusters of severe cases indicate the need for further intensive surveillance.	[Xie, Yi-hong; Tang, Zhenzhu; Tan, Yi] Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Nanning, Guangxi, Peoples R China; [Xie, Yi-hong; Chongsuvivatwong, Virasakdi; McNeil, Edward B.] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkla, Thailand; [Xie, Yi-hong] Minist Publ Hlth, Bur Epidemiol, Int Field Epidemiol Training Program, Bangkok, Thailand	Prince of Songkla University; Ministry of Public Health - Thailand	Chongsuvivatwong, V (corresponding author), Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkla, Thailand.	cvirasak@gmail.com	Xie, Yao Jie/K-7001-2014	Xie, Yao Jie/0000-0001-9289-4985; McNeil, Edward Braddon/0000-0002-9492-1040				AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; [别芹芹 Bie Qinqin], 2010, 地球信息科学学报, V12, P380; BLOMBERG J, 1974, LANCET, V2, P112; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chen Jin, 2008, Int J Health Geogr, V7, P57, DOI 10.1186/1476-072X-7-57; Chinese Center for Disease Control and Prevention and the Office of the World Health Organization in China, 2008, REP HAND FOOT MOUTH; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Infectious Disease Surveillance Centre (IDSC) National Institute of Infectious Diseases (NID) Japan, 2004, INFECT AGENTS SURVEI, V25, P224; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2011, SATSCAN TM USER GUID; Li LL, 2013, PRACTICAL PREVENTIVE, V20, P165; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063447, 10.1371/journal.pone.0076105]; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, JPN J INFECT DIS, V63, P422; Ma JQ, 2006, DIS SURVEILL, V21, P600; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Ru Wei-Ping, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P448; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shekhar K, 2005, Med J Malaysia, V60, P297; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tango T, 2012, STAT MED, V31, P4207, DOI 10.1002/sim.5478; The Ministry of Health of China, 2010, HAND FOOT MON DIS DI; The Ministry of Health of China, 2008, HAND FOOT MON DIS PR; The Ministry of Health of China, 2009, HAND FOOT MOUTH DIS; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang Ying, 2010, Disease Surveillance, V25, P774; Western Pacific Region WHO, 2013, HAND FOOT MOUTH DIS; Xiao GeXin, 2012, Disease Surveillance, V27, P932; Yu SC, 2012, BIOMED ENVIRON SCI, V25, P645, DOI 10.3967/0895-3988.2012.06.006; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zhu Qi, 2011, Modern Preventive Medicine, V38, P1824	46	65	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88065	10.1371/journal.pone.0088065	http://dx.doi.org/10.1371/journal.pone.0088065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505378	gold, Green Submitted, Green Published			2022-12-25	WOS:000330829200108
J	Park, S; Ang, RR; Duffy, SP; Bazov, J; Chi, KN; Black, PC; Ma, HS				Park, Sunyoung; Ang, Richard R.; Duffy, Simon P.; Bazov, Jenny; Chi, Kim N.; Black, Peter C.; Ma, Hongshen			Morphological Differences between Circulating Tumor Cells from Prostate Cancer Patients and Cultured Prostate Cancer Cells	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; LABEL-FREE ISOLATION; PERIPHERAL-BLOOD; IMMUNOCYTOCHEMICAL DETECTION; BONE-MARROW; SEPARATION; SIZE; PROGRESSION; SURVIVAL; MICROCHANNEL	Circulating tumor cell (CTC) enumeration promises to be an important predictor of clinical outcome for a range of cancers. Established CTC enumeration methods primarily rely on affinity capture of cell surface antigens, and have been criticized for underestimation of CTC numbers due to antigenic bias. Emerging CTC capture strategies typically distinguish these cells based on their assumed biomechanical characteristics, which are often validated using cultured cancer cells. In this study, we developed a software tool to investigate the morphological properties of CTCs from patients with castrate resistant prostate cancer and cultured prostate cancer cells in order to establish whether the latter is an appropriate model for the former. We isolated both CTCs and cultured cancer cells from whole blood using the CellSearch (R) system and examined various cytomorphological characteristics. In contrast with cultured cancer cells, CTCs enriched by CellSearch (R) system were found to have significantly smaller size, larger nuclear-cytoplasmic ratio, and more elongated shape. These CTCs were also found to exhibit significantly more variability than cultured cancer cells in nuclear-cytoplasmic ratio and shape profile.	[Park, Sunyoung; Ang, Richard R.; Duffy, Simon P.; Ma, Hongshen] Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1W5, Canada; [Duffy, Simon P.] Kwantlen Polytech Univ, Dept Biol, Surrey, BC, Canada; [Bazov, Jenny; Chi, Kim N.; Ma, Hongshen] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Chi, Kim N.; Black, Peter C.] BC Canc Agcy, Vancouver Canc Ctr, Vancouver, BC, Canada; [Chi, Kim N.; Black, Peter C.; Ma, Hongshen] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Ma, HS (corresponding author), Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1W5, Canada.	hongma@mech.ubc.ca	Black, Peter/AAE-8424-2020	Black, Peter/0000-0002-2919-7068; Dobrowski, Solomon/0000-0003-2561-3850; Miller, Carol/0000-0002-3091-5602	Natural Science and Engineering Research Council of Canada; Canadian Institutes of Health Research; Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development; Terry Fox Research Institute; Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative; Engineers-in-Scrubs training program at UBC; Prostate Cancer Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development; Terry Fox Research Institute; Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative; Engineers-in-Scrubs training program at UBC; Prostate Cancer Canada	This work was supported by grants from Natural Science and Engineering Research Council of Canada, Canadian Institutes of Health Research, Prostate Cancer Canada, Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development, Engineers-in-Scrubs training program at UBC, Terry Fox Research Institute, and an award from the Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazzam A, 2011, ELECTROPHORESIS, V32, P1327, DOI 10.1002/elps.201000625; Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Andreopoulou E, 2012, INT J CANCER, V130, P1590, DOI 10.1002/ijc.26111; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bhagat AAS, 2008, LAB CHIP, V8, P1906, DOI 10.1039/b807107a; Borgen E, 1999, CYTOTHERAPY, V1, P377, DOI 10.1080/0032472031000141283; BREIER A, 1994, GEN PHYSIOL BIOPHYS, V13, P287; Chi KN, 2012, J CLIN ONCOL, V30; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Desitter I, 2011, ANTICANCER RES, V31, P427; DONG C, 1991, BIORHEOLOGY, V28, P557; Fehm T, 2005, CYTOTHERAPY, V7, P171, DOI 10.1080/14653240510027082; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; Gerhardt T, 2011, LAB CHIP, V11, P2731, DOI 10.1039/c1lc20092e; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Huang SB, 2013, LAB CHIP, V13, P1371, DOI 10.1039/c3lc41256c; Hur SC, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576780; Hyun KA, 2013, BIOSENS BIOELECTRON, V40, P206, DOI 10.1016/j.bios.2012.07.021; Jin C, 2013, LAB CHIP; Joosse SA, 2012, CLIN CANCER RES, V18, P993, DOI 10.1158/1078-0432.CCR-11-2100; Kraeft SK, 2000, CLIN CANCER RES, V6, P434; Lazar DC, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016002; Ligthart ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067148; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Marrinucci D, 2010, J ONCOL, V2010, DOI 10.1155/2010/861341; Matrone MA, 2010, CANCER RES, V70, P7737, DOI 10.1158/0008-5472.CAN-10-1569; McFaul SM, 2012, LAB CHIP, V12, P2369, DOI 10.1039/c2lc21045b; Mehes G, 2001, AM J PATHOL, V159, P17, DOI 10.1016/S0002-9440(10)61667-7; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Otsuka K, 2013, ANTICANCER RES, V33, P625; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Pierga JY, 2004, CLIN CANCER RES, V10, P1392, DOI 10.1158/1078-0432.CCR-0102-03; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Shaffer DR, 2007, CLIN CANCER RES, V13, P2023, DOI 10.1158/1078-0432.CCR-06-2701; SHI YA, 1993, BIOTECHNOL BIOENG, V41, P745, DOI 10.1002/bit.260410709; Shim S, 2011, INTEGR BIOL-UK, V3, P850, DOI 10.1039/c1ib00032b; Sim TS, 2011, LAB CHIP, V11, P93, DOI [10.1039/c0lc00109k, 10.1039/c01c00109k]; Song H, 2003, BIOTECHNOL PROGR, V19, P1742, DOI 10.1021/bp034061n; Sun JS, 2012, LAB CHIP, V12, P3952, DOI 10.1039/c2lc40679a; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; WEISS L, 1992, CANCER METAST REV, V11, P227, DOI 10.1007/BF01307179; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhe XN, 2011, AM J CANCER RES, V1, P740; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3; Zhou J, 2013, LAB CHIP, V13, P1919, DOI 10.1039/c3lc50101a	56	129	139	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85264	10.1371/journal.pone.0085264	http://dx.doi.org/10.1371/journal.pone.0085264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416373	Green Published, gold, Green Submitted			2022-12-25	WOS:000329862500231
J	Xie, YJ; Stewart, SM; Lam, TH; Viswanath, K; Chan, SS				Xie, Yao Jie; Stewart, Sunita M.; Lam, Tai Hing; Viswanath, Kasisomayajula; Chan, Sophia S.			Television Viewing Time in Hong Kong Adult Population: Associations with Body Mass Index and Obesity	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; SCREEN-TIME; RISK; HEALTH; BEHAVIORS; MEDICINE; CHILDREN; LEISURE	Background: Obesity is increasing dramatically in the Asia-Pacific region particularly China. The population of Hong Kong was exposed to modernization far earlier than the rest of China, reflecting conditions that are likely to be replicated as other Chinese cities undergo rapid change. This study examined the relationship between television viewing and obesity in a Hong Kong sample. Information about the relationship between a key sedentary behavior, TV viewing, and obesity, and its moderation by demographic characteristics may identify sectors of the population at highest risk for excess weight. Methods: Data were from Hong Kong Family and Health Information Trends Survey (2009-2010), a population-based survey on the public's use of media for health information and family communication by telephone interviews with 3,016 Hong Kong adults (age >= 18 years). TV viewing time, body mass index (BMI), physical activity and other lifestyle variables were analyzed. Results: Viewing time was longer in women, increased with age but decreased with education level and vigorous physical activity (all P<0.01). Longer TV viewing time was significantly associated with higher BMI (Coefficients B = 0.17, 95% CI: 0.11, 0.24) after adjusting for age, gender, employment status, marital status, education level, smoking activity and vigorous physical activity. This association was stronger in women than men (Coefficients B: 0.19 versus 0.15) and strongest in those aged 18 to 34 years (Coefficients B = 0.35). Furthermore, an hour increase in daily TV viewing was associated with 10% greater odds of being obese. Conclusions: A significant socioeconomic gradient in television viewing time was observed. TV viewing time positively associated with BMI and obesity. The TV viewing - BMI associations were strongest in women and young adults, suggesting vulnerable groups to target for obesity prevention by decreasing TV viewing.	[Xie, Yao Jie; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Stewart, Sunita M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Ctr Community Based Res,Dept Soc & Behav Sci, Boston, MA 02115 USA; [Chan, Sophia S.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hku.hk	Xie, Yao Jie/K-7001-2014	Xie, Yao Jie/0000-0001-9289-4985; McNeil, Edward Braddon/0000-0002-9492-1040	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	This study was a part of the project "FAMILY: A Jockey Club Initiative for a Harmonious Society," which was funded by The Hong Kong Jockey Club Charities Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Banks E, 2011, PUBLIC HEALTH NUTR, V14, P34, DOI 10.1017/S1368980010000674; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-26; Boulos R, 2012, PHYSIOL BEHAV, V107, P146, DOI 10.1016/j.physbeh.2012.05.022; Brown PR, 2001, LEISURE SCI, V23, P131, DOI 10.1080/014904001316896837; Chang PC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-193; Ching PLYH, 1996, AM J PUBLIC HEALTH, V86, P25, DOI 10.2105/AJPH.86.1.25; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Dunstan DW, 2007, DIABETES CARE, V30, P516, DOI 10.2337/dc06-1996; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Dunstan DW, 2004, DIABETES CARE, V27, P2603, DOI 10.2337/diacare.27.11.2603; DURANT RH, 1994, PEDIATRICS, V94, P449; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FitzGerald SJ, 1997, MED SCI SPORT EXER, V29, P910, DOI 10.1097/00005768-199707000-00010; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; Griffiths SM, 2010, ASIA-PAC J PUBLIC HE, V22, p110S, DOI 10.1177/1010539510373000; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Huang WY, 2013, J SCI MED SPORT, V16, P509, DOI 10.1016/j.jsams.2012.12.011; Inoue S, 2012, J EPIDEMIOL, V22, P50, DOI 10.2188/jea.JE20110054; King AC, 2008, ANN BEHAV MED, V35, P251, DOI 10.1007/s12160-008-9032-0; Lobstein T, 2005, OBES REV, V6, P203, DOI 10.1111/j.1467-789X.2005.00191.x; Mamun AA, 2012, PUBLIC HEALTH NUTR, V12, P1; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Nang EEK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-70; Nelson DE, 2004, J HEALTH COMMUN, V9, P443, DOI 10.1080/10810730490504233; Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Qi QB, 2012, CIRCULATION, V126, P1821, DOI 10.1161/CIRCULATIONAHA.112.098061; Scully M, 2009, PUBLIC HEALTH NUTR, V12, P105, DOI 10.1017/S1368980008002012; Teychenne M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-3; Vereecken CA, 2006, PUBLIC HEALTH NUTR, V9, P244, DOI 10.1079/PHN2005847; Viswanath K SR, 2007, MACROSOCIAL DETERMIN, P275; Wijndaele K, 2010, MED SCI SPORT EXER, V42, P1511, DOI 10.1249/MSS.0b013e3181d322ac; World Health Organization Western Pacific Region, 2000, AS PAC PERSP RED OB; Xu F, 2008, PUBLIC HEALTH NUTR, V11, P891, DOI 10.1017/S1368980007001280; Zuzanna B, 2008, MCMASTER J COMMUNICA, V5	44	65	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85440	10.1371/journal.pone.0085440	http://dx.doi.org/10.1371/journal.pone.0085440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24505378	gold, Green Submitted, Green Published			2022-12-25	WOS:000329868200050
J	Yan, YF; Wang, H; Li, DF; Yang, XW; Wang, ZY; Qi, ZZ; Zhang, QW; Cui, BZ; Guo, ZB; Yu, C; Wang, J; Wang, J; Liu, GM; Song, YJ; Li, YR; Cui, YJ; Yang, RF				Yan, Yanfeng; Wang, Hu; Li, Dongfang; Yang, Xianwei; Wang, Zuyun; Qi, Zhizhen; Zhang, Qingwen; Cui, Baizhong; Guo, Zhaobiao; Yu, Chang; Wang, Jun; Wang, Jian; Liu, Guangming; Song, Yajun; Li, Yingrui; Cui, Yujun; Yang, Ruifu			Two-Step Source Tracing Strategy of Yersinia pestis and Its Historical Epidemiology in a Specific Region	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; PLAGUE-TRANSMISSION; MAXIMUM-LIKELIHOOD; INSIGHTS; MICROEVOLUTION; EVOLUTION; DYNAMICS; CHINA; DNA; POLYMORPHISMS	Source tracing of pathogens is critical for the control and prevention of infectious diseases. Genome sequencing by high throughput technologies is currently feasible and popular, leading to the burst of deciphered bacterial genome sequences. Utilizing the flooding genomic data for source tracing of pathogens in outbreaks is promising, and challenging as well. Here, we employed Yersinia pestis genomes from a plague outbreak at Xinghai county of China in 2009 as an example, to develop a simple two-step strategy for rapid source tracing of the outbreak. The first step was to define the phylogenetic position of the outbreak strains in a whole species tree, and the next step was to provide a detailed relationship across the outbreak strains and their suspected relatives. Through this strategy, we observed that the Xinghai plague outbreak was caused by Y. pestis that circulated in the local plague focus, where the majority of historical plague epidemics in the Qinghai-Tibet Plateau may originate from. The analytical strategy developed here will be of great help in fighting against the outbreaks of emerging infectious diseases, by pinpointing the source of pathogens rapidly with genomic epidemiological data and microbial forensics information.	[Yan, Yanfeng; Yang, Xianwei; Guo, Zhaobiao; Song, Yajun; Cui, Yujun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Hu; Wang, Zuyun; Qi, Zhizhen; Zhang, Qingwen; Cui, Baizhong] Qinghai Inst Endem Dis Prevent & Control, Xining, Peoples R China; [Yan, Yanfeng; Li, Dongfang; Yu, Chang; Wang, Jun; Wang, Jian; Li, Yingrui; Cui, Yujun; Yang, Ruifu] BGI Shenzhen, Shenzhen, Peoples R China; [Liu, Guangming] Natl Univ Def Technol, Sch Comp Sci, Changsha, Hunan, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Beijing Genomics Institute (BGI); National University of Defense Technology - China	Cui, YJ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	cuiyujun.new@gmail.com; ruifuyang@gmail.com	Song, Yajun/F-3714-2011; Yang, Ruifu/A-2273-2011; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; Song, Yajun/GQQ-0476-2022; Yu, Chang/AAE-8538-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Song, Yajun/0000-0002-6628-2747; Yang, Ruifu/0000-0003-3219-7269; Song, Yajun/0000-0002-6628-2747; Wang, Jun/0000-0002-2113-5874; Li, Dongfang/0000-0002-6587-2892; Yang, Xianwei/0000-0003-4388-9674; Wang, Jun/0000-0002-8540-8931	State Key Development Program for Basic Research of China [2009CB522601]; Industry Research Special Foundation of China Ministry of Health [201202021]; National Natural Science Foundation of China [31000015]; National Key Program for Infectious Diseases of China [2012ZX10004215, 2013ZX10004221-002]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Industry Research Special Foundation of China Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Diseases of China	This work was supported by the State Key Development Program for Basic Research of China (2009CB522601), the Industry Research Special Foundation of China Ministry of Health (201202021), the National Natural Science Foundation of China (31000015), and the National Key Program for Infectious Diseases of China (2012ZX10004215 and 2013ZX10004221-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P130; Budowle B, 2005, INT J LEGAL MED, V119, P317, DOI 10.1007/s00414-005-0535-y; Colman RE, 2009, EMERG INFECT DIS, V15, P1623, DOI 10.3201/eid1510.090188; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Ji S., 1988, PLAGUE; Kaiser J, 2005, SCIENCE, V308, P31; Keim P, 2001, J CLIN MICROBIOL, V39, P4566, DOI 10.1128/JCM.39.12.4566-4567.2001; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li M, 2005, EMERG INFECT DIS, V11, P1494, DOI 10.3201/eid1109.041147; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066567; Li YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006000; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Takahashi H, 2004, EMERG INFECT DIS, V10, P117, DOI 10.3201/eid1001.030238; Wang H, 2011, CLIN INFECT DIS, V52, P185, DOI 10.1093/cid/ciq107; Yang R, 2012, J BIOTERR BIODEF S, VS3, DOI [10.4172/2157-2526.S3-007, DOI 10.4172/2157-2526.S3-007]; Zhou DS, 2006, MICROBES INFECT, V8, P273, DOI 10.1016/j.micinf.2005.06.006; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]	41	29	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85374	10.1371/journal.pone.0085374	http://dx.doi.org/10.1371/journal.pone.0085374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24866893	Green Submitted, gold, Green Published			2022-12-25	WOS:000329866300074
J	Macho, GA				Macho, Gabriele A.			Baboon Feeding Ecology Informs the Dietary Niche of Paranthropus boisei	PLOS ONE			English	Article							MODERN HUMAN TEETH; PAPIO-CYNOCEPHALUS; HOMINID EVOLUTION; DENTAL MICROWEAR; NATIONAL-PARK; FATTY-ACID; AMINO-ACID; BODY-SIZE; ENAMEL; PATTERNS	Hominins are generally considered eclectic omnivores like baboons, but recent isotope studies call into question the generalist status of some hominins. Paranthropus boisei and Australopithecus bahrelghazali derived 75%-80% of their tissues' delta C-13 from C-4 sources, i.e. mainly low-quality foods like grasses and sedges. Here I consider the energetics of P. boisei and the nutritional value of C-4 foods, taking into account scaling issues between the volume of food consumed and body mass, and P. boisei's food preference as inferred from dento-cranial morphology. Underlying the models are empirical data for Papio cynocephalus dietary ecology. Paranthropus boisei only needed to spend some 37%-42% of its daily feeding time (conservative estimate) on C-4 sources to meet 80% of its daily requirements of calories, and all its requirements for protein. The energetic requirements of 2-4 times the basal metabolic rate (BMR) common to mammals could therefore have been met within a 6-hour feeding/foraging day. The findings highlight the high nutritional yield of many C-4 foods eaten by baboons (and presumably hominins), explain the evolutionary success of P. boisei, and indicate that P. boisei was probably a generalist like other hominins. The diet proposed is consistent with the species' derived morphology and unique microwear textures. Finally, the results highlight the importance of baboon/hominin hand in food acquisition and preparation.	Res Lab Archaeol RLAHA, Oxford, England		Macho, GA (corresponding author), Res Lab Archaeol RLAHA, Oxford, England.	Gabriele.Macho@rlaha.ox.ac.uk			Ministerio de Ciencia e Innovacion [CGL2010-20868]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Funding was provided by Ministerio de Ciencia e Innovacion (CGL2010-20868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2005, CAM S BIO EVOL ANTHR, V44, P157, DOI 10.1017/CBO9780511542343.007; Altmann S.A., 1998, FORAGING SURVIVAL, DOI University of Chicago Press; Altmann SA, 2009, AM J PHYS ANTHROPOL, V140, P615, DOI 10.1002/ajpa.21097; Arafat S. M., 2009, WORLD APPL SCI J, V7, P151; Ashley GM, 2010, QUATERNARY RES, V74, P304, DOI 10.1016/j.yqres.2010.07.015; Bentley-Condit VK, 2009, AM J PRIMATOL, V71, P432, DOI 10.1002/ajp.20670; Bond B, 2005, J FOOD COMPOS ANAL, V18, P675, DOI 10.1016/j.jfca.2004.06.006; Bonnefille R, 2010, GLOBAL PLANET CHANGE, V72, P390, DOI 10.1016/j.gloplacha.2010.01.015; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; Bronikowski AM, 1996, BEHAV ECOL SOCIOBIOL, V39, P11, DOI 10.1007/s002650050262; BYRNE RW, 1993, BEHAV ECOL SOCIOBIOL, V33, P233, DOI 10.1007/BF02027120; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10507, DOI 10.1073/pnas.1222571110; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10501, DOI 10.1073/pnas.1222568110; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; Chivers DJ, 1998, P NUTR SOC, V57, P321, DOI 10.1079/PNS19980047; Codron D, 2008, INT J PRIMATOL, V29, P757, DOI 10.1007/s10764-008-9261-x; COELHO A M JR, 1974, Primates, V15, P263, DOI 10.1007/BF01742287; Coelho A.M. Jr, 1986, P141; Deblauwe I, 2008, AM J PHYS ANTHROPOL, V135, P42, DOI 10.1002/ajpa.20703; DEMES B, 1988, J HUM EVOL, V17, P657, DOI 10.1016/0047-2484(88)90023-1; DEMMENT MW, 1983, AFR J ECOL, V21, P219, DOI 10.1111/j.1365-2028.1983.tb00323.x; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; DUBRUL EL, 1977, AM J PHYS ANTHROPOL, V47, P305, DOI 10.1002/ajpa.1330470211; Elton S, 2006, J ROY ANTHROPOL INST, V12, P19, DOI 10.1111/j.1467-9655.2006.00279.x; Galbany J, 2011, AM J PHYS ANTHROPOL, V144, P51, DOI 10.1002/ajpa.21368; Glew RH, 2006, PLANT FOOD HUM NUTR, V61, P51, DOI 10.1007/s11130-006-0010-z; Grine FE, 2012, AM J PHYS ANTHROPOL, V148, P285, DOI 10.1002/ajpa.22086; HATLEY T, 1980, HUM ECOL, V8, P371, DOI 10.1007/BF01561000; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Jablonski N.G., 1993, THEROPITHECUS RISE F; Jablonski N.G., 2008, KOOBI FORA RES PROJE, V6; Jiang Y, 2003, ARCH ORAL BIOL, V48, P449, DOI 10.1016/S0003-9969(03)00040-2; JOLLY CJ, 1970, MAN, V5, P5, DOI 10.2307/2798801; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; Koch P.L., 1991, ANN REPORT DIRECTOR, P163; Lee-Thorp J, 2012, P NATL ACAD SCI USA, V109, P20369, DOI 10.1073/pnas.1204209109; Lee-Thorp J, 2011, P NATL ACAD SCI USA, V108, P9319, DOI 10.1073/pnas.1105808108; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Macho GA, 2005, ANAT REC PART A, V283A, P310, DOI 10.1002/ar.a.20175; Macho GA, 2004, ANN ANAT, V186, P413, DOI 10.1016/S0940-9602(04)80073-6; Macho GA, 2003, J HUM EVOL, V45, P81, DOI 10.1016/S0047-2484(03)00083-6; Macho GA, 1996, J HUM EVOL, V30, P57, DOI 10.1006/jhev.1996.0004; Macho GA, 2010, J HUM EVOL, V58, P23, DOI 10.1016/j.jhevol.2009.07.004; Macho GA, 2009, J HUM EVOL, V57, P241, DOI 10.1016/j.jhevol.2009.05.003; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; MILTON K, 1988, J NUTR, V118, P1082, DOI 10.1093/jn/118.9.1082; Milton K, 2003, COMP BIOCHEM PHYS A, V136, P47, DOI 10.1016/S1095-6433(03)00084-9; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; OSBORN JW, 1968, J DENT RES, V47, P217, DOI 10.1177/00220345680470020601; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Peters CR, 2005, J HUM EVOL, V48, P219, DOI 10.1016/j.jhevol.2004.11.003; Pochron ST, 2000, FOLIA PRIMATOL, V71, P346, DOI 10.1159/000021758; Pontzer H, 2009, P NATL ACAD SCI USA, V106, P192, DOI 10.1073/pnas.0806105106; Post D. G., 1982, INT J PRIMATOL, V3, P403; POST DG, 1981, ANIM BEHAV, V29, P357, DOI 10.1016/S0003-3472(81)80095-4; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Rensberger J.M., 2000, P252, DOI 10.1017/CBO9780511542626.018; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Ross CF, 2009, J HUM EVOL, V56, P570, DOI 10.1016/j.jhevol.2009.02.007; Sage RF, 2011, J EXP BOT, V63, P6297; Shimizu D, 2005, AM J PHYS ANTHROPOL, V126, P427, DOI 10.1002/ajpa.20031; Shimizu D, 2008, ANAT REC, V291, P175, DOI 10.1002/ar.20633; Shipman P., 1988, P343; Shultz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076750; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Swedell L, 2008, FOLIA PRIMATOL, V79, P476, DOI 10.1159/000164431; TAYLOR CR, 1970, AM J PHYSIOL, V219, P1104, DOI 10.1152/ajplegacy.1970.219.4.1104; Tobias P. V., 1967, CRANIUM MAXILLARY DE; TOBIAS PV, 1980, AM J PHYS ANTHROPOL, V53, P173, DOI 10.1002/ajpa.1330530202; Turesson H, 2010, AM J BOT, V97, P1884, DOI 10.3732/ajb.1000200; Umerie SC, 1997, BIORESOURCE TECHNOL, V62, P63, DOI 10.1016/S0960-8524(97)00040-0; Umerie SC, 2000, BIORESOURCE TECHNOL, V72, P193, DOI 10.1016/S0960-8524(99)00103-0; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; van Woerden JT, 2012, EVOLUTION, V66, P191, DOI 10.1111/j.1558-5646.2011.01434.x; van Woerden JT, 2010, AM NAT, V176, P758, DOI 10.1086/657045; VONKOENIGSWALD W, 1987, NATURE, V328, P150, DOI 10.1038/328150a0; WHITEN A, 1991, PHILOS T ROY SOC B, V334, P187, DOI 10.1098/rstb.1991.0108; WHITEN A, 1987, INT J PRIMATOL, V8, P367, DOI 10.1007/BF02737389; Wood B, 2004, J HUM EVOL, V46, P119, DOI 10.1016/j.jhevol.2003.11.004; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732	83	33	34	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84942	10.1371/journal.pone.0084942	http://dx.doi.org/10.1371/journal.pone.0084942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416315	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500192
J	Zhang, SB; Sun, M; Cao, KF; Hu, H; Zhang, JL				Zhang, Shi-Bao; Sun, Mei; Cao, Kun-Fang; Hu, Hong; Zhang, Jiao-Lin			Leaf Photosynthetic Rate of Tropical Ferns Is Evolutionarily Linked to Water Transport Capacity	PLOS ONE			English	Article							GENOME SIZE; HYDRAULIC CAPACITY; STOMATAL DENSITY; CELL-SIZE; VENATION; DIVERSIFICATION; XYLEM; ARCHITECTURE; CONDUCTANCE; SPOROPHYTES	Ferns usually have relatively lower photosynthetic potential than angiosperms. However, it is unclear whether low photosynthetic potential of ferns is linked to leaf water supply. We hypothesized that there is an evolutionary association of leaf water transport capacity with photosynthesis and stomatal density in ferns. In the present study, a series of functional traits relating to leaf anatomy, hydraulics and physiology were assessed in 19 terrestrial and 11 epiphytic ferns in a common garden, and analyzed by a comparative phylogenetics method. Compared with epiphytic ferns, terrestrial ferns had higher vein density (D-vein), stomatal density (SD), stomatal conductance (g(s)), and photosynthetic capacity (A(max)), but lower values for lower epidermal thickness (LET) and leaf thickness (LT). Across species, all traits varied significantly, but only stomatal length (SL) showed strong phylogenetic conservatism. A(max) was positively correlated with D-vein and g(s) with and without phylogenetic corrections. SD correlated positively with A(max), D-vein and g(s), with the correlation between SD and Dvein being significant after phylogenetic correction. Leaf water content showed significant correlations with LET, LT, and mesophyll thickness. Our results provide evidence that A(max) of the studied ferns is linked to leaf water transport capacity, and there was an evolutionary association between water supply and demand in ferns. These findings add new insights into the evolutionary correlations among traits involving carbon and water economy in ferns.	[Zhang, Shi-Bao; Hu, Hong] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Yunnan, Peoples R China; [Zhang, Shi-Bao; Sun, Mei; Cao, Kun-Fang; Zhang, Jiao-Lin] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Sun, Mei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, JL (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	zjl@xtbg.org.cn	Cao, Kun-Fang/D-2157-2009	Cao, Kun-Fang/0000-0002-2253-7189; Xia, Ningshao/0000-0003-0179-5266; Ge, Shengxiang/0000-0002-7165-3004	National Natural Science Foundation of China [31170315, 30900174, 31270453, 31370362]; West Light Foundation of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is financially supported by the National Natural Science Foundation of China (31170315, 30900174, 31270453, 31370362) and the West Light Foundation of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasamaa K, 2001, AUST J PLANT PHYSIOL, V28, P765, DOI 10.1071/PP00157; Ackerly DD, 1998, AM NAT, V152, P767, DOI 10.1086/286208; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brodersen CR, 2012, PLANT CELL ENVIRON, V35, P1898, DOI 10.1111/j.1365-3040.2012.02524.x; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2013, NEW PHYTOL, V199, P559, DOI 10.1111/nph.12300; Brodribb TJ, 2011, SCIENCE, V331, P582, DOI 10.1126/science.1197985; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Brodribb TJ, 2011, NEW PHYTOL, V192, P437, DOI 10.1111/j.1469-8137.2011.03795.x; Brodribb TJ, 2005, NEW PHYTOL, V165, P839, DOI 10.1111/j.1469-8137.2004.01259.x; Brodribb TJ, 2004, NEW PHYTOL, V162, P663, DOI 10.1111/j.1469-8137.2004.01060.x; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Carins Murphy MR, 2014, PLANT CELL ENVIRON, V37, P124, DOI 10.1111/pce.12136; Carlquist S, 2001, AM J BOT, V88, P1, DOI 10.2307/2657121; Drake PL, 2013, J EXP BOT, V64, P495, DOI 10.1093/jxb/ers347; Dunbar-Co S, 2009, INT J PLANT SCI, V170, P61, DOI 10.1086/593111; Feild TS, 2013, NEW PHYTOL, V199, P720, DOI 10.1111/nph.12311; Feild TS, 2011, P NATL ACAD SCI USA, V108, P8363, DOI 10.1073/pnas.1014456108; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Franks PJ, 2012, PHILOS T R SOC B, V367, P537, DOI 10.1098/rstb.2011.0270; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Hietz P, 1998, OECOLOGIA, V114, P305, DOI 10.1007/s004420050452; HIETZ P., 2010, FERN ECOLOGY, P140, DOI DOI 10.1017/CB09780511844898; Hodgson JG, 2010, ANN BOT-LONDON, V105, P573, DOI 10.1093/aob/mcq011; Laube S, 2003, FUNCT ECOL, V17, P598, DOI 10.1046/j.1365-2435.2003.00760.x; Lo Gullo MA, 2010, FUNCT PLANT BIOL, V37, P566, DOI 10.1071/FP09303; Lomax BH, 2009, NEW PHYTOL, V181, P311, DOI 10.1111/j.1469-8137.2008.02700.x; McAdam SAM, 2013, NEW PHYTOL, V198, P429, DOI 10.1111/nph.12190; McAdam SAM, 2012, PLANT CELL, V24, P1510, DOI 10.1105/tpc.112.096404; McElwain JC, 2011, NEW PHYTOL, V192, P307, DOI 10.1111/j.1469-8137.2011.03865.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Ogburn RM, 2012, PLANT CELL ENVIRON, V35, P1533, DOI 10.1111/j.1365-3040.2012.02503.x; Page CN, 2002, REV PALAEOBOT PALYNO, V119, P1, DOI 10.1016/S0034-6667(01)00127-0; Pittermann J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00285; Pittermann J, 2011, NEW PHYTOL, V192, P449, DOI 10.1111/j.1469-8137.2011.03817.x; Prado K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00255; R Development Core Team, 2012, R LANG ENV STAT COMP; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Sack L, 2013, NEW PHYTOL, V198, P983, DOI 10.1111/nph.12253; Schneider H, 2004, MOL PHYLOGENET EVOL, V31, P1041, DOI 10.1016/j.ympev.2003.09.018; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tanaka Y, 2013, NEW PHYTOL, V198, P757, DOI 10.1111/nph.12186; Torre S, 2003, J AM SOC HORTIC SCI, V128, P598, DOI 10.21273/JASHS.128.4.0598; Uhl D, 1999, PALAEOGEOGR PALAEOCL, V149, P15, DOI 10.1016/S0031-0182(98)00189-8; Walls RL, 2011, AM J BOT, V98, P244, DOI 10.3732/ajb.1000154; Wang J-H, 2012, PHYSIOL PLANTARUM, V147, P283; Watkins JE, 2012, INT J PLANT SCI, V173, P695, DOI 10.1086/665974; Watkins JE, 2010, AM J BOT, V97, P2007, DOI 10.3732/ajb.1000124; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Zhang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040080	55	35	41	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84682	10.1371/journal.pone.0084682	http://dx.doi.org/10.1371/journal.pone.0084682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	25029500	Green Published, gold, Green Submitted			2022-12-25	WOS:000329866300036
J	Dong, J; Han, QF; Zhu, TY; Ren, YP; Chen, JH; Zhao, HP; Chen, MH; Xu, R; Wang, Y; Hao, CM; Zhang, R; Zhang, XH; Wang, M; Tian, N; Wang, HY				Dong, Jie; Han, Qing-Feng; Zhu, Tong-Ying; Ren, Ye-Ping; Chen, Jiang-Hua; Zhao, Hui-Ping; Chen, Meng-Hua; Xu, Rong; Wang, Yue; Hao, Chuan-Ming; Zhang, Rui; Zhang, Xiao-Hui; Wang, Mei; Tian, Na; Wang, Hai-Yan			The Associations of Uric Acid, Cardiovascular and All-Cause Mortality in Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; RENAL-FUNCTION DECLINE; HIGH BLOOD-PRESSURE; HEMODIALYSIS-PATIENTS; RISK-FACTOR; ENDOTHELIAL DYSFUNCTION; ATHEROSCLEROSIS RISK; LOWERING THERAPY; ARTERY-DISEASE	Aims: To investigate whether uric acid (UA) is an independent predictor of cardiovascular (CV) and all-cause mortality in peritoneal dialysis (PD) patients after controlling for recognized CV risk factors. Methods: A total of 2264 patients on chronic PD were collected from seven centers affiliated with the Socioeconomic Status on the Outcome of Peritoneal Dialysis (SSOP) Study. All demographic and laboratory data were recorded at baseline. Multivariate Cox regression was used to calculate the hazard ratio (HR) of CV and all-cause mortality with adjustments for recognized traditional and uremia-related CV factors. Results: There were no significant differences in baseline characteristics between patients with (n = 2193) and without (n = 71) UA measured. Each 1 mg/dL of increase in UA was associated with higher all-cause mortality with 1.05(1.00 similar to 1.10) of HR and higher CV mortality with 1.12 (1.05 similar to 1.20) of HR after adjusting for age, gender and center size. The highest gender-specific tertile of UA predicted higher all-cause mortality with 1.23(1.00 similar to 1.52) of HR and higher CV mortality with 1.69 (1.21 similar to 2.38) of HR after adjusting for age, gender and center size. The predictive value of UA was stronger in patients younger than 65 years without CV disease or diabetes at baseline. The prognostic value of UA as both continuous and categorical variable weakened or disappeared after further adjusted for uremia-related and traditional CV risk factors. Conclusions: The prognostic value of UA in CV and all-cause mortality was weak in PD patients generally, which was confounded by uremia-related and traditional CV risk factors.	[Dong, Jie; Xu, Rong; Wang, Hai-Yan] Peking Univ, Dept Med, Div Renal, Hosp 1, Beijing 100871, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Minist Hlth, Key Lab Renal Dis, Beijing, Peoples R China; [Dong, Jie; Xu, Rong; Wang, Hai-Yan] Minist Educ, Key Lab Renal Dis, Beijing, Peoples R China; [Han, Qing-Feng; Wang, Yue] Peking Univ, Hosp 3, Dept Nephrol, Beijing 100871, Peoples R China; [Zhu, Tong-Ying] Fudan Univ, Dept Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China; [Ren, Ye-Ping; Zhang, Rui] Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Zhang, Xiao-Hui] Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Mei] Peking Univ, Peoples Hosp, Dept Nephrol, Beijing 100871, Peoples R China; [Chen, Meng-Hua; Tian, Na] Ningxia Med Univ, Gen Hosp, Dept Nephrol, Ningxia, Peoples R China	Peking University; Peking University; Peking University; Fudan University; Harbin Medical University; Zhejiang University; Peking University; Ningxia Medical University	Dong, J (corresponding author), Peking Univ, Dept Med, Div Renal, Hosp 1, Beijing 100871, Peoples R China.	dongjie@medmail.com.cn	tian, na/GVR-9226-2022; Dong, Jie/AFM-0048-2022; Dong, Jinwei/C-4949-2009	Biradar, Chandrashekhar/0000-0002-9532-9452; Xiao, Xiangming/0000-0003-0956-7428; Dong, Jinwei/0000-0001-5687-803X	Education Department, China; Baxer Clinical Research Award from Baxter Corp, China; ISN Research Award from the ISN GO RP Committee	Education Department, China; Baxer Clinical Research Award from Baxter Corp, China; ISN Research Award from the ISN GO RP Committee	This study is supported in part by New Century Excellent Talents from The Education Department, China, Baxer Clinical Research Award from Baxter Corp, China, and an ISN Research Award from the ISN GO R&P Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RW, 1994, NEW ENGL J MED, V331, P468, DOI 10.1056/NEJM199408183310709; Badve SV, 2011, NAT REV NEPHROL, V7, P295, DOI 10.1038/nrneph.2010.186; Caravaca F, 2005, NEFROLOGIA, V25, P645; Chen J, 2012, AM J CARDIOL, V110, P136, DOI 10.1016/j.amjcard.2012.02.061; Chen YM, 2011, AM J NEPHROL, V33, P97, DOI 10.1159/000322966; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Elsayed EF, 2007, ARCH INTERN MED, V167, P1130, DOI 10.1001/archinte.167.11.1130; Garg JP, 2005, ARTHRITIS RHEUM-US, V52, P290, DOI 10.1002/art.20781; Hsu SP, 2004, NEPHROL DIAL TRANSPL, V19, P457, DOI 10.1093/ndt/gfg563; Iuliano L, 2001, LIPIDS, V36, pS41, DOI 10.1007/s11745-001-0680-1; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Jonasson T, 2005, CLIN CHEM LAB MED, V43, P628, DOI 10.1515/CCLM.2005.108; Jun M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008176.pub2; Kanbay M, 2012, AM J NEPHROL, V36, P324, DOI 10.1159/000342390; Kanbay M, 2011, AM J NEPHROL, V33, P298, DOI 10.1159/000324847; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223; Latif W, 2011, CLIN J AM SOC NEPHRO, V6, P2470, DOI 10.2215/CJN.00670111; Lee SMK, 2009, AM J NEPHROL, V29, P79, DOI 10.1159/000151292; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Melendez-Ramirez G, 2012, ENDOCR RES, V37, P1, DOI 10.3109/07435800.2011.566235; Moriarity JT, 2000, ANN EPIDEMIOL, V10, P136, DOI 10.1016/S1047-2797(99)00037-X; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Navaneethan SD, 2009, NEPHROL DIAL TRANSPL, V24, P1260, DOI 10.1093/ndt/gfn621; Navaneethan SD, 2009, COCHRANE DATABASE SY; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Palmer SC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001436; Pan Y, 2012, BRIT J NUTR, V108, P400, DOI 10.1017/S0007114511007033; Park JT, 2009, NEPHROL DIAL TRANSPL, V24, P3520, DOI 10.1093/ndt/gfp272; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Smith SC, 2004, CIRCULATION, V109, P3112, DOI 10.1161/01.CIR.0000133427.35111.67; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Suliman ME, 2006, AM J KIDNEY DIS, V48, P761, DOI 10.1053/j.ajkd.2006.08.019; Suzuki T, 2007, NITRIC OXIDE-BIOL CH, V16, P266, DOI 10.1016/j.niox.2006.10.008; Tangri N, 2010, AM J KIDNEY DIS, V56, P247, DOI 10.1053/j.ajkd.2010.06.004; Wang AYM, 2007, PERITON DIALYSIS INT, V27, pS228; Wannamethee SG, 1997, HEART, V78, P147, DOI 10.1136/hrt.78.2.147; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766; Zhang LX, 2012, NEPHROL DIAL TRANSPL, V27, P1836, DOI 10.1093/ndt/gfr597	43	62	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e82342	10.1371/journal.pone.0082342	http://dx.doi.org/10.1371/journal.pone.0082342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416142	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500015
J	Fretwell, PT; Trathan, PN; Wienecke, B; Kooyman, GL				Fretwell, Peter T.; Trathan, Phil N.; Wienecke, Barbara; Kooyman, Gerald L.			Emperor Penguins Breeding on Iceshelves	PLOS ONE			English	Article							ANTARCTIC PENINSULA; SOUTHERN-OCEAN; CLIMATE-CHANGE; VARIABILITY; RESPONSES	We describe a new breeding behaviour discovered in emperor penguins; utilizing satellite and aerial-survey observations four emperor penguin breeding colonies have been recorded as existing on ice-shelves. Emperors have previously been considered as a sea-ice obligate species, with 44 of the 46 colonies located on sea-ice (the other two small colonies are on land). Of the colonies found on ice-shelves, two are newly discovered, and these have been recorded on shelves every season that they have been observed, the other two have been recorded both on ice-shelves and sea-ice in different breeding seasons. We conduct two analyses; the first using synthetic aperture radar data to assess why the largest of the four colonies, for which we have most data, locates sometimes on the shelf and sometimes on the sea-ice, and find that in years where the sea-ice forms late, the colony relocates onto the ice-shelf. The second analysis uses a number of environmental variables to test the habitat marginality of all emperor penguin breeding sites. We find that three of the four colonies reported in this study are in the most northerly, warmest conditions where sea-ice is often sub-optimal. The emperor penguin's reliance on sea-ice as a breeding platform coupled with recent concerns over changed sea-ice patterns consequent on regional warming, has led to their designation as "near threatened'' in the IUCN red list. Current climate models predict that future loss of sea-ice around the Antarctic coastline will negatively impact emperor numbers; recent estimates suggest a halving of the population by 2052. The discovery of this new breeding behaviour at marginal sites could mitigate some of the consequences of sea-ice loss; potential benefits and whether these are permanent or temporary need to be considered and understood before further attempts are made to predict the population trajectory of this iconic species.	[Fretwell, Peter T.; Trathan, Phil N.] British Antarctic Survey, Cambridge CB3 0ET, England; [Wienecke, Barbara] Australian Antarctic Div, Hobart, Tas, Australia; [Kooyman, Gerald L.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Australian Antarctic Division; University of California System; University of California San Diego; Scripps Institution of Oceanography	Fretwell, PT (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	ptf@bas.ac.uk		Staniland, Iain/0000-0003-2736-9134; , gerald/0000-0002-8872-2950	BAS-NERC ecosystems programme; NERC [bas0100025, bas010011] Funding Source: UKRI; Natural Environment Research Council [bas0100025, bas010011] Funding Source: researchfish	BAS-NERC ecosystems programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this study came internally from BAS-NERC ecosystems programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Barbraud C, 2012, MAR ECOL PROG SER, V454, P285, DOI 10.3354/meps09616; Barbraud C, 2011, ANTARCT SCI, V23, P461, DOI 10.1017/S0954102011000356; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Cook AJ, 2010, CRYOSPHERE, V4, P77, DOI 10.5194/tc-4-77-2010; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; IUCN, 2013, IUCN RED LIST THREAT; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; KLAGES N, 1989, POLAR BIOL, V9, P385, DOI 10.1007/BF00442529; KOOYMAN GL, 1993, ANTARCT SCI, V5, P143, DOI 10.1017/S0954102093000203; Larsen C., 1894, GEOGR J, V4, P333, DOI [DOI 10.2307/1773537, 10.2307/1773537]; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Morris EM, 2003, ANTARCT RES SER, V79, P61; Rack W, 2004, ANN GLACIOL-SER, V39, P505, DOI 10.3189/172756404781814005; Serrezer MC, 2007, SCIENCE, V315, P5818; Sime LC, 2009, NATURE, V462, P342, DOI 10.1038/nature08564; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Trathan PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014738; Turner J., 2009, ANTARCTIC CLIMATE CH; van Lipzig NPM, 2002, INT J CLIMATOL, V22, P1197, DOI 10.1002/joc.798; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Wienecke B, 2012, POLAR BIOL, V35, P1289, DOI 10.1007/s00300-012-1172-9; Wienecke B, 2010, POLAR REC, V46, P271, DOI 10.1017/S0032247409990283	29	56	63	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85285	10.1371/journal.pone.0085285	http://dx.doi.org/10.1371/journal.pone.0085285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24533131	Green Published, Green Accepted, gold			2022-12-25	WOS:000329862500234
J	Knudsen, JG; Murholm, M; Carey, AL; Bienso, RS; Basse, AL; Allen, TL; Hidalgo, J; Kingwell, BA; Febbraio, MA; Hansen, JB; Pilegaard, H				Knudsen, Jakob G.; Murholm, Maria; Carey, Andrew L.; Bienso, Rasmus S.; Basse, Astrid L.; Allen, Tamara L.; Hidalgo, Juan; Kingwell, Bronwyn A.; Febbraio, Mark A.; Hansen, Jacob B.; Pilegaard, Henriette			Role of IL-6 in Exercise Training- and Cold-Induced UCP1 Expression in Subcutaneous White Adipose Tissue	PLOS ONE			English	Article							INTERLEUKIN-6 STIMULATES LIPOLYSIS; HUMAN SKELETAL-MUSCLE; UNCOUPLING PROTEIN; INDUCED INCREASE; GENE-EXPRESSION; GAMMA; ADIPOCYTES; STRESS; MICE; FAT	Expression of brown adipose tissue (BAT) associated proteins like uncoupling protein 1 (UCP1) in inguinal WAT (iWAT) has been suggested to alter iWAT metabolism. The aim of this study was to investigate the role of interleukin-6 (IL-6) in exercise training and cold exposure-induced iWAT UCP1 expression. The effect of daily intraperitoneal injections of IL-6 (3 ng/g) in C57BL/6 mice for 7 days on iWAT UCP1 expression was examined. In addition, the expression of UCP1 in iWAT was determined in response to 3 days of cold exposure (4 degrees C) and 5 weeks of exercise training in wild type (WT) and whole body IL-6 knockout (KO) mice. Repeated injections of IL-6 in C57BL/6 mice increased UCP1 mRNA but not UCP1 protein content in iWAT. Cold exposure increased iWAT UCP1 mRNA content similarly in IL-6 KO and WT mice, while exercise training increased iWAT UCP1 mRNA in WT mice but not in IL-6 KO mice. Additionally, a cold exposure-induced increase in iWAT UCP1 protein content was blunted in IL-6 KO mice, while UCP1 protein content in iWAT was lower in both untrained and exercise trained IL-6 KO mice than in WT mice. In conclusion, repeated daily increases in plasma IL-6 can increase iWAT UCP1 mRNA content and IL-6 is required for an exercise training-induced increase in iWAT UCP1 mRNA content. In addition IL-6 is required for a full induction of UCP1 protein expression in response to cold exposure and influences the UCP1 protein content iWAT of both untrained and exercise trained animals.	[Knudsen, Jakob G.; Bienso, Rasmus S.; Pilegaard, Henriette] Univ Copenhagen, Ctr Inflammat & Metab, Dept Biol, Copenhagen, Denmark; [Murholm, Maria; Basse, Astrid L.; Hansen, Jacob B.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Murholm, Maria; Basse, Astrid L.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Carey, Andrew L.; Kingwell, Bronwyn A.] Baker IDI Heart & Diabet Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia; [Allen, Tamara L.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Hidalgo, Juan] Univ Autonoma Barcelona, Dept Neurosci, E-08193 Barcelona, Spain	University of Copenhagen; University of Copenhagen; University of Copenhagen; Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Autonomous University of Barcelona	Pilegaard, H (corresponding author), Univ Copenhagen, Ctr Inflammat & Metab, Dept Biol, Copenhagen, Denmark.	hpilegaard@bio.ku.dk	Basse, Astrid L/M-4630-2014; Pilegaard, Henriette/M-2315-2014; Hansen, Jacob B/F-3775-2010; Hidalgo, Juan/C-9082-2011; Knudsen, Jakob G/Q-2227-2018; Febbraio, Mark/AAE-9632-2019; Kingwell, Bronwyn A/B-1183-2009	Basse, Astrid L/0000-0002-6532-9232; Pilegaard, Henriette/0000-0002-1071-0327; Hansen, Jacob B/0000-0001-5249-2586; Hidalgo, Juan/0000-0003-0921-1122; Knudsen, Jakob G/0000-0001-7237-8457; Carey, Andrew/0000-0003-3452-1501; Andersen, Stig Ejdrup/0000-0002-1914-4720; Febbraio, Mark/0000-0002-9296-4418	Novo Nordisk Foundation; Lundbeck Foundation; Danish Research Foundation; Danish Council for Independent Research in the Natural Sciences; Augustinus Foundation; National Health and Medical Research Council of Australia (NHMRC) [526606]; EU [HEALTH-F2-2011-278373]; Danish National Research Foundation [02-512-55]; Danish Ministry of Science, Technology and Innovation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Research Foundation; Danish Council for Independent Research in the Natural Sciences; Augustinus Foundation; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); EU(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science, Technology and Innovation	The study was supported by grants from the Novo Nordisk Foundation, the Lundbeck Foundation, The Danish Research Foundation, The Danish Council for Independent Research in the Natural Sciences, the Augustinus Foundation, the National Health and Medical Research Council of Australia (NHMRC grant no. 526606) and the EU FP7 project DIABAT (HEALTH-F2-2011-278373). Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology and Innovation. Mark A. Febbraio and Bronwyn A. Kingwell are Senior Principal Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adser H, 2011, ACTA PHYSL; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brandt C, 2012, ACTA PHYSIOL, V205, P224, DOI 10.1111/j.1748-1716.2011.02373.x; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; COUSIN B, 1992, J CELL SCI, V103, P931; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hidalgo J, 2010, BRAIN BEHAV IMMUN, V24, P119, DOI 10.1016/j.bbi.2009.09.002; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Iwen KA, 2011, METABOLISM, V60, P430, DOI 10.1016/j.metabol.2010.03.011; Ji CB, 2011, J BIOENERG BIOMEMBR, V43, P367, DOI 10.1007/s10863-011-9361-8; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Pedersen L, 2011, J PHYSL; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ringholm S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064123; Seydoux J, 1978, Experientia Suppl, V32, P153; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051233; Wan ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041719; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; Wolsk E, 2010, AJP ENDOCRINOLOGY ME; Yang YQ, 2008, ENDOCRINE, V33, P261, DOI 10.1007/s12020-008-9085-7; Yildirim NC, 2010, CLIN EXP IMMUNOL, V161, P171, DOI 10.1111/j.1365-2249.2010.04156.x	32	160	167	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84910	10.1371/journal.pone.0084910	http://dx.doi.org/10.1371/journal.pone.0084910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24466106	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500189
J	Wang, WJ; Yan, JQ; Wang, HK; Shi, MM; Zhang, MJ; Yang, WP; Peng, CH; Li, HW				Wang, Weijie; Yan, Jiqi; Wang, Huakai; Shi, Minmin; Zhang, Mingjun; Yang, Weiping; Peng, Chenghong; Li, Hongwei			Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2	PLOS ONE			English	Article							HEPATIC STELLATE CELL; GROWTH-FACTOR RECEPTOR; LIVER FIBROSIS; HEPATOCYTE PROLIFERATION; INDUCED APOPTOSIS; PATHWAYS; ACTIVATION; EXPRESSION; SURVIVAL; KINASE	Objective: Hepatic stellate cells (HSCs) transdifferentiation and subsequent inflammation are important pathological processes involved in the formation of cirrhotic portal hypertension. This study characterizes the pathogenetic mechanisms leading to cholestatic liver fibrosis and portal hypertension, and focuses on mammalian target of rapamycin (mTOR) pathway as a potential modulator in the early phase of cirrhotic portal hypertension. Methods: Early cirrhotic portal hypertension was induced by bile duct ligation (BDL) for three weeks. One week after operation, sham-operated (SHAM) and BDL rats received rapamycin (2 mg/kg/day) by intraperitoneal injection for fourteen days. Vehicle-treated SHAM and BDL rats served as controls. Fibrosis, inflammation, and portal pressure were evaluated by histology, morphometry, and hemodynamics. Expressions of pro-fibrogenic and pro-inflammatory genes in liver were measured by RT-PCR; alpha smooth muscle actin (alpha-SMA) and antigen Ki67 were detected by immunohistochemistry; expressions of AKT/mTOR signaling molecules, extracellular-signal-regulated kinase 1/2 (ERK1/2), p-ERK1/2, and interleukin-1 beta (IL-1 beta) were assessed by western blot. Results: The AKT/mTOR signaling pathway was markedly activated in the early phase of cirrhotic portal hypertension induced by BDL in rats. mTOR blockade by rapamycin profoundly improved liver function by limiting inflammation, fibrosis and portal pressure. Rapamycin significantly inhibited the expressions of phosphorylated 70KD ribosomal protein S6 kinase (p-P70S6K) and phosphorylated ribosomal protein S6 (p-S6) but not p-AKT Ser473 relative to their total proteins in BDL-Ra rats. Those results suggested that mTOR Complex 1 (mTORC1) rather than mTORC2 was inhibited by rapamycin. Interestingly, we also found that the level of p-ERK1/2 to ERK1/2 was significantly increased in BDL rats, which was little affected by rapamycin. Conclusions: The AKT/mTOR signaling pathway played an important role in the early phase of cirrhotic portal hypertension in rats, which could be a potential target for therapeutic intervention in the early phase of such pathophysiological progress.	[Wang, Weijie; Yan, Jiqi; Wang, Huakai; Yang, Weiping; Peng, Chenghong; Li, Hongwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Wang, Weijie; Yan, Jiqi; Wang, Huakai; Shi, Minmin; Zhang, Mingjun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Digest Surg,Key Lab Syst Biomed Ver, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, JQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China.	jiqiyan@yahoo.com	Yang, Wei/HIA-0360-2022	Liang, Ying/0000-0002-4939-8705; Luo, Chunxiong/0000-0001-8974-7693; Fu, Qibin/0000-0002-1419-5676; Peng, Chenghong/0000-0002-5573-7873	Foundation of Shanghai Natural Science [09ZR1418600]; National Natural Science of China [81070358]	Foundation of Shanghai Natural Science; National Natural Science of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the Foundation of Shanghai Natural Science (09ZR1418600) and the National Natural Science (81070358) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro D, 2002, HEPATOLOGY, V36, P297, DOI 10.1053/jhep.2002.34741; Biecker E, 2005, J PHARMACOL EXP THER, V313, P952, DOI 10.1124/jpet.104.079616; Bridle KR, 2009, LIVER TRANSPLANT, V15, P1315, DOI 10.1002/lt.21804; Chen GQG, 2012, ACTA MATH SCI, V32, P1; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cichoz-Lach H, 2008, J PHYSIOL PHARMACOL, V59, P231; Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160; Dixon M, 1999, HEPATOLOGY, V29, P1418, DOI 10.1002/hep.510290516; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fernandez M, 2007, HEPATOLOGY, V46, P1208, DOI 10.1002/hep.21785; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Gabele E, 2005, J BIOL CHEM, V280, P13374, DOI 10.1074/jbc.M409444200; Gabele E, 2003, FRONT BIOSCI-LANDMRK, V8, pD69, DOI 10.2741/887; Geerts AM, 2008, HEPATOL RES, V38, P1130, DOI 10.1111/j.1872-034X.2008.00369.x; Giron-Gonzalez JA, 2004, LIVER INT, V24, P437, DOI 10.1111/j.1478-3231.2004.0951.x; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mehal WZ, 2007, LIVER IMMUNOLOGY PRI, V9, P111; Mejias M, 2010, J HEPATOL, V52, P529, DOI 10.1016/j.jhep.2010.01.004; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Neef M, 2006, J HEPATOL, V45, P786, DOI 10.1016/j.jhep.2006.07.030; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Patsenker E, 2011, J HEPATOL, V55, P388, DOI 10.1016/j.jhep.2010.10.044; Qiao L, 2002, HEPATOLOGY, V35, P779, DOI 10.1053/jhep.2002.32533; Rao YP, 2002, HEPATOLOGY, V35, P307, DOI 10.1053/jhep.2002.31104; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Svegliati-Baroni G, 2005, GASTROENTEROLOGY, V128, P1042, DOI 10.1053/j.gastro.2005.01.007; Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Wang Y, 2008, WORLD J GASTROENTERO, V14, P5186, DOI 10.3748/wjg.14.5186; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019	44	183	191	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e83908	10.1371/journal.pone.0083908	http://dx.doi.org/10.1371/journal.pone.0083908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24416258	Green Submitted, gold, Green Published			2022-12-25	WOS:000329460800022
J	Wang, LL; Sun, XY; Li, SY; Zhang, T; Zhang, W; Zhai, PH				Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui			Application of Organic Amendments to a Coastal Saline Soil in North China: Effects on Soil Physical and Chemical Properties and Tree Growth	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; MICROBIAL COMMUNITIES; CATION-EXCHANGE; SEWAGE-SLUDGE; BEET VINASSE; SODIC SOILS; NITROGEN; RECLAMATION; PHOSPHORUS; POTASSIUM	The ability of the following four organic amendments to ameliorate saline soil in coastal northern China was investigated from April 2010 to October 2012 in a field experiment: green waste compost (GWC), sedge peat (SP), furfural residue (FR), and a mixture of GWC, SP and FR (1: 1: 1 by volume) (GSF). Compared to a non-amended control (CK), the amendments, which were applied at 4.5 kg organic matter m(-3), dramatically promoted plant growth; improved soil structure; increased the cation exchange capacity (CEC), organic carbon, and available nutrients; and reduced the salt content, electrical conductivity (EC), and exchangeable sodium percentage (ESP). At the end of the experiment in soil amended with GSF, bulk density, EC, and ESP had decreased by 11, 87, and 71%, respectively, and total porosity and organic carbon had increased by 25 and 96% respectively, relative to the CK. The GSF treatment resulted in a significantly lower Na++K+ content than the other treatments. CEC and the contents of available N, P, and K were significantly higher in the GSF-treated soil than in the CK and were the highest in all treatments. The FR treatment resulted in the lowest pH value and Ca2+ concentration, which decreased by 8% and 39%, respectively, relative to the CK. Overall, the results indicate that a combination of green waste compost, sedge peat and furfural residue (GSF treatment) has substantial potential for ameliorating saline soils in the coastal areas of northern China, and it works better than each amendment alone. Utilization of GWC and FR can be an alternative organic amendment to substitute the nonrenewable SP in saline soil amelioration.	[Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Wang, Linlin] Forestry Res Inst Hulun Buir, Hulun Buir, Inner Mongolia, Peoples R China	Beijing Forestry University	Sun, XY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	sunxy1965@126.com; lisuyan@bjfu.edu.cn	; Williams, Robert W./H-8789-2016	Habibovic, Pamela/0000-0001-8249-5155; Williams, Robert W./0000-0001-8924-4447; Deng, Hong-Wen/0000-0002-0387-8818; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs [2009BADB2B0504]; Fundamental Research Funds for the Central Universities; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496, R01AR057049, R01AR050066, R01AR064825, R01AR051190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG020321, R01AG026564, P01AG018397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs (No. 2009BADB2B0504), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MK, 2007, COMMUN SOIL SCI PLAN, V38, P1691, DOI 10.1080/00103620701435464; Amezketa E, 2005, AGRON J, V97, P983, DOI 10.2134/agronj2004.0236; Antil Rajinder Singh, 2007, Archives of Agronomy and Soil Science, V53, P519, DOI 10.1080/03650340701571033; BAO SD, 2005, ANAL SOIL AGROCHEMIS; BARKHAM JP, 1993, BIODIVERS CONSERV, V2, P556, DOI 10.1007/BF00056749; Barzegar AR, 1997, SOIL SCI SOC AM J, V61, P1131, DOI 10.2136/sssaj1997.03615995006100040020x; Bhattacharyya P, 2007, CHEMOSPHERE, V66, P1789, DOI 10.1016/j.chemosphere.2006.07.062; Brady AC, 2002, NATURE PROPERTIES SO; Clark GJ, 2007, SOIL BIOL BIOCHEM, V39, P2806, DOI 10.1016/j.soilbio.2007.06.003; Cooperband L., 2002, BUILDING SOIL ORGANI; David R, 2002, GEODERMA, V107, P271, DOI 10.1016/S0016-7061(01)00152-5; Feng YJ, 2006, PEDOSPHERE, V16, P668, DOI 10.1016/S1002-0160(06)60101-X; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; Hanay A, 2004, COMPOST SCI UTIL, V12, P175, DOI 10.1080/1065657x.2004.10702177; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; JACKSON M. L., 1958, Soil Chemical Analysis.; Kahlown MA, 2003, AGR WATER MANAGE, V62, P127, DOI 10.1016/S0378-3774(03)00096-9; Kaya C, 2001, J PLANT NUTR, V24, P357, DOI 10.1081/PLN-100001394; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liang YC, 2003, GEODERMA, V115, P149, DOI 10.1016/S0016-7061(03)00084-3; Liu GQ, 2009, BIORESOURCE TECHNOL, V100, P5103, DOI 10.1016/j.biortech.2009.03.081; Mamedov AI, 2002, SOIL TILL RES, V68, P121, DOI 10.1016/S0167-1987(02)00115-0; Melero S, 2007, EUR J AGRON, V26, P327, DOI 10.1016/j.eja.2006.11.004; Oo AN, 2013, LAND DEGRAD DEV, DOI 101002/ldr2208; Page A.L., 1982, AGRONOMY SERIES, V9, DOI DOI 10.1002/JP1N.19851480319; Pocknee S, 1997, SOIL SCI SOC AM J, V61, P86, DOI 10.2136/sssaj1997.03615995006100010014x; Qadir M, 2007, ADV AGRON, V96, P197, DOI 10.1016/S0065-2113(07)96006-X; Qadir M, 2004, SCI TOTAL ENVIRON, V323, P1, DOI 10.1016/j.scitotenv.2003.10.012; Qadir M, 1998, SOIL TILL RES, V45, P119, DOI 10.1016/S0933-3630(96)00130-4; Qadir M, 2000, LAND DEGRAD DEV, V11, P501, DOI 10.1002/1099-145X(200011/12)11:6<501::AID-LDR405>3.0.CO;2-S; RICHARDS LA, 1954, AGR HDB, V60, P98; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Roca-Perez L, 2009, CHEMOSPHERE, V75, P781, DOI 10.1016/j.chemosphere.2008.12.058; Ros M, 2003, SOIL BIOL BIOCHEM, V35, P463, DOI 10.1016/S0038-0717(02)00298-5; Sumner M.E., 2000, HDB SOIL SCI; Sun R, 2011, BIORESOURCES, V6, P317; Tejada M, 2008, BIORESOURCE TECHNOL, V99, P1758, DOI 10.1016/j.biortech.2007.03.052; Tejada M, 2006, SOIL BIOL BIOCHEM, V38, P1413, DOI 10.1016/j.soilbio.2005.10.017; Tejada M, 2006, SOIL SCI SOC AM J, V70, P900, DOI 10.2136/sssaj2005.0271; Tejada M, 2005, EUR J AGRON, V23, P336, DOI 10.1016/j.eja.2005.02.005; TUCKER BM, 1954, AUST J AGR RES, V5, P706, DOI 10.1071/AR9540706; Wang Z.Q., 1993, SALINE SOIL IN CHINA; Warman PR, 2005, BIORESOURCE TECHNOL, V96, P955, DOI 10.1016/j.biortech.2004.08.003; Wichern J, 2006, GEODERMA, V137, P100, DOI 10.1016/j.geoderma.2006.08.001; Withers PJA, 2003, SOIL USE MANAGE, V19, P28, DOI 10.1111/j.1475-2743.2003.tb00276.x; Wong VNL, 2009, APPL SOIL ECOL, V41, P29, DOI 10.1016/j.apsoil.2008.08.006; Xing Y, 2012, CELL CHEM TECHNOL, V46, P249; Yazdanpanah N, 2013, AGR WATER MANAGE, V120, P39, DOI 10.1016/j.agwat.2012.08.017; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; Zhang XC, 2002, J HYDROL, V260, P194, DOI 10.1016/S0022-1694(01)00612-6	51	125	145	10	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89185	10.1371/journal.pone.0089185	http://dx.doi.org/10.1371/journal.pone.0089185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	25229501	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700132
J	Wang, LS; Lu, WL; Zhang, L; Huang, Y; Scheib, R; Liu, XY; Myers, L; Lu, L; Farber, CR; Liu, GF; Wang, CY; Deng, HW; Williams, RW; Wang, YJ; Gu, WK; Jiao, Y				Wang, Lishi; Lu, Wenli; Zhang, Lei; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Myers, Linda; Lu, Lu; Farber, Charles R.; Liu, Gaifen; Wang, Cong-Yi; Deng, Hongwen; Williams, Robert W.; Wang, Yongjun; Gu, Weikuan; Jiao, Yan			Trps1 Differentially Modulates the Bone Mineral Density between Male and Female Mice and Its Polymorphism Associates with BMD Differently between Women and Men	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRICHORHINOPHALANGEAL-SYNDROME; MISSENSE MUTATION; GENE-EXPRESSION; POPULATION; IDENTIFICATION; METAANALYSIS; NETWORKS; LINKAGE; GROWTH	The objective of our study was to identify genetic factors that regulate bone mineral density (BMD) in mice using well defined recombinant inbred strains. For this purpose we chose the BXD recombinant inbred (RI) strains derived from progeny of the C57BL/6J (B6) and DBA/2J (D2) progenitor strains. We sampled both male and female mice (similar to 4 each) of 46 strains at 3 months-of-age, measured their BMD, and conducted QTL mapping. The data were analyzed to identify candidates genes contained within the most significant quantitative trait locus (QTL). Evaluation of candidate genes included functional assessment, single nucleotide polymorphism (SNP) genotyping and direct sequencing. We established that there was a QTL for BMD in males on chromosome 15 that has the impact larger than QTLs on all other chromosomes. The QTL on chromosome 15 was narrowed to a genomic region between 38 Mbp and 52 Mbp. By examining transcripts within this region, we found an important candidate gene: trichorhinophalangeal syndrome, type I (Trps1). SNP analysis identified a nonsynonymous SNP (rs32398060) in Trps1 that co-segregated with bone mineral density. Analysis of association between this SNP within TRPS1 and BMD in a human population confirmed its significance.	[Wang, Lishi; Lu, Wenli; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Gu, Weikuan; Jiao, Yan] Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA; [Wang, Lishi] Inner Mongolia Med Univ, Dept Basic Med, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Lei; Deng, Hongwen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA USA; [Myers, Linda] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN USA; [Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Farber, Charles R.] Univ Virginia, Dept Med, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Farber, Charles R.] Univ Virginia, Dept Biochem & Mol Genet, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Liu, Gaifen; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Cong-Yi] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Biomed Res, Wuhan 430074, Hubei, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; Inner Mongolia Medical University; Tulane University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Virginia; University of Virginia; Capital Medical University; Huazhong University of Science & Technology	Gu, WK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA.	wgu@uthsc.edu; yjiao2@utusc.edu	; Williams, Robert W./H-8789-2016	Habibovic, Pamela/0000-0001-8249-5155; Williams, Robert W./0000-0001-8924-4447; Deng, Hong-Wen/0000-0002-0387-8818; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH) [R01 AR51190]; Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221, R01 AR/AG 41398, R01 AR050066, R03 AG20321]; Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China [31100902]; National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; NHLBI [N02-HL-64278]; NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility [P01-AG018397]; NIH NIA; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496, R01AR057049, R01AR050066, R01AR064825, R01AR051190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG020321, R01AG026564, P01AG018397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility; NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by grants from the National Institute of Arthritis (NIA) and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(R01 AR51190 to W.G.), Genediscovery Core at UTHSC, and the Veterans Administration Medical Center in Memphis, Tennessee. H. W. D. was partially supported by grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221), the Franklin D. Dickson/Missouri Endowment and the Edward G. Schlieder Endowment. L.Z. was partially supported by National Natural Science Foundation of China (project 31100902). The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Funding support for the Framingham Bone Mineral Density datasets was provided by NIH grants R01 AR/AG 41398, R01 AR050066 and R03 AG20321. Funding support for the Genetic Determinants of Bone Fragility (the Indiana fragility study) was provided through the NIA Division of Geriatrics and Clinical Gerontology. Genetic Determinants of Bone Fragility is a genome-wide association studies funded as part of the NIA Division of Geriatrics and Clinical Gerontology. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the NIA Division of Geriatrics and Clinical Gerontology and the NIA Division of Aging Biology. Support for the collection of datasets and samples were provided by the parent grant, Genetic Determinants of Bone Fragility (P01-AG018397). Funding support for the genotyping which was performed at the Johns Hopkins University Center for Inherited Diseases Research was provided by the NIH NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2012, BONE; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Beamer WG, 1999, MAMM GENOME, V10, P1043, DOI 10.1007/s003359901159; BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; CARRINGTON PR, 1994, J AM ACAD DERMATOL, V31, P331, DOI 10.1016/S0190-9622(94)70166-0; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Garnero P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P50; Geisert EE, 2009, MOL VIS, V15, P1730; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishimori N, 2008, J BONE MINER RES, V23, P1529, DOI 10.1359/JBMR.080414; Jiao Y, 2008, GENOMICS, V91, P407, DOI 10.1016/j.ygeno.2007.12.010; Klein RF, 1998, J BONE MINER RES, V13, P1648, DOI 10.1359/jbmr.1998.13.11.1648; Kolta S, 2003, J CLIN DENSITOM, V6, P251, DOI 10.1385/JCD:6:3:251; Li GHY, 2011, HUM GENET, V130, P539, DOI 10.1007/s00439-011-0972-2; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Lynch RM, 2010, PHYSIOL GENOMICS, V41, P244, DOI 10.1152/physiolgenomics.00020.2010; Milner LC, 2010, INT REV NEUROBIOL, V91, P173, DOI 10.1016/S0074-7742(10)91006-4; NOLTORP S, 1986, ANN RHEUM DIS, V45, P31, DOI 10.1136/ard.45.1.31; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Pei YF, 2013, HUM MOL GENET; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rossi A, 2007, BRIT J DERMATOL, V157, P1021, DOI 10.1111/j.1365-2133.2007.08158.x; Sarafoglou K, 2010, CLIN GENET, V78, P591, DOI 10.1111/j.1399-0004.2010.01434.x; SCHNITZLER CM, 1993, CALCIFIED TISSUE INT, V53, pS27, DOI 10.1007/BF01673398; Soon G, 2006, CALCIFIED TISSUE INT, V78, P186, DOI 10.1007/s00223-005-0191-8; Suwanwela J, 2011, J BONE MINER RES, V26, P747, DOI 10.1002/jbmr.271; Tariq M, 2008, BRIT J DERMATOL, V159, P476, DOI 10.1111/j.1365-2133.2008.08658.x; Tremollieres F, 2010, MATURITAS, V65, P348, DOI 10.1016/j.maturitas.2009.12.023; Vaccaro M, 2009, PEDIATR DERMATOL, V26, P171, DOI 10.1111/j.1525-1470.2009.00905.x; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xiong Q, 2008, BIOINFORMATICS, V24, P1011, DOI 10.1093/bioinformatics/btn002; Xiong Q, 2009, GENOMICS, V93, P401, DOI 10.1016/j.ygeno.2008.12.008; Yu H, 2007, CALCIFIED TISSUE INT, V80, P103, DOI 10.1007/s00223-006-0187-z; Zhang L, 2009, ANN HUM GENET, V73, P601, DOI 10.1111/j.1469-1809.2009.00539.x	42	125	145	10	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84485	10.1371/journal.pone.0084485	http://dx.doi.org/10.1371/journal.pone.0084485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	25229501	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500131
